PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bastin, C; Feyers, D; Majerus, S; Balteau, E; Degueldre, C; Luxen, A; Maquet, P; Salmon, E; Collette, F				Bastin, Christine; Feyers, Dorothee; Majerus, Steve; Balteau, Evelyne; Degueldre, Christian; Luxen, Andre; Maquet, Pierre; Salmon, Eric; Collette, Fabienne			The Neural Substrates of Memory Suppression: A fMRI Exploration of Directed Forgetting	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; RECOGNITION MEMORY; EPISODIC MEMORY; PREFRONTAL CORTEX; COGNITIVE CONTROL; RETRIEVAL; ITEM; FAMILIARITY; ATTENTION; RECOLLECTION	The directed forgetting paradigm is frequently used to determine the ability to voluntarily suppress information. However, little is known about brain areas associated with information to forget. The present study used functional magnetic resonance imaging to determine brain activity during the encoding and retrieval phases of an item-method directed forgetting recognition task with neutral verbal material in order to apprehend all processing stages that information to forget and to remember undergoes. We hypothesized that regions supporting few selective processes, namely recollection and familiarity memory processes, working memory, inhibitory and selection processes should be differentially activated during the processing of to-be-remembered and to-be-forgotten items. Successful encoding and retrieval of items to remember engaged the entorhinal cortex, the hippocampus, the anterior medial prefrontal cortex, the left inferior parietal cortex, the posterior cingulate cortex and the precuneus; this set of regions is well known to support deep and associative encoding and retrieval processes in episodic memory. For items to forget, encoding was associated with higher activation in the right middle frontal and posterior parietal cortex, regions known to intervene in attentional control. Items to forget but nevertheless correctly recognized at retrieval yielded activation in the dorsomedial thalamus, associated with familiarity-based memory processes and in the posterior intraparietal sulcus and the anterior cingulate cortex, involved in attentional processes.	[Bastin, Christine; Feyers, Dorothee; Balteau, Evelyne; Degueldre, Christian; Luxen, Andre; Maquet, Pierre; Salmon, Eric; Collette, Fabienne] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Majerus, Steve; Collette, Fabienne] Univ Liege, Dept Psychol Cognit & Behav, Liege, Belgium	University of Liege; University of Liege	Bastin, C (corresponding author), Univ Liege, Cyclotron Res Ctr, Liege, Belgium.	f.collette@ulg.ac.be	Majerus, Steve/D-4678-2009; Salmon, Eric/AAE-4901-2020	Salmon, Eric/0000-0003-2520-9241; Bastin, Christine/0000-0002-4556-9490; Majerus, Steve/0000-0002-8206-8097; , Pierre/0000-0003-3106-3357	Belgian National Fund for Scientific Research (FRS-FNRS); University of Liege; InterUniversity Attraction Pole (IAP) [P6/29]; French Speaking Community Concerted Research Action [ARC-06/11-340]	Belgian National Fund for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); University of Liege(University of Liege); InterUniversity Attraction Pole (IAP)(Belgian Federal Science Policy Office); French Speaking Community Concerted Research Action	This research was supported by the Belgian National Fund for Scientific Research (FRS-FNRS to SM, EB, PM, FC), by the University of Liege, by the InterUniversity Attraction Pole (IAP P6/29 to CB) and the French Speaking Community Concerted Research Action (ARC-06/11-340 to DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim AM, 2005, J COGNITIVE NEUROSCI, V17, P652, DOI 10.1162/0898929053467578; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Badre David, 2002, Behav Cogn Neurosci Rev, V1, P206, DOI 10.1177/1534582302001003002; Basden BH, 1996, MEMORY, V4, P633, DOI 10.1080/741941000; BASDEN BH, 1993, J EXP PSYCHOL LEARN, V19, P603, DOI 10.1037/0278-7393.19.3.603; Bjork R.A., 1989, VARIETIES MEMORY CON, P309; BJORK RA, 1970, J VERB LEARN VERB BE, V9, P255, DOI 10.1016/S0022-5371(70)80059-7; BJORK RA, 1973, J EXP PSYCHOL, V99, P22, DOI 10.1037/h0034757; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; Bunge SA, 2004, BRAIN COGNITION, V56, P141, DOI 10.1016/j.bandc.2003.08.001; Cabeza R, 2008, NEUROPSYCHOLOGIA, V46, P1813, DOI 10.1016/j.neuropsychologia.2008.03.019; Cansino S, 2002, CEREB CORTEX, V12, P1048, DOI 10.1093/cercor/12.10.1048; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Ciaramelli E, 2008, NEUROPSYCHOLOGIA, V46, P1828, DOI 10.1016/j.neuropsychologia.2008.03.022; Collette F, 2005, HUM BRAIN MAPP, V25, P409, DOI 10.1002/hbm.20118; CONTENT A, 1990, ANN PSYCHOL, V90, P551; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Davachi L, 2001, J COGNITIVE NEUROSCI, V13, P1059, DOI 10.1162/089892901753294356; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Dobbins IG, 2003, NEUROPSYCHOLOGIA, V41, P318, DOI 10.1016/S0028-3932(02)00164-1; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; GARDINER JM, 1994, PSYCHON B REV, V1, P107, DOI 10.3758/BF03200764; Giovanello KS, 2004, HIPPOCAMPUS, V14, P5; Hauswald A, 2011, SOC COGN AFFECT NEUR, V6, P450, DOI 10.1093/scan/nsq061; Henson RNA, 1999, J NEUROSCI, V19, P3962; Henson RNA, 2005, J COGNITIVE NEUROSCI, V17, P1058, DOI 10.1162/0898929054475208; Hogge M, 2008, AGING NEUROPSYCHOL C, V15, P471, DOI 10.1080/13825580701878065; Jackson O, 2004, NEUROIMAGE, V21, P456, DOI 10.1016/j.neuroimage.2003.09.050; JOHNSON HM, 1994, PSYCHOL BULL, V116, P274, DOI 10.1037/0033-2909.116.2.274; Kensinger EA, 2003, J NEUROSCI, V23, P2407; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; MacLeod CM, 1999, PSYCHON B REV, V6, P123, DOI 10.3758/BF03210819; MacLeod CM, 1998, INTENTIONAL FORGETTING: INTERDISCIPLINARY APPROACHES, P1; Macmillan N. A., 1991, DETECTION THEORY USE; Majerus S, 2006, NEUROIMAGE, V32, P880, DOI 10.1016/j.neuroimage.2006.03.048; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Mitchell JP, 2007, PSYCHOL SCI, V18, P292, DOI 10.1111/j.1467-9280.2007.01891.x; Montaldi D, 2006, HIPPOCAMPUS, V16, P504, DOI 10.1002/hipo.20178; Nee DE, 2007, NEUROIMAGE, V38, P740, DOI 10.1016/j.neuroimage.2007.07.066; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Nowicka A, 2011, CEREB CORTEX, V21, P539, DOI 10.1093/cercor/bhq117; Nowicka A, 2009, PSYCHOPHYSIOLOGY, V46, P1108, DOI 10.1111/j.1469-8986.2009.00839.x; Nowicka A, 2009, INT J PSYCHOPHYSIOL, V71, P97, DOI 10.1016/j.ijpsycho.2008.06.009; Otten LJ, 2001, CEREB CORTEX, V11, P1150, DOI 10.1093/cercor/11.12.1150; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; PALLER KA, 1990, J EXP PSYCHOL LEARN, V16, P1021, DOI 10.1037/0278-7393.16.6.1021; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Paz-Caballero MD, 2004, CLIN NEUROPHYSIOL, V115, P369, DOI 10.1016/j.clinph.2003.09.011; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; Reber PJ, 2002, J NEUROSCI, V22, P9541; Sahakyan L, 2002, J EXP PSYCHOL LEARN, V28, P1064, DOI 10.1037//0278-7393.28.6.1064; Schnider A, 2000, J NEUROSCI, V20, P5880, DOI 10.1523/JNEUROSCI.20-15-05880.2000; Simons JS, 2005, J NEUROPHYSIOL, V94, P813, DOI 10.1152/jn.01200.2004; Spaniol J, 2009, NEUROPSYCHOLOGIA, V47, P1765, DOI 10.1016/j.neuropsychologia.2009.02.028; Treyer V, 2003, J COGNITIVE NEUROSCI, V15, P610, DOI 10.1162/089892903321662985; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Ullsperger M, 2000, J COGNITIVE NEUROSCI, V12, P924, DOI 10.1162/08989290051137477; Uncapher MR, 2009, NEUROBIOL LEARN MEM, V91, P139, DOI 10.1016/j.nlm.2008.10.011; van Hooff JC, 2011, BRAIN RES, V1392, P80, DOI 10.1016/j.brainres.2011.04.004; Van Hooff JC, 2009, BRAIN COGNITION, V71, P153, DOI 10.1016/j.bandc.2009.05.001; Velanova K, 2003, J NEUROSCI, V23, P8460; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Weis S, 2004, NEUROREPORT, V15, P2729; Wyland CL, 2003, NEUROPSYCHOLOGIA, V41, P1863, DOI 10.1016/j.neuropsychologia.2003.08.001; Wylie GR, 2008, CEREB CORTEX, V18, P670, DOI 10.1093/cercor/bhm101; Yonelinas AP, 2001, NEUROREPORT, V12, P359, DOI 10.1097/00001756-200102120-00035; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005; Zacks Rose T., 1994, P241; Zacks RT, 1996, J EXP PSYCHOL LEARN, V22, P143, DOI 10.1037/0278-7393.22.1.143	70	43	44	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29905	10.1371/journal.pone.0029905	http://dx.doi.org/10.1371/journal.pone.0029905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238671	Green Published, Green Submitted, gold			2022-12-27	WOS:000301188800044
J	Guo, XX; Li, JK; Wang, TJ; Liu, ZH; Chen, X; Li, YD; Gu, ZL; Mao, XM; Guan, WJ; Li, YQ				Guo, Xiaoxian; Li, Jingkai; Wang, Tanjun; Liu, Zhenhua; Chen, Xin; Li, Yudong; Gu, Zhenglong; Mao, Xuming; Guan, Wenjun; Li, Yongquan			A Mutation in Intracellular Loop 4 Affects the Drug-Efflux Activity of the Yeast Multidrug Resistance ABC Transporter Pdr5p	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTERS; SACCHAROMYCES-CEREVISIAE; P-GLYCOPROTEIN; DOMAIN; ARCHITECTURE; SUSCEPTIBILITY; SPECIFICITY; GENOME; CANCER	Multidrug resistance protein Pdr5p is a yeast ATP-binding cassette (ABC) transporter in the plasma membrane. It confers multidrug resistance by active efflux of intracellular drugs. However, the highly polymorphic Pdr5p from clinical strain YJM789 loses its ability to expel azole and cyclohexmide. To investigate the role of amino acid changes in this functional change, PDR5 chimeras were constructed by segmental replacement of homologous BY4741 PDR5 fragments. Functions of PDR5 chimeras were evaluated by fluconazole and cycloheximide resistance assays. Their expression, ATPase activity, and efflux efficiency for other substrates were also analyzed. Using multiple lines of evidence, we show that an alanine-to-methionine mutation at position 1352 located in the predicted short intracellular loop 4 significantly contributes to the observed transport deficiency. The degree of impairment is likely correlated to the size of the mutant residue.	[Guo, Xiaoxian; Li, Jingkai; Wang, Tanjun; Liu, Zhenhua; Chen, Xin; Mao, Xuming; Guan, Wenjun; Li, Yongquan] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Gu, Zhenglong] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Li, Yudong] Zhejiang Gongshang Univ, Coll Food Sci & Biotechnol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Cornell University; Zhejiang Gongshang University	Guo, XX (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	gwj1017@zju.edu.cn; lyq@zju.edu.cn	li, Yu/HCI-9086-2022; li, yu/HGL-9518-2022; Li, Yudong/GSN-4036-2022; Mao, Xu-Ming/AAI-4212-2020		National Natural Science Foundation of China [31170032]; Zhejiang Provincial Natural Science Foundation of China [Y2100685]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085286] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Natural Science Foundation of China (No. 31170032) and Zhejiang Provincial Natural Science Foundation of China (No. Y2100685). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ananthaswamy N, 2010, BIOCHEMISTRY-US, V49, P4440, DOI 10.1021/bi100394j; Bauer BE, 1999, BBA-BIOMEMBRANES, V1461, P217, DOI 10.1016/S0005-2736(99)00160-1; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; de Thozee CP, 2007, MOL MICROBIOL, V63, P811, DOI 10.1111/j.1365-2958.2006.05562.x; Egner R, 2000, MOL MICROBIOL, V35, P1255, DOI 10.1046/j.1365-2958.2000.01798.x; Egner R, 1998, MOL BIOL CELL, V9, P523, DOI 10.1091/mbc.9.2.523; Ejendal KFK, 2002, CURR PROTEIN PEPT SC, V3, P503, DOI 10.2174/1389203023380521; Ernst R, 2005, METHOD ENZYMOL, V400, P460, DOI 10.1016/S0076-6879(05)00026-1; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Glavinas Hristos, 2004, Current Drug Delivery, V1, P27, DOI 10.2174/1567201043480036; Golin J, 2007, BIOCHEM BIOPH RES CO, V356, P1, DOI 10.1016/j.bbrc.2007.02.011; Guan WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011309; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leonessa F, 2003, ENDOCR-RELAT CANCER, V10, P43, DOI 10.1677/erc.0.0100043; MCCUSKER JH, 1994, GENETICS, V136, P1261; Pagant S, 2008, J BIOL CHEM, V283, P26444, DOI 10.1074/jbc.M803912200; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Rutledge RM, 2011, J STRUCT BIOL, V173, P333, DOI 10.1016/j.jsb.2010.10.012; Sauna ZE, 2008, J BIOL CHEM, V283, P35010, DOI 10.1074/jbc.M806446200; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Tutulan-Cunita AC, 2005, GENES CELLS, V10, P409, DOI 10.1111/j.1365-2443.2005.00847.x; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	35	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29520	10.1371/journal.pone.0029520	http://dx.doi.org/10.1371/journal.pone.0029520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238618	Green Submitted, Green Published, gold			2022-12-27	WOS:000301188800019
J	Samoudi, G; Nissbrandt, H; Dutia, MB; Bergquist, F				Samoudi, Ghazaleh; Nissbrandt, Hans; Dutia, Mayank B.; Bergquist, Filip			Noisy Galvanic Vestibular Stimulation Promotes GABA Release in the Substantia Nigra and Improves Locomotion in Hemiparkinsonian Rats	PLOS ONE			English	Article							ENHANCED BALANCE CONTROL; STOCHASTIC RESONANCE; DOPAMINE RELEASE; PARKINSONS-DISEASE; MOTOR-PERFORMANCE; GLOBUS-PALLIDUS; STRIATUM; BRAIN; MICRODIALYSIS; GLUTAMATE	Background: The vestibular system is connected to spinal, cerebellar and cerebral motor control structures and can be selectively activated with external electrodes. The resulting sensation of disturbed balance can be avoided by using stochastic stimulation patterns. Adding noise to the nervous system sometimes improves function. Small clinical trials suggest that stochastic vestibular stimulation (SVS) may improve symptoms in Parkinson's disease. We have investigated this claim and possible mechanisms using the 6-hydroxydopamine (6-OHDA) hemilesion model of Parkinson's disease. Methodology/Principal Findings: Animals were tested in the accelerating rod test and the Montoya staircase test of skilled forelimb use. In 6-OHDA hemilesioned animals, SVS improved rod performance by 56 +/- 11 s. At group level L-DOPA treatment had no effect, but positive responders improved time on rod by 60 +/- 19 s. Skilled forelimb use was not altered by SVS. To investigate how SVS may influence basal ganglia network activity, intracerebral microdialysis was employed in four regions of interest during and after SVS. In presence of the c-amino buturic acid (GABA) transporter inhibitor NNC 711, SVS induced an increase in GABA to 150 +/- 15% of baseline in the substantia nigra (SN) of unlesioned animals, but had no effect in the pedunculopontine nucleus (PPN), the striatum or the ventromedial thalamus (VM). Dopamine release remained stable in all areas, as did GABA and amine concentrations in the SN of unstimulated controls. Following SVS, a sustained increase in GABA concentrations was observed in the ipsilesional, but not in the contralesional SN of 6-OHDA hemilesioned rats. In contrast, L-DOPA treatment produced a similar increase of GABA in the ipsi-and contra-lesional SN. Conclusions/Significance: SVS improves rod performance in a rat model of Parkinson's disease, possibly by increasing nigral GABA release in a dopamine independent way. We propose that SVS could be useful for treating symptoms of Parkinson's disease.	[Samoudi, Ghazaleh; Nissbrandt, Hans; Bergquist, Filip] Univ Gothenburg, Sahlgrenska Acad, Dept Pharmacol, Inst Neurosci & Physiol, Gothenburg, Sweden; [Dutia, Mayank B.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Bergquist, Filip] Sahlgrens Univ Hosp, Dept Neurol, Gothenburg, Sweden	University of Gothenburg; University of Edinburgh; Sahlgrenska University Hospital	Samoudi, G (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Pharmacol, Inst Neurosci & Physiol, Gothenburg, Sweden.	filip.bergquist@gu.se	Bergquist, Filip/G-1402-2010	Bergquist, Filip/0000-0002-3437-0267	Swedish Research Council [2009-2618]; Parkinsonfonden (Swedish Parkinson Foundation); Svenska lakaresallskapet (Swedish Medical Association); Jeansons stiftelse Goteborgs lakaresallskap (Gothenburg Medical Association)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Parkinsonfonden (Swedish Parkinson Foundation); Svenska lakaresallskapet (Swedish Medical Association); Jeansons stiftelse Goteborgs lakaresallskap (Gothenburg Medical Association)	This study was sponsored by the Swedish Research Council, grant no 2009-2618, Parkinsonfonden (Swedish Parkinson Foundation), Svenska lakaresallskapet (Swedish Medical Association), and Jeansons stiftelse and Goteborgs lakaresallskap (Gothenburg Medical Association). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara T, 2010, CHEM PHYS, V375, P616, DOI 10.1016/j.chemphys.2010.04.027; Andersson DR, 2006, EUR J NEUROSCI, V24, P617, DOI 10.1111/j.1460-9568.2006.04953.x; Andersson DR, 2010, EXP NEUROL, V221, P251, DOI 10.1016/j.expneurol.2009.11.011; Baker KB, 2010, EXP NEUROL, V222, P219, DOI 10.1016/j.expneurol.2009.12.030; Bergquist F, 2003, BRAIN RES, V973, P81, DOI 10.1016/S0006-8993(03)02555-1; Bergquist F, 1998, J NEUROCHEM, V70, P1532; Bergquist F, 2008, J PHYSIOL-LONDON, V586, P4441, DOI 10.1113/jphysiol.2008.155291; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Bostan AC, 2010, P NATL ACAD SCI USA, V107, P8452, DOI 10.1073/pnas.1000496107; Dakin CJ, 2007, J PHYSIOL-LONDON, V583, P1117, DOI 10.1113/jphysiol.2007.133264; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; Funke K, 2007, EUR J NEUROSCI, V26, P1322, DOI 10.1111/j.1460-9568.2007.05735.x; Gravelle DC, 2002, NEUROREPORT, V13, P1853, DOI 10.1097/00001756-200210280-00004; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Hospedales TM, 2008, NEURAL COMPUT, V20, P756, DOI 10.1162/neco.2007.09-06-339; Kosko B., 2006, NOISE; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lappin JM, 2009, J CEREBR BLOOD F MET, V29, P554, DOI 10.1038/jcbfm.2008.146; Li SC, 2006, NEUROCOMPUTING, V69, P1553, DOI 10.1016/j.neucom.2005.06.015; Lindgren HS, 2010, J NEUROCHEM, V112, P1465, DOI 10.1111/j.1471-4159.2009.06556.x; Lobel E, 1998, J NEUROPHYSIOL, V80, P2699, DOI 10.1152/jn.1998.80.5.2699; Manjarrez E, 2007, NEUROSCI LETT, V415, P231, DOI 10.1016/j.neulet.2007.01.030; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Mian OS, 2009, J PHYSIOL-LONDON, V587, P2869, DOI 10.1113/jphysiol.2009.171256; Mulavara AP, 2011, EXP BRAIN RES, V210, P303, DOI 10.1007/s00221-011-2633-z; Ostergaard K, 2006, MOVEMENT DISORD, V21, P624, DOI 10.1002/mds.20776; Pal S, 2009, J VESTIBUL RES-EQUIL, V19, P137, DOI 10.3233/VES-2009-0360; Palsson E, 2010, PSYCHOPHARMACOLOGIA, V214, P675; Pan WD, 2008, J NEUROL, V255, P1657, DOI 10.1007/s00415-008-0950-3; Pavlik AE, 1999, EXP BRAIN RES, V124, P273, DOI 10.1007/s002210050623; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; Scinicariello AP, 2002, J VESTIBUL RES-EQUIL, V12, P77; Scinicariello AP, 2001, BIOL CYBERN, V84, P475, DOI 10.1007/PL00007991; Sikstrom S, 2007, PSYCHOL REV, V114, P1047, DOI 10.1037/0033-295X.114.4.1047; Smith Paul F, 2010, Front Neurol, V1, P141, DOI 10.3389/fneur.2010.00141; Timmerman W, 1997, SYNAPSE, V27, P242, DOI 10.1002/(SICI)1098-2396(199711)27:3<242::AID-SYN9>3.0.CO;2-D; Umemura A, 2010, PARKINSONISM RELAT D, V16, P582, DOI 10.1016/j.parkreldis.2010.07.008; Wells C, 2005, PSYCHOL SCI, V16, P313, DOI 10.1111/j.0956-7976.2005.01533.x; Wilkinson D, 2005, J INT NEUROPSYCH SOC, V11, P925, DOI 10.1017/S1355617705051076; Wilkinson D, 2008, EXP BRAIN RES, V189, P243, DOI 10.1007/s00221-008-1463-0; Wilkinson D, 2010, J NEUROPSYCHOL, V4, P107, DOI 10.1348/174866409X468205; Windels F, 2000, EUR J NEUROSCI, V12, P4141, DOI 10.1046/j.1460-9568.2000.00296.x; Winn Philip, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS194, DOI 10.1016/j.parkreldis.2008.04.030; Yamamoto Y, 2005, ANN NEUROL, V58, P175, DOI 10.1002/ana.20574; YU XL, 1989, IEEE T BIO-MED ENG, V36, P36, DOI 10.1109/10.16447; Zeng FG, 2000, BRAIN RES, V869, P251, DOI 10.1016/S0006-8993(00)02475-6	49	43	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29308	10.1371/journal.pone.0029308	http://dx.doi.org/10.1371/journal.pone.0029308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238601	Green Published, gold, Green Submitted			2022-12-27	WOS:000301188800011
J	Shindo, T; Misas-Villamil, JC; Horger, AC; Song, J; van der Hoorn, RAL				Shindo, Takayuki; Misas-Villamil, Johana C.; Hoerger, Anja C.; Song, Jing; van der Hoorn, Renier A. L.			A Role in Immunity for Arabidopsis Cysteine Protease RD21, the Ortholog of the Tomato Immune Protease C14	PLOS ONE			English	Article							CF-2-DEPENDENT DISEASE RESISTANCE; HYALOPERONOSPORA-ARABIDOPSIDIS; PHYTOPHTHORA-INFESTANS; PLANT-PATHOGEN; THALIANA; DEFENSE; GENE; EFFECTOR; PROTEINS; TARGETS	Secreted papain-like Cys proteases are important players in plant immunity. We previously reported that the C14 protease of tomato is targeted by cystatin-like EPIC proteins that are secreted by the oomycete pathogen Phytophthora infestans (Pinf) during infection. C14 has been under diversifying selection in wild potato species coevolving with Pinf and reduced C14 levels result in enhanced susceptibility for Pinf. Here, we investigated the role C14-EPIC-like interactions in the natural pathosystem of Arabidopsis with the oomycete pathogen Hyaloperonospora arabidopsidis (Hpa). In contrast to the Pinf-solanaceae pathosystem, the C14 orthologous protease of Arabidopsis, RD21, does not evolve under diversifying selection in Arabidopsis, and rd21 null mutants do not show phenotypes upon compatible and incompatible Hpa interactions, despite the evident lack of a major leaf protease. Hpa isolates express highly conserved EPIC-like proteins during infections, but it is unknown if these HpaEPICs can inhibit RD21 and one of these HpaEPICs even lacks the canonical cystatin motifs. The rd21 mutants are unaffected in compatible and incompatible interactions with Pseudomonas syringae pv. tomato, but are significantly more susceptible for the necrotrophic fungal pathogen Botrytis cinerea, demonstrating that RD21 provides immunity to a necrotrophic pathogen.	[Shindo, Takayuki; Misas-Villamil, Johana C.; Hoerger, Anja C.; van der Hoorn, Renier A. L.] Max Planck Gesell, Chem Genom Ctr, Plant Chemet Lab, Cologne, Germany; [Shindo, Takayuki; Misas-Villamil, Johana C.; Hoerger, Anja C.; van der Hoorn, Renier A. L.] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Song, Jing] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA	Max Planck Society; Max Planck Society; Case Western Reserve University	Shindo, T (corresponding author), Max Planck Gesell, Chem Genom Ctr, Plant Chemet Lab, Cologne, Germany.	hoorn@mpipz.mpg.de	Song, Jing/F-7567-2014; van der Hoorn, Renier/AAU-1005-2020	van der Hoorn, Renier/0000-0002-3692-7487; Horger, Anja/0000-0001-6816-195X; Misas Villamil, Johana Catherine/0000-0002-9623-0710	Max Planck Society; Deutsche Forschungsgemeinschaft [HO 3983/7-1]	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was financially supported by the Max Planck Society and the Deutsche Forschungsgemeinschaft (project HO 3983/7-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bernoux M, 2008, PLANT CELL, V20, P2252, DOI 10.1105/tpc.108.058685; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Boudart G, 2005, PROTEOMICS, V5, P212, DOI 10.1002/pmic.200400882; Cao J, 2011, NATURE GENE IN PRESS; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Coates ME, 2010, ANNU REV PHYTOPATHOL, V48, P329, DOI 10.1146/annurev-phyto-080508-094422; Drake R, 1996, PLANT MOL BIOL, V30, P755, DOI 10.1007/BF00019009; Francois O, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000075; Gilroy EM, 2007, PLANT J, V52, P1, DOI 10.1111/j.1365-313X.2007.03226.x; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Harrak H, 2001, GENOME, V44, P368, DOI 10.1139/gen-44-3-368; Hatsugai N, 2009, GENE DEV, V23, P2496, DOI 10.1101/gad.1825209; Hayashi Y, 2001, PLANT CELL PHYSIOL, V42, P894, DOI 10.1093/pcp/pce144; Hey J, 1997, GENETICS, V145, P833; Holub EB, 2008, EUR J PLANT PATHOL, V122, P91, DOI 10.1007/s10658-008-9286-1; Kaschani F, 2011, PLANT SIGNAL BEHAV, V6, P109, DOI 10.4161/psb.6.1.14190; Kaschani F, 2010, PLANT PHYSIOL, V154, P1794, DOI 10.1104/pp.110.158030; KOIZUMI M, 1993, GENE, V129, P175, DOI 10.1016/0378-1119(93)90266-6; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Misas-Villamil JC, 2008, CURR OPIN PLANT BIOL, V11, P380, DOI 10.1016/j.pbi.2008.04.007; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; PARKER JE, 1993, PLANT J, V4, P821, DOI 10.1046/j.1365-313X.1993.04050821.x; Ramos-Onsins SE, 2008, MOL ECOL, V17, P1211, DOI 10.1111/j.1365-294X.2007.03633.x; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; SCHAFFER MA, 1988, PLANT PHYSIOL, V87, P431, DOI 10.1104/pp.87.2.431; SCHAFFER MA, 1990, PLANT PHYSIOL, V93, P1486, DOI 10.1104/pp.93.4.1486; Schmid KJ, 2005, GENETICS, V166, P373; Shabab M, 2008, PLANT CELL, V20, P1169, DOI 10.1105/tpc.107.056325; Song J, 2009, P NATL ACAD SCI USA, V106, P1654, DOI 10.1073/pnas.0809201106; Tian MY, 2007, PLANT PHYSIOL, V143, P364, DOI 10.1104/pp.106.090050; van der Hoorn RAL, 2004, PLANT PHYSIOL, V135, P1170, DOI 10.1104/pp.104.041467; van Esse HP, 2008, PLANT CELL, V20, P1948, DOI 10.1105/tpc.108.059394; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Wang Z, 2008, NAT CHEM BIOL, V4, P557, DOI 10.1038/nchembio.104; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yamada K, 2001, PLANT PHYSIOL, V127, P1626, DOI 10.1104/pp.010551; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419	42	81	87	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29317	10.1371/journal.pone.0029317	http://dx.doi.org/10.1371/journal.pone.0029317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238602	Green Published, Green Submitted, gold			2022-12-27	WOS:000301188800012
J	Wieczorek, J; Bloom, D; Guralnick, R; Blum, S; Doring, M; Giovanni, R; Robertson, T; Vieglais, D				Wieczorek, John; Bloom, David; Guralnick, Robert; Blum, Stan; Doring, Markus; Giovanni, Renato; Robertson, Tim; Vieglais, David			Darwin Core: An Evolving Community-Developed Biodiversity Data Standard	PLOS ONE			English	Article							CLIMATE-CHANGE; SCIENCE	Biodiversity data derive from myriad sources stored in various formats on many distinct hardware and software platforms. An essential step towards understanding global patterns of biodiversity is to provide a standardized view of these heterogeneous data sources to improve interoperability. Fundamental to this advance are definitions of common terms. This paper describes the evolution and development of Darwin Core, a data standard for publishing and integrating biodiversity information. We focus on the categories of terms that define the standard, differences between simple and relational Darwin Core, how the standard has been implemented, and the community processes that are essential for maintenance and growth of the standard. We present case-study extensions of the Darwin Core into new research communities, including metagenomics and genetic resources. We close by showing how Darwin Core records are integrated to create new knowledge products documenting species distributions and changes due to environmental perturbations.	[Wieczorek, John; Bloom, David] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Guralnick, Robert] Univ Colorado, Boulder, CO 80309 USA; [Blum, Stan] Calif Acad Sci, San Francisco, CA 94118 USA; [Doring, Markus; Robertson, Tim] Global Biodivers Informat Facil, Copenhagen, Denmark; [Giovanni, Renato] Ctr Referencia Informacao Ambiental, Sao Paulo, Brazil; [Vieglais, David] Univ Kansas, Lawrence, KS 66045 USA	University of California System; University of California Berkeley; University of Colorado System; University of Colorado Boulder; California Academy of Sciences; University of Kansas	Wieczorek, J (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	dbloom@vertnet.org	Vieglais, Dave/C-7356-2009	Vieglais, Dave/0000-0002-6513-4996; De Giovanni, Renato/0000-0002-7104-7266; Doring, Markus/0000-0001-7757-1889; Bloom, David/0000-0003-1273-1807	U.S. National Science Foundation [NSF-9808739, DBI-0345448, DBI-0108161]; Gordon and Betty Moore Foundation; Global Biodiversity Information Facility, GBIF; Direct For Biological Sciences [0940673] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1062193, 1062200, 1062148] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Global Biodiversity Information Facility, GBIF; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The U.S. National Science Foundation (http://www.nsf.gov/) funded three individual projects that contributed to Darwin Core: Species Analyst Project (NSF-9808739), ORNIS (DBI-0345448), and MaNIS (DBI-0108161). The Gordon and Betty Moore Foundation provided individual grants to the BioGeomancer Project and to TDWG, both of which had influence on the Darwin Core (http://www.moore.org/). Global Biodiversity Information Facility, GBIF, sponsored a workshop to prepare Darwin Core for the standards track, in February 2009 (http://www.gbif.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALERCIA A., 2001, FAO IPGRI MULTICROP; [Anonymous], 1995, GLOBAL BIODIVERSITY; ASC, 1993, BIOL COLL D IN PRESS; Blum S, 2000, CATALOGING WEB METAD, V21, P113; Canhos V.P., 2004, Biodiversity Informatics, V1, P1; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chapman AD, 2006, GLOBAL BIODIVERSITY; Constable H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000309; Endresen DTF., 2012, BIODIVERS INFORM, V8, DOI [10.17161/bi.v8i1.4095, DOI 10.17161/BI.V8I1.4095]; Fegraus E.H., 2005, B ECOLOGICAL SOC AM, V86, P158, DOI DOI 10.1890/0012-9623(2005)86[158:MTVOED]2.0.CO;2; Field D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001088; GBIF, 2008, WORK PROGR 2009 2010; Guralnick RP, ECOLOGICAL IN PRESS; Hill AW, 2010, POSITION PAPER FUTUR; Inouye DW, 2000, P NATL ACAD SCI USA, V97, P1630, DOI 10.1073/pnas.97.4.1630; IWGSC (Interagency Working Group on Scientific Collections), 2009, SCI COLL MISS CRIT I; Jehl Jr. J, 1994, STUD AVIAN BIOL, V15, P1; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Jetz W, TRENDS ECOL IN PRESS; Loreau M, 2006, NATURE, V442, P245, DOI 10.1038/442245a; Lynch C, 2001, D LIB MAGAZINE, V7, P4; McLaren S. B., 1996, DOCUMENTATION STANDA; McLaren SB, 1988, J MAMMAL, V69, P217; McLeod SA, 1991, GUIDELINES STANDARDS, P33; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Morris RA, 2011, AUDUBON CORE; National Academy of Sciences (NAS), 2010, GRAND CHALL ENV SCI; Ocean Biogeographic Information System (OBIS), 2010, OBIS SCHEM VERS 1 1; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pennisi E, 2005, SCIENCE, V308, P187, DOI 10.1126/science.308.5719.187; Peterson A. Townsend, 2003, Bulletin of the British Ornithologists' Club, V123A, P186; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 2005, AUK, V122, P987, DOI 10.1642/0004-8038(2005)122[0987:FAOATB]2.0.CO;2; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; POUNDS JA, 1994, CONSERV BIOL, V8, P72, DOI 10.1046/j.1523-1739.1994.08010072.x; Remsen D, 2010, BEST PRACTICES PUBLI; Remsen DP, 2010, GBIF GNA PROFILE REF; Root Terry L., 1994, Studies in Avian Biology, V15, P191; Steele HL, 2005, FEMS MICROBIOL LETT, V247, P105, DOI 10.1016/j.femsle.2005.05.011; Stein Barbara R., 2004, Biodiversity Informatics, V1, P14; Stockwell DRB, 2006, ECOL MODEL, V195, P139, DOI 10.1016/j.ecolmodel.2005.11.016; TDWG, 2005, ACC BIOL COLL DAT AB; TDWG, 2010, PAL EL DEF VERS 1 0; The President's Council of Advisors on Science and Technology, 2011, SUST ENV CAP PROT SO; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; van Hintum T, 2009, EPGRIS3 PROPOSAL INC; Vieglais DA, 1998, 2 AS PAC C BIOT 23 2; Vieglais David, 2000, Oceanography, V13, P10; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weibel S, 1998, DUBLIN COREMETADATA; Wilson EO, 1998, DIVERSITY LIFE; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823	53	442	471	7	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29715	10.1371/journal.pone.0029715	http://dx.doi.org/10.1371/journal.pone.0029715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238640	Green Submitted, Green Published, gold			2022-12-27	WOS:000301188800029
J	Dhiman, M; Zago, MP; Nunez, S; Amoroso, A; Rementeria, H; Dousset, P; Burgos, FN; Garg, NJ				Dhiman, Monisha; Paola Zago, Maria; Nunez, Sonia; Amoroso, Alejandro; Rementeria, Hugo; Dousset, Pierre; Nunez Burgos, Federico; Garg, Nisha Jain			Cardiac-Oxidized Antigens Are Targets of Immune Recognition by Antibodies and Potential Molecular Determinants in Chagas Disease Pathogenesis	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTION; TERT-BUTYL-NITRONE; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; CARDIOMYOPATHY; EXPRESSION; PROTEINS; CANDIDATES; IMBALANCE; RELEASE	Trypanosoma cruzi elicits reactive oxygen species (ROS) of inflammatory and mitochondrial origin in infected hosts. In this study, we examined ROS-induced oxidative modifications in the heart and determined whether the resultant oxidized cardiac proteins are targets of immune response and of pathological significance in Chagas disease. Heart biopsies from chagasic mice, rats and human patients exhibited, when compared to those from normal controls, a substantial increase in protein 4-hydroxynonenal (4-HNE), malondialdehyde (MDA), carbonyl, and 3-nitrotyrosine (3-NT) adducts. To evaluate whether oxidized proteins gain antigenic properties, heart homogenates or isolated cardiomyocytes were oxidized in vitro and one-or two-dimensional gel electrophoresis (2D-GE)/Western blotting (WB) was performed to investigate the proteomic oxidative changes and recognition of oxidized proteins by sera antibodies in chagasic rodents (mice, rats) and human patients. Human cardiomyocytes exhibited LD50 sensitivity to 30 mu M 4-HNE and 100 mu M H2O2 at 6 h and 12 h, respectively. In vitro oxidation with 4-HNE or H2O2 resulted in a substantial increase in 4-HNE-and carbonyl-modified proteins that correlated with increased recognition of cardiac (cardiomyocytes) proteins by sera antibodies of chagasic rodents and human patients. 2D-GE/Western blotting followed by MALDI-TOF-MS/MS analysis to identify cardiac proteins that were oxidized and recognized by human chagasic sera yielded 82 unique proteins. We validated the 2D-GE results by enzyme-linked immunosorbent assay (ELISA) and WB and demonstrated that oxidation of recombinant titin enhanced its immunogenicity and recognition by sera antibodies from chagasic hosts (rats and humans). Treatment of infected rats with phenyl-alpha-tert-butyl nitrone (PBN, antioxidant) resulted in normalized immune detection of cardiac proteins associated with control of cardiac pathology and preservation of heart contractile function in chagasic rats. We conclude that ROS-induced, cardiac-oxidized antigens are targets of immune recognition by antibodies and molecular determinants for pathogenesis during Chagas disease.	[Dhiman, Monisha; Garg, Nisha Jain] Univ Texas Med Branch, Dept Microbiol & Immunol, Ctr Trop Dis, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Paola Zago, Maria] Univ Nacl Salta, Fac Ciencias Salud, Inst Patol Expt, Salta, Argentina; [Nunez, Sonia; Nunez Burgos, Federico] Hosp Publ Gest Descentralizada San Bernardo, Salta, Argentina; [Amoroso, Alejandro; Rementeria, Hugo; Dousset, Pierre] Hosp San Bernardo, Serv Cirugia Cardiovasc, Salta, Argentina; [Garg, Nisha Jain] Univ Texas Med Branch, Ctr Trop Dis, Inst Human Infect & Immun, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Dhiman, M (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Ctr Trop Dis, Inst Human Infect & Immun, Galveston, TX 77555 USA.	nigarg@utmb.edu	da Penha Zago-Gomes, Maria/I-6608-2015	Dhiman, Monisha/0000-0001-5923-3384	National Institute of Allergy and Infectious Diseases [AI054578]; National Heart Lung and Blood Institute of the National Institutes of Health [HL094802, HL088230]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL088230, R01HL094802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054578] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases (AI054578) and National Heart Lung and Blood Institute (HL094802, HL088230) of the National Institutes of Health to Dr. Garg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ba XQ, 2010, J BIOL CHEM, V285, P11596, DOI 10.1074/jbc.M109.076984; Berger F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-510; Bhatia V, 2004, INFECT IMMUN, V72, P6245, DOI 10.1128/IAI.72.11.6245-6254.2004; de Oliveira TB, 2007, INT J CARDIOL, V116, P357, DOI 10.1016/j.ijcard.2006.04.046; Bonney KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014571; Buhrke T, 2011, DEV GROWTH DIFFER, V53, P411, DOI 10.1111/j.1440-169X.2011.01258.x; Butterfield DA, 1998, ANN NY ACAD SCI, V854, P448, DOI 10.1111/j.1749-6632.1998.tb09924.x; Cardoni RL, 1997, AM J TROP MED HYG, V56, P329, DOI 10.4269/ajtmh.1997.56.329; Castro L, 2011, FREE RADICAL RES, V45, P37, DOI 10.3109/10715762.2010.516254; Chen L, 2001, EUR J IMMUNOL, V31, P265, DOI 10.1002/1521-4141(200101)31:1<265::AID-IMMU265>3.3.CO;2-C; Chevion M, 2000, FREE RADICAL RES, V33, pS99; Criteria Committee of the New York Heart Association, 1994, NOMENCLATURE CRITERI, V9th, P253; Cunha-Neto E, 2001, AUTOIMMUNITY, V34, P187, DOI 10.3109/08916930109007383; Cunha-Neto E, 2011, AUTOIMMUN REV, V10, P163, DOI 10.1016/j.autrev.2010.09.019; Cunha-Neto E, 2009, MEM I OSWALDO CRUZ, V104, P252, DOI 10.1590/S0074-02762009000900032; de Souza AP, 2010, MEM I OSWALDO CRUZ, V105, P746, DOI 10.1590/S0074-02762010000600003; Dhiman M, 2008, AM J PATHOL, V173, P728, DOI 10.2353/ajpath.2008.080047; Dhiman M, 2011, J PATHOL, V225, P583, DOI 10.1002/path.2975; Dhiman M, 2009, CLIN VACCINE IMMUNOL, V16, P660, DOI 10.1128/CVI.00019-09; Doolan P, 2010, BIOTECHNOL BIOENG, V106, P42, DOI 10.1002/bit.22670; Guinazu N, 2010, INT J PARASITOL, V40, P1531, DOI 10.1016/j.ijpara.2010.05.012; Gupta S., 2009, INTERDISCIP PERSPECT, V2009, P1, DOI [DOI 10.1155/2009/190354, 10.1155/2009/190354]; Gupta S, 2009, FREE RADICAL BIO MED, V47, P1414, DOI 10.1016/j.freeradbiomed.2009.08.008; Gutierrez FRS, 2009, PARASITE IMMUNOL, V31, P673, DOI 10.1111/j.1365-3024.2009.01108.x; Herberth M, 2011, PROTEOMICS, V11, P94, DOI 10.1002/pmic.201000291; Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560; Lachtermacher S, 2011, STEM CELL REV; Liu KX, 2010, PROTEOMICS, V10, P4463, DOI 10.1002/pmic.201000078; Macao LB, 2007, INT J CARDIOL; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murray J, 2008, ADV DRUG DELIVER REV, V60, P1497, DOI 10.1016/j.addr.2008.05.003; Nussinovitch U, 2010, CLIN REV ALLERGY IMM; Pan TL, 2010, PROTEOMICS, V10, P914, DOI 10.1002/pmic.200900178; Perez-Ayala A, 2011, ANN TROP MED PARASIT, V105, P25, DOI 10.1179/136485910X12851868780423; Perez-Fuentes R, 2003, INT J PARASITOL, V33, P293, DOI 10.1016/S0020-7519(02)00283-7; Ribeiro CM, 2010, INT J CARDIOL, V145, P27, DOI 10.1016/j.ijcard.2009.06.033; Silva JS, 2003, FRONT BIOSCI-LANDMRK, V8, pS314, DOI 10.2741/1012; Strauss DG, 2011, HEART, V97, P357, DOI 10.1136/hrt.2010.210047; Thomas Sterling, 2010, Human Genomics, V4, P353; Wallukat G, 2010, J AM COLL CARDIOL, V55, P463, DOI 10.1016/j.jacc.2009.06.064; Wen JJ, 2008, MICROBES INFECT, V10, P1201, DOI 10.1016/j.micinf.2008.06.013; Wen JJ, 2006, AM J PATHOL, V169, P1953, DOI 10.2353/ajpath.2006.060475; Wen JJ, 2006, FREE RADICAL BIO MED, V41, P270, DOI 10.1016/j.freeradbiomed.2006.04.009; Wen JJ, 2010, J AM COLL CARDIOL, V55, P2499, DOI 10.1016/j.jacc.2010.02.030; Wen JJ, 2008, J BIOENERG BIOMEMBR, V40, P587, DOI 10.1007/s10863-008-9184-4; Wen JJ, 2004, FREE RADICAL BIO MED, V37, P2072, DOI 10.1016/j.freeradbiomed.2004.09.011; Wen JJ, 2004, FREE RADICAL BIO MED, V37, P1821, DOI 10.1016/j.freeradbiomed.2004.08.018; World Health Organization, 2010, CHAG DIS CONTR EL; Zacks MA, 2005, AN ACAD BRAS CIENC, V77, P695, DOI 10.1590/S0001-37652005000400009	49	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28449	10.1371/journal.pone.0028449	http://dx.doi.org/10.1371/journal.pone.0028449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238578	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200009
J	Mao, PZ; Meshul, CK; Thuillier, P; Goldberg, NRS; Reddy, PH				Mao, Peizhong; Meshul, Charles K.; Thuillier, Philippe; Goldberg, Natalie R. S.; Reddy, P. Hemachandra			CART Peptide Is a Potential Endogenous Antioxidant and Preferentially Localized in Mitochondria	PLOS ONE			English	Article							AMPHETAMINE-REGULATED TRANSCRIPT; OXIDATIVE STRESS; MESOLIMBIC DOPAMINE; NUCLEUS-ACCUMBENS; MESSENGER-RNA; BODY-WEIGHT; DNA-DAMAGE; COCAINE; BRAIN; DISEASE	The multifunctional neuropeptide Cocaine and Amphetamine Regulated Transcript (CART) is secreted from hypothalamus, pituitary, adrenal gland and pancreas. It also can be found in circulatory system. This feature suggests a general role for CART in different cells. In the present study, we demonstrate that CART protects mitochondrial DNA (mtDNA), cellular proteins and lipids against the oxidative action of hydrogen peroxide, a widely used oxidant. Using cis-parinaric acid as a sensitive reporting probe for peroxidation in membranes, and a lipid-soluble azo initiator of peroxyl radicals, 2,2'-Azobis(2,4-dimethylvaleronitrile) we found that CART is an antioxidant. Furthermore, we found that CART localized to mitochondria in cultured cells and mouse brain neuronal cells. More importantly, pretreatment with CART by systemic injection protects against a mouse oxidative stress model, which mimics the main features of Parkinson's disease. Given the unique molecular structure and biological features of CART, we conclude that CART is an antioxidant peptide (or antioxidant hormone). We further propose that it may have strong therapeutic properties for human diseases in which oxidative stress is strongly involved such as Parkinson's disease.	[Mao, Peizhong; Reddy, P. Hemachandra] Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Mao, Peizhong; Thuillier, Philippe] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Mao, Peizhong; Thuillier, Philippe] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Meshul, Charles K.; Goldberg, Natalie R. S.] Portland VA Med Ctr, Res Serv, Portland, OR USA; [Meshul, Charles K.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Meshul, Charles K.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Reddy, P. Hemachandra] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Mao, PZ (corresponding author), Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr, Beaverton, OR USA.	maop@ohsu.edu			American Heart Association [0565527Z]; Department of Veterns Affairs; National Institutes of Health [CA112083-01, AG028072, AG026051, RR000163]; NATIONAL CANCER INSTITUTE [R01CA112083] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028072, R03AG026051] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Department of Veterns Affairs; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	These studies were supported by the American Heart Association (Beginning Grant-in-Aid 0565527Z) to PM, the Department of Veterns Affairs Merit Review Program to CK, and the National Institutes of Health to PT (CA112083-01) and to PHR (AG028072, AG026051), and to ONPRC (RR000163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asnicar MA, 2001, ENDOCRINOLOGY, V142, P4394, DOI 10.1210/en.142.10.4394; Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; Bartell S. M., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P146; Bech P, 2008, J CLIN ENDOCR METAB, V93, P1246, DOI 10.1210/jc.2007-1946; Bene R, 2009, ACTA CLIN CROAT, V48, P377; Benes FM, 2001, TRENDS NEUROSCI, V24, P11, DOI 10.1016/S0166-2236(00)01660-X; Bjorkqvist M, 2007, MOVEMENT DISORD, V22, P1952, DOI 10.1002/mds.21447; Brischoux F, 2002, J NEUROBIOL, V52, P221, DOI 10.1002/neu.10077; Calkins MJ, 2011, BBA-MOL BASIS DIS, V1812, P507, DOI 10.1016/j.bbadis.2011.01.007; Couceyro PR, 1997, J CHEM NEUROANAT, V12, P229, DOI 10.1016/S0891-0618(97)00212-3; Dallvechia-Adams S, 2002, J COMP NEUROL, V448, P360, DOI 10.1002/cne.10268; Dallvechia-Adams S, 2001, J COMP NEUROL, V434, P29, DOI 10.1002/cne.1162; Darvesh AS, 2011, EXPERT OPIN DRUG DIS, V6, P109, DOI 10.1517/17460441.2011.547189; Del Gaizo V, 2003, MOL THER, V7, P720, DOI 10.1016/S1525-0016(03)00130-8; del Giudice EM, 2001, DIABETES, V50, P2157, DOI 10.2337/diabetes.50.9.2157; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; Ekblad E, 2006, PEPTIDES, V27, P2024, DOI 10.1016/j.peptides.2005.12.015; Goldberg NRS, 2011, NEUROSCIENCE, V172, P443, DOI 10.1016/j.neuroscience.2010.09.062; HALLIWELL B, 1995, FREE RADICAL BIO MED, V18, P125, DOI 10.1016/0891-5849(95)91457-3; Hardeland R, 2005, ENDOCRINE, V27, P119, DOI 10.1385/ENDO:27:2:119; Holmer HK, 2005, NEUROSCIENCE, V136, P333, DOI 10.1016/j.neuroscience.2005.08.003; Hubert GW, 2008, BIOCHEM PHARMACOL, V75, P57, DOI 10.1016/j.bcp.2007.07.028; Hunter RG, 2004, TRENDS ENDOCRIN MET, V15, P454, DOI 10.1016/j.tem.2004.09.010; Hunter RG, 2007, BRAIN RES, V1152, P234, DOI 10.1016/j.brainres.2007.03.042; Hunter RG, 2003, CNS NEUROL DISORD-DR, V2, P201, DOI 10.2174/1568007033482896; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Jaworski JN, 2003, LIFE SCI, V73, P741, DOI 10.1016/S0024-3205(03)00394-1; Jenner Peter, 2007, Handb Clin Neurol, V83, P507, DOI 10.1016/S0072-9752(07)83024-7; Kamens HM, 2005, GENES BRAIN BEHAV, V4, P253, DOI 10.1111/j.1601-183X.2004.00100.x; Kastin AJ, 1999, AM J PHYSIOL-ENDOC M, V277, pE901, DOI 10.1152/ajpendo.1999.277.5.E901; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kim MS, 2009, J PEDIATR ENDOCR MET, V22, P565; Kong WM, 2003, FASEB J, V17, P1688, DOI 10.1096/fj.02-0805fje; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Kuhar MJ, 2000, REGUL PEPTIDES, V89, P1, DOI 10.1016/S0167-0115(00)00096-3; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Ludvigsen S, 2001, BIOCHEMISTRY-US, V40, P9082, DOI 10.1021/bi010433u; Manczak M, 2010, J ALZHEIMERS DIS, V20, pS609, DOI 10.3233/JAD-2010-100564; Mao P, 2007, MOL PSYCHIATR, V12, P223, DOI 10.1038/sj.mp.4001928; Mao P., 2011, DEPRESS RES TREAT, V2011, P1, DOI 10.1155/2011/762139; Mao PZ, 2008, IUBMB LIFE, V60, P684, DOI 10.1002/iub.101; Mao PZ, 2007, EUR J NEUROSCI, V26, P624, DOI 10.1111/j.1460-9568.2007.05691.x; Mao PZ, 2011, BBA-MOL BASIS DIS, V1812, P1359, DOI 10.1016/j.bbadis.2011.08.005; Mao PZ, 2010, BBA-MOL BASIS DIS, V1802, P66, DOI 10.1016/j.bbadis.2009.07.002; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Meshul CK, 2000, NEUROSCIENCE, V96, P91, DOI 10.1016/S0306-4522(99)90481-5; Ojeda SR, 2006, ENDOCRINOLOGY, V147, P1166, DOI 10.1210/en.2005-1136; Paddenberg R, 2003, AM J PHYSIOL-LUNG C, V284, pL710, DOI 10.1152/ajplung.00149.2002; Philpot K, 2006, PEPTIDES, V27, P1987, DOI 10.1016/j.peptides.2005.11.028; Pohanka M, 2011, MINI REV ME IN PRESS; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; Reddy PH, 2008, NEUROMOL MED, V10, P291, DOI 10.1007/s12017-008-8044-z; REICHLIN S, 1993, NEW ENGL J MED, V329, P1246; Reiter R, 1997, LIFE SCI, V60, P2255, DOI 10.1016/S0024-3205(97)00030-1; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Robinson S, 2003, EXP NEUROL, V180, P73, DOI 10.1016/S0014-4886(02)00050-X; Rogge G, 2008, NAT REV NEUROSCI, V9, P747, DOI 10.1038/nrn2493; Schang AY, 2011, NEUROMETHODS, V50, P55, DOI 10.1007/978-1-60761-883-6_3; Schultz K, 2009, NEUROSCI LETT, V453, P104, DOI 10.1016/j.neulet.2009.02.008; SHULL S, 1991, J BIOL CHEM, V266, P24398; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; Snyder SH, 2009, J NEUROSCI, V29, P12717, DOI 10.1523/JNEUROSCI.3670-09.2009; TSUCHIYA M, 1994, METHOD ENZYMOL, V234, P371; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vicentic A, 2004, ENDOCRINOLOGY, V145, P4119, DOI 10.1210/en.2003-1648; Vicentic A, 2006, PEPTIDES, V27, P1934, DOI 10.1016/j.peptides.2006.03.031; Wierup N, 2005, REGUL PEPTIDES, V129, P203, DOI 10.1016/j.regpep.2005.02.016; Wilson GL, 1997, DIABETES, V46, P1291, DOI 10.2337/diabetes.46.8.1291; Wu B, 2006, BIOCHEM BIOPH RES CO, V347, P656, DOI 10.1016/j.bbrc.2006.06.117; Xu Y, 2006, P NATL ACAD SCI USA, V103, P14489, DOI 10.1073/pnas.0602932103; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Zhou C, 2008, ANN NY ACAD SCI, V1147, P93, DOI 10.1196/annals.1427.023	74	38	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29343	10.1371/journal.pone.0029343	http://dx.doi.org/10.1371/journal.pone.0029343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235287	Green Submitted, gold, Green Published			2022-12-27	WOS:000301123400048
J	Watson, L; Richardson, ARW; Holt, RCL; Jones, CA; Beresford, MW				Watson, Louise; Richardson, Amanda R. W.; Holt, Richard C. L.; Jones, Caroline A.; Beresford, Michael W.			Henoch Schonlein Purpura - A 5-Year Review and Proposed Pathway	PLOS ONE			English	Article							SIGNIFICANT PROTEINURIA; RENAL INVOLVEMENT; FOLLOW-UP; CHILDREN; NEPHRITIS; PROGNOSIS; POPULATION; ADULTS; RISK	Henoch Schonlein Purpura (HSP) is the commonest systemic vasculitis of childhood typically presenting with a palpable purpuric rash and frequently involving the renal system. We are the first group to clinically assess, critically analyse and subsequently revise a nurse led monitoring pathway for this condition. A cohort of 102 children presenting with HSP to a secondary/tertiary level UK paediatric hospital over a five year period, were monitored using a nurse led care pathway. Using this cohort, the incidence (6.21 cases per 100,000 children per year) and natural disease course of HSP nephritis (46% initial renal inflammation; 9% subsequent renal referral; 1% renal biopsy and immunosuppression) was determined. Older patients were at higher risk of requiring a renal referral (renal referral 12.3 (8.4-13.5) years vs. normal outcome 6.0 (3.7-8.5) years; p<0.01). A normal urinalysis on day 7 had a 97% (confidence interval 90 to 99%) negative predictive value in predicting a normal renal outcome. Using this data and existing literature base, The Alder Hey Henoch Schonlein Purpura Pathway was developed, a revised pathway for the screening of poor renal outcome in HSP. This is based on a six-month monitoring period for all patients presenting with HSP, which importantly prioritises patients according to the urine findings on day 7 and thus intensively monitors those at higher risk of developing nephritis. The pathway could be easily adapted for use in different settings and resources. The introduction of a standardised pathway for the monitoring of HSP will facilitate the implementation of disease registries to further our understanding of the condition and permit future clinical trials.	[Watson, Louise; Beresford, Michael W.] Univ Liverpool, Alder Hey Childrens NHS Fdn Trust Hosp, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England; [Richardson, Amanda R. W.; Holt, Richard C. L.; Jones, Caroline A.] Alder Hey Childrens NHS Fdn Trust Hosp, Dept Paediat Nephrol, Liverpool, Merseyside, England	Alder Hey Children's NHS Foundation Trust; University of Liverpool; Alder Hey Children's NHS Foundation Trust	Watson, L (corresponding author), Univ Liverpool, Alder Hey Childrens NHS Fdn Trust Hosp, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England.	Louise.watson@liv.ac.uk	Beresford, Michael William/AAB-5261-2021	Beresford, Michael William/0000-0002-5400-9911; Oni, Louise/0000-0002-1532-2390; Holt, Richard/0000-0003-1619-325X				[Anonymous], 2004, PEDIATRICS S, V114, P555; Bogdanovic R, 2009, ACTA PAEDIATR, V98, P1882, DOI 10.1111/j.1651-2227.2009.01445.x; Butani L, 2007, CLIN PEDIATR, V46, P505, DOI 10.1177/0009922806298896; Calvino MC, 2001, MEDICINE, V80, P279, DOI 10.1097/00005792-200109000-00001; COUNAHAN R, 1977, BRIT MED J, V2, P11, DOI 10.1136/bmj.2.6078.11; DAWOD ST, 1990, ANN TROP PAEDIATR, V10, P279, DOI 10.1080/02724936.1990.11747443; Garcia-Porrua C, 2002, SEMIN ARTHRITIS RHEU, V32, P149, DOI 10.1053/sarh.2002.33980; Gardner-Medwin JMM, 2002, LANCET, V360, P1197, DOI 10.1016/S0140-6736(02)11279-7; Gedalia Abraham, 2004, Curr Rheumatol Rep, V6, P195, DOI 10.1007/s11926-004-0068-2; Halling SE, 2010, PEDIATR NEPHROL, V25, P1101, DOI 10.1007/s00467-010-1444-y; KOSKIMIES O, 1981, ARCH DIS CHILD, V56, P482, DOI 10.1136/adc.56.6.482; Kumar L, 1998, Indian Pediatr, V35, P19; Lambers Heerspink HJ, 2010, J AM SOC NEPHROL, V21, P1355, DOI 10.1681/ASN.2010010063; Lewis R, 2009, J ADV NURS, V65, P706, DOI 10.1111/j.1365-2648.2008.04927.x; Lin SJ, 1998, ASIAN PAC J ALLERGY, V16, P21; McCarthy HJ, 2010, EUR J PEDIATR, V169, P643, DOI 10.1007/s00431-009-1101-2; MILLS JA, 1990, ARTHRITIS RHEUM, V33, P1114; Mir S, 2007, PEDIATR NEPHROL, V22, P64, DOI 10.1007/s00467-006-0278-0; Narchi H, 2005, ARCH DIS CHILD, V90, P916, DOI 10.1136/adc.2005.074641; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Pabunruang Wasuthida, 2002, Journal of the Medical Association of Thailand, V85, pS1213; Ronkainen J, 2002, LANCET, V360, P666, DOI 10.1016/S0140-6736(02)09835-5; Sano H, 2002, EUR J PEDIATR, V161, P196, DOI 10.1007/s00431-002-0922-z; Saulsbury FT, 1999, MEDICINE, V78, P395, DOI 10.1097/00005792-199911000-00005; Scharer K, 1999, PEDIATR NEPHROL, V13, P816, DOI 10.1007/s004670050707; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; Shin JI, 2006, SCAND J RHEUMATOL, V35, P56, DOI 10.1080/03009740510026841; Spasojevic-Dimitrijeva B, 2011, SRP ARK CELOK LEK, V139, P174, DOI 10.2298/SARH1104174S; STEWART M, 1988, EUR J PEDIATR, V147, P113, DOI 10.1007/BF00442205; Wakaki H, 2011, PEDIATR NEPHROL, V26, P921, DOI 10.1007/s00467-011-1827-8; Weiss PF, 2007, PEDIATRICS, V120, P1079, DOI 10.1542/peds.2007-0667; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Worrall JC, 2009, CAN J EMERG MED, V11, P540	33	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29512	10.1371/journal.pone.0029512	http://dx.doi.org/10.1371/journal.pone.0029512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235302	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400064
J	Zeng, Y; Wang, W; Ma, J; Wang, XG; Guo, MX; Li, WX				Zeng, Yan; Wang, Wei; Ma, Jian; Wang, Xianguo; Guo, Mingxiong; Li, Wenxin			Knockdown of ZNF268, which Is Transcriptionally Downregulated by GATA-1, Promotes Proliferation of K562 Cells	PLOS ONE			English	Article							ZINC-FINGER GENE; C-MYC; MEGAKARYOCYTIC DIFFERENTIATION; ERYTHROID-DIFFERENTIATION; HEMATOPOIETIC DEVELOPMENT; LEUKEMIA; EXPRESSION; LINEAGE; ERYTHROPOIESIS; PROTOONCOGENE	The human ZNF268 gene encodes a typical KRAB-C2H2 zinc finger protein that may participate in hematopoiesis and leukemogenesis. A recent microarray study revealed that ZNF268 expression continuously decreases during erythropoiesis. However, the molecular mechanisms underlying regulation of ZNF268 during hematopoiesis are not well understood. Here we found that GATA-1, a master regulator of erythropoiesis, repressed the promoter activity and transcription of ZNF268. Electrophoretic mobility shift assays and chromatin immunoprecipitation assays showed that GATA-1 directly bound to a GATA binding site in the ZNF268 promoter in vitro and in vivo. Knockdown of ZNF268 in K562 erythroleukemia cells with specific siRNA accelerated cellular proliferation, suppressed apoptosis, and reduced expression of erythroid-specific developmental markers. It also promoted growth of subcutaneous K562-derived tumors in nude mice. These results suggest that ZNF268 is a crucial downstream target and effector of GATA-1. They also suggest the downregulation of ZNF268 by GATA-1 is important in promoting the growth and suppressing the differentiation of K562 erythroleukemia cells.	[Zeng, Yan; Wang, Wei; Ma, Jian; Wang, Xianguo; Guo, Mingxiong; Li, Wenxin] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Guo, Mingxiong; Li, Wenxin] Wuhan Univ, Coll Life Sci, Key Lab, Minist Educ Plant Dev Biol, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Zeng, Y (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	guomx@whu.edu.cn; liwxlab@whu.edu.cn		Wang, Wei/0000-0001-7429-1013	National Natural Science Foundation of China [30871245]; National High Technology Research and Development Program of China (863 Program) [2006AA02A306]; Specialized Research Fund for the Doctoral Program of Higher Education of China [200804861004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Natural Science Foundation of China Grant 30871245, National High Technology Research and Development Program of China (863 Program) Grant 2006AA02A306 and Specialized Research Fund for the Doctoral Program of Higher Education of China Grant 200804861004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boone DN, 2011, P NATL ACAD SCI USA, V108, P632, DOI 10.1073/pnas.1008848108; Chylicki K, 2000, CELL GROWTH DIFFER, V11, P315; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Fujiwara Y, 2004, BLOOD, V103, P583, DOI 10.1182/blood-2003-08-2870; Furukawa Y, 2000, BRIT J HAEMATOL, V110, P663, DOI 10.1046/j.1365-2141.2000.02253.x; Gou DM, 2001, BBA-GENE STRUCT EXPR, V1518, P306, DOI 10.1016/S0167-4781(01)00194-4; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Gubin AN, 1999, GENOMICS, V59, P168, DOI 10.1006/geno.1999.5855; Guo MX, 2006, J BIOL CHEM, V281, P24623, DOI 10.1074/jbc.M602753200; Hoffman B, 2002, ONCOGENE, V21, P3414, DOI 10.1038/sj.onc.1205400; Joslin JM, 2007, BLOOD, V110, P719, DOI 10.1182/blood-2007-01-068809; Kaneko H, 2010, CURR OPIN HEMATOL, V17, P163, DOI 10.1097/MOH.0b013e32833800b8; Kinjo K, 2005, CELL CYCLE, V4, P1134, DOI 10.4161/cc.4.9.1991; KOEFFLER HP, 1980, BLOOD, V56, P344; Komor M, 2005, STEM CELLS, V23, P1154, DOI 10.1634/stemcells.2004-0171; Krackhardt AM, 2002, BLOOD, V100, P2123, DOI 10.1182/blood-2002-02-0513; LOKEN MR, 1987, BLOOD, V69, P255; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; OKUMURA N, 1992, BLOOD, V80, P642; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; PEVNY L, 1995, DEVELOPMENT, V121, P163; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; Shafarenko M, 2004, BLOOD, V103, P4259, DOI 10.1182/blood-2002-09-2704; Shao HJ, 2006, INT J MOL MED, V18, P457; SIMON MC, 1992, NAT GENET, V1, P92, DOI 10.1038/ng0592-92; Sun Chong, 2006, Yichuan, V28, P513; Sun Y, 2004, INT J MOL MED, V14, P971; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Tsiftsoglou AS, 2003, PHARMACOL THERAPEUT, V100, P257, DOI 10.1016/j.pharmthera.2003.09.002; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; Wang D, 2008, J BIOL CHEM, V283, P16299, DOI 10.1074/jbc.M706426200; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; Yang GH, 2009, J CELL BIOCHEM, V107, P548, DOI 10.1002/jcb.22156; Yuan JY, 2009, J CELL MOL MED, V13, P4551, DOI 10.1111/j.1582-4934.2008.00585.x; Zhao ZZ, 2008, ONCOL REP, V20, P1243, DOI 10.3892/or_00000136	38	17	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29518	10.1371/journal.pone.0029518	http://dx.doi.org/10.1371/journal.pone.0029518			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235304	gold, Green Submitted, Green Published			2022-12-27	WOS:000301123400066
J	Zhang, Y; Sun, HL; Fan, LH; Ma, Y; Sun, YP; Pu, J; Yang, J; Qiao, J; Ma, GP; Liu, JH				Zhang, Yi; Sun, Honglei; Fan, Lihong; Ma, Yuan; Sun, Yipeng; Pu, Juan; Yang, Jun; Qiao, Jian; Ma, Guangpeng; Liu, Jinhua			Acute Respiratory Distress Syndrome Induced by a Swine 2009 H1N1 Variant in Mice	PLOS ONE			English	Article							INFLUENZA-A; VIRUS; LUNG; PATHOGENESIS; PATHOGENICITY; HEMAGGLUTININ; SUBSTITUTION; REPLICATION; MACROPHAGES; SURFACTANT	Background: Acute respiratory distress syndrome (ARDS) induced by pandemic 2009 H1N1 influenza virus has been widely reported and was considered the main cause of death in critically ill patients with 2009 H1N1 infection. However, no animal model has been developed for ARDS caused by infection with 2009 H1N1 virus. Here, we present a mouse model of ARDS induced by 2009 H1N1 virus. Methodology Principal Findings: Mice were inoculated with A/swine/Shandong/731/2009 (SD/09), which was a 2009 H1N1 influenza variant with a G222D mutation in the hemagglutinin. Clinical symptoms were recorded every day. Lung injury was assessed by lung water content and histopathological observation. Arterial blood gas, leukocyte count in the bronchial alveolar lavage fluid and blood, virus titers, and cytokine levels in the lung were measured at various times post-inoculation. Mice infected with SD/09 virus showed typical ARDS symptoms characterized by 60% lethality on days 8-10 post-inoculation, highly edematous lungs, inflammatory cellular infiltration, alveolar and interstitial edema, lung hemorrhage, progressive and severe hypoxemia, and elevated levels of proinflammatory cytokines and chemokines. Conclusions/Significance: These results suggested that we successfully established an ARDS mouse model induced by a virulent 2009 H1N1 variant without previous adaptation, which may be of benefit for evaluating the pathogenesis or therapy of human ARDS caused by 2009 H1N1 virus.	[Zhang, Yi; Sun, Honglei; Fan, Lihong; Ma, Yuan; Sun, Yipeng; Pu, Juan; Yang, Jun; Qiao, Jian; Liu, Jinhua] China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Coll Vet Med, Minist Agr, Beijing 100094, Peoples R China; [Ma, Guangpeng] China Rural Technol Dev Ctr, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Zhang, Y (corresponding author), China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Coll Vet Med, Minist Agr, Beijing 100094, Peoples R China.	maguangpeng1977@163.com; ljh@cau.edu.cn			National Natural Science Foundation of China [31172324, 31172323]; National Basic Research Program (973 Program) [2011CB504702]; National Key Technologies Research and Development Program [2010BAD04B01]; China Postdoctoral Science Foundation [2011M500456]; Chinese Universities Scientific Fund [2011BH041]; Taishan Scholar Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program)(National Basic Research Program of China); National Key Technologies Research and Development Program(National Key Technology R&D Program); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chinese Universities Scientific Fund; Taishan Scholar Foundation	This work was supported by the National Natural Science Foundation of China (No. 31172324, 31172323), the National Basic Research Program (973 Program) (No. 2011CB504702), the National Key Technologies Research and Development Program (2010BAD04B01), China Postdoctoral Science Foundation funded project (2011M500456), and Chinese Universities Scientific Fund (2011BH041). Dr. Liu was funded by the Taishan Scholar Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard DL, 2009, ANTIVIR RES, V82, pA110, DOI 10.1016/j.antiviral.2008.12.014; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P435, DOI DOI 10.1007/S00134-010-2021-3; Chen Cheng-Yu, 2005, J Chin Med Assoc, V68, P4, DOI 10.1016/S1726-4901(09)70124-8; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; COCHRANE CG, 1983, J CLIN INVEST, V71, P754, DOI 10.1172/JCI110823; Connelly KG, 1997, ANNU REV MED, V48, P429; Estenssoro E, 2010, AM J RESP CRIT CARE, V182, P41, DOI [10.1164/rccm.201001-0037OC, 10.1164/201001-0037OC]; Fagan KA, 1999, J CLIN INVEST, V103, P291, DOI 10.1172/JCI3862; Fukushi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021207; Garigliany MM, 2010, EMERG INFECT DIS, V16, P595, DOI 10.3201/eid1604.091061; Greene KE, 1999, AM J RESP CRIT CARE, V160, P1843, DOI 10.1164/ajrccm.160.6.9901117; Griese M, 1999, EUR RESPIR J, V13, P1455, DOI 10.1034/j.1399-3003.1999.13f36.x; Hagau N, 2010, CRIT CARE, V14, DOI 10.1186/cc9324; HAMILTON MA, 1977, ENVIRON SCI TECHNOL, V11, P714, DOI 10.1021/es60130a004; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kilander A, 2010, EUROSURVEILLANCE, V15, P1, DOI DOI 10.1128/JVI.01136-10; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lang JD, 2005, AM J RESP CRIT CARE, V171, P147, DOI 10.1164/rccm.200302-305OC; Levy MM, 2005, AM J RESP CRIT CARE, V171, P518, DOI 10.1164/rccm.200405-621WS; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Majeski EI, 2003, AM J PATHOL, V163, P1467, DOI 10.1016/S0002-9440(10)63504-3; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; Nick JA, 2000, J IMMUNOL, V164, P2151, DOI 10.4049/jimmunol.164.4.2151; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; PEIRIS M, 2008, INNATE IMMUNITY PULM, P56, DOI DOI 10.1164/RCCM.200511-1751OC; Pinilla I, 2011, EMERG RADIOL, V18, P313, DOI 10.1007/s10140-011-0964-5; Roch A, 2010, INTENS CARE MED, V36, P1899, DOI 10.1007/s00134-010-2021-3; TOKELVIN KW, 2010, CLIN INFECT DIS, V50, P850, DOI DOI 10.1164/RCCM.201001-0037OC; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Udobi KF, 2003, AM FAM PHYSICIAN, V67, P315; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; World Health Organization, H1N1 NOW POSTP PER; Xu LL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-325; Xu T, 2006, AM J RESP CRIT CARE, V174, P1011, DOI 10.1164/rccm.200511-1751OC; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145; Zheng BJ, 2010, EXP BIOL MED, V235, P981, DOI 10.1258/ebm.2010.010071	42	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29347	10.1371/journal.pone.0029347	http://dx.doi.org/10.1371/journal.pone.0029347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235288	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400049
J	Nguyen, KDT; Morley, SA; Lai, CH; Clark, MS; Tan, KS; Bates, AE; Peck, LS				Nguyen, Khanh Dung T.; Morley, Simon A.; Lai, Chien-Houng; Clark, Melody S.; Tan, Koh Siang; Bates, Amanda E.; Peck, Lloyd S.			Upper Temperature Limits of Tropical Marine Ectotherms: Global Warming Implications	PLOS ONE			English	Article							CLIMATE-CHANGE; THERMAL TOLERANCE; AERIAL EXPOSURE; HEAT TOLERANCE; OCYPODID CRAB; CAPACITY; OXYGEN; OCEAN; SIZE; ACCLIMATION	Animal physiology, ecology and evolution are affected by temperature and it is expected that community structure will be strongly influenced by global warming. This is particularly relevant in the tropics, where organisms are already living close to their upper temperature limits and hence are highly vulnerable to rising temperature. Here we present data on upper temperature limits of 34 tropical marine ectotherm species from seven phyla living in intertidal and subtidal habitats. Short term thermal tolerances and vertical distributions were correlated, i.e., upper shore animals have higher thermal tolerance than lower shore and subtidal animals; however, animals, despite their respective tidal height, were susceptible to the same temperature in the long term. When temperatures were raised by 1 degrees C hour(-1), the upper lethal temperature range of intertidal ectotherms was 41-52 degrees C, but this range was narrower and reduced to 37-41 degrees C in subtidal animals. The rate of temperature change, however, affected intertidal and subtidal animals differently. In chronic heating experiments when temperature was raised weekly or monthly instead of every hour, upper temperature limits of subtidal species decreased from 40 degrees C to 35.4 degrees C, while the decrease was more than 10 degrees C in high shore organisms. Hence in the long term, activity and survival of tropical marine organisms could be compromised just 2-3 degrees C above present seawater temperatures. Differences between animals from environments that experience different levels of temperature variability suggest that the physiological mechanisms underlying thermal sensitivity may vary at different rates of warming.	[Nguyen, Khanh Dung T.; Lai, Chien-Houng; Tan, Koh Siang] Natl Univ Singapore, Trop Marine Sci Inst, Singapore 117548, Singapore; [Morley, Simon A.; Clark, Melody S.; Peck, Lloyd S.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England; [Bates, Amanda E.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia	National University of Singapore; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Tasmania	Nguyen, KDT (corresponding author), Natl Univ Singapore, Trop Marine Sci Inst, Singapore 117548, Singapore.	tmsntkd@nus.edu.sg	Clark, Melody S/D-7371-2014; Tan, Koh Siang/GOH-0321-2022; Bates, Amanda E./ABD-6874-2021	Clark, Melody S/0000-0002-3442-3824; Tan, Koh Siang/0000-0002-4599-9482; Bates, Amanda E./0000-0002-0198-4537	Science and Engineering Research Council of the Agency for Science, Technology and Research, Singapore [0821010024]; British Antarctic Survey; Natural Environment Research Council; Australian National Network in Marine Science (ANNiMS) Springboard initiative; National University of Singapore; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Science and Engineering Research Council of the Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); British Antarctic Survey; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Australian National Network in Marine Science (ANNiMS) Springboard initiative; National University of Singapore(National University of Singapore); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by research grant 0821010024 from the Science and Engineering Research Council of the Agency for Science, Technology and Research, Singapore (http://www.a-star.edu.sg/) to K. S. Tan. The British Antarctic Survey collaboration with the National University of Singapore, was supported as part of the Polar Science for Planet Earth programme (Ecosystems/Adaptations and Physiology Work Package), funded by the Natural Environment Research Council. A. E. Bates was funded by the Australian National Network in Marine Science (ANNiMS) Springboard initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Castaneda LE, 2004, EVOL ECOL RES, V6, P579; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Compton TJ, 2007, J EXP MAR BIOL ECOL, V352, P200, DOI 10.1016/j.jembe.2007.07.010; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Finke GR, 2007, MAR ECOL PROG SER, V343, P57, DOI 10.3354/meps06918; Gastineau G, 2009, J CLIMATE, V22, P3993, DOI 10.1175/2009JCLI2794.1; Gaston KJ, 2009, P ROY SOC B-BIOL SCI, V276, P1391, DOI [10.1098/rspb.2009.0100, 10.1098/rspb.2008.1480]; Gherardi F, 1999, J MAR BIOL ASSOC UK, V79, P281, DOI 10.1017/S0025315498000319; Gin KYH, 2000, J PLANKTON RES, V22, P1465, DOI 10.1093/plankt/22.8.1465; HEATWOLE H, 1968, COMP BIOCHEM PHYSIOL, V27, P807, DOI 10.1016/0010-406X(68)90620-8; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Helmuth B, 2005, ANNU REV PHYSIOL, V67, P177, DOI 10.1146/annurev.physiol.67.040403.105027; HONG WK, 1983, VELIGER, V26, P119; Huey RB, 2009, P NATL ACAD SCI USA, V106, P3647, DOI 10.1073/pnas.0900934106; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; IPCC, 2001, ADV CLIM CHANG RES; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Laurance WF, 2011, BIOL CONSERV, V144, P548, DOI 10.1016/j.biocon.2010.10.010; Lee SL, 2009, RAFFLES B ZOOL, V57, P551; Liu ZY, 2005, J CLIMATE, V18, P4684, DOI 10.1175/JCLI3579.1; Marshall DJ, 2010, P ROYAL SOC B; Marshall DJ, 2011, BIOL LETT; MAYER AG, 1914, PAP TORTUGAS LAB, V6, P3; Mora C, 2006, J THERM BIOL, V31, P337, DOI 10.1016/j.jtherbio.2006.01.005; Morley SA, 2009, COMP BIOCHEM PHYS A, V153, P154, DOI 10.1016/j.cbpa.2009.02.001; Munoz JLP, 2008, J THERM BIOL, V33, P149, DOI 10.1016/j.jtherbio.2007.10.002; Munoz JLP, 2005, COMP BIOCHEM PHYS A, V142, P92, DOI 10.1016/j.cbpa.2005.08.002; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Peck LS, 2009, POLAR BIOL, V32, P399, DOI 10.1007/s00300-008-0532-y; Peck LS, 2007, OECOLOGIA, V154, P479, DOI 10.1007/s00442-007-0858-0; Peck LS, 2004, FUNCT ECOL, V18, P625, DOI 10.1111/j.0269-8463.2004.00903.x; Peck LS, 2011, MAR GEN IN PRESS; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Reid DG, 2007, ZOOTAXA, P3; Rezende EL, 2011, FUNCT ECOL, V25, P111, DOI 10.1111/j.1365-2435.2010.01778.x; Richard J, 2011, PLOS ONE; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; Spicer J. I., 1999, PHYSL DIVERSITY ITS; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; Stillman JH, 1996, J EXP BIOL, V199, P1845; STIRLING HP, 1982, J EXP MAR BIOL ECOL, V63, P133, DOI 10.1016/0022-0981(82)90027-2; Takeda S, 1996, J EXP MAR BIOL ECOL, V198, P237, DOI 10.1016/0022-0981(96)00007-X; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Turton S., 2004, ENV CRISIS CLIMATE C; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Xie SP, 2010, J CLIMATE, V23, P966, DOI 10.1175/2009JCLI3329.1; Zuur Alain F., 2009, P1	56	144	151	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29340	10.1371/journal.pone.0029340	http://dx.doi.org/10.1371/journal.pone.0029340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242115	Green Published, gold, Green Accepted			2022-12-27	WOS:000300677000026
J	Sanborn, AF; Heath, JE; Phillips, PK; Heath, MS; Noriega, FG				Sanborn, Allen F.; Heath, James E.; Phillips, Polly K.; Heath, Maxine S.; Noriega, Fernando G.			Thermal Adaptation and Diversity in Tropical Ecosystems: Evidence from Cicadas (Hemiptera, Cicadidae)	PLOS ONE			English	Article							AFRICAN PLATYPLEURINE CICADAS; TEMPERATURE RESPONSES; SPECIES-DIVERSITY; VERTICAL STRATIFICATION; LATITUDINAL GRADIENTS; BODY-TEMPERATURE; CACAMA-VALVATA; ANOLIS LIZARDS; RAIN-FOREST; HOMOPTERA	The latitudinal gradient in species diversity is a central problem in ecology. Expeditions covering approximately 16 degrees 54' of longitude and 21 degrees 4' of latitude and eight Argentine phytogeographic regions provided thermal adaptation data for 64 species of cicadas. We test whether species diversity relates to the diversity of thermal environments within a habitat. There are general patterns of the thermal response values decreasing in cooler floristic provinces and decreasing maximum potential temperature within a habitat except in tropical forest ecosystems. Vertical stratification of the plant communities leads to stratification in species using specific layers of the habitat. There is a decrease in thermal tolerances in species from the understory communities in comparison to middle level or canopy fauna. The understory Herrera umbraphila Sanborn & Heath is the first diurnally active cicada identified as a thermoconforming species. The body temperature for activity in H. umbraphila is less than and significantly different from active body temperatures of all other studied species regardless of habitat affiliation. These data suggest that variability in thermal niches within the heterogeneous plant community of the tropical forest environments permits species diversification as species adapt their physiology to function more efficiently at temperatures different from their potential competitors.	[Sanborn, Allen F.] Barry Univ, Dept Biol, Miami Shores, FL USA; [Noriega, Fernando G.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA	State University System of Florida; Florida International University	Sanborn, AF (corresponding author), Barry Univ, Dept Biol, Miami Shores, FL USA.	asanborn@mail.barry.edu			Fulbright Foundation; Tinker Foundation; United States Public Health Service [GMS07143]; Sigma Xi; Special Program for the Improvement and Development of the Ecological Research; University of Illinois Graduate College; Barry University	Fulbright Foundation; Tinker Foundation; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Sigma Xi; Special Program for the Improvement and Development of the Ecological Research; University of Illinois Graduate College; Barry University	Financial support for this work was provided by the Fulbright Foundation (JEH), Tinker Foundation (MSH, AFS), United States Public Health Service traineeship GMS07143 (AFS), Sigma Xi (AFS), Special Program for the Improvement and Development of the Ecological Research (FGN), University of Illinois Graduate College (AFS), and Barry University (AFS). The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala AC, 1967, NAT APPL SCI B, V20, P334; Basset Y, 2001, BIOL J LINN SOC, V72, P585, DOI 10.1111/j.1095-8312.2001.tb01340.x; Cabrera A. L., 1971, SOC ARGENTINA BOT, V14, P1; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; DeVries PJ, 1997, BIOL J LINN SOC, V62, P343, DOI 10.1111/j.1095-8312.1997.tb01630.x; Dobzhansky T., 1950, American Scientist, V38, P209; Eyans GC, 1939, J ECOL, V27, P436, DOI 10.2307/2256374; Forster J. R., 1778, OBSERVATIONS MADE VO; Grimbacher PS, 2007, AUSTRAL ECOL, V32, P77, DOI 10.1111/j.1442-9993.2007.01735.x; Haddow A. J., 1961, Transactions of the Royal Entomological Society of London, V113, P257; HADDOW AJ, 1947, B ENTOMOL RES, V37, P301, DOI 10.1017/S000748530003042X; HALES WAYNE B., 1949, BULL AMER METEOROL SOC, V30, P124; HASTINGS JM, 1991, OECOLOGIA, V85, P513, DOI 10.1007/BF00323763; Hastings JM, 1989, T KY ACAD SCI, V50, P145; HEATH J E, 1970, Physiologist, V13, P399; HEATH JE, 1967, AM MIDL NAT, V77, P64, DOI 10.2307/2423426; HEATH JE, 1972, PHYSIOL ZOOL, V45, P238, DOI 10.1086/physzool.45.3.30152503; HEATH JE, 1970, PHYSIOL ZOOL, V43, P145, DOI 10.1086/physzool.43.3.30155525; Heath MS, 2007, ANN ENTOMOL SOC AM, V100, P483, DOI 10.1603/0013-8746(2007)100[483:ANSOCO]2.0.CO;2; Heath M.S., 1972, Plateau, V45, P31; HERTZ PE, 1992, ECOLOGY, V73, P1405, DOI 10.2307/1940686; HUEY RB, 1976, ECOLOGY, V57, P985, DOI 10.2307/1941063; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; INGER RF, 1959, ECOLOGY, V40, P127, DOI 10.2307/1929930; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; KATO M, 1995, RES POPUL ECOL, V37, P59, DOI 10.1007/BF02515762; LONGINO J T, 1990, Psyche (Cambridge), V97, P81, DOI 10.1155/1990/36505; MAC ARTHUR ROBERT H., 1967; May M.L., 1985, P507; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Phillips Polly K., 2007, Acta Zoologica Sinica, V53, P454; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; RAND A S, 1968, Proceedings of the United States National Museum, V125, P1; Rodgers DJ, 1998, ECOGRAPHY, V21, P392, DOI 10.1111/j.1600-0587.1998.tb00404.x; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; ROSENZWEIG ML, 1992, J MAMMAL, V73, P715, DOI 10.2307/1382191; Sanborn AF, 2000, J COMP PHYSIOL A, V186, P551, DOI 10.1007/s003590000110; Sanborn AF, 2004, PHYSIOL BIOCHEM ZOOL, V77, P816, DOI 10.1086/422226; Sanborn AF, 2004, BIOL J LINN SOC, V83, P281, DOI 10.1111/j.1095-8312.2004.00394.x; Sanborn AF, 2004, TROP ZOOL, V17, P65, DOI 10.1080/03946975.2004.10531199; SANBORN AF, 1995, FLA ENTOMOL, V78, P319, DOI 10.2307/3495905; SANBORN AF, 1995, J THERM BIOL, V20, P451, DOI 10.1016/0306-4565(95)00004-G; SANBORN AF, 1992, COMP BIOCHEM PHYS A, V102, P751, DOI 10.1016/0300-9629(92)90736-A; Sanborn AF, 2000, COMP BIOCHEM PHYS A, V125, P141, DOI 10.1016/S1095-6433(99)00169-5; Sanborn AF, 2004, J THERM BIOL, V29, P97, DOI 10.1016/j.jtherbio.2003.11.007; Sanborn AF, 2003, NATURWISSENSCHAFTEN, V90, P305, DOI 10.1007/s00114-003-0428-1; Sanborn AF, 2002, WEST N AM NATURALIST, V62, P437; Sanborn AF, 2003, J THERM BIOL, V28, P347, DOI 10.1016/S0306-4565(03)00013-5; Sanborn AF, 2002, J THERM BIOL, V27, P365, DOI 10.1016/S0306-4565(02)00004-9; Sanborn AF, 2001, FASEB J, V15, pA1106; Sanborn AF, 2011, SOUTHWEST NAT, V56, P363; Sanborn AF, 2011, J THERM BIOL, V36, P386, DOI 10.1016/j.jtherbio.2011.07.001; Sanborn AF, 2011, EUR J ENTOMOL, V108, P365, DOI 10.14411/eje.2011.045; Sanborn Allen F., 2009, Open Access Insect Physiology, V1, P13; Sanborn AF, 2011, J THERM BIOL, V36, P150, DOI 10.1016/j.jtherbio.2011.01.002; Sanborn Allen F., 2002, Denisia, V4, P455; Sanborn AF, 2010, ANN ENTOMOL SOC AM, V103, P860, DOI 10.1603/AN10040; Schulze CH, 2001, PLANT ECOL, V153, P133, DOI 10.1023/A:1017589711553; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; Szarzynski J, 2001, PLANT ECOL, V153, P231, DOI 10.1023/A:1017536512887; Takeuchi K, 2009, SCIENCE, V323, P1740, DOI 10.1126/science.1165712; Tanabe S, 2002, ECOL ENTOMOL, V27, P720, DOI 10.1046/j.1365-2311.2002.00469.x; TERBORGH J, 1973, AM NAT, V107, P481, DOI 10.1086/282852; Toolson EC, 1998, AM ZOOL, V38, P568; Turner J.R.G., 1986, Antenna, V10, P18; Turner JRG, 2004, BASIC APPL ECOL, V5, P435, DOI 10.1016/j.baae.2004.08.004; TURNER JRG, 1987, OIKOS, V48, P195, DOI 10.2307/3565855; Villet MH, 2003, CAN J ZOOL, V81, P1437, DOI 10.1139/Z03-119; von Humboldt A, 1807, ANSICHTEN NATUR WISS, P334; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109	71	17	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29368	10.1371/journal.pone.0029368	http://dx.doi.org/10.1371/journal.pone.0029368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242117	Green Submitted, Green Published, gold			2022-12-27	WOS:000300677000029
J	Lepez, T; Vandewoestyne, M; Hussain, S; Van Nieuwerburgh, F; Poppe, K; Velkeniers, B; Kaufman, JM; Deforce, D				Lepez, Trees; Vandewoestyne, Mado; Hussain, Shahid; Van Nieuwerburgh, Filip; Poppe, Kris; Velkeniers, Brigitte; Kaufman, Jean-Marc; Deforce, Dieter			Fetal Microchimeric Cells in Blood of Women with an Autoimmune Thyroid Disease	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; HASHIMOTOS-THYROIDITIS; GRAVES-DISEASE; SYSTEMIC-SCLEROSIS; PERIPHERAL-BLOOD; POSTPARTUM; LONG; DNA	Context: Hashimoto's thyroiditis (HT) and Graves' disease (GD), two autoimmune thyroid diseases (AITD), occur more frequently in women than in men and show an increased incidence in the years following parturition. Persisting fetal cells could play a role in the development of these diseases. Objective: Aim of this study was to detect and characterize fetal cells in blood of postpartum women with and without an AITD. Participants: Eleven patients with an AITD and ten healthy volunteers, all given birth to a son maximum 5 years before analysis, and three women who never had been pregnant, were included. None of them had any other disease of the thyroid which could interfere with the results obtained. Methods: Fluorescence in situ hybridization (FISH) and repeated FISH were used to count the number of male fetal cells. Furthermore, the fetal cells were further characterized. Results: In patients with HT, 7 to 11 fetal cells per 1.000.000 maternal cells were detected, compared to 14 to 29 fetal cells in patients with GD (p = 0,0061). In patients with HT, mainly fetal CD8(+) T cells were found, while in patients with GD, fetal B and CD4(+) T cells were detected. In healthy volunteers with son, 0 to 5 fetal cells were observed, which was significantly less than the number observed in patients (p < 0,05). In women who never had been pregnant, no male cells were detected. Conclusion: This study shows a clear association between fetal microchimeric cells and autoimmune thyroid diseases.	[Lepez, Trees; Vandewoestyne, Mado; Hussain, Shahid; Van Nieuwerburgh, Filip; Deforce, Dieter] Univ Ghent, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium; [Poppe, Kris; Velkeniers, Brigitte] Univ Hosp Brussels VUB, Dept Endocrinol, Brussels, Belgium; [Kaufman, Jean-Marc] Ghent Univ Hosp, Dept Endocrinol, Ghent, Belgium	Ghent University; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Ghent University; Ghent University Hospital	Lepez, T (corresponding author), Univ Ghent, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium.	Dieter.Deforce@UGent.be	Deforce, Dieter LD/J-4725-2013; Hussain, Shahid/AAP-5065-2021; Van Nieuwerburgh, Filip/H-9697-2015	Deforce, Dieter LD/0000-0002-0635-661X; Hussain, Shahid/0000-0003-4826-3339; Van Nieuwerburgh, Filip/0000-0001-8815-5485; Poppe, Kris/0000-0002-5452-4243	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen, Belgium); Scientific Research Flanders (FWO, Belgium); Laboratory of Pharmaceutical Biotechnology	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen, Belgium)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Scientific Research Flanders (FWO, Belgium)(FWO); Laboratory of Pharmaceutical Biotechnology	The research was funded by a PhD grant from the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen, Belgium, www.iwt.be) to Trees Lepez and Mado Vandewoestyne and by a grant from the Fund of Scientific Research Flanders (FWO, Belgium, www.fwo.be) awarded to the Laboratory of Pharmaceutical Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2003, J AM ACAD DERMATOL, V48, P641, DOI 10.1067/mjd.2003.257; Ando T, 2003, J CLIN ENDOCR METAB, V88, P2965, DOI 10.1210/jc.2002-021903; Ando T, 2002, J CLIN ENDOCR METAB, V87, P3315, DOI 10.1210/jc.87.7.3315; Artlett CM, 1998, NEW ENGL J MED, V338, P1186, DOI 10.1056/NEJM199804233381704; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Brent GA, 2008, NEW ENGL J MED, V358, P2594, DOI 10.1056/NEJMcp0801880; Brix TH, 2009, J CLIN ENDOCR METAB, V94, P4439, DOI 10.1210/jc.2009-0813; Burlingham WJ, 2009, NEW ENGL J MED, V360, P1355, DOI 10.1056/NEJMcibr0810752; Cirello V, 2010, INT J CANCER, V126, P2874, DOI 10.1002/ijc.24993; Dayan CM, 1996, NEW ENGL J MED, V335, P99, DOI 10.1056/NEJM199607113350206; Evans PC, 1999, BLOOD, V93, P2033, DOI 10.1182/blood.V93.6.2033.406k18_2033_2037; Imaizumi M, 2002, ENDOCRINOLOGY, V143, P247, DOI 10.1210/en.143.1.247; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Klintschar M, 2006, EUR J ENDOCRINOL, V154, P237, DOI 10.1530/eje.1.02080; Klintschar M, 2001, J CLIN ENDOCR METAB, V86, P2494, DOI 10.1210/jc.86.6.2494; Lambert N, 2003, AUTOIMMUN REV, V2, P133, DOI 10.1016/S1568-9972(02)00149-0; Lapaire O, 2007, J MATERN-FETAL NEO M, V20, P1, DOI 10.1080/14767050601144834; Lee TH, 1999, BLOOD, V93, P3127; Li YQ, 2011, CURR OPIN RHEUMATOL, V23, P102, DOI 10.1097/BOR.0b013e328341378c; Liu J, 1998, FERTIL STERIL, V70, P729, DOI 10.1016/S0015-0282(98)00244-1; Lo YMD, 2000, CLIN CHEM, V46, P1301; Nelson JL, 1996, ARTHRITIS RHEUM, V39, P191, DOI 10.1002/art.1780390203; Prummel MF, 2004, EUR J ENDOCRINOL, V150, P605, DOI 10.1530/eje.0.1500605; Renne C, 2004, J CLIN ENDOCR METAB, V89, P5810, DOI 10.1210/jc.2004-1049; Scaletti C, 2002, ARTHRITIS RHEUM, V46, P445, DOI 10.1002/art.10049; Srivatsa B, 2001, LANCET, V358, P2034, DOI 10.1016/S0140-6736(01)07099-4; Tomer Y, 2010, THYROID, V20, P715, DOI 10.1089/thy.2010.1644; van Tol MJD, 1998, BONE MARROW TRANSPL, V21, P497, DOI 10.1038/sj.bmt.1701122; Vandewoestyne M, 2009, INT J LEGAL MED, V123, P441, DOI 10.1007/s00414-009-0341-z; Vandewoestyne M, 2009, INT J LEGAL MED, V123, P169, DOI 10.1007/s00414-008-0271-1; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277	31	27	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29646	10.1371/journal.pone.0029646	http://dx.doi.org/10.1371/journal.pone.0029646			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216337	Green Published, gold, Green Submitted			2022-12-27	WOS:000300674900049
J	Switzer, WM; Zheng, HQ; Simmons, G; Zhou, YC; Tang, SH; Shankar, A; Kapusinszky, B; Delwart, EL; Heneine, W				Switzer, William M.; Zheng, HaoQiang; Simmons, Graham; Zhou, Yanchen; Tang, Shaohua; Shankar, Anupama; Kapusinszky, Beatrix; Delwart, Eric L.; Heneine, Walid			No Evidence of Murine Leukemia Virus-Related Viruses in Live Attenuated Human Vaccines	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; PROSTATE-CANCER; MOUSE DNA; XMRV; CONTAMINATION; PCR; RETROVIRUS; BLOOD; TRANSMISSION; ASSOCIATION	Background: The association of xenotropic murine leukemia virus (MLV)-related virus (XMRV) in prostate cancer and chronic fatigue syndrome reported in previous studies remains controversial as these results have been questioned by recent data. Nonetheless, concerns have been raised regarding contamination of human vaccines as a possible source of introduction of XMRV and MLV into human populations. To address this possibility, we tested eight live attenuated human vaccines using generic PCR for XMRV and MLV sequences. Viral metagenomics using deep sequencing was also done to identify the possibility of other adventitious agents. Results: All eight live attenuated vaccines, including Japanese encephalitis virus (JEV) (SA-14-14-2), varicella (Varivax), measles, mumps, and rubella (MMR-II), measles (Attenuvax), rubella (Meruvax-II), rotavirus (Rotateq and Rotarix), and yellow fever virus were negative for XMRV and highly related MLV sequences. However, residual hamster DNA, but not RNA, containing novel endogenous gammaretrovirus sequences was detected in the JEV vaccine using PCR. Metagenomics analysis did not detect any adventitious viral sequences of public health concern. Intracisternal A particle sequences closest to those present in Syrian hamsters and not mice were also detected in the JEV SA-14-14-2 vaccine. Combined, these results are consistent with the production of the JEV vaccine in Syrian hamster cells. Conclusions: We found no evidence of XMRV and MLV in eight live attenuated human vaccines further supporting the safety of these vaccines. Our findings suggest that vaccines are an unlikely source of XMRV and MLV exposure in humans and are consistent with the mounting evidence on the absence of these viruses in humans.	[Switzer, William M.; Zheng, HaoQiang; Tang, Shaohua; Shankar, Anupama; Heneine, Walid] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Simmons, Graham; Zhou, Yanchen; Kapusinszky, Beatrix; Delwart, Eric L.] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94143 USA; [Simmons, Graham; Zhou, Yanchen; Kapusinszky, Beatrix; Delwart, Eric L.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco	Switzer, WM (corresponding author), Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	bswitzer@cdc.gov	Simmons, Graham/G-3523-2012	Simmons, Graham/0000-0002-9615-7023; Delwart, Eric/0000-0002-6296-4484	US Congress; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105770] Funding Source: NIH RePORTER	US Congress; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	As a US government institution, funding is provided by the US Congress. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley DWC, 2008, EXPERT OPIN BIOL TH, V8, P95, DOI 10.1517/14712598.8.1.95; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023484; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017592; Furuta RA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-20; Garson JA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-13; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Hussain AI, 2003, J VIROL, V77, P1105, DOI 10.1128/JVI.77.2.1105-1111.2003; Knox K, 2011, SCIENCE; Lintas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016609; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lobigs M, 2010, J GEN VIROL, V91, P1407, DOI 10.1099/vir.0.019190-0; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Maric R, 2011, RETROVIROLOGY, V8, pA213; Miyazawa T, 2010, BIOLOGICALS, V38, P371, DOI 10.1016/j.biologicals.2010.03.003; Morse II H. C., 2007, MOUSE BIOMEDICAL RES, V2, P269; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Paprotka T, 2011, SCIENCE; Qiu X, 2011, RETROVIROLOGY, V8, pA222; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Sakuma T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-23; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Satterfield BC, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-12; Sfanos KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020874; Shepherd AJ, 2003, BIOLOGICALS, V31, P251, DOI 10.1016/S1045-1056(03)00065-4; Shin CH, 2011, J VIROL; Shirato K, 2005, J VIROL METHODS, V126, P119, DOI 10.1016/j.jviromet.2005.02.001; Silverman RH, 2010, NAT REV UROL, V7, P392, DOI 10.1038/nrurol.2010.77; Simmons G, 2011, TRANSFUSION, V51, P643, DOI 10.1111/j.1537-2995.2011.03063.x; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-112; Switzer WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019065; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Tsang SX, 1999, J VIROL, V73, P5843, DOI 10.1128/JVI.73.7.5843-5851.1999; Tuke PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019953; van der Kuyl AC, 2011, FRONTIERS MICROBIOLO, V1, P1; Victoria JG, 2010, J VIROL, V84, P6033, DOI 10.1128/JVI.02690-09; Yu YX, 2010, VACCINE, V28, P3635, DOI 10.1016/j.vaccine.2010.02.105	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29223	10.1371/journal.pone.0029223	http://dx.doi.org/10.1371/journal.pone.0029223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216219	Green Published, Green Submitted, gold			2022-12-27	WOS:000299684700042
J	Anedda, F; Zucchelli, M; Schepis, D; Hellquist, A; Corrado, L; D'Alfonso, S; Achour, A; McInerney, G; Bertorello, A; Lordal, M; Befrits, R; Bjork, J; Bresso, F; Torkvist, L; Halfvarson, J; Kere, J; D'Amato, M				Anedda, Francesca; Zucchelli, Marco; Schepis, Danika; Hellquist, Anna; Corrado, Lucia; D'Alfonso, Sandra; Achour, Adnane; McInerney, Gerald; Bertorello, Alejandro; Lordal, Mikael; Befrits, Ragnar; Bjork, Jan; Bresso, Francesca; Torkvist, Leif; Halfvarson, Jonas; Kere, Juha; D'Amato, Mauro			Multiple Polymorphisms Affect Expression and Function of the Neuropeptide S Receptor (NPSR1)	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; BIOLOGICAL-ACTIVITY; GENE POLYMORPHISM; ASSOCIATION; ASTHMA; SUSCEPTIBILITY; HAPLOTYPES; LINKAGE; PHARMACOLOGY; ENVIRONMENT	Background: neuropeptide S (NPS) and its receptor NPSR1 act along the hypothalamic-pituitary-adrenal axis to modulate anxiety, fear responses, nociception and inflammation. The importance of the NPS-NPSR1 signaling pathway is highlighted by the observation that, in humans, NPSR1 polymorphism associates with asthma, inflammatory bowel disease, rheumatoid arthritis, panic disorders, and intermediate phenotypes of functional gastrointestinal disorders. Because of the genetic complexity at the NPSR1 locus, however, true causative variations remain to be identified, together with their specific effects on receptor expression or function. To gain insight into the mechanisms leading to NPSR1 disease-predisposing effects, we performed a thorough functional characterization of all NPSR1 promoter and coding SNPs commonly occurring in Caucasians (minor allele frequency >0.02). Principal Findings: we identified one promoter SNP (rs2530547 [-103]) that significantly affects luciferase expression in gene reporter assays and NPSR1 mRNA levels in human leukocytes. We also detected quantitative differences in NPS-induced genome-wide transcriptional profiles and CRE-dependent luciferase activities associated with three NPSR1 non-synonymous SNPs (rs324981 [Ile107Asn], rs34705969 [Cys197Phe], rs727162 [Arg241Ser]), with a coding variant exhibiting a loss-of-function phenotype (197Phe). Potential mechanistic explanations were sought with molecular modelling and bioinformatics, and a pilot study of 2230 IBD cases and controls provided initial support to the hypothesis that different cis-combinations of these functional SNPs variably affect disease risk. Significance: these findings represent a first step to decipher NPSR1 locus complexity and its impact on several human conditions NPS antagonists have been recently described, and our results are of potential pharmacogenetic relevance.	[Anedda, Francesca; Zucchelli, Marco; Hellquist, Anna; Kere, Juha; D'Amato, Mauro] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Anedda, Francesca] CNR, Inst Neurogenet & Neuropharmacol, Monserrato, Italy; [Schepis, Danika; Achour, Adnane; McInerney, Gerald] Karolinska Inst, Dept Microbiol Tumor Cell Biol, Stockholm, Sweden; [Corrado, Lucia; D'Alfonso, Sandra] Univ Piemonte Orientale, Dept Med Sci, Novara, Italy; [Corrado, Lucia; D'Alfonso, Sandra] IRCAD, Novara, Italy; [Achour, Adnane] Karolinska Univ Hosp, Ctr Infect Med, Stockholm, Sweden; [Bertorello, Alejandro; Lordal, Mikael; Befrits, Ragnar; Bjork, Jan; Bresso, Francesca] Karolinska Inst, Dept Med, Stockholm, Sweden; [Torkvist, Leif] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Halfvarson, Jonas] Orebro Univ Hosp, Dept Internal Med, Orebro, Sweden; [Halfvarson, Jonas] Univ Orebro, Sch Hlth & Med Sci, Orebro, Sweden; [Kere, Juha] Karolinska Inst, Ctr Biosci, Stockholm, Sweden; [Kere, Juha] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Kere, Juha] Sci Life Lab, Stockholm, Sweden	Karolinska Institutet; Consiglio Nazionale delle Ricerche (CNR); Karolinska Institutet; University of Eastern Piedmont Amedeo Avogadro; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Orebro University; Orebro University; Karolinska Institutet; University of Helsinki	Anedda, F (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden.	juhakere@ki.se; maurodamato@ki.se	Halfvarson, Jonas/AAU-4687-2020; Kere, Juha/A-9179-2008; McInerney, Gerald/G-5344-2012; D'Amato, Mauro/B-5050-2019; Kere, Juha/AAX-9117-2021; D'Amato, Mauro/F-2450-2010; D'Alfonso, Sandra/K-7295-2014	Kere, Juha/0000-0003-1974-0271; McInerney, Gerald/0000-0003-2257-7241; D'Amato, Mauro/0000-0003-2743-5197; Kere, Juha/0000-0003-1974-0271; D'Amato, Mauro/0000-0003-2743-5197; D'Alfonso, Sandra/0000-0002-3983-9925; Halfvarson, Jonas/0000-0003-0122-7234; Rapa, Anna/0000-0002-5523-5224; Achour, Adnane/0000-0003-0432-710X	Swedish Research Council; Prof Nanna Svartz Fond; Ruth and Richard Julin Foundation; Novo Nordisk Foundation; Academy of Finland; Sigrid Juselius Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Prof Nanna Svartz Fond; Ruth and Richard Julin Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by the Swedish Research Council, Prof Nanna Svartz Fond, and Ruth and Richard Julin Foundation [to MD]; the Swedish Research Council, Novo Nordisk Foundation, Academy of Finland, and Sigrid Juselius Foundation [to JK]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bernier V, 2006, J BIOL CHEM, V281, P24704, DOI 10.1074/jbc.M603691200; Bresso F, 2007, INFLAMM BOWEL DIS, V13, P531, DOI 10.1002/ibd.20067; Camarda V, 2008, J MED CHEM, V51, P655, DOI 10.1021/jm701204n; Camilleri M, 2010, GASTROENTEROLOGY, V138, P98, DOI 10.1053/j.gastro.2009.08.051; D'Amato M, 2007, GASTROENTEROLOGY, V133, P808, DOI 10.1053/j.gastro.2007.06.012; D'Amato M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009315; Dal Ben D, 2010, CHEMMEDCHEM, V5, P371, DOI 10.1002/cmdc.200900467; Domschke K, MOL PSYCHIA IN PRESS; Donner J, 2010, BIOL PSYCHIAT, V68, P474, DOI 10.1016/j.biopsych.2010.05.039; Duangdao DM, 2009, BEHAV BRAIN RES, V205, P1, DOI 10.1016/j.bbr.2009.07.024; Einarsdottir E, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-8; Ekelund E, 2009, ACTA DERM-VENEREOL, V89, P115, DOI 10.2340/00015555-0549; Guerrini R, 2010, MED RES REV, V30, P751, DOI 10.1002/med.20180; Guerrini R, 2009, J MED CHEM, V52, P4068, DOI 10.1021/jm900604g; Guerrini R, 2009, J MED CHEM, V52, P524, DOI 10.1021/jm8012294; Hersh CP, 2007, AM J RESP CRIT CARE, V176, P849, DOI 10.1164/rccm.200704-592OC; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; Kallupi M, 2010, P NATL ACAD SCI USA, V107, P19567, DOI 10.1073/pnas.1004100107; Kormann MSD, 2005, AM J RESP CRIT CARE, V171, P1358, DOI 10.1164/rccm.200410-1312OC; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Malerba G, 2007, CLIN EXP ALLERGY, V37, P83, DOI 10.1111/j.1365-2222.2006.02615.x; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Melen E, 2005, AM J RESP CRIT CARE, V171, P1089, DOI 10.1164/rccm.200410-1317OC; Nepomuceno D, 2010, EUR J PHARMACOL, V635, P27, DOI 10.1016/j.ejphar.2010.03.008; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okamura N, 2008, J PHARMACOL EXP THER, V325, P893, DOI 10.1124/jpet.107.135103; Okamura N, 2007, PROG NEURO-PSYCHOPH, V31, P1444, DOI 10.1016/j.pnpbp.2007.06.026; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pape HC, 2010, NEUROPHARMACOLOGY, V58, P29, DOI 10.1016/j.neuropharm.2009.06.001; Pulkkinen V, 2006, HUM MOL GENET, V15, P1667, DOI 10.1093/hmg/ddl090; Raczka KA, 2010, MOL PSYCHIATR, V15, P1067, DOI 10.1038/mp.2010.79; Reinscheid Rainer K., 2008, V46, P145, DOI 10.1007/400_2007_051; Reinscheid RK, 2005, J PHARMACOL EXP THER, V315, P1338, DOI 10.1124/jpet.105.093427; Ruzza C, 2010, PEPTIDES, V31, P915, DOI 10.1016/j.peptides.2010.02.012; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Torkvist L, 2010, INFLAMM BOWEL DIS, V16, P907, DOI 10.1002/ibd.21105; Veal CD, 2005, J INVEST DERMATOL, V125, P399, DOI 10.1111/j.0022-202X.2005.23828.x; Vendelin J, 2005, AM J RESP CELL MOL, V33, P262, DOI 10.1165/rcmb.2004-0405OC; Vendelin J, 2006, HUM MOL GENET, V15, P2923, DOI 10.1093/hmg/ddl234; Vergara C, 2009, CLIN EXP ALLERGY, V39, P1558, DOI 10.1111/j.1365-2222.2009.03311.x; Wu H, 2008, GENES IMMUN, V9, P224, DOI 10.1038/gene.2008.8; Xu YL, 2007, J COMP NEUROL, V500, P84, DOI 10.1002/cne.21159; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005; Zucchelli M, 2009, INFLAMM BOWEL DIS, V15, P1562, DOI 10.1002/ibd.20963	48	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29523	10.1371/journal.pone.0029523	http://dx.doi.org/10.1371/journal.pone.0029523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216302	Green Published, gold, Green Submitted			2022-12-27	WOS:000299113600086
J	Sutcliffe, CG; van Dijk, JH; Munsanje, B; Hamangaba, F; Siniwymaanzi, P; Thuma, PE; Moss, WJ				Sutcliffe, Catherine G.; van Dijk, Janneke H.; Munsanje, Bornface; Hamangaba, Francis; Siniwymaanzi, Pamela; Thuma, Philip E.; Moss, William J.			Risk Factors for Pre-Treatment Mortality among HIV-Infected Children in Rural Zambia: A Cohort Study	PLOS ONE			English	Article							TO-FOLLOW-UP; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; PROGRAM; OUTCOMES; SERVICE; CARE; DETERMINANTS; SURVIVAL; LOSSES	Background: Many HIV-infected children in sub-Saharan Africa enter care at a late stage of disease. As preparation of the child and family for antiretroviral therapy (ART) can take several clinic visits, some children die prior to ART initiation. This study was undertaken to determine mortality rates and clinical predictors of mortality during the period prior to ART initiation. Methods: A prospective cohort study of HIV-infected treatment-naive children was conducted between September 2007 and September 2010 at the HIV clinic at Macha Hospital in rural Southern Province, Zambia. HIV-infected children younger than 16 years of age who were treatment-naive at study enrollment were eligible for analysis. Mortality rates prior to ART initiation were calculated and risk factors for mortality were evaluated. Results: 351 children were included in the study, of whom 210 (59.8%) were eligible for ART at study enrollment. Among children ineligible for ART at enrollment, 6 children died (mortality rate: 0.33; 95% CI: 0.15, 0.74). Among children eligible at enrollment, 21 children died before initiation of ART and their mortality rate (2.73 per 100 person-years; 95% CI: 1.78, 4.18) was significantly higher than among children ineligible for ART (incidence rate ratio: 8.20; 95% CI: 3.20, 24.83). In both groups, mortality was highest in the first three months of follow-up. Factors associated with mortality included younger age, anemia and lower weight-for-age z-score at study enrollment. Conclusions: These results underscore the need to increase efforts to identify HIV-infected children at an earlier age and stage of disease progression so they can enroll in HIV care and treatment programs prior to becoming eligible for ART and these deaths can be prevented.	[Sutcliffe, Catherine G.; Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [van Dijk, Janneke H.; Munsanje, Bornface; Hamangaba, Francis; Siniwymaanzi, Pamela; Thuma, Philip E.] Macha Hosp, Macha Res Trust, Choma, Zambia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sutcliffe, CG (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	csutclif@jhsph.edu		Sutcliffe, Catherine/0000-0001-8512-8326	Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC) [U62/CCU322428]	Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was made possible by support from the President's Emergency Plan for AIDS Relief (PEPFAR) through Cooperative Agreement U62/CCU322428 from the Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC), Global AIDS Program. The findings and conclusions included in its content are solely the responsibility of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Arrive E, 2008, JAIDS-J ACQ IMM DEF, V49, P523, DOI 10.1097/QAI.0b013e31818aadce; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Carlucci JG, 2008, JAIDS-J ACQ IMM DEF, V47, P615, DOI 10.1097/QAI.0b013e318165dc25; Charlebois ED, 2010, JAIDS-J ACQ IMM DEF, V55, P330, DOI 10.1097/QAI.0b013e3181e583da; Davies MA, 2009, SAMJ S AFR MED J, V99, P730; *DHS, 2007, J TROP PEDIATRICS, V53, P398; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Gibb DM, 2008, AIDS, V22, P97, DOI 10.1097/01.aids.0000302262.51286.a5; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Marazzi M C, 2006, Minerva Pediatr, V58, P483; Raguenaud ME, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-54; Sutcliffe CG, 2008, CLIN INFECT DIS, V47, P837, DOI 10.1086/591203; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Sutcliffe CG, 2010, PEDIATR INFECT DIS J, V29, P849, DOI 10.1097/INF.0b013e3181e753a8; Togun T, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-24; van Dijk JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019006; van Dijk JH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-169; Walker AS, 2006, JAIDS-J ACQ IMM DEF, V42, P637, DOI 10.1097/01.qai.0000226334.34717.dc; WHO, WHO CHILD GROWTH STA; *WHO, 2008, WHO TECHN REF GROUP; WHO, 2001, IRON DEFICIENCY ANAE; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organization, 2010, UN ACC SCAL PRIOR HI	26	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29294	10.1371/journal.pone.0029294	http://dx.doi.org/10.1371/journal.pone.0029294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216237	Green Published, gold			2022-12-27	WOS:000299113600075
J	Cottrell, G; Kouwaye, B; Pierrat, C; le Port, A; Bouraima, A; Fonton, N; Hounkonnou, MN; Massougbodji, A; Corbel, V; Garcia, A				Cottrell, Gilles; Kouwaye, Bienvenue; Pierrat, Charlotte; le Port, Agnes; Bouraima, Aziz; Fonton, Noel; Hounkonnou, Mahouton Norbert; Massougbodji, Achille; Corbel, Vincent; Garcia, Andre			Modeling the Influence of Local Environmental Factors on Malaria Transmission in Benin and Its Implications for Cohort Study	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM TRANSMISSION; INSECTICIDE RESISTANCE; INFECTION; MORBIDITY; SUSCEPTIBILITY; ANTIBODIES; INTENSITY; DISTRICT; VECTORS; DISEASE	Malaria remains endemic in tropical areas, especially in Africa. For the evaluation of new tools and to further our understanding of host-parasite interactions, knowing the environmental risk of transmission-even at a very local scale-is essential. The aim of this study was to assess how malaria transmission is influenced and can be predicted by local climatic and environmental factors. As the entomological part of a cohort study of 650 newborn babies in nine villages in the Tori Bossito district of Southern Benin between June 2007 and February 2010, human landing catches were performed to assess the density of malaria vectors and transmission intensity. Climatic factors as well as household characteristics were recorded throughout the study. Statistical correlations between Anopheles density and environmental and climatic factors were tested using a three-level Poisson mixed regression model. The results showed both temporal variations in vector density (related to season and rainfall), and spatial variations at the level of both village and house. These spatial variations could be largely explained by factors associated with the house's immediate surroundings, namely soil type, vegetation index and the proximity of a watercourse. Based on these results, a predictive regression model was developed using a leave-one-out method, to predict the spatiotemporal variability of malaria transmission in the nine villages. This study points up the importance of local environmental factors in malaria transmission and describes a model to predict the transmission risk of individual children, based on environmental and behavioral characteristics.	[Cottrell, Gilles; Kouwaye, Bienvenue; Pierrat, Charlotte] IRD, Cotonou, Benin; [Cottrell, Gilles; Kouwaye, Bienvenue; Pierrat, Charlotte; le Port, Agnes; Garcia, Andre] IRD, Paris, France; [Cottrell, Gilles; Kouwaye, Bienvenue; Pierrat, Charlotte; le Port, Agnes; Garcia, Andre] Univ Paris 05, Fac Pharm, Paris, France; [Cottrell, Gilles; Kouwaye, Bienvenue; Pierrat, Charlotte; Bouraima, Aziz] ISBA, Cotonou, Benin; [Cottrell, Gilles; Kouwaye, Bienvenue; Pierrat, Charlotte; Bouraima, Aziz; Massougbodji, Achille] CERPAGE, Contonou, Benin; [Kouwaye, Bienvenue; Pierrat, Charlotte; Fonton, Noel; Hounkonnou, Mahouton Norbert] Univ Abomey Calavi, Int Chair Math Phys & Applicat, ICMPA UNESCO Chair, Cotonou, Benin; [Pierrat, Charlotte] CREC, IRD, Ecol Genet Evolut & Controle MIVEGEC, CNRS UM1 5290 IRD 224, Cotonou, Benin; [Pierrat, Charlotte] Univ Paris 01, F-75231 Paris 05, France; [Massougbodji, Achille] FSS, Cotonou, Benin	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; University of Abomey Calavi; Entomological Research Center of Cotonou (CREC); Institut de Recherche pour le Developpement (IRD); heSam Universite; Universite Pantheon-Sorbonne	Cottrell, G (corresponding author), IRD, Cotonou, Benin.	Gilles.Cottrell@ird.fr	Garcia, Andre/S-2959-2016; Garcia, Andre/ABA-1820-2020; Hounkonnou, Mahouton Norbert/AAF-4695-2019; Corbel, VIncent/G-9576-2016	Garcia, Andre/0000-0002-1808-472X; Garcia, Andre/0000-0002-1808-472X; Hounkonnou, Mahouton Norbert/0000-0002-6231-4975; Cottrell, Gilles/0000-0002-7964-8963; Le Port, Agnes/0000-0002-8337-6569; corbel, vincent/0000-0003-0995-3257	Agence Nationale de la Recherche (ANR) [040-01]; Ministere des Affaires Etrangeres (France) [N<SUP>o</SUP>2006-22]; Institut de Recherche pour le Developpement	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ministere des Affaires Etrangeres (France); Institut de Recherche pour le Developpement	Agence Nationale de la Recherche (ANR www.agence-nationale-recherche.fr) project SEST 2006 (040-01); Ministere des Affaires Etrangeres (France, www.diplomatie.gouv.fr) project REFS N<SUP>o</SUP>2006-22; and the Institut de Recherche pour le Developpement, which financially and materially supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageep TB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-123; [Anonymous], 2009, WHO WORLD MAL REP; [Anonymous], 1968, ANOPHELINAE AFR S SA; Atieli H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-108; Bardaji A, 2011, J INFECT DIS, V203, P691, DOI 10.1093/infdis/jiq049; Barnes KI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S1-S8; Bojang KA, 2005, VACCINE, V23, P4148, DOI 10.1016/j.vaccine.2005.03.019; Briet OJT, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-76; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Cot M, 2003, AM J EPIDEMIOL, V157, P203, DOI 10.1093/aje/kwf192; Damien GB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-380; Dery DB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-314; Dicko A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001045; Djenontin A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-83; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ellman R, 1998, ANN TROP MED PARASIT, V92, P741, DOI 10.1080/00034989858989; Gillies M, 1987, ANOPHELINAE AFRICA S; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Guthmann JP, 2002, TROP MED INT HEALTH, V7, P518, DOI 10.1046/j.1365-3156.2002.00883.x; Haghdoost AA, 2008, TROP MED INT HEALTH, V13, P1501, DOI 10.1111/j.1365-3156.2008.02166.x; Hurd H, 2010, PARASITE MEDIATED EN, P349; Killeen GF, 2007, T ROY SOC TROP MED H, V101, P867, DOI 10.1016/j.trstmh.2007.04.022; Lacroix R, 2005, PLOS BIOL, V3, P1590, DOI 10.1371/journal.pbio.0030298; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; Mourou JR, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-321; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Nguyen QT, 2010, INT J PARASITOL, V41, P109; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Olson SH, 2009, EMERG INFECT DIS, V15, P659, DOI 10.3201/eid1504.080822; Pierrat C, 2010, REV ESPACES IN PRESS; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; Sylla EHK, 2001, PARASITOL RES, V87, P530, DOI 10.1007/s004360100407; WIRTZ RA, 1987, B WORLD HEALTH ORGAN, V65, P39; Ye Y, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-8	38	36	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28812	10.1371/journal.pone.0028812	http://dx.doi.org/10.1371/journal.pone.0028812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238582	Green Published, gold			2022-12-27	WOS:000301070200012
J	Ohta, H; Arai, S; Akita, K; Ohta, T; Fukuda, S				Ohta, Hitomi; Arai, Shigeyuki; Akita, Kenji; Ohta, Tsunetaka; Fukuda, Shigeharu			Effects of NK-4 in a Transgenic Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-PROTEIN; OXIDATIVE STRESS; A-BETA; IMMUNOPHARMACOLOGICAL ACTIONS; MISSENSE MUTATIONS; MEMORY DEFICITS; CYANINE DYES; BRAIN; GENE	Beta-amyloid (A beta) peptides are considered to play a major role in the pathogenesis of Alzheimer's disease (AD) and molecules that can prevent pathways of A beta toxicity may be potential therapeutic agents for treatment of AD. We have previously reported that NK-4, a cyanine photosensitizing dye, displays neurotrophic and antioxidant activities. In this study, we report the effects of NK-4 on the toxicity of A beta and on cognitive function and A beta concentration in a transgenic mouse model of AD (Tg2576). In vitro, NK-4 effectively protected neuronal cells from toxicity induced by Ab. In addition, it displayed profound inhibitory activities on Ab fibril formation. In vivo, Tg2576 mice received an intraperitoneal injection at 100 or 500 mg/kg of NK-4 once a day, five times a week for 9 months. Administration of NK-4 to the mice attenuated impairment of recognition memory, associative memory, and learning ability, as assessed by a novel object recognition test, a passive avoidance test, and a water maze test, respectively. NK-4 decreased the brain Ab concentration while increasing the plasma amyloid level in a dose-dependent manner. NK-4 also improved memory impairments of ICR mice induced by direct intracerebroventricular administration of Ab. These lines of evidence suggest that NK-4 may affect multiple pathways of amyloid pathogenesis and could be useful for treatment of AD.	[Ohta, Hitomi; Arai, Shigeyuki; Akita, Kenji; Ohta, Tsunetaka; Fukuda, Shigeharu] Hayashibara Biochem Labs Inc, Res Ctr, Okayama, Japan	Hayashibara Biochemical Laboratories, Inc.	Ohta, H (corresponding author), Hayashibara Biochem Labs Inc, Res Ctr, Okayama, Japan.	htmohta@hayashibara.co.jp			Hayashibara Biochemical Laboratories Inc; Cell Biology Institute, Hayashibara Biochemical Laboratories, Inc.	Hayashibara Biochemical Laboratories Inc; Cell Biology Institute, Hayashibara Biochemical Laboratories, Inc.	Funding for this study was provided by Hayashibara Biochemical Laboratories Inc. The authors are employees of Hayashibara Biochemical Laboratories Inc., and they participated in study design, data collection, decision to publish and preparation of the manuscript.; We would like to thank Dr. Makoto Takeuchi (Cell Biology Institute, Hayashibara Biochemical Laboratories, Inc.) for supporting the EM study.	Agdeppa ED, 2003, NEUROSCIENCE, V117, P723, DOI 10.1016/S0306-4522(02)00907-7; AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Arendash GW, 2004, BRAIN RES, V1012, P29, DOI 10.1016/j.brainres.2004.02.081; Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Brightwell JJ, 2007, LEARN MEMORY, V14, P195, DOI 10.1101/lm.395407; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Clapcote SJ, 2004, BEHAV BRAIN RES, V152, P35, DOI 10.1016/j.bbr.2003.09.030; Clapcote SJ, 2006, GENETICS, V173, P2407, DOI 10.1534/genetics.106.060749; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gevais F, 1999, CELL, V97, P395; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; Horgan J, 2007, J ALZHEIMERS DIS, V12, P115; Hsiao K, 1998, EXP GERONTOL, V33, P883, DOI 10.1016/S0531-5565(98)00045-X; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Ishihara M, 2006, IN VIVO, V20, P845; Kogure K, 1998, BIOL PHARM BULL, V21, P180; Koya-Miyata S, 2010, BIOL PHARM BULL, V33, P1872, DOI 10.1248/bpb.33.1872; Kunikata T, 2002, BIOL PHARM BULL, V25, P1018, DOI 10.1248/bpb.25.1018; Kurinami H, 2008, INT J MOL MED, V21, P531; Lashuel HA, 2002, J BIOL CHEM, V277, P42881, DOI 10.1074/jbc.M206593200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Levites Y, 2006, FASEB J, V20, P2576, DOI 10.1096/fj.06-6463fje; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; MATTSON MP, 1995, BRAIN RES, V676, P219, DOI 10.1016/0006-8993(95)00148-J; Maurice T, 1996, BRAIN RES, V706, P181, DOI 10.1016/0006-8993(95)01032-7; Mito Keiichiro, 1996, Frontiers of Medical and Biological Engineering, V7, P81; Montkowski A, 1997, BRAIN RES, V762, P12, DOI 10.1016/S0006-8993(97)00370-3; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Nagai T, 2002, FASEB J, V16, P50, DOI 10.1096/fj.02-0448fje; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nicolle MM, 2003, LEARN MEMORY, V10, P520, DOI 10.1101/lm.64803; Ohta H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017137; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pillot T, 1999, J NEUROCHEM, V73, P1626, DOI 10.1046/j.1471-4159.1999.0731626.x; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rustay NR, 2010, BRAIN RES, V1311, P136, DOI 10.1016/j.brainres.2009.11.040; SASAKI Y, 1987, FOLIA PHARMACOL JPN, V89, P1, DOI 10.1254/fpj.89.1; SASAKI Y, 1987, FOLIA PHARMACOL JPN, V89, P9, DOI 10.1254/fpj.89.9; Save E, 2000, BEHAV BRAIN RES, V109, P195, DOI 10.1016/S0166-4328(99)00173-4; Savory J, 1999, NEUROTOXICOLOGY, V20, P805; SHEARMAN MS, 1994, P NATL ACAD SCI USA, V91, P1470, DOI 10.1073/pnas.91.4.1470; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; TAMAOKA A, 1994, J BIOL CHEM, V269, P32721; Thomas T, 2001, NEUROREPORT, V12, P3263, DOI 10.1097/00001756-200110290-00024; Tomita K, 2011, HUM MOL GENET, V20, P2834, DOI 10.1093/hmg/ddr194; Ushio C, 2009, BIOMED RES-TOKYO, V30, P365, DOI 10.2220/biomedres.30.365; Van Dam D, 2006, NEUROBIOL LEARN MEM, V85, P164, DOI 10.1016/j.nlm.2005.09.006; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Winters BD, 2005, J NEUROSCI, V25, P4243, DOI 10.1523/JNEUROSCI.0480-05.2005; Wolfer DP, 1997, BRAIN RES, V771, P1, DOI 10.1016/S0006-8993(97)00673-2; YOSHIOKA K, 1991, BIOCHEM BIOPH RES CO, V178, P1141, DOI 10.1016/0006-291X(91)91011-Z; Zhu XW, 2001, J NEUROCHEM, V76, P435, DOI 10.1046/j.1471-4159.2001.00046.x	61	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e30007	10.1371/journal.pone.0030007	http://dx.doi.org/10.1371/journal.pone.0030007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238689	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200066
J	Zhang, XL; Dai, YH; Zhang, SY; She, WD; Du, XP; Shui, XJ				Zhang, Xiuling; Dai, Yanhong; Zhang, Shuyi; She, Wandong; Du, Xiaoping; Shui, Xiuji			Small Tympanic Membrane Perforations in the Inferior Quadrants Do Not Impact the Manubrium Vibration in Guinea Pigs	PLOS ONE			English	Article							MIDDLE-EAR; HEARING-LOSS; TRANSMISSION	Background: It has been believed that location of the perforation has a significant impact on hearing loss. However, recent studies have demonstrated that the perforation sites had no impact on hearing loss. We measured the velocity and pattern of the manubrium vibration in guinea pigs with intact and perforated eardrum using a laser Doppler vibrometer in order to determine the effects of different location perforations on the middle ear transfer functions. Methods: Two bullas from 2 guinea pigs were used to determine stability of the umbo velocities, and 12 bullas from six guinea pigs to determine the effects of different location perforations on sound transmission. The manubrium velocity was measured at three points on the manubrium in the frequencies of 0.5-8 kHz before and after a perforation was made. The sites of perforations were in anterior-inferior (AI) quadrants of left ears and posterior-inferior (PI) quadrants of right ears. Results: The manubrium vibration velocity losses were noticed in the perforated ears only below 1.5 kHz. The maximum velocity loss was about 7 dB at 500 Hz with the PI perforation. No significant difference in the velocity loss was found between AI and PI perforations. The average ratio of short process velocity to the umbo velocity was approximately 0.5 at all frequencies. No significant differences were found before and after perforation at all frequencies (p>0.05) except 7 kHz (p = 0.004) for both AI and PI perforations. Conclusions: The manubrium vibration velocity losses from eardrum perforation were frequency-dependent and the largest losses occur at low frequencies. Manubrium velocity losses caused by small acute inferior perforations in guinea pigs have no significant impact on middle ear sound transmission at any frequency tested. The manubrium vibration axis may be perpendicular to the manubrium below 8 kHz in guinea pigs.	[Zhang, Xiuling; Dai, Yanhong; She, Wandong] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Otolaryngol Head & Neck Surg, Nanjing, Jiangsu, Peoples R China; [Zhang, Shuyi; Shui, Xiuji] Nanjing Univ, Inst Acoust, Lab Modern Acoust, Nanjing, Jiangsu, Peoples R China; [Du, Xiaoping] Hough Ear Inst, Oklahoma City, OK USA	Nanjing University; Nanjing University	She, WD (corresponding author), Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Otolaryngol Head & Neck Surg, Nanjing, Jiangsu, Peoples R China.	shewandong@163.com			Health Bureau of Nanjing City, Jiangsu Province, China [YKK08054]	Health Bureau of Nanjing City, Jiangsu Province, China	This study was supported by a grant (No: YKK08054) for the Development of Medical Sciences from the Health Bureau of Nanjing City, Jiangsu Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD SW, 1979, J LARYNGOL OTOL, V93, P1091, DOI 10.1017/S0022215100088162; Akache F, 2007, AUDIOL NEURO-OTOL, V12, P49, DOI 10.1159/000097247; ANTHONY WP, 1972, ARCHIV OTOLARYNGOL, V95, P506; Bigelow DC, 1996, LARYNGOSCOPE, V106, P71, DOI 10.1097/00005537-199601000-00014; DAVIDSON BJ, 1992, AM FAM PHYSICIAN, V45, P1777; Fleischer G, 1978, Adv Anat Embryol Cell Biol, V55, P3; Gan RZ, 2009, J ACOUST SOC AM, V126, P243, DOI 10.1121/1.3129129; GOODE RL, 1993, AM J OTOL, V14, P247; Ibekwe TS, 2009, BMC EAR NOSE THROAT, V9, DOI 10.1186/1472-6815-9-1; KHANNA SM, 1969, ARCH KLIN EXP OHR, V193, P78, DOI 10.1007/BF00417239; Maharjan M, 2009, Kathmandu Univ Med J (KUMJ), V7, P397; Mehta RP, 2006, OTOL NEUROTOL, V27, P136, DOI 10.1097/01.mao.0000176177.17636.53; SAUNDERS JC, 1982, J COMP PHYSIOL, V146, P517, DOI 10.1007/BF00609448; Voss SE, 2001, ACTA OTO-LARYNGOL, V121, P169; Voss SE, 2001, J ACOUST SOC AM, V110, P1432, DOI 10.1121/1.1394195; Voss SE, 2001, J ACOUST SOC AM, V110, P1445, DOI 10.1121/1.1394196; Voss SE, 2007, J ACOUST SOC AM, V122, P2135, DOI 10.1121/1.2769617	17	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28961	10.1371/journal.pone.0028961	http://dx.doi.org/10.1371/journal.pone.0028961			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238584	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200014
J	Flores, C; Ma, SF; Pino-Yanes, M; Wade, MS; Perez-Mendez, L; Kittles, RA; Wang, DL; Papaiahgari, S; Ford, JG; Kumar, R; Garcia, JGN				Flores, Carlos; Ma, Shwu-Fan; Pino-Yanes, Maria; Wade, Michael S.; Perez-Mendez, Lina; Kittles, Rick A.; Wang, Deli; Papaiahgari, Srinivas; Ford, Jean G.; Kumar, Rajesh; Garcia, Joe G. N.			African Ancestry Is Associated with Asthma Risk in African Americans	PLOS ONE			English	Article							ETHNICALLY DIVERSE POPULATIONS; NUCLEOTIDE-POLYMORPHISM PANEL; SKIN COLOR; GENETIC ANCESTRY; CHILDHOOD ASTHMA; BLOOD-PRESSURE; RACIAL-DISCRIMINATION; ADMIXTURE PROPORTIONS; SOCIOECONOMIC-STATUS; ADMIXED POPULATIONS	Background: Asthma is a common complex condition with clear racial and ethnic differences in both prevalence and severity. Asthma consultation rates, mortality, and severe symptoms are greatly increased in African descent populations of developed countries. African ancestry has been associated with asthma, total serum IgE and lower pulmonary function in African-admixed populations. To replicate previous findings, here we aimed to examine whether African ancestry was associated with asthma susceptibility in African Americans. In addition, we examined for the first time whether African ancestry was associated with asthma exacerbations. Methodology/Principal Findings: After filtering for self-reported ancestry and genotype data quality, samples from 1,117 self-reported African-American individuals from New York and Baltimore (394 cases, 481 controls), and Chicago (321 cases followed for asthma exacerbations) were analyzed. Genetic ancestry was estimated based on ancestry informative markers (AIMs) selected for being highly divergent among European and West African populations (95 AIMs for New York and Baltimore, and 66 independent AIMs for Chicago). Among case-control samples, the mean African ancestry was significantly higher in asthmatics than in non-asthmatics (82.0+/-14.0% vs. 77.8+/-18.1%, mean difference 4.2% [ 95% confidence interval (CI): 2.0-6.4], p < 0.0001). This association remained significant after adjusting for potential confounders (odds ratio: 4.55, 95% CI: 1.69-12.29, p = 0.003). African ancestry failed to show an association with asthma exacerbations (p = 0.965) using a model based on longitudinal data of the number of exacerbations followed over 1.5 years. Conclusions/Significance: These data replicate previous findings indicating that African ancestry constitutes a risk factor for asthma and suggest that elevated asthma rates in African Americans can be partially attributed to African genetic ancestry.	[Flores, Carlos; Pino-Yanes, Maria; Perez-Mendez, Lina] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Flores, Carlos; Pino-Yanes, Maria; Perez-Mendez, Lina] Hosp Univ NS Candelaria, Res Unit, Tenerife, Spain; [Ma, Shwu-Fan] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA; [Wade, Michael S.; Garcia, Joe G. N.] Univ Illinois, Dept Med, Inst Personalized Resp Med, Chicago, IL USA; [Kittles, Rick A.] Univ Illinois, Dept Med, Hematol Oncol Sect, Chicago, IL USA; [Wang, Deli; Kumar, Rajesh] Northwestern Univ, Chicago, IL 60611 USA; [Papaiahgari, Srinivas; Ford, Jean G.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Kumar, Rajesh] Childrens Mem Hosp, Div Allergy & Immunol, Chicago, IL 60614 USA	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Ann & Robert H. Lurie Children's Hospital of Chicago	Flores, C (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain.	cflores@ull.es	Pino-Yanes, Maria/C-8498-2017; Flores, Carlos/R-1159-2019	Pino-Yanes, Maria/0000-0003-0332-437X; Perez-Mendez, Lina/0000-0001-8246-333X; Kumar, Rajesh/0000-0002-1962-7108; Papaiahgari, Srinivas/0000-0002-1110-7562; Flores, Carlos/0000-0001-5352-069X	National Heart Lung Blood Institute NIH [HL91899, HL58064, GM07019]; Spanish Ministry of Science and Innovation [PI081383, EMER07/001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064, K23HL093023] Funding Source: NIH RePORTER	National Heart Lung Blood Institute NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Heart Lung Blood Institute NIH grants HL91899, HL58064, and GM07019, and by grants from the Spanish Ministry of Science and Innovation PI081383 and EMER07/001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbami LJ, 2002, PEDIATRICS, V110, P315, DOI 10.1542/peds.110.2.315; Barnes Kathleen C, 2007, Proc Am Thorac Soc, V4, P58, DOI 10.1513/pats.200607-146JG; Blumenthal MN, 2004, GENES IMMUN, V5, P226, DOI 10.1038/sj.gene.6364063; Borrell LN, 2006, SOC SCI MED, V63, P1415, DOI 10.1016/j.socscimed.2006.04.008; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; El-Ekiaby A, 2006, AM J RESP CRIT CARE, V174, P508, DOI 10.1164/rccm.200603-431OC; Flores C, 2007, GENET EPIDEMIOL, V31, P296, DOI 10.1002/gepi.20210; Ford JG, 2001, CHEST, V120, P1129, DOI 10.1378/chest.120.4.1129; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; GLEIBERMAN L, 1995, ANN HUM BIOL, V22, P69, DOI 10.1080/03014469500003712; Gupta RS, 2008, J ALLERGY CLIN IMMUN, V121, P639, DOI 10.1016/j.jaci.2007.11.036; Hancock DB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000623; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; HOPP RJ, 1984, J ALLERGY CLIN IMMUN, V73, P265, DOI 10.1016/S0091-6749(84)80018-4; KLAG MJ, 1991, JAMA-J AM MED ASSOC, V265, P599, DOI 10.1001/jama.265.5.599; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Krieger N, 1998, AM J PUBLIC HEALTH, V88, P1308, DOI 10.2105/AJPH.88.9.1308; Kumar R, 2010, NEW ENGL J MED, V363, P321, DOI 10.1056/NEJMoa0907897; Lester LA, 2001, J ALLERGY CLIN IMMUN, V108, P357, DOI 10.1067/mai.2001.117796; Lind JM, 2007, HUM GENET, V120, P713, DOI 10.1007/s00439-006-0261-7; Little J, 2006, HUGENETTM HUGE REV H; Marsh DG, 1997, NAT GENET, V15, P389; Mathias RA, 2010, J ALLERGY CLIN IMMUN, V125, P336, DOI 10.1016/j.jaci.2009.08.031; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Mountain JL, 2004, NAT GENET, V36, pS48, DOI 10.1038/ng1456; National Heart Lung Blood Institute, 1997, 2 NAT HEART LUNG BLO; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pritchard JK, 2000, GENETICS, V155, P945; Seibold MA, 2008, HUM MOL GENET, V17, P2681, DOI 10.1093/hmg/ddn168; Shalowitz MU, 2007, AMBUL PEDIATR, V7, P271, DOI 10.1016/j.ambp.2007.03.004; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Standardization of Spirometry, 1994, AM J RESP CRIT CARE, V152, P1107; Stefflova K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007842; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun XG, 2010, J ALLERGY CLIN IMMUN, V126, P241, DOI 10.1016/j.jaci.2010.04.036; Sweet E, 2007, AM J PUBLIC HEALTH, V97, P2253, DOI 10.2105/AJPH.2006.088799; Tian C, 2007, AM J HUM GENET, V80, P1014, DOI 10.1086/513522; Tian C, 2006, AM J HUM GENET, V79, P640, DOI 10.1086/507954; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Tsai HJ, 2006, HUM GENET, V118, P626, DOI 10.1007/s00439-005-0080-2; Tsai HJ, 2005, HUM GENET, V118, P424, DOI 10.1007/s00439-005-0067-z; Vergara C, 2009, HUM GENET, V125, P565, DOI 10.1007/s00439-009-0649-2; Yang JJ, 2008, J ALLERGY CLIN IMMUN, V122, P820, DOI 10.1016/j.jaci.2008.07.044; Zakharia F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r141; Zhang F, HUM HERED, V69, P28	55	43	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e26807	10.1371/journal.pone.0026807	http://dx.doi.org/10.1371/journal.pone.0026807			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	903NK	22235241	Green Submitted, Green Published, gold			2022-12-27	WOS:000301123400002
J	Ma, YY; Liang, DM; Liu, J; Axcrona, K; Kvalheim, G; Stokke, T; Nesland, JM; Suo, ZH				Ma, Yuanyuan; Liang, Dongming; Liu, Jian; Axcrona, Karol; Kvalheim, Gunnar; Stokke, Trond; Nesland, Jahn M.; Suo, Zhenhe			Prostate Cancer Cell Lines under Hypoxia Exhibit Greater Stem-Like Properties	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; GENE-EXPRESSION; INDUCIBLE FACTORS; OVARIAN-CANCER; NEUROENDOCRINE CELLS; STROMAL CELLS; SELF-RENEWAL; HIF-1-ALPHA; RESISTANCE; BREAST	Hypoxia is an important environmental change in many cancers. Hypoxic niches can be occupied by cancer stem/progenitor-like cells that are associated with tumor progression and resistance to radiotherapy and chemotherapy. However, it has not yet been fully elucidated how hypoxia influences the stem-like properties of prostate cancer cells. In this report, we investigated the effects of hypoxia on human prostate cancer cell lines, PC-3 and DU145. In comparison to normoxia (20% O-2), 7% O-2 induced higher expressions of HIF-1 alpha and HIF-2 alpha, which were associated with upregulation of Oct3/4 and Nanog; 1% O-2 induced even greater levels of these factors. The upregulated NANOG mRNA expression in hypoxia was confirmed to be predominantly retrogene NANOGP8. Similar growth rates were observed for cells cultivated under hypoxic and normoxic conditions for 48 hours; however, the colony formation assay revealed that 48 hours of hypoxic pretreatment resulted in the formation of more colonies. Treatment with 1% O-2 also extended the G(0)/G(1) stage, resulting in more side population cells, and induced CD44 and ABCG2 expressions. Hypoxia also increased the number of cells positive for ABCG2 expression, which were predominantly found to be CD44(bright) cells. Correspondingly, the sorted CD44(bright) cells expressed higher levels of ABCG2, Oct3/4, and Nanog than CD44(dim) cells, and hypoxic pretreatment significantly increased the expressions of these factors. CD44(bright) cells under normoxia formed significantly more colonies and spheres compared with the CD44(dim) cells, and hypoxic pretreatment even increased this effect. Our data indicate that prostate cancer cells under hypoxia possess greater stem-like properties.	[Ma, Yuanyuan; Liang, Dongming; Liu, Jian; Nesland, Jahn M.; Suo, Zhenhe] Univ Oslo, Norwegian Radium Hosp, Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Axcrona, Karol] Univ Oslo, Norwegian Radium Hosp, Oslo Univ Hosp, Dept Urol, Oslo, Norway; [Kvalheim, Gunnar] Univ Oslo, Norwegian Radium Hosp, Oslo Univ Hosp, Dept Cell Therapy, Oslo, Norway; [Stokke, Trond] Univ Oslo, Norwegian Radium Hosp, Oslo Univ Hosp, Dept Radiat Biol,Inst Canc Res, Oslo, Norway; [Ma, Yuanyuan; Nesland, Jahn M.; Suo, Zhenhe] Univ Oslo, Inst Clin Med, Fac Med, Dept Pathol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Ma, YY (corresponding author), Univ Oslo, Norwegian Radium Hosp, Oslo Univ Hosp, Dept Pathol, Oslo, Norway.	zhenhes@medisin.uio.no		, Karol/0000-0002-5011-0107	Norwegian Radium Hospital Research Foundation [333005]	Norwegian Radium Hospital Research Foundation	This work was supported by The Norwegian Radium Hospital Research Foundation with grant number 333005 to ZS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambady S, 2010, INT J DEV BIOL, V54, P1743, DOI 10.1387/ijdb.103192sa; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Bae KM, 2010, J UROLOGY, V183, P2045, DOI 10.1016/j.juro.2009.12.092; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bhatt RI, 2003, CYTOM PART A, V54A, P89, DOI 10.1002/cyto.a.10058; Bryant CS, 2010, ARCH GYNECOL OBSTET, V282, P677, DOI 10.1007/s00404-010-1381-9; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016466; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cortes-Dericks L, 2010, INT J ONCOL, V37, P437, DOI 10.3892/ijo_00000692; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Crea F, 2009, ANTI-CANCER AGENT ME, V9, P1105, DOI 10.2174/187152009789735053; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Hong SP, 2009, INT J CANCER, V125, P2323, DOI 10.1002/ijc.24573; Hua KQ, 2009, ONCOL REP, V21, P893, DOI 10.3892/or_00000300; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Ishimoto T, 2010, CANCER SCI, V101, P673, DOI 10.1111/j.1349-7006.2009.01430.x; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Khandrika L, 2009, ONCOGENE, V28, P1248, DOI 10.1038/onc.2008.476; Kim JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007166; Kim Y, 2009, CANCER RES, V69, P9271, DOI 10.1158/0008-5472.CAN-09-1605; Kim Y, 2009, CURR MOL MED, V9, P425, DOI 10.2174/156652409788167113; Kimbro KS, 2006, ENDOCR-RELAT CANCER, V13, P739, DOI 10.1677/erc.1.00728; Koh MY, 2009, CELL CYCLE, V8, P1359, DOI 10.4161/cc.8.9.8303; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Li ZZ, 2010, CURR TOP MICROBIOL, V345, P21, DOI 10.1007/82_2010_75; Liu T, 2010, MOL CELL BIOCHEM, V340, P265, DOI 10.1007/s11010-010-0426-5; Lukacs RU, 2008, COLD SH Q B, V73, P491, DOI 10.1101/sqb.2008.73.012; Ma T, 2009, BIOTECHNOL PROGR, V25, P32, DOI 10.1002/btpr.128; Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472; Malladi P, 2007, TISSUE ENG, V13, P1159, DOI 10.1089/ten.2006.0265; Marignol L, 2008, CANCER TREAT REV, V34, P313, DOI 10.1016/j.ctrv.2008.01.006; Marsden CG, 2009, METHODS MOL BIOL, V590, P363, DOI 10.1007/978-1-60327-378-7_23; Mathews LA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-267; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mohan A, 2006, BRIT J OPHTHALMOL, V90, P889, DOI 10.1136/bjo.2005.089219; Monsef N, 2007, PROSTATE, V67, P1219, DOI 10.1002/pros.20594; Mori R, 2010, PROSTATE, V70, P1692, DOI 10.1002/pros.21204; Nirasawa S, 2009, ONCOL REP, V22, P587, DOI 10.3892/or_00000476; Oates JE, 2009, STEM CELLS DEV, V18, P1515, DOI 10.1089/scd.2008.0302; Palapattu GS, 2009, PROSTATE, V69, P787, DOI 10.1002/pros.20928; Park JY, 2009, BIOCHEM BIOPH RES CO, V382, P96, DOI 10.1016/j.bbrc.2009.02.129; Pascal Laura E, 2007, BMC Urol, V7, P6, DOI 10.1186/1471-2490-7-6; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Ponti D, 2006, EUR J CANCER, V42, P1219, DOI 10.1016/j.ejca.2006.01.031; Saigusa S, 2009, ANN SURG ONCOL, V16, P3488, DOI 10.1245/s10434-009-0617-z; Sharifi N, 2006, CANCER BIOL THER, V5, P901, DOI 10.4161/cbt.5.8.2949; Shin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021492; Sotomayor P, 2009, PROSTATE, V69, P401, DOI 10.1002/pros.20895; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Yasuda S, 2006, GENES CELLS, V11, P1115, DOI 10.1111/j.1365-2443.2006.01000.x; Zhang JY, 2006, FEBS J, V273, P1723, DOI 10.1111/j.1742-4658.2006.05186.x	56	66	69	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29170	10.1371/journal.pone.0029170	http://dx.doi.org/10.1371/journal.pone.0029170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216200	Green Published, Green Submitted, gold			2022-12-27	WOS:000300676300033
J	Villarroya, J; Dorado, B; Vila, MR; Garcia-Arumi, E; Domingo, P; Giralt, M; Hirano, M; Villarroya, F				Villarroya, Joan; Dorado, Beatriz; Vila, Maya R.; Garcia-Arumi, Elena; Domingo, Pere; Giralt, Marta; Hirano, Michio; Villarroya, Francesc			Thymidine Kinase 2 Deficiency-Induced Mitochondrial DNA Depletion Causes Abnormal Development of Adipose Tissues and Adipokine Levels in Mice	PLOS ONE			English	Article							GENE-EXPRESSION; BIOGENESIS; TRANSCRIPTION; ADIPOCYTE; ACTIVATION; MUTATIONS; TRANSPORT; MYOPATHY; DEPOTS; LIPOMA	Mammal adipose tissues require mitochondrial activity for proper development and differentiation. The components of the mitochondrial respiratory chain/oxidative phosphorylation system (OXPHOS) are encoded by both mitochondrial and nuclear genomes. The maintenance of mitochondrial DNA (mtDNA) is a key element for a functional mitochondrial oxidative activity in mammalian cells. To ascertain the role of mtDNA levels in adipose tissue, we have analyzed the alterations in white (WAT) and brown (BAT) adipose tissues in thymidine kinase 2 (Tk2) H126N knockin mice, a model of TK2 deficiency-induced mtDNA depletion. We observed respectively severe and moderate mtDNA depletion in TK2-deficient BAT and WAT, showing both tissues moderate hypotrophy and reduced fat accumulation. Electron microscopy revealed altered mitochondrial morphology in brown but not in white adipocytes from TK2-deficient mice. Although significant reduction in mtDNA-encoded transcripts was observed both in WAT and BAT, protein levels from distinct OXPHOS complexes were significantly reduced only in TK2-deficient BAT. Accordingly, the activity of cytochrome c oxidase was significantly lowered only in BAT from TK2-deficient mice. The analysis of transcripts encoding up to fourteen components of specific adipose tissue functions revealed that, in both TK2-deficient WAT and BAT, there was a consistent reduction of thermogenesis related gene expression and a severe reduction in leptin mRNA. Reduced levels of resistin mRNA were found in BAT from TK2-deficient mice. Analysis of serum indicated a dramatic reduction in circulating levels of leptin and resistin. In summary, our present study establishes that mtDNA depletion leads to a moderate impairment in mitochondrial respiratory function, especially in BAT, causes substantial alterations in WAT and BAT development, and has a profound impact in the endocrine properties of adipose tissues.	[Villarroya, Joan; Giralt, Marta; Villarroya, Francesc] Univ Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain; [Villarroya, Joan; Giralt, Marta; Villarroya, Francesc] Univ Barcelona, Inst Biomed IBUB, Barcelona, Spain; [Villarroya, Joan; Domingo, Pere] Hosp Santa Creu & Sant Pau, Inst Recerca, Barcelona, Spain; [Villarroya, Joan; Giralt, Marta; Villarroya, Francesc] ISCIII, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Santiago De Compostela, Spain; [Dorado, Beatriz; Hirano, Michio] Columbia Univ Med Ctr, Dept Neurol, New York, NY USA; [Vila, Maya R.; Garcia-Arumi, Elena] Hosp Univ Vall dHebron, Inst Recerca, Barcelona, Spain; [Garcia-Arumi, Elena] ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Valencia, Spain	University of Barcelona; University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Columbia University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Villarroya, J (corresponding author), Univ Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain.	joanvillarroya@gmail.com	Villarroya, Francesc/K-4357-2014; Villarroya, Joan/W-4066-2018; Garcia-Arumi, Elena/ABH-4229-2020; Giralt, Marta/A-4756-2013; Domingo, Pere/CAF-3577-2022; Domingo, Pere/AAP-7571-2021	Villarroya, Joan/0000-0002-7859-1109; Giralt, Marta/0000-0001-7968-4190; Domingo, Pere/0000-0003-1138-5770; Villarroya, Francesc/0000-0003-1266-9142; Dorado, Beatriz/0000-0002-1958-4558; Garcia-Arumi, Elena/0000-0003-0096-3336	Ministerio de Ciencia e Innovacion [SAF2008-01896]; Instituto de Salud Carlos III; Red de Investigacion en SIDA [PI081715]; Fundacion para la Investigacion y la Prevencion del Sida en Espana (FIPSE) [36610/06]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Red de Investigacion en SIDA; Fundacion para la Investigacion y la Prevencion del Sida en Espana (FIPSE)	Ministerio de Ciencia e Innovacion SAF2008-01896, Instituto de Salud Carlos III and Red de Investigacion en SIDA PI081715, Fundacion para la Investigacion y la Prevencion del Sida en Espana (FIPSE)36610/06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143; Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x; Bogacka I, 2005, J CLIN ENDOCR METAB, V90, P6650, DOI 10.1210/jc.2005-1024; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carmona MC, 2002, J BIOL CHEM, V277, P21489, DOI 10.1074/jbc.M201710200; Chevillotte E, 2007, DIABETES, V56, P1042, DOI 10.2337/db06-1300; Cote HC, 2005, ANTIVIR THER, P10; Dessolin S, 1997, FASEB J, V11, P382, DOI 10.1096/fasebj.11.5.9141506; DeVos P, 1996, J CLIN INVEST, V98, P1004, DOI 10.1172/JCI118860; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3; GREENWOOD MR, 1974, J LIPID RES, V15, P474; Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; HE YF, 1995, J BIOL CHEM, V270, P28887, DOI 10.1074/jbc.270.48.28887; HOUSTEK J, 1995, J BIOL CHEM, V270, P7689, DOI 10.1074/jbc.270.13.7689; Kim MJ, 2008, ANTIMICROB AGENTS CH, V52, P1670, DOI 10.1128/AAC.01449-07; LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603; LIN PY, 1977, J NUTR, V107, P1715, DOI 10.1093/jn/107.9.1715; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A; Nagy GS, 2003, CLIN INFECT DIS, V36, P795, DOI 10.1086/367859; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nolan D, 2003, AIDS, V17, P1329, DOI 10.1097/00002030-200306130-00007; Oliver P, 2003, MOL CELL BIOCHEM, V252, P397, DOI 10.1023/A:1025500605884; Oliver P, 2001, PFLUG ARCH EUR J PHY, V442, P383, DOI 10.1007/s004240100540; Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122; Pace CS, 2003, ANTIVIR THER, V8, P323; Ravussin E, 2009, OBES REV, V10, P265, DOI 10.1111/j.1467-789X.2008.00559.x; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Shi XR, 2008, J BIOL CHEM, V283, P30658, DOI 10.1074/jbc.M800510200; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2; Suzuki Y, 2004, DIABETES RES CLIN PR, V63, P225, DOI 10.1016/j.diabres.2003.10.024; Suzuki Y, 2002, DIABETES CARE, V25, P407, DOI 10.2337/diacare.25.2.407; Vila MR, 2008, J NEUROL SCI, V267, P137, DOI 10.1016/j.jns.2007.10.019; Vila MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47; Villarroya F, 2005, TRENDS PHARMACOL SCI, V26, P88, DOI 10.1016/j.tips.2004.12.005; Villarroya J, 2010, ANTIVIR THER, V15, P1021, DOI 10.3851/IMP1669; Villarroya J, 2009, OBESITY, V17, P1814, DOI 10.1038/oby.2009.152; Villena JA, 2002, CELL MOL LIFE SCI, V59, P1934, DOI 10.1007/PL00012516; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133	47	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29691	10.1371/journal.pone.0029691	http://dx.doi.org/10.1371/journal.pone.0029691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216345	Green Published, Green Submitted, gold			2022-12-27	WOS:000300674900054
J	Zhang, G; Karns, R; Sun, GY; Indugula, SR; Cheng, H; Havas-Augustin, D; Novokmet, N; Rudan, D; Durakovic, Z; Missoni, S; Chakraborty, R; Rudan, P; Deka, R				Zhang, Ge; Karns, Rebekah; Sun, Guangyun; Indugula, Subba Rao; Cheng, Hong; Havas-Augustin, Dubravka; Novokmet, Natalija; Rudan, Dusko; Durakovic, Zijad; Missoni, Sasa; Chakraborty, Ranajit; Rudan, Pavao; Deka, Ranjan			Extent of Height Variability Explained by Known Height-Associated Genetic Variants in an Isolated Population of the Adriatic Coast of Croatia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON SNPS EXPLAIN; ADULT HEIGHT; QUANTITATIVE TRAITS; LARGE PROPORTION; GENOTYPE CALLS; LOCI; HERITABILITY; GROWTH; IDENTIFICATION	Background: Human height is a classical example of a polygenic quantitative trait. Recent large-scale genome-wide association studies (GWAS) have identified more than 200 height-associated loci, though these variants explain only 2 similar to 10% of overall variability of normal height. The objective of this study was to investigate the variance explained by these loci in a relatively isolated population of European descent with limited admixture and homogeneous genetic background from the Adriatic coast of Croatia. Methodology/Principal Findings: In a sample of 1304 individuals from the island population of Hvar, Croatia, we performed genome-wide SNP typing and assessed the variance explained by genetic scores constructed from different panels of height-associated SNPs extracted from five published studies. The combined information of the 180 SNPs reported by Lango Allen el al. explained 7.94% of phenotypic variation in our sample. Genetic scores based on 20 similar to 50 SNPs reported by the remaining individual GWA studies explained 3 similar to 5% of height variance. These percentages of variance explained were within ranges comparable to the original studies and heterogeneity tests did not detect significant differences in effect size estimates between our study and the original reports, if the estimates were obtained from populations of European descent. Conclusions/Significance: We have evaluated the portability of height-associated loci and the overall fitting of estimated effect sizes reported in large cohorts to an isolated population. We found proportions of explained height variability were comparable to multiple reference GWAS in cohorts of European descent. These results indicate similar genetic architecture and comparable effect sizes of height loci among populations of European descent.	[Zhang, Ge] Cincinnati Childrens Hosp, Div Human Genet, Cincinnati, OH 45229 USA; [Karns, Rebekah; Sun, Guangyun; Indugula, Subba Rao; Cheng, Hong; Deka, Ranjan] Univ Cincinnati, Dept Environm Hlth, Ctr Genome Informat, Cincinnati, OH USA; [Havas-Augustin, Dubravka; Novokmet, Natalija; Rudan, Dusko; Durakovic, Zijad; Missoni, Sasa; Rudan, Pavao] Inst Anthropol Res, Zagreb, Croatia; [Chakraborty, Ranajit] Univ N Texas Hlth Sci Ctr, Inst Invest Genet, Ctr Computat Genom, Ft Worth, TX USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Institute for Anthropological Research Zagreb; University of North Texas System; University of North Texas Health Science Center	Zhang, G (corresponding author), Cincinnati Childrens Hosp, Div Human Genet, Cincinnati, OH 45229 USA.	ranjan.deka@uc.edu	Missoni, Sasa/G-8821-2013; Zhang, Ge/F-1809-2011	Missoni, Sasa/0000-0002-6542-9970	National Institutes of Health, United States of America [R01 DK069845, R01 DK069845-4S, P30 ES006096]; Croatian Ministry of Science, Education and Sports [196-1962766-2751, 196-1962766-2747, 196-0342282-0291]; National Institutes of Environmental Health Sciences, USA [T32 ES010957]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, T32ES010957] Funding Source: NIH RePORTER	National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); National Institutes of Environmental Health Sciences, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study was supported by grants from the National Institutes of Health, United States of America (R01 DK069845, R01 DK069845-4S and P30 ES006096) and from the Croatian Ministry of Science, Education and Sports (196-1962766-2751, 196-1962766-2747 and 196-0342282-0291). RK was supported by a training grant fellowship from the National Institutes of Environmental Health Sciences, USA (T32 ES010957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2009, EUR J HUM GENET, V17, P1070, DOI 10.1038/ejhg.2009.5; Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042; Carvalho BS, 2010, BIOINFORMATICS, V26, P242, DOI 10.1093/bioinformatics/btp624; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, GENET EPIDEMIOL, V21, P273, DOI 10.1002/gepi.1034; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frayling TM, 2002, DIABETES, V51, P2313, DOI 10.2337/diabetes.51.7.2313; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Johansson A, 2009, HUM MOL GENET, V18, P373, DOI 10.1093/hmg/ddn350; Karns R, 2011, EUR J HUM GENET, V19, P341, DOI 10.1038/ejhg.2010.178; Kim JJ, 2010, J HUM GENET, V55, P27, DOI 10.1038/jhg.2009.116; Knight S, 2011, GENET EPIDEMIOL, V35, P174, DOI 10.1002/gepi.20565; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Lettre G, 2007, HUM GENET, V122, P129, DOI 10.1007/s00439-007-0385-4; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liu JZ, 2010, TWIN RES HUM GENET, V13, P179, DOI 10.1375/twin.13.2.179; Okada Y, 2010, HUM MOL GENET, V19, P2303, DOI 10.1093/hmg/ddq091; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Polasek O, 2009, CROAT MED J, V50, P7, DOI 10.3325/cmj.2009.50.7; Rudan P, 2004, COLLEGIUM ANTROPOL, V28, P321; RUDAN P, 1992, SOC ST HUM, V33, P204; Saint Pierre Aude, 2009, BMC Proc, V3 Suppl 7, pS122; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Walenkamp MJE, 2006, HORM RES, V66, P221, DOI 10.1159/000095161; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang TL, 2008, EUR J HUM GENET, V16, P1380, DOI 10.1038/ejhg.2008.113; Zhang G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010375	46	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29475	10.1371/journal.pone.0029475	http://dx.doi.org/10.1371/journal.pone.0029475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216288	gold, Green Published, Green Submitted			2022-12-27	WOS:000300674900038
J	Liu, WS; Swetzig, WM; Medisetty, R; Das, GM				Liu, Wensheng; Swetzig, Wendy M.; Medisetty, Rajesh; Das, Gokul M.			Estrogen-Mediated Upregulation of Noxa Is Associated with Cell Cycle Progression in Estrogen Receptor-Positive Breast Cancer Cells	PLOS ONE			English	Article							BCL-2 FAMILY; DEPENDENT APOPTOSIS; BH3-ONLY PROTEINS; LEUKEMIA-CELLS; RISK-FACTORS; C-MYC; EXPRESSION; P53; ALPHA; PUMA	Noxa is a Bcl-2-homology domain (BH3)-only protein reported to be a proapoptotic member of the Bcl-2 family. Estrogen has been well documented to stimulate cell growth and inhibit apoptosis in estrogen receptor (ER)-positive breast cancer cells. Intriguingly, recent reports have shown that 17 beta-estradiol (E2) induces Noxa expression, although the mechanisms underlying E2-mediated induction of Noxa and its functional significance are unknown. Using MCF7 human breast cancer cells as an experimental model, we show that Noxa is upregulated by E2 via p53-independent processes that involve c-Myc and ER alpha. Experiments using small interfering ribonucleic acids (siRNA) to specifically knock down p53, c-Myc, and ER alpha demonstrated that c-Myc and ER alpha, but not p53, are involved in the transcriptional upregulation of Noxa following E2 treatment. Furthermore, while E2 promoted the recruitment of c-Myc and ER alpha to the NOXA promoter in chromatin immunoprecipitation (ChIP) assays, E2 did not induce p53 recruitment. Interestingly, E2-mediated upregulation of Noxa was not associated with apoptosis. However, siRNA-mediated knockdown of Noxa resulted in cell cycle arrest in G(0)/G(1)-phase and significantly delayed the G(1)-to-S-phase transition following E2 treatment, indicating that Noxa expression is required for cell cycle progression in ER-positive breast cancer cells.	[Liu, Wensheng] SUNY Buffalo, Dept Pediat, Buffalo, NY 14260 USA; [Swetzig, Wendy M.; Das, Gokul M.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Ctr Genet & Pharmacol, Buffalo, NY 14263 USA; [Medisetty, Rajesh] Dr Reddys Labs Ltd, Dept Biol, Hyderabad, Andhra Pradesh, India; [Liu, Wensheng; Swetzig, Wendy M.; Medisetty, Rajesh; Das, Gokul M.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Ctr Genet & Pharmacol, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; Dr. Reddy's Laboratories Ltd.; Roswell Park Cancer Institute	Liu, WS (corresponding author), SUNY Buffalo, Dept Pediat, Buffalo, NY 14260 USA.	Gokul.Das@RoswellPark.org	Medisetty, Rajesh/AAB-6043-2020; Das, Gokul M/A-5772-2013; liu, wen/HGE-3071-2022	Das, Gokul M/0000-0003-2937-8093; 	National Cancer Institute (NCI) [CA079911]; Susan G. Komen for the Cure Foundation [BCTR0600180]; NCI Cancer Center [CA016056]; National Institutes of Health [CA009072]; NATIONAL CANCER INSTITUTE [T32CA009072, R01CA079911, P30CA016056] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (NCI) grant CA079911 (Dr. Das), the Susan G. Komen for the Cure Foundation grant BCTR0600180 (Dr. Das), the NCI Cancer Center Support Grant CA016056 (to Roswell Park Cancer Institute), and the National Institutes of Health T32 grant CA009072 (Dr. Swetzig). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Bajic VB, 2003, NUCLEIC ACIDS RES, V31, P3605, DOI 10.1093/nar/gkg517; Bretz J, 2011, BLOOD, V117, P2179, DOI 10.1182/blood-2010-06-288027; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Colditz GA, 1998, JNCI-J NATL CANCER I, V90, P814, DOI 10.1093/jnci/90.11.814; Dewson G, 2010, CELL HEALTH CYTOSKEL, V2, P9; Diallo JS, 2007, CLIN CANCER RES, V13, P7044, DOI 10.1158/1078-0432.CCR-07-1224; DUBIK D, 1988, J BIOL CHEM, V263, P12705; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Gimenez-Cassina A, 2010, MOL CELL, V40, P687, DOI 10.1016/j.molcel.2010.11.037; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; HENDERSON IC, 1993, CANCER-AM CANCER SOC, V71, P2127, DOI 10.1002/1097-0142(19930315)71:6+<2127::AID-CNCR2820711602>3.0.CO;2-2; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Hetz C, 2008, TRENDS CELL BIOL, V18, P38, DOI 10.1016/j.tcb.2007.10.003; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Jordan VC, 2007, NAT REV CANCER, V7, P46, DOI 10.1038/nrc2048; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Kutuk O, 2009, CARCINOGENESIS, V30, P1517, DOI 10.1093/carcin/bgp165; Lallemand C, 2007, ONCOGENE, V26, P328, DOI 10.1038/sj.onc.1209795; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Liu WS, 2006, J BIOL CHEM, V281, P9837, DOI 10.1074/jbc.C600001200; Lowman XH, 2010, MOL CELL, V40, P823, DOI 10.1016/j.molcel.2010.11.035; Mackus WJM, 2005, LEUKEMIA, V19, P427, DOI 10.1038/sj.leu.2403623; MCGUIRE WL, 1978, SEMIN ONCOL, V5, P428; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; PIKE MC, 1983, NATURE, V303, P767, DOI 10.1038/303767a0; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Ploner C, 2009, APOPTOSIS, V14, P821, DOI 10.1007/s10495-009-0355-5; Sayeed A, 2007, CANCER RES, V67, P7746, DOI 10.1158/0008-5472.CAN-06-3724; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Schuler M, 2003, CELL DEATH DIFFER, V10, P451, DOI 10.1038/sj.cdd.4401180; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Shibue T, 2006, INT J CANCER, V119, P2036, DOI 10.1002/ijc.21751; Stender JD, 2007, MOL ENDOCRINOL, V21, P2112, DOI 10.1210/me.2006-0474; Tozlu S, 2006, ENDOCR-RELAT CANCER, V13, P1109, DOI 10.1677/erc.1.01120; Wang Z, 2008, ANTICANCER RES, V28, P1667; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wong JV, 2011, CELL CYCLE, V10; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	47	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29466	10.1371/journal.pone.0029466	http://dx.doi.org/10.1371/journal.pone.0029466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216287	Green Published, gold, Green Submitted			2022-12-27	WOS:000299684700059
J	McKenzie, JA; Bixby, EC; Silva, MJ				McKenzie, Jennifer A.; Bixby, Elise C.; Silva, Matthew J.			Differential Gene Expression from Microarray Analysis Distinguishes Woven and Lamellar Bone Formation in the Rat Ulna following Mechanical Loading	PLOS ONE			English	Article							NITRIC-OXIDE; CATHEPSIN-K; FRACTURE; ANGIOGENESIS; INFLAMMATION; SUPPRESSION; REGULATOR; PATHWAYS; MODEL	Formation of woven and lamellar bone in the adult skeleton can be induced through mechanical loading. Although much is known about the morphological appearance and structural properties of the newly formed bone, the molecular responses to loading are still not well understood. The objective of our study was to use a microarray to distinguish the molecular responses between woven and lamellar bone formation induced through mechanical loading. Rat forelimb loading was completed in a single bout to induce the formation of woven bone (WBF loading) or lamellar bone (LBF loading). A set of normal (non-loaded) rats were used as controls. Microarrays were performed at three timepoints after loading: 1 hr, 1 day and 3 days. Confirmation of microarray results was done for a select group of genes using quantitative real-time PCR (qRT-PCR). The micorarray identified numerous genes and pathways that were differentially regulated for woven, but not lamellar bone formation. Few changes in gene expression were evident comparing lamellar bone formation to normal controls. A total of 395 genes were differentially expressed between formation of woven and lamellar bone 1 hr after loading, while 5883 and 5974 genes were differentially expressed on days 1 and 3, respectively. Results suggest that not only are the levels of expression different for each type of bone formation, but that distinct pathways are activated only for woven bone formation. A strong early inflammatory response preceded an increase in angiogenic and osteogenic gene expression for woven bone formation. Furthermore, at later timepoints there was evidence of bone resorption after WBF loading. In summary, the vast coverage of the microarray offers a comprehensive characterization of the early differences in expression between woven and lamellar bone formation.	[McKenzie, Jennifer A.; Bixby, Elise C.; Silva, Matthew J.] Washington Univ, Dept Orthopaed, St Louis, MO 63130 USA; [McKenzie, Jennifer A.; Silva, Matthew J.] Washington Univ, Dept Biomed Engn, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	McKenzie, JA (corresponding author), Washington Univ, Dept Orthopaed, St Louis, MO 63130 USA.	mckenziej@wudosis.wustl.edu		Silva, Matthew/0000-0001-7375-4522	NIH/NIAMS [R01AR050211, P30AR057235]; ASBMR; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235, R01AR050211] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); ASBMR; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by NIH/NIAMS R01AR050211, P30AR057235 (Washington University Center for Musculoskeletal Research) and ASBMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam I, 2005, J BONE MINER RES, V20, P438, DOI 10.1359/JBMR.041124; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bais M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005393; Bentolila V, 1998, BONE, V23, P275, DOI 10.1016/S8756-3282(98)00104-5; Berchner-Pfannschmidt U, 2008, EUR RESPIR J, V32, P210, DOI 10.1183/09031936.00013408; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Dean DB, 2009, FRONT BIOSCI-LANDMRK, V14, P2878, DOI 10.2741/3419; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Georges S, 2009, CYTOKINE GROWTH F R, V20, P29, DOI 10.1016/j.cytogfr.2008.11.005; Ghadjar P, 2009, INT J CANCER, V125, P741, DOI 10.1002/ijc.24468; Heiner DE, 2006, J ORTHOP TRAUMA, V20, P27, DOI 10.1097/01.bot.0000184143.90448.aa; Hsieh YF, 2002, J ORTHOP RES, V20, P764, DOI 10.1016/S0736-0266(01)00161-9; Iqbal J, 2005, BIOCHEM BIOPH RES CO, V328, P751, DOI 10.1016/j.bbrc.2004.12.087; Khan Safdar N, 2008, HSS J, V4, P149, DOI 10.1007/s11420-008-9087-2; Kidd LJ, 2010, BONE, V46, P369, DOI 10.1016/j.bone.2009.10.009; Komori T, 2009, CELL TISSUE RES; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; Kotiya AA, 2010, BONE; Krishnan V, 2001, ENDOCRINOLOGY, V142, P940, DOI 10.1210/en.142.2.940; Kubota T, 2009, J BONE MINER METAB, V27, P265, DOI 10.1007/s00774-009-0064-8; Lecaille F, 2008, BIOCHIMIE, V90, P208, DOI 10.1016/j.biochi.2007.08.011; Li J, 2002, CALCIFIED TISSUE INT, V70, P320, DOI 10.1007/s00223-001-1025-y; LI KC, 1990, CALCIFIED TISSUE INT, V47, P308, DOI 10.1007/BF02555914; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Martinez MD, 2010, BONE; Matsuzaki H, 2007, CALCIFIED TISSUE INT, V80, P391, DOI 10.1007/s00223-007-9031-3; McKenzie JA, 2011, BONE, V48, P250, DOI 10.1016/j.bone.2010.09.005; Meyer MH, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-24; Mollace V, 2005, PHARMACOL REV, V57, P217, DOI 10.1124/pr.57.2.1; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003; Robling AG, 2006, ANN REV BIOMED ENG; Roosa SMM, 2011, J BONE MINER RES, V26, P100, DOI 10.1002/jbmr.193; Rosenkilde MM, 2004, APMIS, V112, P481, DOI 10.1111/j.1600-0463.2004.apm11207-0808.x; Rundle CH, 2006, BONE, V38, P521, DOI 10.1016/j.bone.2005.09.015; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Simon AM, 2002, J BONE MINER RES, V17, P963, DOI 10.1359/jbmr.2002.17.6.963; Sugiyama T, 2010, BONE, V46, P314, DOI 10.1016/j.bone.2009.08.054; Tami AE, 2003, J ORTHOP RES, V21, P1018, DOI 10.1016/S0736-0266(03)00099-8; Trevino V, 2007, MOL MED, V13, P527, DOI 10.2119/2006-00107.Trevino; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; TURNER CH, 1994, J BONE MINER RES, V9, P87; Turner CH, 1996, AM J PHYSIOL-ENDOC M, V270, pE634, DOI 10.1152/ajpendo.1996.270.4.E634; Uthgenannt BA, 2007, J BONE MINER RES, V22, P1548, DOI 10.1359/JBMR.0070614; Uthgenannt BA, 2007, J BIOMECH, V40, P317, DOI 10.1016/j.jbiomech.2006.01.005; van Hinsbergh VWM, 2008, CARDIOVASC RES, V78, P203, DOI 10.1093/cvr/cvm102; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wise JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012987; Wohl GR, 2009, BONE, V44, P320, DOI 10.1016/j.bone.2008.09.010; Wu Q, 2009, NEUROSCI LETT, V463, P254, DOI 10.1016/j.neulet.2009.07.078; Xing WR, 2005, J CELL BIOCHEM, V96, P1049, DOI 10.1002/jcb.20606; Zaman G, 2010, BONE, V46, P628, DOI 10.1016/j.bone.2009.10.021; Zhao QX, 2009, BIOCHEM BIOPH RES CO, V380, P721, DOI 10.1016/j.bbrc.2009.01.139	56	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29328	10.1371/journal.pone.0029328	http://dx.doi.org/10.1371/journal.pone.0029328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216249	Green Submitted, Green Published, gold			2022-12-27	WOS:000299684700048
J	Almeida, FBD; Carvalho, FC; Mariano, VS; Alegre, ACP; Silva, RD; Hanna, ES; Roque-Barreira, MC				Dos Reis Almeida, Fausto Bruno; Carvalho, Fernanda Caroline; Mariano, Vania Sammartino; Paiva Alegre, Ana Claudia; Silva, Roberto do Nascimento; Hanna, Ebert Seixas; Roque-Barreira, Maria Cristina			Influence of N-Glycosylation on the Morphogenesis and Growth of Paracoccidioides brasiliensis and on the Biological Activities of Yeast Proteins	PLOS ONE			English	Article							BINDING LECTIN; PURIFICATION; TUNICAMYCIN; CHITINASE; SECRETION; VIRULENCE; LAMININ	The fungus Paracoccidioides brasiliensis is a human pathogen that causes paracoccidioidomycosis, the most prevalent systemic mycosis in Latin America. The cell wall of P. brasiliensis is a network of glycoproteins and polysaccharides, such as chitin, that perform several functions. N-linked glycans are involved in glycoprotein folding, intracellular transport, secretion, and protection from proteolytic degradation. Here, we report the effects of tunicamycin (TM)-mediated inhibition of N-linked glycosylation on P. brasiliensis yeast cells. The underglycosylated yeasts were smaller than their fully glycosylated counterparts and exhibited a drastic reduction of cell budding, reflecting impairment of growth and morphogenesis by TM treatment. The intracellular distribution in TM-treated yeasts of the P. brasiliensis glycoprotein paracoccin was investigated using highly specific antibodies. Paracoccin was observed to accumulate at intracellular locations, far from the yeast wall. Paracoccin derived from TM-treated yeasts retained the ability to bind to laminin despite their underglycosylation. As paracoccin has N-acetyl-beta-D-glucosaminidase (NAGase) activity and induces the production of TNF-alpha and nitric oxide (NO) by macrophages, we compared these properties between glycosylated and underglycosylated yeast proteins. Paracoccin demonstrated lower NAGase activity when underglycosylated, although no difference was detected between the pH and temperature optimums of the two forms. Murine macrophages stimulated with underglycosylated yeast proteins produced significantly lower levels of TNF-alpha and NO. Taken together, the impaired growth and morphogenesis of tunicamycin-treated yeasts and the decreased biological activities of underglycosylated fungal components suggest that N-glycans play important roles in P. brasiliensis yeast biology.	[Dos Reis Almeida, Fausto Bruno; Carvalho, Fernanda Caroline; Mariano, Vania Sammartino; Paiva Alegre, Ana Claudia; Hanna, Ebert Seixas; Roque-Barreira, Maria Cristina] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol Bioagentes Patogen, Ribeirao Preto, SP, Brazil; [Silva, Roberto do Nascimento] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Ribeirao Preto, SP, Brazil; [Hanna, Ebert Seixas] Univ Sao Paulo, Invent Biotecnol Ltda ME, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Almeida, FBD (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol Bioagentes Patogen, Ribeirao Preto, SP, Brazil.	mcrbarre@fmrp.usp.br	HANNA, EBERT S/C-9569-2012; Silva, Roberto/F-3897-2012; Mariano, Vania/L-1953-2014; Mariano, Vânia Sammartino/AAV-1851-2020; Almeida, Fausto/N-6540-2013; Roque-Barreira, Maria-Cristina/A-4552-2008; HANNA, EBERT SEIXAS/H-7512-2019	Silva, Roberto/0000-0002-8992-7130; Mariano, Vânia Sammartino/0000-0002-5399-5676; Almeida, Fausto/0000-0002-3782-3698; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; 	Sao Paulo State Research Funding Agency (FAPESP); National Research Council (CNPq)	Sao Paulo State Research Funding Agency (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Sao Paulo State Research Funding Agency (FAPESP). Additional financial help was provided by the National Research Council (CNPq). FBRA, FCC, VSM, and ACPA were supported by fellowships from FAPESP. MCRB is indebted to CNPq for her research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKITA EM, 1993, J IMMUNOL METHODS, V160, P207, DOI 10.1016/0022-1759(93)90179-B; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Brooks S.A., 2002, FUNCTIONAL MOL GLYCO; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; BRUMMER E, 1990, INFECT IMMUN, V58, P2628, DOI 10.1128/IAI.58.8.2628-2636.1990; Almeida FBDR, 2007, BIOTECHNOL LETT, V29, P1189, DOI 10.1007/s10529-007-9372-z; Coltri KC, 2006, MICROBES INFECT, V8, P704, DOI 10.1016/j.micinf.2005.09.008; de Barros MC, 2009, CARBOHYD RES, V344, P1682, DOI 10.1016/j.carres.2009.06.006; De Groot PWJ, 2005, FUNGAL GENET BIOL, V42, P657, DOI 10.1016/j.fgb.2005.04.002; Almeida FBD, 2010, YEAST, V27, P67, DOI 10.1002/yea.1731; Duo-Chuan L, 2006, MYCOPATHOLOGIA, V161, P345, DOI 10.1007/s11046-006-0024-y; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Eriksen SH, 1998, CURR MICROBIOL, V37, P117, DOI 10.1007/s002849900348; Ganiko L, 2007, MICROBES INFECT, V9, P695, DOI 10.1016/j.micinf.2007.02.012; Gesztesi JL, 1996, HYBRIDOMA, V15, P415, DOI 10.1089/hyb.1996.15.415; Kung LA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.64; Kurokawa Cilmery S., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P257, DOI 10.1590/S0036-46652005000500004; Lenardon MD, 2010, CURR OPIN MICROBIOL, V13, P416, DOI 10.1016/j.mib.2010.05.002; Levitz SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000758; Linehan SA, 2000, MICROBES INFECT, V2, P279, DOI 10.1016/S1286-4579(00)00300-2; Macoris SAG, 2006, MEM I OSWALDO CRUZ, V101, P331, DOI 10.1590/S0074-02762006000300019; Mora-Montes HM, 2007, EUKARYOT CELL, V6, P2184, DOI 10.1128/EC.00350-07; MOROSOLI R, 1988, ARCH BIOCHEM BIOPHYS, V265, P183, DOI 10.1016/0003-9861(88)90383-9; Nagai K, 1997, GLYCOBIOLOGY, V7, P769, DOI 10.1093/glycob/7.6.769; Netto C F, 1969, Rev Inst Med Trop Sao Paulo, V11, P177; Rast DM, 2003, PHYTOCHEMISTRY, V64, P339, DOI 10.1016/S0031-9422(03)00350-9; SANBLAS G, 1993, J MED VET MYCOL, V31, P99; Seidl Verena, 2008, Fungal Biology Reviews, V22, P36, DOI 10.1016/j.fbr.2008.03.002; Mendes-Giannini MJS, 2006, MICROBES INFECT, V8, P1550, DOI 10.1016/j.micinf.2006.01.012; Svidzinski Terezinha Inez Estivalet, 1999, Revista do Instituto de Medicina Tropical de Sao Paulo, V41, P279, DOI 10.1590/S0036-46651999000500003; Tomazett PK, 2005, GENET MOL RES, V4, P309; ULHOA CJ, 1992, ENZYME MICROB TECH, V14, P236, DOI 10.1016/0141-0229(92)90072-V; Ulhoa CJ, 2001, BBA-GEN SUBJECTS, V1528, P39, DOI 10.1016/S0304-4165(01)00170-2; Varki A., 1999, ESSENTIALS GLYCOBIOL; VILLAR LA, 1989, J MED VET MYCOL, V27, P141; YABUKI M, 1986, J GEN APPL MICROBIOL, V32, P25, DOI 10.2323/jgam.32.25	39	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29216	10.1371/journal.pone.0029216	http://dx.doi.org/10.1371/journal.pone.0029216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216217	Green Published, gold, Green Submitted			2022-12-27	WOS:000299113600068
J	Du, J; Leng, J; Habegger, L; Sboner, A; McDermott, D; Gerstein, M				Du, Jiang; Leng, Jing; Habegger, Lukas; Sboner, Andrea; McDermott, Drew; Gerstein, Mark			IQSeq: Integrated Isoform Quantification Analysis Based on Next-Generation Sequencing	PLOS ONE			English	Article							EXPRESSION; GENE	With the recent advances in high-throughput RNA sequencing (RNA-Seq), biologists are able to measure transcription with unprecedented precision. One problem that can now be tackled is that of isoform quantification: here one tries to reconstruct the abundances of isoforms of a gene. We have developed a statistical solution for this problem, based on analyzing a set of RNA-Seq reads, and a practical implementation, available from archive. gersteinlab.org/proj/rnaseq/IQSeq, in a tool we call IQSeq (Isoform Quantification in next-generation Sequencing). Here, we present theoretical results which IQSeq is based on, and then use both simulated and real datasets to illustrate various applications of the tool. In order to measure the accuracy of an isoform-quantification result, one would try to estimate the average variance of the estimated isoform abundances for each gene (based on resampling the RNA-seq reads), and IQSeq has a particularly fast algorithm (based on the Fisher Information Matrix) for calculating this, achieving a speedup of similar to 500 times compared to brute-force resampling. IQSeq also calculates an information theoretic measure of overall transcriptome complexity to describe isoform abundance for a whole experiment. IQSeq has many features that are particularly useful in RNA-Seq experimental design, allowing one to optimally model the integration of different sequencing technologies in a cost-effective way. In particular, the IQSeq formalism integrates the analysis of different sample (i.e. read) sets generated from different technologies within the same statistical framework. It also supports a generalized statistical partial-sample-generation function to model the sequencing process. This allows one to have a modular, "plugin-able" read-generation function to support the particularities of the many evolving sequencing technologies.	[Du, Jiang; McDermott, Drew; Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Leng, Jing; Habegger, Lukas; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA; [Sboner, Andrea; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA	Yale University; Yale University; Yale University	Du, J (corresponding author), Yale Univ, Dept Comp Sci, POB 2158, New Haven, CT 06520 USA.	Mark.Gerstein@yale.edu	Sboner, Andrea/C-6487-2008	Sboner, Andrea/0000-0001-6915-3070				BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Du J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000432; GELINAS RE, 1977, CELL, V11, P533, DOI 10.1016/0092-8674(77)90071-X; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Heber Steffen, 2002, Bioinformatics, V18 Suppl 1, pS181; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Lacroix V, 2008, LECT N BIOINFORMAT, V5251, P50, DOI 10.1007/978-3-540-87361-7_5; Li J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r50; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Schervish M J., 1995, THEORY STAT; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Trapnell C, 2010, NAT BIOTECHNOL; Van der Vaart AW, 2000, ASYMPTOTIC STAT, V3; Xing Y, 2006, NUCLEIC ACIDS RES, V34, P3150, DOI 10.1093/nar/gkl396	22	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29175	10.1371/journal.pone.0029175	http://dx.doi.org/10.1371/journal.pone.0029175			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238592	Green Submitted, gold, Green Published			2022-12-27	WOS:000301188800006
J	Rodrigues, R; Paranhos-Baccala, G; Vernet, G; Peyrefitte, CN				Rodrigues, Raquel; Paranhos-Baccala, Glaucia; Vernet, Guy; Peyrefitte, Christophe N.			Crimean-Congo Hemorrhagic Fever Virus-Infected Hepatocytes Induce ER-Stress and Apoptosis Crosstalk	PLOS ONE			English	Article							INCREASES ENDOTHELIAL PERMEABILITY; XBP1 MESSENGER-RNA; DENGUE VIRUS; UP-REGULATION; PROTEIN; ACTIVATION; CELLS; PATHOGENESIS; EXPRESSION; NECROSIS	Crimean-Congo hemorrhagic fever virus (CCHFV) is a widely distributed tick-borne member of the Nairovirus genus (Bunyaviridae) with a high mortality rate in humans. CCHFV induces a severe disease in infected patients that includes, among other symptoms, massive liver necrosis and failure. The interaction between liver cells and CCHFV is therefore important for understanding the pathogenesis of this disease. Here, we described the in vitro CCHFV-infection and replication in the hepatocyte cell line, Huh7, and the induced cellular and molecular response modulation. We found that CCHFV was able to infect and replicate to high titres and to induce a cytopathic effect (CPE). We also observed by flow cytometry and real time quantitative RT-PCR evidence of apoptosis, with the participation of the mitochondrial pathway. On the other hand, we showed that the replication of CCHFV in hepatocytes was able to interfere with the death receptor pathway of apoptosis. Furthermore, we found in CCHFV-infected cells the over-expression of PUMA, Noxa and CHOP suggesting the crosstalk between the ER-stress and mitochondrial apoptosis. By ELISA, we observed an increase of IL-8 in response to viral replication; however apoptosis was shown to be independent from IL-8 secretion. When we compared the induced cellular response between CCHFV and DUGV, a mild or non-pathogenic Nairovirus for humans, we found that the most striking difference was the absence of CPE and apoptosis. Despite the XBP1 splicing and PERK gene expression induced by DUGV, no ER-stress and apoptosis crosstalk was observed. Overall, these results suggest that CCHFV is able to induce ER-stress, activate inflammatory mediators and modulate both mitochondrial and death receptor pathways of apoptosis in hepatocyte cells, which may, in part, explain the role of the liver in the pathogenesis of CCHFV.	[Rodrigues, Raquel; Paranhos-Baccala, Glaucia; Vernet, Guy; Peyrefitte, Christophe N.] Fdn Merieux, Emerging Pathogens Lab, Lyon, France; [Peyrefitte, Christophe N.] Inst Rech Biomed Armees, Unite Virol, La Tronche, France		Rodrigues, R (corresponding author), Fdn Merieux, Emerging Pathogens Lab, Lyon, France.	glaucia.baccala@fondation-merieux.org	Rodrigues, Raquel/GZM-7677-2022		Fondation Merieux and Service de Sante des Armees; Direction Generale de l'Armement	Fondation Merieux and Service de Sante des Armees; Direction Generale de l'Armement	This study was funded by Fondation Merieux and Service de Sante des Armees and the Direction Generale de l'Armement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acrani GO, 2010, VIRUS RES, V149, P56, DOI 10.1016/j.virusres.2009.12.013; Andersson I, 2006, J MED VIROL, V78, P216, DOI 10.1002/jmv.20530; Andersson I, 2008, J MED VIROL, V80, P1397, DOI 10.1002/jmv.21222; Back SH, 2006, J BIOL CHEM, V281, P18691, DOI 10.1074/jbc.M602030200; Bente DA, 2010, J VIROL, V84, P11089, DOI 10.1128/JVI.01383-10; Bereczky S, 2010, J GEN VIROL, V91, P1473, DOI 10.1099/vir.0.019034-0; BIFFL WL, 1995, J TRAUMA, V39, P98, DOI 10.1097/00005373-199507000-00013; Bray Mike, 2007, P221, DOI 10.1007/978-1-4020-6106-6_17; Burt FJ, 1997, ARCH PATHOL LAB MED, V121, P839; Burt FJ, 1996, EPIDEMIOL INFECT, V116, P353, DOI 10.1017/S0950268800052687; Castedo M, 2003, ANN NY ACAD SCI, V1010, P19, DOI 10.1196/annals.1299.004; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; CHARLOTTE F, 1994, AM J PATHOL, V144, P460; CHILD PL, 1967, ARCH PATHOL, V83, P434; Chinikar S, 2010, EURO SURVEILL, V15; Chiou HL, 2006, BIOCHEM BIOPH RES CO, V345, P453, DOI 10.1016/j.bbrc.2006.04.118; Christova I, 2009, EMERG INFECT DIS, V15, P983, DOI 10.3201/eid1506.081567; Colon-Ramos DA, 2003, MOL BIOL CELL, V14, P4162, DOI 10.1091/mbc.E03-03-0139; Connolly-Andersen A-M, 2011, J VIROL; Connolly-Andersen AM, 2009, VIROLOGY, V390, P157, DOI 10.1016/j.virol.2009.06.010; Dembek ZF, 2007, MED ASPECTS BIOL WAR; Ding XH, 2005, AM J PATHOL, V167, P1043, DOI 10.1016/S0002-9440(10)61193-5; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; Ergonul O, 2006, J INFECT DIS, V193, P941, DOI 10.1086/500836; Gadaleta P, 2005, VIRUS RES, V109, P65, DOI 10.1016/j.virusres.2004.10.007; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Gowen BB, 2008, ANTIVIR RES, V78, P79, DOI 10.1016/j.antiviral.2007.10.002; Green J, 2006, J INFECT DIS, V193, P802, DOI 10.1086/500510; Guicciardi ME, 2010, SEMIN LIVER DIS, V30, P402, DOI 10.1055/s-0030-1267540; Honig JE, 2004, VIROLOGY, V318, P10, DOI 10.1016/j.virol.2003.09.021; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; Jaax NK, 1996, ARCH PATHOL LAB MED, V120, P140; Kalkeri G, 2001, VIROLOGY, V282, P26, DOI 10.1006/viro.2000.0835; Karlberg H, 2011, J BIOL CHEM, V286, P3227, DOI 10.1074/jbc.M110.149369; Kim SR, 2010, BIOCHEM BIOPH RES CO, V397, P413, DOI 10.1016/j.bbrc.2010.05.106; Klomporn P, 2011, VIROLOGY, V409, P189, DOI 10.1016/j.virol.2010.10.010; Koo BCA, 2006, J VIROL, V80, P7885, DOI 10.1128/JVI.00519-06; Krieg A, BR J CANC, V88, P918; Leibowitz Brian, 2010, Cancer Biol Ther, V9, P417, DOI 10.4161/cbt.9.6.11392; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Liberman E, 1999, J VIROL, V73, P3718, DOI 10.1128/JVI.73.5.3718-3722.1999; Lim Seong In, 2005, J Vet Sci, V6, P251; Lin CF, 2002, J IMMUNOL, V169, P657, DOI 10.4049/jimmunol.169.2.657; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Matsuda T, 2005, J GEN VIROL, V86, P1055, DOI 10.1099/vir.0.80531-0; Medin CL, 2006, J INFECT DIS, V193, P1070, DOI 10.1086/502630; Morchang A, 2011, VIRUS RES, V156, P25, DOI 10.1016/j.virusres.2010.12.012; Ozturk B, 2010, J CLIN VIROL, V47, P115, DOI 10.1016/j.jcv.2009.10.015; Papa A, 2010, CLIN MICROBIOL INFEC, V16, P843, DOI 10.1111/j.1469-0691.2009.02996.x; Papa A, 2008, SCAND J INFECT DIS, V40, P978, DOI 10.1080/00365540802144125; Papa A, 2011, EMERG INFECT DIS, V17, P141, DOI 10.3201/eid1701.100073; Pekosz A, 1996, J VIROL, V70, P5329, DOI 10.1128/JVI.70.8.5329-5335.1996; Petreaca ML, 2007, MOL BIOL CELL, V18, P5014, DOI 10.1091/mbc.E07-01-0004; Peyrefitte CN, 2010, J GEN VIROL, V91, P189, DOI 10.1099/vir.0.015701-0; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Raghupathy R, 1998, J MED VIROL, V56, P280, DOI 10.1002/(SICI)1096-9071(199811)56:3&lt;280::AID-JMV18&gt;3.0.CO;2-I; Rai MA, 2008, J MED VIROL, V80, P1004, DOI 10.1002/jmv.21159; Rodrigues R, 2011, J VIROL METHODS, V176, P74, DOI 10.1016/j.jviromet.2011.06.003; Saksida A, 2010, CLIN VACCINE IMMUNOL, V17, P1086, DOI 10.1128/CVI.00530-09; Schnittler HJ, 2003, THROMB HAEMOSTASIS, V89, P967; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Shang J, 2005, METHODS, V35, P390, DOI 10.1016/j.ymeth.2004.10.012; SWANEPOEL R, 1987, AM J TROP MED HYG, V36, P120, DOI 10.4269/ajtmh.1987.36.120; TERRELL TG, 1973, AM J PATHOL, V73, P477; WALKER DH, 1982, AM J PATHOL, V107, P349; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; WINN WC, 1975, B WORLD HEALTH ORGAN, V52, P535; Xia H, 2011, INT J INFECT DIS; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	76	51	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29712	10.1371/journal.pone.0029712	http://dx.doi.org/10.1371/journal.pone.0029712			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238639	gold, Green Published, Green Submitted			2022-12-27	WOS:000301188800028
J	Wang, XD; Gu, F; He, K; Chen, LH; Chen, L				Wang, Xiao-Dong; Gu, Feng; He, Kang; Chen, Ling-Hui; Chen, Lin			Preattentive Extraction of Abstract Auditory Rules in Speech Sound Stream: A Mismatch Negativity Study Using Lexical Tones	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; PHONEME REPRESENTATIONS; INVOLUNTARY ATTENTION; CORTEX; PERCEPTION; BRAIN; RESPONSES; PATTERNS; MEMORY; FMRI	Background: Extraction of linguistically relevant auditory features is critical for speech comprehension in complex auditory environments, in which the relationships between acoustic stimuli are often abstract and constant while the stimuli per se are varying. These relationships are referred to as the abstract auditory rule in speech and have been investigated for their underlying neural mechanisms at an attentive stage. However, the issue of whether or not there is a sensory intelligence that enables one to automatically encode abstract auditory rules in speech at a preattentive stage has not yet been thoroughly addressed. Methodology/ Principal Findings: We chose Chinese lexical tones for the current study because they help to define word meaning and hence facilitate the fabrication of an abstract auditory rule in a speech sound stream. We continuously presented native Chinese speakers with Chinese vowels differing in formant, intensity, and level of pitch to construct a complex and varying auditory stream. In this stream, most of the sounds shared flat lexical tones to form an embedded abstract auditory rule. Occasionally the rule was randomly violated by those with a rising or falling lexical tone. The results showed that the violation of the abstract auditory rule of lexical tones evoked a robust preattentive auditory response, as revealed by whole-head electrical recordings of the mismatch negativity (MMN), though none of the subjects acquired explicit knowledge of the rule or became aware of the violation. Conclusions/Significance: Our results demonstrate that there is an auditory sensory intelligence in the perception of Chinese lexical tones. The existence of this intelligence suggests that the humans can automatically extract abstract auditory rules in speech at a preattentive stage to ensure speech communication in complex and noisy auditory environments without drawing on conscious resources.	[Wang, Xiao-Dong; Gu, Feng; He, Kang; Chen, Lin] Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Sch Life Sci, Hefei 230026, Peoples R China; [Wang, Xiao-Dong; Gu, Feng; He, Kang; Chen, Lin] Univ Sci & Technol China, Auditory Res Lab, Hefei 230026, Peoples R China; [Chen, Ling-Hui] Univ Sci & Technol China, iFlytek Speech Lab, Sch Informat Sci & Technol, Hefei 230026, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wang, XD (corresponding author), Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Sch Life Sci, Hefei 230026, Peoples R China.	linchen@ustc.edu.cn	Chen, Lin/N-8327-2013	Chen, Lin/0000-0002-5847-2989; Gu, Feng/0000-0002-5954-5596	National Basic Research Program of China [2011CB504506, 2007CB512306]; National Natural Science Foundation of China [30970977, 30730041]; CAS [KSCX1-YW-R-36]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences)	This work was supported by the National Basic Research Program of China (Grants 2011CB504506 and 2007CB512306), the National Natural Science Foundation of China (Grants 30970977 and 30730041) and the CAS Knowledge Innovation Project (Grant KSCX1-YW-R-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsalou LW, 2003, PHILOS T R SOC B, V358, P1177, DOI 10.1098/rstb.2003.1319; Bishop DVM, 2005, COGNITIVE BRAIN RES, V24, P177, DOI 10.1016/j.cogbrainres.2004.12.007; Bonte ML, 2005, CLIN NEUROPHYSIOL, V116, P2765, DOI 10.1016/j.clinph.2005.08.012; Bunge SA, 2005, J NEUROSCI, V25, P10347, DOI 10.1523/JNEUROSCI.2937-05.2005; Carral V, 2005, NEUROREPORT, V16, P301, DOI 10.1097/00001756-200502280-00020; Celsis P, 1999, NEUROIMAGE, V9, P135, DOI 10.1006/nimg.1998.0389; Chandrasekaran B, 2009, EAR HEARING, V30, P552, DOI 10.1097/AUD.0b013e3181a7e1c2; CUTLER A, 1983, NATURE, V304, P159, DOI 10.1038/304159a0; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Dehaene-Lambertz G, 2000, J COGNITIVE NEUROSCI, V12, P635, DOI 10.1162/089892900562390; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Escera C, 2001, EUR J NEUROSCI, V14, P877, DOI 10.1046/j.0953-816x.2001.01707.x; Eulitz C, 2004, J COGNITIVE NEUROSCI, V16, P577, DOI 10.1162/089892904323057308; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; GIARD MH, 1995, J COGNITIVE NEUROSCI, V7, P133, DOI 10.1162/jocn.1995.7.2.133; Horvath J, 2008, BIOL PSYCHOL, V79, P139, DOI 10.1016/j.biopsycho.2008.04.001; Jacobsen T, 2004, PSYCHOPHYSIOLOGY, V41, P654, DOI 10.1111/1469-8986.2004.00175.x; Jacquemot C, 2003, J NEUROSCI, V23, P9541; Jacquemot C, 2006, TRENDS COGN SCI, V10, P480, DOI 10.1016/j.tics.2006.09.002; Kawahara H, 1999, SPEECH COMMUN, V27, P187, DOI 10.1016/S0167-6393(98)00085-5; Krueger F, 2009, TRENDS COGN SCI, V13, P103, DOI 10.1016/j.tics.2008.12.005; Luo H, 2006, P NATL ACAD SCI USA, V103, P19558, DOI 10.1073/pnas.0607065104; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; McLoughlin IV, 2008, SIGNAL PROCESS, V88, P448, DOI 10.1016/j.sigpro.2007.09.003; Menon RS, 1999, TRENDS COGN SCI, V3, P207, DOI 10.1016/S1364-6613(99)01329-7; Moulines WVE, 1995, SPEECH CODING SYNTHE, P519; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Naatanen R, 2010, BRAIN RES REV, V64, P123, DOI 10.1016/j.brainresrev.2010.03.001; Obleser J, 2009, TRENDS COGN SCI, V13, P14, DOI 10.1016/j.tics.2008.09.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peter V, 2010, NEUROSCI LETT, V482, P71, DOI 10.1016/j.neulet.2010.07.010; Phillips C, 2000, J COGNITIVE NEUROSCI, V12, P1038, DOI 10.1162/08989290051137567; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pratt H, 2009, CLIN NEUROPHYSIOL, V120, P360, DOI 10.1016/j.clinph.2008.10.158; Pulvermuller F, 2001, NEUROIMAGE, V14, P607, DOI 10.1006/nimg.2001.0864; SAARINEN J, 1992, NEUROREPORT, V3, P1149, DOI 10.1097/00001756-199212000-00030; Schroger E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001131; Sharma A, 2000, J ACOUST SOC AM, V107, P2697, DOI 10.1121/1.428655; Shestakova A, 2002, NEUROREPORT, V13, P1813, DOI 10.1097/00001756-200210070-00025; Steinberg J, 2010, J COGNITIVE NEUROSCI, V22, P2174, DOI 10.1162/jocn.2009.21408; Steinberg J, 2010, INT J PSYCHOPHYSIOL, V77, P13, DOI 10.1016/j.ijpsycho.2010.03.011; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; Tsang YK, 2011, NEUROSCI LETT, V487, P268, DOI 10.1016/j.neulet.2010.10.035; Wang Y, 2004, APPL PSYCHOLINGUIST, V25, P449, DOI 10.1017/S0142716404001213; Wang Y, 2001, BRAIN LANG, V78, P332, DOI 10.1006/brln.2001.2474; Wouter WMJ, 2001, SPEECH AUDIO PROCESS, V9, P30; Xu Y, 1997, J PHONETICS, V25, P61, DOI 10.1006/jpho.1996.0034; Zachau S, 2005, NEUROREPORT, V16, P2015, DOI 10.1097/00001756-200512190-00009	49	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e30027	10.1371/journal.pone.0030027	http://dx.doi.org/10.1371/journal.pone.0030027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	904IR	22238691	gold, Green Published			2022-12-27	WOS:000301188800055
J	Kittelberger, KA; Piazza, F; Tesco, G; Reijmers, LG				Kittelberger, Kara A.; Piazza, Fabrizio; Tesco, Giuseppina; Reijmers, Leon G.			Natural Amyloid-Beta Oligomers Acutely Impair the Formation of a Contextual Fear Memory in Mice	PLOS ONE			English	Article							CELLULAR PRION PROTEIN; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; IN-VIVO; A-BETA; SECRETED OLIGOMERS; SOLUBLE OLIGOMERS; TRANSGENIC MICE; BRAIN	Memory loss is one of the hallmark symptoms of Alzheimer's disease (AD). It has been proposed that soluble amyloid-beta (Abeta) oligomers acutely impair neuronal function and thereby memory. We here report that natural Abeta oligomers acutely impair contextual fear memory in mice. A natural Abeta oligomer solution containing Abeta monomers, dimers, trimers, and tetramers was derived from the conditioned medium of 7PA2 cells, a cell line that expresses human amyloid precursor protein containing the Val717Phe familial AD mutation. As a control we used 7PA2 conditioned medium from which Abeta oligomers were removed through immunodepletion. Separate groups of mice were injected with Abeta and control solutions through a cannula into the lateral brain ventricle, and subjected to fear conditioning using two tone-shock pairings. One day after fear conditioning, mice were tested for contextual fear memory and tone fear memory in separate retrieval trials. Three experiments were performed. For experiment 1, mice were injected three times: 1 hour before and 3 hours after fear conditioning, and 1 hour before context retrieval. For experiments 2 and 3, mice were injected a single time at 1 hour and 2 hours before fear conditioning respectively. In all three experiments there was no effect on tone fear memory. Injection of Abeta 1 hour before fear conditioning, but not 2 hours before fear conditioning, impaired the formation of a contextual fear memory. In future studies, the acute effect of natural Abeta oligomers on contextual fear memory can be used to identify potential mechanisms and treatments of AD associated memory loss.	[Kittelberger, Kara A.; Piazza, Fabrizio; Tesco, Giuseppina] Tufts Univ, Sch Med, Dept Neurosci, Alzheimers Dis Res Lab, Boston, MA 02111 USA	Tufts University	Kittelberger, KA (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Alzheimers Dis Res Lab, Boston, MA 02111 USA.	leon.reijmers@tufts.edu	Piazza, Fabrizio/L-2094-2016	Piazza, Fabrizio/0000-0002-3385-3224	Alzheimer's Association [NIRG-09-132400]; National Institutes of Health (NIH) [DP2 OD006446, R01 AG025952, R01 AG033016]; Tufts Center for Neuroscience Research [(P30 NS047243]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025952, R01AG033016] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006446] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts Center for Neuroscience Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	LGR is supported by an Alzheimer's Association New Investigator Research Grant (NIRG-09-132400), and a National Institutes of Health (NIH) Director's New Innovator Award (DP2 OD006446). GT is supported by NIH grants R01 AG025952 and R01 AG033016. This work was supported by the Tufts Center for Neuroscience Research (P30 NS047243; Jackson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; Freir D.B., 2010, NEUROBIOL AGING; Granic I, 2010, J ALZHEIMERS DIS, V19, P991, DOI 10.3233/JAD-2010-1297; Hamann S, 2002, NEUROPSYCHOLOGIA, V40, P1187, DOI 10.1016/S0028-3932(01)00223-8; Hoefer M, 2008, BRAIN, V131, P1646, DOI 10.1093/brain/awn082; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Krafft GA, 2010, NEUROPHARMACOLOGY, V59, P230, DOI 10.1016/j.neuropharm.2010.07.012; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; O'Hare E, 2010, BEHAV BRAIN RES, V210, P32, DOI 10.1016/j.bbr.2010.01.044; O'Shea SD, 2008, SENSORS-BASEL, V8, P7428, DOI 10.3390/s8117428; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Poling A, 2008, BEHAV BRAIN RES, V193, P230, DOI 10.1016/j.bbr.2008.06.001; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Reed MN, 2009, NEUROBIOL AGING, DOI [10.1016/j.neurobiolaging.2009.1011.1007, DOI 10.1016/J.NEUROBIOLAGING.2009.1011.1007]; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Roh JH, 2011, J NEUROL; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2011, METHODS MOL BIOL, V670, P33, DOI 10.1007/978-1-60761-744-0_3; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Townsend M, 2006, ANN NEUROL, V60, P668, DOI 10.1002/ana.21051; Van Dam D, 2003, EUR J NEUROSCI, V17, P388, DOI 10.1046/j.1460-9568.2003.02444.x; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004	38	31	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29940	10.1371/journal.pone.0029940	http://dx.doi.org/10.1371/journal.pone.0029940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238679	gold, Green Published, Green Submitted			2022-12-27	WOS:000301070200060
J	Perea-Blazquez, A; Davy, SK; Bell, JJ				Perea-Blazquez, Alejandra; Davy, Simon K.; Bell, James J.			Estimates of Particulate Organic Carbon Flowing from the Pelagic Environment to the Benthos through Sponge Assemblages	PLOS ONE			English	Article							BAIKALS LITTORAL-ZONE; IN-SITU; CALLYSPONGIA-VAGINALIS; APLYSINA-AEROPHOBA; SUSPENSION FEEDERS; NATURAL DIET; ENERGY-FLOW; MARINE; REEF; PROCHLOROCOCCUS	Despite the importance of trophic interactions between organisms, and the relationship between primary production and benthic diversity, there have been few studies that have quantified the carbon flow from pelagic to benthic environments as a result of the assemblage level activity of suspension-feeding organisms. In this study, we examine the feeding activity of seven common sponge species from the Taputeranga marine reserve on the south coast of Wellington in New Zealand. We analysed the diet composition, feeding efficiency, pumping rates, and the number of food particles (specifically picoplanktonic prokaryotic cells) retained by sponges. We used this information, combined with abundance estimates of the sponges and estimations of the total amount of food available to sponges in a known volume of water (89,821 m(3)), to estimate: (1) particulate organic carbon (POC) fluxes through sponges as a result of their suspension-feeding activities on picoplankton; and (2) the proportion of the available POC from picoplankton that sponges consume. The most POC acquired by the sponges was from non-photosynthetic bacterial cells (ranging from 0.09 to 4.69 g C d(-1) with varying sponge percentage cover from 0.5 to 5%), followed by Prochlorococcus (0.07 to 3.47 g C d(-1)) and then Synechococcus (0.05 to 2.34 g C d(-1)) cells. Depending on sponge abundance, the amount of POC that sponges consumed as a proportion of the total POC available was 0.2-12.1% for Bac, 0.4-21.3% for Prochlo, and 0.3-15.8% for Synecho. The flux of POC for the whole sponge assemblage, based on the consumption of prokaryotic picoplankton, ranged from 0.07-3.50 g C m(2) d(-1). This study is the first to estimate the contribution of a sponge assemblage (rather than focusing on individual sponge species) to POC flow from three groups of picoplankton in a temperate rocky reef through the feeding activity of sponges and demonstrates the importance of sponges to energy flow in rocky reef environments.	[Perea-Blazquez, Alejandra; Davy, Simon K.; Bell, James J.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	Victoria University Wellington	Perea-Blazquez, A (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	alejandra.perea@vuw.ac.nz		Bell, James/0000-0001-9996-945X; Davy, Simon/0000-0003-3584-5356	Victoria University of Wellington	Victoria University of Wellington	This work was supported by the Victoria University of Wellington, and a PhD scholarship was provided to AP-B and research consumable costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYLING AM, 1981, ECOLOGY, V62, P830, DOI 10.2307/1937749; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Baird D, 2004, MAR ECOL PROG SER, V279, P45, DOI 10.3354/meps279045; Baird D, 2007, MAR ECOL PROG SER, V351, P25, DOI 10.3354/meps07137; Becerro MA, 2003, BIOL J LINN SOC, V78, P429, DOI 10.1046/j.0024-4066.2002.00165.x; Bell A. H., 1999, Memoirs of the Queensland Museum, V44, P51; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Berman Jade, 2010, Open Marine Biology Journal, V4, P12, DOI 10.2174/1874450801004010012; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; CAMPBELL L, 1994, LIMNOL OCEANOGR, V39, P954, DOI 10.4319/lo.1994.39.4.0954; Cattaneo-Vietti R, 1999, SCI MAR, V63, P113, DOI 10.3989/scimar.1999.63s1113; Charpy L, 1998, MAR ECOL PROG SER, V162, P57, DOI 10.3354/meps162057; Cheshire AC, 1997, MAR FRESHWATER RES, V48, P589, DOI 10.1071/MF96070; CHISHOLM SW, 1992, ARCH MICROBIOL, V157, P297, DOI 10.1007/BF00245165; Christaki U, 1999, LIMNOL OCEANOGR, V44, P52, DOI 10.4319/lo.1999.44.1.0052; Coma R, 2001, MAR ECOL PROG SER, V219, P305, DOI 10.3354/meps219305; COURTIES C, 1994, NATURE, V370, P255, DOI 10.1038/370255a0; De Caralt S, 2008, MAR ECOL PROG SER, V360, P97, DOI 10.3354/meps07365; de Goeij JM, 2008, MAR ECOL PROG SER, V357, P139, DOI 10.3354/meps07403; de Goeij JM, 2008, LIMNOL OCEANOGR, V53, P1376, DOI 10.4319/lo.2008.53.4.1376; de Goeij JM, 2007, LIMNOL OCEANOGR, V52, P2608, DOI 10.4319/lo.2007.52.6.2608; Diaz MC, 2001, B MAR SCI, V69, P535; DUCKLOW HW, 1993, DEEP-SEA RES PT II, V40, P245, DOI 10.1016/0967-0645(93)90016-G; Duckworth AR, 2006, MAR BIOL RES, V2, P243, DOI 10.1080/17451000600781775; Gatti S, 2002, MAR BIOL, V140, P1075, DOI 10.1007/s00227-002-0786-9; Gili JM, 2006, MAR ECOL PROG SER, V322, P43, DOI 10.3354/meps322043; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; Guillou L, 2001, AQUAT MICROB ECOL, V26, P201, DOI 10.3354/ame026201; GUO C, 1995, MAR BIOL, V122, P333; HALL JA, 1991, BRIT PHYCOL J, V26, P169, DOI 10.1080/00071619100650131; Hanson CE, 2009, ESTUAR COAST SHELF S, V84, P289, DOI 10.1016/j.ecss.2009.05.019; Herman PMJ, 1999, ADV ECOL RES, V29, P195; HUYSECOM J, 1988, PHYSIOL ZOOL, V61, P535, DOI 10.1086/physzool.61.6.30156162; Ilan M, 1995, BIOL BULL, V189, P363, DOI 10.2307/1542154; Jimenez E, 2007, LIMNOL OCEANOGR, V52, P948, DOI 10.4319/lo.2007.52.3.0948; Kowalke J., 1998, BER POLARFORSCH, V286, P1; Lemloh Marie-Louise, 2009, BMC Ecology, V9, P4, DOI 10.1186/1472-6785-9-4; Leon YM, 2002, MAR ECOL PROG SER, V245, P249, DOI 10.3354/meps245249; Loh TL, 2009, J EXP MAR BIOL ECOL, V374, P45, DOI 10.1016/j.jembe.2009.04.007; Lopez CB, 2006, ECOSYSTEMS, V9, P422, DOI 10.1007/s10021-005-0113-7; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Marie D, 2001, CURR PROTOC CYTOM; Maury O, 2007, PROG OCEANOGR, V74, P479, DOI 10.1016/j.pocean.2007.05.002; Menge BA, 1999, ECOL MONOGR, V69, P297, DOI 10.1890/0012-9615(1999)069[0297:TDABUR]2.0.CO;2; MEYLAN A, 1988, SCIENCE, V239, P393, DOI 10.1126/science.239.4838.393; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Patten NL, 2006, J MAR BIOL ASSOC UK, V86, P563, DOI 10.1017/S0025315406013476; Perea-Blazquez A, 2011, INTERACTIONS SPONGES; Perea-Blazquez Alejandra, 2010, Open Marine Biology Journal, V4, P65, DOI 10.2174/1874450801004010065; Peters KJ, 2009, MAR ECOL PROG SER, V385, P77, DOI 10.3354/meps08026; Pfannkuchen M, 2009, J EXP MAR BIOL ECOL, V369, P65, DOI 10.1016/j.jembe.2008.10.027; Pile A.J., 1997, P1403; Pile AJ, 2006, DEEP-SEA RES PT I, V53, P1148, DOI 10.1016/j.dsr.2006.03.008; Pile AJ, 2005, B MAR SCI, V76, P743; Pile AJ, 1996, MAR ECOL PROG SER, V141, P95, DOI 10.3354/meps141095; Pile AJ, 1997, LIMNOL OCEANOGR, V42, P178, DOI 10.4319/lo.1997.42.1.0178; Pinkerton MH, 2008, J EXP MAR BIOL ECOL, V367, P189, DOI 10.1016/j.jembe.2008.09.022; REISWIG HM, 1973, J EXP MAR BIOL ECOL, V14, P231; REISWIG HM, 1975, CAN J ZOOL, V53, P582, DOI 10.1139/z75-072; REISWIG HM, 1971, BIOL BULL, V141, P568, DOI 10.2307/1540270; Ribes M, 1999, MAR ECOL PROG SER, V176, P179, DOI 10.3354/meps176179; Ribes M, 2005, LIMNOL OCEANOGR, V50, P1480, DOI 10.4319/lo.2005.50.5.1480; Ribes M, 2000, SCI MAR, V64, P265, DOI 10.3989/scimar.2000.64s1265; Ribes M, 1999, J PLANKTON RES, V21, P1077, DOI 10.1093/plankt/21.6.1077; Richter C, 2001, NATURE, V413, P726, DOI 10.1038/35099547; Savarese M, 1997, LIMNOL OCEANOGR, V42, P171; Scanlan D., 2001, MICROBIOLOGY TODAY, V28, P128; Schlappy ML, 2007, J MAR BIOL ASSOC UK, V87, P1677, DOI 10.1017/S0025315407058146; STUART V, 1984, MAR ECOL PROG SER, V16, P27, DOI 10.3354/meps016027; Team R. D. C, 2011, R LANG ENV STAT COMP; Ting CS, 2002, TRENDS MICROBIOL, V10, P134, DOI 10.1016/S0966-842X(02)02319-3; Topcu NE, 2010, J EXP MAR BIOL ECOL, V389, P61, DOI 10.1016/j.jembe.2010.03.017; Trussell GC, 2006, MAR ECOL PROG SER, V323, P149, DOI 10.3354/meps323149; WATERBURY JB, 1979, NATURE, V277, P293, DOI 10.1038/277293a0; Whipple SJ, 1999, ECOL MODEL, V114, P251, DOI 10.1016/S0304-3800(98)00154-9; Wollast R, 1998, SEA, V10, P213; Wright IC, 2006, WELLINGTON S C UNPUB; Wright JT, 1997, J EXP MAR BIOL ECOL, V213, P199, DOI 10.1016/S0022-0981(96)02768-2; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; Yahel G, 2003, LIMNOL OCEANOGR, V48, P141, DOI 10.4319/lo.2003.48.1.0141; Yahel G, 2005, LIMNOL OCEANOGR-METH, V3, P46, DOI 10.4319/lom.2005.3.46; Yahel G, 2007, LIMNOL OCEANOGR, V52, P428, DOI 10.4319/lo.2007.52.1.0428	83	41	42	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29569	10.1371/journal.pone.0029569	http://dx.doi.org/10.1371/journal.pone.0029569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238622	gold, Green Published, Green Submitted			2022-12-27	WOS:000301070200033
J	Sabes-Figuera, R; McCrone, P; Bogic, M; Ajdukovic, D; Franciskovic, T; Colombini, N; Kucukalic, A; Lecic-Tosevski, D; Morina, N; Popovski, M; Schutzwohl, M; Priebe, S				Sabes-Figuera, Ramon; McCrone, Paul; Bogic, Marija; Ajdukovic, Dean; Franciskovic, Tanja; Colombini, Niccolo; Kucukalic, Abdulah; Lecic-Tosevski, Dusica; Morina, Nexhmedin; Popovski, Mihajlo; Schuetzwohl, Matthias; Priebe, Stefan			Long-Term Impact of War on Healthcare Costs: An Eight-Country Study	PLOS ONE			English	Article							MENTAL-DISORDERS; FORMER YUGOSLAVIA; SELF-REPORT; DSM-IV; PREVALENCE; INDIVIDUALS; SEVERITY; OUTCOMES; BALKANS; PTSD	Objective: Exposure to war can negatively affect health and may impact on healthcare costs. Estimating these costs and identifying their predictors is important for appropriate service planning. We aimed to measure use of health services in an adult population who had experienced war in the former-Yugoslavia on average 8 years previously, and to identify characteristics associated with the use and costs of healthcare. Method: War-affected community samples in Bosnia-Herzegovina, Croatia, Kosovo, FYR Macedonia, and Serbia were recruited through a random walk technique. Refugees in Germany, Italy and the UK were contacted through registers, organisations and networking. Current service use was measured for the previous three months and combined with unit costs for each country for the year 2006/7. A two-part approach was used, to identify predictors of service use with a multiple logistic regression model and predictors of cost with a generalised linear regression model. Results: 3,313 participants were interviewed in Balkan countries and 854 refugees in Western European countries. In the Balkan countries, traumatic events and mental health status were related to greater service use while in Western countries these associations were not found. Participants in Balkan countries with post traumatic stress disorder (PTSD) had costs that were 63% higher (p = 0.005) than those without PTSD. Distress experienced during the most traumatic war event was associated with higher costs (p = 0.013). In Western European countries costs were 76% higher if non-PTSD anxiety disorders were present (0.027) and 63% higher for mood disorders (p = 0.006). Conclusions: War experiences and their effects on mental health are associated with increased health care costs even many years later, especially for those who stayed in the area of conflict. Focussing on the mental health impact of war is important for many reasons including those of an economic nature.	[Sabes-Figuera, Ramon; McCrone, Paul] Kings Coll London, Inst Psychiat, Ctr Econ Mental Hlth, London WC2R 2LS, England; [Bogic, Marija; Priebe, Stefan] Queen Mary Univ London, Barts & London Sch Med & Dent, Unit Social & Community Psychiat, London, England; [Ajdukovic, Dean] Univ Zagreb, Fac Humanities & Social Sci, Zagreb 41000, Croatia; [Franciskovic, Tanja] Univ Rijeka, Sch Med, Rijeka, Croatia; [Colombini, Niccolo] Dept Mental Hlth, Modena, Italy; [Kucukalic, Abdulah] Univ Sarajevo, Sch Med, Sarajevo 71000, Bosnia & Herceg; [Lecic-Tosevski, Dusica] Univ Belgrade, Sch Med, Belgrade, Serbia; [Morina, Nexhmedin] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Popovski, Mihajlo] Univ Skopje, Inst Psychol, Skopje, Macedonia; [Schuetzwohl, Matthias] Tech Univ Dresden, Dept Psychiat & Psychotherapy, D-01062 Dresden, Germany	University of London; King's College London; University of London; Queen Mary University London; University of Zagreb; University of Rijeka; University of Sarajevo; University of Belgrade; University of Amsterdam; Saints Cyril & Methodius University of Skopje; Technische Universitat Dresden	Sabes-Figuera, R (corresponding author), Kings Coll London, Inst Psychiat, Ctr Econ Mental Hlth, London WC2R 2LS, England.	Ramon.Sabes-Figuera@kcl.ac.uk	Morina, Nexhmedin/AAK-7071-2021; Ajdukovic, Dean/X-2308-2019; Morina, Nexhmedin/D-4976-2012; Franciskovic, Tanja/R-8177-2018	Morina, Nexhmedin/0000-0002-2331-9140; Franciskovic, Tanja/0000-0003-4106-9461; Priebe, Stefan/0000-0001-9864-3394; McCrone, Paul/0000-0001-7001-4502; Sabes-Figuera, Ramon/0000-0001-9178-9753	European Commission [INCO-CT-2004-509175]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was funded by a grant from the European Commission, contract number INCO-CT-2004-509175. The views expressed are those of the authors and not necessarily those of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager A., 1993, MENTAL HLTH ISSUES R; Beecham J, 2001, MEASURING MENTAL HLT, V2nd, P20024; Bredenkamp C., 2007, WORLD BANK POLICY RE, DOI [10.5771/1435-2869-2008-2-151, DOI 10.5771/1435-2869-2008-2-151]; CALSYN RJ, 1993, EVALUATION REV, V17, P353, DOI 10.1177/0193841X9301700306; Curtis L, 2007, UNIT COSTS HLTH SOCI; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Dunn G, 2003, BRIT J PSYCHIAT, V183, P398, DOI 10.1192/bjp.183.5.398; Elhai J. D., 2005, PSYCHOL SERV, V2, P3, DOI [10.1037/1541-1559.2.1.3, DOI 10.1037/1541-1559.2.1.3]; Fazel M, 2005, LANCET, V365, P1309, DOI 10.1016/S0140-6736(05)61027-6; Goldberg RW, 2002, PSYCHIATR SERV, V53, P879, DOI 10.1176/appi.ps.53.7.879; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Morina N, 2010, J ANXIETY DISORD, V24, P606, DOI 10.1016/j.janxdis.2010.04.001; Nation R. Craig, 2003, WAR BALKANS 1991 200; Netten A., 2001, UNIT COSTS HLTH SOCI; OECD, 2007, MAIN EC IND; Operation USEE, 2001, REG OV; Priebe S, 2004, PSYCHIAT TODAY, V36, P101; Priebe S, 2010, SOC SCI MED, V71, P2170, DOI 10.1016/j.socscimed.2010.09.029; Priebe S, 2010, PSYCHIAT SERV, V61, P598, DOI 10.1176/ps.2010.61.6.598; Priebe S, 2010, ARCH GEN PSYCHIAT, V67, P518, DOI 10.1001/archgenpsychiatry.2010.37; Priebe S, 2009, CROAT MED J, V50, P465, DOI 10.3325/cmj.2009.50.465; Schnurr PP, 2000, J NERV MENT DIS, V188, P496, DOI 10.1097/00005053-200008000-00004; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012; Wolfe Jessica, 1997, P192; World Health O, 2001, CHOOS INT THAT AR CO	27	33	33	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29603	10.1371/journal.pone.0029603	http://dx.doi.org/10.1371/journal.pone.0029603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	902VE	22238627	Green Published, Green Submitted, gold			2022-12-27	WOS:000301070200038
J	Han, JF; Miranda-Saavedra, D; Luebbering, N; Singh, A; Sibbet, G; Ferguson, MAJ; Cleghon, V				Han, Jingfen; Miranda-Saavedra, Diego; Luebbering, Nathan; Singh, Aman; Sibbet, Gary; Ferguson, Michael A. J.; Cleghon, Vaughn			Deep Evolutionary Conservation of an Intramolecular Protein Kinase Activation Mechanism	PLOS ONE			English	Article							TO-EMBRYO TRANSITION; DYRK-FAMILY KINASE; DUAL-SPECIFICITY; TYROSINE-PHOSPHORYLATION; LOOP AUTOPHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; TRYPANOSOMA-BRUCEI; FISSION YEAST; CELL-CYCLE; ELEGANS	DYRK-family kinases employ an intramolecular mechanism to autophosphorylate a critical tyrosine residue in the activation loop. Once phosphorylated, DYRKs lose tyrosine kinase activity and function as serine/threonine kinases. DYRKs have been characterized in organisms from yeast to human; however, all entities belong to the Unikont supergroup, only one of five eukaryotic supergroups. To assess the evolutionary age and conservation of the DYRK intramolecular kinase-activation mechanism, we surveyed 21 genomes representing four of the five eukaryotic supergroups for the presence of DYRKs. We also analyzed the activation mechanism of the sole DYRK (class 2 DYRK) present in Trypanosoma brucei (TbDYRK2), a member of the excavate supergroup and separated from Drosophila by similar to 850 million years. Bioinformatics showed the DYRKs clustering into five known subfamilies, class 1, class 2, Yaks, HIPKs and Prp4s. Only class 2 DYRKs were present in all four supergroups. These diverse class 2 DYRKs also exhibited conservation of N-terminal NAPA regions located outside of the kinase domain, and were shown to have an essential role in activation loop autophosphorylation of Drosophila DmDYRK2. Class 2 TbDYRK2 required the activation loop tyrosine conserved in other DYRKs, the NAPA regions were critical for this autophosphorylation event, and the NAPA-regions of Trypanosoma and human DYRK2 complemented autophosphorylation by the kinase domain of DmDYRK2 in trans. Finally, sequential deletion analysis was used to further define the minimal region required for trans-complementation. Our analysis provides strong evidence that class 2 DYRKs were present in the primordial or root eukaryote, and suggest this subgroup may be the oldest, founding member of the DYRK family. The conservation of activation loop autophosphorylation demonstrates that kinase self-activation mechanisms are also primitive.	[Han, Jingfen; Luebbering, Nathan; Cleghon, Vaughn] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH USA; [Miranda-Saavedra, Diego] Osaka Univ, WPI Immunol Frontier Res Ctr IFReC, Osaka, Japan; [Singh, Aman] Univ Tennessee, Ctr Hlth Sci, Integrated Program Biomed Sci, Memphis, TN 38163 USA; [Sibbet, Gary] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Ferguson, Michael A. J.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland	Cincinnati Children's Hospital Medical Center; Osaka University; University of Tennessee System; University of Tennessee Health Science Center; Beatson Institute; University of Dundee	Han, JF (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH USA.	vaughn.cleghon@cchmc.org	Miranda-Saavedra, Diego/C-2707-2012	Ferguson, Michael/0000-0003-1321-8714	National Institutes of Health [R01GM087374-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was funded by a grant from the National Institutes of Health (R01GM087374-01A1 to VC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Buescher JL, 2010, J BIOL CHEM, V285, P7957, DOI 10.1074/jbc.M109.091603; Cavalier-Smith T, 2003, J MOL EVOL, V56, P540, DOI 10.1007/s00239-002-2424-z; Cheng KCC, 2009, CELL, V139, P560, DOI 10.1016/j.cell.2009.08.047; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Deng XB, 2005, J BIOL CHEM, V280, P4894, DOI 10.1074/jbc.M411894200; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; GARRETT S, 1989, GENE DEV, V3, P1336, DOI 10.1101/gad.3.9.1336; Himpel S, 2001, BIOCHEM J, V359, P497, DOI 10.1042/0264-6021:3590497; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kassis S, 2000, BIOCHEM J, V348, P263, DOI 10.1042/0264-6021:3480263; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Kinstrie R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000579; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Lee K, 2000, CANCER RES, V60, P3631; Li K, 2002, J BIOL CHEM, V277, P47052, DOI 10.1074/jbc.M205374200; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lochhead PA, 2003, BIOCHEM J, V374, P381, DOI 10.1042/BJ20030500; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin DMA, 2009, NUCLEIC ACIDS RES, V37, pD244, DOI 10.1093/nar/gkn834; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Moriya H, 2001, GENE DEV, V15, P1217, DOI 10.1101/gad.884001; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Nett IRE, 2009, EUKARYOT CELL, V8, P617, DOI 10.1128/EC.00366-08; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pang KM, 2004, DEV BIOL, V265, P127, DOI 10.1016/j.ydbio.2003.09.024; Papadopoulos C, 2011, J BIOL CHEM, V286, P5494, DOI 10.1074/jbc.M110.157909; Parry JM, 2009, CURR BIOL, V19, P1752, DOI 10.1016/j.cub.2009.09.015; Pellettieri J, 2003, DEV CELL, V5, P451, DOI 10.1016/S1534-5807(03)00231-4; Quintin S, 2003, EMBO REP, V4, P1175, DOI 10.1038/sj.embor.7400029; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Souza GM, 1998, DEVELOPMENT, V125, P2291; Stitzel ML, 2006, CURR BIOL, V16, P56, DOI 10.1016/j.cub.2005.11.063; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Varjosalo M, 2008, CELL, V133, P537, DOI 10.1016/j.cell.2008.02.047; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	48	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29702	10.1371/journal.pone.0029702	http://dx.doi.org/10.1371/journal.pone.0029702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235329	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000301123400091
J	Yamamura, S; Saini, S; Majid, S; Hirata, H; Ueno, K; Deng, G; Dahiya, R				Yamamura, Soichiro; Saini, Sharanjot; Majid, Shahana; Hirata, Hiroshi; Ueno, Koji; Deng, Guoren; Dahiya, Rajvir			MicroRNA-34a Modulates c-Myc Transcriptional Complexes to Suppress Malignancy in Human Prostate Cancer Cells	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; RECRUITS P-TEFB; RHO-GTPASES; TUMOR-SUPPRESSOR; GENE-EXPRESSION; DNA-REPLICATION; DOWN-REGULATION; CAD PROMOTER; MET RECEPTOR; IN-VIVO	MicroRNA-34a (miR-34a), a potent mediator of tumor suppressor p53, has been reported to function as a tumor suppressor and miR-34a was found to be downregulated in prostate cancer tissues. We studied the functional effects of miR-34a on c-Myc transcriptional complexes in PC-3 prostate cancer cells. Transfection of miR-34a into PC-3 cells strongly inhibited in vitro cell proliferation, cell invasion and promoted apoptosis. Transfection of miR-34a into PC-3 cells also significantly inhibited in vivo xenograft tumor growth in nude mice. miR-34a downregulated expression of c-Myc oncogene by targeting its 39 UTR as shown by luciferase reporter assays. miR-34a was found to repress RhoA, a regulator of cell migration and invasion, by suppressing c-Myc-Skp2-Miz1 transcriptional complex that activates RhoA. Overexpression of c-Myc reversed miR-34a suppression of RhoA expression, suggesting that miR-34a inhibits invasion by suppressing RhoA through c-Myc. miR-34a was also found to repress c-Myc-pTEFB transcription elongation complex, indicating one of the mechanisms by which miR-34a has profound effects on cellular function. This is the first report to document that miR-34a suppresses assembly and function of the c-Myc-Skp2-Miz1 complex that activates RhoA and the c-Myc-pTEFB complex that elongates transcription of various genes, suggesting a novel role of miR-34a in the regulation of transcription by c-Myc complex.	[Yamamura, Soichiro] San Francisco VA Med Ctr, Dept Urol, San Francisco, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Yamamura, S (corresponding author), San Francisco VA Med Ctr, Dept Urol, San Francisco, CA USA.	rdahiya@urology.ucsf.edu	Jackson, Benjamin L/C-4297-2012		NIH [R01CA138642, T32DK007790]; NATIONAL CANCER INSTITUTE [R01CA138642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007790] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Grants R01CA138642, T32DK007790 (NIH), VA Research Enhancement Award Program (REAP) and Merit Review grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Cannell IG, 2010, P NATL ACAD SCI USA, V107, P5375, DOI 10.1073/pnas.0910015107; Cardone RA, 2005, MOL BIOL CELL, V16, P3117, DOI 10.1091/mbc.e04-10-0945; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Chung J, 2004, J BIOL CHEM, V279, P32287, DOI 10.1074/jbc.M403809200; Cole MD, 2008, NAT REV MOL CELL BIO, V9, P810, DOI 10.1038/nrm2467; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Fujiuchi Y, 2003, ONCOL REP, V10, P1001; Gargano B, 2007, CELL CYCLE, V6, P2031, DOI 10.4161/cc.6.16.4554; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hodge JC, 2003, CANCER RES, V63, P1359; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jeffers M, 1996, MOL CELL BIOL, V16, P1115; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Lin C, MOL CELL, V37, P429; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Moiola C, 2010, CELL CYCLE, V9, P3119, DOI 10.4161/cc.9.15.12526; Mueller D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000249; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Shinomiya N, 2004, CANCER RES, V64, P7962, DOI 10.1158/0008-5472.CAN-04-1043; Sridhar SC, 2006, ONCOGENE, V25, P2367, DOI 10.1038/sj.onc.1209269; Tai S, 2011, PROSTATE, V71, P1668, DOI 10.1002/pros.21383; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Xia MX, 2007, NAT STRUCT MOL BIOL, V14, P215, DOI 10.1038/nsmb1208; Yan DS, 2009, INVEST OPHTH VIS SCI, V50, P1559, DOI 10.1167/iovs.08-2681	51	109	114	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29722	10.1371/journal.pone.0029722	http://dx.doi.org/10.1371/journal.pone.0029722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235332	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400094
J	Bigdeli, TB; Maher, BS; Zhao, ZM; van den Oord, EJCG; Thiselton, DL; Sun, JC; Webb, BT; Amdur, RL; Wormley, B; O'Neill, FA; Walsh, D; Riley, BP; Kendler, KS; Fanous, AH				Bigdeli, T. Bernard; Maher, Brion S.; Zhao, Zhongming; van den Oord, Edwin J. C. G.; Thiselton, Dawn L.; Sun, Jingchun; Webb, Bradley T.; Amdur, Richard L.; Wormley, Brandon; O'Neill, Francis A.; Walsh, Dermot; Riley, Brien P.; Kendler, Kenneth S.; Fanous, Ayman H.			Comprehensive Gene-Based Association Study of a Chromosome 20 Linked Region Implicates Novel Risk Loci for Depressive Symptoms in Psychotic Illness	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; INITIATIVE BIPOLAR PEDIGREES; GENOME-WIDE ASSOCIATION; LINKAGE ANALYSIS; SCHIZOPHRENIA FAMILIES; SUSCEPTIBILITY GENES; PSYCHIATRIC-ILLNESS; AFFECTIVE-DISORDER; CLINICAL-FEATURES; COMMON VARIANTS	Background: Prior genomewide scans of schizophrenia support evidence of linkage to regions of chromosome 20. However, association analyses have yet to provide support for any etiologically relevant variants. Methods: We analyzed 2988 LD-tagging single nucleotide polymorphisms (SNPs) in 327 genes on chromosome 20, to test for association with schizophrenia in 270 Irish high-density families (ISHDSF, N = 270 families, 1408 subjects). These SNPs were genotyped using an Illumina iSelect genotyping array which employs the Infinium assay. Given a previous report of novel linkage with chromosome 20p using latent classes of psychotic illness in this sample, association analysis was also conducted for each of five factor-derived scores based on the Operational Criteria Checklist for Psychotic Illness (delusions, hallucinations, mania, depression, and negative symptoms). Tests of association were conducted using the PDTPHASE and QPDTPHASE packages of UNPHASED. Empirical estimates of gene-wise significance were obtained by adaptive permutation of a) the smallest observed P-value and b) the threshold-truncated product of P-values for each locus. Results: While no single variant was significant after LD-corrected Bonferroni-correction, our gene-dropping analyses identified loci which exceeded empirical significance criteria for both gene-based tests. Namely, R3HDML and C20orf39 are significantly associated with depressive symptoms of schizophrenia (P-emp < 2 x 10(-5)) based on the minimum P-value and truncated-product methods, respectively. Conclusions: Using a gene-based approach to family-based association, R3HDML and C20orf39 were found to be significantly associated with clinical dimensions of schizophrenia. These findings demonstrate the efficacy of gene-based analysis and support previous evidence that chromosome 20 may harbor schizophrenia susceptibility or modifier loci.	[Bigdeli, T. Bernard; Maher, Brion S.; Zhao, Zhongming; Riley, Brien P.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA; [Bigdeli, T. Bernard; Maher, Brion S.; Zhao, Zhongming; van den Oord, Edwin J. C. G.; Thiselton, Dawn L.; Webb, Bradley T.; Wormley, Brandon; Riley, Brien P.; Kendler, Kenneth S.; Fanous, Ayman H.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [Maher, Brion S.; Zhao, Zhongming; Thiselton, Dawn L.; Wormley, Brandon; Riley, Brien P.; Kendler, Kenneth S.; Fanous, Ayman H.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Maher, Brion S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Zhao, Zhongming; Sun, Jingchun] Vanderbilt Univ, Dept Psychiat, Med Ctr, Vanderbilt, TN USA; [Zhao, Zhongming; Sun, Jingchun] Vanderbilt Univ, Dept Biomed Informat, Med Ctr, Vanderbilt, TN USA; [Zhao, Zhongming; Sun, Jingchun] Vanderbilt Univ, Dept Canc Biol, Med Ctr, Vanderbilt, TN USA; [van den Oord, Edwin J. C. G.; Webb, Bradley T.] Virginia Commonwealth Univ, Ctr Biomarker Res & Personalized Med, Richmond, VA USA; [Amdur, Richard L.; Fanous, Ayman H.] Washington VA Med Ctr, Mental Hlth Serv Line, Washington, DC USA; [Fanous, Ayman H.] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90033 USA; [O'Neill, Francis A.] Queens Univ Belfast, Dept Psychiat, Belfast, Antrim, North Ireland; [Walsh, Dermot] Hlth Res Board, Dublin, Ireland; [Amdur, Richard L.; Fanous, Ayman H.] Georgetown Univ, Sch Med, Dept Psychiat, Washington, DC USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Vanderbilt University; Vanderbilt University; Vanderbilt University; Virginia Commonwealth University; University of Southern California; Queens University Belfast; Health Research Board - Ireland; Georgetown University	Bigdeli, TB (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA.	ayman.fanous@va.gov	O'Neill, Francis A/C-5582-2008; Bigdeli, Tim B./AAX-7761-2020; Fanous, Ayman H/O-1263-2017; Webb, Bradley T/B-1459-2009; Maher, Brion S/F-9185-2010; Amdur, Richard L/AAE-5345-2019; Kendler, Kenneth/AAF-2876-2019	O'Neill, Francis A/0000-0002-7531-7657; Bigdeli, Tim B./0000-0003-2215-5946; Webb, Bradley T/0000-0002-0576-5366; Amdur, Richard/0000-0002-4900-653X; Wormley, Brandon/0000-0001-8152-0638	U.S. National Institutes of Health [5R25DA026119-03, AA017437]; U.S. National Institute of Mental Health [MH083094]; NARSAD; Department of Veterans Affairs;  [MH041953];  [MH068881]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068881, R01MH083094, R01MH041953, R01MH062276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA017437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA026119] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD(NARSAD); Department of Veterans Affairs(US Department of Veterans Affairs); ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	TBB was supported by U.S. National Institutes of Health grant 5R25DA026119-03. BSM, BPR and KSK were supported by U.S. National Institute of Mental Health grant MH083094. BPR and KSK were supported by grants MH041953 and MH068881. ZZ was supported by U.S. National Institutes of Health grant AA017437 and a NARSAD Maltz Investigator Award. AHF was supported by a grant from the Department of Veterans Affairs Merit Review Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], 2010, R LANG ENV STAT COMP; Arinami T, 2005, AM J HUM GENET, V77, P937, DOI 10.1086/498122; COON H, 1994, AM J MED GENET, V54, P59, DOI 10.1002/ajmg.1320540111; Craddock N, 2006, SCHIZOPHRENIA BULL, V32, P9, DOI 10.1093/schbul/sbj033; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; Craddock N, 2009, BRIT J PSYCHIAT, V195, P97, DOI 10.1192/bjp.bp.108.063156; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DeteraWadleigh SD, 1997, AM J MED GENET, V74, P254, DOI 10.1002/(SICI)1096-8628(19970531)74:3<254::AID-AJMG4>3.0.CO;2-Q; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Etain B, 2006, MOL PSYCHIATR, V11, P685, DOI 10.1038/sj.mp.4001815; Fanous A, 2001, ARCH GEN PSYCHIAT, V58, P669, DOI 10.1001/archpsyc.58.7.669; Fanous AH, 2004, AM J MED GENET B, V125B, P69, DOI 10.1002/ajmg.b.20103; Fanous AH, 2005, AM J PSYCHIAT, V162, P1824, DOI 10.1176/appi.ajp.162.10.1824; Fanous AH, 2005, MOL PSYCHIATR, V10, P6, DOI 10.1038/sj.mp.4001571; Fanous AH, 2008, BIOL PSYCHIAT, V64, P121, DOI 10.1016/j.biopsych.2007.11.023; Fanous Ayman H, 2008, Curr Psychiatry Rep, V10, P164, DOI 10.1007/s11920-008-0028-z; Fullerton JM, 2010, BIOL PSYCHIAT, V67, P478, DOI 10.1016/j.biopsych.2009.10.022; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; Gysin R, 2007, P NATL ACAD SCI USA, V104, P16621, DOI 10.1073/pnas.0706778104; Hamshere ML, 2006, J MED GENET, V43, P563, DOI 10.1136/jmg.2005.035345; Hamshere ML, 2009, BIPOLAR DISORD, V11, P610, DOI 10.1111/j.1399-5618.2009.00736.x; Hardy SW, 2001, GENET EPIDEMIOL, V21, pS441, DOI 10.1002/gepi.2001.21.s1.s441; Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9; Holmans PA, 2009, MOL PSYCHIATR, V14, P786, DOI 10.1038/mp.2009.11; Kaiser R, 2000, MOL PSYCHIATR, V5, P418, DOI 10.1038/sj.mp.4000729; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kendler KS, 1996, AM J MED GENET, V67, P179, DOI 10.1002/(SICI)1096-8628(19960409)67:2<179::AID-AJMG8>3.0.CO;2-N; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; Maher BS, 2010, HUM HERED, V69, P71, DOI 10.1159/000264445; Malhotra AK, 1998, MOL PSYCHIATR, V3, P328, DOI 10.1038/sj.mp.4000412; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; McInnis MG, 2003, BIOL PSYCHIAT, V54, P1265, DOI 10.1016/j.biopsych.2003.08.001; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; Monks SA, 2000, AM J HUM GENET, V66, P576, DOI 10.1086/302745; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; Mutsuddi M, 2006, AM J HUM GENET, V79, P903, DOI 10.1086/508942; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Oedegaard KJ, 2010, J AFFECT DISORDERS, V122, P14, DOI 10.1016/j.jad.2009.06.014; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Peralta V, 2001, SCHIZOPHR RES, V49, P269, DOI 10.1016/S0920-9964(00)00071-2; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Serretti A, 2001, AM J MED GENET, V105, P283, DOI 10.1002/ajmg.1321; Serretti A, 2000, MOL PSYCHIATR, V5, P270, DOI 10.1038/sj.mp.4000726; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shield AJ, 2006, BIOCHEM BIOPH RES CO, V347, P859, DOI 10.1016/j.bbrc.2006.06.189; Souza RP, 2010, SCHIZOPHR RES, V121, P279, DOI 10.1016/j.schres.2010.04.019; Spitzer R. L., 1987, STRUCTURED CLIN INTE; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Straub RE, 2002, MOL PSYCHIATR, V7, P542, DOI 10.1038/sj.mp.4001051; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Teltsh O, 2008, AM J MED GENET B, V147B, P209, DOI 10.1002/ajmg.b.30591; Williams NM, 2003, AM J HUM GENET, V73, P1355, DOI 10.1086/380206; Willour VL, 2003, AM J MED GENET B, V121B, P21, DOI 10.1002/ajmg.b.20051; Wu EQ, 2005, J CLIN PSYCHIAT, V66, P1122, DOI 10.4088/JCP.v66n0906; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang XY, 2000, MOL PSYCHIATR, V5, P239, DOI 10.1038/sj.mp.4000677	66	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e21440	10.1371/journal.pone.0021440	http://dx.doi.org/10.1371/journal.pone.0021440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220189	Green Submitted, Green Published, gold			2022-12-27	WOS:000300677000001
J	Filiatrault, MJ; Stodghill, PV; Myers, CR; Bronstein, PA; Butcher, BG; Lam, H; Grills, G; Schweitzer, P; Wang, W; Schneider, DJ; Cartinhour, SW				Filiatrault, Melanie J.; Stodghill, Paul V.; Myers, Christopher R.; Bronstein, Philip A.; Butcher, Bronwyn G.; Lam, Hanh; Grills, George; Schweitzer, Peter; Wang, Wei; Schneider, David J.; Cartinhour, Samuel W.			Genome-Wide Identification of Transcriptional Start Sites in the Plant Pathogen Pseudomonas syringae pv. tomato str. DC3000	PLOS ONE			English	Article							ESCHERICHIA-COLI; SIGMA-FACTOR; GENE-EXPRESSION; RNA-POLYMERASE; AERUGINOSA; PROMOTERS; REGULON; DEGRADATION; HOMEOSTASIS; COMPLEXITY	RNA-Seq has provided valuable insights into global gene expression in a wide variety of organisms. Using a modified RNA-Seq approach and Illumina's high-throughput sequencing technology, we globally identified 5'-ends of transcripts for the plant pathogen Pseudomonas syringae pv. tomato str. DC3000. A substantial fraction of 5'-ends obtained by this method were consistent with results obtained using global RNA-Seq and 5'RACE. As expected, many 5'-ends were positioned a short distance upstream of annotated genes. We also captured 5'-ends within intergenic regions, providing evidence for the expression of un-annotated genes and non-coding RNAs, and detected numerous examples of antisense transcription, suggesting additional levels of complexity in gene regulation in DC3000. Importantly, targeted searches for sequence patterns in the vicinity of 5'-ends revealed over 1200 putative promoters and other regulatory motifs, establishing a broad foundation for future investigations of regulation at the genomic and single gene levels.	[Filiatrault, Melanie J.; Stodghill, Paul V.; Bronstein, Philip A.; Schneider, David J.; Cartinhour, Samuel W.] ARS, Lant Microbe Interact Res Unit, Robert W Holley Ctr Agr & Hlth, USDA, Ithaca, NY USA; [Filiatrault, Melanie J.; Stodghill, Paul V.; Bronstein, Philip A.; Butcher, Bronwyn G.; Lam, Hanh; Schneider, David J.; Cartinhour, Samuel W.] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY USA; [Myers, Christopher R.; Grills, George; Schweitzer, Peter; Wang, Wei] Cornell Univ, Life Sci Core Labs Ctr, Ithaca, NY USA; [Myers, Christopher R.] Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA	United States Department of Agriculture (USDA); Cornell University; Cornell University; Cornell University	Filiatrault, MJ (corresponding author), ARS, Lant Microbe Interact Res Unit, Robert W Holley Ctr Agr & Hlth, USDA, Ithaca, NY USA.	Melanie.filiatrault@ars.usda.gov	Myers, Christopher R/I-8516-2017; Lam, Hanh/AAV-9060-2020; Schneider, David J/H-2236-2012	Lam, Hanh/0000-0002-6323-2146; Schneider, David J/0000-0002-2124-8385	United States Department of Agriculture-Agricultural Research Service under CRIS [1907-21000-027-00D]	United States Department of Agriculture-Agricultural Research Service under CRIS	This work was supported by United States Department of Agriculture-Agricultural Research Service under CRIS project #1907-21000-027-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa C, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00118; ALBRECHT M, 2009, NUCL ACIDS RES; Albrecht M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r98; Arsene F, 2000, INT J FOOD MICROBIOL, V55, P3, DOI 10.1016/S0168-1605(00)00206-3; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bendtsen KM, 2011, NUCLEIC ACIDS RES, V39, P6879, DOI 10.1093/nar/gkr390; Bronstein PA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-209; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Butcher BG, 2011, J BACTERIOL, V193, P4598, DOI 10.1128/JB.00340-11; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Cho BK, 2009, NAT BIOTECHNOL, V27, P1043, DOI 10.1038/nbt.1582; Croucher NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/j.mib.2010.09.009; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DEVRIES CA, 1994, J BACTERIOL, V176, P6677, DOI 10.1128/JB.176.21.6677-6687.1994; Djordjevic M, 2011, J BACTERIOL, V193, P6305, DOI 10.1128/JB.05947-11; Dornenburg JE, 2010, MBIO, V1; Ferreira AO, 2006, MOL PLANT MICROBE IN, V19, P1167, DOI 10.1094/MPMI-19-1167; Filiatrault MJ, 2010, J BACTERIOL, V192, P2359, DOI 10.1128/JB.01445-09; Firoved AM, 2002, J BACTERIOL, V184, P1057, DOI 10.1128/jb.184.4.1057-1064.2002; Gabriel SE, 2009, J BACTERIOL, V191, P6116, DOI 10.1128/JB.00802-09; Georg J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.63; Guell M, 2011, NAT REV MICROBIOL, V9, P658, DOI 10.1038/nrmicro2620; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Haas CE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-470; HARLEY CB, 1987, NUCLEIC ACIDS RES, V15, P2343, DOI 10.1093/nar/15.5.2343; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Hendrickson EL, 2000, J BACTERIOL, V182, P3508, DOI 10.1128/JB.182.12.3508-3516.2000; HERSHBERGER CD, 1995, P NATL ACAD SCI USA, V92, P7941, DOI 10.1073/pnas.92.17.7941; Hook-Barnard I, 2006, J BACTERIOL, V188, P8352, DOI 10.1128/JB.00853-06; KING EO, 1954, J LAB CLIN MED, V44, P301; Koide T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.42; Krasny L, 2008, MOL MICROBIOL, V69, P42, DOI 10.1111/j.1365-2958.2008.06256.x; Larsen TS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-21; Lee CK, 2008, BIOTECHNOL LETT, V30, P521, DOI 10.1007/s10529-007-9571-7; Lewis DEA, 2004, MOL MICROBIOL, V54, P692, DOI 10.1111/j.1365-2958.2004.04318.x; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lindeberg M, 2008, MOL PLANT MICROBE IN, V21, P685, DOI 10.1094/MPMI-21-6-0685; Martin J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S10; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; Mendoza-Vargas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007526; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Moll S, 2010, RNA BIOL, V7, P508, DOI 10.4161/rna.7.5.12687; Moore CM, 2005, CURR OPIN MICROBIOL, V8, P188, DOI 10.1016/j.mib.2005.02.007; O'Brien HE, 2011, CURR OPIN MICROBIOL, V14, P24, DOI 10.1016/j.mib.2010.12.007; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Qiu Y, 2010, GENOME RES, V20, P1304, DOI 10.1101/gr.107540.110; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Siezen RJ, 2010, MICROB BIOTECHNOL, V3, P125, DOI 10.1111/j.1751-7915.2010.00166.x; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Spira B, 2010, MOL GENET GENOMICS, V284, P489, DOI 10.1007/s00438-010-0584-x; STARNBACH MN, 1992, MOL MICROBIOL, V6, P459, DOI 10.1111/j.1365-2958.1992.tb01490.x; Swingle B, 2008, MOL MICROBIOL, V68, P871, DOI 10.1111/j.1365-2958.2008.06209.x; THONY B, 1989, FEMS MICROBIOL LETT, V63, P341; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; van Vliet AHM, 2010, FEMS MICROBIOL LETT, V302, P1, DOI 10.1111/j.1574-6968.2009.01767.x; Walker KA, 2002, J BACTERIOL, V184, P4783, DOI 10.1128/JB.184.17.4783-4791.2002; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wosten MMSM, 1998, FEMS MICROBIOL REV, V22, P127, DOI 10.1016/S0168-6445(98)00011-4; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Zhao K, 2005, J BIOL CHEM, V280, P17758, DOI 10.1074/jbc.M500393200	64	27	28	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29335	10.1371/journal.pone.0029335	http://dx.doi.org/10.1371/journal.pone.0029335			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216251	Green Submitted, gold, Green Published			2022-12-27	WOS:000300676300047
J	Basu, U; Lozynska, O; Moorwood, C; Patel, G; Wilton, SD; Khurana, TS				Basu, Utpal; Lozynska, Olga; Moorwood, Catherine; Patel, Gopal; Wilton, Steve D.; Khurana, Tejvir S.			Translational Regulation of Utrophin by miRNAs	PLOS ONE			English	Article							THERAPEUTIC UP-REGULATION; SKELETAL-MUSCLE; DYSTROPHIC PHENOTYPE; MUSCULAR-DYSTROPHY; ACTIVATION; EXPRESSION; GENE; HEREGULIN; PROMOTER; TRANSCRIPTION	Background: Utrophin is the autosomal homolog of dystrophin, the product of the Duchenne Muscular Dystrophy (DMD) locus. Its regulation is of therapeutic interest as its overexpression can compensate for dystrophin's absence in animal models of DMD. The tissue distribution and transcriptional regulation of utrophin have been characterized extensively, and more recently translational control mechanisms that may underlie its complex expression patterns have begun to be identified. Methodology/Principal Findings: Using a variety of bioinformatic, molecular and cell biology techniques, we show that the muscle isoform utrophin-A is predominantly suppressed at the translational level in C2C12 myoblasts. The extent of translational inhibition is estimated to be similar to 99% in C2C12 cells and is mediated by both the 5'-and 3'-UTRs of the utrophin-A mRNA. In this study we identify five miRNAs (let-7c, miR-150, miR-196b, miR-296-5p, miR-133b) that mediate the repression, and confirm repression by the previously identified miR-206. We demonstrate that this translational repression can be overcome by blocking the actions of miRNAs, resulting in an increased level of utrophin protein in C2C12 cells. Conclusions/Significance: The present study has identified key inhibitory mechanisms featuring miRNAs that regulate utrophin expression, and demonstrated that these mechanisms can be targeted to increase endogenous utrophin expression in cultured muscle cells. We suggest that miRNA-mediated inhibitory mechanisms could be targeted by methods similar to those described here as a novel strategy to increase utrophin expression as a therapy for DMD.	[Basu, Utpal; Lozynska, Olga; Moorwood, Catherine; Patel, Gopal; Khurana, Tejvir S.] Univ Penn, Sch Med, Dept Physiol, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Wilton, Steve D.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia	University of Pennsylvania; University of Western Australia	Basu, U (corresponding author), Univ Kalyani, Dept Mol Biol & Biotechnol, Kalyani 741235, W Bengal, India.	tsk@mail.med.upenn.edu		Wilton, Steve/0000-0002-9400-893X; Moorwood, Catherine/0000-0002-0589-861X; Basu, Utpal/0000-0002-8063-3777	National Institutes of Health [AR-048871]; Muscular Dystrophy Association [MDA202682]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health [grant number AR-048871 to Dr. Khurana] and the Muscular Dystrophy Association [grant number MDA202682 to Dr. Khurana]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonet-Kerrache A, 2005, BIOCHEM J, V391, P261, DOI 10.1042/BJ20050024; Burton EA, 1999, P NATL ACAD SCI USA, V96, P14025, DOI 10.1073/pnas.96.24.14025; Cerletti M, 2003, GENE THER, V10, P750, DOI 10.1038/sj.gt.3301941; Chakkalakal JV, 2008, NUCLEIC ACIDS RES, V36, P826, DOI 10.1093/nar/gkm1107; Chancellor DR, 2011, J MED CHEM, V54, P3241, DOI 10.1021/jm200135z; Dennis CL, 1996, NUCLEIC ACIDS RES, V24, P1646, DOI 10.1093/nar/24.9.1646; Di Certo MG, 2010, HUM MOL GENET, V19, P752, DOI 10.1093/hmg/ddp539; Galvagni F, 2001, J MOL BIOL, V306, P985, DOI 10.1006/jmbi.2000.4335; Goemans NM, 2011, SYSTEMIC ADM PRO051, P1513; Gramolini AO, 1999, P NATL ACAD SCI USA, V96, P3223, DOI 10.1073/pnas.96.6.3223; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Khurana T S, 1991, Neuromuscul Disord, V1, P185, DOI 10.1016/0960-8966(91)90023-L; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; Khurana TS, 1999, MOL BIOL CELL, V10, P2075, DOI 10.1091/mbc.10.6.2075; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Krag TOB, 2004, P NATL ACAD SCI USA, V101, P13856, DOI 10.1073/pnas.0405972101; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; Miura P, 2005, J BIOL CHEM, V280, P32997, DOI 10.1074/jbc.M503994200; Miura P, 2009, HUM MOL GENET, V18, P4640, DOI 10.1093/hmg/ddp431; Miura P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002309; Moorwood C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026169; Perkins KJ, 2007, MOL BIOL CELL, V18, P2864, DOI 10.1091/mbc.E06-12-1069; Perkins KJ, 2001, NUCLEIC ACIDS RES, V29, P4843, DOI 10.1093/nar/29.23.4843; Rodova M, 2004, NEUROSCI LETT, V363, P163, DOI 10.1016/j.neulet.2004.04.001; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Sonnemann KJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000083; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Tinsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019189; van Deutekom JC, 2007, LOCAL DYSTROPHIN RES, P677	31	39	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29376	10.1371/journal.pone.0029376	http://dx.doi.org/10.1371/journal.pone.0029376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216264	Green Published, Green Submitted, gold			2022-12-27	WOS:000300674900032
J	Maggi, U; Dondossola, D; Consonni, D; Gatti, S; Arnoldi, R; Bossi, M; Rossi, G				Maggi, Umberto; Dondossola, Daniele; Consonni, Dario; Gatti, Stefano; Arnoldi, Rossella; Bossi, Manuela; Rossi, Giorgio			Visceral Artery Aneurysms in Liver Transplant Candidates and in Patients after Liver Transplantation	PLOS ONE			English	Article							SPLENIC ARTERY; HEPATIC-ARTERY; PORTAL-HYPERTENSION; PSEUDOANEURYSMS; MANAGEMENT; CIRRHOSIS; HEPATOBILIARY; COMPLICATIONS; EMBOLIZATION; FEATURES	There are only few reviews concerning visceral aneurysms in cirrhotics, and a small number of papers on visceral aneurysms in liver transplant patients. The present paper investigates this condition in both groups of patients in a 10-year-retrospective study.	[Maggi, Umberto; Dondossola, Daniele; Gatti, Stefano; Arnoldi, Rossella; Bossi, Manuela; Rossi, Giorgio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, UO Chirurg Gen & Trapianti Fegato, Milan, Italy; [Consonni, Dario] Fdn IRCCS Ca Granda Osped Maggiore Policlin, UO Epidemiol, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico	Maggi, U (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, UO Chirurg Gen & Trapianti Fegato, Milan, Italy.	u.maggi@tiscali.it	dondossola, daniele E/A-7978-2016; Rossi, Giorgio/M-3445-2015; Consonni, Dario/AAM-2947-2020; Gatti, Stefano/M-1780-2015; Gatti, Stefano/AAE-3281-2022; maggi, Umberto/M-3074-2015	dondossola, daniele E/0000-0002-4374-3184; Rossi, Giorgio/0000-0002-5588-1306; Consonni, Dario/0000-0002-8935-3843; Gatti, Stefano/0000-0003-2209-4338; Gatti, Stefano/0000-0003-2209-4338; maggi, Umberto/0000-0002-5337-2866; Rossella, Arnoldi/0000-0002-2737-2600				Abbas MA, 2003, J VASC SURG, V38, P41, DOI 10.1016/S0741-5214(03)00090-9; Annicchiarico BE, 2009, TRANSPL P, V41, P1383, DOI 10.1016/j.transproceed.2009.03.025; Asthana S, 2010, CLIN TRANSPLANT, V24, P691, DOI 10.1111/j.1399-0012.2009.01192.x; AYALON A, 1988, TRANSPLANTATION, V45, P386, DOI 10.1097/00007890-198802000-00028; Carr JA, 2000, J VASC SURG, V32, P722, DOI 10.1067/mva.2000.110055; Carr SC, 2001, J VASC SURG, V33, P806, DOI 10.1067/mva.2001.112320; CHEZMAR JL, 1992, AM J ROENTGENOL, V159, P317, DOI 10.2214/ajr.159.2.1632346; DeRoover A, 2001, TRANSPLANTATION, V72, P956, DOI 10.1097/00007890-200109150-00036; Fistouris J, 2006, TRANSPLANT P, V38, P2679, DOI 10.1016/j.transproceed.2006.07.028; Ishizawa T, 2006, J GASTROEN HEPATOL, V21, P1213, DOI 10.1111/j.1440-1746.2006.04554.x; Iswariah H, 2004, J GASTROEN HEPATOL, V19, P1084, DOI 10.1111/j.1440-1746.2004.03597.x; Kim HJ, 2005, AM J ROENTGENOL, V184, P1549, DOI 10.2214/ajr.184.5.01841549; Kobori L, 1997, J HEPATOL, V27, P890, DOI 10.1016/S0168-8278(97)80327-3; Larson RA, 2002, J VASC SURG, V36, P1260, DOI 10.1067/mva.2002.129645; Leelaudomlipi S, 2003, TRANSPL INT, V16, P257, DOI 10.1111/j.1432-2277.2003.tb00296.x; Little AF, 2002, CARDIOVASC INTER RAD, V25, P208, DOI 10.1007/s00270-001-0087-6; Lupattelli T, 2003, TRANSPLANT INT, V16, P756, DOI 10.1007/s00147-003-0607-1; MADARIAGA J, 1992, TRANSPLANTATION, V54, P824, DOI 10.1097/00007890-199211000-00011; Marshall MM, 2001, CLIN RADIOL, V56, P579, DOI 10.1053/crad.2001.0650; Moon DB, 2009, LIVER TRANSPLANT, V15, P1535, DOI 10.1002/lt.21885; Muscari F, 2002, ANN CHIR, V127, P281, DOI 10.1016/S0003-3944(02)00746-0; OHTA M, 1994, HEPATO-GASTROENTEROL, V41, P181; Pasha SF, 2007, MAYO CLIN PROC, V82, P472, DOI 10.4065/82.4.472; Piscaglia F, 1999, HEPATOLOGY, V30, P58, DOI 10.1002/hep.510300112; PUTTINI M, 1982, J CARDIOVASC SURG, V23, P490; Robertson AJ, 1999, TRANSPLANT INT, V12, P68, DOI 10.1111/j.1432-2277.1999.tb00578.x; SHENG R, 1995, CARDIOVASC INTER RAD, V18, P112, DOI 10.1007/BF02807234; Sidhu PS, 2000, EUR RADIOL, V10, P1114; STANLEY JC, 1974, SURGERY, V76, P898; Sunagozaka H, 2006, LIVER INT, V26, P291, DOI 10.1111/j.1478-3231.2005.01231.x; Tan J, 2008, LIVER TRANSPLANT, V14, P1081, DOI 10.1002/lt.21572; Tulsyan N, 2007, J VASC SURG, V45, P276, DOI 10.1016/j.jvs.2006.10.049; ZAJKO AB, 1989, TRANSPLANT P, V21, P2457	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29544	10.1371/journal.pone.0029544	http://dx.doi.org/10.1371/journal.pone.0029544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216310	Green Submitted, gold, Green Published			2022-12-27	WOS:000299113600089
J	Perrin-Tricaud, C; Rutschmann, C; Hennet, T				Perrin-Tricaud, Claire; Rutschmann, Christoph; Hennet, Thierry			Identification of Domains and Amino Acids Essential to the Collagen Galactosyltransferase Activity of GLT25D1	PLOS ONE			English	Article							LYSYL HYDROXYLASE; CRYSTAL-STRUCTURE; TRIPLE-HELIX; PROTEIN; GENE; LIPOPOLYSACCHARIDE; BIOSYNTHESIS; EXPRESSION; MUTATIONS; GALACTOSE	Collagen is modified by hydroxylation and glycosylation of hydroxylysine residues. This glycosylation is initiated by the beta 1,O galactosyltransferases GLT25D1 and GLT25D2. The structurally similar protein cerebral endothelial cell adhesion molecule CEECAM1 was previously reported to be inactive when assayed for collagen glycosyltransferase activity. To address the cause of the absent galactosyltransferase activity, we have generated several chimeric constructs between the active human GLT25D1 and inactive human CEECAM1 proteins. The assay of these chimeric constructs pointed to a short central region and a large C-terminal region of CEECAM1 leading to the loss of collagen galactosyltransferase activity. Examination of the three DXD motifs of the active GLT25D1 by site-directed mutagenesis confirmed the importance of the first (amino acids 166-168) and second motif (amino acids 461-463) for enzymatic activity, whereas the third one was dispensable. Since the second DXD motif is incomplete in CEECAM1, we have restored the motif by introducing the substitution S461D. This change did not restore the activity of the C-terminal region, thereby showing that additional amino acids were required in this C-terminal region to confer enzymatic activity. Finally, we have introduced the substitution Q471R-V472M-N473QP474V in the CEECAM1-C-terminal construct, which is found in most animal GLT25D1 and GLT25D2 isoforms but not in CEECAM1. This substitution was shown to partially restore collagen galactosyltransferase activity, underlining its importance for catalytic activity in the C-terminal domain. Because multiple mutations in different regions of CEECAM1 contribute to the lack of galactosyltransferase activity, we deduced that CEECAM1 is functionally different from the related GLT25D1 protein.	[Perrin-Tricaud, Claire; Rutschmann, Christoph; Hennet, Thierry] Univ Zurich, Inst Pathol, Zurich, Switzerland	University of Zurich	Perrin-Tricaud, C (corresponding author), Hop St Eloi, INSERM U1051, Inst Neurosci, Montpellier, France.	thennet@access.uzh.ch			Swiss National Foundation [310030-129633]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Foundation (www.snf.ch) grant 310030-129633 to T. Hennet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Braman J, 1996, Methods Mol Biol, V57, P31; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Deadman ME, 2006, J BIOL CHEM, V281, P29455, DOI 10.1074/jbc.M604908200; Fritz TA, 2006, J BIOL CHEM, V281, P8613, DOI 10.1074/jbc.M513590200; GALILI U, 1988, J BIOL CHEM, V263, P17755; Griffin R, 2003, MICROBIOL-SGM, V149, P3165, DOI 10.1099/mic.0.26387-0; Hennet T, 1998, J BIOL CHEM, V273, P58, DOI 10.1074/jbc.273.1.58; HYLAND J, 1992, NAT GENET, V2, P228, DOI 10.1038/ng1192-228; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Liefhebber JMP, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-33; Mizuno K, 2003, J BIOL CHEM, V278, P32373, DOI 10.1074/jbc.M304741200; Muller R, 2002, J BIOL CHEM, V277, P32417, DOI 10.1074/jbc.C200381200; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Norman KR, 2000, DEV BIOL, V227, P690, DOI 10.1006/dbio.2000.9897; Osawa T, 2009, BIOCHEM BIOPH RES CO, V378, P10, DOI 10.1016/j.bbrc.2008.08.121; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; Risteli M, 2004, J BIOL CHEM, V279, P37535, DOI 10.1074/jbc.M405638200; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; Schegg B, 2009, MOL CELL BIOL, V29, P943, DOI 10.1128/MCB.02085-07; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; SPIRO RG, 1969, J BIOL CHEM, V244, P602; SPIRO RG, 1971, NATURE-NEW BIOL, V231, P54, DOI 10.1038/newbio231054a0; Starzyk RM, 2000, J INFECT DIS, V181, P181, DOI 10.1086/315163; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0	31	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29390	10.1371/journal.pone.0029390	http://dx.doi.org/10.1371/journal.pone.0029390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216269	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000299113600082
J	Jumpertz, T; Rennhack, A; Ness, J; Baches, S; Pietrzik, CU; Bulic, B; Weggen, S				Jumpertz, Thorsten; Rennhack, Andreas; Ness, Julia; Baches, Sandra; Pietrzik, Claus U.; Bulic, Bruno; Weggen, Sascha			Presenilin Is the Molecular Target of Acidic gamma-Secretase Modulators in Living Cells	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SIGNAL PEPTIDE PEPTIDASE; ALZHEIMERS-DISEASE; MOUSE MODEL; A-BETA; INHIBITORS; MUTATIONS; SITE; COMMON; BIND	The intramembrane-cleaving protease gamma-secretase catalyzes the last step in the generation of toxic amyloid-beta (A beta) peptides and is a principal therapeutic target in Alzheimer's disease. Both preclinical and clinical studies have demonstrated that inhibition of gamma-secretase is associated with prohibitive side effects due to suppression of Notch processing and signaling. Potentially safer are gamma-secretase modulators (GSMs), which are small molecules that selectively lower generation of the highly amyloidogenic A beta 42 peptides but spare Notch processing. GSMs with nanomolar potency and favorable pharmacological properties have been described, but the molecular mechanism of GSMs remains uncertain and both the substrate amyloid precursor protein (APP) and subunits of the gamma-secretase complex have been proposed as the molecular target of GSMs. We have generated a potent photo-probe based on an acidic GSM that lowers A beta 42 generation with an IC50 of 290 nM in cellular assays. By combining in vivo photo-crosslinking with affinity purification, we demonstrated that this probe binds the N-terminal fragment of presenilin (PSEN), the catalytic subunit of the gamma-secretase complex, in living cells. Labeling was not observed for APP or any of the other gamma-secretase subunits. Binding was readily competed by structurally divergent acidic and non-acidic GSMs suggesting a shared mode of action. These findings indicate that potent acidic GSMs target presenilin to modulate the enzymatic activity of the gamma-secretase complex.	[Jumpertz, Thorsten; Ness, Julia; Baches, Sandra; Weggen, Sascha] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Rennhack, Andreas; Bulic, Bruno] Ctr Adv European Studies & Res, Res Grp Chem Biol Neurodegenerat Dis, Bonn, Germany; [Pietrzik, Claus U.] Johannes Gutenberg Univ Mainz, Mol Neurodegenerat Grp, Inst Pathobiochem, Univ Med Ctr, Mainz, Germany	Heinrich Heine University Dusseldorf; Center of Advanced European Studies & Research (CAESAR); Johannes Gutenberg University of Mainz	Jumpertz, T (corresponding author), Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany.	bruno.bulic@caesar.de; sweggen@uni-duesseldorf.de			Federal Ministry of Education [01 GI 1004D, 01 GI 1004C, 01 GI 1004B]	Federal Ministry of Education	This study was supported by the Competence Network Degenerative Dementias of the Federal Ministry of Education (www.bmbf.de/en; grant numbers 01 GI 1004D, 01 GI 1004C, 01 GI 1004B to CUP, BB, and SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett PJ, 2011, BIOCHEMISTRY; Beel AJ, 2009, BIOCHEMISTRY-US, V48, P11837, DOI 10.1021/bi901839d; Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Bergmans BA, 2010, LANCET NEUROL, V9, P215, DOI 10.1016/S1474-4422(09)70332-1; Bulic B, 2011, CURRENT NEU IN PRESS; Bulic B, 2010, NEUROPHARMACOLOGY, V59, P276, DOI 10.1016/j.neuropharm.2010.01.016; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Czirr E, 2007, J BIOL CHEM, V282, P24504, DOI 10.1074/jbc.M700618200; Ebke A, 2011, J BIOL CHEM; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Fuwa H, 2007, ACS CHEM BIOL, V2, P408, DOI 10.1021/cb700073y; Hahn S, 2011, J NEUROCHEM, V116, P385, DOI 10.1111/j.1471-4159.2010.07118.x; Hall A, 2010, BIOORG MED CHEM LETT, V20, P1306, DOI 10.1016/j.bmcl.2009.08.072; Hannam JC, 2007, Patent No. [WO20006043064, 20006043064]; Hieke M, 2010, J MED CHEM, V53, P4691, DOI 10.1021/jm1003073; Howlett DR, 1999, BIOCHEM J, V343, P419, DOI 10.1042/0264-6021:3430419; Iben LG, 2007, J BIOL CHEM, V282, P36829, DOI 10.1074/jbc.M707002200; Imbimbo BP, 2011, EXPERT OPIN INV DRUG, V20, P325, DOI 10.1517/13543784.2011.550572; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Ohki Y, 2011, EMBO J; Okochi M, 2006, J BIOL CHEM, V281, P7890, DOI 10.1074/jbc.M513250200; Okochi M, 1997, FEBS LETT, V418, P162, DOI 10.1016/S0014-5793(97)01378-1; Page RM, 2008, J BIOL CHEM, V283, P677, DOI 10.1074/jbc.M708754200; Page RM, 2010, J BIOL CHEM, V285, P17798, DOI 10.1074/jbc.M110.103283; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Sinz A, 2007, ANGEW CHEM INT EDIT, V46, P660, DOI 10.1002/anie.200602549; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Van Broeck B, 2011, BRIT J PHARMACOL, V163, P375, DOI 10.1111/j.1476-5381.2011.01207.x; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	41	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e30484	10.1371/journal.pone.0030484	http://dx.doi.org/10.1371/journal.pone.0030484			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238696	gold, Green Published, Green Submitted			2022-12-27	WOS:000301188800060
J	Baljinnyam, B; Klauzinska, M; Saffo, S; Callahan, R; Rubin, JS				Baljinnyam, Bolormaa; Klauzinska, Malgorzata; Saffo, Saad; Callahan, Robert; Rubin, Jeffrey S.			Recombinant R-spondin2 and Wnt3a Up- and Down-Regulate Novel Target Genes in C57MG Mouse Mammary Epithelial Cells	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; APICAL ECTODERMAL RIDGE; BETA-CATENIN; WNT/BETA-CATENIN; R-SPONDIN; SYNERGISTIC INDUCTION; TUMOR VIRUS; STEM-CELLS; EXPRESSION; PATHWAY	R-spondins (Rspos) comprise a family of four secreted proteins that have important roles in cell proliferation, cell fate determination and organogenesis. Rspos typically exert their effects by potentiating the Wnt/beta-catenin signaling pathway. To systematically investigate the impact of Rspo/Wnt on gene expression, we performed a microarray analysis using C57MG mouse mammary epithelial cells treated with recombinant Rspo2 and/or Wnt3a. We observed the up- and down-regulation of several previously unidentified target genes, including ones that encode proteins involved in immune responses, effectors of other growth factor signaling pathways and transcription factors. Dozens of these changes were validated by quantitative real time RT-PCR. Time course experiments showed that Rspo2 typically had little or no effect on Wnt-dependent gene expression at 3 or 6 h, but enhanced expression at 24 h, consistent with biochemical data indicating that Rspo2 acts primarily to sustain rather than acutely increase Wnt pathway activation. Up-regulation of gene expression was inhibited by pre-treatment with Dickkopf1, a Wnt/beta-catenin pathway antagonist, and by siRNA knockdown of beta-catenin expression. While Dickkopf1 blocked Rspo2/Wnt3a-dependent down-regulation, a number of down-regulated genes were not affected by beta-catenin knockdown, suggesting that in these instances down-regulation was mediated by a beta-catenin-independent mechanism.	[Baljinnyam, Bolormaa; Saffo, Saad; Rubin, Jeffrey S.] NCI, Lab Cellular & Mol Biol, Bethesda, MD 20892 USA; [Klauzinska, Malgorzata; Callahan, Robert] NCI, Oncogenet Sect, Mammary Biol & Tumorigenesis Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Baljinnyam, B (corresponding author), NCI, Lab Cellular & Mol Biol, Bethesda, MD 20892 USA.	rubinj@mail.nih.gov			National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010251, ZIABC005148] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2008, DEV GROWTH DIFFER, V50, P85, DOI 10.1111/j.1440-169x.2007.00978.x; Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Attisano L, 2004, CANCER METAST REV, V23, P53, DOI 10.1023/A:1025811012690; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Bergmann C, 2006, AM J HUM GENET, V79, P1105, DOI 10.1086/509789; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Bommer GT, 2010, J BIOL CHEM, V285, P1928, DOI 10.1074/jbc.M109.060319; Braeuning A, 2011, TOXICOL SCI, V122, P16, DOI 10.1093/toxsci/kfr080; Cadigan KM, 2008, DEV CELL, V14, P322, DOI 10.1016/j.devcel.2008.02.006; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen JZ, 2002, MOL BIOL REP, V29, P287, DOI 10.1023/A:1020479301379; Chesire DR, 2004, CANCER RES, V64, P2523, DOI 10.1158/0008-5472.CAN-03-3309; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Darash-Yahana M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006695; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Endo Y, 2008, MOL CELL BIOL, V28, P2368, DOI 10.1128/MCB.01780-07; Friedman MS, 2009, J BIOL CHEM, V284, P14117, DOI 10.1074/jbc.M808337200; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Hall JM, 2010, MOL ENDOCRINOL, V24, P359, DOI 10.1210/me.2009-0346; Howe LR, 1999, CANCER RES, V59, P1572; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kamata T, 2004, BBA-GENE STRUCT EXPR, V1676, P51, DOI 10.1016/j.bbaexp.2003.10.009; Kawajiri K, 2009, P NATL ACAD SCI USA, V106, P13481, DOI 10.1073/pnas.0902132106; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Kikuchi A, 2008, CANCER SCI, V99, P202, DOI 10.1111/j.1349-7006.2007.00675.x; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Klauzinska M, 2011, J CELL PHYS IN PRESS; Kurowska-Stolarska M, 2011, J INTERN MED, V269, P29, DOI 10.1111/j.1365-2796.2010.02316.x; Li SJ, 2009, CELL SIGNAL, V21, P916, DOI 10.1016/j.cellsig.2009.02.001; Lin SS, 2009, CANCER LETT, V279, P108, DOI 10.1016/j.canlet.2009.01.029; Liu HJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001249; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lowther W, 2005, J VIROL, V79, P10093, DOI 10.1128/JVI.79.15.10093-10096.2005; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mathew LK, 2008, FASEB J, V22, P3087, DOI 10.1096/fj.08-109009; Meijer J, 2008, CANCER RES, V68, P4701, DOI 10.1158/0008-5472.CAN-08-0482; Molenaar AJ, 2009, BIOMARKERS, V14, P26, DOI 10.1080/13547500902730714; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Nam JS, 2007, DEV BIOL, V311, P124, DOI 10.1016/j.ydbio.2007.08.023; Nam JS, 2007, GENE EXPR PATTERNS, V7, P306, DOI 10.1016/j.modgep.2006.08.006; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Ohtake F, 2009, BIOCHEM PHARMACOL, V77, P474, DOI 10.1016/j.bcp.2008.08.034; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; PEYRAT JP, 1990, J STEROID BIOCHEM, V37, P823, DOI 10.1016/0960-0760(90)90426-L; Prieve Mary G, 2003, BMC Dev Biol, V3, P2, DOI 10.1186/1471-213X-3-2; Prochazkova J, 2011, TOXICOL SCI, V122, P349, DOI 10.1093/toxsci/kfr129; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Semenov MV, 2008, J BIOL CHEM, V283, P21427, DOI 10.1074/jbc.M800014200; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Sugimura R, 2010, BIRTH DEFECTS RES C, V90, P243, DOI 10.1002/bdrc.20195; Szeto W, 2001, CANCER RES, V61, P4197; Taneyhill Lisa, 2004, BMC Developmental Biology, V4; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; Tice DA, 2002, J BIOL CHEM, V277, P14329, DOI 10.1074/jbc.M200334200; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; van de Wetering M, 2002, CELL, V109, pS13, DOI 10.1016/S0092-8674(02)00709-2; Wang JH, 2008, CANCER RES, V68, P10367, DOI 10.1158/0008-5472.CAN-08-2780; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Xu QS, 2011, J BIOL CHEM, V286, P4310, DOI 10.1074/jbc.M110.182576; Zhang S, 2009, ENDOCR-RELAT CANCER, V16, P835, DOI 10.1677/ERC-09-0054; Zhu LJ, 2005, ANAL BIOCHEM, V345, P102, DOI 10.1016/j.ab.2005.07.028; Ziemer LT, 2001, MOL CELL BIOL, V21, P562, DOI 10.1128/MCB.21.2.562-574.2001	77	11	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29455	10.1371/journal.pone.0029455	http://dx.doi.org/10.1371/journal.pone.0029455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238613	Green Published, Green Submitted, gold			2022-12-27	WOS:000301070200029
J	Johnston, DW; Bowers, MT; Friedlaender, AS; Lavigne, DM				Johnston, David W.; Bowers, Matthew T.; Friedlaender, Ari S.; Lavigne, David M.			The Effects of Climate Change on Harp Seals (Pagophilus groenlandicus)	PLOS ONE			English	Article							ARCTIC MARINE MAMMALS; REPRODUCTIVE PARAMETERS; MORTALITY	Harp seals (Pagophilus groenlandicus) have evolved life history strategies to exploit seasonal sea ice as a breeding platform. As such, individuals are prepared to deal with fluctuations in the quantity and quality of ice in their breeding areas. It remains unclear, however, how shifts in climate may affect seal populations. The present study assesses the effects of climate change on harp seals through three linked analyses. First, we tested the effects of short-term climate variability on young-of-the year harp seal mortality using a linear regression of sea ice cover in the Gulf of St. Lawrence against stranding rates of dead harp seals in the region during 1992 to 2010. A similar regression of stranding rates and North Atlantic Oscillation (NAO) index values was also conducted. These analyses revealed negative correlations between both ice cover and NAO conditions and seal mortality, indicating that lighter ice cover and lower NAO values result in higher mortality. A retrospective cross-correlation analysis of NAO conditions and sea ice cover from 1978 to 2011 revealed that NAO-related changes in sea ice may have contributed to the depletion of seals on the east coast of Canada during 1950 to 1972, and to their recovery during 1973 to 2000. This historical retrospective also reveals opposite links between neonatal mortality in harp seals in the Northeast Atlantic and NAO phase. Finally, an assessment of the long-term trends in sea ice cover in the breeding regions of harp seals across the entire North Atlantic during 1979 through 2011 using multiple linear regression models and mixed effects linear regression models revealed that sea ice cover in all harp seal breeding regions has been declining by as much as 6 percent per decade over the time series of available satellite data.	[Johnston, David W.; Bowers, Matthew T.; Friedlaender, Ari S.] Duke Univ, Marine Lab, Div Marine Sci & Conservat, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Lavigne, David M.] Int Fund Anim Welf, Guelph, ON, Canada	Duke University	Johnston, DW (corresponding author), Duke Univ, Marine Lab, Div Marine Sci & Conservat, Nicholas Sch Environm, Beaufort, NC 28516 USA.	david.johnston@duke.edu		Johnston, David/0000-0003-2424-036X	Duke University Marine Laboratory; International Fund for Animal Welfare	Duke University Marine Laboratory; International Fund for Animal Welfare	This work was funded by the Duke University Marine Laboratory and the International Fund for Animal Welfare. The funders had no role in study design, data collection and analysis or decision to publish the manuscript.	Bates D. M., 2010, LME4 MIXED EFFECTS M; Cavalieri D.J., 1996, SEA ICE CONCENTRATIO; Chernook V.I., 2008, MARINE MAMMALS HOLAR, P100; DFO, 2007, REV IC COND POT IMP; Friedlaender AS, 2010, PROG OCEANOGR, V86, P261, DOI 10.1016/j.pocean.2010.04.002; Harris DE, 2006, NORTHEAST NAT, V13, P403, DOI 10.1656/1092-6194(2006)13[403:GAOISS]2.0.CO;2; Hurrell J. W., 2003, N ATLANTIC OSCILLATI, V134, P1, DOI [10.1029/134GM01, DOI 10.1029/134GM01]; Johnston DW, 2005, CLIM RES, V29, P209, DOI 10.3354/cr029209; KJELLQWIST SA, 1995, ICES J MAR SCI, V52, P197, DOI 10.1016/1054-3139(95)80035-2; Kokic P, 2011, ENVIRONMETRICS, V22, P409, DOI 10.1002/env.1074; Kovacs K, 2010, IUCN RED LIST THREAT; KOVACS KM, 1985, J MAMMAL, V66, P556, DOI 10.2307/1380934; KOVACS KM, 2011, MAR BIODIVERS, V41, P181, DOI DOI 10.1007/S12526-010-0061-0; KRAUS SD, 1990, MAR MAMMAL SCI, V6, P278, DOI 10.1111/j.1748-7692.1990.tb00358.x; Lavigne D, 2002, ENCY MARINE MAMMALS, P560; Lavigne D.M., 1988, HARPS HOODS ICE BREE; Lavigne DM, 1999, MAR MAMMAL SCI, V15, P871, DOI 10.1111/j.1748-7692.1999.tb00851.x; Maslanik J., 1999, NEAR REAL TIME DMSP; Moline MA, 2008, ANN NY ACAD SCI, V1134, P267, DOI 10.1196/annals.1439.010; Moore SE, 2008, ECOL APPL, V18, pS157, DOI 10.1890/06-0571.1; Nilssen KT, 1998, SARSIA, V83, P337, DOI 10.1080/00364827.1998.10413693; Oritsland T, 1971, INT COMMISSION NW 3, P185; Pyenson ND, 2011, P ROY SOC B-BIOL SCI, V278, P3608, DOI 10.1098/rspb.2011.0441; QIAN SS, 2009, ENV ECOLOGICAL STAT; Ragen TJ, 2008, ECOL APPL, V18, pS166, DOI 10.1890/06-0734.1; Rosing-Asvid A, 2008, MAR MAMMAL SCI, V24, P730, DOI 10.1111/j.1748-7692.2008.00216.x; SARKAR D., 2010, LATTICE LATTICE GRAP; Sergeant D, 1991, CANADIAN SPECIAL PUB; Sjare B, 2010, ICES J MAR SCI, V67, P304, DOI 10.1093/icesjms/fsp267; Stenson G, 2005, ESTIMATES HUMAN INDU; Stirling I, 2006, ARCTIC, V59, P261; TEMTE JL, 1994, J ZOOL, V233, P369, DOI 10.1111/j.1469-7998.1994.tb05271.x; Toughill K, 1998, TORONTO STAR; Vinnikov KY, 1999, SCIENCE, V286, P1934, DOI 10.1126/science.286.5446.1934; Wang MY, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037820	35	24	25	3	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29158	10.1371/journal.pone.0029158	http://dx.doi.org/10.1371/journal.pone.0029158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238591	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200018
J	Ceci, F; Pietrobon, R; Goncalves, AL				Ceci, Flavio; Pietrobon, Ricardo; Goncalves, Alexandre Leopoldo			Turning Text into Research Networks: Information Retrieval and Computational Ontologies in the Creation of Scientific Databases	PLOS ONE			English	Article								Background: Web-based, free-text documents on science and technology have been increasing growing on the web. However, most of these documents are not immediately processable by computers slowing down the acquisition of useful information. Computational ontologies might represent a possible solution by enabling semantically machine readable data sets. But, the process of ontology creation, instantiation and maintenance is still based on manual methodologies and thus time and cost intensive. Method: We focused on a large corpus containing information on researchers, research fields, and institutions. We based our strategy on traditional entity recognition, social computing and correlation. We devised a semi automatic approach for the recognition, correlation and extraction of named entities and relations from textual documents which are then used to create, instantiate, and maintain an ontology. Results: We present a prototype demonstrating the applicability of the proposed strategy, along with a case study describing how direct and indirect relations can be extracted from academic and professional activities registered in a database of curriculum vitae in free-text format. We present evidence that this system can identify entities to assist in the process of knowledge extraction and representation to support ontology maintenance. We also demonstrate the extraction of relationships among ontology classes and their instances. Conclusion: We have demonstrated that our system can be used for the conversion of research information in free text format into database with a semantic structure. Future studies should test this system using the growing number of free-text information available at the institutional and national levels.	[Ceci, Flavio; Goncalves, Alexandre Leopoldo] Univ Fed Santa Catarina, Dept Knowledge Engn & Management, BR-88040900 Florianopolis, SC, Brazil; [Pietrobon, Ricardo] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Pietrobon, Ricardo] Duke Univ, Res Res Grp, Durham, NC USA	Universidade Federal de Santa Catarina (UFSC); Duke University; Duke University	Ceci, F (corresponding author), Univ Fed Santa Catarina, Dept Knowledge Engn & Management, BR-88040900 Florianopolis, SC, Brazil.	rpietro@duke.edu		Pietrobon, Ricardo/0000-0003-2996-2193				Allemang D, 2008, SEMANTIC WEB WORKING; [Anonymous], LATTES PLATFORM; Chu WW, 2005, CONTROL ENG PRACT, V13, P1105, DOI 10.1016/j.conengprac.2004.12.011; Cimiano P, 2005, LECT NOTES COMPUT SC, V3513, P227; Cimiano P., 2006, ONTOLOGY LEARNING PO; El Sayed A, 2008, COMPSTAT 2008: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P255; Fortuna B, 2008, LECT NOTES ARTIF INT, V5351, P626, DOI 10.1007/978-3-540-89197-0_57; Gacitua R, 2008, KNOWL-BASED SYST, V21, P192, DOI 10.1016/j.knosys.2007.11.009; Goncalves A, 2006, LECT NOTES COMPUT SC, V4016, P122, DOI 10.1007/11775300_11; Granitzer M, 2007, ADV SOFT COMP, V43, P130, DOI 10.1007/978-3-540-72575-6_21; Gruber Tom, 2008, ONTOLOGY ENTRY ENCY; Kozareva Z, 2006, BOOTSTRAPPING NAMED; Mihalcea R, 2007, N AM ASS COMPUTATION; Nadeau D, 2005, BASE LINE INFORM EXT; Osinski S, 2005, IEEE INTELL SYST, V20, P48, DOI 10.1109/MIS.2005.38; Taniar D, 2006, WEB SEMANTICS ONTOLO; Velardi P, 2003, ONTOLOGY LEARNING TE; Witten I. H., 2005, DATA MINING PRACTICA; Zhu JH, 2005, LECT NOTES ARTIF INT, V3782, P518, DOI 10.1109/ISEIM.2005.193603	19	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e27499	10.1371/journal.pone.0027499	http://dx.doi.org/10.1371/journal.pone.0027499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235242	gold, Green Published, Green Submitted			2022-12-27	WOS:000301123400003
J	Rozenfeld, R; Bushlin, I; Gomes, I; Tzavaras, N; Gupta, A; Neves, S; Battini, L; Gusella, GL; Lachmann, A; Ma'ayan, A; Blitzer, RD; Devi, LA				Rozenfeld, Raphael; Bushlin, Ittai; Gomes, Ivone; Tzavaras, Nikos; Gupta, Achla; Neves, Susana; Battini, Lorenzo; Gusella, G. Luca; Lachmann, Alexander; Ma'ayan, Avi; Blitzer, Robert D.; Devi, Lakshmi A.			Receptor Heteromerization Expands the Repertoire of Cannabinoid Signaling in Rodent Neurons	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; DELTA-OPIOID RECEPTORS; KNOCKOUT MICE; ADENYLATE-CYCLASE; MU; CELLS; BRAIN; INTERNALIZATION; ACTIVATION; N18TG2	A fundamental question in G protein coupled receptor biology is how a single ligand acting at a specific receptor is able to induce a range of signaling that results in a variety of physiological responses. We focused on Type 1 cannabinoid receptor (CB1R) as a model GPCR involved in a variety of processes spanning from analgesia and euphoria to neuronal development, survival and differentiation. We examined receptor dimerization as a possible mechanism underlying expanded signaling responses by a single ligand and focused on interactions between CB1R and delta opioid receptor (DOR). Using co-immunoprecipitation assays as well as analysis of changes in receptor subcellular localization upon co-expression, we show that CB1R and DOR form receptor heteromers. We find that heteromerization affects receptor signaling since the potency of the CB1R ligand to stimulate G-protein activity is increased in the absence of DOR, suggesting that the decrease in CB1R activity in the presence of DOR could, at least in part, be due to heteromerization. We also find that the decrease in activity is associated with enhanced PLC-dependent recruitment of arrestin3 to the CB1R-DOR complex, suggesting that interaction with DOR enhances arrestin-mediated CB1R desensitization. Additionally, presence of DOR facilitates signaling via a new CB1R-mediated anti-apoptotic pathway leading to enhanced neuronal survival. Taken together, these results support a role for CB1R-DOR heteromerization in diversification of endocannabinoid signaling and highlight the importance of heteromer-directed signal trafficking in enhancing the repertoire of GPCR signaling.	[Rozenfeld, Raphael; Bushlin, Ittai; Gomes, Ivone; Tzavaras, Nikos; Gupta, Achla; Neves, Susana; Lachmann, Alexander; Ma'ayan, Avi; Blitzer, Robert D.; Devi, Lakshmi A.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY USA; [Bushlin, Ittai; Devi, Lakshmi A.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Bushlin, Ittai; Devi, Lakshmi A.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [Neves, Susana; Lachmann, Alexander; Ma'ayan, Avi; Blitzer, Robert D.; Devi, Lakshmi A.] Mt Sinai Sch Med, Syst Biol Ctr New York, New York, NY USA; [Battini, Lorenzo; Gusella, G. Luca] Mt Sinai Sch Med, Dept Med, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Rozenfeld, R (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY USA.	lakshmi.devi@mssm.edu	Lachmann, Alexander/AAF-1940-2020; Ma'ayan, Avi/AAG-3131-2019; Devi P, Lakshmi/GXM-5982-2022	Lachmann, Alexander/0000-0002-1982-7652; Ma'ayan, Avi/0000-0002-6904-1017; Devi P, Lakshmi/0000-0001-9274-4776	National Institutes of Health [DA08862, DA19521, 1P50GM071558-01A27398, P20AA017067, GM54508, R24 CA095823]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558, R01GM054508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA019521, R37DA008863] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants DA08862, DA19521 to LD and 1P50GM071558-01A27398 (Systems Biology Center of New York) to LD and AM, P20AA017067 to RR, GM54508 to RB and R24 CA095823 to MSSM-Microscopy Shared Resource Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2009, J BIOL CHEM; Berghuis P, 2007, SCIENCE, V316, P1212, DOI 10.1126/science.1137406; Bergmann A, 2002, DEV CELL, V3, P607, DOI 10.1016/S1534-5807(02)00328-3; Berrendero F, 2003, EUR J NEUROSCI, V18, P2197, DOI 10.1046/j.1460-9568.2003.02951.x; Berrendero F, 2002, PSYCHOPHARMACOLOGY, V163, P111, DOI 10.1007/s00213-002-1144-9; Bromberg KD, 2008, SCIENCE, V320, P903, DOI 10.1126/science.1152662; Bushlin I, CURR OPIN PHARM, V10, P80; Cichewicz DL, 2004, EUR J PHARMACOL, V504, P33, DOI 10.1016/j.ejphar.2004.09.050; Coutts AA, 2001, J NEUROSCI, V21, P2425; Cvejic S, 1996, J BIOL CHEM, V271, P4073; Decaillot FM, 2003, NAT STRUCT BIOL, V10, P629, DOI 10.1038/nsb950; DILL JA, 1988, J PHARMACOL EXP THER, V244, P1157; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; FAN SF, 1992, BRAIN RES, V590, P329, DOI 10.1016/0006-8993(92)91116-V; Fedorova E, 2006, J GENE MED, V8, P414, DOI 10.1002/jgm.861; Ghozland S, 2002, J NEUROSCI, V22, P1146, DOI 10.1523/JNEUROSCI.22-03-01146.2002; Gomes I, 2003, METH MOLEC MED, V84, P157; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Gomes I, 2009, FASEB J, V23, P3020, DOI 10.1096/fj.09-132142; Gupta A, SCI SIGNAL, V3, pra54; Gupta A, 2007, J BIOL CHEM, V282, P5116, DOI 10.1074/jbc.M609254200; Gupta A, 2006, MT SINAI J MED, V73, P673; Guzman M, 2002, PHARMACOL THERAPEUT, V95, P175, DOI 10.1016/S0163-7258(02)00256-5; Harkany T, 2008, MOL CELL ENDOCRINOL, V286, pS84, DOI 10.1016/j.mce.2008.02.011; Harkany T, 2007, TRENDS PHARMACOL SCI, V28, P83, DOI 10.1016/j.tips.2006.12.004; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Hong MH, 2009, J NEUROCHEM, V108, P102, DOI 10.1111/j.1471-4159.2008.05740.x; Jin WZ, 1999, J NEUROSCI, V19, P3773; Korzh A, 2008, BRAIN RES, V1189, P23, DOI 10.1016/j.brainres.2007.10.070; LAW PY, 1982, MOL PHARMACOL, V21, P483; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Luttrell LM, 2002, J CELL SCI, V115, P455; Ma'ayan A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254cm1; MACKIE K, 1992, P NATL ACAD SCI USA, V89, P3825, DOI 10.1073/pnas.89.9.3825; MACKIE K, 1995, J NEUROSCI, V15, P6552; Manzanares J, 1999, BRAIN RES, V839, P173, DOI 10.1016/S0006-8993(99)01756-4; Molla-Herman A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003728; Rios C, 2006, BRIT J PHARMACOL, V148, P387, DOI 10.1038/sj.bjp.0706757; Rozenfeld R, BIOCH J, V433, P11; Rozenfeld R, TRAFFIC, V12, P12; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Rozenfeld R, 2007, FASEB J, V21, P2455, DOI 10.1096/fj.06-7793com; Rubovitch V, 2004, MOL BRAIN RES, V120, P138, DOI 10.1016/j.molbrainres.2003.10.012; Shankar H, 2010, J BIOL CHEM, V285, P8316, DOI 10.1074/jbc.M109.062521; Shapira M, 1998, BRAIN RES, V806, P26, DOI 10.1016/S0006-8993(98)00697-0; Smith ER, 2004, J CELL BIOL, V164, P689, DOI 10.1083/jcb.200312028; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Uriguen L, 2005, EUR J NEUROSCI, V22, P2106, DOI 10.1111/j.1460-9568.2005.04372.x; Zhu YX, 1999, NEURON, V24, P243, DOI 10.1016/S0896-6273(00)80836-3	49	59	63	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29239	10.1371/journal.pone.0029239	http://dx.doi.org/10.1371/journal.pone.0029239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235275	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400036
J	Glas, J; Seiderer, J; Bayrle, C; Wetzke, M; Fries, C; Tillack, C; Olszak, T; Beigel, F; Steib, C; Friedrich, M; Diegelmann, J; Czamara, D; Brand, S				Glas, Juergen; Seiderer, Julia; Bayrle, Corinna; Wetzke, Martin; Fries, Christoph; Tillack, Cornelia; Olszak, Torsten; Beigel, Florian; Steib, Christian; Friedrich, Matthias; Diegelmann, Julia; Czamara, Darina; Brand, Stephan			The Role of Osteopontin (OPN/SPP1) Haplotypes in the Susceptibility to Crohn's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DENDRITIC CELLS; MULTIPLE-SCLEROSIS; ULCERATIVE-COLITIS; IL-17 PRODUCTION; GENE-EXPRESSION; PROTECTS MICE; HOST-DEFENSE; T-CELLS; DIFFERENTIATION	Background: Osteopontin represents a multifunctional molecule playing a pivotal role in chronic inflammatory and autoimmune diseases. Its expression is increased in inflammatory bowel disease (IBD). The aim of our study was to analyze the association of osteopontin (OPN/SPP1) gene variants in a large cohort of IBD patients. Methodology/Principal Findings: Genomic DNA from 2819 Caucasian individuals (n = 841 patients with Crohn's disease (CD), n = 473 patients with ulcerative colitis (UC), and n = 1505 healthy unrelated controls) was analyzed for nine OPN SNPs (rs2728127, rs2853744, rs11730582, rs11739060, rs28357094, rs4754 = p.Asp80Asp, rs1126616 = p.Ala236Ala, rs1126772 and rs9138). Considering the important role of osteopontin in Th17-mediated diseases, we performed analysis for epistasis with IBD-associated IL23R variants and analyzed serum levels of the Th17 cytokine IL-22. For four OPN SNPs (rs4754, rs1126616, rs1126772 and rs9138), we observed significantly different distributions between male and female CD patients. rs4754 was protective in male CD patients (p = 0.0004, OR = 0.69). None of the other investigated OPN SNPs was associated with CD or UC susceptibility. However, several OPN haplotypes showed significant associations with CD susceptibility. The strongest association was found for a haplotype consisting of the 8 OPN SNPs rs2728127-rs2853744-rs11730582-rs11439060-rs28357094-rs112661-rs1126772-rs9138 (omnibus p-value = 2.07x10(-8)). Overall, the mean IL-22 secretion in the combined group of OPN minor allele carriers with CD was significantly lower than that of CD patients with OPN wildtype alleles (p = 3.66x10(-5)). There was evidence for weak epistasis between the OPN SNP rs28357094 with the IL23R SNP rs10489629 (p = 4.18x10(-2)) and between OPN SNP rs1126616 and IL23R SNP rs2201841 (p = 4.18x10(-2)) but none of these associations remained significant after Bonferroni correction. Conclusions/Significance: Our study identified OPN haplotypes as modifiers of CD susceptibility, while the combined effects of certain OPN variants may modulate IL-22 secretion.	[Glas, Juergen; Bayrle, Corinna; Fries, Christoph; Friedrich, Matthias; Diegelmann, Julia] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, Aachen, Germany; [Wetzke, Martin] Hannover Med Sch, Dept Pediat, D-3000 Hannover, Germany; [Olszak, Torsten] Harvard Univ, Brigham & Womens Hosp, Div Gastroenterol, Sch Med, Boston, MA 02115 USA; [Czamara, Darina] Max Planck Inst Psychiat, D-80804 Munich, Germany	University of Munich; RWTH Aachen University; Hannover Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Max Planck Society	Glas, J (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	Stephan.Brand@med.uni-muenchen.de	Wetzke, Martin/HDM-2614-2022		Broad Medical Foundation [IBD-0126R2]; Ludwig-Maximilians-University Munich [422]; Robert-Bosch-Foundation; Else Kroner-Fresenius-Stiftung [81/08//EKMS08/01, 2010_EKES.32]; DFG [BR 1912/6-1]; Ludwig- Maximilians-University Munich	Broad Medical Foundation; Ludwig-Maximilians-University Munich; Robert-Bosch-Foundation; Else Kroner-Fresenius-Stiftung; DFG(German Research Foundation (DFG)); Ludwig- Maximilians-University Munich	J. Glas was supported by a grant from the Broad Medical Foundation (IBD-0126R2). J. Seiderer and J. Diegelmann were supported by grants from the Ludwig-Maximilians-University Munich (FoFoLe Nr. 422; Habilitationsstipendium, LMU Excellent to J. S. and Promotionsstipendium to J. D.); J. Seiderer was also supported by the Robert-Bosch-Foundation and the Else Kroner-Fresenius-Stiftung (81/08//EKMS08/01). S. Brand was supported by grants from the DFG (BR 1912/6-1), the Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium 2010; 2010_EKES.32), and by grants of Ludwig- Maximilians-University Munich (Excellence Initiative, Investment Funds 2008 and FoFoLe program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnholt J, 2007, SCAND J IMMUNOL, V65, P453, DOI 10.1111/j.1365-3083.2007.01908.x; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Barizzone N, 2011, HUM IMMUNOL, V72, P930, DOI 10.1016/j.humimm.2011.06.009; Bazzichi L, 2009, MOL MED, V15, P402, DOI 10.2119/molmed.2009.00052; Begum MD, 2007, MICROBIOL IMMUNOL, V51, P135, DOI 10.1111/j.1348-0421.2007.tb03884.x; Braitch M, 2008, ARCH NEUROL-CHICAGO, V65, P633, DOI 10.1001/archneur.65.5.633; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Brand S, 2007, AM J PHYSIOL-GASTR L, V292, pG1019, DOI 10.1152/ajpgi.00239.2006; Buommino E, 2009, ARCH DERMATOL RES, V301, P397, DOI 10.1007/s00403-009-0939-5; Chen GJ, 2010, ARTHRITIS RHEUM-US, V62, P2900, DOI 10.1002/art.27603; Chiocchetti A, 2005, J NEUROIMMUNOL, V163, P172, DOI 10.1016/j.jneuroim.2005.02.020; Chiocchetti A, 2010, INT J IMMUNOPATH PH, V23, P263, DOI 10.1177/039463201002300124; D'Alfonso S, 2005, ARTHRITIS RHEUM, V52, P539, DOI 10.1002/art.20808; da Silva APB, 2009, LAB INVEST, V89, P1169, DOI 10.1038/labinvest.2009.80; Diegelmann J, 2011, J BIOL CHEM     1108; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Forton AC, 2002, HUM MUTAT, V19, DOI 10.1002/humu.9025; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gassler N, 2002, SCAND J GASTROENTERO, V37, P1286, DOI 10.1080/003655202761020560; Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Glas J, 2011, INFLAMM BOWEL DIS, V17, P1917, DOI 10.1002/ibd.21562; Glas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019319; Glas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014466; Glas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010373; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Gordon JN, 2005, GUT, V54, P1213, DOI 10.1136/gut.2004.063412; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Han SZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001757; Heilmann K, 2009, J CELL MOL MED, V13, P1162, DOI 10.1111/j.1582-4934.2008.00428.x; Hensiek AE, 2003, J NEUROL, V250, P943, DOI 10.1007/s00415-003-1120-2; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kariuki SN, 2009, GENES IMMUN, V10, P487, DOI 10.1038/gene.2009.15; Kawamura K, 2005, CLIN DIAGN LAB IMMUN, V12, P206, DOI 10.1128/CDLI.12.1.206-212.2005; Koguchi Y, 2002, INFECT IMMUN, V70, P1042, DOI 10.1128/IAI.70.3.1042-1048.2002; Koguchi Y, 2003, AM J RESP CRIT CARE, V167, P1355, DOI 10.1164/rccm.200209-1113OC; Liaw L, 1998, J CLIN INVEST, V101, P1468; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Marciano R, 2006, ANN RHEUM DIS, V65, P662, DOI 10.1136/ard.2005.040626; Marciano R, 2009, CLIN IMMUNOL, V131, P84, DOI 10.1016/j.clim.2008.11.004; Mas A, 2007, MULT SCLER J, V13, P250, DOI 10.1177/1352458506070944; Masuda H, 2005, J GASTROENTEROL, V40, P409, DOI 10.1007/s00535-005-1567-2; Masuda H, 2003, J SURG RES, V111, P85, DOI 10.1016/S0022-4804(03)00046-5; Maver A, 2009, DIS MARKERS, V27, P295, DOI [10.1155/2009/864313, 10.3233/DMA-2009-0675]; Mishima R, 2007, J CLIN GASTROENTEROL, V41, P167, DOI 10.1097/MCG.0b013e31802d6268; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; Murugaiyan G, 2010, P NATL ACAD SCI USA, V107, P11495, DOI 10.1073/pnas.1002099107; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Murugaiyan G, 2008, J IMMUNOL, V181, P7480, DOI 10.4049/jimmunol.181.11.7480; Niino M, 2003, J NEUROIMMUNOL, V136, P125, DOI 10.1016/S0165-5728(03)00004-3; O'Regan A, 2000, INT J EXP PATHOL, V81, P373, DOI 10.1046/j.1365-2613.2000.00163.x; O'Regan AW, 2000, J LEUKOCYTE BIOL, V68, P495; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ohshima S, 2002, J RHEUMATOL, V29, P2061; Renkl AC, 2005, BLOOD, V106, P946, DOI 10.1182/blood-2004-08-3228; Sato T, 2005, GUT, V54, P1254, DOI 10.1136/gut.2004.048298; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Schmidt-Petersen K, 2009, ATHEROSCLEROSIS, V206, P209, DOI 10.1016/j.atherosclerosis.2009.02.015; Seiderer J, 2008, INFLAMM BOWEL DIS, V14, P437, DOI 10.1002/ibd.20339; Sennels HP, 2008, SCAND J RHEUMATOL, V37, P241, DOI 10.1080/03009740801910320; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Standal T, 2004, EXP ONCOL, V26, P179; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Uede T, 2011, PATHOL INT, V61, P265, DOI 10.1111/j.1440-1827.2011.02649.x; Urcelay E, 2005, J RHEUMATOL, V32, P405; Vogt MHJ, 2010, MULT SCLER J, V16, P443, DOI 10.1177/1352458509359723; Xu AP, 2007, CHINESE MED J-PEKING, V120, P2124, DOI 10.1097/00029330-200712010-00011; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhong J, 2006, INFLAMM BOWEL DIS, V12, P790, DOI 10.1097/00054725-200608000-00015; Zohar R, 1998, EUR J ORAL SCI, V106, P401, DOI 10.1111/j.1600-0722.1998.tb02206.x	76	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29309	10.1371/journal.pone.0029309	http://dx.doi.org/10.1371/journal.pone.0029309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242114	Green Published, Green Submitted, gold			2022-12-27	WOS:000300677000025
J	Barendse, W				Barendse, William			Haplotype Analysis Improved Evidence for Candidate Genes for Intramuscular Fat Percentage from a Genome Wide Association Study of Cattle	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; JAPANESE BLACK CATTLE; FALSE DISCOVERY RATE; LINKAGE DISEQUILIBRIUM; ACID-COMPOSITION; KOREAN CATTLE; BEEF-CATTLE; UNRELATED INDIVIDUALS; MISSING HERITABILITY; STATISTICAL-METHODS	In genome wide association studies (GWAS), haplotype analyses of SNP data are neglected in favour of single point analysis of associations. In a recent GWAS, we found that none of the known candidate genes for intramuscular fat (IMF) had been identified. In this study, data from the GWAS for these candidate genes were re-analysed as haplotypes. First, we confirmed that the methodology would find evidence for association between haplotypes in candidate genes of the calpain-calpastatin complex and musculus longissimus lumborum peak force (LLPF), because these genes had been confirmed through single point analysis in the GWAS. Then, for intramuscular fat percent (IMF), we found significant partial haplotype substitution effects for the genes ADIPOQ and CXCR4, as well as suggestive associations to the genes CEBPA, FASN, and CAPN1. Haplotypes for these genes explained 80% more of the phenotypic variance compared to the best single SNP. For some genes the analyses suggested that there was more than one causative mutation in some genes, or confirmed that some causative mutations are limited to particular subgroups of a species. Fitting the SNPs and their interactions simultaneously explained a similar amount of the phenotypic variance compared to haplotype analyses. Haplotype analysis is a neglected part of the suite of tools used to analyse GWAS data, would be a useful method to extract more information from these data sets, and may contribute to reducing the missing heritability problem.	[Barendse, William] Commonwealth Sci & Ind Res Org, Cooperat Res Ctr Beef Genet Technol, St Lucia, Qld, Australia; [Barendse, William] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Barendse, W (corresponding author), Commonwealth Sci & Ind Res Org, Cooperat Res Ctr Beef Genet Technol, St Lucia, Qld, Australia.	Bill.Barendse@csiro.au	Barendse, William J/D-8608-2011	Barendse, William J/0000-0002-5464-0658	CSIRO; Cooperative Research Centre for Beef Genetic Technologies	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Cooperative Research Centre for Beef Genetic Technologies(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	The methodological work and re-analysis of GWAS data was funded by CSIRO through its contribution to the Cooperative Research Centre for Beef Genetic Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2009, BIOCHEM GENET, V47, P397, DOI 10.1007/s10528-009-9235-5; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bader JS, 2001, PHARMACOGENOMICS, V2, P11, DOI 10.1517/14622416.2.1.11; Barendse W, 2007, GENETICS, V176, P2601, DOI 10.1534/genetics.107.074328; Barendse W, 2007, GENETICS, V175, P843, DOI 10.1534/genetics.106.064535; Barendse W, 2007, GENETICS, V176, P1893, DOI 10.1534/genetics.107.072637; Barendse W, 2005, ANIM GENET, V36, P86, DOI 10.1111/j.1365-2052.2004.01224.x; Barendse W, 2004, AUST J EXP AGR, V44, P669, DOI 10.1071/EA02156; Barendse W, 2010, J ANIM SCI, V88, P47, DOI 10.2527/jas.2009-2178; Barendse W.J., 2002, Patent No. [02064820, W002064820]; Barendse W, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-232; Barendse W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-178; Barendse W, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-41; Barendse W, 2009, ANIM PROD SCI, V49, P558, DOI 10.1071/EA08307; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bickel RD, 2011, PLOS GENET, V7, P8; Bolormaa S, 2011, J ANIM SCI, V89, P2297, DOI 10.2527/jas.2010-3138; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buchanan FC, 2002, GENET SEL EVOL, V34, P105, DOI [10.1051/gse:2001006, 10.1186/1297-9686-34-1-105]; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cheong HS, 2007, MEAT SCI, V77, P257, DOI 10.1016/j.meatsci.2007.03.014; Cheong HS, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-33; Chikuni K, 2002, Method of evaluating useful cattle, Patent No. [WO02077279 CA 2441938, 02077279]; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; COHEN J, 1990, AM PSYCHOL, V45, P1304, DOI 10.1037/0003-066X.45.12.1304; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Devlin B, 2003, HEREDITY, V91, P537, DOI 10.1038/sj.hdy.6800370; DOREAU M, 1994, ANIM FEED SCI TECH, V45, P379, DOI 10.1016/0377-8401(94)90039-6; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Duggal P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-516; EDWARDS JH, 1974, J IMMUNOGENET, V1, P249; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Ferguson DM, 2004, AUST J EXP AGR, V44, P681, DOI 10.1071/EA02161; Gilmour AR, 2009, ASREML USER GUIDE RE; Goodall JJ, 2007, ANIM GENET, V38, P154, DOI 10.1111/j.1365-2052.2007.01576.x; Hale CS, 2000, J ANIM SCI, V78, P2099; Hao K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000109; Harper GS, 2004, AUST J EXP AGR, V44, P653, DOI 10.1071/EA02114; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoashi S, 2007, MAMM GENOME, V18, P880, DOI 10.1007/s00335-007-9072-y; Johnston DJ, 2010, J ANIM SCI, V88, P1917, DOI 10.2527/jas.2009-2305; LEWONTIN RC, 1964, GENETICS, V49, P49; Li C, 2012, ANIM GENET, V43, P93, DOI 10.1111/j.1365-2052.2011.02217.x; Li J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-258; Lillioja S, 2009, DIABETOLOGIA, V52, P1061, DOI 10.1007/s00125-009-1324-9; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Marques E, 2009, J ANIM SCI, V87, P2475, DOI 10.2527/jas.2008-1456; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Meuwissen T, 2010, GENETICS, V185, P1441, DOI 10.1534/genetics.110.113936; Michal JJ, 2006, ANIM GENET, V37, P400, DOI 10.1111/j.1365-2052.2006.01464.x; Morris AP, 2006, AM J HUM GENET, V79, P679, DOI 10.1086/508264; Morris CA, 2007, MAMM GENOME, V18, P64, DOI 10.1007/s00335-006-0102-y; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Morsci NS, 2006, ANIM GENET, V37, P554, DOI 10.1111/j.1365-2052.2006.01528.x; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Page BT, 2002, J ANIM SCI, V80, P3077; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Perry D, 2001, AUST J EXP AGR, V41, P953, DOI 10.1071/EA00092; Neto LRP, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-55; Powell JE, 2012, ANIM GENET, V43, P133, DOI 10.1111/j.1365-2052.2011.02234.x; Roy R, 2006, ANIM GENET, V37, P215, DOI 10.1111/j.1365-2052.2006.01434.x; SASAZUKI T, 1978, NATURE, V272, P359, DOI 10.1038/272359b0; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Shin SC, 2007, ASIAN AUSTRAL J ANIM, V20, P328, DOI 10.5713/ajas.2007.328; Shin SC, 2007, ASIAN AUSTRAL J ANIM, V20, P466, DOI 10.5713/ajas.2007.466; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; Smith SB, 2009, ASIAN AUSTRAL J ANIM, V22, P1225, DOI 10.5713/ajas.2009.r.10; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Taniguchi M, 2004, MAMM GENOME, V15, P142, DOI 10.1007/s00335-003-2286-8; Taylor JF, 1998, ANIM GENET, V29, P194, DOI 10.1111/j.1365-2052.1998.00317.x; Tishkoff SA, 2000, AM J HUM GENET, V67, P518, DOI 10.1086/303000; Upton W, 2001, AUST J EXP AGR, V41, P943, DOI 10.1071/EA00064; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Wang YH, 2009, J ANIM SCI, V87, P119, DOI 10.2527/jas.2008-1082; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WEIR BS, 1980, GENETICS, V95, P477; Weir BS, 1996, GENETIC DATA ANAL, P1; White SN, 2005, J ANIM SCI, V83, P2001; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zhang S, 2008, ANIM GENET, V39, P62, DOI 10.1111/j.1365-2052.2007.01681.x; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	97	41	43	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29601	10.1371/journal.pone.0029601	http://dx.doi.org/10.1371/journal.pone.0029601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216329	Green Submitted, gold, Green Published			2022-12-27	WOS:000300676300072
J	Feart, C; Helmer, C; Fleury, H; Bejot, Y; Ritchie, K; Amouyel, P; Schraen-Maschke, S; Buee, L; Lambert, JC; Letenneur, L; Dartigues, JF				Feart, Catherine; Helmer, Catherine; Fleury, Herve; Bejot, Yannick; Ritchie, Karen; Amouyel, Philippe; Schraen-Maschke, Susanna; Buee, Luc; Lambert, Jean-Charles; Letenneur, Luc; Dartigues, Jean-Francois			Association between IgM Anti-Herpes Simplex Virus and Plasma Amyloid-Beta Levels	PLOS ONE			English	Article							INFECTIOUS AGENTS CONTRIBUTE; ALZHEIMERS-DISEASE; A-BETA; COGNITIVE DECLINE; APOLIPOPROTEIN-E; RISK; TYPE-1; POPULATION; BIOMARKERS; AUTOPHAGY	Objective: Herpes simplex virus (HSV) reactivation has been identified as a possible risk factor for Alzheimer's disease (AD) and plasma amyloid-beta (A beta) levels might be considered as possible biomarkers of the risk of AD. The aim of our study was to investigate the association between anti-HSV antibodies and plasma A beta levels. Methods: The study sample consisted of 1222 subjects (73.9 y in mean) from the Three-City cohort. IgM and IgG anti-HSV antibodies were quantified using an ELISA kit, and plasma levels of A beta(1-40) and A beta(1-42) were measured using an xMAP-based assay technology. Cross-sectional analyses of the associations between anti-HSV antibodies and plasma Ab levels were performed by multi-linear regression. Results: After adjustment for study center, age, sex, education, and apolipoprotein E-e4 polymorphism, plasma A beta(1-42) and A beta(1-40) levels were specifically inversely associated with anti-HSV IgM levels (beta = -20.7, P = 0.001 and beta = -92.4, P = 0.007, respectively). In a sub-sample with information on CLU- and CR1-linked SNPs genotyping (n = 754), additional adjustment for CR1 or CLU markers did not modify these associations (adjustment for CR1 rs6656401, beta = -25.6, P = 0.002 for A beta(1-42) and beta = -132.7, P = 0.002 for A beta(1-40); adjustment for CLU rs2279590, beta = -25.6, P = 0.002 for A beta(1-42) and beta = 2134.8, P = 0.002 for A beta(1-40)). No association between the plasma A beta(1-42)-to-A beta(1-40) ratio and anti-HSV IgM or IgG were evidenced. Conclusion: High anti-HSV IgM levels, markers of HSV reactivation, are associated with lower plasma A beta(1-40) and A beta(1-42) levels, which suggest a possible involvement of the virus in the alterations of the APP processing and potentially in the pathogenesis of AD in human.	[Feart, Catherine; Helmer, Catherine; Letenneur, Luc; Dartigues, Jean-Francois] INSERM, U897, Bordeaux, France; [Feart, Catherine; Helmer, Catherine; Fleury, Herve; Letenneur, Luc; Dartigues, Jean-Francois] Univ Bordeaux Segalen, Bordeaux, France; [Bejot, Yannick] Univ Burgundy, Fac Med Dijon, Univ Hosp Dijon, Dept Neurol,Dijon Stroke Registry,EA4184, Dijon, France; [Ritchie, Karen] INSERM, U888, Montpellier, France; [Ritchie, Karen] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [Amouyel, Philippe; Lambert, Jean-Charles] INSERM, UMR744, F-59045 Lille, France; [Amouyel, Philippe; Schraen-Maschke, Susanna; Buee, Luc; Lambert, Jean-Charles] Univ Lille 2, Inst Pasteur Lille, Lille, France; [Schraen-Maschke, Susanna; Buee, Luc] INSERM, U837, F-59045 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Dijon Bourgogne; Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Feart, C (corresponding author), INSERM, U897, Bordeaux, France.	catherine.feart@isped.u-bordeaux2.fr	Béjot, Yannick/D-3942-2019; FEART, Catherine/A-3339-2016; lambert, jean-charles/F-8787-2013; Ritchie, Karen/G-3571-2013; BUEE, Luc/B-3126-2010; DARTIGUES, Jean François/T-4513-2019; Lambert, jean-charles/A-9553-2014; HELMER, Catherine/I-6581-2015; LETENNEUR, Luc/T-4424-2019; HELMER, Catherine/AAG-5126-2021	Béjot, Yannick/0000-0001-7848-7072; lambert, jean-charles/0000-0003-0829-7817; Ritchie, Karen/0000-0002-0688-8982; BUEE, Luc/0000-0002-6261-4230; Lambert, jean-charles/0000-0003-0829-7817; HELMER, Catherine/0000-0002-5169-7421; LETENNEUR, Luc/0000-0002-3274-937X; Amouyel, Philippe/0000-0001-9088-234X; FEART, Catherine/0000-0002-7959-1610; SCHRAEN, Susanna/0000-0002-7247-4809	Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Regional Governments of Aquitaine and Bourgogne; Fondation de France; Ministry of Research - INSERM; European Community [LSHM-CT-2007-037950]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Regional Governments of Aquitaine and Bourgogne(Region Nouvelle-Aquitaine); Fondation de France(Fondation de France); Ministry of Research - INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); European Community(European Commission)	The Three-City Study is conducted under a partnership agreement between the Institut National de la Sante et de la Recherche Medicale (INSERM), the Institut de Sante Publique et Developpement of the Victor Segalen Bordeaux 2 University, and Sanofi-Aventis. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The 3C Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale, Institut de la Longevite, Regional Governments of Aquitaine and Bourgogne, Fondation de France, and Ministry of Research - INSERM Programme "Cohortes et collections de donnees biologiques". This work was additionally funded by the European Community's cNEUPRO programme (contract LSHM-CT-2007-037950). Role of the sponsors: Study sponsors played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Carter CJ, 2011, NEUROCHEM INT, V58, P301, DOI 10.1016/j.neuint.2010.12.003; Carter CJ, 2010, NEUROSCI LETT, V483, P96, DOI 10.1016/j.neulet.2010.07.066; Cheng SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017966; Cosentino SA, 2010, ARCH NEUROL-CHICAGO, V67, P1485, DOI 10.1001/archneurol.2010.189; Cribbs DH, 2000, BIOCHEMISTRY-US, V39, P5988, DOI 10.1021/bi000029f; De Chiara G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013989; Devanand DP, 2011, NEUROLOGY, V77, P125, DOI 10.1212/WNL.0b013e318224afb7; Dufouil C, 2005, NEUROLOGY, V64, P1531, DOI 10.1212/01.WNL.0000160114.42643.31; Honjo K, 2009, ALZHEIMERS DEMENT, V5, P348, DOI 10.1016/j.jalz.2008.12.001; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; Itzhaki RF, 2006, PROG LIPID RES, V45, P73, DOI 10.1016/j.plipres.2005.11.003; Itzhaki RF, 2008, J ALZHEIMERS DIS, V13, P393; Itzhaki RF, 2010, ALZHEIMERS DEMENT, V6, P83, DOI 10.1016/j.jalz.2009.07.136; Kuhlmann I, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-8; Lachno DR, 2009, J NUTR HEALTH AGING, V13, P220, DOI 10.1007/s12603-009-0062-5; Lambert JC, 2009, NEUROLOGY, V73, P847, DOI 10.1212/WNL.0b013e3181b78448; Lambert JC, 2010, J ALZHEIMERS DIS, V20, P1107, DOI 10.3233/JAD-2010-100018; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Letenneur L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003637; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Malkin JE, 2002, SEX TRANSM INFECT, V78, P201, DOI 10.1136/sti.78.3.201; McNaull BBA, 2010, GERONTOLOGY, V56, P3, DOI 10.1159/000237873; Moreira PI, 2010, EXPERT REV NEUROTHER, V10, P1209, DOI [10.1586/ern.10.84, 10.1586/ERN.10.84]; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Ohana B, 2000, CLIN DIAGN LAB IMMUN, V7, P904, DOI 10.1128/CDLI.7.6.904-908.2000; Piacentini R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.009; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; Santana S, 2011, NEUROBIOL AGING; Schupf N, 2008, P NATL ACAD SCI USA, V105, P14052, DOI 10.1073/pnas.0805902105; Shipley SJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-48; Song F, 2011, J ALZHEIMERS DIS, V26, P365, DOI 10.3233/JAD-2011-101977; Song F, 2009, BRAIN RES REV, V61, P69, DOI 10.1016/j.brainresrev.2009.05.003; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Toledo JB, 2011, ACTA NEUROPATHOL, V122, P401, DOI 10.1007/s00401-011-0861-8; Valyi-Nagy T, 2005, HISTOL HISTOPATHOL, V20, P957, DOI 10.14670/HH-20.957; Wojtowicz WM, 2002, J BIOL CHEM, V277, P35019, DOI 10.1074/jbc.M203518200; Wozniak MA, 2009, J PATHOL, V217, P131, DOI 10.1002/path.2449; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; Wozniak MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025152; Wozniak Matthew A, 2010, Ther Adv Neurol Disord, V3, P141, DOI 10.1177/1756285610370069; Yaffe K, 2011, JAMA-J AM MED ASSOC, V305, P261, DOI 10.1001/jama.2010.1995	44	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29480	10.1371/journal.pone.0029480	http://dx.doi.org/10.1371/journal.pone.0029480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216291	Green Published, gold, Green Submitted			2022-12-27	WOS:000300676300060
J	Pantakani, DVK; Czyzewska, MM; Sikorska, A; Bodda, C; Mannan, AU				Pantakani, D. V. Krishna; Czyzewska, Marta M.; Sikorska, Anna; Bodda, Chiranjeevi; Mannan, Ashraf U.			Oligomerization of ZFYVE27 (Protrudin) Is Necessary to Promote Neurite Extension	PLOS ONE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; ENDOPLASMIC-RETICULUM; MEMBRANE TRAFFICKING; ACTIN CYTOSKELETON; CRYSTAL-STRUCTURE; ENDOSOME FUSION; FYVE DOMAINS; PROTEIN; MUTATION; EEA1	ZFYVE27 (Protrudin) was originally identified as an interacting partner of spastin, which is most frequently mutated in hereditary spastic paraplegia. ZFYVE27 is a novel member of FYVE family, which is implicated in the formation of neurite extensions by promoting directional membrane trafficking in neurons. Now, through a yeast two-hybrid screen, we have identified that ZFYVE27 interacts with itself and the core interaction region resides within the third hydrophobic region (HR3) of the protein. We confirmed the ZFYVE27's self-interaction in the mammalian cells by co-immunoprecipitation and co-localization studies. To decipher the oligomeric nature of ZFYVE27, we performed sucrose gradient centrifugation and showed that ZFYVE27 oligomerizes into dimer/tetramer forms. Sub-cellular fractionation and Triton X-114 membrane phase separation analysis indicated that ZFYVE27 is a peripheral membrane protein. Furthermore, ZFYVE27 also binds to phosphatidylinositol 3-phosphate lipid moiety. Interestingly, cells expressing ZFYVE27(Delta HR3) failed to produce protrusions instead caused swelling of cell soma. When ZFYVE27(Delta HR3) was co-expressed with wild-type ZFYVE27 (ZFYVE27(WT)), it exerted a dominant negative effect on ZFYVE27(WT) as the cells co-expressing both proteins were also unable to induce protrusions and showed cytoplasmic swelling. Altogether, it is evident that a functionally active form of oligomer is crucial for ZFYVE27 ability to promote neurite extensions.	[Pantakani, D. V. Krishna; Czyzewska, Marta M.; Sikorska, Anna; Bodda, Chiranjeevi; Mannan, Ashraf U.] Univ Gottingen, Inst Human Genet, D-3400 Gottingen, Germany	University of Gottingen	Pantakani, DVK (corresponding author), Univ Gottingen, Inst Human Genet, Gosslerstr 12D, D-3400 Gottingen, Germany.	amannan@gwdg.de		Czyzewska, Marta/0000-0002-5843-3445; Sikorska, Anna/0000-0003-1668-2264	Deutsche Forschungsgemeinschaft [MA 3344-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft grant (MA 3344-2) to A. U. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORDIER C, 1981, J BIOL CHEM, V256, P1604; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Callaghan J, 1999, BIOCHEM J, V338, P539, DOI 10.1042/0264-6021:3380539; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Estrada L, 2001, HUM MOL GENET, V10, P485, DOI 10.1093/hmg/10.5.485; Evans K, 2006, P NATL ACAD SCI USA, V103, P10666, DOI 10.1073/pnas.0510863103; Fonknechten N, 2000, HUM MOL GENET, V9, P637, DOI 10.1093/hmg/9.4.637; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hayakawa A, 2004, J BIOL CHEM, V279, P5958, DOI 10.1074/jbc.M310503200; Hayakawa A, 2007, EVOLUTIONARILY CONSE, P95; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jayaraman L, 2000, J BIOL CHEM, V275, P40710, DOI 10.1074/jbc.M005799200; Jiang L, 2004, J CHROMATOGR A, V1023, P317, DOI 10.1016/j.chroma.2003.10.029; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kifayathullah LA, 2010, CYTOGENET GENOME RES, V129, P290, DOI 10.1159/000315906; Landers JE, 2008, NEUROLOGY, V70, P1179, DOI 10.1212/01.wnl.0000289760.85237.4e; Mannan AU, 2006, AM J HUM GENET, V79, P351, DOI 10.1086/504927; Mannan AU, 2006, NEUROGENETICS, V7, P93, DOI 10.1007/s10048-006-0034-4; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Matsuzaki F, 2011, MOL BIOL CE IN PRESS; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Meyer T, 2005, NEUROLOGY, V65, P141, DOI 10.1212/01.wnl.0000167130.31618.0a; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Pantakani DVK, 2008, J NEUROCHEM, V106, P613, DOI 10.1111/j.1471-4159.2008.05414.x; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; Pullan L, 2006, STRUCTURE, V14, P661, DOI 10.1016/j.str.2006.01.012; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Ridley SH, 2001, J CELL SCI, V114, P3991; Saita S, 2009, J BIOL CHEM, V284, P13766, DOI 10.1074/jbc.M807938200; Schmidt MR, 2007, BIOL CELL, V99, P333, DOI 10.1042/BC20070007; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Shoukier M, 2009, EUR J HUM GENET, V17, P187, DOI 10.1038/ejhg.2008.147; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stenmark H, 1999, J CELL SCI, V112, P4175; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Wang L, 2002, CURR BIOL, V12, P1496, DOI 10.1016/S0960-9822(02)01078-3; Wiedemann C, 1998, NATURE, V394, P426, DOI 10.1038/28752; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878	50	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29584	10.1371/journal.pone.0029584	http://dx.doi.org/10.1371/journal.pone.0029584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216323	Green Published, gold, Green Submitted			2022-12-27	WOS:000300676300068
J	Zhang, YC; Wu, Y; Zhu, MH; Wang, C; Wang, JJ; Zhang, Y; Yu, CS; Jiang, TZ				Zhang, Yuanchao; Wu, Yan; Zhu, Maohu; Wang, Chao; Wang, Jiaojian; Zhang, Yun; Yu, Chunshui; Jiang, Tianzi			Reduced Cortical Thickness in Mental Retardation	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; FRAGILE-X-SYNDROME; DENDRITIC SPINE; WORKING-MEMORY; LEARNING-DISABILITY; INTELLECTUAL DISABILITY; COMORBID SCHIZOPHRENIA; DEVELOPMENTAL DELAY	Mental retardation is a developmental disorder associated with impaired cognitive functioning and deficits in adaptive behaviors. Many studies have addressed white matter abnormalities in patients with mental retardation, while the changes of the cerebral cortex have been studied to a lesser extent. Quantitative analysis of cortical integrity using cortical thickness measurement may provide new insights into the gray matter pathology. In this study, cortical thickness was compared between 13 patients with mental retardation and 26 demographically matched healthy controls. We found that patients with mental retardation had significantly reduced cortical thickness in multiple brain regions compared with healthy controls. These regions include the bilateral lingual gyrus, the bilateral fusiform gyrus, the bilateral parahippocampal gyrus, the bilateral temporal pole, the left inferior temporal gyrus, the right lateral orbitofrontal cortex and the right precentral gyrus. The observed cortical thickness reductions might be the anatomical substrates for the impaired cognitive functioning and deficits in adaptive behaviors in patients with mental retardation. Cortical thickness measurement might provide a sensitive prospective surrogate marker for clinical trials of neuroprotective medications.	[Zhang, Yuanchao; Wu, Yan; Wang, Chao; Wang, Jiaojian; Zhang, Yun; Jiang, Tianzi] Univ Elect Sci & Technol China, Key Lab NeuroInformat Minist Educ, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Zhu, Maohu; Jiang, Tianzi] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, LIAMA Ctr Computat Med, Beijing, Peoples R China; [Yu, Chunshui] Tianjin Med Univ Gen Hosp, Dept Radiol, Tianjin, Peoples R China	University of Electronic Science & Technology of China; Chinese Academy of Sciences; Institute of Automation, CAS; Tianjin Medical University	Zhang, YC (corresponding author), Univ Elect Sci & Technol China, Key Lab NeuroInformat Minist Educ, Sch Life Sci & Technol, Chengdu 610054, Peoples R China.	jiangtz@nlpr.ia.ac.cn	Jiang, Tianzi/I-4256-2012	Jiang, Tianzi/0000-0001-9531-291X; Wang, Jiaojian/0000-0002-0421-5709; Yu, Chunshui/0000-0001-5648-5199	Natural Science Foundation of China [81101000]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (grant no. 81101000 to Dr. Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BergerSweeney J, 1997, BEHAV BRAIN RES, V86, P121, DOI 10.1016/S0166-4328(96)02251-6; Bohbot VD, 2000, ANN NY ACAD SCI, V911, P355; Branchi I, 2003, NEUROSCI BIOBEHAV R, V27, P141, DOI 10.1016/S0149-7634(03)00016-2; Chechlacz M, 2003, PEDIATR NEUROL, V29, P11, DOI 10.1016/S0887-8994(03)00152-8; Chung MK, 2005, NEUROIMAGE, V25, P1256, DOI 10.1016/j.neuroimage.2004.12.052; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Fiebach CJ, 2006, NEURON, V51, P251, DOI 10.1016/j.neuron.2006.06.007; Filippi CG, 2003, RADIOLOGY, V229, P44, DOI 10.1148/radiol.2291020049; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; Hoeft F, 2008, ARCH GEN PSYCHIAT, V65, P1087, DOI 10.1001/archpsyc.65.9.1087; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Luck D, 2010, BRAIN COGNITION, V72, P255, DOI 10.1016/j.bandc.2009.09.009; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; MCALPINE C, 1992, BEHAV MODIF, V16, P543, DOI 10.1177/01454455920164006; Menon V, 2000, HUM BRAIN MAPP, V11, P117, DOI 10.1002/1097-0193(200010)11:2<117::AID-HBM50>3.0.CO;2-M; Moorhead TWJ, 2005, NEUROIMAGE, V28, P544, DOI 10.1016/j.neuroimage.2005.04.045; Moorhead TWJ, 2004, NEUROIMAGE, V22, P188, DOI 10.1016/j.neuroimage.2003.12.012; Nagy Z, 2011, CEREB CORTEX, V21, P300, DOI 10.1093/cercor/bhq095; Narr KL, 2007, CEREB CORTEX, V17, P2163, DOI 10.1093/cercor/bhl125; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Rama P, 2001, NEUROIMAGE, V13, P1090, DOI 10.1006/nimg.2001.0777; Ramakers GJA, 2000, AM J MED GENET, V94, P367, DOI 10.1002/1096-8628(20001023)94:5<367::AID-AJMG4>3.0.CO;2-I; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; ROJAHN J, 1995, RES DEV DISABIL, V16, P393, DOI 10.1016/0891-4222(95)00019-J; Rosenquist C, 2003, AM J MENT RETARD, V108, P403, DOI 10.1352/0895-8017(2003)108<403:PAVWMI>2.0.CO;2; Sanderson TL, 1999, LANCET, V354, P1867, DOI 10.1016/S0140-6736(99)01049-1; Schaefer GB, 1999, INT REV PSYCHIATR, V11, P47; Schuchardt K, 2010, J INTELL DISABIL RES, V54, P346, DOI 10.1111/j.1365-2788.2010.01265.x; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Singh V, 2006, BRAIN, V129, P2885, DOI 10.1093/brain/awl256; Soto-Ares G, 2003, PEDIATR RADIOL, V33, P334, DOI 10.1007/s00247-003-0891-z; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Spencer MD, 2005, AM J NEURORADIOL, V26, P2691; Widjaja E, 2008, ACTA RADIOL, V49, P589, DOI 10.1080/02841850801950087; Worsley KJ, 1999, HUM BRAIN MAPP, V8, P98, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<98::AID-HBM5>3.3.CO;2-6; Yu CS, 2008, NEUROIMAGE, V40, P1533, DOI 10.1016/j.neuroimage.2008.01.063; Zhang Y, 2010, AM J NEURORADIOL, V31, P1063, DOI 10.3174/ajnr.A1984	46	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29673	10.1371/journal.pone.0029673	http://dx.doi.org/10.1371/journal.pone.0029673			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216343	gold, Green Submitted, Green Published			2022-12-27	WOS:000300674900052
J	Cantaloube, S; Veyron-Churlet, R; Haddache, N; Daffe, M; Zerbib, D				Cantaloube, Sylvain; Veyron-Churlet, Romain; Haddache, Nabila; Daffe, Mamadou; Zerbib, Didier			The Mycobacterium Tuberculosis FAS-II Dehydratases and Methyltransferases Define the Specificity of the Mycolic Acid Elongation Complexes	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; CRYSTAL-STRUCTURE; CELL-WALL; CYCLOPROPANE SYNTHETASE; ISONIAZID RESISTANCE; OUTER-MEMBRANE; FATTY-ACIDS; BIOSYNTHESIS; SYNTHASE; GENE	Background: The human pathogen Mycobacterium tuberculosis (Mtb) has the originality of possessing a multifunctional mega-enzyme FAS-I (Fatty Acid Synthase-I), together with a multi-protein FAS-II system, to carry out the biosynthesis of common and of specific long chain fatty acids: the mycolic acids (MA). MA are the main constituents of the external mycomembrane that represents a tight permeability barrier involved in the pathogenicity of Mtb. The MA biosynthesis pathway is essential and contains targets for efficient antibiotics. We have demonstrated previously that proteins of FAS-II interact specifically to form specialized and interconnected complexes. This finding suggested that the organization of FAS-II resemble to the architecture of multifunctional mega-enzyme like the mammalian mFAS-I, which is devoted to the fatty acid biosynthesis. Principal Findings: Based on conventional and reliable studies using yeast-two hybrid, yeast-three-hybrid and in vitro Co-immunoprecipitation, we completed here the analysis of the composition and architecture of the interactome between the known components of the Mtb FAS-II complexes. We showed that the recently identified dehydratases HadAB and HadBC are part of the FAS-II elongation complexes and may represent a specific link between the core of FAS-II and the condensing enzymes of the system. By testing four additional methyltransferases involved in the biosynthesis of mycolic acids, we demonstrated that they display specific interactions with each type of complexes suggesting their coordinated action during MA elongation. Significance: These results provide a global update of the architecture and organization of a FAS-II system. The FAS-II system of Mtb is organized in specialized interconnected complexes and the specificity of each elongation complex is given by preferential interactions between condensing enzymes and dehydratase heterodimers. This study will probably allow defining essential and specific interactions that correspond to promising targets for Mtb FAS-II inhibitors.	[Cantaloube, Sylvain; Veyron-Churlet, Romain; Haddache, Nabila; Daffe, Mamadou; Zerbib, Didier] CNRS, IPBS, Toulouse, France; [Cantaloube, Sylvain; Veyron-Churlet, Romain; Haddache, Nabila; Daffe, Mamadou; Zerbib, Didier] Univ Toulouse, Toulouse, France; [Cantaloube, Sylvain; Veyron-Churlet, Romain; Haddache, Nabila; Daffe, Mamadou; Zerbib, Didier] Univ Toulouse 3, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Cantaloube, S (corresponding author), CNRS, IPBS, Toulouse, France.	Didier.Zerbib@ipbs.fr	Veyron-Churlet, Romain/J-4254-2019	Veyron-Churlet, Romain/0000-0001-6902-5917; Zerbib, Didier/0000-0001-7175-502X	Centre National de la Recherche Scientifique (CNRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was funded by the Centre National de la Recherche Scientifique (CNRS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselineau C, 2002, PROG LIPID RES, V41, P501, DOI 10.1016/S0163-7827(02)00008-5; Banerjee A, 1998, MICROBIOL-SGM, V144, P2697, DOI 10.1099/00221287-144-10-2697; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Barkan D, 2010, J BACTERIOL, V192, P3661, DOI 10.1128/JB.00312-10; Barkan D, 2009, CHEM BIOL, V16, P499, DOI 10.1016/j.chembiol.2009.04.001; Bhatt A, 2008, CHEM BIOL, V15, P930, DOI 10.1016/j.chembiol.2008.07.007; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Bleck CKE, 2010, J MICROSC-OXFORD, V237, P23, DOI 10.1111/j.1365-2818.2009.03299.x; Boissier F, 2006, J BIOL CHEM, V281, P4434, DOI 10.1074/jbc.M510250200; Brown AK, 2007, MICROBIOL-SGM, V153, P4166, DOI 10.1099/mic.0.2007/012419-0; Choi KH, 2000, J BIOL CHEM, V275, P28201; Cohen-Gonsaud M, 2002, J MOL BIOL, V320, P249, DOI 10.1016/S0022-2836(02)00463-1; Daffe M., 1999, Tubercle and Lung Disease, V79, P153, DOI 10.1054/tuld.1998.0200; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dinadayala P, 2003, J BIOL CHEM, V278, P7310, DOI 10.1074/jbc.M210501200; Dubnau E, 1998, MOL MICROBIOL, V29, P1526; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Ducasse-Cabanot S, 2004, ANTIMICROB AGENTS CH, V48, P242, DOI 10.1128/AAC.48.1.242-249.2004; Gago G, 2010, FEMS MICROBIOL REV; Gao LY, 2003, MOL MICROBIOL, V49, P1547, DOI 10.1046/j.1365-2958.2003.03667.x; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; GEORGE KM, 1995, J BIOL CHEM, V270, P27292, DOI 10.1074/jbc.270.45.27292; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Glickman MS, 2003, J BIOL CHEM, V278, P7844, DOI 10.1074/jbc.M212458200; Glickman MS, 2001, J BIOL CHEM, V276, P2228, DOI 10.1074/jbc.C000652200; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Huang CC, 2002, J BIOL CHEM, V277, P11559, DOI 10.1074/jbc.M111698200; Jassal M, 2009, LANCET INFECT DIS, V9, P19, DOI 10.1016/S1473-3099(08)70260-3; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Kremer L, 2002, BIOCHEM J, V364, P423, DOI 10.1042/BJ20011628; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Laval F, 2008, J BIOL CHEM, V283, P1419, DOI 10.1074/jbc.M708859200; Lea-Smith DJ, 2007, J BIOL CHEM; Leger M, 2009, CHEM BIOL, V16, P510, DOI 10.1016/j.chembiol.2009.03.012; Leibundgut M, 2008, CURR OPIN STRUC BIOL, V18, P714, DOI 10.1016/j.sbi.2008.09.008; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Marrakchi H, 2002, MICROBIOL-SGM, V148, P951, DOI 10.1099/00221287-148-4-951; Meier JL, 2009, CHEM SOC REV, V38, P2012, DOI 10.1039/b805115c; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Quemard A, 1997, EUR J BIOCHEM, V250, P758, DOI 10.1111/j.1432-1033.1997.00758.x; Rozwarski DA, 1999, J BIOL CHEM, V274, P15582, DOI 10.1074/jbc.274.22.15582; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Sacco E, 2007, BBA-PROTEINS PROTEOM, V1774, P303, DOI 10.1016/j.bbapap.2006.11.016; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; Slayden RA, 2002, TUBERCULOSIS, V82, P149, DOI 10.1054/tube.2002.0333; Smith JL, 2008, SCIENCE, V321, P1304, DOI 10.1126/science.1163785; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Veyron-Churlet R, 2005, J MOL BIOL, V353, P847, DOI 10.1016/j.jmb.2005.09.016; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; YUAN Y, 1995, P NATL ACAD SCI USA, V92, P6630, DOI 10.1073/pnas.92.14.6630; Yuan Y, 1996, P NATL ACAD SCI USA, V93, P12828, DOI 10.1073/pnas.93.23.12828; Yuan Y, 1997, J BIOL CHEM, V272, P10041; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	58	40	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29564	10.1371/journal.pone.0029564	http://dx.doi.org/10.1371/journal.pone.0029564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216317	Green Published, gold, Green Submitted			2022-12-27	WOS:000299684700069
J	Williams, DJ; Sidaway, P; Cunnane, TC; Brain, KL				Williams, Damian J.; Sidaway, Peter; Cunnane, Thomas C.; Brain, Keith L.			Mechanisms Involved in Nicotinic Acetylcholine Receptor-Induced Neurotransmitter Release from Sympathetic Nerve Terminals in the Mouse Vas Deferens	PLOS ONE			English	Article							PRESYNAPTIC CALCIUM STORES; GUINEA-PIG; SYNAPTIC-TRANSMISSION; NORADRENALINE RELEASE; DOPAMINE RELEASE; CA2+ CHANNELS; NEURONS; STIMULATION; EPIBATIDINE; MODULATION	Prejunctional nicotinic acetylcholine receptors (nAChRs) amplify postganglionic sympathetic neurotransmission, and there are indications that intraterminal Ca2+ stores might be involved. However, the mechanisms by which nAChR activation stimulates neurotransmitter release at such junctions is unknown. Rapid local delivery (picospritzing) of the nAChR agonist epibatidine was combined with intracellular sharp microelectrode recording to monitor spontaneous and field-stimulation-evoked neurotransmitter release from sympathetic nerve terminals in the mouse isolated vas deferens. Locally applied epibatidine (1 mu M) produced 'epibatidine-induced depolarisations' (EIDs) that were similar in shape to spontaneous excitatory junction potentials (SEJPs) and were abolished by nonselective nAChR antagonists and the purinergic desensitizing agonist alpha,beta-methylene ATP. The amplitude distribution of EIDs was only slightly shifted towards lower amplitudes by the selective alpha 7 nAChR antagonists alpha-bungarotoxin and methyllcaconitine, the voltage-gated Na+ channel blocker tetrodotoxin or by blocking voltage-gated Ca2+ channels with Cd2+. Lowering the extracellular Ca2+ concentration reduced the frequency of EIDs by 69%, but more surprisingly, the Ca2+-induced Ca2+ release blocker ryanodine greatly decreased the amplitude (by 41%) and the frequency of EIDs by 36%. Ryanodine had no effect on electrically-evoked neurotransmitter release, paired-pulse facilitation, SEJP frequency, SEJP amplitude or SEJP amplitude distribution. These results show that activation of non-alpha 7 nAChRs on sympathetic postganglionic nerve terminals induces high-amplitude junctional potentials that are argued to represent multipacketed neurotransmitter release synchronized by intraterminal Ca2+-induced Ca2+ release, triggered by Ca2+ influx directly through the nAChR. This nAChR-induced neurotransmitter release can be targeted pharmacologically without affecting spontaneous or electrically-evoked neurotransmitter release.	[Williams, Damian J.; Cunnane, Thomas C.] Univ Oxford, Dept Pharmacol, Oxford, England; [Sidaway, Peter; Brain, Keith L.] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England	University of Oxford; University of Birmingham	Williams, DJ (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford, England.	k.l.brain@bham.ac.uk	Brain, Keith L./AFU-7168-2022	Brain, Keith L./0000-0002-0906-7012; Williams, Damian/0000-0001-5891-6300	Wellcome Trust [074128]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (www.wellcome.ac.uk; Programme grant to TCC; research fellowship 074128 to KLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKONDON M, 1992, MOL PHARMACOL, V41, P802; BADIO B, 1994, MOL PHARMACOL, V45, P563; BOEHM S, 1995, NEUROSCIENCE, V69, P221, DOI 10.1016/0306-4522(95)00235-B; Brain KL, 1997, J PHYSIOL-LONDON, V502, P521, DOI 10.1111/j.1469-7793.1997.521bj.x; Brain KL, 2001, NEUROSCIENCE, V106, P395, DOI 10.1016/S0306-4522(01)00280-9; BROCK JA, 1988, J PHYSIOL-LONDON, V399, P607; Collin T, 2005, CURR OPIN NEUROBIOL, V15, P275, DOI 10.1016/j.conb.2005.05.003; Cuprian AM, 2005, BRIT J PHARMACOL, V146, P927, DOI 10.1038/sj.bjp.0706357; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; Dajas-Bailador FA, 2002, J NEUROCHEM, V81, P606, DOI 10.1046/j.1471-4159.2002.00846.x; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; David R, 2010, EUR J NEUROSCI, V31, P978, DOI 10.1111/j.1460-9568.2010.07133.x; Dickinson JA, 2008, MOL PHARMACOL, V74, P348, DOI 10.1124/mol.108.046623; Dolezal V, 1996, BRAIN RES, V740, P75, DOI 10.1016/S0006-8993(96)00876-1; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Fischer H, 2005, J PHYSIOL-LONDON, V563, P119, DOI 10.1113/jphysiol.2004.075788; FUDER H, 1995, REV PHYSIOL BIOCH P, V126, P265, DOI 10.1007/BFb0049778; GERZANICH V, 1995, MOL PHARMACOL, V48, P774; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Haass M, 1997, CARDIOVASC DRUG THER, V10, P657, DOI 10.1007/BF00053022; Harte CB, 2008, J SEX MED, V5, P110, DOI 10.1111/j.1743-6109.2007.00637.x; Kristufek D, 1999, J PHYSIOL-LONDON, V516, P739, DOI 10.1111/j.1469-7793.1999.0739u.x; Le Magueresse C, 2007, HIPPOCAMPUS, V17, P316, DOI 10.1002/hipo.20271; Lindstrom J, 1997, MOL NEUROBIOL, V15, P193, DOI 10.1007/BF02740634; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; NEDERGAARD OA, 1977, EUR J PHARMACOL, V42, P315, DOI 10.1016/0014-2999(77)90165-0; Parker LK, 2010, BRIT J PHARMACOL, V159, P797, DOI 10.1111/j.1476-5381.2009.00574.x; Picciotto MR, 2002, J NEUROBIOL, V53, P641, DOI 10.1002/neu.10102; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; PLENZ E, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology, V341, pR86; Raina P, 2008, ANN INTERN MED, V148, P379, DOI 10.7326/0003-4819-148-5-200803040-00009; RICHARDT G, 1988, KLIN WOCHENSCHR, V66, P21; Sargent PB, 1993, REV NEUROSCI, V16, P403; SCHULZ DW, 1989, NEUROSCI LETT, V98, P310, DOI 10.1016/0304-3940(89)90420-5; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Shoop RD, 2001, J NEUROSCI, V21, P771, DOI 10.1523/JNEUROSCI.21-03-00771.2001; SJOSTRAND NO, 1965, ACTA PHYSL SCAND   S, V257, P1; Smith AB, 1996, J PHYSIOL-LONDON, V497, P657, DOI 10.1113/jphysiol.1996.sp021797; Smith DA, 1998, NEUROSCI LETT, V255, P127, DOI 10.1016/S0304-3940(98)00725-3; SOLIAKOV L, 1995, NEUROPHARMACOLOGY, V34, P1535, DOI 10.1016/0028-3908(95)00122-M; TODOROV L, 1991, BRIT J PHARMACOL, V102, P186, DOI 10.1111/j.1476-5381.1991.tb12151.x; VONKUGELGEN I, 1991, N-S ARCH PHARMACOL, V344, P419, DOI 10.1007/BF00172581; Welsby P, 2006, EUR J NEUROSCI, V24, P3109, DOI 10.1111/j.1460-9568.2006.05187.x; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Williams DJ, 2007, BRIT J PHARMACOL, V150, P906, DOI 10.1038/sj.bjp.0707183; Zago WM, 1999, BRAZ J MED BIOL RES, V32, P999, DOI 10.1590/S0100-879X1999000800010	47	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29209	10.1371/journal.pone.0029209	http://dx.doi.org/10.1371/journal.pone.0029209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216213	Green Published, gold, Green Submitted			2022-12-27	WOS:000299684700040
J	Nilssen, DE; Brandtzaeg, P				Nilssen, Dag E.; Brandtzaeg, Per			Intraepithelial gamma delta T Cells Remain Increased in the Duodenum of AIDS Patients Despite Antiretroviral Treatment	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; CELIAC-DISEASE; HIV-1-INFECTED PATIENTS; IMMUNE ACTIVATION; MUCOSAL IMMUNITY; LYMPHOCYTES; PHENOTYPES; VACCINE; TH17; BETA-2-MICROGLOBULIN	Intraepithelial lymphocytes (IELs) bearing the gamma delta T-cell receptor are a unique intestinal subset whose function remains elusive. Here, we examine how they behave in AIDS and during various regimens of antiretroviral treatment in order to obtain mechanistic insight into their adaptive or innate functional in vivo properties. IELs were studied by multimarker two-colour immunofluorescence in situ staining. Consecutive duodenal biopsies were obtained from advanced infection-prone HIV+ patients (n = 30). The systemic adaptive immune status was monitored by determining T-cell subsets and immunoglobulins in peripheral blood. The gamma delta IEL ratio (median 14.5%, range 1.5-56.3%) was significantly increased (p<0.02) compared with that in clinically healthy HIV- control subjects (n = 11, median 2.8%; range 0.3-38%), although the number of gamma delta IELs per mucosal length unit (U) only tended to be increased (4.0/U in HIV+ versus 3.2/U in HIV- subjects). Notably, the total number of CD3(+) IELs was significantly reduced in AIDS (p<0.0001, 39.6/U in HIV+ versus 86.4/U in HIV- subjects). Almost 100% of the gamma delta IELs were CD8(-) and they often expressed the V delta 1/J delta 1-encoded epitope (median 65.2%). HIV+ patients on highly active antiretroviral therapy only tended to have a lower ratio of gamma delta IELs (median 12.8%) than those receiving no treatment (median 14.3%) or 1 nucleoside analogue (NA) (median 23.5%) or 2 NAs (median 13.0%). This minimal variation among therapy groups, contrasting the treatment response of systemic and local adaptive immunity, harmonizes with the novel idea derived from animal experiments that gamma delta T-cells are largely innate cells in first-line microbial defence.	[Nilssen, Dag E.; Brandtzaeg, Per] Univ Oslo, CIR, Lab Immunohistochem & Immunopathol LIIPAT, Oslo, Norway; [Nilssen, Dag E.; Brandtzaeg, Per] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Pathol, N-0027 Oslo, Norway; [Nilssen, Dag E.] Akershus Univ Hosp, Dept Med, Lorenskog, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo	Nilssen, DE (corresponding author), Univ Oslo, CIR, Lab Immunohistochem & Immunopathol LIIPAT, Oslo, Norway.	per.brandtzaeg@medisin.uio.no			Norwegian Cancer Society; Research Council of Norway; Anders Jahre's Foundation for the Promotion of Science; University of Oslo; Medinnova, Oslo University Hospital, Rikshospitalet	Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Anders Jahre's Foundation for the Promotion of Science; University of Oslo; Medinnova, Oslo University Hospital, Rikshospitalet	This study was supported by grants from the Norwegian Cancer Society, the Research Council of Norway, Anders Jahre's Foundation for the Promotion of Science, University of Oslo, and Medinnova, Oslo University Hospital, Rikshospitalet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardes SS, 2010, CURR HIV RES, V8, P340; Bhagat G, 2008, J CLIN INVEST, V118, P281, DOI 10.1172/JCI30989; BHALLA RB, 1983, CLIN CHEM, V29, P1560; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; BRANDTZAEG P, 1989, NATURE, V341, P113, DOI 10.1038/341113a0; Brandtzaeg P, 1998, CHEM IMMUNOL, V71, P1; BRINCHMANN JE, 1988, CLIN EXP IMMUNOL, V71, P182; BRINCHMANN JE, 1989, J ACQ IMMUN DEF SYND, V2, P398; Broliden K, 2009, J INTERN MED, V265, P5, DOI 10.1111/j.1365-2796.2008.02053.x; Burgers WA, 2009, J IMMUNOL, V182, P4751, DOI 10.4049/jimmunol.0803801; Chennupati V, 2010, J IMMUNOL, V185, P5160, DOI 10.4049/jimmunol.1001652; Ciccone EJ, 2010, MUCOSAL IMMUNOL, V3, P172, DOI 10.1038/mi.2009.129; Ciofani M, 2010, NAT REV IMMUNOL, V10, P657, DOI 10.1038/nri2820; Fenoglio D, 2009, BLOOD, V113, P6611, DOI 10.1182/blood-2009-01-198028; HALSTENSEN TS, 1989, SCAND J IMMUNOL, V30, P665, DOI 10.1111/j.1365-3083.1989.tb02474.x; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Hirbod T, 2008, AIDS, V22, P727, DOI 10.1097/QAD.0b013e3282f56b64; HUITFELDT HS, 1985, HISTOCHEMISTRY, V83, P381, DOI 10.1007/BF00509196; Kanwar B, 2010, CURR OPIN HIV AIDS, V5, P151, DOI 10.1097/COH.0b013e328335c0c1; Klatt NR, 2010, MUCOSAL IMMUNOL, V3, P387, DOI 10.1038/mi.2010.14; Klatt NR, 2010, CURR OPIN HIV AIDS, V5, P135, DOI 10.1097/COH.0b013e3283364846; Loke P, 2010, BLOOD, V116, P2402; Loke P, 2010, BLOOD, V115, pE20, DOI 10.1182/blood-2009-12-257451; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Masopust D, 2009, J INTERN MED, V265, P125, DOI 10.1111/j.1365-2796.2008.02054.x; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Nilssen DE, 1996, J VIROL, V70, P3545, DOI 10.1128/JVI.70.6.3545-3550.1996; NILSSEN DE, 1993, CLIN EXP IMMUNOL, V94, P91; NILSSEN DE, 1993, CLIN IMMUNOL IMMUNOP, V68, P301, DOI 10.1006/clin.1993.1131; Nilssen DE, 2004, GUT, V53, P487, DOI 10.1136/gut.2003.027854; Pabst R, 2008, TRENDS IMMUNOL, V29, P206, DOI 10.1016/j.it.2008.02.006; Pennington DJ, 2005, CURR OPIN IMMUNOL, V17, P108, DOI 10.1016/j.coi.2005.01.009; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Prendergast A, 2010, AIDS, V24, P491, DOI 10.1097/QAD.0b013e3283344895; Sachdeva M, 2010, JAIDS-J ACQ IMM DEF, V54, P447, DOI 10.1097/QAI.0b013e3181e0c7d0; Schneider T, 1998, GUT, V42, P357, DOI 10.1136/gut.42.3.357; Schneider T, 1997, J ACQ IMMUN DEF SYND, V16, P333, DOI 10.1097/00042560-199712150-00004; SELBY WS, 1983, CLIN EXP IMMUNOL, V52, P219; Shacklett BL, 2009, J INTERN MED, V265, P58, DOI 10.1111/j.1365-2796.2008.02042.x; Snijders F, 1996, SCAND J GASTROENTERO, V31, P1176, DOI 10.3109/00365529609036907; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898	42	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29066	10.1371/journal.pone.0029066	http://dx.doi.org/10.1371/journal.pone.0029066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238587	gold, Green Published, Green Submitted			2022-12-27	WOS:000301070200016
J	Schmidt, C; Peigneux, P; Leclercq, Y; Sterpenich, V; Vandewalle, G; Phillips, C; Berthomier, P; Berthomier, C; Tinguely, G; Gais, S; Schabus, M; Desseilles, M; Thanh, DV; Salmon, E; Degueldre, C; Balteau, E; Luxen, A; Cajochen, C; Maquet, P; Collette, F				Schmidt, Christina; Peigneux, Philippe; Leclercq, Yves; Sterpenich, Virginie; Vandewalle, Gilles; Phillips, Christophe; Berthomier, Pierre; Berthomier, Christian; Tinguely, Gilberte; Gais, Steffen; Schabus, Manuel; Desseilles, Martin; Thanh Dang-Vu; Salmon, Eric; Degueldre, Christian; Balteau, Evelyne; Luxen, Andre; Cajochen, Christian; Maquet, Pierre; Collette, Fabienne			Circadian Preference Modulates the Neural Substrate of Conflict Processing across the Day	PLOS ONE			English	Article							OREXIN-A LEVELS; SLEEP-DEPRIVATION; HYPOCRETIN-OREXIN; MORNING-TYPES; ATTENTION; NIGHT; EEG; INTERFERENCE; RESPONSES; WAKING	Human morning and evening chronotypes differ in their preferred timing for sleep and wakefulness, as well as in optimal daytime periods to cope with cognitive challenges. Recent evidence suggests that these preferences are not a simple by-product of socio-professional timing constraints, but can be driven by inter-individual differences in the expression of circadian and homeostatic sleep-wake promoting signals. Chronotypes thus constitute a unique tool to access the interplay between those processes under normally entrained day-night conditions, and to investigate how they impinge onto higher cognitive control processes. Using functional magnetic resonance imaging (fMRI), we assessed the influence of chronotype and time-of-day on conflict processing-related cerebral activity throughout a normal waking day. Sixteen morning and 15 evening types were recorded at two individually adapted time points (1.5 versus 10.5 hours spent awake) while performing the Stroop paradigm. Results show that interference-related hemodynamic responses are maintained or even increased in evening types from the subjective morning to the subjective evening in a set of brain areas playing a pivotal role in successful inhibitory functioning, whereas they decreased in morning types under the same conditions. Furthermore, during the evening hours, activity in a posterior hypothalamic region putatively involved in sleep-wake regulation correlated in a chronotype-specific manner with slow wave activity at the beginning of the night, an index of accumulated homeostatic sleep pressure. These results shed light into the cerebral mechanisms underlying inter-individual differences of higher-order cognitive state maintenance under normally entrained day-night conditions.	[Schmidt, Christina; Peigneux, Philippe; Leclercq, Yves; Sterpenich, Virginie; Vandewalle, Gilles; Phillips, Christophe; Tinguely, Gilberte; Gais, Steffen; Schabus, Manuel; Desseilles, Martin; Thanh Dang-Vu; Salmon, Eric; Degueldre, Christian; Balteau, Evelyne; Luxen, Andre; Maquet, Pierre; Collette, Fabienne] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Schmidt, Christina; Collette, Fabienne] Univ Liege, Cognit & Behav Neurosci Ctr, Liege, Belgium; [Berthomier, Pierre; Berthomier, Christian] PHYSIP SA, Paris, France; [Cajochen, Christian] Univ Basel, Hosp Psychiat, Ctr Chronobiol, Basel, Switzerland; [Peigneux, Philippe] Univ Libre Bruxelles, Neuropsychol & Funct Neuroimaging Res Unit UR2NF, Brussels, Belgium	University of Liege; University of Liege; University of Basel; Universite Libre de Bruxelles	Schmidt, C (corresponding author), Univ Liege, Cyclotron Res Ctr, Liege, Belgium.	f.collette@ulg.ac.be	Schabus, Manuel/C-1704-2010; Salmon, Eric/AAE-4901-2020; Cajochen, Christian/N-6748-2014; Phillips, Christophe/M-3025-2017	Schabus, Manuel/0000-0001-5899-8772; Salmon, Eric/0000-0003-2520-9241; Phillips, Christophe/0000-0002-4990-425X; Vandewalle, Gilles/0000-0003-2483-2752; Dang Vu, Thien Thanh/0000-0002-7235-2721; Peigneux, Philippe/0000-0003-4745-1434; , Pierre/0000-0003-3106-3357; Sterpenich, Virginie/0000-0002-2125-833X; Berthomier, Christian/0000-0002-2300-9476; Desseilles, Martin/0000-0003-4748-3401	Belgian Fonds National de la Recherche Scientifique (FNRS); Fondation Medicale Reine Elisabeth; Pole d'Attraction Interuniversitaire; University of Liege; FNRS; Austrian Science Fund Erwin Schrodinger Fellowship [J2470-B02]; LUNDBECK BCNBP; Swiss National Science Foundation; Daimler-Benz Foundation	Belgian Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Fondation Medicale Reine Elisabeth; Pole d'Attraction Interuniversitaire; University of Liege(University of Liege); FNRS(Fonds de la Recherche Scientifique - FNRS); Austrian Science Fund Erwin Schrodinger Fellowship(Austrian Science Fund (FWF)); LUNDBECK BCNBP(Lundbeck Corporation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Daimler-Benz Foundation	This study was supported by the Belgian Fonds National de la Recherche Scientifique (FNRS), the Fondation Medicale Reine Elisabeth, the Pole d'Attraction Interuniversitaire and the University of Liege. CS, FC, YL, VS, CP, GV, GT, AD, MD, TD-V, ES, EB & PM were supported by the FNRS. MS was supported by an Austrian Science Fund Erwin Schrodinger Fellowship J2470-B02. CS was supported by the LUNDBECK BCNBP grant; PB and CB are co-founders, employees and shareholders of Physip Company that setup Aseega software, CC was supported by Grants of the Swiss National Science Foundation and the Daimler-Benz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis A, 2008, CELL MOL LIFE SCI, V65, P1475, DOI 10.1007/s00018-008-7521-8; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Bayer L, 2004, J NEUROSCI, V24, P6760, DOI 10.1523/JNEUROSCI.1783-04.2004; Bayer L, 2002, J NEUROSCI, V22, P7835; Berthomier C, 2007, SLEEP, V30, P1587, DOI 10.1093/sleep/30.11.1587; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Cajochen C, 1999, Sleep Res Online, V2, P65; Chee MWL, 2008, CURR OPIN NEUROL, V21, P417, DOI 10.1097/WCO.0b013e3283052cf7; Chuah YML, 2006, J NEUROSCI, V26, P7156, DOI 10.1523/JNEUROSCI.0906-06.2006; Collette F, 2006, NEUROSCIENCE, V139, P209, DOI 10.1016/j.neuroscience.2005.05.035; Collette F, 2005, HUM BRAIN MAPP, V25, P409, DOI 10.1002/hbm.20118; Compton RJ, 2003, COGN AFFECT BEHAV NE, V3, P81, DOI 10.3758/CABN.3.2.81; Deboer T, 2003, NAT NEUROSCI, V6, P1086, DOI 10.1038/nn1122; Deboer T, 2007, SLEEP, V30, P257, DOI 10.1093/sleep/30.3.257; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Draganski B, 2002, NAT MED, V8, P1186, DOI 10.1038/nm1102-1186; Drummond SPA, 2005, SLEEP, V28, P1059; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Feinberg I, 2003, SLEEP, V26, P192, DOI 10.1093/sleep/26.2.192; FEINBERG I, 1979, PSYCHOPHYSIOLOGY, V16, P283, DOI 10.1111/j.1469-8986.1979.tb02991.x; Finelli LA, 2001, NEUROPSYCHOPHARMACOL, V25, pS57, DOI 10.1016/S0893-133X(01)00320-7; Goutagny R, 2004, ARCH ITAL BIOL, V142, P487; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Horowitz TS, 2003, PSYCHOL SCI, V14, P549, DOI 10.1046/j.0956-7976.2003.psci_1464.x; KERKHOF GA, 1991, ELECTROEN CLIN NEURO, V78, P197, DOI 10.1016/0013-4694(91)90033-Z; Krauchi K, 1997, J APPL PHYSIOL, V83, P134, DOI 10.1152/jappl.1997.83.1.134; Leclercq Y, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/598206; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; Mongrain V, 2006, EUR J NEUROSCI, V23, P497, DOI 10.1111/j.1460-9568.2005.04561.x; Mongrain V, 2007, SLEEP, V30, P773, DOI 10.1093/sleep/30.6.773; Peyron C, 1998, J NEUROSCI, V18, P9996; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Roberts KL, 2008, J COGNITIVE NEUROSCI, V20, P1063, DOI 10.1162/jocn.2008.20074; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Sagaspe P, 2006, BRAIN COGNITION, V60, P76, DOI 10.1016/j.bandc.2005.10.001; Salomon RM, 2003, BIOL PSYCHIAT, V54, P96, DOI 10.1016/S0006-3223(02)01740-7; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Schmidt C, 2009, SCIENCE, V324, P516, DOI 10.1126/science.1167337; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Van Dongen HPA, 2004, SLEEP, V27, P423; Vandewalle G, 2009, J NEUROSCI, V29, P7948, DOI 10.1523/JNEUROSCI.0229-09.2009; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x; Zeitzer JM, 2003, J NEUROSCI, V23, P3555; Zhang SW, 2004, SLEEP, V27, P619, DOI 10.1093/sleep/27.4.619	48	49	49	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29658	10.1371/journal.pone.0029658	http://dx.doi.org/10.1371/journal.pone.0029658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	902VE	22238632	Green Published, gold			2022-12-27	WOS:000301070200040
J	Brennan, ML; Christley, RM				Brennan, Marnie L.; Christley, Robert M.			Biosecurity on Cattle Farms: A Study in North-West England	PLOS ONE			English	Article							BOVINE TUBERCULOSIS; ZOONOTIC AGENTS; DISEASE; MANAGEMENT; BIOCONTAINMENT; SHEEP; RISK; EPIDEMIC; EFFICACY; HAZARDS	Background: Few studies have considered in detail the range of biosecurity practices undertaken on cattle farms, particularly within the UK. In this study, 56 cattle farmers in a 100 km 2 area of north-west England were questioned regarding their on-farm biosecurity practices, including those relating to animal movements, equipment sharing and companies and contractors visiting the farms. Methodology/Principal Findings: There was great variation between farms in terms of the type of, and extent to which, biosecurity was carried out. For example, the majority of farmers did not isolate stock bought onto the farm, but a small proportion always isolated stock. Many farmers administered treatments post-movement, primarily vaccinations and anthelmintics, but very few farms reported carrying out any health checks after moving animals on. In addition, there appeared to be much variation in the amount of biosecurity carried out by the different companies and contractors visiting the farms. Deadstock collectors and contracted animal waste spreaders, although likely to have a high potential for contact with infectious agents, were reported to infrequently disinfect themselves and their vehicles. Conclusions/Significance: These findings suggest that although certain biosecurity practices are undertaken, many are carried out infrequently or not at all. This may be due to many factors, including cost (in time and money), lack of proven efficacies of practices and lack of relevant education of veterinary surgeons, producers and other herd health specialists. Further research exploring the reasons for the lack of uptake is imperative if preventive medicine is to be utilised fully by the farming industry.	[Brennan, Marnie L.; Christley, Robert M.] Univ Liverpool, Fac Hlth & Life Sci, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Brennan, ML (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Sutton Bonington Campus, Loughborough, Leics, England.	marnie.brennan@nottingham.ac.uk	Brennan, Marnie/H-2351-2011	Brennan, Marnie/0000-0002-4893-6583; Christley, Robert/0000-0001-9250-3032	Department for Environment, Food and Rural Affairs (DEFRA); Higher Education Funding Council for England (HEFCE) [VTRI VT0103]	Department for Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE))	This project was funded by the Department for Environment, Food and Rural Affairs (DEFRA) and by the Higher Education Funding Council for England (HEFCE) under grant VTRI VT0103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amass SF, 2000, SWINE HEALTH PROD, V8, P169; Anderson J. F., 1998, Bovine Practitioner, V32, P61; [Anonymous], 2005, VET REC, V157, P461; [Anonymous], 2007, VET REC, V161, P324; BAMN/APHIS website, 2001, INTR INF DIS CONTR F; Barrington GM, 2006, SMALL RUMINANT RES, V61, P217, DOI 10.1016/j.smallrumres.2005.07.011; Barrington GM, 2002, VET CLIN N AM-FOOD A, V18, P7, DOI 10.1016/S0749-0720(02)00005-1; Bazeley K., 2009, UK Vet: Livestock, V14, P42, DOI 10.1111/j.2044-3870.2009.tb00219.x; Behnke M, 2008, THESIS U LIVERPOOL; Boklund A, 2004, PREV VET MED, V66, P49, DOI 10.1016/j.prevetmed.2004.08.004; Brandt AW, 2008, JAVMA-J AM VET MED A, V232, P262, DOI 10.2460/javma.232.2.262; Brennan ML, 2008, PREV VET MED, V84, P242, DOI 10.1016/j.prevetmed.2007.12.009; Caldow G, 2004, CATTLE PRACT, V12, P149; Caldow G. L., 1998, Cattle Practice, V6, P175; Crawshaw M, 2002, T502 SCOTT AGR COLL; Davison HC, 2003, CATTLE PRACT, V11, P299; DEFRA Archive website, 2009, TB CATTL RED RISK; DEFRA Archive website, 2003, BIOS GUID PREV SPREA; DEFRA Archive website, 2007, IND EV BAS FARM HLTH; DEFRA Archive website, 2007, BOV TB DO YOU KNOW R; DEFRA Archive website, 2002, BETT BIOS PROV PEAC; DEFRA Archive website, 2007, FACT SHEET 2 BIOS PR; Duncan A. L., 1990, In Practice, V12, P29; Elbers ARW, 1999, PREV VET MED, V42, P157, DOI 10.1016/S0167-5877(99)00074-4; Ellis-Iversen J, 2008, VET RES, V39, DOI 10.1051/vetres:2007041; Enticott G, 2008, ENVIRON PLANN A, V40, P1568, DOI 10.1068/a40304; Ganter M, 2008, SMALL RUMINANT RES, V76, P55, DOI 10.1016/j.smallrumres.2007.12.023; Gunn GJ, 2008, PREV VET MED, V84, P310, DOI 10.1016/j.prevetmed.2007.12.003; Gunn GJ, 2004, VET J, V167, P143, DOI 10.1016/S1090-0233(03)00112-6; Hoe FGH, 2006, J DAIRY SCI, V89, P2297, DOI 10.3168/jds.S0022-0302(06)72301-3; Hosie B, 2007, IN PRACTICE, V29, P246; Hovi M, 2005, RES VET SCI, V78, P24; Hutchison ML, 2005, J APPL MICROBIOL, V99, P354, DOI 10.1111/j.1365-2672.2005.02591.x; Hutchison ML, 2005, J APPL MICROBIOL, V99, P58, DOI 10.1111/j.1365-2672.2005.02585.x; JONES PW, 1980, VET REC, V106, P4, DOI 10.1136/vr.106.1.4; Leonard N, 2001, IRISH VET J, V54, P454; Lightner DV, 2005, J WORLD AQUACULT SOC, V36, P229, DOI 10.1111/j.1749-7345.2005.tb00328.x; MAFF/DEFRA Archive website, 2002, FARM BIOS PROT HLTH; Maunsell F, 2008, VET CLIN N AM-FOOD A, V24, P155, DOI 10.1016/j.cvfa.2007.10.007; Menzies FD, 2005, CATTLE PRACT, V13, P441; Moore DA, 2008, JAVMA-J AM VET MED A, V233, P249, DOI 10.2460/javma.233.2.249; Morley PS, 2005, JAVMA-J AM VET MED A, V226, P2053, DOI 10.2460/javma.2005.226.2053; Mort M, 2005, BRIT MED J, V331, P1234, DOI 10.1136/bmj.38603.375856.68; Nerlich B, 2006, ENVIRON VALUE, V15, P441, DOI 10.3197/096327106779116168; Noremark M, 2010, TRANSBOUND EMERG DIS, V57, P225, DOI 10.1111/j.1865-1682.2010.01140.x; Pell AN, 1997, J DAIRY SCI, V80, P2673, DOI 10.3168/jds.S0022-0302(97)76227-1; Pritchard G, 2005, IN PRACTICE, V27, P230; Pritchard G. C., 1996, Cattle Practice, V4, P253; Ribbens S, 2008, PREV VET MED, V83, P228, DOI 10.1016/j.prevetmed.2007.07.009; Robinson SE, 2007, J R SOC INTERFACE, V4, P669, DOI 10.1098/rsif.2007.0214; Scott PR, 2007, VET J, V173, P522, DOI 10.1016/j.tvjl.2006.02.007; Sibley R, 2010, IN PRACTICE, V32, P274, DOI 10.1136/inp.c3913; Smith DR, 1999, P 3 ANN PROF DAIR HE, P87; Smith KA, 2001, SOIL USE MANAGE, V17, P77, DOI 10.1111/j.1475-2743.2001.tb00012.x; Stott AW, 2008, PREV VET MED, V84, P179, DOI 10.1016/j.prevetmed.2007.12.001; Stott AW, 2003, PREV VET MED, V59, P51, DOI 10.1016/S0167-5877(03)00062-X; STRAUCH D, 1994, J VET MED B, V41, P176, DOI 10.1111/j.1439-0450.1994.tb00222.x; Talafha AQ, 2008, TROPICAL ANIMAL HLTH, V41, P499; Thomson JU, 1999, ANN M LIV CONS I NAS, P49; Troutt H. Fred, 2008, Bovine Practitioner, V42, P56; University Of Reading Scottish Agricultural College, 2003, PROJ OZ0144 CONSTR U, P1; van Schaik G, 2001, PREV VET MED, V51, P289, DOI 10.1016/S0167-5877(01)00224-0; van Schaik G, 1998, VET REC, V142, P240, DOI 10.1136/vr.142.10.240; Van Steenwinkel S, 2011, PREV VET MED, V98, P259, DOI 10.1016/j.prevetmed.2010.12.004; Van Winden S, 2008, IN PRACTICE, V30, P30, DOI 10.1136/inpract.30.1.30; Villarroel A, 2007, JAVMA-J AM VET MED A, V230, P808, DOI 10.2460/javma.230.6.808; Ward AI, 2006, ANIM SCI, V82, P767, DOI 10.1017/ASC2006102; Wells SJ, 2000, J DAIRY SCI, V83, P2380, DOI 10.3168/jds.S0022-0302(00)75127-7; Wells SJ, 2002, VET CLIN N AM-FOOD A, V18, P35, DOI 10.1016/S0749-0720(02)00007-5; Woodroffe R, 2006, P NATL ACAD SCI USA, V103, P14713, DOI 10.1073/pnas.0606251103	70	74	75	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28139	10.1371/journal.pone.0028139	http://dx.doi.org/10.1371/journal.pone.0028139			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235244	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400005
J	Wang, DQ; Tang, LH; Gu, ZC; Zheng, X; Yang, MN; Jiang, WK				Wang Duo-quan; Tang Lin-hua; Gu Zhen-cheng; Zheng Xiang; Yang Man-ni; Jiang Wei-kang			Comparative Evaluation of Light-Trap Catches, Electric Motor Mosquito Catches and Human Biting Catches of Anopheles in the Three Gorges Reservoir	PLOS ONE			English	Article							SAMPLING MALARIA VECTORS; HUMAN LANDING CATCH; WESTERN KENYA; MBITA TRAP; COLLECTIONS; CULICIDAE; TANZANIA; DIPTERA; INDOORS; GAMBIA	The mosquito sampling efficiency of light-trap catches and electric motor mosquito catches were compared with that of human biting catches in the Three Gorges Reservoir. There was consistency in the sampling efficiency between light-trap catches and human biting catches for Anopheles sinensis (r = 0.82, P < 0.01) and light-trap catches were 1.52 (1.35-1.71) times that of human biting catches regardless of mosquito density (r = 0.33, P > 0.01), while the correlation between electric motor mosquito catches and human biting catches was found to be not statistically significant (r = 0.43, P > 0.01) and its sampling efficiency was below that of human biting catches. It is concluded that light-traps can be used as an alternative to human biting catches of Anopheles sinensis in the study area and is a promising tool for sampling malaria vector populations.	[Wang Duo-quan; Tang Lin-hua; Gu Zhen-cheng; Zheng Xiang; Yang Man-ni; Jiang Wei-kang] WHO Collaborating Ctr Malaria Schistosomiasis & F, Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; World Health Organization	Wang, DQ (corresponding author), WHO Collaborating Ctr Malaria Schistosomiasis & F, Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai, Peoples R China.	ipdtlh@sh163.net.cn						ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Costantini C, 1998, B ENTOMOL RES, V88, P503, DOI 10.1017/S000748530002602X; DAVIS JR, 1995, MED VET ENTOMOL, V9, P249, DOI 10.1111/j.1365-2915.1995.tb00130.x; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; Githeko AK, 1996, PARASITOL TODAY, V12, P127, DOI 10.1016/0169-4758(96)30001-X; Hii J., 1986, Tropical Biomedicine, V3, P39; Knols BGJ, 1995, T ROY SOC TROP MED H, V89, P604, DOI 10.1016/0035-9203(95)90406-9; LINDSAY SW, 1993, J MED ENTOMOL, V30, P368, DOI 10.1093/jmedent/30.2.368; LINES JD, 1991, B ENTOMOL RES, V81, P77, DOI 10.1017/S0007485300053268; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; MARQUETTI MD, 1992, MEM I OSWALDO CRUZ, V87, P457, DOI 10.1590/S0074-02761992000300023; Mathenge EM, 2002, MED VET ENTOMOL, V16, P67, DOI 10.1046/j.0269-283x.2002.00350.x; Mathenge EM, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-7; Mathenge EM, 2004, AM J TROP MED HYG, V70, P33, DOI 10.4269/ajtmh.2004.70.33; Mbogo CNM, 1999, J AM MOSQUITO CONTR, V3 9, P260; Ministry of Health Disease Prevention and Control Bureau, 2007, HDB MAL CONTR PREV; ODETOYINBO JA, 1969, B WORLD HEALTH ORGAN, V40, P547; RubioPalis Y, 1996, J AM MOSQUITO CONTR, V12, P91; SERVICE MW, 1977, B ENTOMOL RES, V67, P343, DOI 10.1017/S0007485300011184; SHIFF CJ, 1995, MED VET ENTOMOL, V9, P256, DOI 10.1111/j.1365-2915.1995.tb00131.x; Wang DQ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-199; WHO Division of Malaria and Other Parasitic Diseases, 1975, MAN PRACT ENT MAL 2; Wu, 2007, J TROP DIS PARASITOL, V5, P73; ZAIM M, 1986, J AM MOSQUITO CONTR, V2, P511	24	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28988	10.1371/journal.pone.0028988	http://dx.doi.org/10.1371/journal.pone.0028988			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235256	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400017
J	Wade, JJ; McDaid, LJ; Harkin, J; Crunelli, V; Kelso, JAS				Wade, John J.; McDaid, Liam J.; Harkin, Jim; Crunelli, Vincenzo; Kelso, J. A. Scott			Bidirectional Coupling between Astrocytes and Neurons Mediates Learning and Dynamic Coordination in the Brain: A Multiple Modeling Approach	PLOS ONE			English	Article							LESS-THAN-0.1 HZ OSCILLATIONS; LONG-TERM POTENTIATION; SYNAPTIC-TRANSMISSION; CALCIUM OSCILLATIONS; GLIAL-CELLS; HIPPOCAMPAL-NEURONS; NMDA RECEPTORS; IN-SITU; GLUTAMATE; CA2+	In recent years research suggests that astrocyte networks, in addition to nutrient and waste processing functions, regulate both structural and synaptic plasticity. To understand the biological mechanisms that underpin such plasticity requires the development of cell level models that capture the mutual interaction between astrocytes and neurons. This paper presents a detailed model of bidirectional signaling between astrocytes and neurons (the astrocyte-neuron model or AN model) which yields new insights into the computational role of astrocyte-neuronal coupling. From a set of modeling studies we demonstrate two significant findings. Firstly, that spatial signaling via astrocytes can relay a "learning signal" to remote synaptic sites. Results show that slow inward currents cause synchronized postsynaptic activity in remote neurons and subsequently allow Spike-Timing-Dependent Plasticity based learning to occur at the associated synapses. Secondly, that bidirectional communication between neurons and astrocytes underpins dynamic coordination between neuron clusters. Although our composite AN model is presently applied to simplified neural structures and limited to coordination between localized neurons, the principle (which embodies structural, functional and dynamic complexity), and the modeling strategy may be extended to coordination among remote neuron clusters.	[Wade, John J.; McDaid, Liam J.; Harkin, Jim; Kelso, J. A. Scott] Univ Ulster, Sch Comp & Intelligent Syst, Intelligent Syst Res Ctr, Derry, North Ireland; [Crunelli, Vincenzo] Univ Cardiff, Cardiff Sch Biosci, Neurosci Div, Cardiff, S Glam, Wales; [Kelso, J. A. Scott] Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA	Ulster University; Cardiff University; State University System of Florida; Florida Atlantic University	Wade, JJ (corresponding author), Univ Ulster, Sch Comp & Intelligent Syst, Intelligent Syst Res Ctr, Derry, North Ireland.	jj.wade@ulster.ac.uk	; Harkin, Jim/F-8958-2013	Crunelli, Vincenzo/0000-0001-7154-9752; Harkin, Jim/0000-0001-7484-8205; Wade, John Joseph/0000-0003-1300-9429	Intelligent Systems Research Centre under the Centre of Excellence in Intelligent Systems; Integrated Development Fund; InvestNI; Wellcome Trust [91882]; MRC [900671]; European Union [Health F2-2007-202167]; NIMH [080838]; NSF [BCS0826897]; US ONR [N000140510117]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080838] Funding Source: NIH RePORTER	Intelligent Systems Research Centre under the Centre of Excellence in Intelligent Systems; Integrated Development Fund; InvestNI; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSF(National Science Foundation (NSF)); US ONR(Office of Naval Research); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Intelligent Systems Research Centre under the Centre of Excellence in Intelligent Systems grant, funded by the Integrated Development Fund and InvestNI. VC is supported by The Wellcome Trust (grant 91882), the MRC (900671) and the European Union (Health F2-2007-202167). JASK is supported by NIMH grant 080838, NSF grant BCS0826897 and US ONR award N000140510117. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Aguado F, 2002, J NEUROSCI, V22, P9430; Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Alger BE, 2002, PROG NEUROBIOL, V68, P247; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Bacci A, 1999, PHILOS T R SOC B, V354, P403, DOI 10.1098/rstb.1999.0393; Badel L, 2008, J NEUROPHYSIOL, V99, P656, DOI 10.1152/jn.01107.2007; Basar E, 2004, CONC ADV BRAIN RES, P153; Benuskova L, 2007, NEUROCOMPUTING, V70, P2035, DOI 10.1016/j.neucom.2006.10.133; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Bonansco C, 2011, EUR J NEUROSCI, V33, P1483, DOI 10.1111/j.1460-9568.2011.07631.x; Bugmann G, 1997, BIOSYSTEMS, V40, P11, DOI 10.1016/0303-2647(96)01625-5; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Buszsaki G, 2006, RHYTHMS BRAIN, P111; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Corlew R, 2008, NEUROSCIENTIST, V14, P609, DOI 10.1177/1073858408322675; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; De Pitta M, 2009, J BIOL PHYS, V35, P383, DOI 10.1007/s10867-009-9155-y; De Pitta M, 2009, COGN PROCESS, V10, pS55, DOI 10.1007/s10339-008-0242-y; De Pitta M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.030903; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Dupont G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004226; Engel A.K., 2010, DYNAMIC COORDINATION, P267; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fellin T, 2006, PHYSIOLOGY, V21, P208, DOI 10.1152/physiol.00161.2005; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fuhrmann G, 2002, J NEUROPHYSIOL, V87, P140, DOI 10.1152/jn.00258.2001; Fukaya M, 2006, EUR J NEUROSCI, V24, P2177, DOI 10.1111/j.1460-9568.2006.05081.x; Gerstner W, 2002, BIOL CYBERN, V87, P404, DOI 10.1007/s00422-002-0353-y; Gerstner W, 2002, SPIKING NEURON MODEL; Gerstner W, 2009, SCIENCE, V326, P379, DOI 10.1126/science.1181936; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Goldberg M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000909; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Gordon GRJ, 2005, NAT NEUROSCI, V8, P1078, DOI 10.1038/nn1498; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Hebb DO, 1949, ORG BEHAVIOR, P62; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hennequin G, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00143; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hughes SW, 2011, PROG BRAIN RES, V193, P145, DOI 10.1016/B978-0-444-53839-0.00010-7; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; JAHR CE, 1990, J NEUROSCI, V10, P3178; Jolivet R, 2006, J COMPUT NEUROSCI, V21, P35, DOI 10.1007/s10827-006-7074-5; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kaneoke Y, 1996, J NEUROSCI METH, V68, P211, DOI 10.1016/0165-0270(96)00081-7; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kazantsev VB, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.010901; KEIZER J, 1995, MOL BIOL CELL, V6, P945, DOI 10.1091/mbc.6.8.945; Kelso JAS, 1995, DYNAMIC PATTERNS SEL, P218; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kopach O, 2011, PAIN, V152, P912, DOI 10.1016/j.pain.2011.01.016; Kuga N, 2011, J NEUROSCI, V31, P2607, DOI 10.1523/JNEUROSCI.5319-10.2011; Kurosinski P, 2002, ARCH NEUROL-CHICAGO, V59, P1524, DOI 10.1001/archneur.59.10.1524; Larkman AU, 1997, J PHYSIOL-LONDON, V505, P457, DOI 10.1111/j.1469-7793.1997.457bb.x; LI YX, 1994, J THEOR BIOL, V166, P461, DOI 10.1006/jtbi.1994.1041; Lorincz ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004447; Maass W, 1999, NEURAL COMPUT, V11, P903, DOI 10.1162/089976699300016494; Macdonald Christopher L, 2008, Front Neuroeng, V1, P1, DOI 10.3389/neuro.16.001.2008; Marchant J, 1999, EMBO J, V18, P5285, DOI 10.1093/emboj/18.19.5285; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Matrosov VV, 2011, CHAOS, V21, DOI 10.1063/1.3574031; Matveev V, 2000, J NEUROSCI, V20, P1575; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Nadkarni S, 2004, PHYS BIOL, V1, P35, DOI 10.1088/1478-3967/1/1/004; Nadkarni S, 2007, PHYS BIOL, V4, P1, DOI 10.1088/1478-3975/4/1/001; Nadkarni S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000983; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Nimmerjahn A, 2009, NEURON, V62, P400, DOI 10.1016/j.neuron.2009.03.019; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasti L, 2001, J NEUROSCI, V21, P477, DOI 10.1523/JNEUROSCI.21-02-00477.2001; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Phillips WA, 2010, DYNAMIC COORDINATION, P1; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Roberts PD, 2002, BIOL CYBERN, V87, P392, DOI 10.1007/s00422-002-0361-y; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Smith K, 2010, NATURE, V468, P160, DOI 10.1038/468160a; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stamatakis M, 2006, J THEOR BIOL, V241, P649, DOI 10.1016/j.jtbi.2006.01.002; Takata N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002525; Thul R, 2009, CELLULAR OSCILLATORY, P1; Tognoli E, 2009, PROG NEUROBIOL, V87, P31, DOI 10.1016/j.pneurobio.2008.09.014; Toivari E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017914; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Volman V, 2007, NEURAL COMPUT, V19, P303, DOI 10.1162/neco.2007.19.2.303; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wade JJ, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P3149, DOI 10.1109/IJCNN.2011.6033638; Wade JJ, 2010, IEEE T NEURAL NETWOR, V21, P1817, DOI 10.1109/TNN.2010.2074212; Wang DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007486; Wang HM, 2008, CURR BIOL, V18, P1546, DOI 10.1016/j.cub.2008.08.064; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Weerth SH, 2007, CELL CALCIUM, V41, P155, DOI 10.1016/j.ceca.2006.06.006; Wenker I, 2010, J NEUROPHYSIOL, V104, P1216, DOI 10.1152/jn.00429.2010; Xi Q, 2011, AM J PHYSIOL-HEART C, V301, pH428, DOI 10.1152/ajpheart.01277.2010; Zur Nieden R, 2006, CEREB CORTEX, V16, P676, DOI 10.1093/cercor/bhj013	119	82	84	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29445	10.1371/journal.pone.0029445	http://dx.doi.org/10.1371/journal.pone.0029445			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242121	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000300677000033
J	Yamamoto, Y; Yokoyama, K				Yamamoto, Yuji; Yokoyama, Keiko			Common and Unique Network Dynamics in Football Games	PLOS ONE			English	Article							SELF-ORGANIZED CRITICALITY; EVOLUTION; SYSTEMS	The sport of football is played between two teams of eleven players each using a spherical ball. Each team strives to score by driving the ball into the opposing goal as the result of skillful interactions among players. Football can be regarded from the network perspective as a competitive relationship between two cooperative networks with a dynamic network topology and dynamic network node. Many complex large-scale networks have been shown to have topological properties in common, based on a small-world network and scale-free network models. However, the human dynamic movement pattern of this network has never been investigated in a real-world setting. Here, we show that the power law in degree distribution emerged in the passing behavior in the 2006 FIFA World Cup Final and an international "A'' match in Japan, by describing players as vertices connected by links representing passes. The exponent values gamma similar to 3.1 are similar to the typical values that occur in many real-world networks, which are in the range of 2<gamma<3, and are larger than that of a gene transcription network, gamma similar to 1. Furthermore, we reveal the stochastically switched dynamics of the hub player throughout the game as a unique feature in football games. It suggests that this feature could result not only in securing vulnerability against intentional attack, but also in a power law for self-organization. Our results suggest common and unique network dynamics of two competitive networks, compared with the large-scale networks that have previously been investigated in numerous works. Our findings may lead to improved resilience and survivability not only in biological networks, but also in communication networks.	[Yamamoto, Yuji] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Yamamoto, Yuji] Nagoya Univ, Dept Psychol & Human Dev Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Yokoyama, Keiko] Hokkaido Univ, Fac Engn, Div Appl Phys, Kita Ku, Sapporo, Hokkaido 060, Japan; [Yokoyama, Keiko] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	Nagoya University; Nagoya University; Hokkaido University; Japan Society for the Promotion of Science	Yamamoto, Y (corresponding author), Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	yamamoto@htc.nagoya-u.ac.jp			Japan Society for the Promotion of Science [20240060]; Grants-in-Aid for Scientific Research [20240060] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work has been supported in part by Grant-in-Aid for Scientific Research (A) 20240060 from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; BAK P, 1989, NATURE, V342, P780, DOI 10.1038/342780a0; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; Bornholdt S, 2000, PHYS REV LETT, V84, P6114, DOI 10.1103/PhysRevLett.84.6114; Bornholdt S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.066118; Christensen K, 1998, PHYS REV LETT, V81, P2380, DOI 10.1103/PhysRevLett.81.2380; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Gohara K, 1999, FRACTALS, V7, P205, DOI 10.1142/S0218348X99000220; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Herrmann C, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026128; Ito J, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.046226; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Li C, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.035322; Madhavan R, 2004, ACAD MANAGE J, V47, P918, DOI 10.2307/20159631; Meisel C, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061917; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nishikawa J, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036210; Nishikawa J, 2008, INT J BIFURCAT CHAOS, V18, P3665, DOI 10.1142/S0218127408022639; Park K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026131; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Rho K, 2006, PHYSICA A, V364, P557, DOI 10.1016/j.physa.2005.08.086; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Tang HW, 2008, PHYSICA A, V387, P5623, DOI 10.1016/j.physa.2008.05.047; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu XQ, 2009, CHAOS, V19, DOI 10.1063/1.3072787; Yamamoto Y, 2000, HUM MOVEMENT SCI, V19, P341, DOI 10.1016/S0167-9457(00)00018-X; Yokoyama K, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002181	34	56	58	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29638	10.1371/journal.pone.0029638	http://dx.doi.org/10.1371/journal.pone.0029638			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216336	Green Published, Green Submitted, gold			2022-12-27	WOS:000300676300076
J	Ludt, S; Wensing, M; Szecsenyi, J; van Lieshout, J; Rochon, J; Freund, T; Campbell, SM; Ose, D				Ludt, Sabine; Wensing, Michel; Szecsenyi, Joachim; van Lieshout, Jan; Rochon, Justine; Freund, Tobias; Campbell, Stephen M.; Ose, Dominik			Predictors of Health-Related Quality of Life in Patients at Risk for Cardiovascular Disease in European Primary Care	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; MEDICATION ADHERENCE; PREVENTION; MANAGEMENT; EQ-5D; OUTCOMES; POPULATION; INDICATORS; GUIDELINES	Background: Cardiovascular risk management plays an important role in primary care. In patients at high risk for cardiovascular diseases (CVD) lifestyle and, where appropriate, medical interventions are recommended in guidelines. Health-related quality of life (HRQoL) is an important outcome in clinical practice. This study aimed to assess the HRQoL of this patient group and to investigate the impact of both patients' characteristics and practice quality scores on their assessments of HRQoL. Methods and Findings: An observational study in 218 general practices from 8 European countries was conducted. 2142 patients at risk for CVD (33.5% female) with a mean age of 66.3 (SD 9.1) years completed a questionnaire including the EQ-5D instrument and provided data from medical record. Validated quality indicators of general practices were assessed using practice questionnaires and face-to-face interviews. A hierarchical multilevel analysis was performed to identify predictors of EQ-5D scores at patient and practice level. The mean EQ-5D score was 0.78 (SD 0.19). Female gender (r = -0.03, p < 0.0016), age (r = -0.01, p = 0.0387) and lower educational level (r = -0.03, p < 0.0001) were correlated negatively with EQ-5D scores. Clinically more important was the correlation of HRQoL with the frequency of practice contacts (r = -0.12, p < 0.0001) and the number of uncontrolled risk factors (r = -0.01, p < 0.0039). Medication adherence (r = 0.032, p < 0.0001), and physical activity (r = 0.02, p < 0.0001) were identified as positive predictors of HRQoL. The EUPROPEP-score category 'organization' (r = 0.02, p < 0.0001) was positively related to EQ-5D scores, whereas other practice scores were not correlated to EQ-5D-scores. Conclusions: In patients at risk for CVD, good medication adherence, regular physical activity, controlling of biomedical risk factor levels and patient-centered practice organization have been shown to be positively correlated to HRQoL and should therefore be targeted in interventions not only to reduce morbidity but also to sustain or even to ameliorate HRQoL.	[Ludt, Sabine; Szecsenyi, Joachim; Freund, Tobias; Campbell, Stephen M.; Ose, Dominik] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany; [Wensing, Michel; van Lieshout, Jan] Radboud Univ Nijmegen, Sci Inst Qual Healthcare, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Rochon, Justine] Univ Heidelberg Hosp, Inst Med Biometry & Informat, Heidelberg, Germany; [Campbell, Stephen M.] Univ Manchester, Hlth Sci Primary Care Grp, Manchester, Lancs, England	Ruprecht Karls University Heidelberg; Radboud University Nijmegen; Ruprecht Karls University Heidelberg; University of Manchester	Ludt, S (corresponding author), Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany.	sabine.ludt@med.uni-heidelberg.de	Van Lieshout, J./L-4490-2015; Wensing, Michel/H-8113-2014; Ose, Dominik J/F-7691-2013; Ose, Dominik/L-4250-2019	Wensing, Michel/0000-0001-6569-8137; Ose, Dominik J/0000-0002-5079-2152; Ose, Dominik/0000-0002-5079-2152; Campbell, Stephen/0000-0002-2328-4136	EPA; Radboud University Nijmegen (The Netherlands)	EPA(United States Environmental Protection Agency); Radboud University Nijmegen (The Netherlands)(Netherlands Government)	The Bertelsmann Foundation (Gutersloh, Germany) initiated, coordinated, and funded the EPA Cardio project, in collaboration with IQ Healthcare of the Radboud University Nijmegen (The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye NK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-624; Bize R, 2007, PREV MED, V45, P401, DOI 10.1016/j.ypmed.2007.07.017; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Campbell SM, 2008, EUR J CARDIOV PREV R, V15, P509, DOI 10.1097/HJR.0b013e328302f44d; Davis PD, 1995, SURV METHODOL, V21, P99; DRAPER D, 1995, J EDUC BEHAV STAT, V20, P115, DOI 10.3102/10769986020002115; Dyer MTD, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-13; Engels Y, 2006, FAM PRACT, V23, P137, DOI 10.1093/fampra/cmi091; Fahey T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub3; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; Francis K, 1996, PHYS THER, V76, P456, DOI 10.1093/ptj/76.5.456; Gemmell I, 2006, QUAL SAF HEALTH CARE, V15, P339, DOI 10.1136/qshc.2005.017061; Goldsmith KA, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-96; Goldsmith KA, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-54; Govil SR, 2009, AM J PUBLIC HEALTH, V99, P1263, DOI 10.2105/AJPH.2007.132852; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Greiner Wolfgang, 2003, Eur J Health Econ, V4, P222, DOI 10.1007/s10198-003-0182-5; Ho PM, 2008, AM HEART J, V155, P772, DOI 10.1016/j.ahj.2007.12.011; Holt EW, 2010, AGE AGEING, V39, P481, DOI 10.1093/ageing/afq040; Jayasinghe UW, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-50; Jerant A, 2008, QUAL LIFE RES, V17, P1195, DOI 10.1007/s11136-008-9401-y; Krousel-Wood M, 2004, CURR OPIN CARDIOL, V19, P357, DOI 10.1097/01.hco.0000126978.03828.9e; Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733; Ludt S, 2011, EUR J CARDIOVAS 0304; Ludt S, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-70; McElduff P, 2004, QUAL SAF HEALTH CARE, V13, P191, DOI 10.1136/qshc.2003.007401; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Munger Mark A, 2007, MedGenMed, V9, P58; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Quercioli C, 2009, EUR J HEALTH ECON, V10, P389, DOI 10.1007/s10198-008-0139-9; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Salisbury C, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5004; Schroeder K, 2008, COCHRANE DB SYST REV; Segal-Isaacson CJ, 2004, DIABETES EDUCATOR, V30, P774, DOI 10.1177/014572170403000512; Swenson JR, 2000, J PSYCHOSOM RES, V48, P405, DOI 10.1016/S0022-3999(99)00092-6; Szecsenyi J, 2008, DIABETES CARE, V31, P1150, DOI 10.2337/dc07-2104; Topolski T. D., 2006, Preventing Chronic Disease, V3, pA118; Tsai AC, 2005, AM J MANAG CARE, V11, P478; van Lieshout J, 2009, AM J MANAG CARE, V15, P255; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; WENGER NK, 1984, AM J CARDIOL, V54, P908, DOI 10.1016/S0002-9149(84)80232-5; Wensing M, 2000, EUROPEAN J GEN PRACT, V6, P82, DOI DOI 10.3109/13814780009069953; Wensing M, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-3; Westin L, 2005, SCAND CARDIOVASC J, V39, P50, DOI 10.1080/14017430410003903; WHO, 2009, EUROPEAN HEALTH REPORT 2009: HEALTH AND HEALTH SYSTEMS, P1; WHO, 2008, PHARMAFORUM 0121; Williams GC, 2005, ANN BEHAV MED, V29, P11, DOI 10.1207/s15324796abm2902s_4; Xie JP, 2008, CIRCULATION, V118, P491, DOI 10.1161/CIRCULATIONAHA.107.752006; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	50	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29334	10.1371/journal.pone.0029334	http://dx.doi.org/10.1371/journal.pone.0029334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	884DI	22216250	Green Published, gold, Green Submitted			2022-12-27	WOS:000299684700049
J	Carrasco, NK; Perissinotto, R				Carrasco, Nicola K.; Perissinotto, Renzo			Development of a Halotolerant Community in the St. Lucia Estuary (South Africa) during a Hypersaline Phase	PLOS ONE			English	Article							SALTON-SEA MICROECOSYSTEMS; MESOPODOPSIS-AFRICANA; CYCLOPOID COPEPODS; CLIMATE EXTREMES; CALIFORNIA; SALINITY; FOOD; LAKE; DYNAMICS; DIAPAUSE	Background: The St. Lucia Estuary, Africa's largest estuarine lake, is currently experiencing unprecedented freshwater deprivation which has resulted in a northward gradient of drought effects, with hypersaline conditions in its northern lakes. Methodology/Principal Findings: This study documents the changes that occurred in the biotic communities at False Bay from May 2010 to June 2011, in order to better understand ecosystem functioning in hypersaline habitats. Few zooplankton taxa were able to withstand the harsh environmental conditions during 2010. These were the flatworm Macrostomum sp., the harpacticoid copepod Cletocamptus confluens, the cyclopoid copepod Apocyclops cf. dengizicus and the ciliate Fabrea cf. salina. In addition to their exceptional salinity tolerance, they were involved in a remarkably simple food web. In June 2009, a bloom of an orange-pigmented cyanobacterium (Cyanothece sp.) was recorded in False Bay and persisted uninterruptedly for 18 months. Stable isotope analysis suggests that this cyanobacterium was the main prey item of F. cf. salina. This ciliate was then consumed by A. cf. dengizicus, which in turn was presumably consumed by flamingos as they flocked in the area when the copepods attained swarming densities. On the shore, cyanobacteria mats contributed to a population explosion of the staphylinid beetle Bledius pilicollis. Although zooplankton disappeared once salinities exceeded 130, many taxa are capable of producing spores or resting cysts to bridge harsh periods. The hypersaline community was disrupted by heavy summer rains in 2011, which alleviated drought conditions and resulted in a sharp increase in zooplankton stock and diversity. Conclusions/Significance: Despite the current freshwater deprivation crisis, the False Bay region has shown to be resilient, harboring a unique biodiversity with species that are capable of enduring harsh environmental conditions. However, further freshwater deprivation may extend beyond the physiological thresholds of this community, as well as other unique biodiversity components which this system sustains.	[Carrasco, Nicola K.; Perissinotto, Renzo] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Durban, South Africa	University of Kwazulu Natal	Carrasco, NK (corresponding author), Univ KwaZulu Natal, Sch Biol & Conservat Sci, Westville Campus, Durban, South Africa.	nicola.carrasco@gmail.com			National Research Foundation (NRF); Marine and Coastal Management (DEAT-MCM, Cape Town); World Wide Fund (WWF)	National Research Foundation (NRF); Marine and Coastal Management (DEAT-MCM, Cape Town); World Wide Fund (WWF)	Funding for this project was provided by the National Research Foundation (NRF, Pretoria www.nrf.ac.za), Marine and Coastal Management (DEAT-MCM, Cape Town, www.mcmdeat.gov.za) and the World Wide Fund (WWF, www.wwf.org.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN R, 1993, J PLANKTON RES, V15, P643, DOI 10.1093/plankt/15.6.643; Alekseev Victor R., 2007, Monographiae Biologicae, V84, P65; [Anonymous], 1994, CHANGES MARINE COMMU; Begg G.M., 1978, 41 NAT TOWN REG PLAN; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bruton M.N., 1979, Lammergeyer, V27, P1; Carrasco NK, 2011, J PLANKTON RES, V33, P479, DOI 10.1093/plankt/fbq126; Carrasco NK, 2010, J EXP MAR BIOL ECOL, V396, P61, DOI 10.1016/j.jembe.2010.09.008; Carrasco NK, 2010, MAR ECOL PROG SER, V417, P127, DOI 10.3354/meps08799; Carrasco NK, 2010, MAR ECOL PROG SER, V399, P157, DOI 10.3354/meps08355; Caskey LL, 2007, HYDROBIOLOGIA, V576, P185, DOI 10.1007/s10750-006-0301-2; COUCH CA, 1989, ESTUAR COAST SHELF S, V28, P433, DOI 10.1016/0272-7714(89)90090-5; Cyrus Digby, 2006, African Journal of Aquatic Science, V31, P71, DOI 10.2989/16085910609503873; DEXTER DM, 1993, HYDROBIOLOGIA, V267, P203, DOI 10.1007/BF00018802; DYBDAHL MF, 1995, J EXP MAR BIOL ECOL, V192, P195, DOI 10.1016/0022-0981(95)00063-W; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Elloumi J, 2006, ESTUAR COAST SHELF S, V67, P21, DOI 10.1016/j.ecss.2005.10.011; Esteban GF, 2003, PROTIST, V154, P411, DOI 10.1078/143446103322454149; FIELDING PJ, 1991, S AFR J MARINE SCI, V11, P491, DOI 10.2989/025776191784287619; Gomez S, 1976, NITOCRA TAY IN PRESS; Grindley J.R., 1963, Annals of the South African Museum, V46, P373; Grindley J.R., 1981, P117; GRINDLEY J R, 1970, South African Journal of Science, V66, P210; Grindley J.R., 1982, ST LUCIA RES REV; Grindley JR, 1976, ST LUC SCI ADV COUNC; Guermazi W, 2008, CR BIOL, V331, P56, DOI 10.1016/j.crvi.2007.10.006; Gunde-Cimerman N, 2005, ADAPTATION LIFE HIGH; HAIRSTON NG, 1995, BIOL BULL, V189, P42, DOI 10.2307/1542200; Hammer UT., 1986, SALINE LAKE ECOSYSTE, P616; Hansen AM, 2000, J PLANKTON RES, V22, P185, DOI 10.1093/plankt/22.1.185; Hart CM, 1998, HYDROBIOLOGIA, V381, P129, DOI 10.1023/A:1003490215005; HERMAN LH, 1986, B AM MUS NAT HIST, V184, P1; Javor B, 1989, HYPERSALINE ENV MICR; JERLING HL, 1995, S AFR J MARINE SCI, V15, P169; Johansson M, 2004, J PLANKTON RES, V26, P67, DOI 10.1093/plankt/fbg115; KLEIVEN OT, 1992, OIKOS, V65, P197, DOI 10.2307/3545010; Lavens P., 1996, 361 FAO; MARCUS NH, 1982, BIOL BULL, V162, P45, DOI 10.2307/1540969; Moscatello Salvatore, 2009, Saline Syst, V5, P3, DOI 10.1186/1746-1448-5-3; Muir DG, 2011, APPL ENVIRON MICROB, V77, P5888, DOI 10.1128/AEM.00460-11; Nozais C, 2001, MAR ECOL PROG SER, V223, P39, DOI 10.3354/meps223039; PERISSINOTTO R, 1989, MAR ECOL-P S Z N I, V10, P205, DOI 10.1111/j.1439-0485.1989.tb00473.x; Pillay D, 2008, ESTUAR COAST SHELF S, V77, P35, DOI 10.1016/j.ecss.2007.09.004; SCHMIDTNIELSEN K, 1998, ANIMAL PHYSL ADAPTAT; Seaman M.T., 2001, GUIDES FRESHWATER IN, P81; Simpson EP, 1998, HYDROBIOLOGIA, V381, P153, DOI 10.1023/A:1003231708756; SLUSARCZYK M, 1995, ECOLOGY, V76, P1008, DOI 10.2307/1939364; Smith MD, 2011, J ECOL, V99, P651, DOI 10.1111/j.1365-2745.2011.01833.x; STOECKER DK, 1995, J PLANKTON RES, V17, P1105, DOI 10.1093/plankt/17.5.1105; Tiffany MA, 2002, HYDROBIOLOGIA, V473, P103, DOI 10.1023/A:1016529617757; Tiffany MA, 2007, LAKE RESERV MANAGE, V23, P606, DOI 10.1080/07438140709354040; TIMMS BV, 1987, AUST J MAR FRESH RES, V38, P877; Vivier L, 2010, ESTUAR COAST SHELF S, V86, P568, DOI 10.1016/j.ecss.2009.11.012; Wallace J.H., 1975, Investigational Rep oceanogr Res Inst Durban, VNo. 42, P1; Warren JK, 2006, EVAPORITES SEDIMENT, P617; WARWICK RM, 1986, MAR BIOL, V92, P557, DOI 10.1007/BF00392515; WHITFIELD A K, 1978, Environmental Biology of Fishes, V3, P293, DOI 10.1007/BF00001455; Whitfield AK, 2009, AQUAT CONSERV, V19, P838, DOI 10.1002/aqc.1061; WICKHAM SA, 1995, J PLANKTON RES, V17, P1633, DOI 10.1093/plankt/17.8.1633; WICKHAM SA, 1995, LIMNOL OCEANOGR, V40, P1173, DOI 10.4319/lo.1995.40.6.1173; WILLIAMSON CE, 1980, LIMNOL OCEANOGR, V25, P903; Yemani D, 1995, J MAR SCI, V62, P374	62	53	54	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29927	10.1371/journal.pone.0029927	http://dx.doi.org/10.1371/journal.pone.0029927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238676	Green Published, gold, Green Submitted			2022-12-27	WOS:000301188800048
J	Chamchod, F; Ruan, SG				Chamchod, Farida; Ruan, Shigui			Modeling the Spread of Methicillin-Resistant Staphylococcus aureus in Nursing Homes for Elderly	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; VANCOMYCIN-RESISTANT; ANTIBIOTIC-RESISTANCE; COLONIZATION; INFECTION; RESIDENTS; PREVALENCE; HOSPITALS; PATHOGENS; COMMUNITY	Methicillin-resistant Staphylococcus aureus (MRSA) is endemic in many hospital settings, including nursing homes. It is an important nosocomial pathogen that causes mortality and an economic burden to patients, hospitals, and the community. The epidemiology of the bacteria in nursing homes is both hospital-and community-like. Transmission occurs via hands of health care workers (HCWs) and direct contacts among residents during social activities. In this work, mathematical modeling in both deterministic and stochastic frameworks is used to study dissemination of MRSA among residents and HCWs, persistence and prevalence of MRSA in a population, and possible means of controlling the spread of this pathogen in nursing homes. The model predicts that: (i) without strict screening and decolonization of colonized individuals at admission, MRSA may persist; (ii) decolonization of colonized residents, improving hand hygiene in both residents and HCWs, reducing the duration of contamination of HCWs, and decreasing the resident: staff ratio are possible control strategies; (iii) the mean time that a resident remains susceptible since admission may be prolonged by screening and decolonization treatment in colonized individuals; (iv) in the stochastic framework, the total number of colonized residents varies and may increase when the admission of colonized residents, the duration of colonization, the average number of contacts among residents, or the average number of contacts that each resident requires from HCWs increases; (v) an introduction of a colonized individual into an MRSA-free nursing home has a much higher probability of leading to a major outbreak taking off than an introduction of a contaminated HCW.	[Chamchod, Farida; Ruan, Shigui] Univ Miami, Dept Math, Coral Gables, FL 33124 USA	University of Miami	Chamchod, F (corresponding author), Univ Miami, Dept Math, Coral Gables, FL 33124 USA.	ruan@math.miami.edu	Ruan, Shigui/AAF-9165-2020	Ruan, Shigui/0000-0002-6348-8205	National Institutes of Health [R01GM083607]; National Science Foundation [DMS-1022728]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health grant R01GM083607 and National Science Foundation grant DMS-1022728. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen BM, 2000, J HOSP INFECT, V46, P288, DOI 10.1053/jhin.2000.0840; Athreya KB, 1972, BRANCHING PROCESSES; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P6908, DOI 10.1073/pnas.96.12.6908; Baldwin NS, 2009, J AM GERIATR SOC, V57, P620, DOI 10.1111/j.1532-5415.2009.02181.x; Bradley SF, 1997, DRUG AGING, V10, P185, DOI 10.2165/00002512-199710030-00003; Brugnaro P, 2009, INFECTION, V37, P216, DOI 10.1007/s15010-008-8165-1; Chambers HF, 2009, NAT REV MICROBIOL, V298, P1763; COOKSON B, 1989, J CLIN MICROBIOL, V27, P1471, DOI 10.1128/JCM.27.7.1471-1476.1989; Cooper BS, 1999, J HOSP INFECT, V43, P131, DOI 10.1053/jhin.1998.0647; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; D'Agata EMC, 2005, J INFECT DIS, V192, P2004, DOI 10.1086/498041; D'Agata EMC, 2002, J INFECT DIS, V185, P766, DOI 10.1086/339293; D'Agata EMC, 2009, CLIN INFECT DIS, V48, P274, DOI 10.1086/595844; Datta R, 2008, CLIN INFECT DIS, V47, P176, DOI 10.1086/589241; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Emmerson AM, 1996, J HOSP INFECT, V32, P175, DOI 10.1016/S0195-6701(96)90144-9; Eveillard M, 2006, AM J INFECT CONTROL, V34, P108, DOI 10.1016/j.ajic.2006.01.001; Geffers Christine, 2005, Infect Control Hosp Epidemiol, V26, P114, DOI 10.1086/503508; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Haley CC, 2007, J CLIN MICROBIOL, V45, P3031, DOI 10.1128/JCM.00315-07; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; Kajita E, 2007, NAT REV MICROBIOL, V5, P700, DOI 10.1038/nrmicro1660; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Lipsitch M, 2000, P NATL ACAD SCI USA, V97, P1938, DOI 10.1073/pnas.97.4.1938; Lloyd AL, 2004, THEOR POPUL BIOL, V65, P49, DOI 10.1016/j.tpb.2003.07.002; Lloyd AL, 2007, J R SOC INTERFACE, V4, P851, DOI 10.1098/rsif.2007.1064; Manzur A, 2008, CLIN MICROBIOL INFEC, V14, P867, DOI 10.1111/j.1469-0691.2008.02060.x; McBryde ES, 2007, J THEOR BIOL, V245, P470, DOI 10.1016/j.jtbi.2006.11.008; McBryde ES, 2004, J HOSP INFECT, V58, P104, DOI 10.1016/j.jhin.2004.06.010; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; MUDER RR, 1991, ANN INTERN MED, V114, P107, DOI 10.7326/0003-4819-114-2-1-107; Niclaes L, 1999, EPIDEMIOL INFECT, V122, P235, DOI 10.1017/S0950268898001770; O'Sullivan NP, 2000, J HOSP INFECT, V45, P322, DOI 10.1053/jhin.2000.0758; Pelupessy I, 2002, P NATL ACAD SCI USA, V99, P5601, DOI 10.1073/pnas.082412899; SANFORD MD, 1994, CLIN INFECT DIS, V19, P1123, DOI 10.1093/clinids/19.6.1123; Sebille V, 1997, INFECT CONT HOSP EP, V18, P84; Smith DL, 2004, P NATL ACAD SCI USA, V101, P3709, DOI 10.1073/pnas.0400456101; Suetens C, 2006, J AM GERIATR SOC, V54, P1854, DOI 10.1111/j.1532-5415.2006.00972.x; Webb GF, 2005, P NATL ACAD SCI USA, V102, P13343, DOI 10.1073/pnas.0504053102; Wendt C, 1998, J CLIN MICROBIOL, V36, P3734, DOI 10.1128/JCM.36.12.3734-3736.1998	41	37	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29757	10.1371/journal.pone.0029757	http://dx.doi.org/10.1371/journal.pone.0029757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238650	gold, Green Submitted, Green Published			2022-12-27	WOS:000301188800034
J	Mukherjee, J; Tremblay, JM; Leysath, CE; Ofori, K; Baldwin, K; Feng, XC; Bedenice, D; Webb, RP; Wright, PM; Smith, LA; Tzipori, S; Shoemaker, CB				Mukherjee, Jean; Tremblay, Jacqueline M.; Leysath, Clinton E.; Ofori, Kwasi; Baldwin, Karen; Feng, Xiaochuan; Bedenice, Daniela; Webb, Robert P.; Wright, Patrick M.; Smith, Leonard A.; Tzipori, Saul; Shoemaker, Charles B.			A Novel Strategy for Development of Recombinant Antitoxin Therapeutics Tested in a Mouse Botulism Model	PLOS ONE			English	Article							G IMMUNE-COMPLEXES; MONOCLONAL-ANTIBODY; HIGH-AFFINITY; NEUROTOXIN; DOMAIN; AGENTS; NEUTRALIZATION; INHIBITORS; FRAGMENTS; CELLS	Antitoxins are needed that can be produced economically with improved safety and shelf life compared to conventional antisera-based therapeutics. Here we report a practical strategy for development of simple antitoxin therapeutics with substantial advantages over currently available treatments. The therapeutic strategy employs a single recombinant 'targeting agent' that binds a toxin at two unique sites and a 'clearing Ab' that binds two epitopes present on each targeting agent. Co-administration of the targeting agent and the clearing Ab results in decoration of the toxin with up to four Abs to promote accelerated clearance. The therapeutic strategy was applied to two Botulinum neurotoxin (BoNT) serotypes and protected mice from lethality in two different intoxication models with an efficacy equivalent to conventional antitoxin serum. Targeting agents were a single recombinant protein consisting of a heterodimer of two camelid anti-BoNT heavy-chain-only Ab VH (VHH) binding domains and two E-tag epitopes. The clearing mAb was an anti-E-tag mAb. By comparing the in vivo efficacy of treatments that employed neutralizing vs. non-neutralizing agents or the presence vs. absence of clearing Ab permitted unprecedented insight into the roles of toxin neutralization and clearance in antitoxin efficacy. Surprisingly, when a post-intoxication treatment model was used, a toxin-neutralizing heterodimer agent fully protected mice from intoxication even in the absence of clearing Ab. Thus a single, easy-to-produce recombinant protein was as efficacious as polyclonal antiserum in a clinically-relevant mouse model of botulism. This strategy should have widespread application in antitoxin development and other therapies in which neutralization and/or accelerated clearance of a serum biomolecule can offer therapeutic benefit.	[Mukherjee, Jean; Tremblay, Jacqueline M.; Ofori, Kwasi; Baldwin, Karen; Feng, Xiaochuan; Bedenice, Daniela; Tzipori, Saul; Shoemaker, Charles B.] Tufts Cummings Sch Vet Med, Dept Biomed Sci, North Grafton, MA USA; [Leysath, Clinton E.] NIAID, NIH, Bethesda, MD 20892 USA; [Webb, Robert P.; Wright, Patrick M.; Smith, Leonard A.] USA, Med Res Inst Infect Dis, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mukherjee, J (corresponding author), Tufts Cummings Sch Vet Med, Dept Biomed Sci, North Grafton, MA USA.	charles.shoemaker@tufts.edu		Webb, Robert/0000-0001-8253-8979	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); Department of Health and Human Services [N01-AI-30050, U54 AI057159]; NIAID, Bethesda, MD, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030050, ZIAAI001031, U54AI057159] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Health and Human Services; NIAID, Bethesda, MD, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded in part with Federal funds from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), and the Department of Health and Human Services, under Contract No. N01-AI-30050 and Award Number U54 AI057159. Some work was also supported by the Intramural Research Program of the NIAID, Bethesda, MD, USA. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIAID or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekar SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003023; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P299; Arnon SS, 2006, NEW ENGL J MED, V354, P462, DOI 10.1056/NEJMoa051926; Casadevall A, 2002, EMERG INFECT DIS, V8, P833, DOI 10.3201/eid0808.010516; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Davies KA, 2002, ARTHRITIS RHEUM-US, V46, P1028, DOI 10.1002/art.10189; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Eubanks LM, 2010, ACS MED CHEM LETT, V1, P268, DOI 10.1021/ml100074s; Gibbs WW, 2005, SCI AM, V293, P78, DOI 10.1038/scientificamerican0805-78; Hey T, 2005, TRENDS BIOTECHNOL, V23, P514, DOI 10.1016/j.tibtech.2005.07.007; Johansson AG, 1996, HEPATOLOGY, V24, P169, DOI 10.1053/jhep.1996.v24.pm0008707258; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Lovdal T, 2000, J CELL SCI, V113, P3255; Maass DR, 2007, J IMMUNOL METHODS, V324, P13, DOI 10.1016/j.jim.2007.04.008; Maass DR, 2007, INT J PARASITOL, V37, P953, DOI 10.1016/j.ijpara.2007.02.005; Mazuet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012416; Meng Q, 2012, ANAL BIOCHEM, V421, P351, DOI 10.1016/j.ab.2011.09.030; Mohamed N, 2005, INFECT IMMUN, V73, P795, DOI 10.1128/IAI.73.2.795-802.2005; Mukherjee J, 2002, INFECT IMMUN, V70, P612, DOI 10.1128/IAI.70.2.612-619.2002; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; PEARCE LB, 1994, TOXICOL APPL PHARM, V128, P69, DOI 10.1006/taap.1994.1181; Pless DD, 2001, INFECT IMMUN, V69, P570, DOI 10.1128/IAI.69.1.570-574.2001; Pluckthun A, 1997, IMMUNOTECHNOLOGY, V3, P83, DOI 10.1016/S1380-2933(97)00067-5; Rahbarizadeh F, 2011, IMMUNOL INVEST, V40, P299, DOI 10.3109/08820139.2010.542228; Rainey GJA, 2004, NAT REV MICROBIOL, V2, P721, DOI 10.1038/nrmicro977; Sepulveda J, 2010, INFECT IMMUN, V78, P756, DOI 10.1128/IAI.01084-09; SKAPER SD, 1979, DEV NEUROSCI-BASEL, V2, P233, DOI 10.1159/000112485; Sobel J, 2005, CLIN INFECT DIS, V41, P1167, DOI 10.1086/444507; Tremblay JM, 2010, TOXICON, V56, P990, DOI 10.1016/j.toxicon.2010.07.003; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Walker K, 2010, IDRUGS, V13, P743; Webb RP, 2009, VACCINE, V27, P4490, DOI 10.1016/j.vaccine.2009.05.030	34	56	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29941	10.1371/journal.pone.0029941	http://dx.doi.org/10.1371/journal.pone.0029941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238680	Green Published, gold, Green Submitted			2022-12-27	WOS:000301188800050
J	Laatsch, A; Panteli, M; Sornsakrin, M; Hoffzimmer, B; Grewal, T; Heeren, J				Laatsch, Alexander; Panteli, Malamatenia; Sornsakrin, Marijke; Hoffzimmer, Britta; Grewal, Thomas; Heeren, Joerg			Low Density Lipoprotein Receptor-Related Protein 1 Dependent Endosomal Trapping and Recycling of Apolipoprotein E	PLOS ONE			English	Article							TRIGLYCERIDE-RICH LIPOPROTEINS; IN-VIVO; ALPHA-2-MACROGLOBULIN RECEPTOR; CHOLESTEROL EFFLUX; LRP; CLEARANCE; BINDING; LIPASE; ATHEROSCLEROSIS; DEGRADATION	Background: Lipoprotein receptors from the low density lipoprotein (LDL) receptor family are multifunctional membrane proteins which can efficiently mediate endocytosis and thereby facilitate lipoprotein clearance from the plasma. The biggest member of this family, the LDL receptor-related protein 1 (LRP1), facilitates the hepatic uptake of triglyceride-rich lipoproteins (TRL) via interaction with apolipoprotein E (apoE). In contrast to the classical LDL degradation pathway, TRL disintegrate in peripheral endosomes, and core lipids and apoB are targeted along the endocytic pathway for lysosomal degradation. Notably, TRL-derived apoE remains within recycling endosomes and is then mobilized by high density lipoproteins (HDL) for re-secretion. The aim of this study is to investigate the involvement of LRP1 in the regulation of apoE recycling. Principal Findings: Immunofluorescence studies indicate the LRP1-dependent trapping of apoE in EEA1-positive endosomes in human hepatoma cells. This processing is distinct from other LRP1 ligands such as RAP which is efficiently targeted to lysosomal compartments. Upon stimulation of HDL-induced recycling, apoE is released from LRP1-positive endosomes but is targeted to another, distinct population of early endosomes that contain HDL, but not LRP1. For subsequent analysis of the recycling capacity, we expressed the full-length human LRP1 and used an RNA interference approach to manipulate the expression levels of LRP1. In support of LRP1 determining the intracellular fate of apoE, overexpression of LRP1 significantly stimulated HDL-induced apoE recycling. Vice versa LRP1 knockdown in HEK293 cells and primary hepatocytes strongly reduced the efficiency of HDL to stimulate apoE secretion. Conclusion: We conclude that LRP1 enables apoE to accumulate in an early endosomal recycling compartment that serves as a pool for the intracellular formation and subsequent re-secretion of apoE-enriched HDL particles.	[Laatsch, Alexander; Panteli, Malamatenia; Sornsakrin, Marijke; Hoffzimmer, Britta; Heeren, Joerg] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany; [Grewal, Thomas] Univ Sydney, Fac Pharm A15, Sydney, NSW 2006, Australia	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Sydney	Laatsch, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany.	heeren@uke.uni-hamburg.de		Grewal, Thomas/0000-0002-7937-8887	German Research Foundation (DFG) Graduiertenkolleg (GRK) [1459]; National Health and Medical Research Council of Australia [510293, 510294, 1010867]; University of Sydney [2010-02681]	German Research Foundation (DFG) Graduiertenkolleg (GRK)(German Research Foundation (DFG)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney)	This work was supported by the German Research Foundation (DFG) Graduiertenkolleg (GRK 1459). TG is supported by the National Health and Medical Research Council of Australia (510293, 510294, 1010867) and the University of Sydney (2010-02681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; Binder RJ, 2004, P NATL ACAD SCI USA, V101, P6128, DOI 10.1073/pnas.0308180101; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Chen Y, 2010, P NATL ACAD SCI USA, V107, P12011, DOI 10.1073/pnas.0914984107; Czekay RP, 1997, MOL BIOL CELL, V8, P517, DOI 10.1091/mbc.8.3.517; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; Harasaki K, 2005, TRAFFIC, V6, P1014, DOI 10.1111/j.1600-0854.2005.00341.x; Hasty AH, 2005, J LIPID RES, V46, P1433, DOI 10.1194/jlr.M400418-JLR200; Havel RJ, 2004, ARTERIOSCL THROM VAS, V24, P213, DOI 10.1161/01.ATV.0000115382.53810.24; Heeren J, 1999, J CELL SCI, V112, P349; Heeren J, 2006, ARTERIOSCL THROM VAS, V26, P442, DOI 10.1161/01.ATV.0000201282.64751.47; Heeren J, 2004, J BIOL CHEM, V279, P55483, DOI 10.1074/jbc.M409324200; Heeren J, 2003, J BIOL CHEM, V278, P14370, DOI 10.1074/jbc.M209006200; Heeren J, 2002, J MOL MED-JMM, V80, P576, DOI 10.1007/s00109-002-0351-5; Heeren J, 2001, J BIOL CHEM, V276, P42333, DOI 10.1074/jbc.M107461200; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P21162; Laatsch A, 2004, EUR J CELL BIOL, V83, P113, DOI 10.1078/0171-9335-00364; Laatsch A, 2008, ATHEROSCLEROSIS; Lillis AP, 2005, J THROMB HAEMOST, V3, P1884, DOI 10.1111/j.1538-7836.2005.01371.x; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; MEREDITH MJ, 1988, CELL BIOL TOXICOL, V4, P405, DOI 10.1007/BF00117769; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Muller D, 2003, ANN MED, V35, P290, DOI 10.1080/07853890310006488; Out R, 2004, J BIOL CHEM, V279, P18401, DOI 10.1074/jbc.M401170200; Rellin L, 2008, BBA-MOL CELL BIOL L, V1781, P232, DOI 10.1016/j.bbalip.2008.02.001; Rensen PCN, 2000, J BIOL CHEM, V275, P8564, DOI 10.1074/jbc.275.12.8564; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Swift LL, 2001, J BIOL CHEM, V276, P22965, DOI 10.1074/jbc.M100172200; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; Williams KJ, 2010, CURR OPIN LIPIDOL, V21, P218, DOI 10.1097/MOL.0b013e328338cabc; Willnow TE, 1996, BIOCHEM J, V313, P71, DOI 10.1042/bj3130071; WILLNOW TE, 1992, J BIOL CHEM, V267, P26172; WILLNOW TE, 1994, J BIOL CHEM, V269, P15827	41	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29385	10.1371/journal.pone.0029385	http://dx.doi.org/10.1371/journal.pone.0029385			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238606	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200025
J	Chen, CC; Shen, JW; Chung, NC; Min, MY; Cheng, SJ; Liu, IY				Chen, Chien-Chang; Shen, Jhe-Wei; Chung, Ni-Chun; Min, Ming-Yuan; Cheng, Sin-Jong; Liu, Ingrid Y.			Retrieval of Context-Associated Memory is Dependent on the Ca(v)3.2 T-Type Calcium Channel	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CA2+ CHANNELS; SPATIAL MEMORY; FEAR MEMORY; PARKINSONS-DISEASE; GENETIC-VARIATION; NMDA RECEPTORS; MICE DEFICIENT; HIPPOCAMPUS; NEURONS	Among all voltage-gated calcium channels, the T-type Ca2+ channels encoded by the Ca(v)3.2 genes are highly expressed in the hippocampus, which is associated with contextual, temporal and spatial learning and memory. However, the specific involvement of the Ca(v)3.2 T-type Ca2+ channel in these hippocampus-dependent types of learning and memory remains unclear. To investigate the functional role of this channel in learning and memory, we subjected Ca(v)3.2 homozygous and heterozygous knockout mice and their wild-type littermates to hippocampus-dependent behavioral tasks, including trace fear conditioning, the Morris water-maze and passive avoidance. The Ca(v)3.2 (-/-) mice performed normally in the Morris water-maze and auditory trace fear conditioning tasks but were impaired in the context-cued trace fear conditioning, step-down and step-through passive avoidance tasks. Furthermore, long-term potentiation (LTP) could be induced for 180 minutes in hippocampal slices of WTs and Ca(v)3.2 (+/-) mice, whereas LTP persisted for only 120 minutes in Ca(v)3.2 (-/-) mice. To determine whether the hippocampal formation is responsible for the impaired behavioral phenotypes, we next performed experiments to knock down local function of the Ca(v)3.2 T-type Ca2+ channel in the hippocampus. Wild-type mice infused with mibefradil, a T-type channel blocker, exhibited similar behaviors as homozygous knockouts. Taken together, our results demonstrate that retrieval of context-associated memory is dependent on the Ca(v)3.2 T-type Ca2+ channel.	[Chen, Chien-Chang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Shen, Jhe-Wei; Chung, Ni-Chun; Liu, Ingrid Y.] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Min, Ming-Yuan; Cheng, Sin-Jong] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan	Academia Sinica - Taiwan; Tzu Chi University; Academia Sinica - Taiwan; National Taiwan University	Chen, CC (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	ycliu@mail.tcu.edu.tw	Chang, Sin-Jhong/AAL-4118-2020; Chen, Chien-Chang/D-2023-2015; Liu, Ingrid Y/AAN-2606-2021	Chen, Chien-Chang/0000-0001-8850-4278; MIN, MING-YUAN/0000-0003-4211-6725	National Science Council of Taiwan [NSC 95-2745-B-320-005-URD, NSC 96-2314-B-320-003]; Academia Sinica	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by grants NSC 95-2745-B-320-005-URD and NSC 96-2314-B-320-003 from the National Science Council of Taiwan to Dr. Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. Richard F Thompson for helpful comments. We are also grateful for technical support from the Neural Circuit Electrophysiology Core in Academia Sinica. This work is supported in part by Neuroscience Program in Academia Sinica.	Ahi J, 2004, BEHAV BRAIN RES, V149, P17, DOI 10.1016/S0166-4328(03)00207-9; Arnold OH, 1999, NEUROPSYCHOBIOLOGY, V40, P21, DOI 10.1159/000026593; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bourinet E, 2005, EMBO J, V24, P315, DOI 10.1038/sj.emboj.7600515; Carbon M, 2006, J NEUROL SCI, V248, P72, DOI 10.1016/j.jns.2006.05.005; Chan KFY, 2004, EXP NEUROL, V190, P328, DOI 10.1016/j.expneurol.2004.08.001; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; Chen WK, 2010, J NEUROSCI, V30, P10360, DOI 10.1523/JNEUROSCI.1041-10.2010; Chen YC, 2003, ANN NEUROL, V54, P239, DOI 10.1002/ana.10607; Chevalier M, 2006, EUR J NEUROSCI, V23, P2321, DOI 10.1111/j.1460-9568.2006.04761.x; Choi S, 2007, GENES BRAIN BEHAV, V6, P425, DOI 10.1111/j.1601-183X.2006.00268.x; Costa RM, 2001, NAT GENET, V27, P399, DOI 10.1038/86898; Cribbs LL, 2000, FEBS LETT, V466, P54, DOI 10.1016/S0014-5793(99)01756-1; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Dudek SM, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-02-j0002.2001; Gao ZY, 1998, EUR J NEUROSCI, V10, P2416, DOI 10.1046/j.1460-9568.1998.00252.x; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Heron SE, 2004, ANN NEUROL, V55, P595, DOI 10.1002/ana.20028; Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2; ITO K, 1995, NEUROSCI LETT, V183, P112, DOI 10.1016/0304-3940(94)11127-5; Jellinger KA, 2002, J NEURAL TRANSM-SUPP, P347; Kubota M, 2001, BIOCHEM BIOPH RES CO, V282, P242, DOI 10.1006/bbrc.2001.4572; Lacinova L, 2005, GEN PHYSIOL BIOPHYS, V24, P3; Lacinova L, 2008, LIFE SCI, V82, P41, DOI 10.1016/j.lfs.2007.10.009; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Marger F, 2011, P NATL ACAD SCI USA, V108, P11268, DOI 10.1073/pnas.1100869108; McEchron MD, 1998, HIPPOCAMPUS, V8, P638, DOI 10.1002/(SICI)1098-1063(1998)8:6<638::AID-HIPO6>3.0.CO;2-Q; McKinney BC, 2006, LEARN MEMORY, V13, P584, DOI 10.1101/lm.279006; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Mizuno K, 2005, J PHARMACOL SCI, V98, P191, DOI 10.1254/jphs.CRJ05005X; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Nakagawasai O, 2010, BEHAV BRAIN RES, V208, P224, DOI 10.1016/j.bbr.2009.11.042; Nilius B, 2006, CELL CALCIUM, V40, P81, DOI 10.1016/j.ceca.2006.04.011; Normann C, 2005, BRAIN RES, V1037, P187, DOI 10.1016/j.brainres.2005.01.001; Pare D, 2004, TRENDS NEUROSCI, V27, P440, DOI 10.1016/j.tins.2004.05.004; Perez-Reyes E, 2006, CNS NEUROL DISORD-DR, V5, P605, DOI 10.2174/187152706779025508; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Poncer JC, 2003, J PHYSIOLOGY-PARIS, V97, P415, DOI 10.1016/j.jphysparis.2004.01.003; Quartermain D, 2000, EUR J PHARMACOL, V399, P57, DOI 10.1016/S0014-2999(00)00368-X; Quinta-Ferreira ME, 2004, BRAIN RES, V1004, P52, DOI 10.1016/j.brainres.2004.01.013; Smith DM, 2006, HIPPOCAMPUS, V16, P716, DOI 10.1002/hipo.20208; Son WY, 2002, DEV GROWTH DIFFER, V44, P181, DOI 10.1046/j.1440-169X.2002.00633.x; Splawski I, 2006, J BIOL CHEM, V281, P22085, DOI 10.1074/jbc.M603316200; Stella SL, 2000, EUR J NEUROSCI, V12, P3537, DOI 10.1046/j.1460-9568.2000.00235.x; Talley EM, 1999, J NEUROSCI, V19, P1895; Todorovic SM, 2006, CNS NEUROL DISORD-DR, V5, P639, DOI 10.2174/187152706779025490; Veng LM, 2003, MOL BRAIN RES, V110, P193, DOI 10.1016/S0169-328X(02)00643-5; White JA, 2008, LEARN MEMORY, V15, P1, DOI 10.1101/lm.773208; Woodside BL, 2004, NEUROBIOL LEARN MEM, V81, P105, DOI 10.1016/j.nlm.2003.10.003; Yoshimura Y, 2008, EUR J NEUROSCI, V28, P730, DOI 10.1111/j.1460-9568.2008.06384.x; Yunker AMR, 2003, J BIOENERG BIOMEMBR, V35, P533, DOI 10.1023/B:JOBB.0000008024.77488.48	52	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29384	10.1371/journal.pone.0029384	http://dx.doi.org/10.1371/journal.pone.0029384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235292	gold, Green Published, Green Submitted			2022-12-27	WOS:000301123400053
J	Furusawa, Y; Fujiwara, Y; Campbell, P; Zhao, QL; Ogawa, R; Hassan, MA; Tabuchi, Y; Takasaki, I; Takahashi, A; Kondo, T				Furusawa, Yukihiro; Fujiwara, Yoshisada; Campbell, Paul; Zhao, Qing-Li; Ogawa, Ryohei; Hassan, Mariame Ali; Tabuchi, Yoshiaki; Takasaki, Ichiro; Takahashi, Akihisa; Kondo, Takashi			DNA Double-Strand Breaks Induced by Cavitational Mechanical Effects of Ultrasound in Cancer Cell Lines	PLOS ONE			English	Article							DRUG-DELIVERY; APOPTOSIS; ATM; DAMAGE; INDUCTION; AUTOPHOSPHORYLATION; GAMMA-H2AX; REPAIR	Ultrasonic technologies pervade the medical field: as a long established imaging modality in clinical diagnostics; and, with the emergence of targeted high intensity focused ultrasound, as a means of thermally ablating tumours. In parallel, the potential of [non-thermal] intermediate intensity ultrasound as a minimally invasive therapy is also being rigorously assessed. Here, induction of apoptosis in cancer cells has been observed, although definitive identification of the underlying mechanism has thus far remained elusive. A likely candidate process has been suggested to involve sonochemical activity, where reactive oxygen species (ROS) mediate the generation of DNA single-strand breaks. Here however, we provide compelling new evidence that strongly supports a purely mechanical mechanism. Moreover, by a combination of specific assays (neutral comet tail and staining for gamma H2AX foci formation) we demonstrate for the first time that US exposure at even moderate intensities exhibits genotoxic potential, through its facility to generate DNA damage across multiple cancer lines. Notably, colocalization assays highlight that ionizing radiation and ultrasound have distinctly different signatures to their respective gamma H2AX foci formation patterns, likely reflecting the different stress distributions that initiated damage formation. Furthermore, parallel immuno-blotting suggests that DNA-PKcs have a preferential role in the repair of ultrasound-induced damage.	[Furusawa, Yukihiro; Fujiwara, Yoshisada; Zhao, Qing-Li; Ogawa, Ryohei; Hassan, Mariame Ali; Kondo, Takashi] Toyama Univ, Dept Radiol Sci, Toyama 930, Japan; [Campbell, Paul] Univ Dundee, Div Mol Med, Carnegie Lab Phys, Dundee, Scotland; [Tabuchi, Yoshiaki; Takasaki, Ichiro] Toyama Univ, Grad Sch Med Pharmaceut Sci, Life Sci Res Ctr, Div Mol Genet Res, Toyama 930, Japan; [Takahashi, Akihisa] Gunma Univ, Adv Sci Res Leaders Dev Unit, Gunma, Japan	University of Toyama; University of Dundee; University of Toyama; Gunma University	Furusawa, Y (corresponding author), Toyama Univ, Dept Radiol Sci, Toyama 930, Japan.	kondot@med.u-toyama.ac.jp	campbell, paul a/C-3174-2009	campbell, paul a/0000-0001-9417-4586; Tabuchi, Yoshiaki/0000-0002-6007-6176	Japan Society for the Promotion of Science [22390229]; MRC [G0802645] Funding Source: UKRI; Medical Research Council [G0802645] Funding Source: researchfish	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Financial support for this study was provided by a Grant-in-Aid for Scientific Research (B) (22390229), Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2004, FASEB J, V18, P1413, DOI 10.1096/fj.04-1601fje; Ando H, 2006, CANCER LETT, V242, P37, DOI 10.1016/j.canlet.2005.10.032; Ashush H, 2000, CANCER RES, V60, P1014; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Boucaud A, 2004, DRUG DISCOV TODAY, V9, P827, DOI 10.1016/S1359-6446(04)03212-X; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Feril LB, 2005, CANCER LETT, V221, P145, DOI 10.1016/j.canlet.2004.08.034; Feril LB, 2004, J RADIAT RES, V45, P479, DOI 10.1269/jrr.45.479; Furusawa Y, 2010, CANCER LETT, V288, P107, DOI 10.1016/j.canlet.2009.06.029; Hassan MA, 2010, J CONTROL RELEASE, V141, P70, DOI 10.1016/j.jconrel.2009.08.020; Honda H, 2002, ULTRASOUND MED BIOL, V28, P673, DOI 10.1016/S0301-5629(02)00509-4; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; KONDO T, 1993, FREE RADICAL RES COM, V19, pS193, DOI 10.3109/10715769309056s193; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; LEVY D, 1989, J CLIN INVEST, V83, P2074, DOI 10.1172/JCI114119; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Meek K, 2007, MOL CELL BIOL, V27, P3881, DOI 10.1128/MCB.02366-06; Miller DL, 1996, ULTRASOUND MED BIOL, V22, P681, DOI 10.1016/0301-5629(95)02077-2; Milowska K, 2007, BIOMOL ENG, V24, P263, DOI 10.1016/j.bioeng.2007.02.001; Mitragotri S, 2005, NAT REV DRUG DISCOV, V4, P255, DOI 10.1038/nrd1662; Prentice P, 2005, NAT PHYS, V1, P107, DOI 10.1038/nphys148; Raymond SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002175; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Suzuki R, 2011, J CONTROL RELEASE, V149, P36, DOI 10.1016/j.jconrel.2010.05.009; Tachibana K, 1999, LANCET, V353, P1409, DOI 10.1016/S0140-6736(99)01244-1; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005	33	64	65	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29012	10.1371/journal.pone.0029012	http://dx.doi.org/10.1371/journal.pone.0029012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235259	Green Submitted, Green Published, gold			2022-12-27	WOS:000301123400020
J	Ho, WH; Lee, KT; Chen, HY; Ho, TW; Chiu, HC				Ho, Wen-Hsien; Lee, King-Teh; Chen, Hong-Yaw; Ho, Te-Wei; Chiu, Herng-Chia			Disease-Free Survival after Hepatic Resection in Hepatocellular Carcinoma Patients: A Prediction Approach Using Artificial Neural Network	PLOS ONE			English	Article							LOGISTIC-REGRESSION; ARTERIAL CHEMOEMBOLIZATION; CARDIOVASCULAR RISK; MODELS; CANCER; CIRRHOSIS; HEPATECTOMY; UNIVARIATE	Background: A database for hepatocellular carcinoma (HCC) patients who had received hepatic resection was used to develop prediction models for 1-, 3- and 5-year disease-free survival based on a set of clinical parameters for this patient group. Methods: The three prediction models included an artificial neural network (ANN) model, a logistic regression (LR) model, and a decision tree (DT) model. Data for 427, 354 and 297 HCC patients with histories of 1-, 3- and 5-year disease-free survival after hepatic resection, respectively, were extracted from the HCC patient database. From each of the three groups, 80% of the cases (342, 283 and 238 cases of 1-, 3- and 5-year disease-free survival, respectively) were selected to provide training data for the prediction models. The remaining 20% of cases in each group (85, 71 and 59 cases in the three respective groups) were assigned to validation groups for performance comparisons of the three models. Area under receiver operating characteristics curve (AUROC) was used as the performance index for evaluating the three models. Conclusions: The ANN model outperformed the LR and DT models in terms of prediction accuracy. This study demonstrated the feasibility of using ANNs in medical decision support systems for predicting disease-free survival based on clinical databases in HCC patients who have received hepatic resection.	[Ho, Wen-Hsien; Lee, King-Teh; Chiu, Herng-Chia] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Lee, King-Teh] Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan; [Chen, Hong-Yaw] Yuans Hosp, Kaohsiung, Taiwan; [Ho, Te-Wei] Bur Hlth Promot, Dept Hlth, Taipei, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Ho, WH (corresponding author), Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan.	chiu@kmu.edu.tw	Ho, Te-Wei/F-1309-2015	Ho, Te-Wei/0000-0002-4371-6936	National Science Council, Taiwan, Republic of China [NSC 99-2320-B-037-026-MY2, NSC 95-2314-B-037-079-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was in part supported by the National Science Council, Taiwan, Republic of China, under grant numbers NSC 99-2320-B-037-026-MY2 and NSC 95-2314-B-037-079-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bosch FX, 1999, SEMIN LIVER DIS, V19, P271, DOI 10.1055/s-2007-1007117; Chiu JS, 2005, AM J NEPHROL, V25, P507, DOI 10.1159/000088279; Colombet I, 2000, J AM MED INFORM ASSN, P156; Cucchetti A, 2010, J HEPATOL, V52, P880, DOI 10.1016/j.jhep.2009.12.037; Das A, 2008, GASTROENTEROLOGY, V134, P65, DOI 10.1053/j.gastro.2007.10.037; Eftekhar Behzad, 2005, BMC Med Inform Decis Mak, V5, P3; Ercolani G, 2003, ANN SURG, V237, P536, DOI 10.1097/00000658-200304000-00016; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ghoshal UC, 2008, HEPATOL INT, V2, P31, DOI 10.1007/s12072-007-9026-1; Hanai T, 2003, CANCER SCI, V94, P473, DOI 10.1111/j.1349-7006.2003.tb01467.x; Hanazaki K, 2000, J AM COLL SURGEONS, V191, P381, DOI 10.1016/S1072-7515(00)00700-6; Heckerling PS, 2007, INT J MED INFORM, V76, P289, DOI 10.1016/j.ijmedinf.2006.01.005; Ho WH, 2011, EXPERT SYST APPL, V38, P13050, DOI 10.1016/j.eswa.2011.04.109; Ho WH, 2011, EXPERT SYST APPL, V38, P6319, DOI 10.1016/j.eswa.2010.11.110; Ho WH, 2010, NONLINEAR DYNAM, V61, P29, DOI 10.1007/s11071-009-9629-2; Ho WH, 2010, IEEE T AUTOM SCI ENG, V7, P143, DOI 10.1109/TASE.2009.2023673; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Ke Wan-Sheng, 2010, Adv Appl Bioinform Chem, V3, P39; Lee KT, 2009, J SURG ONCOL, V99, P343, DOI 10.1002/jso.21248; Lee SM, 2004, J KOREAN MED SCI, V19, P677, DOI 10.3346/jkms.2004.19.5.677; Li YC, 2000, INT J MED INFORM, V57, P1, DOI 10.1016/S1386-5056(99)00054-4; Liau KH, 2005, CANCER-AM CANCER SOC, V104, P1948, DOI 10.1002/cncr.21415; Liew PL, 2007, DIGEST LIVER DIS, V39, P356, DOI 10.1016/j.dld.2007.01.003; Lin Xiao-Dong, 2006, Hepatobiliary Pancreat Dis Int, V5, P16; Luk JM, 2007, BIOCHEM BIOPH RES CO, V361, P68, DOI 10.1016/j.bbrc.2007.06.172; MacDowell M, 2001, MED DECIS MAKING, V21, P433, DOI 10.1177/02729890122062785; Matsui Y, 2002, JPN J CLIN ONCOL, V32, P530, DOI 10.1093/jjco/hyf114; Nguyen T, 2002, J CLIN EPIDEMIOL, V55, P687, DOI 10.1016/S0895-4356(02)00394-3; Robinson CJ, 2008, AM J OBSTET GYNECOL, V199, p193e1; Samanta B, 2009, ARTIF INTELL MED, V46, P201, DOI 10.1016/j.artmed.2008.12.005; Sasaki A, 2006, EJSO-EUR J SURG ONC, V32, P773, DOI 10.1016/j.ejso.2006.04.002; Shimozawa N, 2004, J AM COLL SURGEONS, V198, P356, DOI 10.1016/j.jamcollsurg.2003.10.017; Simon D, 1990, CLIN METHODS HIST PH, V3rd; Terrin N, 2003, J CLIN EPIDEMIOL, V56, P721, DOI 10.1016/S0895-4356(03)00120-3; Trtica-Majnaric L, 2010, J BIOMED INFORM, V43, P774, DOI 10.1016/j.jbi.2010.04.011; Tsai JT, 2004, IEEE T EVOLUT COMPUT, V8, P365, DOI 10.1109/TEVC.2004.826895; Tsai JT, 2006, IEEE T NEURAL NETWOR, V17, P69, DOI 10.1109/TNN.2005.860885; Viazzi Francesca, 2006, J Hypertens, V24, P1281, DOI 10.1097/01.hjh.0000234107.08368.e5; Witten I. H., 2005, DATA MINING PRACTICA; Yeh CN, 2003, ANN SURG ONCOL, V10, P916, DOI 10.1245/ASO.2003.09.012; Yeh CN, 2002, J SURG ONCOL, V81, P195, DOI 10.1002/jso.10178; Zhang ZJ, 2000, CANCER, V89, P2606	42	45	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29179	10.1371/journal.pone.0029179	http://dx.doi.org/10.1371/journal.pone.0029179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235270	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400031
J	Hu, LL; Chen, C; Huang, T; Cai, YD; Chou, KC				Hu, Le-Le; Chen, Chen; Huang, Tao; Cai, Yu-Dong; Chou, Kuo-Chen			Predicting Biological Functions of Compounds Based on Chemical-Chemical Interactions	PLOS ONE			English	Article							AMINOCYCLOPROPANE CARBOXYLIC-ACID; ORAL ANTIDIABETIC AGENTS; METABOLIC PATHWAYS; DIHYDROPYRIMIDINE DEHYDROGENASE; PROTEIN; THYMINE; BINDING; URACIL; EXPRESSION; MOLECULES	Given a compound, how can we effectively predict its biological function? It is a fundamentally important problem because the information thus obtained may benefit the understanding of many basic biological processes and provide useful clues for drug design. In this study, based on the information of chemical-chemical interactions, a novel method was developed that can be used to identify which of the following eleven metabolic pathway classes a query compound may be involved with: (1) Carbohydrate Metabolism, (2) Energy Metabolism, (3) Lipid Metabolism, (4) Nucleotide Metabolism, (5) Amino Acid Metabolism, (6) Metabolism of Other Amino Acids, (7) Glycan Biosynthesis and Metabolism, (8) Metabolism of Cofactors and Vitamins, (9) Metabolism of Terpenoids and Polyketides, (10) Biosynthesis of Other Secondary Metabolites, (11) Xenobiotics Biodegradation and Metabolism. It was observed that the overall success rate obtained by the method via the 5-fold cross-validation test on a benchmark dataset consisting of 3,137 compounds was 77.97%, which is much higher than 10.45%, the corresponding success rate obtained by the random guesses. Besides, to deal with the situation that some compounds may be involved with more than one metabolic pathway class, the method presented here is featured by the capacity able to provide a series of potential metabolic pathway classes ranked according to the descending order of their likelihood for each of the query compounds concerned. Furthermore, our method was also applied to predict 5,549 compounds whose metabolic pathway classes are unknown. Interestingly, the results thus obtained are quite consistent with the deductions from the reports by other investigators. It is anticipated that, with the continuous increase of the chemical-chemical interaction data, the current method will be further enhanced in its power and accuracy, so as to become a useful complementary vehicle in annotating uncharacterized compounds for their biological functions.	[Hu, Le-Le; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Hu, Le-Le; Chen, Chen] Shanghai Univ, Coll Sci, Dept Chem, Shanghai, Peoples R China; [Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Cai, Yu-Dong] Gordon Life Sci Inst, San Diego, CA USA	Shanghai University; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Hu, LL (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn	Chou, Kuo-Chen/A-8340-2009	cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; Shanghai Municipal Education Commission [12ZZ087]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This research is supported by the National Basic Research Program of China (2011CB510102, 2011CB510101) and Innovation Program of Shanghai Municipal Education Commission (12ZZ087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong A, 2003, ORG LETT, V5, P2331, DOI 10.1021/ol0346887; BERGER R, 1984, CLIN CHIM ACTA, V141, P227, DOI 10.1016/0009-8981(84)90014-7; BLAKE DA, 1979, BIOCHEMISTRY-US, V18, P5475, DOI 10.1021/bi00591a033; Bogdanov P, 2010, IEEE ACM T COMPUT BI, V7, P208, DOI 10.1109/TCBB.2009.81; Cai YD, 2008, MOL DIVERS, V12, P131, DOI 10.1007/s11030-008-9085-9; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Cerny MA, 2006, J AM CHEM SOC, V128, P3346, DOI 10.1021/ja054938+; Chou KC, 2003, BIOCHEM BIOPH RES CO, V308, P148, DOI 10.1016/S0006-291X(03)01342-1; CHOU KC, 1992, J MOL BIOL, V223, P509, DOI 10.1016/0022-2836(92)90666-8; CHOU KC, 1991, PROTEIN ENG, V4, P661, DOI 10.1093/protein/4.6.661; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; COOK AM, 1984, BIOCHEM J, V222, P315, DOI 10.1042/bj2220315; DAVIS CH, 1984, J BACTERIOL, V158, P347, DOI 10.1128/JB.158.1.347-350.1984; Dea-Ayuela MA, 2008, BIOORGAN MED CHEM, V16, P7770, DOI 10.1016/j.bmc.2008.07.023; Du QS, 2008, CURR PROTEIN PEPT SC, V9, P248, DOI 10.2174/138920308784534005; Dutta S, 2009, MOL BIOTECHNOL, V42, P1, DOI 10.1007/s12033-008-9127-7; Habuchi H, 2006, METHOD ENZYMOL, V416, P225, DOI 10.1016/S0076-6879(06)16014-0; Hu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017668; Ihlenfeldt WD, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-20; ISONO F, 1989, J ANTIBIOT, V42, P667, DOI 10.7164/antibiotics.42.667; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; Kobayashi K, 1998, Gan To Kagaku Ryoho, V25, P1217; Kourmpetis YAI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009293; Krentz AJ, 2005, DRUGS, V65, P385, DOI 10.2165/00003495-200565030-00005; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Leblanc A, 2008, PLANT PHYSIOL, V146, P1928, DOI 10.1104/pp.107.109363; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; Levetan C, 2007, CURR MED RES OPIN, V23, P945, DOI 10.1185/030079907X178766; Lu J, 2009, PROTEIN PEPTIDE LETT, V16, P969, DOI 10.2174/092986609788923374; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Mohler ML, 2009, MED RES REV, V29, P125, DOI 10.1002/med.20142; NAKANISHI Y, 1978, J BIOCHEM-TOKYO, V84, P575, DOI 10.1093/oxfordjournals.jbchem.a132162; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; Ohtake S, 2005, J BIOL CHEM, V280, P39115, DOI 10.1074/jbc.M508816200; PODSCHUN B, 1992, BIOCHEM BIOPH RES CO, V182, P609, DOI 10.1016/0006-291X(92)91776-M; RADCHENKO ED, 1983, BIOFIZIKA+, V28, P923; Ralph SG, 2007, PLANT PHYSIOL, V143, P410, DOI 10.1104/pp.106.089425; Remaud G, 2005, J CHROMATOGR B, V823, P98, DOI 10.1016/j.jchromb.2005.05.044; Schapire RE, 1999, MACH LEARN, V37, P297, DOI 10.1023/A:1007614523901; SCHWARTZ AW, 1977, BIOSYSTEMS, V9, P87, DOI 10.1016/0303-2647(77)90016-8; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; SILVERMAN RB, 1984, BIOCHEMISTRY-US, V23, P5206, DOI 10.1021/bi00317a019; SIMAGA S, 1978, Z NATURFORSCH C, V33, P1006; Simon AE, 2009, SCHIZOPHR RES, V108, P182, DOI 10.1016/j.schres.2008.11.004; Sirois S, 2004, J CHEM INF COMP SCI, V44, P1111, DOI 10.1021/ci034270n; SLOMIANY BL, 1993, BIOCHEM MOL BIOL INT, V29, P973; SUMI S, 1995, J CHROMATOGR B, V672, P233, DOI 10.1016/0378-4347(95)00228-B; TSUJI M, 1980, BIOCHIM BIOPHYS ACTA, V612, P373, DOI 10.1016/0005-2744(80)90120-5; Zou P, 2003, GLYCOBIOLOGY, V13, P35, DOI 10.1093/glycob/cwg001	54	15	19	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29491	10.1371/journal.pone.0029491	http://dx.doi.org/10.1371/journal.pone.0029491			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220213	Green Published, Green Submitted, gold			2022-12-27	WOS:000300677000038
J	Wan, KL; Liu, JH; Hauck, Y; Zhang, Y; Liu, J; Zhao, XQ; Liu, ZG; Lu, B; Dong, HY; Jiang, Y; Kremer, K; Vergnaud, G; van Soolingen, D; Pourcel, C				Wan, Kanglin; Liu, Jinghua; Hauck, Yolande; Zhang, Yuanyuan; Liu, Jie; Zhao, Xiuqin; Liu, Zhiguang; Lu, Bing; Dong, Haiyan; Jiang, Yi; Kremer, Kristin; Vergnaud, Gilles; van Soolingen, Dick; Pourcel, Christine			Investigation on Mycobacterium tuberculosis Diversity in China and the Origin of the Beijing Clade	PLOS ONE			English	Article							NUMBER TANDEM REPEATS; INTERSPERSED REPETITIVE UNITS; VARIABLE-NUMBER; GENETIC DIVERSITY; MOLECULAR CHARACTERISTICS; DISCRIMINATORY ABILITY; GENOMIC DELETIONS; HIGH-RESOLUTION; DRUG-RESISTANT; DNA REPEATS	Background: Investigation of the genetic diversity of Mycobacterium tuberculosis in China has shown that Beijing genotype strains play a dominant role in the tuberculosis (TB) epidemic. In order to examine the strain diversity in the whole country, and to study the evolutionary development of Beijing strains, we sought to genotype a large collection of isolates using different methods. Methodology/Principal Findings: We applied a 15-loci VNTR typing analysis on 1,586 isolates from the Beijing municipality and 12 Chinese provinces or autonomous regions. The data was compared to that of 900 isolates from various other worldwide geographic regions outside of China. A total of 1,162/1,586 (73.2%) of the isolates, distributed into 472 VNTR types, were found to belong to the Beijing genotype family and this represented 56 to 94% of the isolates in each of the localizations. VNTR typing revealed that the majority of the non-Beijing isolates fall into two genotype families, which represented 17% of the total number of isolates, and seem largely restricted to China. A small number of East African Indian genotype strains was also observed in this collection. Ancient Beijing strains with an intact region of difference (RD) 181, as well as strains presumably resembling ancestors of the whole Beijing genotype family, were mainly found in the Guangxi autonomous region. Conclusions/Significance: This is the largest M. tuberculosis VNTR-based genotyping study performed in China to date. The high percentage of Beijing isolates in the whole country and the presence in the South of strains representing early branching points may be an indication that the Beijing lineage originated from China, probably in the Guangxi region. Two modern lineages are shown here to represent the majority of non-Beijing Chinese isolates. The observed geographic distribution of the different lineages within China suggests that natural frontiers are major factors in their diffusion.	[Wan, Kanglin; Liu, Jinghua; Hauck, Yolande; Vergnaud, Gilles; Pourcel, Christine] Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Wan, Kanglin; Liu, Jinghua; Hauck, Yolande; Vergnaud, Gilles; Pourcel, Christine] CNRS, F-91405 Orsay, France; [Wan, Kanglin; Liu, Jinghua; Zhang, Yuanyuan; Liu, Jie; Zhao, Xiuqin; Liu, Zhiguang; Lu, Bing; Dong, Haiyan; Jiang, Yi] Natl Inst Communicable Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Kremer, Kristin; van Soolingen, Dick] Natl Inst Publ Hlth & Environm RIVM, Natl Mycobacteria Reference Lab, Bilthoven, Netherlands; [Kremer, Kristin] Radboud Univ Nijmegen, Dept Clin Microbiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kremer, Kristin] Radboud Univ Nijmegen, Dept Pulm Dis, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Vergnaud, Gilles] DGA MRIS Mission Rech & Innovat Sci, Bagneux, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; Radboud University Nijmegen	Wan, KL (corresponding author), Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France.	christine.pourcel@u-psud.fr	Vergnaud, Gilles/P-1304-2015; Vergnaud, Gilles/AAC-1162-2020; Pourcel, Christine/E-4949-2017	Vergnaud, Gilles/0000-0003-0913-194X; Vergnaud, Gilles/0000-0003-0913-194X; Pourcel, Christine/0000-0002-8951-466X	National Key Program of Mega Infectious Diseases [2008ZX100/03-010-02, 2008ZX10003-008]; European and Chinese laboratories [LSHP-CT-2005-012166]	National Key Program of Mega Infectious Diseases; European and Chinese laboratories	This work was financially supported by the project "Transmission Mode of Tuberculosis" (2008ZX100/03-010-02) and "Warning Mode of Tuberculosis" (2008ZX10003-008) of National Key Program of Mega Infectious Diseases. Exchanges between European and Chinese laboratories were supported by The FP7 grant LSHP-CT-2005-012166 "Tuberculosis China." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alland D, 2007, J CLIN MICROBIOL, V45, P39, DOI 10.1128/JCM.02483-05; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Anh DD, 2000, EMERG INFECT DIS, V6, P302; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Dong HY, 2010, J CLIN MICROBIOL, V48, P4102, DOI 10.1128/JCM.00549-10; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Fabre M, 2004, J CLIN MICROBIOL, V42, P3248, DOI 10.1128/JCM.42.7.3248-3255.2004; Fabre M, 2010, INFECT GENET EVOL, V10, P1165, DOI 10.1016/j.meegid.2010.07.016; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Filliol I, 2000, J CLIN MICROBIOL, V38, P2520, DOI 10.1128/JCM.38.7.2520-2524.2000; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Hauck Y, 2009, J ANTIMICROB CHEMOTH, V64, P259, DOI 10.1093/jac/dkp204; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Huang HY, 2010, J CLIN MICROBIOL, V48, P4474, DOI 10.1128/JCM.00930-10; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Iwamoto T, 2007, FEMS MICROBIOL LETT, V270, P67, DOI 10.1111/j.1574-6968.2007.00658.x; Jiao WW, 2007, CHINESE MED J-PEKING, V120, P814, DOI 10.1097/00029330-200705010-00014; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kang HY, 2010, J MED MICROBIOL, V59, P1191, DOI 10.1099/jmm.0.022103-0; Kremer K, 2005, J CLIN MICROBIOL, V43, P314, DOI 10.1128/JCM.43.1.314-320.2005; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Kruuner A, 2001, J CLIN MICROBIOL, V39, P3339, DOI 10.1128/JCM.39.9.3339-3345.2001; Kurepina N, 2005, J CLIN MICROBIOL, V43, P2148, DOI 10.1128/JCM.43.5.2148-2154.2005; Kurepina N. E., 1998, Tubercle and Lung Disease, V79, P31, DOI 10.1054/tuld.1998.0003; Le Fleche P, 2001, BMC Microbiol, V1, P2; Le Fleche P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-37; Li X, 2011, J CLIN MICROBIOL, V49, P392, DOI 10.1128/JCM.00754-10; Lindstedt BA, 2005, ELECTROPHORESIS, V26, P2567, DOI 10.1002/elps.200500096; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Maeda S, 2010, INT J TUBERC LUNG D, V14, P1201; Millet J, 2011, INFECT GENET EVOL; Millet J, 2007, J CLIN MICROBIOL, V45, P3606, DOI 10.1128/JCM.00348-07; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Mokrousov I, 2004, J CLIN MICROBIOL, V42, P2438, DOI 10.1128/JCM.42.6.2438-2444.2004; Mokrousov I, 2006, J CLIN MICROBIOL, V44, P2851, DOI 10.1128/JCM.00705-06; Mokrousov I, 2009, INFECT GENET EVOL, V9, P1400, DOI 10.1016/j.meegid.2009.07.007; Murase Y, 2008, J MED MICROBIOL, V57, P873, DOI 10.1099/jmm.0.47564-0; Oota H, 2002, AM J PHYS ANTHROPOL, V118, P146, DOI 10.1002/ajpa.10056; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Qian LS, 1999, J CLIN MICROBIOL, V37, P471, DOI 10.1128/JCM.37.2.471-474.1999; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Schurch AC, 2010, J CLIN MICROBIOL, V48, P3403, DOI 10.1128/JCM.00370-10; Smittipat N, 2005, J CLIN MICROBIOL, V43, P5034, DOI 10.1128/JCM.43.10.5034-5043.2005; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; Spurgiesz RS, 2003, J CLIN MICROBIOL, V41, P4224, DOI 10.1128/JCM.41.9.4224-4230.2003; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; van der Zanden AGM, 2002, J CLIN MICROBIOL, V40, P4628, DOI 10.1128/JCM.40.12.4628-4639.2002; van Embden JDA, 2000, J BACTERIOL, V182, P2393, DOI 10.1128/JB.182.9.2393-2401.2000; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Vergnaud G, 2006, MOL IDENTIFICATION S, P83; Wada T, 2009, FEMS MICROBIOL LETT, V291, P35, DOI 10.1111/j.1574-6968.2008.01431.x; Wada T, 2007, J MED MICROBIOL, V56, P1052, DOI 10.1099/jmm.0.46990-0; Wang JA, 2011, J CLIN MICROBIOL, V49, P1354, DOI 10.1128/JCM.02274-10; Warren R. M., 2003, AM J RESP CRIT CARE; WHO, 2010, GLOB TUB CONTR 2010; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Yokoyama E, 2010, INFECT GENET EVOL, V10, P913, DOI 10.1016/j.meegid.2010.05.013	75	33	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29190	10.1371/journal.pone.0029190	http://dx.doi.org/10.1371/journal.pone.0029190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220207	Green Published, gold			2022-12-27	WOS:000300677000020
J	Yue, TT; Maupin, KA; Fallon, B; Li, L; Partyka, K; Anderson, MA; Brenner, DE; Kaul, K; Zeh, H; Moser, AJ; Simeone, DM; Feng, ZD; Brand, RE; Haab, BB				Yue, Tingting; Maupin, Kevin A.; Fallon, Brian; Li, Lin; Partyka, Katie; Anderson, Michelle A.; Brenner, Dean E.; Kaul, Karen; Zeh, Herbert; Moser, A. James; Simeone, Diane M.; Feng, Ziding; Brand, Randall E.; Haab, Brian B.			Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers	PLOS ONE			English	Article							ROLLING-CIRCLE AMPLIFICATION; LECTIN SANDWICH ARRAYS; C-TYPE LECTIN; CANCER-PATIENTS; ANTIBODY MICROARRAYS; DENDRITIC CELLS; MUCINS; INFLAMMATION; DIAGNOSIS; GENES	The CA 19-9 assay detects a carbohydrate antigen on multiple protein carriers, some of which may be preferential carriers of the antigen in cancer. We tested the hypothesis that the measurement of the CA 19-9 antigen on individual proteins could improve performance over the standard CA 19-9 assay. We used antibody arrays to measure the levels of the CA 19-9 antigen on multiple proteins in serum or plasma samples from patients with pancreatic adenocarcinoma or pancreatitis. Sample sets from three different institutions were examined, comprising 531 individual samples. The measurement of the CA 19-9 antigen on any individual protein did not improve upon the performance of the standard CA 19-9 assay (82% sensitivity at 75% specificity for early-stage cancer), owing to diversity among patients in their CA 19-9 protein carriers. However, a subset of cancer patients with no elevation in the standard CA 19-9 assay showed elevations of the CA 19-9 antigen specifically on the proteins MUC5AC or MUC16 in all sample sets. By combining measurements of the standard CA 19-9 assay with detection of CA 19-9 on MUC5AC and MUC16, the sensitivity of cancer detection was improved relative to CA 19-9 alone in each sample set, achieving 67-80% sensitivity at 98% specificity. This finding demonstrates the value of measuring glycans on specific proteins for improving biomarker performance. Diagnostic tests with improved sensitivity for detecting pancreatic cancer could have important applications for improving the treatment and management of patients suffering from this disease.	[Yue, Tingting; Maupin, Kevin A.; Fallon, Brian; Partyka, Katie; Haab, Brian B.] Van Andel Inst, Lab Canc Immunodiagnost, Grand Rapids, MI USA; [Li, Lin; Feng, Ziding] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Anderson, Michelle A.; Brenner, Dean E.; Simeone, Diane M.] Univ Michigan, Med Ctr, Ann Arbor, MI USA; [Kaul, Karen] Northshore Univ Hlth Syst, Evanston, IL USA; [Zeh, Herbert; Moser, A. James; Brand, Randall E.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Yue, Tingting] Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA	Van Andel Institute; Fred Hutchinson Cancer Center; University of Michigan System; University of Michigan; NorthShore University Health System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Michigan State University	Yue, TT (corresponding author), Van Andel Inst, Lab Canc Immunodiagnost, Grand Rapids, MI USA.	Brian.haab@vai.org	Moser, A James/AAI-2114-2019		National Cancer Institute [R33 CA122890, CA86400]; National Institute of Diabetes and Digestive and Kidney Diseases [K23 DK082097]; Kutsche Family Professorship at the University of Michigan; Van Andel Research Institute; NATIONAL CANCER INSTITUTE [R33CA122890, U01CA086400, U01CA152653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK082097] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Kutsche Family Professorship at the University of Michigan; Van Andel Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors gratefully acknowledge support of this work from the National Cancer Institute (R33 CA122890, to B. B. H.; CA86400 to D. E. B.); the National Institute of Diabetes and Digestive and Kidney Diseases (K23 DK082097 to M. A. A.); the Kutsche Family Professorship at the University of Michigan (to D. E. B.); and the Van Andel Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsay NV, 2006, AM J GASTROENTEROL, V101, P2330, DOI 10.1111/j.1572-0241.2006.00934.x; Barton JG, 2009, J GASTROINTEST SURG, V13, P2050, DOI 10.1007/s11605-009-0849-z; Belisle JA, 2007, IMMUNOLOGY, V122, P418, DOI 10.1111/j.1365-2567.2007.02660.x; Chen SM, 2007, NAT METHODS, V4, P437, DOI 10.1038/NMETH1035; Forrester S, 2007, MOL ONCOL, V1, P216, DOI 10.1016/j.molonc.2007.06.001; Goonetilleke KS, 2007, EJSO-EUR J SURG ONC, V33, P266, DOI 10.1016/j.ejso.2006.10.004; Haab BB, 2010, ANN SURG, V251, P937, DOI 10.1097/SLA.0b013e3181d7738d; Haab BB, 2010, EXPERT REV PROTEOMIC, V7, P9, DOI 10.1586/EPR.09.102; HIRANO K, 1987, J NATL CANCER I, V79, P1261; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Horwhat John David, 2004, JOP, V5, P289; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Jacobs CB, 2010, ANAL CHIM ACTA, V662, P105, DOI 10.1016/j.aca.2010.01.009; KALTHOFF H, 1986, CANCER RES, V46, P3605; Kloppel G, 2009, ARCH PATHOL LAB MED, V133, P382, DOI 10.1043/1543-2165-133.3.382; LAHDENNE P, 1995, PEDIATR RES, V38, P797, DOI 10.1203/00006450-199511000-00026; Logsdon CD, 2003, CANCER RES, V63, P2649; MAGNANI JL, 1983, CANCER RES, V43, P5489; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; McEver RP, 1997, GLYCOCONJUGATE J, V14, P585, DOI 10.1023/A:1018584425879; Napoletano C, 2007, CANCER RES, V67, P8358, DOI 10.1158/0008-5472.CAN-07-1035; Pepe MS, 2008, J NATL CANCER I, V100, P1432, DOI 10.1093/jnci/djn326; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pines JM, 2009, MED CARE, V47, P782, DOI 10.1097/MLR.0b013e31819748e9; POUR PM, 1988, CANCER RES, V48, P5422; Ringel Jorg, 2003, Mol Cancer, V2, P9, DOI 10.1186/1476-4598-2-9; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Saeland E, 2007, CANCER IMMUNOL IMMUN, V56, P1225, DOI 10.1007/s00262-006-0274-z; Schmidt BF, 1997, J HISTOCHEM CYTOCHEM, V45, P365, DOI 10.1177/002215549704500304; Schweitzer B, 2002, NAT BIOTECHNOL, V20, P359, DOI 10.1038/nbt0402-359; TEMPERO MA, 1987, CANCER RES, V47, P5501; Varki AP, 2008, GLYCOBIOLOGY, V18, P747, DOI 10.1093/glycob/cwn065; Yue T, 2011, PROTEOMICS; Yue TT, 2009, MOL CELL PROTEOMICS, V8, P1697, DOI 10.1074/mcp.M900135-MCP200; Zeng Z, 2009, J CHROMAT A IN PRESS; Zhou HP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r28	36	51	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29180	10.1371/journal.pone.0029180	http://dx.doi.org/10.1371/journal.pone.0029180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220206	Green Accepted, Green Published, gold			2022-12-27	WOS:000300677000019
J	Gregory, MK; Gibson, RA; Cook-Johnson, RJ; Cleland, LG; James, MJ				Gregory, Melissa K.; Gibson, Robert A.; Cook-Johnson, Rebecca J.; Cleland, Leslie G.; James, Michael J.			Elongase Reactions as Control Points in Long-Chain Polyunsaturated Fatty Acid Synthesis	PLOS ONE			English	Article							DELTA-6 DESATURASE; STEARIDONIC ACID; FADS2 GENE; METABOLISM; MICE; N-3; DELTA-6-DESATURASE; EXPRESSION; CLONING; LIVER	Background: D6-Desaturase (Fads2) is widely regarded as rate-limiting in the conversion of dietary a-linolenic acid (18:3n-3; ALA) to the long-chain omega-3 polyunsaturated fatty acid docosahexaenoic acid (22:6n-3; DHA). However, increasing dietary ALA or the direct Fads2 product, stearidonic acid (18:4n-3; SDA), increases tissue levels of eicosapentaenoic acid (20:5n-3; EPA) and docosapentaenoic acid (22:5n-3; DPA), but not DHA. These observations suggest that one or more control points must exist beyond ALA metabolism by Fads2. One possible control point is a second reaction involving Fads2 itself, since this enzyme catalyses desaturation of 24:5n-3 to 24:6n-3, as well as ALA to SDA. However, metabolism of EPA and DPA both require elongation reactions. This study examined the activities of two elongase enzymes as well as the second reaction of Fads2 in order to concentrate on the metabolism of EPA to DHA. Methodology/Principal Findings: The substrate selectivities, competitive substrate interactions and dose response curves of the rat elongases, Elovl2 and Elovl5 were determined after expression of the enzymes in yeast. The competitive substrate interactions for rat Fads2 were also examined. Rat Elovl2 was active with C-20 and C-22 polyunsaturated fatty acids and this single enzyme catalysed the sequential elongation reactions of EPA -> DPA -> 24:5n-3. The second reaction DPA -> 24:5n-3 appeared to be saturated at substrate concentrations not saturating for the first reaction EPA -> DPA. ALA dose-dependently inhibited Fads2 conversion of 24:5n-3 to 24:6n-3. Conclusions: The competition between ALA and 24:5n-3 for Fads2 may explain the decrease in DHA levels observed after certain intakes of dietary ALA have been exceeded. In addition, the apparent saturation of the second Elovl2 reaction, DPA -> 24:5n-3, provides further explanations for the accumulation of DPA when ALA, SDA or EPA is provided in the diet. This study suggests that Elovl2 will be critical in understanding if DHA synthesis can be increased by dietary means.	[Gregory, Melissa K.; Cook-Johnson, Rebecca J.; Cleland, Leslie G.; James, Michael J.] Royal Adelaide Hosp, Rheumatol Unit, Adelaide, SA 5000, Australia; [Gibson, Robert A.] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia	Royal Adelaide Hospital; University of Adelaide	Gregory, MK (corresponding author), Royal Adelaide Hosp, Rheumatol Unit, Adelaide, SA 5000, Australia.	melissa.gregory@health.sa.gov.au	Gibson, Robert Alan/E-7546-2012; Gregory, Melissa/S-1481-2018	Gibson, Robert Alan/0000-0002-8750-525X; Gregory, Melissa/0000-0002-6538-6720	National Health and Medical Research Council of Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the National Health and Medical Research Council of Australia and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki T, 1999, BIOCHEM BIOPH RES CO, V255, P575, DOI 10.1006/bbrc.1999.0235; Blank C, 2002, J LIPID RES, V43, P1537, DOI 10.1194/jlr.M200152-JLR200; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cleland LG, 2005, LIPIDS, V40, P995, DOI 10.1007/s11745-005-1461-6; D'Andrea S, 2002, BIOCHEM J, V364, P49, DOI 10.1042/bj3640049; Gregory MK, 2010, COMP BIOCHEM PHYS B, V155, P178, DOI 10.1016/j.cbpb.2009.11.002; HUANG YS, 1991, BIOCHIM BIOPHYS ACTA, V1082, P319, DOI 10.1016/0005-2760(91)90208-Y; Inagaki K, 2002, BIOSCI BIOTECH BIOCH, V66, P613, DOI 10.1271/bbb.66.613; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; James MJ, 2003, AM J CLIN NUTR, V77, P1140, DOI 10.1093/ajcn/77.5.1140; Leonard AE, 2000, BIOCHEM J, V350, P765, DOI 10.1042/0264-6021:3500765; Leonard AE, 2002, LIPIDS, V37, P733, DOI 10.1007/s11745-002-0955-6; Luthria DL, 1997, BBA-LIPID LIPID MET, V1346, P221, DOI 10.1016/S0005-2760(97)00037-4; Moon YA, 2009, J LIPID RES, V50, P412, DOI 10.1194/jlr.M800383-JLR200; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Pawlosky RJ, 2003, AM J CLIN NUTR, V77, P565, DOI 10.1093/ajcn/77.3.565; Roqueta-Rivera M, 2010, J LIPID RES, V51, P360, DOI 10.1194/jlr.M001180; Stoffel W, 2008, EMBO J, V27, P2281, DOI 10.1038/emboj.2008.156; Stroud CK, 2009, J LIPID RES, V50, P1870, DOI 10.1194/jlr.M900039-JLR200; YAMAZAKI K, 1992, BIOCHIM BIOPHYS ACTA, V1123, P18, DOI 10.1016/0005-2760(92)90166-S; Zadravec D, 2011, J LIPID RES, V52, P245, DOI 10.1194/jlr.M011346	23	103	108	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29662	10.1371/journal.pone.0029662	http://dx.doi.org/10.1371/journal.pone.0029662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216341	Green Submitted, gold, Green Published			2022-12-27	WOS:000299684700074
J	Manning, L; Laman, M; Law, I; Bona, C; Aipit, S; Teine, D; Warrell, J; Rosanas-Urgell, A; Lin, E; Kiniboro, B; Vince, J; Hwaiwhanje, I; Karunajeewa, H; Michon, P; Siba, P; Mueller, I; Davis, TME				Manning, Laurens; Laman, Moses; Law, Irwin; Bona, Cathy; Aipit, Susan; Teine, David; Warrell, Jonathan; Rosanas-Urgell, Anna; Lin, Enmoore; Kiniboro, Benson; Vince, John; Hwaiwhanje, Ilomo; Karunajeewa, Harin; Michon, Pascal; Siba, Peter; Mueller, Ivo; Davis, Timothy M. E.			Features and Prognosis of Severe Malaria Caused by Plasmodium falciparum, Plasmodium vivax and Mixed Plasmodium Species in Papua New Guinean Children	PLOS ONE			English	Article							LIFE-THREATENING MALARIA; AFRICAN CHILDREN; CEREBRAL MALARIA; CLINICAL-FEATURES; INFECTIONS; DISEASE; ALPHA(+)-THALASSEMIA; AREA; OVALOCYTOSIS; CHLOROQUINE	Background: Mortality from severe pediatric falciparum malaria appears low in Oceania but Plasmodium vivax is increasingly recognized as a cause of complications and death. The features and prognosis of mixed Plasmodium species infections are poorly characterized. Detailed prospective studies that include accurate malaria diagnosis and detection of co-morbidities are lacking. Methods and Findings: We followed 340 Papua New Guinean (PNG) children with PCR-confirmed severe malaria (77.1% P. falciparum, 7.9% P. vivax, 14.7% P. falciparum/vivax) hospitalized over a 3-year period. Bacterial cultures were performed to identify co-incident sepsis. Clinical management was under national guidelines. Of 262 children with severe falciparum malaria, 30.9%, 24.8% and 23.2% had impaired consciousness, severe anemia, and metabolic acidosis/hyperlactatemia, respectively. Two (0.8%) presented with hypoglycemia, seven (2.7%) were discharged with neurologic impairment, and one child died (0.4%). The 27 severe vivax malaria cases presented with similar phenotypic features to the falciparum malaria cases but respiratory distress was five times more common (P = 0.001); one child died (3.7%). The 50 children with P. falciparum/vivax infections shared phenotypic features of mono-species infections, but were more likely to present in deep coma and had the highest mortality (8.0%; P = 0.003 vs falciparum malaria). Overall, bacterial cultures were positive in only two non-fatal cases. 83.6% of the children had alpha-thalassemia trait and seven with coma/impaired consciousness had South Asian ovalocytosis (SAO). Conclusions: The low mortality from severe falciparum malaria in PNG children may reflect protective genetic factors other than alpha-thalassemia trait/SAO, good nutrition, and/or infrequent co-incident sepsis. Severe vivax malaria had similar features but severe P. falciparum/vivax infections were associated with the most severe phenotype and worst prognosis.	[Manning, Laurens; Laman, Moses; Karunajeewa, Harin; Davis, Timothy M. E.] Univ Western Australia, Sch Med & Pharmacol, Fremantle Hosp, Fremantle, WA, Australia; [Laman, Moses; Law, Irwin; Bona, Cathy; Aipit, Susan; Teine, David; Warrell, Jonathan; Rosanas-Urgell, Anna; Lin, Enmoore; Kiniboro, Benson; Michon, Pascal; Siba, Peter; Mueller, Ivo] Papua New Guinea Inst Med Res, Madang, Madang Province, Papua N Guinea; [Vince, John] Univ Papua New Guinea, Sch Med & Hlth Sci, Port Moresby, Papua N Guinea; [Hwaiwhanje, Ilomo] Goroka Base Hosp, Dept Pediat, Goroka, Eastern Highlan, Papua N Guinea	University of Western Australia; PNG Institute Of Medical Research; University of Papua New Guinea	Manning, L (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Fremantle Hosp, Fremantle, WA, Australia.	tdavis@cyllene.uwa.edu.au	Rosanas-Urgell, Anna/D-3193-2015; Manning, Laurens A/H-5360-2014; Mueller, Ivo/C-7251-2013; Davis, Timothy ME/M-5144-2014	Rosanas-Urgell, Anna/0000-0002-0432-5203; Manning, Laurens A/0000-0003-4334-5351; Mueller, Ivo/0000-0001-6554-6889; Lin, Enmoore/0000-0002-8584-7627; Davis, Timothy/0000-0003-0749-7411; Law, Irwin/0000-0002-1194-677X; Laman, Moses/0000-0003-0964-805X	National Health and Medical Research Council (NHMRC) [513782]; MalariaGen Genomic Epidemiology Network; Fogarty Foundation; Royal Australian College of Physician	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); MalariaGen Genomic Epidemiology Network; Fogarty Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Royal Australian College of Physician	This study was funded by a National Health and Medical Research Council (NHMRC) grant (#513782). The authors also acknowledge support from the MalariaGen Genomic Epidemiology Network. ML was supported by a Fogarty Foundation scholarship, LM by a Basser scholarship from the Royal Australian College of Physicians and an NHMRC scholarship, and TMED by an NHMRC Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre MA, 2010, EMERG INFECT DIS, V16, P1611, DOI 10.3201/eid1610.100685; Allen SJ, 1996, QJM-INT J MED, V89, P779, DOI 10.1093/qjmed/89.10.779; Allen SJ, 1999, AM J TROP MED HYG, V60, P1056, DOI 10.4269/ajtmh.1999.60.1056; Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; Anstey NM, 2007, J INFECT DIS, V195, P589, DOI 10.1086/510756; Barcus MJ, 2007, AM J TROP MED HYG, V77, P984, DOI 10.4269/ajtmh.2007.77.984; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bejon P, 2007, PLOS MED, V4, P1333, DOI 10.1371/journal.pmed.0040251; Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X; Bruce MC, 2000, SCIENCE, V287, P845, DOI 10.1126/science.287.5454.845; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; Davis TME, 1997, BRIT J CLIN PHARMACO, V44, P1, DOI 10.1046/j.1365-2125.1997.00597.x; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Dzeing-Ella A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-1; Fernandez-Becerra C, 2009, TRENDS PARASITOL, V25, P44, DOI 10.1016/j.pt.2008.09.012; GENTON B, 1995, NATURE, V378, P564, DOI 10.1038/378564a0; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Imbert P, 2002, T ROY SOC TROP MED H, V96, P278, DOI 10.1016/S0035-9203(02)90099-4; Imrie H, 2006, AM J TROP MED HYG, V74, P965, DOI 10.4269/ajtmh.2006.74.965; JAROLIM P, 1991, P NATL ACAD SCI USA, V88, P11022, DOI 10.1073/pnas.88.24.11022; Karunajeewa HA, 2006, ANTIMICROB AGENTS CH, V50, P968, DOI 10.1128/AAC.50.3.968-974.2006; Karunajeewa HA, 2008, NEW ENGL J MED, V359, P2545, DOI 10.1056/NEJMoa0804915; Kochar DK, 2009, AM J TROP MED HYG, V80, P194, DOI 10.4269/ajtmh.2009.80.194; Kochar DK, 2010, AM J TROP MED HYG, V83, P981, DOI 10.4269/ajtmh.2010.09-0633; Lacerda MVG, 2004, ACTA TROP, V90, P187, DOI 10.1016/j.actatropica.2003.12.001; Laman M, 2010, CLIN INFECT DIS, V51, P534, DOI 10.1086/655679; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; Luxemburger C, 1997, T ROY SOC TROP MED H, V91, P256, DOI 10.1016/S0035-9203(97)90066-3; Maitland K, 1997, T ROY SOC TROP MED H, V91, P562, DOI 10.1016/S0035-9203(97)90026-2; Manning L, 2011, AM J TROP MED HYG, V85, P50, DOI 10.4269/ajtmh.2011.11-0095; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Mockenhaupt FP, 2004, BLOOD, V104, P2003, DOI 10.1182/blood-2003-11-4090; Mockenhaupt FP, 2004, AM J TROP MED HYG, V71, P167, DOI 10.4269/ajtmh.2004.71.167; MOLYNEUX ME, 1989, Q J MED, V71, P441; MOOSA AA, 1995, LANCET, V345, P1290, DOI 10.1016/S0140-6736(95)90931-1; Ohrt C, 2002, J INFECT DIS, V186, P540, DOI 10.1086/341938; Okeniyi John, 2008, Congenit Heart Dis, V3, P73, DOI 10.1111/j.1747-0803.2007.00153.x; Paediatrics Society of PNG, 2005, STAND TREATM COMM IL; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; Ranque S, 2008, PEDIATR INFECT DIS J, V27, P130, DOI 10.1097/INF.0b013e31815988ed; SCHAPIRA A, 1993, T ROY SOC TROP MED H, V87, P299, DOI 10.1016/0035-9203(93)90136-E; SCHELLENBERG JRMA, 1994, PARASITOL TODAY, V10, P439, DOI 10.1016/0169-4758(94)90179-1; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; Smith T, 2001, T ROY SOC TROP MED H, V95, P1, DOI 10.1016/S0035-9203(01)90314-1; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; STACE J, 1982, PAPUA NEW GUINEA MED, V25, P230; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; UNAIDS, 2010, GLOB REP FACT SHEET; WHITE NJ, 1992, LANCET, V339, P317, DOI 10.1016/0140-6736(92)91644-N; YENCHITSOMANUS PT, 1985, AM J HUM GENET, V37, P778; Zimmerman PA, 2004, TRENDS PARASITOL, V20, P440, DOI 10.1016/j.pt.2004.07.004	54	59	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29203	10.1371/journal.pone.0029203	http://dx.doi.org/10.1371/journal.pone.0029203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216212	Green Published, gold			2022-12-27	WOS:000299684700039
J	Stoewer, S; Goense, J; Keliris, GA; Bartels, A; Logothetis, NK; Duncan, J; Sigala, N				Stoewer, Steffen; Goense, Jozien; Keliris, Georgios A.; Bartels, Andreas; Logothetis, Nikos K.; Duncan, John; Sigala, Natasha			An Analysis Approach for High-Field fMRI Data from Awake Non-Human Primates	PLOS ONE			English	Article							ECHO-PLANAR; FUNCTIONAL MRI; TEMPLATE IMAGES; MAGNETIC-FIELD; VISUAL-CORTEX; TEMPORAL-LOBE; OFF-RESONANCE; HUMAN BRAIN; 7 T; MACAQUE	fMRI experiments with awake non-human primates (NHP) have seen a surge of applications in recent years. However, the standard fMRI analysis tools designed for human experiments are not optimal for analysis of NHP fMRI data collected at high fields. There are several reasons for this, including the trial-based nature of NHP experiments, with inter-trial periods being of no interest, and segmentation artefacts and distortions that may result from field changes due to movement. We demonstrate an approach that allows us to address some of these issues consisting of the following steps: 1) Trial-based experimental design. 2) Careful control of subject movement. 3) Computer-assisted selection of trials devoid of artefacts and animal motion. 4) Nonrigid between-trial and rigid within-trial realignment of concatenated data from temporally separated trials and sessions. 5) Linear interpolation of inter-trial intervals and high-pass filtering of temporally continuous data 6) Removal of interpolated data and reconcatenation of datasets before statistical analysis with SPM. We have implemented a software toolbox, fMRI Sandbox (http://code.google.com/p/fmri-sandbox/), for semi-automated application of these processing steps that interfaces with SPM software. Here, we demonstrate that our methodology provides significant improvements for the analysis of awake monkey fMRI data acquired at high-field. The method may also be useful for clinical applications with subjects that are unwilling or unable to remain motionless for the whole duration of a functional scan.	[Stoewer, Steffen; Goense, Jozien; Keliris, Georgios A.; Bartels, Andreas; Logothetis, Nikos K.] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Bartels, Andreas] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany; [Logothetis, Nikos K.] Univ Manchester, Manchester, Lancs, England; [Duncan, John] MRC Cognit & Brain Sci Unit, Cambridge, England; [Sigala, Natasha] Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England	Max Planck Society; Eberhard Karls University of Tubingen; University of Manchester; University of Brighton; University of Sussex	Stoewer, S (corresponding author), Max Planck Inst Biol Cybernet, Tubingen, Germany.	steffen.stoewer@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019; Keliris, Georgios A/B-6692-2008; Sigala, Natasha/ABH-3181-2020; Sigala, Natasha/K-1750-2013; Bartels, Andreas/A-9446-2014	Keliris, Georgios A/0000-0001-6732-1261; Sigala, Natasha/0000-0002-9456-6093; Sigala, Natasha/0000-0002-9456-6093; Bartels, Andreas/0000-0002-4939-7817; Duncan, John S/0000-0002-1373-0681; Duncan, John/0000-0002-9695-2764	James McDonnell Foundation [220020081]; Max Planck Society; UK Medical Research Council [MC_US_A060_0002]; UK Royal Society [DH051644]; MRC [MC_U105580448] Funding Source: UKRI; Medical Research Council [MC_U105580448] Funding Source: researchfish	James McDonnell Foundation; Max Planck Society(Max Planck Society); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by James McDonnell Foundation project grant No: 220020081 (NKL, JD, NS), the Max Planck Society, the UK Medical Research Council intramural program MC_US_A060_0002 (JD) and the UK Royal Society (DH051644) (NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Birn RM, 1998, MAGNET RESON MED, V40, P55, DOI 10.1002/mrm.1910400108; Black KJ, 2001, NEUROIMAGE, V14, P736, DOI 10.1006/nimg.2001.0752; Black KJ, 2001, NEUROIMAGE, V14, P744, DOI 10.1006/nimg.2001.0871; Blaimer Martin, 2004, Top Magn Reson Imaging, V15, P223, DOI 10.1097/01.rmr.0000136558.09801.dd; Croft RJ, 2000, NEUROPHYSIOL CLIN, V30, P5, DOI 10.1016/S0987-7053(00)00055-1; de Zwart Jacco A, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P17; EHMAN RL, 1989, RADIOLOGY, V173, P255, DOI 10.1148/radiology.173.1.2781017; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Ekstrom LB, 2009, J NEUROSCI, V29, P10683, DOI 10.1523/JNEUROSCI.0673-09.2009; Frackowiak RSJ., 2003, HUMAN BRAIN FUNCTION; Frey S, 2011, NEUROIMAGE, V55, P1435, DOI 10.1016/j.neuroimage.2011.01.040; Goense JBM, 2008, NEUROIMAGE, V39, P1081, DOI 10.1016/j.neuroimage.2007.09.038; Goense JBM, 2010, METHODS, V50, P178, DOI 10.1016/j.ymeth.2009.08.003; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Huettel SA, 2009, FUNCTIONAL MAGNETIC; Hutchison RM, 2011, NEUROIMAGE, V56, P1546, DOI 10.1016/j.neuroimage.2011.02.063; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Jezzard P, 1999, HUM BRAIN MAPP, V8, P80, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<80::AID-HBM2>3.0.CO;2-C; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Keliris GA, 2007, NEUROIMAGE, V36, P550, DOI 10.1016/j.neuroimage.2007.02.057; Kolster H, 2009, J NEUROSCI, V29, P7031, DOI 10.1523/JNEUROSCI.0518-09.2009; Ku SP, 2011, NEURON, V70, P352, DOI 10.1016/j.neuron.2011.02.048; Lamberton F, 2007, J MAGN RESON IMAGING, V26, P747, DOI 10.1002/jmri.21039; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Logothetis NK, 2002, NEURON, V35, P227, DOI 10.1016/S0896-6273(02)00775-4; Luo WL, 2003, NEUROIMAGE, V19, P1014, DOI 10.1016/S1053-8119(03)00149-6; Lutcke H, 2006, MAGN RESON IMAGING, V24, P1, DOI 10.1016/j.mri.2005.10.028; Mazaika P. K., 2009, HUM BRAIN MAPP C SAN; MCKINNON GC, 1993, MAGNET RESON MED, V30, P609, DOI 10.1002/mrm.1910300512; McLaren DG, 2009, NEUROIMAGE, V45, P52, DOI 10.1016/j.neuroimage.2008.10.058; Pfeuffer J, 2004, MAGN RESON IMAGING, V22, P1343, DOI 10.1016/j.mri.2004.10.004; Pfeuffer J, 2002, MAGN RESON MED, V47, P344, DOI 10.1002/mrm.10065; Pfeuffer J, 2007, MAGN RESON IMAGING, V25, P869, DOI 10.1016/j.mri.2007.03.002; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Quallo MM, 2010, NEUROIMAGE, V52, P1328, DOI 10.1016/j.neuroimage.2010.05.006; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Srihasam K, 2010, NEUROIMAGE, V51, P267, DOI 10.1016/j.neuroimage.2010.01.082; Stoewer S, 2011, MAGN RESON IMAGING, V29, P1390, DOI 10.1016/j.mri.2011.05.003; Stoewer S, 2010, MAGN RESON IMAGING, V28, P1120, DOI 10.1016/j.mri.2009.12.024; Van Essen DC, 2002, CURR OPIN NEUROBIOL, V12, P574, DOI 10.1016/S0959-4388(02)00361-6; Wan X, 1997, MAGNET RESON MED, V37, P932, DOI 10.1002/mrm.1910370619; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055	45	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29697	10.1371/journal.pone.0029697	http://dx.doi.org/10.1371/journal.pone.0029697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238636	Green Published, Green Accepted, gold			2022-12-27	WOS:000301188800026
J	Bachlava, E; Taylor, CA; Tang, SX; Bowers, JE; Mandel, JR; Burke, JM; Knapp, SJ				Bachlava, Eleni; Taylor, Christopher A.; Tang, Shunxue; Bowers, John E.; Mandel, Jennifer R.; Burke, John M.; Knapp, Steven J.			SNP Discovery and Development of a High-Density Genotyping Array for Sunflower	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; INBRED LINES; GENOME; ASSAY; IDENTIFICATION; ANNOTATION; DIVERSITY; BLAST2GO	Recent advances in next-generation DNA sequencing technologies have made possible the development of high-throughput SNP genotyping platforms that allow for the simultaneous interrogation of thousands of single-nucleotide polymorphisms (SNPs). Such resources have the potential to facilitate the rapid development of high-density genetic maps, and to enable genome-wide association studies as well as molecular breeding approaches in a variety of taxa. Herein, we describe the development of a SNP genotyping resource for use in sunflower (Helianthus annuus L.). This work involved the development of a reference transcriptome assembly for sunflower, the discovery of thousands of high quality SNPs based on the generation and analysis of ca. 6 Gb of transcriptome re-sequencing data derived from multiple genotypes, the selection of 10,640 SNPs for inclusion in the genotyping array, and the use of the resulting array to screen a diverse panel of sunflower accessions as well as related wild species. The results of this work revealed a high frequency of polymorphic SNPs and relatively high level of cross-species transferability. Indeed, greater than 95% of successful SNP assays revealed polymorphism, and more than 90% of these assays could be successfully transferred to related wild species. Analysis of the polymorphism data revealed patterns of genetic differentiation that were largely congruent with the evolutionary history of sunflower, though the large number of markers allowed for finer resolution than has previously been possible.	[Bachlava, Eleni; Taylor, Christopher A.; Tang, Shunxue; Bowers, John E.; Knapp, Steven J.] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA; [Bowers, John E.; Mandel, Jennifer R.; Burke, John M.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bachlava, E (corresponding author), Monsanto Co, Woodland, CA 95695 USA.	jmburke@uga.edu	Bowers, John/AAD-7601-2019; Bowers, John/B-9245-2009; Burke, John M/A-3502-2013	Bowers, John/0000-0001-8984-9796; Burke, John M/0000-0002-1412-5539; Mandel, Jennifer/0000-0003-3539-2991; Bowers, John/0000-0001-5693-2796	Advanta Semillas; Dow Agrosciences; Pioneer Hi-Bred; Syngenta; Georgia Research Alliance	Advanta Semillas; Dow Agrosciences; Pioneer Hi-Bred; Syngenta(Syngenta); Georgia Research Alliance	This work was supported by funding from Advanta Semillas (http://www.advantasemillas.com.ar/en/#/prehome), Dow Agrosciences(www.dowagro.com/), Pioneer Hi-Bred (pioneer.com), Syngenta (syngenta.com), and the Georgia Research Alliance (gra.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Ching A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-19; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fahrenkrug SC, 2002, ANIM GENET, V33, P186, DOI 10.1046/j.1365-2052.2002.00846.x; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Fusari CM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-7; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; HEISER C. B. JUN., 1951, Proceedings of the American Philosophical Society, V95, P432; Hyten DL, 2008, THEOR APPL GENET, V116, P945, DOI 10.1007/s00122-008-0726-2; Kane NC, 2011, BOTANY, V89, P429, DOI [10.1139/B11-032, 10.1139/b11-032]; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kolkman JM, 2007, GENETICS, V177, P457, DOI 10.1534/genetics.107.074054; Lai Z, 2005, THEOR APPL GENET, V111, P1532, DOI 10.1007/s00122-005-0082-4; Liang C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-115; Liu AZ, 2006, GENETICS, V173, P321, DOI 10.1534/genetics.105.051110; Mandel J, 2011, THEOR APPL GENET, V123, P693, DOI 10.1007/s00122-011-1619-3; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Morton BR, 2006, GENETICS, V172, P569, DOI 10.1534/genetics.105.049916; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; NEI M, 1978, GENETICS, V89, P583; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pritchard JK, 2000, GENETICS, V155, P945; Putt E.D., 1997, SUNFLOWER TECHNOLOGY, V2nd ed., P1, DOI [10.2134/agronmonogr35, DOI 10.2134/AGRONMONOGR35.C1]; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Soleri Daniela, 1993, Journal of Ethnobiology, V13, P203; Timme RE, 2007, AM J BOT, V94, P1837, DOI 10.3732/ajb.94.11.1837; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang FK, 2004, GENOMICS, V84, P785, DOI 10.1016/j.ygeno.2004.06.015; Zhu YL, 2003, GENETICS, V163, P1123	33	90	91	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29814	10.1371/journal.pone.0029814	http://dx.doi.org/10.1371/journal.pone.0029814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238659	Green Submitted, gold, Green Published			2022-12-27	WOS:000301070200050
J	Vecchio, G; Galeone, A; Brunetti, V; Maiorano, G; Sabella, S; Cingolani, R; Pompa, PP				Vecchio, Giuseppe; Galeone, Antonio; Brunetti, Virgilio; Maiorano, Gabriele; Sabella, Stefania; Cingolani, Roberto; Pompa, Pier Paolo			Concentration-Dependent, Size-Independent Toxicity of Citrate Capped AuNPs in Drosophila melanogaster	PLOS ONE			English	Article							GOLD NANOPARTICLES; OXIDATIVE STRESS; IN-VITRO; PARTICLE-SIZE; P53; PROTEIN; CYTOTOXICITY; SHOCK; DELIVERY; CELLS	The expected potential benefits promised by nanotechnology in various fields have led to a rapid increase of the presence of engineered nanomaterials in a high number of commercial goods. This is generating increasing questions about possible risks for human health and environment, due to the lack of an in-depth assessment of the physical/chemical factors responsible for their toxic effects. In this work, we evaluated the toxicity of monodisperse citrate-capped gold nanoparticles (AuNPs) of different sizes (5, 15, 40, and 80 nm) in the model organism Drosophila melanogaster, upon ingestion. To properly evaluate and distinguish the possible dose-and/or size-dependent toxicity of the AuNPs, we performed a thorough assessment of their biological effects, using two different dose-metrics. In the first approach, we kept constant the total surface area of the differently sized AuNPs (Total Exposed Surface area approach, TES), while, in the second approach, we used the same number concentration of the four different sizes of AuNPs (Total Number of Nanoparticles approach, TNN). We observed a significant AuNPs-induced toxicity in vivo, namely a strong reduction of Drosophila lifespan and fertility performance, presence of DNA fragmentation, as well as a significant modification in the expression levels of genes involved in stress responses, DNA damage recognition and apoptosis pathway. Interestingly, we found that, within the investigated experimental conditions, the toxic effects in the exposed organisms were directly related to the concentration of the AuNPs administered, irrespective of their size.	[Vecchio, Giuseppe; Galeone, Antonio; Brunetti, Virgilio; Maiorano, Gabriele; Sabella, Stefania; Pompa, Pier Paolo] Italian Inst Technol, Ctr Biomol Nanotechnol UniLe, Lecce, Italy; [Cingolani, Roberto] Italian Inst Technol, Cent Res Labs, Genoa, Italy	Istituto Italiano di Tecnologia - IIT; Istituto Italiano di Tecnologia - IIT	Vecchio, G (corresponding author), Italian Inst Technol, Ctr Biomol Nanotechnol UniLe, Lecce, Italy.	giuseppe.vecchio@iit.it; pierpaolo.pompa@iit.it	Brunetti, Virgilio/AGZ-3500-2022; Vecchio, Giuseppe/C-4823-2011; Maiorano, Gabriele/J-7808-2015	Vecchio, Giuseppe/0000-0002-3002-8501; Maiorano, Gabriele/0000-0003-2205-2293; Galeone, Antonio/0000-0002-8678-7726; Brunetti, Virgilio/0000-0002-7615-1150				Adams MD, 2002, NAT REV GENET, V3, P189, DOI 10.1038/nrg752; Ahamed M, 2010, TOXICOL APPL PHARM, V242, P263, DOI 10.1016/j.taap.2009.10.016; Alkilany AM, 2009, SMALL, V5, P701, DOI 10.1002/smll.200801546; Arts MJSJ, 2004, ECOTOXICOLOGY, V13, P739, DOI 10.1007/s10646-003-4473-5; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bauer JH, 2005, CURR BIOL, V15, P2063, DOI 10.1016/j.cub.2005.10.051; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Botas Juan, 2007, Nat Genet, V39, P589, DOI 10.1038/ng0507-589; Boverhof DR, 2010, ANAL BIOANAL CHEM, V396, P953, DOI 10.1007/s00216-009-3103-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bratton SB, 2010, J CELL SCI, V123, P3209, DOI 10.1242/jcs.073643; Brown SD, 2010, J AM CHEM SOC, V132, P4678, DOI 10.1021/ja908117a; Brunner TJ, 2006, ENVIRON SCI TECHNOL, V40, P4374, DOI 10.1021/es052069i; Chien S, 2002, NUCLEIC ACIDS RES, V30, P149, DOI 10.1093/nar/30.1.149; Cho WS, 2010, TOXICOL APPL PHARM, V245, P116, DOI 10.1016/j.taap.2010.02.013; Choi CHJ, 2010, P NATL ACAD SCI USA, V107, P1235, DOI 10.1073/pnas.0914140107; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Daish TJ, 2004, DEV CELL, V7, P909, DOI 10.1016/j.devcel.2004.09.018; Demir ER, 2011, NANOTOXICOLOGY, V5, P417, DOI 10.3109/17435390.2010.529176; Donaldson K, 2004, OCCUP ENVIRON MED, V61, P727, DOI 10.1136/oem.2004.013243; Duffin R, 2007, INHAL TOXICOL, V19, P849, DOI 10.1080/08958370701479323; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fortunato JJ, 2006, NEUROCHEM RES, V31, P671, DOI 10.1007/s11064-006-9065-3; Foster KA, 2006, PROG NEUROBIOL, V79, P136, DOI 10.1016/j.pneurobio.2006.07.001; Franzellitti S, 2005, BIOCHEM BIOPH RES CO, V336, P1157, DOI 10.1016/j.bbrc.2005.08.244; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Ghosh P, 2008, ADV DRUG DELIVER REV, V60, P1307, DOI 10.1016/j.addr.2008.03.016; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Han G., 2007, NANOBIOTECHNOLOGY, V3, P40, DOI DOI 10.1007/S12030-007-0005-3; He H, 2008, ANAL CHEM, V80, P5951, DOI 10.1021/ac8005796; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jennings BH, 2011, MATER TODAY, V14, P190, DOI 10.1016/S1369-7021(11)70113-4; Kazantsev A, 2002, NAT GENET, V30, P367, DOI 10.1038/ng864; Khan JA, 2007, CHEMBIOCHEM, V8, P1237, DOI 10.1002/cbic.200700165; Kim B, 2010, NAT NANOTECHNOL, V5, P465, DOI [10.1038/nnano.2010.58, 10.1038/NNANO.2010.58]; Kohler HR, 2005, COMP BIOCHEM PHYS C, V141, P398, DOI 10.1016/j.cbpc.2005.09.003; Kumar S, 2000, CELL DEATH DIFFER, V7, P1039, DOI 10.1038/sj.cdd.4400756; Laubitz D, 2006, EXP PHYSIOL, V91, P867, DOI 10.1113/expphysiol.2006.033365; Lee JS, 2006, J AM CHEM SOC, V128, P8899, DOI 10.1021/ja061651j; Lee JH, 2003, FEBS LETT, V550, P5, DOI 10.1016/S0014-5793(03)00771-3; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li JJ, 2010, BIOMATERIALS, V31, P5996, DOI 10.1016/j.biomaterials.2010.04.014; Liu XO, 2007, COLLOID SURFACE B, V58, P3, DOI 10.1016/j.colsurfb.2006.08.005; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynes MA, 2007, ANN NY ACAD SCI, V1113, P159, DOI 10.1196/annals.1391.010; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Maiorano G, 2010, ACS NANO, V4, P7481, DOI 10.1021/nn101557e; Matthews KA, 2005, NAT REV GENET, V6, P179, DOI 10.1038/nrg1554; May P, 1999, ONCOGENE, V18, P7621, DOI 10.1038/sj.onc.1203285; Mu CJ, 2010, ACS NANO, V4, P1511, DOI 10.1021/nn9017334; Murdock RC, 2008, TOXICOL SCI, V101, P239, DOI 10.1093/toxsci/kfm240; Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Oberdorster G, 2010, J INTERN MED, V267, P89, DOI 10.1111/j.1365-2796.2009.02187.x; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Pernodet N, 2006, SMALL, V2, P766, DOI 10.1002/smll.200500492; Pompa PP, 2011, NANO RES, V4, P405, DOI 10.1007/s12274-011-0095-z; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prives C, 1999, J PATHOL, V187, P112; Rand MD, 2010, NEUROTOXICOL TERATOL, V32, P74, DOI 10.1016/j.ntt.2009.06.004; Reiter Lawrence T, 2002, Expert Opin Ther Targets, V6, P387; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Rubin GM, 2000, SCIENCE, V287, P2216, DOI 10.1126/science.287.5461.2216; Sabella S., 2011, J NANOSCI LETT, V1, P145; Sabella S, 2011, J NANOPART RES, V13, P6821, DOI 10.1007/s11051-011-0590-x; Schrand AM, 2010, WIRES NANOMED NANOBI, V2, P544, DOI 10.1002/wnan.103; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Silbermann R, 2000, EVOLUTION, V54, P2038; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Sonavane G, 2008, COLLOID SURFACE B, V66, P274, DOI 10.1016/j.colsurfb.2008.07.004; Stone V, 2006, NAT NANOTECHNOL, V1, P23, DOI 10.1038/nnano.2006.69; STREMSDOERFER G, 1988, J ELECTROCHEM SOC, V135, P2881, DOI 10.1149/1.2095453; Tower J, 2011, EXP GERONTOL, V46, P355, DOI 10.1016/j.exger.2010.09.002; TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202; Vincent A, 2010, J MOL CELL BIOL, V2, P74, DOI 10.1093/jmcb/mjp042; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Wang ST, 2010, ANGEW CHEM INT EDIT, V49, P3777, DOI 10.1002/anie.201000062; Warheit DB, 2008, TOXICOL SCI, V101, P183, DOI 10.1093/toxsci/kfm279; Wu T, 1998, J Tongji Med Univ, V18, P204; Xia T, 2004, ENVIRON HEALTH PERSP, V112, P1347, DOI 10.1289/ehp.7167; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k; Yang H, 2009, J APPL TOXICOL, V29, P69, DOI 10.1002/jat.1385; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zou XQ, 2006, NANOTECHNOLOGY, V17, P4758, DOI 10.1088/0957-4484/17/18/038	93	61	63	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29980	10.1371/journal.pone.0029980	http://dx.doi.org/10.1371/journal.pone.0029980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238688	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200065
J	Gonthier, DJ				Gonthier, David J.			Do Herbivores Eavesdrop on Ant Chemical Communication to Avoid Predation?	PLOS ONE			English	Article							OVIPOSITION BEHAVIOR; COMMUNITY STRUCTURE; INSECT HERBIVORES; COFFEE PRODUCTION; AZTECA; CUES; GLAND; PLANTS; DAMAGE; SCENT	Strong effects of predator chemical cues on prey are common in aquatic and marine ecosystems, but are thought to be rare in terrestrial systems and specifically for arthropods. For ants, herbivores are hypothesized to eavesdrop on ant chemical communication and thereby avoid predation or confrontation. Here I tested the effect of ant chemical cues on herbivore choice and herbivory. Using Margaridisa sp. flea beetles and leaves from the host tree (Conostegia xalapensis), I performed paired-leaf choice feeding experiments. Coating leaves with crushed ant liquids (Azteca instabilis), exposing leaves to ant patrolling prior to choice tests (A. instabilis and Camponotus textor) and comparing leaves from trees with and without A. instabilis nests resulted in more herbivores and herbivory on control (no ant-treatment) relative to ant-treatment leaves. In contrast to A. instabilis and C. textor, leaves previously patrolled by Solenopsis geminata had no difference in beetle number and damage compared to control leaves. Altering the time A. instabilis patrolled treatment leaves prior to choice tests (0-, 5-, 30-, 90-, 180-min.) revealed treatment effects were only statistically significant after 90- and 180-min. of prior leaf exposure. This study suggests, for two ecologically important and taxonomically diverse genera (Azteca and Camponotus), ant chemical cues have important effects on herbivores and that these effects may be widespread across the ant family. It suggests that the effect of chemical cues on herbivores may only appear after substantial previous ant activity has occurred on plant tissues. Furthermore, it supports the hypothesis that herbivores use ant chemical communication to avoid predation or confrontation with ants.	[Gonthier, David J.] Univ Toledo, Dept Environm Sci, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Gonthier, DJ (corresponding author), Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA.	Gonthier@umich.edu			University of Toledo; Sigma Xi; National Science Foundation Division of Environmental Biology [0349388]; National Science Foundation under Division of Graduate Education [0718128]; University of Michigan; Direct For Biological Sciences [1262086] Funding Source: National Science Foundation	University of Toledo; Sigma Xi; National Science Foundation Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation under Division of Graduate Education; University of Michigan(University of Michigan System); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	A University of Toledo Travel Grant, Sigma Xi - Grant-in-Aid of Research, and National Science Foundation Division of Environmental Biology-0349388 to I. Perfecto and J. Vandermeer funded this research. This material is based upon work supported by the National Science Foundation Graduate Student Research Fellowship under Division of Graduate Education-0718128. This article was made available as Open Access with the support of the University of Michigan Compact for Open-Access Publishing Equity Fund, http://lib.umich.edu/cope. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS ES, 1994, OECOLOGIA, V97, P202, DOI 10.1007/BF00323150; Adandonon A, 2009, INT J PEST MANAGE, V55, P285, DOI 10.1080/09670870902878418; Agrawal AA, 1998, ECOLOGY, V79, P2100, DOI 10.1890/0012-9658(1998)079[2100:LDAACI]2.0.CO;2; BOLTON B, 1995, J NAT HIST, V29, P1037, DOI 10.1080/00222939500770411; Brettschneider H, 2005, J INSECT BEHAV, V18, P381, DOI 10.1007/s10905-005-3697-z; Brown GE, 2006, CAN J ZOOL, V84, P1, DOI 10.1139/Z05-166; Chamberlain SA, 2009, ECOLOGY, V90, P2384, DOI 10.1890/08-1490.1; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Do Nascimento RR, 1998, J CHEM ECOL, V24, P1629, DOI 10.1023/A:1020864427854; Federle W, 1998, INSECT SOC, V45, P1, DOI 10.1007/s000400050064; Feener DH, 1996, ANIM BEHAV, V51, P61, DOI 10.1006/anbe.1996.0005; Gonthier DJ, 2010, J TROP ECOL, V26, P343, DOI 10.1017/S0266467409990666; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Halitschke R, 2008, ECOL LETT, V11, P24, DOI 10.1111/j.1461-0248.2007.01123.x; HEFETZ A, 1978, SCIENCE, V201, P454, DOI 10.1126/science.201.4354.454; Holldobler B., 1990, pi; JAFFE K, 1984, J INSECT PHYSIOL, V30, P265, DOI 10.1016/0022-1910(84)90126-4; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Kohl E, 2003, CHEMOECOLOGY, V13, P113, DOI 10.1007/s00049-003-0237-1; Longino John T., 2006, Myrmecologische Nachrichten, V8, P131; LONGINO JT, 1989, BIOTROPICA, V21, P126, DOI 10.2307/2388703; Martin S, 2009, J CHEM ECOL, V35, P1151, DOI 10.1007/s10886-009-9695-4; Mathis KA, 2011, J INSECT BEHAV, V24, P186, DOI 10.1007/s10905-010-9247-3; Menzel F, 2010, ECOL ENTOMOL, V35, P495, DOI 10.1111/j.1365-2311.2010.01206.x; Morgan E. David, 2008, Myrmecological News, V11, P79; Nakamura S, 2005, PLANT PROD SCI, V8, P27, DOI 10.1626/pps.8.27; NOLTE DL, 1994, J CHEM ECOL, V20, P1505, DOI 10.1007/BF02059876; OBIN MS, 1985, J CHEM ECOL, V11, P1757, DOI 10.1007/BF01012125; Offenberg J, 2004, P ROY SOC B-BIOL SCI, V271, pS433, DOI 10.1098/rsbl.2004.0210; Oliveira PS, 1999, FUNCT ECOL, V13, P623, DOI 10.1046/j.1365-2435.1999.00360.x; Oliver TH, 2008, ECOL ENTOMOL, V33, P523, DOI 10.1111/j.1365-2311.2008.01009.x; Oliver TH, 2007, P ROY SOC B-BIOL SCI, V274, P3127, DOI 10.1098/rspb.2007.1251; Peacor SD, 2001, P NATL ACAD SCI USA, V98, P3904, DOI 10.1073/pnas.071061998; Peckarsky BL, 2002, ECOLOGY, V83, P612, DOI 10.2307/3071867; Perfecto I, 2006, AGR ECOSYST ENVIRON, V117, P218, DOI 10.1016/j.agee.2006.04.007; Persons MH, 2001, ANIM BEHAV, V61, P43, DOI 10.1006/anbe.2000.1594; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; Rudgers JA, 2003, OECOLOGIA, V135, P51, DOI 10.1007/s00442-002-1168-1; Ruther J, 2000, PHYSIOL ENTOMOL, V25, P172, DOI 10.1046/j.1365-3032.2000.00183.x; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Sokal R.R., 2012, BIOMETRY; SPSS, 2007, SPSS GRAD STUD VERS; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; SULLIVAN TP, 1984, J CHEM ECOL, V10, P1809, DOI 10.1007/BF00987363; SWIHART RK, 1991, ECOL APPL, V1, P98, DOI 10.2307/1941851; Trager MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014308; Van Mele P, 2009, PHYSIOL ENTOMOL, V34, P256, DOI 10.1111/j.1365-3032.2009.00685.x; Vandermeer J, 2002, AGROFOREST SYST, V56, P271, DOI 10.1023/A:1021328820123; Vandermeer J, 2010, BIOSCIENCE, V60, P527, DOI 10.1525/bio.2010.60.7.8; West B. T., 2007, LINEAR MIXED MODELS; WHEELER JW, 1975, SCIENCE, V187, P254, DOI 10.1126/science.1111099	51	11	11	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28703	10.1371/journal.pone.0028703	http://dx.doi.org/10.1371/journal.pone.0028703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235248	Green Published, gold			2022-12-27	WOS:000301123400009
J	Yu, XL; Zhang, J; Hong, L; Wang, JY; Yuan, ZA; Zhang, X; Ghildyal, R				Yu, Xuelian; Zhang, Jing; Hong, Liang; Wang, Jiayu; Yuan, Zhengan; Zhang, Xi; Ghildyal, Reena			High Prevalence of Human Parvovirus 4 Infection in HBV and HCV Infected Individuals in Shanghai	PLOS ONE			English	Article							BLOOD-DONORS; HEPATITIS-B; DRUG-USERS; PARV4; B19; PERSISTENCE; ANTIBODIES; FREQUENCY; PLASMA; SERUM	Human parvovirus 4 (PARV4) has been detected in blood and diverse tissues samples from HIV/AIDS patients who are injecting drug users. Although B19 virus, the best characterized human parvovirus, has been shown to co-infect patients with hepatitis B or hepatitis C virus (HBV, HCV) infection, the association of PARV4 with HBV or HCV infections is still unknown. The aim of this study was to characterise the association of viruses belonging to PARV4 genotype 1 and 2 with chronic HBV and HCV infection in Shanghai. Serum samples of healthy controls, HCV infected subjects and HBV infected subjects were retrieved from Shanghai Center for Disease Control and Prevention (SCDC) Sample Bank. Parvovirus-specific nested-PCR was performed and results confirmed by sequencing. Sequences were compared with reference sequences obtained from Genbank to derive phylogeny trees. The frequency of parvovirus molecular detection was 16-22%, 33% and 41% in healthy controls, HCV infected and HBV infected subjects respectively, with PARV4 being the only parvovirus detected. HCV infected and HBV infected subjects had a significantly higher PARV4 prevalence than the healthy population. No statistical difference was found in PARV4 prevalence between HBV or HCV infected subjects. PARV4 sequence divergence within study groups was similar in healthy subjects, HBV or HCV infected subjects. Our data clearly demonstrate that PARV4 infection is strongly associated with HCV and HBV infection in Shanghai but may not cause increased disease severity.	[Yu, Xuelian; Zhang, Jing; Hong, Liang; Wang, Jiayu; Zhang, Xi] Hongkou Dist Ctr Dis Control & Prevent, Microbiol Lab, Shanghai, Peoples R China; [Yuan, Zhengan] Hongkou Dist Ctr Dis Control & Prevent, Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Ghildyal, Reena] Univ Canberra, Fac Sci Appl, Ctr Res Therapeut Solut, Resp Virol Grp, Canberra, ACT 2601, Australia	Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; University of Canberra	Yu, XL (corresponding author), Hongkou Dist Ctr Dis Control & Prevent, Microbiol Lab, Shanghai, Peoples R China.	Reena.Ghildyal@canberra.edu.au		Ghildyal, Reena/0000-0002-3147-4976	Shanghai Municipal Natural Science Foundation [09ZR1426800]; Shanghai Municipal Talents Development Foundation [2009-42]	Shanghai Municipal Natural Science Foundation; Shanghai Municipal Talents Development Foundation	This work was funded by Shanghai Municipal Natural Science Foundation (Grant No. 09ZR1426800), and Shanghai Municipal Talents Development Foundation (Grant No. 2009-42). The funders had no role in study design, data collection and analysis, decision to publish or presentation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Fryer JF, 2007, VOX SANG, V93, P341, DOI 10.1111/j.1423-0410.2007.00979.x; Fryer JF, 2007, TRANSFUSION, V47, P1054, DOI 10.1111/j.1537-2995.2007.01235.x; Fryer JF, 2007, EMERG INFECT DIS, V13, P175; Fryer JF, 2006, EMERG INFECT DIS, V12, P151, DOI 10.3201/eid1201.050916; Heegaard ED, 2002, J CLIN MICROBIOL, V40, P933, DOI 10.1128/JCM.40.3.933-936.2002; Hsu TC, 2005, J GASTROEN HEPATOL, V20, P733, DOI 10.1111/j.1440-1746.2005.03815.x; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Lurcharchaiwong W, 2008, INFECTION, V36, P488, DOI 10.1007/s15010-008-7336-4; Manning A, 2007, J INFECT DIS, V195, P1345, DOI 10.1086/513280; Schneider B, 2008, HAEMOPHILIA, V14, P978, DOI 10.1111/j.1365-2516.2008.01800.x; Sharp CP, 2009, J INFECT DIS, V200, P1119, DOI 10.1086/605646; Simmonds P, 2007, EMERG INFECT DIS, V13, P1386, DOI 10.3201/eid1309.070428; Simmons R, 2011, J INFECT DIS, V203, P1378, DOI 10.1093/infdis/jir036; Toan NL, 2006, J HEPATOL, V45, P361, DOI 10.1016/j.jhep.2006.03.013; Touinssi M, 2011, J MED VIROL, V83, P717, DOI 10.1002/jmv.22003; Vallerini D, 2008, EMERG INFECT DIS, V14, P185, DOI 10.3201/eid1401.070610	17	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29474	10.1371/journal.pone.0029474	http://dx.doi.org/10.1371/journal.pone.0029474			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235298	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400060
J	Zhang, Y; Su, SL; Zhang, F; Shi, RH; Gao, W				Zhang, Yuan; Su, Shiliang; Zhang, Feng; Shi, Runhe; Gao, Wei			Characterizing Spatiotemporal Dynamics of Methane Emissions from Rice Paddies in Northeast China from 1990 to 2010	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; NITROUS-OXIDE EVOLUTION; PRODUCTION SYSTEMS; FIELD VALIDATION; SIMULATION-MODEL; WATER MANAGEMENT; RAINFALL EVENTS; SOIL DRIVEN; DNDC MODEL; CH4	Background: Rice paddies have been identified as major methane (CH4) source induced by human activities. As a major rice production region in Northern China, the rice paddies in the Three-Rivers Plain (TRP) have experienced large changes in spatial distribution over the recent 20 years (from 1990 to 2010). Consequently, accurate estimation and characterization of spatiotemporal patterns of CH4 emissions from rice paddies has become an pressing issue for assessing the environmental impacts of agroecosystems, and further making GHG mitigation strategies at regional or global levels. Methodology/Principal Findings: Integrating remote sensing mapping with a process-based biogeochemistry model, Denitrification and Decomposition (DNDC), was utilized to quantify the regional CH4 emissions from the entire rice paddies in study region. Based on site validation and sensitivity tests, geographic information system (GIS) databases with the spatially differentiated input information were constructed to drive DNDC upscaling for its regional simulations. Results showed that (1) The large change in total methane emission that occurred in 2000 and 2010 compared to 1990 is distributed to the explosive growth in amounts of rice planted; (2) the spatial variations in CH4 fluxes in this study are mainly attributed to the most sensitive factor soil properties, i.e., soil clay fraction and soil organic carbon (SOC) content, and (3) the warming climate could enhance CH4 emission in the cool paddies. Conclusions/Significance: The study concluded that the introduction of remote sensing analysis into the DNDC upscaling has a great capability in timely quantifying the methane emissions from cool paddies with fast land use and cover changes. And also, it confirmed that the northern wetland agroecosystems made great contributions to global greenhouse gas inventory.	[Zhang, Yuan; Shi, Runhe; Gao, Wei] E China Normal Univ, Key Lab Geog Informat Sci, Minist Educ, Shanghai 200062, Peoples R China; [Zhang, Yuan] Chinese Acad Sci, Res Ctr Remote Sensing & Geosci, NE Inst Geog & Agroecol, Changchun, Peoples R China; [Su, Shiliang] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Feng] Lanzhou Univ, Key Lab Arid & Grassland Agroecol, Lanzhou 730000, Peoples R China	East China Normal University; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Zhejiang University; Lanzhou University	Zhang, Y (corresponding author), E China Normal Univ, Key Lab Geog Informat Sci, Minist Educ, Shanghai 200062, Peoples R China.	yuan.zhang75@gmail.com	SHI, Runhe/N-2213-2019		National Natural Science Foundation of China [41001202]; National Basic Research Program of China (973) [2010CB951603]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973)(National Basic Research Program of China)	1. National Natural Science Foundation of China (No. 41001202). (http://www.nsfc.gov.cn/nsfc/cen/00/download.html) 2. National Basic Research Program of China (973) (No. 2010CB951603). (http://www.most.gov.cn/eng/index.htm) The two projects granted by the funders provided substantial financial support for the study, and took a role in soil data collection and analysis, agricultural management information survey for preparing the manuscript.	ANASTASI C, 1992, J GEOPHYS RES-ATMOS, V97, P7521, DOI 10.1029/92JD00157; Babu YJ, 2006, NUTR CYCL AGROECOSYS, V74, P157, DOI 10.1007/s10705-005-6111-5; Babu YJ, 2005, CURR SCI INDIA, V89, P1904; BACHELET D, 1993, CHEMOSPHERE, V26, P219, DOI 10.1016/0045-6535(93)90423-3; Cai ZC, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002046; Cai ZC, 1999, SOIL SCI PLANT NUTR, V45, P1, DOI 10.1080/00380768.1999.10409320; Cai ZC, 2000, J GEOPHYS RES-ATMOS, V105, P17231, DOI 10.1029/2000JD900014; CAO MK, 1995, AGR ECOSYST ENVIRON, V55, P129, DOI 10.1016/0167-8809(95)00613-W; CAO MK, 1995, GLOBAL BIOGEOCHEM CY, V9, P183, DOI 10.1029/94GB03231; Cao MK, 1996, CHEMOSPHERE, V33, P879, DOI 10.1016/0045-6535(96)00231-7; Cao MK, 1998, ATMOS ENVIRON, V32, P3293, DOI 10.1016/S1352-2310(98)00105-8; FAO, 2011, FAO STAT DAT; Frolking S, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001425; Giltrap DL, 2010, AGR ECOSYST ENVIRON, V136, P292, DOI 10.1016/j.agee.2009.06.014; HOLZAPFELPSCHORN A, 1986, J GEOPHYS RES-ATMOS, V91, P1803, DOI 10.1029/JD091iD11p11803; IPCC, 2006, 2006 IPCC GUIDELINES, V3, P1; Kern JS, 1997, NUTR CYCL AGROECOSYS, V49, P181, DOI 10.1023/A:1009710425295; KHALIL MAK, 1991, ENVIRON SCI TECHNOL, V25, P979, DOI 10.1021/es00017a023; Li CS, 2006, J ENVIRON QUAL, V35, P1554, DOI 10.2134/jeq2005.0208; Li CS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002045; Li CS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015370; LI CS, 1992, J GEOPHYS RES-ATMOS, V97, P9759, DOI 10.1029/92JD00509; LI CS, 1994, GLOBAL BIOGEOCHEM CY, V8, P237, DOI 10.1029/94GB00767; Matthews RB, 2000, NUTR CYCL AGROECOSYS, V58, P141, DOI 10.1023/A:1009894619446; NBSC, 2011, CHIN STAT YB 2010; NEUE HU, 1993, BIOSCIENCE, V43, P466, DOI 10.2307/1311906; Pathak H, 2005, BIOGEOSCIENCES, V2, P113, DOI 10.5194/bg-2-113-2005; 王明星, 1993, Advances in Atmospheric Sciences, V10, P307; Salas W, 2007, AQUAT CONSERV, V17, P319, DOI 10.1002/aqc.837; Sass RL, 1992, GLOBAL BIOGEOCHEM CY, V6, P249, DOI 10.1029/92GB01674; Scheehle EA, 2006, ENERGY J, V27, P33, DOI [10.5547/ISSN0195-6574-EJ-VolSI2006-NoSI3-2, DOI 10.5547/ISSN0195-6574-EJ-VOLSI2006-NOSI3-2]; Shi X. Z., 2004, Soil Survey Horizons, V45, P129; SINHA SK, 1995, CURR SCI INDIA, V68, P643; Smith P, 1997, GEODERMA, V81, P153, DOI 10.1016/S0016-7061(97)00087-6; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song CC, 2009, GLOBAL CHANGE BIOL, V15, P692, DOI 10.1111/j.1365-2486.2008.01821.x; Takeuchi W, 2001, P 22 AS C REM SENS 5, V1, P422; U. S. Environmental Protection Agency (USEPA), 2006, GLOB ANTHR NON CO2 G; van Bodegom PM, 2001, GEOCHIM COSMOCHIM AC, V65, P2055, DOI 10.1016/S0016-7037(01)00563-4; Verburg PH, 2006, PLANT ECOL, V182, P89, DOI 10.1007/s11258-005-9033-z; Verburg PH, 2001, GLOBAL CHANGE BIOL, V7, P31, DOI 10.1046/j.1365-2486.2001.00389.x; Wang YiYong, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P170; Wassmann R, 1998, PLANT SOIL, V203, P227, DOI 10.1023/A:1004357411814; WASSMANN R, 1993, BIOGEOCHEMISTRY, V20, P83, DOI 10.1007/BF00004136; Xiao XM, 2005, REMOTE SENS ENVIRON, V95, P480, DOI 10.1016/j.rse.2004.12.009; Yagi K, 1996, GLOBAL BIOGEOCHEM CY, V10, P255, DOI 10.1029/96GB00517; YAGI K, 1990, SOIL SCI PLANT NUTR, V36, P599, DOI 10.1080/00380768.1990.10416797; Yan XY, 2005, GLOBAL CHANGE BIOL, V11, P1131, DOI 10.1111/j.1365-2486.2005.00976.x; Yao H, 1996, GLOBAL BIOGEOCHEM CY, V10, P641, DOI 10.1029/96GB02348; Yu DS, 2007, J ENVIRON MANAGE, V85, P680, DOI 10.1016/j.jenvman.2006.09.020; Zhang L, 2009, BIOGEOSCIENCES, V6, P739, DOI 10.5194/bg-6-739-2009; Zhang Y, 2011, BIOGEOSCIENCES, V8, P1225, DOI 10.5194/bg-8-1225-2011; Zhang Y, 2002, ECOL MODEL, V151, P75, DOI 10.1016/S0304-3800(01)00527-0; Zheng X, 1997, CHINESE J ATMOSPHERI, V21, P167	54	9	10	13	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29156	10.1371/journal.pone.0029156	http://dx.doi.org/10.1371/journal.pone.0029156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235268	gold, Green Submitted, Green Published			2022-12-27	WOS:000301123400029
J	Mort, RL; Bentley, AJ; Martin, FL; Collinson, JM; Douvaras, P; Hill, RE; Morley, SD; Fullwood, NJ; West, JD				Mort, Richard L.; Bentley, Adam J.; Martin, Francis L.; Collinson, J. Martin; Douvaras, Panagiotis; Hill, Robert E.; Morley, Steven D.; Fullwood, Nigel J.; West, John D.			Effects of Aberrant Pax6 Gene Dosage on Mouse Corneal Pathophysiology and Corneal Epithelial Homeostasis	PLOS ONE			English	Article							STEM-CELL FUNCTION; EYE DEVELOPMENT; ABNORMALITIES; MUTATIONS; DEFECTS; MODEL; DIFFERENTIATION; EXPRESSION; MIGRATION; PATTERNS	Background: Altered dosage of the transcription factor PAX6 causes multiple human eye pathophysiologies. PAX6(+/-) heterozygotes suffer from aniridia and aniridia-related keratopathy (ARK), a corneal deterioration that probably involves a limbal epithelial stem cell (LESC) deficiency. Heterozygous Pax6(+/Sey-Neu) (Pax6(+/-)) mice recapitulate the human disease and are a good model of ARK. Corneal pathologies also occur in other mouse Pax6 mutants and in PAX77(Tg/-) transgenics, which over-express Pax6 and model human PAX6 duplication. Methodology/Principal Findings: We used electron microscopy to investigate ocular defects in Pax6(+/-) heterozygotes (low Pax6 levels) and PAX77(Tg/-) transgenics (high Pax6 levels). As well as the well-documented epithelial defects, aberrant Pax6 dosage had profound effects on the corneal stroma and endothelium in both genotypes, including cellular vacuolation, similar to that reported for human macular corneal dystrophy. We used mosaic expression of an X-linked LacZ transgene in X-inactivation mosaic female (XLacZ(Tg/-)) mice to investigate corneal epithelial maintenance by LESC clones in Pax6(+/-) and PAX77(Tg/-) mosaic mice. PAX77(Tg/-) mosaics, over-expressing Pax6, produced normal corneal epithelial radial striped patterns (despite other corneal defects), suggesting that centripetal cell movement was unaffected. Moderately disrupted patterns in Pax6(+/-) mosaics were corrected by introducing the PAX77 transgene (in Pax6(+/-), PAX77(Tg/-) mosaics). Pax6(Leca4/+), XLacZ(Tg/-) mosaic mice (heterozygous for the Pax6(Leca4) missense mutation) showed more severely disrupted mosaic patterns. Corrected corneal epithelial stripe numbers (an indirect estimate of active LESC clone numbers) declined with age (between 15 and 30 weeks) in wild-type XLacZ(Tg/-) mosaics. In contrast, corrected stripe numbers were already low at 15 weeks in Pax6(+/-) and PAX77(Tg/-) mosaic corneas, suggesting Pax6 under-and over-expression both affect LESC clones. Conclusions/Significance: Pax6(+/-) and PAX77(Tg/-) genotypes have only relatively minor effects on LESC clone numbers but cause more severe corneal endothelial and stromal defects. This should prompt further investigations of the pathophysiology underlying human aniridia and ARK.	[Mort, Richard L.; Douvaras, Panagiotis; West, John D.] Univ Edinburgh, Div Reprod & Dev Sci, Edinburgh, Midlothian, Scotland; [Mort, Richard L.; Hill, Robert E.] Univ Edinburgh, Med Res Council Human Genet Unit, Med Res Council Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Bentley, Adam J.; Fullwood, Nigel J.] Univ Lancaster, Div Biomed & Life Sci, Lancaster, England; [Martin, Francis L.] Univ Lancaster, Ctr Biophoton, Lancaster, England; [Collinson, J. Martin] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Morley, Steven D.] Univ Edinburgh, Sch Clin Sci & Community Hlth, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Lancaster University; Lancaster University; University of Aberdeen; University of Edinburgh	Mort, RL (corresponding author), Univ Edinburgh, Div Reprod & Dev Sci, Edinburgh, Midlothian, Scotland.	John.West@ed.ac.uk	West, John/E-3621-2012; Collinson, Jon Martin/I-9997-2019; Mort, Richard/X-5592-2019; Morley, Steve/AAY-9985-2020; Martin, Francis L/J-4585-2019	Mort, Richard/0000-0002-3566-8217; Martin, Francis L/0000-0001-8562-4944; Fullwood, Nigel James/0000-0002-9405-8515; Morley, Steven/0000-0002-7355-3349; Douvaras, Panagiotis/0000-0002-4430-997X; West, John/0000-0002-5886-0359	University of Edinburgh, College of Medicine and Veterinary Medicine; Medical Research Council [G9630132]; Wellcome Trust [065035]; GlaxoSmithKline; MRC [MC_U127584494, G1002033, MC_PC_U127584494] Funding Source: UKRI; Medical Research Council [MC_PC_U127584494, MC_U127584494, G1002033] Funding Source: researchfish	University of Edinburgh, College of Medicine and Veterinary Medicine; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); GlaxoSmithKline(GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by a University of Edinburgh, College of Medicine and Veterinary Medicine PhD studentship (to RM with JW and SM) plus grants from the Medical Research Council (G9630132 to JW) and Wellcome Trust (065035 to JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Sarah McDonald and Natalia Best for performing some of the preliminary mosaic analysis experiments and staff at CRB-AA and BRR, University of Edinburgh, for specialised technical services. We also thank Veronica van Heyningen and Dirk A. Kleinjan for providing an initial stock of PAX77<SUP>Tg/-</SUP> mice, Ian Jackson and Sally Cross for providing Pax6<SUP>Leca4/+</SUP> mice and Seong-Seng Tan for permission to use H253 mice. The Pax6<SUP>Leca4</SUP> mutation (GENA368) was derived in an ENU mutagenesis screen that was funded, in part, by GlaxoSmithKline and we thank them for permitting us access to these mice via a materials transfer agreement.	Aalfs CM, 1997, AM J MED GENET, V73, P267, DOI 10.1002/(SICI)1096-8628(19971219)73:3<267::AID-AJMG7>3.0.CO;2-P; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Baulmann DC, 2002, MECH DEVELOP, V118, P3, DOI 10.1016/S0925-4773(02)00260-5; Beebe DC, 1996, INVEST OPHTH VIS SCI, V37, P1815; BUCK RC, 1985, INVEST OPHTH VIS SCI, V26, P1296; Chanas SA, 2009, INVEST OPHTH VIS SCI, V50, P4045, DOI 10.1167/iovs.07-1630; Collinson JM, 2004, INT J DEV BIOL, V48, P793, DOI 10.1387/ijdb.041885jc; Collinson JM, 2000, DEVELOPMENT, V127, P945; Collinson JM, 2004, INVEST OPHTH VIS SCI, V45, P1101, DOI 10.1167/iovs.03-1118; Collinson JM, 2003, DEV BIOL, V255, P303, DOI 10.1016/S0012-1606(02)00095-7; Collinson JM, 2002, DEV DYNAM, V224, P432, DOI 10.1002/dvdy.10124; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Davis J, 2003, J CELL SCI, V116, P2157, DOI 10.1242/jcs.00441; Dora N, 2009, THESIS U ABERDEEN; Dora N, 2008, DEV DYNAM, V237, P1295, DOI 10.1002/dvdy.21528; Endo M, 2007, MOL THER, V15, P579, DOI 10.1038/sj.mt.6300092; Favor J, 2000, MAMM GENOME, V11, P520, DOI 10.1007/s003350010099; Favor J, 2008, GENETICS, V179, P1345, DOI 10.1534/genetics.108.088591; GLASER T, 1994, NAT GENET, V8, P203, DOI 10.1038/ng1094-203a; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hanson I, 1999, HUM MOL GENET, V8, P165, DOI 10.1093/hmg/8.2.165; Hever AM, 2006, CLIN GENET, V69, P459, DOI 10.1111/j.1399-0004.2006.00619.x; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HOGAN BLM, 1988, DEVELOPMENT, V103, P115; Holland EJ, 2003, OPHTHALMOLOGY, V110, P125, DOI 10.1016/S0161-6420(02)01451-3; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Kanakubo S, 2006, GENES CELLS, V11, P919, DOI 10.1111/j.1365-2443.2006.00992.x; Koroma BM, 1997, INVEST OPHTH VIS SCI, V38, P108; Kroeber M, 2010, HUM MOL GENET, V19, P3332, DOI 10.1093/hmg/ddq237; KRUSE FE, 1994, EYE, V8, P170, DOI 10.1038/eye.1994.42; Kucerova R, 2006, INVEST OPHTH VIS SCI, V47, P5276, DOI 10.1167/iovs.06-0581; Lehrer MS, 1998, J CELL SCI, V111, P2867; Leiper LJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-27; Leiper LJ, 2009, INVEST OPHTH VIS SCI, V50, P1122, DOI 10.1167/iovs.08-2812; Lewis D, 2000, GLYCOBIOLOGY, V10, P305, DOI 10.1093/glycob/10.3.305; Li W, 2007, CELL RES, V17, P26, DOI 10.1038/sj.cr.7310137; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Manuel M, 2007, DEVELOPMENT, V134, P545, DOI 10.1242/dev.02764; Manuel M, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-59; Mort RL, 2009, J ANAT, V215, P698, DOI 10.1111/j.1469-7580.2009.01150.x; Mort RL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-4; Nagasaki T, 2003, INVEST OPHTH VIS SCI, V44, P558, DOI 10.1167/iovs.02-0705; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; NISHIDA K, 1995, AM J OPHTHALMOL, V120, P368, DOI 10.1016/S0002-9394(14)72167-1; Ou J, 2008, J PATHOL, V215, P421, DOI 10.1002/path.2371; Ou JX, 2010, INVEST OPHTH VIS SCI, V51, P1415, DOI 10.1167/iovs.09-4023; Prosser J, 1998, HUM MUTAT, V11, P93, DOI 10.1002/(SICI)1098-1004(1998)11:2<93::AID-HUMU1>3.0.CO;2-M; PUANGSRICHARERN V, 1995, OPHTHALMOLOGY, V102, P1476; Quinn JC, 1996, GENE DEV, V10, P435, DOI 10.1101/gad.10.4.435; Ramaesh T, 2005, EXP EYE RES, V81, P224, DOI 10.1016/j.exer.2005.02.002; Ramaesh T, 2003, INVEST OPHTH VIS SCI, V44, P1871, DOI 10.1167/iovs.02-0576; Ramaesh T, 2006, INVEST OPHTH VIS SCI, V47, P1911, DOI 10.1167/iovs.05-1028; Ramaesh T, 2009, EXP EYE RES, V89, P263, DOI 10.1016/j.exer.2009.03.016; Ren HW, 1996, CURR EYE RES, V15, P1054, DOI 10.3109/02713689609017655; ROBERTS RC, 1967, GENET RES, V9, P121, DOI 10.1017/S0016672300010387; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Secker GA, 2009, STEMBOOK, DOI [10.3824/stembook.1.48.1, DOI 10.3824/STEMBOOK.1.48.1]; SNIP RC, 1973, INVEST OPHTH VISUAL, V12, P88; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; TAN SS, 1993, NAT GENET, V3, P170, DOI 10.1038/ng0293-170; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; van Heyningen V, 2002, HUM MOL GENET, V11, P1161, DOI 10.1093/hmg/11.10.1161; Zhang W, 2008, MOL VIS, V14, P1929	66	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e28895	10.1371/journal.pone.0028895	http://dx.doi.org/10.1371/journal.pone.0028895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220198	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000300677000010
J	Shutto, Y; Shimada, M; Kitajima, M; Yamabe, H; Razzaque, MS				Shutto, Yoshiko; Shimada, Michiko; Kitajima, Maiko; Yamabe, Hideaki; Razzaque, Mohammed S.			Lack of Awareness among Future Medical Professionals about the Risk of Consuming Hidden Phosphate-Containing Processed Food and Drinks	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SERUM PHOSPHATE; GENETIC-EVIDENCE; METABOLISM; CALCIUM; DIETARY; HYPERPHOSPHATEMIA; CALCIFICATION; HOMEOSTASIS; POPULATION	Phosphate toxicity is an important determinant of mortality in patients with chronic kidney disease (CKD), particularly those undergoing hemodialysis treatments. CKD patients are advised to take a low phosphate-containing diet, and are additionally prescribed with phosphate-lowering drugs. Since these patients usually seek guidance from their physicians and nurses for their dietary options, we conducted a survey to determine the levels of awareness regarding the high phosphate content in commercially processed food and drinks among medical and nursing students at the Hirosaki University School of Medicine in Japan. For this survey, 190 medical and nursing students (average age 21.7+/-3 years) were randomly selected, and provided with a list of questions aimed at evaluating their awareness of food and drinks containing artificially added phosphate ingredients. While 98.9% of these students were aware of the presence of sugar in commercially available soda drinks, only 6.9% were aware of the presence of phosphate (phosphoric acid). Similarly, only 11.6% of these students were aware of the presence of phosphate in commercially processed food, such as hamburgers and pizza. Moreover, around two thirds of the surveyed students (67.7%) were unaware of the harmful effects of unrestricted consumption of phosphate-containing food and drinks. About 28% of the surveyed students consume such "fast food" once a week, while 40% drink at least 1 similar to 5 cans of soda drinks/week. After realizing the potential long-term risks of consuming excessive phosphate-containing food and drinks, 40.5% of the survey participants considered reducing their phosphate intake by minimizing the consumption of commercially processed "fast food" items and soda drinks. Moreover, another 48.4% of students showed interest in obtaining more information on the negative health effects of consuming excessive amounts of phosphate. This survey emphasizes the need for educational initiative to raise awareness of the health risks posed by excessive consumption of phosphate additives.	[Razzaque, Mohammed S.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Shutto, Yoshiko] Hirosaki Univ, Dept Hlth Promot, Grad Sch Hlth Sci, Hirosaki, Aomori, Japan; [Shimada, Michiko; Kitajima, Maiko; Yamabe, Hideaki] Hirosaki Univ, Dept Cardiol Resp Med & Nephrol, Grad Sch Med, Hirosaki, Aomori, Japan	Harvard University; Harvard School of Dental Medicine; Hirosaki University; Hirosaki University	Shutto, Y (corresponding author), Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, 188 Longwood Ave, Boston, MA 02115 USA.	mrazzaque@hms.harvard.edu	Razzaque, Mohammed S./K-4282-2019; saez, lourdes basurto/AAO-6641-2020		NIH [R01-077276]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by NIH grant No. R01-077276. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel T, 2010, NEPHROL DIAL TRANSPL, V25, P3241, DOI 10.1093/ndt/gfq161; Antoniucci DM, 2006, J CLIN ENDOCR METAB, V91, P3144, DOI 10.1210/jc.2006-0021; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Block G, 2003, SEMIN DIALYSIS, V16, P140, DOI 10.1046/j.1525-139X.2003.160301.x; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Econs MJ, 1999, BONE, V25, P131, DOI 10.1016/S8756-3282(99)00108-8; Eddington H, 2010, CLIN J AM SOC NEPHRO, V5, P2251, DOI 10.2215/CJN.00810110; Haig A, 1889, Med Chir Trans, V72, P399; HONDA M, 1989, Japanese Journal of Nutrition, V47, P241; Hruska K, 2011, KIDNEY INT, V79, pS9, DOI 10.1038/ki.2011.24; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Kanbay M, 2009, BLOOD PURIFICAT, V27, P220, DOI 10.1159/000197562; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Ketteler M, 2009, BLOOD PURIFICAT, V27, P345, DOI 10.1159/000209247; Marraffa JM, 2004, PEDIATR EMERG CARE, V20, P453, DOI 10.1097/01.pec.0000132217.65600.52; Molony DA, 2011, ADV CHRONIC KIDNEY D, V18, P120, DOI 10.1053/j.ackd.2011.02.004; Ohnishi M, 2011, BIOCHEM BIOPH RES CO, DOI [10.1016/j.bbrc.2011.1010.1076, DOI 10.1016/J.BBRC.2011.1010.1076]; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Ohnishi M, 2009, CIRC-CARDIOVASC GENE, V2, P583, DOI 10.1161/CIRCGENETICS.108.847814; Razzaque MS, 2007, AGEING RES REV, V6, P211, DOI 10.1016/j.arr.2007.06.001; Razzaque MS, 2011, KIDNEY INT, V79, P708, DOI 10.1038/ki.2010.432; Razzaque MS, 2011, CLIN SCI, V120, P91, DOI 10.1042/CS20100377; Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196; Razzaque MS, 2009, AM J PHYSIOL-RENAL, V296, pF470, DOI 10.1152/ajprenal.90538.2008; Razzaque MS, 2011, IUBMB LIFE, V63, P240, DOI 10.1002/iub.437; Sigrist MK, 2009, J RENAL CARE, V35, P71, DOI 10.1111/j.1755-6686.2009.00064.x; Snively CS, 2004, AM FAM PHYSICIAN, V70, P1921; Terai K, 2009, BRIT J PHARMACOL, V156, P1267, DOI 10.1111/j.1476-5381.2008.00108.x; Tokunaga S, 2002, ANN EPIDEMIOL, V12, P157, DOI 10.1016/S1047-2797(01)00307-6	29	23	23	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29105	10.1371/journal.pone.0029105	http://dx.doi.org/10.1371/journal.pone.0029105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220204	Green Published, Green Submitted, gold			2022-12-27	WOS:000300677000017
J	Liu, XW; Cai, H; Huang, H; Long, ZW; Shi, YQ; Wang, YN				Liu, Xiaowen; Cai, Hong; Huang, Hua; Long, Ziwen; Shi, Yingqiang; Wang, Yanong			The Prognostic Significance of Apoptosis-Related Biological Markers in Chinese Gastric Cancer Patients	PLOS ONE			English	Article							BCL-2 EXPRESSION; P53 EXPRESSION; HELICOBACTER-PYLORI; CELL-PROLIFERATION; CARCINOMA; ADENOCARCINOMA; PROTEINS; GROWTH; OVEREXPRESSION; SURVIVAL	Background and Objective: The prognosis varied among the patients with the same stage, therefore there was a need for new prognostic and predictive factors. The aim of this study was to evaluate the relationship of apoptosis-related biological markers such as p53, bcl-2, bax, and c-myc, and clinicopathological features and their prognostic value. Methods: From 1996 to 2007, 4426 patients had undergone curative D2 gastrectomy for gastric cancer at Fudan University Shanghai Cancer Center. Among 501 patients, the expression levels of p53, bcl-2, bax, and c-myc were examined by immunohistochemistry. The prognostic value of biological markers and the correlation between biological markers and other clinicopathological factors were investigated. Results: There were 339 males and 162 females with a mean age of 57. The percentages of positive expression of p53, bcl-2, bax, and c-myc were 65%, 22%, 43%, and 58%, respectively. There was a strong correlation between p53, bax, and c-myc expression (P = 0.00). There was significant association between bcl-2, and bax expression (P < 0.05). p53 expression correlated with histological grade (P = 0.01); bcl-2 expression with pathological stage (P = 0.00); bax expression with male (P = 0.02), histological grade (P = 0.01), Borrmann type (P = 0.01), tumor location (P = 0.00), lymph node metastasis (P = 0.03), and pathological stage (P = 0.03); c-myc expression with Borrmann type (P = 0.00). bcl-2 expression was related with good survival in univariate analysis (P = 0.01). Multivariate analysis showed that bcl-2 expression and pathological stage were defined as independent prognostic factors. There were significant differences of overall 5-year survival rates according to bcl-2 expression or not in stage IIB (P = 0.03). Conclusion: The expression of bcl-2 was an independent prognostic factor for patients with gastric cancer; it might be a candidate for the gastric cancer staging system.	[Liu, Xiaowen; Cai, Hong; Huang, Hua; Long, Ziwen; Shi, Yingqiang; Wang, Yanong] Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcoma, Shanghai 200433, Peoples R China; [Liu, Xiaowen; Cai, Hong; Huang, Hua; Long, Ziwen; Shi, Yingqiang; Wang, Yanong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Liu, XW (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcoma, Shanghai 200433, Peoples R China.	wangyn1111@hotmail.com						ADACHI Y, 1994, GUT, V35, P1368, DOI 10.1136/gut.35.10.1368; Aizawa K, 1999, INT J ONCOL, V14, P85; Al-Moundhri MS, 2005, J SURG ONCOL, V91, P243, DOI 10.1002/jso.20324; Anagnostopoulos GK, 2007, ACTA GASTRO-ENT BELG, V70, P285; Bartchewsky W, 2010, DIGEST DIS SCI, V55, P111, DOI 10.1007/s10620-008-0699-7; Chau I, 2004, J CLIN ONCOL, V22, P2359; Dicken BJ, 2004, ANN SURG ONCOL, V11, P629, DOI 10.1245/ASO.2004.09.002; Eloubeidi MA, 2002, CANCER-AM CANCER SOC, V95, P1434, DOI 10.1002/cncr.10868; Fenoglio-Preiser CM, 2003, HUM MUTAT, V21, P258, DOI 10.1002/humu.10180; GABBERT HE, 1995, CANCER, V76, P720, DOI 10.1002/1097-0142(19950901)76:5<720::AID-CNCR2820760503>3.0.CO;2-E; Galizia G, 2006, J SURG ONCOL, V93, P241, DOI 10.1002/jso.20402; Ishida H, 1997, CANCER, V80, P1034; KORSMEYER SJ, 1992, BLOOD, V80, P879; KRAJEWSKI S, 1994, AM J PATHOL, V145, P1323; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Lee Dong Soo, 2005, Korean J Gastroenterol, V45, P394; Lee HK, 2003, INT J COLORECTAL DIS, V18, P518, DOI 10.1007/s00384-003-0491-2; Lee KE, 2003, JPN J CLIN ONCOL, V33, P173, DOI 10.1093/jjco/hyg039; Lerut T, 2003, J THORAC CARDIOV SUR, V126, P1121, DOI 10.1016/S0022-5223(03)00941-3; Liu XW, 2009, ANN SURG ONCOL, V16, P1875, DOI 10.1245/s10434-009-0449-x; Maeda S, 2002, J CLIN PATHOL-MOL PA, V55, P286, DOI 10.1136/mp.55.5.286; Maehara Y, 1999, BRIT J CANCER, V79, P1255, DOI 10.1038/sj.bjc.6690201; MAEHARA Y, 1995, BRIT J CANCER, V71, P999, DOI 10.1038/bjc.1995.192; MARUYAMA K, 1987, SCAND J GASTROENTERO, V22, P63, DOI 10.3109/00365528709091021; MOTOJIMA K, 1994, SURGERY, V116, P890; Nakanishi H, 1997, ONCOLOGY, V54, P238; NINOMIYA I, 1991, ONCOLOGY-BASEL, V48, P149; Okuyama T, 2002, ONCOLOGY-BASEL, V63, P353, DOI 10.1159/000066223; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PIETENPOL JA, 1994, CANCER RES, V54, P3714; SAEGUSA M, 1995, J CANCER RES CLIN, V121, P357, DOI 10.1007/BF01225688; Shibata A, 2006, CANC EPIDEMIOLOGY PR, P707; Tsamandas AC, 2009, ANTICANCER RES, V29, P703; Wiksten JP, 2002, ONCOLOGY-BASEL, V63, P180, DOI 10.1159/000063813; Ye YW, 2009, DIGEST SURG, V26, P384, DOI 10.1159/000226766; Yokota T, 2004, SCAND J GASTROENTERO, V39, P380, DOI 10.1080/00365520310008629; Zhang H, 2004, WORLD J GASTROENTERO, V10, P227	37	45	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29670	10.1371/journal.pone.0029670	http://dx.doi.org/10.1371/journal.pone.0029670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216342	Green Submitted, Green Published, gold			2022-12-27	WOS:000300676300078
J	Rieben, S; Kalinina, O; Schmid, B; Zeller, SL				Rieben, Silvan; Kalinina, Olena; Schmid, Bernhard; Zeller, Simon L.			Gene Flow in Genetically Modified Wheat	PLOS ONE			English	Article							BARLEY SEED PROTEINS; TRANSGENIC WHEAT; MAIZE; ENVIRONMENT; RESISTANCE; MARKER; EXPRESSION; ECOLOGY; BIOLOGY; RISKS	Understanding gene flow in genetically modified (GM) crops is critical to answering questions regarding risk-assessment and the coexistence of GM and non-GM crops. In two field experiments, we tested whether rates of cross-pollination differed between GM and non-GM lines of the predominantly self-pollinating wheat Triticum aestivum. In the first experiment, outcrossing was studied within the field by planting "phytometers'' of one line into stands of another line. In the second experiment, outcrossing was studied over distances of 0.5-2.5 m from a central patch of pollen donors to adjacent patches of pollen recipients. Cross-pollination and outcrossing was detected when offspring of a pollen recipient without a particular transgene contained this transgene in heterozygous condition. The GM lines had been produced from the varieties Bobwhite or Frisal and contained Pm3b or chitinase/glucanase transgenes, respectively, in homozygous condition. These transgenes increase plant resistance against pathogenic fungi. Although the overall outcrossing rate in the first experiment was only 3.4%, Bobwhite GM lines containing the Pm3b transgene were six times more likely than non-GM control lines to produce outcrossed offspring. There was additional variation in outcrossing rate among the four GM-lines, presumably due to the different transgene insertion events. Among the pollen donors, the Frisal GM line expressing a chitinase transgene caused more outcrossing than the GM line expressing both a chitinase and a glucanase transgene. In the second experiment, outcrossing after cross-pollination declined from 0.7-0.03% over the test distances of 0.5-2.5 m. Our results suggest that pollen-mediated gene flow between GM and non-GM wheat might only be a concern if it occurs within fields, e.g. due to seed contamination. Methodologically our study demonstrates that outcrossing rates between transgenic and other lines within crops can be assessed using a phytometer approach and that gene-flow distances can be efficiently estimated with population-level PCR analyses.	[Rieben, Silvan; Kalinina, Olena; Schmid, Bernhard; Zeller, Simon L.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland	University of Zurich	Rieben, S (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	silvan.rieben@gmail.com	Schmid, Bernhard/C-8625-2009; Kalinina, Olena/J-5986-2019; Kalinina, Olena/H-6275-2011	Schmid, Bernhard/0000-0002-8430-3214; 	Swiss National Science Foundation [NRP 59 (SNF 405940-115607)]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was supported by the Swiss National Science Foundation and is part of the wheat-cluster.ch, a sub-unit of the national research programme NRP 59 (SNF 405940-115607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006751; Andersson HC, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1879; Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; Beckie HJ, 2008, PLANT SCI, V175, P615, DOI 10.1016/j.plantsci.2008.05.021; Bieri S, 2003, MOL BREEDING, V11, P37, DOI 10.1023/A:1022145915983; Bliffeld M, 1999, THEOR APPL GENET, V98, P1079, DOI 10.1007/s001220051170; Brunner S, 2011, PLANT BIOTECHNOL J, V9, P897, DOI 10.1111/j.1467-7652.2011.00603.x; Ceddia MG, 2007, ECOL MODEL, V205, P169, DOI 10.1016/j.ecolmodel.2007.02.025; Cellini F, 2004, FOOD CHEM TOXICOL, V42, P1089, DOI 10.1016/j.fct.2004.02.003; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Clements F. E., 1924, PHYTOMETER METHOD EC, P106; Conner AJ, 2003, PLANT J, V33, P19, DOI 10.1046/j.0960-7412.2002.001607.x; Crawley M.J., 2007, R BOOK; Daniell H, 2002, NAT BIOTECHNOL, V20, P581, DOI 10.1038/nbt0602-581; DEVRIES AP, 1971, EUPHYTICA, V20, P152, DOI 10.1007/BF00056076; Dietiker D, 2011, CROP SCI, V51, P829, DOI 10.2135/cropsci2010.06.0311; Eastham K, 2002, SIGNIFICANCE GENE FL, P75; Esser KH, 2006, BIOTECHNIQUES, V40, P238, DOI 10.2144/06402AF01; Gatford KT, 2006, EUPHYTICA, V151, P383, DOI 10.1007/s10681-006-9160-1; GRIFFIN WB, 1987, NEW ZEAL J AGR RES, V30, P287; Gustafson DI, 2005, CROP SCI, V45, P1286, DOI 10.2135/cropsci2004.0137; Hedrick P. W., 2004, GENETICS POPULATIONS; HERMSEN JGT, 1963, EUPHYTICA, V12, P1; JORGENSEN RB, 1994, AM J BOT, V81, P1620, DOI 10.2307/2445340; Kalinina O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028091; Kang HW, 1998, PLANT MOL BIOL REP, V16, P90, DOI 10.1023/A:1007418606098; Lawrie RG, 2006, CROP SCI, V46, P247, DOI 10.2135/cropsci2005.04-0021; LEAH R, 1991, J BIOL CHEM, V266, P1564; Levin D. A., 1974, EVOL BIOL, V7, P139, DOI DOI 10.1007/978-1-4615-6944-2_5; MARTIN TJ, 1990, CROP SCI, V30, P59, DOI 10.2135/cropsci1990.0011183X003000010013x; Matus-Cadiz MA, 2007, CROP SCI, V47, P573, DOI 10.2135/cropsci06.07.0441; McCullagh P, 1989, CRC MONOGRAPHS STAT; Mercer KL, 2008, AGR ECOSYST ENVIRON, V123, P109, DOI 10.1016/j.agee.2007.05.007; Pineyro-Nelson A, 2009, MOL ECOL, V18, P750, DOI 10.1111/j.1365-294X.2008.03993.x; Pla M, 2006, TRANSGENIC RES, V15, P219, DOI 10.1007/s11248-005-4945-x; R Development Core Team, 2010, R A LANG ENV STAT CO; Reed J, 2001, IN VITRO CELL DEV-PL, V37, P127; Rieger MA, 2002, SCIENCE, V296, P2386, DOI 10.1126/science.1071682; SCHMID B, 1994, EVOLUTION, V48, P1525, DOI 10.1111/j.1558-5646.1994.tb02194.x; Schoenenberger N, 2006, GENETICS, V174, P2061, DOI 10.1534/genetics.106.058529; Snow AA, 2005, ECOL APPL, V15, P377, DOI 10.1890/04-0539; Stein N, 2001, PLANT BREEDING, V120, P354, DOI 10.1046/j.1439-0523.2001.00615.x; Vries A. P. de, 1974, Euphytica, V23, P601, DOI 10.1007/BF00022483; Waines JG, 2003, CROP SCI, V43, P451, DOI 10.2135/cropsci2003.0451; Weber WE, 2007, J AGRON CROP SCI, V193, P79, DOI 10.1111/j.1439-037X.2006.00245.x; Wolfenbarger LL, 2000, SCIENCE, V290, P2088, DOI 10.1126/science.290.5499.2088; Yahiaoui N, 2004, PLANT J, V37, P528, DOI 10.1046/j.1365-313X.2003.01977.x; Zeller SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011405; ZHU Q, 1994, BIO-TECHNOL, V12, P807, DOI 10.1038/nbt0894-807	50	27	31	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29730	10.1371/journal.pone.0029730	http://dx.doi.org/10.1371/journal.pone.0029730			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216349	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000300674900057
J	Rose, G; Crocco, P; De Rango, F; Montesanto, A; Passarino, G				Rose, Giuseppina; Crocco, Paolina; De Rango, Francesco; Montesanto, Alberto; Passarino, Giuseppe			Further Support to the Uncoupling-to-Survive Theory: The Genetic Variation of Human UCP Genes Is Associated with Longevity	PLOS ONE			English	Article							RESTING METABOLIC-RATE; PROTEIN-2 ALA55VAL POLYMORPHISM; SKELETAL-MUSCLE UCP3; ENERGY-METABOLISM; OXIDATIVE STRESS; ADIPOSE-TISSUE; ROBUST-TESTS; CELL-DEATH; OBESITY; MICE	In humans Uncoupling Proteins (UCPs) are a group of five mitochondrial inner membrane transporters with variable tissue expression, which seem to function as regulators of energy homeostasis and antioxidants. In particular, these proteins uncouple respiration from ATP production, allowing stored energy to be released as heat. Data from experimental models have previously suggested that UCPs may play an important role on aging rate and lifespan. We analyzed the genetic variability of human UCPs in cohorts of subjects ranging between 64 and 105 years of age (for a total of 598 subjects), to determine whether specific UCP variability affects human longevity. Indeed, we found that the genetic variability of UCP2, UCP3 and UCP4 do affect the individual's chances of surviving up to a very old age. This confirms the importance of energy storage, energy use and modulation of ROS production in the aging process. In addition, given the different localization of these UCPs (UCP2 is expressed in various tissues including brain, hearth and adipose tissue, while UCP3 is expressed in muscles and Brown Adipose Tissue and UCP4 is expressed in neuronal cells), our results may suggest that the uncoupling process plays an important role in modulating aging especially in muscular and nervous tissues, which are indeed very responsive to metabolic alterations and are very important in estimating health status and survival in the elderly.	[Rose, Giuseppina; Crocco, Paolina; De Rango, Francesco; Montesanto, Alberto; Passarino, Giuseppe] Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy	University of Calabria	Rose, G (corresponding author), Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy.	g.passarino@unical.it	Crocco, Paolina/AAX-2695-2020; Montesanto, Alberto/J-8828-2016	Montesanto, Alberto/0000-0002-9563-2216; De Rango, Francesco/0000-0002-2328-8487; crocco, paolina/0000-0001-7803-5340; Rose, Giuseppina/0000-0002-4264-4184	Fondi di Ateneo Unical	Fondi di Ateneo Unical	This work was supported by Fondi di Ateneo Unical (ex 60%) to GP and GR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104; Andrews Zane B, 2010, Curr Aging Sci, V3, P102; Andrews ZB, 2009, AM J PHYSIOL-ENDOC M, V296, pE621, DOI 10.1152/ajpendo.90903.2008; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Astrup A, 1999, INT J OBESITY, V23, P1030, DOI 10.1038/sj.ijo.0801040; Barbieri M, 2008, EXP GERONTOL, V43, P74, DOI 10.1016/j.exger.2007.06.003; Barbieri M, 2012, AGE, V34, P235, DOI 10.1007/s11357-011-9210-z; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bevilacqua L, 2005, AM J PHYSIOL-ENDOC M, V289, pE429, DOI 10.1152/ajpendo.00435.2004; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Bezaire V, 2007, FASEB J, V21, P312, DOI 10.1096/fj.06-6966rev; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Bouchard C, 1997, HUM MOL GENET, V6, P1887, DOI 10.1093/hmg/6.11.1887; Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203; Brand MD, 2002, BIOCHEM J, V368, P597, DOI 10.1042/BJ20021077; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Buemann B, 2001, INT J OBESITY, V25, P467, DOI 10.1038/sj.ijo.0801564; Calle ML, 2008, STAT MED, V27, P6532, DOI 10.1002/sim.3431; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chan CB, 2006, BIOCHEM SOC T, V34, P802, DOI 10.1042/BST0340802; Chen HH, 2007, OBES SURG, V17, P926, DOI 10.1007/s11695-007-9171-6; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Cortez-Pinto H, 1998, BIOCHEM BIOPH RES CO, V251, P313, DOI 10.1006/bbrc.1998.9473; Crocco P, 2011, BIOGERONTOLOGY, V12, P265, DOI 10.1007/s10522-011-9321-z; da Silva CCC, 2008, AGING CELL, V7, P552, DOI 10.1111/j.1474-9726.2008.00407.x; Dalgaard LT, 2011, J OBES, V2011, DOI 10.1155/2011/340241; Dalgaard LT, 2003, OBES RES, V11, P1420, DOI 10.1038/oby.2003.191; de la Monte SM, 2006, J ALZHEIMERS DIS, V9, P167; Diao J, 2008, P NATL ACAD SCI USA, V105, P12057, DOI 10.1073/pnas.0710434105; Dietrich MO, 2010, PFLUG ARCH EUR J PHY, V459, P269, DOI 10.1007/s00424-009-0729-0; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Freidlin B, 2002, HUM HERED, V53, P146, DOI 10.1159/000064976; Fridell YWC, 2009, AGING-US, V1, P699, DOI 10.18632/aging.100067; Fridell YWC, 2004, J BIOENERG BIOMEMBR, V36, P219, DOI 10.1023/B:JOBB.0000031973.20153.c6; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Frisard M, 2006, ENDOCRINE, V29, P27, DOI 10.1385/ENDO:29:1:27; Frisard MI, 2007, J GERONTOL A-BIOL, V62, P752, DOI 10.1093/gerona/62.7.752; Girousse A, 2009, DIABETOLOGIA, V52, P1638, DOI 10.1007/s00125-009-1385-9; Harper ME, 2004, ACTA PHYSIOL SCAND, V182, P321, DOI 10.1111/j.1365-201X.2004.01370.x; Horvath TL, 2003, BIOCHEM PHARMACOL, V65, P1917, DOI 10.1016/S0006-2952(03)00143-6; Hsu YH, 2008, DIABETES, V57, P1101, DOI 10.2337/db07-1269; Jia JJ, 2009, OBES REV, V10, P519, DOI 10.1111/j.1467-789X.2009.00569.x; Karakelides H, 2005, CURR TOP DEV BIOL, V68, P123, DOI 10.1016/S0070-2153(05)68005-2; Kopecky J, 2004, PHYSIOL RES, V53, pS225; Lee YH, 2008, BIOCHEM BIOPH RES CO, V371, P767, DOI 10.1016/j.bbrc.2008.04.144; Li YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001397; Liu D, 2006, NEUROMOL MED, V8, P389, DOI 10.1385/NMM:8:3:389; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Manini TM, 2010, AGEING RES REV, V9, P1, DOI 10.1016/j.arr.2009.08.002; Mattson MP, 2003, TRENDS MOL MED, V9, P196, DOI 10.1016/S1471-4914(03)00046-7; McDonald RB, 2008, EXP GERONTOL, V43, P1061, DOI 10.1016/j.exger.2008.09.011; Mookerjee SA, 2010, MECH AGEING DEV, V131, P463, DOI 10.1016/j.mad.2010.03.010; Murray AJ, 2004, LANCET, V364, P1786, DOI 10.1016/S0140-6736(04)17402-3; Nabben M, 2008, FEBS LETT, V582, P4147, DOI 10.1016/j.febslet.2008.11.016; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Nubel T, 2006, HORM RES, V65, P300, DOI 10.1159/000092847; Paradis E, 2003, TRENDS MOL MED, V9, P522, DOI 10.1016/j.molmed.2003.10.009; Passarino G, 2006, HUM HERED, V62, P213, DOI 10.1159/000097305; Pecqueur C, 2001, J MOL MED, V79, P48, DOI 10.1007/s001090000150; Rizzo MR, 2005, J CLIN ENDOCR METAB, V90, P409, DOI 10.1210/jc.2004-0390; Roberts SB, 2006, PHYSIOL REV, V86, P651, DOI 10.1152/physrev.00019.2005; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Rose G, 2011, EXP GERONTOL; Rossi Paola, 2008, Curr Aging Sci, V1, P182; Saleh MC, 2002, DIABETOLOGIA, V45, P174, DOI 10.1007/s00125-001-0737-x; Salopuro T, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-94; Samec S, 1999, PFLUG ARCH EUR J PHY, V438, P452, DOI 10.1007/s004240051061; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schrauwen P, 1999, INT J OBESITY, V23, P1242, DOI 10.1038/sj.ijo.0801057; Schrauwen P, 1999, DIABETES, V48, P146, DOI 10.2337/diabetes.48.1.146; Smorodchenko A, 2009, BBA-BIOMEMBRANES, V1788, P2309, DOI 10.1016/j.bbamem.2009.07.018; So HC, 2011, BEHAV GENET, V41, P768, DOI 10.1007/s10519-011-9450-9; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Szolnoki Z, 2011, ACTA NEUROL SCAND, V123, P352, DOI 10.1111/j.1600-0404.2010.01391.x; Szolnoki Z, 2009, NEUROMOL MED, V11, P101, DOI 10.1007/s12017-009-8071-4; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Walder K, 1998, HUM MOL GENET, V7, P1431, DOI 10.1093/hmg/7.9.1431; Wang H, 2004, AM J PHYSIOL-ENDOC M, V286, pE1, DOI 10.1152/ajpendo.00231.2003; Wei ZL, 2009, NEUROTOX RES, V16, P14, DOI 10.1007/s12640-009-9039-8; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Willig AL, 2009, METABOLISM, V58, P877, DOI 10.1016/j.metabol.2009.02.016; Wilson MMG, 2003, J APPL PHYSIOL, V95, P1728, DOI 10.1152/japplphysiol.00313.2003; Wolkow CA, 2006, AGEING RES REV, V5, P196, DOI 10.1016/j.arr.2006.03.007; Xu K, 2011, DIABETOLOGIA, V54, P2315, DOI 10.1007/s00125-011-2245-y; Yang XL, 2002, MOL GENET METAB, V75, P369, DOI 10.1016/S1096-7192(02)00008-2; Yu XH, 2005, CLIN CHEM, V51, P1451, DOI 10.1373/clinchem.2004.044859; Zang Y, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-91; Zang Y, 2010, J STAT SOFTW, V33, P1	94	51	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29650	10.1371/journal.pone.0029650	http://dx.doi.org/10.1371/journal.pone.0029650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216339	gold, Green Submitted, Green Published			2022-12-27	WOS:000300674900051
J	Garcia, M; Stathopoulos, A				Garcia, Mayra; Stathopoulos, Angelike			Lateral Gene Expression in Drosophila Early Embryos Is Supported by Grainyhead-Mediated Activation and Tiers of Dorsally-Localized Repression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; VENTRAL AXIS; DORSOVENTRAL AXIS; PIPSQUEAK ENCODES; NERVOUS-SYSTEM; HOMEOBOX GENE; DPP; NEUROECTODERM; SCHNURRI; PATHWAY	The general consensus in the field is that limiting amounts of the transcription factor Dorsal establish dorsal boundaries of genes expressed along the dorsal-ventral (DV) axis of early Drosophila embryos, while repressors establish ventral boundaries. Yet recent studies have provided evidence that repressors act to specify the dorsal boundary of intermediate neuroblasts defective (ind), a gene expressed in a stripe along the DV axis in lateral regions of the embryo. Here we show that a short 12 base pair sequence ("the A-box'') present twice within the ind CRM is both necessary and sufficient to support transcriptional repression in dorsal regions of embryos. To identify binding factors, we conducted affinity chromatography using the A-box element and found a number of DNA-binding proteins and chromatin-associated factors using mass spectroscopy. Only Grainyhead (Grh), a CP2 transcription factor with a unique DNA-binding domain, was found to bind the A-box sequence. Our results suggest that Grh acts as an activator to support expression of ind, which was surprising as we identified this factor using an element that mediates dorsally-localized repression. Grh and Dorsal both contribute to ind transcriptional activation. However, another recent study found that the repressor Capicua (Cic) also binds to the A-box sequence. While Cic was not identified through our A-box affinity chromatography, utilization of the same site, the A-box, by both factors Grh (activator) and Cic (repressor) may also support a "switch-like'' response that helps to sharpen the ind dorsal boundary. Furthermore, our results also demonstrate that TGF-beta signaling acts to refine ind CRM expression in an A-box independent manner in dorsal-most regions, suggesting that tiers of repression act in dorsal regions of the embryo.	[Garcia, Mayra; Stathopoulos, Angelike] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Garcia, M (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	angelike@caltech.edu			NSF; NIH [R01GM077668]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077668] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a predoctoral NSF fellowship to M. G. and grant R01GM077668 from the NIH to A. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adryan B, 2009, FLYTF ORG DROSOPHILA; Ajuria L, 2011, DEVELOPMENT, V138, P915, DOI 10.1242/dev.057729; ARORA K, 1995, CELL, V81, P781, DOI 10.1016/0092-8674(95)90539-1; Biehs B, 1996, GENE DEV, V10, P2922, DOI 10.1101/gad.10.22.2922; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; BRAY SJ, 1991, GENE DEV, V5, P1672, DOI 10.1101/gad.5.9.1672; Chu H, 1998, GENE DEV, V12, P3613, DOI 10.1101/gad.12.22.3613; Cornell R, 2000, CURRENT OPINION NEUR, V10, P8; Cowden J, 2003, DEV BIOL, V262, P335, DOI 10.1016/S0012-1606(03)00395-6; Dai H, 2000, DEV BIOL, V227, P373, DOI 10.1006/dbio.2000.9901; DOYLE HJ, 1989, GENE DEV, V3, P1518, DOI 10.1101/gad.3.10.1518; DYNLACHT BD, 1989, GENE DEV, V3, P1677, DOI 10.1101/gad.3.11.1677; Ferguson E, 1992, CELL, V71, P10; Ghiglione C, 2002, DEVELOPMENT, V129, P175; GRIEDER NC, 1995, CELL, V81, P791, DOI 10.1016/0092-8674(95)90540-5; Grillo M, 2011, GENETICS, V187, P513, DOI 10.1534/genetics.110.121624; Harrison MM, 2010, DEV BIOL, V345, P248, DOI 10.1016/j.ydbio.2010.06.026; Hodgson JW, 2001, MOL CELL BIOL, V21, P4528, DOI 10.1128/MCB.21.14.4528-4543.2001; Huang DH, 2002, MOL CELL BIOL, V22, P6261, DOI 10.1128/MCB.22.17.6261-6271.2002; Huang JD, 1995, GENE DEV, V9, P3177, DOI 10.1101/gad.9.24.3177; IP YT, 1992, GENE DEV, V6, P1728, DOI 10.1101/gad.6.9.1728; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; Isshiki T, 1997, DEVELOPMENT, V124, P3099; Jazwinska A, 1999, DEVELOPMENT, V126, P3323; JIANG J, 1992, EMBO J, V11, P3147, DOI 10.1002/j.1460-2075.1992.tb05387.x; JIANG J, 1993, EMBO J, V12, P3201, DOI 10.1002/j.1460-2075.1993.tb05989.x; Jiang J, 1991, GENE DEV, V5, P10; JIMENEZ F, 1995, EMBO J, V14, P3487, DOI 10.1002/j.1460-2075.1995.tb07355.x; Jimenez G, 2000, GENE DEV, V14, P224; Kadonaga J, 1991, CURRENT PROTOCOLS MO; Kim M, 2011, P NATL ACAD SCI USA, V108, P650, DOI 10.1073/pnas.1016386108; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lee HY, 2004, MECH DEVELOP, V121, P37, DOI 10.1016/j.mod.2003.11.002; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Liaw GJ, 1995, GENE DEV, V9, P3163, DOI 10.1101/gad.9.24.3163; Liberman LM, 2009, P NATL ACAD SCI USA, V106, P22317, DOI 10.1073/pnas.0906227106; Liberman LM, 2009, DEV BIOL, V327, P578, DOI 10.1016/j.ydbio.2008.12.020; Luschnig S, 2004, GENETICS, V167, P325, DOI 10.1534/genetics.167.1.325; Mizutani C, 2006, PLOS BIOL, V4, P12; Morel V, 2000, GENE DEV, V14, P11; Nusslein-Volhard C, 1984, ROUX ARCH DEVEL BIOL, V193, P15; Ozdemir A, 2011, GENOME RES, V21, P566, DOI 10.1101/gr.104018.109; Perrimon N, 1998, INT J DEV BIOL, V42, P243; Pyrowolakis G, 2004, DEV CELL, V7, P229, DOI 10.1016/j.devcel.2004.07.008; RAY RP, 1991, DEVELOPMENT, V113, P35; Reeves G. T., 2009, PERSPECTIVES GENERAT; Rushlow C, 2001, GENE DEV, V15, P340, DOI 10.1101/gad.861401; RUTLEDGE BJ, 1992, GENE DEV, V6, P1503, DOI 10.1101/gad.6.8.1503; Schnepp B, 1996, GENE DEV, V10, P2302, DOI 10.1101/gad.10.18.2302; Small S, 1996, DEV BIOL, V175, P314, DOI 10.1006/dbio.1996.0117; STAEHLINGHAMPTON K, 1995, DEVELOPMENT, V121, P3393; Stathopoulos A, 2005, DEV BIOL, V280, P482, DOI 10.1016/j.ydbio.2005.02.003; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; STEIN D, 1991, CELL, V65, P725, DOI 10.1016/0092-8674(91)90381-8; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Von Ohlen T, 2000, DEV BIOL, V224, P362, DOI 10.1006/dbio.2000.9789; Wang SQ, 2009, NAT CELL BIOL, V11, P890, DOI 10.1038/ncb1898; Weber U, 1995, EMBO J, V14, P6247, DOI 10.1002/j.1460-2075.1995.tb00315.x; Weiss JB, 1998, GENE DEV, V12, P3591, DOI 10.1101/gad.12.22.3591; Zandi E, 1997, GENE DEV, V11, P1299, DOI 10.1101/gad.11.10.1299	61	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29172	10.1371/journal.pone.0029172	http://dx.doi.org/10.1371/journal.pone.0029172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216201	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000299684700035
J	Nylund, GM; Weinberger, F; Rempt, M; Pohnert, G				Nylund, Goran M.; Weinberger, Florian; Rempt, Martin; Pohnert, Georg			Metabolomic Assessment of Induced and Activated Chemical Defence in the Invasive Red Alga Gracilaria vermiculophylla	PLOS ONE			English	Article							INDUCED HERBIVORE RESISTANCE; CHONDRUS-CRISPUS; INNATE IMMUNITY; LAMINARIA-DIGITATA; MASS-SPECTROMETRY; ACID TREATMENT; ENEMY RELEASE; MARINE ALGA; BALTIC SEA; PLANTS	In comparison with terrestrial plants the mechanistic knowledge of chemical defences is poor for marine macroalgae. This restricts our understanding in the chemically mediated interactions that take place between algae and other organisms. Technical advances such as metabolomics, however, enable new approaches towards the characterisation of the chemically mediated interactions of organisms with their environment. We address defence responses in the red alga Gracilaria vermiculophylla using mass spectrometry based metabolomics in combination with bioassays. Being invasive in the north Atlantic this alga is likely to possess chemical defences according to the prediction that well-defended exotics are most likely to become successful invaders in systems dominated by generalist grazers, such as marine macroalgal communities. We investigated the effect of intense herbivore feeding and simulated herbivory by mechanical wounding of the algae. Both processes led to similar changes in the metabolic profile. Feeding experiments with the generalist isopod grazer Idotea baltica showed that mechanical wounding caused a significant increase in grazer resistance. Structure elucidation of the metabolites of which some were up-regulated more than 100 times in the wounded tissue, revealed known and novel eicosanoids as major components. Among these were prostaglandins, hydroxylated fatty acids and arachidonic acid derived conjugated lactones. Bioassays with pure metabolites showed that these eicosanoids are part of the innate defence system of macroalgae, similarly to animal systems. In accordance with an induced defence mechanism application of extracts from wounded tissue caused a significant increase in grazer resistance and the up-regulation of other pathways than in the activated defence. Thus, this study suggests that G. vermiculophylla chemically deters herbivory by two lines of defence, a rapid wound-activated process followed by a slower inducible defence. By unravelling involved pathways using metabolomics this work contributes significantly to the understanding of activated and inducible defences for marine macroalgae.	[Nylund, Goran M.; Rempt, Martin; Pohnert, Georg] Univ Jena, Inst Inorgan & Analyt Chem, Jena, Germany; [Weinberger, Florian] Leibniz Inst Meereswissensch IFM GEOMAR, Kiel, Germany	Friedrich Schiller University of Jena; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Nylund, GM (corresponding author), Univ Gothenburg, Dept Marine Ecol Tjamo, Stromstad, Sweden.	goran.nylund@marecol.gu.se	Weinberger, Florian/O-5554-2015; Pohnert, Georg/D-3721-2013	Weinberger, Florian/0000-0003-3366-6880; Pohnert, Georg/0000-0003-2351-6336	FORMAS [2007-1033]; Volkswagen Foundation; German Research Foundation [Po628/5-1]; LLUR Schleswig-Holstein	FORMAS(Swedish Research Council Formas); Volkswagen Foundation(Volkswagen); German Research Foundation(German Research Foundation (DFG)); LLUR Schleswig-Holstein	This research was supported by FORMAS through contract 2007-1033 and by the Volkswagen Foundation within the framework of a Lichtenberg Professorship. The German Research Foundation is acknowledged for support of MR and GP (Po628/5-1). FW was supported by LLUR Schleswig-Holstein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amade P, 1998, AQUAT TOXICOL, V43, P287, DOI 10.1016/S0166-445X(98)00054-X; Anderson M.J., 2005, PERMANOVA A FORTRAN; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANDERSON MJ, 2004, CAP A FORTRAN COMPUT; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; BALDWIN IT, 1993, OECOLOGIA, V94, P534, DOI 10.1007/BF00566969; BARBOSA P, 1986, J CHEM ECOL, V12, P1319, DOI 10.1007/BF01012351; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Bouarab K, 2004, PLANT PHYSIOL, V135, P1838, DOI 10.1104/pp.103.037622; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; Cetrulo GL, 2000, MAR ECOL PROG SER, V207, P243, DOI 10.3354/meps207243; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Coleman RA, 2007, FUNCT ECOL, V21, P101, DOI 10.1111/j.1365-2435.2006.01210.x; Collen J, 2006, J EXP BOT, V57, P3869, DOI 10.1093/jxb/erl171; Cronin G, 1996, ECOLOGY, V77, P2287, DOI 10.2307/2265731; Dicke M, 2003, BASIC APPL ECOL, V4, P27, DOI 10.1078/1439-1791-00131; Engkvist R, 2004, AQUAT ECOL, V38, P403, DOI 10.1023/B:AECO.0000035162.07481.1f; Engkvist Roland, 2000, Aquatic Ecology, V34, P253, DOI 10.1023/A:1009919526259; Freshwater DW, 2006, BIOL INVASIONS, V8, P631, DOI 10.1007/s10530-005-1809-5; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gaquerel E, 2007, BBA-MOL CELL BIOL L, V1771, P565, DOI 10.1016/j.bbalip.2007.02.007; GIAMOUSTARIS A, 1995, ANN APPL BIOL, V126, P347, DOI 10.1111/j.1744-7348.1995.tb05371.x; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; HAY ME, 1989, OECOLOGIA, V81, P418, DOI 10.1007/BF00377093; HAY ME, 1987, ECOLOGY, V68, P1567, DOI 10.2307/1939849; Honda K, 1997, J CHEM ECOL, V23, P1703, DOI 10.1023/B:JOEC.0000006445.61545.82; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Joshi J, 2005, ECOL LETT, V8, P704, DOI 10.1111/j.1461-0248.2005.00769.x; Kakinuma M, 2006, MAR BIOL, V149, P97, DOI 10.1007/s00227-005-0215-y; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kupper FC, 2006, J EXP BOT, V57, P1991, DOI 10.1093/jxb/erj146; Legendre P., 2012, NUMERICAL ECOLOGY; Lind EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010429; Lion U, 2006, CHEMBIOCHEM, V7, P457, DOI 10.1002/cbic.200500365; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; NATHANSON JA, 1984, SCIENCE, V226, P184, DOI 10.1126/science.6207592; Nyberg CD, 2009, EUR J PHYCOL, V44, P395, DOI 10.1080/09670260802592808; PAUL VJ, 1992, J EXP MAR BIOL ECOL, V160, P191, DOI 10.1016/0022-0981(92)90237-5; PAUL VJ, 2001, MARINE CHEM ECOLOGY, P355; Pavia H, 2000, ECOLOGY, V81, P3212; Pohnert G, 2004, TOP CURR CHEM, V239, P179, DOI 10.1007/b95453; Prince EK, 2010, ANAL BIOANAL CHEM, V396, P193, DOI 10.1007/s00216-009-3162-5; Rempt M, 2010, ANGEW CHEM INT EDIT, V49, P4755, DOI 10.1002/anie.201000825; Ritter A, 2008, NEW PHYTOL, V180, P809, DOI 10.1111/j.1469-8137.2008.02626.x; Rosenthal GA., 1992, HERBIVORES THEIR INT; Rueness J, 2005, PHYCOLOGIA, V44, P120, DOI 10.2216/0031-8884(2005)44[120:LHAMSO]2.0.CO;2; Sajiki J, 1998, J CHROMATOGR A, V795, P227, DOI 10.1016/S0021-9673(97)00943-6; Sajiki J, 1997, FISHERIES SCI, V63, P128, DOI 10.2331/fishsci.63.128; Sajiki J, 1999, FISHERIES SCI, V65, P914, DOI 10.2331/fishsci.65.914; Schaffner U, 2011, ECOLOGY, V92, P829, DOI 10.1890/10-1230.1; Taylor RB, 2003, OECOLOGIA, V136, P412, DOI 10.1007/s00442-003-1280-x; THOMSEN MS, 2007, AQUAT INVASIONS, V2, P83, DOI DOI 10.3391/ai.2007.2.2.1; Toth GB, 2007, MAR BIOL, V151, P1597, DOI 10.1007/s00227-007-0605-4; Toth GB, 2007, J ECOL, V95, P425, DOI 10.1111/j.1365-2745.2007.01224.x; Tseng CK, 1999, BOT MAR, V42, P209, DOI 10.1515/BOT.1999.024; Weber H, 2002, TRENDS PLANT SCI, V7, P217, DOI 10.1016/S1360-1385(02)02250-1; Weinberger F, 2002, CHEMBIOCHEM, V3, P1260, DOI 10.1002/1439-7633(20021202)3:12<1260::AID-CBIC1260>3.0.CO;2-5; Weinberger F, 2007, BIOL BULL-US, V213, P290, DOI 10.2307/25066646; Weinberger F, 2011, J CHEM ECOL, V37, P677, DOI 10.1007/s10886-011-9981-9; Weinberger F, 2011, MAR ECOL PROG SER, V427, P83, DOI 10.3354/meps09044; Weinberger F, 2008, AQUAT BIOL, V3, P251, DOI 10.3354/ab00083; Wikstrom SA, 2006, OECOLOGIA, V148, P593, DOI 10.1007/s00442-006-0407-2; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9; Wolfe GV, 1997, NATURE, V387, P894, DOI 10.1038/43168	66	80	80	4	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29359	10.1371/journal.pone.0029359	http://dx.doi.org/10.1371/journal.pone.0029359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216258	Green Published, gold, Green Accepted			2022-12-27	WOS:000299113600080
J	Behnken, S; Hertweck, C				Behnken, Swantje; Hertweck, Christian			Cryptic Polyketide Synthase Genes in Non-Pathogenic Clostridium SPP	PLOS ONE			English	Article							BIOSYNTHESIS	Modular type I polyketide synthases (PKS) produce a vast array of bacterial metabolites with highly diverse biological functions. Notably, all known polyketides were isolated from aerobic bacteria, and yet no example has been reported for strict anaerobes. In this study we explored the diversity and distribution of PKS genes in the genus Clostridium. In addition to comparative genomic analyses combined with predictions of modular type I polyketide synthase (PKS) gene clusters in sequenced genomes of Clostridium spp., a representative selection of other species inhabiting a variety of ecological niches was investigated by PCR screening for PKS genes. Our data reveal that all studied pathogenic Clostridium spp. are devoid of putative PKS genes. In stark contrast, cryptic PKS genes are widespread in genomes of non-pathogenic Clostridium species. According to phylogenetic analyses, the Clostridium PKS genes have unusual and diverse origins. However, reverse transcription quantitative PCR demonstrates that these genes are silent under standard cultivation conditions, explaining why the related metabolites have been overlooked until now. This study presents clostridia as a putative source for novel bioactive polyketides.	[Behnken, Swantje; Hertweck, Christian] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Hertweck, Christian] Univ Jena, Chair Nat Prod Chem, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Behnken, S (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany.	christian.hertweck@hki-jena.de	Hertweck, Christian/AAZ-8452-2021; Hertweck, Christian/G-1896-2014	Hertweck, Christian/0000-0002-0367-337X; Hertweck, Christian/0000-0002-0367-337X	International Leibniz Research School for Biomolecular and Microbial Interactions	International Leibniz Research School for Biomolecular and Microbial Interactions	This work was funded by the International Leibniz Research School for Biomolecular and Microbial Interactions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blodgett JAV, 2010, P NATL ACAD SCI USA, V107, P11692, DOI 10.1073/pnas.1001513107; Boakes S, 2004, J MOL MICROB BIOTECH, V8, P73, DOI 10.1159/000084562; Du LH, 2001, METAB ENG, V3, P78, DOI 10.1006/mben.2000.0171; Herlemann DPR, 2009, APPL ENVIRON MICROB, V75, P2841, DOI 10.1128/AEM.02698-08; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Ishida K, 2010, J AM CHEM SOC, V132, P13966, DOI 10.1021/ja105003g; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; Jenke-Kodama H, 2006, PLOS COMPUT BIOL, V2, P1210, DOI 10.1371/journal.pcbi.0020132; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lincke T, 2010, ANGEW CHEM INT EDIT, V49, P2011, DOI 10.1002/anie.200906114; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lou L, 2011, J AM CHEM SOC; Metsa-Ketela M, 2002, APPL ENVIRON MICROB, V68, P4472, DOI 10.1128/AEM.68.9.4472-4479.2002; Moldenhauer J, 2007, ANGEW CHEM INT EDIT, V46, P8195, DOI 10.1002/anie.200703386; Nguyen T, 2008, NAT BIOTECHNOL, V26, P225, DOI 10.1038/nbt1379; Paredes CJ, 2005, NAT REV MICROBIOL, V3, P969, DOI 10.1038/nrmicro1288; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Piel J, 2010, NAT PROD REP, V27, P996, DOI 10.1039/b816430b; Scherlach K, 2009, ORG BIOMOL CHEM, V7, P1753, DOI 10.1039/b821578b; Teta R, 2010, CHEMBIOCHEM, V11, P2506, DOI 10.1002/cbic.201000542; Winter JM, 2011, CURR OPIN CHEM BIOL, V15, P22, DOI 10.1016/j.cbpa.2010.10.020; Yadav G, SEARCHPKS	22	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29609	10.1371/journal.pone.0029609	http://dx.doi.org/10.1371/journal.pone.0029609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235310	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400072
J	Berg, RK; Melchjorsen, J; Rintahaka, J; Diget, E; Soby, S; Horan, KA; Gorelick, RJ; Matikainen, S; Larsen, CS; Ostergaard, L; Paludan, SR; Mogensen, TH				Berg, Randi K.; Melchjorsen, Jesper; Rintahaka, Johanna; Diget, Elisabeth; Soby, Stine; Horan, Kristy A.; Gorelick, Robert J.; Matikainen, Sampsa; Larsen, Carsten S.; Ostergaard, Lars; Paludan, Soren R.; Mogensen, Trine H.			Genomic HIV RNA Induces Innate Immune Responses through RIG-I-Dependent Sensing of Secondary-Structured RNA	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; NF-KAPPA-B; PLASMACYTOID DENDRITIC CELLS; HERPES-SIMPLEX-VIRUS; TOLL-LIKE RECEPTORS; CYTOSOLIC DNA; RECOGNITION; INFECTION	Background: Innate immune responses have recently been appreciated to play an important role in the pathogenesis of HIV infection. Whereas inadequate innate immune sensing of HIV during acute infection may contribute to failure to control and eradicate infection, persistent inflammatory responses later during infection contribute in driving chronic immune activation and development of immunodeficiency. However, knowledge on specific HIV PAMPs and cellular PRRs responsible for inducing innate immune responses remains sparse. Methods/Principal Findings: Here we demonstrate a major role for RIG-I and the adaptor protein MAVS in induction of innate immune responses to HIV genomic RNA. We found that secondary structured HIV-derived RNAs induced a response similar to genomic RNA. In primary human peripheral blood mononuclear cells and primary human macrophages, HIV RNA induced expression of IFN-stimulated genes, whereas only low levels of type I IFN and tumor necrosis factor alpha were produced. Furthermore, secondary structured HIV-derived RNA activated pathways to NF-kappa B, MAP kinases, and IRF3 and co-localized with peroxisomes, suggesting a role for this organelle in RIG-I-mediated innate immune sensing of HIV RNA. Conclusions/Significance: These results establish RIG-I as an innate immune sensor of cytosolic HIV genomic RNA with secondary structure, thereby expanding current knowledge on HIV molecules capable of stimulating the innate immune system.	[Berg, Randi K.; Melchjorsen, Jesper; Diget, Elisabeth; Soby, Stine; Larsen, Carsten S.; Ostergaard, Lars; Mogensen, Trine H.] Aarhus Univ Hosp Skejby, Dept Infect Dis, Aarhus, Denmark; [Rintahaka, Johanna; Matikainen, Sampsa] Finnish Inst Occupat Hlth, Unit Excellence Immunotoxicol, Helsinki, Finland; [Horan, Kristy A.; Paludan, Soren R.] Univ Aarhus, Dept Biomed, Aarhus, Denmark; [Gorelick, Robert J.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD USA	Aarhus University; Finnish Institute of Occupational Health; Aarhus University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Berg, RK (corresponding author), Aarhus Univ Hosp Skejby, Dept Infect Dis, Aarhus, Denmark.	trine.mogensen@dadlnet.dk	Matikainen, Sampsa/AAH-8654-2021; Ostergaard, Lars/AAA-3020-2020	Ostergaard, Lars/0000-0003-2459-0511; Ostergaard, Lars/0000-0002-7619-605X; Mogensen, Trine Hyrup/0000-0002-1853-9704	Danish Medical Research Council; Kong Christian IX and Dronning Louises Jubilaeumslegat; Fonden til Laegevidenskabens Fremme; Scandinavian Society of Antimicrobial Chemotherapy; Marie Curie Incoming International Fellowship; Faculty of Health Science, Aarhus University; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; SAIC-Frederick, Inc.; U.S. Government	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kong Christian IX and Dronning Louises Jubilaeumslegat; Fonden til Laegevidenskabens Fremme; Scandinavian Society of Antimicrobial Chemotherapy; Marie Curie Incoming International Fellowship(European Commission); Faculty of Health Science, Aarhus University; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); SAIC-Frederick, Inc.; U.S. Government	This work was supported by The Danish Medical Research Council (THM), Kong Christian IX and Dronning Louises Jubilaeumslegat (THM), Fonden til Laegevidenskabens Fremme (THM), and Scandinavian Society of Antimicrobial Chemotherapy (JM). KAH is recipient of a Marie Curie Incoming International Fellowship and RKB was supported by a PhD Stipend from the Faculty of Health Science, Aarhus University. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E with SAIC-Frederick, Inc. (RJG). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Neither SAIC-Frederick, Inc., nor the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following competing interest: One of the authors (RJG) has an affiliation to SAIC-Frederick, Inc., which is a U.S. Government contractor, thus funding comes from the U.S. Government. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bochud PY, 2007, AIDS, V21, P441, DOI 10.1097/QAD.0b013e328012b8ac; Breckpot K, 2010, J VIROL, V84, P5627, DOI 10.1128/JVI.00014-10; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brown JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003664; Chang JJ, 2010, J INFECT DIS, V202, pS297, DOI 10.1086/655657; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Doehle BP, 2009, J VIROL, V83, P10395, DOI 10.1128/JVI.00849-09; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kikuchi M, 2006, INVEST OPHTH VIS SCI, V47, P4803, DOI 10.1167/iovs.06-0521; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lempicki RA, 2000, P NATL ACAD SCI USA, V97, P13778, DOI 10.1073/pnas.250472097; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Medzhitov R, 2008, NATURE, V455, P591, DOI 10.1038/455591a; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Melchjorsen J, 2006, J GEN VIROL, V87, P1099, DOI 10.1099/vir.0.81541-0; Melchjorsen J, 2010, J VIROL, V84, P11350, DOI 10.1128/JVI.01106-10; Mogensen TH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-54; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Murray SM, 2010, J VIROL, V84, P12082, DOI 10.1128/JVI.01466-10; OTT DE, 1995, AIDS RES HUM RETROV, V11, P1003, DOI 10.1089/aid.1995.11.1003; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Rintahaka J, 2008, J IMMUNOL, V180, P1749, DOI 10.4049/jimmunol.180.3.1749; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tilling R, 2002, AIDS, V16, P589, DOI 10.1097/00002030-200203080-00010; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	55	108	108	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29291	10.1371/journal.pone.0029291	http://dx.doi.org/10.1371/journal.pone.0029291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235281	Green Submitted, Green Published, gold			2022-12-27	WOS:000301123400042
J	Greenstein, RJ; Su, LY; Brown, ST				Greenstein, Robert J.; Su, Liya; Brown, Sheldon T.			Vitamins A & D Inhibit the Growth of Mycobacteria in Radiometric Culture	PLOS ONE			English	Article							AVIUM SUBSPECIES PARATUBERCULOSIS; TUBERCULOSIS; SUSCEPTIBILITY; DRUGS; 6-MERCAPTOPURINE; RESISTANCE; INFECTION; RETINOIDS; SUNLIGHT; PHASE	Background: The role of vitamins in the combat of disease is usually conceptualized as acting by modulating the immune response of an infected, eukaryotic host. We hypothesized that some vitamins may directly influence the growth of prokaryotes, particularly mycobacteria. Methods: The effect of four fat-soluble vitamins was studied in radiometric Bactec (R) culture. The vitamins were A (including a precursor and three metabolites,) D, E and K. We evaluated eight strains of three mycobacterial species (four of M. avium subspecies paratuberculosis (MAP), two of M. avium and two of M. tb. complex). Principal Findings: Vitamins A and D cause dose-dependent inhibition of all three mycobacterial species studied. Vitamin A is consistently more inhibitory than vitamin D. The vitamin A precursor, beta-carotene, is not inhibitory, whereas three vitamin A metabolites cause inhibition. Vitamin K has no effect. Vitamin E causes negligible inhibition in a single strain. Significance: We show that vitamin A, its metabolites Retinyl acetate, Retinoic acid and 13-cis Retinoic acid and vitamin D directly inhibit mycobacterial growth in culture. These data are compatible with the hypothesis that complementing the immune response of multicellular organisms, vitamins A and D may have heretofore unproven, unrecognized, independent and probable synergistic, direct antimycobacterial inhibitory activity.	[Greenstein, Robert J.] James J Peters Vet Affairs Med Ctr, Dept Surg, Bronx, NY USA; [Greenstein, Robert J.; Su, Liya] James J Peters Vet Affairs Med Ctr, Lab Mol Surg Res, Bronx, NY USA; [Brown, Sheldon T.] James J Peters Vet Affairs Med Ctr, Dept Med, Bronx, NY USA; [Brown, Sheldon T.] Mt Sinai Sch Med, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai	Greenstein, RJ (corresponding author), James J Peters Vet Affairs Med Ctr, Dept Surg, Bronx, NY USA.	BGAxis@aol.com			Becton-Dickinson	Becton-Dickinson	This project was extramurally funded by Becton-Dickinson, whose sole contribution was to provide the authors with the culture medium used in these experiments. Intramural funds were from the Bronx Veterans Medical Research Foundation, Inc. a charity at the James J. Peters VAMC Bronx NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand PK, 2008, J MICROBIOL IMMUNOL, V41, P17; Anand PK, 2003, BIOCHEM BIOPH RES CO, V310, P876, DOI 10.1016/j.bbrc.2003.09.087; BENTLEY R, 1982, MICROBIOL REV, V46, P241, DOI 10.1128/MMBR.46.3.241-280.1982; Bernheim F, 1940, SCIENCE, V92, P204, DOI 10.1126/science.92.2383.204; BERTRAM MA, 1986, J INFECT DIS, V154, P194, DOI 10.1093/infdis/154.1.194; BROWN ST, 1993, ANTIMICROB AGENTS CH, V37, P398, DOI 10.1128/AAC.37.3.398; Bruce D, 2010, EXP BIOL MED, V235, P921, DOI 10.1258/ebm.2010.010061; CHIODINI RJ, 1986, J CLIN MICROBIOL, V24, P357, DOI 10.1128/JCM.24.3.357-363.1986; DAMATO JJ, 1990, VET MICROBIOL, V22, P31, DOI 10.1016/0378-1135(90)90122-C; FLEMETAKIS AC, 1989, J CHEMOTHERAPY, V1, P374, DOI 10.1080/1120009X.1989.11738926; FRANCIS J, 1949, NATURE, V163, P365, DOI 10.1038/163365b0; FRANCIS J, 1953, BIOCHEM J, V55, P596, DOI 10.1042/bj0550596; Greenstein RJ, 2009, SEQUELAE AND LONG-TERM CONSEQUENCES OF INFECTIOUS DISEASES, P135; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Greenstein RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000161; Greenstein RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000516; Greenstein RJ, 2011, DIGEST DIS SCI, V56, P368, DOI 10.1007/s10620-010-1301-7; Greenstein RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011099; Greenstein RJ, 2009, INT J INFECT DIS, V13, pE254, DOI 10.1016/j.ijid.2008.10.016; Greenstein RJ, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-4; Greenstein RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002496; Hewison M, 2010, MOL CELL ENDOCRINOL, V321, P103, DOI 10.1016/j.mce.2010.02.013; Holick MF, 2011, NAT REV ENDOCRINOL, V7, P73, DOI 10.1038/nrendo.2010.234; Krishnan MY, 2009, J ANTIMICROB CHEMOTH, V64, P1018, DOI 10.1093/jac/dkp339; Krishnan MY, 2009, J ANTIMICROB CHEMOTH, V64, P310, DOI 10.1093/jac/dkp184; Kurosu M, 2007, J MED CHEM, V50, P3973, DOI 10.1021/jm070638m; Lalor MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016709; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Mellanby E, 1929, BMJ-BRIT MED J, V1929, P984; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Nerich V, 2011, ALIMENT PHARM THER, V33, P940, DOI 10.1111/j.1365-2036.2011.04601.x; Pattison CL, 1930, BRIT MED J, V1930, P178, DOI 10.1136/bmj.2.3630.178; Pechere M, 2002, DERMATOLOGY, V205, P153, DOI 10.1159/000063903; RASTOGI N, 1992, ANTIMICROB AGENTS CH, V36, P2843, DOI 10.1128/AAC.36.12.2843; Ross A, 1994, RETINOIDS BIOL CHEM, P597; Rusch-Gerdes S, 2006, J CLIN MICROBIOL, V44, P688, DOI 10.1128/JCM.44.3.688-692.2006; Semba RD, 1999, J NUTR, V129, P783, DOI 10.1093/jn/129.4.783; Shapira Y, 2010, CLIN REV ALLERG IMMU, V38, P169, DOI 10.1007/s12016-009-8150-1; Shin SJ, 2008, ANTIMICROB AGENTS CH, V52, P418, DOI 10.1128/AAC.00678-07; SIDDIQI SH, 1981, J CLIN MICROBIOL, V13, P908, DOI 10.1128/JCM.13.5.908-912.1981; SNOW GA, 1970, BACTERIOL REV, V34, P99, DOI 10.1128/MMBR.34.2.99-125.1970; Springer B, 2009, J CLIN MICROBIOL, V47, P1773, DOI 10.1128/JCM.02501-08; Sutherland R, 1934, BMJ-BRIT MED J, V1934, P791, DOI 10.1136/bmj.1.3826.791; Woolley DW, 1940, P SOC EXP BIOL MED, V45, P357, DOI 10.3181/00379727-45-11682	46	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29631	10.1371/journal.pone.0029631	http://dx.doi.org/10.1371/journal.pone.0029631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235314	Green Submitted, Green Published, gold			2022-12-27	WOS:000301123400076
J	Labrecque, MP; Takhar, MK; Hollingshead, BD; Prefontaine, GG; Perdew, GH; Beischlag, TV				Labrecque, Mark P.; Takhar, Mandeep K.; Hollingshead, Brett D.; Prefontaine, Gratien G.; Perdew, Gary H.; Beischlag, Timothy V.			Distinct Roles for Aryl Hydrocarbon Receptor Nuclear Translocator and Ah Receptor in Estrogen-Mediated Signaling in Human Cancer Cell Lines	PLOS ONE			English	Article							DIOXIN RECEPTOR; GENE-EXPRESSION; TRANSCRIPTIONAL RESPONSE; SYNERGISTIC INDUCTION; BINDING ACTIVITY; PROTEIN ARNT; RECRUITMENT; COACTIVATOR; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; ACTIVATION	The activated AHR/ARNT complex (AHRC) regulates the expression of target genes upon exposure to environmental contaminants such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Importantly, evidence has shown that TCDD represses estrogen receptor (ER) target gene activation through the AHRC. Our data indicates that AHR and ARNT act independently from each other at non-dioxin response element sites. Therefore, we sought to determine the specific functions of AHR and ARNT in estrogen-dependent signaling in human MCF7 breast cancer and human ECC-1 endometrial carcinoma cells. Knockdown of AHR with siRNA abrogates dioxin-inducible repression of estrogen-dependent gene transcription. Intriguingly, knockdown of ARNT does not effect TCDD-mediated repression of estrogen-regulated transcription, suggesting that AHR represses ER function independently of ARNT. This theory is supported by the ability of the selective AHR modulator 3',4'-dimethoxy-alpha-naphthoflavone (DiMNF) to repress estrogen-inducible transcription. Furthermore, basal and estrogen-activated transcription of the genes encoding cathepsin-D and pS2 are down-regulated in MCF7 cells but up-regulated in ECC-1 cells in response to loss of ARNT. These responses are mirrored at the protein level with cathepsin-D. Furthermore, knock-down of ARNT led to opposite but corresponding changes in estrogen-stimulated proliferation in both MCF7 and ECC-1 cells. We have obtained experimental evidence demonstrating a dioxin-dependent repressor function for AHR and a dioxin-independent co-activator/co-repressor function for ARNT in estrogen signalling. These results provide us with further insight into the mechanisms of transcription factor crosstalk and putative therapeutic targets in estrogen-positive cancers.	[Labrecque, Mark P.; Takhar, Mandeep K.; Prefontaine, Gratien G.; Beischlag, Timothy V.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Hollingshead, Brett D.; Perdew, Gary H.] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA	Simon Fraser University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Labrecque, MP (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	tvb@sfu.ca	Labrecque, Mark/GPP-4575-2022	Labrecque, Mark/0000-0001-7887-7599	Canadian Breast Cancer Foundation - BC/Yukon; Natural Sciences and Engineering Research Council; National Institutes of Health [ES04869]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004869] Funding Source: NIH RePORTER	Canadian Breast Cancer Foundation - BC/Yukon; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Canadian Breast Cancer Foundation - BC/Yukon, the Natural Sciences and Engineering Research Council to Dr. Beischlag, and a National Institutes of Health grant ES04869 to Dr. Perdew. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2006, CANCER LETT, V238, P1, DOI 10.1016/j.canlet.2005.06.018; Alexander DL, 1998, J CELL SCI, V111, P3311; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; ASTROFF B, 1990, MOL CELL ENDOCRINOL, V72, P247, DOI 10.1016/0303-7207(90)90149-3; ASTROFF B, 1988, TOXICOL APPL PHARM, V95, P435, DOI 10.1016/0041-008X(88)90361-4; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Beischlag TV, 2005, J BIOL CHEM, V280, P21607, DOI 10.1074/jbc.C500090200; Beischlag TV, 2004, J BIOL CHEM, V279, P54620, DOI 10.1074/jbc.M410456200; Beischlag TV, 2002, MOL CELL BIOL, V22, P4319, DOI 10.1128/MCB.22.12.4319-4333.2002; BIEGEL L, 1990, J STEROID BIOCHEM, V37, P725, DOI 10.1016/0960-0760(90)90357-Q; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Brunnberg S, 2003, P NATL ACAD SCI USA, V100, P6517, DOI 10.1073/pnas.1136688100; Carver LA, 1997, J BIOL CHEM, V272, P11452; Castro-Rivera E, 1999, MOL CELL ENDOCRINOL, V150, P11, DOI 10.1016/S0303-7207(99)00041-6; Chen YH, 2006, J BIOL CHEM, V281, P12242, DOI 10.1074/jbc.M512537200; DiNatale BC, 2010, J BIOL CHEM, V285, P24388, DOI 10.1074/jbc.M110.118570; Elizondo G, 2000, MOL PHARMACOL, V57, P1056; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; GALLO MA, 1986, TOXICOL LETT, V32, P123, DOI 10.1016/0378-4274(86)90058-5; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hestermann EV, 2003, MOL CELL BIOL, V23, P7920, DOI 10.1128/MCB.23.21.7920-7925.2003; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Hollingshead BD, 2008, CANCER RES, V68, P3609, DOI 10.1158/0008-5472.CAN-07-6168; Kazlauskas A, 1999, J BIOL CHEM, V274, P13519, DOI 10.1074/jbc.274.19.13519; Kharat I, 1996, J BIOL CHEM, V271, P10533, DOI 10.1074/jbc.271.18.10533; Kim JH, 2004, J BIOL CHEM, V279, P49842, DOI 10.1074/jbc.M408535200; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kollara A, 2006, BIOCHEM BIOPH RES CO, V346, P526, DOI 10.1016/j.bbrc.2006.05.148; Kumar MB, 1999, GENE EXPRESSION, V8, P273; Ma Q, 1997, J BIOL CHEM, V272, P8878; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Matthews J, 2005, MOL CELL BIOL, V25, P5317, DOI 10.1128/MCB.25.13.5317-5328.2005; Murray IA, 2011, MOL PHARMACOL, V79, P508, DOI 10.1124/mol.110.069369; Murray IA, 2010, CHEM RES TOXICOL, V23, P955, DOI 10.1021/tx100045h; Nguyen TA, 1999, ARCH BIOCHEM BIOPHYS, V367, P250, DOI 10.1006/abbi.1999.1282; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Partch CL, 2011, P NATL ACAD SCI USA, V108, P7739, DOI 10.1073/pnas.1101357108; Partch CL, 2009, J BIOL CHEM, V284, P15184, DOI 10.1074/jbc.M808479200; Perdew GH, 2010, J PHARMACOL EXP THER, V335, P273, DOI 10.1124/jpet.110.170654; PONGRATZ I, 1992, J BIOL CHEM, V267, P13728; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Ricci MS, 1999, IN VITRO CELL DEV-AN, V35, P183, DOI 10.1007/s11626-999-0025-5; Ruegg J, 2008, MOL ENDOCRINOL, V22, P304, DOI 10.1210/me.2007-0128; Safe S, 2000, J MAMMARY GLAND BIOL, V5, P295, DOI 10.1023/A:1009550912337; Tian Y, 1999, J BIOL CHEM, V274, P510, DOI 10.1074/jbc.274.1.510; Vendrell JA, 2004, J MOL ENDOCRINOL, V32, P397, DOI 10.1677/jme.0.0320397; ZACHAREWSKI TR, 1994, CANCER RES, V54, P2707	48	37	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29545	10.1371/journal.pone.0029545	http://dx.doi.org/10.1371/journal.pone.0029545			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235307	Green Submitted, Green Published, gold			2022-12-27	WOS:000301123400069
J	Wong, D; Kea, B; Pesich, R; Higgs, BW; Zhu, W; Brown, P; Yao, YH; Fiorentino, D				Wong, David; Kea, Bory; Pesich, Rob; Higgs, Brandon W.; Zhu, Wei; Brown, Patrick; Yao, Yihong; Fiorentino, David			Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; GENE-EXPRESSION; LUPUS-ERYTHEMATOSUS; MONOCLONAL-ANTIBODY; CUTANEOUS LESIONS; PATHOGENESIS; POLYMYOSITIS; SUBSETS; ALPHA; IDENTIFICATION	Background: Dermatomyositis (DM) is an autoimmune disease that mainly affects the skin, muscle, and lung. The pathogenesis of skin inflammation in DM is not well understood. Methodology and Findings: We analyzed genome-wide expression data in DM skin and compared them to those from healthy controls. We observed a robust upregulation of interferon (IFN)-inducible genes in DM skin, as well as several other gene modules pertaining to inflammation, complement activation, and epidermal activation and differentiation. The interferon (IFN)-inducible genes within the DM signature were present not only in DM and lupus, but also cutaneous herpes simplex-2 infection and to a lesser degree, psoriasis. This IFN signature was absent or weakly present in atopic dermatitis, allergic contact dermatitis, acne vulgaris, systemic sclerosis, and localized scleroderma/morphea. We observed that the IFN signature in DM skin appears to be more closely related to type I than type II IFN based on in vitro IFN stimulation expression signatures. However, quantitation of IFN mRNAs in DM skin shows that the majority of known type I IFNs, as well as IFN g, are overexpressed in DM skin. In addition, both IFN-beta and IFN-gamma (but not other type I IFN) transcript levels were highly correlated with the degree of the in vivo IFN transcriptional response in DM skin. Conclusions and Significance: As in the blood and muscle, DM skin is characterized by an overwhelming presence of an IFN signature, although it is difficult to conclusively define this response as type I or type II. Understanding the significance of the IFN signature in this wide array of inflammatory diseases will be furthered by identification of the nature of the cells that both produce and respond to IFN, as well as which IFN subtype is biologically active in each diseased tissue.	[Wong, David; Kea, Bory; Fiorentino, David] Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA; [Pesich, Rob; Brown, Patrick] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Higgs, Brandon W.; Zhu, Wei; Yao, Yihong] MedImmune, Translat Sci, Gaithersburg, MD USA	Stanford University; Stanford University; AstraZeneca; Medimmune	Wong, D (corresponding author), Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA.	fiorentino@stanford.edu		Higgs, Brandon/0000-0002-2951-0245; Kea, Bory/0000-0002-9719-5988; Fiorentino, David/0000-0001-7951-3674				ARAHATA K, 1984, ANN NEUROL, V16, P193, DOI 10.1002/ana.410160206; Baechler EC, 2007, MOL MED, V13, P59, DOI 10.2119/2006-00085.Baechler; Callen JP, 2006, CLIN DERMATOL, V24, P363, DOI 10.1016/j.clindermatol.2006.07.001; Caproni M, 2004, BRIT J DERMATOL, V151, P784, DOI 10.1111/j.1365-2133.2004.06144.x; Crowson AN, 1996, HUM PATHOL, V27, P15, DOI 10.1016/S0046-8177(96)90132-X; De Paepe B, 2009, CURR OPIN RHEUMATOL, V21, P610, DOI 10.1097/BOR.0b013e3283317b31; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Ghoreishi M, 2010, BRIT J DERMATOL, V163, P57, DOI 10.1111/j.1365-2133.2010.09775.x; Greenberg SA, 2009, BRIT J DERMATOL, V160, P464, DOI 10.1111/j.1365-2133.2008.08967.x; Greenberg SA, 2005, ANN NEUROL, V57, P664, DOI 10.1002/ana.20464; Greenberg SA, 2004, CURR OPIN NEUROL, V17, P359, DOI 10.1097/00019052-200406000-00018; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1829, DOI 10.1038/jid.2010.36; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122; Krathen M. S., 2008, V10, P313, DOI 10.1159/000131751; Magro CM, 1997, J CUTAN PATHOL, V24, P543, DOI 10.1111/j.1600-0560.1997.tb01458.x; Mammen AL, 2010, ANN NY ACAD SCI, V1184, P134, DOI 10.1111/j.1749-6632.2009.05119.x; MASCARO JM, 1995, ARCH DERMATOL, V131, P1386, DOI 10.1001/archderm.131.12.1386; McNiff JM, 2008, J CUTAN PATHOL, V35, P452, DOI 10.1111/j.1600-0560.2007.00848.x; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Niewold TB, 2009, ARTHRITIS RHEUM, V60, P1815, DOI 10.1002/art.24555; O'Hanlon Terrance P, 2009, Curr Rheumatol Rep, V11, P287; Page G, 2004, ARTHRITIS RHEUM, V50, P199, DOI 10.1002/art.11428; Plager DA, 2007, EXP DERMATOL, V16, P28, DOI 10.1111/j.1600-0625.2006.00504.x; Saaf AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004017; Sanda C, 2006, J INTERF CYTOK RES, V26, P462, DOI 10.1089/jir.2006.26.462; Shrestha S, 2010, ARTHRITIS RHEUM-US, V62, P2813, DOI 10.1002/art.27529; Sontheimer RD, 2002, DERMATOL CLIN, V20, P387, DOI 10.1016/S0733-8635(02)00021-9; Tezak Z, 2002, J IMMUNOL, V168, P4154, DOI 10.4049/jimmunol.168.8.4154; Walsh RJ, 2007, ARTHRITIS RHEUM, V56, P3784, DOI 10.1002/art.22928; Wenzel J, 2006, CLIN EXP DERMATOL, V31, P576, DOI 10.1111/j.1365-2230.2006.02150.x; Wenzel J, 2005, BRIT J DERMATOL, V153, P462, DOI 10.1111/j.1365-2133.2005.06786.x; Wenzel J, 2008, J INVEST DERMATOL, V128, P2392, DOI 10.1038/jid.2008.96; Yao YH, 2009, ARTHRITIS RHEUM, V60, P1785, DOI 10.1002/art.24557; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737	36	119	121	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29161	10.1371/journal.pone.0029161	http://dx.doi.org/10.1371/journal.pone.0029161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235269	gold, Green Published, Green Submitted			2022-12-27	WOS:000301123400030
J	Athanasiadis, G; Buil, A; Souto, JC; Borrell, M; Lopez, S; Martinez-Perez, A; Lathrop, M; Fontcuberta, J; Almasy, L; Soria, JM				Athanasiadis, Georgios; Buil, Alfonso; Carlos Souto, Juan; Borrell, Montserrat; Lopez, Sonia; Martinez-Perez, Angel; Lathrop, Mark; Fontcuberta, Jordi; Almasy, Laura; Manuel Soria, Jose			A Genome-Wide Association Study of the Protein C Anticoagulant Pathway	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; THROMBOPHILIA GAIT PROJECT; FACTOR-VA-INACTIVATION; VENOUS THROMBOSIS; EPCR GENE; RISK-FACTORS; SEPCR LEVELS; RECEPTOR; COMPLEX; POLYMORPHISMS	The Protein C anticoagulant pathway regulates blood coagulation by preventing the inadequate formation of thrombi. It has two main plasma components: protein C and protein S. Individuals with protein C or protein S deficiency present a dramatically increased incidence of thromboembolic disorders. Here, we present the results of a genome-wide association study (GWAS) for protein C and protein S plasma levels in a set of extended pedigrees from the Genetic Analysis of Idiopathic Thrombophilia (GAIT) Project. A total number of 397 individuals from 21 families were typed for 307,984 SNPs using the InfiniumH 317 k Beadchip (Illumina). Protein C and protein S (free, functional and total) plasma levels were determined with biochemical assays for all participants. Association with phenotypes was investigated through variance component analysis. After correcting for multiple testing, two SNPs for protein C plasma levels (rs867186 and rs8119351) and another two for free protein S plasma levels (rs1413885 and rs1570868) remained significant on a genome-wide level, located in and around the PROCR and the DNAJC6 genomic regions respectively. No SNPs were significantly associated with functional or total protein S plasma levels, although rs1413885 from DNAJC6 showed suggestive association with the functional protein S phenotype, possibly indicating that this locus plays an important role in protein S metabolism. Our results provide evidence that PROCR and DNAJC6 might play a role in protein C and free protein S plasma levels in the population studied, warranting further investigation on the role of these loci in the etiology of venous thromboembolism and other thrombotic diseases.	[Athanasiadis, Georgios; Lopez, Sonia; Martinez-Perez, Angel; Manuel Soria, Jose] Hosp Santa Creu & Sant Pau, Res Inst, Unit Genom Complex Dis, Barcelona, Spain; [Buil, Alfonso] Univ Geneva, Dept Genet & Dev, Geneva, Switzerland; [Carlos Souto, Juan; Borrell, Montserrat; Fontcuberta, Jordi] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Hematol, Haemostasis & Thrombosis Unit, E-08193 Barcelona, Spain; [Lathrop, Mark] Ctr Natl Genotypage, Evry, France; [Almasy, Laura] SW Fdn Biomed Res, Dept Populat Genet, San Antonio, TX 78284 USA	Hospital of Santa Creu i Sant Pau; University of Geneva; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; CEA; UDICE-French Research Universities; Universite Paris Saclay; Texas Biomedical Research Institute	Athanasiadis, G (corresponding author), Hosp Santa Creu & Sant Pau, Res Inst, Unit Genom Complex Dis, Barcelona, Spain.	jsoria@santpau.cat	Athanasiadis, Georgios/A-7745-2012; Almasy, Laura/V-3156-2019; Soria Fernández, José Manuel/AAD-6761-2019; Martinez-Perez, Angel/AAC-4339-2019; Lopez, Sonia/AAC-8830-2019	Athanasiadis, Georgios/0000-0002-2927-4035; Soria Fernández, José Manuel/0000-0002-6226-4293; Martinez-Perez, Angel/0000-0002-5934-1454; Lopez, Sonia/0000-0002-5023-5153; Buil, Alfonso/0000-0002-3097-1014	American National Institutes of Health [2 R01 HL070751-05]; "Instituto de Salud Carlos III" of the Spanish "Ministerio de Ciencia e Innovacion" (MICINN) [PI-08/0420, PI-08/0756, RECAVA-RD06/0014]; MICINN [SAF2005/04738, SAF2008/01859]; "Programa d'Estabilitzacio d'Investigadors de la Direccio d'Estrategia I Coordinacio del Departament de Salut" (Generalitat de Catalunya); Fondo Investigacion Sanitaria; "Subprograma Nacional de Contratacion e Incorporacion de Investigadores Juan de la Cierva" (MICINN); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070751] Funding Source: NIH RePORTER	American National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Instituto de Salud Carlos III" of the Spanish "Ministerio de Ciencia e Innovacion" (MICINN); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); "Programa d'Estabilitzacio d'Investigadors de la Direccio d'Estrategia I Coordinacio del Departament de Salut" (Generalitat de Catalunya)(Generalitat de Catalunya); Fondo Investigacion Sanitaria(Instituto de Salud Carlos III); "Subprograma Nacional de Contratacion e Incorporacion de Investigadores Juan de la Cierva" (MICINN); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was partially supported by grant 2 R01 HL070751-05 from the American National Institutes of Health; grants PI-08/0420, PI-08/0756 and RECAVA-RD06/0014 from the "Instituto de Salud Carlos III" of the Spanish "Ministerio de Ciencia e Innovacion" (MICINN); and grants SAF2005/04738 and SAF2008/01859 (MICINN). JMS was supported by the "Programa d'Estabilitzacio d'Investigadors de la Direccio d'Estrategia I Coordinacio del Departament de Salut" (Generalitat de Catalunya), SL was supported by the programa "Sara Borell" from Fondo Investigacion Sanitaria and GA by the "Subprograma Nacional de Contratacion e Incorporacion de Investigadores Juan de la Cierva" (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Almasy L, 2003, ARTERIOSCL THROM VAS, V23, P508, DOI 10.1161/01.ATV.0000055740.22563.C5; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blangero J, 2003, J THROMB HAEMOST, V1, P1391, DOI 10.1046/j.1538-7836.2003.00310.x; Blangero J, 2001, ADV GENET, V42, P151, DOI 10.1016/S0065-2660(01)42021-9; Blangero J, 2000, HUM BIOL, V72, P35; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Buil A, 2004, ARTERIOSCL THROM VAS, V24, P1321, DOI 10.1161/01.ATV.0000132408.13064.09; Camire RM, 2009, J THROMB HAEMOST, V7, P1951, DOI 10.1111/j.1538-7836.2009.03622.x; Dahlback B, 2007, THROMB HAEMOSTASIS, V98, P90, DOI 10.1160/TH07-04-0269; De Willige SU, 2004, J THROMB HAEMOST, V2, P1305, DOI 10.1046/j.1538-7836.2004.00855.x; Franco RF, 2001, HUM GENET, V109, P369, DOI 10.1007/s004390100593; Galanaud JP, 2010, J THROMB HAEMOST, V8, P707, DOI 10.1111/j.1538-7836.2010.03770.x; GANDRILLE S, 1995, BLOOD, V85, P130, DOI 10.1182/blood.V85.1.130.bloodjournal851130; Hackeng TM, 2006, P NATL ACAD SCI USA, V103, P3106, DOI 10.1073/pnas.0504240103; Koeleman BPC, 1997, SEMIN HEMATOL, V34, P256; Lane DA, 1996, THROMB HAEMOSTASIS, V76, P651; Laszik Z, 1997, CIRCULATION, V96, P3633; Maurissen LFA, 2008, BLOOD, V111, P3034, DOI 10.1182/blood-2007-06-089987; Medina P, 2005, THROMB HAEMOSTASIS, V94, P389, DOI 10.1160/TH05-02-0089; Navarro S, 2008, HAEMATOLOGICA, V93, P885, DOI 10.3324/haematol.12448; Pintao MC, 2011, J THROMB HAEMOST, V9, P969, DOI 10.1111/j.1538-7836.2011.04256.x; Reiner AP, 2008, J THROMB HAEMOST, V6, P1625, DOI 10.1111/j.1538-7836.2008.03118.x; REITSMA PH, 1995, THROMB HAEMOSTASIS, V73, P876; Simioni P, 2006, THROMB RES, V117, P523, DOI 10.1016/j.thromres.2005.04.029; Souto JC, 2000, CIRCULATION, V101, P1546, DOI 10.1161/01.CIR.101.13.1546; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; SPEK CA, 1995, ARTERIOSCL THROM VAS, V15, P214, DOI 10.1161/01.ATV.15.2.214; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Tanck MWT, 2011, THROMB HAEMOSTASIS, V105, P199, DOI 10.1160/TH10-06-0383; Tang WH, 2010, BLOOD, V116, P5032, DOI 10.1182/blood-2010-05-283739; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92; WALKER FJ, 1981, J BIOL CHEM, V256, P1128; WALKER FJ, 1987, ARCH BIOCHEM BIOPHYS, V252, P322, DOI 10.1016/0003-9861(87)90037-3; Wichers IM, 2009, THROMB HAEMOSTASIS, V101, P465, DOI 10.1160/TH08-06-0405	37	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29168	10.1371/journal.pone.0029168	http://dx.doi.org/10.1371/journal.pone.0029168			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216198	Green Submitted, gold, Green Published			2022-12-27	WOS:000300676300032
J	El-Sayed, AM; Tracy, M; Scarborough, P; Galea, S				El-Sayed, Abdulrahman M.; Tracy, Melissa; Scarborough, Peter; Galea, Sandro			Ethnic Inequalities in Mortality: The Case of Arab-Americans	PLOS ONE			English	Article							RISK-FACTORS; EPIDEMIOLOGIC RESEARCH; ACCULTURATIVE STRESS; BIRTH-OUTCOMES; UNITED-STATES; SOCIAL-CLASS; MENTAL-HEALTH; PRETERM BIRTH; GLOBAL BURDEN; SEPTEMBER 11	Background: Although nearly 112 million residents of the United States belong to a non-white ethnic group, the literature about differences in health indicators across ethnic groups is limited almost exclusively to Hispanics. Features of the social experience of many ethnic groups including immigration, discrimination, and acculturation may plausibly influence mortality risk. We explored life expectancy and age-adjusted mortality risk of Arab-Americans (AAs), relative to non-Arab and non-Hispanic Whites in Michigan, the state with the largest per capita population of AAs in the US. Methodology/Principal Findings: Data were collected about all deaths to AAs and non-Arab and non-Hispanic Whites in Michigan between 1990 and 2007, and year 2000 census data were collected for population denominators. We calculated life expectancy, age-adjusted all-cause, cause-specific, and age-specific mortality rates stratified by ethnicity and gender among AAs and non-Arab and non-Hispanic Whites. Among AAs, life expectancies among men and women were 2.0 and 1.4 years lower than among non-Arab and non-Hispanic White men and women, respectively. AA men had higher mortality than non-Arab and non-Hispanic White men due to infectious diseases, chronic diseases, and homicide. AA women had higher mortality than non-Arab and non-Hispanic White women due to chronic diseases. Conclusions/Significance: Despite better education and higher income, AAs have higher age-adjusted mortality risk than non-Arab and non-Hispanic Whites, particularly due to chronic diseases. Features specific to AA culture may explain some of these findings.	[El-Sayed, Abdulrahman M.; Tracy, Melissa; Galea, Sandro] Columbia Univ, Dept Epidemiol, New York, NY 10027 USA; [El-Sayed, Abdulrahman M.; Scarborough, Peter] Univ Oxford, Dept Publ Hlth, Oxford, England; [El-Sayed, Abdulrahman M.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Tracy, Melissa] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ctr Social Epidemiol & Populat Hlth, Ann Arbor, MI 48109 USA	Columbia University; University of Oxford; Columbia University; University of Michigan System; University of Michigan	El-Sayed, AM (corresponding author), Columbia Univ, Dept Epidemiol, New York, NY 10027 USA.	ame2145@columbia.edu	Scarborough, Peter/ABD-6111-2021; Galea, Sandro/GLR-6066-2022; El-Sayed, Abdulrahman/F-7427-2013	Scarborough, Peter/0000-0002-2378-2944; El-Sayed, Abdulrahman/0000-0002-4809-5630; Galea, Sandro/0000-0002-7534-0945	National Institutes of Health [DA022720, DA017642]; Rhodes Trust; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022720, R01DA017642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rhodes Trust; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funded in part by National Institutes of Health grants DA022720 and DA017642 and the Rhodes Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajrouch KJ, 2007, J CROSS-CULT GERONTO, V22, P167, DOI 10.1007/s10823-006-9033-z; Amer Mona M, 2007, J Immigr Minor Health, V9, P335, DOI 10.1007/s10903-007-9045-y; [Anonymous], 2004, LIFE COURSE APPROACH; *AR AM I FDN, 2003, STAT PROF MICH; Arias E, 2010, AM J PUBLIC HEALTH, V100, pS171, DOI 10.2105/AJPH.2008.135863; BERRY JW, 1987, INT MIGR REV, V21, P491, DOI 10.2307/2546607; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Brittingham A, 2003, ARAB POPULATION 2000; COOPER R, 1984, AM HEART J, V108, P715, DOI 10.1016/0002-8703(84)90662-8; CREWS D E, 1991, Ethnicity and Disease, V1, P42; Dallo FJ, 2011, J IMMIGR MINOR; Division of Health Statistics, 1977, MAN MORT AN MAN METH; El Reda DK, 2007, MATERN CHILD HLTH J, V11, P622, DOI 10.1007/s10995-007-0199-y; El-Sayed A, 2008, ETHNIC DIS, V18, P348; El-Sayed AM, 2010, ETHNIC HEALTH, V15, P639, DOI 10.1080/13557858.2010.505979; El-Sayed AM, 2010, J EPIDEMIOL COMMUN H, V64, P155, DOI 10.1136/jech.2008.084491; El-Sayed AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-272; El-Sayed AM, 2009, PEDIATRICS, V123, pe438, DOI 10.1542/peds.2008-1634; Elo IT, 2009, ANNU REV SOCIOL, V35, P553, DOI 10.1146/annurev-soc-070308-115929; Eschbach K, 2004, AM J PUBLIC HEALTH, V94, P1807, DOI 10.2105/AJPH.94.10.1807; Finch BK, 2001, HISPANIC J BEHAV SCI, V23, P399, DOI 10.1177/0739986301234004; Finch Brian Karl, 2003, J Immigr Health, V5, P109, DOI 10.1023/A:1023987717921; Grekin ER, 2008, J STUD ALCOHOL DRUGS, V69, P472, DOI 10.15288/jsad.2008.69.472; Gwatkin DR, 1999, WORLD BANK GLOBAL FO; Hatahet W, 2002, INT J FOOD SCI NUTR, V53, P325, DOI 10.1080/09637480220138124; Hovey J D, 2000, J Immigr Health, V2, P119, DOI 10.1023/A:1009556802759; Hovey JD, 1996, J AM ACAD CHILD PSY, V35, P1183, DOI 10.1097/00004583-199609000-00016; Humes KR, 2011, OVERVIEW RACE HISPAN; Jaber LA, 2003, DIABETES CARE, V26, P2010, DOI 10.2337/diacare.26.7.2010; Jaber LA, 2003, DIABETES CARE, V26, P308, DOI 10.2337/diacare.26.2.308; JABER LA, 1995, ANN PHARMACOTHER, V29, P573, DOI 10.1177/106002809502900603; Jamil H, 2009, J IMMIGR MINOR HEALT, V11, P310, DOI 10.1007/s10903-008-9125-7; Jamil H, 2008, ETHNIC DIS, V18, P464; Joseph S., 2003, ENCY WOMEN ISLAMIC C; Kaufman JS, 1995, PUBLIC HEALTH REP, V110, P662; Kridli SAO, 2006, ETHNIC DIS, V16, P351; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Lauderdale DS, 2006, DEMOGRAPHY, V43, P185, DOI 10.1353/dem.2006.0008; Lauderdale DS, 2002, DEMOGRAPHY, V39, P529, DOI 10.1353/dem.2002.0028; Lee JS, 2004, INT J INTERCULT REL, V28, P399, DOI 10.1016/j.ijintrel.2004.08.005; McKenzie K, 1996, BRIT MED J, V313, P426; Moradi B, 2004, J COUNS PSYCHOL, V51, P418, DOI 10.1037/0022-0167.51.4.418; Muntaner C, 1996, AM J EPIDEMIOL, V144, P531; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nasseri K, 2007, CANCER DETECT PREV, V31, P424, DOI 10.1016/j.cdp.2007.10.006; Nasseri K, 2011, J IMMIGR MINOR HEALT, V13, P361, DOI 10.1007/s10903-009-9270-7; Padela AI, 2010, AM J PUBLIC HEALTH, V100, P284, DOI 10.2105/AJPH.2009.164954; Rosenberg H M, 1999, Vital Health Stat 2, P1; Ruggles S, 2009, INTEGRATED PUBLIC US; SENIOR PA, 1994, BRIT MED J, V309, P327, DOI 10.1136/bmj.309.6950.327; Singh RB, 1999, INT J CARDIOL, V69, P139, DOI 10.1016/S0167-5273(99)00010-8; SORLIE PD, 1995, AM J PUBLIC HEALTH, V85, P949, DOI 10.2105/AJPH.85.7.949; Stolley PD, 1999, INT J HEALTH SERV, V29, P905, DOI 10.2190/QAAH-P5DT-WMP8-8HNL; United States Census Bureau, 2009, DAT GEN ABD M ELS; Wilkinson R., 1996, UNHEALTHY SOC AFFLIC; Williams DR, 1997, ANN EPIDEMIOL, V7, P322, DOI 10.1016/S1047-2797(97)00051-3; Wrobel NH, 2009, J CROSS-CULT GERONTO, V24, P273, DOI 10.1007/s10823-009-9096-8	59	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29185	10.1371/journal.pone.0029185	http://dx.doi.org/10.1371/journal.pone.0029185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	897SK	22216204	Green Published, gold			2022-12-27	WOS:000300676300034
J	Charles, H; Balmand, S; Lamelas, A; Cottret, L; Perez-Brocal, V; Burdin, B; Latorre, A; Febvay, G; Colella, S; Calevro, F; Rahbe, Y				Charles, Hubert; Balmand, Severine; Lamelas, Araceli; Cottret, Ludovic; Perez-Brocal, Vicente; Burdin, Beatrice; Latorre, Amparo; Febvay, Gerard; Colella, Stefano; Calevro, Federica; Rahbe, Yvan			A Genomic Reappraisal of Symbiotic Function in the Aphid/Buchnera Symbiosis: Reduced Transporter Sets and Variable Membrane Organisations	PLOS ONE			English	Article							ACYRTHOSIPHON-PISUM; PEA APHID; AMINO-ACIDS; MICROBIAL GENOME; BACTERIAL ENDOSYMBIONTS; BUCHNERA; EVOLUTION; DATABASE; HOMOPTERA; RESOURCE	Buchnera aphidicola is an obligate symbiotic bacterium that sustains the physiology of aphids by complementing their exclusive phloem sap diet. In this study, we reappraised the transport function of different Buchnera strains, from the aphids Acyrthosiphon pisum, Schizaphis graminum, Baizongia pistaciae and Cinara cedri, using the re-annotation of their transmembrane proteins coupled with an exploration of their metabolic networks. Although metabolic analyses revealed high interdependencies between the host and the bacteria, we demonstrate here that transport in Buchnera is assured by low transporter diversity, when compared to free-living bacteria, being mostly based on a few general transporters, some of which probably have lost their substrate specificity. Moreover, in the four strains studied, an astonishing lack of inner-membrane importers was observed. In Buchnera, the transport function has been shaped by the distinct selective constraints occurring in the Aphididae lineages. Buchnera from A. pisum and S. graminum have a three-membraned system and similar sets of transporters corresponding to most compound classes. Transmission electronic microscopic observations and confocal microscopic analysis of intracellular pH fields revealed that Buchnera does not show any of the typical structures and properties observed in integrated organelles. Buchnera from B. pistaciae seem to possess a unique double membrane system and has, accordingly, lost all of its outer-membrane integral proteins. Lastly, Buchnera from C. cedri revealed an extremely poor repertoire of transporters, with almost no ATP-driven active transport left, despite the clear persistence of the ancestral three-membraned system.	[Charles, Hubert; Balmand, Severine; Febvay, Gerard; Colella, Stefano; Calevro, Federica; Rahbe, Yvan] Univ Lyon, INRA, INSA Lyon, UMR203 BF2I, Villeurbanne, France; [Charles, Hubert; Cottret, Ludovic; Rahbe, Yvan] INRIA Rhone Alpes, BAMBOO, Montbonnot St Martin, France; [Lamelas, Araceli; Perez-Brocal, Vicente; Latorre, Amparo] Univ Valencia, Inst Cavanilles Biodiversidad Biol & Evolut, Valencia, Spain; [Lamelas, Araceli; Perez-Brocal, Vicente; Latorre, Amparo] CSISP, Area Genom & Salud, Valencia, Spain; [Perez-Brocal, Vicente; Latorre, Amparo] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Cottret, Ludovic] Univ Lyon 1, UMR CNRS LBBE 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Burdin, Beatrice] Univ Lyon, Ctr Technol Microstruct CT, Villeurbanne, France	INRAE; Institut National des Sciences Appliquees de Lyon - INSA Lyon; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Charles, H (corresponding author), Univ Lyon, INRA, INSA Lyon, UMR203 BF2I, Villeurbanne, France.	hubert.charles@insa-lyon.fr	Perez Brocal, Vicente/K-3627-2014; Rahbe, Yvan/B-9389-2009; Colella, Stefano/A-7040-2008; FEBVAY, Gérard/B-2215-2008; Latorre, Amparo/E-4997-2015; /AAD-2293-2020; CHARLES, Hubert/B-9392-2011; Lamelas Cabello, Araceli/B-6129-2015; Cabello, Araceli Lamelas/Q-6726-2018; Cabello, Araceli Lamelas/AAC-6066-2019	Perez Brocal, Vicente/0000-0002-1927-9676; Rahbe, Yvan/0000-0002-0074-4443; Colella, Stefano/0000-0003-3139-6055; FEBVAY, Gérard/0000-0002-0654-2340; Latorre, Amparo/0000-0002-9146-7284; /0000-0001-7418-7750; CHARLES, Hubert/0000-0002-0809-4705; Cabello, Araceli Lamelas/0000-0002-1939-5642; Cabello, Araceli Lamelas/0000-0002-1939-5642; Calevro, Federica/0000-0001-7856-9617	Agence National de la Recherche (ANR, France); Biotechnology and Biological Sciences Research Council (BBSRC, UK); Ministerio de Ciencia e Innovacion (Spain) [BFU2009-CO2-01]	Agence National de la Recherche (ANR, France)(French National Research Agency (ANR)); Biotechnology and Biological Sciences Research Council (BBSRC, UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by the Agence National de la Recherche (ANR, France) the Biotechnology and Biological Sciences Research Council (BBSRC, UK) within the MetNet4SyBio project (http://www.metnet4sysbio.org/), and the project BFU2009-CO2-01 from the Ministerio de Ciencia e Innovacion (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Akahane S, 2003, J BIOCHEM, V133, P173, DOI 10.1093/jb/mvg021; Alcock F, 2010, SCIENCE, V327, P649, DOI 10.1126/science.1182129; Arispe N, 2000, J BIOL CHEM, V275, P30839, DOI 10.1074/jbc.M005226200; Bandyopadhyay S, 2001, PLANT SCI, V161, P1025, DOI 10.1016/S0168-9452(01)00507-6; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; Bermingham J, 2009, APPL ENVIRON MICROB, V75, P7294, DOI 10.1128/AEM.01472-09; Biggin PC, 2003, CURR BIOL, V13, pR183, DOI 10.1016/S0960-9822(03)00119-2; BLACKMAN R.L., 1984, ORIENT INSECTS; Blackman RL, 1994, CONSUMER BEHAV, P344; Borenstein E, 2008, P NATL ACAD SCI USA, V105, P14482, DOI 10.1073/pnas.0806162105; Bourtzis Kostas, 2006, P1; Bouvaine S, 2011, J GEN VIROL, V92, P1467, DOI 10.1099/vir.0.029355-0; Brinza L, 2009, CR BIOL, V332, P1034, DOI 10.1016/j.crvi.2009.09.007; Burgos Zepeda MY, 2009, BIOCHIM BIOPHYS ACTA, V1804, P755; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; CHACON E, 1994, BIOPHYS J, V66, P942, DOI 10.1016/S0006-3495(94)80904-X; Clark MA, 2000, EVOLUTION, V54, P517, DOI 10.1111/j.0014-3820.2000.tb00054.x; Clark MA, 1999, MOL BIOL EVOL, V16, P1586, DOI 10.1093/oxfordjournals.molbev.a026071; Cottret L, 2008, LECT N BIOINFORMAT, V5251, P233, DOI 10.1007/978-3-540-87361-7_20; Cottret L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000904; Cottret L, 2010, NUCLEIC ACIDS RES, V38, pW132, DOI 10.1093/nar/gkq312; Cristofoletti PT, 2003, J INSECT PHYSIOL, V49, P11, DOI 10.1016/S0022-1910(02)00222-6; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Dinant S, 2008, CR BIOL, V331, P334, DOI 10.1016/j.crvi.2008.03.001; DOUGLAS AE, 1988, INSECT BIOCHEM, V18, P599, DOI 10.1016/0020-1790(88)90012-1; DOUGLAS AE, 1992, J INSECT PHYSIOL, V38, P565, DOI 10.1016/0022-1910(92)90107-O; Douglas AE, 2008, NEW PHYTOL, V177, P849, DOI 10.1111/j.1469-8137.2007.02326.x; Elberse IAM, 2003, OECOLOGIA, V137, P564, DOI 10.1007/s00442-003-1383-4; Fares MA, 2004, TRENDS GENET, V20, P413, DOI 10.1016/j.tig.2004.07.001; FATH MJ, 1989, J BACTERIOL, V171, P3158, DOI 10.1128/jb.171.6.3158-3161.1989; Febvay G, 1999, J EXP BIOL, V202, P2639; FEBVAY G, 1995, ARCH INSECT BIOCHEM, V29, P45, DOI 10.1002/arch.940290106; Fichant G, 2006, FEMS MICROBIOL LETT, V256, P333, DOI 10.1111/j.1574-6968.2006.00139.x; Gattiker A, 2003, COMPUT BIOL CHEM, V27, P49, DOI 10.1016/S1476-9271(02)00094-4; Giordana B, 2003, J INSECT PHYSIOL, V49, P1115, DOI 10.1016/j.jinsphys.2003.08.010; Gosalbes MJ, 2008, J BACTERIOL, V190, P6026, DOI 10.1128/JB.00525-08; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; HINDE R, 1971, J INSECT PHYSIOL, V17, P2035, DOI 10.1016/0022-1910(71)90147-8; Hogenhout SA, 2000, J VIROL, V74, P4541, DOI 10.1128/JVI.74.10.4541-4548.2000; Holopainen JK, 1997, GLOB CHANGE BIOL, V3, P139, DOI 10.1046/j.1365-2486.1997.00067.x; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Lamelas A, 2011, APPL ENV MI IN PRESS, V13, P4464; Lamelas A, 2008, APPL ENVIRON MICROB, V74, P4236, DOI 10.1128/AEM.00022-08; Lemasters JJ, 1999, METHOD ENZYMOL, V302, P341, DOI 10.1016/S0076-6879(99)02031-5; Liadouze I, 1996, SYMBIOSIS, V21, P115; Lin S, 2010, NAT CHEM BIOL, V6, P682, DOI [10.1038/nchembio.420, 10.1038/NCHEMBIO.420]; Lodish H., 2008, MOL CELL BIOL, V6th ed.; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; MacDonald SJ, 2011, MOL ECOL, V20, P2073, DOI 10.1111/j.1365-294X.2011.05031.x; Maddalo G, 2011, J PROTEOME RES, V10, P1848, DOI 10.1021/pr101105c; Maezawa K, 2006, J BACTERIOL, V188, P6539, DOI 10.1128/JB.00561-06; Majander K, 2005, NAT BIOTECHNOL, V23, P475, DOI 10.1038/nbt1077; Misra RV, 2005, NUCLEIC ACIDS RES, V33, pD329, DOI 10.1093/nar/gki028; MIZUNO T, 1979, J BIOCHEM-TOKYO, V86, P991, DOI 10.1093/oxfordjournals.jbchem.a132631; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140; Morioka M, 1998, METHOD ENZYMOL, V290, P181, DOI 10.1016/S0076-6879(98)90018-0; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Nakabachi A, 1999, J INSECT PHYSIOL, V45, P1, DOI 10.1016/S0022-1910(98)00104-8; Nishikori K, 2009, J INSECT PHYSIOL, V55, P351, DOI 10.1016/j.jinsphys.2009.01.001; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; ONeill SL, 1997, INFLUENTIAL PASSENGE; Ortiz-Rivas B, 2010, MOL PHYLOGENET EVOL, V55, P305, DOI 10.1016/j.ympev.2009.12.005; Panek H, 2002, MICROBIOL-SGM, V148, P2273, DOI 10.1099/00221287-148-8-2273; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; Paulsen IT, 1998, J MOL BIOL, V277, P573, DOI 10.1006/jmbi.1998.1609; Perez-Brocal V, 2011, INT J EVOL BIOL, P250154; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; Poliakov A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007039; Prickett MD, 2006, BIOINFORMATICS, V22, P641, DOI 10.1093/bioinformatics/btk024; Ramsey JS, 2010, INSECT MOL BIOL, V19, P241, DOI 10.1111/j.1365-2583.2009.00945.x; Reese JC, 1999, HDB CORN INSECTS ENT; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Reymond N, 2006, APPL ENVIRON MICROB, V72, P7760, DOI 10.1128/AEM.01118-06; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; SASAKI T, 1995, J INSECT PHYSIOL, V41, P41, DOI 10.1016/0022-1910(94)00080-Z; Sato S, 1997, J BIOCHEM-TOKYO, V122, P41, DOI 10.1093/oxfordjournals.jbchem.a021738; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Shigenobu S, 2011, CELL MOL LIFE SCI, V68, P1297, DOI 10.1007/s00018-011-0645-2; SMITH JM, 1989, NATURE, V341, P284, DOI 10.1038/341284a0; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; Thomas GH, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-24; Toft C, 2008, MOL BIOL EVOL, V25, P2069, DOI 10.1093/molbev/msn153; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Vellozo AF, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar008; Vinuelas J, 2011, MOL MICROBIOL, V81, P1271, DOI 10.1111/j.1365-2958.2011.07760.x; Vinuelas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-143; Wernegreen JJ, 2004, PLOS BIOL, V2, P307, DOI 10.1371/journal.pbio.0020068; Wilkinson TL, 2001, PHYSIOL ENTOMOL, V26, P86, DOI 10.1046/j.1365-3032.2001.00214.x; Wilson ACC, 2010, INSECT MOL BIOL, V19, P249, DOI 10.1111/j.1365-2583.2009.00942.x; Wool D, 2002, POPUL ECOL, V44, P281, DOI 10.1007/s101440200032; Ziegler H, 1975, TRANSPORT PLANTS, V1, P59	100	37	38	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29096	10.1371/journal.pone.0029096	http://dx.doi.org/10.1371/journal.pone.0029096			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22229056	Green Published, gold			2022-12-27	WOS:000300674900012
J	Rieg, AD; Rossaint, R; Uhlig, S; Martin, C				Rieg, Annette D.; Rossaint, Rolf; Uhlig, Stefan; Martin, Christian			Cardiovascular Agents Affect the Tone of Pulmonary Arteries and Veins in Precision-Cut Lung Slices	PLOS ONE			English	Article							ARGININE-VASOPRESSIN; ANGIOTENSIN-II; RESPONSES; RECEPTOR; RAT; ACTIVATION; MECHANISMS; VESSELS	Introduction: Cardiovascular agents are pivotal in the therapy of heart failure. Apart from their action on ventricular contractility and systemic afterload, they affect pulmonary arteries and veins. Although these effects are crucial in heart failure with coexisting pulmonary hypertension or lung oedema, they are poorly defined, especially in pulmonary veins. Therefore, we investigated the pulmonary vascular effects of adrenoceptor agonists, vasopressin and angiotensin II in the model of precision-cut lung slices that allows simultaneous studies of pulmonary arteries and veins. Materials and Methods: Precision-cut lung slices were prepared from guinea pigs and imaged by videomicroscopy. Concentration-response curves of cardiovascular drugs were analysed in pulmonary arteries and veins. Results: Pulmonary veins responded stronger than arteries to alpha(1)-agonists (contraction) and beta(2)-agonists (relaxation). Notably, inhibition of beta(2)-adrenoceptors unmasked the alpha(1)-mimetic effect of norepinephrine and epinephrine in pulmonary veins. Vasopressin and angiotensin II contracted pulmonary veins via V-1a and AT(1) receptors, respectively, without affecting pulmonary arteries. Discussion: Vasopressin and (nor) epinephrine in combination with beta(2)-inhibition caused pulmonary venoconstriction. If applicable in humans, these treatments would enhance capillary hydrostatic pressures and lung oedema, suggesting their cautious use in left heart failure. Vice versa, the prevention of pulmonary venoconstriction by AT(1) receptor antagonists might contribute to their beneficial effects seen in left heart failure. Further, alpha 1-mimetic agents might exacerbate pulmonary hypertension and right ventricular failure by contracting pulmonary arteries, whereas vasopressin might not.	[Rieg, Annette D.; Rossaint, Rolf] Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, Dept Anaesthesiol, Med Fac Aachen, D-52062 Aachen, Germany	RWTH Aachen University	Rieg, AD (corresponding author), Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, Dept Anaesthesiol, Med Fac Aachen, D-52062 Aachen, Germany.	arieg@ukaachen.de	Uhlig, Stefan/A-7290-2014	Uhlig, Stefan/0000-0003-2332-1280				Aldasoro M, 2008, CRIT CARE MED, V36, P193, DOI 10.1097/01.CCM.0000292155.06797.62; Back M, 2002, ACTA PHYSIOL SCAND, V174, P9, DOI 10.1046/j.1365-201x.2002.00928.x; Baker JG, 2010, BRIT J PHARMACOL, V160, P1048, DOI 10.1111/j.1476-5381.2010.00754.x; Bronquard C, 2007, FUND CLIN PHARMACOL, V21, P55, DOI 10.1111/j.1472-8206.2006.00457.x; Camarda V, 2002, N-S ARCH PHARMACOL, V365, P141, DOI 10.1007/s00210-001-0503-0; CUMMING GR, 1963, CAN MED ASSOC J, V88, P827; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Dzau VJ, 2001, AM J CARDIOL, V88, p1L; Evans AM, 2011, CURR OPIN ANESTHESIO, V24, P13, DOI 10.1097/ACO.0b013e3283421201; EVORA PRB, 1993, CHEST, V103, P1241, DOI 10.1378/chest.103.4.1241; FERRELL WR, 1989, J PHYSIOL-LONDON, V414, P377, DOI 10.1113/jphysiol.1989.sp017693; Gao YS, 1998, J APPL PHYSIOL, V84, P1535, DOI 10.1152/jappl.1998.84.5.1535; Gao YS, 2005, AM J PHYSIOL-LUNG C, V288, pL213, DOI 10.1152/ajplung.00103.2004; GOLDSMITH SR, 1986, J AM COLL CARDIOL, V8, P779, DOI 10.1016/S0735-1097(86)80417-X; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; HYMAN A, 1969, J PHARMACOL EXP THER, V165, P87; HYMAN AL, 1981, CIRC RES, V48, P407, DOI 10.1161/01.RES.48.3.407; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Leather HA, 2002, CRIT CARE MED, V30, P2548, DOI 10.1097/00003246-200211000-00024; Maupoil V, 2007, BRIT J PHARMACOL, V150, P899, DOI 10.1038/sj.bjp.0707177; Montani D, 2009, EUR RESPIR J, V33, P189, DOI 10.1183/09031936.00090608; Norel X, 2004, BRIT J PHARMACOL, V142, P788, DOI 10.1038/sj.bjp.0705843; Novella S, 2007, EUR J CARDIO-THORAC, V32, P69, DOI 10.1016/j.ejcts.2007.03.047; PETTIBONE DJ, 1992, LIFE SCI, V50, P1953, DOI 10.1016/0024-3205(92)90524-S; Ressmeyer AR, 2006, EUR RESPIR J, V28, P603, DOI 10.1183/09031936.06.00004206; RUSS RD, 1992, J APPL PHYSIOL, V73, P473, DOI 10.1152/jappl.1992.73.2.473; SAI Y, 1995, EUR J PHARMACOL, V282, P235, DOI 10.1016/0014-2999(95)00343-J; Shi WB, 1998, BRIT J PHARMACOL, V123, P1525, DOI 10.1038/sj.bjp.0701759; Udelson JE, 2001, CIRCULATION, V104, P2417, DOI 10.1161/hc4501.099313; UMA S, 1988, J PHARM PHARMACOL, V40, P219, DOI 10.1111/j.2042-7158.1988.tb05227.x; Vincent JL, 2008, BEST PRACT RES-CLIN, V22, P243, DOI 10.1016/j.bpa.2008.03.004	31	25	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29698	10.1371/journal.pone.0029698	http://dx.doi.org/10.1371/journal.pone.0029698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216346	gold, Green Published, Green Submitted			2022-12-27	WOS:000300674900055
J	Tanaka, T; Kai, S; Koyama, T; Daijo, H; Adachi, T; Fukuda, K; Hirota, K				Tanaka, Tomoharu; Kai, Shinichi; Koyama, Tomohiro; Daijo, Hiroki; Adachi, Takehiko; Fukuda, Kazuhiko; Hirota, Kiichi			General Anesthetics Inhibit Erythropoietin Induction under Hypoxic Conditions in the Mouse Brain	PLOS ONE			English	Article							INDUCIBLE FACTOR-1 ACTIVATION; UP-REGULATION; ISCHEMIC TOLERANCE; CEREBRAL-ISCHEMIA; DEPENDENT MANNER; TARGET GENES; FACTOR-I; EXPRESSION; HIF-1-ALPHA; RECEPTOR	Background: Erythropoietin (EPO), originally identified as a hematopoietic growth factor produced in the kidney and fetal liver, is also endogenously expressed in the central nervous system (CNS). EPO in the CNS, mainly produced in astrocytes, is induced under hypoxic conditions in a hypoxia-inducible factor (HIF)-dependent manner and plays a dominant role in neuroprotection and neurogenesis. We investigated the effect of general anesthetics on EPO expression in the mouse brain and primary cultured astrocytes. Methodology/Principal Findings: BALB/c mice were exposed to 10% oxygen with isoflurane at various concentrations (0.10-1.0%). Expression of EPO mRNA in the brain was studied, and the effects of sevoflurane, halothane, nitrous oxide, pentobarbital, ketamine, and propofol were investigated. In addition, expression of HIF-2 alpha protein was studied by immunoblotting. Hypoxia-induced EPO mRNA expression in the brain was significantly suppressed by isoflurane in a concentration-dependent manner. A similar effect was confirmed for all other general anesthetics. Hypoxia-inducible expression of HIF-2 alpha protein was also significantly suppressed with isoflurane. In the experiments using primary cultured astrocytes, isoflurane, pentobarbital, and ketamine suppressed hypoxia-inducible expression of HIF-2 alpha protein and EPO mRNA. Conclusions/Significance: Taken together, our results indicate that general anesthetics suppress activation of HIF-2 and inhibit hypoxia-induced EPO upregulation in the mouse brain through a direct effect on astrocytes.	[Tanaka, Tomoharu; Kai, Shinichi; Koyama, Tomohiro; Daijo, Hiroki; Fukuda, Kazuhiko; Hirota, Kiichi] Kyoto Univ Hosp, Dept Anesthesia, Kyoto 606, Japan; [Adachi, Takehiko] Kitano Hosp, Tazuke Kofukai Med Res Inst, Dept Anesthesia, Osaka, Japan	Kyoto University; Kitano Hospital	Tanaka, T (corresponding author), Kyoto Univ Hosp, Dept Anesthesia, Kyoto 606, Japan.	665tana@kuhp.kyoto-u.ac.jp; hif1@mac.com	Hirota, Kiichi/E-9181-2010	Hirota, Kiichi/0000-0003-1110-0827	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [21591992] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; ASOU H, 1989, NEUROSCI RES, V6, P369, DOI 10.1016/0168-0102(89)90030-8; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Calvert JW, 2006, J APPL PHYSIOL, V101, P853, DOI 10.1152/japplphysiol.00268.2006; Cattano D, 2008, CAN J ANAESTH, V55, P429, DOI 10.1007/BF03016309; Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; El Hasnaoui-Saadani R, 2009, AM J PHYSIOL-REG I, V296, pR801, DOI 10.1152/ajpregu.00119.2008; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; FINK BR, 1973, ANESTHESIOLOGY, V39, P199, DOI 10.1097/00000542-197308000-00011; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Ginsberg MD, 2009, STROKE, V40, pS111, DOI 10.1161/STROKEAHA.108.528877; Gu GJ, 2008, J APPL PHYSIOL, V104, P1185, DOI 10.1152/japplphysiol.00323.2007; Hemmings HC, 1998, TOXICOL LETT, V101, P89, DOI 10.1016/S0378-4274(98)00170-2; Hieber S, 2009, EUR J ANAESTH, V26, P201, DOI 10.1097/EJA.0b013e3283212cbb; Hirota K, 2005, BIOCHEM BIOPH RES CO, V338, P610, DOI 10.1016/j.bbrc.2005.08.193; Hirota Kiichi, 2002, J Anesth, V16, P150, DOI 10.1007/s005400200011; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Hui AS, 2006, FASEB J, V20, P466, DOI 10.1096/fj.05-5086com; Itoh T, 2001, FEBS LETT, V509, P225, DOI 10.1016/S0014-5793(01)03119-2; Itoh Tatsuya, 2004, J Anesth, V18, P203; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kevin LG, 2005, ANESTH ANALG, V101, P1275, DOI 10.1213/01.ANE.0000180999.81013.D0; Kim I, 2008, NEUROREPORT, V19, P1699, DOI 10.1097/WNR.0b013e32831743fb; Kress HG, 1997, ANAESTHESIST, V46, pS8, DOI 10.1007/PL00002469; Li QF, 2006, ANESTHESIOLOGY, V105, P1211, DOI 10.1097/00000542-200612000-00021; Li QF, 2008, BRAIN RES, V1245, P26, DOI 10.1016/j.brainres.2008.09.069; Marti HH, 2004, J EXP BIOL, V207, P3233, DOI 10.1242/jeb.01049; Marti HH, 1996, EUR J NEUROSCI, V8, P666, DOI 10.1111/j.1460-9568.1996.tb01252.x; MASUDA S, 1994, J BIOL CHEM, V269, P19488; McAuliffe JJ, 2009, ANESTHESIOLOGY, V111, P533, DOI 10.1097/ALN.0b013e3181b060d3; Mellon RD, 2007, ANESTH ANALG, V104, P509, DOI 10.1213/01.ane.0000255729.96438.b0; MICHENFELDER JD, 1973, ANESTHESIOLOGY, V38, P445, DOI 10.1097/00000542-197305000-00006; Miyazaki H, 1997, ANESTHESIOLOGY, V86, P1359, DOI 10.1097/00000542-199706000-00018; Miyazaki H, 1997, ANESTHESIOLOGY, V86, p1358A; Nishi K, 2008, ANTIOXID REDOX SIGN, V10, P983, DOI 10.1089/ars.2007.1825; Noguchi CT, 2007, CRIT REV ONCOL HEMAT, V64, P159, DOI 10.1016/j.critrevonc.2007.03.001; Ntaios G, 2008, ACTA NEUROL SCAND, V118, P362, DOI 10.1111/j.1600-0404.2008.01039.x; Patel P, 2009, ANESTHESIOLOGY, V110, P703, DOI 10.1097/ALN.0b013e31819c42a4; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Raphael J, 2008, ANESTHESIOLOGY, V108, P415, DOI 10.1097/ALN.0b013e318164cab1; Rappaport B, 2011, NEW ENGL J MED, V364, P1387, DOI 10.1056/NEJMp1102155; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Sanchez PE, 2009, P NATL ACAD SCI USA, V106, P9848, DOI 10.1073/pnas.0901840106; Sato Y, 2005, ANESTHESIOLOGY, V102, P557, DOI 10.1097/00000542-200503000-00013; Selim M, 2007, NEW ENGL J MED, V356, P706, DOI 10.1056/NEJMra062668; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stockmann C, 2006, CLIN EXP PHARMACOL P, V33, P968, DOI 10.1111/j.1440-1681.2006.04474.x; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Takabuchi S, 2004, FEBS LETT, V577, P434, DOI 10.1016/j.febslet.2004.10.042; Tanaka T, 2010, AM J PHYSIOL-REG I, V298, pR661, DOI 10.1152/ajpregu.00732.2009; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Toda Y, 1999, PATHOL INT, V49, P479, DOI 10.1046/j.1440-1827.1999.00875.x; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Tseng MY, 2009, J NEUROSURG, V111, P171, DOI 10.3171/2009.3.JNS081332; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1995, GENETICS, V92, P5510; Weidemann A, 2009, KIDNEY INT, V75, P682, DOI 10.1038/ki.2008.687; Yamasaki M, 2005, BRAIN RES, V1050, P15, DOI 10.1016/j.brainres.2005.05.037; Yeo EJ, 2008, ANN HEMATOL, V87, P11, DOI 10.1007/s00277-007-0359-6; Yu XB, 2002, DEVELOPMENT, V129, P505; Yu XB, 2001, BLOOD, V98, P475, DOI 10.1182/blood.V98.2.475; Zhu CL, 2009, PEDIATRICS, V124, pE218, DOI 10.1542/peds.2008-3553	73	31	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29378	10.1371/journal.pone.0029378	http://dx.doi.org/10.1371/journal.pone.0029378			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216265	Green Published, Green Submitted, gold			2022-12-27	WOS:000300674900033
J	Wisner, ALS; Potter, AA; Koster, W				Wisner, Amanda L. S.; Potter, Andrew A.; Koester, Wolfgang			Effect of the Salmonella Pathogenicity Island 2 Type III Secretion System on Salmonella Survival in Activated Chicken Macrophage-Like HD11 Cells	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; NADPH PHAGOCYTE OXIDASE; DENDRITIC CELLS; HOST-CELLS; INTRACELLULAR SURVIVAL; ANTIGEN PRESENTATION; FUNCTIONAL-ANALYSIS; IMMUNE-RESPONSES; OXIDATIVE BURST; INFECTION	In order to better identify the role of the Salmonella pathogenicity island 2 (SPI-2) type III secretion system (T3SS) in chickens, we used the well-known gentamicin protection assay with activated HD11 cells. HD11 cells are a macrophage-like chicken cell line that can be stimulated with phorbol 12-myristate 13-acetate (PMA) to exhibit more macrophage-like morphology and greater production of reactive oxygen species (ROS). Activated HD11 cells were infected with a wild-type Salmonella enterica subspecies enterica serovar Typhimurium (S. Typhimurium) strain, a SPI-2 mutant S. Typhimurium strain, a wild-type Salmonella enterica subspecies enterica serovar Enteritidis (S. Enteritidis) strain, a SPI-2 mutant S. Enteritidis strain, or a non-pathogenic Escherichia coli (E. coli) strain. SPI-2 mutant strains were found to survive as well as their parent strain at all time points post-uptake (PU) by the HD11 cells, up to 24 h PU, while the E. coli strain was no longer recoverable by 3 h PU. We can conclude from these observations that the SPI-2 T3SS of S. Typhimurium and S. Enteritidis is not important for survival of Salmonella in the activated macrophage-like HD11 cell line, and that Salmonella must employ other mechanisms for survival in this environment, as E. coli is effectively eliminated.	[Wisner, Amanda L. S.; Potter, Andrew A.; Koester, Wolfgang] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Wisner, Amanda L. S.] Izaak Walton Killam Hlth Ctr, Canadian Ctr Vaccinol, Halifax, NS, Canada	University of Saskatchewan; Dalhousie University	Wisner, ALS (corresponding author), Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada.	wolfgang.koester@usask.ca	Köster, Wolfgang WL/B-4698-2011		Natural Sciences and Engineering Research Council of Canada (NSERC); Saskatchewan Health Research Foundation (SHRF)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Saskatchewan Health Research Foundation (SHRF)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), Saskatchewan Health Research Foundation (SHRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaghdadi H, 2009, J IMMUNOL, V183, P3778, DOI 10.4049/jimmunol.0900843; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Ashkar AA, 2009, INFECT IMMUN, V77, P214, DOI 10.1128/IAI.01066-08; Aussel L, 2011, MOL MICROBIOL, V80, P628, DOI 10.1111/j.1365-2958.2011.07611.x; Babu US, 2006, DEV COMP IMMUNOL, V30, P942, DOI 10.1016/j.dci.2005.12.001; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Brown NF, 2005, PLOS PATHOG, V1, P252, DOI 10.1371/journal.ppat.0010032; Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676; Ciraci C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-545; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Coombes BK, 2005, TRENDS MICROBIOL, V13, P92, DOI 10.1016/j.tim.2005.01.008; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Desin TS, 2009, INFECT IMMUN, V77, P2866, DOI 10.1128/IAI.00039-09; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Forest CG, 2010, MICROBIOL-SGM, V156, P3689, DOI 10.1099/mic.0.041624-0; Fournier B, 2009, INFECT IMMUN, V77, P4121, DOI 10.1128/IAI.00656-09; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Gallois A, 2001, J IMMUNOL, V166, P5741, DOI 10.4049/jimmunol.166.9.5741; Halici S, 2008, INFECT IMMUN, V76, P4924, DOI 10.1128/IAI.00531-08; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; Hensel M, 1997, MOL MICROBIOL, V24, P155, DOI 10.1046/j.1365-2958.1997.3271699.x; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Horst SA, 2010, J BACTERIOL, V192, P2929, DOI 10.1128/JB.01652-09; Kuhle V, 2004, CELL MOL LIFE SCI, V61, P2812, DOI 10.1007/s00018-004-4248-z; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Okamura M, 2005, VET IMMUNOL IMMUNOP, V107, P327, DOI 10.1016/j.vetimm.2005.05.009; Olekhnovich IN, 2006, J MOL BIOL, V357, P373, DOI 10.1016/j.jmb.2006.01.007; Schlumberger MC, 2006, CURR OPIN MICROBIOL, V9, P46, DOI 10.1016/j.mib.2005.12.006; Shea JE, 1999, INFECT IMMUN, V67, P213, DOI 10.1128/IAI.67.1.213-219.1999; Slauch JM, 2011, MOL MICROBIOL, V80, P580, DOI 10.1111/j.1365-2958.2011.07612.x; Srikanth CV, 2007, IMMUNOL RES, V37, P61, DOI 10.1007/BF02686090; Srinivasan A, 2006, ARCH IMMUNOL THER EX, V54, P25, DOI 10.1007/s00005-006-0003-5; Thompson A, 2006, CURR OPIN MICROBIOL, V9, P109, DOI 10.1016/j.mib.2005.12.010; THRASHER A, 1992, BLOOD, V80, P1125; Uchiya K, 2004, INFECT IMMUN, V72, P6860, DOI 10.1128/IAI.72.12.6860-6869.2004; Uchiya K, 2004, INFECT IMMUN, V72, P1964, DOI 10.1128/IAI.72.4.1964-1973.2004; Uematsu S, 2009, J GASTROENTEROL, V44, P803, DOI 10.1007/s00535-009-0094-y; Vazquez-Torres A, 2001, MICROBES INFECT, V3, P1313, DOI 10.1016/S1286-4579(01)01492-7; Vazquez-Torres A, 2001, P NATL ACAD SCI USA, V98, P2561, DOI 10.1073/pnas.041618998; Vieira A, 2009, WHO GLOBAL FOODBORNE; Winstanley C, 2001, J MED MICROBIOL, V50, P116, DOI 10.1099/0022-1317-50-2-116; Wisner ALS, 2010, MICROBIOL-SGM, V156, P2770, DOI 10.1099/mic.0.038018-0; World Health Organization, 2007, FOOD SAF FOODB ILLN; Zhang S, 2008, DEV BIOLOGICALS, V132, P141, DOI 10.1159/000317154	45	15	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29787	10.1371/journal.pone.0029787	http://dx.doi.org/10.1371/journal.pone.0029787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216355	Green Published, Green Submitted, gold			2022-12-27	WOS:000300674900059
J	Cabezon, O; Garcia-Bocanegra, I; Molina-Lopez, R; Marco, I; Blanco, JM; Hofle, U; Margalida, A; Bach-Raich, E; Darwich, L; Echeverria, I; Obon, E; Hernandez, M; Lavin, S; Dubey, JP; Almeria, S				Cabezon, Oscar; Garcia-Bocanegra, Ignacio; Molina-Lopez, Rafael; Marco, Ignasi; Blanco, Juan M.; Hoefle, Ursula; Margalida, Antoni; Bach-Raich, Esther; Darwich, Laila; Echeverria, Israel; Obon, Elena; Hernandez, Mauro; Lavin, Santiago; Dubey, Jitender P.; Almeria, Sonia			Seropositivity and Risk Factors Associated with Toxoplasma gondii Infection in Wild Birds from Spain	PLOS ONE			English	Article							PREVALENCE; ANTIBODIES; SEROPREVALENCE; ANIMALS; MAMMALS; DIET; PIGS; DEER	Toxoplasma gondii is a zoonotic intracellular protozoan parasite of worldwide distribution that infects many species of warm-blooded animals, including birds. To date, there is scant information about the seropositivity of T. gondii and the risk factors associated with T. gondii infection in wild bird populations. In the present study, T. gondii infection was evaluated on sera obtained from 1079 wild birds belonging to 56 species (including Falconiformes (n = 610), Strigiformes (n = 260), Ciconiiformes (n = 156), Gruiformes (n = 21), and other orders (n = 32), from different areas of Spain. Antibodies to T. gondii (modified agglutination test, MAT titer >= 1:25) were found in 282 (26.1%, IC95%: 23.5-28.7) of the 1079 birds. This study constitute the first extensive survey in wild birds species in Spain and reports for the first time T. gondii antibodies in the griffon vulture (Gyps fulvus), short-toed snake-eagle (Circaetus gallicus), Bonelli's eagle (Aquila fasciata), golden eagle (Aquila chrysaetos), bearded vulture (Gypaetus barbatus), osprey (Pandion haliaetus), Montagu's harrier (Circus pygargus), Western marsh-harrier (Circus aeruginosus), peregrine falcon (Falco peregrinus), long-eared owl (Asio otus), common scops owl (Otus scops), Eurasian spoonbill (Platalea leucorodia), white stork (Ciconia ciconia), grey heron (Ardea cinerea), common moorhen (Gallinula chloropus); in the International Union for Conservation of Nature (IUCN) "vulnerable'' Spanish imperial eagle (Aquila adalberti), lesser kestrel (Falco naumanni) and great bustard (Otis tarda); and in the IUCN "near threatened'' red kite (Milvus milvus). The highest seropositivity by species was observed in the Eurasian eagle owl (Bubo bubo) (68.1%, 98 of 144). The main risk factors associated with T. gondii seropositivity in wild birds were age and diet, with the highest exposure in older animals and in carnivorous wild birds. The results showed that T. gondii infection is widespread and can be at a high level in many wild birds in Spain, most likely related to their feeding behaviour.	[Cabezon, Oscar; Marco, Ignasi; Bach-Raich, Esther; Lavin, Santiago] Univ Autonoma Barcelona, Fac Vet, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge, Bellaterra, Spain; [Garcia-Bocanegra, Ignacio] Univ Cordoba, Fac Vet, Dept Sanidad Anim, Cordoba, Spain; [Molina-Lopez, Rafael; Obon, Elena] Generalitat Catalunya, Direccio Gen Medi Nat & Biodiversitat Forestal Ca, Ctr Fauna Salvatge Torreferrussa, Barcelona, Spain; [Blanco, Juan M.] Ctr Estudios Rapaces Iber, Sevilleja De La Jara, Castilla La Man, Spain; [Hoefle, Ursula] Univ Castilla La Mancha Junta de Castilla La Manc, CSIC, Inst Invest Recursos Cineget IREC, Ciudad Real, Spain; [Margalida, Antoni] Bearded Vulture Study & Protect Grp, El Pont De Suert, Lleida, Spain; [Margalida, Antoni] Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland; [Darwich, Laila; Almeria, Sonia] Univ Autonoma Barcelona, CReSA, E-08193 Barcelona, Spain; [Darwich, Laila; Echeverria, Israel; Almeria, Sonia] Univ Autonoma Barcelona, Fac Vet, Dept Sanitat & Anat Anim, Bellaterra, Spain; [Hernandez, Mauro] Clin Vet Oftalmol OCUVET, Madrid, Spain; [Dubey, Jitender P.] ARS, Anim Parasit Dis Lab, Anim & Nat Resources Inst, USDA, Beltsville, MD USA	Autonomous University of Barcelona; Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Fundacion para la Conservacion del Quebranthuesos (FCQ); University of Bern; Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; United States Department of Agriculture (USDA)	Cabezon, O (corresponding author), Univ Autonoma Barcelona, Fac Vet, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge, Bellaterra, Spain.	Sonia.Almeria@uab.es	Cabezón, Oscar/AAV-7876-2020; Höfle, Ursula/F-8585-2013; Marco, Ignasi/E-8633-2015; Darwich, Laila/F-5330-2016; Lavín, Santiago/L-5975-2014; Almeria, Sonia/N-4663-2014; Margalida, Antoni/A-2723-2011; Margalida, Antoni/AAG-5337-2020; Cabezon, Oscar/L-3812-2014; Bocanegra, Ignacio Garcia/G-1443-2016; Margalida, Antoni/A-2723-2011	Höfle, Ursula/0000-0002-6868-079X; Marco, Ignasi/0000-0001-7479-3419; Darwich, Laila/0000-0001-9027-9452; Lavín, Santiago/0000-0001-5655-588X; Almeria, Sonia/0000-0002-0558-5488; Margalida, Antoni/0000-0002-0576-3993; Cabezon, Oscar/0000-0001-7543-8371; Bocanegra, Ignacio Garcia/0000-0003-3388-2604; Margalida, Antoni/0000-0002-7383-671X; Margalida, Antoni/0000-0002-3904-6212; Molina Lopez, Rafael/0000-0002-9043-2346; Obon, Elena/0000-0003-4228-717X	Spanish CICYT [AGL2010-21273-C03/GAN]	Spanish CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT))	This study received partial support from the Spanish CICYT grant AGL2010-21273-C03/GAN. The study was part of an agreement with Direccion General del Medio Natural (CRAS, Junta de Castilla y Leon), Departament d'Agricultura, Ramaderia, Pesca, Alimentacio i Medi Natural (Torreferrussa, Generalitat de Catalunya), Consejeria de Medio Ambiente (Junta de Andalucia), SEFaS (Universitat Autonoma de Barcelona) and IREC (Ciudad Real) for donation of wild bird samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeria S, 2004, VET PARASITOL, V123, P265, DOI 10.1016/j.vetpar.2004.06.010; Alvarado-Esquivel C, 2011, J PARASITOL, V97, P809, DOI 10.1645/GE-2844.1; [Anonymous], 2009, TOXOPLASMOSIS ANIMAL; Aubert D, 2008, J WILDLIFE DIS, V44, P172, DOI 10.7589/0090-3558-44.1.172; Cabezon O, 2004, J PARASITOL, V90, P643, DOI 10.1645/GE-257R; Calix M., 2018, EUROPEAN RED LIST SA; Dabritz HA, 2008, J PARASITOL, V94, P675, DOI 10.1645/GE-1342.1; Darwich L, 2012, VET PARASITOL, V183, P377, DOI 10.1016/j.vetpar.2011.07.024; De Juana E, 2001, GUIA AVES ESPANA; Dubey JP, 2008, INT J PARASITOL, V38, P1257, DOI 10.1016/j.ijpara.2008.03.007; Dubey JP, 2010, J PARASITOL, V96, P937, DOI 10.1645/GE-2501.1; Dubey J.P., 1988, P1; Dubey JP, 2002, VET PARASITOL, V106, P121, DOI 10.1016/S0304-4017(02)00034-1; DUBEY JP, 1987, EQUINE VET J, V19, P337, DOI 10.1111/j.2042-3306.1987.tb01426.x; Gamarra JA, 2008, VET PARASITOL, V153, P152, DOI 10.1016/j.vetpar.2008.01.028; Garcia-Bocanegra I, 2012, VET J, V191, P257, DOI 10.1016/j.tvjl.2010.11.011; Garcia-Bocanegra I, 2010, VET PARASITOL, V167, P36, DOI 10.1016/j.vetpar.2009.09.044; Garcia-Bocanegra I, 2010, PARASITOL INT, V59, P421, DOI 10.1016/j.parint.2010.06.001; Gauss CBL, 2006, VET PARASITOL, V136, P193, DOI 10.1016/j.vetpar.2005.11.013; Gauss CBL, 2005, VET PARASITOL, V131, P151, DOI 10.1016/j.vetpar.2005.04.023; Gauss CBL, 2003, J PARASITOL, V89, P1067, DOI 10.1645/GE-114; Gondim LSQ, 2010, VET PARASITOL, V168, P121, DOI 10.1016/j.vetpar.2009.09.055; Hejlicek K, 1997, J WILDLIFE DIS, V33, P480, DOI 10.7589/0090-3558-33.3.480; HOSMER DW, 1989, APPL LOGISTIC REGRES; Jones JL, 2010, EXP PARASITOL, V124, P10, DOI 10.1016/j.exppara.2009.03.013; KAPPERUD G, 1978, J WILDLIFE DIS, V14, P157, DOI 10.7589/0090-3558-14.2.157; de Godoi FSL, 2010, REV BRAS PARASITOL V, V19, P238; Lopes AP, 2011, PARASITOL RES, V108, P1163, DOI 10.1007/s00436-010-2158-6; Margalida A, 2012, IBIS, V154, P184, DOI 10.1111/j.1474-919X.2011.01189.x; Margalida A, 2009, IBIS, V151, P235; Molina-Lopez R, 2012, RES VET SCI, V93, P300, DOI 10.1016/j.rvsc.2011.05.011; Pistorius PA, 2008, WILSON J ORNITHOL, V120, P631, DOI 10.1676/07-101.1; Resendes AR, 2002, J PARASITOL, V88, P1029, DOI 10.1645/0022-3395(2002)088[1029:DTIAMP]2.0.CO;2; Roelke ME, 2008, EUR J WILDLIFE RES, V54, P171, DOI 10.1007/s10344-007-0122-2; SMITH DD, 1995, J WILDLIFE DIS, V31, P15, DOI 10.7589/0090-3558-31.1.15; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; WEIGEL RM, 1995, J PARASITOL, V81, P736, DOI 10.2307/3283964; Zhang SY, 2000, PARASITOL INT, V49, P171, DOI 10.1016/S1383-5769(00)00041-6	38	39	40	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29549	10.1371/journal.pone.0029549	http://dx.doi.org/10.1371/journal.pone.0029549			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216311	gold, Green Submitted, Green Published			2022-12-27	WOS:000299684700067
J	Moya, M; Benet, M; Guzman, C; Tolosa, L; Garcia-Monzon, C; Pareja, E; Castell, JV; Jover, R				Moya, Marta; Benet, Marta; Guzman, Carla; Tolosa, Laia; Garcia-Monzon, Carmelo; Pareja, Eugenia; Vicente Castell, Jose; Jover, Ramiro			Foxa1 Reduces Lipid Accumulation in Human Hepatocytes and Is Down-Regulated in Nonalcoholic Fatty Liver	PLOS ONE			English	Article							ACYL-COA OXIDASE; NUCLEAR FACTOR 3-GAMMA; TRANSCRIPTION FACTOR; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; HEPATIC STEATOSIS; PLASMA-MEMBRANE; ACID TRANSPORT; FACTOR 3-BETA; BILE-ACID	Triglyceride accumulation in nonalcoholic fatty liver (NAFL) results from unbalanced lipid metabolism which, in the liver, is controlled by several transcription factors. The Foxa subfamily of winged helix/forkhead box (Fox) transcription factors comprises three members which play important roles in controlling both metabolism and homeostasis through the regulation of multiple target genes in the liver, pancreas and adipose tissue. In the mouse liver, Foxa2 is repressed by insulin and mediates fasting responses. Unlike Foxa2 however, the role of Foxa1 in the liver has not yet been investigated in detail. In this study, we evaluate the role of Foxa1 in two human liver cell models, primary cultured hepatocytes and HepG2 cells, by adenoviral infection. Moreover, human and rat livers were analyzed to determine Foxa1 regulation in NAFL. Results demonstrate that Foxa1 is a potent inhibitor of hepatic triglyceride synthesis, accumulation and secretion by repressing the expression of multiple target genes of these pathways (e.g., GPAM, DGAT2, MTP, APOB). Moreover, Foxa1 represses the fatty acid transporter protein FATP2 and lowers fatty acid uptake. Foxa1 also increases the breakdown of fatty acids by inducing peroxisomal fatty acid beta-oxidation and ketone body synthesis. Finally, Foxa1 is able to largely up-regulate UCP1, thereby dissipating energy and consistently decreasing the mitochondria membrane potential. We also report that human and rat NAFL have a reduced Foxa1 expression, possibly through a protein kinase C-dependent pathway. We conclude that Foxa1 is an antisteatotic factor that coordinately tunes several lipid metabolic pathways to block triglyceride accumulation in hepatocytes. However, Foxa1 is down-regulated in human and rat NAFL and, therefore, increasing Foxa1 levels could protect from steatosis. Altogether, we suggest that Foxa1 could be a novel therapeutic target for NAFL disease and insulin resistance.	[Moya, Marta; Benet, Marta; Guzman, Carla; Tolosa, Laia; Vicente Castell, Jose; Jover, Ramiro] Univ Hosp La Fe, Expt Hepatol Unit, Valencia, Spain; [Pareja, Eugenia] Univ Hosp La Fe, Surg & Liver Transplantat Unit, Valencia, Spain; [Benet, Marta; Garcia-Monzon, Carmelo; Vicente Castell, Jose; Jover, Ramiro] CIBERehd, Barcelona, Spain; [Garcia-Monzon, Carmelo] Univ Hosp Santa Cristina, Liver Res Unit, Inst Invest Sanitaria Princesa, Madrid, Spain; [Vicente Castell, Jose; Jover, Ramiro] Univ Valencia, Dept Biochem & Mol Biol, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Valencia	Moya, M (corresponding author), Univ Hosp La Fe, Expt Hepatol Unit, Valencia, Spain.	ramiro.jover@uv.es	Tolosa, Laia/N-6614-2015; Jover, Ramiro/O-9796-2017; Benet, Marta/H-4168-2017; Castell, Jose V/I-9529-2016	Tolosa, Laia/0000-0002-1740-0874; Jover, Ramiro/0000-0002-4914-5804; Castell, Jose V/0000-0003-1179-6430; Benet Gimenez, Marta/0000-0002-7910-4755	Fondo de Investigacion Sanitaria (FIS, Instituto de Salud Carlos III) [PI 07/0550, PI 10/00194, PI 10/00067]; EC [PL037712]; Fundacion Eugenio Rodriguez Pascual; CIBERehd [EHD-10-DOC2]; Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation [CA 09/00122]	Fondo de Investigacion Sanitaria (FIS, Instituto de Salud Carlos III)(Instituto de Salud Carlos III); EC(European CommissionEuropean Commission Joint Research Centre); Fundacion Eugenio Rodriguez Pascual; CIBERehd; Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been partly supported by grants PI 07/0550, PI 10/00194 and PI 10/00067 from Fondo de Investigacion Sanitaria (FIS, Instituto de Salud Carlos III); by the EC Integrated Project CARCINOGENOMICS (PL037712); and by the Fundacion Eugenio Rodriguez Pascual. M. B. was a recipient of a CIBERehd contract (EHD-10-DOC2) and C. G. was a recipient of a contract (CA 09/00122) from the Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benet M, 2010, J BIOL CHEM, V285, P28457, DOI 10.1074/jbc.M110.118364; Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853; Castell JV, 1997, GENE THER, V4, P455, DOI 10.1038/sj.gt.3300416; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Costanzo P, 1999, FEBS LETT, V454, P61, DOI 10.1016/S0014-5793(99)00775-9; Del Mar Gonzalez-Barroso M, 2000, Obes Rev, V1, P61, DOI 10.1046/j.1467-789x.2000.00009.x; Duncan SA, 1998, SCIENCE, V281, P692, DOI 10.1126/science.281.5377.692; Ehehalt R, 2006, MOL CELL BIOCHEM, V284, P135, DOI 10.1007/s11010-005-9034-1; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Falcon A, 2010, AM J PHYSIOL-ENDOC M, V299, pE384, DOI 10.1152/ajpendo.00226.2010; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gomez-Lechon MJ, 2007, CHEM-BIOL INTERACT, V165, P106, DOI 10.1016/j.cbi.2006.11.004; Howell JJ, 2009, J BIOL CHEM, V284, P24816, DOI 10.1074/jbc.M109.042135; Hughes DE, 2003, HEPATOLOGY, V37, P1414, DOI 10.1053/jhep.2003.50253; Ishigaki Y, 2005, DIABETES, V54, P322, DOI 10.2337/diabetes.54.2.322; Kaestner KH, 1998, MOL CELL BIOL, V18, P4245, DOI 10.1128/MCB.18.7.4245; Kampf JP, 2007, PHYSIOLOGY, V22, P7, DOI 10.1152/physiol.00011.2006; LAI E, 1990, GENE DEV, V4, P1427, DOI 10.1101/gad.4.8.1427; LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416; Lewis GF, 1997, CURR OPIN LIPIDOL, V8, P146, DOI 10.1097/00041433-199706000-00004; Moya M, 2010, CHEM-BIOL INTERACT, V184, P376, DOI 10.1016/j.cbi.2010.01.008; Pfaffl MW, 2001, BIOTECHNOL LETT, V23, P275, DOI 10.1023/A:1005658330108; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Rausa FM, 2000, MOL CELL BIOL, V20, P8264, DOI 10.1128/MCB.20.21.8264-8282.2000; REUBSAET FAG, 1988, BIOCHIM BIOPHYS ACTA, V958, P434, DOI 10.1016/0005-2760(88)90229-9; Ruyter B, 1997, BBA-LIPID LIPID MET, V1348, P331, DOI 10.1016/S0005-2760(97)00080-5; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Shen W, 2001, J BIOL CHEM, V276, P42812, DOI 10.1074/jbc.M106344200; Shih DQ, 1999, P NATL ACAD SCI USA, V96, P10152, DOI 10.1073/pnas.96.18.10152; SMALL GM, 1985, BIOCHEM J, V227, P205, DOI 10.1042/bj2270205; Sund NJ, 2000, MOL CELL BIOL, V20, P5175, DOI 10.1128/MCB.20.14.5175-5183.2000; Tan YJ, 2002, HEPATOLOGY, V35, P30, DOI 10.1053/jhep.2002.30317; Vatamaniuk MZ, 2006, DIABETES, V55, P2730, DOI 10.2337/db05-0470; Wakusawa S, 2001, BIOCHEM PHARMACOL, V61, P1339, DOI 10.1016/S0006-2952(01)00601-3; Wang HY, 2005, TRENDS MOL MED, V11, P262, DOI 10.1016/j.molmed.2005.04.003; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002	40	55	58	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e30014	10.1371/journal.pone.0030014	http://dx.doi.org/10.1371/journal.pone.0030014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238690	Green Published, Green Submitted, gold			2022-12-27	WOS:000301188800054
J	Scott, KEN; Wheeler, FB; Davis, AL; Thomas, MJ; Ntambi, JM; Seals, DF; Kridel, SJ				Scott, Kristen E. N.; Wheeler, Frances B.; Davis, Amanda L.; Thomas, Michael J.; Ntambi, James M.; Seals, Darren F.; Kridel, Steven J.			Metabolic Regulation of Invadopodia and Invasion by Acetyl-CoA Carboxylase 1 and De novo Lipogenesis	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; BREAST-CANCER CELLS; WASP-WIP COMPLEX; PODOSOME FORMATION; PROSTATE-CANCER; N-WASP; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ACTIN CYTOSKELETON; MEMBRANE CURVATURE; FOCAL ADHESIONS	Invadopodia are membrane protrusions that facilitate matrix degradation and cellular invasion. Although lipids have been implicated in several aspects of invadopodia formation, the contributions of de novo fatty acid synthesis and lipogenesis have not been defined. Inhibition of acetyl-CoA carboxylase 1 (ACC1), the committed step of fatty acid synthesis, reduced invadopodia formation in Src-transformed 3T3 (3T3-Src) cells, and also decreased the ability to degrade gelatin. Inhibition of fatty acid synthesis through AMP-activated kinase (AMPK) activation and ACC phosphorylation also decreased invadopodia incidence. The addition of exogenous 16: 0 and 18: 1 fatty acid, products of de novo fatty acid synthesis, restored invadopodia and gelatin degradation to cells with decreased ACC1 activity. Pharmacological inhibition of ACC also altered the phospholipid profile of 3T3-Src cells, with the majority of changes occurring in the phosphatidylcholine (PC) species. Exogenous supplementation with the most abundant PC species, 34: 1 PC, restored invadopodia incidence, the ability to degrade gelatin and the ability to invade through matrigel to cells deficient in ACC1 activity. On the other hand, 30: 0 PC did not restore invadopodia and 36: 2 PC only restored invadopodia incidence and gelatin degradation, but not cellular invasion through matrigel. Pharmacological inhibition of ACC also reduced the ability of MDA-MB-231 breast, Snb19 glioblastoma, and PC-3 prostate cancer cells to invade through matrigel. Invasion of PC-3 cells through matrigel was also restored by 34: 1 PC supplementation. Collectively, the data elucidate the novel metabolic regulation of invadopodia and the invasive process by de novo fatty acid synthesis and lipogenesis.	[Scott, Kristen E. N.; Wheeler, Frances B.; Davis, Amanda L.; Seals, Darren F.; Kridel, Steven J.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Thomas, Michael J.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Thomas, Michael J.; Seals, Darren F.; Kridel, Steven J.] Wake Forest Sch Med, Ctr Comprehens Canc, Winston Salem, NC USA; [Ntambi, James M.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	Wake Forest University; Wake Forest University; Wake Forest University; University of Wisconsin System; University of Wisconsin Madison	Scott, KEN (corresponding author), Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA.	skridel@wakehealth.edu			North Carolina Biotechnology Grant [2007-IDG-1021]; National Institutes of Health (NIH) [1 S10 RR027940]; National Institutes of Health/National Cancer Institute (NIH/NCI) [CA114104]; Department of Defense [W81XWH-09-1-0024]; NATIONAL CANCER INSTITUTE [R01CA114104, T32CA079448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027940] Funding Source: NIH RePORTER	North Carolina Biotechnology Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the North Carolina Biotechnology Grant 2007-IDG-1021, a National Institutes of Health (NIH) Shared Instrumentation Grant 1 S10 RR027940, National Institutes of Health/National Cancer Institute (NIH/NCI) CA114104, and by the Department of Defense Prostate Cancer Research Program W81XWH-09-1-0024. CP-640186 was a generous gift from Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Achiriloaie M, 1999, MOL CELL BIOL, V19, P1410; Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Albrechtsen R, 2011, EXP CELL RES, V317, P195, DOI 10.1016/j.yexcr.2010.10.003; Alo PL, 1996, CANCER, V77, P474, DOI 10.1002/(SICI)1097-0142(19960201)77:3<474::AID-CNCR8>3.0.CO;2-K; ANSELL GB, 1982, PHOSPHOLIPIDS, P1; Baron A, 2004, J CELL BIOCHEM, V91, P47, DOI 10.1002/jcb.10708; Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blume C, 2007, J BIOL CHEM, V282, P4601, DOI 10.1074/jbc.M608866200; Bowden ET, 2001, METHOD CELL BIOL, V63, P613; Buschman MD, 2009, MOL BIOL CELL, V20, P1302, DOI 10.1091/mbc.E08-09-0949; Caldieri G, 2009, J CELL MOL MED, V13, P1728, DOI 10.1111/j.1582-4934.2008.00568.x; Camassei FD, 2003, MED PEDIATR ONCOL, V40, P302, DOI 10.1002/mpo.10274; Chellaiah MA, 2001, J BIOL CHEM, V276, P47434, DOI 10.1074/jbc.M107494200; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Conde E, 2007, HUM PATHOL, V38, P1351, DOI 10.1016/j.humpath.2007.01.022; Cory GOC, 2007, CURR BIOL, V17, pR455, DOI 10.1016/j.cub.2007.04.015; DeLong CJ, 2001, J LIPID RES, V42, P1959; Devaux PF, 2004, TRAFFIC, V5, P241, DOI 10.1111/j.1600-0854.2004.0170.x; Diaz B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000368; EPSTEIN JI, 1995, UROLOGY, V45, P81, DOI 10.1016/S0090-4295(95)96904-7; Favero CB, 2007, BRAIN RES, V1168, P1, DOI 10.1016/j.brainres.2007.06.087; Gansler TS, 1997, HUM PATHOL, V28, P686, DOI 10.1016/S0046-8177(97)90177-5; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Gimona M, 2006, INT J BIOCHEM CELL B, V38, P1875, DOI 10.1016/j.biocel.2006.05.003; Harwood HJ, 2003, J BIOL CHEM, V278, P37099, DOI 10.1074/jbc.M304481200; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Horiguchi A, 2008, J UROLOGY, V180, P1137, DOI 10.1016/j.juro.2008.04.135; Iqbal Z, 2010, AM J HUM GENET, V86, P254, DOI 10.1016/j.ajhg.2010.01.009; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77; Little JL, 2007, CANCER RES, V67, P1262, DOI 10.1158/0008-5472.CAN-06-1794; Mao J, 2009, P NATL ACAD SCI; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Milgraum LZ, 1997, CLIN CANCER RES, V3, P2115; Miranda L, 2010, BIOCHEM BIOPH RES CO, V396, P656, DOI 10.1016/j.bbrc.2010.04.151; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; Moser TS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000954; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Myers RB, 2001, J UROLOGY, V165, P1027, DOI 10.1016/S0022-5347(05)66596-2; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Oikawa T, 2009, CELL ADHES MIGR, V3, P195, DOI 10.4161/cam.3.2.7510; Rossi S, 2003, MOL CANCER RES, V1, P707; Rottiers P, 2009, J CELL SCI, V122, P4311, DOI 10.1242/jcs.057448; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Rysman E, 2010, CANCER RES, V70, P8117, DOI 10.1158/0008-5472.CAN-09-3871; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Sebastiani V, 2004, GYNECOL ONCOL, V92, P101, DOI 10.1016/j.ygyno.2003.10.027; Shurbaji MS, 1996, HUM PATHOL, V27, P917, DOI 10.1016/S0046-8177(96)90218-X; Swinnen JV, 2003, BIOCHEM BIOPH RES CO, V302, P898, DOI 10.1016/S0006-291X(03)00265-1; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Tsuboi S, 2009, J BIOL CHEM, V284, P8548, DOI 10.1074/jbc.M805638200; Tsuboi T, 2003, J BIOL CHEM, V278, P52042, DOI 10.1074/jbc.M307800200; Van Kessel W S, 1977, Biochim Biophys Acta, V486, P524; WITTERS LA, 1994, INT J BIOCHEM, V26, P589, DOI 10.1016/0020-711X(94)90018-3; Xu J., 2001, PREPARATION CULTURE; Yamaguchi H, 2011, J CELL BIOL, V193, P1275, DOI 10.1083/jcb.201009126; Yamaguchi H, 2010, ONCOTARGET, V1, P320; Yamaguchi H, 2010, CANCER SCI, V101, P1632, DOI 10.1111/j.1349-7006.2010.01574.x; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	66	39	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29761	10.1371/journal.pone.0029761	http://dx.doi.org/10.1371/journal.pone.0029761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238651	Green Published, Green Submitted, gold			2022-12-27	WOS:000301188800035
J	Wu, WB; Sun, ZC; Wu, JW; Peng, XM; Gan, HC; Zhang, CY; Ji, LL; Xie, JH; Zhu, HY; Ren, SF; Gu, JX; Zhang, SW				Wu, Weibin; Sun, Zhichao; Wu, Jingwen; Peng, Xiaomin; Gan, Huacheng; Zhang, Chunyi; Ji, Lingling; Xie, Jianhui; Zhu, Haiyan; Ren, Shifang; Gu, Jianxin; Zhang, Songwen			Trihydrophobin 1 Phosphorylation by c-Src Regulates MAPK/ERK Signaling and Cell Migration	PLOS ONE			English	Article							FOCAL ADHESION KINASE; GROWTH-FACTOR; BREAST-CANCER; PROTEIN; FAMILY; ERK; ACTIVATION; IDENTIFICATION; COMPLEX; NELF	c-Src activates Ras-MAPK/ERK signaling pathway and regulates cell migration, while trihydrophobin 1 (TH1) inhibits MAPK/ERK activation and cell migration through interaction with A-Raf and PAK1 and inhibiting their kinase activities. Here we show that c-Src interacts with TH1 by GST-pull down assay, coimmunoprecipitation and confocal microscopy assay. The interaction leads to phosphorylation of TH1 at Tyr-6 in vivo and in vitro. Phosphorylation of TH1 decreases its association with A-Raf and PAK1. Further study reveals that Tyr-6 phosphorylation of TH1 reduces its inhibition on MAPK/ERK signaling, enhances c-Src mediated cell migration. Moreover, induced tyrosine phosphorylation of TH1 has been found by EGF and estrogen treatments. Taken together, our findings demonstrate a novel mechanism for the comprehensive regulation of Ras/Raf/MEK/ERK signaling and cell migration involving tyrosine phosphorylation of TH1 by c-Src.	[Wu, Weibin; Sun, Zhichao; Wu, Jingwen; Peng, Xiaomin; Gan, Huacheng; Zhang, Chunyi; Ji, Lingling; Xie, Jianhui; Zhu, Haiyan; Ren, Shifang; Gu, Jianxin; Zhang, Songwen] Fudan Univ, Ctr Gene Res, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Wu, Weibin; Gu, Jianxin] Fudan Univ, Inst Biomed Sci, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Wu, Weibin; Sun, Zhichao; Wu, Jingwen; Peng, Xiaomin; Gan, Huacheng; Zhang, Chunyi; Ji, Lingling; Xie, Jianhui; Zhu, Haiyan; Ren, Shifang; Gu, Jianxin; Zhang, Songwen] Fudan Univ, Dept Biochem & Mol Biol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Wu, WB (corresponding author), Fudan Univ, Ctr Gene Res, Shanghai Med Coll, Shanghai 200433, Peoples R China.	jxgu@shmu.edu.cn; songwenzhang@fudan.edu.cn	zhu, xueqiong/U-1320-2019	Wu, Weibin/0000-0003-3637-754X	National Natural Science Fund [81070235, 31000348, 31000600]; Shanghai Rising-Star Program [11QA1400600]; Research Fund for the Doctoral Program of Higher Education of China [20100071120038]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Fund (81070235, 31000348, 31000600), Shanghai Rising-Star Program (11QA1400600) and Research Fund for the Doctoral Program of Higher Education of China (20100071120038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ghazaleh R, 2001, BIOCHEM J, V360, P255, DOI 10.1042/0264-6021:3600255; Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; BANGA SS, 1995, MOL GEN GENET, V246, P148, DOI 10.1007/BF00294677; BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Bonthron DT, 2000, HUM GENET, V107, P165, DOI 10.1007/s004390000344; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Carragher NO, 2003, CURR BIOL, V13, P1442, DOI 10.1016/S0960-9822(03)00544-X; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Chen JZ, 2008, NAT CLIN PRACT GASTR, V5, P306, DOI 10.1038/ncpgasthep1141; Chen YJ, 2008, MOL BIOL CELL, V19, P2973, DOI 10.1091/mbc.E07-10-1058; Cheng CM, 2009, J BIOL CHEM, V284, P8786, DOI 10.1074/jbc.M806144200; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Cole PA, 2003, CURR OPIN CHEM BIOL, V7, P580, DOI 10.1016/j.cbpa.2003.08.009; Fincham VJ, 1996, J CELL BIOL, V135, P1551, DOI 10.1083/jcb.135.6.1551; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Hunger-Glaser I, 2003, J BIOL CHEM, V278, P22631, DOI 10.1074/jbc.M210876200; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Kodama H, 2003, HYPERTENSION, V41, P1372, DOI 10.1161/01.HYP.0000069698.11814.F4; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Liu WC, 2004, J BIOL CHEM, V279, P10167, DOI 10.1074/jbc.M307994200; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Mayer EL, 2010, CLIN CANCER RES, V16, P3526, DOI 10.1158/1078-0432.CCR-09-1834; Melillo RM, 1999, CANCER RES, V59, P1120; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Penela P, 2001, EMBO J, V20, P5129, DOI 10.1093/emboj/20.18.5129; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Sun GQ, 1998, ONCOGENE, V17, P1587, DOI 10.1038/sj.onc.1202076; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yin XL, 2002, MOL CELL BIOCHEM, V231, P69, DOI 10.1023/A:1014437024129; Yu CF, 2002, J BIOL CHEM, V277, P19382, DOI 10.1074/jbc.M200732200; Zou WY, 2010, CANCER SCI, V101, P2156, DOI 10.1111/j.1349-7006.2010.01656.x	54	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29920	10.1371/journal.pone.0029920	http://dx.doi.org/10.1371/journal.pone.0029920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238675	Green Published, gold, Green Submitted			2022-12-27	WOS:000301188800047
J	Aloi, C; Salina, A; Pasquali, L; Lugani, F; Perri, K; Russo, C; Tallone, R; Ghiggeri, GM; Lorini, R; d'Annunzio, G				Aloi, Concetta; Salina, Alessandro; Pasquali, Lorenzo; Lugani, Francesca; Perri, Katia; Russo, Chiara; Tallone, Ramona; Ghiggeri, Gian Marco; Lorini, Renata; d'Annunzio, Giuseppe			Wolfram Syndrome: New Mutations, Different Phenotype	PLOS ONE			English	Article							DIABETES-MELLITUS; OPTIC ATROPHY; ENDOPLASMIC-RETICULUM; WFS1 MUTATIONS; GENE; EXPRESSION; CELLS; WFS1/WOLFRAMIN; INSIPIDUS; DIAGNOSIS	Background: Wolfram Syndrome (WS) is an autosomal recessive neurodegenerative disorder characterized by Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness identified by the acronym "DIDMOAD". The WS gene, WFS1, encodes a transmembrane protein called Wolframin, which recent evidence suggests may serve as a novel endoplasmic reticulum calcium channel in pancreatic beta-cells and neurons. WS is a rare disease, with an estimated prevalence of 1/550.000 children, with a carrier frequency of 1/354. The aim of our study was to determine the genotype of WS patients in order to establish a genotype/phenotype correlation. Methodology/Principal Findings: We clinically evaluated 9 young patients from 9 unrelated families (6 males, 3 females). Basic criteria for WS clinical diagnosis were coexistence of insulin-treated diabetes mellitus and optic atrophy occurring before 15 years of age. Genetic analysis for WFS1 was performed by direct sequencing. Molecular sequencing revealed 5 heterozygous compound and 3 homozygous mutations. All of them were located in exon 8, except one in exon 4. In one proband only an heterozygous mutation (A684V) was found. Two new variants c.2663 C>A and c. 1381 A>C were detected. Conclusions/Significance: Our study increases the spectrum of WFS1 mutations with two novel variants. The male patient carrying the compound mutation [c.1060_1062delTTC]+[c.2663 C>A] showed the most severe phenotype: diabetes mellitus, optic atrophy (visual acuity 5/10), deafness with deep auditory bilaterally 8000 Hz, diabetes insipidus associated to reduced volume of posterior pituitary and pons. He died in bed at the age of 13 years. The other patient carrying the compound mutation [c.409_424dup16]+[c.1381 A>C] showed a less severe phenotype (DM, OA).	[Aloi, Concetta; Salina, Alessandro; Pasquali, Lorenzo; Lugani, Francesca; Perri, Katia; Russo, Chiara; Tallone, Ramona; Lorini, Renata; d'Annunzio, Giuseppe] Univ Genoa, Pediat Clin, IRCCS G Gaslini Inst, Genoa, Italy; [Pasquali, Lorenzo] Ctr Invest Biomed Red CIBER Diabet & Enfermedades, Barcelona, Spain; [Lugani, Francesca] Columbia Univ, Dept Med, Div Nephrol, New York, NY USA; [Lugani, Francesca; Ghiggeri, Gian Marco] IRCCS G Gaslini Inst, Lab Pathophysiol Uremia, Genoa, Italy; [Lugani, Francesca; Ghiggeri, Gian Marco] IRCCS G Gaslini Inst, Dept Nephrol, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Columbia University; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini	Aloi, C (corresponding author), Univ Genoa, Pediat Clin, IRCCS G Gaslini Inst, Genoa, Italy.	giuseppedannunzio@ospedale-gaslini.ge.it	Aloi, Concetta/AAS-6518-2020; Salina, Alessandro/AAA-7715-2020; Ghiggeri, Gian Marco/N-4712-2015; Pasquali, Lorenzo/B-6239-2008; d'Annunzio, Giuseppe/J-7368-2018; Perri, Katia/AAC-2247-2020; Lugani, Francesca/J-7183-2016	Aloi, Concetta/0000-0002-5937-0781; Salina, Alessandro/0000-0003-0133-6705; Ghiggeri, Gian Marco/0000-0003-3659-9062; Pasquali, Lorenzo/0000-0003-2423-1826; d'Annunzio, Giuseppe/0000-0002-1856-2277; Lugani, Francesca/0000-0002-4189-8561				Awata T, 2000, BIOCHEM BIOPH RES CO, V268, P612, DOI 10.1006/bbrc.2000.2169; BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6; Chaussenot A, 2011, ANN NEUROL, V69, P501, DOI 10.1002/ana.22160; Colosimo A, 2003, HUM MUTAT, V21, P622, DOI 10.1002/humu.10215; Cryns K, 2003, HUM MUTAT, V22, P275, DOI 10.1002/humu.10258; D'Annunzio G, 2008, DIABETES CARE, V31, P1743, DOI 10.2337/dc08-0178; Domenech E, 2004, PRENATAL DIAG, V24, P787, DOI 10.1002/pd.982; Domenech E, 2002, EUR J HUM GENET, V10, P421, DOI 10.1038/sj.ejhg.5200823; El-Shanti H, 2000, AM J HUM GENET, V66, P1229, DOI 10.1086/302858; Fawcett KA, 2010, DIABETES, V59, P741, DOI 10.2337/db09-0920; Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678; Gasparin MRR, 2009, EUR J ENDOCRINOL, V160, P309, DOI 10.1530/EJE-08-0698; Genis D, 1997, ACTA NEUROPATHOL, V93, P426, DOI 10.1007/s004010050635; Giuliano Fabienne, 2005, Hum Mutat, V25, P99, DOI 10.1002/humu.9300; Gomez-Zaera M, 2001, MOL GENET METAB, V72, P72, DOI 10.1006/mgme.2000.3107; Hardy C, 1999, AM J HUM GENET, V65, P1279, DOI 10.1086/302609; Hofmann S, 2003, HUM MOL GENET, V12, P2003, DOI 10.1093/hmg/ddg214; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Kadayifci A, 2001, Acta Medica (Hradec Kralove), V44, P115; Khanim F, 2001, HUM MUTAT, V17, P357, DOI 10.1002/humu.1110.abs; KINSLEY BT, 1995, DIABETES CARE, V18, P1566, DOI 10.2337/diacare.18.12.1566; Kumar S, 2010, PEDIATR DIABETES, V11, P28, DOI 10.1111/j.1399-5448.2009.00518.x; LORINI R, 1992, AUTOIMMUNITY, V11, P255, DOI 10.3109/08916939209035163; Maghnie M, 2003, NEW ENGL J MED, V343, P998; Medlej R, 2004, J CLIN ENDOCR METAB, V89, P1656, DOI 10.1210/jc.2002-030015; Megighian D, 2004, INT J PEDIATR OTORHI, V68, P243, DOI 10.1016/j.ijporl.2003.10.012; Naserke HE, 1998, DIABETOLOGIA, V41, P681, DOI 10.1007/s001250050968; Osman AA, 2003, J BIOL CHEM, V278, P52755, DOI 10.1074/jbc.M310331200; Philbrook C, 2005, EXP GERONTOL, V40, P671, DOI 10.1016/j.exger.2005.06.008; Piccoli GB, 2003, NEPHROL DIAL TRANSPL, V18, P206, DOI 10.1093/ndt/18.1.206; Riggs AC, 2005, DIABETOLOGIA, V48, P2313, DOI 10.1007/s00125-005-1947-4; Rigoli L, 2011, CLIN GENET, V79, P103, DOI 10.1111/j.1399-0004.2010.01522.x; Sequeira A, 2003, AM J MED GENET B, V119B, P108, DOI 10.1002/ajmg.b.20011; Simsek E, 2003, ACTA PAEDIATR, V92, P55; Smith CJA, 2004, DIABETES CARE, V27, P2003, DOI 10.2337/diacare.27.8.2003; Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021; Takeda K, 2001, HUM MOL GENET, V10, P477, DOI 10.1093/hmg/10.5.477; Tekgul S, 1999, J UROLOGY, V161, P616, DOI 10.1016/S0022-5347(01)61982-7; Tessa A, 2001, Hum Mutat, V17, P348, DOI 10.1002/humu.32; Tranebjaerg L, 2009, GENE REV, V24; Waschbisch A, 2011, J NEUROL SCI, V300, P191, DOI 10.1016/j.jns.2010.08.044; Wolfram DJ, 1938, P MAYO CLIN, V13, P715; Yamamoto H, 2006, EXP EYE RES, V83, P1303, DOI 10.1016/j.exer.2006.06.010; Zalloua P, 2008, HUM MOL GENET, V17, P4012, DOI 10.1093/hmg/ddn304	44	42	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29150	10.1371/journal.pone.0029150	http://dx.doi.org/10.1371/journal.pone.0029150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238590	Green Published, Green Submitted, gold			2022-12-27	WOS:000301070200017
J	Qiu, DJ; Huang, LM; Liu, S; Lin, SJ				Qiu, Dajun; Huang, Liangmin; Liu, Sheng; Lin, Senjie			Nuclear, Mitochondrial and Plastid Gene Phylogenies of Dinophysis miles (Dinophyceae): Evidence of Variable Types of Chloroplasts	PLOS ONE			English	Article							REAL-TIME PCR; HIGH-LEVEL; MOLECULAR EVIDENCE; MYRIONECTA-RUBRA; DINOFLAGELLATE; DIVERSITY; CELL; KLEPTOPLASTIDY; MORPHOLOGY; ACUMINATA	The Dinophysis genus is an ecologically and evolutionarily important group of marine dinoflagellates, yet their molecular phylogenetic positions and ecological characteristics such as trophic modes remain poorly understood. Here, a population of Dinophysis miles var. indica was sampled from South China Sea in March 2010. Nuclear ribosomal RNA gene (rDNA) SSU, ITS1-5.8S-ITS2 and LSU, mitochondrial genes encoding cytochrome B (cob) and cytochrome C oxidase subunit I (cox1), and plastid rDNA SSU were PCR amplified and sequenced. Phylogenetic analyses based on cob, cox1, and the nuclear rRNA regions showed that D. miles was closely related to D. tripos and D. caudata while distinct from D. acuminata. Along with morphology the LSU and ITS1-5.8S-ITS2 molecular data confirmed that this population was D. miles var. indica. Furthermore, the result demonstrated that ITS1-5.8S-ITS2 fragment was the most effective region to distinguish D. miles from other Dinophysis species. Three distinct types of plastid rDNA sequences were detected, belonging to plastids of a cryptophyte, a haptophyte, and a cyanobacterium, respectively. This is the first documentation of three photosynthetic entities associated with a Dinophysis species. While the cyanobacterial sequence likely represented an ectosymbiont of the D. miles cells, the detection of the cryptophyte and haptophyte plastid sequences indicates that the natural assemblage of D. miles likely retain more than one type of plastids from its prey algae for temporary use in photosynthesis. The result, together with recent findings of plastid types in other Dinophysis species, suggests that more systematic research is required to understand the complex nutritional physiology of this genus of dinoflagellates.	[Qiu, Dajun; Huang, Liangmin; Liu, Sheng; Lin, Senjie] Chinese Acad Sci, S China Sea Inst Oceanol, Key Lab Marine Bioresources Sustainable Utilizat, Guangzhou, Guangdong, Peoples R China; [Qiu, Dajun; Liu, Sheng] Chinese Acad Sci, Trop Marine Biol Res Stn Hainan, Sanya, Peoples R China; [Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Connecticut	Qiu, DJ (corresponding author), Chinese Acad Sci, S China Sea Inst Oceanol, Key Lab Marine Bioresources Sustainable Utilizat, Guangzhou, Guangdong, Peoples R China.	senjie.lin@uconn.edu	Qiu, Dajun/D-3045-2017; Lin, Senjie/A-7466-2011; Guo, chentao/G-7320-2016; Qiu, Dajun/I-5944-2019; zhang, yaqun/J-8478-2014	Qiu, Dajun/0000-0003-2315-3432; Qiu, Dajun/0000-0003-2315-3432; 	National Science Foundation of China [41129001, 40828006, 41006067, 41076096]; Chinese Academy of Sciences/SAFEA [KZCX2-YW-T001]; US National Science Foundation [EF - 0629624]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences/SAFEA(Chinese Academy of Sciences); US National Science Foundation(National Science Foundation (NSF))	This research is supported by the National Science Foundation of China-Overseas Collaboration Fund (41129001, 40828006) (http://www.nsfc.gov.cn/), Chinese Academy of Sciences/SAFEA International Partnership Program for Creative Research Teams grants KZCX2-YW-T001 (http://www.cas.cn/), the National Science Foundation of China (41006067, 41076096) (http://www.nsfc.gov.cn/) and the US National Science Foundation "Assembly of a Tree of Life" grant EF - 0629624 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	CARPENTER EJ, 1995, EUR J PHYCOL, V30, P1, DOI 10.1080/09670269500650751; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Escalera L, 2011, PROTIST, V162, P304, DOI 10.1016/j.protis.2010.07.003; Fensome RA, 1993, MICROPALEONTOLOGY SP, V7, P355; Foster RA, 2006, J PHYCOL, V42, P243, DOI 10.1111/j.1529-8817.2006.00185.x; Garcia-Cuetos L, 2009, HARMFUL ALGAE, V8, P196; Gast RJ, 2007, ENVIRON MICROBIOL, V9, P39, DOI 10.1111/j.1462-2920.2006.01109.x; Gomez F, 2007, REV BIOL TROP, V55, P459; Hackett JD, 2003, J PHYCOL, V39, P440, DOI 10.1046/j.1529-8817.2003.02100.x; Hackett JD, 2009, HARMFUL ALGAE, V8, P873, DOI 10.1016/j.hal.2009.04.004; Handy SM, 2008, HARMFUL ALGAE, V7, P599, DOI 10.1016/j.hal.2007.12.018; Handy SM, 2009, J PHYCOL, V45, P1163, DOI 10.1111/j.1529-8817.2009.00738.x; Janson S, 2004, ENVIRON MICROBIOL, V6, P1102, DOI 10.1111/j.1462-2920.2004.00646.x; Jensen MH, 2009, J PHYCOL, V45, P1136, DOI 10.1111/j.1529-8817.2009.00741.x; Kataoka T, 2009, DEEP-SEA RES PT II, V56, P2779, DOI 10.1016/j.dsr2.2009.06.013; Koike K, 2005, PROTIST, V156, P225, DOI 10.1016/j.protis.2005.04.002; Larsen J., 1992, Fiches d'Identification du Plancton, P1; LESSARD EJ, 1986, J PLANKTON RES, V8, P1209, DOI 10.1093/plankt/8.6.1209; Lin SJ, 2010, P NATL ACAD SCI USA, V107, P20033, DOI 10.1073/pnas.1007246107; Lin S, 2009, APPL ENVIRON MICROB, V75, P1279, DOI 10.1128/AEM.01578-08; Lin Y, 1993, DINOFLAGELLATES S CH, P30; Litaker RW, 2007, J PHYCOL, V43, P344, DOI 10.1111/j.1529-8817.2007.00320.x; LUCAS IAN, 1991, OPHELIA, V33, P213, DOI 10.1080/00785326.1991.10429712; Marasigan AN, 2001, FISHERIES SCI, V67, P994, DOI 10.1046/j.1444-2906.2001.00353.x; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Minnhagen S, 2006, FEMS MICROBIOL ECOL, V57, P47, DOI 10.1111/j.1574-6941.2006.00096.x; MOREYGAINES G, 1982, PHYCOLOGIA, V21, P154, DOI 10.2216/i0031-8884-21-2-154.1; Muhling M, 2008, ISME J, V2, P379, DOI 10.1038/ismej.2007.97; Nagai S, 2008, J PHYCOL, V44, P909, DOI 10.1111/j.1529-8817.2008.00544.x; Nishitani G, 2008, AQUAT MICROB ECOL, V52, P209, DOI 10.3354/ame01233; Nishitani G, 2010, APPL ENVIRON MICROB, V76, P2791, DOI 10.1128/AEM.02566-09; Park MG, 2008, J PHYCOL, V44, P1154, DOI 10.1111/j.1529-8817.2008.00579.x; Park MG, 2006, AQUAT MICROB ECOL, V45, P101, DOI 10.3354/ame045101; Raho N, 2008, HARMFUL ALGAE, V7, P839, DOI 10.1016/j.hal.2008.04.006; Steidinger Karen A., 1997, P387, DOI 10.1016/B978-012693018-4/50005-7; Takahashi Y, 2005, MAR BIOTECHNOL, V7, P95, DOI 10.1007/s10126-004-0482-5; Takishita K, 2002, PROTIST, V153, P293, DOI 10.1078/1434-4610-00106; Tarangkoon W, 2007, J PHYCOL, V43, P38; Taylor FJR, 2008, BIODIVERS CONSERV, V17, P407, DOI 10.1007/s10531-007-9258-3; TAYLOR FJR, 1973, J PHYCOL, V9, P1; TAYLOR FJR, 1980, BIOSYSTEMS, V13, P65, DOI 10.1016/0303-2647(80)90006-4; Wisecaver JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-366; Wood EJF, 1963, DINOFLAGELLATES AUST, P193; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Yamaguchi A, 2005, PHYCOL RES, V53, P30; Zhang H, 2005, APPL ENVIRON MICROB, V71, P7053, DOI 10.1128/AEM.71.11.7053-7063.2005; Zhang H, 2002, APPL ENVIRON MICROB, V68, P989, DOI 10.1128/AEM.68.2.989-994.2002; Zhang H, 2008, APPL ENVIRON MICROB, V74, P1546, DOI 10.1128/AEM.02103-07	48	26	27	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29398	10.1371/journal.pone.0029398	http://dx.doi.org/10.1371/journal.pone.0029398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242118	Green Published, Green Submitted, gold			2022-12-27	WOS:000300677000030
J	Um, JY; Rim, HK; Kim, SJ; Kim, HL; Hong, SH				Um, Jae-Young; Rim, Hong-Kun; Kim, Su-Jin; Kim, Hye-Lin; Hong, Seung-Heon			Functional Polymorphism of IL-1 Alpha and Its Potential Role in Obesity in Humans and Mice	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INTERLEUKIN-1 RECEPTOR ANTAGONIST; ADIPOSE-TISSUE; INSULIN-RESISTANCE; GENE POLYMORPHISM; ALZHEIMERS-DISEASE; METABOLIC SYNDROME; 3T3-L1 ADIPOCYTES; PRIMARY CULTURES; EXPRESSION	Proinflammatory cytokines secreted from adipose tissue contribute to the morbidity associated with obesity. IL-1 alpha is one of the proinflammatory cytokines; however, it has not been clarified whether IL-1 alpha may also cause obesity. In this study, we investigated whether polymorphisms in IL-1 alpha contribute to human obesity. A total of 260 obese subjects were genotyped for IL-1 alpha C-889T (rs1800587) and IL-1 alpha G+4845T (rs17561). Analyses of genotype distributions revealed that both IL-1 alpha polymorphisms C-889T (rs1800587) and G+4845T (rs17561) were associated with an increase in body mass index in obese healthy women. In addition, the effect of rs1800587 on the transcriptional activity of IL-1 alpha was explored in pre-adipocyte 3T3-L1 cells. Significant difference was found between the rs1800587 polymorphism in the regulatory region of the IL-1 alpha gene and transcriptional activity. We extended these observations in vivo to a high-fat diet-induced obese mouse model and in vitro to pre-adipocyte 3T3-L1 cells. IL-1 alpha levels were dramatically augmented in obese mice, and triglyceride was increased 12 hours after IL-1 alpha injection. Taken together, IL-1 alpha treatment regulated the differentiation of preadipocytes. IL-1 alpha C-889T (rs1800587) is a functional polymorphism of IL-1 alpha associated with obesity. IL-1 alpha may have a critical function in the development of obesity.	[Um, Jae-Young; Rim, Hong-Kun; Kim, Hye-Lin] Kyung Hee Univ, Inst Oriental Med, Coll Oriental Med, Dept Pharmacol, Seoul, South Korea; [Kim, Su-Jin] Daegu Hanny Univ, Dept Cosmeceut Sci, Yugok Dong, Kyungsan, South Korea; [Hong, Seung-Heon] Wonkwang Univ, Coll Pharm, Dept Oriental Pharm, Iksan, Jeonbuk, South Korea	Korea Institute of Oriental Medicine (KIOM); Kyung Hee University; Wonkwang University	Um, JY (corresponding author), Kyung Hee Univ, Inst Oriental Med, Coll Oriental Med, Dept Pharmacol, Seoul, South Korea.	jyum@khu.ac.kr	Um, Jae-Young/G-8787-2013		National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0022450]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0022450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastard JP, 1999, CIRCULATION, V99, P2221; BEVILACQUA MP, 1984, J EXP MED, V160, P618, DOI 10.1084/jem.160.2.618; Braddock M, 2004, NAT REV DRUG DISCOV, V3, P1, DOI 10.1038/nrd1342; Chung S, 2006, ENDOCRINOLOGY, V147, P5340, DOI 10.1210/en.2006-0536; Di Renzo L, 2007, PHARMACOL RES, V55, P131, DOI 10.1016/j.phrs.2006.11.002; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; DINARELLO CA, 1993, NEW ENGL J MED, V328, P106; Dominici R, 2002, IMMUNOGENETICS, V54, P82, DOI 10.1007/s00251-002-0445-9; Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772; Fantuzzi G, 1996, J IMMUNOL, V157, P291; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foster CB, 2000, BLOOD, V96, P2562; Ghanim H, 2004, CIRCULATION, V110, P1564, DOI 10.1161/01.CIR.0000142055.53122.FA; He JY, 2006, MOL ENDOCRINOL, V20, P114, DOI 10.1210/me.2005-0107; Janik JE, 1997, J CLIN ENDOCR METAB, V82, P3084, DOI 10.1210/jc.82.9.3084; Juge-Aubry CE, 2003, DIABETES, V52, P1104, DOI 10.2337/diabetes.52.5.1104; Kamari Y, 2007, ATHEROSCLEROSIS, V195, P31, DOI 10.1016/j.atherosclerosis.2006.11.026; Kawaguchi Y, 2007, IMMUNOGENETICS, V59, P441, DOI 10.1007/s00251-007-0213-y; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; LENNARD A, 1992, CYTOKINE, V4, P83, DOI 10.1016/1043-4666(92)90041-O; LIBBY P, 1986, J CLIN INVEST, V78, P1432, DOI 10.1172/JCI112732; MCDOWELL TL, 1995, ARTHRITIS RHEUM, V38, P221, DOI 10.1002/art.1780380210; Mendall MA, 1996, BRIT MED J, V312, P1061; Miranda PJ, 2005, AM HEART J, V149, P33, DOI 10.1016/j.ahj.2004.07.013; Misra A, 2004, NUTRITION, V20, P478, DOI 10.1016/j.nut.2004.01.019; Moreira PR, 2007, J PERIODONTAL RES, V42, P23, DOI 10.1111/j.1600-0765.2006.00910.x; Mracek T, 2004, CYTOKINE, V26, P9, DOI 10.1016/j.cyto.2003.12.001; Ouchi N, 2007, CLIN CHIM ACTA, V380, P24, DOI 10.1016/j.cca.2007.01.026; PRIEUR AM, 1987, LANCET, V2, P1240; Rainero I, 2004, NEUROBIOL AGING, V25, P1293, DOI 10.1016/j.neurobiolaging.2004.02.011; Raymond NC, 2000, INT J EAT DISORDER, V28, P293, DOI 10.1002/1098-108X(200011)28:3&lt;293::AID-EAT6&gt;3.0.CO;2-F; Salmenniemi U, 2004, CIRCULATION, V110, P3842, DOI 10.1161/01.CIR.0000150391.38660.9B; Sciacca FL, 2003, NEUROBIOL AGING, V24, P927, DOI 10.1016/S0197-4580(03)00011-3; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; SWEETING HN, 2007, NUTR J, V6, DOI DOI 10.1186/1475-2891-6-32; Tal H, 2002, J CLIN PERIODONTOL, V29, P882, DOI 10.1034/j.1600-051X.2002.291002.x; Um JY, 2004, CLIN CHEM, V50, P647, DOI 10.1373/clinchem.2003.025858; Uno T, 2008, HORM METAB RES, V40, P8, DOI 10.1055/s-2007-1004515; Wei X, 2007, LIFE SCI, V80, P1152, DOI 10.1016/j.lfs.2006.12.011; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wilasrusmee C, 2002, J SURG RES, V104, P131, DOI 10.1006/jsre.2002.6429; YAP SH, 1991, BIOCHIM BIOPHYS ACTA, V1091, P405, DOI 10.1016/0167-4889(91)90207-E; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	43	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29524	10.1371/journal.pone.0029524	http://dx.doi.org/10.1371/journal.pone.0029524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216303	Green Published, gold, Green Submitted			2022-12-27	WOS:000300674900041
J	Whelan, AO; Villarreal-Ramos, B; Vordermeier, HM; Hogarth, PJ				Whelan, Adam O.; Villarreal-Ramos, Bernardo; Vordermeier, H. Martin; Hogarth, Philip J.			Development of an Antibody to Bovine IL-2 Reveals Multifunctional CD4 T-EM Cells in Cattle Naturally Infected with Bovine Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; GAMMA-INTERFERON; POLYFUNCTIONAL CD4(+); BCG VACCINATION; RESPONSES; MEMORY; EXPRESSION; PROTECTION; CORRELATE; INTERLEUKIN-2	Gaining a better understanding of the T cell mechanisms underlying natural immunity to bovine tuberculosis would help to identify immune correlates of disease progression and facilitate the rational design of improved vaccine and diagnostic strategies. CD4 T cells play an established central role in immunity to TB, and recent interest has focussed on the potential role of multifunctional CD4 T cells expressing IFN-gamma, IL-2 and TNF-alpha. Until now, it has not been possible to assess the contribution of these multifunctional CD4 T cells in cattle due to the lack of reagents to detect bovine IL-2 (bIL-2). Using recombinant phage display technology, we have identified an antibody that recognises biologically active bIL-2. Using this antibody, we have developed a polychromatic flow cytometric staining panel that has allowed the investigation of multifunctional CD4 T-cells responses in cattle naturally infected with M. bovis. Assessment of the frequency of antigen specific CD4 T cell subsets reveals a dominant IFN-gamma(+) IL-2(+)TNF-alpha(+) and IFN-gamma(+) TNF-alpha(+) response in naturally infected cattle. These multifunctional CD4 T cells express a CD44(hi)CD45RO(+)CD62L(lo) T-effector memory (T-EM) phenotype and display higher cytokine median fluorescence intensities than single cytokine producers, consistent with an enhanced 'quality of response' as reported for multifunctional cells in human and murine systems. Through our development of these novel immunological bovine tools, we provide the first description of multifunctional TEM cells in cattle. Application of these tools will improve our understanding of protective immunity in bovine TB and allow more direct comparisons of the complex T cell mediated immune responses between murine models, human clinical studies and bovine TB models in the future.	[Whelan, Adam O.; Villarreal-Ramos, Bernardo; Vordermeier, H. Martin; Hogarth, Philip J.] Anim Hlth & Vet Labs Agcy, Res Grp, Addlestone, Surrey, England	Veterinary Laboratories Agency	Whelan, AO (corresponding author), Anim Hlth & Vet Labs Agcy, Res Grp, Addlestone, Surrey, England.	Philip.hogarth@ahvla.gsi.gov.uk	Whelan, Adam O/C-9497-2011; Hogarth, Philip/C-6085-2011; Vordermeier, H Martin/C-6936-2011	Hogarth, Philip/0000-0002-6343-7846; 	Department for Environment, Food and Rural Affairs, UK	Department for Environment, Food and Rural Affairs, UK(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the Department for Environment, Food and Rural Affairs (Defra; www.defra.gov), UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Ashford DA, 2001, REV SCI TECH OIE, V20, P325, DOI 10.20506/rst.20.1.1266; Bembridge GP, 1995, IMMUNOLOGY, V86, P537; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; CERRETTI DP, 1986, P NATL ACAD SCI USA, V83, P3223, DOI 10.1073/pnas.83.10.3223; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Endsley JJ, 2007, VACCINE, V25, P8384, DOI 10.1016/j.vaccine.2007.10.011; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Kaveh DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021566; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Krebs J., 1997, PB3423 HMSO; Kwong LS, 2010, VET IMMUNOL IMMUNOP, V135, P320, DOI 10.1016/j.vetimm.2010.01.001; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Magalhaes I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003790; Ng KH, 1997, VET IMMUNOL IMMUNOP, V57, P59, DOI 10.1016/S0165-2427(96)05760-1; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Schiott A, 2004, IMMUNOLOGY, V113, P363, DOI 10.1111/j.1365-2567.2004.01974.x; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sester U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017813; Sopp P, 2001, VET IMMUNOL IMMUNOP, V81, P85, DOI 10.1016/S0165-2427(01)00334-8; Sutherland JS, 2010, J IMMUNOL, V184, P6537, DOI 10.4049/jimmunol.1000399; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Waters WR, 2003, INFECT IMMUN, V71, P317, DOI 10.1128/IAI.71.1.317-326.2003; WEINBERG AD, 1988, J IMMUNOL, V141, P1174; Weynants V, 1998, VET IMMUNOL IMMUNOP, V66, P309, DOI 10.1016/S0165-2427(98)00205-0; WOOD PR, 1990, VET IMMUNOL IMMUNOP, V25, P37, DOI 10.1016/0165-2427(90)90108-5	34	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29194	10.1371/journal.pone.0029194	http://dx.doi.org/10.1371/journal.pone.0029194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216206	gold, Green Published, Green Submitted			2022-12-27	WOS:000299684700037
J	Dusek, P; Jech, R; Sieger, T; Vymazal, J; Ruzicka, E; Wackermann, J; Mueller, K				Dusek, Petr; Jech, Robert; Sieger, Tomas; Vymazal, Josef; Ruzicka, Evzen; Wackermann, Jiri; Mueller, Karsten			Abnormal Activity in the Precuneus during Time Perception in Parkinson's Disease: An fMRI Study	PLOS ONE			English	Article							DEEP-BRAIN-STIMULATION; DEFAULT-MODE; REPRODUCTION; DYSFUNCTION; MEMORY; INTERVALS; DOPAMINE; NETWORK; DISCRIMINATION; REPRESENTATION	Background: Parkinson's disease (PD) patients are deficient in time estimation. This deficit improves after dopamine (DA) treatment and it has been associated with decreased internal timekeeper speed, disruption of executive function and memory retrieval dysfunction. Methodology/Findings: The aim of the present study was to explore the neurophysiologic correlates of this deficit. We performed functional magnetic resonance imaging on twelve PD patients while they were performing a time reproduction task (TRT). The TRT consisted of an encoding phase (during which visual stimuli of durations from 5s to 16.6s, varied at 8 levels were presented) and a reproduction phase (during which interval durations were reproduced by a button pressing). Patients were scanned twice, once while on their DA medication (ON condition) and once after medication withdrawal (OFF condition). Differences in Blood-Oxygenation-Level-Dependent (BOLD) signal in ON and OFF conditions were evaluated. The time course of activation in the brain areas with different BOLD signal was plotted. There were no significant differences in the behavioral results, but a trend toward overestimation of intervals <= 11.9s and underestimation of intervals >= 14.1s in the OFF condition (p < 0.088). During the reproduction phase, higher activation in the precuneus was found in the ON condition (p < 0.05 corrected). Time course was plotted separately for long (>= 14.1s) and short (<= 11.9s) intervals. Results showed that there was a significant difference only in long intervals, when activity gradually decreased in the OFF, but remained stable in the ON condition. This difference in precuneus activation was not found during random button presses in a control task. Conclusions/Significance: Our results show that differences in precuneus activation during retrieval of a remembered duration may underlie some aspects of time perception deficit in PD patients. We suggest that DA medication may allow compensatory activation in the precuneus, which results in a more accurate retrieval of remembered interval duration.	[Dusek, Petr; Jech, Robert; Sieger, Tomas; Ruzicka, Evzen] Charles Univ Prague, Dept Neurol, Fac Med 1, Prague, Czech Republic; [Dusek, Petr; Jech, Robert; Sieger, Tomas; Ruzicka, Evzen] Charles Univ Prague, Ctr Clin Neurosci, Fac Med 1, Prague, Czech Republic; [Dusek, Petr; Jech, Robert; Sieger, Tomas; Ruzicka, Evzen] Gen Univ Hosp, Prague, Czech Republic; [Sieger, Tomas] Czech Tech Univ, Dept Cybernet, Fac Elect Engn, CR-16635 Prague, Czech Republic; [Vymazal, Josef] Na Homolce Hosp, Dept Radiol, Prague, Czech Republic; [Wackermann, Jiri] Inst Frontier Areas Psychol & Mental Hlth, Dept Empir & Analyt Psychophys, Freiburg, Germany; [Mueller, Karsten] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany	Charles University Prague; Charles University Prague; General University Hospital Prague; Czech Technical University Prague; Na Homolce Hospital; Max Planck Society	Dusek, P (corresponding author), Charles Univ Prague, Dept Neurol, Fac Med 1, Prague, Czech Republic.	pdusek@gmail.com	Dusek, Petr/F-9084-2017; Sieger, Tomas/AAD-9342-2019; Jech, Robert/HHY-7342-2022; Růžička, Evžen/F-9299-2017	Dusek, Petr/0000-0003-4877-9642; Jech, Robert/0000-0002-9732-8947; Růžička, Evžen/0000-0002-4893-9661; Wackermann, Jiri/0000-0001-5149-4248; Sieger, Tomas/0000-0003-4960-1934	Czech Science Foundation [309/09/1145]; Czech Ministry of Health [IGA MZ CR NT12282-5/2011]; Czech Ministry of Education [0021620849]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Health(Ministry of Health, Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Czech Science Foundation: grant project 309/09/1145, the Czech Ministry of Health: IGA MZ CR NT12282-5/2011 and by the Czech Ministry of Education: research project MSM 0021620849. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyelan M, 2008, J NEUROSCI, V28, P10687, DOI 10.1523/JNEUROSCI.2933-08.2008; ARTIEDA J, 1992, BRAIN, V115, P199, DOI 10.1093/brain/115.1.199; Asanuma K, 2006, BRAIN, V129, P2667, DOI 10.1093/brain/awl162; Beste C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001263; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bueti D, 2010, PERCEPTION, V39, P81, DOI 10.1068/p6405; Carbon M, 2003, CURR OPIN NEUROL, V16, P475, DOI 10.1097/01.wco.0000084225.82329.3c; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cerasa A, 2006, BRAIN RES BULL, V71, P259, DOI 10.1016/j.brainresbull.2006.09.014; Choi JK, 2006, NEUROIMAGE, V30, P700, DOI 10.1016/j.neuroimage.2005.10.029; Coslett HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010324; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Delaveau P, 2010, EUR NEUROPSYCHOPHARM, V20, P784, DOI 10.1016/j.euroneuro.2010.07.001; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Elsinger CL, 2003, J INT NEUROPSYCH SOC, V9, P1088, DOI 10.1017/S1355617703970123; Evans A C, 1992, Neuroimage, V1, P43, DOI 10.1016/1053-8119(92)90006-9; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; Goerendt IK, 2006, J NEURAL TRANSM, V113, P75, DOI 10.1007/s00702-005-0305-5; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Harrington DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017461; Harrington DL, 2004, COGNITIVE BRAIN RES, V21, P193, DOI 10.1016/j.cogbrainres.2004.01.010; Harrington DL, 1998, J NEUROSCI, V18, P1085; Huang CR, 2007, BRAIN, V130, P1834, DOI 10.1093/brain/awm086; Huang CR, 2007, NEUROIMAGE, V34, P714, DOI 10.1016/j.neuroimage.2006.09.003; Jahanshahi M, 2010, BRAIN, V133, P727, DOI 10.1093/brain/awq012; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Jech R, 2005, NEUROREPORT, V16, P1467, DOI 10.1097/01.wnr.0000175616.00936.1c; Jones CRG, 2008, BRAIN COGNITION, V68, P30, DOI 10.1016/j.bandc.2008.02.121; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Kineses ZT, 2008, NEUROIMAGE, V39, P1950, DOI 10.1016/j.neuroimage.2007.09.070; Koch G, 2005, NEUROPSYCHOLOGIA, V43, P1163, DOI 10.1016/j.neuropsychologia.2004.11.017; Koch G, 2004, NEUROLOGY, V63, P2405, DOI 10.1212/01.WNL.0000147336.19972.82; Koch G, 2004, NEUROREPORT, V15, P1071, DOI 10.1097/00001756-200404290-00028; Koch G, 2008, NEUROPSYCHOLOGIA, V46, P1305, DOI 10.1016/j.neuropsychologia.2007.12.005; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Malapani C, 2002, J COGNITIVE NEUROSCI, V14, P311, DOI 10.1162/089892902317236920; Malapani C, 1998, J COGNITIVE NEUROSCI, V10, P316, DOI 10.1162/089892998562762; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Merchant H, 2008, EXP BRAIN RES, V184, P233, DOI 10.1007/s00221-007-1097-7; PASTOR MA, 1992, BRAIN, V115, P211, DOI 10.1093/brain/115.1.211; Pouthas V, 2004, ACTA NEUROBIOL EXP, V64, P367; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Riesen JM, 2001, J NEUROL, V248, P27, DOI 10.1007/s004150170266; Rubia K, 2004, ACTA NEUROBIOL EXP, V64, P329; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; SCHNIDER A, 1995, BRAIN, V118, P485, DOI 10.1093/brain/118.2.485; Shea-Brown E, 2006, BRAIN RES, V1070, P189, DOI 10.1016/j.brainres.2005.10.070; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Stokes PRA, 2011, NEUROPSYCHOPHARMACOL, V36, P763, DOI 10.1038/npp.2010.210; Sysoeva OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012650; Talairach J., 1998, COPLANAR STEREOTAXIC; Tomasi D., 2009, PLOS ONE, V4; Turner R, 1998, EXP BRAIN RES, V123, P5, DOI 10.1007/s002210050538; van Eimeren T, 2009, ARCH NEUROL-CHICAGO, V66, P877, DOI 10.1001/archneurol.2009.97; van Wassenhove V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001437; von Vierodt K, 1868, ZEITSINN NACH VERSUC; Wackermann J, 2006, J THEOR BIOL, V239, P482, DOI 10.1016/j.jtbi.2005.08.024; Wackermann J, 2007, SPAN J PSYCHOL, V10, P20, DOI 10.1017/S1138741600006284; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Wittmann M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.002.2010; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047	68	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29635	10.1371/journal.pone.0029635	http://dx.doi.org/10.1371/journal.pone.0029635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238630	gold, Green Published, Green Submitted			2022-12-27	WOS:000301188800022
J	Kluiver, J; Gibcus, JH; Hettinga, C; Adema, A; Richter, MKS; Halsema, N; Slezak-Prochazka, I; Ding, Y; Kroesen, BJ; van den Berg, A				Kluiver, Joost; Gibcus, Johan H.; Hettinga, Chris; Adema, Annelies; Richter, Mareike K. S.; Halsema, Nancy; Slezak-Prochazka, Izabella; Ding, Ye; Kroesen, Bart-Jan; van den Berg, Anke			Rapid Generation of MicroRNA Sponges for MicroRNA Inhibition	PLOS ONE			English	Article							B-CELL LYMPHOMAS; TRANSGENE EXPRESSION; ENDOGENOUS MICRORNA; MAMMALIAN-CELLS; IN-VIVO; SUPPRESSION; ANTAGOMIRS; VECTORS; HODGKIN; MIR-19	MicroRNA (miRNA) sponges are transcripts with repeated miRNA antisense sequences that can sequester miRNAs from endogenous targets. MiRNA sponges are valuable tools for miRNA loss-of-function studies both in vitro and in vivo. We developed a fast and flexible method to generate miRNA sponges and tested their efficiency in various assays. Using a single directional ligation reaction we generated sponges with 10 or more miRNA binding sites. Luciferase and AGO2-immuno precipitation (IP) assays confirmed effective binding of the miRNAs to the sponges. Using a GFP competition assay we showed that miR-19 sponges with central mismatches in the miRNA binding sites are efficient miRNA inhibitors while sponges with perfect antisense binding sites are not. Quantification of miRNA sponge levels suggests that this is at least in part due to degradation of the perfect antisense sponge transcripts. Finally, we provide evidence that combined inhibition of miRNAs of the miR-17 similar to 92 cluster results in a more effective growth inhibition as compared to inhibition of individual miRNAs. In conclusion, we describe and validate a method to rapidly generate miRNA sponges for miRNA loss-of-function studies.	[Kluiver, Joost; Gibcus, Johan H.; Hettinga, Chris; Adema, Annelies; Richter, Mareike K. S.; Halsema, Nancy; Slezak-Prochazka, Izabella; Kroesen, Bart-Jan; van den Berg, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands; [Ding, Ye] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA	University of Groningen; State University of New York (SUNY) System; Wadsworth Center	Kluiver, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands.	j.l.kluiver@umcg.nl	van den Berg, Anke/H-1718-2011; Kluiver, Joost/G-6406-2014; Gibcus, Johan/F-3550-2012; Slezak-Prochazka, Izabella/F-7674-2019	van den Berg, Anke/0000-0002-8894-2638; Kluiver, Joost/0000-0001-7650-2937; Gibcus, Johan/0000-0002-0851-7560; Slezak-Prochazka, Izabella/0000-0002-0707-2213	Dutch Cancer Society [KWF] [RUG 2006-2634, RUG 2009-4279]; Vanderes Foundation [235]; National Science Foundation [NSF] [0650991]	Dutch Cancer Society [KWF](KWF Kankerbestrijding); Vanderes Foundation; National Science Foundation [NSF](National Science Foundation (NSF))	This work was supported by the Dutch Cancer Society [KWF RUG 2006-2634 and RUG 2009-4279 to B.J.K. and A.v.d.B.], the Vanderes Foundation [VanderEs project 235 to J.K.] and in part by the National Science Foundation [NSF 0650991 to Y.D.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Gibcus JH, 2009, NEOPLASIA, V11, P167, DOI 10.1593/neo.08980; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Kelly EJ, 2008, NAT MED, V14, P1278, DOI 10.1038/nm.1776; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Loya CM, 2009, NAT METHODS, V6, P897, DOI 10.1038/nmeth.1402; Mavrakis KJ, 2010, NAT CELL BIOL, V12, P372, DOI 10.1038/ncb2037; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Papapetrou EP, 2010, STEM CELLS, V28, P287, DOI 10.1002/stem.257; Park CY, 2010, HUM MOL GENET, V19, pR169, DOI 10.1093/hmg/ddq367; Scherr M, 2010, METHODS MOL BIOL, V614, P175, DOI 10.1007/978-1-60761-533-0_12; SIMCOX TG, 1995, GENE, V155, P129, DOI 10.1016/0378-1119(94)00711-Z; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Tan LP, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp715	32	98	113	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29275	10.1371/journal.pone.0029275	http://dx.doi.org/10.1371/journal.pone.0029275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238599	Green Submitted, Green Published, gold			2022-12-27	WOS:000301188800010
J	Menard, C; Quirion, R				Menard, Caroline; Quirion, Remi			Successful Cognitive Aging in Rats: A Role for mGluR5 Glutamate Receptors, Homer 1 Proteins and Downstream Signaling Pathways	PLOS ONE			English	Article							LONG-TERM DEPRESSION; METABOTROPIC GLUTAMATE-RECEPTOR-5; SPATIAL MEMORY; AGED RATS; MAMMALIAN TARGET; HIPPOCAMPAL EXPRESSION; DORSAL HIPPOCAMPUS; NMDA RECEPTORS; RAPAMYCIN MTOR; CA1 REGION	Normal aging is associated with impairments in cognition, especially learning and memory. However, major individual differences are known to exist. Using the classical Morris Water Maze (MWM) task, we discriminated a population of 24-months old Long Evans aged rats in two groups - memory-impaired (AI) and memory-unimpaired (AU) in comparison with 6-months old adult animals. AI rats presented deficits in learning, reverse memory and retention. At the molecular level, an increase in metabotropic glutamate receptors 5 (mGluR5) was observed in post-synaptic densities (PSD) in the hippocampus of AU rats after training. Scaffolding Homer 1b/c proteins binding to group 1 mGluR facilitate coupling with its signaling effectors while Homer 1a reduces it. Both Homer 1a and 1b/c levels were up-regulated in the hippocampus PSD of AU animals following MWM task. Using immunohistochemistry we further demonstrated that mGluR5 as well as Homer 1b/c stainings were enhanced in the CA1 hippocampus sub-field of AU animals. In fact mGluR5 and Homer 1 isoforms were more abundant and co-localized in the hippocampal dendrites in AU rats. However, the ratio of Homer 1a/Homer 1b/c bound to mGluR5 in the PSD was four times lower for AU animals compared to AI rats. Consequently, AU animals presented higher PKC gamma, ERK, p70S6K, mTOR and CREB activation. Finally the expression of immediate early gene Arc/Arg3.1 was shown to be higher in AU rats in accordance with its role in spatial memory consolidation. On the basis of these results, a model of successful cognitive aging with a critical role for mGluR5, Homer 1 proteins and downstream signalling pathways is proposed here.	[Menard, Caroline; Quirion, Remi] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University	Menard, C (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	caroline.menard@douglas.mcgill.ca	Menard, Caroline/AAV-4017-2020	Menard, Caroline/0000-0001-8202-7378	Canadian Institutes of Health Research (CIHR) [MOP-8580]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was supported by a grant from the Canadian Institutes of Health Research (CIHR) to Remi Quirion (Grant #MOP-8580). Caroline Menard is the recipient of a fellowship from CIHR (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Antion MD, 2008, MOL CELL BIOL, V28, P2996, DOI 10.1128/MCB.00201-08; AUBERT I, 1995, NEUROSCIENCE, V67, P277, DOI 10.1016/0306-4522(95)00056-O; Barnes CA, 2003, PHILOS T R SOC B, V358, P765, DOI 10.1098/rstb.2002.1244; Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Benoit CE, 2011, TRENDS PHARMACOL SCI, V32, P43, DOI 10.1016/j.tips.2010.10.002; Bertaso F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009755; Bikbaev A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002155; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Blum S, 1999, J NEUROSCI, V19, P3535; Boric K, 2008, J NEUROSCI, V28, P8034, DOI 10.1523/JNEUROSCI.2036-08.2008; Bortolotto ZA, 2005, NEUROPHARMACOLOGY, V49, P13, DOI 10.1016/j.neuropharm.2005.05.020; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brightwell JJ, 2004, NEUROBIOL LEARN MEM, V81, P19, DOI 10.1016/j.nlm.2003.08.001; Brouillette J, 2008, NEUROBIOL AGING, V29, P1721, DOI 10.1016/j.neurobiolaging.2007.04.007; Brouillette J, 2007, J NEUROCHEM, V102, P1978, DOI 10.1111/j.1471-4159.2007.04666.x; Burke SN, 2010, TRENDS NEUROSCI, V33, P153, DOI 10.1016/j.tins.2009.12.003; Celikel T, 2007, FRONT NEUROSCI-SWITZ, V1, P97, DOI 10.3389/neuro.01.1.1.007.2007; Collett VJ, 2004, BRIT J PHARMACOL, V142, P991, DOI 10.1038/sj.bjp.0705861; Colombo PJ, 2002, HIPPOCAMPUS, V12, P285, DOI 10.1002/hipo.10016; Colombo PJ, 1997, P NATL ACAD SCI USA, V94, P14195, DOI 10.1073/pnas.94.25.14195; Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722; Duncan RS, 2005, EXP BIOL MED, V230, P527, DOI 10.1177/153537020523000803; Fagni Laurent, 2002, Sci STKE, V2002, pre8, DOI 10.1126/stke.2002.137.re8; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gallagher M, 2003, EXP GERONTOL, V38, P71, DOI 10.1016/S0531-5565(02)00159-6; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Ge YA, 2010, P NATL ACAD SCI USA, V107, P16697, DOI 10.1073/pnas.1008200107; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Haberman RP, 2011, NEUROBIOL AGING, V32, P1678, DOI 10.1016/j.neurobiolaging.2009.10.005; HENLEY JM, 1995, BRIT J PHARMACOL, V115, P295, DOI 10.1111/j.1476-5381.1995.tb15876.x; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kammermeier PJ, 2007, P NATL ACAD SCI USA, V104, P6055, DOI 10.1073/pnas.0608991104; Kim R, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-9; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Kollen M, 2010, NEUROBIOL AGING, V31, P129, DOI 10.1016/j.neurobiolaging.2008.03.010; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lauterborn JC, 2000, J NEUROSCI, V20, P8, DOI 10.1523/JNEUROSCI.20-01-00008.2000; Lee HK, 2005, NAT NEUROSCI, V8, P1657, DOI 10.1038/nn1586; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Liu JX, 2008, EPILEPSY RES, V82, P111, DOI 10.1016/j.eplepsyres.2008.07.014; Manahan-Vaughan D, 2005, CEREB CORTEX, V15, P1703, DOI 10.1093/cercor/bhi047; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Monti B, 2005, HIPPOCAMPUS, V15, P1041, DOI 10.1002/hipo.20099; Moron JA, 2007, MOL CELL PROTEOMICS, V6, P29, DOI 10.1074/mcp.M600184-MCP200; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Neyman S, 2008, EUR J NEUROSCI, V27, P1345, DOI 10.1111/j.1460-9568.2008.06109.x; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Nicolle MM, 1999, J NEUROSCI, V19, P9604; Nithianantharajah J, 2009, INT J NEUROSCI, V119, P1014, DOI 10.1080/00207450802328508; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Page G, 2006, NEUROCHEM INT, V49, P413, DOI 10.1016/j.neuint.2006.01.020; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Parsons RG, 2006, J NEUROSCI, V26, P12977, DOI 10.1523/JNEUROSCI.4209-06.2006; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Romano C, 1996, J COMP NEUROL, V367, P403, DOI 10.1002/(SICI)1096-9861(19960408)367:3<403::AID-CNE6>3.0.CO;2-9; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Roselli F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006011; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007; Rowe WB, 1998, NEUROSCIENCE, V83, P669, DOI 10.1016/S0306-4522(97)00464-8; Saito N, 2002, J BIOCHEM, V132, P683, DOI 10.1093/oxfordjournals.jbchem.a003274; Serge A, 2002, J NEUROSCI, V22, P3910, DOI 10.1523/JNEUROSCI.22-10-03910.2002; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Van Keuren-Jensen K, 2006, J NEUROSCI, V26, P7575, DOI 10.1523/JNEUROSCI.5083-05.2006; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Williams BJ, 2006, PSYCHOPHARMACOLOGY, V188, P605, DOI 10.1007/s00213-006-0477-1; Wilson IA, 2006, TRENDS NEUROSCI, V29, P662, DOI 10.1016/j.tins.2006.10.002; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Xu J, 2009, J NEUROSCI, V29, P3676, DOI 10.1523/JNEUROSCI.5716-08.2009; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Yang L, 2004, J NEUROSCI, V24, P10846, DOI 10.1523/JNEUROSCI.2496-04.2004; Zhang W Q, 1991, Hippocampus, V1, P391, DOI 10.1002/hipo.450010407	79	78	80	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e28666	10.1371/journal.pone.0028666	http://dx.doi.org/10.1371/journal.pone.0028666			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238580	gold, Green Published, Green Submitted			2022-12-27	WOS:000301188800002
J	Yu, CR; Lee, YS; Mahdi, RM; Surendran, N; Egwuagu, CE				Yu, Cheng-Rong; Lee, Yun Sang; Mahdi, Rashid M.; Surendran, Narayanan; Egwuagu, Charles E.			Therapeutic Targeting of STAT3 (Signal Transducers and Activators of Transcription 3) Pathway Inhibits Experimental Autoimmune Uveitis	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; T(H)17 CELL-DIFFERENTIATION; CENTRAL-NERVOUS-SYSTEM; T-CELLS; MULTIPLE-SCLEROSIS; IN-VIVO; ENCEPHALOMYELITIS; ADHESION; DISEASE; UVEORETINITIS	Mice with targeted deletion of STAT3 in CD4(+) T-cells do not develop experimental autoimmune uveitis (EAU) or experimental autoimmune encephalomyelitis (EAE), in part, because they cannot generate pathogenic Th17 cells. In this study, we have used ORLL-NIH001, a small synthetic compound that inhibits transcriptional activity of STAT3, to ameliorate EAU, an animal model of human posterior uveitis. We show that by attenuating inflammatory properties of uveitogenic lymphocytes, ORLL-NIH001 inhibited the recruitment of inflammatory cells into the retina during EAU and prevented the massive destruction of the neuroretina caused by pro-inflammatory cytokines produced by the autoreactive lymphocytes. Decrease in disease severity observed in ORLL-NIH001-treated mice, correlated with the down-regulation of alpha 4 beta 1 and alpha 4 beta 7 integrin activation and marked reduction of CCR6 and CXCR3 expression, providing a mechanism by which ORLL-NIH001 mitigated EAU. Furthermore, we show that ORLL-NIH001 inhibited the expansion of human Th17 cells, underscoring its potential as a drug for the treatment of human uveitis. Two synthetic molecules that target the Th17 lineage transcription factors, ROR gamma t and ROR alpha, have recently been suggested as potential drugs for inhibiting Th17 development and treating CNS inflammatory diseases. However, inhibiting STAT3 pathways completely blocks Th17 development, as well as, prevents trafficking of inflammatory cells into CNS tissues, making STAT3 a more attractive therapeutic target. Thus, use of ORLL-NIH001 to target the STAT3 transcription factor, thereby antagonizing Th17 expansion and expression of proteins that mediate T cell chemotaxis, provides an attractive new therapeutic approach for treatment of posterior uveitis and other CNS autoimmune diseases mediated by Th17 cells.	[Yu, Cheng-Rong; Lee, Yun Sang; Mahdi, Rashid M.; Egwuagu, Charles E.] NEI, Mol Immunol Sect, NIH, Bethesda, MD 20892 USA; [Surendran, Narayanan] Orchid Res Labs Ltd, Madras, Tamil Nadu, India	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Egwuagu, CE (corresponding author), NEI, Mol Immunol Sect, NIH, Bethesda, MD 20892 USA.	egwuaguc@nei.nih.gov		Yu, Cheng-Rong/0000-0001-7246-0362	National Eye Institute; National Institutes of Health;  [EY000350-11 DIR]; NATIONAL EYE INSTITUTE [ZIAEY000315, Z01EY000350, ZIAEY000350] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The National Eye Institute and National Institutes of Health Intramural Research Programs funded this research. Funding was for the study entitled "Development of Immunologic therapies against uveitis'' (Project # EY000350-11 DIR). This study was conducted as part of our service and duty as US government employees. The study design, data collection and analysis, decision to publish, or preparation of the manuscript were by individuals listed in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; BARON JL, 1993, J EXP MED, V177, P57, DOI 10.1084/jem.177.1.57; CASPI RR, 1988, J IMMUNOL, V140, P1490; CHAN CC, 1990, J AUTOIMMUN, V3, P247, DOI 10.1016/0896-8411(90)90144-H; Coisne C, 2009, J IMMUNOL, V182, P5909, DOI 10.4049/jimmunol.0803418; Doring A, 2011, EUR J IMMUNOL, V41, P813, DOI 10.1002/eji.201040912; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Egwuagu CE, 2002, J IMMUNOL, V168, P3181, DOI 10.4049/jimmunol.168.7.3181; Egwuagu CE, 2009, CYTOKINE, V47, P149, DOI 10.1016/j.cyto.2009.07.003; Engelhardt B, 1998, J CLIN INVEST, V102, P2096, DOI 10.1172/JCI4271; Engelhardt B, 2008, CURR PHARM DESIGN, V14, P1555, DOI 10.2174/138161208784705432; Forrester John V, 2007, Chem Immunol Allergy, V92, P228, DOI 10.1159/000099274; FORRESTER JV, 1992, CURR EYE RES, V11, P33, DOI 10.3109/02713689208999509; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jabs DA, 2000, AM J OPHTHALMOL, V130, P492, DOI 10.1016/S0002-9394(00)00659-0; Jain P, 2010, J IMMUNOL, V184, P7196, DOI 10.4049/jimmunol.0901404; Jetten AM, 2011, NATURE, V472, P421, DOI 10.1038/472421a; Kanwar JR, 2000, J NEUROIMMUNOL, V103, P146, DOI 10.1016/S0165-5728(99)00245-3; Kanwar JR, 2000, IMMUNOL CELL BIOL, V78, P641, DOI 10.1046/j.1440-1711.2000.00947.x; KORN T, 2009, ANN REV IMMUNOL; Krutzik PO, 2011, METHODS MOL BIOL, V699, P179, DOI 10.1007/978-1-61737-950-5_9; La Heij E, 1998, BRIT J OPHTHALMOL, V82, P432; Laschinger M, 2000, J NEUROIMMUNOL, V102, P32, DOI 10.1016/S0165-5728(99)00156-3; Lee YS, 2011, IMMUNOLOGY, V132, P492, DOI 10.1111/j.1365-2567.2010.03379.x; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Luger D, 2008, J EXP MED; NUSSENBLATT RB, 1991, INVEST OPHTH VIS SCI, V32, P3131; NUSSENBLATT RB, 1990, INT OPHTHALMOL, V14, P303, DOI 10.1007/BF00163549; Shi GP, 2008, J IMMUNOL, V181, P7205, DOI 10.4049/jimmunol.181.10.7205; Shi GP, 2009, J IMMUNOL, V183, P7547, DOI 10.4049/jimmunol.0900519; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Steinman L, 2009, NAT REV IMMUNOL, V9, P440, DOI 10.1038/nri2548; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	38	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e29742	10.1371/journal.pone.0029742	http://dx.doi.org/10.1371/journal.pone.0029742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22238646	Green Published, Green Submitted, gold			2022-12-27	WOS:000312662100033
J	Palmer, ND; McDonough, CW; Hicks, PJ; Roh, BH; Wing, MR; An, SS; Hester, JM; Cooke, JN; Bostrom, MA; Rudock, ME; Talbert, ME; Lewis, JP; Ferrara, A; Lu, LY; Ziegler, JT; Sale, MM; Divers, J; Shriner, D; Adeyemo, A; Rotimi, CN; Ng, MCY; Langefeld, CD; Freedman, BI; Bowden, DW				Palmer, Nicholette D.; McDonough, Caitrin W.; Hicks, Pamela J.; Roh, Bong H.; Wing, Maria R.; An, S. Sandy; Hester, Jessica M.; Cooke, Jessica N.; Bostrom, Meredith A.; Rudock, Megan E.; Talbert, Matthew E.; Lewis, Joshua P.; Ferrara, Assiamira; Lu, Lingyi; Ziegler, Julie T.; Sale, Michele M.; Divers, Jasmin; Shriner, Daniel; Adeyemo, Adebowale; Rotimi, Charles N.; Ng, Maggie C. Y.; Langefeld, Carl D.; Freedman, Barry I.; Bowden, Donald W.		DIAGRAM Consortium; MAGIC Investigators	A Genome-Wide Association Search for Type 2 Diabetes Genes in African Americans	PLOS ONE			English	Article							STAGE RENAL-DISEASE; LARGE-SCALE ASSOCIATION; SUSCEPTIBILITY LOCI; INSULIN-RESISTANCE; FASTING GLUCOSE; TISSUE FACTOR; HOMEODOMAIN PROTEIN; LINKAGE ANALYSIS; COMMON VARIANTS; TCF7L2 GENE	African Americans are disproportionately affected by type 2 diabetes (T2DM) yet few studies have examined T2DM using genome-wide association approaches in this ethnicity. The aim of this study was to identify genes associated with T2DM in the African American population. We performed a Genome Wide Association Study (GWAS) using the Affymetrix 6.0 array in 965 African-American cases with T2DM and end-stage renal disease (T2DM-ESRD) and 1029 population-based controls. The most significant SNPs (n = 550 independent loci) were genotyped in a replication cohort and 122 SNPs (n = 98 independent loci) were further tested through genotyping three additional validation cohorts followed by meta-analysis in all five cohorts totaling 3,132 cases and 3,317 controls. Twelve SNPs had evidence of association in the GWAS (P<0.0071), were directionally consistent in the Replication cohort and were associated with T2DM in subjects without nephropathy (P<0.05). Meta-analysis in all cases and controls revealed a single SNP reaching genome-wide significance (P<2.5X10(-8)). SNP rs7560163 (P = 7.0610(-9), OR (95% CI) = 0.75 (0.67-0.84)) is located intergenically between RND3 and RBM43. Four additional loci (rs7542900, rs4659485, rs2722769 and rs7107217) were associated with T2DM (P<0.05) and reached more nominal levels of significance (P<2.5X10(-5)) in the overall analysis and may represent novel loci that contribute to T2DM. We have identified novel T2DM-susceptibility variants in the African-American population. Notably, T2DM risk was associated with the major allele and implies an interesting genetic architecture in this population. These results suggest that multiple loci underlie T2DM susceptibility in the African-American population and that these loci are distinct from those identified in other ethnic populations.	[Palmer, Nicholette D.; Hicks, Pamela J.; Roh, Bong H.; An, S. Sandy; Bostrom, Meredith A.; Rudock, Megan E.; Bowden, Donald W.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27103 USA; [Palmer, Nicholette D.; McDonough, Caitrin W.; Hicks, Pamela J.; Roh, Bong H.; Wing, Maria R.; An, S. Sandy; Hester, Jessica M.; Cooke, Jessica N.; Bostrom, Meredith A.; Rudock, Megan E.; Talbert, Matthew E.; Lewis, Joshua P.; Ng, Maggie C. Y.; Bowden, Donald W.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; [Palmer, Nicholette D.; McDonough, Caitrin W.; Hicks, Pamela J.; Roh, Bong H.; Wing, Maria R.; An, S. Sandy; Hester, Jessica M.; Cooke, Jessica N.; Bostrom, Meredith A.; Talbert, Matthew E.; Lewis, Joshua P.; Ng, Maggie C. Y.; Bowden, Donald W.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Diabet Res, Winston Salem, NC USA; [Freedman, Barry I.; Bowden, Donald W.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC 27103 USA; [McDonough, Caitrin W.; Cooke, Jessica N.; Talbert, Matthew E.] Wake Forest Univ, Bowman Gray Sch Med, Program Mol Med & Translat Sci, Winston Salem, NC USA; [Ng, Maggie C. Y.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pediat, Winston Salem, NC 27103 USA; [Wing, Maria R.; Hester, Jessica M.; Lewis, Joshua P.] Wake Forest Univ, Bowman Gray Sch Med, Program Mol Genet & Gen, Winston Salem, NC USA; [Lu, Lingyi; Ziegler, Julie T.; Divers, Jasmin; Langefeld, Carl D.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Sale, Michele M.] Univ Virginia, Sch Med, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Shriner, Daniel; Adeyemo, Adebowale; Rotimi, Charles N.] Howard Univ, Ctr Res Genom & Global Hlth, Natl Human Genome Ctr, Bethesda, MD USA; [Ferrara, Assiamira] Kaiser Permanente, Div Res, Oakland, CA USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; University of Virginia; Howard University; Kaiser Permanente	Palmer, ND (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27103 USA.	nallred@wfubmc.edu	Pfeiffer, Andreas F.H./AAJ-2311-2020; Kyvik, Kirsten O/K-5680-2016; Boehm, Bernhard Otto/F-8750-2015; Deloukas, Panos/B-2922-2013; Griffin, Simon J/K-3106-2013; BOUATIA-NAJI, NABILA/D-5863-2013; Davey Smith, George/A-7407-2013; Hide, Winston A/V-2727-2017; Palmer, Colin NA/C-7053-2008; Bochud, Murielle/A-3981-2010; Elliott, Amanda/G-5120-2012; Kaprio, Jaakko/A-1820-2008; Palmer, Lyle John/N-1948-2019; Thorand, Barbara/B-5349-2014; Mukherjee, Sutapa/U-7262-2017; van Hoek, Mandy/B-9325-2014; Study, GoDARTS/K-9448-2016; Hide, Winston/R-3815-2019; Ripatti, Samuli/H-9446-2014; Li, Man/AAX-3400-2020; Polasek, Ozren/B-6002-2011; Singleton, Andrew B/C-3010-2009; Uda, Manuela/AAC-2645-2019; Brunner, Eric/H-2114-2011; Cooke Bailey, Jessica Nicole/AFQ-5925-2022; Kanoni, Stavroula/AAN-7161-2021; Colaus, PsyColaus/K-6607-2013; Pattou, Francois/O-6151-2017; Hui, Jennie/A-9543-2013; de Geus, Eco J.C./M-9318-2015; Bailey, Jessica Cooke/Q-5062-2019; Rudan, Igor/I-1467-2012; Crisponi, Laura/AAC-2642-2019; FROGUEL, Philippe/O-6799-2017; Naitza, Silvia/D-5620-2017; Hide, Winston Hide/C-7217-2009; Pedersen, Oluf/Z-1731-2019; Bonnefond, Amélie/O-2784-2017; Palmer, Lyle John/K-3196-2014; Amin, Najaf N/D-1859-2012; Penninx, Brenda WJH/S-7627-2017; Loos, Ruth J F/Q-2862-2016; Walters, G. Bragi/L-4215-2013; Langenberg, Claudia/ABG-9067-2021; Marmot, M G/Y-3920-2019; Meitinger, Thomas/O-1318-2015; Sayer, Avan Aihie/A-4359-2012; Visvikis-Siest, Sophie/H-2324-2014; Benediktsson, Rafn/R-2457-2018; Timpson, Nicholas/O-7548-2015; Aulchenko, Yurii/M-8270-2013; Doney, Alexander/P-7437-2017; Simpson, Laila/O-7281-2014; Grarup, Niels/K-2807-2015; McCarthy, Mark/M-3763-2015; Coin, Lachlan/A-9001-2014; Willems van Dijk, Ko/A-1798-2008	Pfeiffer, Andreas F.H./0000-0002-6887-0016; Kyvik, Kirsten O/0000-0003-2981-0245; Deloukas, Panos/0000-0001-9251-070X; Griffin, Simon J/0000-0002-2157-4797; Davey Smith, George/0000-0002-1407-8314; Hide, Winston A/0000-0002-8621-3271; Palmer, Colin NA/0000-0002-6415-6560; Bochud, Murielle/0000-0002-5727-0218; Kaprio, Jaakko/0000-0002-3716-2455; Palmer, Lyle John/0000-0002-1628-3055; Thorand, Barbara/0000-0002-8416-6440; Mukherjee, Sutapa/0000-0001-5021-1648; Hide, Winston/0000-0002-8621-3271; Ripatti, Samuli/0000-0002-0504-1202; Li, Man/0000-0002-3839-0281; Polasek, Ozren/0000-0002-5765-1862; Uda, Manuela/0000-0002-4890-6456; Brunner, Eric/0000-0002-0595-4474; Cooke Bailey, Jessica Nicole/0000-0002-4001-8702; Kanoni, Stavroula/0000-0002-1691-9615; Pattou, Francois/0000-0001-8388-3766; Hui, Jennie/0000-0002-1653-2496; de Geus, Eco J.C./0000-0001-6022-2666; Bailey, Jessica Cooke/0000-0002-4001-8702; Rudan, Igor/0000-0001-6993-6884; Crisponi, Laura/0000-0001-9128-8537; FROGUEL, Philippe/0000-0003-2972-0784; Hide, Winston Hide/0000-0002-8621-3271; Pedersen, Oluf/0000-0002-3321-3972; Bonnefond, Amélie/0000-0001-9976-3005; Palmer, Lyle John/0000-0002-1628-3055; Penninx, Brenda WJH/0000-0001-7779-9672; Loos, Ruth J F/0000-0002-8532-5087; Walters, G. Bragi/0000-0002-5415-6487; Langenberg, Claudia/0000-0002-5017-7344; Marmot, M G/0000-0002-2431-6419; Visvikis-Siest, Sophie/0000-0001-8104-8425; Benediktsson, Rafn/0000-0002-2954-9801; Aihie Sayer, Avan/0000-0003-1283-6457; Timpson, Nicholas/0000-0002-7141-9189; Raychaudhuri, Soumya/0000-0002-1901-8265; Glazer, Nicole/0000-0002-6397-609X; Lewis, Joshua/0000-0002-4107-6066; Posthuma, Danielle/0000-0001-7582-2365; Hansen, Torben/0000-0001-8748-3831; Aulchenko, Yurii/0000-0002-7899-1575; Ben-Shlomo, Yoav/0000-0001-6648-3007; Meitinger, Thomas/0000-0002-8838-8403; Gloyn, Anna/0000-0003-1205-1844; Stumvoll, Michael/0000-0001-6225-8240; Dupuis, Josee/0000-0003-2871-3603; Weedon, Michael/0000-0002-6174-6135; Lawlor, Debbie A/0000-0002-6793-2262; Pichler, Irene/0000-0001-8251-0757; Bergman, Richard/0000-0003-1539-4471; Zeggini, Eleftheria/0000-0003-4238-659X; SCUTERI, ANGELO/0000-0003-4784-5441; Waeber, Gerard/0000-0003-4193-788X; Kong, Augustine/0000-0001-8193-5438; Pankow, James/0000-0001-7076-483X; Dina, Christian/0000-0002-7722-7348; Watkins, Hugh/0000-0002-5287-9016; Kovacs, Peter/0000-0002-0290-5423; Kraft, Peter/0000-0002-4472-8103; Goel, Anuj/0000-0003-2307-4021; Doney, Alexander/0000-0002-6210-5620; Ferrara, Assiamira/0000-0002-7505-4826; Simpson, Laila/0000-0001-7189-4791; Wheeler, Eleanor/0000-0002-8616-6444; Grarup, Niels/0000-0001-5526-1070; Hattersley, Andrew/0000-0001-5620-473X; Hillman, David/0000-0001-9987-539X; Beilby, John/0000-0002-4915-2254; McDonough, Caitrin/0000-0001-6393-7288; McCarthy, Mark/0000-0002-4393-0510; Kumari, Meena/0000-0001-9716-1035; Shriner, Daniel/0000-0003-1928-5520; Hingorani, Aroon/0000-0001-8365-0081; Couper, David/0000-0002-4313-9235; Coin, Lachlan/0000-0002-4300-455X; Adeyemo, Adebowale/0000-0002-3105-3231; bennett, amanda/0000-0003-2140-8710; Kivimaki, Mika/0000-0002-4699-5627; Lindgren, Cecilia/0000-0002-4903-9374; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Soranzo, Nicole/0000-0003-1095-3852; Pramstaller, Peter P/0000-0002-9831-8302; Voight, Benjamin/0000-0002-6205-9994; Elliott, Paul/0000-0002-7511-5684; Magi, Reedik/0000-0002-2964-6011; Willemsen, Gonneke/0000-0003-3755-0236; Seedorf, Udo/0000-0003-4652-5358; Jorgensen, Torben/0000-0001-9453-2830; Van Duijn, Cornelia/0000-0002-2374-9204; Forouhi, Nita/0000-0002-5041-248X; Willems van Dijk, Ko/0000-0002-2172-7394	National Institutes of Health [HHSC268200782096C, K99 DK081350, R01 DK066358, R01 DK053591, R01 HL56266, R01 DK070941]; Wake Forest University School of Medicine [M01 RR07122]; ESRC [ES/G007438/1] Funding Source: UKRI; MRC [G0001164, MC_U127592696, G0801056, MC_PC_U127561128, MC_U106179474, MC_PC_U127592696, MC_UP_A620_1015, G0902037, MC_UP_A100_1003, MC_U127561128] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [MC_PC_U127592696, U1475000002, MC_U127592696, G8802774, MC_U127561128, G19/35, G0100222, MC_PC_U127561128, MC_UP_A620_1015, G0600717B, MC_U106179471, MC_U106179474, G0801056B, G0902037, MC_UP_A100_1003, G0001164, G0801056] Funding Source: researchfish; National Institute for Health Research [DHCS/07/07/008] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006094, K99HL098459, R01HL056266] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024, ZIAHG200362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, R01DK053591, K99DK081350, K08DK002600, P30DK063491, R00DK081350, K24DK080140, R01DK070941, R01DK066358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wake Forest University School of Medicine; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSC268200782096C. This work was supported by NIH grants K99 DK081350 (NDP), R01 DK066358 (DWB), R01 DK053591 (DWB), R01 HL56266 (BIF), R01 DK070941 (BIF) and in part by the General Clinical Research Center of the Wake Forest University School of Medicine grant M01 RR07122. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; [Anonymous], GEN MED; [Anonymous], MOL GEN; [Anonymous], DIAB GEN; [Anonymous], U780 INSERM; [Anonymous], CNRSUMR8090 LILL 2 U; [Anonymous], U695 INSERM; [Anonymous], UMR915 INSERM; [Anonymous], GEN COMPL TRAITS; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Centre Hospitalier Universitaire de Poitiers, 0801 CIC INSERM UFR; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fisher RA, 1932, GENETICS, V17, P0107; Florez JC, 2007, CURR OPIN CLIN NUTR, V10, P391, DOI 10.1097/MCO.0b013e3281e2c9be; Foster R, 1996, MOL CELL BIOL, V16, P2689; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman BI, 2009, NEPHROL DIAL TRANSPL, V24, P3366, DOI 10.1093/ndt/gfp316; Freedman BI, 2009, KIDNEY INT, V75, P736, DOI 10.1038/ki.2008.701; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Henkin L, 2003, ANN EPIDEMIOL, V13, P211, DOI 10.1016/S1047-2797(02)00412-X; Herring BP, 2001, J BIOL CHEM, V276, P14482, DOI 10.1074/jbc.M011585200; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Ichikawa K, 1998, ATHEROSCLEROSIS, V136, P281, DOI 10.1016/S0021-9150(97)00221-9; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Keene KL, 2008, HUM GENET, V124, P147, DOI 10.1007/s00439-008-0532-6; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Lewis JP, 2008, DIABETES, V57, P2220, DOI 10.2337/db07-1319; Lim HS, 2005, DIABETIC MED, V22, P249, DOI 10.1111/j.1464-5491.2004.01388.x; Lim HS, 2004, CIRCULATION, V109, P2524, DOI 10.1161/01.CIR.0000129773.70647.94; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; McDonough CW, 2010, KIDNEY INT; Meech R, 2003, J BIOL CHEM, V278, P8269, DOI 10.1074/jbc.M207617200; Meech R, 2005, DEVELOPMENT, V132, P2135, DOI 10.1242/dev.01811; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Palmer ND, 2008, DIABETES, V57, P1093, DOI 10.2337/db07-1169; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Sale MM, 2007, DIABETES, V56, P2638, DOI 10.2337/db07-0012; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wagenknecht Lynne E., 1995, Annals of Epidemiology, V5, P464, DOI 10.1016/1047-2797(95)00062-3; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	63	127	128	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29202	10.1371/journal.pone.0029202	http://dx.doi.org/10.1371/journal.pone.0029202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238593	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000301070200019
J	Cizza, G; Ronsaville, DS; Kleitz, H; Eskandari, F; Mistry, S; Torvik, S; Sonbolian, N; Reynolds, JC; Blackman, MR; Gold, PW; Martinez, PE				Cizza, Giovanni; Ronsaville, Donna S.; Kleitz, Hayley; Eskandari, Farideh; Mistry, Sejal; Torvik, Sara; Sonbolian, Nina; Reynolds, James C.; Blackman, Marc R.; Gold, Philip W.; Martinez, Pedro E.		POWER Premenopausal Osteopenia	Clinical Subtypes of Depression Are Associated with Specific Metabolic Parameters and Circadian Endocrine Profiles in Women: The Power Study	PLOS ONE			English	Article							NATIONAL COMORBIDITY SURVEY; ATYPICAL DEPRESSION; MAJOR DEPRESSION; PREMENOPAUSAL WOMEN; INSULIN-RESISTANCE; FEATURES; PREVALENCE; DISORDER; LEPTIN; OUTPATIENTS	Background: Major depressive disorder (MDD) has been associated with adverse medical consequences, including cardiovascular disease and osteoporosis. Patients with MDD may be classified as having melancholic, atypical, or undifferentiated features. The goal of the present study was to assess whether these clinical subtypes of depression have different endocrine and metabolic features and consequently, varying medical outcomes. Methods: Premenopausal women, ages 21 to 45 years, with MDD (N = 89) and healthy controls (N = 44) were recruited for a prospective study of bone turnover. Women with MDD were classified as having melancholic (N = 51), atypical (N = 16), or undifferentiated (N = 22) features. Outcome measures included: metabolic parameters, body composition, bone mineral density (BMD), and 24 hourly sampling of plasma adrenocorticotropin (ACTH), cortisol, and leptin. Results: Compared with control subjects, women with undifferentiated and atypical features of MDD exhibited greater BMI, waist/hip ratio, and whole body and abdominal fat mass. Women with undifferentiated MDD characteristics also had higher lipid and fasting glucose levels in addition to a greater prevalence of low BMD at the femoral neck compared to controls. Elevated ACTH levels were demonstrated in women with atypical features of depression, whereas higher mean 24-hour leptin levels were observed in the melancholic subgroup. Conclusions: Pre-menopausal women with various features of MDD exhibit metabolic, endocrine, and BMD features that may be associated with different health consequences.	[Cizza, Giovanni; Eskandari, Farideh; Mistry, Sejal; Torvik, Sara; Sonbolian, Nina] NIDDKD, Sect Neuroendocrinol Obes, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Ronsaville, Donna S.; Kleitz, Hayley; Gold, Philip W.; Martinez, Pedro E.] NIMH, Behav Endocrinol Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Reynolds, James C.] NIH, Dept Nucl Med, Warren G Magnuson Clin Ctr, Dept Hlth & Human Serv, Bethesda, MD USA; [Blackman, Marc R.] Vet Affairs Med Ctr, Res Serv, Washington, DC 20422 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Cizza, G (corresponding author), NIDDKD, Sect Neuroendocrinol Obes, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	cizzag@intra.niddk.nih.gov	Blackman, Marc/AAT-5771-2021; Stevens, David/F-4683-2015		National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was fully supported by the Intramural Program of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no current external funding sources for this study.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Alesci S, 2005, J CLIN ENDOCR METAB, V90, P2522, DOI 10.1210/jc.2004-1667; Anisman H, 1999, MOL PSYCHIATR, V4, P182, DOI 10.1038/sj.mp.4000436; Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; ASNIS GM, 1995, AM J PSYCHIAT, V152, P31; Banks WA, 2011, ENDOCRINOLOGY, V152, P2539, DOI 10.1210/en.2011-1161; Benazzi F, 1999, PSYCHIAT RES, V86, P259, DOI 10.1016/S0165-1781(99)00035-9; Brown ES, 2004, BIOL PSYCHIAT, V55, P1, DOI 10.1016/S0006-3223(03)00473-6; Carragher N, 2009, J AFFECT DISORDERS, V113, P88, DOI 10.1016/j.jad.2008.05.015; Cizza G, 2010, HORM METAB RES, V42, P467, DOI 10.1055/s-0030-1252020; Cizza G, 2001, TRENDS ENDOCRIN MET, V12, P198, DOI 10.1016/S1043-2760(01)00407-6; Cizza Giovanni, 2011, Dialogues Clin Neurosci, V13, P73; Cizza G, 2010, J CLIN PSYCHIAT, V71, P1079, DOI 10.4088/JCP.09m05314blu; Cizza G, 2009, TRENDS ENDOCRIN MET, V20, P367, DOI 10.1016/j.tem.2009.05.003; Eikelis N, 2003, HYPERTENSION, V41, P1072, DOI 10.1161/01.HYP.0000066289.17754.49; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Eskandari F, 2005, METABOLISM, V54, P918, DOI 10.1016/j.metabol.2005.02.006; Eskandari F, 2007, ARCH INTERN MED, V167, P2329, DOI 10.1001/archinte.167.21.2329; First M. B., 1997, STRUCTURED CLIN INTE; Fountoulakis KN, 2004, PROG NEURO-PSYCHOPH, V28, P537, DOI 10.1016/j.pnpbp.2004.01.006; Gold PW, 2005, P NATL ACAD SCI USA, V102, P8303, DOI 10.1073/pnas.0503069102; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Gold PW, 1995, ANN NY ACAD SCI, V771, P716, DOI 10.1111/j.1749-6632.1995.tb44723.x; Harlow BL, 2004, J AFFECT DISORDERS, V79, P167, DOI 10.1016/S0165-0327(02)00459-7; Karapanou O, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-115; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lamers F, 2010, J CLIN PSYCHIAT, V71, P1582, DOI 10.4088/JCP.09m05398blu; LEMUS CZ, 1987, J AFFECT DISORDERS, V12, P219, DOI 10.1016/0165-0327(87)90030-9; LIEBOWITZ MR, 1988, ARCH GEN PSYCHIAT, V45, P129; Lu XY, 2007, CURR OPIN PHARMACOL, V7, P648, DOI 10.1016/j.coph.2007.10.010; Marcus SM, 2005, J AFFECT DISORDERS, V87, P141, DOI 10.1016/j.jad.2004.09.008; Matza LS, 2003, ARCH GEN PSYCHIAT, V60, P817, DOI 10.1001/archpsyc.60.8.817; McGinn LK, 1996, PSYCHIAT RES, V60, P191, DOI 10.1016/0165-1781(96)02781-3; McIntyre RS, 2009, CURR DIABETES REP, V9, P51, DOI 10.1007/s11892-009-0010-0; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Novick JS, 2005, J CLIN PSYCHIAT, V66, P1002, DOI 10.4088/JCP.v66n0807; Onyike CU, 2003, AM J EPIDEMIOL, V158, P1139, DOI 10.1093/aje/kwg275; Pande RL, 2008, CIRCULATION, V118, P33, DOI 10.1161/CIRCULATIONAHA.107.721878; Pearson S, 2010, DIABETES CARE, V33, P1128, DOI 10.2337/dc09-1940; Perugi G, 1998, COMPR PSYCHIAT, V39, P63, DOI 10.1016/S0010-440X(98)90080-3; Posternak MA, 2002, COMPR PSYCHIAT, V43, P253, DOI 10.1053/comp.2002.33498; QUITKIN FM, 1985, J AFFECT DISORDERS, V8, P61, DOI 10.1016/0165-0327(85)90073-4; Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b; Thase ME, 2009, NEUROPSYCHOPHARMACOL, V34, P2633, DOI 10.1038/npp.2009.100; Withal A, 2010, J AFFECT DISORDERS, V123, P150, DOI 10.1016/j.jad.2009.07.012; Young EA, 2001, NEUROPSYCHOPHARMACOL, V25, P267, DOI 10.1016/S0893-133X(00)00236-0	46	63	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28912	10.1371/journal.pone.0028912	http://dx.doi.org/10.1371/journal.pone.0028912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	903NK	22235252	gold, Green Published, Green Submitted			2022-12-27	WOS:000301123400013
J	Dahlqvist, J; Torma, H; Badhai, J; Dahl, N				Dahlqvist, Johanna; Torma, Hans; Badhai, Jitendra; Dahl, Niklas			siRNA Silencing of Proteasome Maturation Protein (POMP) Activates the Unfolded Protein Response and Constitutes a Model for KLICK Genodermatosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HUMAN EPIDERMIS; 20S PROTEASOME; C/EBP-BETA; IN-VITRO; FILAGGRIN; KERATINOCYTES; CHOP; SKIN; DIFFERENTIATION	Keratosis linearis with ichthyosis congenita and keratoderma (KLICK) is an autosomal recessive skin disorder associated with a single-nucleotide deletion in the 5'untranslated region of the proteasome maturation protein (POMP) gene. The deletion causes a relative switch in transcription start sites for POMP, predicted to decrease levels of POMP protein in terminally differentiated keratinocytes. To investigate the pathophysiology behind KLICK we created an in vitro model of the disease using siRNA silencing of POMP in epidermal air-liquid cultures. Immunohistochemical analysis of the tissue constructs revealed aberrant staining of POMP, proteasome subunits and the skin differentiation marker filaggrin when compared to control tissue constructs. The staining patterns of POMP siRNA tissue constructs showed strong resemblance to those observed in skin biopsies from KLICK patients. Western blot analysis of lysates from the organotypic tissue constructs revealed an aberrant processing of profilaggrin to filaggrin in samples transfected with siRNA against POMP. Knock-down of POMP expression in regular cell cultures resulted in decreased amounts of proteasome subunits. Prolonged silencing of POMP in cultured cells induced C/EBP homologous protein (CHOP) expression consistent with an activation of the unfolded protein response and increased endoplasmic reticulum (ER) stress. The combined results indicate that KLICK is caused by reduced levels of POMP, leading to proteasome insufficiency in differentiating keratinocytes. Proteasome insufficiency disturbs terminal epidermal differentiation, presumably by increased ER stress, and leads to perturbed processing of profilaggrin. Our findings underline a critical role for the proteasome in human epidermal differentiation.	[Dahlqvist, Johanna; Badhai, Jitendra; Dahl, Niklas] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Torma, Hans] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Torma, Hans] Univ Uppsala Hosp, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University Hospital	Dahlqvist, J (corresponding author), Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.	Dahl@igp.uu.se	Törmä, Hans/F-8152-2011	Törmä, Hans/0000-0002-3617-8551; Badhai, Jitendra/0000-0002-9526-3748	Swedish Research Council [K2010-66X-10829-17-3]; Uppsala University; Science for Life Laboratory; Uppsala University Hospital	Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala University; Science for Life Laboratory; Uppsala University Hospital	This work was supported by the Swedish Research Council (K2010-66X-10829-17-3 to N.D.), Uppsala University, Science for Life Laboratory and Uppsala University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2005, J INVEST DERMATOL, V125, P323, DOI 10.1111/j.0022-202X.2005.23784.x; Badhai J, 2009, FEBS LETT, V583, P2049, DOI 10.1016/j.febslet.2009.05.023; Boudjelal M, 2000, CANCER RES, V60, P2247; Brown SJ, 2009, BRIT J DERMATOL, V161, P884, DOI 10.1111/j.1365-2133.2009.09339.x; Chiribau CB, 2010, MOL CELL BIOL, V30, P3722, DOI 10.1128/MCB.01507-09; Dahlqvist J, 2010, AM J HUM GENET, V86, P596, DOI 10.1016/j.ajhg.2010.02.018; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Fricke B, 2007, EMBO REP, V8, P1170, DOI 10.1038/sj.embor.7401091; GEY GO, 1952, CANCER RES, V12, P264; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hirano Y, 2008, EMBO J, V27, P2204, DOI 10.1038/emboj.2008.148; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Maytin EV, 1998, J INVEST DERMATOL, V110, P238, DOI 10.1046/j.1523-1747.1998.00123.x; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Melin M, 2006, J HUM GENET, V51, P864, DOI 10.1007/s10038-006-0035-z; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001; Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Poumay Y, 2004, ARCH DERMATOL RES, V296, P203, DOI 10.1007/s00403-004-0507-y; Presland RB, 1997, J INVEST DERMATOL, V108, P170, DOI 10.1111/1523-1747.ep12333356; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; PUJOL RM, 1989, ARCH DERMATOL, V125, P103, DOI 10.1001/archderm.125.1.103; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Sugiura K, 2009, J INVEST DERMATOL, V129, P2126, DOI 10.1038/jid.2009.51; Tattersall D, 2009, HUM MOL GENET, V18, P4734, DOI 10.1093/hmg/ddp436; Vahlquist A, 1997, ACTA DERM-VENEREOL, V77, P225; van Steensel MAM, 2005, BRIT J DERMATOL, V152, P155, DOI 10.1111/J.1365-2133.2005.06319.X; Wu WKK, 2010, DRUG RESIST UPDATE, V13, P87, DOI 10.1016/j.drup.2010.04.003	35	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29471	10.1371/journal.pone.0029471	http://dx.doi.org/10.1371/journal.pone.0029471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235297	Green Submitted, Green Published, gold			2022-12-27	WOS:000301123400059
J	Jeong, SJ; Li, SH; Luo, R; Strokes, N; Piao, XH				Jeong, Sung-Jin; Li, Shihong; Luo, Rong; Strokes, Natalie; Piao, Xianhua			Loss of Col3a1, the Gene for Ehlers-Danlos Syndrome Type IV, Results in Neocortical Dyslamination	PLOS ONE			English	Article							BILATERAL FRONTOPARIETAL POLYMICROGYRIA; CONGENITAL MUSCULAR-DYSTROPHIES; PIAL BASEMENT-MEMBRANE; CORTICAL LAMINATION; ALPHA-6 INTEGRINS; III COLLAGEN; CELLS; DYSTROGLYCAN; CORTEX; DEFECTS	It has recently been discovered that Collagen III, the encoded protein of the type IV Ehlers-Danlos Syndrome (EDS) gene, is one of the major constituents of the pial basement membrane (BM) and serves as the ligand for GPR56. Mutations in GPR56 cause a severe human brain malformation called bilateral frontoparietal polymicrogyria, in which neurons transmigrate through the BM causing severe mental retardation and frequent seizures. To further characterize the brain phenotype of Col3a1 knockout mice, we performed a detailed histological analysis. We observed a cobblestone-like cortical malformation, with BM breakdown and marginal zone heterotopias in Col3a1(-/-) mouse brains. Surprisingly, the pial BM appeared intact at early stages of development but starting as early as embryonic day (E) 11.5, prominent BM defects were observed and accompanied by neuronal overmigration. Although collagen III is expressed in meningeal fibroblasts (MFs), Col3a1(-/-) MFs present no obvious defects. Furthermore, the expression and posttranslational modification of alpha-dystroglycan was undisturbed in Col3a1(-/-) mice. Based on the previous finding that mutations in COL3A1 cause type IV EDS, our study indicates a possible common pathological pathway linking connective tissue diseases and brain malformations.	[Jeong, Sung-Jin] Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Jeong, SJ (corresponding author), Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA.	xianhua.piao@childrens.harvard.edu		Piao, Xianhua/0000-0001-7540-6767	NINDS [R01 NS057536]; William Randolph Hearst Fund Award; Goldenson Fellowship Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057536] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); William Randolph Hearst Fund Award; Goldenson Fellowship Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by NINDS grant R01 NS057536 (XP), the William Randolph Hearst Fund Award (SJ), and The Goldenson Fellowship Award (RL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahi-Buisson N, 2010, BRAIN, V133, P3194, DOI 10.1093/brain/awq259; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; BORNSTEIN P, 1980, ANNU REV BIOCHEM, V49, P957, DOI 10.1146/annurev.bi.49.070180.004521; Chang BS, 2003, ANN NEUROL, V53, P596, DOI 10.1002/ana.10520; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; De Arcangelis A, 1999, DEVELOPMENT, V126, P3957; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; EPSTEIN EH, 1975, J BIOL CHEM, V250, P9304; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Germain DP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-32; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Halfter W, 2002, J NEUROSCI, V22, P6029; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0; Inoue T, 2008, J NEUROSCI, V28, P4712, DOI 10.1523/JNEUROSCI.5735-07.2008; KONTUSAARI S, 1990, J CLIN INVEST, V86, P1465, DOI 10.1172/JCI114863; KUIVANIEMI H, 1995, J INVEST DERMATOL, V105, P352, DOI 10.1111/1523-1747.ep12320704; Labelle-Dumais C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002062; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; Little KD, 2004, MOL BIOL CELL, V15, P2375, DOI 10.1091/mbc.E03-12-0886; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Niewmierzycka A, 2005, J NEUROSCI, V25, P7022, DOI 10.1523/JNEUROSCI.1695-05.2005; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; Parrini E, 2006, BRAIN, V129, P1892, DOI 10.1093/brain/awl125; Piao XH, 2005, ANN NEUROL, V58, P680, DOI 10.1002/ana.20616; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Piao XH, 2002, AM J HUM GENET, V70, P1028, DOI 10.1086/339552; PIEZZI RS, 1984, ARCH BIOL MED EXP, V17, P273; Plancke A, 2009, EUR J HUM GENET, V17, P1411, DOI 10.1038/ejhg.2009.76; POPE FM, 1975, P NATL ACAD SCI USA, V72, P1314, DOI 10.1073/pnas.72.4.1314; PROCKOP DJ, 1984, NEW ENGL J MED, V311, P376, DOI 10.1056/NEJM198408093110606; Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Schwarze U, 2001, AM J HUM GENET, V69, P989, DOI 10.1086/324123; SIEVERS J, 1994, J NEUROCYTOL, V23, P135, DOI 10.1007/BF01183867; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Zarbalis K, 2007, P NATL ACAD SCI USA, V104, P14002, DOI 10.1073/pnas.0702618104	45	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29767	10.1371/journal.pone.0029767	http://dx.doi.org/10.1371/journal.pone.0029767			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235340	gold, Green Published, Green Submitted			2022-12-27	WOS:000301123400102
J	Lopez-Cortes, LF; Ruiz-Valderas, R; Jimenez-Jimenez, L; Gonzalez-Escribano, MF; Torres-Cornejo, A; Mata, R; Rivero, A; Pineda, JA; Marquez-Solero, M; Viciana, P				Lopez-Cortes, Luis F.; Ruiz-Valderas, Rosa; Jimenez-Jimenez, Luis; Gonzalez-Escribano, Maria F.; Torres-Cornejo, Almudena; Mata, Rosario; Rivero, Antonio; Pineda, Juan A.; Marquez-Solero, Manuel; Viciana, Pompeyo		Soc Andaluza Enfermedades	Influence of IL28B Polymorphisms on Response to a Lower-Than-Standard Dose peg-IFN-alpha 2a for Genotype 3 Chronic Hepatitis C in HIV-Coinfected Patients	PLOS ONE			English	Article							INTERFERON-ALPHA-2B PLUS RIBAVIRIN; COMPARING PEGYLATED INTERFERON-ALPHA-2B; SUSTAINED VIROLOGICAL RESPONSE; PEGINTERFERON ALPHA-2A; VIRAL-HEPATITIS; VIRUS-INFECTION; TRIAL; MULTICENTER; COMBINATION; EFFICACY	Background: Data on which to base definitive recommendations on the doses and duration of therapy for genotype 3 HCV/HIV-coinfected patients are scarce. We evaluated the efficacy of a lower peginterferon-alpha 2a dose and a shorter duration of therapy than the current standard of care in genotype 3 HCV/HIV-coinfected patients. Methods and Findings: Pilot, open-label, single arm clinical trial which involved 58 Caucasian HCV/HIV-coinfected patients who received weekly 135 mg peginterferon-alpha 2a plus ribavirin 400 mg twice daily during 20 weeks after attaining undetectable viremia. The relationships between baseline patient-related variables, including IL28B genotype, plasma HCV-RNA, ribavirin dose/kg, peginterferon-alpha 2a and ribavirin levels with virological responses were analyzed. Only 4 patients showed lack of response and 5 patients dropped out due to adverse events related to the study medication. Overall, sustained virologic response (SVR) rates were 58.3% by intention-to-treat and 71.4% by per protocol analysis, respectively. Among patients with rapid virologic response (RVR), SVR and relapses rates were 92.6% and 7.4%, respectively. No relationships were observed between viral responses and ribavirin dose/kg, peginterferon-alpha 2a concentrations, ribavirin levels or rs129679860 genotype. Conclusions: Weekly 135 mg pegIFN-alpha 2a could be as effective as the standard 180 mg dose, with a very low incidence of severe adverse events. A 24-week treatment duration appears to be appropriate in patients achieving RVR, but extending treatment up to just 20 weeks beyond negativization of viremia is associated with a high relapse rate in those patients not achieving RVR. There was no influence of IL28B genotype on the virological responses.	[Lopez-Cortes, Luis F.; Ruiz-Valderas, Rosa; Torres-Cornejo, Almudena; Mata, Rosario; Viciana, Pompeyo] Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Unidad Clin Enfermedades Infecciosas, Seville, Spain; [Jimenez-Jimenez, Luis] Hosp Univ Virgen del Rocio, Serv Bioquim Clin, Seville, Spain; [Gonzalez-Escribano, Maria F.] Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Serv Immunol, Seville, Spain; [Rivero, Antonio] Hosp Univ Reina Sofia, Unidad Clin Enfermedades Infecciosas, Cordoba, Spain; [Pineda, Juan A.] Hosp Univ Valme, Unidad Clin Enfermedades Infecciosas, Seville, Spain; [Marquez-Solero, Manuel] Hosp Univ Virgen de la Victoria, Unidad Clin Enfermedades Infecciosas, Malaga, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Universitario Reina Sofia - Cordoba; Hospital Valme; Universidad de Malaga	Lopez-Cortes, LF (corresponding author), Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Unidad Clin Enfermedades Infecciosas, Seville, Spain.	lflopez@telefonica.net	González-Escribano, María Francisca/X-5554-2019; Pineda, Juan A./AAO-9312-2021; IBIS, METABOLICAS/H-9832-2016; IBIS, VIH/O-8856-2015; Rivero, Antonio/ABE-5294-2020; Lopez.Cortes, Luis Fernando/S-5625-2018	Pineda, Juan A./0000-0002-3751-0296; Rivero, Antonio/0000-0001-5005-8268; Lopez.Cortes, Luis Fernando/0000-0002-3804-3458; Marquez, Manuel/0000-0002-7901-6966; Mata, Rosario/0000-0003-4804-1269; Rivero Roman, Antonio/0000-0002-8643-4250	Fundacion Publica Andaluza para la gestion de la Investigacion en Salud de Sevilla; Roche Pharma, S.A. (Spain); Hospitales Universitarios Virgen del Rocio. Seville, Spain; Abbott Laboratories (Spain); Bristol-Myers Squibb; Boehringer Ingelheim Espana S.A; GlaxoSmithkline; Roche Pharma SA	Fundacion Publica Andaluza para la gestion de la Investigacion en Salud de Sevilla; Roche Pharma, S.A. (Spain); Hospitales Universitarios Virgen del Rocio. Seville, Spain; Abbott Laboratories (Spain); Bristol-Myers Squibb(Bristol-Myers Squibb); Boehringer Ingelheim Espana S.A(Boehringer Ingelheim); GlaxoSmithkline(GlaxoSmithKline); Roche Pharma SA	Funding provided by Fundacion Publica Andaluza para la gestion de la Investigacion en Salud de Sevilla. Hospitales Universitarios Virgen del Rocio. Seville, Spain. The enzyme-linked immunosorbent assay Hu-INF-alpha kits for determination of pegIFN-alpha-2a were financed by Roche Pharma, S.A. (Spain). Both had no access to data from this study and no participation during the analysis or publication.; LL-C, PV, F. Lozano, and AR have received honoraria for speaking at symposia organized on behalf of Abbott laboratories (Spain), Bristol-Myers Squibb, GlaxoSmithkline, Gilead Sciences, Janssen-Cilag Espana, Merck Sharp & Dohme Espana, Roche Pharma SA; and have also received unrestricted funds for research from Abbott Laboratories (Spain), Bristol-Myers Squibb, Boehringer Ingelheim Espana S.A, GlaxoSmithkline, and Roche Pharma SA. Other authors: none to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abergel A, 2006, J VIRAL HEPATITIS, V13, P811, DOI 10.1111/j.1365-2893.2006.00768.x; Montes-Cano MA, 2010, HEPATOLOGY, V52, P33, DOI 10.1002/hep.23624; Berenguer J, 2009, J ANTIMICROB CHEMOTH, V63, P1256, DOI 10.1093/jac/dkp106; Cargnel A, 2005, ANTIVIR THER, V10, P309; Carrat F, 2004, JAMA-J AM MED ASSOC, V292, P2839, DOI 10.1001/jama.292.23.2839; Crespo M, 2007, J VIRAL HEPATITIS, V14, P228, DOI 10.1111/j.1365-2893.2006.00779.x; Ferenci P, 2008, HEPATOLOGY, V47, P1816, DOI 10.1002/hep.22262; Foster GR, 2009, J HEPATOL, V50, pS22, DOI 10.1016/S0168-8278(09)60052-0; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Glue P, 2000, CLIN PHARMACOL THER, V68, P556, DOI 10.1067/mcp.2000.110973; Laguno M, 2004, AIDS, V18, pF27, DOI 10.1097/00002030-200409030-00003; Laguno M, 2009, HEPATOLOGY, V49, P22, DOI 10.1002/hep.22598; Lindsay KL, 2001, HEPATOLOGY, V34, P395, DOI 10.1053/jhep.2001.26371; Lopez-Cortes LF, 2008, CLIN PHARMACOL THER, V84, P573, DOI 10.1038/clpt.2008.110; Martin-Carbonero L, 2008, AIDS, V22, P15, DOI 10.1097/QAD.0b013e3282f1da99; Meyer-Wyss B, 2006, J VIRAL HEPATITIS, V13, P457, DOI 10.1111/j.1365-2893.2005.00709.x; Modi MW, 2000, HEPATOLOGY, V32, p394A; Pineda JA, 2010, CLIN INFECT DIS, V51, P788, DOI 10.1086/656235; Pockros PJ, 2004, AM J GASTROENTEROL, V99, P1298, DOI 10.1111/j.1572-0241.2004.30306.x; Reddy KR, 2001, HEPATOLOGY, V33, P433, DOI 10.1053/jhep.2001.21747; Rodriguez-Torres M, 2010, HIV CLIN TRIALS, V11, P1, DOI 10.1310/hct1101-1; Sarrazin C, 2011, J HEPATOL, V54, P415, DOI 10.1016/j.jhep.2010.07.041; Scherzer TM, 2011, J HEPATOL, V54, P866, DOI 10.1016/j.jhep.2010.08.024; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Soriano V, 2007, ANTIVIR THER, V12, P469; Sulkowski MS, 2008, J HEPATOL, V48, P353, DOI 10.1016/j.jhep.2007.11.009; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Weiland O, 2008, J VIRAL HEPATITIS, V15, P641, DOI 10.1111/j.1365-2893.2008.00999.x	30	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28115	10.1371/journal.pone.0028115	http://dx.doi.org/10.1371/journal.pone.0028115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235243	Green Published, gold			2022-12-27	WOS:000301123400004
J	Mimoto, MS; Christian, JL				Mimoto, Mizuho S.; Christian, Jan L.			Friend of GATA (FOG) Interacts with the Nucleosome Remodeling and Deacetylase Complex (NuRD) to Support Primitive Erythropoiesis in Xenopus laevis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-1; ZINC-FINGER PROTEIN; ERYTHROID DEVELOPMENT; HISTONE DEACETYLASE; CELL DEVELOPMENT; MICE LACKING; STEM-CELLS; IN-VIVO; DIFFERENTIATION; HEMATOPOIESIS	Friend of GATA (FOG) plays many diverse roles in adult and embryonic hematopoiesis, however the mechanisms by which it functions and the roles of potential interaction partners are not completely understood. Previous work has shown that overexpression of FOG in Xenopus laevis causes loss of blood suggesting that in contrast to its role in mammals, FOG might normally function to repress erythropoiesis in this species. Using loss-of-function analysis, we demonstrate that FOG is essential to support primitive red blood cell (RBC) development in Xenopus. Moreover, we show that it is specifically required to prevent excess apoptosis of circulating primitive RBCs and that in the absence of FOG, the pro-apoptotic gene Bim-1 is strongly upregulated. To identify domains of FOG that are essential for blood development and, conversely, to begin to understand the mechanism by which overexpressed FOG represses primitive erythropoiesis, we asked whether FOG mutants that are unable to interact with known co-factors retain their ability to rescue blood formation in FOG morphants and whether they repress erythropoiesis when overexpressed in wild type embryos. We find that interaction of FOG with the Nucleosome Remodeling and Deacetylase complex (NuRD), but not with C-terminal Binding Protein, is essential for normal primitive RBC development. In contrast, overexpression of all mutant and wild type constructs causes a comparable repression of primitive erythropoiesis. Together, our data suggest that a requirement for FOG and its interaction with NuRD during primitive erythropoiesis are conserved in Xenopus and that loss of blood upon FOG overexpression is due to a dominant-interfering effect.	[Mimoto, Mizuho S.; Christian, Jan L.] Oregon Hlth & Sci Univ, Sch Med, Dept Cell & Dev Biol, Portland, OR 97201 USA	Oregon Health & Science University	Mimoto, MS (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Cell & Dev Biol, Portland, OR 97201 USA.	jan.christian@neuro.utah.edu			National Institutes of Health [HD050242]; Tartar Trust from Oregon Health and Science University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067473] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD050242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tartar Trust from Oregon Health and Science University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by an National Institutes of Health grant (HD050242) and a Tartar Trust Fellowship from Oregon Health and Science University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigo JD, 2009, BLOOD; Brannon M, 1999, DEVELOPMENT, V126, P3159; Cantor AB, 2005, SEMIN CELL DEV BIOL, V16, P117, DOI 10.1016/j.semcdb.2004.10.006; Cantor AB, 2002, MOL CELL BIOL, V22, P4268, DOI 10.1128/MCB.22.12.4268-4279.2002; Chang AN, 2002, P NATL ACAD SCI USA, V99, P9237, DOI 10.1073/pnas.142302099; CHRISTIAN J L, 1990, New Biologist, V2, P700; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; CROSSLEY M, 1995, MOL CELL BIOL, V15, P2448; DALE L, 1985, J EMBRYOL EXP MORPH, V89, P289; DALE L, 1987, DEVELOPMENT, V99, P527; Dalgin G, 2007, DEV BIOL, V310, P454, DOI 10.1016/j.ydbio.2007.08.012; Deconinck AE, 2000, DEVELOPMENT, V127, P2031; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fox AH, 1998, J BIOL CHEM, V273, P33595, DOI 10.1074/jbc.273.50.33595; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Galloway JL, 2005, DEV CELL, V8, P109, DOI 10.1016/j.devcel.2004.12.001; Gao ZG, 2010, EMBO J, V29, P457, DOI 10.1038/emboj.2009.368; Goldman DC, 2004, ENCY MOL CELL BIOL M, P429; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Katz SG, 2002, MOL CELL BIOL, V22, P3121, DOI 10.1128/MCB.22.9.3121-3128.2002; Lane MC, 1999, DEVELOPMENT, V126, P423; Letting DL, 2004, P NATL ACAD SCI USA, V101, P476, DOI 10.1073/pnas.0306315101; Li X, 2009, BLOOD, V114, P5464, DOI 10.1182/blood-2009-06-227777; Lin AC, 2004, J BIOL CHEM, V279, P55017, DOI 10.1074/jbc.M411240200; Lyons SE, 2002, P NATL ACAD SCI USA, V99, P5454, DOI 10.1073/pnas.082695299; Maeda T, 2009, DEV CELL, V17, P527, DOI 10.1016/j.devcel.2009.09.005; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Moon R. T., 1989, TECHNIQUE, V1, P76; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Peterson-Nedry W, 2008, DEV BIOL, V320, P226, DOI 10.1016/j.ydbio.2008.05.521; Ryan J, 1999, J CELL SCI, V112, P2441; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Sugiyama D, 2008, BLOOD, V111, P1924, DOI 10.1182/blood-2007-08-104489; Svensson EC, 2000, J BIOL CHEM, V275, P20762, DOI 10.1074/jbc.M001522200; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; VONDASSOW G, 1993, GENE DEV, V7, P355, DOI 10.1101/gad.7.3.355; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wang X, 2002, EMBO J, V21, P5225, DOI 10.1093/emboj/cdf527; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; ZON LI, 1995, BLOOD, V86, P2876	51	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29882	10.1371/journal.pone.0029882	http://dx.doi.org/10.1371/journal.pone.0029882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235346	gold, Green Submitted, Green Published			2022-12-27	WOS:000301123400108
J	Muhlau, M; Winkelmann, J; Rujescu, D; Giegling, I; Koutsouleris, N; Gaser, C; Arsic, M; Weindl, A; Reiser, M; Meisenzahl, EM				Muehlau, Mark; Winkelmann, Juliane; Rujescu, Dan; Giegling, Ina; Koutsouleris, Nikolaos; Gaser, Christian; Arsic, Milan; Weindl, Adolph; Reiser, Maximilian; Meisenzahl, Eva M.			Variation within the Huntington's Disease Gene Influences Normal Brain Structure	PLOS ONE			English	Article							CAG REPEATS; BASAL GANGLIA; SEGMENTATION; INFERENCE; MUTATION; BIPOLAR; IMAGES; ONSET; MRI; AGE	Genetics of the variability of normal and diseased brain structure largely remains to be elucidated. Expansions of certain trinucleotide repeats cause neurodegenerative disorders of which Huntington's disease constitutes the most common example. Here, we test the hypothesis that variation within the IT15 gene on chromosome 4, whose expansion causes Huntington's disease, influences normal human brain structure. In 278 normal subjects, we determined CAG repeat length within the IT15 gene on chromosome 4 and analyzed high-resolution T1-weighted magnetic resonance images by the use of voxel-based morphometry. We found an increase of GM with increasing long CAG repeat and its interaction with age within the pallidum, which is involved in Huntington's disease. Our study demonstrates that a certain trinucleotide repeat influences normal brain structure in humans. This result may have important implications for the understanding of both the healthy and diseased brain.	[Muehlau, Mark; Winkelmann, Juliane; Arsic, Milan; Weindl, Adolph] Tech Univ Munich, Dept Neurol, Munich, Germany; [Winkelmann, Juliane] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Winkelmann, Juliane] German Res Ctr Environm Hlth, Inst Human Genet, Helmholtz Zentrum Munich, Munich, Germany; [Rujescu, Dan; Giegling, Ina; Koutsouleris, Nikolaos; Meisenzahl, Eva M.] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany; [Gaser, Christian] Univ Jena, Dept Psychiat, Jena, Germany; [Reiser, Maximilian] Univ Munich, Dept Radiol, Munich, Germany	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Friedrich Schiller University of Jena; University of Munich	Muhlau, M (corresponding author), Tech Univ Munich, Dept Neurol, Munich, Germany.	muehlau@lrz.tum.de	Koutsouleris, Nikolaos/AAJ-7428-2020; Gaser, Christian/F-5103-2010; Giegling, Ina/ABA-3677-2021; Rujescu, Dan/GRS-3875-2022	Gaser, Christian/0000-0002-9940-099X; Winkelmann, Juliane/0000-0003-2667-9691	Merck Serono	Merck Serono(Merck & Company)	This work was supported by Merck Serono to Arsic M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDREW SE, 1994, HUM MOL GENET, V3, P65, DOI 10.1093/hmg/3.1.65; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Aziz NA, 2009, NEUROLOGY, V73, P1280, DOI 10.1212/WNL.0b013e3181bd1121; Binkofski F, 2007, NEUROLOGY, V69, P842, DOI 10.1212/01.wnl.0000267844.72421.6c; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Djousse L, 2003, AM J MED GENET A, V119A, P279, DOI 10.1002/ajmg.a.20190; Douaud G, 2009, NEUROIMAGE, V46, P958, DOI 10.1016/j.neuroimage.2009.03.044; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Everett CM, 2004, BRAIN, V127, P2385, DOI 10.1093/brain/awh278; Fondon JW, 2008, TRENDS NEUROSCI, V31, P328, DOI 10.1016/j.tins.2008.03.006; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Helms G, 2009, NEUROIMAGE, V47, P194, DOI 10.1016/j.neuroimage.2009.03.053; Ilg R, 2008, J NEUROSCI, V28, P4210, DOI 10.1523/JNEUROSCI.5722-07.2008; Joel D, 2001, MOVEMENT DISORD, V16, P407, DOI 10.1002/mds.1096; Kassubek J, 2005, CEREB CORTEX, V15, P846, DOI 10.1093/cercor/bhh185; Klempir J, 2011, MOVEMENT DISORD, V26, P125, DOI 10.1002/mds.23436; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Mai KJ, ATLAS HUMAN BRAIN; Mendlewicz J, 1997, BIOL PSYCHIAT, V42, P1115, DOI 10.1016/S0006-3223(97)00395-8; Meyer-Lindenberg A, 2008, NEUROIMAGE, V40, P655, DOI 10.1016/j.neuroimage.2007.11.058; Naidich T.P., 2009, DUVERNOYS ATLAS HUMA; Oruc L, 1997, AM J HUM GENET, V60, P730; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; RUBINSZTEIN DC, 1994, J MED GENET, V31, P690, DOI 10.1136/jmg.31.9.690; RUBINSZTEIN DC, 1995, AM J MED GENET, V60, P109, DOI 10.1002/ajmg.1320600205; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1	32	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29809	10.1371/journal.pone.0029809	http://dx.doi.org/10.1371/journal.pone.0029809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235343	Green Submitted, Green Published, gold			2022-12-27	WOS:000301123400105
J	Bedenbender, J; Paulus, FM; Krach, S; Pyka, M; Sommer, J; Krug, A; Witt, SH; Rietschel, M; Laneri, D; Kircher, T; Jansen, A				Bedenbender, Johannes; Paulus, Frieder M.; Krach, Soeren; Pyka, Martin; Sommer, Jens; Krug, Axel; Witt, Stephanie H.; Rietschel, Marcella; laneri, DaviDe; Kircher, Tilo; Jansen, Andreas			Functional Connectivity Analyses in Imaging Genetics: Considerations on Methods and Data Interpretation	PLOS ONE			English	Article							MECHANISMS; BRAIN; NETWORKS	Functional magnetic resonance imaging (fMRI) can be combined with genotype assessment to identify brain systems that mediate genetic vulnerability to mental disorders ("imaging genetics"). A data analysis approach that is widely applied is "functional connectivity". In this approach, the temporal correlation between the fMRI signal from a pre-defined brain region (the so-called "seed point") and other brain voxels is determined. In this technical note, we show how the choice of freely selectable data analysis parameters strongly influences the assessment of the genetic modulation of connectivity features. In our data analysis we exemplarily focus on three methodological parameters: (i) seed voxel selection, (ii) noise reduction algorithms, and (iii) use of additional second level covariates. Our results show that even small variations in the implementation of a functional connectivity analysis can have an impact on the connectivity pattern that is as strong as the potential modulation by genetic allele variants. Some effects of genetic variation can only be found for one specific implementation of the connectivity analysis. A reoccurring difficulty in the field of psychiatric genetics is the non-replication of initially promising findings, partly caused by the small effects of single genes. The replication of imaging genetic results is therefore crucial for the long-term assessment of genetic effects on neural connectivity parameters. For a meaningful comparison of imaging genetics studies however, it is therefore necessary to provide more details on specific methodological parameters (e. g., seed voxel distribution) and to give information how robust effects are across the choice of methodological parameters.	[Bedenbender, Johannes; Paulus, Frieder M.; Krach, Soeren; Pyka, Martin; Sommer, Jens; Krug, Axel; laneri, DaviDe; Kircher, Tilo; Jansen, Andreas] Univ Marburg, Dept Psychiat & Psychotherapy, Marburg, Germany; [Krach, Soeren] Univ Marburg, Dept Neurol, Marburg, Germany; [Witt, Stephanie H.; Rietschel, Marcella] Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-6800 Mannheim, Germany	Philipps University Marburg; Philipps University Marburg; Central Institute of Mental Health	Bedenbender, J (corresponding author), Univ Marburg, Dept Psychiat & Psychotherapy, Marburg, Germany.	jansena@med.uni-marburg.de	Krug, Axel/ABC-8530-2020; Kircher, Tilo/AAT-6480-2020; Jansen, Andreas/AAL-5264-2020	Krug, Axel/0000-0002-0564-2497; Kircher, Tilo/0000-0002-2514-2625; Jansen, Andreas/0000-0002-3140-8207; Krach, Soren/0000-0002-4834-8378	Federal Ministry of Education and Research 349 (BMBF) [01GO0204]; University Medical Center Giessen and Marburg [350 13/2009MR]	Federal Ministry of Education and Research 349 (BMBF); University Medical Center Giessen and Marburg	This work was supported by research grants from the Federal Ministry of Education and Research 349 (BMBF grant no. 01GO0204) and from the University Medical Center Giessen and Marburg (grant no. 350 13/2009MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Buckholtz JW, 2007, J NEUROSCI, V27, P1584, DOI 10.1523/JNEUROSCI.5112-06.2007; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Esslinger C, 2011, NEUROIMAGE, V54, P2514, DOI 10.1016/j.neuroimage.2010.10.012; Esslinger C, 2009, SCIENCE, V324, P605, DOI 10.1126/science.1167768; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Kempf L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000252; Li KM, 2009, COMPUT MED IMAG GRAP, V33, P131, DOI 10.1016/j.compmedimag.2008.10.011; Ma LS, 2007, MAGN RESON IMAGING, V25, P47, DOI 10.1016/j.mri.2006.09.032; Marrelec G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014788; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Meyer-Lindenberg A, 2010, NATURE, V468, P194, DOI 10.1038/nature09569; Meyer-Lindenberg A, 2009, HUM BRAIN MAPP, V30, P1938, DOI 10.1002/hbm.20639; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paulus FM, 2011, HUM BRAIN M IN PRESS; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Thimm M, 2011, PSYCHOL MED, P1; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Walter H, 2011, MOL PSYCHIATR, V16, P462, DOI 10.1038/mp.2010.18; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005	24	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e26354	10.1371/journal.pone.0026354	http://dx.doi.org/10.1371/journal.pone.0026354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220190	Green Published, Green Submitted, gold			2022-12-27	WOS:000300677000002
J	Muhldorfer, K; Speck, S; Kurth, A; Lesnik, R; Freuling, C; Muller, T; Kramer-Schadt, S; Wibbelt, G				Muehldorfer, Kristin; Speck, Stephanie; Kurth, Andreas; Lesnik, Rene; Freuling, Conrad; Mueller, Thomas; Kramer-Schadt, Stephanie; Wibbelt, Gudrun			Diseases and Causes of Death in European Bats: Dynamics in Disease Susceptibility and Infection Rates	PLOS ONE			English	Article							HENDRA VIRUS; HOST; RABIES; PCR; LYSSAVIRUS; VESPERTILIONIDAE; CORONAVIRUSES; ECTOPARASITES; CHIROPTERA; PREVALENCE	Background: Bats receive increasing attention in infectious disease studies, because of their well recognized status as reservoir species for various infectious agents. This is even more important, as bats with their capability of long distance dispersal and complex social structures are unique in the way microbes could be spread by these mammalian species. Nevertheless, infection studies in bats are predominantly limited to the identification of specific pathogens presenting a potential health threat to humans. But the impact of infectious agents on the individual host and their importance on bat mortality is largely unknown and has been neglected in most studies published to date. Methodology/Principal Findings: Between 2002 and 2009, 486 deceased bats of 19 European species (family Vespertilionidae) were collected in different geographic regions in Germany. Most animals represented individual cases that have been incidentally found close to roosting sites or near human habitation in urban and urban-like environments. The bat carcasses were subjected to a post-mortem examination and investigated histo-pathologically, bacteriologically and virologically. Trauma and disease represented the most important causes of death in these bats. Comparative analysis of pathological findings and microbiological results show that microbial agents indeed have an impact on bats succumbing to infectious diseases, with fatal bacterial, viral and parasitic infections found in at least 12% of the bats investigated. Conclusions/Significance: Our data demonstrate the importance of diseases and infectious agents as cause of death in European bat species. The clear seasonal and individual variations in disease prevalence and infection rates indicate that maternity colonies are more susceptible to infectious agents, underlining the possible important role of host physiology, immunity and roosting behavior as risk factors for infection of bats.	[Muehldorfer, Kristin; Kramer-Schadt, Stephanie; Wibbelt, Gudrun] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Speck, Stephanie] Bundeswehr Inst Microbiol, Munich, Germany; [Kurth, Andreas; Lesnik, Rene] Robert Koch Inst, Berlin, Germany; [Freuling, Conrad; Mueller, Thomas] Friedrich Loeffler Inst, Wusterhausen, Germany	Leibniz Institut fur Zoo und Wildtierforschung; Bundeswehr Institute of Microbiology (IMB); Robert Koch Institute; Friedrich Loeffler Institute	Muhldorfer, K (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	muehldorfer@izw-berlin.de	Kramer-Schadt, Stephanie/A-8778-2013	Kramer-Schadt, Stephanie/0000-0002-9269-4446	Adolf and Hildegard Isler-Stiftung; FAZIT-Stiftung; Klara Samariter-Stiftung	Adolf and Hildegard Isler-Stiftung; FAZIT-Stiftung; Klara Samariter-Stiftung	This study was supported by the Adolf and Hildegard Isler-Stiftung, the FAZIT-Stiftung (fellowship to KM) and the Klara Samariter-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre LF, 2003, FUNCT ECOL, V17, P201, DOI 10.1046/j.1365-2435.2003.00721.x; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Bisping W, 1988, COLOUR ATLAS DIAGNOS; Bouma HR, 2010, J LEUKOCYTE BIOL, V88, P619, DOI 10.1189/jlb.0310174; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Brenner DJ, 2005, BERGEYS MANUAL SYSTE; Christe P, 2000, ECOL LETT, V3, P207; Christe P, 2007, J ANIM ECOL, V76, P703, DOI 10.1111/j.1365-2656.2007.01255.x; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Ciechanowski M, 2010, ACTA THERIOL, V55, P301, DOI 10.4098/j.at.0001-7051.093.2009; Dacheux L, 2009, EMERG INFECT DIS, V15, P280, DOI 10.3201/eid1502.080637; Daffner B.L., 2001, THESIS U LONDON; Luna LKD, 2007, J CLIN MICROBIOL, V45, P1049, DOI 10.1128/JCM.02426-06; Dean D. J., 1996, LAB TECHNIQUES RABIE; Duignan P., 2003, Surveillance (Wellington), V30, P15; Evans NJ, 2009, EMERG INFECT DIS, V15, P1331, DOI 10.3201/eid1508.090475; Feldhamer GA, 2009, AM MIDL NAT, V162, P43, DOI 10.1674/0003-0031-162.1.43; Freuling C, 2008, VET MICROBIOL, V131, P26, DOI 10.1016/j.vetmic.2008.02.028; Freuling CM, 2011, EMERG INFECT DIS, V17, P1519, DOI 10.3201/eid1708.110201; Gaisler J, 1998, J ZOOL, V244, P439, DOI 10.1111/j.1469-7998.1998.tb00048.x; Georgea DB, 2011, P NATL ACAD SCI USA, V108, P10208, DOI 10.1073/pnas.1010875108; Gloza-Rausch F, 2008, EMERG INFECT DIS, V14, P626, DOI 10.3201/eid1404.071439; Hajkova P, 2007, VET REC, V161, P139, DOI 10.1136/vr.161.4.139; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Harris SL, 2006, BIOL CONSERV, V131, P193, DOI 10.1016/j.biocon.2006.04.006; HART BL, 1992, J PARASITOL, V78, P256, DOI 10.2307/3283472; Johnson N, 2010, VET MICROBIOL, V142, P151, DOI 10.1016/j.vetmic.2010.02.001; Johnson PTJ, 2010, TRENDS ECOL EVOL, V25, P362, DOI 10.1016/j.tree.2010.01.005; Kanuch P, 2007, ACTA CHIROPTEROL, V9, P277, DOI 10.3161/1733-5329(2007)9[277:ARPTFS]2.0.CO;2; Klempa B, 2006, EMERG INFECT DIS, V12, P838, DOI 10.3201/eid1205.051487; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; KUZMIN IV, 2007, RABIES, P259; Kuzmin Ivan V, 2011, Emerg Health Threats J, V4, P7159, DOI 10.3402/ehtj.v4i0.7159; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Linacre Adrian, 2005, Methods Mol Biol, V297, P45; Lucan RK, 2006, FOLIA PARASIT, V53, P147, DOI 10.14411/fp.2006.019; Mickleburgh SP, 2002, ORYX, V36, P18, DOI 10.1017/S0030605301000011; Muhldorfer K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-61; Muhldorfer K, 2011, VET MICROBIOL, V149, P163, DOI 10.1016/j.vetmic.2010.10.002; Muhldorfer K, 2010, EMERG INFECT DIS, V16, P578, DOI 10.3201/eid1603.091035; Muller T, 2007, ARCH VIROL, V152, P273, DOI 10.1007/s00705-006-0853-5; O'Shea TJ, 2011, URBAN ECOSYST, V14, P665, DOI 10.1007/s11252-011-0182-7; Patterson BD, 2007, J TROP ECOL, V23, P177, DOI 10.1017/S0266467406003816; Pearce RD, 2007, J PARASITOL, V93, P518, DOI 10.1645/GE-973R.1; Peterson J.W., 1996, MED MICROBIOLOGY; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Rihtaric D, 2010, ARCH VIROL, V155, P507, DOI 10.1007/s00705-010-0612-5; Sanchez-Seco MP, 2005, J VIROL METHODS, V126, P101, DOI 10.1016/j.jviromet.2005.01.025; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schneider L. G., 1985, Rabies in the tropics. Proceedings of an international conference on rabies control in the tropics, Tunis, Oct. 3-6, 1983, P47; Schrenzel MD, 2008, EMERG INFECT DIS, V14, P1616, DOI 10.3201/eid1410.080703; Simpson VR, 2000, RES VET SCI, V69, P11, DOI 10.1053/rvsc.2000.0384; Sonntag M, 2009, EMERG INFECT DIS, V15, P2052, DOI 10.3201/eid1512.090646; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Talan DA, 1999, NEW ENGL J MED, V340, P85, DOI 10.1056/NEJM199901143400202; ter Hofstede HM, 2005, J ZOOL, V266, P333, DOI 10.1017/S095283690500693X; THIRY E, 1988, J WILDLIFE DIS, V24, P268, DOI 10.7589/0090-3558-24.2.268; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Webster W. A., 1996, P96; Wibbelt G, 2007, J GEN VIROL, V88, P2651, DOI 10.1099/vir.0.83045-0; Wibbelt G, 2010, BIOL LETTERS, V6, P438, DOI 10.1098/rsbl.2010.0267; Wibbelt Gudrun, 2009, P775; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Zahn A, 2004, J ZOOL, V262, P383, DOI 10.1017/S0952836903004722	66	67	68	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29773	10.1371/journal.pone.0029773	http://dx.doi.org/10.1371/journal.pone.0029773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216354	Green Published, gold, Green Submitted			2022-12-27	WOS:000300676300083
J	Marshall, KN; Essington, TE				Marshall, Kristin N.; Essington, Timothy E.			Energetic Conditions Promoting Top-Down Control of Prey by Predators	PLOS ONE			English	Article							FOOD WEBS; TROPHIC CASCADES; ECOLOGICAL COMMUNITIES; INTERACTION STRENGTHS; DYNAMICS; SIZE; PRODUCTIVITY; ECOSYSTEMS; BALANCE; WOLVES	Humans remove large amounts of biomass from natural ecosystems, and large bodied high trophic level animals are especially sensitive and vulnerable to exploitation. The effects of removing top-predators on food webs are often difficult to predict because of limited information on species interaction strengths. Here we used a three species predator-prey model to explore relationships between energetic properties of trophodynamic linkages and interaction strengths to provide heuristic rules that indicate observable energetic conditions that are most likely to lead to stable and strong top-down control of prey by predator species. We found that strong top-down interaction strengths resulted from low levels of energy flow from prey to predators. Strong interactions are more stable when they are a consequence of low per capita predation and when predators are subsidized by recruitment. Diet composition also affects stability, but the relationship depends on the form of the functional response. Our results imply that for generalist satiating predators, strong top-down control on prey is most likely for prey items that occupy a small portion of the diet and when density dependent recruitment is moderately high.	[Marshall, Kristin N.; Essington, Timothy E.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Marshall, KN (corresponding author), Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA.	kristin.marshall@colostate.edu			NOAA-Fisheries Northwest Fishery Science Center; School of Aquatic and Fishery Sciences at the University of Washington	NOAA-Fisheries Northwest Fishery Science Center; School of Aquatic and Fishery Sciences at the University of Washington(University of Washington)	Funding for this work was provided by NOAA-Fisheries Northwest Fishery Science Center (http://www.nwfsc.noaa.gov/) and the School of Aquatic and Fishery Sciences at the University of Washington (http://fish.washington.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlow EL, 1999, NATURE, V398, P330, DOI 10.1038/18672; Berlow EL, 2004, J ANIM ECOL, V73, P585, DOI 10.1111/j.0021-8790.2004.00833.x; Berlow EL, 2009, P NATL ACAD SCI USA, V106, P187, DOI 10.1073/pnas.0806823106; Borer ET, 2005, ECOLOGY, V86, P528, DOI 10.1890/03-0816; Carpenter SR, 2001, ECOL MONOGR, V71, P163, DOI 10.1890/0012-9615(2001)071[0163:TCNALP]2.0.CO;2; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; DEANGELIS DL, 1992, DYNAMICS NUTRIENT CY; Doak DF, 2008, ECOLOGY, V89, P952, DOI 10.1890/07-0965.1; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Holling C. S., 1966, SYSTEMS ANAL ECOLOGY, P195, DOI DOI 10.1016/B978-1-4832-3283-6.50014-5; Ives AR, 2003, ECOL MONOGR, V73, P301, DOI 10.1890/0012-9615(2003)073[0301:ECSAEI]2.0.CO;2; May R.M., 1973, STABILITY COMPLEXITY; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; Neubert MG, 1997, ECOLOGY, V78, P653, DOI 10.1890/0012-9658(1997)078[0653:ATRFMT]2.0.CO;2; Paine RT, 1980, J ANIM ECOL, V49, P666, DOI DOI 10.2307/4220; Peterson RO, 1998, J MAMMAL, V79, P828, DOI 10.2307/1383091; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Rasero M, 1996, J MAR BIOL ASSOC UK, V76, P73, DOI 10.1017/S0025315400029027; Rip JMK, 2010, P ROY SOC B-BIOL SCI, V277, P1743, DOI 10.1098/rspb.2009.2191; Schmitz OJ, 2004, ECOL LETT, V7, P403, DOI 10.1111/j.1461-0248.2004.00592.x; Shurin JB, 2005, J ANIM ECOL, V74, P1029, DOI 10.1111/j.1365-2656.2005.00999.x; Sibert J, 2006, SCIENCE, V314, P1773, DOI 10.1126/science.1135347; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; THURBER JM, 1993, J MAMMAL, V74, P879, DOI 10.2307/1382426; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Vander Zanden MJ, 2005, CAN J FISH AQUAT SCI, V62, P1422, DOI 10.1139/F05-042; Vander Zanden MJ, 2002, ECOLOGY, V83, P2152, DOI 10.1890/0012-9658(2002)083[2152:FAIOBA]2.0.CO;2; Walters C, 1997, REV FISH BIOL FISHER, V7, P139, DOI 10.1023/A:1018479526149; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wilmers CC, 2006, ECOL LETT, V9, P383, DOI 10.1111/j.1461-0248.2006.00890.x; WOOTTON JT, 1992, ECOLOGY, V73, P981, DOI 10.2307/1940174; WOOTTON JT, 1994, ECOLOGY, V75, P151, DOI 10.2307/1939391; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2; YODZIS P, 1992, AM NAT, V139, P1151, DOI 10.1086/285380; Yodzis P, 2000, ECOLOGY, V81, P261, DOI 10.1890/0012-9658(2000)081[0261:DEIFW]2.0.CO;2	39	3	3	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29723	10.1371/journal.pone.0029723	http://dx.doi.org/10.1371/journal.pone.0029723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216348	gold, Green Published, Green Submitted			2022-12-27	WOS:000300674900056
J	Simmons, LW; Peters, M; Rhodes, G				Simmons, Leigh W.; Peters, Marianne; Rhodes, Gillian			Low Pitched Voices Are Perceived as Masculine and Attractive but Do They Predict Semen Quality in Men?	PLOS ONE			English	Article							FORMANT FREQUENCIES INFLUENCE; SPERM COMPETITION; FLUCTUATING ASYMMETRY; FACIAL ATTRACTIVENESS; WOMENS PREFERENCES; HORMONE-RECEPTORS; SEXUAL-DIMORPHISM; MENSTRUAL-CYCLE; MALE PHENOTYPE; MATE-CHOICE	Women find masculinity in men's faces, bodies, and voices attractive, and women's preferences for men's masculine features are thought to be biological adaptations for finding a high quality mate. Fertility is an important aspect of mate quality. Here we test the phenotype-linked fertility hypothesis, which proposes that male secondary sexual characters are positively related to semen quality, allowing females to obtain direct benefits from mate choice. Specifically, we examined women's preferences for men's voice pitch, and its relationship with men's semen quality. Consistent with previous voice research, women judged lower pitched voices as more masculine and more attractive. However men with lower pitched voices did not have better semen quality. On the contrary, men whose voices were rated as more attractive tended to have lower concentrations of sperm in their ejaculate. These data are more consistent with a trade off between sperm production and male investment in competing for and attracting females, than with the phenotype-linked fertility hypothesis.	[Simmons, Leigh W.; Peters, Marianne] Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol M092, Crawley, WA, Australia; [Simmons, Leigh W.; Peters, Marianne; Rhodes, Gillian] Univ Western Australia, Sch Psychol, ARC Ctr Excellence Cognit & Its Disorders, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Simmons, LW (corresponding author), Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol M092, Crawley, WA, Australia.	leigh.simmons@uwa.edu.au	Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474; Rhodes, Gillian/0000-0002-3631-8518	Australian Research Council; Australian Research Council Centre of Excellence for Cognition and its Disorders [CE110001021]	Australian Research Council(Australian Research Council); Australian Research Council Centre of Excellence for Cognition and its Disorders(Australian Research Council)	This work was supported by Australian Research Council Professorial Fellowships to Gillian Rhodes and Leigh Simmons. It was also supported by the Australian Research Council Centre of Excellence for Cognition and its Disorders (project number CE110001021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2003, J ANDROL, V24, P343; Aitken RJ, 2004, NATURE, V432, P48, DOI 10.1038/432048a; Apicella CL, 2007, BIOL LETTERS, V3, P682, DOI 10.1098/rsbl.2007.0410; Apicella CL, 2009, P ROY SOC B-BIOL SCI, V276, P1077, DOI 10.1098/rspb.2008.1542; ARCE JC, 1993, FERTIL STERIL, V59, P398, DOI 10.1016/s0015-0282(16)55684-2; Aribarg A, 1996, FERTIL STERIL, V65, P821; Blank H, 2011, J NEUROSCI, V31, P12906, DOI 10.1523/JNEUROSCI.2091-11.2011; Boersma P., 2020, PRAAT DOING PHONETIC; Bonde JPE, 1998, LANCET, V352, P1172, DOI 10.1016/S0140-6736(97)10514-1; Bruckert L, 2006, P ROY SOC B-BIOL SCI, V273, P83, DOI 10.1098/rspb.2005.3265; COHEN J, 1981, ANDROLOGIA, V13, P491; Collins SA, 2000, ANIM BEHAV, V60, P773, DOI 10.1006/anbe.2000.1523; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Crawley M.J., 1993, GLIM ECOLOGISTS; Dabbs JM, 1999, PERS INDIV DIFFER, V27, P801, DOI 10.1016/S0191-8869(98)00272-4; DESOUZA MJ, 1994, INT J SPORTS MED, V15, P383, DOI 10.1055/s-2007-1021075; Donnelly ET, 1998, FERTIL STERIL, V70, P305, DOI 10.1016/S0015-0282(98)00146-0; Dziminski MA, 2010, REPROD FERT DEVELOP, V22, P516, DOI 10.1071/RD09124; Dziminski MA, 2009, P ROY SOC B-BIOL SCI, V276, P3955, DOI 10.1098/rspb.2009.1334; Evans S, 2008, PHYSIOL BEHAV, V93, P783, DOI 10.1016/j.physbeh.2007.11.033; Feinberg DR, 2011, BEHAV ECOL, V22, P1320, DOI 10.1093/beheco/arr134; Feinberg DR, 2008, EVOL HUM BEHAV, V29, P233, DOI 10.1016/j.evolhumbehav.2007.12.008; Feinberg DR, 2006, HORM BEHAV, V49, P215, DOI 10.1016/j.yhbeh.2005.07.004; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Firman RC, 2003, HUM REPROD, V18, P808, DOI 10.1093/humrep/deg174; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; FLEMING IA, 1994, EVOLUTION, V48, P637, DOI 10.1111/j.1558-5646.1994.tb01350.x; Folstad I, 1997, BEHAV ECOL, V8, P109, DOI 10.1093/beheco/8.1.109; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Garcia-Gonzalez F, 2005, J EVOLUTION BIOL, V18, P1097, DOI 10.1111/j.1420-9101.2005.00889.x; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Harries MLL, 1997, ARCH DIS CHILD, V77, P445, DOI 10.1136/adc.77.5.445; Hillgarth N, 1997, BEHAV ECOL, V8, P108, DOI 10.1093/beheco/8.1.108; Hirano Y, 2001, J ASSIST REPROD GEN, V18, P213; Hodges-Simeon CR, 2011, ARCH SEX BEHAV, V40, P551, DOI 10.1007/s10508-010-9625-0; Hughes SM, 2004, EVOL HUM BEHAV, V25, P295, DOI 10.1016/j.evolhumbehav.2004.06.001; Hughes SM, 2002, EVOL HUM BEHAV, V23, P173, DOI 10.1016/S1090-5138(01)00099-X; Kilgallon SJ, 2005, BIOL LETTERS, V1, P253, DOI 10.1098/rsbl.2005.0324; Little AC, 2007, HORM BEHAV, V51, P633, DOI 10.1016/j.yhbeh.2007.03.006; Little AC, 2011, BEHAV ECOL, V22, P862, DOI 10.1093/beheco/arr061; Locatello L, 2006, J EVOLUTION BIOL, V19, P1595, DOI 10.1111/j.1420-9101.2006.01117.x; Malo AF, 2005, BIOL REPROD, V72, P822, DOI 10.1095/biolreprod.104.036368; Malo AF, 2005, P ROY SOC B-BIOL SCI, V272, P149, DOI 10.1098/rspb.2004.2933; Manning JT, 1998, EVOL HUM BEHAV, V19, P273, DOI 10.1016/S1090-5138(98)00024-5; Matthews IM, 1997, P ROY SOC B-BIOL SCI, V264, P695, DOI 10.1098/rspb.1997.0099; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; Montrose VT, 2008, J EVOLUTION BIOL, V21, P1290, DOI 10.1111/j.1420-9101.2008.01570.x; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Newman SR, 2000, J VOICE, V14, P72, DOI 10.1016/S0892-1997(00)80096-X; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Peters A, 2000, BEHAV ECOL SOCIOBIOL, V47, P438, DOI 10.1007/s002650050688; Peters M, 2008, J EVOLUTION BIOL, V21, P572, DOI 10.1111/j.1420-9101.2007.01477.x; Peters M, 2008, ANIM BEHAV, V76, P297, DOI 10.1016/j.anbehav.2008.02.008; Peters M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004138; Pitcher TE, 2009, J FISH BIOL, V74, P1450, DOI 10.1111/j.1095-8649.2009.02210.x; Pitcher TE, 2001, CAN J ZOOL, V79, P1891, DOI 10.1139/cjz-79-10-1891; Pizzari T, 2004, P ROY SOC B-BIOL SCI, V271, P51, DOI 10.1098/rspb.2003.2577; Pound N, 2009, P ROY SOC B-BIOL SCI, V276, P153, DOI 10.1098/rspb.2008.0990; Preston BT, 2011, ECOL LETT, V14, P1017, DOI 10.1111/j.1461-0248.2011.01668.x; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; Puts DA, 2012, P ROY SOC B-BIOL SCI, V279, P601, DOI 10.1098/rspb.2011.0829; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G., 2007, OXFORD HDB EVOLUTION, P333; Riding D, 2006, J NONVERBAL BEHAV, V30, P55, DOI 10.1007/s10919-006-0005-3; Rogers DW, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-236; Rowe M, 2010, ANIM BEHAV, V79, P1239, DOI 10.1016/j.anbehav.2010.02.020; Rudolfsen G, 2008, AQUAC RES, V39, P212, DOI 10.1111/j.1365-2109.2007.01863.x; Safarinejad MR, 2009, J ENDOCRINOL, V200, P259, DOI 10.1677/JOE-08-0477; Salvador A, 1997, BEHAV ECOL, V8, P135, DOI 10.1093/beheco/8.2.135; Saxton TK, 2006, ETHOLOGY, V112, P1179, DOI 10.1111/j.1439-0310.2006.01278.x; SCOTT IML, 2012, BEHAV ECOLO IN PRESS; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; Simmons LW, 2010, BEHAV ECOL, V21, P1330, DOI 10.1093/beheco/arq154; Simmons LW, 2004, ANIM BEHAV, V68, P297, DOI 10.1016/j.anbehav.2003.11.013; Sjogren B, 2001, CONTRACEPTION, V64, P59, DOI 10.1016/S0010-7824(01)00223-2; Soler C, 2003, EVOL HUM BEHAV, V24, P199, DOI 10.1016/S1090-5138(03)00013-8; Swaddle JP, 2002, P ROY SOC B-BIOL SCI, V269, P2285, DOI 10.1098/rspb.2002.2165; TAUBER PF, 1975, J REPROD FERTIL, V43, P249; Titze IR, 1994, PRINCIPLES VOCAL PRO; Van Dongen S, 2011, EVOL HUM BEHAV, V32, P380, DOI 10.1016/j.evolhumbehav.2011.03.002; Voelter C, 2008, EUR ARCH OTO-RHINO-L, V265, P1239, DOI 10.1007/s00405-008-0632-x; Weeden J, 2005, PSYCHOL BULL, V131, P635, DOI 10.1037/0033-2909.131.5.635; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Wolff SE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1673, DOI 10.1007/s00265-010-0981-5; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Wylie K, 2011, J SEX MED, V8, P1261, DOI 10.1111/j.1743-6109.2011.02269.x; Zirkin BR, 1998, SEMIN CELL DEV BIOL, V9, P417, DOI 10.1006/scdb.1998.0253; ZUK M, 1995, P ROY SOC B-BIOL SCI, V260, P205, DOI 10.1098/rspb.1995.0081	91	30	32	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29271	10.1371/journal.pone.0029271	http://dx.doi.org/10.1371/journal.pone.0029271			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216228	Green Submitted, Green Published, gold			2022-12-27	WOS:000299113600072
J	McGraw, LA; Davis, JK; Thomas, PJ; Young, LJ; Thomas, JW				McGraw, Lisa A.; Davis, Jamie K.; Thomas, Pamela J.; Young, Larry J.; Thomas, James W.		NISC Comparative Sequencing	BAC-Based Sequencing of Behaviorally-Relevant Genes in the Prairie Vole	PLOS ONE			English	Article							NUCLEOTIDE DIVERSITY; RECEPTOR; VASOPRESSIN; EXPRESSION; SUBSTITUTIONS; CONSTRUCTION; POPULATIONS; OXYTOCIN; RATES	The prairie vole (Microtus ochrogaster) is an important model organism for the study of social behavior, yet our ability to correlate genes and behavior in this species has been limited due to a lack of genetic and genomic resources. Here we report the BAC-based targeted sequencing of behaviorally-relevant genes and flanking regions in the prairie vole. A total of 6.4 Mb of non-redundant or haplotype-specific sequence assemblies were generated that span the partial or complete sequence of 21 behaviorally-relevant genes as well as an additional 55 flanking genes. Estimates of nucleotide diversity from 13 loci based on alignments of 1.7 Mb of haplotype-specific assemblies revealed an average pair-wise heterozygosity (8.4x10(-3)). Comparative analyses of the prairie vole proteins encoded by the behaviorally-relevant genes identified > 100 substitutions specific to the prairie vole lineage. Finally, our sequencing data indicate that a duplication of the prairie vole AVPR1A locus likely originated from a recent segmental duplication spanning a minimum of 105 kb. In summary, the results of our study provide the genomic resources necessary for the molecular and genetic characterization of a high-priority set of candidate genes for regulating social behavior in the prairie vole.	[McGraw, Lisa A.; Young, Larry J.] Emory Univ, Ctr Translat Social Neurosci, Atlanta, GA 30322 USA; [McGraw, Lisa A.; Young, Larry J.] N Carolina State Univ, Yerkes Natl Primate Res Ctr, Raleigh, NC 27695 USA; [Davis, Jamie K.; Thomas, James W.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Thomas, Pamela J.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Thomas, Pamela J.; NISC Comparative Sequencing] NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Young, Larry J.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA	Emory University; University of North Carolina; North Carolina State University; Emory University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Emory University	McGraw, LA (corresponding author), N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA.	lamcgraw@ncsu.edu	Young, Larry/HGE-5031-2022	McGraw, Lisa/0000-0001-9627-9082	National Human Genome Research Institute of the National Institutes of Health; National Institutes of Health [1R21MH082225]; NIH [MH064692];  [1F32MH079661];  [RR00165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH064692, R21MH082225, F32MH079661] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The NIH Intramural Sequencing Center was supported by the Intramural Research Program of the National Human Genome Research Institute (www.genome.gov/) of the National Institutes of Health (www.nih.gov). JWT, JKD, and LJY were supported by National Institutes of Health grant 1R21MH082225 and LAM by grant 1F32MH079661. LJY was further supported by NIH MH064692, Autism Speaks (www.autismspeaks.org) and RR00165 to YNPRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragona BJ, 2006, NAT NEUROSCI, V9, P133, DOI 10.1038/nn1613; Aragona BJ, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.015.2009; Baines JF, 2007, GENETICS, V175, P1911, DOI 10.1534/genetics.106.069419; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Blakesley RW, 2004, GENOME RES, V14, P2235, DOI 10.1101/gr.2648404; Bosch OJ, 2009, NEUROPSYCHOPHARMACOL, V34, P1406, DOI 10.1038/npp.2008.154; CARTER CS, 1995, NEUROSCI BIOBEHAV R, V19, P303; Cushing BS, 2008, J NEUROSCI, V28, P10399, DOI 10.1523/JNEUROSCI.1928-08.2008; Cushing BS, 2004, BRAIN RES, V1016, P247, DOI 10.1016/j.brainres.2004.05.010; Davis JK, 2010, GENOME BIOL EVOL, V2, P358, DOI 10.1093/gbe/evq027; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Hellborg L, 2004, MOL BIOL EVOL, V21, P158, DOI 10.1093/molbev/msh008; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kramer KM, 2006, NEUROSCIENCE, V142, P165, DOI 10.1016/j.neuroscience.2006.05.069; Lei K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008931; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lim MM, 2007, HORM BEHAV, V51, P508, DOI 10.1016/j.yhbeh.2007.01.006; Liu Y, 2001, BEHAV NEUROSCI, V115, P910, DOI 10.1037//0735-7044.115.4.910; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; McGraw LA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-70; McGraw LA, 2010, TRENDS NEUROSCI, V33, P103, DOI 10.1016/j.tins.2009.11.006; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pool JE, 2010, GENOME RES, V20, P291, DOI 10.1101/gr.079509.108; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Storz JF, 2008, GENETICS, V180, P367, DOI 10.1534/genetics.108.088732; Thomas JW, 2002, GENOME RES, V12, P1277, DOI 10.1101/gr.283202; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Young KA, 2011, FRONT NEUROENDOCRIN, V32, P53, DOI 10.1016/j.yfrne.2010.07.006; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475; Young LJ, 1996, J NEUROENDOCRINOL, V8, P777, DOI 10.1046/j.1365-2826.1996.05188.x; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007	40	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29345	10.1371/journal.pone.0029345	http://dx.doi.org/10.1371/journal.pone.0029345			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238603	gold, Green Published, Green Submitted			2022-12-27	WOS:000301188800013
J	Kyaw, T; Tay, C; Hosseini, H; Kanellakis, P; Gadowski, T; MacKay, F; Tipping, P; Bobik, A; Toh, BH				Kyaw, Tin; Tay, Christopher; Hosseini, Hamid; Kanellakis, Peter; Gadowski, Tahlia; MacKay, Fabeinne; Tipping, Peter; Bobik, Alex; Toh, Ban-Hock			Depletion of B2 but Not B1a B Cells in BAFF Receptor-Deficient ApoE(-/-) Mice Attenuates Atherosclerosis by Potently Ameliorating Arterial Inflammation	PLOS ONE			English	Article							ACTIVATING FACTOR BAFF; T-CELL; ADHESION MOLECULES; VCAM-1; RESPONSES; LESIONS; IMMUNE; IMMUNOGLOBULIN; POLARIZATION; ENDOTHELIUM	We have recently identified conventional B2 cells as atherogenic and B1a cells as atheroprotective in hypercholesterolemic ApoE(-/-) mice. Here, we examined the development of atherosclerosis in BAFF-R deficient ApoE(-/-) mice because B2 cells but not B1a cells are selectively depleted in BAFF-R deficient mice. We fed BAFF-R-/- ApoE(-/-) (BaffR.ApoE DKO) and BAFF-R+/+ ApoE(-/-) (ApoE KO) mice a high fat diet (HFD) for 8-weeks. B2 cells were significantly reduced by 82%, 81%, 94%, 72% in blood, peritoneal fluid, spleen and peripheral lymph nodes respectively; while B1a cells and non-B lymphocytes were unaffected. Aortic atherosclerotic lesions assessed by oil red-O stained-lipid accumulation and CD68+ macrophage accumulation were decreased by 44% and 50% respectively. B cells were absent in atherosclerotic lesions of BaffR.ApoE DKO mice as were IgG1 and IgG2a immunoglobulins produced by B2 cells, despite low but measurable numbers of B2 cells and IgG1 and IgG2a immunoglobulin concentrations in plasma. Plasma IgM and IgM deposits in atherosclerotic lesions were also reduced. BAFF-R deficiency in ApoE(-/-) mice was also associated with a reduced expression of VCAM-1 and fewer macrophages, dendritic cells, CD4+ and CD8+ T cell infiltrates and PCNA+ cells in lesions. The expression of proinflammatory cytokines, TNF-alpha, IL1-beta and proinflammatory chemokine MCP-1 was also reduced. Body weight and plasma cholesterols were unaffected in BaffR.ApoE DKO mice. Our data indicate that B2 cells are important contributors to the development of atherosclerosis and that targeting the BAFF-R to specifically reduce atherogenic B2 cell numbers while preserving atheroprotective B1a cell numbers may be a potential therapeutic strategy to reduce atherosclerosis by potently reducing arterial inflammation.	[Kyaw, Tin; Tay, Christopher; Hosseini, Hamid; Kanellakis, Peter; Gadowski, Tahlia; Bobik, Alex] Baker IDI Heart & Diabet Inst, Vasc Biol & Atherosclerosis Lab, Melbourne, Vic, Australia; [Kyaw, Tin; Tay, Christopher; Hosseini, Hamid; Tipping, Peter; Toh, Ban-Hock] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Med, Ctr Inflammatory Dis,So Clin Sch, Clayton, Vic 3800, Australia; [MacKay, Fabeinne] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Immunol, Cent Clin Sch, Clayton, Vic 3800, Australia	Baker Heart and Diabetes Institute; Monash University; Monash University	Kyaw, T (corresponding author), Baker IDI Heart & Diabet Inst, Vasc Biol & Atherosclerosis Lab, Melbourne, Vic, Australia.	Tinsoe.Kyaw@bakeridi.edu.au	Mackay, Fabienne/B-7440-2008; Kyaw, Tin/F-7712-2013	Mackay, Fabienne/0000-0002-6074-2693; Gadowski, Tahlia/0000-0002-1531-2010; Kyaw, Tin/0000-0003-4003-7433	National Health and Medical Research Council of Australia; National Heart Foundation of Australia; Victorian Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Victorian Government	This study is supported by the National Health and Medical Research Council of Australia and the National Heart Foundation of Australia and supported in part by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Brink R, 2006, SEMIN IMMUNOL, V18, P276, DOI 10.1016/j.smim.2006.04.003; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; Chan T, 2011, CELL IMMUNOL, V266, P180, DOI 10.1016/j.cellimm.2010.10.002; CID MC, 1994, J CLIN INVEST, V93, P17, DOI 10.1172/JCI116941; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Davidson A, 2010, CURR OPIN IMMUNOL, V22, P732, DOI 10.1016/j.coi.2010.09.010; de Chaisemartin L, 2011, CANC RES; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; HANSSON GK, 1984, ACTA PATH MICRO IM A, V92, P429; Hortelano S, 2010, CARDIOVASC RES, V86, P283, DOI 10.1093/cvr/cvq050; Hyun YM, 2009, J IMMUNOL, V183, P359, DOI 10.4049/jimmunol.0803388; Kanellakis P, 2011, ARTERIOSCL THROM VAS, V31, P313, DOI 10.1161/ATVBAHA.110.218669; Kolbus D, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-58; Kyaw T, 2011, CIRC RES; Kyaw T, 2011, CURR OPIN LIPIDOL, V22, P373, DOI 10.1097/MOL.0b013e32834adaf3; Kyaw T, 2010, J IMMUNOL, V185, P4410, DOI 10.4049/jimmunol.1000033; Lied GA, 2011, SCAND J IMMUNOL, V73, P1, DOI 10.1111/j.1365-3083.2010.02470.x; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Major AS, 2002, ARTERIOSCL THROM VAS, V22, P1892, DOI 10.1161/01.ATV.0000039169.47943.EE; Mallat Z, 2009, J LIPID RES, V50, pS364, DOI 10.1194/jlr.R800092-JLR200; Micha R, 2011, AM J CARDIOL; MILLER DJ, 1991, EUR J IMMUNOL, V21, P1123, DOI 10.1002/eji.1830210506; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ou R, 2008, J VIROL, V82, P2952, DOI 10.1128/JVI.02191-07; PARUMS D, 1981, ATHEROSCLEROSIS, V38, P211, DOI 10.1016/0021-9150(81)90118-0; Rahman ZSM, 2003, J EXP MED, V198, P1157, DOI 10.1084/jem.20030495; Ramos CL, 1999, CIRC RES, V84, P1237, DOI 10.1161/01.RES.84.11.1237; REKHTER MD, 1995, AM J PATHOL, V147, P668; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2009, J THROMB HAEMOST, V7, P332, DOI 10.1111/j.1538-7836.2009.03404.x; Sanz I, 2010, NAT REV RHEUMATOL, V6, P326, DOI 10.1038/nrrheum.2010.68; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Steiner O, 2010, J IMMUNOL, V185, P4846, DOI 10.4049/jimmunol.0903732; Sung B, 1998, NEUROSCI LETT, V246, P117, DOI 10.1016/S0304-3940(98)00235-3; Sutherland APR, 2005, J IMMUNOL, V174, P5537, DOI 10.4049/jimmunol.174.9.5537; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Townsend MJ, 2010, IMMUNOL REV, V237, P264, DOI 10.1111/j.1600-065X.2010.00945.x; YLAHERTTUALA S, 1994, ARTERIOSCLER THROMB, V14, P32, DOI 10.1161/01.ATV.14.1.32	45	117	119	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29371	10.1371/journal.pone.0029371	http://dx.doi.org/10.1371/journal.pone.0029371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238605	gold, Green Published			2022-12-27	WOS:000301070200024
J	Sjolinder, M; Altenbacher, G; Hagner, M; Sun, W; Schedin-Weiss, S; Sjolinder, H				Sjolinder, Mikael; Altenbacher, Georg; Hagner, Matthias; Sun, Wei; Schedin-Weiss, Sophia; Sjolinder, Hong			Meningococcal Outer Membrane Protein NhhA Triggers Apoptosis in Macrophages	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS NHHA; PORIN PORB; SEROGROUP-B; CELLS; SEPSIS; IDENTIFICATION; MITOCHONDRIA; INHIBITION; LYMPHOCYTE; LETHALITY	Phagocytotic cells play a fundamental role in the defense against bacterial pathogens. One mechanism whereby bacteria evade phagocytosis is to produce factors that trigger apoptosis. Here we identify for the first time a meningococcal protein capable of inducing macrophage apoptosis. The conserved meningococcal outer membrane protein NhhA (Neisseria hia/hsf homologue A, also known as Hsf) mediates bacterial adhesion and interacts with extracellular matrix components heparan sulphate and laminin. Meningococci lacking NhhA fail to colonise nasal mucosa in a mouse model of meningococcal disease. We found that exposure of macrophages to NhhA resulted in a highly increased rate of apoptosis that proceeded through caspase activation. Exposure of macrophages to NhhA also led to iNOS induction and nitric oxide production. However, neither nitric oxide production nor TNF-alpha signaling was found to be a prerequisite for NhhA-induced apoptosis. Macrophages exposed to wildtype NhhA-expressing meningococci were also found to undergo apoptosis whereas NhhA-deficient meningococci had a markedly decreased capacity to induce macrophage apoptosis. These data provide new insights on the role of NhhA in meningococcal disease. NhhA-induced macrophage apoptosis could be a mechanism whereby meningococci evade immunoregulatory and phagocytotic actions of macrophages.	[Sjolinder, Mikael; Altenbacher, Georg; Hagner, Matthias; Sjolinder, Hong] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden; [Sun, Wei; Schedin-Weiss, Sophia] Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden	Stockholm University; Uppsala University	Sjolinder, M (corresponding author), Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden.	hong.sjolinder@gmt.su.se		Schedin Weiss, Sophia/0000-0003-2143-7052	Swedish Research Council [2008-2572, 2008-3367]; Swedish Society of Medicine; Magnus Bergvalls Foundation; Harald Jeanssons Foundation; Tore Nilsons Foundation; Ake Wiberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Magnus Bergvalls Foundation; Harald Jeanssons Foundation; Tore Nilsons Foundation; Ake Wiberg Foundation	This work was supported by the Swedish Research Council (Grant no. 2008-2572, 2008-3367, www.vr.se), the Swedish Society of Medicine (www.sls.se), the Magnus Bergvalls Foundation (http://www.magnbergvallsstiftelse.nu), the Harald Jeanssons Foundation (http://www.jeanssonsstiftelser.se), the Tore Nilsons Foundation (http://www.torenilsonsstiftelse.nu), and the Ake Wiberg Foundation (http://www.ake-wiberg.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Milh M, 2001, INFECT IMMUN, V69, P7356, DOI 10.1128/IAI.69.12.7356-7364.2001; Deghmane AE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000405; Echenique-Rivera H, 2011, INFECT IMMUN, V79, P4308, DOI 10.1128/IAI.00198-11; Griffiths NJ, 2011, MOL MICROBIOL; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Jendrossek V, 2003, INFECT IMMUN, V71, P2665, DOI 10.1128/IAI.71.5.2665-2673.2003; MAJDE JA, 1993, PEPTIDES, V14, P629, DOI 10.1016/0196-9781(93)90155-A; Marriott HM, 2004, FASEB J, V18, P1126, DOI 10.1096/fj.03-1450fje; Marshall JC, 2008, BIOCHEM BIOPH RES CO, V369, P532, DOI 10.1016/j.bbrc.2008.02.044; Massari P, 2000, P NATL ACAD SCI USA, V97, P9070, DOI 10.1073/pnas.97.16.9070; Meyer M, 2008, BIOTECHNIQUES, V45, P317, DOI 10.2144/000112908; Muller A, 2000, EMBO J, V19, P5332, DOI 10.1093/emboj/19.20.5332; Muller A, 1999, EMBO J, V18, P339, DOI 10.1093/emboj/18.2.339; Padron J, 1999, FEMS IMMUNOL MED MIC, V25, P385, DOI 10.1016/S0928-8244(99)00113-3; Peak IRA, 2000, FEMS IMMUNOL MED MIC, V28, P329, DOI 10.1111/j.1574-695X.2000.tb01494.x; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Sappington PL, 2002, GASTROENTEROLOGY, V123, P790, DOI 10.1053/gast.2002.35391; Scarselli M, 2006, MOL MICROBIOL, V61, P631, DOI 10.1111/j.1365-2958.2006.05261.x; Sjolinder H, 2008, INFECT IMMUN, V76, P5412, DOI 10.1128/IAI.00478-08; Sprong T, 2002, EUR CYTOKINE NETW, V13, P411; Tunbridge AJ, 2006, INFECT IMMUN, V74, P729, DOI 10.1128/IAI.74.1.729-733.2006; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wesche DE, 2005, J LEUKOCYTE BIOL, V78, P325, DOI 10.1189/jlb.0105017; Weynants VE, 2007, INFECT IMMUN, V75, P5434, DOI 10.1128/IAI.00411-07; Xaus J, 2000, BLOOD, V95, P3823; Xu GW, 2007, CELL RES, V17, P759, DOI 10.1038/cr.2007.52; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100	28	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29586	10.1371/journal.pone.0029586	http://dx.doi.org/10.1371/journal.pone.0029586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238624	gold, Green Published			2022-12-27	WOS:000301070200035
J	Graham, SP; Everett, HE; Haines, FJ; Johns, HL; Sosan, OA; Salguero, FJ; Clifford, DJ; Steinbach, F; Drew, TW; Crooke, HR				Graham, Simon P.; Everett, Helen E.; Haines, Felicity J.; Johns, Helen L.; Sosan, Olubukola A.; Salguero, Francisco J.; Clifford, Derek J.; Steinbach, Falko; Drew, Trevor W.; Crooke, Helen R.			Challenge of Pigs with Classical Swine Fever Viruses after C-Strain Vaccination Reveals Remarkably Rapid Protection and Insights into Early Immunity	PLOS ONE			English	Article							CSF MARKER VACCINE; PHYLOGENETIC ANALYSIS; ORAL IMMUNIZATION; EUROPEAN-UNION; E2; IDENTIFICATION; STRATEGIES; REPLICATION; GENOGROUP; EPIDEMIC	Pre-emptive culling is becoming increasingly questioned as a means of controlling animal diseases, including classical swine fever (CSF). This has prompted discussions on the use of emergency vaccination to control future CSF outbreaks in domestic pigs. Despite a long history of safe use in endemic areas, there is a paucity of data on aspects important to emergency strategies, such as how rapidly CSFV vaccines would protect against transmission, and if this protection is equivalent for all viral genotypes, including highly divergent genotype 3 strains. To evaluate these questions, pigs were vaccinated with the Riemser (R) C-strain vaccine at 1, 3 and 5 days prior to challenge with genotype 2.1 and 3.3 challenge strains. The vaccine provided equivalent protection against clinical disease caused by for the two challenge strains and, as expected, protection was complete at 5 days post-vaccination. Substantial protection was achieved after 3 days, which was sufficient to prevent transmission of the 3.3 strain to animals in direct contact. Even by one day post-vaccination approximately half the animals were partially protected, and were able to control the infection, indicating that a reduction of the infectious potential is achieved very rapidly after vaccination. There was a close temporal correlation between T cell IFN-gamma responses and protection. Interestingly, compared to responses of animals challenged 5 days after vaccination, challenge of animals 3 or 1 days post-vaccination resulted in impaired vaccine-induced T cell responses. This, together with the failure to detect a T cell IFN-gamma response in unprotected and unvaccinated animals, indicates that virulent CSFV can inhibit the potent antiviral host defences primed by C-strain in the early period post vaccination.	[Graham, Simon P.; Everett, Helen E.; Haines, Felicity J.; Johns, Helen L.; Sosan, Olubukola A.; Steinbach, Falko; Drew, Trevor W.; Crooke, Helen R.] Anim Hlth & Vet Labs Agcy, Dept Virol, Addlestone, Surrey, England; [Salguero, Francisco J.] Anim Hlth & Vet Labs Agcy, Pathol & Host Susceptibil Dept, Addlestone, Surrey, England; [Clifford, Derek J.] Anim Hlth & Vet Labs Agcy, Specialist Sci Serv, Addlestone, Surrey, England	Veterinary Laboratories Agency; Veterinary Laboratories Agency; Veterinary Laboratories Agency	Graham, SP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Virol Sect, London, England.	Helen.crooke@ahvla.gsi.gov.uk	Drew, Trevor W/ABB-5205-2020; Salguero, Francisco J/A-7336-2010; Crooke, Helen/D-6710-2011; Graham, Simon P/C-8337-2011; Drew, Trevor W/C-5200-2011; Steinbach, Falko/V-1682-2019; Everett, Helen E/D-7123-2011	Graham, Simon P/0000-0003-4852-405X; Steinbach, Falko/0000-0003-1236-2837; Crooke, Helen/0000-0003-1237-6542; Everett, Helen/0000-0002-1233-4265; Salguero, Francisco Javier/0000-0002-5315-3882; Drew, Trevor/0000-0002-0448-1062	Department for Environment, Food and Rural Affairs of the United Kingdom [SE0778]; European Commission [228394]	Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by project (SE0778) from the Department for Environment, Food and Rural Affairs of the United Kingdom. http://www.defra.gov.uk/. Pathological investigations were supported by the European Commission's Seventh Framework Programme (FP7/2007-2013) under grant agreement nu 228394 (NADIR) (http://cordis.europa.eu/fp7/home_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, EFSA J, V933, P1; Backer JA, 2009, J R SOC INTERFACE, V6, P849, DOI 10.1098/rsif.2008.0408; Beer M, 2007, VACCINE, V25, P5665, DOI 10.1016/j.vaccine.2006.12.036; BIRONT P, 1987, VET MICROBIOL, V14, P105, DOI 10.1016/0378-1135(87)90002-2; Blome S., 2011, VET MICROBIOL; Boklund A, 2009, PREV VET MED, V90, P180, DOI 10.1016/j.prevetmed.2009.04.008; Ceppi M, 2005, J GEN VIROL, V86, P2525, DOI 10.1099/vir.0.80907-0; Cha SH, 2007, VIRUS RES, V126, P256, DOI 10.1016/j.virusres.2007.01.017; Chen N, 2008, VET MICROBIOL, V127, P286, DOI 10.1016/j.vetmic.2007.09.009; Cohen NE, 2007, AGR HUM VALUES, V24, P499, DOI 10.1007/s10460-007-9086-9; DAHLE J, 1995, BERL MUNCH TIERARZTL, V108, P20; Deng MC, 2005, VET MICROBIOL, V106, P187, DOI 10.1016/j.vetmic.2004.12.014; Depner KR, 2001, VET MICROBIOL, V83, P107, DOI 10.1016/S0378-1135(01)00410-2; Dewulf J, 2004, PREV VET MED, V65, P121, DOI 10.1016/j.prevetmed.2004.05.010; Drew T., 2008, MAN DIAGN TESTS VACC, V6th, P1092; Everett H, 2009, VET MICROBIOL; Floegel-Niesmann G, 2001, VET MICROBIOL, V83, P121, DOI 10.1016/S0378-1135(01)00411-4; Graham SP, 2009, VET MICROBIOL; Greiser-Wilke I, 2000, VET MICROBIOL, V77, P17, DOI 10.1016/S0378-1135(00)00253-4; Greiser-Wilke Irene, 2004, Animal Health Research Reviews, V5, P223, DOI 10.1079/AHR200472; Kaden V, 2001, VET MICROBIOL, V82, P301, DOI 10.1016/S0378-1135(01)00400-X; KADEN V, 1982, ARCH EXP VET MED, V36, P593; Koenig P, 2007, VET MICROBIOL, V120, P343, DOI 10.1016/j.vetmic.2006.10.034; Mittelholzer C, 2000, VET MICROBIOL, V74, P293, DOI 10.1016/S0378-1135(00)00195-4; Mourits MCM, 2010, PREV VET MED, V96, P201, DOI 10.1016/j.prevetmed.2010.06.010; Pan CH, 2005, ARCH VIROL, V150, P1101, DOI 10.1007/s00705-004-0485-6; Parchariyanon S, 2000, DEUT TIERARZTL WOCH, V107, P236; Parchariyanon S., 2001, Journal of the Thai Veterinary Medical Association, V52, P9; Paton D, 2002, TRENDS IN EMERGING VIRAL INFECTIONS OF SWINE, P153; PAULY T, 1995, J GEN VIROL, V76, P3039, DOI 10.1099/0022-1317-76-12-3039; Qiu HuaJi, 2006, Agricultural Sciences in China, V5, P1, DOI 10.1016/S1671-2927(06)60013-8; Rau H, 2006, VET RES, V37, P155, DOI 10.1051/vetres:2005049; Sakoda Y, 1999, VET MICROBIOL, V65, P75, DOI 10.1016/S0378-1135(98)00284-3; Sandvik T, 2000, VET REC, V147, P251; Stegeman A, 2000, VET MICROBIOL, V73, P183, DOI 10.1016/S0378-1135(00)00144-9; Suradhat S, 2007, VET MICROBIOL, V119, P1, DOI 10.1016/j.vetmic.2006.10.003; Suradhat S, 2005, VET IMMUNOL IMMUNOP, V106, P197, DOI 10.1016/j.vetimm.2005.02.017; Suradhat S, 2003, VET MICROBIOL, V92, P187, DOI 10.1016/S0378-1135(02)00357-7; Suradhat S, 2001, VET IMMUNOL IMMUNOP, V83, P177, DOI 10.1016/S0165-2427(01)00389-0; Tarradas J, 2010, VET MICROBIOL, V142, P51, DOI 10.1016/j.vetmic.2009.09.043; TERPSTRA C, 1990, DEUT TIERARZTL WOCH, V97, P77; Uttenthal A, 2001, VET MICROBIOL, V83, P85, DOI 10.1016/S0378-1135(01)00409-6; Uttenthal A, 2010, EXPERT REV VACCINES, V9, P73, DOI 10.1586/ERV.09.130; van Oirschot J. T., 2003, VVolume 114, P259; van Oirschot JT, 2003, VET MICROBIOL, V96, P367, DOI 10.1016/j.vetmic.2003.09.008; Vandeputte J, 1999, REV SCI TECH OIE, V18, P638, DOI 10.20506/rst.18.3.1192; von Ruden S, 2008, VET MICROBIOL, V132, P29, DOI 10.1016/j.vetmic.2008.04.022; Weesendorp E, 2010, VET MICROBIOL, V147, P262; Zhang F, 2006, ARCH VIROL, V151, P37, DOI 10.1007/s00705-005-0623-9; Zhu Y, 2009, VIRUS RES, V142, P169, DOI 10.1016/j.virusres.2009.02.011	50	73	79	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29310	10.1371/journal.pone.0029310	http://dx.doi.org/10.1371/journal.pone.0029310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235283	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400044
J	Asano, E; Maeda, M; Hasegawa, H; Ito, S; Hyodo, T; Yuan, H; Takahashi, M; Hamaguchi, M; Senga, T				Asano, Eri; Maeda, Masao; Hasegawa, Hitoki; Ito, Satoko; Hyodo, Toshinori; Yuan, Hong; Takahashi, Masahide; Hamaguchi, Michinari; Senga, Takeshi			Role of Palladin Phosphorylation by Extracellular Signal-Regulated Kinase in Cell Migration	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CROSS-LINKING PROTEIN; ACTIN ORGANIZATION; BINDING PARTNER; ALPHA-ACTININ; SH3 DOMAINS; V-SRC; ADHESION; MOTILITY; ERK	Phosphorylation of actin-binding proteins plays a pivotal role in the remodeling of the actin cytoskeleton to regulate cell migration. Palladin is an actin-binding protein that is phosphorylated by growth factor stimulation; however, the identity of the involved protein kinases remains elusive. In this study, we report that palladin is a novel substrate of extracellular signal-regulated kinase (ERK). Suppression of ERK activation by a chemical inhibitor reduced palladin phosphorylation, and expression of active MEK alone was sufficient for phosphorylation. In addition, an in vitro kinase assay demonstrated direct palladin phosphorylation by ERK. We found that Ser77 and Ser197 are essential residues for phosphorylation. Although the phosphorylation of these residues was not required for actin cytoskeletal organization, we found that expression of non-phosphorylated palladin enhanced cell migration. Finally, we show that phosphorylation inhibits the palladin association with Abl tyrosine kinase. Taken together, our results indicate that palladin phosphorylation by ERK has an anti-migratory function, possibly by modulating interactions with molecules that regulate cell migration.	[Asano, Eri; Hasegawa, Hitoki; Ito, Satoko; Hyodo, Toshinori; Hamaguchi, Michinari; Senga, Takeshi] Nagoya Univ, Grad Sch Med, Div Canc Biol, Nagoya, Aichi 4648601, Japan; [Maeda, Masao] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi 4648601, Japan; [Yuan, Hong] Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, Nagoya, Aichi 4648601, Japan; [Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Dept Pathol, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University	Asano, E (corresponding author), Nagoya Univ, Grad Sch Med, Div Canc Biol, Nagoya, Aichi 4648601, Japan.	tsenga@med.nagoya-u.ac.jp	Takahashi, Masahide/AAN-4770-2020; MAEDA, Masao/P-2709-2015; TAKAHASHI, Masahide/I-7244-2014	Takahashi, Masahide/0000-0002-2803-2683; Maeda, Masao/0000-0001-5936-5790; Hyodo, Toshinori/0000-0003-3046-5338	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Boukhelifa M, 2006, FEBS J, V273, P26, DOI 10.1111/j.1742-4658.2005.05036.x; Boukhelifa M, 2004, CELL MOTIL CYTOSKEL, V58, P17, DOI 10.1002/cm.10173; Boukhelifa M, 2003, MOL CELL NEUROSCI, V23, P661, DOI 10.1016/S1044-7431(03)00127-1; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Clarke DM, 2004, J CELL BIOL, V166, P901, DOI 10.1083/jcb.200404024; Dixon RDS, 2008, J BIOL CHEM, V283, P6222, DOI 10.1074/jbc.M707694200; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Goicoechea SM, 2009, ONCOGENE, V28, P587, DOI 10.1038/onc.2008.408; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010; Han MY, 2007, MOL CELL BIOL, V27, P8190, DOI 10.1128/MCB.00661-07; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Hunger-Glaser I, 2003, J BIOL CHEM, V278, P22631, DOI 10.1074/jbc.M210876200; Ito S, 2010, MOL BIOL CELL, V21, P4120, DOI 10.1091/mbc.E10-05-0459; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kurata H, 2000, EXP CELL RES, V254, P180, DOI 10.1006/excr.1999.4738; Liu XS, 2007, J CELL BIOCHEM, V100, P1288, DOI 10.1002/jcb.21126; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Luo HJ, 2005, MOL CELL NEUROSCI, V29, P507, DOI 10.1016/j.mcn.2004.12.002; Maeda M, 2009, FEBS J, V276, P2775, DOI 10.1111/j.1742-4658.2009.07001.x; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; Mitsushima M, 2004, J BIOL CHEM, V279, P34570, DOI 10.1074/jbc.M402304200; Mykkanen OM, 2001, MOL BIOL CELL, V12, P3060, DOI 10.1091/mbc.12.10.3060; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Otey CA, 2005, INT REV CYTOL, V246, P31, DOI 10.1016/S0074-7696(05)46002-7; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; PAWSON T, 1994, ADV CANCER RES, V64, P87, DOI 10.1016/S0065-230X(08)60835-0; Porter AC, 1998, ONCOGENE, V17, P1343, DOI 10.1038/sj.onc.1202171; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Ronty M, 2005, EXP CELL RES, V310, P88, DOI 10.1016/j.yexcr.2005.06.026; Ronty M, 2004, FEBS LETT, V566, P30, DOI 10.1061/j.febslet.2004.04.006; Ronty M, 2007, EXP CELL RES, V313, P2575, DOI 10.1016/j.yexcr.2007.04.030; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Senga T, 2000, ONCOGENE, V19, P273, DOI 10.1038/sj.onc.1203296; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Taieb D, 2008, CANCER RES, V68, P4588, DOI 10.1158/0008-5472.CAN-08-0958; Yamasaki Y, 2007, BIOCHEM BIOPH RES CO, V361, P7, DOI 10.1016/j.bbrc.2007.06.159; Zhang X, CELL MOL BIOL LETT, V16, P279	39	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29338	10.1371/journal.pone.0029338	http://dx.doi.org/10.1371/journal.pone.0029338			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216253	Green Published, gold, Green Submitted			2022-12-27	WOS:000300676300048
J	La, D; Czarnecki, C; El-Gabalawy, H; Kumar, A; Meyers, AFA; Bastien, N; Simonsen, JN; Plummer, FA; Luo, M				La, David; Czarnecki, Chris; El-Gabalawy, Hani; Kumar, Anand; Meyers, Adrienne F. A.; Bastien, Nathalie; Simonsen, J. Neil; Plummer, Francis A.; Luo, Ma			Enrichment of Variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU Patients: An Exploratory Study	PLOS ONE			English	Article							HLA-C; ALLELE FREQUENCIES; VIRUS-INFECTION; SWINE FLU; INFLUENZA; KIR; IDENTIFICATION; DISEASE; BINDING; POLYMORPHISMS	Background: Infection by the pandemic influenza A (H1N1/09) virus resulted in significant pathology among specific ethnic groups worldwide. Natural Killer (NK) cells are important in early innate immune responses to viral infections. Activation of NK cells, in part, depend on killer-cell immunoglobulin-like receptors (KIR) and HLA class I ligand interactions. To study factors involved in NK cell dysfunction in overactive immune responses to H1N1 infection, KIR3DL1/S1 and KIR2DL2/L3 allotypes and cognate HLA ligands of H1N1/09 intensive-care unit (ICU) patients were determined. Methodology and Findings: KIR3DL1/S1, KIR2DL2/L3, and HLA -B and -C of 51 H1N1/09 ICU patients and 105 H1N1negative subjects (St. Theresa Point, Manitoba) were characterized. We detected an increase of 3DL1 ligand-negative pairs (3DL1/S1(+)Bw6(+)Bw4(-)), and a lack of 2DL1 HLA-C2 ligands, among ICU patients. They were also significantly enriched for 2DL2/L3 ligand-positive pairs (P<0.001, Pc<0.001; Odds Ratio: 6.3158, CI95%: 2.481-16.078). Relative to St. Theresa aboriginals (STh) and Venezuelan Amerindians (VA), allotypes enriched among aboriginal ICU patients (Ab) were: 2DL3 (Ab>VA, P = 0.024, Pc = 0.047; Odds Ratio: 2.563, CI95%: 1.109-5.923), 3DL1* 00101 (Ab>VA, P<0.001, Pc<0.001), 3DL1* 01502 (Ab>STh, P = 0.034, Pc = 0.268), and 3DL1* 029 (Ab>STh, P = 0.039, Pc = 0.301). Aboriginal patients ligandpositive for 3DL1/S1 and 2DL1 had the lowest probabilities of death (R-d) (R-d = 28%), compared to patients that were 3DL1/ S1 ligand-negative (Rd = 52%) or carried 3DL1*029 (Rd = 52%). Relative to Caucasoids (CA), two allotypes were enriched among non-aboriginal ICU patients (NAb): 3DL1*00401 (NAb>CA, P<0.001, Pc<0.001) and 3DL1*01502 (CA, NAb, P = 0.012, Pc = 0.156). Non-aboriginal patients with ligands for all three KIRs (3DL1/S1, 2DL2/L3, and 2DL1) had the lowest probabilities of death (R-d = 36%), compared to subjects with 3DL1* 01502 (R-d = 48%) and/or 3DL1*00401 (R-d = 58%). Conclusions: Specific KIR3DL1/S1 allotypes, 3DL1/S1 and 2DL1 ligand-negative pairs, and 2DL2/L3 ligand-positive pairs were enriched among ICU patients. This suggests a possible association with NK cell dysfunction in patients with overactive immune responses to H1N1/09, leading to severe disease.	[La, David; Czarnecki, Chris; Meyers, Adrienne F. A.; Bastien, Nathalie; Simonsen, J. Neil; Plummer, Francis A.; Luo, Ma] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Meyers, Adrienne F. A.; Plummer, Francis A.; Luo, Ma] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [El-Gabalawy, Hani] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Kumar, Anand] Univ Manitoba, Hlth Sci Ctr, Sect Crit Care Med, Winnipeg, MB, Canada; [Kumar, Anand] Univ Manitoba, St Boniface Hosp, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	La, D (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	ma.luo@phac-aspc.gc.ca		El-Gabalawy, Hani/0000-0002-0796-4422	Federal funding for H1N1 research; Roche, Canada	Federal funding for H1N1 research; Roche, Canada(Roche Holding)	This study was supported by the Federal funding for H1N1 research and in part by Roche, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, PAND H1N1 2009 UPD 7; Carlson J.M., 2009, MSRTR200953; Carr WH, 2005, J IMMUNOL, V175, P5222, DOI 10.4049/jimmunol.175.8.5222; Carrington M, 2004, HUM IMMUNOL, V65, P1191, DOI 10.1016/j.humimm.2004.08.154; Carrington M, 2003, THE KIR GENE CLUSTER; Chitnis Amit S, 2010, WMJ, V109, P201; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; Dee S, 2010, NEW ZEAL MED J, V123, P45; Denney L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010675; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Embree J, 2010, BIOCHEM CELL BIOL, V88, P589, DOI 10.1139/O10-025; Fauci AS, 2005, NAT REV IMMUNOL, V5, P835, DOI 10.1038/nri1711; Gardiner CM, 2001, J IMMUNOL, V166, P2992, DOI 10.4049/jimmunol.166.5.2992; Gendzekhadze K, 2006, IMMUNOGENETICS, V58, P474, DOI 10.1007/s00251-006-0108-3; Gillespie GMA, 2007, AIDS RES HUM RETROV, V23, P451, DOI 10.1089/aid.2006.0165; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; Hardie RA, 2010, HUM IMMUNOL, V71, P1251, DOI 10.1016/j.humimm.2010.09.013; Hoglund P, 2010, NAT REV IMMUNOL, V10, P724, DOI 10.1038/nri2835; Jamil KM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/298348; Kaufman MA, 2009, MED J AUSTRALIA, V191, P154, DOI 10.5694/j.1326-5377.2009.tb02726.x; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kulkarni S, 2008, SEMIN IMMUNOL, V20, P343, DOI 10.1016/j.smim.2008.06.003; La Ruche G, 2009, EURO SURVEILL, V14; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Liu BX, 2004, J GEN VIROL, V85, P423, DOI 10.1099/vir.0.19596-0; Lowry R., 2011, VASSARSTATS WEBSITE; Luo M, 2002, TISSUE ANTIGENS, V59, P370, DOI 10.1034/j.1399-0039.2002.590503.x; LUTZ CT, 1994, J IMMUNOL, V153, P4099; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Norman PJ, 2007, NAT GENET, V39, P1092, DOI 10.1038/ng2111; O'Riordan S, 2010, CAN MED ASSOC J, V182, P39, DOI 10.1503/cmaj.091724; Paine S, 2010, EUROSURVEILLANCE, V15, P9; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Reinders J, 2005, HUM IMMUNOL, V66, P912, DOI 10.1016/j.humimm.2005.06.010; Rempel JD, 2011, EUR J HUM GENET, V19, P1276, DOI 10.1038/ejhg.2011.114; Robinson J, 2005, NUCLEIC ACIDS RES, V33, pD523, DOI 10.1093/nar/gki032; Robinson J, 2000, TISSUE ANTIGENS, V55, P280, DOI 10.1034/j.1399-0039.2000.550314.x; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Turner SJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-130; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wada K, 2010, INFLUENZA OTHER RESP, V4, P179, DOI 10.1111/j.1750-2659.2010.00143.x; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1; Webster P, 2009, CAN MED ASSOC J, V181, pE90, DOI 10.1503/cmaj.091355; World Health Organization, 2010, PAND H1N1 2009 UPD 1; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884; Zarychanski R, 2010, CAN MED ASSOC J, V182, P257, DOI 10.1503/cmaj.091884	51	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29200	10.1371/journal.pone.0029200	http://dx.doi.org/10.1371/journal.pone.0029200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216211	Green Published, Green Submitted, gold			2022-12-27	WOS:000300676300036
J	Schwachtje, J; Karojet, S; Thormahlen, I; Bernholz, C; Kunz, S; Brouwer, S; Schwochow, M; Kohl, K; van Dongen, JT				Schwachtje, Jens; Karojet, Silke; Thormaehlen, Ina; Bernholz, Carolin; Kunz, Sabine; Brouwer, Stephan; Schwochow, Melanie; Koehl, Karin; van Dongen, Joost T.			A Naturally Associated Rhizobacterium of Arabidopsis thaliana Induces a Starvation-Like Transcriptional Response while Promoting Growth	PLOS ONE			English	Article							PLANT-GROWTH; BACTERIAL ENDOPHYTES; PSEUDOMONAS-BRASSICACEARUM; SOIL; EXPRESSION; REVEALS; SUCROSE; TRANSPORTERS; RHIZOSPHERE; DIAZOTROPHS	Plant growth promotion by rhizobacteria is a known phenomenon but the underlying mechanisms are poorly understood. We searched for plant growth-promoting rhizobacteria that are naturally associated with Arabidopsis thaliana to investigate the molecular mechanisms that are involved in plant growth-promotion. We isolated a Pseudomonas bacterium (Pseudomonas sp. G62) from roots of field-grown Arabidopsis plants that has not been described previously and analyzed its effect on plant growth, gene expression and the level of sugars and amino acids in the host plant. Inoculation with Pseudomonas sp. G62 promoted plant growth under various growth conditions. Microarray analysis revealed rapid changes in transcript levels of genes annotated to energy-, sugar-and cell wall metabolism in plants 6 h after root inoculation with P. sp. G62. The expression of several of these genes remained stable over weeks, but appeared differentially regulated in roots and shoots. The global gene expression profile observed after inoculation with P. sp. G62 showed a striking resemblance with previously described carbohydrate starvation experiments, although plants were not depleted from soluble sugars, and even showed a slight increase of the sucrose level in roots 5 weeks after inoculation. We suggest that the starvation-like transcriptional phenotype while steady state sucrose levels are not reduced - is induced by a yet unknown signal from the bacterium that simulates sugar starvation. We discuss the potential effects of the sugar starvation signal on plant growth promotion.	[Schwachtje, Jens; Karojet, Silke; Thormaehlen, Ina; Bernholz, Carolin; Kunz, Sabine; Brouwer, Stephan; Schwochow, Melanie; Koehl, Karin; van Dongen, Joost T.] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	Max Planck Society	Schwachtje, J (corresponding author), Max Planck Inst Mol Plant Physiol, Potsdam, Germany.	schwachtje@mpimp-golm.mpg.de; dongen@mpimp-golm.mpg.de	Thormählen, Ina/M-9081-2013; Thormählen, Ina/ABC-9612-2021; van Dongen, Joost T/F-5372-2016	Thormählen, Ina/0000-0002-8993-8745; van Dongen, Joost T/0000-0001-7944-9289; Brouwer, Stephan/0000-0002-9777-2992	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The research was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandham R, 2008, J BASIC MICROB, V48, P439, DOI 10.1002/jobm.200700380; Bartels A, 2007, PLANT PHYSIOL BIOCH, V45, P178, DOI 10.1016/j.plaphy.2007.02.005; Baudoin E, 2003, SOIL BIOL BIOCHEM, V35, P1183, DOI 10.1016/S0038-0717(03)00179-2; Belimov AA, 2007, J EXP BOT, V58, P1485, DOI 10.1093/jxb/erm010; Biemelt S, 2006, J PLANT PHYSIOL, V163, P307, DOI 10.1016/j.jplph.2005.10.011; Binder S, 2007, PHYSIOL PLANTARUM, V129, P68, DOI 10.1111/j.1399-3054.2006.00800.x; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Bloemberg GV, 2000, MOL PLANT MICROBE IN, V13, P1170, DOI 10.1094/MPMI.2000.13.11.1170; Bonfante P, 2008, TRENDS PLANT SCI, V13, P492, DOI 10.1016/j.tplants.2008.07.001; Burgmann H, 2004, APPL ENVIRON MICROB, V70, P240, DOI 10.1128/AEM.70.1.240-247.2004; Cartieaux F, 2003, PLANT J, V36, P177, DOI 10.1046/j.1365-313X.2003.01867.x; Cartieaux F, 2008, MOL PLANT MICROBE IN, V21, P244, DOI 10.1094/MPMI-21-2-0244; Charpentier M, 2010, CURR OPIN PLANT BIOL, V13, P556, DOI 10.1016/j.pbi.2010.08.003; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Cooper JE, 2007, J APPL MICROBIOL, V103, P1355, DOI 10.1111/j.1365-2672.2007.03366.x; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Desender S, 2007, CELL MICROBIOL, V9, P21, DOI 10.1111/j.1462-5822.2006.00831.x; Ferguson BJ, 2010, J INTEGR PLANT BIOL, V52, P61, DOI 10.1111/j.1744-7909.2010.00899.x; Geigenberger P, 1998, PLANTA, V205, P428, DOI 10.1007/s004250050340; Glick BR, 2007, EUR J PLANT PATHOL, V119, P329, DOI 10.1007/s10658-007-9162-4; Glick BR, 2007, CRIT REV PLANT SCI, V26, P227, DOI 10.1080/07352680701572966; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Goss EM, 2005, GENETICS, V169, P21, DOI 10.1534/genetics.104.031351; Hallmann J, 2006, MICROBIAL ROOT ENDOP, V9, P15, DOI DOI 10.1007/3-540-33526-9_2; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; HONMA M, 1978, AGR BIOL CHEM TOKYO, V42, P1825, DOI 10.1080/00021369.1978.10863261; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Jakob K, 2007, MOL PLANT MICROBE IN, V20, P146, DOI 10.1094/MPMI-20-2-0146; JONES MGK, 1977, PLANT PHYSIOL, V60, P379, DOI 10.1104/pp.60.3.379; Krajinski F, 2007, PHYTOCHEMISTRY, V68, P75, DOI 10.1016/j.phytochem.2006.09.035; Lohse M, 2010, PLANT PHYSIOL, V153, P642, DOI 10.1104/pp.109.152553; Long HH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002702; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Mantelin S, 2006, PLANTA, V223, P591, DOI 10.1007/s00425-005-0106-y; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; Mercado-Blanco J, 2007, ANTON LEEUW INT J G, V92, P367, DOI 10.1007/s10482-007-9167-1; Miyamoto T, 2004, APPL ENVIRON MICROB, V70, P6580, DOI 10.1128/AEM.70.11.6580-6586.2004; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Osuna D, 2007, PLANT J, V49, P463, DOI 10.1111/j.1365-313X.2006.02979.x; Ott T, 2005, CURR BIOL, V15, P531, DOI 10.1016/j.cub.2005.01.042; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schenk PM, 2005, PLANT PHYSIOL BIOCH, V43, P997, DOI 10.1016/j.plaphy.2005.09.002; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sessitsch A, 2002, FEMS MICROBIOL ECOL, V39, P23, DOI 10.1111/j.1574-6941.2002.tb00903.x; Sheng XF, 2008, ENVIRON POLLUT, V156, P1164, DOI 10.1016/j.envpol.2008.04.007; Sherson SM, 2003, J EXP BOT, V54, P525, DOI 10.1093/jxb/erg055; Sikorski J, 2001, ENVIRON MICROBIOL, V3, P176, DOI 10.1046/j.1462-2920.2001.00174.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Sturz AV, 1999, PLANT PATHOL, V48, P360, DOI 10.1046/j.1365-3059.1999.00351.x; Stuurman N, 2000, MOL PLANT MICROBE IN, V13, P1163, DOI 10.1094/MPMI.2000.13.11.1163; Sulpice R, 2009, P NATL ACAD SCI USA, V106, P10348, DOI 10.1073/pnas.0903478106; Takai R, 2008, MOL PLANT MICROBE IN, V21, P1635, DOI 10.1094/MPMI-21-12-1635; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Usadel B, 2008, PLANT PHYSIOL, V146, P1834, DOI 10.1104/pp.107.115592; van Loon LC, 2007, EUR J PLANT PATHOL, V119, P243, DOI 10.1007/s10658-007-9165-1; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Ventura M, 2001, FEMS MICROBIOL ECOL, V36, P113, DOI 10.1111/j.1574-6941.2001.tb00831.x; Verhagen BWM, 2004, MOL PLANT MICROBE IN, V17, P895, DOI 10.1094/MPMI.2004.17.8.895; Verma SC, 2001, J BIOTECHNOL, V91, P127, DOI 10.1016/S0168-1656(01)00333-9; Wang YQ, 2005, MOL PLANT MICROBE IN, V18, P385, DOI 10.1094/MPMI-18-0385; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004; Zhang HM, 2008, PLANT J, V56, P264, DOI 10.1111/j.1365-313X.2008.03593.x	70	31	31	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29382	10.1371/journal.pone.0029382	http://dx.doi.org/10.1371/journal.pone.0029382			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216267	Green Published, Green Submitted, gold			2022-12-27	WOS:000300676300052
J	Cederlund, A; Olliver, M; Rekha, RS; Lindh, M; Lindbom, L; Normark, S; Henriques-Normark, B; Andersson, J; Agerberth, B; Bergman, P				Cederlund, Andreas; Olliver, Marie; Rekha, Rokeya Sultana; Lindh, Monica; Lindbom, Lennart; Normark, Staffan; Henriques-Normark, Birgitta; Andersson, Jan; Agerberth, Birgitta; Bergman, Peter			Impaired Release of Antimicrobial Peptides into Nasal Fluid of Hyper-IgE and CVID Patients	PLOS ONE			English	Article							CELL-DIFFERENTIATION; EXPRESSION; IMMUNOGLOBULIN; INFECTIONS; IMMUNODEFICIENCY; DEFICIENCY; MECHANISMS; INDUCTION; RESPONSES; DEFENSE	Background: Patients with primary immunodeficiency (PID) often suffer from frequent respiratory tract infections. Despite standard treatment with IgG-substitution and antibiotics many patients do not improve significantly. Therefore, we hypothesized that additional immune deficits may be present among these patients. Objective: To investigate if PID patients exhibit impaired production of antimicrobial peptides (AMPs) in nasal fluid and a possible link between AMP-expression and Th17-cells. Methods: Nasal fluid, nasopharyngeal swabs and peripheral blood mononuclear cells (PBMCs) were collected from patients and healthy controls. AMP levels were measured in nasal fluid by Western blotting. Nasal swabs were cultured for bacteria. PBMCs were stimulated with antigen and the supernatants were assessed for IL-17A release by ELISA. Results: In healthy controls and most patients, AMP levels in nasal fluid were increased in response to pathogenic bacteria. However, this increase was absent in patients with common variable immunodeficiency (CVID) and Hyper-IgE syndrome (HIES), despite the presence of pathogenic bacteria. Furthermore, stimulation of PBMCs revealed that both HIES and CVID patients exhibited an impaired production of IL-17A. Conclusion: CVID and HIES patients appear to have a dysregulated AMP response to pathogenic bacteria in the upper respiratory tract, which could be linked to an aberrant Th17 cell response.	[Cederlund, Andreas; Rekha, Rokeya Sultana; Lindh, Monica; Agerberth, Birgitta] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Olliver, Marie; Normark, Staffan; Henriques-Normark, Birgitta] Karolinska Inst, Dept Microbiol Tumor & Cellbiol, Stockholm, Sweden; [Rekha, Rokeya Sultana] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Lindbom, Lennart] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Andersson, Jan; Bergman, Peter] Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden; [Bergman, Peter] Karolinska Univ Hosp, Div Clin Microbiol, Dept Lab Med, Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; International Centre for Diarrhoeal Disease Research (ICDDR); Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Cederlund, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	peter.bergman@ki.se		Lindbom, Lennart/0000-0001-9243-257X; Olliver, Marie/0000-0003-4115-2716; Bergman, Peter/0000-0003-3306-3713	Karolinska Institutet; Stockholm County Council; DA Hagelen; Ake Wiberg; Magnus Bergwall foundations; Swedish Research Council [58X-11217-14-3]; Torsten and Ragnar Soderberg Foundation; Swedish Cancer Society; Swedish Foundation; Royal Swedish Academy of Sciences; Swedish Association for Medical Microbiology	Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); DA Hagelen; Ake Wiberg; Magnus Bergwall foundations; Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten and Ragnar Soderberg Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation; Royal Swedish Academy of Sciences; Swedish Association for Medical Microbiology	PB holds a PostDoc position financed by Karolinska Institutet and the Stockholm County Council. PB also receives grants from DA Hagelen, Ake Wiberg and Magnus Bergwall foundations as well as Karolinska Institutet and Swedish Association for Medical Microbiology. BA is funded by the Swedish Research Council (58X-11217-14-3), the Torsten and Ragnar Soderberg Foundation, the Swedish Cancer Society and Karolinska Institutet. The Swedish Foundation for Strategic Research supports BA, JA and LL with a joint grant where PB is included as a junior scientist and coordinator. BH-N and SN are supported by Torsten and Ragnar Soderberg foundation, the Swedish Research Council, the Royal Swedish Academy of Sciences, the Swedish foundation for Strategic Research and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerberth B, 2006, CURR TOP MICROBIOL, V306, P67; Barbosa RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022848; Berger M, 2008, IMMUNOL ALLERGY CLIN, V28, px; Berger M, 2008, IMMUNOL ALLERGY CLIN, V28, P413, DOI 10.1016/j.iac.2008.01.008; Cederlund A, 2010, J INNATE IMMUN, V2, P508, DOI 10.1159/000317665; Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hemdan NY, 2010, AUTOIMMUN REV, V9, P785, DOI 10.1016/j.autrev.2010.07.003; Kainulainen L, 2010, J ALLERGY CLIN IMMUN, V126, P120, DOI 10.1016/j.jaci.2010.04.016; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; Koslowski MJ, 2010, INT J MED MICROBIOL, V300, P34, DOI 10.1016/j.ijmm.2009.08.011; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Lucas M, 2010, J ALLERGY CLIN IMMUN, V125, P1354, DOI 10.1016/j.jaci.2010.02.040; Maarschalk-Ellerbroek LJ, 2011, INT J ANTIMICROB AG, V37, P396, DOI 10.1016/j.ijantimicag.2010.11.027; Mamishi S, 2010, BRAZ J INFECT DIS, V14, P351, DOI 10.1590/S1413-86702010000400007; McAleer JP, 2011, J LEUKOCYTE BIOL, V90, P263, DOI 10.1189/jlb.0211099; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Minegishi Y, 2009, CURR OPIN IMMUNOL, V21, P487, DOI 10.1016/j.coi.2009.07.013; Mintz R, 2010, IMMUNOL LETT, V130, P97, DOI 10.1016/j.imlet.2009.12.006; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Mouillot G, 2010, J CLIN IMMUNOL, V30, P746, DOI 10.1007/s10875-010-9424-3; Ng WF, 2010, J ALLERGY CLIN IMMUN, V126, P1006, DOI 10.1016/j.jaci.2010.08.027; Nguyen-Jackson H, 2010, BLOOD, V115, P3354, DOI 10.1182/blood-2009-08-240317; Oksenhendler E, 2008, CLIN INFECT DIS, V46, P1547, DOI 10.1086/587669; Olinder-Nielsen AM, 2007, SCAND J INFECT DIS, V39, P44, DOI 10.1080/00365540600951192; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Orange JS, 2010, CLIN IMMUNOL, V137, P21, DOI 10.1016/j.clim.2010.06.012; Orange JS, 2006, J ALLERGY CLIN IMMUN, V117, pS525, DOI 10.1016/j.jaci.2006.01.015; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Saukkoriipi A, 2004, MOL CELL PROBE, V18, P147, DOI 10.1016/j.mcp.2003.11.003; van de Ven AAJM, 2010, CLIN IMMUNOL, V135, P63, DOI 10.1016/j.clim.2009.11.010; VANEPPS DE, 1983, CLIN EXP IMMUNOL, V53, P678; Wood PM, 2010, CURR OPIN HEMATOL, V17, P356, DOI 10.1097/MOH.0b013e328338f69e; Yong PFK, 2008, CLIN IMMUNOL, V127, P34, DOI 10.1016/j.clim.2007.12.007; Yoshio H, 2003, PEDIATR RES, V53, P211, DOI 10.1203/01.PDR.0000047471.47777.B0; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	39	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29316	10.1371/journal.pone.0029316	http://dx.doi.org/10.1371/journal.pone.0029316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216247	gold, Green Published, Green Submitted			2022-12-27	WOS:000300674900027
J	Saade, S; Cazier, JB; Ghassibe-Sabbagh, M; Youhanna, S; Badro, DA; Kamatani, Y; Hager, J; Yeretzian, JS; El-Khazen, G; Haber, M; Salloum, AK; Douaihy, B; Othman, R; Shasha, N; Kabbani, S; El Bayeh, H; Chammas, E; Farrall, M; Gauguier, D; Platt, DE; Zalloua, PA				Saade, Stephanie; Cazier, Jean-Baptiste; Ghassibe-Sabbagh, Michella; Youhanna, Sonia; Badro, Danielle A.; Kamatani, Yoichiro; Hager, Joerg; Yeretzian, Joumana S.; El-Khazen, Georges; Haber, Marc; Salloum, Angelique K.; Douaihy, Bouchra; Othman, Raed; Shasha, Nabil; Kabbani, Samer; El Bayeh, Hamid; Chammas, Elie; Farrall, Martin; Gauguier, Dominique; Platt, Daniel E.; Zalloua, Pierre A.		FGENTCARD Consortium	Large Scale Association Analysis Identifies Three Susceptibility Loci for Coronary Artery Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RISK; GENE; EXPRESSION; COMPLEX; VARIANTS; ATHEROSCLEROSIS; REPLICATION; DELETION; ANRIL	Genome wide association studies (GWAS) and their replications that have associated DNA variants with myocardial infarction (MI) and/or coronary artery disease (CAD) are predominantly based on populations of European or Eastern Asian descent. Replication of the most significantly associated polymorphisms in multiple populations with distinctive genetic backgrounds and lifestyles is crucial to the understanding of the pathophysiology of a multifactorial disease like CAD. We have used our Lebanese cohort to perform a replication study of nine previously identified CAD/MI susceptibility loci (LTA, CDKN2A-CDKN2B, CELSR2-PSRC1-SORT1, CXCL12, MTHFD1L, WDR12, PCSK9, SH2B3, and SLC22A3), and 88 genes in related phenotypes. The study was conducted on 2,002 patients with detailed demographic, clinical characteristics, and cardiac catheterization results. One marker, rs6922269, in MTHFD1L was significantly protective against MI (OR = 0.68, p = 0.0035), while the variant rs4977574 in CDKN2A-CDKN2B was significantly associated with MI (OR = 1.33, p = 0.0086). Associations were detected after adjustment for family history of CAD, gender, hypertension, hyperlipidemia, diabetes, and smoking. The parallel study of 88 previously published genes in related phenotypes encompassed 20,225 markers, three quarters of which with imputed genotypes The study was based on our genome-wide genotype data set, with imputation across the whole genome to HapMap II release 22 using HapMap CEU population as a reference. Analysis was conducted on both the genotyped and imputed variants in the 88 regions covering selected genes. This approach replicated HNRNPA3P1-CXCL12 association with CAD and identified new significant associations of CDKAL1, ST6GAL1, and PTPRD with CAD. Our study provides evidence for the importance of the multifactorial aspect of CAD/MI and describes genes predisposing to their etiology.	[Saade, Stephanie; Ghassibe-Sabbagh, Michella; Youhanna, Sonia; Badro, Danielle A.; Yeretzian, Joumana S.; Haber, Marc; Salloum, Angelique K.; Douaihy, Bouchra; El Bayeh, Hamid; Chammas, Elie; Zalloua, Pierre A.] Lebanese Amer Univ, Sch Med, Beirut, Lebanon; [Cazier, Jean-Baptiste; Farrall, Martin; Gauguier, Dominique] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Kamatani, Yoichiro] CEPH, Paris, France; [Hager, Joerg] Ctr Natl Genotypage, CEA Genom Inst, Evry, France; [El-Khazen, Georges] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland; [Othman, Raed; Shasha, Nabil; Kabbani, Samer] Raf Hariri Univ Hosp, Div Cardiol, Beirut, Lebanon; [Gauguier, Dominique] Ctr Rech Cordeliers, INSERM UMRS872, Paris, France; [Platt, Daniel E.] IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA; [Zalloua, Pierre A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Lebanese American University; University of Oxford; Wellcome Centre for Human Genetics; CEA; UDICE-French Research Universities; Universite Paris Saclay; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; International Business Machines (IBM); Harvard University; Harvard T.H. Chan School of Public Health	Saade, S (corresponding author), Lebanese Amer Univ, Sch Med, Beirut, Lebanon.	pzalloua@lau.edu.lb	Ghassibe, Michella/A-7256-2011; Gauguier, Dominique/G-2190-2016; Khazen, Georges/AAC-2923-2020; Haber, Marc/Y-5090-2019; Cazier, Jean-Baptiste/GLR-2949-2022; Cazier, Jean-Baptiste/F-2369-2010; Haber, Marc/D-2553-2012; Ghassibe-Sabbagh, Michella/AAG-5710-2019; Kamatani, Yoichiro/N-5513-2015	Gauguier, Dominique/0000-0001-6156-9530; Haber, Marc/0000-0003-1000-1448; Cazier, Jean-Baptiste/0000-0001-7581-9051; Cazier, Jean-Baptiste/0000-0001-7581-9051; Haber, Marc/0000-0003-1000-1448; Ghassibe-Sabbagh, Michella/0000-0003-2107-9929; youhanna, sonia/0000-0002-9376-8478; Holy Spirit University of Kaslik (USEK), FACULTY OF MEDICINE AND MEDICAL SCIENCESHoly Spirit University of Kaslik (USEK)/0000-0001-6734-4105; Khazen, Geroges/0000-0002-9244-2978; zalloua, pierre/0000-0002-8494-5081; saade, stephanie/0000-0003-3817-7234; Badro, Danielle A/0000-0003-4487-9144	Wellcome Trust [075491/Z/04, 057733]; European Commission (FGENTCARD) [LSHG-CT-2006-037683]; BHF Clinical Research Excellence award	Wellcome Trust(Wellcome TrustEuropean Commission); European Commission (FGENTCARD)(European Commission); BHF Clinical Research Excellence award	This work is supported by the Wellcome Trust core award grant number 075491/Z/04 and a grant from the European Commission (FGENTCARD, LSHG-CT-2006-037683). Dominique Gauguier holds a Wellcome Trust senior fellowship in basic biomedical science (057733). Martin Farrall is supported by a BHF Clinical Research Excellence award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah KG, 2008, ANN HUM GENET, V72, P654, DOI 10.1111/j.1469-1809.2008.00454.x; Below JE, 2011, DIABETOLOGIA, V54, P2047, DOI 10.1007/s00125-011-2188-3; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Folkersen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007677; Ghazouani L, 2010, J THROMB THROMBOLYS, V29, P114, DOI 10.1007/s11239-009-0336-0; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; KHOURY MJ, 1998, MODERN EPIDEMIOLOGY, P609; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lluis-Ganella C, 2010, REV ESP CARDIOL, V63, P925, DOI 10.1016/S0300-8932(10)70204-9; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Mehta NN, 2009, CIRCULATION, V120, pS589; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Peden JF, 2011, NATURE GENETICS; Prasannan P, 2003, J BIOL CHEM, V278, P43178, DOI 10.1074/jbc.M304319200; Risch N, 2000, J CLIN INVEST, V105, P1503, DOI 10.1172/JCI10266; Rodriguez C, 2010, BIOCHEM BIOPH RES CO, V392, P129, DOI 10.1016/j.bbrc.2009.12.159; Ronald J, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-52; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schunkert H., 2011, NAT GENET, V43, P333, DOI 10.1038/ng.784; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SLATKIN M, 1991, GENET RES, V58, P167, DOI 10.1017/S0016672300029827; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; van Velzen JE, 2010, CIRC-CARDIOVASC IMAG, V3, P718, DOI 10.1161/CIRCIMAGING.109.913541; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wang F, 2011, NATURE GENETICS; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang X, 2010, BIOINFORMATICS, V26, pi217, DOI 10.1093/bioinformatics/btq186	45	66	68	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29427	10.1371/journal.pone.0029427	http://dx.doi.org/10.1371/journal.pone.0029427			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216278	Green Published, gold, Green Submitted			2022-12-27	WOS:000300674900034
J	Hellyer, JMH; DeVries, AS; Jenkins, SM; Lackore, KA; James, KM; Ziegenfuss, JY; Poland, GA; Tilburt, JC				Hellyer, Joan M. Henriksen; DeVries, Aaron S.; Jenkins, Sarah M.; Lackore, Kandace A.; James, Katherine M.; Ziegenfuss, Jeanette Y.; Poland, Gregory A.; Tilburt, Jon C.			Attitudes toward and Uptake of H1N1 Vaccine among Health Care Workers during the 2009 H1N1 Pandemic	PLOS ONE			English	Article							MANDATORY INFLUENZA VACCINATION; UNITED-STATES	Background: Though recommended by many and mandated by some, influenza vaccination rates among health care workers, even in pandemics, remain below optimal levels. The objective of this study was to assess vaccination uptake, attitudes, and distinguishing characteristics (including doctor-nurse differences) of health care workers who did and did not receive the pandemic H1N1 influenza vaccine in late 2009. Methodology/Principal Findings: In early 2010 we mailed a self-administered survey to 800 physicians and 800 nurses currently licensed and practicing in Minnesota. 1,073 individuals responded (cooperation rate: 69%). 85% and 62% of Minnesota physicians and nurses, respectively, reported being vaccinated. Accurately estimating the risk of vaccine side effects (OR 2.0; 95% CI 1.5-2.7), agreeing with a professional obligation to be vaccinated (OR 10.1; 95% CI 7.1-14.2), an ethical obligation to follow public health authorities' recommendations (OR 9.9; 95% CI 6.6-14.9), and laws mandating pandemic vaccination (OR 3.1; 95% CI 2.3-4.1) were all independently associated with receiving the H1N1 influenza vaccine. Conclusions/Significance: While a majority of health care workers in one midwestern state reported receiving the pandemic H1N1 vaccine, physicians and nurses differed significantly in vaccination uptake. Several key attitudes and perceptions may influence health care workers' decisions regarding vaccination. These data inform how states might optimally enlist health care workers' support in achieving vaccination goals during a pandemic.	[Hellyer, Joan M. Henriksen] Mayo Clin, Program Professionalism & Eth, Rochester, MN 55905 USA; [DeVries, Aaron S.] Minnesota Dept Hlth, Infect Dis Epidemiol Prevent & Control Div, St Paul, MN USA; [Jenkins, Sarah M.; Lackore, Kandace A.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [James, Katherine M.; Tilburt, Jon C.] Mayo Clin, Biomed Eth Res Unit, Rochester, MN USA; [Ziegenfuss, Jeanette Y.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA; [Ziegenfuss, Jeanette Y.] Mayo Clin, Dept Hlth Sci Res, Survey Res Ctr, Rochester, MN USA; [Poland, Gregory A.] Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN USA; [Poland, Gregory A.] Mayo Clin, Program Translat Immunovirol & Biodef, Rochester, MN USA; [Tilburt, Jon C.] Mayo Clin, Div Gen Internal Med, Rochester, MN USA	Mayo Clinic; Minnesota Department of Health (MHD); Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Hellyer, JMH (corresponding author), Mayo Clin, Program Professionalism & Eth, Rochester, MN 55905 USA.	james.katherine@mayo.edu		DeVries, Aaron/0000-0001-9211-0722				AAPOR, 2016, STAND DEF FIN DISP C; Alkuwari MG, 2011, VACCINE, V29, P2206, DOI 10.1016/j.vaccine.2010.08.093; *AM NURS ASS, 2006, REP BOARD DIR SEAS I; American Medical Association Council on Ethical and Judicial Affairs, 2010, ROUT UN IMM PHYS VAC; Babcock HM, 2010, CLIN INFECT DIS, V50, P459, DOI 10.1086/650752; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Burtson PL, 2010, J ADV NURS, V66, P1819, DOI 10.1111/j.1365-2648.2010.05336.x; Caban-Martinez AJ, 2010, PREV MED, V50, P210, DOI 10.1016/j.ypmed.2010.01.001; Centers for Disease Control and Prevention, 2010, INT GUID IN CONTR ME; Centers for Disease Control and Prevention, 2009, NIOSH STAT RISK SER; Chor JSY, 2011, VACCINE, V29, P7364, DOI 10.1016/j.vaccine.2011.07.079; Godin G, 2010, INFECT CONT HOSP EP, V31, P689, DOI 10.1086/653614; Harris K. M., 2010, Morbidity and Mortality Weekly Report, V59, P357; Kaboli F, 2010, INFECT CONT HOSP EP, V31, P1017, DOI 10.1086/655465; King WD, 2006, J GEN INTERN MED, V21, P181, DOI [10.1007/s11606-006-0255-0, 10.1111/j.1525-1497.2006.00325.x]; Lerner M, 2010, TWIN CITIES METROHOS; Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1; Minnesota Department of Health, 2009, INFL 2009; Minnesota Department of Health Infectious Disease Epidemiology Prevention and Control Division, 2009, 2009 H1N1 INFL MINN; National Center for Immunization and Respiratory Diseases CDC, 2009, MMWR Recomm Rep, V58, P1; Oria PA, 2011, VACCINE, V29, P3617, DOI 10.1016/j.vaccine.2011.01.063; Parry HM, 2011, J HOSP INFECT, V78, P302, DOI 10.1016/j.jhin.2011.02.009; Poland GA, 2008, INFECT CONT HOSP EP, V29, P170, DOI 10.1086/526432; Rakita RM, 2010, INFECT CONT HOSP EP, V31, P881, DOI 10.1086/656210; Rhudy LM, 2010, WORLDV EVID-BASED NU, V7, P111, DOI 10.1111/j.1741-6787.2010.00190.x; Tanguy M, 2011, VACCINE, V29, P4190, DOI 10.1016/j.vaccine.2011.03.107; Vellozzi C, 2010, VACCINE, V28, P7248, DOI 10.1016/j.vaccine.2010.09.021; Virseda S, 2010, VACCINE, V28, P4751, DOI 10.1016/j.vaccine.2010.04.101; Walker FJ, 2006, INFECT CONT HOSP EP, V27, P257, DOI 10.1086/501538; Zhang J, 2011, INT J NURS STUD	30	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29478	10.1371/journal.pone.0029478	http://dx.doi.org/10.1371/journal.pone.0029478			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216290	Green Published, Green Submitted, gold			2022-12-27	WOS:000299684700061
J	Shaw, GTW; Shih, ESC; Chen, CH; Hwang, MJ				Shaw, Grace T. W.; Shih, Edward S. C.; Chen, Chun-Houh; Hwang, Ming-Jing			Preservation of Ranking Order in the Expression of Human Housekeeping Genes	PLOS ONE			English	Article							MESSENGER-RNA DECAY; GENOME; MOUSE; TRANSCRIPTION; COEXPRESSION; SELECTION; PROFILES; PROMOTER; PATHWAYS; SUBUNITS	Housekeeping (HK) genes fulfill the basic needs for a cell to survive and function properly. Their ubiquitous expression, originally thought to be constant, can vary from tissue to tissue, but this variation remains largely uncharacterized and it could not be explained by previously identified properties of HK genes such as short gene length and high GC content. By analyzing microarray expression data for human genes, we uncovered a previously unnoted characteristic of HK gene expression, namely that the ranking order of their expression levels tends to be preserved from one tissue to another. Further analysis by tensor product decomposition and pathway stratification identified three main factors of the observed ranking preservation, namely that, compared to those of non-HK (NHK) genes, the expression levels of HK genes show a greater degree of dispersion (less overlap), stableness (a smaller variation in expression between tissues), and correlation of expression. Our results shed light on regulatory mechanisms of HK gene expression that are probably different for different HK genes or pathways, but are consistent and coordinated in different tissues.	[Shaw, Grace T. W.; Hwang, Ming-Jing] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Shaw, Grace T. W.; Shih, Edward S. C.; Hwang, Ming-Jing] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chen, Chun-Houh] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Shih, Edward S. C.; Hwang, Ming-Jing] Acad Sinica, Inst Biol Chem, Chem Biol & Mol Biophys Program, Taiwan Int Grad Program, Taipei, Taiwan; [Shih, Edward S. C.] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Tsing Hua University	Shaw, GTW (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan.	mjhwang@ibms.sinica.edu.tw	Hwang, Ming-jing/E-9210-2012; Chen, Chun-houh/AAP-2640-2021	Hwang, Ming-jing/0000-0002-9657-5663; Chen, Chun-houh/0000-0003-0899-7477	National Science Council of Taiwan (NSC) [97-2627-P001-004]	National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan)	This work was supported in part by a grant from the National Science Council of Taiwan (NSC grant no. 97-2627-P001-004). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter O, 2005, P NATL ACAD SCI USA, V102, P17559, DOI 10.1073/pnas.0509033102; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Chiaromonte F, 2003, GENOME RES, V13, P2602, DOI 10.1101/gr.1169203; CHOI JK, 1991, MOL CELL BIOL, V11, P4473, DOI 10.1128/MCB.11.9.4473; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Cuccurese M, 2005, NUCLEIC ACIDS RES, V33, P5965, DOI 10.1093/nar/gki905; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; FREIENST.C, 1974, P NATL ACAD SCI USA, V71, P3435, DOI 10.1073/pnas.71.9.3435; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; GIALLONGO A, 1989, MOL CELL BIOL, V9, P224, DOI 10.1128/MCB.9.1.224; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; GRZIWA A, 1994, EUR J BIOCHEM, V223, P1061, DOI 10.1111/j.1432-1033.1994.tb19084.x; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; HAWLEY DK, 1987, J BIOL CHEM, V262, P3452; Hengst U, 2007, SEMIN CELL DEV BIOL, V18, P209, DOI 10.1016/j.semcdb.2007.01.003; Herrera F, 2005, J BIOTECHNOL, V117, P337, DOI 10.1016/j.jbiotec.2005.03.001; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; KAGAWA Y, 1990, INT J BIOCHEM, V22, P219; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lemay S, 1996, KIDNEY INT, V50, P85, DOI 10.1038/ki.1996.290; Li B, 2000, EMBO J, V19, P4091, DOI 10.1093/emboj/19.15.4091; Li C., 2001, GENOME BIOL, V2, DOI [10.1186/gb-2001-2-8-research0032, DOI 10.1186/GB-2001-2-8-RESEARCH0032]; Lisowski P, 2008, J APPL GENET, V49, P367, DOI 10.1007/BF03195635; Luo F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-299; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Nishida Y, 2006, J PHARMACOL SCI, V101, P52, DOI 10.1254/jphs.FP0050881; Pelz CR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-520; PETERSEN BH, 1990, J CLIN ENDOCR METAB, V70, P1756, DOI 10.1210/jcem-70-6-1756; Rogler CE, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh116; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Russcher H, 2007, J MOL ENDOCRINOL, V38, P91, DOI 10.1677/jme.1.02117; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Szabo A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r59; Tengowski MW, 2007, BIOL REPROD, V76, P149, DOI 10.1095/biolreprod.106.053173; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tu ZD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-31; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Venn J, 1880, LONDON EDINBURGH DUB, V10, P1, DOI [DOI 10.1080/14786448008626877, 10.1080/14786448008626877]; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P5212, DOI 10.1093/nar/gkg699; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Watson JD, 1965, FUNCTIONING HIGHER E; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; WILLIAMS T, 1988, P NATL ACAD SCI USA, V85, P3527, DOI 10.1073/pnas.85.10.3527; Yamada H, 1997, BIOCHEM BIOPH RES CO, V231, P835, DOI 10.1006/bbrc.1997.6198; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Zanardi P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.060402; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172; ZWICKL P, 1994, NAT STRUCT BIOL, V1, P765, DOI 10.1038/nsb1194-765	59	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29314	10.1371/journal.pone.0029314	http://dx.doi.org/10.1371/journal.pone.0029314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216246	Green Submitted, Green Published, gold			2022-12-27	WOS:000299684700046
J	Thornhill, DJ; Rotjan, RD; Todd, BD; Chilcoat, GC; Iglesias-Prieto, R; Kemp, DW; LaJeunesse, TC; Reynolds, JM; Schmidt, GW; Shannon, T; Warner, ME; Fitt, WK				Thornhill, Daniel J.; Rotjan, Randi D.; Todd, Brian D.; Chilcoat, Geoff C.; Iglesias-Prieto, Roberto; Kemp, Dustin W.; LaJeunesse, Todd C.; Reynolds, Jennifer McCabe; Schmidt, Gregory W.; Shannon, Thomas; Warner, Mark E.; Fitt, William K.			A Connection between Colony Biomass and Death in Caribbean Reef-Building Corals	PLOS ONE			English	Article							TISSUE BIOMASS; PHOTOSYSTEM-II; LONG-TERM; ZOOXANTHELLAE; DIVERSITY; GROWTH; CARBON; LIGHT; REPRODUCTION; SYMBIODINIUM	Increased sea-surface temperatures linked to warming climate threaten coral reef ecosystems globally. To better understand how corals and their endosymbiotic dinoflagellates (Symbiodinium spp.) respond to environmental change, tissue biomass and Symbiodinium density of seven coral species were measured on various reefs approximately every four months for up to thirteen years in the Upper Florida Keys, United States (1994-2007), eleven years in the Exuma Cays, Bahamas (1995-2006), and four years in Puerto Morelos, Mexico (2003-2007). For six out of seven coral species, tissue biomass correlated with Symbiodinium density. Within a particular coral species, tissue biomasses and Symbiodinium densities varied regionally according to the following trends: Mexico >= Florida Keys >= Bahamas. Average tissue biomasses and symbiont cell densities were generally higher in shallow habitats (1-4 m) compared to deeper-dwelling conspecifics (12-15 m). Most colonies that were sampled displayed seasonal fluctuations in biomass and endosymbiont density related to annual temperature variations. During the bleaching episodes of 1998 and 2005, five out of seven species that were exposed to unusually high temperatures exhibited significant decreases in symbiotic algae that, in certain cases, preceded further decreases in tissue biomass. Following bleaching, Montastraea spp. colonies with low relative biomass levels died, whereas colonies with higher biomass levels survived. Bleaching-or disease-associated mortality was also observed in Acropora cervicornis colonies; compared to A. palmata, all A. cervicornis colonies experienced low biomass values. Such patterns suggest that Montastraea spp. and possibly other coral species with relatively low biomass experience increased susceptibility to death following bleaching or other stressors than do conspecifics with higher tissue biomass levels.	[Thornhill, Daniel J.] Defenders Wildlife, Dept Field Conservat, Washington, DC 20036 USA; [Thornhill, Daniel J.] Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA; [Rotjan, Randi D.] New England Aquarium, Edgerton Res Lab, Boston, MA USA; [Todd, Brian D.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Chilcoat, Geoff C.; Kemp, Dustin W.; Reynolds, Jennifer McCabe; Fitt, William K.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Iglesias-Prieto, Roberto] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Cancun, Mexico; [LaJeunesse, Todd C.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Shannon, Thomas] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Warner, Mark E.] Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA	Bowdoin College; University of California System; University of California Davis; University System of Georgia; University of Georgia; Universidad Nacional Autonoma de Mexico; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Tulane University; University of Delaware	Thornhill, DJ (corresponding author), Defenders Wildlife, Dept Field Conservat, Washington, DC 20036 USA.	thornhill.dan@gmail.com; fitt@uga.edu	Rotjan, Randi D/T-7575-2019; Warner, Mark E/J-6241-2013; LaJeunesse, Todd/B-1720-2009	Rotjan, Randi D/0000-0002-3401-9784; Todd, Brian/0000-0003-3133-791X; LaJeunesse, Todd/0000-0001-7607-9358; Kemp, Dustin/0000-0002-9396-1518; Warner, Mark/0000-0003-1015-9413	National Science Foundation, National Oceanic and Atmospheric Administration [9906976, 0137007]; Office of Naval Research; Bleaching Group of the Coral Reef Targeted Research and Capacity Building for Management	National Science Foundation, National Oceanic and Atmospheric Administration; Office of Naval Research(Office of Naval Research); Bleaching Group of the Coral Reef Targeted Research and Capacity Building for Management	The National Science Foundation (grants 9906976 and 0137007), National Oceanic and Atmospheric Administration, the Office of Naval Research and the Bleaching Group of the Coral Reef Targeted Research and Capacity Building for Management funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2003, FUNCT ECOL, V17, P246, DOI 10.1046/j.1365-2435.2003.00731.x; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Battey J.F., 1988, P79; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; EDMUNDS PJ, 1986, MAR BIOL, V92, P339, DOI 10.1007/BF00392674; EDMUNDS PJ, 1994, MAR BIOL, V121, P137, DOI 10.1007/BF00349482; Fagoonee I, 1999, SCIENCE, V283, P843, DOI 10.1126/science.283.5403.843; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; FITT WK, 1993, CORAL REEFS, V12, P57, DOI 10.1007/BF00302102; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GLYNN PW, 1984, ENVIRON CONSERV, V11, P133, DOI 10.1017/S0376892900013825; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; JOHANNES RE, 1970, LIMNOL OCEANOGR, V15, P822, DOI 10.4319/lo.1970.15.5.0822; Lesser MP, 2004, J EXP MAR BIOL ECOL, V300, P217, DOI 10.1016/j.jembe.2003.12.027; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; MARSH JA, 1970, ECOLOGY, V51, P254; Mendes JM, 2002, MAR ECOL PROG SER, V235, P93, DOI 10.3354/meps235093; Muscatine L, 2005, P NATL ACAD SCI USA, V102, P1525, DOI 10.1073/pnas.0408921102; MUSCATINE L, 1984, PROC R SOC SER B-BIO, V222, P181, DOI 10.1098/rspb.1984.0058; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; MUSCATINE L, 1989, MAR BIOL, V100, P185, DOI 10.1007/BF00391957; Palardy JE, 2008, J EXP MAR BIOL ECOL, V367, P180, DOI 10.1016/j.jembe.2008.09.015; PORTER JW, 1989, P NATL ACAD SCI USA, V86, P9342, DOI 10.1073/pnas.86.23.9342; Rodriguez-Roman A, 2005, MAR BIOL, V146, P1063, DOI 10.1007/s00227-004-1529-x; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sachs JL, 2006, P ROY SOC B-BIOL SCI, V273, P425, DOI 10.1098/rspb.2005.3346; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Santos SR, 2004, MOL ECOL, V13, P459, DOI 10.1046/j.1365-294X.2003.02058.x; SOROKIN YI, 1973, LIMNOL OCEANOGR, V18, P380, DOI 10.4319/lo.1973.18.3.0380; SOROKIN YI, 1991, AUST J MAR FRESH RES, V42, P729, DOI 10.1071/MF9910729; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; Thornhill DJ, 2006, CORAL REEFS, V25, P515, DOI 10.1007/s00338-006-0157-y; Thornhill DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006262; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; TRENCH RK, 1974, HELGOLAND WISS MEER, V26, P174, DOI 10.1007/BF01611382; van Woesik R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009185; Warner ME, 2006, LIMNOL OCEANOGR, V51, P1887, DOI 10.4319/lo.2006.51.4.1887; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Warner ME, 2002, MAR BIOL, V141, P31, DOI 10.1007/s00227-002-0807-8; Wilkinson C, 2000, STATUS CORAL REEFS W	46	74	74	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29535	10.1371/journal.pone.0029535	http://dx.doi.org/10.1371/journal.pone.0029535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216307	Green Published, Green Submitted, gold			2022-12-27	WOS:000299684700065
J	Ducharme, G; Lowe, GC; Goutagny, R; Williams, S				Ducharme, Guillaume; Lowe, Germaine C.; Goutagny, Romain; Williams, Sylvain			Early Alterations in Hippocampal Circuitry and Theta Rhythm Generation in a Mouse Model of Prenatal Infection: Implications for Schizophrenia	PLOS ONE			English	Article							PARVALBUMIN-POSITIVE INTERNEURONS; IMMUNE ACTIVATION; ANIMAL-MODEL; NEURAL OSCILLATIONS; ADULT SCHIZOPHRENIA; GAMMA OSCILLATIONS; WORKING-MEMORY; GABA NEURONS; BRAIN; EXPOSURE	Post-mortem studies suggest that GABAergic neurotransmission is impaired in schizophrenia. However, it remains unclear if these changes occur early during development and how they impact overall network activity. To investigate this, we used a mouse model of prenatal infection with the viral mimic, polyriboinosinic-polyribocytidilic acid (poly I: C), a model based on epidemiological evidence that an immune challenge during pregnancy increases the prevalence of schizophrenia in the offspring. We found that prenatal infection reduced the density of parvalbumin-but not somatostatin-positive interneurons in the CA1 area of the hippocampus and strongly reduced the strength of inhibition early during postnatal development. Furthermore, using an intact hippocampal preparation in vitro, we found reduced theta oscillation generated in the CA1 area. Taken together, these results suggest that redistribution in excitatory and inhibitory transmission locally in the CA1 is associated with a significant alteration in network function. Furthermore, given the role of theta rhythm in memory, our results demonstrate how a risk factor for schizophrenia can affect network function early in development that could contribute to cognitive deficits observed later in the disease.	[Ducharme, Guillaume; Lowe, Germaine C.; Goutagny, Romain; Williams, Sylvain] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University	Ducharme, G (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	sylvain.williams@gmail.com	goutagny, romain/C-1461-2018	goutagny, romain/0000-0002-1268-533X	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Institutes of Health Research (CIHR) http://www.cihr-irsc.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abazyan B, 2010, BIOL PSYCHIAT, V68, P1172, DOI 10.1016/j.biopsych.2010.09.022; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Benes FM, 1996, SYNAPSE, V22, P338; Benes FM, 2007, P NATL ACAD SCI USA, V104, P10164, DOI 10.1073/pnas.0703806104; Bitanihirwe BKY, 2010, NEUROPSYCHOPHARMACOL, V35, P2462, DOI 10.1038/npp.2010.129; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Boutros NN, 2008, SCHIZOPHR RES, V99, P225, DOI 10.1016/j.schres.2007.11.020; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Brown AS, 2005, AM J PSYCHIAT, V162, P767, DOI 10.1176/appi.ajp.162.4.767; Brown AS, 2001, BIOL PSYCHIAT, V49, P473, DOI 10.1016/S0006-3223(01)01068-X; Buka SL, 2007, BIOL PSYCHIAT; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Campo CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005505; Clarke MC, 2009, AM J PSYCHIAT, V166, P1025, DOI 10.1176/appi.ajp.2009.08010031; Dickerson DD, 2010, J NEUROSCI, V30, P12424, DOI 10.1523/JNEUROSCI.3046-10.2010; Duzel E, 2010, CURR OPIN NEUROBIOL, V20, P143, DOI 10.1016/j.conb.2010.01.004; Ebert T, 2005, ISRAEL MED ASSOC J, V7, P35; Francois J, 2009, INT J NEUROPSYCHOPH, V12, P1097, DOI 10.1017/S1461145709009985; Gonzalez-Burgos G, 2010, CURR PSYCHIAT REP, V12, P335, DOI 10.1007/s11920-010-0124-8; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Karlsgodt KH, 2011, BIOL PSYCHIAT, V69, P28, DOI 10.1016/j.biopsych.2010.09.012; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Lega BC, 2012, HIPPOCAMPUS, V22, P748, DOI 10.1002/hipo.20937; Lisman JE, 2008, TRENDS NEUROSCI; Lodge DJ, 2009, J NEUROSCI, V29, P2344, DOI 10.1523/JNEUROSCI.5419-08.2009; MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189, DOI 10.1001/archpsyc.1988.01800260109013; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Meyer U, 2005, NEUROSCI BIOBEHAV R, V29, P913, DOI 10.1016/j.neubiorev.2004.10.012; Meyer U, 2008, BRAIN BEHAV IMMUN, V22, P469, DOI 10.1016/j.bbi.2007.09.012; Nullmeier S, 2011, EUR J NEUROSCI, V33, P689, DOI 10.1111/j.1460-9568.2010.07563.x; Reynolds GP, 2001, J CHEM NEUROANAT, V22, P95, DOI 10.1016/S0891-0618(01)00113-2; Samuelsson AM, 2006, AM J PHYSIOL-REG I, V290, pR1345, DOI 10.1152/ajpregu.00268.2005; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Sorensen HJ, 2008, SCHIZOPHR B; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106; Xiao JC, 2009, MICROBES INFECT, V11, P1011, DOI 10.1016/j.micinf.2009.07.007; Zhang ZJ, 2002, SCHIZOPHR RES, V55, P1, DOI 10.1016/S0920-9964(01)00188-8; Zuckerman L, 2003, NEUROPSYCHOPHARMACOL, V28, P1778, DOI 10.1038/sj.npp.1300248	48	36	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29754	10.1371/journal.pone.0029754	http://dx.doi.org/10.1371/journal.pone.0029754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238649	Green Published, gold, Green Submitted			2022-12-27	WOS:000301188800033
J	Takeuchi, Y; Hori, M; Oda, Y				Takeuchi, Yuichi; Hori, Michio; Oda, Yoichi			Lateralized Kinematics of Predation Behavior in a Lake Tanganyika Scale-Eating Cichlid Fish	PLOS ONE			English	Article							TROUT SALMO-GAIRDNERI; PREY CAPTURE; PERISSODUS-MICROLEPIS; LARVAL ZEBRAFISH; PERFORMANCE; EVOLUTION; MAUTHNER; ASYMMETRY; START; ADVANTAGES	Behavioral lateralization has been documented in many vertebrates. The scale-eating cichlid fish Perissodus microlepis is well known for exhibiting lateral dimorphism in its mouth morphology and lateralized behavior in robbing scales from prey fish. A previous field study indicated that this mouth asymmetry closely correlates with the side on which prey is attacked, but details of this species' predation behavior have not been previously analyzed because of the rapidity of the movements. Here, we studied scale-eating behavior in cichlids in a tank through high-speed video monitoring and quantitative assessment of behavioral laterality and kinematics. The fish observed showed a clear bias toward striking on one side, which closely correlated with their asymmetric mouth morphologies. Furthermore, the maximum angular velocity and amplitude of body flexion were significantly larger during attacks on the preferred side compared to those on the nonpreferred side, permitting increased predation success. In contrast, no such lateral difference in movement elements was observed in acoustically evoked flexion during the escape response, which is similar to flexion during scale eating and suggests that they share a common motor control pathway. Thus the neuronal circuits controlling body flexion during scale eating may be functionally lateralized upstream of this common motor pathway.	[Takeuchi, Yuichi; Oda, Yoichi] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648601, Japan; [Hori, Michio] Kyoto Univ, Dept Biol Sci, Kyoto, Japan	Nagoya University; Kyoto University	Takeuchi, Y (corresponding author), Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648601, Japan.	takeuchi.yuichi@i.mbox.nagoya-u.ac.jp	Takeuchi, Yuichi/G-6201-2013	Takeuchi, Yuichi/0000-0002-7096-3086	Japan Society for the Promotion of Science [22.7689]; Challenging Exploratory Research [23650164]; Scientific Research [23300126, 21370010]; Priority Area [14087203]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research [22300126] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Challenging Exploratory Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Scientific Research; Priority Area; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly supported by a Research Fellowship of the Japan Society for the Promotion of Science (22.7689 to YT), Challenging Exploratory Research (23650164 to YO), Scientific Research (23300126 to YO; 21370010 to MH), Priority Area (14087203 to MH), and the Global Center of Excellence Program "Advanced Systems-Biology: Designing The Biological Function" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102; BEDDOW TA, 1995, J EXP BIOL, V198, P203; Bisazza A, 2000, LATERALITY, V5, P269, DOI 10.1080/135765000406111; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; Borla MA, 2002, BRAIN BEHAV EVOLUT, V60, P207, DOI 10.1159/000066699; Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; CANFIELD JG, 1993, J COMP PHYSIOL A, V172, P611, DOI 10.1007/BF00213683; Dadda M, 2006, ANIM BEHAV, V72, P523, DOI 10.1016/j.anbehav.2005.10.019; Domenici P, 1997, J EXP BIOL, V200, P1165; EATON RC, 1977, J EXP BIOL, V66, P65; EATON RC, 1981, J COMP PHYSIOL, V144, P521, DOI 10.1007/BF01326837; Ewert JP, 2001, COMP BIOCHEM PHYS A, V128, P417, DOI 10.1016/S1095-6433(00)00333-0; FABER DS, 1989, ANN NY ACAD SCI, V563, P11, DOI 10.1111/j.1749-6632.1989.tb42187.x; Fryer G, 1972, CICHLID FISHES GREAT; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Hale ME, 2002, J EXP BIOL, V205, P2005; Higham TE, 2007, J EXP BIOL, V210, P107, DOI 10.1242/jeb.02634; Hori M., 1987, P219; HORI M, 1993, SCIENCE, V260, P216, DOI 10.1126/science.260.5105.216; HORI M, 1991, ECOL INT B, V19, P89; Hori M, 2007, ZOOL SCI, V24, P486, DOI 10.2108/zsj.24.486; Kohashi T, 2008, J NEUROSCI, V28, P10641, DOI 10.1523/JNEUROSCI.1435-08.2008; Lee HJ, 2010, J FISH BIOL, V76, P1940, DOI 10.1111/j.1095-8649.2010.02620.x; LIEM K F, 1976, Bulletin of the Museum of Comparative Zoology, V147, P319; Lippolis G, 2009, BRAIN BEHAV EVOLUT, V73, P295, DOI 10.1159/000230674; Nakajima M, 2004, AM NAT, V163, P692, DOI 10.1086/382733; NSHOMBO M, 1985, JPN J ICHTHYOL, V32, P66; Orger MB, 2008, NAT NEUROSCI, V11, P327, DOI 10.1038/nn2048; Rogers LJ, 2009, PHILOS T R SOC B, V364, P943, DOI 10.1098/rstb.2008.0225; Rogers LJ, 2000, BRAIN LANG, V73, P236, DOI 10.1006/brln.2000.2305; Rogers LJ, 2004, P ROY SOC B-BIOL SCI, V271, pS420, DOI 10.1098/rsbl.2004.0200; Rogers LJ, 2002, COMP VERTEBRATE LATE; Sato T, 2007, J NEUROSCI, V27, P5271, DOI 10.1523/JNEUROSCI.0883-07.2007; SAZIMA I, 1983, ENVIRON BIOL FISH, V9, P87, DOI 10.1007/BF00690855; Sillar KT, 2009, CURR BIOL, V19, pR353, DOI 10.1016/j.cub.2009.02.025; Spierts ILY, 1999, J EXP BIOL, V202, P393; Stewart TA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-8; Takahashi R, 2007, J FISH BIOL, V70, P1458, DOI 10.1111/j.1095-8649.2007.01423.x; Takahashi R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-195; Takeuchi Y, 2010, ECOL FRESHW FISH, V19, P239, DOI 10.1111/j.1600-0633.2010.00408.x; Takeuchi Y, 2008, ANIM BEHAV, V75, P1359, DOI 10.1016/j.anbehav.2007.09.008; Takeuchi Y, 2010, BEHAV BRAIN RES, V208, P106, DOI 10.1016/j.bbr.2009.11.021; Ting SC, 2008, J EXP BIOL, V211, P3147, DOI 10.1242/jeb.020263; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Van Dooren TJM, 2010, EVOLUTION, V64, P2159, DOI 10.1111/j.1558-5646.2010.00977.x; WEBB PW, 1976, J EXP BIOL, V65, P157; WEBB PW, 1975, J EXP BIOL, V63, P451; WEBB PW, 1980, CAN J ZOOL, V58, P1462, DOI 10.1139/z80-201; Wintzer AP, 2005, J FISH BIOL, V67, P409, DOI 10.1111/j.0022-1112.2005.00748.x; Wohl S, 2007, J EXP BIOL, V210, P311, DOI 10.1242/jeb.02646; ZOTTOLI SJ, 1977, J EXP BIOL, V66, P243	51	38	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29272	10.1371/journal.pone.0029272	http://dx.doi.org/10.1371/journal.pone.0029272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238598	Green Published, gold, Green Submitted			2022-12-27	WOS:000301188800009
J	Mellata, M; Maddux, JT; Nam, T; Thomson, N; Hauser, H; Stevens, MP; Mukhopadhyay, S; Sarker, S; Crabbe, A; Nickerson, CA; Santander, J; Curtiss, R				Mellata, Melha; Maddux, Jacob T.; Nam, Timothy; Thomson, Nicholas; Hauser, Heidi; Stevens, Mark P.; Mukhopadhyay, Suman; Sarker, Shameema; Crabbe, Aurelie; Nickerson, Cheryl A.; Santander, Javier; Curtiss, Roy, III			New Insights into the Bacterial Fitness-Associated Mechanisms Revealed by the Characterization of Large Plasmids of an Avian Pathogenic E. coli	PLOS ONE			English	Article							COMPLETE DNA-SEQUENCE; ESCHERICHIA-COLI; VIRULENCE FACTORS; BIOFILM FORMATION; SALMONELLA-MINNESOTA; COMPARATIVE GENOMICS; TSH AUTOTRANSPORTER; NEONATAL MENINGITIS; CHI-7122 O78K80H9; CARBON NUTRITION	Extra-intestinal pathogenic E. coli (ExPEC), including avian pathogenic E. coli (APEC), pose a considerable threat to both human and animal health, with illness causing substantial economic loss. APEC strain chi 7122 (O78:K80:H9), containing three large plasmids [pChi7122-1 (IncFIB/FIIA-FIC), pChi7122-2 (IncFII), and pChi7122-3 (IncI(2))]; and a small plasmid pChi7122-4 (ColE2-like), has been used for many years as a model strain to study the molecular mechanisms of ExPEC pathogenicity and zoonotic potential. We previously sequenced and characterized the plasmid pChi7122-1 and determined its importance in systemic APEC infection; however the roles of the other pChi7122 plasmids were still ambiguous. Herein we present the sequence of the remaining pChi7122 plasmids, confirming that pChi7122-2 and pChi7122-3 encode an ABC iron transport system (eitABCD) and a putative type IV fimbriae respectively, whereas pChi7122-4 is a cryptic plasmid. New features were also identified, including a gene cluster on pChi7122-2 that is not present in other E. coli strains but is found in Salmonella serovars and is predicted to encode the sugars catabolic pathways. In vitro evaluation of the APEC chi 7122 derivative strains with the three large plasmids, either individually or in combinations, provided new insights into the role of plasmids in biofilm formation, bile and acid tolerance, and the interaction of E. coli strains with 3-D cultures of intestinal epithelial cells. In this study, we show that the nature and combinations of plasmids, as well as the background of the host strains, have an effect on these phenomena. Our data reveal new insights into the role of extra-chromosomal sequences in fitness and diversity of ExPEC in their phenotypes.	[Mellata, Melha; Maddux, Jacob T.; Nam, Timothy; Sarker, Shameema; Crabbe, Aurelie; Nickerson, Cheryl A.; Santander, Javier; Curtiss, Roy, III] Arizona State Univ, Biodesign Inst, Tempe, AZ 85281 USA; [Nickerson, Cheryl A.; Santander, Javier; Curtiss, Roy, III] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Thomson, Nicholas; Hauser, Heidi] Wellcome Trust Sanger Inst, Cambridge, England; [Stevens, Mark P.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Stevens, Mark P.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Mukhopadhyay, Suman] NIAID, Zoonot Dis Bacteriol & Mycol Branch, Div Microbiol & Infect Dis, NIH,HHS, Bethesda, MD 20892 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Wellcome Trust Sanger Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mellata, M (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85281 USA.	melha.mellata@asu.edu	Mellata, Melha/AAP-5491-2020; Santander, Javier/AAU-9423-2020; Thomson, Nicholas/P-5988-2014	Ravel, Jacques/0000-0002-0851-2233; Thomson, Nicholas/0000-0002-4432-8505; Crabbe, Aurelie/0000-0003-3084-4418; Stevens, Mark/0000-0003-2174-5039; Mellata, Melha/0000-0002-4967-7173	U.S. Department of Agriculture National Research Initiative (USDA NRI) CSREES [2007-35201-18519]; National Institutes of Health [R21 AI090416]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090416] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/D/20320000, BB/E001661/1, BBS/E/D/20231761] Funding Source: researchfish; BBSRC [BBS/E/D/20320000, BBS/E/D/20231761, BB/E001661/1] Funding Source: UKRI	U.S. Department of Agriculture National Research Initiative (USDA NRI) CSREES; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for research was provided by the U.S. Department of Agriculture National Research Initiative (USDA NRI) CSREES grant 2007-35201-18519 to Dr. Curtiss III, and National Institutes of Health grant R21 AI090416 to Dr. Mellata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alteri CJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000448; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Barrila J, 2010, NAT REV MICROBIOL, V8, P791, DOI 10.1038/nrmicro2423; Barua S, 2002, MOL MICROBIOL, V43, P629, DOI 10.1046/j.1365-2958.2002.02768.x; Bausch C, 1998, J BACTERIOL, V180, P3704, DOI 10.1128/JB.180.14.3704-3710.1998; Berriman Matt, 2003, Briefings in Bioinformatics, V4, P124, DOI 10.1093/bib/4.2.124; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; BRANDENBURG K, 1993, BIOPHYS J, V64, P1215, DOI 10.1016/S0006-3495(93)81488-7; Brown PK, 1996, P NATL ACAD SCI USA, V93, P11149, DOI 10.1073/pnas.93.20.11149; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI; Crabbe A, 2011, CELL MICROBIOL, V13, P469, DOI 10.1111/j.1462-5822.2010.01548.x; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dho-Moulin M, 1999, VET RES, V30, P299; Dozois CM, 2000, INFECT IMMUN, V68, P4145, DOI 10.1128/IAI.68.7.4145-4154.2000; Dudley EG, 2006, INFECT IMMUN, V74, P2102, DOI 10.1128/IAI.74.4.2102-2114.2006; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; European Committee on Antimicrobial Susceptibility Testing (EU-CAST), 2008, BREAKP TABL INT MICS; Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; FURUYA N, 1995, J BACTERIOL, V177, P46, DOI 10.1128/jb.177.1.46-51.1995; George DB, 2010, EPIDEMIOL INFECT, V138, P1679, DOI 10.1017/S0950268810001639; Gerlt JA, 2005, ARCH BIOCHEM BIOPHYS, V433, P59, DOI 10.1016/j.abb.2004.07.034; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Guerra B, 2003, J ANTIMICROB CHEMOTH, V52, P489, DOI 10.1093/jac/dkg362; Gunn JS, 2000, MICROBES INFECT, V2, P907, DOI 10.1016/S1286-4579(00)00392-0; Gyohda A, 2004, ADV BIOPHYS, V38, P183, DOI 10.1016/S0065-227X(04)80166-7; HAYDON DJ, 1991, FEMS MICROBIOL LETT, V79, P291, DOI 10.1016/0378-1097(91)90101-F; Huang SH, 2000, MICROBES INFECT, V2, P1237, DOI 10.1016/S1286-4579(00)01277-6; HUISMAN GW, 1994, SCIENCE, V265, P537, DOI 10.1126/science.7545940; Jana S, 2005, PROTEIN EXPRES PURIF, V40, P86, DOI 10.1016/j.pep.2004.10.005; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Johnson JR, 2005, FOODBORNE PATHOG DIS, V2, P38, DOI 10.1089/fpd.2005.2.38; Johnson JR, 2005, INT J MED MICROBIOL, V295, P383, DOI 10.1016/j.ijmm.2005.07.005; Johnson TJ, 2007, APPL ENVIRON MICROB, V73, P1976, DOI 10.1128/AEM.02171-06; Johnson TJ, 2006, ANTIMICROB AGENTS CH, V50, P3929, DOI 10.1128/AAC.00569-06; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Johnson TJ, 2005, ANTIMICROB AGENTS CH, V49, P4681, DOI 10.1128/AAC.49.11.4681-4688.2005; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Kaper JB, 2005, INT J MED MICROBIOL, V295, P355, DOI 10.1016/j.ijmm.2005.06.008; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Kikuchi T, 2005, MICROBIOL IMMUNOL, V49, P875, DOI 10.1111/j.1348-0421.2005.tb03678.x; Kim SR, 1997, J BACTERIOL, V179, P3594, DOI 10.1128/jb.179.11.3594-3603.1997; Komano T, 1999, ANNU REV GENET, V33, P171, DOI 10.1146/annurev.genet.33.1.171; Kostakioti M, 2004, INFECT IMMUN, V72, P5548, DOI 10.1128/IAI.72.10.5548-5554.2004; Lee YW, 2010, LETT APPL MICROBIOL, V50, P452, DOI 10.1111/j.1472-765X.2010.02813.x; Lim JY, 2007, APPL ENVIRON MICROB, V73, P2037, DOI 10.1128/AEM.02643-06; Lin JS, 1996, APPL ENVIRON MICROB, V62, P3094, DOI 10.1128/AEM.62.9.3094-3100.1996; Macfarlane S, 2008, J CLIN GASTROENTEROL, V42, pS142, DOI 10.1097/MCG.0b013e31816207df; May T, 2010, ISME J; Mellata M, 2003, INFECT IMMUN, V71, P494, DOI 10.1128/IAI.71.1.494-503.2003; Mellata M, 2003, INFECT IMMUN, V71, P536, DOI 10.1128/IAI.71.1.536-540.2003; Mellata M, 2010, INFECT IMMUN, V78, P1528, DOI 10.1128/IAI.00981-09; Mellata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004232; Mokady D, 2005, INT J MED MICROBIOL, V295, P455, DOI 10.1016/j.ijmm.2005.07.007; Moller AK, 2003, INFECT IMMUN, V71, P2142, DOI 10.1128/IAI.71.4.2142-2152.2003; Nickerson CA, 2001, INFECT IMMUN, V69, P7106, DOI 10.1128/IAI.69.11.7106-7120.2001; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Prouty AM, 2002, INFECT IMMUN, V70, P2640, DOI 10.1128/IAI.70.5.2640-2649.2002; PROVENCE DL, 1994, INFECT IMMUN, V62, P1369, DOI 10.1128/IAI.62.4.1369-1380.1994; Reisner A, 2006, J BACTERIOL, V188, P3582, DOI 10.1128/JB.188.10.3582-3588.2006; Richards JJ, 2009, CHEMBIOCHEM, V10, P2287, DOI 10.1002/cbic.200900317; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; RUSSO TA, 1995, INFECT IMMUN, V63, P1263, DOI 10.1128/IAI.63.4.1263-1269.1995; SEYDEL U, 1993, J STRUCT BIOL, V110, P232, DOI 10.1006/jsbi.1993.1026; Skold O, 2001, VET RES, V32, P261, DOI 10.1051/vetres:2001123; Smith JL, 2007, FOODBORNE PATHOG DIS, V4, P134, DOI 10.1089/fpd.2007.0087; Snyder S, 1999, BIOCHEMISTRY-US, V38, P10758, DOI 10.1021/bi990867d; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Srimanote P, 2002, INFECT IMMUN, V70, P3094, DOI 10.1128/IAI.70.6.3094-3100.2002; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Sundin GW, 1996, MOL ECOL, V5, P133, DOI 10.1111/j.1365-294X.1996.tb00299.x; Tivendale KA, 2010, INFECT IMMUN, V78, P3412, DOI 10.1128/IAI.00347-10; Tivendale KA, 2009, J CLIN MICROBIOL, V47, P2513, DOI 10.1128/JCM.00391-09; Tivendale KA, 2009, MICROBIOL-SGM, V155, P450, DOI 10.1099/mic.0.023143-0; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Wibbenmeyer JA, 2002, INFECT IMMUN, V70, P121, DOI 10.1128/IAI.70.1.121-126.2002; Yoshida H, 2008, J MOL BIOL, V384, P690, DOI 10.1016/j.jmb.2008.09.067	90	17	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29481	10.1371/journal.pone.0029481	http://dx.doi.org/10.1371/journal.pone.0029481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238616	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200030
J	Taylor-Robinson, DC; Lloyd-Williams, F; Orton, L; Moonan, M; O'Flaherty, M; Capewell, S				Taylor-Robinson, David Carlton; Lloyd-Williams, Ffion; Orton, Lois; Moonan, May; O'Flaherty, Martin; Capewell, Simon			Barriers to Partnership Working in Public Health: A Qualitative Study	PLOS ONE			English	Article							ENGLAND	Background: Public health provision in England is undergoing dramatic changes. Currently established partnerships are thus likely to be significantly disrupted by the radical reforms outlined in the Public Health White Paper. We therefore explored the process of partnership working in public health, in order to better understand the potential opportunities and threats associated with the proposed changes. Methodology/Principal Findings: 70 participants took part in an in-depth qualitative study involving 40 semi-structured interviews and three focus group discussions. Participants were senior and middle grade public health decision makers working in Primary Care Trusts, Local Authorities, Department of Health, academia, General Practice and Hospital Trusts and the third sector in England. Despite mature arrangements for partnership working in many areas, and much support for joint working in principle, many important barriers exist. These include cultural issues such as a lack of shared values and language, the inherent complexity of intersectoral collaboration for public health, and macro issues including political and resource constraints. There is particular uncertainty and anxiety about the future of joint working relating to the availability and distribution of scarce and diminishing financial resources. There is also the concern that existing effective collaborative networks may be completely disrupted as the proposed changes unfold. The extent to which the proposed reforms might mitigate or potentiate these issues remains unclear. However the threats currently remain more salient than opportunities. Conclusions: The current re-organisation of public health offers real opportunity to address some of the barriers to partnership working identified in this study. However, significant threats exist. These include the breakup of established networks, and the risk of cost cutting on effective public health interventions.	[Taylor-Robinson, David Carlton; Lloyd-Williams, Ffion; Orton, Lois; Moonan, May; O'Flaherty, Martin; Capewell, Simon] Dept Publ Hlth & Policy, Liverpool, Merseyside, England		Taylor-Robinson, DC (corresponding author), Dept Publ Hlth & Policy, Liverpool, Merseyside, England.	dctr@liv.ac.uk		O'Flaherty, Martin/0000-0001-8944-4131; Orton, Lois/0000-0002-9641-523X	Liverpool Institute for Health Inequalities Research (LivHIR); Medical Research Council MRC) [G0802448]; MRC [G0900847, G0802448] Funding Source: UKRI; Medical Research Council [G0900847, G0802448] Funding Source: researchfish	Liverpool Institute for Health Inequalities Research (LivHIR); Medical Research Council MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by a research grant from the Liverpool Institute for Health Inequalities Research (LivHIR). Dr. Taylor-Robinson is supported by a Medical Research Council MRC)Population Health Scientist Fellowship (G0802448). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GUARDIAN; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Bauld L, 2005, J SOC POLICY, V34, P427, DOI 10.1017/S0047279405008858; Benzeval M., 2005, HLTH ACTION ZONES PA; Blackman T, 2006, PUBLIC POLICY ADMIN, V21, P66, DOI [DOI 10.1177/095207670602100206, 10.1177/095207670602100206]; Campbell F., 2010, SOCIAL DETERMINANTS; DH, 2010, EQ EXC LIB NHS; DH, 2010, HLTH LIV HLTH PEOPL; FPH, 2010, PAST WORKF CENS; Glaser B.G., 1968, DISCOV GROUNDED THEO; Griffiths S, 2007, J R SOC PROMO HEALTH, V127, P219, DOI 10.1177/1466424007081782; Hammersley Martin, 2007, ETHNOGRAPHY; Health Committee, 2011, 12 HLTH COMM; Heart of Mersey, AB US; Hunter D. J., 2010, PUBLIC HLTH SYSTEM E; Hunter D. J., 2007, PUBLIC HLTH SYSTEM E; Hunter DJ, 2010, J PUBLIC HEALTH-UK, V32, P309, DOI 10.1093/pubmed/fdq061; Hunter DJ, 2011, PARTNERSHIP WORKING; Jones J, 2011, HLTH PROMOTION INT; Krueger RA, 1998, ANAL REPORTING FOCUS; Lambert SD, 2008, J ADV NURS, V62, P228, DOI 10.1111/j.1365-2648.2007.04559.x; Levenson R, 1999, PERSPECTIVES PUBLIC, P144; Local Government Association, 2010, LG GROUP DAY BRIEF H; Local Government Association, 2010, SOC DET HLTH ROL LOC; Marks L, 2011, PUBLIC HLTH GOVERNAN; Markwell S, 2009, UNDERSTANDING ORG ST; Marmot M, 2010, MARMOT REV; NHS, 2008, HEART IMPR; O'Dowd A, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2136; Petchey, 2006, CRITICAL PUBLIC HLTH, V16, P73, DOI [https://doi.org/10.1080/09581590600602229, DOI 10.1080/09581590600602229]; Petticrew M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-314; Ritchie D, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-173; Smith KE, 2009, J PUBLIC HEALTH-UK, V31, P210, DOI 10.1093/pubmed/fdp002; Taylor-Robinson D, 2011, BIGGER CUTS LOCAL AU; Taylor-Robinson D, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1487; Taylor-Robinson DC, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-415; Wildridge Valerie, 2004, Health Info Libr J, V21 Suppl 1, P3; Wilkinson A, 2011, BMA NEWS	38	38	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29536	10.1371/journal.pone.0029536	http://dx.doi.org/10.1371/journal.pone.0029536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	902VE	22238619	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200031
J	Walker, SL; Ariga, J; Mathias, JR; Coothankandaswamy, V; Xie, XY; Distel, M; Koster, RW; Parsons, MJ; Bhalla, KN; Saxena, MT; Mumm, JS				Walker, Steven L.; Ariga, Junko; Mathias, Jonathan R.; Coothankandaswamy, Veena; Xie, Xiayang; Distel, Martin; Koester, Reinhard W.; Parsons, Michael J.; Bhalla, Kapil N.; Saxena, Meera T.; Mumm, Jeff S.			Automated Reporter Quantification In Vivo: High-Throughput Screening Method for Reporter-Based Assays in Zebrafish	PLOS ONE			English	Article							TRANSGENIC ZEBRAFISH; SMALL MOLECULES; DRUG DISCOVERY; CELLS; MODEL; ABLATION; SYSTEM; REGENERATION; RESOLUTION; IDENTIFY	Reporter-based assays underlie many high-throughput screening (HTS) platforms, but most are limited to in vitro applications. Here, we report a simple whole-organism HTS method for quantifying changes in reporter intensity in individual zebrafish over time termed, Automated Reporter Quantification in vivo (ARQiv). ARQiv differs from current "highcontent'' (e.g., confocal imaging-based) whole-organism screening technologies by providing a purely quantitative data acquisition approach that affords marked improvements in throughput. ARQiv uses a fluorescence microplate reader with specific detection functionalities necessary for robust quantification of reporter signals in vivo. This approach is: 1) Rapid; achieving true HTS capacities (i.e., >50,000 units per day), 2) Reproducible; attaining HTS-compatible assay quality (i.e., Z'-factors of >= 0.5), and 3) Flexible; amenable to nearly any reporter-based assay in zebrafish embryos, larvae, or juveniles. ARQiv is used here to quantify changes in: 1) Cell number; loss and regeneration of two different fluorescently tagged cell types (pancreatic beta cells and rod photoreceptors), 2) Cell signaling; relative activity of a transgenic Notch-signaling reporter, and 3) Cell metabolism; accumulation of reactive oxygen species. In summary, ARQiv is a versatile and readily accessible approach facilitating evaluation of genetic and/or chemical manipulations in living zebrafish that complements current "high-content'' whole-organism screening methods by providing a first-tier in vivo HTS drug discovery platform.	[Walker, Steven L.; Ariga, Junko; Xie, Xiayang; Mumm, Jeff S.] Georgia Hlth Sci Univ, Dept Cellular Biol & Anat, Augusta, GA 30904 USA; [Mathias, Jonathan R.; Saxena, Meera T.] Luminomics Inc, Augusta, GA USA; [Coothankandaswamy, Veena; Bhalla, Kapil N.] Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA USA; [Distel, Martin; Koester, Reinhard W.] Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Parsons, Michael J.] Johns Hopkins Univ, Dept Surg, Baltimore, MD USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Johns Hopkins University	Walker, SL (corresponding author), Georgia Hlth Sci Univ, Dept Cellular Biol & Anat, Augusta, GA 30904 USA.	jmumm@georgiahealth.edu	Distel, Martin/AAN-6408-2020; Mumm, Jeff S/F-3125-2013	Distel, Martin/0000-0001-5942-0817; Bhalla, Kapil/0000-0001-5209-5126; Koster, Reinhard/0000-0001-6593-8196; Mumm, Jeff/0000-0002-2575-287X	National Institutes of Health [R44-HD047089, R41-DK082060, RC4-DK090816, R01-DK080730]; March of Dimes Basil O'Conner Starter Scholar Award [5-FY10-7]; Washington University Olin Cup Award; Life Science Foundation of the Helmholtz Gemeinschaft and the Helmholtz Gemeinschaft; Georgia Health Sciences University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R43HD047089, R44HD047089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080730, RC4DK090816, R41DK082060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R43NS067916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Basil O'Conner Starter Scholar Award(March of Dimes); Washington University Olin Cup Award; Life Science Foundation of the Helmholtz Gemeinschaft and the Helmholtz Gemeinschaft; Georgia Health Sciences University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the following grants from the National Institutes of Health: R44-HD047089 (JSM and MTS), R41-DK082060 (MTS and MJP), RC4-DK090816 (MJP and JSM), and R01-DK080730 (MJP). Support was also provided by a March of Dimes Basil O'Conner Starter Scholar Award (5-FY10-7 to JSM), the Washington University Olin Cup Award (JSM and MTS), the Life Science Foundation of the Helmholtz Gemeinschaft and the Helmholtz Gemeinschaft (RWK and MD), as well as Georgia Health Sciences University (JSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021076; Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; Ariga Junko, 2010, J Vis Exp, DOI 10.3791/2093; Baker M, 2011, NAT METHODS, V8, P47, DOI 10.1038/nmeth0111-47; Bang PI, 2002, J NEUROSCI METH, V118, P177, DOI 10.1016/S0165-0270(02)00118-8; Berghmans S, 2007, EPILEPSY RES, V75, P18, DOI 10.1016/j.eplepsyres.2007.03.015; Bernardos RL, 2006, GENE EXPR PATTERNS, V6, P1007, DOI 10.1016/j.modgep.2006.04.006; Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732; Clemons PA, 2004, CURR OPIN CHEM BIOL, V8, P334, DOI 10.1016/j.cbpa.2004.04.002; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Daroczi B, 2006, CLIN CANCER RES, V12, P7086, DOI 10.1158/1078-0432.CCR-06-0514; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Eggeling C, 2003, DRUG DISCOV TODAY, V8, P632, DOI 10.1016/S1359-6446(03)02752-1; Godinho L, 2005, DEVELOPMENT, V132, P5069, DOI 10.1242/dev.02075; Goessling W, 2007, J CLIN ONCOL, V25, P2473, DOI 10.1200/JCO.2006.08.9821; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Goll MG, 2009, GENETICS, V182, P747, DOI 10.1534/genetics.109.102079; Hamaoka T, 2002, GENESIS, V34, P215, DOI 10.1002/gene.10155; Jones KS, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-23; KESTON AS, 1965, ANAL BIOCHEM, V11, P1, DOI 10.1016/0003-2697(65)90034-5; Kitambi SS, 2009, MECH DEVELOP, V126, P464, DOI 10.1016/j.mod.2009.01.002; Kucenas S, 2008, NAT NEUROSCI, V11, P143, DOI 10.1038/nn2025; Lam CS, 2009, DEV DYNAM, V238, P475, DOI 10.1002/dvdy.21853; Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008; Langheinrich U, 2003, BIOESSAYS, V25, P904, DOI 10.1002/bies.10326; Milan DJ, 2006, AM J PHYSIOL-HEART C, V291, pH269, DOI 10.1152/ajpheart.00960.2005; Milan DJ, 2003, CIRCULATION, V107, P1355, DOI 10.1161/01.CIR.0000061912.88753.87; Mumm JS, 2006, NEURON, V52, P609, DOI 10.1016/j.neuron.2006.10.004; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Mumm JS, 2009, TARGETED REGIONAL CE; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Pardo-Martin C, 2010, NAT METHODS, V7, P634, DOI [10.1038/NMETH.1481, 10.1038/nmeth.1481]; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Pelkowski SD, 2011, BEHAV BRAIN RES, V223, P135, DOI 10.1016/j.bbr.2011.04.033; Peravali R, 2011, BIOTECHNIQUES, V50, P319, DOI 10.2144/000113669; Peterson RT, 2004, METHOD CELL BIOL, V76, P569; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Pisharath H, 2007, MECH DEVELOP, V124, P218, DOI 10.1016/j.mod.2006.11.005; Rishton GM, 2003, DRUG DISCOV TODAY, V8, P86, DOI 10.1016/S1359644602025722; Rohde CB, 2007, P NATL ACAD SCI USA, V104, P13891, DOI 10.1073/pnas.0706513104; Rubinstein AL, 2003, CURR OPIN DRUG DI DE, V6, P218; Sato Y, 2005, J NEUROSCI, V25, P4889, DOI 10.1523/JNEUROSCI.0679-05.2005; Scheer N, 2001, DEVELOPMENT, V128, P1099; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Schroeter EH, 2006, VISUAL NEUROSCI, V23, P833, DOI 10.1017/S0952523806230219; Shin JT, 2002, ANNU REV GENOM HUM G, V3, P311, DOI 10.1146/annurev.genom.3.031402.131506; Tran TC, 2007, CANCER RES, V67, P11386, DOI 10.1158/0008-5472.CAN-07-3126; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Walker Michael J. A., 2004, Drug Discovery Today Targets, V3, P208, DOI 10.1016/S1741-8372(04)02449-1; Wang YY, 2011, DEVELOPMENT, V138, P609, DOI 10.1242/dev.059097; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao H, 2009, J NEUROSURG, V111, P238, DOI 10.3171/2008.8.JNS08644; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84	56	61	63	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29916	10.1371/journal.pone.0029916	http://dx.doi.org/10.1371/journal.pone.0029916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238673	Green Published, Green Submitted, gold			2022-12-27	WOS:000301070200058
J	Dutta, NK; Mehra, S; Martinez, AN; Alvarez, X; Renner, NA; Morici, LA; Pahar, B; MacLean, AG; Lackner, AA; Kaushal, D				Dutta, Noton K.; Mehra, Smriti; Martinez, Alejandra N.; Alvarez, Xavier; Renner, Nicole A.; Morici, Lisa A.; Pahar, Bapi; MacLean, Andrew G.; Lackner, Andrew A.; Kaushal, Deepak			The Stress-Response Factor SigH Modulates the Interaction between Mycobacterium tuberculosis and Host Phagocytes	PLOS ONE			English	Article							INHIBITS MACROPHAGE RESPONSES; IFN-GAMMA; TRANSCRIPTIONAL RESPONSES; APOPTOSIS; EXPRESSION; ACTIVATION; INDUCTION; SURVIVAL; IMMUNITY	The Mycobacterium tuberculosis stress response factor SigH plays a crucial role in modulating the pathogen's response to heat, oxidative-stress, envelope damage and hypoxia. We hypothesized that the lack of this key stress response factor would alter the interaction between the pathogen and its host cells. We compared the interaction of Mtb, Mtb: Delta-sigH and a strain where the mutation had been genetically complemented (Mtb: Delta-sigH: CO) with primary rhesus macaque bone marrow derived macrophages (Rh-BMDMs). The expression of numerous inducible and homeostatic (CCL) beta-chemokines and several apoptotic markers was induced to higher levels in the cells infected with Mtb: Delta-sigH, relative to Mtb or the complemented strain. The differential expression of these genes manifested into functional differences in chemotaxis and apoptosis in cells infected with these two strains. The mutant strain also exhibited reduced late-stage survival in Rh-BMDMs. We hypothesize that the product of one or more SigH-dependent genes may modulate the innate interaction of Mtb with host cells, effectively reducing the chemokine-mediated recruitment of immune effector cells, apoptosis of infected monocytes and enhancing the long-term survival and replication of the pathogen in this milieu The significantly higher induction of Prostaglandin Synthetase 2 (PTGS2 or COX2) in Rh-BMDMs infected with Mtb relative to Mtb: Delta-sigH may explain reduced apoptosis in Mtb-infected cells, as PTGS2 is known to inhibit p53-dependent apoptosis. The SigH-regulon modulates the innate interaction of Mtb with host phagocytes, perhaps as part of a strategy to limit its clearance and prolong its survival. The SigH regulon appears to be required to modulate innate immune responses directed against Mtb.	[Dutta, Noton K.; Mehra, Smriti; Martinez, Alejandra N.; Kaushal, Deepak] Tulane Natl Primate Res Ctr, Div Bacteriol, Covington, LA USA; [Dutta, Noton K.; Mehra, Smriti; Martinez, Alejandra N.; Kaushal, Deepak] Tulane Natl Primate Res Ctr, Div Parasitol, Covington, LA USA; [Alvarez, Xavier; Renner, Nicole A.; Pahar, Bapi; MacLean, Andrew G.; Lackner, Andrew A.] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA; [Morici, Lisa A.; Lackner, Andrew A.; Kaushal, Deepak] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA	Tulane University; Tulane University; Tulane University; Tulane University	Dutta, NK (corresponding author), Tulane Natl Primate Res Ctr, Div Bacteriol, Covington, LA USA.	dkaushal@tulane.edu	MacLean, Andrew/R-9906-2019; Pahar, Bapi/AFM-3129-2022; Dutta, Noton K./K-5202-2012	Pahar, Bapi/0000-0003-1949-973X; Dutta, Noton K./0000-0002-5066-3342; MacLean, Andrew/0000-0002-0356-0674	National Center for Research Resources (NCRR) Centers for Biomedical Research Excellence (CoBRE) [P20RR020159]; National Institutes of Health [R01AI089323, R01HL106790, R21AI091457, R21RR026006, R01MH077544]; Tulane National Primate Research Center Base [P51RR000164]; Louisiana Vaccine Center (LVC)/South Louisiana Institute for Infectious Disease Research (SLIIDR) [LEQSF(2007-12)-ENH-PKSFI-PRS]; Tulane Research Enhancement Fund; Tulane Center for Infectious Diseases; Louisiana Board of Regents [LEQSF(2007-12)-GF-15]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR026006, P20RR020159, P51RR000164] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI091457, R01AI089323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077544] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR) Centers for Biomedical Research Excellence (CoBRE); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane National Primate Research Center Base; Louisiana Vaccine Center (LVC)/South Louisiana Institute for Infectious Disease Research (SLIIDR); Tulane Research Enhancement Fund; Tulane Center for Infectious Diseases; Louisiana Board of Regents; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Center for Research Resources (NCRR) Centers for Biomedical Research Excellence (CoBRE) (grant P20RR020159); supported in part by National Institutes of Health grants (to DK): R01AI089323, R01HL106790, R21AI091457 and R21RR026006 and (to AGM) R01MH077544; the Tulane National Primate Research Center Base grant (P51RR000164); a cooperative pilot grant (LEQSF(2007-12)-ENH-PKSFI-PRS) from the Louisiana Vaccine Center (LVC)/South Louisiana Institute for Infectious Disease Research (SLIIDR) (to DK); a grant from Tulane Research Enhancement Fund (to DK); post-doctoral awards from Tulane Center for Infectious Diseases (to NKD and SM) and a doctoral award to NR from the Louisiana Board of Regents (LEQSF(2007-12)-GF-15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Bai XY, 2011, TUBERCULOSIS, V91, P26, DOI 10.1016/j.tube.2010.11.005; Beatty WL, 2000, INFECT IMMUN, V68, P6997, DOI 10.1128/IAI.68.12.6997-7002.2000; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; Chaturvedi R, 2010, J BIOL CHEM, V285, P30389, DOI 10.1074/jbc.M110.135251; Choi EM, 2005, BIOCHEM BIOPH RES CO, V328, P1107, DOI 10.1016/j.bbrc.2005.01.072; Dutta NK, 2010, PLOS ONE, V8; Dutta NK, 2010, J INFECT DIS, V201, P1743, DOI 10.1086/652497; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; Estorninho M, 2010, MICROBIOL-SGM, V156, P3445, DOI 10.1099/mic.0.042275-0; Fontan PA, 2009, J BACTERIOL, V191, P5628, DOI 10.1128/JB.00510-09; Fontan PA, 2008, J INFECT DIS, V198, P877, DOI 10.1086/591098; Fortune SM, 2004, J IMMUNOL, V172, P6272, DOI 10.4049/jimmunol.172.10.6272; Fratazzi C, 1997, J IMMUNOL, V158, P4320; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gormus BJ, 2004, J MED PRIMATOL, V33, P134, DOI 10.1111/j.1600-0684.2004.00062.x; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Gupta D, 2010, J IMMUNOL, V184, P5444, DOI 10.4049/jimmunol.0903283; Hacker G, 2006, CELL CYCLE, V5, P2421, DOI 10.4161/cc.5.21.3397; Han JA, 2002, EMBO J, V21, P5635, DOI 10.1093/emboj/cdf591; Kaufmann SHE, 2006, NAT REV IMMUNOL, V6, P699, DOI 10.1038/nri1920; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kernodle DS, 2010, CLIN INFECT DIS, V51, P177, DOI 10.1086/653533; Khader SA, 2009, J IMMUNOL, V183, P8004, DOI 10.4049/jimmunol.0901937; Kincaid EZ, 2003, J IMMUNOL, V171, P2042, DOI 10.4049/jimmunol.171.4.2042; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Mehra S, 2011, MYCOBACTERI IN PRESS; Mehra S, 2011, J MED PRIMATOL, V40, P233, DOI 10.1111/j.1600-0684.2011.00485.x; Mehra S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012266; Mehra S, 2010, J INFECT DIS, V202, P943, DOI 10.1086/654820; Mehra S, 2009, J BACTERIOL, V191, P3965, DOI 10.1128/JB.00064-09; Mendez-Samperio P, 2008, J INFECTION, V57, P374, DOI 10.1016/j.jinf.2008.08.010; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Moreno JM, 2002, IMMUNOLOGY, V106, P257, DOI 10.1046/j.1365-2567.2002.01403.x; Nagabhushanam V, 2003, J IMMUNOL, V171, P4750, DOI 10.4049/jimmunol.171.9.4750; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pai RK, 2003, J IMMUNOL, V171, P175, DOI 10.4049/jimmunol.171.1.175; Paige C, 2010, CELL MICROBIOL, V12, P301, DOI 10.1111/j.1462-5822.2009.01424.x; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Raman S, 2001, J BACTERIOL, V183, P6119, DOI 10.1128/JB.183.20.6119-6125.2001; Raviglione MC, 2007, B WORLD HEALTH ORGAN, V85, P327, DOI 10.2471/BLT.06.038513; Renner NA, 2011, J NEUROVIROL, V17, P146, DOI 10.1007/s13365-010-0017-y; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Sadagopal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005531; Saukkonen JJ, 2002, INFECT IMMUN, V70, P1684, DOI 10.1128/IAI.70.4.1684-1693.2002; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Sherrid AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011622; Singhal A, 2007, INFECT IMMUN, V75, P2500, DOI 10.1128/IAI.01743-06; Sly LM, 2003, J IMMUNOL, V170, P430, DOI 10.4049/jimmunol.170.1.430; Stewart GR, 2002, COMPAR FUNCT GENOM, V3, P348, DOI 10.1002/cfg.183; Ting LM, 1999, J IMMUNOL, V163, P3898; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Winau F, 2004, CELL MICROBIOL, V6, P599, DOI 10.1111/j.1462-5822.2004.00408.x	58	47	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28958	10.1371/journal.pone.0028958	http://dx.doi.org/10.1371/journal.pone.0028958			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235255	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400016
J	Gan, X; Gould, SJ				Gan, Xin; Gould, Stephen J.			HIV Pol Inhibits HIV Budding and Mediates the Severe Budding Defect of Gag-Pol	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MEMBRANE-PROTEINS; PLASMA-MEMBRANE; RELEASE; P6; OVEREXPRESSION; MACROPHAGES; PARTICLES; EXOSOMES; PROTEASE	The prevailing hypothesis of HIV budding posits that the viral Gag protein drives budding, and that the Gag p6 peptide plays an essential role by recruiting host-cell budding factors to sites of HIV assembly. HIV also expresses a second Gag protein, p160 Gag-Pol, which lacks p6 and fails to bud from cells, consistent with the prevailing hypothesis of HIV budding. However, we show here that the severe budding defect of Gag-Pol is not caused by the absence of p6, but rather, by the presence of Pol. Specifically, we show that (i) the budding defect of Gag-Pol is unaffected by loss of HIV protease activity and is therefore an intrinsic property of the Gag-Pol polyprotein, (ii) the N-terminal 433 amino acids of Gag and Gag-Pol are sufficient to drive virus budding even though they lack p6, (iii) the severe budding defect of Gag-Pol is caused by a dominant, cis-acting inhibitor of budding in the HIV Pol domain, and (iv) Gag-Pol inhibits Gag and virus budding in trans, even at normal levels of Gag and Gag-Pol expression. These and other data support an alternative hypothesis of HIV budding as a process that is mediated by the normal, non-viral pathway of exosome/microvesicle biogenesis.	[Gan, Xin; Gould, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Gan, X (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	sgould@jhmi.edu			National Institutes of Health [R01 DK45787]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the National Institutes of Health (R01 DK45787). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; FREED EO, 2006, FIELDS VIROLOGY, P2107; Gan X, 2011, MOL BIOL CELL, V22, P817, DOI 10.1091/mbc.E10-07-0625; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; KARACOSTAS V, 1993, VIROLOGY, V193, P661, DOI 10.1006/viro.1993.1174; Krishnamoorthy L, 2009, NAT CHEM BIOL, V5, P244, DOI 10.1038/nchembio.151; Llewellyn GN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001167; Marsh M, 2009, BIOCHEM SOC T, V37, P185, DOI 10.1042/BST0370185; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; PARK JS, 1991, J VIROL, V65, P5111, DOI 10.1128/JVI.65.9.5111-5117.1991; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Shen B, 2011, J BIOL CHEM IN PRESS; Shen BY, 2011, J BIOL CHEM, V286, P14383, DOI 10.1074/jbc.M110.208660; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; SMITH AJ, 1993, J VIROL, V67, P2266, DOI 10.1128/JVI.67.4.2266-2275.1993; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004	29	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29421	10.1371/journal.pone.0029421	http://dx.doi.org/10.1371/journal.pone.0029421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235295	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400056
J	Hebert, L; Moumen, B; Pons, N; Duquesne, F; Breuil, MF; Goux, D; Batto, JM; Laugier, C; Renault, P; Petry, S				Hebert, Laurent; Moumen, Bouziane; Pons, Nicolas; Duquesne, Fabien; Breuil, Marie-France; Goux, Didier; Batto, Jean-Michel; Laugier, Claire; Renault, Pierre; Petry, Sandrine			Genomic Characterization of the Taylorella Genus	PLOS ONE			English	Article							CONTAGIOUS EQUINE METRITIS; TRIPARTITE TRICARBOXYLATE TRANSPORTER; IV SECRETION SYSTEMS; PHOSPHOTRANSFERASE SYSTEM; GENITAL INFECTION; VI SECRETION; SP NOV.; EQUIGENITALIS; SEQUENCE; PROTEIN	The Taylorella genus comprises two species: Taylorella equigenitalis, which causes contagious equine metritis, and Taylorella asinigenitalis, a closely-related species mainly found in donkeys. We herein report on the first genome sequence of T. asinigenitalis, analyzing and comparing it with the recently-sequenced T. equigenitalis genome. The T. asinigenitalis genome contains a single circular chromosome of 1,638,559 bp with a 38.3% GC content and 1,534 coding sequences (CDS). While 212 CDSs were T. asinigenitalis-specific, 1,322 had orthologs in T. equigenitalis. Two hundred and thirty-four T. equigenitalis CDSs had no orthologs in T. asinigenitalis. Analysis of the basic nutrition metabolism of both Taylorella species showed that malate, glutamate and alpha-ketoglutarate may be their main carbon and energy sources. For both species, we identified four different secretion systems and several proteins potentially involved in binding and colonization of host cells, suggesting a strong potential for interaction with their host. T. equigenitalis seems better-equipped than T. asinigenitalis in terms of virulence since we identified numerous proteins potentially involved in pathogenicity, including hemagluttinin-elated proteins, a type IV secretion system, TonB-dependent lactoferrin and transferrin receptors, and YadA and Hep_Hag domains containing proteins. This is the first molecular characterization of Taylorella genus members, and the first molecular identification of factors potentially involved in T. asinigenitalis and T. equigenitalis pathogenicity and host colonization. This study facilitates a genetic understanding of growth phenotypes, animal host preference and pathogenic capacity, paving the way for future functional investigations into this largely unknown genus.	[Hebert, Laurent; Duquesne, Fabien; Breuil, Marie-France; Laugier, Claire; Petry, Sandrine] ANSES, Dozule Lab Equine Dis, Dozule, France; [Moumen, Bouziane; Pons, Nicolas; Batto, Jean-Michel; Renault, Pierre] INRA, Micalis UMR1319, Jouy En Josas, France; [Goux, Didier] Univ Caen Basse Normandie, Ctr Microscopie Appl & Biol, Caen, France; [Goux, Didier] IFR146 ICORE, Caen, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universite de Caen Normandie	Hebert, L (corresponding author), ANSES, Dozule Lab Equine Dis, Dozule, France.	laurent.hebert@anses.fr; sandrine.petry@anses.fr	Hébert, Laurent/AAQ-1949-2021; Hébert, Laurent/GLV-5872-2022	Hébert, Laurent/0000-0002-5738-9913; PETRY, Sandrine/0000-0002-3091-575X	Basse-Normandie Regional Council; Institut Francais du Cheval et de l'Equitation; ANSES	Basse-Normandie Regional Council(Region Normandie); Institut Francais du Cheval et de l'Equitation; ANSES	This work was supported by the Basse-Normandie Regional Council, the Institut Francais du Cheval et de l'Equitation, http://www.ifce.fr), and a grant from ANSES (http://www.anses.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JC, 2005, BIOINFORMATICS, V21, P3665, DOI 10.1093/bioinformatics/bti601; Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Antoine R, 2005, J MOL BIOL, V351, P799, DOI 10.1016/j.jmb.2005.05.071; Archer CT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-9; Arioli S, 2009, MICROBIOL-SGM, V155, P1953, DOI 10.1099/mic.0.024737-0; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Beddek AJ, 2010, BIOMETALS, V23, P377, DOI 10.1007/s10534-010-9299-z; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BERTRAM TA, 1982, INFECT IMMUN, V37, P1241, DOI 10.1128/IAI.37.3.1241-1247.1982; BleuminkPluym NMC, 1996, CLIN DIAGN LAB IMMUN, V3, P47, DOI 10.1128/CDLI.3.1.47-50.1996; Boel G, 2003, J MOL MICROB BIOTECH, V5, P206, DOI 10.1159/000071072; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Breuil MF, 2011, VET MICROBIOL, V148, P260, DOI 10.1016/j.vetmic.2010.08.028; Brooks BW, 2010, CAN J VET RES, V74, P18; Bunikis I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000009; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Chinen A, 2000, GENE, V259, P109, DOI 10.1016/S0378-1119(00)00459-5; CROWHURST RC, 1977, VET REC, V100, P476, DOI 10.1136/vr.100.22.476-a; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; van de Guchte M, 2006, P NATL ACAD SCI USA, V103, P9274, DOI 10.1073/pnas.0603024103; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Duquesne F, 2007, RES VET SCI, V82, P47, DOI 10.1016/j.rvsc.2006.05.001; Eisen JA, 2000, GENOME BIOL, V1; Garduno RA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00122; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hebert L, 2011, J BACTERIOL, V193, P1785, DOI 10.1128/JB.01547-10; Heilmann C, 2011, ADV EXP MED BIOL, V715, P105, DOI 10.1007/978-94-007-0940-9_7; HITCHCOCK PJ, 1985, INFECT IMMUN, V48, P94, DOI 10.1128/IAI.48.1.94-108.1985; Jang SS, 2001, INT J SYST EVOL MICR, V51, P971, DOI 10.1099/00207713-51-3-971; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jehl MA, 2011, NUCLEIC ACIDS RES, V39, pD591, DOI 10.1093/nar/gkq1154; JIN RZ, 1984, J GEN MICROBIOL, V130, P83; Joseph B, 2007, MICROBES INFECT, V9, P1188, DOI 10.1016/j.micinf.2007.05.006; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; KANEMARU T, 1992, J VET MED SCI, V54, P345, DOI 10.1292/jvms.54.345; Katz JB, 2000, J AM VET MED ASSOC, V216, P1945, DOI 10.2460/javma.2000.216.1945; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020999; LINDMARK DG, 1982, INFECT IMMUN, V36, P531, DOI 10.1128/IAI.36.2.531-534.1982; Lolkema JS, 1998, CURR OPIN MICROBIOL, V1, P248, DOI 10.1016/S1369-5274(98)80018-0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maruyama F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-358; Matsuda M, 2003, VET MICROBIOL, V97, P111, DOI 10.1016/j.vetmic.2003.08.001; McGlynn P, 2002, TRENDS GENET, V18, P413, DOI 10.1016/S0168-9525(02)02720-8; Motherway MOC, 2011, P NATL ACAD SCI US; Mulligan C, 2011, FEMS MICROBIOL REV, V35, P68, DOI 10.1111/j.1574-6976.2010.00236.x; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Penz T, 2010, VIRULENCE, V1, P541, DOI 10.4161/viru.1.6.13800; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; Pons N, 2008, J MOL MICROB BIOTECH, V14, P67, DOI 10.1159/000106084; Preston GM, 1998, CURR OPIN MICROBIOL, V1, P589, DOI 10.1016/S1369-5274(98)80094-5; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Rego AT, 2010, BIOCHEM J, V425, P475, DOI 10.1042/BJ20091518; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Sasindran SJ, 2007, FUTURE MICROBIOL, V2, P619, DOI 10.2217/17460913.2.6.619; Sisto A, 2010, ANTON LEEUW INT J G, V98, P505, DOI 10.1007/s10482-010-9468-7; Stathopoulos C, 2000, MICROBES INFECT, V2, P1061, DOI 10.1016/S1286-4579(00)01260-0; SUGIMOTO C, 1983, CURR MICROBIOL, V9, P155, DOI 10.1007/BF01567289; Tamura K, 2011, MOL BIOL EVOL; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Temple LM, 2010, INFECT IMMUN, V78, P2370, DOI 10.1128/IAI.00140-10; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIMONEY PJ, 1977, VET REC, V101, P103, DOI 10.1136/vr.101.5.103-a; Timoney PJ, 2011, J ANIM SCI; Tiyawisutsri R, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-19; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Vinogradov E, 2008, CARBOHYD RES, V343, P3079, DOI 10.1016/j.carres.2008.09.015; Vinogradov E, 2008, BIOCHEM CELL BIOL, V86, P278, DOI [10.1139/O08-036, 10.1139/o08-036]; Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x; Willems A, 2002, INT J SYST EVOL MICR, V52, P179, DOI 10.1099/00207713-52-1-179; Winnen B, 2003, RES MICROBIOL, V154, P457, DOI 10.1016/S0923-2508(03)00126-8; Yang J, 2008, NUCLEIC ACIDS RES, V36, pD539, DOI 10.1093/nar/gkm951	83	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29953	10.1371/journal.pone.0029953	http://dx.doi.org/10.1371/journal.pone.0029953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235352	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400114
J	Hellard, E; Pontier, D; Sauvage, F; Poulet, H; Fouchet, D				Hellard, Eleonore; Pontier, Dominique; Sauvage, Frank; Poulet, Herve; Fouchet, David			True versus False Parasite Interactions: A Robust Method to Take Risk Factors into Account and Its Application to Feline Viruses	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HERPES-SIMPLEX VIRUS; INFECTION ABCD GUIDELINES; SUB-SAHARAN AFRICA; INTERSPECIFIC ASSOCIATIONS; LEUKEMIA-VIRUS; DOMESTIC CATS; CONCOMITANT INFECTION; VIRAL RHINOTRACHEITIS; INTESTINAL HELMINTHS	Background: Multiple infections are common in natural host populations and interspecific parasite interactions are therefore likely within a host individual. As they may seriously impact the circulation of certain parasites and the emergence and management of infectious diseases, their study is essential. In the field, detecting parasite interactions is rendered difficult by the fact that a large number of co-infected individuals may also be observed when two parasites share common risk factors. To correct for these ``false interactions'', methods accounting for parasite risk factors must be used. Methodology/Principal Findings: In the present paper we propose such a method for presence-absence data (i.e., serology). Our method enables the calculation of the expected frequencies of single and double infected individuals under the independence hypothesis, before comparing them to the observed ones using the chi-square statistic. The method is termed" the corrected chi-square.'' Its robustness was compared to a pre-existing method based on logistic regression and the corrected chi-square proved to be much more robust for small sample sizes. Since the logistic regression approach is easier to implement, we propose as a rule of thumb to use the latter when the ratio between the sample size and the number of parameters is above ten. Applied to serological data for four viruses infecting cats, the approach revealed pairwise interactions between the Feline Herpesvirus, Parvovirus and Calicivirus, whereas the infection by FIV, the feline equivalent of HIV, did not modify the risk of infection by any of these viruses. Conclusions/Significance: This work therefore points out possible interactions that can be further investigated in experimental conditions and, by providing a user-friendly R program and a tutorial example, offers new opportunities for animal and human epidemiologists to detect interactions of interest in the field, a crucial step in the challenge of multiple infections.	[Hellard, Eleonore; Pontier, Dominique; Sauvage, Frank; Fouchet, David] Univ Lyon, Lyon, France; [Hellard, Eleonore; Pontier, Dominique; Sauvage, Frank; Fouchet, David] Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Poulet, Herve] Merial, Rech & Dev, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Merial SASU	Hellard, E (corresponding author), Univ Lyon, Lyon, France.	eleonore.hellard@univ-lyon1.fr		Pontier, Dominique/0000-0003-4700-3543	Lyon Biopole	Lyon Biopole	This work was supported by Lyon Biopole (programme FIV VAX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; ADAMS DB, 1989, INT J PARASITOL, V19, P717, DOI 10.1016/0020-7519(89)90056-8; ALBRECHT MA, 1989, J VIROL, V63, P1861, DOI 10.1128/JVI.63.5.1861-1868.1989; Allen AR, 2010, P ROY SOC B-BIOL SCI, V277, P2737, DOI 10.1098/rspb.2010.0830; ANDERSON DR, 1994, ECOLOGY, V75, P1780, DOI 10.2307/1939637; Behnke JM, 2005, J ANIM ECOL, V74, P982, DOI 10.1111/j.1365-2656.2005.00995.x; Behnke JM, 2001, PARASITOLOGY, V122, pS39, DOI 10.1017/S0031182000016796; BEHNKE JM, 1978, EXP PARASITOL, V46, P121, DOI 10.1016/0014-4894(78)90162-5; Beldomenico PM, 2009, EPIDEMIOL INFECT, V137, P1295, DOI 10.1017/S0950268808001866; BENDINELLI M, 1995, CLIN MICROBIOL REV, V8, P87, DOI 10.1128/CMR.8.1.87; Bentwich Z, 1999, IMMUNOL TODAY, V20, P485, DOI 10.1016/S0167-5699(99)01499-1; Berthier K, 2000, P ROY SOC B-BIOL SCI, V267, P2049, DOI 10.1098/rspb.2000.1248; Bilge-Dagalp S, 2008, REV MED VET-TOULOUSE, V159, P385; Bucknell D, 1996, J HELMINTHOL, V70, P185, DOI 10.1017/S0022149X0001539X; BUONAVOGLIA C, 1993, J VET MED B, V40, P343, DOI 10.1111/j.1439-0450.1993.tb00148.x; BUSH AO, 1986, CAN J ZOOL, V64, P132, DOI 10.1139/z86-022; Celum C.L., 2004, HERPES, V11, p36A; CHRISTENSEN NO, 1987, PARASITOL RES, V73, P387, DOI 10.1007/BF00538196; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2002, LANCET, V359, P2177, DOI 10.1016/S0140-6736(02)09095-5; COURCHAMP F, 1994, CR ACAD SCI III-VIE, V317, P1123; Courtin D, 2008, INFECT GENET EVOL, V8, P229, DOI 10.1016/j.meegid.2008.02.007; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; CSIZA CK, 1971, AM J VET RES, V32, P419; DAWSON S, 1991, AIDS, V5, P747, DOI 10.1097/00002030-199106000-00016; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; Faulkner H, 2005, T ROY SOC TROP MED H, V99, P301, DOI 10.1016/j.trstmh.2004.05.006; Fenton A, 2010, ECOL LETT, V13, P606, DOI 10.1111/j.1461-0248.2010.01458.x; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Fouchet D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007377; Frontera E, 2005, VET PARASITOL, V127, P295, DOI 10.1016/j.vetpar.2004.11.001; GASKELL RM, 1977, VET REC, V100, P128, DOI 10.1136/vr.100.7.128; GASKELL RM, 1982, VET REC, V111, P359, DOI 10.1136/vr.111.16.359; GOLDEN MP, 1992, J INFECT DIS, V166, P494, DOI 10.1093/infdis/166.3.494; Graham AL, 2002, Q REV BIOL, V77, P409, DOI 10.1086/344414; Graham AL, 2005, J INFECT DIS, V191, P410, DOI 10.1086/426871; Graham AL, 2008, P NATL ACAD SCI USA, V105, P566, DOI 10.1073/pnas.0707221105; Graham AL, 2007, TRENDS PARASITOL, V23, P284, DOI 10.1016/j.pt.2007.04.005; GRMEK MD, 1969, ANN ESC, V24, P1473; Harris JB, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000403; HAUKISALMI V, 1993, J ANIM ECOL, V62, P221, DOI 10.2307/5353; Haukisalmi V, 1998, OECOLOGIA, V116, P565, DOI 10.1007/s004420050622; Hellard E, 2011, PREV VET MED, V101, P250, DOI 10.1016/j.prevetmed.2011.04.020; HENG MCY, 1994, LANCET, V343, P255, DOI 10.1016/S0140-6736(94)91110-X; Hoffman IF, 1999, AIDS, V13, P487, DOI 10.1097/00002030-199903110-00007; HofmannLehmann R, 1996, CLIN DIAGN LAB IMMUN, V3, P554, DOI 10.1128/CDLI.3.5.554-562.1996; HOSTE H, 1992, INT J PARASITOL, V22, P173, DOI 10.1016/0020-7519(92)90098-6; Hoste H., 1993, Transactions Royal Society of South Australia, V117, P171; Howard SC, 2001, PARASITOLOGY, V122, P233, DOI 10.1017/S0031182001007272; Huang YX, 2006, P ROY SOC B-BIOL SCI, V273, P1229, DOI 10.1098/rspb.2005.3454; Ikeda Y, 1998, J VIROL, V72, P6932, DOI 10.1128/JVI.72.8.6932-6936.1998; Jolles AE, 2008, ECOLOGY, V89, P2239, DOI 10.1890/07-0995.1; Karvonen Anssi, 2009, Journal of Animal Ecology, V78, P945, DOI 10.1111/j.1365-2656.2009.01562.x; Kaur G, 2009, TISSUE ANTIGENS, V74, P373, DOI 10.1111/j.1399-0039.2009.01337.x; KAWAGUCHI Y, 1991, VIROLOGY, V184, P449, DOI 10.1016/0042-6822(91)90868-C; KNOWLES JO, 1989, VET REC, V124, P336, DOI 10.1136/vr.124.13.336; Kramnik I, 2008, CURR TOP MICROBIOL, V321, P123; Krasnov BR, 2006, J ANIM ECOL, V75, P1330, DOI 10.1111/j.1365-2656.2006.01156.x; KURIS AM, 1994, ANNU REV ECOL SYST, V25, P189, DOI 10.1146/annurev.es.25.110194.001201; LAFFERTY KD, 1994, ECOLOGY, V75, P2275, DOI 10.2307/1940883; Lello J, 2004, NATURE, V428, P840, DOI 10.1038/nature02490; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; LIBERG O, 1980, OIKOS, V35, P336, DOI 10.2307/3544649; LOTZ JM, 1991, PARASITOLOGY, V103, P127, DOI 10.1017/S0031182000059370; Maher D, 2005, TROP MED INT HEALTH, V10, P734, DOI 10.1111/j.1365-3156.2005.01456.x; Marchandeau S, 2004, VET REC, V155, P589, DOI 10.1136/vr.155.19.589; Mcnab T, 2010, VIROLOGY, V404, P261, DOI 10.1016/j.virol.2010.05.001; MOSCA JD, 1987, NATURE, V325, P67, DOI 10.1038/325067a0; Mwangi TW, 2006, ANN TROP MED PARASIT, V100, P551, DOI 10.1179/136485906X118468; Nacher M, 2002, PARASITE IMMUNOL, V24, P391, DOI 10.1046/j.1365-3024.2002.00470.x; Nakamichi M, 2003, PRIMATES, V44, P239, DOI 10.1007/s10329-003-0036-x; Natoli E, 2005, NEUROSCI BIOBEHAV R, V29, P151, DOI 10.1016/j.neubiorev.2004.06.011; Ostrowski S, 2003, J WILDLIFE DIS, V39, P696, DOI 10.7589/0090-3558-39.3.696; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Pedersen NC, 1987, VIRUS INFECT CARNIVO, P247; Pontier D, 1998, P ROY SOC B-BIOL SCI, V265, P167, DOI 10.1098/rspb.1998.0278; Pontier D, 2009, CR BIOL, V332, P321, DOI 10.1016/j.crvi.2008.07.012; Poulet H, 2007, J COMP PATHOL, V137, pS67, DOI 10.1016/j.jcpa.2007.04.020; Poulin R, 2001, PARASITOLOGY, V122, pS3, DOI 10.1017/S0031182000016991; POVEY RC, 1970, J SMALL ANIM PRACT, V11, P485, DOI 10.1111/j.1748-5827.1970.tb05599.x; Radford AD, 2009, J FELINE MED SURG, V11, P556, DOI 10.1016/j.jfms.2009.05.004; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; REIF JS, 1976, AM J EPIDEMIOL, V103, P81, DOI 10.1093/oxfordjournals.aje.a112208; REUBEL GH, 1992, VET IMMUNOL IMMUNOP, V35, P95, DOI 10.1016/0165-2427(92)90124-9; REUBEL GH, 1994, J ACQ IMMUN DEF SYND, V7, P1003; Rodriguez M, 1999, PARASITE IMMUNOL, V21, P177, DOI 10.1046/j.1365-3024.1999.00218.x; Say L, 2002, POLAR BIOL, V25, P838, DOI 10.1007/s00300-002-0427-2; SCHALL JJ, 1994, OECOLOGIA, V97, P326, DOI 10.1007/BF00317322; Scott FW, 1999, AM J VET RES, V60, P652; Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43; SPARGER EE, 1993, VET CLIN N AM-SMALL, V23, P173, DOI 10.1016/S0195-5616(93)50011-6; Stancampiano L, 2010, VET PARASITOL, V170, P88, DOI 10.1016/j.vetpar.2010.01.031; Steinel A, 2001, J WILDLIFE DIS, V37, P594, DOI 10.7589/0090-3558-37.3.594; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; TENORIO AP, 1991, VET IMMUNOL IMMUNOP, V29, P1, DOI 10.1016/0165-2427(91)90048-H; Thiry E, 2009, J FELINE MED SURG, V11, P547, DOI 10.1016/j.jfms.2009.05.003; Troyer JL, 2005, J VIROL, V79, P8282, DOI 10.1128/JVI.79.13.8282-8294.2005; Truyen U, 2009, J FELINE MED SURG, V11, P538, DOI 10.1016/j.jfms.2009.05.002; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; Weiss E, 2004, HERPES S1, V11, p24A; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Willett BJ, 1997, IMMUNOL TODAY, V18, P182, DOI 10.1016/S0167-5699(97)84665-8; Worrall E., 2003, RELATIONSHIP SOCIOEC	104	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29618	10.1371/journal.pone.0029618	http://dx.doi.org/10.1371/journal.pone.0029618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235312	Green Submitted, Green Published, gold			2022-12-27	WOS:000301123400074
J	Lu, HF; Jiang, W; Ghiassi, M; Lee, S; Nitin, M				Lu, Hongfei; Jiang, Wu; Ghiassi, M.; Lee, Sean; Nitin, Mantri			Classification of Camellia (Theaceae) Species Using Leaf Architecture Variations and Pattern Recognition Techniques	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; SUPPORT VECTOR MACHINES; SINENSIS L.; IDENTIFICATION; PLANT; DISCRIMINATION; ANATOMY; SPECTROSCOPY; GREEN; MODEL	Leaf characters have been successfully utilized to classify Camellia (Theaceae) species; however, leaf characters combined with supervised pattern recognition techniques have not been previously explored. We present results of using leaf morphological and venation characters of 93 species from five sections of genus Camellia to assess the effectiveness of several supervised pattern recognition techniques for classifications and compare their accuracy. Clustering approach, Learning Vector Quantization neural network (LVQ-ANN), Dynamic Architecture for Artificial Neural Networks (DAN2), and C-support vector machines (SVM) are used to discriminate 93 species from five sections of genus Camellia (11 in sect. Furfuracea, 16 in sect. Paracamellia, 12 in sect. Tuberculata, 34 in sect. Camellia, and 20 in sect. Theopsis). DAN2 and SVM show excellent classification results for genus Camellia with DAN2's accuracy of 97.92% and 91.11% for training and testing data sets respectively. The RBF-SVM results of 97.92% and 97.78% for training and testing offer the best classification accuracy. A hierarchical dendrogram based on leaf architecture data has confirmed the morphological classification of the five sections as previously proposed. The overall results suggest that leaf architecture-based data analysis using supervised pattern recognition techniques, especially DAN2 and SVM discrimination methods, is excellent for identification of Camellia species.	[Lu, Hongfei; Jiang, Wu] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China; [Ghiassi, M.; Lee, Sean] Santa Clara Univ, Santa Clara, CA 95053 USA; [Nitin, Mantri] RMIT Univ, Hlth Innovat Res Inst, Sch Appl Sci, Melbourne, Vic, Australia	Zhejiang Normal University; Santa Clara University; Royal Melbourne Institute of Technology (RMIT)	Lu, HF (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China.	luhongfei63@yahoo.com.cn	Lu, Hongfei/F-9526-2013	Lu, Hongfei/0000-0001-9732-0833; Mantri, Nitin/0000-0002-7621-035X	Science and Technology research Plan of Jinhua city, China [2009-2-020]	Science and Technology research Plan of Jinhua city, China	This study was supported by grants from the Science and Technology research Plan of Jinhua city, China (No. 2009-2-020). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirezaie J, 1997, IEEE T NUCL SCI, V44, P194, DOI 10.1109/23.568805; Antonios P, 2005, FAO NEWSROOM    0714; Berrueta LA, 2007, J CHROMATOGR A, V1158, P196, DOI 10.1016/j.chroma.2007.05.024; Bila S, 1999, INT J RF MICROW C E, V9, P297, DOI 10.1002/(SICI)1099-047X(199905)9:3<297::AID-MMCE13>3.0.CO;2-W; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Calvillo-Canadell L, 2002, REV PALAEOBOT PALYNO, V122, P171, DOI 10.1016/S0034-6667(02)00135-5; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chang H.T., 1984, CAMELLIAS; Chang HT, 1998, FL REIPUBL POPULARIS; Chen L., 2005, J AM SOC HORTIC SCI, V40, P993; Chen L, 2007, EUPHYTICA, V154, P239, DOI 10.1007/s10681-006-9292-3; Chen QS, 2007, SPECTROCHIM ACTA A, V66, P568, DOI 10.1016/j.saa.2006.03.038; Chen QS, 2009, SPECTROCHIM ACTA A, V72, P845, DOI 10.1016/j.saa.2008.12.002; Chen QS, 2008, J PHARMACEUT BIOMED, V48, P1321, DOI 10.1016/j.jpba.2008.09.016; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; CLEAL C J, 1981, Estudios Geologicos (Madrid), V37, P77; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dong XW, 2008, BIOORGAN MED CHEM, V16, P8151, DOI 10.1016/j.bmc.2008.07.031; Foody GM, 2006, REMOTE SENS ENVIRON, V103, P179, DOI 10.1016/j.rse.2006.04.001; Gao JY, 2005, COLLECTED SPECIES GE; Gayatri M, 2010, INT J COMPUT SCI NET, V10, P290; Ghiassi M, 2005, INT J FORECASTING, V21, P341, DOI 10.1016/j.ijforecast.2004.10.008; Ghiassi M, 2005, NEUROCOMPUTING, V63, P397, DOI 10.1016/j.neucom.2004.03.014; Ghiassi M, 2010, EXPERT SYST APPL, V37, P3118, DOI 10.1016/j.eswa.2009.09.017; Ghiassi M, 2009, COMPUT IND ENG, V57, P287, DOI 10.1016/j.cie.2008.11.027; Goren-Bar D, 2001, LECT NOTES ARTIF INT, V2109, P188; Hickey L. J., 1979, ANATOMY DICOTYLEDONS, V1, P25, DOI DOI 10.1016/J.PALWOR.2017.03.004; HICKEY LJ, 1973, AM J BOT, V60, P17, DOI 10.2307/2441319; Jack LB, 2002, MECH SYST SIGNAL PR, V16, P373, DOI 10.1006/mssp.2001.1454; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jiang B, 2010, PLANT SYST EVOL, V290, P1, DOI 10.1007/s00606-010-0342-x; KOHLER E, 1993, FEDDES REPERT, V104, P145; Kohonen T., 1988, IEEE INT C NEURAL N, V1, P1; Kumar K.S., 2011, EUROPEAN J SCI RES, V51, P53; Kusumoputro B, 2002, ISA T, V41, P395, DOI 10.1016/S0019-0578(07)60097-4; Lin XY, 2008, J SYST EVOL, V46, P183, DOI 10.3724/SP.J.1002.2008.07057; Linnaeus C, 1753, SPECIES PLANTARUM, DOI DOI 10.5962/BHL.TITLE.669; Liu ZY, 2010, COMPUT ELECTRON AGR, V72, P99, DOI 10.1016/j.compag.2010.03.003; Lu HF, 2008, PLANT SYST EVOL, V274, P223, DOI 10.1007/s00606-008-0047-6; Lu HF, 2008, TAXON, V57, P1274, DOI 10.1002/tax.574018; Lu HF, 2011, J FOOD ENG, V104, P149, DOI 10.1016/j.jfoodeng.2010.12.007; Lu HF, 2010, J AGR FOOD CHEM, V58, P2995, DOI 10.1021/jf903655a; Lu HF, 2009, EXPERT SYST APPL, V36, P9388, DOI 10.1016/j.eswa.2008.12.065; Lv G, 2005, ELECTR POW SYST RES, V75, P9, DOI 10.1016/j.epsr.2004.07.013; Meade C, 2003, BOT J LINN SOC, V143, P231, DOI 10.1046/j.1095-8339.2003.00223.x; MELVILLE R, 1976, TAXON, V25, P549, DOI 10.2307/1220108; Ming T. L., 2000, MONOGRAPH GENUS CAME; Mugnai S, 2008, PLANT SYST EVOL, V270, P95, DOI 10.1007/s00606-007-0601-7; Olmez T, 2003, PATTERN RECOGN LETT, V24, P617, DOI 10.1016/S0167-8655(02)00281-7; Pandolfi C, 2009, TAXON, V58, P925, DOI 10.1002/tax.583020; Pandolfi C, 2009, EUPHYTICA, V166, P411, DOI 10.1007/s10681-008-9828-9; Pi EX, 2011, EXPERT SYST APPL, V38, P3009, DOI 10.1016/j.eswa.2010.08.090; Pi EX, 2009, BOT J LINN SOC, V159, P456, DOI 10.1111/j.1095-8339.2009.00952.x; Plotze RD, 2005, CAN J BOT, V83, P287, DOI [10.1139/b05-002, 10.1139/B05-002]; Premoli AC, 2008, BOT J LINN SOC, V121, P25; RAO VS, 1980, MICROSC ACTA, V83, P307; Roggo Y, 2003, ANAL CHIM ACTA, V477, P187, DOI 10.1016/S0003-2670(02)01422-8; Roth-Nebelsick A, 2001, ANN BOT-LONDON, V87, P553, DOI 10.1006/anbo.2001.1391; SEALY J. R., 1958, A Revision of the Genus Camellia.; Umer M. F., 2007, Information Technology Journal, V6, P154; Vijayan K, 2009, AM J BOT, V96, P1348, DOI 10.3732/ajb.0800205; Wefky A, 2011, APPL SOFT COMPUT, V11, P3580, DOI 10.1016/j.asoc.2011.01.030; Yang Jun-Bo, 2006, Acta Botanica Yunnanica, V28, P108; Ye P, 2011, KEY ENG MATER, V464, P38, DOI 10.4028/www.scientific.net/KEM.464.38; Zetter R, 1984, BEITRAGE PALAONTOLOG, V11; Zhang QY, 2005, SENSOR ACTUAT B-CHEM, V110, P370, DOI 10.1016/j.snb.2005.02.017; Zhang XH, 2007, ACTA PHYTOTAXON SIN, V45, P167, DOI 10.1360/aps06137; Zhao JW, 2010, SENSOR LETT, V8, P570, DOI 10.1166/sl.2010.1313; Zheng H, 2011, LWT-FOOD SCI TECHNOL, V44, P1273, DOI 10.1016/j.lwt.2010.12.023; Zheng H, 2011, EXPERT SYST APPL, V38, P5591, DOI 10.1016/j.eswa.2010.10.076; Zheng H, 2010, J FOOD ENG, V101, P402, DOI 10.1016/j.jfoodeng.2010.07.028	71	25	36	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29704	10.1371/journal.pone.0029704	http://dx.doi.org/10.1371/journal.pone.0029704			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235330	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400092
J	Rizzato, C; Torres, J; Plummer, M; Munoz, N; Franceschi, S; Camorlinga-Ponce, M; Fuentes-Panana, EM; Canzian, F; Kato, I				Rizzato, Cosmeri; Torres, Javier; Plummer, Martyn; Munoz, Nubia; Franceschi, Silvia; Camorlinga-Ponce, Margarita; Fuentes-Panana, Ezequiel M.; Canzian, Federico; Kato, Ikuko			Variations in Helicobacter pylori Cytotoxin-Associated Genes and Their Influence in Progression to Gastric Cancer: Implications for Prevention	PLOS ONE			English	Article							IV SECRETION SYSTEM; COMPLETE GENOME SEQUENCE; CODON USAGE BIAS; PATHOGENICITY ISLAND; CAGA GENE; INFECTION; DISEASE; PROTEIN; VACA; REGION	Helicobacter pylori (HP) is a bacterium that colonizes the human stomach and can establish a long-term infection of the gastric mucosa. Persistent Hp infection often induces gastritis and is associated with the development of peptic ulcer disease, atrophic gastritis, and gastric adenocarcinoma. Virulent HP isolates harbor the cag (cytotoxin-associated genes) pathogenicity island (cagPAI), a 40 kb stretch of DNA that encodes components of a type IV secretion system (T4SS). This T4SS forms a pilus for the injection of virulence factors into host target cells, such as the CagA oncoprotein. We analyzed the genetic variability in cagA and other selected genes of the HP cagPAI (cagC, cagE, cagL, cagT, cagV and cag Gamma) using DNA extracted from frozen gastric biopsies or from clinical isolates. Study subjects were 95 cagA+ patients that were histologically diagnosed with chronic gastritis or gastric cancer in Venezuela and Mexico, areas with high prevalence of Hp infection. Sequencing reactions were carried out by both Sanger and next-generation pyrosequencing (454 Roche) methods. We found a total of 381 variants with unambiguous calls observed in at least 10% of the originally tested samples and reference strains. We compared the frequencies of these genetic variants between gastric cancer and chronic gastritis cases. Twenty-six SNPs (11 non-synonymous and 14 synonymous) showed statistically significant differences (P<0.05), and two SNPs, in position 1039 and 1041 of cagE, showed a highly significant association with cancer (p-value = 2.07 x 10(-6)), and the variant codon was located in the VirB3 homology domain of Agrobacterium. The results of this study may provide preliminary information to target antibiotic treatment to high-risk individuals, if effects of these variants are confirmed in further investigations.	[Rizzato, Cosmeri; Canzian, Federico] German Canc Res Ctr, Heidelberg, Germany; [Torres, Javier; Camorlinga-Ponce, Margarita; Fuentes-Panana, Ezequiel M.] Inst Mexicano Seguro Social, Unidad Med Alta Especialidad UMAE Pediat, Unidad Invest Enfermedades Infecciosas, Mexico City, DF, Mexico; [Plummer, Martyn; Franceschi, Silvia] Int Agcy Res Canc, F-69372 Lyon, France; [Munoz, Nubia] Natl Canc Inst Colombia, Bogota, Colombia; [Kato, Ikuko] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA	Helmholtz Association; German Cancer Research Center (DKFZ); Instituto Mexicano del Seguro Social; World Health Organization; International Agency for Research on Cancer (IARC); Barbara Ann Karmanos Cancer Institute; Wayne State University	Rizzato, C (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	katoi@med.wayne.edu	Rizzato, Cosmeri/AAI-1261-2020; Fuentes-Pananá, Ezequiel/AAI-2856-2020; Canzian, Federico/I-2804-2014; franceschi, silvia/M-2452-2014	franceschi, silvia/0000-0003-4181-8071; Fuentes-Panana, Ezequiel M./0000-0003-2872-0459; Canzian, Federico/0000-0002-4261-4583; Plummer, Martyn/0000-0001-5130-6497	Fundacion IMSS, Mexico	Fundacion IMSS, Mexico	JT is a recipient of an Exclusivity scholarship from Fundacion IMSS, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta N, 2010, WORLD J GASTROENTERO, V16, P3936, DOI 10.3748/wjg.v16.i31.3936; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Argent RH, 2008, CLIN CANCER RES, V14, P2227, DOI 10.1158/1078-0432.CCR-07-2022; Argent RH, 2008, J MED MICROBIOL, V57, P145, DOI 10.1099/jmm.0.47465-0; Azuma T, 2002, J INFECT DIS, V186, P1621, DOI 10.1086/345374; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; Basso D, 2008, GASTROENTEROLOGY, V135, P91, DOI 10.1053/j.gastro.2008.03.041; Batista SA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-61; Buti L, 2011, P NATL ACAD SCI USA, V108, P9238, DOI 10.1073/pnas.1106200108; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Choi KD, 2007, DIGEST DIS SCI, V52, P960, DOI 10.1007/s10620-005-9030-z; CLABOTS CR, 1993, J CLIN MICROBIOL, V31, P1870, DOI 10.1128/JCM.31.7.1870-1875.1993; Compare D, 2010, EUR REV MED PHARMACO, V14, P302; El-Etr SH, 2004, J INFECT DIS, V190, P1516, DOI 10.1086/424526; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; Hatakeyama M, 2006, INT J CANCER, V119, P1217, DOI 10.1002/ijc.21831; Higashi H, 2005, J BIOL CHEM, V280, P23130, DOI 10.1074/jbc.M503583200; Hofman V, 2000, INFECT IMMUN, V68, P5225, DOI 10.1128/IAI.68.9.5225-5233.2000; Kerr JE, 2010, J BACTERIOL, V192, P4923, DOI 10.1128/JB.00557-10; Kim SS, 2011, CANCER LETT, V305, P228, DOI 10.1016/j.canlet.2010.07.014; Kloster M, 2008, NUCLEIC ACIDS RES, V36, P3819, DOI 10.1093/nar/gkn288; Konturek PC, 2009, J PHYSIOL PHARMACOL, V60, P3; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kutter S, 2008, J BACTERIOL, V190, P2161, DOI 10.1128/JB.01341-07; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lafay B, 2000, MICROBIOL-UK, V146, P851, DOI 10.1099/00221287-146-4-851; Munoz N, 1996, IARC SCI PUBL, P125; Olbermann P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001069; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Peek RM, 2010, PHYSIOL REV, V90, P831, DOI 10.1152/physrev.00039.2009; Peek RM, 2006, J PATHOL, V208, P233, DOI 10.1002/path.1868; Plummer M, 2007, J NATL CANCER I, V99, P1328, DOI 10.1093/jnci/djm120; Plummer M, 2007, JNCI-J NATL CANCER I, V99, P137, DOI 10.1093/jnci/djk017; POST LE, 1980, J BIOL CHEM, V255, P4660; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Reyes-Leon A, 2007, INFECT IMMUN, V75, P3445, DOI 10.1128/IAI.01951-06; Romano M, 2006, NAT CLIN PRACT GASTR, V3, P622, DOI 10.1038/ncpgasthep0634; Rudi J, 1998, J CLIN MICROBIOL, V36, P944, DOI 10.1128/JCM.36.4.944-948.1998; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Saha A, 2010, GASTROENTEROLOGY, V139, P239, DOI 10.1053/j.gastro.2010.03.036; Sicinschi LA, 2010, CLIN MICROBIOL INFEC, V16, P369, DOI 10.1111/j.1469-0691.2009.02811.x; Sieveking D, 2004, J GASTROEN HEPATOL, V19, P982, DOI 10.1111/j.1440-1746.2004.03413.x; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Terradot L, 2011, FEBS J, V278, P1213, DOI 10.1111/j.1742-4658.2011.08037.x; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Yamaoka Y, 1999, GASTROENTEROLOGY, V117, P342, DOI 10.1053/gast.1999.0029900342; Yeh YC, 2011, MOL CARCINOGEN, V50, P751, DOI 10.1002/mc.20753; Zahrl D, 2005, MICROBIOL-SGM, V151, P3455, DOI 10.1099/mic.0.28141-0; Zhong QA, 2011, MOL BIOL REP, V38, P503, DOI 10.1007/s11033-010-0134-y	55	38	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29605	10.1371/journal.pone.0029605	http://dx.doi.org/10.1371/journal.pone.0029605			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235308	Green Submitted, gold, Green Published			2022-12-27	WOS:000301123400070
J	Stuckey, DJ; Carr, CA; Camelliti, P; Tyler, DJ; Davies, KE; Clarke, K				Stuckey, Daniel J.; Carr, Carolyn A.; Camelliti, Patrizia; Tyler, Damian J.; Davies, Kay E.; Clarke, Kieran			In vivo MRI Characterization of Progressive Cardiac Dysfunction in the mdx Mouse Model of Muscular Dystrophy	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; LATE GADOLINIUM ENHANCEMENT; LEFT-VENTRICULAR FUNCTION; ACUTE MYOCARDIAL-INFARCTION; DELAYED-ENHANCEMENT; HEART-FAILURE; MICE; STRESS; CARDIOMYOPATHY; DIAPHRAGM	Aims: The mdx mouse has proven to be useful in understanding the cardiomyopathy that frequently occurs in muscular dystrophy patients. Here we employed a comprehensive array of clinically relevant in vivo MRI techniques to identify early markers of cardiac dysfunction and follow disease progression in the hearts of mdx mice. Methods and Results: Serial measurements of cardiac morphology and function were made in the same group of mdx mice and controls (housed in a non-SPF facility) using MRI at 1, 3, 6, 9 and 12 months after birth. Left ventricular (LV) and right ventricular (RV) systolic and diastolic function, response to dobutamine stress and myocardial fibrosis were assessed. RV dysfunction preceded LV dysfunction, with RV end systolic volumes increased and RV ejection fractions reduced at 3 months of age. LV ejection fractions were reduced at 12 months, compared with controls. An abnormal response to dobutamine stress was identified in the RV of mdx mice as early as 1 month. Late-gadolinium-enhanced MRI identified increased levels of myocardial fibrosis in 6, 9 and 12-month-old mdx mice, the extent of fibrosis correlating with the degree of cardiac remodeling and hypertrophy. Conclusions: MRI could identify cardiac abnormalities in the RV of mdx mice as young as 1 month, and detected myocardial fibrosis at 6 months. We believe these to be the earliest MRI measurements of cardiac function reported for any mice, and the first use of late-gadolinium-enhancement in a mouse model of congenital cardiomyopathy. These techniques offer a sensitive and clinically relevant in vivo method for assessment of cardiomyopathy caused by muscular dystrophy and other diseases.	[Stuckey, Daniel J.; Carr, Carolyn A.; Tyler, Damian J.; Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Cardiac Metab Res Grp, Oxford, England; [Davies, Kay E.] Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, Oxford, England; [Camelliti, Patrizia] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Heart Sci Ctr, London, England	University of Oxford; University of Oxford; Imperial College London	Stuckey, DJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, London, England.	daniel.stuckey1@imperial.ac.uk	Camelliti, Patrizia/AAA-4489-2020; Camelliti, Patrizia/F-8012-2018	Camelliti, Patrizia/0000-0002-1346-8089; Camelliti, Patrizia/0000-0002-1346-8089; stuckey, daniel/0000-0001-8888-627X; Tyler, Damian/0000-0002-0780-8905	British Heart Foundation [RG/07/004/22659, RG/07/059/23259]; Imperial College; British Heart Foundation [FS/10/002/28078, PS/02/002/14893] Funding Source: researchfish; Medical Research Council [MC_U137761449] Funding Source: researchfish; MRC [MC_U137761449] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Imperial College; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The British Heart Foundation [RG/07/004/22659 and RG/07/059/23259]. Dr Camelliti is supported by an Imperial College Junior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Angelini C, 1996, J NEUROL SCI, V142, P70, DOI 10.1016/0022-510X(96)00144-X; Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Au CG, 2011, INT J EXP PATHOL, V92, P57, DOI 10.1111/j.1365-2613.2010.00750.x; Baer FM, 1998, J AM COLL CARDIOL, V31, P1040, DOI 10.1016/S0735-1097(98)00032-1; Barison A, 2009, J NEUROL, V256, P283, DOI 10.1007/s00415-009-0055-7; Bellenger NG, 2002, J CARDIOV MAGN RESON, V4, P255, DOI 10.1081/JCMR-120003951; Bia BL, 1999, J MOL CELL CARDIOL, V31, P1857, DOI 10.1006/jmcc.1999.1018; Bohl S, 2008, INT J CARDIOVAS IMAG, V24, P597, DOI 10.1007/s10554-008-9300-x; Bohl S, 2009, AM J PHYSIOL-HEART C, V296, pH1200, DOI 10.1152/ajpheart.01294.2008; Bostick B, 2010, MUSCLE NERVE, V42, P600, DOI 10.1002/mus.21763; Bruder O, 2010, J AM COLL CARDIOL, V56, P875, DOI 10.1016/j.jacc.2010.05.007; Carr CA, 2008, AM J PHYSIOL-HEART C, V295, pH533, DOI 10.1152/ajpheart.00094.2008; Choi KA, 2001, CIRCULATION, V104, P1101, DOI 10.1161/hc3501.096798; Crisp A, 2011, HUM MOL GENET, V20, P413, DOI 10.1093/hmg/ddq477; Danialou G, 2001, FASEB J, V15, P1655, DOI 10.1096/fj.01-0030fje; Fayssoil A, 2010, HEART FAIL REV, V15, P103, DOI 10.1007/s10741-009-9156-8; Finsterer J, 2003, CARDIOLOGY, V99, P1, DOI 10.1159/000068446; FUJII Y, 1993, CAN J ANAESTH, V40, P453, DOI 10.1007/BF03009517; Guillaume MD, 2008, TEX HEART I J, V35, P367; HARPOLE DH, 1992, AM HEART J, V124, P273, DOI 10.1016/0002-8703(92)90587-L; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Klitzner TS, 2005, PEDIATRICS, V116, P1569, DOI 10.1542/peds.2005-2448; Kwong RY, 2006, CIRCULATION, V113, P2733, DOI 10.1161/CIRCULATIONAHA.105.570648; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; Li W, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-40; Mavrogeni S, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-33; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; O'Sullivan CA, 2005, AM J CARDIOL, V96, P622, DOI 10.1016/j.amjcard.2005.04.031; Protti A, 2010, J MAGN RESON IMAGING, V32, P878, DOI 10.1002/jmri.22325; Puchalski MD, 2009, INT J CARDIOVAS IMAG, V25, P57, DOI 10.1007/s10554-008-9352-y; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Schneider JE, 2003, J MAGN RESON IMAGING, V18, P691, DOI 10.1002/jmri.10411; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Silva MC, 2007, J AM COLL CARDIOL, V49, P1874, DOI 10.1016/j.jacc.2006.10.078; Song WH, 2010, J MOL CELL CARDIOL, V49, P380, DOI 10.1016/j.yjmcc.2010.05.009; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Stuckey DJ, 2008, MAGN RESON MED, V60, P582, DOI 10.1002/mrm.21677; Stuckey DJ, 2008, NMR BIOMED, V21, P765, DOI 10.1002/nbm.1268; Tandri H, 2005, J AM COLL CARDIOL, V45, P98, DOI 10.1016/j.jacc.2004.09.053; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Townsend D, 2007, MOL THER, V15, P1086, DOI 10.1038/sj.mt.6300144; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Van Erp C, 2010, MUSCLE NERVE, V42, P504, DOI 10.1002/mus.21716; Varghese A, 2004, HEART, V90, DOI 10.1136/hrt.2004.041277; Wiesmann F, 2002, AM J PHYSIOL-HEART C, V283, pH1065, DOI 10.1152/ajpheart.00802.2001; Wiesmann F, 2001, CIRC RES, V88, P563, DOI 10.1161/01.RES.88.6.563; Wu B, 2008, P NATL ACAD SCI USA, V105, P14814, DOI 10.1073/pnas.0805676105; Yilmaz A, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-50; Zhang W, 2008, J MOL CELL CARDIOL, V45, P754, DOI 10.1016/j.yjmcc.2008.09.125	51	55	55	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28569	10.1371/journal.pone.0028569	http://dx.doi.org/10.1371/journal.pone.0028569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235247	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400008
J	Hoopes, JD; Driebe, EM; Kelley, E; Engelthaler, DM; Keim, PS; Perelson, AS; Rong, L; Went, GT; Nguyen, JT				Hoopes, Justin D.; Driebe, Elizabeth M.; Kelley, Erin; Engelthaler, David M.; Keim, Paul S.; Perelson, Alan S.; Rong, Libin; Went, Gregory T.; Nguyen, Jack T.			Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus	PLOS ONE			English	Article							NEURAMINIDASE INHIBITORS; ANTIRETROVIRAL THERAPY; MUTATION-RATES; UNITED-STATES; H1N1 VIRUS; B VIRUSES; IN-VITRO; INFECTION; EMERGENCE; INDINAVIR	Widespread resistance among circulating influenza A strains to at least one of the anti-influenza drugs is a major public health concern. A triple combination antiviral drug (TCAD) regimen comprised of amantadine, oseltamivir, and ribavirin has been shown to have synergistic and broad spectrum activity against influenza A strains, including drug resistant strains. Here, we used mathematical modeling along with three different experimental approaches to understand the effects of single agents, double combinations, and the TCAD regimen on resistance in influenza in vitro, including: 1) serial passage at constant drug concentrations, 2) serial passage at escalating drug concentrations, and 3) evaluation of the contribution of each component of the TCAD regimen to the suppression of resistance. Consistent with the modeling which demonstrated that three drugs were required to suppress the emergence of resistance in influenza A, treatment with the TCAD regimen resulted in the sustained suppression of drug resistant viruses, whereas treatment with amantadine alone or the amantadine-oseltamivir double combination led to the rapid selection of resistant variants which comprised,100% of the population. Furthermore, the TCAD regimen imposed a high genetic barrier to resistance, requiring multiple mutations in order to escape the effects of all the drugs in the regimen. Finally, we demonstrate that each drug in the TCAD regimen made a significant contribution to the suppression of virus breakthrough and resistance at clinically achievable concentrations. Taken together, these data demonstrate that the TCAD regimen was superior to double combinations and single agents at suppressing resistance, and that three drugs at a minimum were required to impede the selection of drug resistant variants in influenza A virus. The use of mathematical modeling with multiple experimental designs and molecular readouts to evaluate and optimize combination drug regimens for the suppression of resistance may be broadly applicable to other infectious diseases.	[Hoopes, Justin D.; Went, Gregory T.; Nguyen, Jack T.] Adamas Pharmaceut Inc, Emeryville, CA 94608 USA; [Driebe, Elizabeth M.; Kelley, Erin; Engelthaler, David M.; Keim, Paul S.] Translat Genom Res Inst, Flagstaff, AZ USA; [Perelson, Alan S.] Los Alamos Natl Lab, Los Alamos, NM USA; [Rong, Libin] Oakland Univ, Rochester, MI USA	Translational Genomics Research Institute; United States Department of Energy (DOE); Los Alamos National Laboratory; Oakland University	Nguyen, JT (corresponding author), Adamas Pharmaceut Inc, Emeryville, CA 94608 USA.	jnguyen@adamaspharma.com	Perelson, Alan S/Z-1959-2019	Perelson, Alan S/0000-0002-2455-0002	U.S. Department of Energy [DE-AC52-06NA25396]; National Institutes of Health [N01-AI-050020, RR006555, P30-EB011339]; Los Alamos LDRD; National Science Foundation [NSF PHY05-51164]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR006555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB011339] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011095] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Los Alamos LDRD(United States Department of Energy (DOE)Los Alamos National Laboratory); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Portions of this work were done under the auspices of the U.S. Department of Energy under contract DE-AC52-06NA25396 and supported in part by National Institutes of Health grants N01-AI-050020, RR006555, P30-EB011339, the Los Alamos LDRD Program and by the National Science Foundation under Grant No. NSF PHY05-51164 (ASP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. These studies were also funded by Adamas Pharmaceuticals, who through the employment of JDH, GTW, and JTN were involved in the design, data collection and analysis, decision to publish, and preparation of the manuscript. No additional external funding received for this study.	Abed Y, 2005, ANTIMICROB AGENTS CH, V49, P556, DOI 10.1128/AAC.49.2.556-559.2005; Abed Y, 2002, J INFECT DIS, V186, P1074, DOI 10.1086/344237; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P969; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P433; Daar ES, 2005, AIDS RES HUM RETROV, V21, P343, DOI 10.1089/aid.2005.21.343; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Dybul Mark, 2002, MMWR Recomm Rep, V51, P1; Freistadt MS, 2004, DRUG RESIST UPDATE, V7, P19, DOI 10.1016/j.drup.2003.12.003; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gulick RM, 1998, JAMA-J AM MED ASSOC, V280, P35, DOI 10.1001/jama.280.1.35; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; Hurt AC, 2009, J VIROL, V83, P10366, DOI 10.1128/JVI.01200-09; Ilyushina NA, 2006, ANTIVIR RES, V70, P121, DOI 10.1016/j.antiviral.2006.01.012; Ison MG, 2003, ANTIVIR THER, V8, P183; Jordan R, 2002, BMJ-BRIT MED J, V324, P757, DOI 10.1136/bmj.324.7340.757; Laohpongspaisan C, 2009, J CHEM INF MODEL, V49, P847, DOI 10.1021/ci800267a; Liu CM, 2010, J VIROL METHODS, V163, P109, DOI 10.1016/j.jviromet.2009.09.007; Markowitz M, 1999, J INFECT DIS, V179, P527, DOI 10.1086/314628; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; McKimm-Breschkin JL, 1998, J VIROL, V72, P2456, DOI 10.1128/JVI.72.3.2456-2462.1998; McKimmBreschkin JL, 1996, ANTIMICROB AGENTS CH, V40, P40, DOI 10.1128/AAC.40.1.40; Mishin VP, 2005, ANTIMICROB AGENTS CH, V49, P4515, DOI 10.1128/AAC.49.11.4515-4520.2005; Mohler L, 2005, BIOTECHNOL BIOENG, V90, P46, DOI 10.1002/bit.20363; Monto A, 2010, AM J GASTROENTEROL, V105, P989, DOI 10.1038/ajg.2009.726; Mustaquim D., 2010, Morbidity and Mortality Weekly Report, V59, P901; Nguyen HT, 2010, CLIN INFECT DIS, V51, P983, DOI 10.1086/656439; Nguyen JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009332; Nguyen JT, 2009, ANTIMICROB AGENTS CH, V53, P4115, DOI 10.1128/AAC.00476-09; Nobusawa E, 2006, J VIROL, V80, P3675, DOI 10.1128/JVI.80.7.3675-3678.2006; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Okomo-Adhiambo M, 2010, ANTIMICROB AGENTS CH, V54, P1834, DOI 10.1128/AAC.01608-09; PARVIN JD, 1986, J VIROL, V59, P377, DOI 10.1128/JVI.59.2.377-383.1986; Peebles P., 2009, Morbidity and Mortality Weekly Report, V58, P369; Perelson AS, 1997, AIDS, V11, pS17; Saenz RA, 2010, J VIROL, V84, P3974, DOI 10.1128/JVI.02078-09; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; WARD CL, 2008, J VIRAL HEPAT	43	37	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29778	10.1371/journal.pone.0029778	http://dx.doi.org/10.1371/journal.pone.0029778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220216	gold, Green Submitted, Green Published			2022-12-27	WOS:000300677000061
J	Arenkiel, BR; Hasegawa, H; Yi, JJ; Larsen, RS; Wallace, ML; Philpot, BD; Wang, F; Ehlers, MD				Arenkiel, Benjamin R.; Hasegawa, Hiroshi; Yi, Jason J.; Larsen, Rylan S.; Wallace, Michael L.; Philpot, Benjamin D.; Wang, Fan; Ehlers, Michael D.			Activity-Induced Remodeling of Olfactory Bulb Microcircuits Revealed by Monosynaptic Tracing	PLOS ONE			English	Article							LONG-TERM POTENTIATION; EXTERNAL PLEXIFORM LAYER; NEWLY GENERATED NEURONS; SHORT-AXON CELLS; ADULT NEUROGENESIS; GRANULE CELLS; SYNAPTIC INTEGRATION; NEWBORN NEURONS; STEM-CELLS; INTERNEURONS	The continued addition of new neurons to mature olfactory circuits represents a remarkable mode of cellular and structural brain plasticity. However, the anatomical configuration of newly established circuits, the types and numbers of neurons that form new synaptic connections, and the effect of sensory experience on synaptic connectivity in the olfactory bulb remain poorly understood. Using in vivo electroporation and monosynaptic tracing, we show that postnatal-born granule cells form synaptic connections with centrifugal inputs and mitral/tufted cells in the mouse olfactory bulb. In addition, newly born granule cells receive extensive input from local inhibitory short axon cells, a poorly understood cell population. The connectivity of short axon cells shows clustered organization, and their synaptic input onto newborn granule cells dramatically and selectively expands with odor stimulation. Our findings suggest that sensory experience promotes the synaptic integration of new neurons into cell type-specific olfactory circuits.	[Arenkiel, Benjamin R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Arenkiel, Benjamin R.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Hasegawa, Hiroshi; Wang, Fan; Ehlers, Michael D.] Duke Univ, Dept Cell Biol, Durham, NC USA; [Yi, Jason J.; Wang, Fan; Ehlers, Michael D.] Duke Univ, Dept Neurobiol, Durham, NC USA; [Larsen, Rylan S.; Philpot, Benjamin D.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Wallace, Michael L.; Philpot, Benjamin D.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA; [Philpot, Benjamin D.] Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC USA; [Philpot, Benjamin D.] Univ N Carolina, Neurodev Disorders Res Ctr, Chapel Hill, NC USA; [Ehlers, Michael D.] Pfizer Global Res & Dev, Neurosci Res Unit, Groton, CT USA; [Arenkiel, Benjamin R.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Pfizer; Baylor College of Medicine	Arenkiel, BR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	arenkiel@bcm.edu; michael.ehlers@pfizer.com		Larsen, Rylan/0000-0002-7136-1175; Wallace, Michael/0000-0002-7270-8521; Arenkiel, Benjamin/0000-0001-9047-2420; Yi, Jason/0000-0001-9648-9899	National Institute of Neurological Disorders and Stroke [R00NS064171]; McNair foundation; National Eye Institute [R01EY018323]; National Institute of Health [MH086339, NS047574, MH046478]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY018323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH091817, R01MH086339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS064171, R01NS047574] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); McNair foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a National Institute of Neurological Disorders and Stroke grant R00NS064171 and the McNair foundation (BRA), a National Eye Institute grant R01EY018323 (BDP), National Institute of Health grants MH086339, NS047574, and MH046478 (MDE) and the Howard Hughes Medical Institute (MDE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Arenkiel BR, 2009, NATURE, V461, P900, DOI 10.1038/nature08536; Arenkiel BR, 2003, DEV DYNAM, V227, P379, DOI 10.1002/dvdy.10323; Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; Balliet JW, 1998, J VIROL, V72, P671, DOI 10.1128/JVI.72.1.671-676.1998; Balu R, 2007, J NEUROSCI, V27, P5621, DOI 10.1523/JNEUROSCI.4630-06.2007; Batista-Brito R, 2008, J NEUROSCI, V28, P3966, DOI 10.1523/JNEUROSCI.5625-07.2008; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Bergles DE, 2010, BRAIN RES REV, V63, P130, DOI 10.1016/j.brainresrev.2009.12.003; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; Bolton MM, 2009, CURR OPIN NEUROBIOL, V19, P491, DOI 10.1016/j.conb.2009.09.007; Bovetti S, 2007, J MOL HISTOL, V38, P563, DOI 10.1007/s10735-007-9111-8; Bovetti S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006359; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chesler AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001517; Davison IG, 2007, J NEUROSCI, V27, P2091, DOI 10.1523/JNEUROSCI.3779-06.2007; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Egger V, 2006, SEMIN CELL DEV BIOL, V17, P424, DOI 10.1016/j.semcdb.2006.04.006; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Eyre MD, 2008, J NEUROSCI, V28, P8217, DOI 10.1523/JNEUROSCI.2490-08.2008; Eyre MD, 2009, EUR J NEUROSCI, V29, P1397, DOI 10.1111/j.1460-9568.2009.06703.x; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Freeman MR, 2006, CURR OPIN NEUROBIOL, V16, P119, DOI 10.1016/j.conb.2005.12.004; Gao Y, 2009, NAT MED; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hamilton KA, 2005, NEUROSCIENCE, V133, P819, DOI 10.1016/j.neuroscience.2005.03.008; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; HANDYSIDE AH, 1989, ROUX ARCH DEV BIOL, V198, P48, DOI 10.1007/BF00376370; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hensch TK, 2004, SCIENCE, V303, P1678, DOI 10.1126/science.1091031; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; KOSAKA K, 1994, EXP BRAIN RES, V99, P191, DOI 10.1007/BF00239586; Kosaka T, 2008, NEUROSCI RES, V60, P56, DOI 10.1016/j.neures.2007.09.008; Lee MC, 2010, NEURON, V66, P859, DOI 10.1016/j.neuron.2010.05.015; Lemasson M, 2005, J NEUROSCI, V25, P6816, DOI 10.1523/JNEUROSCI.1114-05.2005; Lepousez G, 2010, J COMP NEUROL, V518, P1976, DOI 10.1002/cne.22317; Livneh Y, 2009, J NEUROSCI, V29, P86, DOI 10.1523/JNEUROSCI.4105-08.2009; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lledo PM, 2005, TRENDS NEUROSCI, V28, P248, DOI 10.1016/j.tins.2005.03.005; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Megason SG, 2002, DEVELOPMENT, V129, P2087; Mejia-Gervacio S, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-4; Migliore M, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07.012.2007, 10.3389/neuro.07/012.2007]; Miyamichi K, 2010, NATURE; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Narayan S, 2003, J VIROL, V77, P1977, DOI 10.1128/JVI.77.3.1977-1983.2003; ORONA E, 1984, J COMP NEUROL, V226, P346, DOI 10.1002/cne.902260305; Panzanelli P, 2004, EUR J NEUROSCI, V20, P2945, DOI 10.1111/j.1460-9568.2004.03776.x; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pressler RT, 2006, NEURON, V49, P889, DOI 10.1016/j.neuron.2006.02.019; PRICE JL, 1970, J CELL SCI, V7, P125; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; Rancz EA, 2011, NAT NEUROSCI; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; SCHNEIDER SP, 1978, BRAIN RES BULL, V3, P73, DOI 10.1016/0361-9230(78)90063-1; Schoppa NE, 2003, TRENDS NEUROSCI, V26, P501, DOI 10.1016/S0166-2236(03)00228-5; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Selever J, 2011, JOVE-J VIS EXP, DOI 10.3791/2807; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, P159; Shipley M.T., 2004, RAT NERVOUS SYSTEM, P922; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; Urban NN, 2002, PHYSIOL BEHAV, V77, P607, DOI 10.1016/S0031-9384(02)00895-8; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Weible AP, 2010, J NEUROSCI, V30, P16509, DOI 10.1523/JNEUROSCI.2442-10.2010; Whitman MC, 2007, J NEUROSCI, V27, P9951, DOI 10.1523/JNEUROSCI.1633-07.2007; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Willhite DC, 2006, P NATL ACAD SCI USA, V103, P12592, DOI 10.1073/pnas.0602032103; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006	90	69	70	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29423	10.1371/journal.pone.0029423	http://dx.doi.org/10.1371/journal.pone.0029423			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216277	Green Published, Green Submitted, gold			2022-12-27	WOS:000300676300058
J	Cao-Lormeau, VM; Roche, C; Aubry, M; Teissier, A; Lastere, S; Daudens, E; Mallet, HP; Musso, D; Aaskov, J				Cao-Lormeau, Van-Mai; Roche, Claudine; Aubry, Maite; Teissier, Anita; Lastere, Stephane; Daudens, Elise; Mallet, Henri-Pierre; Musso, Didier; Aaskov, John			Recent Emergence of Dengue Virus Serotype 4 in French Polynesia Results from Multiple Introductions from Other South Pacific Islands	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GENOTYPE; EVOLUTION; TYPE-1; MICROEVOLUTION; TRANSMISSION; SEQUENCES; STRAINS; ASSAYS	Background: Infection by dengue virus (DENV) is a major public health concern in hundreds of tropical and subtropical countries. French Polynesia (FP) regularly experiences epidemics that initiate, or are consecutive to, DENV circulation in other South Pacific Island Countries (SPICs). In January 2009, after a decade of serotype 1 (DENV-1) circulation, the first cases of DENV-4 infection were reported in FP. Two months later a new epidemic emerged, occurring about 20 years after the previous circulation of DENV-4 in FP. In this study, we investigated the epidemiological and molecular characteristics of the introduction, spread and genetic microevolution of DENV-4 in FP. Methodology/Principal Findings: Epidemiological data suggested that recent transmission of DENV-4 in FP started in the Leeward Islands and this serotype quickly displaced DENV-1 throughout FP. Phylogenetic analyses of the nucleotide sequences of the envelope (E) gene of 64 DENV-4 strains collected in FP in the 1980s and in 2009-2010, and some additional strains from other SPICs showed that DENV-4 strains from the SPICs were distributed into genotypes IIa and IIb. Recent FP strains were distributed into two clusters, each comprising viruses from other but distinct SPICs, suggesting that emergence of DENV-4 in FP in 2009 resulted from multiple introductions. Otherwise, we observed that almost all strains collected in the SPICs in the 1980s exhibit an amino acid (aa) substitution V287I within domain I of the E protein, and all recent South Pacific strains exhibit a T365I substitution within domain III. Conclusions/Significance: This study confirmed the cyclic re-emergence and displacement of DENV serotypes in FP. Otherwise, our results showed that specific aa substitutions on the E protein were present on all DENV-4 strains circulating in SPICs. These substitutions probably acquired and subsequently conserved could reflect a founder effect to be associated with epidemiological, geographical, eco-biological and social specificities in SPICs.	[Cao-Lormeau, Van-Mai; Roche, Claudine; Aubry, Maite] Inst Louis Malarde, Lab Rech Virol Med, Papeete, Tahiti, France; [Teissier, Anita; Lastere, Stephane; Musso, Didier] Inst Louis Malarde, Lab Anal Biol Med, Papeete, Tahiti, France; [Daudens, Elise; Mallet, Henri-Pierre] Direct Sante, Bur Veille Sanit, Papeete, Tahiti, France; [Aaskov, John] Queensland Univ Technol, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT)	Cao-Lormeau, VM (corresponding author), Inst Louis Malarde, Lab Rech Virol Med, Papeete, Tahiti, France.	mlormeau@ilm.pf	Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020; Cao-Lormeau, Van-Mai/H-4879-2018	Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971; Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Aubry, Maite/0000-0002-9913-5794	Ministere des Affaires Etrangeres et Europeennes, France [138/1/2008, 75/1/2009]; "Agence nationale pour la Recherche", France [ANR-09-MIEN-028-01]	Ministere des Affaires Etrangeres et Europeennes, France; "Agence nationale pour la Recherche", France(French National Research Agency (ANR))	This work was supported by the "Fonds de Cooperation Economique, Sociale et Culturelle pour le Pacifique" -Ministere des Affaires Etrangeres et Europeennes, France (Conventions N<SUP>o</SUP>138/1/2008, 75/1/2009), (URL: http://www.diplomatie.gouv.fr) and by the "Agence nationale pour la Recherche", France (Decision attributive d'aide N<SUP>o</SUP>ANR-09-MIEN-028-01), URL: http://www.agence-nationale-recherche.fr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-Nuegoonpipat A, 2004, VIROLOGY, V329, P505, DOI 10.1016/j.virol.2004.08.029; AbuBakar S, 2002, J GEN VIROL, V83, P2437, DOI 10.1099/0022-1317-83-10-2437; Alliot FA, 1887, BORDEAUX TH MED; Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886; Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0; Bessoff K, 2008, CLIN VACCINE IMMUNOL, V15, P1513, DOI 10.1128/CVI.00140-08; Cao-Lormeau VM, 2007, AM J TROP MED HYG, V77, P129; CHUNGUE E, 1995, J GEN VIROL, V76, P1877, DOI 10.1099/0022-1317-76-7-1877; Chungue E., 1998, Pacific Health Dialog, V5, P154; Daudens E., 2009, Bulletin Epidemiologique Hebdomadaire, P499; de Melo FL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000390; Descloux E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000493; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forshey BM, 2009, EMERG INFECT DIS, V15, P1815, DOI 10.3201/eid1511.090663; GUBLER DJ, 1978, AM J TROP MED HYG, V27, P581, DOI 10.4269/ajtmh.1978.27.581; Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811; Guzman MG, 2010, EXPERT REV VACCINES, V9, P137, DOI [10.1586/erv.09.139, 10.1586/ERV.09.139]; Imrie A, 2006, ANN TROP MED PARASIT, V100, P327, DOI 10.1179/136485906X105589; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klungthong C, 2008, J VIROL METHODS, V154, P175, DOI 10.1016/j.jviromet.2008.07.021; Klungthong C, 2004, VIROLOGY, V329, P168, DOI 10.1016/j.virol.2004.08.003; Laigret J, 1967, Bull Soc Pathol Exot Filiales, V60, P339; Laille M, 2004, AM J TROP MED HYG, V71, P478, DOI 10.4269/ajtmh.2004.71.478; Lanciotti RS, 1997, J GEN VIROL, V78, P2279, DOI 10.1099/0022-1317-78-9-2279; Lepers C, 2008, DENGUE FEVER SITUATI; Li DS, 2010, EMERG INFECT DIS, V16, P123, DOI 10.3201/eid1601.091275; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; MOREAU JP, 1973, AM J TROP MED HYG, V22, P237, DOI 10.4269/ajtmh.1973.22.237; Pandey BD, 2000, MICROBIOL IMMUNOL, V44, P179, DOI 10.1111/j.1348-0421.2000.tb02480.x; Parc F, 1981, Med Trop (Mars), V41, P93; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; ROSEN L, 1954, AM J TROP MED HYG, V3, P878, DOI 10.4269/ajtmh.1954.3.878; Saugrain J, 1970, B SOC PATHOL EXOT, V63, P631; Shu PY, 2009, AM J TROP MED HYG, V80, P1039, DOI 10.4269/ajtmh.2009.80.1039; Singh Narendra, 2005, Pac Health Dialog, V12, P111; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang YX, 2011, VIRUS GENES, V42, P200, DOI 10.1007/s11262-010-0567-3; *WHO, 2008, DENG DENG HAEM FEV; Wiegant A, 2007, DENGUE FEVER EPIDEMI; World Health Organization, 2009, DENGUE GUIDELINES DI	43	46	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29555	10.1371/journal.pone.0029555	http://dx.doi.org/10.1371/journal.pone.0029555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216313	gold, Green Published, Green Submitted			2022-12-27	WOS:000300676300064
J	Buschiazzo, E; Beck, JS; Gemmell, NJ				Buschiazzo, Emmanuel; Beck, Josephine S.; Gemmell, Neil J.			Design and Implementation of Degenerate Microsatellite Primers for the Mammalian Clade	PLOS ONE			English	Article							MARKERS; CONSERVATION; LOCI; SEQUENCES; AMPLIFICATION; EVOLUTION; ALIGNMENT; SUCCESS; UTILITY; BARLEY	Microsatellites are popular genetic markers in molecular ecology, genetic mapping and forensics. Unfortunately, despite recent advances, the isolation of de novo polymorphic microsatellite loci often requires expensive and intensive groundwork. Primers developed for a focal species are commonly tested in a related, non-focal species of interest for the amplification of orthologous polymorphic loci; when successful, this approach significantly reduces cost and time of microsatellite development. However, transferability of polymorphic microsatellite loci decreases rapidly with increasing evolutionary distance, and this approach has shown its limits. Whole genome sequences represent an under-exploited resource to develop cross-species primers for microsatellites. Here we describe a three-step method that combines a novel in silico pipeline that we use to (1) identify conserved microsatellite loci from a multiple genome alignments, (2) design degenerate primer pairs, with (3) a simple PCR protocol used to implement these primers across species. Using this approach we developed a set of primers for the mammalian clade. We found 126,306 human microsatellites conserved in mammalian aligned sequences, and isolated 5,596 loci using criteria based on wide conservation. From a random subset of similar to 1000 dinucleotide repeats, we designed degenerate primer pairs for 19 loci, of which five produced polymorphic fragments in up to 18 mammalian species, including the distinctly related marsupials and monotremes, groups that diverged from other mammals 120-160 million years ago. Using our method, many more cross-clade microsatellite loci can be harvested from the currently available genomic data, and this ability is set to improve exponentially as further genomes are sequenced.	[Buschiazzo, Emmanuel; Beck, Josephine S.; Gemmell, Neil J.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand	University of Canterbury	Buschiazzo, E (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA.	elbuzzo@gmail.com	Gemmell, Neil J/C-6774-2009	Gemmell, Neil J/0000-0003-0671-3637	Royal Society of New Zealand [UOC 202]	Royal Society of New Zealand(Royal Society of New Zealand)	This work was supported by a Royal Society of New Zealand Marsden grant (UOC 202) to NJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; AMOS B, 1993, SCIENCE, V260, P670, DOI 10.1126/science.8480176; Barbara T, 2007, MOL ECOL, V16, P3759, DOI 10.1111/j.1365-294X.2007.03439.x; Buschiazzo E, 2009, AUST J ZOOL, V57, P175, DOI 10.1071/ZO09038; Buschiazzo E, 2006, BIOESSAYS, V28, P1040, DOI 10.1002/bies.20470; Buschiazzo E, 2010, GENOME BIOL EVOL, V2, P153, DOI 10.1093/gbe/evq007; Carreras-Carbonell J, 2008, CONSERV GENET, V9, P181, DOI 10.1007/s10592-007-9322-2; Dawson DA, 2010, MOL ECOL RESOUR, V10, P475, DOI 10.1111/j.1755-0998.2009.02775.x; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; ESTOUP A, 1995, GENETICS, V140, P679; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Farber CR, 2004, ANIM GENET, V35, P28, DOI 10.1111/j.1365-2052.2003.01077.x; FITZSIMMONS NN, 1995, MOL BIOL EVOL, V12, P432; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gadberry MD, 2005, BIOINFORMATICS, V21, P1263, DOI 10.1093/bioinformatics/bti134; Garza JC, 2000, MAMM GENOME, V11, P1117, DOI 10.1007/s003350010200; Gemmell NJ, 1997, MOL ECOL, V6, P661, DOI 10.1046/j.1365-294X.1997.00235.x; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hannan AJ, 2010, TRENDS GENET, V26, P59, DOI 10.1016/j.tig.2009.11.008; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kelkar YD, 2008, GENOME RES, V18, P30, DOI 10.1101/gr.7113408; Kupper C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-502; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Liewlaksaneeyanawin C, 2004, THEOR APPL GENET, V109, P361, DOI 10.1007/s00122-004-1635-7; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Moore SS, 1998, ANIM GENET, V29, P33, DOI 10.1046/j.1365-2052.1998.00234.x; Osborne AJ, 2011, MOL ECOL RESOUR, V11, P503, DOI 10.1111/j.1755-0998.2010.02962.x; Primmer CR, 1996, MOL ECOL, V5, P365, DOI 10.1046/j.1365-294X.1996.00092.x; Primmer CR, 2005, J AVIAN BIOL, V36, P348; Raveendran M, 2008, AM J PRIMATOL, V70, P906, DOI 10.1002/ajp.20581; Raveendran M, 2006, GENOMICS, V88, P706, DOI 10.1016/j.ygeno.2006.08.009; Rico C, 1996, P ROY SOC B-BIOL SCI, V263, P549, DOI 10.1098/rspb.1996.0083; Robertson BC, 2004, J APPL ECOL, V41, P1042, DOI 10.1111/j.0021-8901.2004.00984.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Sainudiin R, 2004, GENETICS, V168, P383, DOI 10.1534/genetics.103.022665; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; STALLINGS RL, 1995, GENOMICS, V25, P107, DOI 10.1016/0888-7543(95)80115-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vanpe C, 2009, AUST J ZOOL, V57, P219, DOI 10.1071/ZO09033; Varshney RK, 2005, PLANT SCI, V168, P195, DOI 10.1016/j.plantsci.2004.08.001; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Wu C-H, 2011, GENETICS, DOI [10.1534/genetics.1110.125260, DOI 10.1534/GENETICS.1110.125260]; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x	52	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29582	10.1371/journal.pone.0029582	http://dx.doi.org/10.1371/journal.pone.0029582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216321	Green Published, gold, Green Submitted			2022-12-27	WOS:000300674900044
J	Greve, G; Alechine, E; Pasantes, JJ; Hodler, C; Rietschel, W; Robinson, TJ; Schempp, W				Greve, Gabriele; Alechine, Evguenia; Pasantes, Juan J.; Hodler, Christine; Rietschel, Wolfram; Robinson, Terence J.; Schempp, Werner			Y-Chromosome Variation in Hominids: Intraspecific Variation Is Limited to the Polygamous Chimpanzee	PLOS ONE			English	Article							GORILLA-GORILLA-GORILLA; ORANGUTAN PONGO-PYGMAEUS; NUCLEOTIDE DIVERSITY; DISTAMYCIN A/DAPI; WESTERN GORILLAS; SEX-CHROMOSOMES; HOMINOID APES; GREAT APES; DNA; POPULATIONS	Background: We have previously demonstrated that the Y-specific ampliconic fertility genes DAZ (deleted in azoospermia) and CDY (chromodomain protein Y) varied with respect to copy number and position among chimpanzees (Pan troglodytes). In comparison, seven Y-chromosomal lineages of the bonobo (Pan paniscus), the chimpanzee's closest living relative, showed no variation. We extend our earlier comparative investigation to include an analysis of the intraspecific variation of these genes in gorillas (Gorilla gorilla) and orangutans (Pongo pygmaeus), and examine the resulting patterns in the light of the species' markedly different social and mating behaviors. Methodology/Principal Findings: Fluorescence in situ hybridization analysis (FISH) of DAZ and CDY in 12 Y-chromosomal lineages of western lowland gorilla (G. gorilla gorilla) and a single lineage of the eastern lowland gorilla (G. beringei graueri) showed no variation among lineages. Similar findings were noted for the 10 Y-chromosomal lineages examined in the Bornean orangutan (Pongo pygmaeus), and 11 Y-chromosomal lineages of the Sumatran orangutan (P. abelii). We validated the contrasting DAZ and CDY patterns using quantitative real-time polymerase chain reaction (qPCR) in chimpanzee and bonobo. Conclusion/Significance: High intraspecific variation in copy number and position of the DAZ and CDY genes is seen only in the chimpanzee. We hypothesize that this is best explained by sperm competition that results in the variant DAZ and CDY haplotypes detected in this species. In contrast, bonobos, gorillas and orangutans-species that are not subject to sperm competition-showed no intraspecific variation in DAZ and CDY suggesting that monoandry in gorillas, and preferential female mate choice in bonobos and orangutans, probably permitted the fixation of a single Y variant in each taxon. These data support the notion that the evolutionary history of a primate Y chromosome is not simply encrypted in its DNA sequences, but is also shaped by the social and behavioral circumstances under which the specific species has evolved.	[Greve, Gabriele; Alechine, Evguenia; Pasantes, Juan J.; Hodler, Christine; Schempp, Werner] Univ Freiburg, Inst Human Genet, D-79106 Freiburg, Germany; [Alechine, Evguenia] Univ Buenos Aires, Sch Pharm & Biochem, Serv Huellas Digitales Genet, Buenos Aires, DF, Argentina; [Pasantes, Juan J.] Univ Vigo, Dept Biochem Genet & Immunol, Vigo 36310, Spain; [Rietschel, Wolfram] Wilhelma Zool Bot Garten, Stuttgart, Germany; [Robinson, Terence J.] Univ Stellenbosch, Dept Bot & Zool, Evolutionary Genom Grp, ZA-7600 Stellenbosch, South Africa	University of Freiburg; University of Buenos Aires; Universidade de Vigo; Stellenbosch University	Greve, G (corresponding author), Univ Freiburg, Med Ctr, Dept Internal Med, Freiburg, Germany.	werner.schempp@uniklinik-freiburg.de	; Robinson, Terence J./K-7342-2017	Alechine, Evguenia/0000-0001-6002-3093; Robinson, Terence J./0000-0002-4298-4891; Pasantes, Juan J/0000-0001-6515-3946	Deutsche Forschungsgemeinschaft [SCHE 214/8]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (SCHE 214/8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archidiacono N, 1998, CHROMOSOMA, V107, P241, DOI 10.1007/s004120050303; BERNSTEIN R, 1986, HUM GENET, V74, P223; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Bradley BJ, 2004, CURR BIOL, V14, P510, DOI 10.1016/j.cub.2004.02.062; Bradley BJ, 2005, P NATL ACAD SCI USA, V102, P9418, DOI 10.1073/pnas.0502019102; Caswell JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000057; DAHL JF, 1986, J HUM EVOL, V15, P369, DOI 10.1016/S0047-2484(86)80017-3; Delgado RA, 2000, EVOL ANTHROPOL, V9, P201; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; Fischer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021605; Furuichi T, 2009, PRIMATES, V50, P197, DOI 10.1007/s10329-009-0141-6; Galdigas BMF, 1978, INT J PRIMATOL, V9, P1; Garner KJ, 1996, MOL PHYLOGENET EVOL, V6, P39, DOI 10.1006/mpev.1996.0056; Gatti S, 2004, AM J PRIMATOL, V63, P111, DOI 10.1002/ajp.20045; Glaser B, 1998, MAMM GENOME, V9, P226, DOI 10.1007/s003359900730; Gonder MK, 2011, P NATL ACAD SCI USA, V108, P4766, DOI 10.1073/pnas.1015422108; Groves C.P., 2001, PRIMATE TAXONOMY; HAAF T, 1987, J HERED, V78, P287, DOI 10.1093/oxfordjournals.jhered.a110389; HARCOURT AH, 1995, FUNCT ECOL, V9, P468, DOI 10.2307/2390011; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; JAGER RJ, 1990, NATURE, V348, P452, DOI 10.1038/348452a0; Jensen-Seaman MI, 2001, J HERED, V92, P475, DOI 10.1093/jhered/92.6.475; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Kalpers J, 2003, ORYX, V37, P326, DOI 10.1017/S0030605303000589; Kano T, 1992, BEHAV ECOLOGY; Kirsch S, 2008, GENOME RES, V18, P1030, DOI 10.1101/gr.076711.108; Knebel S, 2011, CYTOGENET GENOME RES, V132, P219, DOI 10.1159/000322080; Kuhl H, 2001, CHROMOSOME RES, V9, P215, DOI 10.1023/A:1012219820317; Kuroki Y, 2006, NAT GENET, V38, P158, DOI 10.1038/ng1729; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; MACKINNON J, 1974, ANIM BEHAV, V22, P3, DOI 10.1016/S0003-3472(74)80054-0; Marques-Bonet T, 2009, ANNU REV GENOM HUM G, V10, P355, DOI 10.1146/annurev.genom.9.081307.164420; MULLER G, 1991, HUM GENET, V88, P59, DOI 10.1007/BF00204930; Nadler RD, 1995, NEGLECTED APE, P223; Nsubuga AM, 2008, AM J PHYS ANTHROPOL, V135, P263, DOI 10.1002/ajpa.20740; PARISH AR, 1994, ETHOL SOCIOBIOL, V15, P157, DOI 10.1016/0162-3095(94)90038-8; Parnell RJ, 2002, AM J PRIMATOL, V56, P193, DOI 10.1002/ajp.1074; Pasantes JJ, 1997, CHROMOSOME RES, V5, P537, DOI 10.1023/A:1008850819150; RIED T, 1992, P NATL ACAD SCI USA, V89, P1388, DOI 10.1073/pnas.89.4.1388; Robbins MM, 2004, AM J PRIMATOL, V64, P145, DOI 10.1002/ajp.20069; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; RYDER OA, 1993, J HERED, V84, P405, DOI 10.1093/oxfordjournals.jhered.a111362; Schaller F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012482; SCHEMPP W, 1983, HUM GENET, V63, P171, DOI 10.1007/BF00291539; SCHEMPP W, 1995, CHROMOSOME RES, V3, P227, DOI 10.1007/BF00713047; Schempp W, 1993, CHROMOSOME RES, V1, P69, DOI 10.1007/BF00710609; SCHMID M, 1986, CYTOGENET CELL GENET, V41, P71, DOI 10.1159/000132207; SCHMID M, 1984, HUM GENET, V67, P72, DOI 10.1007/BF00270562; Schurmann C, 1981, PRIMATE BEHAV SOCIOB, P130; Shaffer LG, 2009, INT SYST HUM CYT NOM; Skaletsky H, 2003, NATURE, V423, P855; Stone AC, 2002, P NATL ACAD SCI USA, V99, P43, DOI 10.1073/pnas.012364999; Taylor K, 1996, GENOME RES, V6, P235, DOI 10.1101/gr.6.4.235; Toder R, 1993, CHROMOSOME RES, V1, P117, DOI 10.1007/BF00710034; UTAMI SS, 2000, THESIS UTRECHT U NET; van Schaik, 2009, ORANGUTANS GEOGRAPHI; van Schaik CP, 1999, PRIMATES, V40, P69, DOI 10.1007/BF02557703; Verma RS, 1997, J MED GENET, V34, P817, DOI 10.1136/jmg.34.10.817; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; Warren KS, 2001, MOL BIOL EVOL, V18, P472, DOI 10.1093/oxfordjournals.molbev.a003826; WEBER B, 1987, CYTOGENET CELL GENET, V45, P26, DOI 10.1159/000132420; WEBER B, 1986, CYTOGENET CELL GENET, V43, P72, DOI 10.1159/000132300; WEBER B, 1988, CYTOGENET CELL GENET, V47, P26, DOI 10.1159/000132499; Wimmer R, 2002, CYTOGENET GENOME RES, V96, P287, DOI 10.1159/000063021; Xu XF, 1996, J MOL EVOL, V43, P431, DOI 10.1007/PL00006103; Yu N, 2004, GENETICS, V166, P1375, DOI 10.1534/genetics.166.3.1375; Yu YH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-96; Zhi L, 1996, CURR BIOL, V6, P1326, DOI 10.1016/S0960-9822(02)70719-7	71	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29311	10.1371/journal.pone.0029311	http://dx.doi.org/10.1371/journal.pone.0029311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216243	Green Published, gold, Green Submitted			2022-12-27	WOS:000300674900026
J	Kalis, M; Bolmeson, C; Esguerra, JLS; Gupta, S; Edlund, A; Tormo-Badia, N; Speidel, D; Holmberg, D; Mayans, S; Khoo, NKS; Wendt, A; Eliasson, L; Cilio, CM				Kalis, Martins; Bolmeson, Caroline; Esguerra, Jonathan L. S.; Gupta, Shashank; Edlund, Anna; Tormo-Badia, Neivis; Speidel, Dina; Holmberg, Dan; Mayans, Sofia; Khoo, Nelson K. S.; Wendt, Anna; Eliasson, Lena; Cilio, Corrado M.			Beta-Cell Specific Deletion of Dicer1 Leads to Defective Insulin Secretion and Diabetes Mellitus	PLOS ONE			English	Article							MICRORNA EXPRESSION; GENE-EXPRESSION; DIFFERENTIATION; QUANTIFICATION; IDENTIFICATION; PATHWAY; DRIVEN	Mature microRNAs (miRNAs), derived through cleavage of pre-miRNAs by the Dicer1 enzyme, regulate protein expression in many cell-types including cells in the pancreatic islets of Langerhans. To investigate the importance of miRNAs in mouse insulin secreting beta-cells, we have generated mice with a beta-cells specific disruption of the Dicer1 gene using the Cre-lox system controlled by the rat insulin promoter (RIP). In contrast to their normoglycaemic control littermates (RIP-Cre(+/-) Dicer1(Delta/wt)), RIP-Cre(+/-) Dicer1(flox/flox) mice (RIP-Cre Dicer1(Delta/Delta)) developed progressive hyperglycaemia and full-blown diabetes mellitus in adulthood that recapitulated the natural history of the spontaneous disease in mice. Reduced insulin gene expression and concomitant reduced insulin secretion preceded the hyperglycaemic state and diabetes development. Immunohistochemical, flow cytometric and ultrastructural analyses revealed altered islet morphology, marked decreased beta-cell mass, reduced numbers of granules within the beta-cells and reduced granule docking in adult RIP-Cre Dicer1(Delta/Delta) mice. beta-cell specific Dicer1 deletion did not appear to disrupt fetal and neonatal beta-cell development as 2-week old RIP-Cre Dicer1(Delta/Delta) mice showed ultrastructurally normal beta-cells and intact insulin secretion. In conclusion, we have demonstrated that a beta-cell specific disruption of the miRNAs network, although allowing for apparently normal beta-cell development, leads to progressive impairment of insulin secretion, glucose homeostasis and diabetes development.	[Kalis, Martins; Bolmeson, Caroline; Tormo-Badia, Neivis; Khoo, Nelson K. S.; Cilio, Corrado M.] Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Cellular Autoimmun Unit,Lund Univ Diabet Ctr, Malmo, Sweden; [Holmberg, Dan; Mayans, Sofia] Umea Univ, Dept Med Genet, Umea, Sweden; [Gupta, Shashank; Holmberg, Dan; Mayans, Sofia] Univ Copenhagen, Fac Life Sci, Dept Dis Biol, Copenhagen, Denmark	Lund University; Skane University Hospital; Umea University; University of Copenhagen	Kalis, M (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Cellular Autoimmun Unit,Lund Univ Diabet Ctr, Malmo, Sweden.	lena.eliasson@med.lu.se; corrado.cilio@med.lu.se	Esguerra, Jonathan/M-2366-2014; Eliasson, Lena/E-9294-2012	Esguerra, Jonathan/0000-0001-8454-6606; Eliasson, Lena/0000-0002-6467-5029; Mayans, Sofia/0000-0002-9912-8252; Wendt, Anna/0000-0001-8807-5979	Swedish Research Council; Linneus grant; EFSD-MSD; Knut and Alice Wallenberg Foundation; Marianne and Marcus Wallenberg Foundation; Novo Nordisk Foundation; Swedish Diabetes Foundation; Albert Pahlssons Foundation; Magnus Bergwall Foundation; Royal Physiographic Society in Lund; Lars Hiertas Minne Foundation; UMAS foundation; O. E. and Edla Johanssons Scientific Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Linneus grant; EFSD-MSD; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Marianne and Marcus Wallenberg Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Diabetes Foundation; Albert Pahlssons Foundation; Magnus Bergwall Foundation; Royal Physiographic Society in Lund; Lars Hiertas Minne Foundation; UMAS foundation; O. E. and Edla Johanssons Scientific Foundation	This work was supported by the Swedish Research Council (project grants (LE and CC), collaboration grant (LE coordinator), CC and AW(PI:s)), Linneus grant to Lund University Diabetes Center (coordinator Leif Groop; LE and CC (PI: s), (JE co-PI)), EFSD-MSD, The Knut and Alice Wallenberg Foundation, The Marianne and Marcus Wallenberg Foundation, Novo Nordisk Foundation, The Swedish Diabetes Foundation, Albert Pahlssons Foundation, Magnus Bergwall Foundation, The Royal Physiographic Society in Lund, Lars Hiertas Minne Foundation, UMAS foundation and O. E. and Edla Johanssons Scientific Foundation. LE has a Senior Research position supported by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Alanentalo T, 2010, DIABETES, V59, P1756, DOI 10.2337/db09-1400; Andrali SS, 2008, BIOCHEM J, V415, P1, DOI 10.1042/BJ20081029; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bolmeson C, 2011, BIOCHEM BIOPH RES CO, V404, P16, DOI 10.1016/j.bbrc.2010.11.024; Bravo-Egana V, 2008, BIOCHEM BIOPH RES CO, V366, P922, DOI 10.1016/j.bbrc.2007.12.052; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; El Ouaamari A, 2008, DIABETES; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Esguerra JLS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018613; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; GITTES GK, 1992, P NATL ACAD SCI USA, V89, P1128, DOI 10.1073/pnas.89.3.1128; Goodge KA, 2000, SEMIN CELL DEV BIOL, V11, P235, DOI 10.1006/scdb.2000.0172; Groop L, 2000, INT J CLIN PRACT, P3; Hennessy Erica, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000781; Herrera PL, 2000, DEVELOPMENT, V127, P2317; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Ketting RF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-210; Kolfschoten IGM, 2009, DIABETES OBES METAB, V11, P118, DOI 10.1111/j.1463-1326.2009.01118.x; Lee EK, 2010, ENDOCRINOLOGY, V151, P1403, DOI 10.1210/en.2009-1123; Lovis P, 2008, DIABETES, V57, P2728, DOI 10.2337/db07-1252; Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Morita S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004212; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Salehi A, 1999, ENDOCRINOLOGY, V140, P3045, DOI 10.1210/en.140.7.3045; SCHNELL AH, 1988, CELL TISSUE RES, V252, P9; Sevignani C, 2006, MAMM GENOME, V17, P189, DOI 10.1007/s00335-005-0066-3; Song JH, 2010, GENESIS, V48, P628, DOI 10.1002/dvg.20672; Vikman J, 2009, FASEB J, V23, P58, DOI 10.1096/fj.08-105734; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200	42	99	101	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29166	10.1371/journal.pone.0029166	http://dx.doi.org/10.1371/journal.pone.0029166			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216196	Green Published, Green Submitted, gold			2022-12-27	WOS:000300674900019
J	Martins, J; Castelo-Branco, M; Batista, A; Oliveiros, B; Santiago, AR; Galvao, J; Fernandes, E; Carvalho, F; Cavadas, C; Ambrosio, AF				Martins, Joao; Castelo-Branco, Miguel; Batista, Ana; Oliveiros, Barbara; Santiago, Ana Raquel; Galvao, Joana; Fernandes, Eduarda; Carvalho, Felix; Cavadas, Claudia; Ambrosio, Antonio F.			Effects of 3,4-Methylenedioxymethamphetamine Administration on Retinal Physiology in the Rat	PLOS ONE			English	Article							CENTRAL SEROUS CHORIORETINOPATHY; NITRIC-OXIDE; (MDMA)-INDUCED NEUROTOXICITY; BODY-TEMPERATURE; CIRCADIAN-RHYTHM; CAT RETINA; B-WAVE; MDMA; ECSTASY; ELECTRORETINOGRAM	3,4-Methylenedioxymethamphetamine (MDMA; ecstasy) is known to produce euphoric states, but may also cause adverse consequences in humans, such as hyperthermia and neurocognitive deficits. Although MDMA consumption has been associated with visual problems, the effects of this recreational drug in retinal physiology have not been addressed hitherto. In this work, we evaluated the effect of a single MDMA administration in the rat electroretinogram (ERG). Wistar rats were administered MDMA (15 mg/kg) or saline and ERGs were recorded before (Baseline ERG), and 3 h, 24 h, and 7 days after treatment. A high temperature (HT) saline-treated control group was also included. Overall, significantly augmented and shorter latency ERG responses were found in MDMA and HT groups 3 h after treatment when compared to Baseline. Twenty-four hours after treatment some of the alterations found at 3 h, mainly characterized by shorter latency, tended to return to Baseline values. However, MDMA-treated animals still presented increased scotopic a-wave and b-wave amplitudes compared to Baseline ERGs, which were independent of temperature elevation though the latter might underlie the acute ERG alterations observed 3 h after MDMA administration. Seven days after MDMA administration recovery from these effects had occurred. The effects seem to stem from specific changes observed at the a-wave level, which indicates that MDMA affects subacutely (at 24 h) retinal physiology at the outer retinal (photoreceptor/bipolar) layers. In conclusion, we have found direct evidence that MDMA causes subacute enhancement of the outer retinal responses (most prominent in the a-wave), though ERG alterations resume within one week. These changes in photoreceptor/bipolar cell physiology may have implications for the understanding of the subacute visual manifestations induced by MDMA in humans.	[Martins, Joao; Castelo-Branco, Miguel; Batista, Ana; Oliveiros, Barbara; Santiago, Ana Raquel; Galvao, Joana; Ambrosio, Antonio F.] Univ Coimbra, Fac Med, IBILI, Ctr Ophthalmol & Vis Sci, Coimbra, Portugal; [Martins, Joao; Cavadas, Claudia; Ambrosio, Antonio F.] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, Coimbra, Portugal; [Fernandes, Eduarda] Univ Porto, Fac Pharm, Dept Biol Sci, REQUIMTE Lab Toxicol, P-4100 Oporto, Portugal; [Carvalho, Felix] Univ Porto, Fac Pharm, REQUIMTE Dept Chem Sci, Oporto, Portugal; [Ambrosio, Antonio F.] AIBILI, Coimbra, Portugal; [Cavadas, Claudia] Univ Coimbra, Fac Pharm, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade do Porto; Universidade do Porto; Universidade de Coimbra; Universidade de Coimbra	Martins, J (corresponding author), Univ Coimbra, Fac Med, IBILI, Ctr Ophthalmol & Vis Sci, Coimbra, Portugal.	afambrosio@fmed.uc.pt	Fernandes, Eduarda/D-4943-2013; Cavadas, Claudia/K-8271-2014; Castelo-Branco, Miguel/E-5689-2010; Ambrósio, António F/I-3722-2012; Batista, Ana/GQZ-8972-2022; Batista, Ana/AAY-2523-2020; Santiago, Ana Raquel/I-6566-2013; Castelo-Branco, Miguel/F-3866-2019; Carvalho, Félix/D-4914-2013; Oliveiros, Bárbara/AAR-4529-2020; Cavadas, Claudia/AAB-6904-2021; Oliveiros, Bárbara/AHD-0826-2022	Fernandes, Eduarda/0000-0001-6424-0976; Cavadas, Claudia/0000-0001-8020-9266; Ambrósio, António F/0000-0002-0477-1641; Batista, Ana/0000-0002-5672-8266; Santiago, Ana Raquel/0000-0002-7541-7041; Castelo-Branco, Miguel/0000-0003-4364-6373; Carvalho, Félix/0000-0003-3858-3494; Cavadas, Claudia/0000-0001-8020-9266; Oliveiros, Bárbara/0000-0001-7836-8161; Martins, Joao/0000-0001-7764-286X	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal; FCT/FEDER/Plurianual	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT/FEDER/Plurianual	This work was supported by the Fundacao para a Ciencia e a Tecnologia (FCT), Portugal. FCT/FEDER/Plurianual contract to IBILI. http://alfa.fct.mctes.pt/index.phtml.en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre N, 1999, NEUROREPORT, V10, P3675, DOI 10.1097/00001756-199911260-00039; AHMED B, 1989, INT J HYPERTHER, V5, P675, DOI 10.3109/02656738909140492; Alvaro AR, 2008, NEUROSCIENCE, V152, P97, DOI 10.1016/j.neuroscience.2007.12.027; ARDEN GB, 1978, J PHYSIOL-LONDON, V280, P55, DOI 10.1113/jphysiol.1978.sp012372; Balogh B, 2004, PSYCHOPHARMACOLOGY, V173, P296, DOI 10.1007/s00213-004-1787-9; Baumann MH, 2007, PSYCHOPHARMACOLOGY, V189, P407, DOI 10.1007/s00213-006-0322-6; Cadoni C, 2005, BRAIN RES, V1055, P143, DOI 10.1016/j.brainres.2005.07.002; Capela JP, 2007, NEUROTOXICOLOGY, V28, P868, DOI 10.1016/j.neuro.2007.04.005; Capela JP, 2009, MOL NEUROBIOL, V39, P210, DOI 10.1007/s12035-009-8064-1; Carvalho M, 2010, CURR PHARM BIOTECHNO, V11, P476, DOI 10.2174/138920110791591535; Castelo-Branco M, 1998, J NEUROSCI, V18, P6395; Colbron S, 2002, BRAIN RES, V956, P45, DOI 10.1016/S0006-8993(02)03478-9; CREIGHTON FJ, 1991, BRIT J PSYCHIAT, V159, P713, DOI 10.1192/bjp.159.5.713; Darvesh AS, 2005, J PHARMACOL EXP THER, V312, P694, DOI 10.1124/jpet.104.074849; De Letter EA, 2002, J ANAL TOXICOL, V26, P113, DOI 10.1093/jat/26.2.113; De Letter EA, 2004, FORENSIC SCI INT, V141, P85, DOI 10.1016/j.forsciint.2003.12.015; De Letter EA, 2010, CURR PHARM BIOTECHNO, V11, P453; Farre M, 2004, PSYCHOPHARMACOLOGY, V173, P364, DOI 10.1007/s00213-004-1789-7; Fawcett RJ, 2007, BRAIN RES BULL, V73, P278, DOI 10.1016/j.brainresbull.2007.04.002; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Gudelsky GA, 1996, J NEUROCHEM, V66, P243; Hassan L, 2001, RETINA-J RET VIT DIS, V21, P559, DOI 10.1097/00006982-200110000-00030; HENRY JA, 1992, LANCET, V340, P384, DOI 10.1016/0140-6736(92)91469-O; Jimenez A, 2004, TOXICOL APPL PHARM, V196, P223, DOI 10.1016/j.taap.2003.12.017; Kim SH, 1997, DOC OPHTHALMOL, V94, P201, DOI 10.1007/BF02582979; Lorincz ML, 2008, INT J NEUROSCI, V118, P1374, DOI 10.1080/00207450601050147; Lyvers M, 2006, DRUG ALCOHOL REV, V25, P269, DOI 10.1080/09595230600657758; Mechan A, 2006, NEUROPSYCHOPHARMACOL, V31, P339, DOI 10.1038/sj.npp.1300808; Michael JC, 2003, AM J OPHTHALMOL, V136, P182, DOI 10.1016/S0002-9394(03)00076-X; Miranda M, 2007, NEUROCHEM RES, V32, P1156, DOI 10.1007/s11064-007-9285-1; Miranda-Anaya M, 2002, J BIOL RHYTHM, V17, P526, DOI 10.1177/0748730402238235; Mizota A, 2002, INVEST OPHTH VIS SCI, V43, P3754; Montoliu C, 1999, BIOCHEM PHARMACOL, V58, P255, DOI 10.1016/S0006-2952(99)00104-5; Moschos M, 1999, DOC OPHTHALMOL, V99, P123, DOI 10.1023/A:1002691917441; NAKATSUKA K, 1985, INVEST OPHTH VIS SCI, V26, P1109; Neuenschwander S, 1999, VISION RES, V39, P2485, DOI 10.1016/S0042-6989(99)00042-5; Nymark S, 2005, J PHYSIOL-LONDON, V567, P923, DOI 10.1113/jphysiol.2005.090662; O'Shea E, 2006, BRIT J PHARMACOL, V148, P778, DOI 10.1038/sj.bjp.0706783; Passie T, 2002, AUST NZ J PSYCHIAT, V36, P266; REDBURN DA, 1987, J NEUROSCI, V7, P319; Robson JG, 2003, J PHYSIOL-LONDON, V547, P509, DOI 10.1113/jphysiol.2002.030304; Rogers G, 2009, Health Technol Assess, V13, piii, DOI 10.3310/hta13050; Sharif NA, 2006, MOL VIS, V12, P1040; Shenouda SK, 2010, CURR PHARM BIOTECHNO, V11, P470, DOI 10.2174/138920110791591526; SKRANDIES W, 1988, EXP BRAIN RES, V71, P231; Solis-Chagoyan H, 2008, COMP BIOCHEM PHYS A, V149, P373, DOI 10.1016/j.cbpa.2008.01.040; Takahata K, 2003, INVEST OPHTH VIS SCI, V44, P1760, DOI 10.1167/iovs.02-0471; Tamburini I, 2006, ANN NY ACAD SCI, V1074, P377, DOI 10.1196/annals.1369.037; Velten IM, 2001, BRIT J OPHTHALMOL, V85, P403, DOI 10.1136/bjo.85.4.403; Vielma A, 2010, EXP EYE RES; Wallace TL, 2001, PSYCHOPHARMACOLOGY, V153, P321, DOI 10.1007/s002130000578; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Zheng YW, 1998, BRAIN RES, V795, P257, DOI 10.1016/S0006-8993(98)00313-8	53	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29583	10.1371/journal.pone.0029583	http://dx.doi.org/10.1371/journal.pone.0029583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216322	Green Submitted, Green Published, gold			2022-12-27	WOS:000300674900045
J	Matejcic, M; Li, DP; Prescott, NJ; Lewis, CM; Mathew, CG; Parker, MI				Matejcic, Marco; Li, DongPing; Prescott, Natalie J.; Lewis, Cathryn M.; Mathew, Christopher G.; Parker, M. Iqbal			Association of a Deletion of GSTT2B with an Altered Risk of Oesophageal Squamous Cell Carcinoma in a South African Population: A Case-Control Study	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; CANCER-RISK; GENETIC POLYMORPHISMS; CYTOCHROME-P450 1A1; P1 POLYMORPHISMS; ENZYME-ACTIVITY; GENOTYPE; M1; T1; ALCOHOL	Background: Polymorphisms in the Glutathione S-transferase genes are associated with altered risks in many cancers, but their role in oesophageal cancer is unclear. Recently a 37-kb deletion polymorphism of GSTT2B that reduces expression of GSTT2 has been described. We evaluated the influence of the GSTT1 and GSTT2B deletion polymorphisms, and the GSTP1 Ile105Val polymorphism (rs1695) on susceptibility to oesophageal squamous cell carcinoma (OSCC) in the Black and Mixed Ancestry populations of South Africa. Methods and Results: The GSTT1, GSTT2B and GSTP1 variants were genotyped in 562 OSCC cases and 907 controls, and tested for association with OSCC and for interaction with smoking and alcohol consumption. Linkage disequilibrium (LD) between the deletions at GSTT1 and GSTT2B was determined, and the haplotypes tested for association with OSCC. Neither the GSTT1 deletion nor the GSTP1 Ile105Val polymorphism was associated with OSCC risk in the Black or Mixed Ancestry populations. The GSTT2B deletion was not associated with OSCC risk in the Black population, but was associated with reduced risk of OSCC in the Mixed Ancestry population (OR = 0.71; 95% Cl 0.57-0.90, p = 0.004). Case-only analysis showed no interaction between the GST polymorphisms and smoking or alcohol consumption. LD between the neighboring GSTT1 and GSTT2B deletions was low in both populations (r(Black)(2) = 0.04; r(MxA)(2)= 0.07), thus these deletions should be assessed independently for effects on disease risk. Conclusions: Although there was no association between the GSTT1 deletion polymorphism or the GSTP1 Ile105Val polymorphism with OSCC, our results suggest that the presence of the recently described GSTT2B deletion may have a protective effect on the risk of OSCC in the Mixed Ancestry South African population. This is the first report of the contribution of the GSTT2B deletion to cancer risk.	[Matejcic, Marco; Li, DongPing; Parker, M. Iqbal] Int Ctr Genet Engn & Biotechnol, Cape Town, South Africa; [Matejcic, Marco; Li, DongPing; Parker, M. Iqbal] UCT Fac Hlth Sci, IIDMM, Cape Town, South Africa; [Matejcic, Marco; Li, DongPing; Parker, M. Iqbal] UCT Fac Hlth Sci, Div Med Biochem, Cape Town, South Africa; [Prescott, Natalie J.; Lewis, Cathryn M.; Mathew, Christopher G.] Kings Coll London, Guys Hosp, Dept Med & Mol Genet, London WC2R 2LS, England; [Lewis, Cathryn M.] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England	International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; University of Cape Town; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London	Matejcic, M (corresponding author), Int Ctr Genet Engn & Biotechnol, Cape Town, South Africa.	iqbal.parker@uct.ac.za	Prescott, Natalie J/F-6490-2011; Mathew, Christopher G/G-3434-2015; Lewis, Cathryn/M-8766-2019; Lewis, Cathryn M/A-5225-2010; Prescott, Natalie/AHE-5121-2022	Prescott, Natalie J/0000-0002-5901-7371; Mathew, Christopher G/0000-0003-4178-1838; Lewis, Cathryn/0000-0002-8249-8476; Lewis, Cathryn M/0000-0002-8249-8476; Prescott, Natalie/0000-0002-5901-7371	Association for International Cancer Research [09-0625]; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; International Centre for Genetic Engineering and Biotechnology (ICGEB); South African Medical Research Council and the University of Cape Town; Medical Research Council UK; International Union of Biochemistry and Molecular Biology (IUBMB); Generation Trust; National Institutes of Health Research Biomedical Research Centre; NHS Foundation Trust; King's College London; Medical Research Council [G9817803B] Funding Source: researchfish	Association for International Cancer Research; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; International Centre for Genetic Engineering and Biotechnology (ICGEB); South African Medical Research Council and the University of Cape Town(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); International Union of Biochemistry and Molecular Biology (IUBMB); Generation Trust; National Institutes of Health Research Biomedical Research Centre(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHS Foundation Trust; King's College London(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Association for International Cancer Research [grant number 09-0625] to MIP and CGM. MIP was also supported by the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation, the International Centre for Genetic Engineering and Biotechnology (ICGEB), the South African Medical Research Council and the University of Cape Town. CGM and NJP were supported by the Medical Research Council UK, The Generation Trust, the National Institutes of Health Research Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. MM was awarded a Wood/Whelan Fellowship by the International Union of Biochemistry and Molecular Biology (IUBMB) to perform part of the work in the laboratory of CGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CH, 2003, CLIN CHEM LAB MED, V41, P600, DOI 10.1515/CCLM.2003.090; Adhikari M, 2005, HISTORY COMPASS, V3, DOI 10.1111/j.1478-0542.2005.00177.x; Bruhn C, 1998, BIOCHEM PHARMACOL, V56, P1189, DOI 10.1016/S0006-2952(98)00191-9; Coggan M, 1998, BIOCHEM J, V334, P617, DOI 10.1042/bj3340617; Dandara C, 2006, CARCINOGENESIS, V27, P791, DOI 10.1093/carcin/bgi257; Dandara C, 2002, CLIN CHEM LAB MED, V40, P952, DOI 10.1515/CCLM.2002.167; DAY NE, 1994, CANCER SURV, V20, P43; Dlamini Z, 2005, ETHNIC DIS, V15, P786; DOUGLAS KT, 1987, ADV ENZYMOL RAMB, V59, P103; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Dufour C, 2005, HAEMATOLOGICA, V90, P1027; Eaton DL, 1999, TOXICOL SCI, V49, P156, DOI 10.1093/toxsci/49.2.156; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Freedman ND, 2007, AM J EPIDEMIOL, V165, P1424, DOI 10.1093/aje/kwm051; Garte S, 2001, CANCER EPIDEM BIOMAR, V10, P1239; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; Hendricks D, 2002, IUBMB LIFE, V53, P263, DOI 10.1080/15216540212643; Howlader N, 2011, SEER CANC STAT REV 1; Ishiguro S, 2009, CANCER LETT, V275, P240, DOI 10.1016/j.canlet.2008.10.020; Kamangar F, 2007, ARCH IRAN MED, V10, P70; Komiya Y, 2005, J CANCER RES CLIN, V131, P238, DOI 10.1007/s00432-004-0634-z; Li DP, 2008, CLIN CHEM LAB MED, V46, P323, DOI 10.1515/CCLM.2008.073; Li DP, 2010, BMC GENET, V11, DOI [10.1186/1471-2156-11-47, 10.1186/1471-2164-11-446]; Li DP, 2005, CLIN CHEM LAB MED, V43, P370, DOI 10.1515/CCLM.2005.067; Ma WJ, 2010, WORLD J GASTROENTERO, V16, P641, DOI 10.3748/wjg.v16.i5.641; McIlwain CC, 2006, ONCOGENE, V25, P1639, DOI 10.1038/sj.onc.1209373; Nakajima T, 1996, CARCINOGENESIS, V17, P1477, DOI 10.1093/carcin/17.7.1477; NELSON HH, 1995, CARCINOGENESIS, V16, P1243, DOI 10.1093/carcin/16.5.1243; Parl FF, 2005, CANCER LETT, V221, P123, DOI 10.1016/j.canlet.2004.06.016; Rankin Sheila C., 2008, CARCINOMA ESOPHAGUS; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Rossini A, 2007, CARCINOGENESIS, V28, P2537, DOI 10.1093/carcin/bgm222; Santovito A, 2010, GENET MOL BIOL, V33, P434, DOI 10.1590/S1415-47572010005000059; Schneider J, 2004, CANCER LETT, V208, P65, DOI 10.1016/j.canlet.2004.01.002; Sprenger R, 2000, PHARMACOGENETICS, V10, P557, DOI 10.1097/00008571-200008000-00009; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; VENTER FS, 1993, S AFR MED J, V83, P808; Voho A, 2006, CANCER DETECT PREV, V30, P144, DOI 10.1016/j.cdp.2005.11.004; Watson MA, 1998, CARCINOGENESIS, V19, P275, DOI 10.1093/carcin/19.2.275; Whittington AT, 1999, BIOCHEM J, V337, P141, DOI 10.1042/0264-6021:3370141; Yang CX, 2005, WORLD J GASTROENTERO, V11, P2531, DOI 10.3748/wjg.v11.i17.2531; Zendehdel K, 2009, CANCER CAUSE CONTROL, V20, P2031, DOI 10.1007/s10552-009-9399-7; Zhao YZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000472	43	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29366	10.1371/journal.pone.0029366	http://dx.doi.org/10.1371/journal.pone.0029366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216261	gold, Green Submitted, Green Published			2022-12-27	WOS:000300674900030
J	Carvalho, S; Leite, J; Galdo-Alvarez, S; Goncalves, OF				Carvalho, Sandra; Leite, Jorge; Galdo-Alvarez, Santiago; Goncalves, Oscar F.			Psychophysiological Correlates of Sexually and Non-Sexually Motivated Attention to Film Clips in a Workload Task	PLOS ONE			English	Article							POTENTIAL TECHNIQUE; P300; EMOTION; AROUSAL; WOMEN; PHYSIOLOGY; RESPONSES; COMPONENT; DESIRE	Some authors have speculated that the cognitive component (P3) of the Event-Related Potential (ERP) can function as a psychophysiological measure of sexual interest. The aim of this study was to determine if the P3 ERP component in a workload task can be used as a specific and objective measure of sexual motivation by comparing the neurophysiologic response to stimuli of motivational relevance with different levels of valence and arousal. A total of 30 healthy volunteers watched different films clips with erotic, horror, social-positive and social-negative content, while answering an auditory oddball paradigm. Erotic film clips resulted in larger interference when compared to both the social-positive and auditory alone conditions. Horror film clips resulted in the highest levels of interference with smaller P3 amplitudes than erotic and also than social-positive, social-negative and auditory alone condition. No gender differences were found. Both horror and erotic film clips significantly decreased heart rate (HR) when compared to both social-positive and social-negative films. The erotic film clips significantly increased the skin conductance level (SCL) compared to the social-negative films. The horror film clips significantly increased the SCL compared to both social-positive and social-negative films. Both the highly arousing erotic and non-erotic (horror) movies produced the largest decrease in the P3 amplitude, a decrease in the HR and an increase in the SCL. These data support the notion that this workload task is very sensitive to the attentional resources allocated to the film clip, although they do not act as a specific index of sexual interest. Therefore, the use of this methodology seems to be of questionable utility as a specific measure of sexual interest or as an objective measure of the severity of Hypoactive Sexual Desire Disorder.	[Carvalho, Sandra; Leite, Jorge; Goncalves, Oscar F.] Univ Minho, Neuropsychophysiol Lab, Ctr Res Psychol Cipsi, Sch Psychol EPsi, Braga, Portugal; [Galdo-Alvarez, Santiago] Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Santiago De Compostela, Spain	Universidade do Minho; Universidade de Santiago de Compostela	Carvalho, S (corresponding author), Univ Minho, Neuropsychophysiol Lab, Ctr Res Psychol Cipsi, Sch Psychol EPsi, Braga, Portugal.	sandrarc@psi.uminho.pt	Carvalho, Sandra/H-1214-2014; Leite, Jorge/M-9341-2019; Gonçalves, Óscar F./G-5278-2010; Leite, Jorge/E-4404-2013; Galdo-Alvarez, Santiago/D-3954-2011	Carvalho, Sandra/0000-0003-1759-5146; Leite, Jorge/0000-0002-0323-9012; Gonçalves, Óscar F./0000-0003-2735-9155; Leite, Jorge/0000-0002-0323-9012; Galdo-Alvarez, Santiago/0000-0002-5242-3203	Portuguese Foundation for Science and Technology [SFRH/BD/64355/2009, SFRH/BD/41484/2007]; Spanish Xunta de Galicia [DOG 233]; BIAL	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Spanish Xunta de Galicia; BIAL(Bial Group)	This work was supported by the Portuguese Foundation for Science and Technology with individual grants (SFRH/BD/64355/2009 and SFRH/BD/41484/2007) and by the Spanish Xunta de Galicia (DOG 233 -Resolution date: 2009 November 18). The authors also wish to thank the BIAL grant "The Neuropsychophysiological Basis of Empathy: The Role of Neuroendocrine; Autonomic and Central Nervous System Variables" for providing financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokhin AP, 2006, BRAIN RES, V1093, P167, DOI 10.1016/j.brainres.2006.03.108; Baldaro B, 2001, PERCEPT MOTOR SKILL, V93, P797, DOI 10.2466/PMS.93.7.797-805; Both S, 2010, J PSYCHOSOM OBST GYN, V31, P207, DOI 10.3109/0167482X.2010.528628; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; Bradley MM, 1996, PSYCHOPHYSIOLOGY, V33, P662, DOI 10.1111/j.1469-8986.1996.tb02362.x; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Briggs KE, 2009, INT J PSYCHOPHYSIOL, V72, P299, DOI 10.1016/j.ijpsycho.2009.01.009; Canli T, 2000, J NEUROSCI, V20; CARVALHO S, EMOTIONAL MOVI UNPUB; Codispoti M, 2008, INT J PSYCHOPHYSIOL, V69, P90, DOI 10.1016/j.ijpsycho.2008.03.004; Costa RM, 2008, INT J PSYCHOPHYSIOL, V67, P64, DOI 10.1016/j.ijpsycho.2007.10.005; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; Donchin E, 1987, Electroencephalogr Clin Neurophysiol Suppl, V39, P338; DONCHIN E, 1986, PSYCHOPHYSIOLOGY SYS, P702; Graham CA, 2000, PSYCHOPHYSIOLOGY, V37, P76, DOI 10.1017/S0048577200981964; GRAHAM FK, 1966, PSYCHOL BULL, V65, P305, DOI 10.1037/h0023258; GRATTON E, 1983, BIOPHYS J, V44, P315, DOI 10.1016/S0006-3495(83)84305-7; GROSS JJ, 1993, J PERS SOC PSYCHOL, V64, P970, DOI 10.1037/0022-3514.64.6.970; Hamm AO, 2003, SER AFFECTIVE SCI, P187; Hiller J, 2005, J MENS HLTH GENDER, V2, P339, DOI DOI 10.1016/j.jmhg.2005.05.003; HOHNSBEIN J, 1995, BIOL PSYCHOL, V40, P73, DOI 10.1016/0301-0511(95)05109-0; JOHNSON R, 1993, PSYCHOPHYSIOLOGY, V30, P90; Katayama J, 1999, CLIN NEUROPHYSIOL, V110, P463, DOI 10.1016/S1388-2457(98)00035-2; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KRAMER A, 1991, PSYCHOPHYSIOLOGY HUM, P179; Krug R, 2000, PSYCHOPHYSIOLOGY, V37, P111, DOI 10.1017/S0048577200980594; LAAN E, 1995, PSYCHOPHYSIOLOGY, V32, P476, DOI 10.1111/j.1469-8986.1995.tb02099.x; Lacey J., 1967, PSYCHOL STRESS ISSUE, P14; Lang P.J., 2008, A8 U FLOR; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Luck S.J., 2005, INTRO EVENT RELATED; Messaoudi R, 2011, INT J IMPOT RES, V23, P81, DOI 10.1038/ijir.2011.8; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Palomba D, 2000, INT J PSYCHOPHYSIOL, V36, P45, DOI 10.1016/S0167-8760(99)00099-9; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Rozenkrants B, 2008, CLIN NEUROPHYSIOL, V119, P2260, DOI 10.1016/j.clinph.2008.07.213; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; Schupp HT, 1997, PSYCHOPHYSIOLOGY, V34, P1, DOI 10.1111/j.1469-8986.1997.tb02409.x; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Smith JC, 2005, BIOL PSYCHOL, V69, P247, DOI 10.1016/j.biopsycho.2004.09.001; Spencer NA, 2004, HORM BEHAV, V46, P362, DOI 10.1016/j.yhbeh.2004.06.002; van Lankveld JJDM, 2008, BIOL PSYCHOL, V79, P200, DOI 10.1016/j.biopsycho.2008.04.016; Vardi Y, 2006, J UROLOGY, V176, P2736, DOI 10.1016/j.juro.2006.07.134; Vardi Y, 2009, J SEX MED, V6, P1688, DOI 10.1111/j.1743-6109.2009.01280.x; Weinberg A, 2010, EMOTION, V10, P767, DOI 10.1037/a0020242	50	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29530	10.1371/journal.pone.0029530	http://dx.doi.org/10.1371/journal.pone.0029530			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	876NF	22216305	Green Published, Green Submitted, gold			2022-12-27	WOS:000299113600087
J	Costa, L; Rybski, D; Kropp, JP				Costa, Luis; Rybski, Diego; Kropp, Juergen P.			A Human Development Framework for CO2 Reductions	PLOS ONE			English	Article							EMISSIONS; TARGETS; ENERGY; CARBON	Although developing countries are called to participate in CO2 emission reduction efforts to avoid dangerous climate change, the implications of proposed reduction schemes in human development standards of developing countries remain a matter of debate. We show the existence of a positive and time-dependent correlation between the Human Development Index (HDI) and per capita CO2 emissions from fossil fuel combustion. Employing this empirical relation, extrapolating the HDI, and using three population scenarios, the cumulative CO2 emissions necessary for developing countries to achieve particular HDI thresholds are assessed following a Development As Usual approach (DAU). If current demographic and development trends are maintained, we estimate that by 2050 around 85% of the world's population will live in countries with high HDI (above 0.8). In particular, 300 Gt of cumulative CO2 emissions between 2000 and 2050 are estimated to be necessary for the development of 104 developing countries in the year 2000. This value represents between 20 % to 30 % of previously calculated CO2 budgets limiting global warming to 2 degrees C. These constraints and results are incorporated into a CO2 reduction framework involving four domains of climate action for individual countries. The framework reserves a fair emission path for developing countries to proceed with their development by indexing country-dependent reduction rates proportional to the HDI in order to preserve the 2 degrees C target after a particular development threshold is reached. For example, in each time step of five years, countries with an HDI of 0.85 would need to reduce their per capita emissions by approx. 17% and countries with an HDI of 0.9 by 33 %. Under this approach, global cumulative emissions by 2050 are estimated to range from 850 up to 1100 Gt of CO2. These values are within the uncertainty range of emissions to limit global temperatures to 2 degrees C.	[Costa, Luis; Rybski, Diego; Kropp, Juergen P.] Potsdam Inst Climate Impact Res, Potsdam, Germany	Potsdam Institut fur Klimafolgenforschung	Costa, L (corresponding author), Potsdam Inst Climate Impact Res, Potsdam, Germany.	carvalho@pik-potsdam.de	Kropp, Juergen/D-8220-2012	Kropp, Juergen/0000-0001-7791-3420; Rybski, Diego/0000-0001-6125-7705	BaltCICA; Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety of Germany	BaltCICA; Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety of Germany	The authors acknowledge the financial support from BaltCICA (Baltic Sea Region Programme 2007-2013). They wish to thank the Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety of Germany who supports this work within the framework of the International Climate Protection Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo J., 2005, MILLENNIUM ECOSYSTEM; Atkinson G., 1997, MEASURING SUSTAINABL; Baer P., 2008, GREENHOUSE DEV RIGHT; Bolin B, 2001, P NATL ACAD SCI USA, V98, P4850, DOI 10.1073/pnas.081078998; Bongaarts J, 2010, POPUL DEV REV, V36, P402; Bowerman NHA, 2011, PHILOS T R SOC A, V369, P45, DOI 10.1098/rsta.2010.0288; Broecker WS, 2007, SCIENCE, V315, P1371, DOI 10.1126/science.1139585; Brooks N, 2005, GLOBAL ENVIRON CHANG, V15, P151, DOI 10.1016/j.gloenvcha.2004.12.006; COCKLIN C, 2007, MITIGATION CONTRIBUT; den Elzen M, 2008, CLIMATIC CHANGE, V91, P249, DOI 10.1007/s10584-008-9484-z; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; HOSMER DW, 2000, WILEY PS TX, P1; JIAHUA P, 2005, INT ENVIRON AGREEM-P, V5, P89; Malmgren RD, 2009, SCIENCE, V325, P1696, DOI 10.1126/science.1174562; Manning MR, 2010, NAT GEOSCI, V3, P376, DOI 10.1038/ngeo880; Mason RL, 1989, STAT DESIGN ANAL EXP; MEINSHAUSEN M, 2007, STYLIZED EMISSION PA; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Montalvo JG, 2010, J COMP ECON, V38, P2, DOI 10.1016/j.jce.2009.10.005; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Neumayer E, 2001, ECOL ECON, V39, P101, DOI 10.1016/S0921-8009(01)00201-4; Patt AG, 2010, P NATL ACAD SCI USA, V107, P1333, DOI 10.1073/pnas.0910253107; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Rhemtulla JM, 2009, P NATL ACAD SCI USA, V106, P6082, DOI 10.1073/pnas.0810076106; Rogelj J, 2010, NATURE, V464, P1126, DOI 10.1038/4641126a; SCHELLNHUBER HJ, 2006, AVOIDING DANGEROUS C, P281; Steinberger JK, 2010, ECOL ECON, V70, P425, DOI 10.1016/j.ecolecon.2010.09.014; *UNDP, 2008, 1 UNDP; UNDP, 2009, OV BARR HUM MOB DEV; Watson R.T., 2001, CLIMATE CHANGE 2001, P388; *WBGU, 2006, SOLV CLIM DIL BUDG A; Wigley TML, 2007, SCIENCE, V316, P829; Zickfeld K, 2009, P NATL ACAD SCI USA, V106, P16129, DOI 10.1073/pnas.0805800106	33	52	52	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29262	10.1371/journal.pone.0029262	http://dx.doi.org/10.1371/journal.pone.0029262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	876NF	22216227	Green Published, gold, Green Submitted			2022-12-27	WOS:000299113600071
J	Stein, T; Peelen, MV; Sterzer, P				Stein, Timo; Peelen, Marius V.; Sterzer, Philipp			Adults' Awareness of Faces Follows Newborns' Looking Preferences	PLOS ONE			English	Article							CONTINUOUS FLASH SUPPRESSION; BINOCULAR-RIVALRY; INTEROCULAR SUPPRESSION; DIFFERENTIAL DEVELOPMENT; FACIAL EXPRESSIONS; CORTICAL RESPONSES; ADAPTATION DEPENDS; INVISIBLE OBJECTS; VISUAL AWARENESS; STIMULI	From the first days of life, humans preferentially orient towards upright faces, likely reflecting innate subcortical mechanisms. Here, we show that binocular rivalry can reveal face detection mechanisms in adults that are surprisingly similar to inborn face detection mechanism. We used continuous flash suppression (CFS), a variant of binocular rivalry, to render stimuli invisible at the beginning of each trial and measured the time upright and inverted stimuli needed to overcome such interocular suppression. Critically, specific stimulus properties previously shown to modulate looking preferences in neonates similarly modulated adults' awareness of faces presented during CFS. First, the advantage of upright faces in overcoming CFS was strongly modulated by contrast polarity and direction of illumination. Second, schematic patterns consisting of three dark blobs were suppressed for shorter durations when the arrangement of these blobs respected the face-like configuration of the eyes and the mouth, and this effect was modulated by contrast polarity. No such effects were obtained in a binocular control experiment not involving CFS, suggesting a crucial role for face-sensitive mechanisms operating outside of conscious awareness. These findings indicate that visual awareness of faces in adults is governed by perceptual mechanisms that are sensitive to similar stimulus properties as those modulating newborns' face preferences.	[Stein, Timo; Sterzer, Philipp] Charite Campus Mitte, Dept Psychiat, Berlin, Germany; [Stein, Timo; Sterzer, Philipp] Univ Berlin, Berlin Sch Mind & Brain, Berlin, Germany; [Peelen, Marius V.] Univ Trento, Ctr Interdipartimentale Mente Cervello, Rovereto, Italy; [Sterzer, Philipp] Univ Berlin, Bernstein Ctr Computat Neurosci, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Trento	Stein, T (corresponding author), Charite Campus Mitte, Dept Psychiat, Berlin, Germany.	timo.stein@bccn-berlin.de	Peelen, Marius V/D-1780-2010	Peelen, Marius V/0000-0002-4026-7303; Stein, Timo/0000-0002-8484-0933	German Research Foundation [STE-1430/2-1]; Studienstiftung des deutschen Volkes	German Research Foundation(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes	This work was supported by the German Research Foundation (Emmy Noether Programme, STE-1430/2-1) and by Studienstiftung des deutschen Volkes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amihai I, 2011, CONSCIOUS COGN, V20, P269, DOI 10.1016/j.concog.2010.08.004; Anderson ML, 2010, BEHAV BRAIN SCI, V33, P245, DOI 10.1017/S0140525X10000853; Andrews TJ, 1997, P NATL ACAD SCI USA, V94, P9905, DOI 10.1073/pnas.94.18.9905; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; BLAKE R, 1977, J EXP PSYCHOL HUMAN, V3, P251, DOI 10.1037/0096-1523.3.2.251; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; de Gelder BC, 2003, P NATL ACAD SCI USA, V100, P13105, DOI 10.1073/pnas.1735530100; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Duchaine BC, 2006, CURR OPIN NEUROBIOL, V16, P166, DOI 10.1016/j.conb.2006.03.003; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Farroni T, 2005, P NATL ACAD SCI USA, V102, P17245, DOI 10.1073/pnas.0502205102; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; FOX R, 1969, PERCEPT PSYCHOPHYS, V5, P215, DOI 10.3758/BF03210542; Gilad S, 2009, P NATL ACAD SCI USA, V106, P5353, DOI 10.1073/pnas.0812396106; Golarai G, 2007, NAT NEUROSCI, V10, P512, DOI 10.1038/nn1865; GOREN CC, 1975, PEDIATRICS, V56, P544; Jiang Y, 2007, PSYCHOL SCI, V18, P349, DOI 10.1111/j.1467-9280.2007.01902.x; Jiang Y, 2006, CURR BIOL, V16, P2023, DOI 10.1016/j.cub.2006.08.084; Johnson M H, 1990, J Cogn Neurosci, V2, P81, DOI 10.1162/jocn.1990.2.2.81; Johnson MH, 2000, DEVELOPMENTAL SCI, V3, P41, DOI 10.1111/1467-7687.00097; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; JOHNSON MH, 1991, COGNITION, V40, P1, DOI 10.1016/0010-0277(91)90045-6; Kanwisher N, 1998, COGNITION, V68, pB1, DOI 10.1016/S0010-0277(98)00035-3; Kim CY, 2005, TRENDS COGN SCI, V9, P381, DOI 10.1016/j.tics.2005.06.012; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Levelt WJM, 1965, BINOCULAR RIVALRY; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Moradi F, 2005, NEURON, V45, P169, DOI 10.1016/j.neuron.2004.12.018; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Pasley BN, 2004, NEURON, V42, P163, DOI 10.1016/S0896-6273(04)00155-2; Peelen MV, 2009, DEVELOPMENTAL SCI, V12, pF16, DOI 10.1111/j.1467-7687.2009.00916.x; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Stein T, 2011, J VISION, V11, DOI 10.1167/11.8.5; Stein T, 2011, COGNITION, V119, P307, DOI 10.1016/j.cognition.2011.01.008; Sterzer P, 2011, PSYCHOL MED, V41, P1615, DOI 10.1017/S0033291710002540; Sterzer P, 2009, TRENDS COGN SCI, V13, P310, DOI 10.1016/j.tics.2009.04.006; Sterzer P, 2008, J VISION, V8, DOI 10.1167/8.15.10; Sterzer P, 2009, NEUROIMAGE, V46, P803, DOI 10.1016/j.neuroimage.2009.02.046; Tomalski P, 2009, NEUROREPORT, V20, P1309, DOI 10.1097/WNR.0b013e32832f0acd; Tomalski P, 2009, PERCEPTION, V38, P569, DOI 10.1068/p6137; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Tsuchiya N, 2006, J VISION, V6, P1068, DOI 10.1167/6.10.6; Tsuchiya N, 2009, NAT NEUROSCI, V12, P1224, DOI 10.1038/nn.2380; Valenza E, 1996, J EXP PSYCHOL HUMAN, V22, P892, DOI 10.1037/0096-1523.22.4.892; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004; Yang E, 2007, EMOTION, V7, P882, DOI 10.1037/1528-3542.7.4.882; Yovel G, 2005, CURR BIOL, V15, P2256, DOI 10.1016/j.cub.2005.10.072; Zhou GM, 2010, CONSCIOUS COGN, V19, P408, DOI 10.1016/j.concog.2009.12.009	51	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29361	10.1371/journal.pone.0029361	http://dx.doi.org/10.1371/journal.pone.0029361			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	876NF	22216259	gold, Green Published, Green Submitted			2022-12-27	WOS:000299113600081
J	Xu, YM; Xin, YQ; Diao, Y; Lu, CY; Fu, J; Luo, L; Yin, ZM				Xu, Yimiao; Xin, Yinqiang; Diao, Ying; Lu, Changyan; Fu, Jin; Luo, Lan; Yin, Zhimin			Synergistic Effects of Apigenin and Paclitaxel on Apoptosis of Cancer Cells	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; STRESS-INDUCED APOPTOSIS; HUMAN TUMOR-CELLS; OXIDATIVE STRESS; GENE-EXPRESSION; REACTIVE OXYGEN; CASPASE-2 ACTIVATION; GLUCOSE DEPRIVATION; SPECIES GENERATION; MITOCHONDRIAL	Background: It was well known that the clinical use of chemotherapeutic drugs is restricted by severe adverse reactions and drug resistances. Thus it is necessary to figure out a strategy to increase the specific anti-tumor efficiency of chemotherapeutic drugs. Apigenin, a kind of flavonoids, has been reported to possess anticancer activities with very low cytotoxicity to normal tissue. Methodology/Principal Findings: Our results from cell viability assay, western-blots and TdT-mediated dUTP-biotin nick end labeling (TUNEL) assay demonstrated the synergistic pro-apoptotic effects of a low dose of apigenin and paclitaxel in human cancer cell lines. To analyze the underlying mechanism, we examined reactive oxygen species (ROS) staining after cells were treated with a combination of apigenin and paclitaxel, or each of them alone. Data from flow-cytometry showed that superoxides but not reduction of peroxides accumulated in HeLa cells treated with apigenin or a combination of apigenin and paclitaxel. Apigenin and paclitaxel-induced HeLa cell apoptosis was related to the level of ROS in cells. We further evaluated activity and protein level of superoxide dismutase (SOD). Apigenin significantly inhibited SOD activity but did not alter the SOD protein level suggesting that apigenin promoted ROS accumulation through suppressing enzyme activity of SOD. Addition of Zn2+, Cu2+ and Mn2+ to cell lysates inhibited apigenin's effects on SOD activity. At the same time, data from caspase-2 over-expression and knocked-down experiments demonstrated that caspase-2 participated in apigenin and paclitaxel-induced HeLa cell apoptosis. Conclusions/Significance: Taken together, our study demonstrated that apigenin can sensitize cancer cells to paclitaxel induced apoptosis through suppressing SOD activity, which then led to accumulation of ROS and cleavage of caspase-2, suggesting that the combined use of apigenin and paclitaxel was an effective way to decrease the dose of paclitaxel taken.	[Xu, Yimiao; Xin, Yinqiang; Diao, Ying; Lu, Changyan; Fu, Jin; Yin, Zhimin] Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Luo, Lan] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing University	Xu, YM (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China.	lanluo@nju.edu.cn; yinzhimin@njnu.edu.cn			National Nature Science Foundation of China [81072433, 31071000]; Jiangsu Major Nature Science Foundation of High Education [07KJA18026]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Major Nature Science Foundation of High Education; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants from the National Nature Science Foundation of China (Nos. 81072433 and 31071000), Jiangsu Major Nature Science Foundation of High Education (No. 07KJA18026) and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; AJANI JA, 1994, J NATL CANCER I, V86, P51, DOI 10.1093/jnci/86.1.51; Akashi M, 1996, INT J CANCER, V68, P384, DOI 10.1002/(SICI)1097-0215(19961104)68:3<384::AID-IJC18>3.0.CO;2-8; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Blackburn RV, 1999, FREE RADICAL BIO MED, V26, P419, DOI 10.1016/S0891-5849(98)00217-2; Braga M, 2008, APOPTOSIS, V13, P822, DOI 10.1007/s10495-008-0216-7; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chen WJ, 2008, J AGR FOOD CHEM, V56, P2996, DOI 10.1021/jf0730744; CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517; CHOU TC, 1991, MEDIAN EFFECT PRINCI, P61; Crespo I, 2008, FOOD CHEM TOXICOL, V46, P1555, DOI 10.1016/j.fct.2007.12.014; Das KC, 1998, J BIOL CHEM, V273, P34639, DOI 10.1074/jbc.273.51.34639; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dziadyk JM, 2004, ANTICANCER RES, V24, P27; Ferret Pierre-Jacques, 2002, BMC Immunol, V3, P3; Gao YH, 2010, APOPTOSIS, V15, P822, DOI 10.1007/s10495-010-0495-7; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Itoh Y, 2004, AM J RESP CRIT CARE, V169, P113, DOI 10.1164/rccm.200307-901OC; Ju W, 2007, MOL PHARMACOL, V71, P1381, DOI 10.1124/mol.106.032185; Kinnula VL, 2004, FREE RADICAL BIO MED, V36, P718, DOI 10.1016/j.freeradbiomed.2003.12.010; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Kobayashi T, 2002, CANCER LETT, V176, P17, DOI 10.1016/S0304-3835(01)00738-8; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Madesh M, 2009, MOL CELL BIOL, V29, P3099, DOI 10.1128/MCB.01845-08; Miyoshi N, 2007, ARCH BIOCHEM BIOPHYS, V466, P274, DOI 10.1016/j.abb.2007.07.026; Noel S, 2006, TOXICOL IN VITRO, V20, P1168, DOI 10.1016/j.tiv.2006.03.007; OBERLEY LW, 1981, MED HYPOTHESES, V7, P21, DOI 10.1016/0306-9877(81)90018-9; Olsson M, 2009, ONCOGENE, V28, P1949, DOI 10.1038/onc.2009.36; Patel D, 2007, INT J ONCOL, V30, P233; PATRICE L, 2002, SCIENCE, V297, P1352; Prasad V, 2006, FREE RADICAL BIO MED, V41, P431, DOI 10.1016/j.freeradbiomed.2006.03.009; Ria F, 2001, BRIT J CANCER, V84, P529, DOI 10.1054/bjoc.2000.1594; Safra T, 2009, GYNECOL ONCOL, V114, P215, DOI 10.1016/j.ygyno.2009.04.008; Scharstuhl A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006688; Scripture CD, 2006, CURR NEUROPHARMACOL, V4, P165, DOI 10.2174/157015906776359568; Spitz DR, 2000, ANN NY ACAD SCI, V899, P349, DOI 10.1111/j.1749-6632.2000.tb06199.x; Su DM, 2009, MOL CANCER THER, V8, P1292, DOI 10.1158/1535-7163.MCT-08-1030; Tamm C, 2008, APOPTOSIS, V13, P354, DOI 10.1007/s10495-007-0172-7; Wang WQ, 2000, MOL CARCINOGEN, V28, P102; Wang XM, 2005, CELL PHYSIOL BIOCHEM, V16, P147, DOI 10.1159/000089840; Way TD, 2004, J BIOL CHEM, V279, P4479, DOI 10.1074/jbc.M305529200; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; WILLIAMS R, MINERALS HUMAN LIFE; Wilson CR, 2001, TOXICON, V39, P175, DOI 10.1016/S0041-0101(00)00146-X; Wrighton KH, 2009, NAT REV MOL CELL BIO, V10, P739, DOI 10.1038/nrm2788; Yu YS, 2009, J AGR FOOD CHEM, V57, P7673, DOI 10.1021/jf901327g; Zhang JM, 2005, J MASS SPECTROM, V40, P350, DOI 10.1002/jms.793; Zhang YP, 2007, MECH AGEING DEV, V128, P213, DOI 10.1016/j.mad.2006.11.030	51	89	94	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29169	10.1371/journal.pone.0029169	http://dx.doi.org/10.1371/journal.pone.0029169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216199	Green Published, gold, Green Submitted			2022-12-27	WOS:000299113600063
J	Chabout, J; Serreau, P; Ey, E; Bellier, L; Aubin, T; Bourgeron, T; Granon, S				Chabout, Jonathan; Serreau, Pierre; Ey, Elodie; Bellier, Ludovic; Aubin, Thierry; Bourgeron, Thomas; Granon, Sylvie			Adult Male Mice Emit Context-Specific Ultrasonic Vocalizations That Are Modulated by Prior Isolation or Group Rearing Environment	PLOS ONE			English	Article							LABORATORY RATS; BEHAVIORAL-RESPONSES; SOCIAL REWARD; MOUSE MODEL; FEMALE MICE; CALLS; COMMUNICATION; PLAYBACK; EXPRESSION; SITUATIONS	Social interactions in mice are frequently analysed in genetically modified strains in order to get insight of disorders affecting social interactions such as autism spectrum disorders. Different types of social interactions have been described, mostly between females and pups, and between adult males and females. However, we recently showed that social interactions between adult males could also encompass cognitive and motivational features. During social interactions, rodents emit ultrasonic vocalizations (USVs), but it remains unknown if call types are differently used depending of the context and if they are correlated with motivational state. Here, we recorded the calls of adult C57BL/6J male mice in various behavioral conditions, such as social interaction, novelty exploration and restraint stress. We introduced a modulator for the motivational state by comparing males maintained in isolation and males maintained in groups before the experiments. Male mice uttered USVs in all social and non-social situations, and even in a stressful restraint context. They nevertheless emitted the most important number of calls with the largest diversity of call types in social interactions, particularly when showing a high motivation for social contact. For mice maintained in social isolation, the number of calls recorded was positively correlated with the duration of social contacts, and most calls were uttered during contacts between the two mice. This correlation was not observed in mice maintained in groups. These results open the way for a deeper understanding and characterization of acoustic signals associated with social interactions. They can also help evaluating the role of motivational states in the emission of acoustic signals.	[Chabout, Jonathan; Serreau, Pierre; Bellier, Ludovic; Granon, Sylvie] Univ Paris 11, Ctr Neurosci Paris Sud, Team Neurobiol Prise Decis, Orsay, France; [Chabout, Jonathan; Serreau, Pierre; Bellier, Ludovic; Aubin, Thierry; Granon, Sylvie] CNRS, UMR 8195, F-91405 Orsay, France; [Serreau, Pierre] Inst Pasteur, CNRS, URA 2182, Neurobiol Integrat Syst Cholinerg Unit, Paris, France; [Ey, Elodie; Bourgeron, Thomas] Inst Pasteur, CNRS, URA 2182, Genet Humaine & Fonct Cognit Unit, Paris, France; [Aubin, Thierry] Univ Paris 11, Ctr Neurosci Paris Sud, Team Commun Acoust, Orsay, France	UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Saclay	Chabout, J (corresponding author), Univ Paris 11, Ctr Neurosci Paris Sud, Team Neurobiol Prise Decis, Orsay, France.	sylvie.granon@u-psud.fr	Granon, Sylvie/J-9224-2019	Ey, Elodie/0000-0002-8202-3163; Bourgeron, Thomas/0000-0001-8164-9220; Granon, sylvie/0000-0001-9384-3119				Ahrens AM, 2009, BEHAV BRAIN RES, V197, P205, DOI 10.1016/j.bbr.2008.08.037; Arriaga G, 2011, THESIS DUKE U US; Avale ME, 2011, FASEB J OFFICIAL MAR, P1; Bollen B, 2007, NEUROSCI LETT, V420, P268, DOI 10.1016/j.neulet.2007.05.012; Borta A, 2006, BEHAV BRAIN RES, V166, P271, DOI 10.1016/j.bbr.2005.08.009; Bourgeron T, 2006, CONTEMPORARY CLIN NE, P151; Branchi I, 1998, DEV PSYCHOBIOL, V33, P249, DOI 10.1002/(SICI)1098-2302(199811)33:3<249::AID-DEV5>3.0.CO;2-R; BRUDZYNSKI SM, 1995, PHYSIOL BEHAV, V57, P1039, DOI 10.1016/0031-9384(95)00003-2; Brudzynski SM, 2002, J COMP PSYCHOL, V116, P73, DOI 10.1037//0735-7036.116.1.73; BRUDZYNSKI SM, 1992, PHYSIOL BEHAV, V52, P655, DOI 10.1016/0031-9384(92)90393-G; Brudzynski SM, 2007, BEHAV BRAIN RES, V182, P261, DOI 10.1016/j.bbr.2007.03.004; Burgdorf J, 2008, J COMP PSYCHOL, V122, P357, DOI 10.1037/a0012889; Elie JE, 2011, J ACOUST SOC AM, V129, P4037, DOI 10.1121/1.3570959; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Ey E, 2011, AUTISM RES, V4, P5, DOI 10.1002/aur.175; Fendt M, 2006, NEUROSCI LETT, V401, P10, DOI 10.1016/j.neulet.2006.02.069; Fischer J, 2010, GENES BRAIN BEHA JUN, P1; Granon S, 2003, P NATL ACAD SCI USA, V100, P9596, DOI 10.1073/pnas.1533498100; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Hamilton SM, 2011, BEHAV BRAIN RES, V218, P29, DOI 10.1016/j.bbr.2010.11.026; Hammerschmidt K, 2009, BIOL LETTERS, V5, P589, DOI 10.1098/rsbl.2009.0317; Hegoburu C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00025; Hoffmann F, 2012, PHYSIOL BEHAV, V105, P766, DOI 10.1016/j.physbeh.2011.10.011; Hoffmann F, 2009, PHYSIOL BEHAV, V96, P602, DOI 10.1016/j.physbeh.2008.12.014; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Litvin Y, 2007, BEHAV BRAIN RES, V182, P166, DOI 10.1016/j.bbr.2006.11.038; McGregor Peter K., 1996, P409; Meise K, 2008, THESIS U BIELEFELD G; Menuet C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025770; Moles A, 2007, BEHAV BRAIN RES, V182, P223, DOI 10.1016/j.bbr.2007.01.020; Moy SS, 2006, AM J MED GENET C, V142C, P40, DOI 10.1002/ajmg.c.30081; Panksepp JB, 2007, GENES BRAIN BEHAV, V6, P661, DOI 10.1111/j.1601-183X.2006.00295.x; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rendall D, 2011, J ACOUST SOC AM, V113, P3390; Sadananda M, 2008, NEUROSCI LETT, V435, P17, DOI 10.1016/j.neulet.2008.02.002; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Scattoni ML, 2010, GENES BRAIN BEHA JUL, P1; Schehka S, 2007, J COMP PHYSIOL A, V193, P845, DOI 10.1007/s00359-007-0236-8; SCHERER KR, 1988, PSYCHOTHER PSYCHOSOM, V49, P179, DOI 10.1159/000288082; Takahashi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014115; Timmer M, 2010, PSYCHONEUROENDOCRINO, V35, P1543, DOI 10.1016/j.psyneuen.2010.05.011; Trezza V, 2011, J NEUROSCI, V31, P6362, DOI 10.1523/JNEUROSCI.5492-10.2011; Wohr M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001365; Wohr M, 2009, PHARMACOL BIOCHEM BE, V94, P285, DOI 10.1016/j.pbb.2009.09.008	47	107	108	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29401	10.1371/journal.pone.0029401	http://dx.doi.org/10.1371/journal.pone.0029401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238608	Green Published, gold			2022-12-27	WOS:000301188800014
J	Naparus, M; Kuntner, M				Naparus, Magdalena; Kuntner, Matjaz			A GIS Model Predicting Potential Distributions of a Lineage: A Test Case on Hermit Spiders (Nephilidae: Nephilengys)	PLOS ONE			English	Article							SPECIES DISTRIBUTION; ARANEAE; DIVERSITY; EVOLUTION; ECOLOGY	Background: Although numerous studies model species distributions, these models are almost exclusively on single species, while studies of evolutionary lineages are preferred as they by definition study closely related species with shared history and ecology. Hermit spiders, genus Nephilengys, represent an ecologically important but relatively species-poor lineage with a globally allopatric distribution. Here, we model Nephilengys global habitat suitability based on known localities and four ecological parameters. Methodology/Principal Findings: We geo-referenced 751 localities for the four most studied Nephilengys species: N. cruentata (Africa, New World), N. livida (Madagascar), N. malabarensis (S-SE Asia), and N. papuana (Australasia). For each locality we overlaid four ecological parameters: elevation, annual mean temperature, annual mean precipitation, and land cover. We used linear backward regression within ArcGIS to select two best fit parameters per species model, and ModelBuilder to map areas of high, moderate and low habitat suitability for each species within its directional distribution. For Nephilengys cruentata suitable habitats are mid elevation tropics within Africa (natural range), a large part of Brazil and the Guianas (area of synanthropic spread), and even North Africa, Mediterranean, and Arabia. Nephilengys livida is confined to its known range with suitable habitats being mid-elevation natural and cultivated lands. Nephilengys malabarensis, however, ranges across the Equator throughout Asia where the model predicts many areas of high ecological suitability in the wet tropics. Its directional distribution suggests the species may potentially spread eastwards to New Guinea where the suitable areas of N. malabarensis largely surpass those of the native N. papuana, a species that prefers dry forests of Australian (sub) tropics. Conclusions: Our model is a customizable GIS tool intended to predict current and future potential distributions of globally distributed terrestrial lineages. Its predictive potential may be tested in foreseeing species distribution shifts due to habitat destruction and global climate change.	[Naparus, Magdalena; Kuntner, Matjaz] Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Ljubljana, Slovenia; [Naparus, Magdalena] Tular Cave Lab, Kranj, Slovenia; [Kuntner, Matjaz] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Kuntner, Matjaz] Hubei Univ, Coll Life Sci, Wuhan 430062, Peoples R China	National Institute of Biology - Slovenia; Slovenian Academy of Sciences & Arts (SASA); Smithsonian Institution; Smithsonian National Museum of Natural History; Hubei University	Naparus, M (corresponding author), Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Ljubljana, Slovenia.	kuntner@gmail.com	Kuntner, Matjaz/AAE-2195-2020		Slovenian Research Agency [J1-2063]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was made possible by the Slovenian Research Agency (grant J1-2063 to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Berger JD, 2008, AUST J AGR RES, V59, P691, DOI 10.1071/AR07384; Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106; Booms TL, 2010, POLAR BIOL, V33, P347, DOI 10.1007/s00300-009-0711-5; Brito JC, 2009, BIOL CONSERV, V142, P3020, DOI 10.1016/j.biocon.2009.08.001; Carr M., 2007, SMART LAND USE ANAL; Cordellier M, 2009, MOL ECOL, V18, P534, DOI 10.1111/j.1365-294X.2008.04042.x; Echarri F, 2009, J ORNITHOL, V150, P75, DOI 10.1007/s10336-008-0319-5; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Environmental Systems Research Institute Inc., 2010, ARCGIS VERS 9 3 1; Fernandez Miguel A., 2009, Biodiversity Informatics, V6, P36; Foelix R. F, 2011, BIOL SPIDERS; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; Global Land Cover 2000 Project (GLC 2000), 2003, GLOB LAND COV YEAR 2; Goodchild FM, 1986, SPATIAL AUTOCORRELAT; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2004, J APPL ECOL, V41, P1103, DOI 10.1111/j.0021-8901.2004.00980.x; Kuntner M, 2008, J ARACHNOL, V36, P583, DOI 10.1636/T07-54.1; Kuntner M, 2007, SYST ENTOMOL, V32, P95, DOI 10.1111/j.1365-3113.2006.00348.x; Kuntner M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-119; Kuntner M, 2011, MOL PHYLOGENET EVOL, V59, P477, DOI 10.1016/j.ympev.2011.02.002; Kuntner M, 2010, BIOL J LINN SOC, V99, P849, DOI 10.1111/j.1095-8312.2010.01414.x; Kuntner M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007516; Maher M, 2010, LINING DATA ARCGIS G; Poquet JM, 2011, FRESHWATER BIOL, V56, P448, DOI 10.1111/j.1365-2427.2010.02511.x; Martinez-Freiria F, 2008, DIVERS DISTRIB, V14, P452, DOI 10.1111/j.1472-4642.2007.00446.x; Meier R, 2004, CONSERV BIOL, V18, P478, DOI 10.1111/j.1523-1739.2004.00233.x; Mitchell A., 2005, ESRI GUIDE GIS ANAL; Murray-Smith C, 2009, CONSERV BIOL, V23, P151, DOI 10.1111/j.1523-1739.2008.01075.x; Oyana TJ, 2006, AVIAN DIS, V50, P508, DOI 10.1637/7597-040506.1; Robinson TP, 2010, ECOL MODEL, V221, P2261, DOI 10.1016/j.ecolmodel.2010.04.018; Skidmore AK, 2011, INT J GEOGR INF SCI, V25, P337, DOI 10.1080/13658816.2011.554296; Svensson K, 2009, EMERG INFECT DIS, V15, P1937, DOI 10.3201/eid1512.090487; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Vink CJ, 2011, BIOL INVASIONS, V13, P1003, DOI 10.1007/s10530-010-9885-6	39	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e30047	10.1371/journal.pone.0030047	http://dx.doi.org/10.1371/journal.pone.0030047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238692	gold, Green Submitted, Green Published			2022-12-27	WOS:000301188800056
J	Pattnaik, S; Vaidyanathan, S; Pooja, DG; Deepak, S; Panda, B				Pattnaik, Swetansu; Vaidyanathan, Srividya; Pooja, Durgad G.; Deepak, Sa; Panda, Binay			Customisation of the Exome Data Analysis Pipeline Using a Combinatorial Approach	PLOS ONE			English	Article							DNA-SEQUENCING DATA; READ ALIGNMENT; GENERATION; POPULATION; ALGORITHMS; FRAMEWORK; FORMAT	The advent of next generation sequencing (NGS) technologies have revolutionised the way biologists produce, analyse and interpret data. Although NGS platforms provide a cost-effective way to discover genome-wide variants from a single experiment, variants discovered by NGS need follow up validation due to the high error rates associated with various sequencing chemistries. Recently, whole exome sequencing has been proposed as an affordable option compared to whole genome runs but it still requires follow up validation of all the novel exomic variants. Customarily, a consensus approach is used to overcome the systematic errors inherent to the sequencing technology, alignment and post alignment variant detection algorithms. However, the aforementioned approach warrants the use of multiple sequencing chemistry, multiple alignment tools, multiple variant callers which may not be viable in terms of time and money for individual investigators with limited informatics know-how. Biologists often lack the requisite training to deal with the huge amount of data produced by NGS runs and face difficulty in choosing from the list of freely available analytical tools for NGS data analysis. Hence, there is a need to customise the NGS data analysis pipeline to preferentially retain true variants by minimising the incidence of false positives and make the choice of right analytical tools easier. To this end, we have sampled different freely available tools used at the alignment and post alignment stage suggesting the use of the most suitable combination determined by a simple framework of pre-existing metrics to create significant datasets.	[Pattnaik, Swetansu; Vaidyanathan, Srividya; Pooja, Durgad G.; Deepak, Sa; Panda, Binay] Ganit Labs, BioIT Ctr, Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India; [Pattnaik, Swetansu; Panda, Binay] Strand Life Sci, Bangalore, Karnataka, India		Pattnaik, S (corresponding author), Ganit Labs, BioIT Ctr, Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India.	binay@ganitlabs.in		Pattnaik, Swetansu/0000-0003-3598-7733; vaidyanathan, srividya/0000-0003-3931-5942	Department of Information Technology, Government of India [18(4)/2010-E-Infra.]; Department of IT, BT and ST, Government of Karnataka, India [3451-00-090-2-22]; Strand Life Sciences; Narayana Hrudayalaya	Department of Information Technology, Government of India(Ministry of Electronics and Information Technology (MEITY), Government of India); Department of IT, BT and ST, Government of Karnataka, India; Strand Life Sciences; Narayana Hrudayalaya	Research in Ganit Labs is funded by grants from the Department of Information Technology, Government of India (Ref no:18(4)/2010-E-Infra., 31-03-2010) and the Department of IT, BT and ST, Government of Karnataka, India (Ref no:3451-00-090-2-22) under the "Bio-IT Project''. Exome sequencing data used in this study were generated by funds jointly provided by Strand Life Sciences and Narayana Hrudayalaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asan, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r95; Buetow KH, 1999, NAT GENET, V21, P323, DOI 10.1038/6851; De S, 2010, P NATL ACAD SCI USA, V107, P13004, DOI 10.1073/pnas.0914454107; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Edmonson MN, 2011, BIOINFORMATICS, V27, P865, DOI 10.1093/bioinformatics/btr032; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Freudenberg-Hua Y, 2003, GENOME RES, V13, P2271, DOI 10.1101/gr.1299703; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Ruffalo M, 2011, BIOINFORMATICS, V27, P2790, DOI 10.1093/bioinformatics/btr477	19	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e30080	10.1371/journal.pone.0030080	http://dx.doi.org/10.1371/journal.pone.0030080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238694	Green Published, Green Submitted, gold			2022-12-27	WOS:000301188800058
J	Peleg, AY; Miyakis, S; Ward, DV; Earl, AM; Rubio, A; Cameron, DR; Pillai, S; Moellering, RC; Eliopoulos, GM				Peleg, Anton Y.; Miyakis, Spiros; Ward, Doyle V.; Earl, Ashlee M.; Rubio, Aileen; Cameron, David R.; Pillai, Satish; Moellering, Robert C., Jr.; Eliopoulos, George M.			Whole Genome Characterization of the Mechanisms of Daptomycin Resistance in Clinical and Laboratory Derived Isolates of Staphylococcus aureus	PLOS ONE			English	Article							METHICILLIN-RESISTANT; VANCOMYCIN-INTERMEDIATE; IN-VIVO; SUSCEPTIBILITY; BACTEREMIA; STRAINS; NONSUSCEPTIBILITY; POLYMORPHISM; PHENOTYPE; ALIGNMENT	Background: Daptomycin remains one of our last-line anti-staphylococcal agents. This study aims to characterize the genetic evolution to daptomycin resistance in S. aureus. Methods: Whole genome sequencing was performed on a unique collection of isogenic, clinical (21 strains) and laboratory (12 strains) derived strains that had been exposed to daptomycin and developed daptomycin-nonsusceptibility. Electron microscopy (EM) and lipid membrane studies were performed on selected isolates. Results: On average, six coding region mutations were observed across the genome in the clinical daptomycin exposed strains, whereas only two mutations on average were seen in the laboratory exposed pairs. All daptomycin-nonsusceptible strains had a mutation in a phospholipid biosynthesis gene. This included mutations in the previously described mprF gene, but also in other phospholipid biosynthesis genes, including cardiolipin synthase (cls2) and CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase (pgsA). EM and lipid membrane composition analyses on two clinical pairs showed that the daptomycin-nonsusceptible strains had a thicker cell wall and an increase in membrane lysyl-phosphatidylglycerol. Conclusion: Point mutations in genes coding for membrane phospholipids are associated with the development of reduced susceptibility to daptomycin in S. aureus. Mutations in cls2 and pgsA appear to be new genetic mechanisms affecting daptomycin susceptibility in S. aureus.	[Peleg, Anton Y.; Cameron, David R.] Monash Univ, Dept Microbiol, Sch Biomed Sci, Melbourne, Vic 3004, Australia; [Peleg, Anton Y.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Peleg, Anton Y.; Miyakis, Spiros; Pillai, Satish; Moellering, Robert C., Jr.; Eliopoulos, George M.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Miyakis, Spiros; Pillai, Satish; Moellering, Robert C., Jr.; Eliopoulos, George M.] Harvard Univ, Sch Med, Boston, MA USA; [Miyakis, Spiros] Aristotle Univ Thessaloniki, Dept Med 3, GR-54006 Thessaloniki, Greece; [Ward, Doyle V.; Earl, Ashlee M.] Broad Inst, Boston, MA USA; [Rubio, Aileen] Cubist Pharmaceut, Boston, MA USA	Monash University; Florey Institute of Neuroscience & Mental Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Aristotle University of Thessaloniki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Peleg, AY (corresponding author), Monash Univ, Dept Microbiol, Sch Biomed Sci, Melbourne, Vic 3004, Australia.	apeleg@bidmc.harvard.edu	Miyakis, Spiros/I-6703-2012	Miyakis, Spiros/0000-0003-4268-1599; Peleg, Anton/0000-0002-2296-2126; Earl, Ashlee/0000-0001-7857-9145; Cameron, David/0000-0003-3700-5625	National Institute of Allergy and Infectious Diseases; National Institutes of Health; Department of Health and Human Services [HHSN272200900018C, HHSN266200400001C]; National Health and Medical Research Council [APP606961]; Australian Postgraduate Award; Cubist Pharmaceuticals	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Cubist Pharmaceuticals	This work was supported in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200900018C and Contract No. HHSN266200400001C, a National Health and Medical Research Council Biomedical Fellowship to A.Y.P. (APP606961), and an Australian Postgraduate Award to D. R. C. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors also thank Cubist Pharmaceuticals for funding the lipid membrane analyses and TEM as described in the manuscript. Co-author A.R. is an employee of Cubist Pharmaceuticals and performed the lipid membrane studies. A.R. was also involved in reviewing the manuscript before submission; however, the company had no role in the overall study design, decision to publish or preparation of the manuscript. No additional external funding was received for this study.	Arias CA, 2011, NEW ENGL J MED, V365, P892, DOI 10.1056/NEJMoa1011138; Bertsche U, 2011, ANTIMICROB AGENTS CH, V55, P3922, DOI 10.1128/AAC.01226-10; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boyle-Vavra S, 2011, ANTIMICROB AGENTS CH, V55, P2018, DOI 10.1128/AAC.01593-10; Camargo ILBD, 2008, ANTIMICROB AGENTS CH, V52, P4289, DOI 10.1128/AAC.00417-08; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Collignon P, 2005, EMERG INFECT DIS, V11, P554, DOI 10.3201/eid1104.040772; Cotroneo N, 2008, ANTIMICROB AGENTS CH, V52, P2223, DOI 10.1128/AAC.01410-07; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Hayden MK, 2005, J CLIN MICROBIOL, V43, P5285, DOI 10.1128/JCM.43.10.5285-5287.2005; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Jones T, 2008, ANTIMICROB AGENTS CH, V52, P269, DOI 10.1128/AAC.00719-07; Jung D, 2008, CHEM PHYS LIPIDS, V154, P120, DOI 10.1016/j.chemphyslip.2008.04.004; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Marty FM, 2006, J CLIN MICROBIOL, V44, P595, DOI 10.1128/JCM.44.2.595-597.2006; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Muthaiyan A, 2008, ANTIMICROB AGENTS CH, V52, P980, DOI 10.1128/AAC.01121-07; Nusbaum C, 2009, NAT METHODS, V6, P67, DOI [10.1038/NMETH.1286, 10.1038/nmeth.1286]; Palmer Kelli L, 2011, Antimicrob Agents Chemother, V55, P3345, DOI 10.1128/AAC.00207-11; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Sakoulas G, 2006, ANTIMICROB AGENTS CH, V50, P1581, DOI 10.1128/AAC.50.4.1581-1585.2006; SHORT SA, 1972, J BACTERIOL, V109, P820, DOI 10.1128/JB.109.2.820-826.1972; Skiest DJ, 2006, J CLIN MICROBIOL, V44, P655, DOI 10.1128/JCM.44.2.655-656.2006; Straus SK, 2006, BBA-BIOMEMBRANES, V1758, P1215, DOI 10.1016/j.bbamem.2006.02.009; Yang SJ, 2010, ANTIMICROB AGENTS CH, V54, P3079, DOI 10.1128/AAC.00122-10; Yang SJ, 2009, J INFECT DIS, V200, P1916, DOI 10.1086/648473	33	111	116	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e28316	10.1371/journal.pone.0028316	http://dx.doi.org/10.1371/journal.pone.0028316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238576	Green Published, Green Submitted, gold			2022-12-27	WOS:000301188800001
J	Kebbi-Beghdadi, C; Lienard, J; Uyttebroeck, F; Baud, D; Riederer, BM; Greub, G				Kebbi-Beghdadi, Carole; Lienard, Julia; Uyttebroeck, Frederic; Baud, David; Riederer, Beat M.; Greub, Gilbert			Identification of Immunogenic Proteins of Waddlia chondrophlia	PLOS ONE			English	Article							CHLAMYDIA-LIKE ORGANISMS; COMMUNITY-ACQUIRED PNEUMONIA; HUMAN-ANTIBODY RESPONSES; HUMAN MACROPHAGES; BOVINE ABORTION; PARACHLAMYDIA-ACANTHAMOEBAE; BARTONELLA-HENSELAE; TRACT INFECTION; ANTIGENS; TRACHOMATIS	Evidence is growing for a role of Waddlia chondrophila as an agent of adverse pregnancy outcomes in both humans and ruminants. This emerging pathogen, member of the order Chlamydiales, is also implicated in bronchiolitis and lower respiratory tract infections. Until now, the serological diagnosis of W. chondrophila infection has mainly relied on manually intensive tests including micro-immunofluorescence and Western blotting. Thus, there is an urgent need to establish reliable high throughput serological assays. Using a combined genomic and proteomic approach, we detected 57 immunogenic proteins of W. chondrophila, of which 17 were analysed by mass spectrometry. Two novel hypothetical proteins, Wim3 and Wim4, were expressed as recombinant proteins in Escherichia coli, purified and used as antigens in an ELISA test. Both proteins were recognized by sera of rabbits immunized with W. chondrophila as well as by human W. chondrophila positive sera but not by rabbit pre-immune sera nor human W. chondrophila negative sera. These results demonstrated that the approach chosen is suitable to identify immunogenic proteins that can be used to develop a serological test. This latter will be a valuable tool to further clarify the pathogenic potential of W. chondrophila.	[Kebbi-Beghdadi, Carole; Lienard, Julia; Uyttebroeck, Frederic; Baud, David; Greub, Gilbert] Univ Hosp Ctr, Inst Microbiol, CRIB, Lausanne, Switzerland; [Riederer, Beat M.] Univ Lausanne, Dept Cellular Biol & Morphol, Lausanne, Switzerland; [Riederer, Beat M.] Cery, Dept Psychiat Neurosci, Prote Unit, Prilly, Switzerland	University of Lausanne	Kebbi-Beghdadi, C (corresponding author), Univ Hosp Ctr, Inst Microbiol, CRIB, Lausanne, Switzerland.	gilbert.greub@chuv.ch	Greub, Gilbert GG/K-5804-2017	Greub, Gilbert GG/0000-0001-9529-3317; Baud, David/0000-0001-9914-6496; Kebbi Beghdadi, Carole/0000-0003-1158-6361	National Swiss Research Fundation [310030-130466]; Societe Academique Vaudoise through Paul Blanc; SICPA (Security Inks Control Partnership Administration) Foundation; Leenards Foundation	National Swiss Research Fundation; Societe Academique Vaudoise through Paul Blanc; SICPA (Security Inks Control Partnership Administration) Foundation; Leenards Foundation	This work was supported by the National Swiss Research Fundation, grant 310030-130466. David Baud is supported by the "Societe Academique Vaudoise" through the "Paul Blanc" grant and the SICPA (Security Inks Control Partnership Administration) Foundation. Gilbert Greub is supported by the Leenards Foundation through a career award entitled "Bourse Leenards pour la releveac academique en medecine clinique a Lausanne". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud D, 2009, CLIN MICROBIOL INFEC, V15, P213, DOI 10.1111/j.1469-0691.2008.02134.x; Baud D, 2009, EMERG INFECT DIS, V15, P120, DOI 10.3201/eid1501.080911; Baud D, 2007, EMERG INFECT DIS, V13, P1239, DOI 10.3201/eid1308.070315; Baud D, 2008, CURR OPIN INFECT DIS, V21, P70, DOI 10.1097/QCO.0b013e3282f3e6a5; Baud D, 2011, CLIN INFECT DIS, V52, P1469, DOI 10.1093/cid/cir205; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bertelli C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010890; Boonjakuakul JK, 2007, INFECT IMMUN, V75, P2548, DOI 10.1128/IAI.01974-06; Borel N, 2007, EMERG INFECT DIS, V13, P1904, DOI 10.3201/eid1312.070655; Centeno C, 2007, CELL DEATH DIFFER, V14, P240, DOI 10.1038/sj.cdd.4401988; Christiansen G, 2002, BEST PRACT RES CL OB, V16, P889, DOI 10.1053/beog.2002.0324; Ciervo A, 2002, CLIN DIAGN LAB IMMUN, V9, P66, DOI 10.1128/CDLI.9.1.66-74.2002; Collingro A, 2011, MOL BIOL EV IN PRESS; Croxatto A, 2010, MICROBIOL-SGM, V156, P340, DOI 10.1099/mic.0.034546-0; DelVecchio VG, 2006, APPL ENVIRON MICROB, V72, P6355, DOI 10.1128/AEM.00455-06; Deuchande R, 2010, VET REC, V166, P598, DOI 10.1136/vr.c2435; DILBECK PM, 1990, J CLIN MICROBIOL, V28, P814, DOI 10.1128/JCM.28.4.814-816.1990; Dilbeck-Robertson P, 2003, J VET DIAGN INVEST, V15, P568, DOI 10.1177/104063870301500609; Eberhardt C, 2009, PROTEOMICS, V9, P1967, DOI 10.1002/pmic.200700670; Everett KDE, 2000, VET MICROBIOL, V75, P109, DOI 10.1016/S0378-1135(00)00213-3; Forsbach-Birk V, 2010, CLIN MICROBIOL INFEC, V16, P1237, DOI 10.1111/j.1469-0691.2009.03041.x; Friedman MG, 2006, J CLIN PATHOL, V59, P331, DOI 10.1136/jcp.2004.025601; Goy G, 2009, EUR J CLIN MICROBIOL, V28, P1483, DOI 10.1007/s10096-009-0804-7; Goy G, 2008, MICROBES INFECT, V10, P556, DOI 10.1016/j.micinf.2008.02.003; Greub G, 2009, CLIN MICROBIOL INFEC, V15, P18, DOI 10.1111/j.1469-0691.2008.02633.x; Greub G, 2003, INFECT IMMUN, V71, P5979, DOI 10.1128/IAI.71.10.5979-5985.2003; Greub G, 2009, CLIN MICROBIOL INFEC, V15, P2, DOI 10.1111/j.1469-0691.2008.02632.x; Greub Gilbert, 2010, Int J Syst Evol Microbiol, V60, P2691, DOI 10.1099/ijs.0.028225-0; Greub G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008423; Hahn DL, 2002, FRONT BIOSCI-LANDMRK, V7, pE66, DOI 10.2741/hahn; Haider S, 2008, FEMS MICROBIOL LETT, V281, P198, DOI 10.1111/j.1574-6968.2008.01099.x; Heinz E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-634; Henning K, 2002, VET MICROBIOL, V85, P285, DOI 10.1016/S0378-1135(01)00510-7; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Kebbi-Beghdadi C, 2011, MICROBES INFECT, V13, P566, DOI 10.1016/j.micinf.2011.01.020; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lamoth F, 2010, EXPERT REV ANTI-INFE, V8, P775, DOI 10.1586/ERI.10.52; McCool TL, 2008, DIAGN MICR INFEC DIS, V60, P17, DOI 10.1016/j.diagmicrobio.2007.07.017; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Qi M, 2011, INFECT IMMUNITY; Sanchez-Campillo M, 1999, ELECTROPHORESIS, V20, P2269, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2269::AID-ELPS2269>3.0.CO;2-D; Sharma J, 2006, INFECT IMMUN, V74, P1490, DOI 10.1128/IAI.74.3.1490-1499.2006; Sharma J, 2004, INFECT IMMUN, V72, P7164, DOI 10.1128/IAI.72.12.7164-7171.2004; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175	45	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28605	10.1371/journal.pone.0028605	http://dx.doi.org/10.1371/journal.pone.0028605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238579	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200010
J	Krishnan, S; Mali, RS; Koehler, KR; Vemula, S; Chatterjee, A; Ghosh, J; Ramdas, B; Ma, PL; Hashino, E; Kapur, R				Krishnan, Subha; Mali, Raghuveer Singh; Koehler, Karl R.; Vemula, Sasidhar; Chatterjee, Anindya; Ghosh, Joydeep; Ramdas, Baskar; Ma, Peilin; Hashino, Eri; Kapur, Reuben			Class I-A PI3Kinase Regulatory Subunit, p85 alpha, Mediates Mast Cell Development through Regulation of Growth and Survival Related Genes	PLOS ONE			English	Article							TYROSINE KINASE RECEPTOR; C-KIT LIGAND; CANCER CELLS; MICE; PROLIFERATION; 3-KINASE; MASTOCYTOSIS; CARCINOMA; APOPTOSIS; PATHWAYS	Stem cell factor (SCF) mediated KIT receptor activation plays a pivotal role in mast cell growth, maturation and survival. However, the signaling events downstream from KIT are poorly understood. Mast cells express multiple regulatory subunits of class 1(A) PI3Kinase (PI3K) including p85 alpha, p85 beta, p50 alpha, and p55 alpha. While it is known that PI3K plays an essential role in mast cells; the precise mechanism by which these regulatory subunits impact specific mast cell functions including growth, survival and cycling are not known. We show that loss of p85 alpha impairs the growth, survival and cycling of mast cell progenitors (MCp). To delineate the molecular mechanism (s) by which p85 alpha regulates mast cell growth, survival and cycling, we performed microarray analyses to compare the gene expression profile of MCps derived from WT and p85 alpha-deficient mice in response to SCF stimulation. We identified 151 unique genes exhibiting altered expression in p85 alpha-deficient cells in response to SCF stimulation compared to WT cells. Functional categorization based on DAVID bioinformatics tool and Ingenuity Pathway Analysis (IPA) software relates the altered genes due to lack of p85 alpha to transcription, cell cycle, cell survival, cell adhesion, cell differentiation, and signal transduction. Our results suggest that p85 alpha is involved in mast cell development through regulation of expression of growth, survival and cell cycle related genes.			Krishnan, S (corresponding author), Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA.	rkapur@iupui.edu	Ma, Peilin/F-9377-2014; Ma, Peilin/O-3927-2014	Ma, Peilin/0000-0002-7499-2335; Ghosh, Joydeep/0000-0003-2497-964X; Koehler, Karl/0000-0002-0685-538X	National Institutes of Health (NIH) [R01 HL077177, R01 HL08111, R01 HL075816]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077177, R01HL075816] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from National Institutes of Health (NIH): R01 HL077177 (RK), R01 HL08111 (RK) and R01 HL075816 (RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Beer TW, 2008, AM J DERMATOPATH, V30, P27, DOI 10.1097/DAD.0b013e31815c932a; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; Elpek GO, 2001, J CLIN PATHOL, V54, P940, DOI 10.1136/jcp.54.12.940; Feger F, 2002, TRENDS IMMUNOL, V23, P151, DOI 10.1016/S1471-4906(01)02156-1; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; GALLI SJ, 1987, AM J PATHOL, V127, P191; Gautam A, 2003, ONCOGENE, V22, P2135, DOI 10.1038/sj.onc.1206232; Gautam A, ONCOGENE, V22, P2135; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; IEMURA A, 1994, AM J PATHOL, V144, P321; IKEBUCHI K, 1987, P NATL ACAD SCI USA, V84, P9035, DOI 10.1073/pnas.84.24.9035; Jaju RJ, 2001, BLOOD, V98, P1264, DOI 10.1182/blood.V98.4.1264; KIRSHENBAUM AS, 1991, J IMMUNOL, V146, P1410; KITAMURA Y, 1979, BLOOD, V53, P492; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Longley BJ, 1996, NAT GENET, V12, P312, DOI 10.1038/ng0396-312; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Mali RS, 2011, CANCER CELL, V20, P357, DOI 10.1016/j.ccr.2011.07.016; Munugalavadla V, 2008, MOL CELL BIOL, V28, P7182, DOI 10.1128/MCB.00920-08; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Okkenhaug K, 2003, BIOCHEM SOC T, V31, P270, DOI 10.1042/bst0310270; OKU Y, 1984, IMMUNOLOGY, V53, P337; Sasaki T, 2002, J BIOCHEM, V131, P495, DOI 10.1093/oxfordjournals.jbchem.a003126; Schiemann WP, 2002, J BIOL CHEM, V277, P27367, DOI 10.1074/jbc.M200148200; Secombe J, 2004, CELL, V117, P153, DOI 10.1016/S0092-8674(04)00336-8; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; SERVE H, 1995, EMBO J, V14, P473, DOI 10.1002/j.1460-2075.1995.tb07023.x; SERVE H, 1994, J BIOL CHEM, V269, P6026; Strouch MJ, 2010, CLIN CANCER RES, V16, P2257, DOI 10.1158/1078-0432.CCR-09-1230; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; TSAI M, 1991, J EXP MED, V174, P125, DOI 10.1084/jem.174.1.125; Yang J, 2010, BLOOD, V115, P51, DOI 10.1182/blood-2009-06-223719; Zhang WP, 2000, BIOCHEM BIOPH RES CO, V274, P872, DOI 10.1006/bbrc.2000.3244; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	34	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28979	10.1371/journal.pone.0028979	http://dx.doi.org/10.1371/journal.pone.0028979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238586	Green Published, Green Submitted, gold			2022-12-27	WOS:000301070200015
J	Thiolloy, S; Edwards, JR; Fingleton, B; Rifkin, DB; Matrisian, LM; Lynch, CC				Thiolloy, Sophie; Edwards, James R.; Fingleton, Barbara; Rifkin, Daniel B.; Matrisian, Lynn M.; Lynch, Conor C.			An Osteoblast-Derived Proteinase Controls Tumor Cell Survival via TGF-beta Activation in the Bone Microenvironment	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BINDING-PROTEIN; BREAST-CANCER; EXTRACELLULAR-MATRIX; TRANSFORMING GROWTH-FACTOR-BETA-1; GELATINASE-A; LATENT; MATRIX-METALLOPROTEINASE-9; METALLOPROTEINASE; METASTASIS	Background: Breast to bone metastases frequently induce a "vicious cycle'' in which osteoclast mediated bone resorption and proteolysis results in the release of bone matrix sequestered factors that drive tumor growth. While osteoclasts express numerous proteinases, analysis of human breast to bone metastases unexpectedly revealed that bone forming osteoblasts were consistently positive for the proteinase, MMP-2. Given the role of MMP-2 in extracellular matrix degradation and growth factor/cytokine processing, we tested whether osteoblast derived MMP-2 contributed to the vicious cycle of tumor progression in the bone microenvironment. Methodology/Principal Findings: To test our hypothesis, we utilized murine models of the osteolytic tumor-bone microenvironment in immunocompetent wild type and MMP-2 null mice. In longitudinal studies, we found that host MMP-2 significantly contributed to tumor progression in bone by protecting against apoptosis and promoting cancer cell survival (caspase-3; immunohistochemistry). Our data also indicate that host MMP-2 contributes to tumor induced osteolysis (mu CT, histomorphometry). Further ex vivo/in vitro experiments with wild type and MMP-2 null osteoclast and osteoblast cultures identified that 1) the absence of MMP-2 did not have a deleterious effect on osteoclast function (cd11B isolation, osteoclast differentiation, transwell migration and dentin resorption assay); and 2) that osteoblast derived MMP-2 promoted tumor survival by regulating the bioavailability of TGF beta, a factor critical for cell-cell communication in the bone (ELISA, immunoblot assay, clonal and soft agar assays). Conclusion/Significance: Collectively, these studies identify a novel "mini-vicious cycle'' between the osteoblast and metastatic cancer cells that is key for initial tumor survival in the bone microenvironment. In conclusion, the findings of our study suggest that the targeted inhibition of MMP-2 and/or TGFb would be beneficial for the treatment of bone metastases.	[Thiolloy, Sophie; Fingleton, Barbara; Matrisian, Lynn M.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37203 USA; [Edwards, James R.] Univ Oxford, Nuffield Orthopaed Ctr, Oxford, England; [Rifkin, Daniel B.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Lynch, Conor C.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Tumor Biol, Tampa, FL 33682 USA	Vanderbilt University; Nuffield Orthopaedic Centre; University of Oxford; New York University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Thiolloy, S (corresponding author), Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37203 USA.	conor.lynch@moffitt.org		Fingleton, Barbara/0000-0003-1132-0782	NCI [7RO1 CA143094, 1R01 CA84360, 1U54-CA126505, 1R01 CA034282]; Vanderbilt University [P50 CA98131]; Department of Defense [BC051038]; NATIONAL CANCER INSTITUTE [R01CA084360, P50CA098131, R01CA143094, U54CA126505, R01CA034282, P30CA076292] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt University; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was funded by the following: NCI; (www.cancer.gov) 7RO1 CA143094 (CCL), 1R01 CA84360 (LMM), 1U54-CA126505 (LMM) 1R01 CA034282 (DBR and BD). P50 CA98131 awarded to Prof. Carlos Arteaga, Vanderbilt University. Pilot project to CCL DOD (www.cdmrp.org). ST is supported by the Department of Defense under award number BC051038. Views and opinions of, and endorsements by the author(s) do not reflect those of the US Army or the Department of Defense. Breast Cancer Research Fund of the Community Foundation of Middle Tennessee to ST http://www.cfmt.org/funds/health/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN EH, 2008, J BONE MINER RES; Bonfil RD, 2006, INT J CANCER, V118, P2721, DOI 10.1002/ijc.21645; Breckon JJW, 1999, J BONE MINER RES, V14, P1880, DOI 10.1359/jbmr.1999.14.11.1880; Chen Y, 2002, FEBS LETT, V517, P277, DOI 10.1016/S0014-5793(02)02648-0; Clines GA, 2011, J BONE MINER RES, V26, P2523, DOI 10.1002/jbmr.450; COLEMAN RE, 1987, BRIT J CANCER, V55, P61, DOI 10.1038/bjc.1987.13; Coleman RE, 2008, CLIN CANCER RES, V14, P6387, DOI 10.1158/1078-0432.CCR-08-1572; Compston JE, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730387; Cowell S, 1998, BIOCHEM J, V331, P453, DOI 10.1042/bj3310453; Dabovic B, 2005, BONE, V37, P25, DOI 10.1016/j.bone.2005.02.021; Dabovic B, 2002, J ENDOCRINOL, V175, P129, DOI 10.1677/joe.0.1750129; Dabovic B, 2002, J CELL BIOL, V156, P227, DOI 10.1083/jcb.200111080; DALLAS SL, 1995, J CELL BIOL, V131, P539, DOI 10.1083/jcb.131.2.539; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; Delaisse JM, 2000, CLIN CHIM ACTA, V291, P223, DOI 10.1016/S0009-8981(99)00230-2; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; Dybedal I, 1997, BLOOD, V90, P3395, DOI 10.1182/blood.V90.9.3395; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; Fiore E, 2002, ONCOGENE, V21, P5213, DOI 10.1038/sj.onc.1205684; Fournier PGJ, 2010, BONE, V47, pS268, DOI 10.1016/j.bone.2010.01.332; FOWLKES JL, 1994, J BIOL CHEM, V269, P25742; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Guise TA, 2003, CLIN ORTHOP RELAT R, pS32, DOI 10.1097/01.blo.0000093055.96273.69; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Guise Theresa A., 2000, Cancer, V88, P2892, DOI 10.1002/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y; Halpern J, 2006, CLIN EXP METASTAS, V23, P345, DOI 10.1007/s10585-006-9044-8; Harrell PC, 2005, EXP CELL RES, V303, P308, DOI 10.1016/j.yexcr.2004.09.020; Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581; Holmbeck K, 2003, J CELL BIOL, V163, P661, DOI 10.1083/jcb.200307061; Inoue K, 2006, J BIOL CHEM, V281, P33814, DOI 10.1074/jbc.M607290200; Itoh T, 1998, CANCER RES, V58, P1048; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Kakonen SM, 2003, CANCER-AM CANCER SOC, V97, P834, DOI 10.1002/cncr.11132; Koli K, 2004, J CELL BIOL, V167, P123, DOI 10.1083/jcb.200403067; LUCAS C, 1990, J IMMUNOL, V145, P1415; Lynch CC, 2005, CANCER CELL, V7, P485, DOI 10.1016/j.ccr.2005.04.013; Lynch CC, 2010, BONE; Maeda S, 2002, CALCIFIED TISSUE INT, V70, P54, DOI 10.1007/s002230010032; Maeda S, 2001, J BONE MINER RES, V16, P1281, DOI 10.1359/jbmr.2001.16.7.1281; Martignetti JA, 2001, NAT GENET, V28, P261, DOI 10.1038/90100; Martin M, 2008, CANC RES; Martin TJ, 2009, CRIT REV EUKAR GENE, V19, P73, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.40; Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Muraoka-Cook RS, 2006, ONCOGENE, V25, P3408, DOI 10.1038/sj.onc.1208964; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; Nabha SM, 2006, CLIN EXP METASTAS, V23, P335, DOI 10.1007/s10585-006-9042-x; Penttinen C, 2002, J CELL SCI, V115, P3457; Prudova A, 2010, MOL CELL PROTEOMICS; Quinn JMW, 2001, J BONE MINER RES, V16, P1787, DOI 10.1359/jbmr.2001.16.10.1787; Saharinen J, 1999, CYTOKINE GROWTH F R, V10, P99, DOI 10.1016/S1359-6101(99)00010-6; Sterner-Kock A, 2002, GENE DEV, V16, P2264, DOI 10.1101/gad.229102; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tester AM, 2004, CANCER RES, V64, P652, DOI 10.1158/0008-5472.CAN-0384-2; Thiolloy S, 2009, CANCER RES, V69, P6747, DOI 10.1158/0008-5472.CAN-08-3949; THRAILKILL KM, 1995, ENDOCRINOLOGY, V136, P3527, DOI 10.1210/en.136.8.3527; Todorovic V, 2007, DEVELOPMENT, V134, P3723, DOI 10.1242/dev.008599; Urban Z, 2009, AM J HUM GENET, V85, P593, DOI 10.1016/j.ajhg.2009.09.013; VAES G, 1972, BIOCHEM J, V126, P275, DOI 10.1042/bj1260275; Yoneda T, 1997, J CLIN INVEST, V99, P2509, DOI 10.1172/JCI119435; Yu Q, 2000, GENE DEV, V14, P163	62	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29862	10.1371/journal.pone.0029862	http://dx.doi.org/10.1371/journal.pone.0029862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238668	Green Submitted, Green Published, gold			2022-12-27	WOS:000301070200055
J	Corcuera, L; Gil-Pelegrin, E; Notivol, E				Corcuera, Leyre; Gil-Pelegrin, Eustaquio; Notivol, Eduardo			Intraspecific Variation in Pinus Pinaster PSII Photochemical Efficiency in Response to Winter Stress and Freezing Temperatures	PLOS ONE			English	Article							ILEX SUBSP BALLOTA; CHLOROPHYLL FLUORESCENCE; QUERCUS-COCCIFERA; PHOTOSYSTEM-II; BLACK SPRUCE; PHENOTYPIC PLASTICITY; XANTHOPHYLL CYCLE; REFLECTANCE INDEX; CO2 ASSIMILATION; SEASONAL-CHANGES	As part of a program to select maritime pine (Pinus pinaster Ait.) genotypes for resistance to low winter temperatures, we examined variation in photosystem II activity by chlorophyll fluorescence. Populations and families within populations from contrasting climates were tested during two consecutive winters through two progeny trials, one located at a continental and xeric site and one at a mesic site with Atlantic influence. We also obtained the LT50, or the temperature that causes 50% damage, by controlled freezing and the subsequent analysis of chlorophyll fluorescence in needles and stems that were collected from populations at the continental trial site. P. pinaster showed sensitivity to winter stress at the continental site, during the colder winter. The combination of low temperatures, high solar irradiation and low precipitation caused sustained decreases in maximal photochemical efficiency (F-v/F-m), quantum yield of non-cyclic electron transport (Phi(PSII)) and photochemical quenching (qP). The variation in photochemical parameters was larger among families than among populations, and population differences appeared only under the harshest conditions at the continental site. As expected, the environmental effects (winter and site) on the photochemical parameters were much larger than the genotypic effects (population or family). LT50 was closely related to the minimum winter temperatures of the population's range. The dark-adapted F-v/F-m ratio discriminated clearly between interior and coastal populations. In conclusion, variations in F-v/F-m, Phi(PSII), qP and non-photochemical quenching (NPQ) in response to winter stress were primarily due to the differences between the winter conditions and the sites and secondarily due to the differences among families and their interactions with the environment. Populations from continental climates showed higher frost tolerance (LT50) than coastal populations that typically experience mild winters. Therefore, LT50, as estimated by F-v/F-m, is a reliable indicator of frost tolerance among P. pinaster populations.	[Corcuera, Leyre; Gil-Pelegrin, Eustaquio; Notivol, Eduardo] Govt Aragon, Forest Resources Unit, Res & Technol Agr Ctr CITA, Zaragoza, Spain		Corcuera, L (corresponding author), Govt Aragon, Forest Resources Unit, Res & Technol Agr Ctr CITA, Zaragoza, Spain.	lcorcuera@aragon.es	Notivol, Eduardo/D-3045-2011; Gil-Pelegrín, Eustaquio/M-5129-2014	Notivol, Eduardo/0000-0003-4272-4536; Gil-Pelegrín, Eustaquio/0000-0002-4053-6681	Spanish INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria) [RTA2005-00131-00-00]; MCI (Ministeriode Ciencia e Innovacion) [AGL-2010-21153-CO2-02]	Spanish INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria); MCI (Ministeriode Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was sponsored by the Spanish INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria) project RTA2005-00131-00-00 and MCI (Ministeriode Ciencia e Innovacion) project AGL-2010-21153-CO2-02. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS WW, 1995, PLANT CELL ENVIRON, V18, P117, DOI 10.1111/j.1365-3040.1995.tb00345.x; ADAMS WW, 1994, PHYSIOL PLANTARUM, V92, P451, DOI 10.1111/j.1399-3054.1994.tb08835.x; ALIA R, 1995, SILVAE GENET, V44, P75; Alia R, 1997, CAN J FOREST RES, V27, P1548, DOI 10.1139/cjfr-27-10-1548; Aranda I, 2005, TREE PHYSIOL, V25, P1085, DOI 10.1093/treephys/25.8.1085; Baquedano FJ, 2007, PHOTOSYNTHETICA, V45, P229, DOI 10.1007/s11099-007-0037-x; Baquedano FJ, 2006, TREES-STRUCT FUNCT, V20, P689, DOI 10.1007/s00468-006-0084-0; Baquedano FJ, 2008, EUR J FOREST RES, V127, P495, DOI 10.1007/s10342-008-0232-8; Belkhodja R, 1998, PHOTOSYNTH RES, V56, P265, DOI 10.1023/A:1006039917599; Benowicz A, 2001, FOREST ECOL MANAG, V154, P23, DOI 10.1016/S0378-1127(00)00607-1; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; Climent J, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009016; Colom MR, 2003, TREES-STRUCT FUNCT, V17, P207, DOI 10.1007/s00468-002-0222-2; Corcuera L, 2005, TREE PHYSIOL, V25, P599, DOI 10.1093/treephys/25.5.599; Corcuera L, 2005, TREES-STRUCT FUNCT, V19, P99, DOI 10.1007/s00468-004-0368-1; Corcuera L, 2012, TREES-STRUCT FUNCT, V26, P799, DOI 10.1007/s00468-011-0651-x; Corcuera L, 2011, TREES-STRUCT FUNCT, V25, P1033, DOI 10.1007/s00468-011-0578-2; Corcuera L, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010048; Egerton JJG, 2000, ECOLOGY, V81, P1437, DOI 10.2307/177220; EPRON D, 1992, PLANT CELL ENVIRON, V15, P809, DOI 10.1111/j.1365-3040.1992.tb02148.x; Fracheboud Y, 1999, J EXP BOT, V50, P1533, DOI 10.1093/jexbot/50.338.1533; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; HARBINSON J, 1989, PLANT PHYSIOL, V90, P1029, DOI 10.1104/pp.90.3.1029; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Koehn AC, 2003, CAN J FOREST RES, V33, P1102, DOI 10.1139/X03-035; Ladjal M, 2000, TREE PHYSIOL, V20, P1235; Lamontagne M, 1998, CAN J FOREST RES, V28, P1, DOI 10.1139/cjfr-28-1-1; Lamontagne M, 2000, TREE PHYSIOL, V20, P249; Larcher W, 2000, PLANT BIOSYST, V134, P279, DOI 10.1080/11263500012331350455; LINDGREN K, 1993, TREE PHYSIOL, V13, P97, DOI 10.1093/treephys/13.1.97; Lopez R, 2009, TREES-STRUCT FUNCT, V23, P509, DOI 10.1007/s00468-008-0297-5; Lu PX, 2003, FOREST ECOL MANAG, V178, P329, DOI 10.1016/S0378-1127(02)00481-4; Major JE, 2003, TREE PHYSIOL, V23, P685, DOI 10.1093/treephys/23.10.685; Major JE, 1996, CAN J FOREST RES, V26, P1922, DOI 10.1139/x26-217; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Medlyn BE, 2002, PLANT CELL ENVIRON, V25, P1155, DOI 10.1046/j.1365-3040.2002.00890.x; Ogren E, 1999, TREE PHYSIOL, V19, P749; Peguero-Pina JJ, 2008, OECOLOGIA, V156, P1, DOI 10.1007/s00442-007-0957-y; Prieto P, 2009, ACTA PHYSIOL PLANT, V31, P729, DOI 10.1007/s11738-009-0285-4; *SAS I INC, 1999, SAS ONLINEDOC VERS 8; Soukupova J, 2008, FUNCT PLANT BIOL, V35, P63, DOI 10.1071/FP07158; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Verhoeven AS, 1997, PLANT PHYSIOL, V113, P817, DOI 10.1104/pp.113.3.817; Warren CR, 2005, TREE PHYSIOL, V25, P1369, DOI 10.1093/treephys/25.11.1369; Weng JH, 2009, TREES-STRUCT FUNCT, V23, P347, DOI 10.1007/s00468-008-0283-y; Zas R, 2004, SILVAE GENET, V53, P124, DOI 10.1515/sg-2004-0022	46	21	22	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e28772	10.1371/journal.pone.0028772	http://dx.doi.org/10.1371/journal.pone.0028772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220195	Green Published, gold			2022-12-27	WOS:000300677000007
J	Joshi, YB; Pratico, D				Joshi, Yash B.; Pratico, Domenico			Knockout of 5-Lipoxygenase Results in Age-Dependent Anxiety-Like Behavior in Female Mice	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; PATHWAY; PHARMACOGENETICS; BIOSYNTHESIS; LEUKOTRIENES; INVOLVEMENT	Background: The enzyme 5-lipoxygenase (5LO) has been implicated in a variety of neurological and psychiatric disorders including anxiety. Knockout of 5LO has previously been shown to alter anxiety-like behavior in mice at a young age but the effect of 5LO knockout on older animals has not been characterized. Methodology/Principal Findings: Here we used the elevated plus maze behavioral paradigm to measure anxiety-like behavior in female mice lacking 5LO (5LO-KO) at three different ages. Adolescent 5LO-KO animals did not significantly differ from wild-type (WT) animals in anxiety-like behavior. However, adult and older mice exhibited increased anxiety-like behavior compared to WT controls. Conclusions: These results indicate that 5LO plays a role in the development of the anxiety-like phenotype in an age-dependent manner in female mice. Future work should further investigate this interaction as 5LO may prove to be an important molecular target for the development of novel anxiolytic therapies.	[Joshi, Yash B.; Pratico, Domenico] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Joshi, YB (corresponding author), Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA.	praticod@temple.edu	Pratico, Domenico/ABA-9590-2020		National Institutes of Health/National Institute on Aging [AG33568]; NATIONAL INSTITUTE ON AGING [R01AG033568] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported in part by a grant from National Institutes of Health/National Institute on Aging to D. P. (AG33568). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinnici CM, 2007, NEUROBIOL AGING, V28, P1457, DOI 10.1016/j.neurobiolaging.2006.06.007; Chu J, 2011, AM J PATHOL, V178, P1762, DOI 10.1016/j.ajpath.2010.12.032; Duroudier NP, 2009, ALLERGY, V64, P823, DOI 10.1111/j.1398-9995.2009.02015.x; Fahlstrom A, 2011, NEUROBIOL AGING, V32, P1868, DOI 10.1016/j.neurobiolaging.2009.11.003; FEUERSTEIN G, 1987, FASEB J, V1, P186, DOI 10.1096/fasebj.1.3.3040505; Johnston NW, 2007, PEDIATRICS, V120, pE702, DOI 10.1542/peds.2006-3317; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Klotsman M, 2007, PHARMACOGENET GENOM, V17, P189, DOI 10.1097/FPC.0b013e3280120043; Kurtuncu M, 2008, J NEURAL TRANSM, V115, P389, DOI 10.1007/s00702-007-0848-8; Manev Radmila, 2004, Critical Reviews in Neurobiology, V16, P181, DOI 10.1615/CritRevNeurobiol.v16.i12.190; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pergola C, 2011, FASEB J, V25, P3377, DOI 10.1096/fj.11-182758; Pergola C, 2008, P NATL ACAD SCI USA, V105, P19881, DOI 10.1073/pnas.0809120105; Puccio S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015163; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Stewart LR, 2001, J NEUROSCI RES, V65, P565, DOI 10.1002/jnr.1186; Uz T, 2002, RESTOR NEUROL NEUROS, V20, P15; Uz T, 2008, NEUROSCI LETT, V436, P269, DOI 10.1016/j.neulet.2008.03.041; Uz Tolga, 2008, Open Neuropsychopharmacol J, V1, P1, DOI 10.2174/1876523800801010001; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Whitney LW, 2001, J NEUROIMMUNOL, V121, P40, DOI 10.1016/S0165-5728(01)00438-6; Zhao J, 2009, PSYCHOSOM MED, V71, P691, DOI 10.1097/PSY.0b013e3181b05c57	22	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29448	10.1371/journal.pone.0029448	http://dx.doi.org/10.1371/journal.pone.0029448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220211	gold, Green Submitted, Green Published			2022-12-27	WOS:000300677000034
J	Cabilla, JP; Nudler, SI; Ronchetti, SA; Quinteros, FA; Lasaga, M; Duvilanski, BH				Cabilla, Jimena P.; Nudler, Silvana I.; Ronchetti, Sonia A.; Quinteros, Fernanda A.; Lasaga, Mercedes; Duvilanski, Beatriz H.			Nitric Oxide-Sensitive Guanylyl Cyclase Is Differentially Regulated by Nuclear and Non-Nuclear Estrogen Pathways in Anterior Pituitary Gland	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; 3'-UNTRANSLATED REGION; RNA STABILIZATION; BINDING PROTEIN; EXPRESSION; RECEPTOR; HUR; SUBUNIT; STABILITY; ALPHA-1	17 beta-estradiol (E2) regulates hormonal release as well as proliferation and cell death in the pituitary. The main nitric oxide receptor, nitric oxide sensitive-or soluble guanylyl cyclase (sGC), is a heterodimer composed of two subunits, alpha and beta, that catalyses cGMP formation. alpha 1 beta 1 is the most abundant and widely expressed heterodimer, showing the greater activity. Previously we have shown that E2 decreased sGC activity but exerts opposite effects on sGC subunits increasing alpha 1 and decreasing beta 1 mRNA and protein levels. In the present work we investigate the mechanisms by which E2 differentially regulates sGC subunits' expression on rat anterior pituitary gland. Experiments were performed on primary cultures of anterior pituitary cells from adult female Wistar rats at random stages of estrous cycle. After 6 h of E2 treatment, alpha 1 mRNA and protein expression is increased while beta 1 levels are down-regulated. E2 effects on sGC expression are partially dependent on de novo transcription while de novo translation is fully required. E2 treatment decreased HuR mRNA stabilization factor and increased AUF1 p37 mRNA destabilization factor. E2-elicited beta 1 mRNA decrease correlates with a mRNA destabilization environment in the anterior pituitary gland. On the other hand, after 6 h of treatment, E2-BSA (1 nM) and E2-dendrimer conjugate (EDC, 1 nM) were unable to modify alpha 1 or beta 1 mRNA levels, showing that nuclear receptor is involved in E2 actions. However, at earlier times (3 h), 1 nM EDC causes a transient decrease of alpha 1 in a PI3k-dependent fashion. Our results show for the first time that E2 is able to exert opposite actions in the anterior pituitary gland, depending on the activation of classical or non-classical pathways. Thus, E2 can also modify sGC expression through membrane-initiated signals bringing to light a new point of regulation in NO/sGC pathway.	[Cabilla, Jimena P.; Nudler, Silvana I.; Ronchetti, Sonia A.; Quinteros, Fernanda A.; Duvilanski, Beatriz H.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, Dept Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Lasaga, Mercedes] Univ Buenos Aires, Fac Med, Inst Invest Reprod, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Cabilla, JP (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, Dept Quim Biol, RA-1113 Buenos Aires, DF, Argentina.	jcabilla@ffyb.uba.ar		Lasaga, Mercedes/0000-0001-9916-3712	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 32311]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 5536]; Universidad de Buenos Aires [M025, B052]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 32311), Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 5536) and Universidad de Buenos Aires (M025 and B052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arao Y, 2004, MOL ENDOCRINOL, V18, P2255, DOI 10.1210/me.2004-0103; Arao Y, 2002, BIOCHEM J, V361, P125, DOI 10.1042/0264-6021:3610125; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Blake CA, 2005, EXP BIOL MED, V230, P800, DOI 10.1177/153537020523001104; Budworth J, 1999, BIOCHEM BIOPH RES CO, V263, P696, DOI 10.1006/bbrc.1999.1444; Cabilla JP, 2006, ENDOCRINOLOGY, V147, P4311, DOI 10.1210/en.2006-0367; Cabilla JP, 2009, AM J PHYSIOL-ENDOC M, V296, pE731, DOI 10.1152/ajpendo.90795.2008; Cai C, 2007, ONCOGENE, V26, P1606, DOI 10.1038/sj.onc.1209956; Chen LH, 2000, CIRC RES, V86, P520, DOI 10.1161/01.RES.86.5.520; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Gonda TJ, 2008, EXPERT OPIN BIOL TH, V8, P713, DOI [10.1517/14712598.8.6.713, 10.1517/14712598.8.6.713 ]; Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186; Ing NH, 2008, J BIOL CHEM, V283, P1764, DOI 10.1074/jbc.M704745200; Jurado S, 2006, J CELL SCI, V119, P1622, DOI 10.1242/jcs.02867; Kloss S, 2005, HYPERTENSION, V45, P1200, DOI 10.1161/01.HYP.0000165674.58470.8f; Kloss S, 2003, J BIOL CHEM, V278, P2377, DOI 10.1074/jbc.M206453200; KOYAMA C, 1995, ENDOCR PATHOL, V6, P67, DOI 10.1007/BF02914990; Krakauer T, 2008, INT REV IMMUNOL, V27, P286, DOI 10.1080/08830180802317957; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Levin ER, 2009, J PHYSIOL-LONDON, V587, P5019, DOI 10.1113/jphysiol.2009.177097; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Marro ML, 2008, J BIOL CHEM, V283, P20027, DOI 10.1074/jbc.M801223200; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; OISHI Y, 1993, ANAT RECORD, V235, P111, DOI 10.1002/ar.1092350111; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Pifarre P, 2009, INT J BIOCHEM CELL B, V41, P1719, DOI 10.1016/j.biocel.2009.02.022; Renner U, 1996, EUR J ENDOCRINOL, V135, P515, DOI 10.1530/eje.0.1350515; Rodriguez-Pascual F, 2000, J BIOL CHEM, V275, P26040, DOI 10.1074/jbc.M910460199; Sharina IG, 2000, P NATL ACAD SCI USA, V97, P10878, DOI 10.1073/pnas.190331697; Simoncini T, 2003, ARTERIOSCL THROM VAS, V23, P198, DOI 10.1161/01.ATV.0000053846.71621.93; Smigrodzki R, 1996, DEV BRAIN RES, V97, P226, DOI 10.1016/S0165-3806(96)00162-9; Syed FA, 2005, J BONE MINER RES, V20, P1992, DOI 10.1359/JBMR.050713; Tao YX, 2002, NEUROSCIENCE, V112, P439, DOI 10.1016/S0306-4522(02)00075-1; Velardez MO, 2003, HORM RES, V60, P111, DOI 10.1159/000072521; Venema RC, 2003, AM J PHYSIOL-HEART C, V285, pH669, DOI 10.1152/ajpheart.01025.2002; Wang W, 2000, EMBO J, V19, P1; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Zarate S, 2009, AM J PHYSIOL-ENDOC M, V296, pE664, DOI 10.1152/ajpendo.90785.2008	40	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29402	10.1371/journal.pone.0029402	http://dx.doi.org/10.1371/journal.pone.0029402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216273	Green Published, gold, Green Submitted			2022-12-27	WOS:000300676300056
J	Engel, KMY; Schrock, K; Teupser, D; Holdt, LM; Tonjes, A; Kern, M; Dietrich, K; Kovacs, P; Krugel, U; Scheidt, HA; Schiller, J; Huster, D; Brockmann, GA; Augustin, M; Thiery, J; Bluher, M; Stumvoll, M; Schoneberg, T; Schulz, A				Engel, Kathrin M. Y.; Schroeck, Kristin; Teupser, Daniel; Holdt, Lesca Miriam; Toenjes, Anke; Kern, Matthias; Dietrich, Kerstin; Kovacs, Peter; Kruegel, Ute; Scheidt, Holger A.; Schiller, Juergen; Huster, Daniel; Brockmann, Gudrun A.; Augustin, Martin; Thiery, Joachim; Blueher, Matthias; Stumvoll, Michael; Schoeneberg, Torsten; Schulz, Angela			Reduced Food Intake and Body Weight in Mice Deficient for the G Protein-Coupled Receptor GPR82	PLOS ONE			English	Article							ANTITHROMBOTIC DRUGS; NATURAL-SELECTION; DNA POLYMORPHISM; HUMAN GENOME; IDENTIFICATION; EXPRESSION; PHENOTYPE; EVOLUTION; PROTOCOL; OBESITY	G protein-coupled receptors (GPCR) are involved in the regulation of numerous physiological functions. Therefore, GPCR variants may have conferred important selective advantages during periods of human evolution. Indeed, several genomic loci with signatures of recent selection in humans contain GPCR genes among them the X-chromosomally located gene for GPR82. This gene encodes a so-called orphan GPCR with unknown function. To address the functional relevance of GPR82 gene-deficient mice were characterized. GPR82-deficient mice were viable, reproduced normally, and showed no gross anatomical abnormalities. However, GPR82-deficient mice have a reduced body weight and body fat content associated with a lower food intake. Moreover, GPR82-deficient mice showed decreased serum triacylglyceride levels, increased insulin sensitivity and glucose tolerance, most pronounced under Western diet. Because there were no differences in respiratory and metabolic rates between wild-type and GPR82-deficient mice our data suggest that GPR82 function influences food intake and, therefore, energy and body weight balance. GPR82 may represent a thrifty gene most probably representing an advantage during human expansion into new environments.	[Engel, Kathrin M. Y.; Schroeck, Kristin; Schoeneberg, Torsten; Schulz, Angela] Univ Leipzig, Fac Med, Inst Biochem, Leipzig, Germany; [Teupser, Daniel; Holdt, Lesca Miriam; Thiery, Joachim] Univ Leipzig, Fac Med, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Toenjes, Anke; Kern, Matthias; Blueher, Matthias; Stumvoll, Michael] Univ Leipzig, Fac Med, Dept Internal Med, Leipzig, Germany; [Dietrich, Kerstin; Kovacs, Peter] Univ Leipzig, Fac Med, Interdisciplinary Ctr Clin Res, Leipzig, Germany; [Kruegel, Ute] Univ Leipzig, Fac Med, Rudolf Boehm Inst Pharmacol & Toxicol, Leipzig, Germany; [Scheidt, Holger A.; Schiller, Juergen; Huster, Daniel] Univ Leipzig, Fac Med, Inst Med Phys & Biophys, Leipzig, Germany; [Brockmann, Gudrun A.] Humboldt Univ, Inst Anim Sci, D-10099 Berlin, Germany; [Augustin, Martin] Ingenium Pharmaceut AG, Martinsried, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Humboldt University of Berlin	Engel, KMY (corresponding author), Univ Leipzig, Fac Med, Inst Biochem, Leipzig, Germany.	schoberg@medizin.uni-leipzig.de	Engel, Kathrin M/AAQ-1309-2021; Stumvoll, Michael/ABE-1121-2021; Scheidt, Holger A./C-1416-2014	Engel, Kathrin M/0000-0003-0611-7042; Stumvoll, Michael/0000-0001-6225-8240; Kovacs, Peter/0000-0002-0290-5423; Krugel, Ute/0000-0002-2317-2302	Deutsche Forschungsgemeinschaft [FOR 748]; Bundesministerium fur Bildung und Forschung (IFB); State of Saxony (LIFE)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (IFB); State of Saxony (LIFE)	This work was supported by grants of the Deutsche Forschungsgemeinschaft (FOR 748), Bundesministerium fur Bildung und Forschung (IFB) and the State of Saxony (LIFE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bjorbaek C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bottcher Y, 2009, DIABETES, V58, P2119, DOI 10.2337/db08-1458; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Decherf S, 2010, P NATL ACAD SCI USA, V107, P4471, DOI 10.1073/pnas.0905190107; Despres J P, 1998, Obes Res, V6 Suppl 1, p8S; Engemaier E, 2006, GENOMICS, V87, P254, DOI 10.1016/j.ygeno.2005.10.001; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; FU YX, 1993, GENETICS, V133, P693; Fuchs B, 2010, PROG LIPID RES, V49, P450, DOI 10.1016/j.plipres.2010.07.001; Gloriam DE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-338; Holdt LM, 2010, ARTERIOSCL THROM VAS, V30, P620, DOI 10.1161/ATVBAHA.109.196832; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Huster D, 1998, BIOCHEMISTRY-US, V37, P17299, DOI 10.1021/bi980078g; Kim-Saijo M, 2003, EUR J IMMUNOL, V33, P2531, DOI 10.1002/eji.200324255; Lee DK, 2001, GENE, V275, P83, DOI 10.1016/S0378-1119(01)00651-5; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liebscher I, 2011, J BIOL CHEM, V286, P2101, DOI 10.1074/jbc.M110.196659; Masuya H, 2005, MAMM GENOME, V16, P829, DOI 10.1007/s00335-005-2430-8; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Nonaka Y, 2005, BIOCHEM BIOPH RES CO, V337, P281, DOI 10.1016/j.bbrc.2005.09.052; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Salto C, 2001, MOL ENDOCRINOL, V15, P2115, DOI 10.1210/me.15.12.2115; Schiller J, 2002, J FOOD LIPIDS, V9, P185, DOI 10.1111/j.1745-4522.2002.tb00218.x; Schoneberg T, 2007, PURINERG SIGNAL, V3, P255, DOI 10.1007/s11302-007-9064-0; Schoneberg T, 1999, BBA-GENE STRUCT EXPR, V1446, P57, DOI 10.1016/S0167-4781(99)00081-0; Schulz A, 2003, J BIOL CHEM, V278, P35531, DOI 10.1074/jbc.M303346200; Strotmann R, 2011, MOL CELL ENDOCRINOL, V331, P170, DOI 10.1016/j.mce.2010.07.012; Sugo T, 2006, BIOCHEM BIOPH RES CO, V341, P1078, DOI 10.1016/j.bbrc.2006.01.069; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; TAJIMA F, 1989, GENETICS, V123, P585; Teuber K, 2010, CHEM PHYS LIPIDS, V163, P552, DOI 10.1016/j.chemphyslip.2010.04.005; The International HapMap Consortium, 2005, NATURE, V437, P1299, DOI DOI 10.1038/NATURE04226; Tonjes A, 2009, HUM MOL GENET, V18, P4662, DOI 10.1093/hmg/ddp423; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200	44	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29400	10.1371/journal.pone.0029400	http://dx.doi.org/10.1371/journal.pone.0029400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216272	Green Submitted, Green Published, gold			2022-12-27	WOS:000300676300055
J	Hui, MQ; Li, J; Wen, XT; Yao, L; Long, ZY				Hui, Mingqi; Li, Juan; Wen, Xiaotong; Yao, Li; Long, Zhiying			An Empirical Comparison of Information-Theoretic Criteria in Estimating the Number of Independent Components of fMRI Data	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; INTRINSIC DIMENSIONALITY; FUNCTIONAL CONNECTIVITY; RESAMPLING METHODS; MODEL SELECTION; NOISE; BRAIN; REGRESSION; INFERENCE; SIGNALS	Background: Independent Component Analysis (ICA) has been widely applied to the analysis of fMRI data. Accurate estimation of the number of independent components of fMRI data is critical to reduce over/under fitting. Although various methods based on Information Theoretic Criteria (ITC) have been used to estimate the intrinsic dimension of fMRI data, the relative performance of different ITC in the context of the ICA model hasn't been fully investigated, especially considering the properties of fMRI data. The present study explores and evaluates the performance of various ITC for the fMRI data with varied white noise levels, colored noise levels, temporal data sizes and spatial smoothness degrees. Methodology: Both simulated data and real fMRI data with varied Gaussian white noise levels, first-order auto-regressive (AR(1)) noise levels, temporal data sizes and spatial smoothness degrees were carried out to deeply explore and evaluate the performance of different traditional ITC. Principal Findings: Results indicate that the performance of ITCs depends on the noise level, temporal data size and spatial smoothness of fMRI data. 1) High white noise levels may lead to underestimation of all criteria and MDL/BIC has the severest underestimation at the higher Gaussian white noise level. 2) Colored noise may result in overestimation that can be intensified by the increase of AR(1) coefficient rather than the SD of AR(1) noise and MDL/BIC shows the least overestimation. 3) Larger temporal data size will be better for estimation for the model of white noise but tends to cause severer overestimation for the model of AR(1) noise. 4) Spatial smoothing will result in overestimation in both noise models. Conclusions: 1) None of ITC is perfect for all fMRI data due to its complicated noise structure. 2) If there is only white noise in data, AIC is preferred when the noise level is high and otherwise, Laplace approximation is a better choice. 3) When colored noise exists in data, MDL/BIC outperforms the other criteria.	[Hui, Mingqi; Li, Juan; Yao, Li; Long, Zhiying] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Wen, Xiaotong] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL USA; [Yao, Li] Beijing Normal Univ, Coll Informat Sci & Technol, Beijing 100875, Peoples R China	Beijing Normal University; State University System of Florida; University of Florida; Beijing Normal University	Hui, MQ (corresponding author), Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	friskying@163.com			National Natural Science Foundation of China [60805040, 90820019, 60628101, 60931003]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	The current work is supported by the National Natural Science Foundation of China (Grant Nos. 60805040, 90820019, 60628101), Key Program of National Natural Science Foundation of China (60931003) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Bartels A, 2005, NEUROIMAGE, V24, P339, DOI 10.1016/j.neuroimage.2004.08.044; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; BICKEL P, 1992, J AM STAT ASSOC, V87, P90, DOI 10.2307/2290456; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; Calhoun V, 2003, 4 INT S IND COMP AN; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cavanaugh JE, 1999, STAT PROBABIL LETT, V42, P333, DOI 10.1016/S0167-7152(98)00200-4; Cordes D, 2006, NEUROIMAGE, V29, P145, DOI 10.1016/j.neuroimage.2005.07.054; Esposito F, 2003, NEUROIMAGE, V20, P2209, DOI 10.1016/j.neuroimage.2003.08.012; Fishler E, 2002, IEEE T SIGNAL PROCES, V50, P1027, DOI 10.1109/78.995060; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Hojen-Sorensen PADFR, 2002, NEUROCOMPUTING, V49, P213, DOI 10.1016/S0925-2312(02)00516-7; Huettel S., FUNCTIONAL MAGNETIC; HURVICH CM, 1990, AM STAT, V44, P214, DOI 10.2307/2685338; Jaakko S, 2003, J MACH LEARN RES, V4, P1447; Karhunen J, 1997, INT J NEURAL SYST, V8, P219, DOI 10.1142/S0129065797000239; Liavas AP, 2001, IEEE T SIGNAL PROCES, V49, P1689, DOI 10.1109/78.934138; Locascio JJ, 1997, HUM BRAIN MAPP, V5, P168, DOI 10.1002/(SICI)1097-0193(1997)5:3<168::AID-HBM3>3.0.CO;2-1; Ma LS, 2007, MAGN RESON IMAGING, V25, P47, DOI 10.1016/j.mri.2006.09.032; Martin JM, 1998, HUMAN BRAIN MAPPING, V6, P160; Moritz CH, 2005, NEUROIMAGE, V25, P181, DOI 10.1016/j.neuroimage.2004.11.009; Purdon PL, 1998, HUM BRAIN MAPP, V6, P239, DOI 10.1002/(SICI)1097-0193(1998)6:4<239::AID-HBM4>3.3.CO;2-0; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; WAX M, 1985, IEEE T ACOUST SPEECH, V33, P387, DOI 10.1109/TASSP.1985.1164557; Xie XP, 2009, NEUROCOMPUTING, V72, P1042, DOI 10.1016/j.neucom.2008.04.003	30	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29274	10.1371/journal.pone.0029274	http://dx.doi.org/10.1371/journal.pone.0029274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216229	Green Published, gold, Green Submitted			2022-12-27	WOS:000300674900022
J	Schoof, N; Iles, MM; Bishop, DT; Newton-Bishop, JA; Barrett, JH				Schoof, Nils; Iles, Mark M.; Bishop, D. Timothy; Newton-Bishop, Julia A.; Barrett, Jennifer H.		GenoMEL Consortium	Pathway-Based Analysis of a Melanoma Genome-Wide Association Study: Analysis of Genes Related to Tumour-Immunosuppression	PLOS ONE			English	Article							REGULATORY T-CELLS; MALIGNANT-MELANOMA; DENDRITIC CELLS; IDENTIFIES 3; SET; SUSCEPTIBILITY; POLYMORPHISMS; CANCER; EXPRESSION; TOLERANCE	Systemic immunosuppression is a risk factor for melanoma, and sunburn-induced immunosuppression is thought to be causal. Genes in immunosuppression pathways are therefore candidate melanoma-susceptibility genes. If variants within these genes individually have a small effect on disease risk, the association may be undetected in genome-wide association (GWA) studies due to low power to reach a high significance level. Pathway-based approaches have been suggested as a method of incorporating a priori knowledge into the analysis of GWA studies. In this study, the association of 1113 single nucleotide polymorphisms (SNPs) in 43 genes (39 genomic regions) related to immunosuppression have been analysed using a gene-set approach in 1539 melanoma cases and 3917 controls from the GenoMEL consortium GWA study. The association between melanoma susceptibility and the whole set of tumour-immunosuppression genes, and also predefined functional subgroups of genes, was considered. The analysis was based on a measure formed by summing the evidence from the most significant SNP in each gene, and significance was evaluated empirically by case-control label permutation. An association was found between melanoma and the complete set of genes (p(emp) = 0.002), as well as the subgroups related to the generation of tolerogenic dendritic cells (p(emp) = 0.006) and secretion of suppressive factors (p(emp) = 0.0004), thus providing preliminary evidence of involvement of tumour-immunosuppression gene polymorphisms in melanoma susceptibility. The analysis was repeated on a second phase of the GenoMEL study, which showed no evidence of an association. As one of the first attempts to replicate a pathway-level association, our results suggest that low power and heterogeneity may present challenges.	[Schoof, Nils; Iles, Mark M.; Bishop, D. Timothy; Newton-Bishop, Julia A.; Barrett, Jennifer H.] Univ Leeds, Sect Epidemiol & Biostat, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Schoof, Nils] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [GenoMEL Consortium] Melanoma Genet Consortium GenoMEL, Leeds, W Yorkshire, England	University of Leeds; Karolinska Institutet	Schoof, N (corresponding author), Univ Leeds, Sect Epidemiol & Biostat, Leeds Inst Mol Med, Leeds, W Yorkshire, England.	J.H.Barrett@leeds.ac.uk	Marti, Rosa/A-2256-2010; Bruno, William/N-7477-2013; Scarrà, Giovanna Bianchi/G-8933-2014; Maubec, Eve/V-4296-2017; Höiom, Veronica/F-4153-2012; Vabres, Pierre/V-3850-2019; bertazzi, pietro alberto/D-5039-2017; Lesueur, Fabienne/R-2178-2017; Ghiorzo, Paola/CAG-0673-2022; Martin, Ludovic/K-2674-2015; hayward, nicholas k/C-1367-2015; Bakker, Egbert/D-3525-2009; Mann, Graham J/G-4758-2014; Pastorino, Lorenza/E-6084-2018; Demenais, Florence/G-3298-2013; Badenas, Celia/ABH-5480-2020; Vabres, Pierre/D-3906-2011; Duffy, David L/B-7392-2013; Puig, Susana/AAB-2091-2020; Akslen, Lars A/C-1202-2017; Webb, Penelope/D-5736-2013; Armstrong, Bruce/K-9464-2015; Jenkins, Mark/P-7803-2015	Marti, Rosa/0000-0001-6866-6114; Bruno, William/0000-0002-0337-0168; Scarrà, Giovanna Bianchi/0000-0002-6127-1192; Maubec, Eve/0000-0003-1658-6686; Vabres, Pierre/0000-0001-8693-3183; bertazzi, pietro alberto/0000-0003-3475-2449; Lesueur, Fabienne/0000-0001-7404-4549; Ghiorzo, Paola/0000-0002-3651-8173; hayward, nicholas k/0000-0003-4760-1033; Bakker, Egbert/0000-0002-2843-7357; Mann, Graham J/0000-0003-1301-405X; Pastorino, Lorenza/0000-0002-2575-8331; Demenais, Florence/0000-0001-8361-0936; Badenas, Celia/0000-0002-0621-0477; Vabres, Pierre/0000-0001-8693-3183; Duffy, David L/0000-0001-7227-632X; Puig, Susana/0000-0003-1337-9745; Akslen, Lars A/0000-0003-2710-9543; Arance, Ana/0000-0003-2896-1957; Webb, Penelope/0000-0003-0733-5930; Randerson-Moor, Juliette/0000-0003-0303-0072; Schoof, Nils/0000-0003-0509-9217; Lipsker, Dan/0000-0003-4675-0336; Nielsen, Kari/0000-0002-7363-0455; Armstrong, Bruce/0000-0001-8940-7525; Aitken, Joanne Frances/0000-0001-6859-2186; Jenkins, Mark/0000-0002-8964-6160; Gruis, Nelleke/0000-0002-5210-9150; Bishop, Tim/0000-0002-8752-8785; Vasen, Hans/0000-0003-2682-2603; Kefford, Richard/0000-0001-9251-9229; Iles, Mark/0000-0002-2603-6509; Cust, Anne/0000-0002-5331-6370; Aguilera, Paula/0000-0002-1825-7707; Novakovic, Srdjan/0000-0002-8888-4810; Barrett, Jenny/0000-0002-1720-7724; Newton-Bishop, Julia/0000-0001-9147-6802; malvehy, josep/0000-0002-6998-914X; BERARD, frederic/0000-0003-0094-6122; Vidal-Sicart, Sergi/0000-0002-6303-3606; Leccia, M.Therese/0000-0003-1222-0396	GenoMEL EU [FP6 LSHC-CT-2006-018702]; Cancer Research UK Programme Award [C588/A4994, C588/A10589]; Cancer Research UK [10589] Funding Source: researchfish	GenoMEL EU; Cancer Research UK Programme Award(Cancer Research UK); Cancer Research UK(Cancer Research UK)	The funding for this project comes from GenoMEL EU FP6 LSHC-CT-2006-018702 and Cancer Research UK Programme Award (C588/A4994 and C588/A10589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala SS, 2010, MELANOMA RES, V20, P1, DOI 10.1097/CMR.0b013e328333bbc8; Arefayene Million, 2006, Proceedings of the American Association for Cancer Research Annual Meeting, V47, P1119; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Bouwhuis MG, 2010, CANCER IMMUNOL IMMUN, V59, P303, DOI 10.1007/s00262-009-0751-2; Chang YM, 2009, INT J EPIDEMIOL, V38, P814, DOI 10.1093/ije/dyp166; Chasman DI, 2008, GENET EPIDEMIOL, V32, P658, DOI 10.1002/gepi.20334; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Donawho CK, 1996, J IMMUNOL, V157, P781; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Gajewski TF, 2007, CLIN CANCER RES, V13, P5256, DOI 10.1158/1078-0432.CCR-07-0892; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; GUILLOUX Y, 1994, EUR J IMMUNOL, V24, P1966, DOI 10.1002/eji.1830240905; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Howell WM, 2003, EUR J IMMUNOGENET, V30, P409, DOI 10.1111/j.1365-2370.2003.00425.x; Kryczek I, 2009, CANCER RES, V69, P3995, DOI 10.1158/0008-5472.CAN-08-3804; Le Mire L, 2006, BRIT J DERMATOL, V154, P472, DOI 10.1111/j.1365-2133.2005.07094.x; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; McCann J, 1999, J NATL CANCER I, V91, P911, DOI 10.1093/jnci/91.11.911; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Mourmouras V, 2007, BRIT J DERMATOL, V157, P531, DOI 10.1111/j.1365-2133.2007.08057.x; Munn DH, 2004, TRENDS MOL MED, V10, P15, DOI 10.1016/j.molmed.2003.11.003; Nam D, 2010, NUCLEIC ACIDS RES, V38, pW749, DOI 10.1093/nar/gkq428; Nathanson, 1976, Natl Cancer Inst Monogr, V44, P67; Nikolova PN, 2007, CANCER IMMUNOL IMMUN, V56, P371, DOI 10.1007/s00262-006-0193-z; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Polak ME, 2007, BRIT J CANCER, V96, P1879, DOI 10.1038/sj.bjc.6603763; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2020, R LANG ENV STAT COMP; Schoof N, 2009, GENES IMMUN, V10, P586, DOI 10.1038/gene.2009.40; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suciu-Foca N, 2009, HUM IMMUNOL, V70, P277, DOI 10.1016/j.humimm.2009.03.003; Tintle Nathan L, 2009, BMC Proc, V3 Suppl 7, pS96; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Vereecken P, 2009, MELANOMA RES, V19, P316, DOI 10.1097/CMR.0b013e32832ec001; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	46	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29451	10.1371/journal.pone.0029451	http://dx.doi.org/10.1371/journal.pone.0029451			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216283	Green Published, gold			2022-12-27	WOS:000300674900036
J	Carolan, JC; Murray, TE; Fitzpatrick, U; Crossley, J; Schmidt, H; Cederberg, B; McNally, L; Paxton, RJ; Williams, PH; Brown, MJF				Carolan, James C.; Murray, Tomas E.; Fitzpatrick, Una; Crossley, John; Schmidt, Hans; Cederberg, Bjorn; McNally, Luke; Paxton, Robert J.; Williams, Paul H.; Brown, Mark J. F.			Colour Patterns Do Not Diagnose Species: Quantitative Evaluation of a DNA Barcoded Cryptic Bumblebee Complex	PLOS ONE			English	Article							PARASITOID FLIES DIPTERA; MITOCHONDRIAL-DNA; HYMENOPTERA; BEES; CONSERVATION; DECLINE; DELIMITATION; DIVERSITY; TAXONOMY; APIDAE	Cryptic diversity within bumblebees (Bombus) has the potential to undermine crucial conservation efforts designed to reverse the observed decline in many bumblebee species worldwide. Central to such efforts is the ability to correctly recognise and diagnose species. The B. lucorum complex (Bombus lucorum, B. cryptarum and B. magnus) comprises one of the most abundant and important group of wild plant and crop pollinators in northern Europe. Although the workers of these species are notoriously difficult to diagnose morphologically, it has been claimed that queens are readily diagnosable from morphological characters. Here we assess the value of colour-pattern characters in species identification of DNA-barcoded queens from the B. lucorum complex. Three distinct molecular operational taxonomic units were identified each representing one species. However, no uniquely diagnostic colour-pattern character state was found for any of these three molecular units and most colour-pattern characters showed continuous variation among the units. All characters previously deemed to be unique and diagnostic for one species were displayed by specimens molecularly identified as a different species. These results presented here raise questions on the reliability of species determinations in previous studies and highlights the benefits of implementing DNA barcoding prior to ecological, taxonomic and conservation studies of these important key pollinators.	[Carolan, James C.] Natl Univ Ireland Maynooth, Dept Biol, Maynooth, Kildare, Ireland; [Carolan, James C.; McNally, Luke; Brown, Mark J. F.] Trinity Coll Dublin, Sch Nat Sci, Dept Zool, Dublin, Ireland; [Murray, Tomas E.; Paxton, Robert J.] Univ Halle Wittenberg, Inst Biol, Halle, Germany; [Murray, Tomas E.; Paxton, Robert J.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Fitzpatrick, Una] Natl Biodivers Data Ctr, Waterford, Ireland; [Cederberg, Bjorn] Univ Agr Sci Uppsala, Swedish Species Informat Ctr, Uppsala, Sweden; [Williams, Paul H.] Nat Hist Museum, Dept Entomol, London SW7 5BD, England; [Brown, Mark J. F.] Royal Holloway Univ London, Sch Biol Sci, London, England	Maynooth University; Trinity College Dublin; Martin Luther University Halle Wittenberg; Queens University Belfast; Swedish University of Agricultural Sciences; Natural History Museum London; University of London; Royal Holloway University London	Carolan, JC (corresponding author), Natl Univ Ireland Maynooth, Dept Biol, Maynooth, Kildare, Ireland.	james.c.carolan@gmail.com	Murray, Tomás E/C-5540-2013; Paxton, Robert John/D-7082-2015	Paxton, Robert John/0000-0003-2517-1351; McNally, Luke/0000-0002-1928-6235; Carolan, James/0000-0001-5092-674X	Higher Education Authority of Ireland; Science Foundation Ireland [EEEOBF131]	Higher Education Authority of Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by a grant from the Higher Education Authority of Ireland (http://www.hea.ie/) as part of its North-South Research Programme for Peace and Reconciliation to RJP and MJFB and a Science Foundation Ireland (http://www.sfi.ie/) grant EEEOBF131 to MJFB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Alford DV, 1975, BUMBLEBEES; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Bertsch A, 2005, INSECT SOC, V52, P45, DOI 10.1007/s00040-004-0761-1; Bertsch Andreas, 2009, Beitraege zur Entomologie, V59, P287; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Brower AVZ, 2006, SYST BIODIVERS, V4, P127, DOI 10.1017/S147720000500191X; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Cameron SA, 2007, BIOL J LINN SOC, V91, P161, DOI 10.1111/j.1095-8312.2007.00784.x; Carvell C, 2011, ECOL APPL, V21, P1760, DOI 10.1890/10-0677.1; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dorow WHO, 2004, NATURWALDRESERVATE H; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards M, 2005, FIELD GUIDE BUMBLEBE; Emery VJ, 2009, MOL ECOL RESOUR, V9, P217, DOI 10.1111/j.1755-0998.2009.02647.x; Eruger E., 1939, Schriften des Naturwissenschaftichen Vereins fuer Schleswig-Holstein, V23, P28; Fisher BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001787; Fitzpatrick U, 2007, BIOL CONSERV, V136, P185, DOI 10.1016/j.biocon.2006.11.012; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foottit RG, 2009, MOL ECOL RESOUR, V9, P188, DOI 10.1111/j.1755-0998.2009.02644.x; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Gibbs J, 2009, ZOOTAXA, P1; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2011, J APPL ECOL, V48, P3, DOI 10.1111/j.1365-2664.2010.01929.x; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hopwood JL, 2008, BIOL CONSERV, V141, P2632, DOI 10.1016/j.biocon.2008.07.026; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kosior A, 2007, ORYX, V41, P79, DOI 10.1017/S0030605307001597; Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2; Lee W, 2011, MOL ECOL RESOUR, V11, P32, DOI 10.1111/j.1755-0998.2010.02877.x; Lye GC, 2011, J ECON ENTOMOL, V104, P107, DOI 10.1603/EC10092; Lye GC, 2009, BIOL CONSERV, V142, P2023, DOI 10.1016/j.biocon.2009.03.032; Magnacca KN, 2010, MOL ECOL RESOUR, V10, P60, DOI 10.1111/j.1755-0998.2009.02724.x; Murray TE, 2008, CONSERV GENET, V9, P653, DOI 10.1007/s10592-007-9394-z; Pages M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-184; PLOWRIGHT RC, 1980, EVOLUTION, V34, P622, DOI 10.2307/2408017; Prys-Jones OE, 1991, BUMBLEBEES; RASMONT P, 1984, Spixiana, V7, P135; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Rivera J, 2009, MOL ECOL RESOUR, V9, P224, DOI 10.1111/j.1755-0998.2009.02648.x; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Sheffield CS, 2009, MOL ECOL RESOUR, V9, P196, DOI 10.1111/j.1755-0998.2009.02645.x; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; von Hagen E, 2003, HUMMELN BESTIMMEN AN; Waters J, 2011, INSECT CONSERV DIVER, V4, P46, DOI 10.1111/j.1752-4598.2010.00101.x; Williams P, 2007, BIOL J LINN SOC, V92, P97, DOI 10.1111/j.1095-8312.2007.00878.x; Williams PH, 2011, ZOOL J LINN SOC-LOND, V163, P813, DOI 10.1111/j.1096-3642.2011.00729.x; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; WILLIAMS PH, 1982, J APICULT RES, V21, P236, DOI 10.1080/00218839.1982.11100549; Williams PH, 2000, BWARS NEWSLETTER, P15	59	91	95	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29251	10.1371/journal.pone.0029251	http://dx.doi.org/10.1371/journal.pone.0029251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238595	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000301188800008
J	Dewan, M; Kumar, A; Saxena, A; De, A; Mozumdar, S				Dewan, Manika; Kumar, Ajeet; Saxena, Amit; De, Arnab; Mozumdar, Subho			Using Hydrophilic Ionic Liquid, [bmim]BF4 - Ethylene Glycol System as a Novel Media for the Rapid Synthesis of Copper Nanoparticles	PLOS ONE			English	Article							EFFICIENT CATALYST; NI-NANOPARTICLES; TEMPERATURE; CHLORIDE; SOLVENTS	In this work, we present a novel method for the synthesis of copper nanoparticles. We utilize the charge compensatory effect of ionic liquid [bmim]BF4 in conjunction with ethylene glycol for providing electro-steric stabilization to copper nanoparticles prepared from copper sulphate using hydrazine hydrate as a reducing agent. The formed copper nanoparticles showed extended stability over a period of one year. Copper nanoparticles thus prepared were characterized by powder X-ray diffraction measurements (pXRD), transmission electron microscopy (TEM) and quasi elastic light scattering (QELS) techniques. Powder X-ray diffraction (pXRD) analysis revealed relevant Bragg's reflection for crystal structure of copper. Powder X-ray diffraction plots also revealed no oxidized material of copper nanoparticles. TEM showed nearly uniform distribution of the particles in methanol and confirmed by QELS. Typical applications of copper nanoparticles include uses in conductive films, lubrication and nanofluids. Currently efforts are under way in our laboratory for using these nanoparticles as catalysts for a variety of organic reactions.	[Dewan, Manika; Kumar, Ajeet; Saxena, Amit; Mozumdar, Subho] Univ Delhi, Dept Chem, Delhi 110007, India; [De, Arnab] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY USA	University of Delhi; Columbia University	Dewan, M (corresponding author), Univ Delhi, Dept Chem, Delhi 110007, India.	subhoscom@yahoo.co.in						Antonietti M, 2004, ANGEW CHEM INT EDIT, V43, P4988, DOI 10.1002/anie.200460091; Dewan M, 2010, TETRAHEDRON LETT, V51, P6108, DOI 10.1016/j.tetlet.2010.09.052; Dhas NA, 1998, CHEM MATER, V10, P1446, DOI 10.1021/cm9708269; Earle MJ, 2000, PURE APPL CHEM, V72, P1391, DOI 10.1351/pac200072071391; Germani R, 2007, TETRAHEDRON LETT, V48, P1767, DOI 10.1016/j.tetlet.2007.01.038; Ha SH, 2010, KOREAN J CHEM ENG, V27, P1360, DOI 10.1007/s11814-010-0386-1; He YF, 2008, J PHOTOCH PHOTOBIO A, V197, P253, DOI 10.1016/j.jphotochem.2008.01.001; Holomb R, 2008, J RAMAN SPECTROSC, V39, P793, DOI 10.1002/jrs.1912; Jin K, 2002, CHEM COMMUN, P2872, DOI 10.1039/b209937n; Kachoosangi RT, 2009, ANAL CHEM, V81, P435, DOI 10.1021/ac801853r; Kamavaram V, 2008, INT J THERM SCI, V47, P773, DOI 10.1016/j.ijthermalsci.2007.06.012; Khanna PK, 2007, MATER LETT, V61, P4711, DOI 10.1016/j.matlet.2007.03.014; Kim KS, 2005, KOREAN J CHEM ENG, V22, P717, DOI 10.1007/BF02705788; Kumar A, 2008, CATAL COMMUN, V10, P17, DOI 10.1016/j.catcom.2008.07.030; Kumar A, 2008, CATAL COMMUN, V9, P778, DOI 10.1016/j.catcom.2007.08.021; Kumar A, 2008, CATAL LETT, V122, P98, DOI 10.1007/s10562-007-9349-5; Kumar A, 2011, TETRAHEDRON LETT, V52, P4835, DOI 10.1016/j.tetlet.2011.07.016; Kumar A, 2010, CATAL COMMUN, V11, P679, DOI 10.1016/j.catcom.2010.01.017; Liu X, 2006, TRIBOL LETT, V23, P191, DOI 10.1007/s11249-006-9050-7; Paczal A, 2007, MONATSH CHEM, V138, P1115, DOI 10.1007/s00706-007-0759-2; Redel E, 2008, CHEM COMMUN, P1789, DOI 10.1039/b718055a; Salavati-Niasari M, 2009, MATER LETT, V63, P441, DOI 10.1016/j.matlet.2008.11.023; Seddon KR, 2000, PURE APPL CHEM, V72, P2275, DOI 10.1351/pac200072122275; Trohalaki S, 2005, QSAR COMB SCI, V24, P485, DOI 10.1002/qsar.200430927; Wang L, 2007, SCI CHINA SER B, V50, P63, DOI 10.1007/s11426-007-0016-x; Zhang JD, 2010, J MATER CHEM, V20, P9798, DOI 10.1039/c0jm01970d; Zhang M, 2008, J DISPER SCI TECHNOL, V29, P508, DOI 10.1080/01932690701728734; Zhou Y, 2005, CURR NANOSCI, V1, P35, DOI 10.2174/1573413052953174; Zhu HT, 2005, NANOTECHNOLOGY, V16, P3079, DOI 10.1088/0957-4484/16/12/059; Zhu JM, 2007, J PHYS CHEM C, V111, P7629, DOI 10.1021/jp0711850	30	26	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29131	10.1371/journal.pone.0029131	http://dx.doi.org/10.1371/journal.pone.0029131			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238589	gold, Green Published, Green Submitted			2022-12-27	WOS:000301188800005
J	Bolze, A; Abhyankar, A; Grant, AV; Patel, B; Yadav, R; Byun, M; Caillez, D; Emile, JF; Pastor-Anglada, M; Abel, L; Puel, A; Govindarajan, R; de Pontual, L; Casanova, JL				Bolze, Alexandre; Abhyankar, Avinash; Grant, Audrey V.; Patel, Bhavi; Yadav, Ruchi; Byun, Minji; Caillez, Daniel; Emile, Jean-Francois; Pastor-Anglada, Marcal; Abel, Laurent; Puel, Anne; Govindarajan, Rajgopal; de Pontual, Loic; Casanova, Jean-Laurent			A Mild Form of SLC29A3 Disorder: A Frameshift Deletion Leads to the Paradoxical Translation of an Otherwise Noncoding mRNA Splice Variant	PLOS ONE			English	Article							SEQUENCING-BASED DISCOVERY; H SYNDROME; ENT FAMILY; NUCLEOSIDE; MUTATIONS; PROTEIN; TRANSPORTERS; DEFICIENCY; HUMANS; HENT3	We investigated two siblings with granulomatous histiocytosis prominent in the nasal area, mimicking rhinoscleroma and Rosai-Dorfman syndrome. Genome-wide linkage analysis and whole-exome sequencing identified a homozygous frameshift deletion in SLC29A3, which encodes human equilibrative nucleoside transporter-3 (hENT3). Germline mutations in SLC29A3 have been reported in rare patients with a wide range of overlapping clinical features and inherited disorders including H syndrome, pigmented hypertrichosis with insulin-dependent diabetes, and Faisalabad histiocytosis. With the exception of insulin-dependent diabetes and mild finger and toe contractures in one sibling, the two patients with nasal granulomatous histiocytosis studied here displayed none of the many SLC29A3-associated phenotypes. This mild clinical phenotype probably results from a remarkable genetic mechanism. The SLC29A3 frameshift deletion prevents the expression of the normally coding transcripts. It instead leads to the translation, expression, and function of an otherwise noncoding, out-of-frame mRNA splice variant lacking exon 3 that is eliminated by nonsense-mediated mRNA decay (NMD) in healthy individuals. The mutated isoform differs from the wild-type hENT3 by the modification of 20 residues in exon 2 and the removal of another 28 amino acids in exon 3, which include the second transmembrane domain. As a result, this new isoform displays some functional activity. This mechanism probably accounts for the narrow and mild clinical phenotype of the patients. This study highlights the 'rescue' role played by a normally noncoding mRNA splice variant of SLC29A3, uncovering a new mechanism by which frameshift mutations can be hypomorphic.	[Bolze, Alexandre; Abhyankar, Avinash; Byun, Minji; Abel, Laurent; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA; [Grant, Audrey V.; Abel, Laurent; Puel, Anne; Casanova, Jean-Laurent] Univ Paris 05, INSERM U980, Lab Human Genet Infect Dis, Necker Branch,Inst Natl Sante & Rech Med, Paris, France; [Patel, Bhavi; Yadav, Ruchi; Govindarajan, Rajgopal] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Caillez, Daniel] Jacques Monod Hosp, Pathol Lab, Grp Hosp Havre, Montivilliers, France; [Emile, Jean-Francois] Univ Versailles SQY, EA4340, Boulogne, France; [Emile, Jean-Francois] Ambroise Pare Hosp, APHP, Boulogne, France; [Pastor-Anglada, Marcal] Univ Barcelona, Inst Biomed IBUB, Dept Biochem & Mol Biol, Barcelona, Spain; [Pastor-Anglada, Marcal] Natl Inst Study Liver & Gastrointestinal Dis CIBE, Barcelona, Spain; [de Pontual, Loic] Univ Paris 13, Jean Verdier Hosp, APHP, Dept Pediat, Bondy, France; [Casanova, Jean-Laurent] Necker Hosp Sick Children, Pediat Immunol Hematol Unit, Paris, France	Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University System of Georgia; University of Georgia; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; University of Barcelona; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Jean-Verdier - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Bolze, A (corresponding author), Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA.	alexandre.bolze@gmail.com	Casanova, Jean-Laurent/I-3418-2017; Puel, Anne/H-7305-2017; Abel, Laurent/H-8888-2017; Pastor Anglada, Marcal/C-3730-2017	Puel, Anne/0000-0003-2603-0323; Abel, Laurent/0000-0001-7016-6493; Pastor Anglada, Marcal/0000-0003-3712-1773; Casanova, Jean-Laurent/0000-0002-7782-4169; Byun, Minji/0000-0002-2830-4079; DE PONTUAL, LOIC/0000-0002-3123-0453; Bolze, Alexandre/0000-0001-7399-2766	INSERM; University Paris Descartes; Rockefeller University Center for Clinical Translational Science [5UL1RR024143]; Rockefeller University; St. Giles Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris Descartes; Rockefeller University Center for Clinical Translational Science; Rockefeller University; St. Giles Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from INSERM, University Paris Descartes, The Rockefeller University Center for Clinical Translational Science grant number 5UL1RR024143, The Rockefeller University and St. Giles Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alcais A, 2010, ANN NY ACAD SCI, V1214, P18, DOI 10.1111/j.1749-6632.2010.05834.x; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arnaud L, 2011, BLOOD, V117, P2778, DOI 10.1182/blood-2010-06-294108; Avitan-Hersh E, 2011, AM J DERMATOPATH, V33, P47, DOI 10.1097/DAD.0b013e3181ee547c; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Bhuvanagiri M, 2010, BIOCHEM J, V430, P365, DOI 10.1042/BJ20100699; Boisson-Dupuis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018524; Bolze A, 2010, AM J HUM GENET, V87, P873, DOI 10.1016/j.ajhg.2010.10.028; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Cliffe ST, 2009, HUM MOL GENET, V18, P2257, DOI 10.1093/hmg/ddp161; de Pontual L, 2008, CLIN INFECT DIS, V47, P1396, DOI 10.1086/592966; Doviner V, 2010, AM J DERMATOPATH, V32, P118, DOI 10.1097/DAD.0b013e3181b28572; Govindarajan R, 2009, AM J PHYSIOL-GASTR L, V296, pG910, DOI 10.1152/ajpgi.90672.2008; Hansen KD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000525; Hyde RJ, 2001, MOL MEMBR BIOL, V18, P53, DOI 10.1080/09687680110033765; Jonard L, 2012, EUR J MED GENET, V55, P56, DOI 10.1016/j.ejmg.2011.06.009; Kang N, 2010, J BIOL CHEM, V285, P28343, DOI 10.1074/jbc.M110.109199; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Molho-Pessach V, 2008, AM J HUM GENET, V83, P529, DOI 10.1016/j.ajhg.2008.09.013; Morgan NV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000833; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Priya TP, 2010, BRIT J DERMATOL, V162, P1132, DOI 10.1111/j.1365-2133.2010.09653.x; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Spiegel R, 2010, EUR J MED GENET, V53, P309, DOI 10.1016/j.ejmg.2010.06.012; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; Vasile VC, 2006, BIOCHEM BIOPH RES CO, V345, P998, DOI 10.1016/j.bbrc.2006.04.151; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	38	38	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29708	10.1371/journal.pone.0029708	http://dx.doi.org/10.1371/journal.pone.0029708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238637	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200042
J	Garin, I; de Nanclares, GP; Gastaldo, E; Harries, LW; Rubio-Cabezas, O; Castano, L				Garin, Intza; Perez de Nanclares, Guiomar; Gastaldo, Elena; Harries, Lorna W.; Rubio-Cabezas, Oscar; Castano, Luis			Permanent Neonatal Diabetes Caused by Creation of an Ectopic Splice Site within the INS Gene	PLOS ONE			English	Article							INSULIN GENE; MUTATIONS; NONSENSE; PATHWAY; DECAY	Background: The aim of this study was to characterize the genetic etiology in a patient who presented with permanent neonatal diabetes at 2 months of age. Methodology/Principal Findings: Regulatory elements and coding exons 2 and 3 of the INS gene were amplified and sequenced from genomic and complementary DNA samples. A novel heterozygous INS mutation within the terminal intron of the gene was identified in the proband and her affected father. This mutation introduces an ectopic splice site leading to the insertion of 29 nucleotides from the intronic sequence into the mature mRNA, which results in a longer and abnormal transcript. Conclusions/Significance: This study highlights the importance of routinely sequencing the exon-intron boundaries and the need to carry out additional studies to confirm the pathogenicity of any identified intronic genetic variants.	[Garin, Intza; Perez de Nanclares, Guiomar; Castano, Luis] Univ Politecn Valencia Euskal Herriko Unibertsita, Endocrinol & Diabet Res Grp, Hosp Cruces, Baracaldo, Bizkaia, Spain; [Garin, Intza; Perez de Nanclares, Guiomar; Castano, Luis] Ctr Invest Biomed Red Endermedads Raras CIBERER, Ctr Invest Biomed Red Diabet & Endermedades Metab, Baracaldo, Bizkaia, Spain; [Gastaldo, Elena] Hosp La Ribera, Valencia, Spain; [Harries, Lorna W.] Peninsula Coll Med & Dent, Inst Biomed & Clin Sci, Exeter, Devon, England; [Rubio-Cabezas, Oscar] Hosp Infantil Univ Nino Jesus, Dept Pediat Endocrinol, Madrid, Spain; [Rubio-Cabezas, Oscar] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopat Obesidad & Nutr, Madrid, Spain	Hospital Universitario Cruces; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Exeter; University of Plymouth; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Garin, I (corresponding author), Univ Politecn Valencia Euskal Herriko Unibertsita, Endocrinol & Diabet Res Grp, Hosp Cruces, Baracaldo, Bizkaia, Spain.	lcastano@osakidetza.net	Harries, Lorna/D-2241-2014; Perez de Nanclares, Guiomar/P-1057-2018; , Ivan/D-6804-2012	Perez de Nanclares, Guiomar/0000-0002-2424-5294; Harries, Lorna/0000-0001-7791-8061; , Ivan/0000-0002-3108-058X; Castano, Luis/0000-0003-0437-9401	Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas (CIBERDEM); Instituto de Salud Carlos III of the Spanish Ministry of Health [PI09/1492, PI06/0690, CP03/0064, SIVI 1395/09]; FIS [I3SNS-I3SNSCA10/01056]; Wellcome Trust [WT081278MA]; Instituto de Salud Carlos III [FIS CM06/00013]	Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas (CIBERDEM); Instituto de Salud Carlos III of the Spanish Ministry of Health(Instituto de Salud Carlos III); FIS(Instituto de Salud Carlos III); Wellcome Trust(Wellcome TrustEuropean Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by the Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas (CIBERDEM; grant MODIAB) and PI09/1492 from the Instituto de Salud Carlos III of the Spanish Ministry of Health to LC; PI06/0690 from the Instituto de Salud Carlos III of the Spanish Ministry of Health to GPN. IG was supported by FIS-programs I3SNS-I3SNSCA10/01056. GPN is co-funded the Instituto de Salud Carlos III of the Spanish Ministry of Health I3SNS Program (grant CP03/0064; SIVI 1395/09). LWH was funded by the Wellcome Trust (grant number WT081278MA). ORC was funded by a Rio Hortega Research Fellowship from the Instituto de Salud Carlos III (FIS CM06/00013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Fendler Wojciech, 2011, Diabetes Care, V34, pe9, DOI 10.2337/dc10-1142; Garin I, 2010, P NATL ACAD SCI USA, V107, P3105, DOI 10.1073/pnas.0910533107; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; Liu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013333; Meur G, 2010, DIABETES, V59, P653, DOI 10.2337/db09-1091; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; Park SY, 2010, BIOCHEM BIOPH RES CO, V391, P1449, DOI 10.1016/j.bbrc.2009.12.090; Polak M, 2008, DIABETES, V57, P1115, DOI 10.2337/db07-1358; Raile K, 2011, EUR J ENDOCRINOL, V165, P255, DOI 10.1530/EJE-11-0208; Russo L, 2011, DIABETOLOGIA, V54, P1693, DOI 10.1007/s00125-011-2094-8; Silva AL, 2009, FEBS LETT, V583, P499, DOI 10.1016/j.febslet.2008.12.058; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Stoy J, 2010, REV ENDOCR METAB DIS, V11, P205, DOI 10.1007/s11154-010-9151-3; Vasudevan S, 2002, BIOESSAYS, V24, P785, DOI 10.1002/bies.10153; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	20	22	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29205	10.1371/journal.pone.0029205	http://dx.doi.org/10.1371/journal.pone.0029205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235272	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400033
J	Hargrove, J; van Schalkwyk, C; Eastwood, H				Hargrove, John; van Schalkwyk, Cari; Eastwood, Hayden			BED Estimates of HIV Incidence: Resolving the Differences, Making Things Simpler	PLOS ONE			English	Article							TYPE-1 INCIDENCE	Objective: Develop a simple method for optimal estimation of HIV incidence using the BED capture enzyme immunoassay. Design: Use existing BED data to estimate mean recency duration, false recency rates and HIV incidence with reference to a fixed time period, T. Methods: Compare BED and cohort estimates of incidence referring to identical time frames. Generalize this approach to suggest a method for estimating HIV incidence from any cross-sectional survey. Results: Follow-up and BED analyses of the same, initially HIV negative, cases followed over the same set time period T, produce estimates of the same HIV incidence, permitting the estimation of the BED mean recency period for cases who have been HIV positive for less than T. Follow-up of HIV positive cases over T, similarly, provides estimates of the false-recent rate appropriate for T. Knowledge of these two parameters for a given population allows the estimation of HIV incidence during T by applying the BED method to samples from cross-sectional surveys. An algorithm is derived for providing these estimates, adjusted for the false-recent rate. The resulting estimator is identical to one derived independently using a more formal mathematical analysis. Adjustments improve the accuracy of HIV incidence estimates. Negative incidence estimates result from the use of inappropriate estimates of the false-recent rate and/or from sampling error, not from any error in the adjustment procedure. Conclusions: Referring all estimates of mean recency periods, false-recent rates and incidence estimates to a fixed period T simplifies estimation procedures and allows the development of a consistent method for producing adjusted estimates of HIV incidence of improved accuracy. Unadjusted BED estimates of incidence, based on life-time recency periods, would be both extremely difficult to produce and of doubtful value.	[Hargrove, John; van Schalkwyk, Cari; Eastwood, Hayden] Univ Stellenbosch, Ctr Excellence Epidemiol Modelling & Anal SACEMA, Natl Res Fdn, Dept Sci & Technol, ZA-7600 Stellenbosch, South Africa	National Research Foundation - South Africa; Stellenbosch University	Hargrove, J (corresponding author), Univ Stellenbosch, Ctr Excellence Epidemiol Modelling & Anal SACEMA, Natl Res Fdn, Dept Sci & Technol, ZA-7600 Stellenbosch, South Africa.	jhargrove@sun.ac.za		van Schalkwyk, Cari/0000-0001-5154-1390	Department of Science and Technology, Government of South Africa; Canadian International Development Agency (CIDA) [A033749]	Department of Science and Technology, Government of South Africa; Canadian International Development Agency (CIDA)	SACEMA receives core funding from the Department of Science and Technology, Government of South Africa. This work was supported by funding from the Canadian International Development Agency (CIDA; Project A033749). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Brookmeyer R, 2009, AIDS, V23, P2066, DOI 10.1097/QAD.0b013e32832f3dbb; Brookmeyer R, 2009, AIDS, V23, P485, DOI 10.1097/QAD.0b013e3283269e28; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Hargrove JW, 2009, AIDS, V23, P2061, DOI 10.1097/QAD.0b013e32832f3d8b; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; McDougal JS, 2009, AIDS, V23, P2064, DOI 10.1097/QAD.0b013e32832eff6e; McWalter TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007368; McWalter TA, 2010, J MATH BIOL, V60, P687, DOI 10.1007/s00285-009-0282-7; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; *UNAIDS, 2005, STAT US BED ASS EST; Welte A, 2009, AIDS, V23, P2062, DOI 10.1097/QAD.0b013e32832eff59; Welte AMT, 2011, EPIDEMIOLOGY UNPUB	14	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29736	10.1371/journal.pone.0029736	http://dx.doi.org/10.1371/journal.pone.0029736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235334	Green Published, gold			2022-12-27	WOS:000301123400096
J	Sanchis, A; Alba, L; Latorre, V; Sevilla, LM; Perez, P				Sanchis, Ana; Alba, Lorena; Latorre, Victor; Sevilla, Lisa M.; Perez, Paloma			Keratinocyte-Targeted Overexpression of the Glucocorticoid Receptor Delays Cutaneous Wound Healing	PLOS ONE			English	Article							GROWTH-FACTORS; BETA-CATENIN; SKIN; INHIBITION; DISRUPTION; BINDING; GENE	Delayed wound healing is one of the most common secondary adverse effects associated to the therapeutic use of glucocorticoid (GC) analogs, which act through the ligand-dependent transcription factor GC-receptor (GR). GR function is exerted through DNA-binding-dependent and -independent mechanisms, classically referred to as transactivation (TA) and transrepression (TR). Currently both TA and TR are thought to contribute to the therapeutical effects mediated by GR; however their relative contribution to unwanted side effects such as delayed wound healing is unknown. We evaluated skin wound healing in transgenic mice with keratinocyte-restricted expression of either wild type GR or a mutant GR that is TA-defective but efficient in TR (K5-GR and K5-GR-TR mice, respectively). Our data show that at days (d) 4 and 8 following wounding, healing in K5-GR mice was delayed relative to WT, with reduced recruitment of granulocytes and macrophages and diminished TNF-alpha and IL-1 beta expression. TGF-beta 1 and Kgf expression was repressed in K5-GR skin whereas TGF-beta 3 was up-regulated. The re-epithelialization rate was reduced in K5-GR relative to WT, as was formation of granulation tissue. In contrast, K5-GR-TR mice showed delays in healing at d4 but re-established the skin breach at d8 concomitant with decreased repression of pro-inflammatory cytokines and growth factors relative to K5-GR mice. Keratinocytes from both transgenic mice closed in vitro wounds slower relative to WT, consistent with the in vivo defects in cell migration. Overall, the delay in the early stages of wound healing in both transgenic models is similar to that elicited by systemic treatment with dexamethasone. Wound responses in the transgenic keratinocytes correlated with reduced ERK activity both in vivo and in vitro. We conclude that the TR function of GR is sufficient for negatively regulating early stages of wound closure, while TA by GR is required for delaying later stages of healing.	[Sanchis, Ana; Alba, Lorena; Latorre, Victor; Sevilla, Lisa M.; Perez, Paloma] CSIC, IBV, Dept Pathol & Cell & Mol Therapy, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Sanchis, A (corresponding author), CSIC, IBV, Dept Pathol & Cell & Mol Therapy, Valencia, Spain.	pperez@ibv.csic.es	Sevilla, Lisa M/L-5704-2014; Perez, Paloma/K-8841-2017	Sevilla, Lisa M/0000-0002-7134-0411; Perez, Paloma/0000-0002-7166-2824; Alba-Castellon, Lorena/0000-0003-3449-7820; Latorre, Victor/0000-0002-7985-1638	Ministerio de Ciencia e Innovacion from the Spanish government [SAF2008-00540]; Ministerio de Ciencia e Innovacion [BES-2009-021944]; Junta de Ampliacion de Estudios-Consejo Superior de Investigaciones Cientificas; European Funds	Ministerio de Ciencia e Innovacion from the Spanish government(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Ampliacion de Estudios-Consejo Superior de Investigaciones Cientificas; European Funds	This work was supported by Grant SAF2008-00540 of the Ministerio de Ciencia e Innovacion from the Spanish government. VL was the recipient of a fellowship Formacion de Personal Investigador from the Ministerio de Ciencia e Innovacion (BES-2009-021944), and LMS was funded by a postdoctoral contract Junta de Ampliacion de Estudios-Consejo Superior de Investigaciones Cientificas cofunded by European Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bayo P, 2008, ENDOCRINOLOGY, V149, P1377, DOI 10.1210/en.2007-0814; Beer H D, 2000, Vitam Horm, V59, P217, DOI 10.1016/S0083-6729(00)59008-6; Cascallana JL, 2005, ENDOCRINOLOGY, V146, P2629, DOI 10.1210/en.2004-1246; Choi EH, 2005, FASEB J, V19, P1332; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Davies L, 2008, MOL ENDOCRINOL, V22, P1331, DOI 10.1210/me.2007-0360; De Bosscher K, 2010, J STEROID BIOCHEM, V120, P96, DOI 10.1016/j.jsbmb.2010.02.027; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Donet E, 2008, MOL ENDOCRINOL, V22, P799, DOI 10.1210/me.2007-0284; Grose R, 2002, EMBO REP, V3, P575, DOI 10.1093/embo-reports/kvf119; HELMBERG A, 1995, EMBO J, V14, P452, DOI 10.1002/j.1460-2075.1995.tb07021.x; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Komi-Kuramochi A, 2005, J ENDOCRINOL, V186, P273, DOI 10.1677/joe.1.06055; Lai JJ, 2009, J CLIN INVEST, V119, P3739, DOI 10.1172/JCI39335; Lee B, 2005, J MOL BIOL, V345, P1083, DOI 10.1016/j.jmb.2004.11.027; Perez P, 2001, FASEB J, V15, P2030, DOI 10.1096/fj.00-0772fje; Radoja N, 2000, MOL CELL BIOL, V20, P4328, DOI 10.1128/MCB.20.12.4328-4339.2000; Ramot Y, 2009, BIOESSAYS, V31, P389, DOI 10.1002/bies.200800121; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Revollo JR, 2009, ANN NY ACAD SCI, V1179, P167, DOI 10.1111/j.1749-6632.2009.04986.x; Sanchis A, 2010, INT J DEV BIOL, V54, P1473, DOI 10.1387/ijdb.103071as; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Slominski Andrzej, 2008, Drug Discov Today Dis Mech, V5, P137; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; Stanisic V, 2010, PROG BRAIN RES, V181, P153, DOI 10.1016/S0079-6123(08)81009-6; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Takayama S, 2006, J BIOL CHEM, V281, P17856, DOI 10.1074/jbc.M602290200; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Turchi L, 2002, J INVEST DERMATOL, V119, P56, DOI 10.1046/j.1523-1747.2002.01805.x; Vukelic S, 2011, J BIOL CHEM; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yemelyanov A, 2007, ONCOGENE, V26, P1885, DOI 10.1038/sj.onc.1209991	36	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29701	10.1371/journal.pone.0029701	http://dx.doi.org/10.1371/journal.pone.0029701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235328	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400090
J	Walker, CLF; Aryee, MJ; Boschi-Pinto, C; Black, RE				Walker, Christa L. Fischer; Aryee, Martin J.; Boschi-Pinto, Cynthia; Black, Robert E.			Estimating Diarrhea Mortality among Young Children in Low and Middle Income Countries	PLOS ONE			English	Article							DEATH	Background: Diarrhea remains one of the leading causes of morbidity and mortality among children under 5 years of age, but in many low and middle-income countries where vital registration data are lacking, updated estimates with regard to the proportion of deaths attributable to diarrhea are needed. Methods: We conducted a systematic literature review to identify studies reporting diarrhea proportionate mortality for children 1-59 mo of age published between 1980 and 2009. Using the published proportionate mortality estimates and country level covariates we constructed a logistic regression model to estimate country and regional level proportionate mortality and estimated uncertainty bounds using Monte-Carlo simulations. Findings: We identified more than 90 verbal autopsy studies from around the world to contribute data to a single-cause model. We estimated diarrhea proportionate mortality for 84 countries in 6 regions and found diarrhea to account for between 10.0% of deaths in the Americas to 31.3% of deaths in the South-east Asian region. Discussion: Diarrhea remains a leading cause of death for children 1-59 mo of age. Published literature can be used to create a single-cause mortality disease model to estimate mortality for countries lacking vital registration data.	[Walker, Christa L. Fischer; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Aryee, Martin J.] Johns Hopkins Univ, Sch Med, Dept Oncol, Div Biostat & Bioinformat, Baltimore, MD 21205 USA; [Boschi-Pinto, Cynthia] World Hlth Org, Dept Child & Adolescent Hlth & Dev, Geneva, Switzerland; [Boschi-Pinto, Cynthia] Univ Fed Fluminense, Rio De Janeiro, Brazil	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of Geneva; World Health Organization; Universidade Federal Fluminense	Walker, CLF (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.	cfischer@jhsph.edu	Pinto, Cynthia Boschi/AAA-6990-2020; Aryee, Martin/AAC-8113-2020	Pinto, Cynthia Boschi/0000-0002-0069-7974; Black, Robert/0000-0001-9926-7984	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was supported by grants from the Bill and Melinda Gates Foundation to the US Fund for UNICEF for CHERG and to the University of Washington for the Global Burden of Disease Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjuik M, 2009, ATLAS MALARIA RISK A; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Boschi-Pinto C, 2008, B WORLD HEALTH ORGAN, V86, P710, DOI 10.2471/BLT.07.050054; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Gutierrez G, 1996, B WORLD HEALTH ORGAN, V74, P189; Johnson HL, 2010, INT J EPIDEMIOL, V39, P1103, DOI 10.1093/ije/dyq074; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rudan I, LANCET, V375, P1083; United Nations, 1983, MAN 10 IND TECHN DEM; Victora CG, 1996, HEALTH POLICY PLANN, V11, P132, DOI 10.1093/heapol/11.2.132; You D, 2010, LANCET, V375, P100, DOI 10.1016/S0140-6736(09)61601-9	13	35	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29151	10.1371/journal.pone.0029151	http://dx.doi.org/10.1371/journal.pone.0029151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235266	Green Submitted, Green Published, gold			2022-12-27	WOS:000301123400027
J	Norrstrom, N; Getz, WM; Holmgren, NMA				Norrstrom, Niclas; Getz, Wayne M.; Holmgren, Noel M. A.			Selection against Accumulating Mutations in Niche-Preference Genes Can Drive Speciation	PLOS ONE			English	Article							SYMPATRIC SPECIATION; EVOLUTION; MODELS; COMPETITION; ROBUSTNESS; DIVERSITY; DYNAMICS	Our current understanding of sympatric speciation is that it occurs primarily through disruptive selection on ecological genes driven by competition, followed by reproductive isolation through reinforcement-like selection against inferior intermediates/heterozygotes. Our evolutionary model of selection on resource recognition and preference traits suggests a new mechanism for sympatric speciation. We find speciation can occur in three phases. First a polymorphism of functionally different phenotypes is established through evolution of specialization. On the gene level, regulatory functions have evolved in which some alleles are conditionally switched off (i.e. are silent). These alleles accumulate harmful mutations that potentially may be expressed in offspring through recombination. Second mating associated with resource preference invades because harmful mutations in parents are not expressed in the offspring when mating assortatively, thereby dividing the population into two pre-zygotically isolated resource-specialist lineages. Third, silent alleles that evolved in phase one now accumulate deleterious mutations over the following generations in a Bateson-Dobzhansky-Muller fashion, establishing a post-zygotic barrier to hybridization.	[Norrstrom, Niclas; Holmgren, Noel M. A.] Univ Skovde, Syst Biol Res Ctr, Skovde, Sweden; [Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa	University of Skovde; University of California System; University of California Berkeley; University of Kwazulu Natal	Norrstrom, N (corresponding author), Univ Skovde, Syst Biol Res Ctr, Skovde, Sweden.	noel.holmgren@his.se	Getz, Wayne/I-4521-2013	Getz, Wayne/0000-0001-8784-9354; Holmgren, Noel/0000-0003-3000-8786	James S. McDonnell Foundation 21st Century Science Initiative [2003016]	James S. McDonnell Foundation 21st Century Science Initiative	This work was funded by a James S. McDonnell Foundation 21st Century Science Initiative Award (2003016, http://www.jsmf.org/grants/d. php?id=2003016) to WMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERS RP, 1993, J COMP PHYSIOL A, V173, P169, DOI 10.1007/BF00192976; Azevedo RBR, 2006, NATURE, V440, P87, DOI 10.1038/nature04488; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Bell MA, 2004, EVOLUTION, P814; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Bornholdt S, 2000, P ROY SOC B-BIOL SCI, V267, P2281, DOI 10.1098/rspb.2000.1280; Bush G.L., 1975, P187; Coyne JA, 1998, PHILOS T ROY SOC B, V353, P287, DOI 10.1098/rstb.1998.0210; Dethier V.G, 1947, CHEM INSECT ATTRACTA; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Diehl S.R., 1989, P345; Dobzhansky T., 1937; Doebeli M, 1996, J EVOLUTION BIOL, V9, P893, DOI 10.1046/j.1420-9101.1996.9060893.x; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Fierst JL, 2010, EVOLUTION, V64, P675, DOI 10.1111/j.1558-5646.2009.00861.x; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Fitzpatrick BM, 2009, J EVOLUTION BIOL, V22, P2342, DOI 10.1111/j.1420-9101.2009.01833.x; Friesen VL, 2007, P NATL ACAD SCI USA, V104, P18589, DOI 10.1073/pnas.0700446104; Fry JD, 2003, EVOLUTION, V57, P1735; Gavrilets S, 2003, EVOLUTION, V57, P2197; Gavrilets S, 2006, J THEOR BIOL, V239, P172, DOI 10.1016/j.jtbi.2005.08.041; Geritz SAH, 2000, P ROY SOC B-BIOL SCI, V267, P1671, DOI 10.1098/rspb.2000.1194; Getz WM, 1996, ECOLOGY, V77, P2014, DOI 10.2307/2265697; GETZ WM, 1989, THEOR POPUL BIOL, V36, P34, DOI 10.1016/0040-5809(89)90022-1; Haykin S., 1994, NEURAL NETWORKS, DOI 10.5555/521706; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Holmgren NMA, 2000, EVOL ECOL RES, V2, P81; Holmgren NMA, 1999, BIOL J LINN SOC, V66, P145; Holmgren NMA, 2007, PHILOS T R SOC B, V362, P431, DOI 10.1098/rstb.2006.1970; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; Norrstrom N, 2006, EVOL BIOINFORM ONLIN, V2, P1; Olsson SB, 2006, J EXP BIOL, V209, P3729, DOI 10.1242/jeb.02444; Orr HA, 2001, EVOLUTION, V55, P1085; Panova M, 2006, MOL ECOL, V15, P4021, DOI 10.1111/j.1365-294X.2006.03067.x; Ray A, 2008, PLOS BIOL, V6, P1069, DOI 10.1371/journal.pbio.0060125; Rueffler C, 2006, TRENDS ECOL EVOL, V21, P238, DOI 10.1016/j.tree.2006.03.003; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Ryan MJ, 2000, SIGNAL DECODIN UNPUB; Ryan PG, 2007, SCIENCE, V315, P1420, DOI 10.1126/science.1138829; Said I, 2003, J INSECT PHYSIOL, V49, P857, DOI 10.1016/S0022-1910(03)00137-9; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; SMITH JM, 1966, AM NAT, V100, P637, DOI 10.1086/282457; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Taylor EB, 2000, P ROY SOC B-BIOL SCI, V267, P2375, DOI 10.1098/rspb.2000.1294; ten Tusscher KHWJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-159; Tosh C.R., 2010, MODELLING PERCEPTION; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; Van Dooren TJM, 1999, J THEOR BIOL, V198, P519, DOI 10.1006/jtbi.1999.0929; Van Dooren TJM, 2006, EVOLUTION, V60, P1991, DOI 10.1554/05-259.1; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005	53	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29487	10.1371/journal.pone.0029487	http://dx.doi.org/10.1371/journal.pone.0029487			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216293	Green Published, gold			2022-12-27	WOS:000300674900039
J	Wei, CX; Ding, SM; You, HH; Zhang, YR; Wang, Y; Yang, X; Yuan, JL				Wei, Chenxi; Ding, Shumao; You, Huihui; Zhang, Yaran; Wang, Yao; Yang, Xu; Yuan, Junlin			An Immunoassay for Dibutyl Phthalate Based on Direct Hapten Linkage to the Polystyrene Surface of Microtiter Plates	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; MONOCLONAL-ANTIBODY; SENSITIVE IMMUNOASSAY; RESIDUES; ELISA; PURIFICATION; GENERATION; HERBICIDE; ACID	Background: Dibutyl phthalate (DBP) is predominantly used as a plasticizer inplastics to make them flexible. Extensive use of phthalates in both industrial processes and other consumer products has resulted in the ubiquitous presence of phthalates in the environment. In order to better determine the level of pollution in the environment and evaluate the potential adverse effects of exposure to DBP, immunoassay for DBP was developed. Methodology/Principal Findings: A monoclonal antibody specific to DBP was produced from a stable hybridoma cell line generated by lymphocyte hybridoma technique. An indirect competitive enzyme-linked immunosorbent assay (icELISA) employing direct coating of hapten on polystyrene microtiter plates was established for the detection of DBP. Polystyrene surface was first oxidized by permanganate in dilute sulfuric acid to generate carboxyl groups. Then dibutyl 4-aminophthalate, which is an analogue of DBP, was covalently linked to the carboxyl groups of polystyrene surface with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC). Compared with conjugate coated format (IC50 = 106 ng/mL), the direct hapten coated format (IC50 = 14.6 ng/mL) improved assay sensitivity after careful optimization of assay conditions. The average recovery of DBP from spiked water sample was 104.4% and the average coefficient of variation was 9.95%. Good agreement of the results obtained by the hapten coated icELISA and gas chromatography-mass spectrometry further confirmed the reliability and accuracy of the icELISA for the detection of DBP in certain plastic and cosmetic samples. Conclusions/Significance: The stable and efficient hybridoma cell line obtained is an unlimited source of sensitive and specific antibody to DBP. The hapten coated format is proposed as generally applicable because the carboxyl groups on modified microtiter plate surface enables stable immobilization of aminated or hydroxylated hapten with EDC. The developed hapten coated icELISA can be used as a convenient quantitative tool for the sensitive and accurate monitoring DBP in water, plastic and cosmetic samples.	[Wei, Chenxi; Ding, Shumao; You, Huihui; Zhang, Yaran; Yang, Xu; Yuan, Junlin] Huazhong Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China; [Wang, Yao] Fudan Univ, Coll Life Sci, Shanghai 200433, Peoples R China	Central China Normal University; Fudan University	Wei, CX (corresponding author), Huazhong Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China.	yangxu@mail.ccnu.edu.cn; yuanjl@mail.ccnu.edu.cn	Wei, Chenxi/C-8630-2016	Wei, Chenxi/0000-0002-3837-1881	National Science Foundation of China [51076079, 51136002]; Huazhong Normal University [2009029]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huazhong Normal University	This work was supported by the National Science Foundation of China (51076079; 51136002) and the Graduate Independent Research Project of Huazhong Normal University (2009029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KC, 2004, J AGR FOOD CHEM, V52, P4583, DOI 10.1021/jf049646r; ATSDR, 2001, TOX PROF DI N BUT PH; Brun EM, 2004, J IMMUNOL METHODS, V295, P21, DOI 10.1016/j.jim.2004.08.014; Crowther J.R., 2001, ELISA GUIDEBOOK, P1; Estevez MC, 2005, ANAL CHEM, V77, P5283, DOI 10.1021/ac0502910; Feng Y, 2009, TALANTA, V80, P803, DOI 10.1016/j.talanta.2009.07.070; Holthues H, 2001, FRESEN J ANAL CHEM, V371, P897, DOI 10.1007/s002160101050; Hu YX, 2002, CELL RES, V12, P157, DOI 10.1038/sj.cr.7290122; James W.G., 1995, MONOCLONAL ANTIBODIE, P141; Jen JF, 2006, J CHROMATOGR A, V1130, P28, DOI 10.1016/j.chroma.2006.06.029; Kaur J, 2004, ANAL CHIM ACTA, V506, P133, DOI 10.1016/j.aca.2003.11.009; Kim KO, 2002, J AGR FOOD CHEM, V50, P6675, DOI 10.1021/jf025703+; Kramer PM, 2004, J AGR FOOD CHEM, V52, P2462, DOI 10.1021/jf035498d; Lee JK, 2002, J AGR FOOD CHEM, V50, P1791, DOI 10.1021/jf011150b; Lei HT, 2010, ANAL CHIM ACTA, V665, P84, DOI 10.1016/j.aca.2010.03.007; Lei HY, 2010, AFR J BIOTECHNOL, V9, P3026; Manclus JJ, 1996, J AGR FOOD CHEM, V44, P4052, DOI 10.1021/jf960144q; Mercader JV, 2008, J AGR FOOD CHEM, V56, P2581, DOI 10.1021/jf800157s; Moon JK, 2007, J AGR FOOD CHEM, V55, P5416, DOI 10.1021/jf070358f; Nakata M, 2001, PEST MANAG SCI, V57, P269, DOI 10.1002/ps.286; NTP-CERHR, 2003, NTP CERHR MON; Pastor-Navarro N, 2007, ANAL CHIM ACTA, V594, P211, DOI 10.1016/j.aca.2007.05.045; Plaza G, 2000, POL J ENVIRON STUD, V9, P231; Ramon-Azcon J, 2009, J AGR FOOD CHEM, V57, P375, DOI 10.1021/jf802821n; REIK LM, 1987, J IMMUNOL METHODS, V100, P123, DOI 10.1016/0022-1759(87)90180-3; Serodio P, 2006, WATER RES, V40, P2572, DOI 10.1016/j.watres.2006.05.002; Sugawara Y, 1998, ANAL CHEM, V70, P1092, DOI 10.1021/ac9708203; TEMPONI M, 1989, HYBRIDOMA, V8, P85, DOI 10.1089/hyb.1989.8.85; van Wezel AP, 2000, ECOTOX ENVIRON SAFE, V46, P305, DOI 10.1006/eesa.2000.1930; Wang ZH, 2007, ANAL CHEM, V79, P4471, DOI 10.1021/ac070064t; Watanabe E, 2002, J AGR FOOD CHEM, V50, P3637, DOI 10.1021/jf0114684; Xu T, 2007, J AGR FOOD CHEM, V55, P3764, DOI 10.1021/jf063287d; Yanaihara N, 2002, US patent, Patent No. [6.399.318, 6399318]; Yang ZY, 2006, J AGR FOOD CHEM, V54, P4551, DOI 10.1021/jf0606196; Zammatteo N, 1996, ANAL BIOCHEM, V236, P85, DOI 10.1006/abio.1996.0135; Zeravik J, 2004, ANAL CHEM, V76, P1021, DOI 10.1021/ac030217m; Zhang K, 2008, FOOD ADDIT CONTAM A, V25, P1416, DOI 10.1080/02652030802163380; Zhang MC, 2006, ANAL BIOANAL CHEM, V386, P1401, DOI 10.1007/s00216-006-0703-z; Zhou SX, 2005, CHINESE J PESTICIDES, V44, P337	39	28	33	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29196	10.1371/journal.pone.0029196	http://dx.doi.org/10.1371/journal.pone.0029196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216208	gold, Green Published, Green Submitted			2022-12-27	WOS:000300674900020
J	Okoshi, R; Shu, CL; Ihara, S; Fukui, Y				Okoshi, Rintaro; Shu, Chung-Li; Ihara, Sayoko; Fukui, Yasuhisa			Heregulin beta-1 Induces Loss of Cell-Cell Contact and Enhances Expression of MUC1 at the Cell Surface in HCC2998 and MKN45-1 Cells	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; BREAST-CANCER; TIGHT JUNCTIONS; GASTRIC-CANCER; ACTIVATION; CARCINOMA; MOLECULES; PATHWAY; LINES; ADENOCARCINOMAS	Signal transduction and cell responses after stimulation with heregulin beta-1 (HRG) are examined in HCC2998 and MKN45-1 cells, which have been used for a model system to study the formation of signet ring carcinomas, one of poorly differentiated adenocarcinomas. HRG stimulation causes rounding of the cells, responding to HRG. The adherens junction, which is present in the control cells, is disrupted and cell-cell interaction is lost after stimulation. Inhibition of phosphatidylinositol (PI)-3 kinase or p38 MAP kinase blocked this reaction, which indicates that the PI-3 kinase-p38 MAP kinase pathway is required for this reaction. Inhibition of the p38 MAP kinase pathway resulted in immediate restoration of cell-cell interaction. This result indicates that signaling for adherent molecules is strictly regulated by growth factor signaling. Expression of MUC1 at the cell surface is also observed and found to be expressed only after HRG stimulation. The total amount of MUC1 remains unchanged, suggesting that this amount is not due to induction of gene expression but to translocation of MUC1 from the inner membrane to the plasma membrane. This reaction is independent of the cytohesin pathway but dependent on PI-3 kinase activity. In addition to these reactions, HRG stimulates cell growth of both HCC2998 and MKN45-1 cells, depending on the ERK pathway given that the MEK inhibitor abolishes this effect. Therefore, HRG induces various reactions in HCC2998 and MKN45-1 cells by different pathways. These reactions are all related to characteristics of tumors, which implicates that HRG signaling can contribute to the formation of tumors.	[Okoshi, Rintaro; Shu, Chung-Li; Fukui, Yasuhisa] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Ihara, Sayoko] Univ Tokyo, Grad Sch Agr & Life Sci, Div Appl Biol Chem, Bunkyo Ku, Tokyo, Japan; [Fukui, Yasuhisa] Hoshi Univ, Lab Signal Transduct, Shinagawa Ku, Tokyo 142, Japan	National Health Research Institutes - Taiwan; University of Tokyo; Hoshi University	Okoshi, R (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.	990412@nhri.org.tw	Fukui, Yasuhisa/E-8806-2010		Japan's Ministry of Education, Culture, Sports, Science and Technology [20013044]; National Institute of Biomedical Innovation, Japan; National Health Research Institutes, Taiwan	Japan's Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation, Japan(National Institute of Biomedical Innovation); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	Grants-in-aid from Japan's Ministry of Education, Culture, Sports, Science and Technology, #20013044; a grant from the National Institute of Biomedical Innovation, Japan; and a grant from the National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA S, 1988, JPN J SURG, V18, P438, DOI 10.1007/BF02471470; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Britsch S, 2007, ADV ANAT EMBRYOL CEL, V190, P1; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Hamburger AW, 2008, J MAMMARY GLAND BIOL, V13, P225, DOI 10.1007/s10911-008-9077-5; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Jones FE, 1996, CELL GROWTH DIFFER, V7, P1031; Kanakry CG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001369; Kath R, 2000, J CANCER RES CLIN, V126, P233, DOI 10.1007/s004320050038; Kobayashi M, 1999, P NATL ACAD SCI USA, V96, P4874, DOI 10.1073/pnas.96.9.4874; Kobayashi M, 2003, ONCOGENE, V22, P1294, DOI 10.1038/sj.onc.1206256; McNeil C, 1998, J NATL CANCER I, V90, P882, DOI 10.1093/jnci/90.12.882; Metro G, 2008, EXPERT OPIN PHARMACO, V9, P2583, DOI 10.1517/14656566.9.15.2583 ; Moasser MM, 2007, ONCOGENE, V26, P6577, DOI 10.1038/sj.onc.1210478; MOTOYAMA T, 1979, Acta Medica et Biologica, V27, P49; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Oka T, 2007, J BIOL CHEM, V282, P2011, DOI 10.1074/jbc.M605153200; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Sekiguchi M, 1983, SOSHIKIBAIYO, V9, P201; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; Stern DF, 2008, J MAMMARY GLAND BIOL, V13, P215, DOI 10.1007/s10911-008-9083-7; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tsukita S, 1999, CURR OPIN CELL BIOL, V11, P628, DOI 10.1016/S0955-0674(99)00016-2; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Xu QY, 2003, ONCOGENE, V22, P5537, DOI 10.1038/sj.onc.1206796; Yaguchi SI, 2006, JNCI-J NATL CANCER I, V98, P545, DOI 10.1093/jnci/djj133; YANAGIHARA K, 1991, CANCER RES, V51, P381; Yokota T, 1998, TOHOKU J EXP MED, V186, P121, DOI 10.1620/tjem.186.121; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Yokoyama A, 2007, BIOCHEM BIOPH RES CO, V355, P200, DOI 10.1016/j.bbrc.2007.01.133	36	1	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29599	10.1371/journal.pone.0029599	http://dx.doi.org/10.1371/journal.pone.0029599			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216327	Green Published, gold, Green Submitted			2022-12-27	WOS:000299684700073
J	Wolf, A; Beuerlein, K; Eckart, C; Weiser, H; Dickkopf, B; Muller, H; Sakurai, H; Kracht, M				Wolf, Alexander; Beuerlein, Knut; Eckart, Christoph; Weiser, Hendrik; Dickkopf, Beate; Mueller, Helmut; Sakurai, Hiroaki; Kracht, Michael			Identification and Functional Characterization of Novel Phosphorylation Sites in TAK1-Binding Protein (TAB) 1	PLOS ONE			English	Article							NF-KAPPA-B; KINASE KINASE KINASE; IL-1 SIGNALING PATHWAY; TAK1 MAPKKK; ACTIVATING PROTEIN; NUCLEAR EXPORT; IN-VIVO; CYTOKINE; P38-ALPHA; TRANSDUCTION	TAB1 was defined as a regulatory subunit of the protein kinase TAK1, which functions upstream in the pathways activated by interleukin (IL)-1, tumor necrosis factor (TNF), toll-like receptors (TLRs) and stressors. However, TAB1 also functions in the p38 MAPK pathway downstream of TAK1. We identified amino acids (aa) 452/453 and 456/457 of TAB1 as novel sites phosphorylated by TAK1 as well as by p38 MAPK in intact cells as well as in vitro. Serines 452/453 and 456/457 were phosphorylated upon phosphatase blockade by calyculin A, or in response to IL-1 or translational stressors such as anisomycin and sorbitol. Deletion or phospho-mimetic mutations of aa 452-457 of TAB1 retain TAB1 and p38 MAPK in the cytoplasm. The TAB1 mutant lacking aa 452-457 decreases TAB1-dependent phosphorylation of p38 MAPK. It also enhances TAB1-dependent CCL5 secretion in response to IL-1 and increases activity of a post-transcriptional reporter gene, which contains the CCL5 39 untranslated region. These data suggest a complex role of aa 452-457 of TAB1 in controlling p38 MAPK activity and subcellular localization and implicate these residues in TAK1-or p38 MAPK-dependent post-transcriptional control of gene expression.	[Wolf, Alexander; Beuerlein, Knut; Eckart, Christoph; Weiser, Hendrik; Dickkopf, Beate; Mueller, Helmut; Kracht, Michael] Univ Giessen, Rudolf Buchheim Inst Pharmacol, Giessen, Germany; [Sakurai, Hiroaki] Toyama Univ, Div Pathogen Biochem, Inst Nat Med, Toyama 930, Japan	Justus Liebig University Giessen; University of Toyama	Wolf, A (corresponding author), Univ Giessen, Rudolf Buchheim Inst Pharmacol, Giessen, Germany.	Michael.Kracht@pharma.med.uni-giessen.de	Sakurai, Hiroaki/AAE-4294-2019	Kracht, Michael/0000-0002-8501-043X; Sakurai, Hiroaki/0000-0003-0657-9570	Deutsche Forschungsgemeinschaft [Kr1143/5-3, Kr1143/7-1, TRR81/B2]; Excellence Cluster Cardio-Pulmonary System (ECCPS); LOEWE/UGMLC	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster Cardio-Pulmonary System (ECCPS)(German Research Foundation (DFG)); LOEWE/UGMLC	This work was supported by grants from the Deutsche Forschungsgemeinschaft Kr1143/5-3, Kr1143/7-1 and TRR81/B2 (to Dr. Kracht). Work from Dr. Kracht was further supported by the Excellence Cluster Cardio-Pulmonary System (ECCPS), and the LOEWE/UGMLC program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askari N, 2009, BIOCHEMISTRY-US, V48, P2497, DOI 10.1021/bi900024v; Baril C, 2009, GENETICS, V181, P567, DOI 10.1534/genetics.108.096461; Ben-Levy R, 1998, CURR BIOL, V8, P1049, DOI 10.1016/S0960-9822(98)70442-7; Bertelsen M, 2007, CELL SIGNAL, V19, P646, DOI 10.1016/j.cellsig.2006.08.017; Brown K, 2005, J MOL BIOL, V354, P1013, DOI 10.1016/j.jmb.2005.09.098; Casola A, 2002, AM J PHYSIOL-LUNG C, V283, pL1280, DOI 10.1152/ajplung.00162.2002; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Chuderland D, 2008, MOL CELL, V31, P850, DOI 10.1016/j.molcel.2008.08.007; Conner SH, 2006, BIOCHEM J, V399, P427, DOI 10.1042/BJ20061077; Dingwall C, 1998, CURR BIOL, V8, pR922, DOI 10.1016/S0960-9822(98)00010-4; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Gang L, 2006, J BIOL CHEM, V281, P6087, DOI 10.1074/jbc.M507610200; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Ge BX, 2003, J BIOL CHEM, V278, P2286, DOI 10.1074/jbc.M210918200; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; Hoffmann E, 2005, J BIOL CHEM, V280, P9706, DOI 10.1074/jbc.M407071200; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; Holtmann H, 2001, J BIOL CHEM, V276, P3508, DOI 10.1074/jbc.M004376200; Inagaki M, 2008, J BIOL CHEM, V283, P33080, DOI 10.1074/jbc.M807574200; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jin G, 2004, P NATL ACAD SCI USA, V101, P2028, DOI 10.1073/pnas.0307314101; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kang YJ, 2006, J BIOL CHEM, V281, P26225, DOI 10.1074/jbc.M606800200; Kettner-Buhrow D, 2006, BIOCHEM BIOPH RES CO, V347, P566, DOI 10.1016/j.bbrc.2006.06.121; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Li MG, 2003, J BIOL CHEM, V278, P12013, DOI 10.1074/jbc.M211474200; Liu QH, 2009, NAT CELL BIOL, V11, P154, DOI 10.1038/ncb1823; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Mendoza H, 2008, BIOCHEM J, V409, P711, DOI 10.1042/BJ20071149; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Ono K, 2001, J BIOL CHEM, V276, P24396, DOI 10.1074/jbc.M102631200; Prickett TD, 2008, J BIOL CHEM; Rzeczkowski K, 2011, J CELL BIOL, V194, P581, DOI 10.1083/jcb.201006089; Sakurai H, 2002, BIOCHEM BIOPH RES CO, V297, P1277, DOI 10.1016/S0006-291X(02)02379-3; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Thiefes A, 2005, J BIOL CHEM, V280, P27728, DOI 10.1074/jbc.M411657200; Thiefes A, 2006, EMBO REP, V7, P838, DOI 10.1038/sj.embor.7400754; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Zhou HM, 2006, MOL CELL BIOL, V26, P3824, DOI 10.1128/MCB.26.10.3824-3834.2006	53	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29256	10.1371/journal.pone.0029256	http://dx.doi.org/10.1371/journal.pone.0029256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216226	Green Published, Green Submitted, gold			2022-12-27	WOS:000299684700045
J	Chepelev, NL; Bennitz, JD; Huang, T; McBride, S; Willmore, WG				Chepelev, Nikolai L.; Bennitz, Joshua D.; Huang, Ting; McBride, Skye; Willmore, William G.			The Nrf1 CNC-bZIP Protein Is Regulated by the Proteasome and Activated by Hypoxia	PLOS ONE			English	Article							ANTIOXIDANT RESPONSE ELEMENT; TRANSCRIPTION FACTOR NRF1; ENDOPLASMIC-RETICULUM MEMBRANE; N-TERMINAL DOMAIN; OXIDATIVE STRESS; GENE-EXPRESSION; HEME OXYGENASE-1; PATHWAY; CELLS; DEGRADATION	Background: Nrf1 (nuclear factor-erythroid 2 p45 subunit-related factor 1) is a transcription factor mediating cellular responses to xenobiotic and pro-oxidant stress. Nrf1 regulates the transcription of many stress-related genes through the electrophile response elements (EpREs) located in their promoter regions. Despite its potential importance in human health, the mechanisms controlling Nrf1 have not been addressed fully. Principal Findings: We found that proteasomal inhibitors MG-132 and clasto-lactacystin-b-lactone stabilized the protein expression of full-length Nrf1 in both COS7 and WFF2002 cells. Concomitantly, proteasomal inhibition decreased the expression of a smaller, N-terminal Nrf1 fragment, with an approximate molecular weight of 23 kDa. The EpRE-luciferase reporter assays revealed that proteasomal inhibition markedly inhibited the Nrf1 transactivational activity. These results support earlier hypotheses that the 26 S proteasome processes Nrf1 into its active form by removing its inhibitory N-terminal domain anchoring Nrf1 to the endoplasmic reticulum. Immunoprecipitation demonstrated that Nrf1 is ubiquitinated and that proteasomal inhibition increased the degree of Nrf1 ubiquitination. Furthermore, Nrf1 protein had a half-life of approximately 5 hours in COS7 cells. In contrast, hypoxia (1% O-2) significantly increased the luciferase reporter activity of exogenous Nrf1 protein, while decreasing the protein expression of p65, a shorter form of Nrf1, known to act as a repressor of EpRE-controlled gene expression. Finally, the protein phosphatase inhibitor okadaic acid activated Nrf1 reporter activity, while the latter was repressed by the PKC inhibitor staurosporine. Conclusions: Collectively, our data suggests that Nrf1 is controlled by several post-translational mechanisms, including ubiquitination, proteolytic processing and proteasomal-mediated degradation as well as by its phosphorylation status.	[Chepelev, Nikolai L.; Bennitz, Joshua D.; Huang, Ting; McBride, Skye; Willmore, William G.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Willmore, William G.] Carleton Univ, Inst Biochem, Ottawa, ON K1S 5B6, Canada	Carleton University; Carleton University	Chepelev, NL (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	Bill_Willmore@carleton.ca		Bennitz, Joshua/0000-0003-3475-7848	Natural Sciences and Engineering Research Council (NSERC) of Canada	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada to WGW and an NSERC Canada Graduate Scholarship to NLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chepelev NL, 2011, FREE RADICAL BIO MED, V50, P645, DOI 10.1016/j.freeradbiomed.2010.12.023; Dickinson DA, 2003, FASEB J, V17, P473, DOI 10.1096/fj.02-0566fje; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Kitamuro T, 2003, J BIOL CHEM, V278, P9125, DOI 10.1074/jbc.M209939200; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kuznetsova AV, 2003, P NATL ACAD SCI USA, V100, P2706, DOI 10.1073/pnas.0436037100; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; Magnani M., 2000, Current Drug Targets, V1, P387, DOI 10.2174/1389450003349056; Mera K, 2010, BIOCHEM BIOPH RES CO, V397, P350, DOI 10.1016/j.bbrc.2010.05.128; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; NIKI E, 1990, METHOD ENZYMOL, V186, P100; Nouhi Z, 2007, FEBS LETT, V581, P5401, DOI 10.1016/j.febslet.2007.10.041; Numazawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC334, DOI 10.1152/ajpcell.00043.2003; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Satoh T, 2009, BIOCHEM BIOPH RES CO, V380, P298, DOI 10.1016/j.bbrc.2009.01.063; SCHNEIDERPOETSC.T, 2010, CHEM BIOL, V6, P209; Schultz Michelle A, 2010, Cancers (Basel), V2, P1354, DOI 10.3390/cancers2021354; Sekhar KR, 2002, ONCOGENE, V21, P6829, DOI 10.1038/sj.onc.1205905; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Tanaka K, 2001, BIOCHIMIE, V83, P351, DOI 10.1016/S0300-9084(01)01237-8; TERAO K, 1986, Journal of Free Radicals in Biology and Medicine, V2, P193; Waleh NS, 1998, CARCINOGENESIS, V19, P1333, DOI 10.1093/carcin/19.8.1333; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Yamasaki M, 2007, ONCOL REP, V18, P1145; Zhang H, 2008, AM J RESP CELL MOL, V38, P483, DOI 10.1165/rcmb.2007-0260OC; Zhang HQ, 2010, BBA-GENE REGUL MECH, V1799, P496, DOI 10.1016/j.bbagrm.2010.05.003; Zhang Y, 2007, BIOCHEM J, V408, P161, DOI 10.1042/BJ20070761; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhang YG, 2010, BIOCHEM J, V430, P497, DOI 10.1042/BJ20100471; Zhang YG, 2009, BIOCHEM J, V418, P293, DOI 10.1042/BJ20081575; Zhao R, 2011, ENVIRON HEALTH PERSP, V119, P56, DOI 10.1289/ehp.1002304; Zhu M, 2001, BIOCHEM BIOPH RES CO, V289, P212, DOI 10.1006/bbrc.2001.5944	50	28	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29167	10.1371/journal.pone.0029167	http://dx.doi.org/10.1371/journal.pone.0029167			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216197	gold, Green Published, Green Submitted			2022-12-27	WOS:000299113600062
J	De Vleeschauwer, S; Jungraithmayr, W; Wauters, S; Willems, S; Rinaldi, M; Vaneylen, A; Verleden, S; Willems-Widyastuti, A; Bracke, K; Brusselle, G; Verbeken, E; Van Raemdonck, D; Verleden, G; Vanaudenaerde, B				De Vleeschauwer, Stephanie; Jungraithmayr, Wolfgang; Wauters, Shana; Willems, Stijn; Rinaldi, Manuela; Vaneylen, Annemie; Verleden, Stijn; Willems-Widyastuti, Anna; Bracke, Ken; Brusselle, Guy; Verbeken, Erik; Van Raemdonck, Dirk; Verleden, Geert; Vanaudenaerde, Bart			Chronic Rejection Pathology after Orthotopic Lung Transplantation in Mice: The Development of a Murine BOS Model and Its Drawbacks	PLOS ONE			English	Article							OBLITERATIVE BRONCHIOLITIS; ANIMAL-MODEL; MOUSE MODEL; ALLOGRAFT; INJURY	Almost all animal models for chronic rejection (CR) after lung transplantation (LTx) fail to resemble the human situation. It was our attempt to develop a representative model of CR in mice. Orthotopic LTx was performed in allografts receiving daily immunosuppression with steroids and cyclosporine. Controls included isografts and mice only undergoing thoracotomy (SHAM). Allografts were sacrificed 2, 4, 6, 8, 10 or 12 weeks after LTx. Pulmonary function was measured repeatedly in the 12w allografts, isografts and SHAM mice. Histologically, all allografts demonstrated acute rejection (AR) around the blood vessels and airways two weeks after LTx. This decreased to 50-75% up to 10 weeks and was absent after 12 weeks. Obliterative bronchiolitis (OB) lesions were observed in 25-50% of the mice from 4-12 weeks. Isografts and lungs of SHAM mice were normal after 12 weeks. Pulmonary function measurements showed a decline in FEV0.1, TLC and compliance in the allografts postoperatively (2 weeks) with a slow recovery over time. After this initial decline, lung function of allografts increased more than in isografts and SHAM mice indicating that pulmonary function measurement is not a good tool to diagnose CR in a mouse. We conclude that a true model for CR, with clear OB lesions in about one third of the animals, but without a decline in lung function, is possible. This model is an important step forward in the development of an ideal model for CR which will open new perspectives in unraveling CR pathogenesis and exploring new treatment options.	[De Vleeschauwer, Stephanie; Willems, Stijn; Rinaldi, Manuela; Vaneylen, Annemie; Verleden, Stijn; Willems-Widyastuti, Anna; Verleden, Geert; Vanaudenaerde, Bart] Katholieke Univ Leuven, Lab Pneumol, Louvain, Belgium; [Wauters, Shana; Van Raemdonck, Dirk] Katholieke Univ Leuven, Lab Expt Thorac Surg, Louvain, Belgium; [Verleden, Geert] Univ Hosp Leuven, Dept Pneumol, Louvain, Belgium; [Van Raemdonck, Dirk] Univ Hosp Leuven, Dept Thorac Surg, Louvain, Belgium; [Verbeken, Erik] Univ Hosp Leuven, Dept Pathol, Louvain, Belgium; [Jungraithmayr, Wolfgang] Univ Zurich Hosp, Lab Thorac Surg, CH-8091 Zurich, Switzerland; [Bracke, Ken; Brusselle, Guy] Univ Hosp Gent, Dept Resp Med, Ghent, Belgium	KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; University of Zurich; University Zurich Hospital; Ghent University; Ghent University Hospital	De Vleeschauwer, S (corresponding author), Katholieke Univ Leuven, Lab Pneumol, Louvain, Belgium.	bart.vanaudenaerde@med.kuleuven.be	Jungraithmayr, Wolfgang/F-3882-2015; Bracke, Ken R/GSN-7630-2022; Van Raemdonck, Dirk/AAL-4147-2020	Jungraithmayr, Wolfgang/0000-0002-1442-4862; Bracke, Ken R/0000-0001-5906-4605; Verleden, Stijn/0000-0002-9656-5844; Vanaudenaerde, Bart/0000-0001-6435-6901; Widyastuti, Anna/0000-0003-2149-935X; Van Raemdonck, Dirk/0000-0003-1261-0992; Brusselle, Guy/0000-0001-7021-8505	KUL [OT/050/10]; FWO (Fonds Wetenschappelijk Onderzoek)-Flanders [G.0643.08, G.0723.10]	KUL; FWO (Fonds Wetenschappelijk Onderzoek)-Flanders	GV is holder of the GSK (Belgium) chair in respiratory pharmacology at the Katholieke Universiteit Leuven (KUL), and is supported by grants from the KUL (OT/050/10) and the FWO (Fonds Wetenschappelijk Onderzoek)-Flanders: G.0643.08 and G.0723.10. DVR and BV are senior clinical investigators of the FWO-Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel JZ, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-87; CASTANEDA AR, 1972, J CARDIOVASC SURG, V13, P523; De Vleeschauwer SI, 2011, LAB ANIM-UK, V45, P81, DOI 10.1258/la.2010.010111; Draenert A, 2011, INT J EXP PATHOL, V92, P18, DOI 10.1111/j.1365-2613.2010.00752.x; Egan JJ, 2004, AM J RESP CRIT CARE, V170, P931, DOI 10.1164/rccm.2408010; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Fan L, 2011, AM J TRANSPLANT, V11, P911, DOI 10.1111/j.1600-6143.2011.03482.x; Gelman AE, 2008, J IMMUNOL, V180, P4754, DOI 10.4049/jimmunol.180.7.4754; Glanville AR, 2008, AM J RESP CRIT CARE, V177, P1033, DOI 10.1164/rccm.200706-951OC; HAMMAINEN PT, 1993, SCAND J THORAC CARD, V27, P71, DOI 10.3109/14017439309098694; Hele DJ, 2001, RESPIR RES, V2, P169, DOI 10.1186/rr55; Jungraithmayr W, 2010, EUR RESPIR J, V35, P1354, DOI 10.1183/09031936.00110609; Jungraithmayr W, 2010, PEPTIDES, V31, P585, DOI 10.1016/j.peptides.2009.12.012; Jungraithmayr WM, 2009, J THORAC CARDIOV SUR, V137, P486, DOI 10.1016/j.jtcvs.2008.10.007; McDyer John F, 2007, Proc Am Thorac Soc, V4, P37, DOI 10.1513/pats.200605-107JG; Okazaki M, 2007, AM J TRANSPLANT, V7, P1672, DOI 10.1111/j.1600-6143.2007.01819.x; Okazaki M, 2007, AM J RESP CELL MOL, V37, P625, DOI 10.1165/rcmb.2007-0257RC; Sayegh MH, 2004, NEW ENGL J MED, V351, P2761, DOI 10.1056/NEJMon043418; Stewart S, 2007, J HEART LUNG TRANSPL, V26, P1229, DOI 10.1016/j.healun.2007.10.017; Svetlecic J, 2004, LUNG, V182, P119, DOI 10.1007/s00408-003-1049-3; VEITH FJ, 1970, ANN SURG, V171, P553, DOI 10.1097/00000658-197004000-00012; Vessie EL, 2005, TRANSPL IMMUNOL, V15, P35, DOI 10.1016/j.trim.2005.02.006; Voswinckel R, 2004, EUR RESPIR J, V24, P524, DOI 10.1183/09031936.04.10004904	23	33	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29802	10.1371/journal.pone.0029802	http://dx.doi.org/10.1371/journal.pone.0029802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238655	gold, Green Published, Green Submitted			2022-12-27	WOS:000301188800039
J	Hubner, TR				Huebner, Tom R.			Bone Histology in Dysalotosaurus lettowvorbecki (Ornithischia: Iguanodontia) - Variation, Growth, and Implications	PLOS ONE			English	Article							PREDICTING BODY-MASS; SAUROPOD DINOSAURS; BEHAVIORAL-IMPLICATIONS; ALLOMETRIC EQUATIONS; TYRANNOSAURUS-REX; SEXUAL-MATURITY; RELATIVE GROWTH; PATTERNS; RATES; AGE	Background: Dysalotosaurus lettowvorbecki is a small ornithopod dinosaur known from thousands of bones and several ontogenetic stages. It was found in a single locality within the Tendaguru Formation of southeastern Tanzania, possibly representing a single herd. Dysalotosaurus provides an excellent case study for examining variation in bone microstructure and life history and helps to unravel the still mysterious growth pattern of small ornithopods. Methodology/Principal Findings: Five different skeletal elements were sampled, revealing microstructural variation between individuals, skeletal elements, cross sectional units, and ontogenetic stages. The bone wall consists of fibrolamellar bone with strong variability in vascularization and development of growth cycles. Larger bones with a high degree of utilization have high relative growth rates and seldom annuli/LAGs, whereas small and less intensively used bones have lower growth rates and a higher number of these resting lines. Due to the scarcity of annuli/LAGs, the reconstruction of the life history of Dysalotosaurus was carried out using regularly developed and alternating slow and fast growing zones. Dysalotosaurus was a precocial dinosaur, which experienced sexual maturity at ten years, had an indeterminate growth pattern, and maximum growth rates comparable to a large kangaroo. Conclusions/Significance: The variation in the bone histology of Dysalotosaurus demonstrates the influence of size, utilization, and shape of bones on relative growth rates. Annuli/LAGs are not the only type of annual growth cycles that can be used to reconstruct the life history of fossil vertebrates, but the degree of development of these lines may be of importance for the reconstruction of paleobehavior. The regular development of annuli/LAGs in subadults and adults of large ornithopods therefore reflects higher seasonal stress due to higher food demands, migration, and altricial breeding behavior. Small ornithopods often lack regularly developed annuli/LAGs due to lower food demands, no need for migration, and precocial behavior.	Niedersachs Landesmuseum Hannover, Hannover, Germany		Hubner, TR (corresponding author), Niedersachs Landesmuseum Hannover, Hannover, Germany.	Tom-Ray@gmx.net			Deutsche Forschungsgemeinschaft (DFG) [RA1012/4-1, RA1012/4-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was funded by the grants RA1012/4-1 and RA1012/4-2 of the Deutsche Forschungsgemeinschaft (DFG) www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberhan M., 2002, MITTEILUNGEN MUSEUM, V2, P201; Amprino R., 1947, ARCH BIOL SCI, V58, P315; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Andrews R.M., 1982, Biology of Reptilia, V13, P273; Bell PR, 2008, ALCHERINGA, V32, P271, DOI 10.1080/03115510802096101; Botha J, 2005, PALAEONTOLOGY, V48, P385, DOI 10.1111/j.1475-4983.2005.00447.x; Botha J, 2000, J VERTEBR PALEONTOL, V20, P705, DOI 10.1671/0272-4634(2000)020[0705:GPDFTB]2.0.CO;2; BURR DB, 1992, ANAT RECORD, V232, P180, DOI 10.1002/ar.1092320203; Bussert R, 2009, FOSS REC, V12, P141, DOI 10.1002/mmng.200900004; Bybee PJ, 2006, J MORPHOL, V267, P347, DOI 10.1002/jmor.10406; Carrano MT, 1999, ACTA PALAEONTOL POL, V44, P237; CARRIER D, 1990, J ZOOL, V222, P375, DOI 10.1111/j.1469-7998.1990.tb04039.x; CASE TJ, 1978, PALEOBIOLOGY, V4, P320, DOI 10.1017/S0094837300006023; Castanet J, 1977, Bulletin biol Fr Belg, V111, P183; Castanet J, 2004, J ZOOL, V263, P31, DOI 10.1017/S0952836904004844; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Castanet J., 1993, BONE, P245; Cawley GC, 2010, J ZOOL, V280, P355, DOI 10.1111/j.1469-7998.2009.00665.x; Cerda IA, 2008, AMEGHINIANA, V45, P529; Chinsamy A, 2008, BIOL LETTERS, V4, P282, DOI 10.1098/rsbl.2008.0004; CHINSAMY A, 1995, J VERTEBR PALEONTOL, V15, P96, DOI 10.1080/02724634.1995.10011209; Chinsamy A, 1998, J VERTEBR PALEONTOL, V18, P385, DOI 10.1080/02724634.1998.10011066; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; Chinsamy A, 1993, OWEN MOD GEOL, V18, P319; Chinsamy A, 2006, ACTA PALAEONTOL POL, V51, P325; Chinsamy A, 2009, ANAT REC, V292, P1478, DOI 10.1002/ar.20991; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Chure Daniel, 1994, P298; Cooper LN, 2008, P ROY SOC B-BIOL SCI, V275, P2609, DOI 10.1098/rspb.2008.0912; CURREY J, 1984, AM ZOOL, V24, P5; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; de Buffrenil V, 2008, J MORPHOL, V269, P533, DOI 10.1002/jmor.10604; de Margerie E, 2004, J EXP BIOL, V207, P869, DOI 10.1242/jeb.00841; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; de Ricqles A., 1983, Acta Palaeontologica Polonica, V28, P225; de Ricqles A.J., 1976, Linnean Soc Symp Ser, V3, P123; de Ricqles AJ, 2000, ZOOL J LINN SOC-LOND, V129, P349, DOI 10.1006/zjls.1999.0239; de Ricqles Armand J., 2003, Annales de Paleontologie, V89, P67, DOI 10.1016/S0753-3969(03)00005-3; DODSON P, 1975, J ZOOL, V175, P315; Enlow D. E., 1958, Texas Journal of Science, V10, P187; ENLOW DH, 1962, AM J ANAT, V110, P79, DOI 10.1002/aja.1001100202; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 1999, NATURE, V398, P205, DOI 10.1038/18343; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Erickson GM, 2006, SCIENCE, V313, P213, DOI 10.1126/science.1125721; Forster CA, 1990, OSTROM J PAL, V64, P164; Francillon-Vieillot H., 1990, P471; GALTON PM, 1977, NATURE, V268, P230, DOI 10.1038/268230a0; Heinrich Wolf-Dieter, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V2, P25; HOLMES J. R., 1958, JOUR COMP PATH AND THERAP, V68, P439, DOI 10.1016/S0368-1742(58)80049-1; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 2009, J VERTEBR PALEONTOL, V29, P734, DOI 10.1671/039.029.0312; Horner John R., 1994, P312; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; HORNER JR, 1979, NATURE, V282, P296, DOI 10.1038/282296a0; HORNER JR, 1988, NATURE, V332, P256, DOI 10.1038/332256a0; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; Hubner TR, 2011, THESIS LUDWIGMAXIMIL; Hubner TR, 2010, ZOOL J LINN SOC-LOND, V160, P366, DOI 10.1111/j.1096-3642.2010.00620.x; Huh M, 2010, NEUES JAHRB GEOL P-A, V259, P1, DOI 10.1127/0077-7749/2010/0102; HUTTON JM, 1986, COPEIA, P332, DOI 10.2307/1444994; Janensch W., 1914, ARCH BIONTOLOGIE, V3, P227; JARMAN P J, 1973, East African Wildlife Journal, V11, P329; Jorgenson JT, 1997, ECOLOGY, V78, P1019, DOI 10.1890/0012-9658(1997)078[1019:EOASDA]2.0.CO;2; Klein N, 2004, THESIS RHEINISCHE F; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Klein N, 2007, SP PALAEONT, P169; Klein N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011613; Klevezal G., 1996, RECORDING STRUCTURES; Lee AH, 2004, J ANAT, V204, P197, DOI 10.1111/j.0021-8782.2004.00275.x; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Lehman Thomas M., 2007, P259; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; Maier G., 2003, AFRICAN DINOSAURS UN; Mihlbachler MC, 2003, PALEOBIOLOGY, V29, P412, DOI 10.1666/0094-8373(2003)029<0412:DOLMRT>2.0.CO;2; Mulhern DM, 2003, AM J PHYS ANTHROPOL, V122, P127, DOI 10.1002/ajpa.10294; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P393; NORMAN DB, 1985, AM NAT, V126, P151, DOI 10.1086/284406; OWENSMITH N, 1993, J ANIM ECOL, V62, P428, DOI 10.2307/5192; Packard GC, 2009, J ZOOL, V279, P102, DOI 10.1111/j.1469-7998.2009.00594.x; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; PEABODY FE, 1961, J MORPHOL, V108, P11, DOI 10.1002/jmor.1051080103; Proaktor G, 2008, ECOLOGY, V89, P2604, DOI 10.1890/07-0833.1; Ray R, 2004, J VERTEBR PALEONTOL, V24, P634; Ray S, 2004, J VERTEBR PALEONTOL, V24, P180, DOI 10.1671/1914-14; Reck H., 1925, GEOLOGISCHE CHARAKTE, V31, P1; Redelstorff R, 2009, J VERTEBR PALEONTOL, V29, p170A; REID REH, 1984, S ZOOLOGICAL SOC LON, V52, P629; Ricqles A., 1991, BONE BONE MATRIX BON, V3, P1, DOI DOI 10.1111/J.0021-8782.2004.00275.X; Rimblot-Baly Frederique, 1995, Annales de Paleontologie, V81, P49; RUSSELL DA, 1980, MEMOIRES SOC GEOLOGI, V139, P169; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Sander PM, 2004, ORG DIVERS EVOL, V4, P165, DOI 10.1016/j.ode.2003.12.002; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Scheetz R.D., 1999, THESIS MONTANA STATE; Schweitzer MH, 2005, SCIENCE, V308, P1456, DOI 10.1126/science.1112158; SINGH IJ, 1974, J MORPHOL, V144, P421, DOI 10.1002/jmor.1051440404; Starck JM, 2002, J MORPHOL, V254, P232, DOI 10.1002/jmor.10029; Tumarkin-Deratzian AR, 2009, ANAT REC, V292, P1485, DOI 10.1002/ar.20972; TUMARKINDERATZI.AR, 2003, THESIS U PENNSYLVANI; Turvey ST, 2005, NATURE, V435, P940, DOI 10.1038/nature03635; Varricchio DJ, 2007, P ROY SOC B-BIOL SCI, V274, P1361, DOI 10.1098/rspb.2006.0443; Varricchio David J., 1993, Journal of Vertebrate Paleontology, V13, P99; WELLS JW, 1963, NATURE, V197, P948, DOI 10.1038/197948a0; Werning S, 2005, THESIS U OKLAHOMA NO; Winkler D. A., 1994, Journal of Vertebrate Paleontology, V14, p53A; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Woodward HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023339; Woodward HN, 2009, J VERTEBR PALEONTOL, V29, P807, DOI 10.1671/039.029.0310	115	63	64	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29958	10.1371/journal.pone.0029958	http://dx.doi.org/10.1371/journal.pone.0029958			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238683	Green Published, gold			2022-12-27	WOS:000301188800053
J	Li, SH; Nachtigall, PE; Breese, M; Supin, AY				Li, Songhai; Nachtigall, Paul E.; Breese, Marlee; Supin, Alexander Ya.			Hearing Sensation Levels of Emitted Biosonar Clicks in an Echolocating Atlantic Bottlenose Dolphin	PLOS ONE			English	Article							FALSE KILLER WHALE; MESOPLODON-DENSIROSTRIS; NEURAL ATTENUATION; TURSIOPS-TRUNCATUS; RESPONSES; BEHAVIOR; PREY; PORPOISES; PULSES; SOUNDS	Emitted biosonar clicks and auditory evoked potential (AEP) responses triggered by the clicks were synchronously recorded during echolocation in an Atlantic bottlenose dolphin (Tursiops truncatus) trained to wear suction-cup EEG electrodes and to detect targets by echolocation. Three targets with target strengths of -34, -28, and -22 dB were used at distances of 2 to 6.5 m for each target. The AEP responses were sorted according to the corresponding emitted click source levels in 5-dB bins and averaged within each bin to extract biosonar click-related AEPs from noise. The AEP amplitudes were measured peak-to-peak and plotted as a function of click source levels for each target type, distance, and target-present or target-absent condition. Hearing sensation levels of the biosonar clicks were evaluated by comparing the functions of the biosonar click-related AEP amplitude-versus-click source level to a function of external (in free field) click-related AEP amplitude-versus-click sound pressure level. The results indicated that the dolphin's hearing sensation levels to her own biosonar clicks were equal to that of external clicks with sound pressure levels 16 to 36 dB lower than the biosonar click source levels, varying with target type, distance, and condition. These data may be assumed to indicate that the bottlenose dolphin possesses effective protection mechanisms to isolate the self-produced intense biosonar beam from the animal's ears during echolocation.	[Li, Songhai; Nachtigall, Paul E.; Breese, Marlee] Univ Hawaii, Marine Mammal Res Program, Hawaii Inst Marine Biol, Kailua, HI USA; [Supin, Alexander Ya.] Russian Acad Sci, Inst Ecol & Evolut, Moscow, Russia; [Li, Songhai] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Peoples R China	University of Hawaii System; Russian Academy of Sciences; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Li, SH (corresponding author), Natl Univ Singapore, Marine Mammal Res Lab, Trop Marine Sci Inst, Singapore 117548, Singapore.	songhai@hawaii.edu	Li, Songhai/A-2652-2012	Li, Songhai/0000-0003-4977-1722	Office of Naval Research [N00014-08-1-1106]	Office of Naval Research(Office of Naval Research)	The study was supported by the Office of Naval Research Grant No. N00014-08-1-1106 to PEN with thanks to Bob Gisiner, Mike Weiss and Neil Abercrombie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2005, P ROY SOC B-BIOL SCI, V272, P797, DOI 10.1098/rspb.2004.3024; Akamatsu T, 2010, J EXP BIOL, V213, P146, DOI 10.1242/jeb.037655; Au W. W., 1993, SONAR DOLPHINS; Gellermann LW, 1933, PEDAGOG SEMIN J GEN, V42, P206; Ibsen SD, 2009, J ACOUST SOC AM, V125, P1214, DOI 10.1121/1.3050274; Johnson M, 2008, P ROY SOC B-BIOL SCI, V275, P133, DOI 10.1098/rspb.2007.1190; Johnson M, 2004, P ROY SOC B-BIOL SCI, V271, pS383, DOI 10.1098/rsbl.2004.0208; Li SH, 2011, J EXP BIOL, V214, P2027, DOI 10.1242/jeb.053397; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Mohl B, 2003, J ACOUST SOC AM, V114, P1143, DOI 10.1121/1.1586258; Nachtigall P. E., 1988, ANIMAL SONAR PROCESS; Nachtigall PE, 2008, J EXP BIOL, V211, P1714, DOI 10.1242/jeb.013862; Norris K. S., 1968, BIOL MARINE MAMMALS, P391; POPOV VV, 1990, J COMP PHYSIOL A, V166, P385; SCHEVILL WE, 1953, J EXP ZOOL, V124, P147, DOI 10.1002/jez.1401240108; SCHEVILL WE, 1953, J ACOUST SOC AM, V25, P1016, DOI 10.1121/1.1907202; SCHUSTERMAN RJ, 1980, ANIMAL SONAR SYSTEMS, P11; Soto NA, 2008, J ANIM ECOL, V77, P936, DOI 10.1111/j.1365-2656.2008.01393.x; SUGA N, 1972, SCIENCE, V177, P82, DOI 10.1126/science.177.4043.82; SUGA N, 1974, SCIENCE, V183, P1211, DOI 10.1126/science.183.4130.1211; Supin AY, 2006, J ACOUST SOC AM, V120, P518, DOI 10.1121/1.2202862; Supin AY, 2010, J ACOUST SOC AM, V127, P3830, DOI 10.1121/1.3425733; Supin AY, 2004, J ACOUST SOC AM, V115, P3218, DOI 10.1121/1.1707088; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Zimmer WMX, 2005, J ACOUST SOC AM, V117, P3919, DOI 10.1121/1.1910225	25	42	44	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29793	10.1371/journal.pone.0029793	http://dx.doi.org/10.1371/journal.pone.0029793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238654	Green Submitted, gold, Green Published			2022-12-27	WOS:000301188800038
J	Ling, DJ				Ling, Daijun			SASqPCR: Robust and Rapid Analysis of RT-qPCR Data in SAS	PLOS ONE			English	Article							DATA NORMALIZATION; PCR DATA	Reverse transcription quantitative real-time PCR (RT-qPCR) is a key method for measurement of relative gene expression. Analysis of RT-qPCR data requires many iterative computations for data normalization and analytical optimization. Currently no computer program for RT-qPCR data analysis is suitable for analytical optimization and user-controllable customization based on data quality, experimental design as well as specific research aims. Here I introduce an all-in-one computer program, SASqPCR, for robust and rapid analysis of RT-qPCR data in SAS. This program has multiple macros for assessment of PCR efficiencies, validation of reference genes, optimization of data normalizers, normalization of confounding variations across samples, and statistical comparison of target gene expression in parallel samples. Users can simply change the macro variables to test various analytical strategies, optimize results and customize the analytical processes. In addition, it is highly automatic and functionally extendable. Thus users are the actual decision-makers controlling RT-qPCR data analyses. SASqPCR and its tutorial are freely available at http://code.google.com/p/sasqpcr/downloads/list.	Beckman Res Inst City Hope, Dept Neurosci, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope	Ling, DJ (corresponding author), Beckman Res Inst City Hope, Dept Neurosci, Duarte, CA USA.	lingdaijun@gmail.com			American Federation for Aging Research; Sidell-kagan Foundation; American Health Assistance Foundation	American Federation for Aging Research; Sidell-kagan Foundation; American Health Assistance Foundation(BrightFocus Foundation)	The author received no outside funding for this work. However, the author's salary was supported by American Federation for Aging Research (a postdoctoral fellowship to the author in 2009-2010), Sidell-kagan Foundation and American Health Assistance Foundation (grants to Paul M. Salvaterra, Ph.D., Department of Neuroscience, Beckman Research Institute of City of Hope, California). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Ling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017762; Ling DJ, 2011, ACTA NEUROPATHOL, V121, P183, DOI 10.1007/s00401-010-0772-0; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pfaffl Michael W., 2009, P65; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, P47	12	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29788	10.1371/journal.pone.0029788	http://dx.doi.org/10.1371/journal.pone.0029788			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238653	Green Published, Green Submitted, gold			2022-12-27	WOS:000301188800037
J	Del Giudice, M; Booth, T; Irwing, P				Del Giudice, Marco; Booth, Tom; Irwing, Paul			The Distance Between Mars and Venus: Measuring Global Sex Differences in Personality	PLOS ONE			English	Article							HIGHER-ORDER FACTORS; BIG 5; GENDER-DIFFERENCES; HEXACO MODEL; TRAITS; SELECTION; ASSOCIATIONS; PROMISCUITY; DIMENSIONS; SCHIZOTYPY	Background: Sex differences in personality are believed to be comparatively small. However, research in this area has suffered from significant methodological limitations. We advance a set of guidelines for overcoming those limitations: (a) measure personality with a higher resolution than that afforded by the Big Five; (b) estimate sex differences on latent factors; and (c) assess global sex differences with multivariate effect sizes. We then apply these guidelines to a large, representative adult sample, and obtain what is presently the best estimate of global sex differences in personality. Methodology/Principal Findings: Personality measures were obtained from a large US sample (N = 10,261) with the 16PF Questionnaire. Multigroup latent variable modeling was used to estimate sex differences on individual personality dimensions, which were then aggregated to yield a multivariate effect size (Mahalanobis D). We found a global effect size D = 2.71, corresponding to an overlap of only 10% between the male and female distributions. Even excluding the factor showing the largest univariate ES, the global effect size was D = 1.71 (24% overlap). These are extremely large differences by psychological standards. Significance: The idea that there are only minor differences between the personality profiles of males and females should be rejected as based on inadequate methodology.	[Del Giudice, Marco] Univ Turin, Dept Psychol, Turin, Italy; [Booth, Tom; Irwing, Paul] Univ Manchester, Manchester Business Sch, Manchester M13 9PL, Lancs, England	University of Turin; University of Manchester	Del Giudice, M (corresponding author), Univ Turin, Dept Psychol, Turin, Italy.	marco.delgiudice@unito.it	Del Giudice, Marco/F-7007-2010; Carroll, Joseph/D-1158-2011	Del Giudice, Marco/0000-0001-8526-1573; Carroll, Joseph/0000-0003-2656-1378; Booth, Tom/0000-0002-4235-1381; Irwing, Paul/0000-0002-4751-2156	Regione Piemonte, bando Scienze Umane e Sociali [4/2006]	Regione Piemonte, bando Scienze Umane e Sociali(Regione Piemonte)	Marco Del Giudice was supported by Regione Piemonte, bando Scienze Umane e Sociali 2008, L.R. n. 4/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer J, 2009, BEHAV BRAIN SCI, V32, P249, DOI 10.1017/S0140525X09990951; Ashton MC, 2007, PERS SOC PSYCHOL REV, V11, P150, DOI 10.1177/1088868306294907; Ashton MC, 2010, J RES PERS, V44, P734, DOI 10.1016/j.jrp.2010.09.003; BENTLER PM, 1978, J CONSULT CLIN PSYCH, V46, P1053, DOI 10.1037/0022-006X.46.5.1053; Biernat M, 2003, AM PSYCHOL, V58, P1019, DOI 10.1037/0003-066X.58.12.1019; Booth T, 2011, PERS INDIV DIFFER, V50, P553, DOI 10.1016/j.paid.2010.11.026; Bourdage JS, 2007, PERS INDIV DIFFER, V43, P1506, DOI 10.1016/j.paid.2007.04.008; Buss DM, 2011, SEX ROLES, V64, P768, DOI 10.1007/s11199-011-9987-3; BUSS DM, 1995, AM PSYCHOL, V50, P164, DOI 10.1037/0003-066X.50.3.164; Cattell HEP, 2008, SAGE HDB PERSONALITY; CATTELL RB, 1995, EDUC PSYCHOL MEAS, V55, P926, DOI 10.1177/0013164495055006002; CHURCH AT, 1994, J PERS SOC PSYCHOL, V66, P93, DOI 10.1037/0022-3514.66.1.93; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conn S.R., 1994, 16PF 5 EDITION TECHN; Costa PT, 2001, J PERS SOC PSYCHOL, V81, P322, DOI [10.1037/0022-3514.81.2.322, 10.1037//0022-3514.81.2.322]; COSTA PT, 1995, J PERS ASSESS, V64, P21, DOI 10.1207/s15327752jpa6401_2; Davies APC, 2008, FDN EVOLUTIONARY PSY, P261; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Del Giudice M, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00041; Del Giudice M, 2009, EVOL PSYCHOL-US, V7, P264, DOI 10.1177/147470490900700209; DeYoung CG, 2007, J PERS SOC PSYCHOL, V93, P880, DOI 10.1037/0022-3514.93.5.880; DeYoung CG, 2006, J PERS SOC PSYCHOL, V91, P1138, DOI 10.1037/0022-3514.91.6.1138; Digman JM, 1997, J PERS SOC PSYCHOL, V73, P1246, DOI 10.1037/0022-3514.73.6.1246; Eagly AH, 1999, AM PSYCHOL, V54, P408, DOI 10.1037/0003-066X.54.6.408; EAGLY AH, 1995, AM PSYCHOL, V50, P145, DOI 10.1037/0003-066X.50.3.145; Ellis L., 2008, SEX DIFFERENCES SUMM; Fausto-Sterling Anne, 1992, MYTHS GENDER BIOL TH; French BF, 2006, STRUCT EQU MODELING, V13, P378, DOI 10.1207/s15328007sem1303_3; Geary D.C., 2010, MALE FEMALE EVOLUTIO; Halpern Diane F, 2007, Psychol Sci Public Interest, V8, P1, DOI 10.1111/j.1529-1006.2007.00032.x; HARNER EJ, 1977, THEOR POPUL BIOL, V12, P21, DOI 10.1016/0040-5809(77)90033-8; Haselton MG, 2006, HUM NATURE-INT BIOS, V17, P50, DOI 10.1007/s12110-006-1020-0; Hedges LV, 2008, CHILD DEV PERSPECT, V2, P167, DOI 10.1111/j.1750-8606.2008.00060.x; Hough LM, 2001, INT J SELECT ASSESS, V9, P152, DOI 10.1111/1468-2389.00171; Huberty C. J, 2005, MAHALANOBIS DISTANCE; Hyde JS, 2006, AM PSYCHOL, V61, P641, DOI 10.1037/0003-066X.61.6.641b; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; Jonason PK, 2009, EUR J PERSONALITY, V23, P5, DOI 10.1002/per.698; Just C, 2011, PERS INDIV DIFFER, V50, P765, DOI 10.1016/j.paid.2011.01.008; KELLY EL, 1987, J PERS SOC PSYCHOL, V52, P27, DOI 10.1037/0022-3514.52.1.27; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; Lee K, 2005, J PERS, V73, P1437, DOI 10.1111/j.1467-6494.2005.00354.x; Lippa RA, 2010, PERS SOC PSYCHOL COM, V3, P1; Lippa RA, 2006, AM PSYCHOL, V61, P639, DOI 10.1037/0003-066X.61.6.639; Lucas RE, 2000, J PERS SOC PSYCHOL, V79, P452, DOI 10.1037//0022-3514.79.3.452; Maccoby E.E., 1978, PSYCHOL SEX DIFFEREN, V2; Markey PM, 2007, J RES PERS, V41, P1199, DOI 10.1016/j.jrp.2007.02.004; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Merz EL, 2011, PERS INDIV DIFFER, V51, P915, DOI 10.1016/j.paid.2011.07.022; Miller GF, 2007, SCHIZOPHR RES, V93, P317, DOI 10.1016/j.schres.2007.02.007; Musek J, 2007, J RES PERS, V41, P1213, DOI 10.1016/j.jrp.2007.02.003; Nettle D, 2006, P ROY SOC B-BIOL SCI, V273, P611, DOI 10.1098/rspb.2005.3349; Nettle D., 2007, OXFORD HDB EVOLUTION, P479; Noftle EE, 2006, J RES PERS, V40, P179, DOI 10.1016/j.jrp.2004.11.003; Powell DM, 2011, PERS INDIV DIFFER, V50, P106, DOI 10.1016/j.paid.2010.09.010; R Core Team, 2021, R LANGUAGE ENV STAT; Reiser B, 2001, COMMUN STAT-SIMUL C, V30, P37, DOI 10.1081/SAC-100001856; Rossier J, 2004, EUR J PSYCHOL ASSESS, V20, P27, DOI 10.1027/1015-5759.20.1.27; Rushton JP, 2011, WILEY BLACKWELL HDB; Saucier G, 2009, SOC PERSONAL PSYCHOL, V3, P620, DOI 10.1111/j.1751-9004.2009.00188.x; Schmitt DP, 2008, J PERS SOC PSYCHOL, V94, P168, DOI 10.1037/0022-3514.94.1.168; Schmitt DP, 2008, EVOL PSYCHOL-US, V6, P246, DOI 10.1177/147470490800600204; Schmitt DP, 2000, J RES PERS, V34, P141, DOI 10.1006/jrpe.1999.2267; Schmitt DP, 2004, EUR J PERSONALITY, V18, P301, DOI 10.1002/per.520; Soto CJ, 2011, J PERS SOC PSYCHOL, V100, P330, DOI 10.1037/a0021717; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Weisberg YJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00178; Widaman K.F., 1997, SCI PREVENTION METHO, P281, DOI [10.1037/10222-009, DOI 10.1037/10222-009]; Wiebe R. P., 2004, INDIVIDUAL DIFFERENC, V2, P38; Zou GY, 2007, STAT MED, V26, P3054, DOI 10.1002/sim.2830; ZUCKERMAN M, 1993, J PERS SOC PSYCHOL, V65, P757, DOI 10.1037/0022-3514.65.4.757	71	92	92	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29265	10.1371/journal.pone.0029265	http://dx.doi.org/10.1371/journal.pone.0029265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	902VE	22238596	gold, Green Published, Green Submitted			2022-12-27	WOS:000301070200020
J	Millett, C; Laverty, AA; Stylianou, N; Bibbins-Domingo, K; Pape, UJ				Millett, Christopher; Laverty, Anthony A.; Stylianou, Neophytos; Bibbins-Domingo, Kirsten; Pape, Utz J.			Impacts of a National Strategy to Reduce Population Salt Intake in England: Serial Cross Sectional Study	PLOS ONE			English	Article							HYPERTENSION MANAGEMENT; CHRONIC DISEASES; BLOOD-PRESSURE; HEALTH SURVEY; IMPROVEMENT; PREVENTION; BENEFITS; COSTS; DIET	Background: The UK introduced an ambitious national strategy to reduce population levels of salt intake in 2003. The aim of this study was to evaluate the impact of this strategy on salt intake in England, including potential effects on health inequalities. Methods: Secondary analysis of data from the Health Survey for England. Our main outcome measure was trends in estimated daily salt intake from 2003-2007, as measured by spot urine. Secondary outcome measures were knowledge of government guidance and voluntary use of salt in food preparation over this time period. Results: There were significant reductions in salt intake between 2003 and 2007 (-0.175grams per day per year, p<0.001). Intake decreased uniformly across all other groups but remained significantly higher in younger persons, men, ethnic minorities and lower social class groups and those without hypertension in 2007. Awareness of government guidance on salt use was lowest in those groups with the highest intake (semi-skilled manual v professional; 64.9% v 71.0% AOR 0.76 95% CI 0.58-0.99). Self reported use of salt added at the table reduced significantly during the study period (56.5% to 40.2% p<0.001). Respondents from ethnic minority groups remained significantly more likely to add salt during cooking (white 42.8%, black 74.1%, south Asian 88.3%) and those from lower social class groups (unskilled manual 46.6%, professional 35.2%) were more likely to add salt at the table. Conclusions: The introduction a national salt reduction strategy was associated with uniform but modest reductions in salt intake in England, although it is not clear precisely which aspects of the strategy contributed to this. Knowledge of government guidance was lower and voluntary salt use and total salt intake was higher among occupational and ethnic groups at greatest risk of cardiovascular disease.	[Millett, Christopher; Laverty, Anthony A.; Stylianou, Neophytos; Pape, Utz J.] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England; [Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA	Imperial College London; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Millett, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England.	a.laverty@imperial.ac.uk		Laverty, Anthony/0000-0003-1318-8439; Stylianou, Neophytos/0000-0002-3445-724X; Millett, Christopher/0000-0002-0793-9884	Higher Education, Council for England; National Institute for Health Research; National Institute for Health Research Biomedical Research Centre; National Institute for Health Research Collaboration; Imperial Centre for Patient Safety and Service Quality	Higher Education, Council for England; National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research Collaboration; Imperial Centre for Patient Safety and Service Quality	CM is funded by the Higher Education Funding Council for England and the National Institute for Health Research. AL is funded by the National Institute for Health Research. The Department of Primary Care and Public Health at Imperial College is grateful for support from the National Institute for Health Research Biomedical Research Centre Funding scheme, the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care scheme, and the Imperial Centre for Patient Safety and Service Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SALT HLTH; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Ashworth M, 2008, BMJ, P337; Association of Cereal Food Manufacturers, NEWS; BENNETT S, 1995, J EPIDEMIOL COMMUN H, V49, P363, DOI 10.1136/jech.49.4.363; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Cappuccio F., 2011, BMJ, V343; Department of Health, 1994, DEP HLTH REP CARD RE; Erlinger TP, 2003, PREV MED, V37, P327, DOI 10.1016/S0091-7435(03)00140-3; Falaschetti E, 2009, HYPERTENSION, V53, P480, DOI 10.1161/HYPERTENSIONAHA.108.125617; Mateo GF, 2010, J EPIDEMIOL COMMUN H, V64, pA26, DOI 10.1136/jech.2010.120956.66; Food Standards Agency, UK SALT RED IN; Food Standards Agency: Eat Well Be Well, FOOD STAND AG EAT WE; Foods Standards Agency, HEALTH EAT; Frohlich KL, 2008, AM J PUBLIC HEALTH, V98, P216, DOI 10.2105/AJPH.2007.114777; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; Health Survey for England, 2009, METH DOC, V2; Health Survey for England, 2006, LAT TRENDS; Health Survey for England, 2007, AD DIET HLTH EAT; Health Survey for England, 2007, METH DOC, V2; Healthy People 2020, 2010, FDN HLTH MEAS REP HE; Joffres MR, 2007, CAN J CARDIOL, V23, P437, DOI 10.1016/S0828-282X(07)70780-8; Laatikainen T, 2006, EUR J CLIN NUTR, V60, P965, DOI 10.1038/sj.ejcn.1602406; National Centre for Social Research, 2007, SURV 24 HOUR SPOT UR; National Centre for Social Research, 2008, ASS DIET SOD LEV AD; National Centre for Social Research, NAT CTR SOC RES ASS; Nishida C, 2004, PUBLIC HEALTH NUTR, V7, P245, DOI 10.1079/PHN2003592; Primatesta P, 2006, J HYPERTENS, V24, P1187, DOI 10.1097/01.hjh.0000226210.95936.bc; Scientific Advisory Committee on Nutrition, 2003, SALT HLTH; Spangler CM, 2010, ANN INTERNAL MED; The National Diet and Nutrition Survey, HEADL RES YEARS 1 2; The National Diet and Nutrition Survey, 2003, VIT MIN INT UR AN, V3; Vollmer WM, 2001, ANN INTERN MED, V135, P1019, DOI 10.7326/0003-4819-135-12-200112180-00005; World Health Organisation, 2007, FOR TECHN M RED SALT; World Health Organization, POP SOD RED STRAT; Wyness LA, 2011, PUBLIC HEALTH NUTR, V15, P1	37	55	57	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29836	10.1371/journal.pone.0029836	http://dx.doi.org/10.1371/journal.pone.0029836			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238665	Green Published, Green Submitted, gold			2022-12-27	WOS:000301070200054
J	Ota, H; Akishita, M; Akiyoshi, T; Kahyo, T; Setou, M; Ogawa, S; Iijima, K; Eto, M; Ouchi, Y				Ota, Hidetaka; Akishita, Masahiro; Akiyoshi, Takuyu; Kahyo, Tomoaki; Setou, Mitsutoshi; Ogawa, Sumito; Iijima, Katsuya; Eto, Masato; Ouchi, Yasuyoshi			Testosterone Deficiency Accelerates Neuronal and Vascular Aging of SAMP8 Mice: Protective Role of eNOS and SIRT1	PLOS ONE			English	Article							HUMAN-ENDOTHELIAL-CELLS; ALZHEIMERS-DISEASE; ELDERLY-MEN; PREMATURE SENESCENCE; THERAPEUTIC TARGET; IN-VIVO; MEMORY; ATHEROSCLEROSIS; HYPOTHESIS; INFLAMMATION	Oxidative stress and atherosclerosis-related vascular disorders are risk factors for cognitive decline with aging. In a small clinical study in men, testosterone improved cognitive function; however, it is unknown how testosterone ameliorates the pathogenesis of cognitive decline with aging. Here, we investigated whether the cognitive decline in senescence-accelerated mouse prone 8 (SAMP8), which exhibits cognitive impairment and hypogonadism, could be reversed by testosterone, and the mechanism by which testosterone inhibits cognitive decline. We found that treatment with testosterone ameliorated cognitive function and inhibited senescence of hippocampal vascular endothelial cells of SAMP8. Notably, SAMP8 showed enhancement of oxidative stress in the hippocampus. We observed that an NAD(+)-dependent deacetylase, SIRT1, played an important role in the protective effect of testosterone against oxidative stress-induced endothelial senescence. Testosterone increased eNOS activity and subsequently induced SIRT1 expression. SIRT1 inhibited endothelial senescence via up-regulation of eNOS. Finally, we showed, using co-culture system, that senescent endothelial cells promoted neuronal senescence through humoral factors. Our results suggest a critical role of testosterone and SIRT1 in the prevention of vascular and neuronal aging.	[Ota, Hidetaka; Akishita, Masahiro; Akiyoshi, Takuyu; Ogawa, Sumito; Iijima, Katsuya; Eto, Masato; Ouchi, Yasuyoshi] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo, Japan; [Kahyo, Tomoaki; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Mol Anat, Hamamatsu, Shizuoka 4313192, Japan	University of Tokyo; Hamamatsu University School of Medicine	Ota, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo, Japan.	akishita-tky@umin.ac.jp		Eto, Masato/0000-0002-6036-3431	Ministry of Education, Science, Culture and Sports of Japan [20249041, 21390220, 21790621]	Ministry of Education, Science, Culture and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Culture and Sports of Japan (20249041, 21390220, 21790621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akishita M, 2001, J HYPERTENS, V19, P1083, DOI 10.1097/00004872-200106000-00013; Bialek M, 2004, POL J PHARMACOL, V56, P509; Canudas AM, 2005, MECH AGEING DEV, V126, P1300, DOI 10.1016/j.mad.2005.07.008; Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200; Casserly I, 2004, LANCET, V363, P1139, DOI 10.1016/S0140-6736(04)15900-X; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; DEFRIES JC, 1970, BEHAV GENET, V1, P195, DOI 10.1007/BF01074652; del Valle J, 2010, J ALZHEIMERS DIS, V19, P1303, DOI 10.3233/JAD-2010-1321; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; FLOOD JF, 1995, PHYSIOL BEHAV, V57, P669, DOI 10.1016/0031-9384(94)00318-1; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Goglia L, 2010, MOL HUM REPROD, V16, P761, DOI 10.1093/molehr/gaq049; Guarente L, 2000, GENE DEV, V14, P1021; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Holland J, 2011, MATURITAS, V69, P322, DOI 10.1016/j.maturitas.2011.05.012; Honaramooz A, 2002, NATURE, V418, P778, DOI 10.1038/nature00918; Jessup JA, 2011, MENOPAUSE, V18, P698, DOI 10.1097/gme.0b013e31820390a2; Kaufman JM, 2005, ENDOCR REV, V26, P833, DOI 10.1210/er.2004-0013; LUKACS H, 1995, HORM BEHAV, V29, P42, DOI 10.1006/hbeh.1995.1004; MACIAG T, 1981, J CELL BIOL, V91, P420, DOI 10.1083/jcb.91.2.420; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Matsushita N, 2005, GENES CELLS, V10, P321, DOI 10.1111/j.1365-2443.2005.00836.x; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Michan S, 2010, J NEUROSCI, V30, P9695, DOI 10.1523/JNEUROSCI.0027-10.2010; Moffat SD, 2002, J CLIN ENDOCR METAB, V87, P5001, DOI 10.1210/jc.2002-020419; Ota H, 2008, ARTERIOSCL THROM VAS, V28, P1634, DOI 10.1161/ATVBAHA.108.164368; Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008; Ota H, 2010, J ATHEROSCLER THROMB, V17, P431, DOI 10.5551/jat.3525; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Ramsden M, 2003, NEUROSCIENCE, V122, P573, DOI 10.1016/j.neuroscience.2003.08.048; SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107; Sinclair D, 1998, ANNU REV MICROBIOL, V52, P533, DOI 10.1146/annurev.micro.52.1.533; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Tan R S, 2003, Aging Male, V6, P13, DOI 10.1080/713604736; Tang BL, 2011, TRANSL RES, V157, P276, DOI 10.1016/j.trsl.2010.11.006; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tomobe K, 2009, NEUROCHEM RES, V34, P660, DOI 10.1007/s11064-009-9923-x; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yu J, 2010, ENDOCRINOLOGY, V151, P1822, DOI 10.1210/en.2009-1048; Zhang WR, 2007, J CEREBR BLOOD F MET, V27, P1931, DOI 10.1038/sj.jcbfm.9600494	45	56	61	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29598	10.1371/journal.pone.0029598	http://dx.doi.org/10.1371/journal.pone.0029598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238626	Green Submitted, Green Published, gold			2022-12-27	WOS:000301070200037
J	Borneman, AR; McCarthy, JM; Chambers, PJ; Bartowsky, EJ				Borneman, Anthony R.; McCarthy, Jane M.; Chambers, Paul J.; Bartowsky, Eveline J.			Functional Divergence in the Genus Oenococcus as Predicted by Genome Sequencing of the Newly-Described Species, Oenococcus kitaharae	PLOS ONE			English	Article							DISTILLED SHOCHU RESIDUE; LACTIC-ACID BACTERIA; LEUCONOSTOC-OENOS; MALOLACTIC FERMENTATION; SP-NOV; LACTOBACILLUS-PLANTARUM; WINE; DIVERSITY; DATABASE; COMPOST	Oenococcus kitaharae is only the second member of the genus Oenococcus to be identified and is the closest relative of the industrially important wine bacterium Oenococcus oeni. To provide insight into this new species, the genome of the type strain of O. kitaharae, DSM 17330, was sequenced. Comparison of the sequenced genomes of both species show that the genome of O. kitaharae DSM 17330 contains many genes with predicted functions in cellular defence (bacteriocins, antimicrobials, restriction-modification systems and a CRISPR locus) which are lacking in O. oeni. The two genomes also appear to differentially encode several metabolic pathways associated with amino acid biosynthesis and carbohydrate utilization and which have direct phenotypic consequences. This would indicate that the two species have evolved different survival techniques to suit their particular environmental niches. O. oeni has adapted to survive in the harsh, but predictable, environment of wine that provides very few competitive species. However O. kitaharae appears to have adapted to a growth environment in which biological competition provides a significant selective pressure by accumulating biological defence molecules, such as bacteriocins and restriction-modification systems, throughout its genome.	[Borneman, Anthony R.; McCarthy, Jane M.; Chambers, Paul J.; Bartowsky, Eveline J.] Australian Wine Res Inst, Glen Osmond, SA, Australia	Australian Wine Research Institute	Borneman, AR (corresponding author), Australian Wine Res Inst, Glen Osmond, SA, Australia.	anthony.borneman@awri.com.au		Borneman, Anthony/0000-0001-8491-7235	Grape and Wine Research Development Corporation; Australian Government; South Australian State Government	Grape and Wine Research Development Corporation; Australian Government(Australian GovernmentCGIAR); South Australian State Government	The Australian Wine Research Institute (AWRI), a member of the Wine Innovation Cluster in Adelaide, is supported by Australia's grapegrowers and winemakers through their investment body the Grape and Wine Research Development Corporation with matching funds from the Australian Government. Systems Biology research at the AWRI is performed using resources provided as part of the National Collaborative Research Infrastructure Strategy, an initiative of the Australian Government, in addition to funds from the South Australian State Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bartowsky EJ, 2009, LETT APPL MICROBIOL, V48, P149, DOI 10.1111/j.1472-765X.2008.02505.x; Bartowsky EJ, 2005, AUST J GRAPE WINE R, V11, P174, DOI 10.1111/j.1755-0238.2005.tb00286.x; Bartowsky EJ, 2011, APPL MICROBIOL BIOT, V92, P441, DOI 10.1007/s00253-011-3546-2; Borneman AR, 2010, APPL MICROBIOL BIOT, V86, P681, DOI 10.1007/s00253-009-2425-6; Bringel F, 1997, J BACTERIOL, V179, P2697, DOI 10.1128/jb.179.8.2697-2706.1997; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chelo IM, 2007, MICROBIOLOGY, V156, P420; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; DAVIS C, 1985, APPL ENVIRON MICROB, V50, P872, DOI 10.1128/AEM.50.4.872-876.1985; DAVIS CR, 1988, AM J ENOL VITICULT, V39, P137; De Bruyne K, 2010, INT J SYST EVOL MICR, V60, P1999, DOI 10.1099/ijs.0.019323-0; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dicks L. M. T., 2009, BERGEYS MANUAL SYSTE, P635; DICKS LMT, 1995, INT J SYST BACTERIOL, V45, P395, DOI 10.1099/00207713-45-2-395; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endo A, 2005, INT J SYST EVOL MICR, V55, P83, DOI 10.1099/ijs.0.63248-0; Endo A, 2005, J BIOSCI BIOENG, V99, P216, DOI 10.1263/jbb.99.216; Endo A, 2007, INT J SYST EVOL MICR, V57, P870, DOI 10.1099/ijs.0.64743-0; Endo A, 2007, INT J SYST EVOL MICR, V57, P708, DOI 10.1099/ijs.0.64618-0; Endo A, 2006, INT J SYST EVOL MICR, V56, P2345, DOI 10.1099/ijs.0.64288-0; GARVIE EI, 1967, J GEN MICROBIOL, V48, P431, DOI 10.1099/00221287-48-3-431; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HENICKKLING T, 1986, J APPL BACTERIOL, V61, P287, DOI 10.1111/j.1365-2672.1986.tb04289.x; Henschke P. A., 1993, WINE MICROBIOLOGY BI, P77, DOI DOI 10.1089/END.2014.0018; Hernandez-Orte P, 2002, J AGR FOOD CHEM, V50, P2891, DOI 10.1021/jf011395o; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mills DA, 2005, FEMS MICROBIOL REV, V29, P465, DOI 10.1016/j.femsre.2005.04.011; Ramos A, 1996, APPL ENVIRON MICROB, V62, P2577, DOI 10.1128/AEM.62.7.2577-2585.1996; SALYERS AA, 1995, MICROBIOL REV, V59, P579, DOI 10.1128/MMBR.59.4.579-590.1995; Sao-Jose C, 2004, VIROLOGY, V325, P82, DOI 10.1016/j.virol.2004.04.029; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Terrade N, 2009, INT J FOOD MICROBIOL, V133, P8, DOI 10.1016/j.ijfoodmicro.2009.03.020; van Kranenburg R, 2005, APPL ENVIRON MICROB, V71, P1223, DOI 10.1128/AEM.71.3.1223-1230.2005; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; WIBOWO D, 1985, AM J ENOL VITICULT, V36, P302	39	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29626	10.1371/journal.pone.0029626	http://dx.doi.org/10.1371/journal.pone.0029626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235313	Green Submitted, Green Published, gold			2022-12-27	WOS:000301123400075
J	Hopkins, JB; Ferguson, JM				Hopkins, John B., III; Ferguson, Jake M.			Estimating the Diets of Animals Using Stable Isotopes and a Comprehensive Bayesian Mixing Model	PLOS ONE			English	Article							INCORPORATING CONCENTRATION-DEPENDENCE; DISCRIMINATION FACTORS DELTA-N-15; NITROGEN ISOTOPES; PRIOR INFORMATION; SEASONAL-CHANGES; CARBON; DELTA-C-13; UNCERTAINTY; BEARS; MANAGEMENT	Using stable isotope mixing models (SIMMs) as a tool to investigate the foraging ecology of animals is gaining popularity among researchers. As a result, statistical methods are rapidly evolving and numerous models have been produced to estimate the diets of animals-each with their benefits and their limitations. Deciding which SIMM to use is contingent on factors such as the consumer of interest, its food sources, sample size, the familiarity a user has with a particular framework for statistical analysis, or the level of inference the researcher desires to make (e. g., population-or individual-level). In this paper, we provide a review of commonly used SIMM models and describe a comprehensive SIMM that includes all features commonly used in SIMM analysis and two new features. We used data collected in Yosemite National Park to demonstrate IsotopeR's ability to estimate dietary parameters. We then examined the importance of each feature in the model and compared our results to inferences from commonly used SIMMs. IsotopeR's user interface (in R) will provide researchers a user-friendly tool for SIMM analysis. The model is also applicable for use in paleontology, archaeology, and forensic studies as well as estimating pollution inputs.	[Hopkins, John B., III] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Ferguson, Jake M.] Univ Florida, Dept Biol, Gainesville, FL USA	Montana State University System; Montana State University Bozeman; State University System of Florida; University of Florida	Hopkins, JB (corresponding author), Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA.	jbhopkins3@gmail.com	Ferguson, Jake/A-7093-2013	Ferguson, Jake/0000-0002-5034-9089	University of Florida; Department of Biology, University of Florida	University of Florida(University of Florida); Department of Biology, University of Florida	Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund and J.M. Ponciano (Department of Biology, University of Florida). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; AMBROSE SH, 1986, OECOLOGIA, V69, P395, DOI 10.1007/BF00377062; [Anonymous], 1908, BIOMETRIKA, V6, P1; BenDavid M, 1997, CAN J ZOOL, V75, P803, DOI 10.1139/z97-102; BenDavid M, 1997, OECOLOGIA, V111, P280, DOI 10.1007/s004420050236; BOUTTON TW, 1978, OECOLOGIA, V36, P21, DOI 10.1007/BF00344568; Bowen GJ, 2009, AM J PHYS ANTHROPOL, V139, P494, DOI 10.1002/ajpa.21008; Carroll RJ, 2006, MEASUREMENT ERROR NO; Caut S, 2008, CAN J ZOOL, V86, P438, DOI 10.1139/Z08-012; Caut S, 2008, FUNCT ECOL, V22, P255, DOI 10.1111/j.1365-2435.2007.01360.x; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Chamberlain CP, 2005, P NATL ACAD SCI USA, V102, P16707, DOI 10.1073/pnas.0508529102; Dawson TE, 1998, OECOLOGIA, V117, P476, DOI 10.1007/s004420050683; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; del Rio CM, 2005, PHYSIOLOGICAL ADAPTATIONS TO FEEDING INVERTEBRATES, P141; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DENIRO MJ, 1978, SCIENCE, V201, P906, DOI 10.1126/science.201.4359.906; Felicetti LA, 2003, CAN J ZOOL, V81, P763, DOI [10.1139/z03-054, 10.1139/Z03-054]; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; FRY B, 1978, GEOCHIM COSMOCHIM AC, V42, P1299, DOI 10.1016/0016-7037(78)90124-2; FRY B, 1988, LIMNOL OCEANOGR, V33, P1182, DOI 10.4319/lo.1988.33.5.1182; Gelman A., 2004, BAYESIAN DATA ANAL; Graber D. M., 1981, 5 CPSU U CAL; Graber D.M., 1983, INT C BEAR RES MANAG, V5, P1, DOI DOI 10.2307/3872514; Greenleaf SS, 2009, URSUS, V20, P94, DOI 10.2192/08GR027.1; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Hobson K.A., 1992, CONDOR, V94, P187; Hobson KA, 2000, CAN J ZOOL, V78, P1332, DOI 10.1139/cjz-78-8-1332; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Hopkins JB, 2010, URSUS, V21, P154, DOI 10.2192/URSUS-D-10-00005.1; Jackson AL, 2009, ECOL LETT, V12, pE1, DOI 10.1111/j.1461-0248.2008.01233.x; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; KLINE TC, 1993, CAN J FISH AQUAT SCI, V50, P2350, DOI 10.1139/f93-259; Koch PL, 2002, OECOLOGIA, V133, P14, DOI 10.1007/s00442-002-0977-6; KOCH PL, 1995, SCIENCE, V267, P1340, DOI 10.1126/science.267.5202.1340; Kurle CM, 2008, ECOLOGY EVOLUTIONARY, P158; Lele SR, 2007, ECOL LETT, V10, P551, DOI 10.1111/j.1461-0248.2007.01047.x; Mealey SP, 1980, INT C BEAR RES MAN, V4, P281; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Mowat G, 2006, CAN J ZOOL, V84, P473, DOI 10.1139/z06-016; NAKAMURA K, 1982, BIOMED MASS SPECTROM, V9, P390, DOI 10.1002/bms.1200090906; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Parnell A., 2008, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Peng TH, 1986, CHANGING CARBON CYCL; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Phillips DL, 2001, OECOLOGIA, V127, P166, DOI 10.1007/s004420000571; Pinheiro JC, 2009, MIXED EFFECTS MODELS; Polischuk SC, 2001, CAN J ZOOL, V79, P499, DOI 10.1139/cjz-79-3-499; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; QUAY PD, 1992, SCIENCE, V256, P74, DOI 10.1126/science.256.5053.74; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Robbins CT, 2002, OECOLOGIA, V133, P10, DOI 10.1007/s00442-002-0978-5; SCHWARCZ HP, 1991, J ARCHAEOL SCI, V18, P261, DOI 10.1016/0305-4403(91)90065-W; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Sonnerup RE, 1999, GLOBAL BIOGEOCHEM CY, V13, P857, DOI 10.1029/1999GB900027; Szepanski MM, 1999, OECOLOGIA, V120, P327, DOI 10.1007/s004420050866; VOGEL JC, 1978, S AFR J SCI, V74, P298; Ward EJ, 2010, ENVIRON SCI TECHNOL, V44, P4645, DOI 10.1021/es100053v; Whitledge GW, 1997, CAN J FISH AQUAT SCI, V54, P2555, DOI 10.1139/cjfas-54-11-2555; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x	70	145	152	5	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28478	10.1371/journal.pone.0028478	http://dx.doi.org/10.1371/journal.pone.0028478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235246	Green Submitted, Green Published, gold			2022-12-27	WOS:000301123400007
J	Liu, JS; Wang, L; Wang, DL; Bonser, SP; Sun, F; Zhou, YF; Gao, Y; Teng, X				Liu, Jushan; Wang, Ling; Wang, Deli; Bonser, Stephen P.; Sun, Fang; Zhou, Yifa; Gao, Ying; Teng, Xing			Plants Can Benefit from Herbivory: Stimulatory Effects of Sheep Saliva on Growth of Leymus chinensis	PLOS ONE			English	Article							GENTIANELLA-CAMPESTRIS; CRUCIFEROUS PLANTS; APICAL DOMINANCE; TOLERANCE; RESPONSES; DEFOLIATION; ECOLOGY; OVERCOMPENSATION; COMPENSATION; ADAPTATION	Background: Plants and herbivores can evolve beneficial interactions. Growth factors found in animal saliva are probably key factors underlying plant compensatory responses to herbivory. However, there is still a lack of knowledge about how animal saliva interacts with herbivory intensities and how saliva can mobilize photosynthate reserves in damaged plants. Methodology/Principal Findings: The study examined compensatory responses to herbivory and sheep saliva addition for the grass species Leymus chinensis in three experiments over three years. The first two experiments were conducted in a factorial design with clipping (four levels in 2006 and five in 2007) and two saliva treatment levels. The third experiment examined the mobilization and allocation of stored carbohydrates following clipping and saliva addition treatments. Animal saliva significantly increased tiller number, number of buds, and biomass, however, there was no effect on height. Furthermore, saliva effects were dependent on herbivory intensities, associated with meristem distribution within perennial grass. Animal saliva was found to accelerate hydrolyzation of fructans and accumulation of glucose and fructose. Conclusions/Significance: The results demonstrated a link between saliva and the mobilization of carbohydrates following herbivory, which is an important advance in our understanding of the evolution of plant responses to herbivory. Herbivory intensity dependence of the effects of saliva stresses the significance of optimal grazing management.	[Liu, Jushan; Wang, Ling; Wang, Deli; Sun, Fang; Zhou, Yifa; Gao, Ying; Teng, Xing] NE Normal Univ, Key Lab Vegetat Ecol, Minist Educ, Inst Grassland Sci, Changchun, Peoples R China; [Bonser, Stephen P.] Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	Northeast Normal University - China; University of New South Wales Sydney	Liu, JS (corresponding author), NE Normal Univ, Key Lab Vegetat Ecol, Minist Educ, Inst Grassland Sci, Changchun, Peoples R China.	wangl890@nenu.edu.cn; wangd@nenu.edu.cn	Bonser, Stephen/A-9942-2013; thorhallsdottir, anna gudrun/B-6037-2011	thorhallsdottir, anna gudrun/0000-0001-7201-6931; , Ying/0000-0002-6484-091X; Bonser, Stephen/0000-0002-6608-9912	State Key Basic Research Program [2007CB106801]; State Agricultural Commonweal Project [200903060-2, 201003019]; National Natural Science Foundation of China [7 30571318, 30600427, 30590382]	State Key Basic Research Program; State Agricultural Commonweal Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the State Key Basic Research Program (2007CB106801), State Agricultural Commonweal Project (200903060-2, 201003019), and the National Natural Science Foundation of China (No. 7 30571318, 30600427, 30590382). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ba L, 2006, PLANT ECOL, V183, P19, DOI 10.1007/s11258-005-9002-6; BELSKY AJ, 1986, AM NAT, V127, P870, DOI 10.1086/284531; Bergman M, 2002, OIKOS, V96, P164, DOI 10.1034/j.1600-0706.2002.960118.x; Bonner J, 1937, SCIENCE, V85, P183, DOI 10.1126/science.85.2198.183; Briske D. D., 1991, GRAZING MANAGEMENT E, P85; CAPINERA JL, 1980, J ECON ENTOMOL, V73, P258, DOI 10.1093/jee/73.2.258; COHEN S, 1962, J BIOL CHEM, V237, P1555; CRAWLEY MJ, 1987, TRENDS ECOL EVOL, V2, P167, DOI 10.1016/0169-5347(87)90070-X; DETLING JK, 1981, J CHEM ECOL, V7, P239, DOI 10.1007/BF00995746; DYER MI, 1980, P NATL ACAD SCI-BIOL, V77, P4836, DOI 10.1073/pnas.77.8.4836; DYER MI, 1976, ECOLOGY, V57, P762, DOI 10.2307/1936189; ENGELBRECHT L, 1969, NATURE, V223, P319, DOI 10.1038/223319a0; Flemmer AC, 2002, J RANGE MANAGE, V55, P150, DOI 10.2307/4003351; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; FRAZIER WA, 1974, J BIOL CHEM, V249, P5918; Gao Y, 2007, ENV EXPT BOT; Garrido E, 2011, NEW PHYTOLOGIST; Gavloski JE, 2000, ENVIRON ENTOMOL, V29, P1, DOI 10.1603/0046-225X-29.1.1; Gavloski JE, 2000, ENVIRON ENTOMOL, V29, P1258, DOI 10.1603/0046-225X-29.6.1258; Gavloski JE, 2000, ENVIRON ENTOMOL, V29, P1273, DOI 10.1603/0046-225X-29.6.1273; Harris P., 1974, Agro-Ecosystems, V1, P219, DOI 10.1016/0304-3746(74)90028-6; Huhta AP, 2000, EVOL ECOL, V14, P373, DOI 10.1023/A:1011028722860; JEWISS OR, 1972, J BRIT GRASSLAND SOC, V27, P65; JOHNSTON A, 1972, CAN J ANIM SCI, V52, P573, DOI 10.4141/cjas72-070; KATO R, 1993, PLANT CELL PHYSIOL, V34, P789; KREBS C J, 1972, P694; Lennartsson T, 1997, AM NAT, V149, P1147, DOI 10.1086/286043; Lothier J, 2007, J EXP BOT, V58, P1969, DOI 10.1093/jxb/erm053; MATCHES AG, 1992, J PROD AGRIC, V5, P1; McNaughton SJ, 1985, OECOLOGIA, V65, P478, DOI 10.1007/BF00379660; MCNAUGHTON SJ, 1979, AM NAT, V113, P691, DOI 10.1086/283426; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; MCNAUGHTON SJ, 1983, ECOLOGY, V64, P307, DOI 10.2307/1937078; MCNAUGHTON SJ, 1976, SCIENCE, V191, P92, DOI 10.1126/science.191.4222.92; MILES PW, 1967, NATURE, V213, P801, DOI 10.1038/213801a0; MURPHY JS, 1992, J RANGE MANAGE, V45, P419, DOI 10.2307/4002896; OLSON BE, 1988, OIKOS, V51, P374, DOI 10.2307/3565321; Ongaro V, 2008, J EXP BOT, V59, P67, DOI 10.1093/jxb/erm134; OWEN DF, 1976, OIKOS, V27, P488, DOI 10.2307/3543467; PAIGE KN, 1987, AM NAT, V129, P407, DOI 10.1086/284645; Poveda K, 2010, ECOL APPL, V20, P1787, DOI 10.1890/09-1726.1; REARDON PO, 1974, J RANGE MANAGE, V27, P400, DOI 10.2307/3896502; Rooke T, 2003, AFRICAN J ECOLOGY, V41; ROSENTHAL JP, 1995, OECOLOGIA, V102, P146, DOI 10.1007/BF00333245; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Shi DC, 2005, PLANT SOIL, V271, P15, DOI 10.1007/s11104-004-1307-z; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Teng X, 2010, RANGELAND J, V32, P419, DOI 10.1071/RJ09061; Tiffin P, 2000, EVOL ECOL, V14, P523, DOI 10.1023/A:1010881317261; Tomlinson KW, 2004, FUNCT ECOL, V18, P489, DOI 10.1111/j.0269-8463.2004.00873.x; TUOMI J, 1994, ECOLOGY, V75, P1429, DOI 10.2307/1937466; Vittoria A, 1960, ACTA MED VET, V6, P379; Wang D, 2008, RANGELAND J, V30, P247, DOI 10.1071/RJ08005; Wang L, 2010, OECOLOGIA, V164, P193, DOI 10.1007/s00442-010-1676-3; Wang L, 2010, J APPL ECOL, V47, P868, DOI 10.1111/j.1365-2664.2010.01837.x; Wang L, 2010, OIKOS, V119, P401, DOI 10.1111/j.1600-0706.2009.17774.x; WILSON JB, 1988, ANN BOT-LONDON, V61, P433, DOI 10.1093/oxfordjournals.aob.a087575; Zhang Z, 2007, J ARID ENVIRON, V70, P111, DOI 10.1016/j.jaridenv.2006.12.002	59	111	120	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29259	10.1371/journal.pone.0029259	http://dx.doi.org/10.1371/journal.pone.0029259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235277	Green Submitted, Green Published, gold			2022-12-27	WOS:000301123400038
J	Qu, ZQ; Zhou, Y; Zeng, YS; Lin, YK; Li, Y; Zhong, ZQ; Chan, WY				Qu, Ze-qiang; Zhou, Yan; Zeng, Yuan-shan; Lin, Yu-kun; Li, Yan; Zhong, Zhi-qiang; Chan, Wood Yee			Protective Effects of a Rhodiola Crenulata Extract and Salidroside on Hippocampal Neurogenesis against Streptozotocin-Induced Neural Injury in the Rat	PLOS ONE			English	Article							PEROXIDE-INDUCED APOPTOSIS; OXIDATIVE STRESS; STEM-CELLS; INTRACEREBROVENTRICULAR STREPTOZOTOCIN; COGNITIVE IMPAIRMENT; ENERGY-METABOLISM; DENTATE GYRUS; ROSEA EXTRACT; OLIVE OIL; TYROSOL	Previously we have demonstrated that a Rhodiola crenulata extract (RCE), containing a potent antioxidant salidroside, promotes neurogenesis in the hippocampus of depressive rats. The current study was designed to further investigate the protective effect of the RCE on neurogenesis in a rat model of Alzheimer's disease (AD) induced by an intracerebroventricular injection of streptozotocin (STZ), and to determine whether this neuroprotective effect is induced by the antioxidative activity of salidroside. Our results showed that pretreatment with the RCE significantly improved the impaired neurogenesis and simultaneously reduced the oxidative stress in the hippocampus of AD rats. In vitro studies revealed that (1) exposure of neural stem cells (NSCs) from the hippocampus to STZ strikingly increased intracellular reactive oxygen species (ROS) levels, induced cell death and perturbed cell proliferation and differentiation, (2) hydrogen peroxide induced similar cellular activities as STZ, (3) pre-incubation of STZ-treated NSCs with catalase, an antioxidant, suppressed all these cellular activities induced by STZ, and (4) likewise, pre-incubation of STZ-treated NSCs with salidroside, also an antioxidant, suppressed all these activities as catalase: reduction of ROS levels and NSC death with simultaneous increases in proliferation and differentiation. Our findings indicated that the RCE improved the impaired hippocampal neurogenesis in the rat model of AD through protecting NSCs by its main ingredient salidroside which scavenged intracellular ROS.	[Qu, Ze-qiang; Zhou, Yan; Zeng, Yuan-shan; Lin, Yu-kun; Li, Yan; Zhong, Zhi-qiang] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Histol & Embryol, Div Neurosci, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Yuan-shan] Sun Yat Sen Univ, Minist Educ, Key Lab Stem Cells & Tissue Engn, Guangzhou 510275, Guangdong, Peoples R China; [Chan, Wood Yee] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Chinese University of Hong Kong	Qu, ZQ (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Histol & Embryol, Div Neurosci, Guangzhou 510275, Guangdong, Peoples R China.	zengysh@mail.sysu.edu.cn; wy-chan@cuhk.edu.hk	Chan, Wood Yee/R-6692-2018	Chan, Wood Yee/0000-0002-7114-1463	Administrative Bureau of Chinese Traditional Medicine of Guangdong Province [2007109]	Administrative Bureau of Chinese Traditional Medicine of Guangdong Province	This research was supported by a research grant of the Administrative Bureau of Chinese Traditional Medicine of Guangdong Province (No. 2007109) to YSZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1999, BRAIN RES, V830, P146, DOI 10.1016/S0006-8993(99)01421-3; Abidov M, 2003, B EXP BIOL MED+, V136, P585, DOI 10.1023/B:BEBM.0000020211.24779.15; Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Ande SR, 2008, YEAST, V25, P349, DOI 10.1002/yea.1592; Beauquis J, 2006, EUR J NEUROSCI, V23, P1539, DOI 10.1111/j.1460-9568.2006.04691.x; Bolzan AD, 2002, MUTAT RES-REV MUTAT, V512, P121, DOI 10.1016/S1383-5742(02)00044-3; Bu Y, 2007, NEUROSCI LETT, V414, P218, DOI 10.1016/j.neulet.2006.08.094; Butterfield DA, 2006, EUR J PHARMACOL, V545, P39, DOI 10.1016/j.ejphar.2006.06.026; Cai L, 2008, ACTA BIOCH BIOPH SIN, V40, P796, DOI [10.1111/j.1745-7270.2008.00463.x, 10.1093/abbs/40.9.796]; Cao LL, 2006, J ASIAN NAT PROD RES, V8, P159, DOI 10.1080/1028602042000325645; CARLBERG I, 1975, J BIOL CHEM, V250, P5475; Chen QG, 2009, PHYTOMEDICINE, V16, P830, DOI 10.1016/j.phymed.2009.03.011; Chen X, 2008, BRAIN RES, V1238, P189, DOI 10.1016/j.brainres.2008.07.051; Chen X, 2009, MOL CELL BIOCHEM, V332, P85, DOI 10.1007/s11010-009-0177-3; Cruz-Sanchez FF, 2010, J NEUROL SCI, V299, P163, DOI 10.1016/j.jns.2010.08.029; Cui SY, 2003, ANAL BIOANAL CHEM, V377, P370, DOI 10.1007/s00216-003-2045-4; De Sanctis R, 2004, BIOFACTORS, V20, P147, DOI 10.1002/biof.5520200304; Di Benedetto R, 2007, NUTR METAB CARDIOVAS, V17, P535, DOI 10.1016/j.numecd.2006.03.005; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Duittoz AH, 2001, J NEUROSCI METH, V107, P131, DOI 10.1016/S0165-0270(01)00363-6; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Gibson GE, 2005, NEUROBIOL AGING, V26, P575, DOI 10.1016/j.neurobiolaging.2004.07.017; Gille L, 2002, PHARMACOL TOXICOL, V90, P317, DOI 10.1034/j.1600-0773.2002.900605.x; Giovannini L, 2002, INT J TISSUE REACT, V24, P53; Grunblatt E, 2007, J NEUROCHEM, V101, P757, DOI 10.1111/j.1471-4159.2006.04368.x; Grundke-Iqbal I, 2002, NEUROBIOL AGING, V23, pS563; Guglielmotto M, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.003.2010; Guglielmotto M, 2009, THESCIENTIFICWORLDJO, V9, P781, DOI 10.1100/tsw.2009.93; Guo JS, 2007, NEUROREPORT, V18, P863, DOI 10.1097/WNR.0b013e32811d6d36; Herrera DG, 2003, P NATL ACAD SCI USA, V100, P7919, DOI 10.1073/pnas.1230907100; Hoyer S, 2008, J NEURAL TRANSM, V115, P1241, DOI 10.1007/s00702-008-0079-7; Ishrat T, 2006, BEHAV BRAIN RES, V171, P9, DOI 10.1016/j.bbr.2006.03.009; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Jin K, 2006, BRAIN RES, V1085, P183, DOI 10.1016/j.brainres.2006.02.081; Johnston APW, 2007, AM J PHYSIOL-CELL PH, V292, pC1033, DOI 10.1152/ajpcell.00338.2006; Kanupriya D, 2005, MOL CELL BIOCHEM, V275, P1, DOI 10.1007/s11010-005-7637-1; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Khanum F, 2005, COMPR REV FOOD SCI F, V4, P55, DOI 10.1111/j.1541-4337.2005.tb00073.x; Lannert H, 1998, BEHAV NEUROSCI, V112, P1199, DOI 10.1037/0735-7044.112.5.1199; LAZAROVA MB, 1986, METHOD FIND EXP CLIN, V8, P547; Ledergerber D, 2006, EXP NEUROL, V199, P130, DOI 10.1016/j.expneurol.2006.02.010; Lee SH, 2008, J CELL PHYSIOL, V216, P269, DOI 10.1002/jcp.21402; Lester-Coll N, 2006, J ALZHEIMERS DIS, V9, P13; Li XF, 2011, BRAIN RES, V1382, P9, DOI 10.1016/j.brainres.2011.01.015; Lopez-Toledano MA, 2004, J NEUROSCI, V24, P5439, DOI 10.1523/JNEUROSCI.0974-04.2004; Loru D, 2009, TOXICOL IND HEALTH, V25, P301, DOI 10.1177/0748233709103028; Manda K, 2009, J PINEAL RES, V46, P71, DOI 10.1111/j.1600-079X.2008.00632.x; Mohapel P, 2005, NEUROBIOL AGING, V26, P939, DOI 10.1016/j.neurobiolaging.2004.07.015; Nakamura S, 2008, CHEM PHARM BULL, V56, P536, DOI 10.1248/cpb.56.536; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ouyang JF, 2010, J PHARM PHARMACOL, V62, P530, DOI 10.1211/jpp.62.04.0017; Pabbidi RM, 2008, MOL PHARMACOL, V73, P995, DOI 10.1124/mol.107.041707; Pang Y, 2000, J NEUROSCI RES, V62, P510, DOI 10.1002/1097-4547(20001115)62:4<510::AID-JNR5>3.3.CO;2-6; Paxinos G., RAT BRAIN STEREOTAXI, VSeventh; PETKOV V D, 1986, Acta Physiologica et Pharmacologica Bulgarica, V12, P3; Qian EW, 2011, J ETHNOPHARMACOL, V133, P308, DOI 10.1016/j.jep.2010.09.025; Qin Ya-jing, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2842; Qu ZQ, 2009, BIOMED ENVIRON SCI, V22, P318, DOI 10.1016/S0895-3988(09)60062-3; Rivas-Arancibia S, 2010, TOXICOL SCI, V113, P187, DOI 10.1093/toxsci/kfp252; Sato M, 2005, ARTERIOSCL THROM VAS, V25, P341, DOI 10.1161/01.ATV.0000152608.29351.8f; Sauerzweig S, 2009, J NEUROSCI METH, V177, P149, DOI 10.1016/j.jneumeth.2008.10.009; Sonkusare S, 2005, LIFE SCI, V77, P1, DOI 10.1016/j.lfs.2004.10.036; Spasov AA, 2000, PHYTOMEDICINE, V7, P85, DOI 10.1016/S0944-7113(00)80078-1; St-Laurent-Thibault C, 2011, CURR ALZHEIMER RES, V8, P543, DOI 10.2174/156720511796391845; Sugaya K, 2006, PANMINERVA MED, V48, P87; Sultana R, 2010, J ALZHEIMERS DIS, V19, P341, DOI 10.3233/JAD-2010-1222; Taupin Philippe, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P16; Tyurina YY, 2000, TOXICOLOGY, V148, P93, DOI 10.1016/S0300-483X(00)00199-2; Uchida Y, 2007, J BIOL CHEM, V282, P19700, DOI 10.1074/jbc.M703099200; Valente T, 2009, J ALZHEIMERS DIS, V18, P849, DOI 10.3233/JAD-2009-1188; Wang R, 2004, NEUROSCIENCE, V126, P305, DOI 10.1016/j.neuroscience.2004.03.048; Wen PH, 2004, EXP NEUROL, V188, P224, DOI 10.1016/j.expneurol.2004.04.002; Wing SL, 2003, WILD ENVIRON MED, V14, P9, DOI 10.1580/1080-6032(2003)014[0009:LOEORO]2.0.CO;2; Xiong Y, 2009, BIOMATERIALS, V30, P3711, DOI 10.1016/j.biomaterials.2009.03.046; Yu PZ, 2007, CHEM BIODIVERS, V4, P508, DOI 10.1002/cbdv.200790043; Yu S, 2008, CELL MOL NEUROBIOL, V28, P1067, DOI 10.1007/s10571-008-9284-z; Zafrilla P, 2006, CURR MED CHEM, V13, P1075, DOI 10.2174/092986706776360978; Zhang L, 2007, EUR J PHARMACOL, V564, P18, DOI 10.1016/j.ejphar.2007.01.089; Zhang L, 2010, NEUROCHEM INT, V57, P547, DOI 10.1016/j.neuint.2010.06.021; Zhang SQ, 2011, MOL CELL BIOCHEM, V354, P161, DOI 10.1007/s11010-011-0815-4; Zhang ZJ, 2009, CHIN J INTEGR MED, V15, P177, DOI 10.1007/s11655-009-0177-x; Zhong H, 2010, J PHARMACOL SCI, V114, P399, DOI 10.1254/jphs.10078FP; Ziabreva I, 2006, J PSYCHOSOM RES, V61, P311, DOI 10.1016/j.jpsychores.2006.07.017	83	139	152	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29641	10.1371/journal.pone.0029641	http://dx.doi.org/10.1371/journal.pone.0029641			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235318	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400080
J	Simpson, JE; Slade, E; Riutta, T; Taylor, ME				Simpson, Jake E.; Slade, Eleanor; Riutta, Terhi; Taylor, Michele E.			Factors Affecting Soil Fauna Feeding Activity in a Fragmented Lowland Temperate Deciduous Woodland	PLOS ONE			English	Article							BAIT-LAMINA TEST; DECOMPOSITION RATES; FOREST SOILS; LEAF-LITTER; BIODIVERSITY; MICROCLIMATE; GRADIENTS; ABUNDANCE; RESPONSES; DYNAMICS	British temperate broadleaf woodlands have been widely fragmented since the advent of modern agriculture and development. As a result, a higher proportion of woodland area is now subject to edge effects which can alter the efficiency of ecosystem functions. These areas are particularly sensitive to drought. Decomposition of detritus and nutrient cycling are driven by soil microbe and fauna coactivity. The bait lamina assay was used to assess soil fauna trophic activity in the upper soil horizons at five sites in Wytham Woods, Oxfordshire: two edge, two intermediate and one core site. Faunal trophic activity was highest in the core of the woodland, and lowest at the edge, which was correlated with a decreasing soil moisture gradient. The efficiency of the assay was tested using four different bait flavours: standardised, ash (Fraxinus excelsior L.), oak (Quercus robur L.), and sycamore (Acer pseudoplatanus L.). The standardised bait proved the most efficient flavour in terms of feeding activity. This study suggests that decomposition and nutrient cycling may be compromised in many of the UK's small, fragmented woodlands in the event of drought or climate change.	[Simpson, Jake E.; Taylor, Michele E.] NERC, Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Simpson, Jake E.] Univ London Imperial Coll Sci Technol & Med, Dept Biol, London, England; [Slade, Eleanor] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford OX1 3PS, England; [Riutta, Terhi] Univ Oxford, Sch Geog Environm, Environm Change Inst, Oxford, England	UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Imperial College London; University of Oxford; University of Oxford	Simpson, JE (corresponding author), NERC, Ctr Ecol & Hydrol, Wallingford, Oxon, England.	jakesimpson3000@gmail.com	Slade, Eleanor M/O-3874-2014	Slade, Eleanor M/0000-0002-6108-1196; Riutta, Terhi/0000-0002-8308-5307	Centre for Ecology and Hydrology; Earthwatch Institute; Environmental Change Network; Centre for Ecology and Hydrology (Natural Environment Research Council); Natural Environment Research Council [CEH010021] Funding Source: researchfish	Centre for Ecology and Hydrology; Earthwatch Institute; Environmental Change Network; Centre for Ecology and Hydrology (Natural Environment Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Centre for Ecology and Hydrology funded this project. Drs E. Slade and T. Riutta were funded by the HSBC Climate Partnership Programme through the Earthwatch Institute. This work was also supported by the Environmental Change Network, funded through the Centre for Ecology and Hydrology (Natural Environment Research Council) (http://www.ceh.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2006, J ECOL, V94, P713, DOI 10.1111/j.1365-2745.2006.01142.x; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2007, AR4 CLIM CHANG 2007; Berg B, 2006, ADV ECOL RES, V38, P1, DOI 10.1016/S0065-2504(05)38001-X; Butt N., 2009, INITIAL RESULTS ESTA; CHEN JQ, 1995, ECOL APPL, V5, P74, DOI 10.2307/1942053; Davies-Colley RJ, 2000, NEW ZEAL J ECOL, V24, P111; Eggleton P, 2009, SOIL BIOL BIOCHEM, V41, P1857, DOI 10.1016/j.soilbio.2009.06.007; Environmental Change Network, 2010, ECN SIT WYTH; Ewers RM, 2008, P NATL ACAD SCI USA, V105, P5426, DOI 10.1073/pnas.0800460105; Fenn K., 2010, BIOGEOSC DIS, V7, P3735, DOI [10.5194/bgd-7-3735-2010, DOI 10.5194/BGD-7-3735-2010]; Filzek PDB, 2004, ECOTOXICOLOGY, V13, P807, DOI 10.1007/s10646-003-4478-0; Forestry Commission, 2009, FOR FACTS FIG 2009 S; Forster B, 2004, ECOTOXICOLOGY, V13, P129, DOI 10.1023/B:ECTX.0000012410.99020.97; Geissen V, 1999, BIOL FERT SOILS, V29, P335, DOI 10.1007/s003740050562; Gestel CAM, 2003, BIOL FERT SOILS, V37, P115, DOI 10.1007/s00374-002-0575-0; Gongalsky KB, 2004, APPL SOIL ECOL, V25, P111, DOI 10.1016/j.apsoil.2003.09.001; Gongalsky KB, 2008, APPL SOIL ECOL, V39, P84, DOI 10.1016/j.apsoil.2007.11.007; Hamel C, 2007, APPL SOIL ECOL, V36, P199, DOI 10.1016/j.apsoil.2007.02.004; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Helling B, 1998, APPL SOIL ECOL, V7, P207, DOI 10.1016/S0929-1393(97)00065-6; HENDRIKSEN NB, 1990, BIOL FERT SOILS, V10, P17; Herbst M, 2008, TREE PHYSIOL, V28, P959, DOI 10.1093/treephys/28.6.959; Hollis JM, 1984, CRITERIA DIFFERENTIA; Jenkins GJ, 2009, UK CLIMATE PROJECTIO; Joschko M, 2006, AGR ECOSYST ENVIRON, V112, P367, DOI 10.1016/j.agee.2005.08.026; Kratz W, 1998, ENVIRON SCI POLLUT R, V5, P94, DOI 10.1007/BF02986394; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lavelle P, 1997, ADV ECOL RES, V27, P93, DOI 10.1016/S0065-2504(08)60007-0; Mulder C, 2005, J BIOGEOGR, V32, P1775, DOI 10.1111/j.1365-2699.2005.01321.x; O'Neill EG, 2003, GLOBAL CHANGE BIOL, V9, P117, DOI 10.1046/j.1365-2486.2003.00538.x; Osler GHR, 2007, ECOLOGY, V88, P1611, DOI 10.1890/06-1357.1; Rodwell J.S., 1991, WOODLANDS SCRUB, VI; Rombke J, 2006, J TROP ECOL, V22, P313, DOI 10.1017/S0266467406003166; Sayer EJ, 2006, BIOL REV, V81, P1, DOI 10.1017/S1464793105006846; Staley JT, 2007, EUR J SOIL BIOL, V43, P189, DOI 10.1016/j.ejsobi.2007.02.010; Sykes J. M., 1996, UK ENV CHANGE NETWOR; Taylor AR, 2005, SOIL BIOL BIOCHEM, V37, P2117, DOI 10.1016/j.soilbio.2005.03.015; terra protecta GmbH, 1999, BAIT LAM TEST; Vasconcelos SS, 2007, BIOTROPICA, V39, P593, DOI 10.1111/j.1744-7429.2007.00313.x; Vetter S, 2004, SOIL BIOL BIOCHEM, V36, P387, DOI 10.1016/j.soilbio.2003.10.012; VONTORNE E, 1990, PEDOBIOLOGIA, V34, P89; Watts K., 2006, Quarterly Journal of Forestry, V100, P273; YOUNG A, 1994, BIOL CONSERV, V67, P63, DOI 10.1016/0006-3207(94)90010-8	44	41	43	3	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29616	10.1371/journal.pone.0029616	http://dx.doi.org/10.1371/journal.pone.0029616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235311	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000301123400073
J	Thomas, JL; Ochocinska, MJ; Hitchcock, PF; Thummel, R				Thomas, Jennifer L.; Ochocinska, Margaret J.; Hitchcock, Peter F.; Thummel, Ryan			Using the Tg(nrd:egfp)/albino Zebrafish Line to Characterize In Vivo Expression of neurod	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NEUROD; MULLER GLIA; CELL-DEATH; STEM-CELLS; REGENERATION; ROD; DIFFERENTIATION; RETINA; GENES; MODEL	In this study, we used a newly-created transgenic zebrafish, Tg(nrd:egfp)/albino, to further characterize the expression of neurod in the developing and adult retina and to determine neurod expression during adult photoreceptor regeneration. We also provide observations regarding the expression of neurod in a variety of other tissues. In this line, EGFP is found in cells of the developing and adult retina, pineal gland, cerebellum, olfactory bulbs, midbrain, hindbrain, neural tube, lateral line, inner ear, pancreas, gut, and fin. Using immunohistochemistry and in situ hybridization, we compare the expression of the nrd: egfp transgene to that of endogenous neurod and to known retinal cell types. Consistent with previous data based on in situ hybridizations, we show that during retinal development, the nrd: egfp transgene is not expressed in proliferating retinal neuroepithelium, and is expressed in a subset of retinal neurons. In contrast to previous studies, nrd: egfp is gradually re-expressed in all rod photoreceptors. During photoreceptor regeneration in adult zebrafish, in situ hybridization reveals that neurod is not expressed in Muller glial-derived neuronal progenitors, but is expressed in photoreceptor progenitors as they migrate to the outer nuclear layer and differentiate into new rod photoreceptors. During photoreceptor regeneration, expression of the nrd: egfp matches that of neurod. We conclude that Tg(nrd:egfp)/albino is a good representation of endogenous neurod expression, is a useful tool to visualize neurod expression in a variety of tissues and will aid investigating the fundamental processes that govern photoreceptor regeneration in adults.	[Thomas, Jennifer L.; Thummel, Ryan] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Thomas, Jennifer L.; Thummel, Ryan] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI USA; [Ochocinska, Margaret J.; Hitchcock, Peter F.] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA	Wayne State University; Wayne State University; University of Michigan System; University of Michigan	Thummel, R (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.	rthummel@med.wayne.edu	Hitchcock, Peter/AAY-9559-2020	Hitchcock, Peter/0000-0001-9454-2684	National Institutes of Health [R21EY019401, R01EY018417, P30EY04068, R01EY07060, P30EY07003]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY004068, R01EY007060, P30EY007003, R21EY019401, R01EY018417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by National Institutes of Health grants R21EY019401 (RT) R01EY018417 (RT), P30EY04068 (RT), R01EY07060 (PFH), P30EY07003 (PFH), the Research to Prevent Blindness (PFH), and start-up funds to RT, including an unrestricted grant from Research to Prevent Blindness to the Wayne State University, Department of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TJ, 2010, EXP EYE RES, V91, P601, DOI 10.1016/j.exer.2010.07.017; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Chae JH, 2004, MOL CELLS, V18, P271; Eames SC, 2010, ZEBRAFISH, V7, P205, DOI 10.1089/zeb.2009.0640; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Hitchcock P, 2004, J COMP NEUROL, V477, P108, DOI 10.1002/cne.20244; Inoue T, 2002, DEVELOPMENT, V129, P831; JOHNSON SL, 1995, GENETICS, V141, P1583; Jurczyk A, 2011, GEN COMP ENDOCR, V170, P334, DOI 10.1016/j.ygcen.2010.10.010; Kani S, 2010, DEV BIOL, V343, P1, DOI 10.1016/j.ydbio.2010.03.024; Kaslin J, 2009, J NEUROSCI, V29, P6142, DOI 10.1523/JNEUROSCI.0072-09.2009; Kassen SC, 2007, DEV NEUROBIOL, V67, P1009, DOI 10.1002/dneu.20362; Kelly OG, 2000, DEV DYNAM, V218, P615, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1027>3.0.CO;2-8; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; Lawoko-Kerali G, 2004, MECH DEVELOP, V121, P287, DOI 10.1016/j.mod.2003.12.006; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Liu M, 2000, GENE DEV, V14, P2839, DOI 10.1101/gad.840500; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Montgomery JE, 2010, J COMP NEUROL, V518, P800, DOI 10.1002/cne.22243; Morrow EM, 1999, DEVELOPMENT, V126, P23; Mueller T, 2002, BRAIN RES BULL, V57, P377, DOI 10.1016/S0361-9230(01)00694-3; Mutoh H, 1997, P NATL ACAD SCI USA, V94, P3560, DOI 10.1073/pnas.94.8.3560; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Ochocinska MJ, 2009, MECH DEVELOP, V126, P128, DOI 10.1016/j.mod.2008.11.009; Ochocinska MJ, 2007, J COMP NEUROL, V501, P1, DOI 10.1002/cne.21150; Olsen AS, 2010, WOUND REPAIR REGEN, V18, P532, DOI 10.1111/j.1524-475X.2010.00613.x; Osorio J, 2010, J COMP NEUROL, V518, P851, DOI 10.1002/cne.22247; Pennesi ME, 2003, J NEUROSCI, V23, P453; Poss KD, 2007, SEMIN CELL DEV BIOL, V18, P36, DOI 10.1016/j.semcdb.2006.11.009; Rauch GJ, 2003, SUBMISSION CURATION; Sarrazin AF, 2006, DEV BIOL, V295, P534, DOI 10.1016/j.ydbio.2006.03.037; Sherpa T, 2008, DEV NEUROBIOL, V68, P166, DOI 10.1002/dneu.20568; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Thummel R, 2008, EXP EYE RES, V87, P433, DOI 10.1016/j.exer.2008.07.009; Thummel R, 2008, DEV NEUROBIOL, V68, P392, DOI 10.1002/dneu.20596; Thummel R, 2006, THESCIENTIFICWORLDJO, V6, P65, DOI 10.1100/tsw.2006.328; Vihtelic TS, 2000, J NEUROBIOL, V44, P289, DOI 10.1002/1097-4695(20000905)44:3<289::AID-NEU1>3.0.CO;2-H; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wu DM, 2001, INVEST OPHTH VIS SCI, V42, P2115; Yan RT, 2004, INVEST OPHTH VIS SCI, V45, P48, DOI 10.1167/iovs.03-0774; Yan RT, 1998, J NEUROBIOL, V36, P485	46	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29128	10.1371/journal.pone.0029128	http://dx.doi.org/10.1371/journal.pone.0029128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235264	gold, Green Published, Green Submitted			2022-12-27	WOS:000301123400025
J	Yancovitz, M; Litterman, A; Yoon, J; Ng, E; Shapiro, RL; Berman, RS; Pavlick, AC; Darvishian, F; Christos, P; Mazumdar, M; Osman, I; Polsky, D				Yancovitz, Molly; Litterman, Adam; Yoon, Joanne; Ng, Elise; Shapiro, Richard L.; Berman, Russell S.; Pavlick, Anna C.; Darvishian, Farbod; Christos, Paul; Mazumdar, Madhu; Osman, Iman; Polsky, David			Intra- and Inter-Tumor Heterogeneity of BRAF(V600E)Mutations in Primary and Metastatic Melanoma	PLOS ONE			English	Article							BRAF MUTATIONS; B-RAF; ONCOGENIC MUTATIONS; KINASE INHIBITOR; TARGETED THERAPY; MAPK PATHWAY; RESISTANCE; PROGRESSION; CELLS; POLYCLONALITY	The rationale for using small molecule inhibitors of oncogenic proteins as cancer therapies depends, at least in part, on the assumption that metastatic tumors are primarily clonal with respect to mutant oncogene. With the emergence of BRAF(V600E) as a therapeutic target, we investigated intra-and inter-tumor heterogeneity in melanoma using detection of the BRAF(V600E) mutation as a marker of clonality. BRAF mutant-specific PCR (MS-PCR) and conventional sequencing were performed on 112 tumors from 73 patients, including patients with matched primary and metastatic specimens (n = 18). Nineteen patients had tissues available from multiple metastatic sites. Mutations were detected in 36/112 (32%) melanomas using conventional sequencing, and 85/112 (76%) using MS-PCR. The better sensitivity of the MS-PCR to detect the mutant BRAF(V600E) allele was not due to the presence of contaminating normal tissue, suggesting that the tumor was comprised of subclones of differing BRAF genotypes. To determine if tumor subclones were present in individual primary melanomas, we performed laser microdissection and mutation detection via sequencing and BRAF(V600E)-specific SNaPshot analysis in 9 cases. Six of these cases demonstrated differing proportions of BRAF(V600E) and BRAF wild-type cells in distinct microdissected regions within individual tumors. Additional analyses of multiple metastatic samples from individual patients using the highly sensitive MS-PCR without microdissection revealed that 5/19 (26%) patients had metastases that were discordant for the BRAF(V600E) mutation. In conclusion, we used highly sensitive BRAF mutation detection methods and observed substantial evidence for heterogeneity of the BRAF(V600E) mutation within individual melanoma tumor specimens, and among multiple specimens from individual patients. Given the varied clinical responses of patients to BRAF inhibitor therapy, these data suggest that additional studies to determine possible associations between clinical outcomes and intra-and inter-tumor heterogeneity could prove fruitful.	[Yancovitz, Molly; Litterman, Adam; Yoon, Joanne; Ng, Elise; Pavlick, Anna C.; Osman, Iman; Polsky, David] NYU, Dept Dermatol, Langone Med Ctr, New York, NY 10016 USA; [Shapiro, Richard L.; Berman, Russell S.] NYU, Dept Surg, Langone Med Ctr, New York, NY 10016 USA; [Pavlick, Anna C.; Osman, Iman] NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA; [Darvishian, Farbod; Polsky, David] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA; [Christos, Paul; Mazumdar, Madhu] Cornell Univ, Dept Publ Hlth, Weill Med Coll, New York, NY 10021 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Cornell University	Yancovitz, M (corresponding author), NYU, Dept Dermatol, Langone Med Ctr, New York, NY 10016 USA.	david.polsky@nyumc.org	Polsky, David/AAO-6254-2020	Polsky, David/0000-0001-9554-5289; Berman, Russell/0000-0002-5026-5651	NYU Cancer Institute Center [5P30CA16087-31];  [R21 CA109388];  [T32 AR07190 - 31]; NATIONAL CANCER INSTITUTE [P30CA016087, R21CA109388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007190] Funding Source: NIH RePORTER	NYU Cancer Institute Center; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	DP and IO were supported by R21 CA109388. MY was supported by T32 AR07190 - 31. This project utilized the New York University (NYU) Langone Medical Center Experimental Pathology Shared Resource, which is supported by NYU Cancer Institute Center Support Grant, 5P30CA16087-31. The work was also supported in part by the use of facilities at the Manhattan Veterans Affairs Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bennett DC, 2008, PIGM CELL MELANOMA R, V21, P27, DOI 10.1111/j.1755-148X.2007.00433.x; Board RE, 2009, BRIT J CANCER, V101, P1724, DOI 10.1038/sj.bjc.6605371; CHAPMAN PB, 2011, N ENGL J MED; Cooke SL, 2010, ONCOGENE, V29, P4905, DOI 10.1038/onc.2010.245; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dias-Santagata D, 2011, MODERN PATHOL, V24, P974, DOI 10.1038/modpathol.2011.48; Dong JL, 2003, CANCER RES, V63, P3883; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Fecher LA, 2008, CURR OPIN ONCOL, V20, P183, DOI 10.1097/CCO.0b013e3282f5271c; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Flaherty K, 2009, J CLIN ONCOL, V27; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gorden A, 2003, CANCER RES, V63, P3955; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hingorani SR, 2003, CANCER RES, V63, P5198; Jakob JA, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.8500; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kaplan FM, 2011, ONCOGENE, V30, P366, DOI 10.1038/onc.2010.408; Katona TM, 2007, AM J SURG PATHOL, V31, P1029, DOI 10.1097/PAS.0b013e31802b3488; Kefford R, 2010, J CLIN ONCOL, VIII; Kumar R, 2003, CLIN CANCER RES, V9, P3362; Liang SL, 2007, CANCER RES, V67, P5814, DOI 10.1158/0008-5472.CAN-06-4233; Liegl B, 2008, J PATHOL, V216, P64, DOI 10.1002/path.2382; Lin J, 2011, BRIT J CANCER, V104, P464, DOI 10.1038/sj.bjc.6606072; Lin JR, 2009, JNCI-J NATL CANCER I, V101, P1423, DOI 10.1093/jnci/djp309; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Miller CJ, 2004, J INVEST DERMATOL, V123, P990, DOI 10.1111/j.0022-202X.2004.23468.x; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Paraiso KHT, 2010, BRIT J CANCER, V102, P1724, DOI 10.1038/sj.bjc.6605714; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Sensi M, 2006, ONCOGENE; Shinozaki M, 2004, CLIN CANCER RES, V10, P1753, DOI 10.1158/1078-0432.CCR-1169-3; Solit D, 2010, PIGM CELL MELANOMA R, V23, P760, DOI 10.1111/j.1755-148X.2010.00779.x; Solit DB, 2008, CLIN CANCER RES, V14, P8302, DOI 10.1158/1078-0432.CCR-08-1002; Su ZL, 2011, J MOL DIAGN, V13, P74, DOI 10.1016/j.jmoldx.2010.11.010; Sumimoto H, 2004, ONCOGENE, V23, P6031, DOI 10.1038/sj.onc.1207812; Taniguchi K, 2008, CANCER SCI, V99, P929, DOI 10.1111/j.1349-7006.2008.00782.x; Uribe P, 2003, AM J DERMATOPATH, V25, P365, DOI 10.1097/00000372-200310000-00001; Yancovitz M, 2007, J MOL DIAGN, V9, P178, DOI 10.2353/jmoldx.2007.060135	44	220	229	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29336	10.1371/journal.pone.0029336	http://dx.doi.org/10.1371/journal.pone.0029336			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235286	Green Submitted, Green Published, gold			2022-12-27	WOS:000301123400047
J	Nowack, A; Malarkey, EB; Yao, J; Bleckert, A; Hill, J; Bajjalieh, SM				Nowack, Amy; Malarkey, Erik B.; Yao, Jia; Bleckert, Adam; Hill, Jessica; Bajjalieh, Sandra M.			Levetiracetam Reverses Synaptic Deficits Produced by Overexpression of SV2A	PLOS ONE			English	Article							7S SNARE COMPLEXES; REGULATE NEUROTRANSMITTER RELEASE; ANTIEPILEPTIC DRUG LEVETIRACETAM; VESICLE PROTEIN; TARDIVE-DYSKINESIA; SECRETORY VESICLES; ASYMMETRIC ACCUMULATION; ANTICONVULSANT DRUG; BINDING-SITE; EXOCYTOSIS	Levetiracetam is an FDA-approved drug used to treat epilepsy and other disorders of the nervous system. Although it is known that levetiracetam binds the synaptic vesicle protein SV2A, how drug binding affects synaptic functioning remains unknown. Here we report that levetiracetam reverses the effects of excess SV2A in autaptic hippocampal neurons. Expression of an SV2A-EGFP fusion protein produced similar to 1.5-fold increase in synaptic levels of SV2, and resulted in reduced synaptic release probability. The overexpression phenotype parallels that seen in neurons from SV2 knockout mice, which experience severe seizures. Overexpression of SV2A also increased synaptic levels of the calcium-sensor protein synaptotagmin, an SV2-binding protein whose stability and trafficking are regulated by SV2. Treatment with levetiracetam rescued normal neurotransmission and restored normal levels of SV2 and synaptotagmin at the synapse. These results indicate that changes in SV2 expression in either direction impact neurotransmission, and suggest that levetiracetam may modulate SV2 protein interactions.	[Nowack, Amy; Malarkey, Erik B.; Yao, Jia; Hill, Jessica; Bajjalieh, Sandra M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Bleckert, Adam] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Nowack, A (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	bajjalie@u.washington.edu	Yao, Jia/D-3484-2009	Yao, Jia/0000-0003-3235-5351	National Institute of Mental Health [R01 MH 059842]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059842] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the National Institute of Mental Health (R01 MH 059842) to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abderrahmani A, 2004, J CELL SCI, V117, P2239, DOI 10.1242/jcs.01041; BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; BAJJALIEH SM, 1993, P NATL ACAD SCI USA, V90, P2150, DOI 10.1073/pnas.90.6.2150; BAJJALIEH SM, 1994, J NEUROSCI, V14, P5223, DOI 10.1523/jneurosci.14-09-05223.1994; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; Bushara KO, 2005, NEUROLOGY, V64, P1078, DOI 10.1212/01.WNL.0000154596.21335.2E; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Cohen JE, 2011, P NATL ACAD SCI USA, V108, P11650, DOI 10.1073/pnas.1017576108; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; De Smedt T, 2007, CNS DRUG REV, V13, P43, DOI 10.1111/j.1527-3458.2007.00004.x; De Smedt T, 2007, CNS DRUG REV, V13, P57, DOI 10.1111/j.1527-3458.2007.00005.x; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dunteman ED, 2005, J PAIN PALLIAT CARE, V19, P35, DOI 10.1300/J354v19n01_07; Enggaard TP, 2006, EUR J PAIN, V10, P193, DOI 10.1016/j.ejpain.2005.03.011; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; Gower AJ, 1995, EPILEPSY RES, V22, P207, DOI 10.1016/0920-1211(95)00077-1; Gronborg M, 2010, J NEUROSCI, V30, P2, DOI 10.1523/JNEUROSCI.4074-09.2010; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Itakura M, 1999, BIOCHEM BIOPH RES CO, V265, P691, DOI 10.1006/bbrc.1999.1756; Janz R, 1998, J NEUROSCI, V18, P9269; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Kaminski RM, 2009, EPILEPSIA, V50, P1729, DOI 10.1111/j.1528-1167.2009.02089.x; Kinrys G, 2006, J CLIN PSYCHIAT, V67, P211, DOI 10.4088/JCP.v67n0206; Kinrys G, 2007, J CLIN PSYCHIAT, V68, P1010, DOI 10.4088/JCP.v68n0705; Lazzell DR, 2004, J BIOL CHEM, V279, P52124, DOI 10.1074/jbc.M407502200; Liu JG, 2007, BIOCHEMISTRY-MOSCOW+, V72, P439, DOI 10.1134/S0006297907040116; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Matveeva EA, 2003, J NEUROCHEM, V84, P621, DOI 10.1046/j.1471-4159.2003.01589.x; Matveeva EA, 2008, EPILEPSIA, V49, P1749, DOI 10.1111/j.1528-1167.2008.01687.x; Matveeva EA, 2007, EPILEPSY RES, V73, P266, DOI 10.1016/j.eplepsyres.2006.11.003; McGavin CL, 2003, NEUROLOGY, V61, P419, DOI 10.1212/01.WNL.0000073538.60021.50; Meehan AL, 2011, J NEUROPHYSIOL, V106, P1227, DOI 10.1152/jn.00279.2011; Morgans CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005230; Mutch SA, 2011, J NEUROSCI, V31, P1461, DOI 10.1523/JNEUROSCI.3805-10.2011; Nowack A, 2010, AM J PHYSIOL-CELL PH, V299, pC960, DOI 10.1152/ajpcell.00259.2010; NOYER M, 1995, EUR J PHARMACOL, V286, P137, DOI 10.1016/0014-2999(95)00436-O; Ohno Y, 2009, BIOCHEM BIOPH RES CO, V390, P415, DOI 10.1016/j.bbrc.2009.09.035; Price MJ, 2004, CLIN J PAIN, V20, P33, DOI 10.1097/00002508-200401000-00007; Schivell AE, 1996, J BIOL CHEM, V271, P27770, DOI 10.1074/jbc.271.44.27770; Striano P, 2007, J NEUROL NEUROSUR PS, V78, P438, DOI 10.1136/jnnp.2006.103275; van Vliet EA, 2009, EPILEPSIA, V50, P422, DOI 10.1111/j.1528-1167.2008.01727.x; Wan QF, 2010, NEURON, V66, P884, DOI 10.1016/j.neuron.2010.05.010; Winden KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020763; Woods SW, 2008, J CLIN PSYCHIAT, V69, P546, DOI 10.4088/JCP.v69n0405; Xu T, 2001, NAT CELL BIOL, V3, P691, DOI 10.1038/35087000; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292; Yang XF, 2007, EPILEPSIA, V48, P1861, DOI 10.1111/j.1528-1167.2006.01132.x; Yang XF, 2009, SEIZURE-EUR J EPILEP, V18, P615, DOI 10.1016/j.seizure.2009.07.004; Yao J, 2010, J NEUROSCI, V30, P5569, DOI 10.1523/JNEUROSCI.4781-09.2010; Zhang W, 2005, J PSYCHOPHARMACOL, V19, P551, DOI 10.1177/0269881105056526; Zivkovic SA, 2008, ACTA NEUROL SCAND, V117, P351, DOI 10.1111/j.1600-0404.2007.00950.x	53	50	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29560	10.1371/journal.pone.0029560	http://dx.doi.org/10.1371/journal.pone.0029560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220214	Green Published, gold, Green Submitted			2022-12-27	WOS:000300677000047
J	Piya, S; White, EJ; Klein, SR; Jiang, H; McDonnell, TJ; Gomez-Manzano, C; Fueyo, J				Piya, Sujan; White, Erin J.; Klein, Sarah R.; Jiang, Hong; McDonnell, Timothy J.; Gomez-Manzano, Candelaria; Fueyo, Juan			The E1B19K Oncoprotein Complexes with Beclin 1 to Regulate Autophagy in Adenovirus-Infected Cells	PLOS ONE			English	Article							MOLECULAR-BASIS; BCL-2 HOMOLOG; BH3 DOMAIN; APOPTOSIS; DEATH; PROTEIN; INTERACTS; INDUCE; 19K; BAX	The mechanisms underlying adenovirus-mediated autophagy are currently unknown. Recently, members of the Bcl-2 protein family have been associated with autophagy. It was also reported that the Bcl-2 homology-3 (BH3) domain encompassed by both Beclin 1 and Bcl-2-like proteins is essential for their pro-autophagy or anti-autophagy functions. Here, we report for the first time that E1B19K, the adenovirus BH3 domain protein, interacts with Beclin 1 to initiate autophagy. Using immunoprecipitation assays we showed that expression of E1B19K in the host cell disrupted the physical interactions between Beclin 1 and Bcl-2 proteins. The displacement of Bcl-2 was coincident with the recruitment of PI3KC3 to the Beclin 1/E1B19K complexes. As a result of the changes in the components of the Beclin 1 interactome, there was activation of PI3KC3, as showed by the identification of PI3K-mediated lipid phosphorylation, and subsequent formation of autophagosomes. Importantly, the BH3 functional domain of E1B19K protein was required for the heterodimerization with Beclin 1. We also showed that transfer of E1B19K was sufficient to trigger autophagy in cancer cells. Consistent with these data, mutant adenoviruses encompassing a deletion of the E1B19K gene produced a marked deficiency in the capability of the virus to induce autophagy as showed by examining the lipidation and cleavage of LC3-I as well as the subcellular localization of LC3-II, the decrease in the levels of p62, and the formation of autophagosomes. Our work offers new information on the mechanisms of action of the adenoviral E1B19K protein as partner of Beclin 1 and positive regulator of autophagy.	[Piya, Sujan; White, Erin J.; Klein, Sarah R.; Jiang, Hong; Gomez-Manzano, Candelaria; Fueyo, Juan] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [McDonnell, Timothy J.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Gomez-Manzano, Candelaria; Fueyo, Juan] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Piya, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA.	cmanzano@mdanderson.org; jfueyo@mdanderson.org		Gomez-Manzano, Candelaria/0000-0002-1259-2133; Fueyo, Juan/0000-0001-6941-2335	National Institutes of Health [P50CA127001]; National Institutes of Health (Cancer Center) [CA016672]; National Brain Tumor Society; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA127001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (Cancer Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Brain Tumor Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (P50CA127001 and the Cancer Center Support Grant CA016672) and the National Brain Tumor Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird SK, 2008, ONCOGENE, V27, P3081, DOI 10.1038/sj.onc.1210977; BOYD JM, 1995, ONCOGENE, V11, P1921; Cuconati A, 2002, GENE DEV, V16, P2465, DOI 10.1101/gad.1012702; FARROW SN, 1995, NATURE, V374, P731, DOI 10.1038/374731a0; Feng W, 2007, J MOL BIOL, V372, P223, DOI 10.1016/j.jmb.2007.06.069; Fueyo J, 2003, J NATL CANCER I, V95, P652, DOI 10.1093/jnci/95.9.652; Han J, 1996, MOL CELL BIOL, V16, P5857; Han JH, 1996, GENE DEV, V10, P461, DOI 10.1101/gad.10.4.461; Han JH, 1998, ONCOGENE, V17, P2993, DOI 10.1038/sj.onc.1202215; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Ito H, 2006, JNCI-J NATL CANCER I, V98, P625, DOI 10.1093/jnci/djj161; Jiang H, CANC RES, V70, P7882; Jiang H, 2011, J VIROL; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; Jiang H, 2011, J VIROL, V85, P4720, DOI 10.1128/JVI.02032-10; Jiang H, 2010, CANCER RES, V70, P7882, DOI 10.1158/0008-5472.CAN-10-1604; Ku B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040025; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; McLaughlin-Drubin ME, 2008, BBA-MOL BASIS DIS, V1782, P127, DOI 10.1016/j.bbadis.2007.12.005; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Rodriguez-Rocha H, 2011, VIROLOGY, V416, P9, DOI 10.1016/j.virol.2011.04.017; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Tyler MA, 2009, AUTOPHAGY, V5, P856, DOI 10.4161/auto.8792; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Yasuda M, 1998, J BIOL CHEM, V273, P12415, DOI 10.1074/jbc.273.20.12415; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	34	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29467	10.1371/journal.pone.0029467	http://dx.doi.org/10.1371/journal.pone.0029467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242123	gold, Green Published, Green Submitted			2022-12-27	WOS:000300677000037
J	Sethi, J; Sanchez-Alavez, M; Tabarean, IV				Sethi, Jasmine; Sanchez-Alavez, Manuel; Tabarean, Iustin V.			Kv4.2 Mediates Histamine Modulation of Preoptic Neuron Activity and Body Temperature	PLOS ONE			English	Article							PYRAMIDAL NEURONS; H-3 RECEPTOR; NUCLEUS; AREA; H-2-RECEPTORS; EXPRESSION; CURRENTS; AROUSAL; LESIONS	Histamine regulates arousal, circadian rhythms, and thermoregulation. Activation of H3 histamine receptors expressed by preoptic GABAergic neurons results in a decrease of their firing rate and hyperthermia. Here we report that an increase in the A-type K+ current in preoptic GABAergic neurons in response to activation of H3 histamine receptors results in decreased firing rate and hyperthermia in mice. The Kv4.2 subunit is required for these actions in spite of the fact that Kv4.2(-/-) preoptic GABAergic neurons display A-type currents and firing characteristics similar to those of wild-type neurons. This electrical remodeling is achieved by robust upregulation of the expression of the Kv4.1 subunit and of a delayed rectifier current. Dynamic clamp experiments indicate that enhancement of the A-type current by a similar amount to that induced by histamine is sufficient to mimic its robust effect on firing rates. These data indicate a central role played by the Kv4.2 subunit in histamine regulation of body temperature and its interaction with pERK1/2 downstream of the H3 receptor. We also reveal that this pathway provides a mechanism for selective modulation of body temperature at the beginning of the active phase of the circadian cycle.	[Sethi, Jasmine; Sanchez-Alavez, Manuel; Tabarean, Iustin V.] Scripps Res Inst, Dept Mol & Integrat Neurosci, La Jolla, CA 92037 USA	Scripps Research Institute	Sethi, J (corresponding author), Scripps Res Inst, Dept Mol & Integrat Neurosci, La Jolla, CA 92037 USA.	tabarean@scripps.edu		Sanchez-Alavez, Manuel/0000-0002-8164-8452	National Institutes of Neurological Disorders and Stroke [NS060799]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060799] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by National Institutes of Neurological Disorders and Stroke grant NS060799. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2006, MOL CELL ENDOCRINOL, V252, P46, DOI 10.1016/j.mce.2006.03.036; Adams JP, 2000, J NEUROCHEM, V75, P2277, DOI 10.1046/j.1471-4159.2000.0752277.x; Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; Bourdeau ML, 2007, J NEUROSCI, V27, P1942, DOI 10.1523/JNEUROSCI.3208-06.2007; Brown RE, 2001, PROG NEUROBIOL, V63, P637, DOI 10.1016/S0301-0082(00)00039-3; Burdakov D, 2002, J NEUROSCI, V22, P6380; Chen JC, 2003, EUR J PHARMACOL, V467, P57, DOI 10.1016/S0014-2999(03)01635-2; COLBOC O, 1982, NEUROPHARMACOLOGY, V21, P45, DOI 10.1016/0028-3908(82)90209-X; Drutel G, 2001, MOL PHARMACOL, V59, P1; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hahn J, 2006, J NEUROSCI, V26, P5240, DOI 10.1523/JNEUROSCI.4976-05.2006; Hannibal J, 2006, AM J PHYSIOL-REG I, V300, pR519; Hu HJ, 2003, J NEUROPHYSIOL, V90, P1671, DOI 10.1152/jn.00340.2003; Hu HJ, 2006, NEURON, V50, P89, DOI 10.1016/j.neuron.2006.03.010; Khaliq ZM, 2008, J NEUROSCI, V28, P10905, DOI 10.1523/JNEUROSCI.2237-08.2008; Kullmann PHM, 2004, J NEUROPHYSIOL, V91, P542, DOI 10.1152/jn.00559.2003; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Lu J, 2001, J NEUROSCI, V21, P4864, DOI 10.1523/JNEUROSCI.21-13-04864.2001; Lundius EG, 2010, J NEUROSCI, V30, P4369, DOI 10.1523/JNEUROSCI.0378-10.2010; Milescu LS, 2008, BIOPHYS J, V95, P66, DOI 10.1529/biophysj.107.118190; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Nakamura K, 2010, P NATL ACAD SCI USA, V107, P8848, DOI 10.1073/pnas.0913358107; Nerbonne JM, 2008, J PHYSIOL-LONDON, V586, P1565, DOI 10.1113/jphysiol.2007.146597; Parmentier R, 2007, BIOCHEM PHARMACOL, V73, P1157, DOI 10.1016/j.bcp.2007.01.002; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PRAST H, 1992, J AUTONOM NERV SYST, V39, P105, DOI 10.1016/0165-1838(92)90050-Q; Sundgren-Andersson AK, 1998, BRAIN RES, V783, P194, DOI 10.1016/S0006-8993(97)01342-5; Tabarean IV, 2005, NEUROSCIENCE, V135, P433, DOI 10.1016/j.neuroscience.2005.06.053; Tanaka M, 2011, J NEUROSCI, V31, P5078, DOI 10.1523/JNEUROSCI.6433-10.2011; Valdes JL, 2006, EUR J NEUROSCI, V23, P1352, DOI 10.1111/j.1460-9568.2006.04659.x; Valdes JL, 2005, EUR J NEUROSCI, V21, P1931, DOI 10.1111/j.1460-9568.2005.04013.x; Yoshida K, 2009, J NEUROSCI, V29, P11954, DOI 10.1523/JNEUROSCI.2643-09.2009; Yuan WL, 2005, J NEUROSCI, V25, P9185, DOI 10.1523/JNEUROSCI.2858-05.2005; Zhou FW, 2006, J NEUROPHYSIOL, V96, P1581, DOI 10.1152/jn.00148.2006	37	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29134	10.1371/journal.pone.0029134	http://dx.doi.org/10.1371/journal.pone.0029134			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220205	Green Submitted, gold, Green Published			2022-12-27	WOS:000300677000018
J	Lagana, AA; Lohe, MA; von Smekal, L				Lagana, Antonio A.; Lohe, Max A.; von Smekal, Lorenz			Interfacing External Quantum Devices to a Universal Quantum Computer	PLOS ONE			English	Article								We present a scheme to use external quantum devices using the universal quantum computer previously constructed. We thereby show how the universal quantum computer can utilize networked quantum information resources to carry out local computations. Such information may come from specialized quantum devices or even from remote universal quantum computers. We show how to accomplish this by devising universal quantum computer programs that implement well known oracle based quantum algorithms, namely the Deutsch, Deutsch-Jozsa, and the Grover algorithms using external black-box quantum oracle devices. In the process, we demonstrate a method to map existing quantum algorithms onto the universal quantum computer.	[Lagana, Antonio A.; Lohe, Max A.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA, Australia; [von Smekal, Lorenz] Tech Univ Darmstadt, Inst Kernphys, Darmstadt, Germany	University of Adelaide; Technical University of Darmstadt	Lagana, AA (corresponding author), Univ Adelaide, Sch Chem & Phys, Adelaide, SA, Australia.	antonio.lagana@adelaide.edu.au	Lohe, Max/C-3193-2012	Lohe, Max/0000-0002-5214-2225				Curcic T, 2004, ACM SIGCOMM COMP COM, V34, P3, DOI 10.1145/1039111.1039117; DEUTSCH D, 1985, P ROY SOC LOND A MAT, V400, P97, DOI 10.1098/rspa.1985.0070; GOLDWASSER S, 1994, P 35 ANN S FDN COMP; Griffiths D.J., 2018, INTRO QUANTUM MECH, V3rd ed.; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Lagana AA, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.052322; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Waser S., 1982, INTRO ARITHMETIC DIG	9	0	0	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29417	10.1371/journal.pone.0029417	http://dx.doi.org/10.1371/journal.pone.0029417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216276	gold, Green Published			2022-12-27	WOS:000300676300057
J	Mueller, H; Fae, KC; Magdorf, K; Ganoza, CA; Wahn, U; Guhlich, U; Feiterna-Sperling, C; Kaufmann, SHE				Mueller, Henrik; Fae, Kellen C.; Magdorf, Klaus; Ganoza, Christian A.; Wahn, Ulrich; Guhlich, Ute; Feiterna-Sperling, Cornelia; Kaufmann, Stefan H. E.			Granulysin-Expressing CD4(+) T Cells as Candidate Immune Marker for Tuberculosis during Childhood and Adolescence	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PEDIATRIC TUBERCULOSIS; MEDIATED CYTOTOXICITY; GLOBAL EPIDEMIOLOGY; EFFECTOR FUNCTIONS; INFECTION; CHILDREN; CLONES; LYMPHOCYTES; DIAGNOSIS	Background: Granulysin produced by cytolytic T cells directly contributes to immune defense against tuberculosis (TB). We investigated granulysin as a candidate immune marker for childhood and adolescent TB. Methods: Peripheral blood mononuclear cells (PBMC) from children and adolescents (1-17 years) with active TB, latent TB infection (LTBI), nontuberculous mycobacteria (NTM) infection and from uninfected controls were isolated and restimulated in a 7-day restimulation assay. Intracellular staining was then performed to analyze antigen-specific induction of activation markers and cytotoxic proteins, notably, granulysin in CD4(+) CD45RO(+) memory T cells. Results: CD4(+) CD45RO(+) T cells co-expressing granulysin with specificity for Mycobacterium tuberculosis (Mtb) were present in high frequency in TB-experienced children and adolescents. Proliferating memory T cells (CFSE(low)CD4(+) CD45RO(+)) were identified as main source of granulysin and these cells expressed both central and effector memory phenotype. PBMC from study participants after TB drug therapy revealed that granulysin-expressing CD4(+) T cells are long-lived, and express several activation and cytotoxicity markers with a proportion of cells being interferon-gamma-positive. In addition, granulysin-expressing T cell lines showed cytolytic activity against Mtb-infected target cells. Conclusions: Our data suggest granulysin expression by CD4(+) memory T cells as candidate immune marker for TB infection, notably, in childhood and adolescence.	[Mueller, Henrik; Fae, Kellen C.; Ganoza, Christian A.; Guhlich, Ute; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Magdorf, Klaus; Wahn, Ulrich; Feiterna-Sperling, Cornelia] Charite, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Mueller, H (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.	kaufmann@MPIIB-Berlin.mpg.de	Ganoza, Christian A/A-8875-2014; Kaufmann, Stefan HE/I-5454-2014	Ganoza, Christian A/0000-0002-5891-5372; Feiterna-Sperling, Cornelia/0000-0003-4171-1098; Kaufmann, Stefan HE/0000-0001-9866-8268	Max Planck Institute for Infection Biology; European Commission's [Health-F3-2009-241745]; Bill and Melinda Gates Foundation (BMGF) [37772]	Max Planck Institute for Infection Biology; European Commission's(European CommissionEuropean Commission Joint Research Centre); Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation)	This study was funded by intramural funds of the Max Planck Institute for Infection Biology and received partial financial support from the European Commission's Framework Programme 7 "NEWTBVAC" (Health-F3-2009-241745; URL of Framework 7 Project NEWTBVAC: http://ec.europa.eu/research/health/infectious-diseases/poverty-diseases/projects/205_en.htm) and the Bill and Melinda Gates Foundation, Grand Challenges in Global Health (BMGF GC6-74 (no. 37772; URL of BMGFGC Projects http://www.grandchallenges.org/Pages/BrowseByGoal.aspx)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian M, 2008, J IMMUNOL, V180, P3436, DOI 10.4049/jimmunol.180.5.3436; BERKE G, 1995, CELL, V81, P9, DOI 10.1016/0092-8674(95)90365-8; Beyers N, 1997, INT J TUBERC LUNG D, V1, P38; BOOM WH, 1991, INFECT IMMUN, V59, P2737, DOI 10.1128/IAI.59.8.2737-2743.1991; Canaday DH, 2001, J IMMUNOL, V167, P2734, DOI 10.4049/jimmunol.167.5.2734; Caruso AM, 1999, J IMMUNOL, V162, P5407; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; Cosmi L, 2007, INT ARCH ALLERGY IMM, V143, P1, DOI 10.1159/000098220; Detjen AK, 2009, CLIN VACCINE IMMUNOL, V16, P1170, DOI 10.1128/CVI.00168-09; Di Liberto D, 2007, TUBERCULOSIS, V87, P322, DOI 10.1016/j.tube.2007.01.003; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; DOLIN PJ, 1994, B WORLD HEALTH ORGAN, V72, P213; Donald PR, 2007, PAEDIATR RESPIR REV, V8, P134, DOI 10.1016/j.prrv.2007.04.001; Ernst WA, 2000, J IMMUNOL, V165, P7102, DOI 10.4049/jimmunol.165.12.7102; Franken KLMC, 2000, PROTEIN EXPRES PURIF, V18, P95, DOI 10.1006/prep.1999.1162; HANSEN PW, 1987, SCAND J IMMUNOL, V25, P295, DOI 10.1111/j.1365-3083.1987.tb01075.x; Huang LP, 2007, J IMMUNOL, V178, P77, DOI 10.4049/jimmunol.178.1.77; Hughes AJ, 2005, CLIN EXP IMMUNOL, V142, P132, DOI 10.1111/j.1365-2249.2005.02884.x; JACOBS RF, 1993, MED CLIN N AM, V77, P1335, DOI 10.1016/S0025-7125(16)30197-3; KAMOUN M, 1992, DNA CELL BIOL, V11, P265, DOI 10.1089/dna.1992.11.265; Kaspar AA, 2001, J IMMUNOL, V167, P350, DOI 10.4049/jimmunol.167.1.350; Kaufmann SHE, 1999, CURR BIOL, V9, pR97, DOI 10.1016/S0960-9822(99)80059-1; Klucar P, 2008, HUM IMMUNOL, V69, P475, DOI 10.1016/j.humimm.2008.05.008; KUMARARATNE DS, 1990, CLIN EXP IMMUNOL, V80, P314; Latinovic-Golic S, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-9; Lewinsohn DM, 1998, J IMMUNOL, V160, P2374; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Maher D, 2006, INT J TUBERC LUNG D, V10, P1205; Maher D, 2006, INT J TUBERC LUNG D, V10, P1091; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Meier S, 2008, CYTOM PART A, V73A, P1035, DOI 10.1002/cyto.a.20640; Merlo A, 2001, INFECT IMMUN, V69, P6022, DOI 10.1128/IAI.69.10.6022-6029.2001; MULLER I, 1987, INFECT IMMUN, V55, P2037; MUTIS T, 1993, EUR J IMMUNOL, V23, P2189, DOI 10.1002/eji.1830230921; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Nemeth J, 2010, EUR CYTOKINE NETW, V21, P34, DOI 10.1684/ecn.2009.0182; Noel PJ, 1996, ADV EXP MED BIOL, V406, P209; Norris PJ, 2001, J VIROL, V75, P9771, DOI 10.1128/JVI.75.20.9771-9779.2001; ORME IM, 1983, J EXP MED, V158, P74, DOI 10.1084/jem.158.1.74; OTTENHOFF THM, 1988, J EXP MED, V168, P1947, DOI 10.1084/jem.168.5.1947; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Rigouts L, 2009, EUR J PEDIATR, V168, P1285, DOI 10.1007/s00431-009-0988-y; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590; Semple PL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/438463; Siawaya JFD, 2007, INT J INFECT DIS, V11, P289, DOI 10.1016/j.ijid.2007.02.001; Starke JR, 2003, TUBERCULOSIS, V83, P208, DOI 10.1016/S1472-9792(02)00088-4; Stenger S, 2001, SCAND J INFECT DIS, V33, P483, DOI 10.1080/00365540110026584; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Walls T, 2004, J INFECTION, V48, P13, DOI 10.1016/S0163-4453(03)00121-X; Williams NS, 1996, J IMMUNOL, V156, P153; Wood R, 2010, INT J TUBERC LUNG D, V14, P406; Yang C, 2009, INT J TUBERC LUNG D, V13, P1360; Yasukawa M, 2000, BLOOD, V95, P2352, DOI 10.1182/blood.V95.7.2352.007k40_2352_2355	56	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29367	10.1371/journal.pone.0029367	http://dx.doi.org/10.1371/journal.pone.0029367			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216262	Green Published, gold, Green Submitted			2022-12-27	WOS:000300674900031
J	Yip, P; Chen, TH; Seshaiah, P; Stephen, LL; Michael-Ballard, KL; Mapes, JP; Mansfield, BC; Bertenshaw, GP				Yip, Ping; Chen, Tzong-Hao; Seshaiah, Partha; Stephen, Laurie L.; Michael-Ballard, Karri L.; Mapes, James P.; Mansfield, Brian C.; Bertenshaw, Greg P.			Comprehensive Serum Profiling for the Discovery of Epithelial Ovarian Cancer Biomarkers	PLOS ONE			English	Article							DIAGNOSTIC MARKERS; CA-125; BENIGN; RISK; HE-4; ANTIGEN-125; VALIDATION; RECURRENCE; ULTRASOUND; SAMPLES	FDA-cleared ovarian cancer biomarkers are limited to CA-125 and HE4 for monitoring and recurrence and OVA1, a multivariate panel consisting of CA-125 and four additional biomarkers, for referring patients to a specialist. Due to relatively poor performance of these tests, more accurate and broadly applicable biomarkers are needed. We evaluated the dysregulation of 259 candidate cancer markers in serum samples from 499 patients. Sera were collected prospectively at 11 monitored sites under a single well-defined protocol. All stages of ovarian cancer and common benign gynecological conditions were represented. To ensure consistency and comparability of biomarker comparisons, all measurements were performed on a single platform, at a single site, using a panel of rigorously calibrated, qualified, high-throughput, multiplexed immunoassays and all analyses were conducted using the same software. Each marker was evaluated independently for its ability to differentiate ovarian cancer from benign conditions. A total of 175 markers were dysregulated in the cancer samples. HE4 (AUC = 0.933) and CA-125 (AUC = 0.907) were the most informative biomarkers, followed by IL-2 receptor alpha, alpha 1-antitrypsin, C-reactive protein, YKL-40, cellular fibronectin, CA-72-4 and prostasin (AUC>0.800). To improve the discrimination between cancer and benign conditions, a simple multivariate combination of markers was explored using logistic regression. When combined into a single panel, the nine most informative individual biomarkers yielded an AUC value of 0.950, significantly higher than obtained when combining the markers in the OVA1 panel (AUC 0.912). Additionally, at a threshold sensitivity of 90%, the combination of the top 9 markers gave 88.9% specificity compared to 63.4% specificity for the OVA1 markers. Although a blinded validation study has not yet been performed, these results indicate that alternative biomarker combinations might lead to significant improvements in the detection of ovarian cancer.	[Yip, Ping; Chen, Tzong-Hao; Seshaiah, Partha; Mansfield, Brian C.; Bertenshaw, Greg P.] Correlog Syst Inc, Germantown, MD USA; [Stephen, Laurie L.; Michael-Ballard, Karri L.; Mapes, James P.] Rules Based Med Inc, Austin, TX USA		Yip, P (corresponding author), Correlog Syst Inc, Germantown, MD USA.	gbertenshaw@gmail.com		Mansfield, Brian/0000-0002-8533-2789; Bertenshaw, Greg/0000-0003-4903-3412	National Cancer Institute, National Institutes of Health, Department of Health and Human Services [HHSN261200700037C, HHSN261200800045C]	National Cancer Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported with funds in part from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, under Contract Numbers HHSN261200700037C and HHSN261200800045C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM CANC SOC, 2007, NCCN OV CANC TREATM; American Cancer Society, 2010, CANC FACTS FIG 2010; Amonkar SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004599; Anastasi E, 2010, TUMOR BIOL, V31, P113, DOI 10.1007/s13277-009-0015-y; Bertenshaw GP, 2008, CANCER EPIDEM BIOMAR, V17, P2872, DOI 10.1158/1055-9965.EPI-08-0464; Buamah P, 2000, J SURG ONCOL, V75, P264, DOI 10.1002/1096-9098(200012)75:4<264::AID-JSO7>3.0.CO;2-Q; Coates RJ, 2008, CLIN CANCER RES, V14, P7575, DOI 10.1158/1078-0432.CCR-08-2296; Cramer DW, 2011, CANCER PREV RES, V4, P365, DOI 10.1158/1940-6207.CAPR-10-0195; Edgell T, 2010, J CANCER RES CLIN, V136, P1079, DOI 10.1007/s00432-009-0755-5; *FDA, 2009, 510K SUBST EQ DET DE; *FDA, 2008, BRIEF DOC IMM DEV PA; FUNG ET, 2006, NOV BIOM AID DIFF DI; Gorelik E, 2005, CANCER EPIDEM BIOMAR, V14, P981, DOI 10.1158/1055-9965.EPI-04-0404; Greene MH, 2008, CANCER EPIDEM BIOMAR, V17, P594, DOI 10.1158/1055-9965.EPI-07-2703; Howlader N, 2011, SEER CANC STAT REV 1; JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; Kalantri Y, 2007, INDIAN J MED RES, V125, P25; KLUG TL, 1984, CANCER RES, V44, P1048; Lomholt AF, 2007, CLIN CHIM ACTA, V380, P128, DOI 10.1016/j.cca.2007.01.022; Mai PL, 2011, CANCER PREV RES, V4, P303, DOI 10.1158/1940-6207.CAPR-11-0053; McIntosh M, 2008, CLIN CANCER RES, V14, P7574, DOI 10.1158/1078-0432.CCR-08-0623; MILLER RW, 2011, OBSTET GYNECOL; Miralles C, 2003, ANN SURG ONCOL, V10, P150, DOI 10.1245/ASO.2003.05.015; Moore RG, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.043; Moore RG, 2009, GYNECOL ONCOL, V112, P40, DOI 10.1016/j.ygyno.2008.08.031; MYERS ER, 2006, MANAGEMENT ADNEXAL M, P130; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; Rose PG, 1998, J CLIN ONCOL, V16, P1494, DOI 10.1200/JCO.1998.16.4.1494; SCHILTHUIS MS, 1987, BRIT J OBSTET GYNAEC, V94, P202; SESHAIAH P, 2010, VALIDATION MULTIVARI; Skates SJ, 2004, J CLIN ONCOL, V22, P4059, DOI 10.1200/JCO.2004.03.091; Skates SJ, 2003, J CLIN ONCOL S, V21, P206, DOI DOI 10.1200/JC0.2003.02.955; Skogstrand K, 2008, J IMMUNOL METHODS, V336, P78, DOI 10.1016/j.jim.2008.04.006; Thorpe JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001281; Timmerman D, 2005, J CLIN ONCOL, V23, P8794, DOI 10.1200/JCO.2005.01.7632; Van Calster B, 2007, JNCI-J NATL CANCER I, V99, P1706, DOI 10.1093/jnci/djm199; Van Gorp T, 2011, BRIT J CANCER, V104, P863, DOI 10.1038/sj.bjc.6606092; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Yurkovetsky Zoya R, 2006, Future Oncol, V2, P733, DOI 10.2217/14796694.2.6.733; Zhu CS, 2011, CANCER PREV RES, V4, P375, DOI 10.1158/1940-6207.CAPR-10-0193	41	42	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29533	10.1371/journal.pone.0029533	http://dx.doi.org/10.1371/journal.pone.0029533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216306	Green Published, Green Submitted, gold			2022-12-27	WOS:000299113600088
J	Jiang, XJ; Castelao, JE; Chavez-Uribe, E; Rodriguez, BF; Munoz, CC; Redondo, CM; Fernandez, MP; Dominguez, AN; Pereira, CD; Martinez, ME; Garcia-Caballero, T; Rodriguez, MF; Antunez, J; Carracedo, A; Forteza-Vila, J; Gago-Dominguez, M				Jiang, Xuejuan; Esteban Castelao, Jose; Chavez-Uribe, Elisabet; Fernandez Rodriguez, Beatriz; Celeiro Munoz, Catuxa; Redondo, Carmen M.; Pena Fernandez, Maite; Novo Dominguez, Alejandro; Doris Pereira, Carina; Elena Martinez, Maria; Garcia-Caballero, Tomas; Fraga Rodriguez, Maximo; Antunez, Jose; Carracedo, Angel; Forteza-Vila, Jeronimo; Gago-Dominguez, Manuela			Family History and Breast Cancer Hormone Receptor Status in a Spanish Cohort	PLOS ONE			English	Article							BRCA1 MUTATION CARRIERS; HISPANIC WHITE WOMEN; ESTROGEN-RECEPTOR; RACIAL/ETHNIC GROUPS; RISK-FACTORS; CONFER SUSCEPTIBILITY; CLINICAL PRESENTATION; COMMON VARIANTS; PROGNOSIS; SURVIVAL	Bakground: Breast cancer is a heterogenous disease that impacts racial/ethnic groups differently. Differences in genetic composition, lifestyles, reproductive factors, or environmental exposures may contribute to the differential presentation of breast cancer among Hispanic women. Materials and Methods: A population-based study was conducted in the city of Santiago de Compostela, Spain. A total of 645 women diagnosed with operable invasive breast cancer between 1992 and 2005 participated in the study. Data on demographics, breast cancer risk factors, and clinico-pathological characteristics of the tumors were collected. Hormone receptor negative tumors were compared with hormone receptor postive tumors on their clinico-pathological characteristics as well as risk factor profiles. Results: Among the 645 breast cancer patients, 78% were estrogen receptor-positive (ER+) or progesterone receptor-positive (PR+), and 22% were ER-&PR-. Women with a family history of breast cancer were more likely to have ER-&PR- tumors than women without a family history (Odds ratio, 1.43; 95% confidence interval, 0.91-2.26). This association was limited to cancers diagnosed before age 50 (Odds ratio, 2.79; 95% confidence interval, 1.34-5.81). Conclusions: An increased proportion of ER-&PR- breast cancer was observed among younger Spanish women with a family history of the disease.	[Jiang, Xuejuan] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Esteban Castelao, Jose; Redondo, Carmen M.] Complejo Hosp Univ Vigo, Oncol & Genet Unit, Vigo, Spain; [Chavez-Uribe, Elisabet; Fernandez Rodriguez, Beatriz; Celeiro Munoz, Catuxa; Pena Fernandez, Maite; Novo Dominguez, Alejandro; Doris Pereira, Carina; Garcia-Caballero, Tomas; Fraga Rodriguez, Maximo; Antunez, Jose; Forteza-Vila, Jeronimo] Complejo Hosp Univ Santiago de Compostela, Santiago De Compostela, Spain; [Elena Martinez, Maria] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA; [Carracedo, Angel; Gago-Dominguez, Manuela] Galician Fdn Genom Med, Santiago De Compostela, Spain	University of Southern California; Complexo Hospitalario Universitario de Vigo; Complexo Hospitalario Universitario de Santiago de Compostela; Arizona Center Cancer Care; University of Arizona	Jiang, XJ (corresponding author), Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA.	xuejuanj@usc.edu	Garcia-Caballero, Tomas/H-7213-2015; Carracedo, Angel/D-4257-2012; Fraga, Máximo/AAC-9417-2020; Gago-Dominguez, Manuela/AAP-6611-2021	Carracedo, Angel/0000-0003-1085-8986; Redondo, Carmen M./0000-0003-4971-2861; Castelao, Jose E/0000-0001-7110-1376; Gago, Manuela/0000-0001-6713-4351; Garcia-Caballero, Tomas/0000-0002-7938-1437	EMERCIII: Programa Grupos Emergentes; Cancer Genetics Unit; Instituto de Salud Carlos III, Spain	EMERCIII: Programa Grupos Emergentes; Cancer Genetics Unit; Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	This study was supported in part by EMERCIII: Programa Grupos Emergentes, Cancer Genetics Unit, Instituto de Salud Carlos III, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; [Anonymous], 2001, GAL WORLD EXT ACT XU, P456; Baumbach L, 2007, AM SOC HUM GEN 57 AN; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chakraborty Bandana M., 1999, Ethnicity and Disease, V9, P278; Chavez-Uribe E, 2007, ONCOL REP, V17, P1109; Chavez-Uribe EM, 2002, EUR J SURG, V168, P37, DOI 10.1080/110241502317307553; Chu KC, 2002, BREAST CANCER RES TR, V74, P199, DOI 10.1023/A:1016361932220; Chu KC, 2001, CANCER, V92, P37, DOI 10.1002/1097-0142(20010701)92:1<37::AID-CNCR1289>3.0.CO;2-F; Colditz GA, 2004, JNCI-J NATL CANCER I, V96, P218, DOI 10.1093/jnci/djh025; Diez O, 2003, HUM MUTAT, V22, P301, DOI 10.1002/humu.10260; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; ELLEDGE RM, 1994, J NATL CANCER I, V86, P705, DOI 10.1093/jnci/86.9.705; ELLIS IO, 2003, WHO CLASSIFICATION T, P9; FRIERSON HF, 1995, AM J CLIN PATHOL, V103, P195; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Hines LM, 2008, CANCER EPIDEM BIOMAR, V17, P2700, DOI 10.1158/1055-9965.EPI-08-0504; John EM, 2007, JAMA-J AM MED ASSOC, V298, P2869, DOI 10.1001/jama.298.24.2869; Lapham SJ, 1993, L136 CPH BUR CENS PO; Li CI, 2003, ARCH INTERN MED, V163, P49, DOI 10.1001/archinte.163.1.49; Llort Gemma, 2002, Hum Mutat, V19, P307, DOI 10.1002/humu.9014.abs; Osorio A, 2000, BRIT J CANCER, V82, P1266, DOI 10.1054/bjoc.1999.1089; Patel TA, 2010, ONCOLOGIST, V15, P466, DOI 10.1634/theoncologist.2010-0004; Sans M, 2000, HUM BIOL, V72, P155; Setiawan VW, 2009, AM J EPIDEMIOL, V169, P1251, DOI 10.1093/aje/kwp036; Shavers VL, 2003, CANCER-AM CANCER SOC, V97, P134, DOI 10.1002/cncr.11051; Shetterly SM, 1998, AM J EPIDEMIOL, V147, P1019, DOI 10.1093/oxfordjournals.aje.a009395; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Symmans WF, 2005, ENDOCR-RELAT CANCER, V12, P1059, DOI 10.1677/erc.1.01051; Teixeira MR, 2005, SEMIN CANCER BIOL, V15, P3, DOI 10.1016/j.semcancer.2004.09.006; Theis B, 1994, Eur J Cancer Prev, V3, P321, DOI 10.1097/00008469-199407000-00004; Tung N, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2478; Watlington AT, 2007, CANCER, V109, P2093, DOI 10.1002/cncr.22640; Vega A, 2002, ANN HUM GENET, V66, P29, DOI 10.1017/S0003480001001014; Vega A, 2001, Hum Mutat, V17, P520, DOI 10.1002/humu.1136; Vona-Davis L, 2009, J WOMENS HEALTH, V18, P883, DOI 10.1089/jwh.2008.1127; Weitzel JN, 2005, CANCER EPIDEM BIOMAR, V14, P1666, DOI 10.1158/1055-9965.EPI-05-0072; Wojcik Barbara E, 2003, Breast J, V9, P175, DOI 10.1046/j.1524-4741.2003.09308.x	39	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29459	10.1371/journal.pone.0029459	http://dx.doi.org/10.1371/journal.pone.0029459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238615	gold, Green Submitted, Green Published			2022-12-27	WOS:000301188800017
J	Bekeredjian-Ding, I; Foermer, S; Kirschning, CJ; Parcina, M; Heeg, K				Bekeredjian-Ding, Isabelle; Foermer, Sandra; Kirschning, Carsten J.; Parcina, Marijo; Heeg, Klaus			Poke Weed Mitogen Requires Toll-Like Receptor Ligands for Proliferative Activity in Human and Murine B Lymphocytes	PLOS ONE			English	Article							PHYTOLACCA-AMERICANA; CELL PROLIFERATION; ACTIVATION; ANTIGEN; DNA; LIPOPOLYSACCHARIDE; MACROPHAGES; CPG; SENSITIVITY; EXPRESSION	Poke weed mitogen (PWM), a lectin purified from Phytolacca americana is frequently used as a B cell-specific stimulus to trigger proliferation and immunoglobulin secretion. In the present study we investigated the mechanisms underlying the B cell stimulatory capacity of PWM. Strikingly, we observed that highly purified PWM preparations failed to induce B cell proliferation. By contrast, commercially available PWM preparations with B cell activity contained Toll-like receptor (TLR) ligands such as TLR2-active lipoproteins, lipopolysaccharide and DNA of bacterial origin. We show that these microbial substances contribute to the stimulatory activity of PWM. Additional experimental data highlight the capacity of PWM to enable B cell activation by immunostimulatory DNA. Based on these findings we propose that the lectin sensitizes B cells for TLR stimulation as described for B cell receptor ligation and that B cell mitogenicity of PWM preparations results from synergistic activity of the poke weed lectin and microbial TLR ligands present in the PWM preparations.	[Bekeredjian-Ding, Isabelle; Foermer, Sandra; Parcina, Marijo; Heeg, Klaus] Univ Heidelberg Hosp, Dept Infect Dis Med Microbiol & Hyg, Heidelberg, Germany; [Kirschning, Carsten J.] Univ Hosp Essen, Inst Med Microbiol, Essen, Germany	Ruprecht Karls University Heidelberg; University of Duisburg Essen	Bekeredjian-Ding, I (corresponding author), Univ Heidelberg Hosp, Dept Infect Dis Med Microbiol & Hyg, Heidelberg, Germany.	isabelle.bekeredjian-ding@med.uni-heidelberg.de	Parcina, Marijo/ABG-4659-2020; Bekeredjian-Ding, Isabelle/I-6197-2013	Bekeredjian-Ding, Isabelle/0000-0001-6646-5888	Medical Faculty of the University of Heidelberg, Germany; medical faculty of the University of Heidelberg	Medical Faculty of the University of Heidelberg, Germany; medical faculty of the University of Heidelberg	IB-D received financial support from the Olympia-Morata program of the Medical Faculty of the University of Heidelberg, Germany. The Olympia-Morata grant is intramural funding from the medical faculty of the University of Heidelberg. There were no external grants involved. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Ando I, 2002, INT IMMUNOPHARMACOL, V2, P1155, DOI 10.1016/S1567-5769(02)00076-0; Avalos AM, 2009, J IMMUNOL, V183, P6262, DOI 10.4049/jimmunol.0901941; Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Bekeredjian-Ding I, 2007, J IMMUNOL, V178, P2803, DOI 10.4049/jimmunol.178.5.2803; Bekeredjian-Ding I, 2006, J IMMUNOL, V176, P7438, DOI 10.4049/jimmunol.176.12.7438; Bekeredjian-Ding I, 2009, IMMUNOLOGY, V128, P311, DOI 10.1111/j.1365-2567.2009.03173.x; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; BORJESON J, 1966, J EXP MED, V124, P859, DOI 10.1084/jem.124.5.859; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Dalpke A, 2006, INFECT IMMUN, V74, P940, DOI 10.1128/IAI.74.2.940-946.2006; De Castro C, 2008, CARBOHYD RES, V343, P1924, DOI 10.1016/j.carres.2008.01.036; Eckl-Dorna J, 2009, BLOOD, V113, P3969, DOI 10.1182/blood-2008-10-185421; FARNES P, 1964, LANCET, V2, P1100; Fujii T, 2004, ACTA CRYSTALLOGR D, V60, P665, DOI 10.1107/S090744490400232X; Han SB, 2003, INT IMMUNOPHARMACOL, V3, P1301, DOI 10.1016/S1567-5769(03)00118-8; Han SB, 2003, INT IMMUNOPHARMACOL, V3, P683, DOI 10.1016/S1567-5769(03)00056-0; Heeg K, 2008, INT J MED MICROBIOL, V298, P33, DOI 10.1016/j.ijmm.2007.07.007; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hou BD, 2011, IMMUNITY, V34, P375, DOI 10.1016/j.immuni.2011.01.011; KILPATRICK DC, 1986, SCAND J IMMUNOL, V24, P11, DOI 10.1111/j.1365-3083.1986.tb02064.x; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Okamoto M, 2004, CLIN DIAGN LAB IMMUN, V11, P483, DOI 10.1128/CDLI.11.3.483-495.2004; Roberts TL, 2011, IMMUNOL CELL BIOL, V89, P517, DOI 10.1038/icb.2010.112; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; SASSO EH, 1989, J IMMUNOL, V142, P2778; Wang YQ, 2003, INT IMMUNOL, V15, P223, DOI 10.1093/intimm/dxg020; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Yang JS, 2006, CLIN VACCINE IMMUNOL, V13, P309, DOI 10.1128/CVI.13.3.309-313.2006; YOKOYAMA K, 1978, BIOCHIM BIOPHYS ACTA, V538, P384, DOI 10.1016/0304-4165(78)90366-5; YOKOYAMA K, 1976, BIOCHIM BIOPHYS ACTA, V427, P443, DOI 10.1016/0005-2795(76)90187-2	32	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29806	10.1371/journal.pone.0029806	http://dx.doi.org/10.1371/journal.pone.0029806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238657	Green Submitted, Green Published, gold			2022-12-27	WOS:000301070200048
J	Konig, S; Nimtz, M; Scheiter, M; Ljunggren, HG; Bryceson, YT; Jansch, L				Koenig, Sebastian; Nimtz, Manfred; Scheiter, Maxi; Ljunggren, Hans-Gustaf; Bryceson, Yenan T.; Jaensch, Lothar			Kinome Analysis of Receptor-Induced Phosphorylation in Human Natural Killer Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; FC-GAMMA-RIIIA; LINKED LYMPHOPROLIFERATIVE DISEASE; CLATHRIN-MEDIATED ENDOCYTOSIS; TANDEM MASS-SPECTROMETRY; FES TYROSINE KINASE; RESTING NK CELLS; T-CELLS; INHIBITORY RECEPTORS; PROTEOMICS ANALYSIS	Background: Natural killer (NK) cells contribute to the defense against infected and transformed cells through the engagement of multiple germline-encoded activation receptors. Stimulation of the Fc receptor CD16 alone is sufficient for NK cell activation, whereas other receptors, such as 2B4 (CD244) and DNAM-1 (CD226), act synergistically. After receptor engagement, protein kinases play a major role in signaling networks controlling NK cell effector functions. However, it has not been characterized systematically which of all kinases encoded by the human genome (kinome) are involved in NK cell activation. Results: A kinase-selective phosphoproteome approach enabled the determination of 188 kinases expressed in human NK cells. Crosslinking of CD16 as well as 2B4 and DNAM-1 revealed a total of 313 distinct kinase phosphorylation sites on 109 different kinases. Phosphorylation sites on 21 kinases were similarly regulated after engagement of either CD16 or co-engagement of 2B4 and DNAM-1. Among those, increased phosphorylation of FYN, KCC2G (CAMK2), FES, and AAK1, as well as the reduced phosphorylation of MARK2, were reproducibly observed both after engagement of CD16 and co-engagement of 2B4 and DNAM-1. Notably, only one phosphorylation on PAK4 was differentally regulated. Conclusions: The present study has identified a significant portion of the NK cell kinome and defined novel phosphorylation sites in primary lymphocytes. Regulated phosphorylations observed in the early phase of NK cell activation imply these kinases are involved in NK cell signaling. Taken together, this study suggests a largely shared signaling pathway downstream of distinct activation receptors and constitutes a valuable resource for further elucidating the regulation of NK cell effector responses.	[Koenig, Sebastian; Nimtz, Manfred; Scheiter, Maxi; Jaensch, Lothar] Helmholtz Zentrum Infekt Forsch, Dept Mol Struct Biol, Braunschweig, Germany; [Ljunggren, Hans-Gustaf; Bryceson, Yenan T.] Karolinska Inst, Dept Med, Ctr Infect Med, Karolinska Univ Hosp Huddinge, Stockholm, Sweden	Helmholtz Association; Helmholtz-Center for Infection Research; Karolinska Institutet; Karolinska University Hospital	Konig, S (corresponding author), Helmholtz Zentrum Infekt Forsch, Dept Mol Struct Biol, Braunschweig, Germany.	lothar.jaensch@helmholtz-hzi.de	Bryceson, Yenan T/D-2121-2018	Bryceson, Yenan T/0000-0002-7783-9934	International Research Training Group [1273]; German Research Foundation; Histocytosis Association of America; Mary Beve's Foundation; Clas Groschinsky's Memorial Fund; Shizu Matsumaras Donation; Karolinska Institute Research Foundation; Swedish Research Council; Swedish Cancer Society	International Research Training Group; German Research Foundation(German Research Foundation (DFG)); Histocytosis Association of America; Mary Beve's Foundation; Clas Groschinsky's Memorial Fund; Shizu Matsumaras Donation; Karolinska Institute Research Foundation(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by the International Research Training Group 1273 funded by the German Research Foundation (Dr. Konig, Dr. Scheiter, Dr. Jansch), the Histocytosis Association of America (Dr. Bryceson), Mary Beve's Foundation (Dr. Bryceson), Clas Groschinsky's Memorial Fund (Dr. Bryceson), Shizu Matsumaras Donation (Dr. Bryceson), the Karolinska Institute Research Foundation (Dr. Bryceson and Dr. Ljunggren), the Swedish Research Council (Dr. Bryceson and Dr. Ljunggren), and the Swedish Cancer Society (Dr. Ljunggren). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2001, J BIOL CHEM, V276, P44003, DOI 10.1074/jbc.M105669200; Abraha AB, 2010, ARCH ENVIRON CON TOX, V59, P661, DOI 10.1007/s00244-010-9520-7; Aguilo JI, 2009, J IMMUNOL, V182, P1972, DOI 10.4049/jimmunol.0801820; Alvarez-Arias DA, 2007, J IMMUNOL, V179, P5281, DOI 10.4049/jimmunol.179.8.5281; AZZONI L, 1992, J EXP MED, V176, P1745, DOI 10.1084/jem.176.6.1745; Bachelet I, 2006, J BIOL CHEM, V281, P27190, DOI 10.1074/jbc.M602359200; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Beal AM, 2009, IMMUNITY, V31, P632, DOI 10.1016/j.immuni.2009.09.004; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Becker F, 2004, CHEM BIOL, V11, P211, DOI 10.1016/j.chembiol.2004.02.001; Bloch-Queyrat C, 2005, J EXP MED, V202, P181, DOI 10.1084/jem.20050449; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Bryceson YT, 2009, BLOOD, V114, P2657, DOI 10.1182/blood-2009-01-201632; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Chen RY, 2006, MOL CELL BIOL, V26, P5559, DOI 10.1128/MCB.00357-06; Chuang SS, 2001, J IMMUNOL, V167, P6210, DOI 10.4049/jimmunol.167.11.6210; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dulla K, 2010, MOL CELL PROTEOMICS, V9, P1167, DOI 10.1074/mcp.M900335-MCP200; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; FANG F, 1993, BIOCHEMISTRY-US, V32, P6995, DOI 10.1021/bi00078a026; Flett A, 2005, BIOCHEM SOC SYMP, V72, P65, DOI 10.1042/bss0720065; Gismondi A, 2000, J IMMUNOL, V164, P2272, DOI 10.4049/jimmunol.164.5.2272; Gringel A, 2006, J CELL PHYSIOL, V209, P568, DOI 10.1002/jcp.20777; Gu CP, 2006, P NATL ACAD SCI USA, V103, P14447, DOI 10.1073/pnas.0606624103; HAMA N, 1995, J EXP MED, V181, P1217, DOI 10.1084/jem.181.3.1217; Hirose T, 1997, EUR J BIOCHEM, V249, P481, DOI 10.1111/j.1432-1033.1997.t01-1-00481.x; Hirose T, 2000, EUR J BIOCHEM, V267, P2113, DOI 10.1046/j.1432-1327.2000.01218.x; Hundertmark C, 2009, BIOINFORMATICS, V25, P1004, DOI 10.1093/bioinformatics/btn551; Irie A, 2006, INT IMMUNOL, V18, P1737, DOI 10.1093/intimm/dxl108; Ishiguro K, 2007, MOL IMMUNOL, V44, P2095, DOI 10.1016/j.molimm.2006.09.012; Ishiguro K, 2006, MOL CELL BIOL, V26, P5497, DOI 10.1128/MCB.02469-05; ITO M, 1988, INT J IMMUNOPHARMACO, V10, P211, DOI 10.1016/0192-0561(88)90051-3; Khurana D, 2007, J IMMUNOL, V178, P3575, DOI 10.4049/jimmunol.178.6.3575; Kim HS, 2010, IMMUNITY, V32, P175, DOI 10.1016/j.immuni.2010.02.004; Kim JE, 2006, J IMMUNOL, V176, P2833, DOI 10.4049/jimmunol.176.5.2833; Knockaert M, 2000, CHEM BIOL, V7, P411, DOI 10.1016/S1074-5521(00)00124-1; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Laurent CE, 2004, MOL CELL BIOL, V24, P9351, DOI 10.1128/MCB.24.21.9351-9358.2004; Lee SH, 2010, J IMMUNOL, V185, P917, DOI 10.4049/jimmunol.1000784; LEIBSON PJ, 1990, J IMMUNOL, V145, P1498; Li Q, 2009, BMB REP, V42, P35, DOI 10.5483/BMBRep.2009.42.1.035; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lin J, 2009, J IMMUNOL, V183, P1215, DOI 10.4049/jimmunol.0803887; Liu DF, 2009, IMMUNITY, V31, P99, DOI 10.1016/j.immuni.2009.05.009; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Manciulea M, 1996, CELL IMMUNOL, V167, P63, DOI 10.1006/cimm.1996.0008; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marx A, 2010, FASEB J, V24, P1637, DOI 10.1096/fj.09-148064; Masilamani M, 2009, TRAFFIC, V10, P1735, DOI 10.1111/j.1600-0854.2009.00973.x; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; McPherson VA, 2009, MOL CELL BIOL, V29, P389, DOI 10.1128/MCB.00904-08; Meng FY, 2005, MASS SPECTROM REV, V24, P126, DOI 10.1002/mas.20009; Nguyen V, 2009, MOL CELL PROTEOMICS, V8, P2418, DOI 10.1074/mcp.M800307-MCP200; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; Oberprieler NG, 2010, BLOOD, V116, P2253, DOI 10.1182/blood-2010-01-266650; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Peterson ME, 2008, IMMUNITY; PIGNATA C, 1993, J IMMUNOL, V151, P6794; Poggi A, 2002, J IMMUNOL, V168, P95, DOI 10.4049/jimmunol.168.1.95; Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681; Reinl T, 2009, MOL CELL PROTEOMICS; Reinl T, 2009, MOL CELL PROTEOMICS, V8, P2778, DOI 10.1074/mcp.M800521-MCP200; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Rogers JA, 1996, J BIOL CHEM, V271, P17519, DOI 10.1074/jbc.271.29.17519; Saborit-Villarroya I, 2008, MOL IMMUNOL, V45, P3446, DOI 10.1016/j.molimm.2008.03.021; Sasanuma H, 2006, BLOOD, V107, P3647, DOI 10.1182/blood-2005-10-4102; Sharma K, 2010, J PROTEOME RES, V9, P2539, DOI 10.1021/pr901192p; Shibuya A, 1998, J IMMUNOL, V161, P1671; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Stapleton D, 1997, FEBS LETT, V409, P452, DOI 10.1016/S0014-5793(97)00569-3; Strowig T, 2008, J IMMUNOL, V180, P7785, DOI 10.4049/jimmunol.180.12.7785; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Takahashi S, 2003, J BIOL CHEM, V278, P49129, DOI 10.1074/jbc.C300289200; Tangye SG, 2000, MOL IMMUNOL, V37, P493, DOI 10.1016/S0161-5890(00)00076-6; Tassi I, 2008, BLOOD, V112, P4109, DOI 10.1182/blood-2008-02-139527; TING AT, 1992, J EXP MED, V176, P1751, DOI 10.1084/jem.176.6.1751; TING AT, 1995, J BIOL CHEM, V270, P16415, DOI 10.1074/jbc.270.27.16415; Truesdell PF, 2009, EXP CELL RES, V315, P2929, DOI 10.1016/j.yexcr.2009.08.021; Udell CM, 2006, J BIOL CHEM, V281, P20949, DOI 10.1074/jbc.M604252200; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Veillette A, 2006, IMMUNOL REV, V214, P22, DOI 10.1111/j.1600-065X.2006.00453.x; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Watzl Carsten, 2010, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1109bs90; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wissing J, 2007, MOL CELL PROTEOMICS, V6, P537, DOI 10.1074/mcp.T600062-MCP200; Yeo MG, 2011, J CELL PHYSIOL, V226, P236, DOI 10.1002/jcp.22335; Zirngibl R, 2001, EXP CELL RES, V266, P87, DOI 10.1006/excr.2001.5217; Zompi S, 2005, IMMUNOL LETT, V97, P31, DOI 10.1016/j.imlet.2004.10.006	99	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29672	10.1371/journal.pone.0029672	http://dx.doi.org/10.1371/journal.pone.0029672			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238634	Green Submitted, gold, Green Published			2022-12-27	WOS:000301070200041
J	Nielsen, FGG; Markus, KG; Friborg, RM; Favrholdt, LM; Stunnenberg, HG; Huynen, M				Nielsen, Fiona G. G.; Markus, Kasper Galschiot; Friborg, Rune Mollegaard; Favrholdt, Lene Monrad; Stunnenberg, Hendrik G.; Huynen, Martijn			CATCHprofiles: Clustering and Alignment Tool for ChIP Profiles	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HUMAN GENOME; DEVELOPMENTAL REGULATORS; CHROMATIN; TRANSCRIPTION; PROMOTERS; METHYLATIONS; ORGANIZATION; OCCUPANCY; POLYCOMB	Chromatin Immuno Precipitation (ChIP) profiling detects in vivo protein-DNA binding, and has revealed a large combinatorial complexity in the binding of chromatin associated proteins and their post-translational modifications. To fully explore the spatial and combinatorial patterns in ChIP-profiling data and detect potentially meaningful patterns, the areas of enrichment must be aligned and clustered, which is an algorithmically and computationally challenging task. We have developed CATCHprofiles, a novel tool for exhaustive pattern detection in ChIP profiling data. CATCHprofiles is built upon a computationally efficient implementation for the exhaustive alignment and hierarchical clustering of ChIP profiling data. The tool features a graphical interface for examination and browsing of the clustering results. CATCHprofiles requires no prior knowledge about functional sites, detects known binding patterns "ab initio", and enables the detection of new patterns from ChIP data at a high resolution, exemplified by the detection of asymmetric histone and histone modification patterns around H2A.Z-enriched sites. CATCHprofiles' capability for exhaustive analysis combined with its ease-of-use makes it an invaluable tool for explorative research based on ChIP profiling data. CATCHprofiles and the CATCH algorithm run on all platforms and is available for free through the CATCH website:http://catch.cmbi.ru.nl/. User support is available by subscribing to the mailing list catch-users@bioinformatics.org.	[Nielsen, Fiona G. G.; Huynen, Martijn] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Markus, Kasper Galschiot; Favrholdt, Lene Monrad] Univ So Denmark, Dept Math & Comp Sci, Odense, Denmark; [Nielsen, Fiona G. G.; Stunnenberg, Hendrik G.; Huynen, Martijn] Nijmegen Ctr Mol Life Sci, Fac Sci, Nijmegen, Netherlands; [Friborg, Rune Mollegaard] Univ Copenhagen, eSci Ctr, Copenhagen, Denmark	Radboud University Nijmegen; University of Southern Denmark; Radboud University Nijmegen; University of Copenhagen	Nielsen, FGG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands.	h.stunnenberg@ncmls.ru.nl; m.huynen@cmbi.ru.nl	Huynen, Martijn A/A-1530-2014; Huijnen, M.A./H-8051-2014; Stunnenberg, Hendrik G./D-6875-2012	Huynen, Martijn A/0000-0001-6189-5491; Stunnenberg, Hendrik G./0000-0002-0066-1576; Favrholdt, Lene/0000-0003-3054-2997; Nielsen, Fiona/0000-0002-2988-7480	European HEROIC project for epigenetic research; Stichting Nationale Computerfaciliteiten (National Computing Facilities Foundation, NCF); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organization for Scientific Research, NWO)	European HEROIC project for epigenetic research; Stichting Nationale Computerfaciliteiten (National Computing Facilities Foundation, NCF); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organization for Scientific Research, NWO)(Netherlands Organization for Scientific Research (NWO))	The work of FN was funded in part by the European HEROIC project for epigenetic research (EU FP6 Integrated Project). This work was sponsored by the Stichting Nationale Computerfaciliteiten (National Computing Facilities Foundation, NCF) for the use of supercomputer facilities, with financial support from the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organization for Scientific Research, NWO). Supercomputer access was provided by SARA (the Dutch National High Performance Computing and e-Science Support Center) and by the Life Sciences Department of Barcelona Supercomputing Center, Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrera LO, 2006, CURR OPIN CELL BIOL, V18, P291, DOI 10.1016/j.ceb.2006.04.002; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bishop C. M., 2006, J ELECT IMAG, V16, P140; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Fischer JJ, 2008, GENOMICS, V91, P41, DOI 10.1016/j.ygeno.2007.08.010; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hon G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000201; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Lai WKM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r126; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Reid G, 2009, INT J BIOCHEM CELL B, V41, P155, DOI 10.1016/j.biocel.2008.08.028; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tolstorukov MY, 2009, GENOME RES, V19, P967, DOI 10.1101/gr.084830.108; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88	28	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28272	10.1371/journal.pone.0028272	http://dx.doi.org/10.1371/journal.pone.0028272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238575	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200007
J	Bensellam, M; Duvillie, B; Rybachuk, G; Laybutt, DR; Magnan, C; Guiot, Y; Pouyssegur, J; Jonas, JC				Bensellam, Mohammed; Duvillie, Bertrand; Rybachuk, Galyna; Laybutt, D. Ross; Magnan, Christophe; Guiot, Yves; Pouyssegur, Jacques; Jonas, Jean-Christophe			Glucose-Induced O-2 Consumption Activates Hypoxia Inducible Factors 1 and 2 in Rat Insulin-Secreting Pancreatic Beta-Cells	PLOS ONE			English	Article							OXYGEN-CONSUMPTION; LACTATE-DEHYDROGENASE; CHRONIC HYPERGLYCEMIA; GENE-EXPRESSION; CALCIUM INFLUX; FREE CA2+; C-MYC; ISLETS; DIFFERENTIATION; HIF-1-ALPHA	Background: Glucose increases the expression of glycolytic enzymes and other hypoxia-response genes in pancreatic betacells. Here, we tested whether this effect results from the activation of Hypoxia-Inducible-factors (HIF) 1 and 2 in a hypoxia-dependent manner. Methodology/Principal Findings: Isolated rat islets and insulin-secreting INS-1E cells were stimulated with nutrients at various pO(2) values or treated with the HIF activator CoCl2. HIF-target gene mRNA levels and HIF subunit protein levels were measured by real-time RT-PCR, Western Blot and immunohistochemistry. The formation of pimonidazole-protein adducts was used as an indicator of hypoxia. In INS-1E and islet beta-cells, glucose concentration-dependently stimulated formation of pimonidazole-protein adducts, HIF1 and HIF2 nuclear expression and HIF-target gene mRNA levels to a lesser extent than CoCl2 or a four-fold reduction in pO(2). Islets also showed signs of HIF activation in diabetic Lepr(db/db) but not non-diabetic Lepr(db/+) mice. In vitro, these glucose effects were reproduced by nutrient secretagogues that bypass glycolysis, and were inhibited by a three-fold increase in pO(2) or by inhibitors of Ca2+ influx and insulin secretion. In INS-1E cells, small interfering RNA-mediated knockdown of Hif1 alpha and Hif2 alpha, alone or in combination, indicated that the stimulation of glycolytic enzyme mRNA levels depended on both HIF isoforms while the vasodilating peptide adrenomedullin was a HIF2-specific target gene. Conclusions/Significance: Glucose-induced O-2 consumption creates an intracellular hypoxia that activates HIF1 and HIF2 in rat beta-cells, and this glucose effect contributes, together with the activation of other transcription factors, to the glucose stimulation of expression of some glycolytic enzymes and other hypoxia response genes.	[Bensellam, Mohammed; Rybachuk, Galyna; Guiot, Yves; Jonas, Jean-Christophe] Catholic Univ Louvain, Inst Rech Expt & Clin, B-1200 Brussels, Belgium; [Duvillie, Bertrand] Univ Paris 05, INSERM U845, Fac Med, Res Ctr Growth & Signalling,Hop Necker, Paris, France; [Laybutt, D. Ross] St Vincents Hosp, Diabet & Obes Res Program, Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Magnan, Christophe] Univ Paris 07, CNRS, Unite Biol Fonct & Adaptat, Paris, France; [Pouyssegur, Jacques] Univ Nice, Inst Dev Biol & Canc Res, CNRS UMR 6543, Ctr A Lacassagne, Nice, France	Universite Catholique Louvain; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Bensellam, M (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, B-1200 Brussels, Belgium.	jean-christophe.jonas@uclouvain.be	Bensellam, Mohammed/AAI-4760-2020; Duvillie, Bertrand/N-4343-2018; magnan, christophe/AAJ-7622-2021; Jonas, Jean-Christophe/C-6766-2011	Duvillie, Bertrand/0000-0003-0551-8100; magnan, christophe/0000-0002-7044-2571; Jonas, Jean-Christophe/0000-0001-9882-5438; Bensellam, Mohammed/0000-0002-1641-1694	Fonds de la Recherche Scientifique Medicale [3.4516.09]; General Direction of Scientific Research of the French Community of Belgium [ARC 05/10-328]; Interuniversity Poles of Attraction Program [P6/42]; METOXIA-EU-FP7; European Foundation; Merck Sharp Dohme; EFSD; Juvenile Diabetes Research Foundation; Novo Nordisk A/S; Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM); sanofiaventis Group; sanofi-aventis Group; Novo-Nordisk A/S	Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); General Direction of Scientific Research of the French Community of Belgium; Interuniversity Poles of Attraction Program; METOXIA-EU-FP7; European Foundation(European Science Foundation (ESF)); Merck Sharp Dohme(Merck & Company); EFSD; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Novo Nordisk A/S(Novo Nordisk); Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM); sanofiaventis Group(Sanofi-Aventis); sanofi-aventis Group(Sanofi-Aventis); Novo-Nordisk A/S(Novo Nordisk)	This work was supported by grant 3.4516.09 from the Fonds de la Recherche Scientifique Medicale (to Dr. Jonas), grant ARC 05/10-328 from the General Direction of Scientific Research of the French Community of Belgium and the Interuniversity Poles of Attraction Program (P6/42)-Belgian Science Policy (to Dr. Jonas), METOXIA-EU-FP7 (to Dr. Pouyssegur), a grant from the European Foundation for the Study of Diabetes in partnership with Merck Sharp & Dohme (EFSD/MSD Partnership for European Studies on Beta Cell Function and Survival: Basic Research Programme) (to Dr. Jonas), a grant from the EFSD in partnership with the Juvenile Diabetes Research Foundation and Novo Nordisk A/S (EFSD/JDRF/Novo Nordisk European Programme in Type 1 Diabetes Research) (to Dr. Duvillie), and a grant from the Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM) in partnership with sanofiaventis Group (to Dr. Duvillie). Dr. Bensellam was Research Fellow and Dr. Jonas is Research Director of the Fonds de la Recherche Scientifique-FNRS (Belgium). These funding agencies and their commercial partners had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Jonas and Dr. Duvillie obtained grants from non-commercial funding agencies that raised funds through partnerships with Merck Sharp & Dohme, sanofi-aventis Group and Novo-Nordisk A/S. There are no patents, marketed products, or products in development related to this research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Arteel GE, 1998, EUR J BIOCHEM, V253, P743, DOI 10.1046/j.1432-1327.1998.2530743.x; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bensellam M, 2009, DIABETOLOGIA, V52, P463, DOI 10.1007/s00125-008-1245-z; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Buchwald P, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-5; Cantley J, 2009, J CLIN INVEST, V119, P125, DOI 10.1172/JCI26934; Carlsson PO, 2002, ACTA PHYSIOL SCAND, V176, P275, DOI 10.1046/j.1365-201X.2002.01049.x; Carlsson PO, 1997, DIABETES, V46, P947, DOI 10.2337/diabetes.46.6.947; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; Collier JJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE48, DOI 10.1152/ajpendo.00357.2006; Collier JJ, 2003, J BIOL CHEM, V278, P6588, DOI 10.1074/jbc.M208011200; Diraison F, 2008, J LIPID RES, V49, P814, DOI 10.1194/jlr.M700533-JLR200; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Heinis M, 2010, DIABETES, V59, P662, DOI 10.2337/db09-0891; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Hinke SA, 2004, J PHYSIOL-LONDON, V558, P369, DOI 10.1113/jphysiol.2004.064881; HOSOKAWA H, 1995, DIABETES, V44, P1328, DOI 10.2337/diabetes.44.11.1328; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; HUTTON JC, 1980, DIABETOLOGIA, V18, P395; Ishihara H, 1999, J CLIN INVEST, V104, P1621, DOI 10.1172/JCI7515; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Jung SR, 2009, AM J PHYSIOL-ENDOC M, V297, pE717, DOI 10.1152/ajpendo.00282.2009; Jung SK, 2000, J BIOL CHEM, V275, P6642, DOI 10.1074/jbc.275.9.6642; Khaldi MZ, 2004, AM J PHYSIOL-ENDOC M, V287, pE207, DOI 10.1152/ajpendo.00426.2003; Kjorholt C, 2005, DIABETES, V54, P2755, DOI 10.2337/diabetes.54.9.2755; Lau J, 2009, CURR OPIN ORGAN TRAN, V14, P688, DOI 10.1097/MOT.0b013e32833239ff; Laybutt DR, 2002, J BIOL CHEM, V277, P10912, DOI 10.1074/jbc.M111751200; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; LONGO EA, 1991, J BIOL CHEM, V266, P9314; Ma ZH, 2007, DIABETES, V56, P1095, DOI 10.2337/db06-0322; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Moritz W, 2002, FASEB J, V16, P745, DOI 10.1096/fj.01-0403fje; Olsson R, 2011, DIABETES, V60, P2068, DOI 10.2337/db09-0877; Ortsater H, 2002, PFLUG ARCH EUR J PHY, V444, P506, DOI 10.1007/s00424-002-0842-9; PIPELEERS D, 1994, DIABETOLOGIA, V37, pS57, DOI 10.1007/BF00400827; Puri S, 2009, DIABETES, V58, P433, DOI 10.2337/db08-0749; Quintens R, 2008, BIOCHEM SOC T, V36, P300, DOI 10.1042/BST0360300; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Roche E, 1997, J BIOL CHEM, V272, P3091, DOI 10.1074/jbc.272.5.3091; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Sweet IR, 2006, DIABETES, V55, P3509, DOI 10.2337/db06-0400; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; Wang HY, 2002, J BIOL CHEM, V277, P32746, DOI 10.1074/jbc.M201635200; Wang WJ, 2005, J ENDOCRINOL, V185, P445, DOI 10.1677/joe.1.06092; Xavier GD, 2000, P NATL ACAD SCI USA, V97, P4023, DOI 10.1073/pnas.97.8.4023; Zehetner J, 2008, GENE DEV, V22, P3135, DOI 10.1101/gad.496908	51	69	73	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29807	10.1371/journal.pone.0029807	http://dx.doi.org/10.1371/journal.pone.0029807			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235342	gold, Green Published, Green Submitted			2022-12-27	WOS:000301123400104
J	Fischer, V; Maisch, MW; Naish, D; Kosma, R; Liston, J; Joger, U; Kruger, FJ; Perez, JP; Tainsh, J; Appleby, RM				Fischer, Valentin; Maisch, Michael W.; Naish, Darren; Kosma, Ralf; Liston, Jeff; Joger, Ulrich; Krueger, Fritz J.; Perez, Judith Pardo; Tainsh, Jessica; Appleby, Robert M.			New Ophthalmosaurid Ichthyosaurs from the European Lower Cretaceous Demonstrate Extensive Ichthyosaur Survival across the Jurassic-Cretaceous Boundary	PLOS ONE			English	Article							PLATYPTERYGIUS-AUSTRALIS; REPTILIA ICHTHYOSAURIA; LOWER SAXONY; EXTINCTION; EVOLUTION; GENUS; ICHTHYOPTERYGIA; REDESCRIPTION; GREENSAND; PATTERNS	Background: Ichthyosauria is a diverse clade of marine amniotes that spanned most of the Mesozoic. Until recently, most authors interpreted the fossil record as showing that three major extinction events affected this group during its history: one during the latest Triassic, one at the Jurassic-Cretaceous boundary (JCB), and one (resulting in total extinction) at the Cenomanian-Turonian boundary. The JCB was believed to eradicate most of the peculiar morphotypes found in the Late Jurassic, in favor of apparently less specialized forms in the Cretaceous. However, the record of ichthyosaurs from the Berriasian-Barremian interval is extremely limited, and the effects of the end-Jurassic extinction event on ichthyosaurs remains poorly understood. Methodology/Principal Findings: Based on new material from the Hauterivian of England and Germany and on abundant material from the Cambridge Greensand Formation, we name a new ophthalmosaurid, Acamptonectes densus gen. et sp. nov. This taxon shares numerous features with Ophthalmosaurus, a genus now restricted to the Callovian-Berriasian interval. Our phylogenetic analysis indicates that Ophthalmosauridae diverged early in its history into two markedly distinct clades, Ophthalmosaurinae and Platypterygiinae, both of which cross the JCB and persist to the late Albian at least. To evaluate the effect of the JCB extinction event on ichthyosaurs, we calculated cladogenesis, extinction, and survival rates for each stage of the Oxfordian-Barremian interval, under different scenarios. The extinction rate during the JCB never surpasses the background extinction rate for the Oxfordian-Barremian interval and the JCB records one of the highest survival rates of the interval. Conclusions/Significance: There is currently no evidence that ichthyosaurs were affected by the JCB extinction event, in contrast to many other marine groups. Ophthalmosaurid ichthyosaurs remained diverse from their rapid radiation in the Middle Jurassic to their total extinction at the beginning of the Late Cretaceous.	[Fischer, Valentin] Univ Liege, Dept Geol, Liege, Belgium; [Fischer, Valentin] Royal Belgian Inst Nat Sci, Dept Paleontol, Brussels, Belgium; [Naish, Darren] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England; [Naish, Darren] Univ Southampton, Sch Ocean & Earth Sci, Southampton, Hants, England; [Kosma, Ralf; Joger, Ulrich; Krueger, Fritz J.] Staatliches Nat Hist Museum, Braunschweig, Germany; [Liston, Jeff; Tainsh, Jessica] Univ Glasgow, Div Environm & Evolutionary Biol, Sch Life Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Perez, Judith Pardo] Heidelberg Univ, Inst Geowissensch, Heidelberg, Germany	University of Liege; Royal Belgian Institute of Natural Sciences; University of Portsmouth; NERC National Oceanography Centre; University of Southampton; University of Glasgow; Ruprecht Karls University Heidelberg	Fischer, V (corresponding author), Univ Liege, Dept Geol, Liege, Belgium.	v.fischer@ulg.ac.be	Liston, Jeff J./I-4600-2015	Liston, Jeff J./0000-0002-6763-5452; Fischer, Valentin/0000-0002-8808-6747; Maisch, Michael Werner/0000-0002-1890-728X	FNRS; Stiftung NordLB-Offentliche	FNRS(Fonds de la Recherche Scientifique - FNRS); Stiftung NordLB-Offentliche	VF is supported by a FNRS grant (Aspirant du F.R.S.-FNRS). The Braunschweig team thanks the Stiftung NordLB-Offentliche for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews CW, 1910, DESCRIPTIVE CATALO 1; Andrews CW, 1910, GEOLOGICAL MAGAZINE, V4, P202, DOI [10.1017/S0016756800133321, DOI 10.1017/S0016756800133321]; APPLEBY R. M., 1956, PROC ZOOL SOC LONDON, V126, P403; Araujo Ricardo, 2008, Irish Journal of Earth Sciences, V26, P17; Arens NC, 2008, PALEOBIOLOGY, V34, P456, DOI 10.1666/07034.1; Arkhangelsky MS, 2008, PALEONTOL J+, V42, P287, DOI 10.1134/S0031030108030106; Arkhangelsky M.S., 2001, PALEONTOL J+, V35, P521; Arkhangelsky MS., 2001, PALEONTOL J, V35, P629; BAKKER R. T., 1993, SPECIAL PAPERS GEOLO, V39, P641; Bardet N, 2000, J PALEONTOL, V74, P503, DOI 10.1666/0022-3360(2000)074<0503:ANIFTU>2.0.CO;2; BARDET N, 1990, GEOBIOS-LYON, V23, P169, DOI 10.1016/S0016-6995(06)80049-5; BARDET N, 1992, TERRA NOVA, V4, P649, DOI 10.1111/j.1365-3121.1992.tb00614.x; Bardet N, 1989, MEMORIES SOC ACAD BO, V6; Bardet Nathalie, 1997, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V205, P339; Bardet Nathalie, 1995, Palaeovertebrata (Montpellier), V24, P177; Bardet Nathalie, 1994, Historical Biology, V7, P313; Barrett PM, 2002, CRETACEOUS RES, V23, P231, DOI 10.1006/cres.2002.0312; Baur G., 1887, American Naturalist, Vxxi, P837; Benson RBJ, 2010, P ROY SOC B-BIOL SCI, V277, P829, DOI 10.1098/rspb.2009.1845; Broili F., 1909, Palaeontographica Stuttgart, V55; Broili Ferdinand, 1907, Palaeontographica Stuttgart, V54; Buchy MC, 2010, J PALEONTOL, V84, P149; Butler RJ, 2009, PALEOBIOLOGY, V35, P432, DOI 10.1666/0094-8373-35.3.432; Choo Brian, 1999, Records of the Western Australian Museum Supplement, V57, P207; Danelian T, 2001, MAR MICROPALEONTOL, V43, P239, DOI 10.1016/S0377-8398(01)00029-9; Druckenmiller PS, 2010, CAN J EARTH SCI, V47, P1037, DOI 10.1139/E10-028; Efimov DV, 2010, CRETACEOUS SYSTEM RU, P132; Efimov V.M., 1999, Paleontologicheskii Zhurnal, V1, P92; Ensom PC, 2009, CRETACEOUS RES, V30, P699, DOI 10.1016/j.cretres.2008.12.005; Fernandez M, 2005, J VERTEBR PALEONTOL, V25, P583, DOI 10.1671/0272-4634(2005)025[0583:ROPHVH]2.0.CO;2; Fernandez M, 2007, J PALEONTOL, V81, P368, DOI 10.1666/0022-3360(2007)81[368:RAPPOC]2.0.CO;2; Fernandez MS, 1999, J PALEONTOL, V73, P677, DOI 10.1017/S0022336000032492; Fischer V, 2011, CRETACEOUS RES, V32, P155, DOI 10.1016/j.cretres.2010.11.005; Fischer V, 2011, ACTA PALAEO IN PRESS; Fischer V, 2011, J VERTEBR PALEONTOL, V31, P1010, DOI 10.1080/02724634.2011.595464; Foote M, 2007, PALEOBIOLOGY, V33, P261, DOI 10.1666/06068.1; Forrest R, 2003, P YORKS GEOL SOC, V54, P269, DOI 10.1144/pygs.54.4.269; GILMORE C. W., 1905, MEM CARNEGIE MUS, V2, P77; Gilmore CW, 1906, MEMOIRS CARNEGIE MUS, VII, P325; Goloboff P, 2010, T N T 1 1 TREE ANAL; Hopson P., 2008, RR0803 BRIT GEOL SUR; JOHNSON R, 1977, CAN J EARTH SCI, V14, P1916, DOI 10.1139/e77-162; Kear BP, 2005, ZOOL J LINN SOC-LOND, V145, P583, DOI 10.1111/j.1096-3642.2005.00199.x; Kiprijanoff W., 1881, MEMOIRES ACAD IMPERI, V28, P1; Kirton A.M., 1983, REV BRIT UPPER JURAS; Kolb C, 2009, PALAEONTOGR ABT A, V288, P151; Lethiers F, 2001, EVOLUTION BIOSPHERE; Lindstrom S, 2011, PALAEOGEOGR PALAEOCL, V308, P445, DOI 10.1016/j.palaeo.2011.05.052; Lingham-Soliar T, 2003, NEUES JAHRB GEOL P-A, V228, P421; Maisch Michael W., 2000, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V298, P1; Massare Judy A., 2006, Paludicola, V5, P242; Maxwell EE, 2006, PALAEONTOLOGY, V49, P1043, DOI 10.1111/j.1475-4983.2006.00589.x; Maxwell EE, 2006, CAN J EARTH SCI, V43, P1291, DOI 10.1139/E06-029; Maxwell EE, 2011, J MORPHOL, V272, P129, DOI 10.1002/jmor.10898; Maxwell EE, 2010, J VERTEBR PALEONTOL, V30, P1059, DOI 10.1080/02724634.2010.483546; Maxwell EE, 2010, J VERTEBR PALEONTOL, V30, P403, DOI 10.1080/02724631003617944; MCGOWAN C, 1976, CAN J EARTH SCI, V13, P668, DOI 10.1139/e76-070; MCGOWAN C, 1972, Contributions to Geology University of Wyoming, V11, P9; MCGOWAN C, 1978, J PALEONTOL, V52, P1155; MCGOWAN C, 1992, CAN J EARTH SCI, V29, P380, DOI 10.1139/e92-034; McGowan C., 1973, B BRIT MUS NAT HIST, V24, P1; McGowan C, 2003, HDB PALEOHERPETOLO 8; Motani R, 2005, ANNU REV EARTH PL SC, V33, P395, DOI 10.1146/annurev.earth.33.092203.122707; Motani R, 1996, NATURE, V382, P347, DOI 10.1038/382347a0; Neale J.W., 1971, Bulletin Cent Rech Pau, V5, P663; Neale J. W., 1968, Proceedings of the Yorkshire Geological Society, V36, P309; Nixon KC., 1999, WINCLADA; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Rawson P.F., 1978, SPECIAL REPORT, V9, P1; ROMER ALFRED SHERWOOD, 1968, CONTRIB GEOL, V7, P27; Sander P. Martin, 2000, Palaeontologische Zeitschrift, V74, P1; Seeley H.G., 1874, Q J GEOL SOC, V30, P696, DOI DOI 10.1144/GSL.JGS.1874.030.01-04.64; Seibertz Ekbert, 2008, Braunschweiger Naturkundliche Schriften, V8, P273; Sirotti Achille, 2002, Bollettino della Societa Paleontologica Italiana, V41, P237; Thorne PM, 2011, P NATL ACAD SCI USA, V108, P8339, DOI 10.1073/pnas.1018959108; WADE M, 1984, LETHAIA, V17, P99, DOI 10.1111/j.1502-3931.1984.tb01713.x; WADE M, 1990, Memoirs of the Queensland Museum, V28, P115; Woods MA, 2008, P GEOLOGIST ASSOC, V119, P229, DOI 10.1016/S0016-7878(08)80303-3; Young MT, 2010, ZOOL J LINN SOC-LOND, V158, P801, DOI 10.1111/j.1096-3642.2009.00571.x; Young MT, 2011, ZOOLOGICAL IN PRESS; Zammit M, 2010, J VERTEBR PALEONTOL, V30, P1726, DOI 10.1080/02724634.2010.521930	81	92	99	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29234	10.1371/journal.pone.0029234	http://dx.doi.org/10.1371/journal.pone.0029234			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235274	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400035
J	Hirono, M; Saitow, F; Kudo, M; Suzuki, H; Yanagawa, Y; Yamada, M; Nagao, S; Konishi, S; Obata, K				Hirono, Moritoshi; Saitow, Fumihito; Kudo, Moeko; Suzuki, Hidenori; Yanagawa, Yuchio; Yamada, Masahisa; Nagao, Soichi; Konishi, Shiro; Obata, Kunihiko			Cerebellar Globular Cells Receive Monoaminergic Excitation and Monosynaptic Inhibition from Purkinje Cells	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; GOLGI CELLS; LUGARO CELL; MEMBRANE-PROPERTIES; LEVOROTATORY FORM; MOUSE CEREBELLUM; RAT CEREBELLUM; GRANULAR LAYER; STELLATE CELLS; IPSC KINETICS	Inhibitory interneurons in the cerebellar granular layer are more heterogeneous than traditionally depicted. In contrast to Golgi cells, which are ubiquitously distributed in the granular layer, small fusiform Lugaro cells and globular cells are located underneath the Purkinje cell layer and small in number. Globular cells have not been characterized physiologically. Here, using cerebellar slices obtained from a strain of gene-manipulated mice expressing GFP specifically in GABAergic neurons, we morphologically identified globular cells, and compared their synaptic activity and monoaminergic influence of their electrical activity with those of small Golgi cells and small fusiform Lugaro cells. Globular cells were characterized by prominent IPSCs together with monosynaptic inputs from the axon collaterals of Purkinje cells, whereas small Golgi cells or small fusiform Lugaro cells displayed fewer and smaller spontaneous IPSCs. Globular cells were silent at rest and fired spike discharges in response to application of either serotonin (5-HT) or noradrenaline. The two monoamines also facilitated small Golgi cell firing, but only 5-HT elicited firing in small fusiform Lugaro cells. Furthermore, globular cells likely received excitatory monosynaptic inputs through mossy fibers. Because globular cells project their axons long in the transversal direction, the neuronal circuit that includes interplay between Purkinje cells and globular cells could regulate Purkinje cell activity in different microzones under the influence of monoamines and mossy fiber inputs, suggesting that globular cells likely play a unique modulatory role in cerebellar motor control.	[Hirono, Moritoshi; Obata, Kunihiko] RIKEN, Brain Sci Inst, Obata Res Unit, Saitama, Japan; [Hirono, Moritoshi; Kudo, Moeko; Yamada, Masahisa] RIKEN, Brain Sci Inst, Yamada Res Unit, Saitama, Japan; [Hirono, Moritoshi; Kudo, Moeko; Nagao, Soichi] RIKEN, Brain Sci Inst, Lab Motor Learning Control, Saitama, Japan; [Saitow, Fumihito; Suzuki, Hidenori] Nippon Med Sch, Dept Pharmacol, Tokyo 113, Japan; [Saitow, Fumihito; Suzuki, Hidenori; Yanagawa, Yuchio] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Gunma, Japan; [Konishi, Shiro] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Dept Neurophysiol, Kagawa, Japan	RIKEN; RIKEN; RIKEN; Nippon Medical School; Japan Science & Technology Agency (JST); Gunma University; Tokushima Bunri University	Hirono, M (corresponding author), RIKEN, Brain Sci Inst, Obata Res Unit, Saitama, Japan.	hironom@brain.riken.jp; skonishi@kph.bunri-u.ac.jp	Konishi, Shiro/ABA-5905-2020	Hirono, Moritoshi/0000-0001-6068-1045; Saitow, Fumihito/0000-0002-5625-8460	RIKEN; Narishige Neuroscience Research Foundation; Takeda Science Foundation; MEXT, Japan [22700423, 20019010, 22300105, 23115503]	RIKEN; Narishige Neuroscience Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Special Postdoctral Researchers Program from RIKEN (MH), Narishige Neuroscience Research Foundation (MH), Takeda Science Foundation (MH, YY), and Grant-in-Aid from the MEXT, Japan to MH [#22700423] and YY [#20019010, #22300105, #23115503]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; Bosman LWJ, 2005, J NEUROPHYSIOL, V94, P338, DOI 10.1152/jn.00084.2005; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Dean I, 2003, J NEUROSCI, V23, P4457; Dieudonne S, 1998, J PHYSIOL-LONDON, V510, P845, DOI 10.1111/j.1469-7793.1998.845bj.x; Dieudonne S, 2000, J NEUROSCI, V20, P1837; Dieudonne S, 2001, NEUROSCIENTIST, V7, P207, DOI 10.1177/107385840100700306; Dittman JS, 1998, J NEUROSCI, V18, P6147; Doischer D, 2008, J NEUROSCI, V28, P12956, DOI 10.1523/JNEUROSCI.2890-08.2008; Dumoulin A, 2001, J NEUROSCI, V21, P6045, DOI 10.1523/JNEUROSCI.21-16-06045.2001; Forti L, 2006, J PHYSIOL-LONDON, V574, P711, DOI 10.1113/jphysiol.2006.110858; Frings M, 2010, EXP BRAIN RES, V201, P167, DOI 10.1007/s00221-009-2020-1; Geurts FJ, 2003, CEREBELLUM, V2, P290, DOI 10.1080/14734220310011948; Geurts FJ, 2001, NEUROSCIENCE, V104, P499, DOI 10.1016/S0306-4522(01)00058-6; Golgi C., 1883, RIV SPERIMENTALE FRE, V9, P1; Hirono M, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn764; Holtzman T, 2006, J PHYSIOL-LONDON, V577, P69, DOI 10.1113/jphysiol.2006.117218; Jorntell H, 2003, J NEUROSCI, V23, P9620; Kanichay RT, 2008, J NEUROSCI, V28, P8955, DOI 10.1523/JNEUROSCI.5469-07.2008; KERR CW, 1992, BRAIN RES, V591, P253, DOI 10.1016/0006-8993(92)91705-J; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Laine J, 1998, NEUROREPORT, V9, P2399, DOI 10.1097/00001756-199807130-00045; Laine J, 1996, J COMP NEUROL, V375, P618, DOI 10.1002/(SICI)1096-9861(19961125)375:4<618::AID-CNE5>3.0.CO;2-4; LAINE J, 1994, J COMP NEUROL, V339, P159, DOI 10.1002/cne.903390202; Laine J, 2002, NEUROSCIENCE, V115, P363, DOI 10.1016/S0306-4522(02)00421-9; LI SJ, 1993, BRAIN RES, V617, P87, DOI 10.1016/0006-8993(93)90617-V; Lugaro E., 1894, RIV SPER FRENIATR ME, V20, P297; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MIDTGAARD J, 1992, J PHYSIOL-LONDON, V457, P329, DOI 10.1113/jphysiol.1992.sp019381; MIYASHITA Y, 1984, NEUROSCI LETT, V51, P177, DOI 10.1016/0304-3940(84)90547-0; Oades RD, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-48; Orduz D, 2007, P NATL ACAD SCI USA, V104, P17831, DOI 10.1073/pnas.0707489104; Palay S. L., 1974, CEREBELLAR CORTEX CY; Ruigrok TJH, 2011, J NEUROSCI, V31, P712, DOI 10.1523/JNEUROSCI.1959-10.2011; Saitow F, 2005, J NEUROSCI, V25, P2108, DOI 10.1523/JNEUROSCI.4254-04.2005; Saitow F, 2009, J NEUROPHYSIOL, V101, P1361, DOI 10.1152/jn.90750.2008; Sassoe-Pognetto M, 2000, J COMP NEUROL, V420, P481, DOI 10.1002/(SICI)1096-9861(20000515)420:4<481::AID-CNE6>3.0.CO;2-5; Schilling K, 2008, HISTOCHEM CELL BIOL, V130, P601, DOI 10.1007/s00418-008-0483-y; Simat M, 2007, J COMP NEUROL, V500, P71, DOI 10.1002/cne.21142; STRAHLENDORF JC, 1984, EXP BRAIN RES, V56, P50; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; TROUILLAS P, 1988, ARCH NEUROL-CHICAGO, V45, P1217, DOI 10.1001/archneur.1988.00520350055016; TROUILLAS P, 1995, ARCH NEUROL-CHICAGO, V52, P456, DOI 10.1001/archneur.1995.00540290042016; Xu-Friedman MA, 2003, J NEUROSCI, V23, P2182	45	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29663	10.1371/journal.pone.0029663	http://dx.doi.org/10.1371/journal.pone.0029663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235322	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400084
J	Kana, R; Kotabova, E; Sobotka, R; Prasil, O				Kana, Radek; Kotabova, Eva; Sobotka, Roman; Prasil, Ondrej			Non-Photochemical Quenching in Cryptophyte Alga Rhodomonas salina Is Located in Chlorophyll a/c Antennae	PLOS ONE			English	Article							PHOTOPROTECTIVE ENERGY-DISSIPATION; DIATOM THALASSIOSIRA-PSEUDONANA; TRANSTHYLAKOID PROTON GRADIENT; PHOTOSYSTEM-II FLUORESCENCE; LIGHT-HARVESTING COMPLEXES; XANTHOPHYLL CYCLE; PHAEODACTYLUM-TRICORNUTUM; CAROTENOID COMPOSITION; CHLOROPLAST MEMBRANES; PROTEIN	Photosynthesis uses light as a source of energy but its excess can result in production of harmful oxygen radicals. To avoid any resulting damage, phototrophic organisms can employ a process known as non-photochemical quenching (NPQ), where excess light energy is safely dissipated as heat. The mechanism(s) of NPQ vary among different phototrophs. Here, we describe a new type of NPQ in the organism Rhodomonas salina, an alga belonging to the cryptophytes, part of the chromalveolate supergroup. Cryptophytes are exceptional among photosynthetic chromalveolates as they use both chlorophyll a/c proteins and phycobiliproteins for light harvesting. All our data demonstrates that NPQ in cryptophytes differs significantly from other chromalveolates - e.g. diatoms and it is also unique in comparison to NPQ in green algae and in higher plants: (1) there is no light induced xanthophyll cycle; (2) NPQ resembles the fast and flexible energetic quenching (qE) of higher plants, including its fast recovery; (3) a direct antennae protonation is involved in NPQ, similar to that found in higher plants. Further, fluorescence spectroscopy and biochemical characterization of isolated photosynthetic complexes suggest that NPQ in R. salina occurs in the chlorophyll a/c antennae but not in phycobiliproteins. All these results demonstrate that NPQ in cryptophytes represents a novel class of effective and flexible non-photochemical quenching.	[Kana, Radek; Kotabova, Eva; Sobotka, Roman; Prasil, Ondrej] Czech Acad Sci, Inst Microbiol, Trebon, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Kana, R (corresponding author), Czech Acad Sci, Inst Microbiol, Trebon, Czech Republic.	kana@alga.cz	Kaňa, Radek/A-6434-2009; Kotabova, Eva/E-4560-2011; Sobotka, Roman/J-3077-2014; Prasil, Ondrej/H-2454-2014	Kaňa, Radek/0000-0001-5768-6902; Kotabova, Eva/0000-0003-1092-3020; Sobotka, Roman/0000-0001-5909-3879; Prasil, Ondrej/0000-0002-0012-4359	Czech Science Foundation [206/09/094]; Institutional Research Concept from the Ministry of Education, Youth and Sports of the Czech Republic [AV0Z50200510, MSM6007665808]; Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.05/2.1.00/03.0110]	Czech Science Foundation(Grant Agency of the Czech Republic); Institutional Research Concept from the Ministry of Education, Youth and Sports of the Czech Republic; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	Czech Science Foundation 206/09/094 (http://www.gacr.cz/international.htm). Institutional Research Concept from the Ministry of Education, Youth and Sports of the Czech Republic AV0Z50200510 and MSM6007665808. Ministry of Education, Youth and Sports of the Czech Republic - project Algatech CZ.1.05/2.1.00/03.0110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Andersson M, 2006, MAR BIOL, V149, P653, DOI 10.1007/s00227-005-0174-3; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Bathke L, 1999, PLANT BIOLOGY, V1, P516, DOI 10.1055/s-2007-978546; Bode S, 2009, P NATL ACAD SCI USA, V106, P12311, DOI 10.1073/pnas.0903536106; Bonente G, 2008, PHOTOCHEM PHOTOBIOL, V84, P1359, DOI 10.1111/j.1751-1097.2008.00456.x; Bruyant F, 2005, LIMNOL OCEANOGR, V50, P850, DOI 10.4319/lo.2005.50.3.0850; Buchel C, 2003, BIOCHEMISTRY-US, V42, P13027, DOI 10.1021/bi0349468; Collini E, 2010, NATURE, V463, P644, DOI 10.1038/nature08811; Crouchman S, 2006, FEBS LETT, V580, P2053, DOI 10.1016/j.febslet.2006.03.005; Cruz JA, 2005, J EXP BOT, V56, P395, DOI 10.1093/jxb/eri022; Delphin E, 1998, PLANT PHYSIOL, V118, P103, DOI 10.1104/pp.118.1.103; Delphin E, 1996, BIOCHEMISTRY-US, V35, P9435, DOI 10.1021/bi960528+; DOUGLAS SE, 1991, NATURE, V350, P148, DOI 10.1038/350148a0; Durnford DG, 1999, J MOL EVOL, V48, P59, DOI 10.1007/PL00006445; Eisenstadt D, 2008, ENVIRON MICROBIOL, V10, P1997, DOI 10.1111/j.1462-2920.2008.01616.x; Esteban R, 2009, EUR J PHYCOL, V44, P221, DOI 10.1080/09670260802439109; Finazzi G, 2006, BIOCHEMISTRY-US, V45, P1490, DOI 10.1021/bi0521588; Funk C, 2011, BBA-BIOENERGETICS, V1807, P841, DOI 10.1016/j.bbabio.2011.03.011; Garcia-Mendoza E, 2007, NEW PHYTOL, V173, P526, DOI 10.1111/j.1469-8137.2006.01951.x; Goss R, 2006, J PLANT PHYSIOL, V163, P1008, DOI 10.1016/j.jplph.2005.09.008; Green BR, 2011, PHOTOSYNTH RES, V107, P103, DOI 10.1007/s11120-010-9584-2; Grouneva I, 2009, BBA-BIOENERGETICS, V1787, P929, DOI 10.1016/j.bbabio.2009.02.004; Gundermann K, 2008, PHOTOSYNTH RES, V95, P229, DOI 10.1007/s11120-007-9262-1; Havelkova-Dousova H, 2004, PHOTOSYNTHETICA, V42, P273, DOI 10.1023/B:PHOT.0000040600.04502.32; Holzwarth AR, 2009, CHEM PHYS LETT, V483, P262, DOI 10.1016/j.cplett.2009.10.085; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Horton P, 2008, FEBS J, V275, P1069, DOI 10.1111/j.1742-4658.2008.06263.x; INGRAM K, 1983, BIOCHIM BIOPHYS ACTA, V722, P310, DOI 10.1016/0005-2728(83)90078-6; Jahns P, 2011, BIOCH BIOPH IN PRESS; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Janssen J, 2008, INT MICROBIOL, V11, P171, DOI 10.2436/20.1501.01.57; Jegerschold C, 2000, J BIOL CHEM, V275, P12781, DOI 10.1074/jbc.275.17.12781; Johnson MP, 2010, PLANT J, V61, P283, DOI 10.1111/j.1365-313X.2009.04051.x; Kana R, 2008, ENVIRON EXP BOT, V64, P90, DOI 10.1016/j.envexpbot.2008.02.006; Kana R, 2009, BBA-BIOENERGETICS, V1787, P1170, DOI 10.1016/j.bbabio.2009.04.013; Kana R, 2009, FEBS LETT, V583, P670, DOI 10.1016/j.febslet.2009.01.016; Kereihe S, 2008, BBA-BIOENERGETICS, V1777, P1122, DOI 10.1016/j.bbabio.2008.04.045; Kirilovsky D, 2007, PHOTOSYNTH RES, V91, P291; Kirilovsky D, 2007, PHOTOSYNTH RES, V93, P7, DOI 10.1007/s11120-007-9168-y; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Kotabova E, 2011, FEBS LETT, V585, P1941, DOI 10.1016/j.febslet.2011.05.015; Lambrev PH, 2010, PLANT PHYSIOL, V152, P1611, DOI 10.1104/pp.109.148213; Lavaud J, 2002, FEBS LETT, V523, P163, DOI 10.1016/S0014-5793(02)02979-4; Lavaud J, 2002, PLANT PHYSIOL, V129, P1398, DOI 10.1104/pp.002014; Lavaud J, 2006, PLANT CELL PHYSIOL, V47, P1010, DOI 10.1093/pcp/pcj058; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; LICHTLE C, 1987, BIOCHIM BIOPHYS ACTA, V894, P76, DOI 10.1016/0005-2728(87)90214-3; Liu LN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003134; MACPHERSON AN, 2003, LIGHT HARVESTING ANT; Masojidek J, 2004, PLANT BIOLOGY, V6, P342, DOI 10.1055/s-2004-820884; Masojidek J, 1999, PLANTA, V209, P126, DOI 10.1007/s004250050614; Miloslavina Y, 2009, BBA-BIOENERGETICS, V1787, P1189, DOI 10.1016/j.bbabio.2009.05.012; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 1999, PLANT PHYSIOL, V119, P531, DOI 10.1104/pp.119.2.531; RUBAN AV, 1995, PLANT PHYSIOL, V108, P721, DOI 10.1104/pp.108.2.721; Ruban AV, 1996, BIOCHEMISTRY-US, V35, P674, DOI 10.1021/bi9524878; RUBAN AV, 1994, BBA-BIOENERGETICS, V1186, P123, DOI 10.1016/0005-2728(94)90143-0; RUBAN AV, 1992, FEBS LETT, V309, P175, DOI 10.1016/0014-5793(92)81089-5; Schubert H, 2006, MAR BIOL, V149, P1003, DOI 10.1007/s00227-006-0265-9; van der Weij-De Wit, 2006, J PHYS CHEM B, V110, P25066, DOI 10.1021/jp061546w; Walters RG, 1996, P NATL ACAD SCI USA, V93, P14204, DOI 10.1073/pnas.93.24.14204; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Zhu SH, 2010, BBA-BIOENERGETICS, V1797, P1449, DOI 10.1016/j.bbabio.2010.04.003	74	42	42	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29700	10.1371/journal.pone.0029700	http://dx.doi.org/10.1371/journal.pone.0029700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235327	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400089
J	Koo, OK; Amalaradjou, MAR; Bhunia, AK				Koo, Ok Kyung; Amalaradjou, Mary Anne Roshni; Bhunia, Arun K.			Recombinant Probiotic Expressing Listeria Adhesion Protein Attenuates Listeria monocytogenes Virulence In Vitro	PLOS ONE			English	Article							ESCHERICHIA-COLI; CACO-2 CELLS; BIFIDOBACTERIUM STRAINS; COMPETITIVE-EXCLUSION; BARRIER FUNCTION; LACTOBACILLUS; SURFACE; RECEPTOR; INVASION; PATHOGENS	Background: Listeria monocytogenes, an intracellular foodborne pathogen, infects immunocompromised hosts. The primary route of transmission is through contaminated food. In the gastrointestinal tract, it traverses the epithelial barrier through intracellular or paracellular routes. Strategies to prevent L. monocytogenes entry can potentially minimize infection in high-risk populations. Listeria adhesion protein (LAP) aids L. monocytogenes in crossing epithelial barriers via the paracellular route. The use of recombinant probiotic bacteria expressing LAP would aid targeted clearance of Listeria from the gut and protect high-risk populations from infection. Methodology/Principal Findings: The objective was to investigate the ability of probiotic bacteria or LAP-expressing recombinant probiotic Lactobacillus paracasei (Lbp(LAP)) to prevent L. monocytogenes adhesion, invasion, and transwell-based transepithelial translocation in a Caco-2 cell culture model. Several wild type probiotic bacteria showed strong adhesion to Caco-2 cells but none effectively prevented L. monocytogenes infection. Pre-exposure to Lbp(LAP) for 1, 4, 15, or 24 h significantly (P<0.05) reduced adhesion, invasion, and transepithelial translocation of L. monocytogenes in Caco-2 cells, whereas pre-exposure to parental Lb. paracasei had no significant effect. Similarly, Lbp(LAP) pre-exposure reduced L. monocytogenes translocation by as much as 46% after 24 h. Lbp(LAP) also prevented L. monocytogenes-mediated cell damage and compromise of tight junction integrity. Furthermore, Lbp(LAP) cells reduced L. monocytogenes-mediated cell cytotoxicity by 99.8% after 1 h and 79% after 24 h. Conclusions/Significance: Wild type probiotic bacteria were unable to prevent L. monocytogenes infection in vitro. In contrast, Lbp(LAP) blocked adhesion, invasion, and translocation of L. monocytogenes by interacting with host cell receptor Hsp60, thereby protecting cells from infection. These data show promise for the use of recombinant probiotics in preventing L. monocytogenes infection in high-risk populations.	[Koo, Ok Kyung; Amalaradjou, Mary Anne Roshni; Bhunia, Arun K.] Purdue Univ, Dept Food Sci, Mol Food Microbiol Lab, W Lafayette, IN 47907 USA; [Bhunia, Arun K.] Univ Arkansas, Dept Comparat Pathobiol, Fayetteville, AR 72703 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Arkansas System; University of Arkansas Fayetteville	Koo, OK (corresponding author), Univ Arkansas, Dept Food Sci, Fayetteville, AR 72703 USA.	bhunia@purdue.edu	Bhunia, Arun K./K-7639-2012; amalaradjou, mary anne roshni/D-2004-2012	Bhunia, Arun K./0000-0003-3640-1554; Amalaradjou, Mary Anne Roshni/0000-0001-7411-2206	U.S. Department of Agriculture [1935-42000-035]	U.S. Department of Agriculture(United States Department of Agriculture (USDA))	AKB, OKK, and MARA were supported by the U.S. Department of Agriculture (Project number 1935-42000-035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemka A, 2010, INFECT IMMUN, V78, P2812, DOI 10.1128/IAI.01249-09; [Anonymous], 2002, GUIDELINES EVALUATIO; Banerjee P, 2009, TRENDS BIOTECHNOL, V27, P179, DOI 10.1016/j.tibtech.2008.11.006; Banerjee P, 2008, LAB INVEST, V88, P196, DOI 10.1038/labinvest.3700703; Banerjee P, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-8; Barrett KE, 2010, GUT, V59, P427, DOI 10.1136/gut.2009.195016; Bodey GP, 2005, CLIN INFECT DIS, V40, pS239, DOI 10.1086/427328; Botes M, 2008, ARCH MICROBIOL, V190, P573, DOI 10.1007/s00203-008-0408-0; Burkholder KM, 2010, INFECT IMMUN, V78, P5062, DOI 10.1128/IAI.00516-10; Burkholder KM, 2009, MICROBES INFECT, V11, P859, DOI 10.1016/j.micinf.2009.05.006; Candela M, 2008, INT J FOOD MICROBIOL, V125, P286, DOI 10.1016/j.ijfoodmicro.2008.04.012; Chen XY, 2007, INT J FOOD MICROBIOL, V115, P307, DOI 10.1016/j.ijfoodmicro.2006.11.007; COCONNIER MH, 1993, FEMS MICROBIOL LETT, V110, P299, DOI 10.1016/0378-1097(93)90119-M; Collado MC, 2006, J FOOD PROTECT, V69, P1675, DOI 10.4315/0362-028X-69.7.1675; Cook SI, 1998, ALIMENT PHARM THER, V12, P499, DOI 10.1046/j.1365-2036.1998.00337.x; Corr SC, 2007, P NATL ACAD SCI USA, V104, P7617, DOI 10.1073/pnas.0700440104; Corthesy B, 2005, J INFECT DIS, V192, P1441, DOI 10.1086/444425; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Cruz Nestor, 1994, Journal of Burn Care and Rehabilitation, V15, P207, DOI 10.1097/00004630-199405000-00002; Culligan EP, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-19; Delcenserie V, 2008, CURR ISSUES MOL BIOL, V10, P37; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Ferber D, 2010, SCIENCE, V329, P1010, DOI 10.1126/science.329.5995.1010; Fishman JA, 2010, INFECT DIS CLIN N AM, V24, P273, DOI 10.1016/j.idc.2010.01.005; Focareta A, 2006, GASTROENTEROLOGY, V130, P1688, DOI 10.1053/j.gastro.2006.02.005; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Fukushima Y, 1998, INT J FOOD MICROBIOL, V42, P39, DOI 10.1016/S0168-1605(98)00056-7; GAILLARD JL, 1987, INFECT IMMUN, V55, P2822, DOI 10.1128/IAI.55.11.2822-2829.1987; Granato D, 1999, APPL ENVIRON MICROB, V65, P1071; Gueimonde M, 2007, INT J FOOD MICROBIOL, V113, P228, DOI 10.1016/j.ijfoodmicro.2006.05.017; Hebert C, 2011, INFECT DIS CLIN N AM, V25, P181, DOI 10.1016/j.idc.2010.11.006; HOLCK A, 1992, J GEN MICROBIOL, V138, P1353, DOI 10.1099/00221287-138-7-1353; Innocentin S, 2009, APPL ENVIRON MICROB, V75, P4870, DOI 10.1128/AEM.00825-09; Jagadeesan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020694; Jagadeesan B, 2010, MICROBIOL-SGM, V156, P2782, DOI 10.1099/mic.0.036509-0; Jaradat ZW, 2003, MED MICROBIOL IMMUN, V192, P85, DOI 10.1007/S00430-002-0150-1; Jaradat ZW, 2002, APPL ENVIRON MICROB, V68, P4876, DOI 10.1128/AEM.68.10.4876-4883.2002; Kajikawa A, 2007, VACCINE, V25, P3599, DOI 10.1016/j.vaccine.2007.01.055; Kaushik JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008099; Keeney KM, 2011, CURR OPIN MICROBIOL, V14, P92, DOI 10.1016/j.mib.2010.12.012; Kim KP, 2006, FEMS MICROBIOL LETT, V256, P324, DOI 10.1111/j.1574-6968.2006.00140.x; Koo OK, 2011, J APPL MICROBIOL, V111, P93, DOI 10.1111/j.1365-2672.2011.05040.x; Koo OK, 2010, LISTERIA ADHESION PR; Koo OK, 2009, ANAL CHEM, V81, P3094, DOI 10.1021/ac9000833; Kruger C, 2002, NAT BIOTECHNOL, V20, P702, DOI 10.1038/nbt0702-702; Lee YK, 2003, J MED MICROBIOL, V52, P925, DOI 10.1099/jmm.0.05009-0; Liong MT, 2008, NUTR REV, V66, P192, DOI 10.1111/j.1753-4887.2008.00024.x; Liu XM, 2008, APPL ENVIRON MICROB, V74, P4626, DOI 10.1128/AEM.00104-08; Liu ZH, 2011, MOL BIOL REP, V38, P3471, DOI 10.1007/s11033-010-0457-8; Maassen CBM, 1999, VACCINE, V17, P2117, DOI 10.1016/S0264-410X(99)00010-9; Medellin-Pena MJ, 2009, APPL ENVIRON MICROB, V75, P1165, DOI 10.1128/AEM.01651-08; Menon A, 2003, COMP IMMUNOL MICROB, V26, P157, DOI 10.1016/S0147-9571(02)00039-5; Neeser JR, 2000, GLYCOBIOLOGY, V10, P1193, DOI 10.1093/glycob/10.11.1193; Ng SC, 2009, INFLAMM BOWEL DIS, V15, P300, DOI 10.1002/ibd.20602; Oelschlaeger TA, 2010, INT J MED MICROBIOL, V300, P57, DOI 10.1016/j.ijmm.2009.08.005; Oliveira MLS, 2003, FEMS MICROBIOL LETT, V227, P25, DOI 10.1016/S0378-1097(03)00645-1; Paton AW, 2005, GASTROENTEROLOGY, V128, P1219, DOI 10.1053/j.gastro.2005.01.050; Pavan S, 2003, CLIN DIAGN LAB IMMUN, V10, P696, DOI 10.1128/CDLI.10.4.696-701.2003; Pentecost M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000900; Pizarro-Cerda J, 2002, CELL MICROBIOL, V4, P101, DOI 10.1046/j.1462-5822.2002.00169.x; Pouwels PH, 2001, METHOD ENZYMOL, V336, P369, DOI 10.1016/S0076-6879(01)36602-8; Resta-Lenert S, 2006, GASTROENTEROLOGY, V130, P731, DOI 10.1053/j.gastro.2005.12.015; Salminen S, 2010, CURR OPIN BIOTECH, V21, P157, DOI 10.1016/j.copbio.2010.03.016; Sanchez B, 2008, FEMS IMMUNOL MED MIC, V54, P1, DOI 10.1111/j.1574-695X.2008.00454.x; Santiago NI, 1999, APPL ENVIRON MICROB, V65, P2765; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schaumburg J, 2004, PROTEOMICS, V4, P2991, DOI 10.1002/pmic.200400928; Servin AL, 2003, BEST PRACT RES CL GA, V17, P741, DOI 10.1016/S1521-6918(03)00052-0; Sleator Roy D., 2007, Science Progress, V90, P1, DOI 10.3184/003685007780440530; Sleator RD, 2009, MICROBIOL-SGM, V155, P2463, DOI 10.1099/mic.0.030205-0; Thomas DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016577; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vanderpool C, 2008, INFLAMM BOWEL DIS, V14, P1585, DOI 10.1002/ibd.20525; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Wampler JL, 2004, INFECT IMMUN, V72, P931, DOI 10.1128/IAI.72.2.931-936.2004; Wells J, 2011, ANNU REV FOOD SCI T, V2, P423, DOI 10.1146/annurev-food-022510-133640; Wine E, 2009, FEMS MICROBIOL LETT, V300, P146, DOI 10.1111/j.1574-6968.2009.01781.x; Xu H, 2009, LETT APPL MICROBIOL, V49, P434, DOI 10.1111/j.1472-765X.2009.02684.x; Yamada F, 2006, J MICROBIOL METH, V66, P96, DOI 10.1016/j.mimet.2005.10.017	81	65	69	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29277	10.1371/journal.pone.0029277	http://dx.doi.org/10.1371/journal.pone.0029277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235279	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400040
J	Williams, PT				Williams, Paul T.			Quantile-Specific Penetrance of Genes Affecting Lipoproteins, Adiposity and Height	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; BODY-MASS INDEX; PHYSICAL-ACTIVITY; POPULATION-DISTRIBUTION; VIGOROUS EXERCISE; WALKING DISTANCE; STATIN THERAPY; WEIGHT-GAIN; CHOLESTEROL; ASSOCIATION	Quantile-dependent penetrance is proposed to occur when the phenotypic expression of a SNP depends upon the population percentile of the phenotype. To illustrate the phenomenon, quantiles of height, body mass index (BMI), and plasma lipids and lipoproteins were compared to genetic risk scores (GRS) derived from single nucleotide polymorphisms (SNP) s having established genome-wide significance: 180 SNPs for height, 32 for BMI, 37 for low-density lipoprotein (LDL)cholesterol, 47 for high-density lipoprotein (HDL)-cholesterol, 52 for total cholesterol, and 31 for triglycerides in 1930 subjects. Both phenotypes and GRSs were adjusted for sex, age, study, and smoking status. Quantile regression showed that the slope of the genotype-phenotype relationships increased with the percentile of BMI (P = 0.002), LDL-cholesterol (P = 3610 28), HDL-cholesterol (P = 5610 26), total cholesterol (P = 2.5610 26), and triglyceride distribution (P = 7.5610 26), but not height (P = 0.09). Compared to a GRS's phenotypic effect at the 10th population percentile, its effect at the 90 th percentile was 4.2-fold greater for BMI, 4.9-fold greater for LDL-cholesterol, 1.9-fold greater for HDL-cholesterol, 3.1-fold greater for total cholesterol, and 3.3-fold greater for triglycerides. Moreover, the effect of the rs1558902 (FTO) risk allele was 6.7-fold greater at the 90th than the 10th percentile of the BMI distribution, and that of the rs3764261 (CETP) risk allele was 2.4-fold greater at the 90th than the 10th percentile of the HDL-cholesterol distribution. Conceptually, it maybe useful to distinguish environmental effects on the phenotype that in turn alters a gene's phenotypic expression (quantile-dependent penetrance) from environmental effects affecting the gene's phenotypic expression directly (gene-environment interaction).	Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Williams, PT (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.	ptwilliams@lbl.gov			National Heart, Lung, and Blood Institute [U01 HL69757, HL094717];  [AG032004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094717, U01HL069757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG032004] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants U01 HL69757 and HL094717 and from the National Heart, Lung, and Blood Institute and AG032004. The funding agency had no involvement in the interpretation of these results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; [Anonymous], 1982, JACKKNIFE BOOTSTRAP; Barber MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009763; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Chasman DI, 2004, JAMA-J AM MED ASSOC, V291, P2821, DOI 10.1001/jama.291.23.2821; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FUMERON F, 1995, J CLIN INVEST, V96, P1664, DOI 10.1172/JCI118207; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gould WW, 1992, STATA TECHNICAL B, P19, DOI DOI 10.1201/9781315120256-; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Guey LT, 2011, GENET EPIDEMIOL, V35, P236, DOI 10.1002/gepi.20572; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; Scott RA, 2010, EUR J HUM GENET, V18, P1339, DOI 10.1038/ejhg.2010.131; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Simon JA, 2006, AM J CARDIOL, V97, P843, DOI 10.1016/j.amjcard.2005.09.134; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spielmann N, 2007, PHYSIOL GENOMICS, V31, P25, DOI 10.1152/physiolgenomics.00281.2006; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vimaleswaran KS, 2009, AM J CLIN NUTR, V90, P425, DOI 10.3945/ajcn.2009.27652; WARNICK GR, 1985, CLIN CHEM, V31, P217; Williams PT, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.041822; Williams PT, 2008, MED SCI SPORT EXER, V40, P296, DOI 10.1249/mss.0b013e31815b6475; Williams PT, 2007, MED SCI SPORT EXER, V39, P801, DOI 10.1249/mss.0b013e31803349b1; Williams PT, 2005, MED SCI SPORT EXER, V37, P1893, DOI 10.1249/01.mss.0000175860.51204.85; Williams PT, 2005, OBES RES, V13, P1370, DOI 10.1038/oby.2005.166; Williams PT, 2004, ATHEROSCLEROSIS, V174, P363, DOI 10.1016/j.atherosclerosis.2004.01.031; Williams PT, 2004, INT J OBESITY, V28, P120, DOI 10.1038/sj.ijo.0802480; Williams PT, 2004, METABOLISM, V53, P700, DOI 10.1016/j.metabol.2004.01.004; Wilund KR, 2002, METABOLISM, V51, P774, DOI 10.1053/meta.2002.32730; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191	36	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28764	10.1371/journal.pone.0028764	http://dx.doi.org/10.1371/journal.pone.0028764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235250	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400011
J	Canning-Clode, J; Fowler, AE; Byers, JE; Carlton, JT; Ruiz, GM				Canning-Clode, Joao; Fowler, Amy E.; Byers, James E.; Carlton, James T.; Ruiz, Gregory M.			'Caribbean Creep' Chills Out: Climate Change and Marine Invasive Species	PLOS ONE			English	Article							GLOBAL BIODIVERSITY; SEVERE WINTER; MORTALITY; COLD; PETROLISTHES; COMMUNITY; INCREASE; SUCCESS; FLORIDA	Background: New marine invasions have been recorded in increasing numbers along the world's coasts due in part to the warming of the oceans and the ability of many invasive marine species to tolerate a broader thermal range than native species. Several marine invertebrate species have invaded the U. S. southern and mid-Atlantic coast from the Caribbean and this poleward range expansion has been termed 'Caribbean Creep'. While models have predicted the continued decline of global biodiversity over the next 100 years due to global climate change, few studies have examined the episodic impacts of prolonged cold events that could impact species range expansions. Methodology/Principal Findings: A pronounced cold spell occurred in January 2010 in the U. S. southern and mid-Atlantic coast and resulted in the mortality of several terrestrial and marine species. To experimentally test whether cold-water temperatures may have caused the disappearance of one species of the 'Caribbean Creep' we exposed the non-native crab Petrolisthes armatus to different thermal treatments that mimicked abnormal and severe winter temperatures. Our findings indicate that Petrolisthes armatus cannot tolerate prolonged and extreme cold temperatures (4-6 degrees C) and suggest that aperiodic cold winters may be a critical 'reset' mechanism that will limit the range expansion of other 'Caribbean Creep' species. Conclusions/Significance: We suggest that temperature 'aberrations' such as 'cold snaps' are an important and overlooked part of climate change. These climate fluctuations should be accounted for in future studies and models, particularly with reference to introduced subtropical and tropical species and predictions of both rates of invasion and rates of unidirectional geographic expansion.	[Canning-Clode, Joao; Fowler, Amy E.; Ruiz, Gregory M.] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Canning-Clode, Joao] Univ Azores, Dept Oceanog & Fisheries, IMAR, Horta, Portugal; [Canning-Clode, Joao] Univ Lisbon, Fac Sci, Ctr Oceanog, P-1699 Lisbon, Portugal; [Byers, James E.] Univ Georgia, Athens, GA 30602 USA; [Carlton, James T.] Williams Coll Mystic Seaport, Mystic, CT USA	Smithsonian Institution; Smithsonian Environmental Research Center; Universidade dos Acores; Universidade de Lisboa; University System of Georgia; University of Georgia; Williams College	Canning-Clode, J (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	canning-clodej@si.edu	Byers, James/AFJ-8413-2022; Canning-Clode, Joao/I-4343-2019; Canning Clode, João/G-5142-2011	Byers, James/0000-0001-9240-0287; Canning-Clode, Joao/0000-0003-2143-6535; Canning Clode, João/0000-0003-2143-6535; Ruiz, Gregory/0000-0003-2499-441X; Fowler, Amy/0000-0003-4876-597X	Smithsonian Marine Science Network; NSF [0961853]	Smithsonian Marine Science Network(Smithsonian InstitutionSmithsonian Tennenbaum Marine Observatories Network); NSF(National Science Foundation (NSF))	This research was funded by a Smithsonian Marine Science Network Fellowship to J.C.C. and the oyster reef grant to J.E.B. (NSF # 0961853). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beukema JJ, 2007, HELGOLAND MAR RES, V61, P71, DOI 10.1007/s10152-006-0054-3; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carlton JT, 2011, ENCY BIOL INVASIONS, P385; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; CRISP DJ, 1964, J ANIM ECOL, V33, P165, DOI 10.2307/2355; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Firth LB, 2011, J EXP MAR BIOL ECOL, V400, P250, DOI 10.1016/j.jembe.2011.02.007; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hollebone AL, 2007, MAR ECOL PROG SER, V336, P211, DOI 10.3354/meps336211; HUTCHINS LW, 1947, ECOL MONOGR, V17, P325, DOI 10.2307/1948663; Kemp DW, 2011, GLOBAL CHANGE BIOL, V17, P3468, DOI 10.1111/j.1365-2486.2011.02487.x; Mazzotti FJ, 2011, BIOL INVASIONS, V13, P143, DOI 10.1007/s10530-010-9797-5; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Portner HO, 2010, J FISH BIOL, V77, P1745, DOI 10.1111/j.1095-8649.2010.02783.x; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Sorte CJB, 2011, J EXP MAR BIOL ECOL, V400, P209, DOI 10.1016/j.jembe.2011.02.009; Sorte CJB, 2010, ECOLOGY, V91, P2198, DOI 10.1890/10-0238.1; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Stillman JH, 2000, PHYSIOL BIOCHEM ZOOL, V73, P200, DOI 10.1086/316738; Strasser M, 2001, HELGOLAND MAR RES, V55, P176, DOI 10.1007/s101520100081; Thieltges DW, 2004, J EXP MAR BIOL ECOL, V311, P375, DOI 10.1016/j.jembe.2004.05.018; Urian AG, 2011, J EXP ZOOL PART A, V315A, P12, DOI 10.1002/jez.644; Wang CZ, 2010, ATMOS SCI LETT, V11, P161, DOI 10.1002/asl.278; Ward NL, 2007, GLOBAL CHANGE BIOL, V13, P1605, DOI 10.1111/j.1365-2486.2007.01399.x; Wethey DS, 2002, INTEGR COMP BIOL, V42, P872, DOI 10.1093/icb/42.4.872	26	44	44	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29657	10.1371/journal.pone.0029657	http://dx.doi.org/10.1371/journal.pone.0029657			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216340	gold, Green Submitted, Green Published			2022-12-27	WOS:000300676300077
J	Gu, W; Liu, JL; Niu, QL; Wang, H; Lou, YQ; Liu, K; Wang, LJ; Wang, ZG; Zhang, JM; Wen, SJ				Gu, Wei; Liu, Jielin; Niu, Qiuli; Wang, Hao; Lou, Yuqing; Liu, Kuo; Wang, Lijuan; Wang, Zuoguang; Zhang, Jingmei; Wen, Shaojun			A-6G and A-20C Polymorphisms in the Angiotensinogen Promoter and Hypertension Risk in Chinese: A Meta-Analysis	PLOS ONE			English	Article							GENE POLYMORPHISMS; BLOOD-PRESSURE; ALDOSTERONE SYSTEM; HAN CHINESE; ASSOCIATION; POPULATION; HAPLOTYPE; VARIANTS; TIBETAN; M235T	Background: Numerous studies in Chinese populations have evaluated the association between the A-6G and A-20C polymorphisms in the promoter region of angiotensinogen gene and hypertension. However, the results remain conflicting. We carried out a meta-analysis for these associations. Methods and Results: Case-control studies in Chinese and English publications were identified by searching the MEDLINE, EMBASE, CNKI, Wanfang, CBM, and VIP databases. The random-effects model was applied for dichotomous outcomes to combine the results of the individual studies. We finally selected 24 studies containing 5932 hypertensive patients and 5231 normotensive controls. Overall, we found significant association between the A-6G polymorphism and the decreased risk of hypertension in the dominant genetic model (AA+AG vs. GG: P = 0.001, OR = 0.71, 95% CI 0.57-0.87, P-heterogeneity = 0.96). The A-20C polymorphism was significantly associated with the increased risk for hypertension in the allele comparison (C vs. A: P = 0.03, OR = 1.14, 95% CI 1.02-1.27, P-heterogeneity = 0.92) and recessive genetic model (CC vs. CA+AA: P = 0.005, OR = 1.71, 95% CI 1.18-2.48, P-heterogeneity = 0.99). In the subgroup analysis by ethnicity, significant association was also found among Han Chinese for both A-6G and A-20C polymorphisms. A borderline significantly decreased risk of hypertension between A-6G and Chinese Mongolian was seen in the allele comparison (A vs. G: P = 0.05, OR = 0.79, 95% CI 0.62-1.00, P-heterogeneity = 0.84). Conclusion: Our meta-analysis indicated significant association between angiotensinogen promoter polymorphisms and hypertension in the Chinese populations, especially in Han Chinese.	[Gu, Wei; Liu, Jielin; Niu, Qiuli; Wang, Hao; Lou, Yuqing; Liu, Kuo; Wang, Lijuan; Wang, Zuoguang; Wen, Shaojun] Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Hypertens Res, Beijing, Peoples R China; [Gu, Wei; Liu, Jielin; Niu, Qiuli; Wang, Hao; Lou, Yuqing; Liu, Kuo; Wang, Lijuan; Wang, Zuoguang; Wen, Shaojun] Capital Med Univ, Beijing, Peoples R China; [Zhang, Jingmei] Capital Med Univ, Beijing Anzhen Hosp, Emergency Ctr Heart Lung & Blood Vessel Dis, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Gu, W (corresponding author), Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Hypertens Res, Beijing, Peoples R China.	zhangjingmei6388@sina.com; wenshaojun@yahoo.com.cn		Wang, Zuoguang/0000-0002-0230-1611; Wang, Hao/0000-0001-5694-1203	National High Technology Research and Development Program [2008AA02Z441]; Ministry of Science and Technology in People's Republic of China [2008BAI52B03]	National High Technology Research and Development Program(National High Technology Research and Development Program of China); Ministry of Science and Technology in People's Republic of China	This work was financially supported by the National High Technology Research and Development Program (2008AA02Z441) (http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm), and the National Eleventh Five-year Plan Program (2008BAI52B03) (http://www.most.gov.cn/eng/programmes1/index.htm) from the Ministry of Science and Technology in People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cavalli-Sforza LL, 1998, P NATL ACAD SCI USA, V95, P11501, DOI 10.1073/pnas.95.20.11501; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Chen Xing-dong, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P752; Dickson ME, 2006, HYPERTENSION, V48, P14, DOI 10.1161/01.HYP.0000227932.13687.60; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EGGER M, 1995, BMJ-BRIT MED J, V310, P752, DOI 10.1136/bmj.310.6982.752; Ge SLB, 1995, RENIN ANGIOTENSIN SY; Hegele RA, 1998, J HUM GENET, V43, P37, DOI 10.1007/s100380050034; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hilgers KF, 2001, HYPERTENSION, V38, P1250, DOI 10.1161/hy1201.096545; [呼日勒 Hu RL], 2007, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V11, P5865; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; Ishigami T, 1999, HYPERTENSION, V34, P430, DOI 10.1161/01.HYP.34.3.430; Jain S, 2010, J BIOL CHEM, V285, P41172, DOI 10.1074/jbc.M110.167585; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Ji LD, 2010, J HYPERTENS, V28, P419, DOI 10.1097/HJH.0b013e32833456b9; Jiang X, 2009, J HUM HYPERTENS, V23, P176, DOI 10.1038/jhh.2008.123; Kong LZ, 2005, REPORT CARDIOVASCULA, P86; Kong Xiangdong, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P488; KURTZ TW, 1993, AM J MED, V94, P77, DOI 10.1016/0002-9343(93)90124-8; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Li Nan-fang, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P23; Liu Y, 1999, CHINESE MED J-PEKING, V112, P115; Liu Y, 2002, ASS STUDIES ANGIOTEN; Liu Yan, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P116; Liu YW, 2001, HYPERTENS RES, V24, P159, DOI 10.1291/hypres.24.159; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Niu WQ, 2007, HYPERTENS RES, V30, P1129, DOI 10.1291/hypres.30.1129; Niu WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017052; Niu WQ, 2009, J HYPERTENS, V27, P1384, DOI 10.1097/HJH.0b013e32832b7e0d; O'Shaughnessy KM, 2001, BRIT J CLIN PHARMACO, V51, P5, DOI 10.1046/j.1365-2125.2001.01254.x; Perazella MA, 2003, J NUCL CARDIOL, V10, P184, DOI 10.1067/mnc.2003.392; Pereira TV, 2008, HYPERTENSION, V51, P778, DOI 10.1161/HYPERTENSIONAHA.107.100370; Qi Y, 2008, J HUM HYPERTENS, V22, P147, DOI 10.1038/sj.jhh.1002282; Qin JH, 2005, ELECTROPHORESIS, V26, P219, DOI 10.1002/elps.200406158; Tsai CT, 2003, HYPERTENSION, V41, P9, DOI 10.1161/01.HYP.0000045080.28739.12; Velez DR, 2006, AM J HYPERTENS, V19, P1278, DOI 10.1016/j.amjhyper.2006.05.020; Wang GY, 2006, EUR J EPIDEMIOL, V21, P287, DOI 10.1007/s10654-005-6006-4; Wang GY, 2006, CHIN J PUBLIC HLTH, V22, P1332; Wang JH, 2002, J FORMOS MED ASSOC, V101, P183; Wang Tan, 2007, Neurosci Bull, V23, P287, DOI 10.1007/s12264-007-0043-9; Wang XF, 2003, 4 POLYMORPHISMS RENI; Wang Z, 2006, ZHONGGUO XIN XUE GUA, V4, P116; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Wu SJ, 2004, PHYSIOL GENOMICS, V17, P79, DOI 10.1152/physiolgenomics.00133.2003; Yang C, 2000, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V17, P149; Yao CY, 2010, SHI YONG YI XUE ZA Z, V26, P3514; Ying CQ, 2010, CLIN EXP HYPERTENS, V32, P293, DOI 10.3109/10641960903443517; Yue YH, 2008, STUDY ASS SINGLE NUC; Zhao YY, 1999, HYPERTENSION, V33, P108, DOI 10.1161/01.HYP.33.1.108	51	5	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29489	10.1371/journal.pone.0029489	http://dx.doi.org/10.1371/journal.pone.0029489			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216295	gold, Green Submitted, Green Published			2022-12-27	WOS:000300676300062
J	Jacobi, D; Caille, A; Borys, JM; Lommez, A; Couet, C; Charles, MA; Oppert, JM				Jacobi, David; Caille, Agnes; Borys, Jean-Michel; Lommez, Agnes; Couet, Charles; Charles, Marie-Aline; Oppert, Jean-Michel		FLVS Study Grp	Parent-Offspring Correlations in Pedometer-Assessed Physical Activity	PLOS ONE			English	Article							FAMILIAL AGGREGATION; UNITED-STATES; RESEMBLANCE; YOUTH; EXERCISE; CHILDREN; FITNESS; GIRLS; AGE	Background: Physical activity is a major component of a healthy lifestyle in youth and adults. To identify determinants of this complex behavior is an important research objective in the process of designing interventions to promote physical activity at population level. In addition to individual determinants, there is evidence documenting familial influences on physical activity. However, the few studies that have addressed this issue with objective measures did not provide data on parent-offspring physical activity relationships throughout childhood and adolescence. The purpose of this study was to assess familial correlations in pedometer-assessed physical activity. Methods: We measured ambulatory activity in 286 French nuclear families (283 mothers, 237 fathers, and 631 children aged 8-18 years) by pedometer recordings (Yamax Digiwalker DW 450) over a week. Correlations were computed with their 95% confidence intervals (CI) for spouse pairs, siblings, mother-offspring, and father-offspring. Data were expressed as steps per day and computed both for the full recording period and separately for weekdays and weekends. Results: The correlations were the highest between siblings (r = 0.28, 95% CI: 0.17-0.38). Parent-offspring correlations were significant in mothers (r = 0.21, 95% CI: 0.12-0.30), especially between mothers and daughters (r = 0.24, 95% CI: 0.12-0.36 vs. r = 0.18, 95% CI: 0.05-0.31 for sons), but were almost nonexistent in fathers. Correlations were generally higher on weekend days compared to weekdays. Mother-offspring correlations did not decrease with increasing age of children (r = 0.17, 95% CI: 0.00-0.34 in 8-11-year-olds, r = 0.20, 95% CI: 0.07-0.33 in 12-15-year-olds, and r = 0.25, 95% CI: 0.07-0.39 in >= 16-year-olds). Finally, between-spouse correlations were significant only during weekend days (r = 0.14, 95% CI: 0.01-0.27). Conclusion: Ambulatory activity correlated within families, with a possible mother effect. Mother-offspring correlations remained significant through the transition from childhood to adolescence. Further studies are required to better understand the respective influences of shared activities, parental modeling and support as well as genetic factors on the familial aggregation of physical activity.	[Jacobi, David; Couet, Charles] Ctr Hosp Reg Univ CHRU Tours, Serv Med Interne Nutr, Tours, France; [Jacobi, David; Couet, Charles] Univ Tours, INSERM, U921, Tours, France; [Caille, Agnes] Univ Tours, INSERM, Ctr Invest Clin CIC 202, Tours, France; [Borys, Jean-Michel; Lommez, Agnes] Fleurbaix Laventie Assoc, Laventie, France; [Charles, Marie-Aline] Ctr Rech Epidemiol & Sante Populat CESP, Team Lifelong Epidemiol Obes Diabet & Renal Dis, INSERM, U1018, Villejuif, France; [Charles, Marie-Aline] Univ Paris 11, Le Kremlin Bicetre, France; [Oppert, Jean-Michel] Hop La Pitie Salpetriere, AP HP, Serv Nutr, Paris, France; [Oppert, Jean-Michel] Univ Paris 06, Ctr Rech Nutr Humaine Ile de France CRNH IdF, Paris, France	CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Jacobi, D (corresponding author), Ctr Hosp Reg Univ CHRU Tours, Serv Med Interne Nutr, Tours, France.	jean-michel.oppert@psl.aphp.fr	Caille, Agnès/K-6628-2012; Charles, Marie Aline/F-8567-2017; jacobi, david/N-8553-2017; Charles, Marie Aline/S-1866-2019; caille, agnes/L-9011-2015; Heude, Barbara/G-3095-2016; Oppert, Jean-Michel/F-2810-2017; FROGUEL, Philippe/O-6799-2017; jacobi, david/J-1322-2014	Charles, Marie Aline/0000-0003-4025-4390; jacobi, david/0000-0001-8674-223X; Charles, Marie Aline/0000-0003-4025-4390; Heude, Barbara/0000-0002-1565-1629; FROGUEL, Philippe/0000-0003-2972-0784; Caille, Agnes/0000-0003-4715-6144	Cedus; Roche; Lesieur; Nestle'France; French Ministry of Health-National Nutrition and Health [PNNS-2002]	Cedus; Roche(Roche Holding); Lesieur; Nestle'France; French Ministry of Health-National Nutrition and Health	Cedus (www.lesucre.com), Roche (www.roche.fr), Lesieur (www.lesieur.fr), and Nestle'France (www.nestle.fr) financially supported the Fleurbaix-Laventie Ville-Sante'study. This project was supported by a research-action grant from the French Ministry of Health-National Nutrition and Health Program (PNNS-2002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beets MW, 2007, SEX ROLES, V56, P125, DOI 10.1007/s11199-006-9154-4; Beydoun MA, 2009, SOC SCI MED, V68, P2137, DOI 10.1016/j.socscimed.2009.03.029; Caspersen CJ, 2000, MED SCI SPORT EXER, V32, P1601; CDC, 2005, MMWR-MORBID MORTAL W, V55, P1; Corder K, 2007, CURR OPIN CLIN NUTR, V10, P597, DOI 10.1097/MCO.0b013e328285d883; Edwardson CL, 2010, PSYCHOL SPORT EXERC, V11, P522, DOI 10.1016/j.psychsport.2010.05.001; ELIASZIW M, 1991, ANN HUM GENET, V55, P77, DOI 10.1111/j.1469-1809.1991.tb00400.x; Ferreira I, 2007, OBES REV, V8, P129, DOI 10.1111/j.1467-789X.2006.00264.x; FREEDSON PS, 1991, RES Q EXERCISE SPORT, V62, P384, DOI 10.1080/02701367.1991.10607538; Fuemmeler BF, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-17; Gustafson SL, 2006, SPORTS MED, V36, P79, DOI 10.2165/00007256-200636010-00006; Jago R, 2010, BMC PUBLIC HEALTH, V15, P10, DOI DOI 10.1186/1471-2458-1110-1194; Kettaneh A, 2005, INT J OBESITY, V29, P586, DOI 10.1038/sj.ijo.0802992; Loucaides Constantinos A, 2006, J Phys Act Health, V3, P267, DOI 10.1123/jpah.3.3.267; MOORE LL, 1991, J PEDIATR-US, V118, P215, DOI 10.1016/S0022-3476(05)80485-8; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Oliver M, 2010, J SCI MED SPORT, V13, P403, DOI 10.1016/j.jsams.2009.05.008; PATTERSON TL, 1987, PREV MED, V16, P616, DOI 10.1016/0091-7435(87)90045-4; PERUSSE L, 1988, AM J CLIN NUTR, V47, P629, DOI 10.1093/ajcn/47.4.629; PERUSSE L, 1989, AM J EPIDEMIOL, V129, P1012, DOI 10.1093/oxfordjournals.aje.a115205; PERUSSE L, 1987, PREV MED, V16, P607, DOI 10.1016/0091-7435(87)90044-2; Physical Activity Guidelines Advisory Committee (PAGAC), 2008, PHYS ACT GUID ADV CO; Rankinen T, 2010, MED SCI SPORT EXER, V42, P835, DOI 10.1249/MSS.0b013e3181d86cec; Romon M, 2004, INT J OBESITY, V28, P1227, DOI 10.1038/sj.ijo.0802725; Rosner B, 1977, APPL STATIST, V26, P179; Seabra AF, 2008, EUR J EPIDEMIOL, V23, P205, DOI 10.1007/s10654-008-9222-x; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Thompson JL, 2010, CHILD CARE HLTH DEV, V36, P265, DOI 10.1111/j.1365-2214.2009.01051.x; Treuth MS, 2001, AM J CLIN NUTR, V74, P529; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Trost SG, 2003, AM J PREV MED, V25, P277, DOI 10.1016/S0749-3797(03)00217-4; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Tudor-Locke C, 2005, PREV MED, V40, P293, DOI 10.1016/j.ypmed.2004.06.003; Tudor-Locke C, 2004, SPORTS MED, V34, P281, DOI 10.2165/00007256-200434050-00001; Tudor-Locke C, 2010, MED SCI SPORT EXER, V42, P2244, DOI 10.1249/MSS.0b013e3181e32d7f; Ukoumunne OC, 2002, STAT MED, V21, P3757, DOI 10.1002/sim.1330; Van Domelen DR, 2011, AM J PREV MED, V41, P136, DOI 10.1016/j.amepre.2011.03.019	37	53	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29195	10.1371/journal.pone.0029195	http://dx.doi.org/10.1371/journal.pone.0029195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216207	Green Published, gold, Green Submitted			2022-12-27	WOS:000300676300035
J	Luo, R; Jin, ZH; Deng, YY; Strokes, N; Piao, XH				Luo, Rong; Jin, Zhaohui; Deng, Yiyu; Strokes, Natalie; Piao, Xianhua			Disease-Associated Mutations Prevent GPR56-Collagen III Interaction	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; GPR56; COLLAGEN	GPR56 is a member of the adhesion G protein-coupled receptor (GPCR) family. Mutations in GPR56 cause a devastating human brain malformation called bilateral frontoparietal polymicrogyria (BFPP). Using the N-terminal fragment of GPR56 (GPR56(N)) as a probe, we have recently demonstrated that collagen III is the ligand of GPR56 in the developing brain. In this report, we discover a new functional domain in GPR56N, the ligand binding domain. This domain contains four disease-associated mutations and two N-glycosylation sites. Our study reveals that although glycosylation is not required for ligand binding, each of the four disease-associated mutations completely abolish the ligand binding ability of GPR56. Our data indicates that these four single missense mutations cause BFPP mostly by abolishing the ability of GPR56 to bind to its ligand, collagen III, in addition to affecting GPR56 protein surface expression as previously shown.	[Luo, Rong] Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Luo, R (corresponding author), Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA.	xianhua.piao@childrens.harvard.edu	Jin, Zhaohui/AAQ-2893-2021; Jin, Zhaohui/AAI-5562-2020	Jin, Zhaohui/0000-0001-7844-5833; Piao, Xianhua/0000-0001-7540-6767	National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS057536]; Flight Attendant Medical Research Institute; Leonard and Isabelle Goldenson Research Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057536] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Flight Attendant Medical Research Institute; Leonard and Isabelle Goldenson Research Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by National Institute of Neurological Disorders and Stroke (NINDS) grant R01 NS057536 (X.P.), a Flight Attendant Medical Research Institute Young Clinical Scientist Award (Z.J.), and the Leonard and Isabelle Goldenson Research Fellowship (R.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiang NY, 2011, J BIOL CHEM, V286, P14215, DOI 10.1074/jbc.M110.183830; Jin ZH, 2007, HUM MOL GENET, V16, P1972, DOI 10.1093/hmg/ddm144; Jin ZH, 2009, PROG MOL BIOL TRANSL, V89, P1, DOI 10.1016/S1877-1173(09)89001-7; Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; Liu M, 1999, GENOMICS, V55, P296, DOI 10.1006/geno.1998.5644; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; Luo R, 2011, PEDIATR NEUROL, V45, P49, DOI 10.1016/j.pediatrneurol.2011.02.004; Nykvist P, 2000, J BIOL CHEM, V275, P8255, DOI 10.1074/jbc.275.11.8255; Piao XH, 2005, ANN NEUROL, V58, P680, DOI 10.1002/ana.20616; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Piao XH, 2002, AM J HUM GENET, V70, P1028, DOI 10.1086/339552; Schioth HB, 2010, ADV EXP MED BIOL, V706, P1; Shashidhar S, 2005, ONCOGENE, V24, P1673, DOI 10.1038/sj.onc.1208395; Strokes N, 2010, ADV EXP MED BIOL, V706, P87; Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103; Yang L, 2011, CANC RES; Zendman AJW, 1999, FEBS LETT, V446, P292, DOI 10.1016/S0014-5793(99)00230-6	18	48	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29818	10.1371/journal.pone.0029818	http://dx.doi.org/10.1371/journal.pone.0029818			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238662	gold, Green Published, Green Submitted			2022-12-27	WOS:000301070200053
J	Menashe, I; Figueroa, JD; Garcia-Closas, M; Chatterjee, N; Malats, N; Picornell, A; Maeder, D; Yang, Q; Prokunina-Olsson, L; Wang, ZM; Real, FX; Jacobs, KB; Baris, D; Thun, M; Albanes, D; Purdue, MP; Kogevinas, M; Hutchinson, A; Fu, YP; Tang, W; Burdette, L; Tardon, A; Serra, C; Carrato, A; Garcia-Closas, R; Lloreta, J; Johnson, A; Schwenn, M; Schned, A; Andriole, G; Black, A; Jacobs, EJ; Diver, RW; Gapstur, SM; Weinstein, SJ; Virtamo, J; Caporaso, NE; Landi, MT; Fraumeni, JF; Chanock, SJ; Silverman, DT; Rothman, N				Menashe, Idan; Figueroa, Jonine D.; Garcia-Closas, Montserrat; Chatterjee, Nilanjan; Malats, Nuria; Picornell, Antoni; Maeder, Dennis; Yang, Qi; Prokunina-Olsson, Ludmila; Wang, Zhaoming; Real, Francisco X.; Jacobs, Kevin B.; Baris, Dalsu; Thun, Michael; Albanes, Demetrius; Purdue, Mark P.; Kogevinas, Manolis; Hutchinson, Amy; Fu, Yi-Ping; Tang, Wei; Burdette, Laurie; Tardon, Adonina; Serra, Consol; Carrato, Alfredo; Garcia-Closas, Reina; Lloreta, Josep; Johnson, Alison; Schwenn, Molly; Schned, Alan; Andriole, Gerald, Jr.; Black, Amanda; Jacobs, Eric J.; Diver, Ryan W.; Gapstur, Susan M.; Weinstein, Stephanie J.; Virtamo, Jarmo; Caporaso, Neil E.; Landi, Maria Teresa; Fraumeni, Joseph F., Jr.; Chanock, Stephen J.; Silverman, Debra T.; Rothman, Nathaniel			Large-Scale Pathway-Based Analysis of Bladder Cancer Genome-Wide Association Data from Five Studies of European Background	PLOS ONE			English	Article							NAT2 SLOW ACETYLATION; AROMATIC-AMINES; CONFERS SUSCEPTIBILITY; GENETIC-VARIATION; MISSING HERITABILITY; SEQUENCE VARIANT; COMPLEX DISEASE; REPAIR PATHWAY; GSTM1 NULL; RISK	Pathway analysis of genome-wide association studies (GWAS) offer a unique opportunity to collectively evaluate genetic variants with effects that are too small to be detected individually. We applied a pathway analysis to a bladder cancer GWAS containing data from 3,532 cases and 5,120 controls of European background (n = 5 studies). Thirteen hundred and ninety-nine pathways were drawn from five publicly available resources (Biocarta, Kegg, NCI-PID, HumanCyc, and Reactome), and we constructed 22 additional candidate pathways previously hypothesized to be related to bladder cancer. In total, 1421 pathways, 5647 genes and similar to 90,000 SNPs were included in our study. Logistic regression model adjusting for age, sex, study, DNA source, and smoking status was used to assess the marginal trend effect of SNPs on bladder cancer risk. Two complementary pathway-based methods (gene-set enrichment analysis [GSEA], and adapted rank-truncated product [ARTP]) were used to assess the enrichment of association signals within each pathway. Eighteen pathways were detected by either GSEA or ARTP at P <= 0.01. To minimize false positives, we used the I-2 statistic to identify SNPs displaying heterogeneous effects across the five studies. After removing these SNPs, seven pathways ('Aromatic amine metabolism' [P-GSEA = 0.0100, P-ARTP = 0.0020], 'NAD biosynthesis' [P-GSEA = 0.0018, P-ARTP = 0.0086], 'NAD salvage' [P-ARTP = 0.0068], 'Clathrin derived vesicle budding' [P-ARTP = 0.0018], 'Lysosome vesicle biogenesis' [P-GSEA = 0.0023, P-ARTP < 0.00012], 'Retrograde neurotrophin signaling' [P-GSEA = 0.00840], and 'Mitotic metaphase/anaphase transition' [P-GSEA = 0.0040]) remained. These pathways seem to belong to three fundamental cellular processes (metabolic detoxification, mitosis, and clathrin-mediated vesicles). Identification of the aromatic amine metabolism pathway provides support for the ability of this approach to identify pathways with established relevance to bladder carcinogenesis.	[Menashe, Idan; Figueroa, Jonine D.; Chatterjee, Nilanjan; Maeder, Dennis; Yang, Qi; Prokunina-Olsson, Ludmila; Baris, Dalsu; Albanes, Demetrius; Purdue, Mark P.; Fu, Yi-Ping; Tang, Wei; Black, Amanda; Weinstein, Stephanie J.; Caporaso, Neil E.; Landi, Maria Teresa; Fraumeni, Joseph F., Jr.; Chanock, Stephen J.; Silverman, Debra T.; Rothman, Nathaniel] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Garcia-Closas, Montserrat] Inst Canc Res, Surrey, England; [Malats, Nuria; Picornell, Antoni; Real, Francisco X.] Spanish Natl Canc Res Ctr, Madrid, Spain; [Wang, Zhaoming; Jacobs, Kevin B.; Hutchinson, Amy; Burdette, Laurie] SAIC Frederick Inc, Core Genotype Facil, Natl Canc Inst Frederick, Frederick, MD USA; [Real, Francisco X.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Thun, Michael; Jacobs, Eric J.; Diver, Ryan W.; Gapstur, Susan M.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Kogevinas, Manolis] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Kogevinas, Manolis] Municipal Inst Med Res, Barcelona, Spain; [Kogevinas, Manolis; Tardon, Adonina; Serra, Consol] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Kogevinas, Manolis] Natl Sch Publ Hlth, Athens, Greece; [Carrato, Alfredo] Ramon y Cajal Univ Hosp, Madrid, Spain; [Garcia-Closas, Reina] Hosp Univ Canarias, Unidad Invest, San Cristobal la Laguna, Spain; [Lloreta, Josep] Univ Pompeu Fabra, Hosp Mar, IMIM, Barcelona, Spain; [Johnson, Alison] Vermont Canc Registry, Burlington, VT USA; [Schwenn, Molly] Maine Canc Registry, Augusta, ME USA; [Schned, Alan] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA; [Andriole, Gerald, Jr.] Washington Univ, Sch Med, Dept Urol, St Louis, MO USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Helsinki, Finland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of London; Institute of Cancer Research - UK; Centro Nacional de Investigaciones Oncologicas (CNIO); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Pompeu Fabra University; American Cancer Society; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; National & Kapodistrian University of Athens; Hospital Universitario Ramon y Cajal; Universidad de la Laguna; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Dartmouth College; Washington University (WUSTL); Finland National Institute for Health & Welfare	Menashe, I (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	menashei@mail.nih.gov	Garcia-Closas, Montserrat/AAZ-6930-2021; TARDON, ADONINA/B-6563-2014; Figueroa, Jonine/GWD-1322-2022; Lloreta, J/I-2112-2014; Lloreta-Trull, Josep/AAZ-1229-2020; Garcia-Closas, Montserrat/F-3871-2015; Purdue, Mark P/C-9228-2016; Menashe, Idan/W-6214-2019; Diver, Ryan/AAG-3469-2019; Lloreta-Trull, Josep/GRR-9682-2022; Albanes, Demetrius/B-9749-2015; Serra, C/E-6879-2014; Pillay, Nischalan/F-9536-2012; Wang, Zhaoming/R-5527-2018; Weinstein, Stephanie J/P-1627-2017; Figueroa, Jonine/AAG-1065-2022; Tang, Wei/H-7103-2013; Menashe, Idan/AAC-8670-2020; Picornell, Antonio/I-2523-2017; Prokunina-Olsson, Ludmila/A-8240-2019; Prokunina-Olsson, Ludmila/V-7960-2019; Kogevinas, Manolis/C-3918-2017; Arribas, Francisco X Real/H-5275-2015; Malats, Nuria/H-7041-2015; Figueroa, Jonine/AFK-2752-2022	Garcia-Closas, Montserrat/0000-0003-1033-2650; TARDON, ADONINA/0000-0001-5150-1209; Figueroa, Jonine/0000-0002-5100-623X; Lloreta, J/0000-0003-1644-9470; Garcia-Closas, Montserrat/0000-0003-1033-2650; Purdue, Mark P/0000-0003-1177-3108; Diver, Ryan/0000-0002-5418-9000; Serra, C/0000-0001-8337-8356; Wang, Zhaoming/0000-0001-7556-3869; Weinstein, Stephanie J/0000-0002-3834-1535; Figueroa, Jonine/0000-0002-5100-623X; Tang, Wei/0000-0002-7089-4391; Menashe, Idan/0000-0003-1961-1461; Picornell, Antonio/0000-0003-3679-9662; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Kogevinas, Manolis/0000-0002-9605-0461; Arribas, Francisco X Real/0000-0001-9501-498X; Malats, Nuria/0000-0003-2538-3784; Figueroa, Jonine/0000-0002-5100-623X; Jacobs, Kevin/0000-0002-4657-6473; Johnson, Alison/0000-0002-1113-1191; CARRATO, ALFREDO/0000-0001-7749-8140	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics [NCI N02-CP-11015, NCI N02-CP-01037]; FIS/Spain [98/1274, 00/0745, PI061614, G03/174]; Fundacio Marato TV3; Red Tematica Investigacion Cooperativa en Cancer (RTICC); Consolider ONCOBIO; The National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI) [HG-06-033-NCI-01, RO1HL091172-01]; Johns Hopkins University Center for Inherited Disease Research [U01HG004438, NIH HHSN268200782096C]; NIH Genes, Environment and Health Initiative [GEI] [HG-06-033-NCI-01, RO1HL091172-01]; GENEVA Coordination Center [U01 HG004446]; National Institutes of Health, NCI, Division of Cancer Epidemiology and Genetics; Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health; NIH; National Cancer Institute; U.S. Public Health Service from the National Cancer Institute, Department of Health and Human Services [N01-CN-45165, N01-RC-45035, N01-RC-37004];  [EU-FP7-201663];  [RO1- CA089715];  [CA34627]; NATIONAL CANCER INSTITUTE [ZIACP010187, ZIACP010201, ZIACP010181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000732] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); FIS/Spain(Instituto de Salud Carlos III); Fundacio Marato TV3; Red Tematica Investigacion Cooperativa en Cancer (RTICC); Consolider ONCOBIO; The National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University Center for Inherited Disease Research; NIH Genes, Environment and Health Initiative [GEI](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GENEVA Coordination Center; National Institutes of Health, NCI, Division of Cancer Epidemiology and Genetics; Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Division of Cancer Prevention, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Public Health Service from the National Cancer Institute, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Support for individual studies that participated in the effort is as follows: SBCS (Dr. Silverman) - Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics and intramural contract number NCI N02-CP-11015. FIS/Spain 98/1274, FIS/Spain 00/0745, PI061614, and G03/174, Fundacio Marato TV3, Red Tematica Investigacion Cooperativa en Cancer (RTICC), Consolider ONCOBIO, EU-FP7-201663; and RO1- CA089715 and CA34627. NEBCS (Dr. Silverman) - Intramural research program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics and intramural contract number NCI N02-CP-01037 PLCO (Dr. Purdue) - The National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI) partly funded DNA extraction and statistical analyses (HG-06-033-NCI-01 and RO1HL091172-01), genotyping at the Johns Hopkins University Center for Inherited Disease Research (U01HG004438 and NIH HHSN268200782096C), and study coordination at the GENEVA (Dr. Caporaso)-The NIH Genes, Environment and Health Initiative [GEI] partly funded DNA extraction and statistical analyses (HG-06-033-NCI-01 and RO1HL091172-01), genotyping at the Johns Hopkins University Center for Inherited Disease Research (U01HG004438 and NIH HHSN268200782096C) and study coordination at the GENEVA Coordination Center (U01 HG004446) for EAGLE and part of PLCO studies. Genotyping for the remaining part of PLCO and all ATBC and CPS-II samples were supported by the Intramural Research Program of the National Institutes of Health, NCI, Division of Cancer Epidemiology and Genetics. The PLCO is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and supported by contracts from the Division of Cancer Prevention, National Cancer Institute, National Institutes of Health. ATBC (Dr. Albanes) - This research was supported in part by the Intramural Research Program of the NIH and the National Cancer Institute. Additionally, this research was supported by U.S. Public Health Service contracts N01-CN-45165, N01-RC-45035, and N01-RC-37004 from the National Cancer Institute, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranzini SE, 2009, HUM MOL GENET; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Chen X, 2010, GENET EPIDEMIOL, V34, P716, DOI 10.1002/gepi.20532; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P360, DOI 10.1002/gepi.10264; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Elbers CC, 2009, GENET EPIDEMIOL; Figueroa JD, 2010, EPIDEMIOLOGY; Figueroa JD, 2007, CARCINOGENESIS, V28, P1788, DOI 10.1093/carcin/bgm132; Figueroa JD, 2007, HUM GENET, V121, P233, DOI 10.1007/s00439-006-0294-y; Garcia-Closas M, 2005, LANCET, V366, P649, DOI 10.1016/S0140-6736(05)67137-1; Hein DW, 2002, MUTAT RES-FUND MOL M, V506, P65, DOI 10.1016/S0027-5107(02)00153-7; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoh J, 2001, GENOME RES, V11, P2115, DOI 10.1101/gr.204001; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; Kirisits A, 2007, INT J BIOCHEM CELL B, V39, P2173, DOI 10.1016/j.biocel.2007.07.012; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; Magni G, 2008, FRONT BIOSCI-LANDMRK, V13, P6135, DOI 10.2741/3143; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarthy MI, 2009, DIABETES; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Moore LE, 2011, CARCINOGENESIS, V32, P182, DOI 10.1093/carcin/bgq223; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Royle SJ, 2006, CELL MOL LIFE SCI, V63, P1823, DOI 10.1007/s00018-005-5587-0; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; SILVERMAN DT, 1992, HEMATOL ONCOL CLIN N, V6, P1; Silverman DT, 2006, CANC EPIDEMIOLOGY PR, V3, P1101; Skipper PL, 2010, CARCINOGENESIS, V31, P50, DOI 10.1093/carcin/bgp267; SKIPPER PL, 1994, ENVIRON HEALTH PERSP, V102, P17, DOI 10.2307/3432145; Talaska G, 2003, J ENVIRON SCI HEAL C, V21, P29, DOI 10.1081/GNC-120021372; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Vineis P, 1997, CANCER CAUSE CONTROL, V8, P346, DOI 10.1023/A:1018453104303; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020	42	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29396	10.1371/journal.pone.0029396	http://dx.doi.org/10.1371/journal.pone.0029396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238607	Green Published, Green Submitted, gold			2022-12-27	WOS:000301070200026
J	Visser, ME; Stead, MC; Walzl, G; Warren, R; Schomaker, M; Grewal, HMS; Swart, EC; Maartens, G				Visser, Marianne E.; Stead, Michael C.; Walzl, Gerhard; Warren, Rob; Schomaker, Michael; Grewal, Harleen M. S.; Swart, Elizabeth C.; Maartens, Gary			Baseline Predictors of Sputum Culture Conversion in Pulmonary Tuberculosis: Importance of Cavities, Smoking, Time to Detection and W-Beijing Genotype	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; MYCOBACTERIUM-TUBERCULOSIS; TREATMENT FAILURE; INTENSIVE PHASE; SOUTH-AFRICA; DISEASE; STRAINS; RELAPSE; SMEAR; RISK	Background: Time to detection (TTD) on automated liquid mycobacterial cultures is an emerging biomarker of tuberculosis outcomes. The M. tuberculosis W-Beijing genotype is spreading globally, indicating a selective advantage. There is a paucity of data on the association between baseline TTD and W-Beijing genotype and tuberculosis outcomes. Aim: To assess baseline predictors of failure of sputum culture conversion, within the first 2 months of antitubercular therapy, in participants with pulmonary tuberculosis. Design: Between May 2005 and August 2008 we conducted a prospective cohort study of time to sputum culture conversion in ambulatory participants with first episodes of smear and culture positive pulmonary tuberculosis attending two primary care clinics in Cape Town, South Africa. Rifampicin resistance (diagnosed on phenotypic susceptibility testing) was an exclusion criterion. Sputum was collected weekly for 8 weeks for mycobacterial culture on liquid media (BACTEC MGIT 960). Due to missing data, multiple imputation was performed. Time to sputum culture conversion was analysed using a Cox-proportional hazards model. Bayesian model averaging determined the posterior effect probability for each variable. Results: 113 participants were enrolled (30.1% female, 10.5% HIV-infected, 44.2% W-Beijing genotype, and 89% cavities). On Kaplan Meier analysis 50.4% of participants underwent sputum culture conversion by 8 weeks. The following baseline factors were associated with slower sputum culture conversion: TTD (adjusted hazard ratio (aHR) = 1.11, 95% CI 1.02; 1.2), lung cavities (aHR = 0.13, 95% CI 0.02; 0.95), ever smoking (aHR = 0.32, 95% CI 0.1; 1.02) and the W-Beijing genotype (aHR = 0.51, 95% CI 0.25; 1.07). On Bayesian model averaging, posterior probability effects were strong for TTD, lung cavitation and smoking and moderate for W-Beijing genotype. Conclusion: We found that baseline TTD, smoking, cavities and W-Beijing genotype were associated with delayed 2 month sputum culture. Larger studies are needed to confirm the relationship between the W-Beijing genotype and sputum culture conversion.	[Visser, Marianne E.] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Stead, Michael C.; Walzl, Gerhard; Warren, Rob] Univ Stellenbosch, MRC Ctr Mol & Cellular Biol, Cape Town, South Africa; [Stead, Michael C.] Univ Cape Town, Div Med Microbiol, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Schomaker, Michael] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Grewal, Harleen M. S.] Univ Bergen, Gade Inst, Haukeland Univ Hosp, Microbiol & Immunol Sect, Bergen, Norway; [Swart, Elizabeth C.] Univ Western Cape, Div Dietet, Cape Town, South Africa; [Maartens, Gary] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa	University of the Western Cape; Stellenbosch University; University of Cape Town; University of Cape Town; University of Bergen; Haukeland University Hospital; University of the Western Cape; University of Cape Town	Visser, ME (corresponding author), Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa.	marianne.visser@gmail.com	Maartens, Gary/S-2788-2019; Schomaker, Michael/K-3840-2019; Grewal, Harleen/ABC-5831-2020; Maartens, Gary/F-3836-2014; Walzl, Gerhard/N-6371-2016; Swart, Elizabeth/O-9619-2014	Maartens, Gary/0000-0003-3080-6606; Schomaker, Michael/0000-0002-8475-0591; Maartens, Gary/0000-0003-3080-6606; Walzl, Gerhard/0000-0003-2487-125X; Swart, Elizabeth/0000-0002-7786-3117; Warren, Robin/0000-0001-5741-7358	Norwegian Programme for Development, Research and Higher Education [NUFUPRO-2007/10183]; Research Council of Norway (RCN) [183694/S50]; National Research Foundation (South Africa)/RCN [180353/S50]; Fogarty International Center [U2RTW007370]; FOGARTY INTERNATIONAL CENTER [U2RTW007370] Funding Source: NIH RePORTER	Norwegian Programme for Development, Research and Higher Education; Research Council of Norway (RCN)(Research Council of Norway); National Research Foundation (South Africa)/RCN; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Norwegian Programme for Development, Research and Higher Education (NUFUPRO-2007/10183) www.siu.no, the Research Council of Norway (RCN)(183694/S50) www.forskningsradet.no, and the National Research Foundation (South Africa)/RCN (180353/S50) www.nrf.ac.za. GM was supported in part by Grant Number U2RTW007370 from the Fogarty International Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altet-Gomez MN, 2005, INT J TUBERC LUNG D, V9, P430; [Anonymous], 2011, GLOB TUB CONTR 2011; [Anonymous], 2003, PROJ TOB PROD CONS T; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Burman WJ, 2009, EMERG INFECT DIS, V15, P1061, DOI 10.3201/eid1507.081253; Buu TN, 2010, CLIN INFECT DIS, V51, P879, DOI 10.1086/656410; Corrigal J, 2006, VACCINATION COVERAGE; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Den Boon S, 2005, INT J TUBERC LUNG D, V9, P1088; DEWIT D, 1990, J CLIN MICROBIOL, V28, P2437, DOI 10.1128/JCM.28.11.2437-2441.1990; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Guler M, 2007, INT J CLIN PRACT, V61, P231, DOI 10.1111/j.1742-1241.2006.01131.x; Hesseling AC, 2010, INT J TUBERC LUNG D, V14, P560; Honaker J., 2011, AMELIA 2 PROGRAM MIS; Hosseinpoor AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020331; Jeremiah K, 2010, THORAX, V65, P1072, DOI 10.1136/thx.2010.134767; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lan NTN, 2006, EMERG INFECT DIS, V12, P736; Lawson L, 2010, TROP MED INT HEALTH, V15, P1481, DOI 10.1111/j.1365-3156.2010.02638.x; Leung CC, 2003, INT J TUBERC LUNG D, V7, P980; Little R.J.A., 2002, STAT ANAL MISSING DA; Mallard K, 2010, J CLIN MICROBIOL, V48, P4512, DOI 10.1128/JCM.01683-10; Marais BJ, 2006, J CLIN MICROBIOL, V44, P3539, DOI 10.1128/JCM.01291-06; MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062; Nahid P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010753; Nicol MP, 2008, T ROY SOC TROP MED H, V102, P955, DOI 10.1016/j.trstmh.2008.03.025; Onyebujoh PC, 1999, LANCET, V354, P116, DOI 10.1016/S0140-6736(98)10448-8; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Parwati I, 2010, J INFECT DIS, V201, P553, DOI 10.1086/650311; Plit ML, 1998, INT J TUBERC LUNG D, V2, P590; Rekha VVB, 2007, INDIAN J MED RES, V126, P452; Richardson M, 2002, INT J TUBERC LUNG D, V6, P1001; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; SCHOEMAN JH, 1994, TUBERCLE LUNG DIS, V75, P371, DOI 10.1016/0962-8479(94)90084-1; Schomaker M, 2010, COMPUT STAT DATA AN, V54, P3336, DOI 10.1016/j.csda.2009.07.023; SCOTT GM, 1990, J INFECTION, V21, P61, DOI 10.1016/0163-4453(90)90669-Y; Siawaya JFD, 2008, J INFECTION, V56, P340, DOI 10.1016/j.jinf.2008.02.007; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Telzak EE, 1997, CLIN INFECT DIS, V25, P666, DOI 10.1086/513772; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; Visser ME, 2011, AM J CLIN NUTR, V93, P93, DOI 10.3945/ajcn.110.001784; Volinsky CT, 1997, J R STAT SOC C-APPL, V46, P433, DOI 10.1111/1467-9876.00082; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; Wang JY, 2009, RESPIROLOGY, V14, P1012, DOI 10.1111/j.1440-1843.2009.01598.x; *WHO, 2006, GUID STAND OP PROC M, pCH17; Wilson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015248; World Health Organization, 2019, WHO REPORT GLOBAL TO	47	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29588	10.1371/journal.pone.0029588	http://dx.doi.org/10.1371/journal.pone.0029588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238625	Green Published, gold			2022-12-27	WOS:000301070200036
J	Bergval, I; Kwok, B; Schuitema, A; Kremer, K; van Soolingen, D; Klatser, P; Anthony, R				Bergval, Indra; Kwok, Brian; Schuitema, Anja; Kremer, Kristin; van Soolingen, Dick; Klatser, Paul; Anthony, Richard			Pre-Existing Isoniazid Resistance, but Not the Genotype of Mycobacterium Tuberculosis Drives Rifampicin Resistance Codon Preference in Vitro	PLOS ONE			English	Article							DRUG-RESISTANCE; ANTIBIOTIC-RESISTANCE; POPULATION-STRUCTURE; RPOB MUTATIONS; FITNESS COST; EVOLUTION; STRAINS; KATG; MUTANTS; GENE	Both the probability of a mutation occurring and the ability of the mutant to persist will influence the distribution of mutants that arise in a population. We studied the interaction of these factors for the in vitro selection of rifampicin (RIF)resistant mutants of Mycobacterium tuberculosis. We characterised two series of spontaneous RIF-resistant in vitro mutants from isoniazid (INH)-sensitive and -resistant laboratory strains and clinical isolates, representing various M. tuberculosis genotypes. The first series were selected from multiple parallel 1 ml cultures and the second from single 10 ml cultures. RIF-resistant mutants were screened by Multiplex Ligation-dependent Probe Amplification (MLPA) or by sequencing the rpoB gene. For all strains the mutation rate for RIF resistance was determined with a fluctuation assay. The most striking observation was a shift towards rpoB-S531L (TCG -> TTG) mutations in a panel of laboratory-generated INH-resistant mutants selected from the 10-ml cultures (p<0.001). All tested strains showed similar mutation rates (1.33x10(-8) to 2.49x10(-7)) except one of the laboratory-generated INH mutants with a mutation rate measured at 5.71x10(-7), more than 10 times higher than that of the INH susceptible parental strain (5.46-7.44x10(-8)). No significant, systematic difference in the spectrum of rpoB-mutations between strains of different genotypes was observed. The dramatic shift towards rpoB-S531L in our INH-resistant laboratory mutants suggests that the relative fitness of resistant mutants can dramatically impact the distribution of (subsequent) mutations that accumulate in a M. tuberculosis population, at least in vitro. We conclude that, against specific genetic backgrounds, certain resistance mutations are particularly likely to spread. Molecular screening for these (combinations of) mutations in clinical isolates could rapidly identify these particular pathogenic strains. We therefore recommend that isolates are screened for the distribution of resistance mutations, especially in regions that are highly endemic for (multi) drug resistant tuberculosis.	[Bergval, Indra; Kwok, Brian; Schuitema, Anja; Klatser, Paul; Anthony, Richard] Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands; [Kremer, Kristin; van Soolingen, Dick] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, TB Reference Lab, Bilthoven, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Med Ctr, Univ Lung Ctr Dekkerswald, Dept Microbiol, NL-6525 ED Nijmegen, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Med Ctr, Univ Lung Ctr Dekkerswald, Dept Pulm Dis, NL-6525 ED Nijmegen, Netherlands	Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; Radboud University Nijmegen	Bergval, I (corresponding author), Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands.	i.bergval@kit.nl	Anthony, Richard M/G-5654-2010; Anthony, Richard/AAP-3406-2020	Anthony, Richard M/0000-0002-0550-5273; Anthony, Richard/0000-0002-0550-5273; Klatser, Paul/0000-0003-2127-9138; Klatser, Paul/0000-0003-3868-2409	EU [037919]	EU(European Commission)	This work was funded by the EU 6th Framework Programme TBAdapt (project no. 037919.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alland D, 2003, J BACTERIOL, V185, P3392, DOI 10.1128/JB.185.11.3392-3399.2003; Anthony Richard M, 2005, Ann Clin Microbiol Antimicrob, V4, P9, DOI 10.1186/1476-0711-4-9; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Bergal IL, 2008, J CLIN MICROBIOL, V46, P689, DOI 10.1128/JCM.01821-07; Bergval IL, 2007, FEMS MICROBIOL LETT, V275, P338, DOI 10.1111/j.1574-6968.2007.00905.x; Bergval IL, 2009, J ANTIMICROB CHEMOTH, V64, P515, DOI 10.1093/jac/dkp237; Bifani P, 2008, J INFECT DIS, V198, P90, DOI 10.1086/588822; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Bjorkman J, 2000, SCIENCE, V287, P1479, DOI 10.1126/science.287.5457.1479; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Cohen T, 2003, LANCET INFECT DIS, V3, P13, DOI 10.1016/S1473-3099(03)00483-3; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; DAVID HL, 1970, APPL MICROBIOL, V20, P810, DOI 10.1128/AEM.20.5.810-814.1970; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gibson AL, 2008, J CLIN MICROBIOL, V46, P1259, DOI 10.1128/JCM.02231-07; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; Heep M, 2001, J CLIN MICROBIOL, V39, P107, DOI 10.1128/JCM.39.1.107-110.2001; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hillemann D, 2005, ANTIMICROB AGENTS CH, V49, P1229, DOI 10.1128/AAC.49.3.1229-1231.2005; Huitric E, 2006, ANTIMICROB AGENTS CH, V50, P2860, DOI 10.1128/AAC.00303-06; Iwamoto T, 2008, ANTIMICROB AGENTS CH, V52, P3805, DOI 10.1128/AAC.00579-08; Jenkins C, 2005, EMERG INFECT DIS, V11, P931; Jenkins C, 2009, J ANTIMICROB CHEMOTH, V63, P1118, DOI 10.1093/jac/dkp125; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Li ZM, 1998, J INFECT DIS, V177, P1030, DOI 10.1086/515254; Lipin MY, 2007, CLIN MICROBIOL INFEC, V13, P620, DOI 10.1111/j.1469-0691.2007.01711.x; Luciani F, 2009, P NATL ACAD SCI USA, V106, P14711, DOI 10.1073/pnas.0902437106; Luria SE, 1943, GENETICS, V28, P491; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; Mariam SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021147; Martinez JL, 2007, NAT REV MICROBIOL, V5, P958, DOI 10.1038/nrmicro1796; Mokrousov I, 2002, RES MICROBIOL, V153, P629, DOI 10.1016/S0923-2508(02)01374-8; Morlock GP, 2000, ANTIMICROB AGENTS CH, V44, P3298, DOI 10.1128/AAC.44.12.3298-3301.2000; O'Sullivan DM, 2010, J MED MICROBIOL, V59, P1533, DOI 10.1099/jmm.0.019091-0; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Rinder H, 1997, MICROB DRUG RESIST, V3, P195, DOI 10.1089/mdr.1997.3.195; Riska PF, 2000, INT J TUBERC LUNG D, V4, pS4; Sander P, 2002, ANTIMICROB AGENTS CH, V46, P1204, DOI 10.1128/AAC.46.5.1204-1211.2002; Saunders NJ, 2011, J INFECTION, V62, P212, DOI 10.1016/j.jinf.2011.01.003; Schurch AC, 2010, INFECT GENET EVOL, V10, P108, DOI 10.1016/j.meegid.2009.10.002; Smith NH, 2003, P NATL ACAD SCI USA, V100, P15271, DOI 10.1073/pnas.2036554100; Toungoussova OS, 2004, FEMS IMMUNOL MED MIC, V42, P281, DOI 10.1016/j.femsim.2004.05.012; Trindade S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000578; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Van Deun A, 2010, INT J TUBERC LUNG D, V14, P131; van Doorn HR, 2006, CLIN MICROBIOL INFEC, V12, P769, DOI 10.1111/j.1469-0691.2006.01495.x; Van Rie A, 2001, J CLIN MICROBIOL, V39, P636, DOI 10.1128/JCM.39.2.636-641.2001; van Soolingen D, 2000, J INFECT DIS, V182, P1788, DOI 10.1086/317598; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Werngren J, 2003, J CLIN MICROBIOL, V41, P1520, DOI 10.1128/JCM.41.4.1520-1524.2003; Yates F., 1934, JR STATIST SOC     S, V1, P217, DOI DOI 10.2307/2983604; zur Wiesch PS, 2010, ANTIMICROB AGENTS CH, V54, P2085, DOI 10.1128/AAC.01460-09	64	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29108	10.1371/journal.pone.0029108	http://dx.doi.org/10.1371/journal.pone.0029108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235262	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400023
J	Cai, CX; Ashktorab, H; Pang, XW; Zhao, Y; Sha, W; Liu, YL; Gu, XB				Cai, Chunxiao; Ashktorab, Hassan; Pang, Xiaowu; Zhao, Yuan; Sha, Wei; Liu, Yulan; Gu, Xinbin			MicroRNA-211 Expression Promotes Colorectal Cancer Cell Growth In Vitro and In Vivo by Targeting Tumor Suppressor CHD5	PLOS ONE			English	Article							HYPERMETHYLATION; FAMILY; GENES	Background: Chromodomain-helicase-DNA-binding protein 5 (CHD5) is a newly identified tumor suppressor that is frequently downregulated in a variety of human cancers. Our previous work revealed that the low expression of CHD5 in colorectal cancer is correlated with CHD5 promoter CpG island hypermethylation. In this study, we investigated the effect of microRNA-211 (miR-211)-regulated CHD5 expression on colorectal tumorigenesis. Methodology/Principal Findings: miR-211 was predicted to target CHD5 by TargetScan software analysis. A stably expressing exogenous miR-211 colorectal cancer cell line (HCT-116(miR-211)) was generated using lentiviral transduction and used as a model for in vitro and in vivo studies. The expression level of miR-211 in HCT-116(miR-211) cells was upregulated by 16-fold compared to vector control cells (HCT-116(vector)). Exogenous miR-211 directly binds to the 3'-untranslated region (3'-UTR) of CHD5 mRNA, resulting in a 50% decrease in CHD5 protein level in HCT-116(miR-211) cells. The levels of cell proliferation, tumor growth, and cell migration of HCT-116(miR-211) cells were significantly higher than HCT-116(vector) cells under both in vitro and in vivo conditions, as determined using the methods of MTT, colony formation, flow cytometry, scratch assay, and tumor xenografts, respectively. In addition, we found that enforced expression of miR-211 in HCT-116 cells was able to alter p53 pathway-associated regulatory proteins, such as MDM2, Bcl-2, Bcl-xL, and Bax. Conclusion/Significance: Our results demonstrate that CHD5 is a direct target of miR-211 regulation. Enforced expression of miR-211 promotes tumor cell growth at least in part by downregulating the expression level of the CHD5 tumor suppressor. Our results provide a better understanding of the association of between miR-211-regulated CHD5 expression and CHD5 function in colorectal tumorigenesis.	[Cai, Chunxiao; Pang, Xiaowu; Liu, Yulan] Peking Univ, Peoples Hosp, Dept Gastroenterol, Beijing 100871, Peoples R China; [Cai, Chunxiao; Zhao, Yuan; Sha, Wei; Gu, Xinbin] Howard Univ, Dept Oral Pathol, Washington, DC 20059 USA; [Ashktorab, Hassan] Howard Univ, Dept Med, Washington, DC 20059 USA; [Ashktorab, Hassan; Gu, Xinbin] Howard Univ, Ctr Canc, Washington, DC 20059 USA	Peking University; Howard University; Howard University; Howard University	Cai, CX (corresponding author), Peking Univ, Peoples Hosp, Dept Gastroenterol, Beijing 100871, Peoples R China.	liuyulan@pkuph.edu.cn; xgu@howard.edu	Ashktorab, hassan/AAJ-2908-2020		National Cancer Health [CA118770, CA102681]; National Center for Research Resources, USA [RCMI 2 G12 RR003048]; NATIONAL CANCER INSTITUTE [R01CA102681, P20CA118770] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003048] Funding Source: NIH RePORTER	National Cancer Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by funding from the National Cancer Health (CA118770 and CA102681) and the National Center for Research Resources (RCMI 2 G12 RR003048), USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2006, GENE CHROMOSOME CANC, V45, P83, DOI 10.1002/gcc.20268; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Chang KW, 2008, J DENT RES, V87, P1063, DOI 10.1177/154405910808701116; Fujita T, 2008, JNCI-J NATL CANCER I, V100, P940, DOI 10.1093/jnci/djn176; Gartel AL, 2008, SEMIN CANCER BIOL, V18, P103, DOI 10.1016/j.semcancer.2008.01.008; Gorringe KL, 2008, NEOPLASIA, V10, P1253, DOI 10.1593/neo.08718; Hao YB, 2011, CANCER PREV RES, V4, P1073, DOI 10.1158/1940-6207.CAPR-10-0333; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kanellopoulou C, 2008, SEMIN CANCER BIOL, V18, P79, DOI 10.1016/j.semcancer.2008.01.002; Kim S, 2009, COMPUT BIOL CHEM, V33, P94, DOI 10.1016/j.compbiolchem.2008.07.016; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Mokarram P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007012; Mulero-Navarro S, 2008, EPIGENETICS-US, V3, P210, DOI 10.4161/epi.3.4.6610; Ozaki T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/603925; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Scholzova E, 2007, CANCER LETT, V246, P12, DOI 10.1016/j.canlet.2006.03.021; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Tang YY, 2008, CHIN J GASTROENTEROL, V17, P994; Voorhoeve PM, 2007, BBA-REV CANCER, V1775, P274, DOI 10.1016/j.bbcan.2006.11.003; Wang X, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-95; White PS, 2005, ONCOGENE, V24, P2684, DOI 10.1038/sj.onc.1208306; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b; Zhao YA, 2010, CANCER PREV RES, V3, P787, DOI 10.1158/1940-6207.CAPR-09-0243; 林泳, 2007, [中华消化杂志, Chinese Journal of Digestion], V27, P711	30	90	98	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29750	10.1371/journal.pone.0029750	http://dx.doi.org/10.1371/journal.pone.0029750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235338	Green Submitted, Green Published, gold			2022-12-27	WOS:000301123400100
J	Hossain, MS; Gresock, J; Edmonds, Y; Helm, R; Potts, M; Ramakrishnan, N				Hossain, M. Shahriar; Gresock, Joseph; Edmonds, Yvette; Helm, Richard; Potts, Malcolm; Ramakrishnan, Naren			Connecting the Dots between PubMed Abstracts	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; LITERATURE-BASED DISCOVERY; REPLICATIVE LIFE-SPAN; PYRUVATE-KINASE; TUMOR-GROWTH; HUMAN-CELLS; TYROSINE PHOSPHORYLATION; BIOMEDICAL LITERATURE; GLUTAMINE-METABOLISM; NICOTINAMIDE EXTENDS	Background: There are now a multitude of articles published in a diversity of journals providing information about genes, proteins, pathways, and diseases. Each article investigates subsets of a biological process, but to gain insight into the functioning of a system as a whole, we must integrate information from multiple publications. Particularly, unraveling relationships between extra-cellular inputs and downstream molecular response mechanisms requires integrating conclusions from diverse publications. Methodology: We present an automated approach to biological knowledge discovery from PubMed abstracts, suitable for "connecting the dots'' across the literature. We describe a storytelling algorithm that, given a start and end publication, typically with little or no overlap in content, identifies a chain of intermediate publications from one to the other, such that neighboring publications have significant content similarity. The quality of discovered stories is measured using local criteria such as the size of supporting neighborhoods for each link and the strength of individual links connecting publications, as well as global metrics of dispersion. To ensure that the story stays coherent as it meanders from one publication to another, we demonstrate the design of novel coherence and overlap filters for use as post-processing steps. Conclusions: We demonstrate the application of our storytelling algorithm to three case studies: i) a many-one study exploring relationships between multiple cellular inputs and a molecule responsible for cell-fate decisions, ii) a many-many study exploring the relationships between multiple cytokines and multiple downstream transcription factors, and iii) a one-to-one study to showcase the ability to recover a cancer related association, viz. the Warburg effect, from past literature. The storytelling pipeline helps narrow down a scientist's focus from several hundreds of thousands of relevant documents to only around a hundred stories. We argue that our approach can serve as a valuable discovery aid for hypothesis generation and connection exploration in large unstructured biological knowledge bases.	[Hossain, M. Shahriar; Gresock, Joseph; Ramakrishnan, Naren] Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA; [Edmonds, Yvette; Helm, Richard] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [Potts, Malcolm] Qatar Univ, Dept Biol & Environm Sci, Doha, Qatar	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Qatar University	Hossain, MS (corresponding author), Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA.	msh@vt.edu	Helm, Richard/N-6249-2018	Helm, Richard/0000-0001-5317-0925	Institute for Critical Technology and Applied Science; Virginia Tech; US National Science Foundation [CCF-0937133]	Institute for Critical Technology and Applied Science; Virginia Tech; US National Science Foundation(National Science Foundation (NSF))	This work is supported in part by the Institute for Critical Technology and Applied Science, Virginia Tech, and the US National Science Foundation through grant CCF-0937133. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beygelzimer A., 2006, P 23 INT C MACH LEAR, P97, DOI [DOI 10.1145/1143844.1143857, 10.1145/1143844.1143857]; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Burke J, 1999, KNOWLEDGE WEB SIMON; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Carpenter B, 2007, LING PIPE 99 99 RECA; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; CIARAMITA M, 2005, UNSUPERVISED LEARNIN, P659; Coulet Adrien, 2011, J Biomed Semantics, V2 Suppl 2, pS10, DOI 10.1186/2041-1480-2-S2-S10; Coulet A, 2010, J BIOMED INFORM, V43, P1009, DOI 10.1016/j.jbi.2010.08.005; Dang CV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe75; Daraselia N, 2004, BIOINFORMATICS, V20, P604, DOI 10.1093/bioinformatics/btg452; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Donaldson I, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-11; Friedman C, 2001, Bioinformatics, V17 Suppl 1, pS74; Gaizauskas R, 2003, BIOINFORMATICS, V19, P135, DOI 10.1093/bioinformatics/19.1.135; Garten A, 2011, HANDB EXP PHARMACOL, V203, P147, DOI 10.1007/978-3-642-17214-4_7; Ha HC, 2004, P NATL ACAD SCI USA, V101, P5087, DOI 10.1073/pnas.0306895101; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hatzivassiloglou V, 2002, INT J MED INFORM, V67, P19, DOI 10.1016/S1386-5056(02)00054-0; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hoffmann Robert, 2005, Sci STKE, V2005, ppe21, DOI 10.1126/stke.2832005pe21; Homayouni R, 2005, BIOINFORMATICS, V21, P104, DOI 10.1093/bioinformatics/bth464; Huang ML, 2004, BIOINFORMATICS, V20, P3604, DOI 10.1093/bioinformatics/bth451; Hur J, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-49; Infante J, 2007, DEMENT GERIATR COGN, V23, P215, DOI 10.1159/000099471; Jack GD, 2007, CELL SIGNAL, V19, P772, DOI 10.1016/j.cellsig.2006.10.005; Jelier R, 2005, BIOINFORMATICS, V21, P2049, DOI 10.1093/bioinformatics/bti268; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Jin Y., 2008, ACM T KNOWL DISCOV D, V2, P1, DOI DOI 10.1145/1342320.1342322; Kang HT, 2006, AGING CELL, V5, P423, DOI 10.1111/j.1474-9726.2006.00234.x; Kang HT, 2009, AGING CELL, V8, P426, DOI 10.1111/j.1474-9726.2009.00487.x; Kersey P, 2006, NAT CELL BIOL, V8, P1183, DOI 10.1038/ncb1495; Kohler J, 2006, BIOINFORMATICS, V22, P1383, DOI 10.1093/bioinformatics/btl081; Krallinger M, 2010, METHODS MOL BIOL, V593, P341, DOI 10.1007/978-1-60327-194-3_16; KUMAR D., 2006, P 12 ACM SIGKDD INT, P604; Kumar D, 2008, IEEE T KNOWL DATA EN, V20, P736, DOI 10.1109/TKDE.2008.32; Leroy G, 2003, J BIOMED INFORM, V36, P145, DOI 10.1016/S1532-0464(03)00039-X; Liekens AML, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r57; Lim CS, 2006, MECH AGEING DEV, V127, P511, DOI 10.1016/j.mad.2006.02.001; Lin FPY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-112; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; McDonald DM, 2004, BIOINFORMATICS, V20, P3370, DOI 10.1093/bioinformatics/bth409; Pan H, 2004, NUCLEIC ACIDS RES, V32, pW230, DOI 10.1093/nar/gkh484; Parida L., 2005, P 20 NAT C ART INT 1, P837; Pati A, 2008, NUCLEIC ACIDS RES, V36, pD69, DOI 10.1093/nar/gkm804; Qu Kunbin, P 2 C AS PAC BIOINF, V29, P53; Ramakrishnan C, 2008, LECT NOTES ARTIF INT, V5268, P146, DOI 10.1007/978-3-540-87696-0_15; Ramakrishnan N., 2004, P 10 ACM SIGKDD INT, DOI DOI 10.1145/1014052.1014083; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Rindflesch TC, 1999, J AM MED INFORM ASSN, P127; Rzhetsky A, 2004, J BIOMED INFORM, V37, P43, DOI 10.1016/j.jbi.2003.10.001; Saric J, 2006, BIOINFORMATICS, V22, P645, DOI 10.1093/bioinformatics/bti597; Sayers E., 2004, BUILDING CUSTOMIZED; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Sekimizu, 1998, Genome Inform Ser Workshop Genome Inform, V9, P62; Shaparenko B, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P619; Shatkay H, 2003, J COMPUT BIOL, V10, P821, DOI 10.1089/106652703322756104; Singh J, 2005, APPL ENVIRON MICROB, V71, P8752, DOI 10.1128/AEM.71.12.8752-8763.2005; Skalamera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020057; Skusa A, 2005, BRIEF BIOINFORM, V6, P263, DOI 10.1093/bib/6.3.263; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Srinivasan P, 2004, BIOINFORMATICS, V20, P290, DOI 10.1093/bioinformatics/bth914; Swanson D. R., 1991, SIGIR Forum, P280; SWANSON DR, 1986, PERSPECT BIOL MED, V30, P7; SWANSON DR, 1989, J AM SOC INFORM SCI, V40, P432, DOI 10.1002/(SICI)1097-4571(198911)40:6<432::AID-ASI5>3.0.CO;2-#; Tan P.-N., 2019, INTRO DATA MINING, V2nd ed.; Tari L, 2010, DISCOVERING DRUG DRU, V26, P547; Theodosiou T, 2008, BIOINFORMATICS, V24, P1935, DOI 10.1093/bioinformatics/btn318; van der Eijk CC, 2004, J AM SOC INF SCI TEC, V55, P436, DOI 10.1002/asi.10392; van Haagen HHHBM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007894; Wren JD, 2004, BIOINFORMATICS, V20, P389, DOI 10.1093/bioinformatics/btg421; Xu Rong, 2008, AMIA Annu Symp Proc, P820; Yu H, 2003, BIOINFORMATICS, V19, pi340, DOI 10.1093/bioinformatics/btg1047; Zaki M.J., 2005, P 11 ACM SIGKDD INT, P364, DOI DOI 10.1145/1081870.1081912; Zaki MJ, 2005, IEEE T KNOWL DATA EN, V17, P462, DOI 10.1109/TKDE.2005.60; Zelenko D, 2003, J MACH LEARN RES, V3, P1083, DOI 10.1162/153244303322533205; Zhao L., 2006, P 12 ACM SIGKDD INT, P827, DOI DOI 10.1145/1150402.1150511; Zhou D, 2008, J BIOMED INFORM, V41, P393, DOI 10.1016/j.jbi.2007.11.008	82	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29509	10.1371/journal.pone.0029509	http://dx.doi.org/10.1371/journal.pone.0029509			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235301	gold, Green Submitted, Green Published			2022-12-27	WOS:000301123400063
J	Saner, P; Loh, YY; Ong, RC; Hector, A				Saner, Philippe; Loh, Yen Yee; Ong, Robert C.; Hector, Andy			Carbon Stocks and Fluxes in Tropical Lowland Dipterocarp Rainforests in Sabah, Malaysian Borneo	PLOS ONE			English	Article							TREE BIOMASS; DEAD WOOD; DYNAMICS; DIVERSITY; EQUATIONS; DENSITY; BALANCE	Deforestation in the tropics is an important source of carbon C release to the atmosphere. To provide a sound scientific base for efforts taken to reduce emissions from deforestation and degradation (REDD+) good estimates of C stocks and fluxes are important. We present components of the C balance for selectively logged lowland tropical dipterocarp rainforest in the Malua Forest Reserve of Sabah, Malaysian Borneo. Total organic C in this area was 167.9 Mg C ha(-1)+/- 3.8 (SD), including: Total aboveground (TAGC: 55%; 91.9 Mg C ha(-1)+/- 2.9 SEM) and belowground carbon in trees (TBGC: 10%; 16.5 Mg C ha(-1)+/- 0.5 SEM), deadwood (8%; 13.2 Mg C ha(-1)+/- 3.5 SEM) and soil organic matter (SOM: 24%; 39.6 Mg C ha(-1)+/- 0.9 SEM), understory vegetation (3%; 5.1 Mg C ha(-1)+/- 1.7 SEM), standing litter (<1%; 0.7 Mg C ha(-1)+/- 0.1 SEM) and fine root biomass (<1%; 0.9 Mg C ha(-1)+/- 0.1 SEM). Fluxes included litterfall, a proxy for leaf net primary productivity (4.9 Mg C ha(-1) yr(-1)+/- 0.1 SEM), and soil respiration, a measure for heterotrophic ecosystem respiration (28.6 Mg C ha(-1) yr(-1)+/- 1.2 SEM). The missing estimates necessary to close the C balance are wood net primary productivity and autotrophic respiration. Twenty-two years after logging TAGC stocks were 28% lower compared to unlogged forest (128 Mg C ha(-1)+/- 13.4 SEM); a combined weighted average mean reduction due to selective logging of -57.8 Mg C ha(-1) (with 95% CI -75.5 to -40.2). Based on the findings we conclude that selective logging decreased the dipterocarp stock by 55-66%. Silvicultural treatments may have the potential to accelerate the recovery of dipterocarp C stocks to pre-logging levels.	[Saner, Philippe; Hector, Andy] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Loh, Yen Yee] Univ Malaysia Sabah, Sch Int Trop Forestry, Sabah, Malaysia; [Ong, Robert C.] Forest Res Ctr Inst, Sabah, Malaysia	University of Zurich; Universiti Malaysia Sabah	Saner, P (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	philippe.saner@uzh.ch	Hector, Andrew/H-4199-2011	Hector, Andrew/0000-0002-1309-7716	University of Zurich; Darwin Initiative (United Kingdom Department for Environment, Food and Rural Affairs); Royal Society [RS243]	University of Zurich; Darwin Initiative (United Kingdom Department for Environment, Food and Rural Affairs); Royal Society(Royal Society of London)	This project was funded by the University of Zurich, with financial support from the Darwin Initiative (United Kingdom Department for Environment, Food and Rural Affairs) and is part of the Royal Society South-East Asia Rainforest Research Programme (Project No. RS243). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basuki TM, 2009, FOREST ECOL MANAG, V257, P1684, DOI 10.1016/j.foreco.2009.01.027; Bennett EL, 2000, BIOL RESOURCE MANAGE, P305; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Bhagwat SA, 2008, CONSERV BIOL, V22, P1368, DOI 10.1111/j.1523-1739.2008.01026.x; Blanc L, 2009, ECOL APPL, V19, P1397, DOI 10.1890/08-1572.1; Borenstein M., 2009, INTRO METAANALYSIS; Brown S, 1997, 134 FAO FOR RES ASS; BURGHOUTS T, 1992, PHILOS T R SOC B, V335, P407, DOI 10.1098/rstb.1992.0032; Butler RA, 2009, CONSERV LETT, V2, P67, DOI 10.1111/j.1755-263X.2009.00047.x; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Chave J, 2010, BIOGEOSCIENCES, V7, P43, DOI 10.5194/bg-7-43-2010; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J., 2005, MEASURING WOOD DENSI; Clark DB, 2000, FOREST ECOL MANAG, V137, P185, DOI 10.1016/S0378-1127(99)00327-8; Delaney M, 1998, BIOTROPICA, V30, P2, DOI 10.1111/j.1744-7429.1998.tb00364.x; Edwards DP, 2010, CONSERV LETT, V3, P313, DOI 10.1111/j.1755-263X.2010.00143.x; Fearnside PM, 1997, FOREST ECOL MANAG, V90, P59, DOI 10.1016/S0378-1127(96)03840-6; Fisher B, 2011, FRONT ECOL ENVIRON, V9, P329, DOI 10.1890/100079; Gale N, 2000, CAN J FOREST RES, V30, P1489, DOI 10.1139/cjfr-30-9-1489; Green IJ, 2005, PLANT SOIL, V276, P23, DOI 10.1007/s11104-004-0331-3; Hautier Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011651; Hector A, 2011, PHILOS T R SOC B, V366, P3303, DOI 10.1098/rstb.2011.0094; Imai N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008267; Katayama A, 2009, AGR FOREST METEOROL, V149, P1666, DOI 10.1016/j.agrformet.2009.05.007; Kato R., 1978, Malayan Nature Journal, V30, P211; Ketterings QM, 2001, FOREST ECOL MANAG, V146, P199, DOI 10.1016/S0378-1127(00)00460-6; Kettle CJ, 2010, SCIENCE         0803; KIRA T, 1978, P561; Krishan G, 2009, CURR SCI INDIA, V96, P1133; Langner A, 2007, GLOBAL CHANGE BIOL, V13, P2329, DOI 10.1111/j.1365-2486.2007.01442.x; MacKinnon K., 1996, ECOLOGY KALIMANTAN, V3; Malhi Y, 2009, GLOBAL CHANGE BIOL, V15, P1255, DOI 10.1111/j.1365-2486.2008.01780.x; MARSH CW, 1992, PHILOS T ROY SOC B, V335, P331, DOI 10.1098/rstb.1992.0025; Martin AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023533; Michaelowa A, 2009, ROUTL EXPLOR ENVIRON, P130; Nabuurs GJ, 1993, CARBON FIXATION FORE; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; Niiyama K, 2010, J TROP ECOL, V26, P271, DOI 10.1017/S0266467410000040; Palace M, 2007, FOREST ECOL MANAG, V238, P309, DOI 10.1016/j.foreco.2006.10.026; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Philips O, 2002, FIELD MANUAL PLOT ES; Pinard MA, 1996, BIOTROPICA, V28, P278, DOI 10.2307/2389193; Pinard MA, 1995, THESIS U FLORIDA GAI; Proctor J., 1983, Tropical rain forest; ecology and management, P267; Pumpanen J, 2004, AGR FOREST METEOROL, V123, P159, DOI 10.1016/j.agrformet.2003.12.001; R Core Team, 2021, R LANGUAGE ENV STAT; Ruesch A., 2008, NEW IPCC TIER 1 GLOB; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Saner P, 2009, THESIS U ZURICH ZURI; Saner P, 2009, FOREST ECOL MANAG, V258, P2007, DOI 10.1016/j.foreco.2009.07.048; Scherer-Lorenzen M, 2005, ECOL STUD-ANAL SYNTH, V176, P347; Slik JWF, 2010, GLOBAL ECOL BIOGEOGR, V19, P50, DOI 10.1111/j.1466-8238.2009.00489.x; Tangki H, 2008, FOREST ECOL MANAG, V256, P1960, DOI 10.1016/j.foreco.2008.07.018; von Oheimb G, 2007, EUR J FOREST RES, V126, P359, DOI 10.1007/s10342-006-0152-4; WALKLEY A, 1947, SOIL SCI, V63, P251, DOI 10.1097/00010694-194704000-00001; Wright SJ, 2006, BIOTROPICA, V38, P287, DOI 10.1111/j.1744-7429.2006.00154.x; Yamashita T, 1995, TROPICS, V5, P57	58	76	79	4	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29642	10.1371/journal.pone.0029642	http://dx.doi.org/10.1371/journal.pone.0029642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235319	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000301123400081
J	Sangeetha, VM; Kadekar, D; Kale, VP; Limaye, LS				Sangeetha, V. M.; Kadekar, Darshana; Kale, Vaijayanti P.; Limaye, Lalita S.			Pharmacological Inhibition of Caspase and Calpain Proteases: A Novel Strategy to Enhance the Homing Responses of Cord Blood HSPCs during Expansion	PLOS ONE			English	Article							EX-VIVO EXPANSION; HEMATOPOIETIC STEM-CELL; BONE-MARROW; IN-VIVO; PERIPHERAL-BLOOD; PROGENITOR CELLS; CD34(+) CELLS; HYALURONIC-ACID; DOWN-REGULATION; ENGRAFTMENT	Background: Expansion of hematopoietic stem/progenitor cells (HSPCs) is a well-known strategy employed to facilitate the transplantation outcome. We have previously shown that the prevention of apoptosis by the inhibition of cysteine proteases, caspase and calpain played an important role in the expansion and engraftment of cord blood (CB) derived HSPCs. We hypothesize that these protease inhibitors might have maneuvered the adhesive and migratory properties of the cells rendering them to be retained in the bone marrow for sustained engraftment. The current study was aimed to investigate the mechanism of the homing responses of CB cells during expansion. Methodology/Principal Findings: CB derived CD34(+) cells were expanded using a combination of growth factors with and without Caspase inhibitor -zVADfmk or Calpain 1 inhibitor- zLLYfmk. The cells were analyzed for the expression of homing-related molecules. In vitro adhesive/migratory interactions and actin polymerization dynamics of HSPCs were assessed. In vivo homing assays were carried out in NOD/SCID mice to corroborate these observations. We observed that the presence of zVADfmk or zLLYfmk (inhibitors) caused the functional up regulation of CXCR4, integrins, and adhesion molecules, reflecting in a higher migration and adhesive interactions in vitro. The enhanced actin polymerization and the RhoGTPase protein expression complemented these observations. Furthermore, in vivo experiments showed a significantly enhanced homing to the bone marrow of NOD/SCID mice. Conclusion/Significance: Our present study reveals another novel aspect of the regulation of caspase and calpain proteases in the biology of HSPCs. The priming of the homing responses of the inhibitor-cultured HSPCs compared to the cytokine-graft suggests that the modulation of these proteases may help in overcoming the major homing defects prevalent in the expansion cultures thereby facilitating the manipulation of cells for transplant procedures.	[Sangeetha, V. M.; Kadekar, Darshana; Kale, Vaijayanti P.; Limaye, Lalita S.] Natl Ctr Cell Sci, Stem Cell Biol Lab, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Sangeetha, VM (corresponding author), Natl Ctr Cell Sci, Stem Cell Biol Lab, Pune Univ Campus, Pune, Maharashtra, India.	lslimaye@nccs.res.in	Kale, Vaijayanti/R-9342-2019; Vadakke-Madathil, Sangeetha/B-5340-2011	Kale, Vaijayanti/0000-0001-7498-7563; Vadakke-Madathil, Sangeetha/0000-0002-4948-9412	Defence Research Development Organization, Life Science Research Board (DRDO,LSRB) Govt. of India; Lady Tata Memorial Trust, Mumbai, India	Defence Research Development Organization, Life Science Research Board (DRDO,LSRB) Govt. of India; Lady Tata Memorial Trust, Mumbai, India	This work was partially supported by grants from Defence Research Development Organization, Life Science Research Board (DRDO,LSRB) Govt. of India. No additional external funding was received for this study. SVM was a recipient of fellowship from Lady Tata Memorial Trust, Mumbai, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2004, BLOOD, V103, P2079, DOI 10.1182/blood-2003-06-1770; Alenzi Faris Q., 2009, Yale Journal of Biology and Medicine, V82, P7; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Berrios VM, 2001, EXP HEMATOL, V29, P1326, DOI 10.1016/S0301-472X(01)00734-2; Bryder D, 2001, J EXP MED, V194, P941, DOI 10.1084/jem.194.7.941; Colvin GA, 2007, J CELL PHYSIOL, V211, P386, DOI 10.1002/jcp.20945; Cortesio CL, 2011, J BIOL CHEM, V286, P9998, DOI 10.1074/jbc.M110.187294; de Boer F, 2002, EXP HEMATOL, V30, P590, DOI 10.1016/S0301-472X(02)00797-X; de Lima M, 2008, BONE MARROW TRANSPL, V41, P771, DOI 10.1038/sj.bmt.1705979; Dimitroff CJ, 2000, P NATL ACAD SCI USA, V97, P13841, DOI 10.1073/pnas.250484797; Ema H, 2004, IMMUNITY, V20, P1, DOI 10.1016/S1074-7613(04)00002-0; Foguenne J, 2005, HAEMATOLOGICA, V90, P445; Foguenne J, 2009, HAEMATOL-HEMATOL J, V94, P185, DOI 10.3324/haematol.13206; Foudi A, 2006, BLOOD, V107, P2243, DOI 10.1182/blood-2005-02-0581; Giet O, 2002, BLOOD, V99, P2023, DOI 10.1182/blood.V99.6.2023; Glimm H, 2000, BLOOD, V96, P4185, DOI 10.1182/blood.V96.13.4185.h8004185_4185_4193; Gold J, 2006, EXP HEMATOL, V34, P680, DOI 10.1016/j.exphem.2006.01.016; Hart C, 2004, STEM CELLS, V22, P580, DOI 10.1634/stemcells.22-4-580; Heng BC, 2007, BIOSCIENCE REP, V27, P257, DOI 10.1007/s10540-007-9051-2; Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; Jaroscak J, 2003, BLOOD, V101, P5061, DOI 10.1182/blood-2001-12-0290; Kerre TCC, 2001, J IMMUNOL, V167, P3692, DOI 10.4049/jimmunol.167.7.3692; Koestler SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004810; Lanzkron SM, 1999, BLOOD, V93, P1916, DOI 10.1182/blood.V93.6.1916.406k15_1916_1921; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Leung KT, 2011, BLOOD, V117, P1840, DOI 10.1182/blood-2010-04-281329; Limaye LS, 2001, J HEMATOTH STEM CELL, V10, P709, DOI 10.1089/152581601753193931; Liu BL, 2003, EXP HEMATOL, V31, P824, DOI 10.1016/S0301-472X(03)00161-9; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Model MA, 1996, BIOCHEM BIOPH RES CO, V224, P516, DOI 10.1006/bbrc.1996.1058; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Nilsson SK, 1997, BLOOD, V90, P4646; Ohmori T, 2010, J BIOL CHEM, V285, P31763, DOI 10.1074/jbc.M109.099085; Oostendorp RAJ, 2000, BONE MARROW TRANSPL, V26, P559, DOI 10.1038/sj.bmt.1702536; Ramirez M, 2001, BRIT J HAEMATOL, V115, P213, DOI 10.1046/j.1365-2141.2001.03084.x; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Sangeetha VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012221; Shirvaikar N, 2011, STEM CELLS DEV, V20, P19, DOI 10.1089/scd.2010.0118; Szilvassy SJ, 2001, EXP HEMATOL, V29, P1494, DOI 10.1016/S0301-472X(01)00751-2; TEIXIDO J, 1992, J CLIN INVEST, V90, P358, DOI 10.1172/JCI115870; Traycoff CM, 1998, EXP HEMATOL, V26, P53; Tung SS, 2010, BEST PRACT RES CL HA, V23, P245, DOI 10.1016/j.beha.2010.06.004; Voermans C, 2001, EXP HEMATOL, V29, P1456, DOI 10.1016/S0301-472X(01)00740-8; Walcheck B, 2006, EUR J IMMUNOL, V36, P968, DOI 10.1002/eji.200535257; Wang Y, 2009, J IMMUNOL, V182, P2449, DOI 10.4049/jimmunol.0802770; Williams DA, 2008, METHOD ENZYMOL, V439, P365, DOI 10.1016/S0076-6879(07)00427-2; Wulf-Goldenberg A, 2008, EUR J CELL BIOL, V87, P69, DOI 10.1016/j.ejcb.2007.08.001; Wyss BK, 2009, EXP HEMATOL, V37, P814, DOI 10.1016/j.exphem.2009.03.005; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104	51	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29383	10.1371/journal.pone.0029383	http://dx.doi.org/10.1371/journal.pone.0029383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235291	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400052
J	Suyama, T; Okada, S; Ishijima, T; Iida, K; Abe, K; Nakai, Y				Suyama, Tatsuya; Okada, Shinji; Ishijima, Tomoko; Iida, Kota; Abe, Keiko; Nakai, Yuji			High Phosphorus Diet-Induced Changes in NaPi-IIb Phosphate Transporter Expression in the Rat Kidney: DNA Microarray Analysis	PLOS ONE			English	Article							P-I; DEPENDENT PHOSPHATE; GENES; COTRANSPORTERS; DISEASE; MICE; BIOINFORMATICS; RECEPTORS; KNOCKOUT; COLLAGEN	The mechanism by which phosphorus levels are maintained in the body was investigated by analyzing changes in gene expression in the rat kidney following administration of a high phosphorus (HP) diet. Male Wistar rats were divided into two groups and fed a diet containing 0.3% (control) or 1.2% (HP) phosphorous for 24 days. Phosphorous retention was not significantly increased in HP rats, but fractional excretion of phosphorus was significantly increased in the HP group compared to controls, with an excessive amount of the ingested phosphorus being passed through the body. DNA microarray analysis of kidney tissue from both groups revealed changes in gene expression profile induced by a HP diet. Among the genes that were upregulated, Gene Ontology (GO) terms related to ossification, collagen fibril organization, and inflammation and immune response were significantly enriched. In particular, there was significant upregulation of type IIb sodium-dependent phosphate transporter (NaPi-IIb) in the HP rat kidney compared to control rats. This upregulation was confirmed by in situ hybridization. Distinct signals for NaPi-IIb in both the cortex and medulla of the kidney were apparent in the HP group, while the corresponding signals were much weaker in the control group. Immunohistochemical analysis showed that NaPi-IIb localized to the basolateral side of kidney epithelial cells surrounding the urinary duct in HP rats but not in control animals. These data suggest that NaPi-IIb is upregulated in the kidney in response to the active excretion of phosphate in HP diet-fed rats.	[Suyama, Tatsuya; Okada, Shinji; Ishijima, Tomoko; Iida, Kota; Abe, Keiko; Nakai, Yuji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan	University of Tokyo	Suyama, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.	aynakai@mail.ecc.u-tokyo.ac.jp	OKADA, Shinji/AFS-7710-2022; NAKAI, Yuji/G-3433-2014	OKADA, Shinji/0000-0002-4465-9961; NAKAI, Yuji/0000-0002-2458-3875	Japan Society for the Promotion of Science [23300273]; Mishima Kaiun Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation)	This study was supported in part by a Grant-in-Aid for Scientific Research to YN (23300273), Japan Society for the Promotion of Science (URL:http://www.jsps.go.jp/english/index. html) and in part by research grants from the Mishima Kaiun Memorial Foundation (to YN, URL: http://www.mishima-kaiun.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Borza DB, 2003, SPRINGER SEMIN IMMUN, V24, P345, DOI 10.1007/s00281-002-0103; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chen ZX, 2007, BIOINFORMATICS, V23, P321, DOI 10.1093/bioinformatics/btl609; Frei P, 2005, AM J PHYSIOL-GASTR L, V288, pG771, DOI 10.1152/ajpgi.00272.2004; Friedman MS, 2006, J CELL BIOCHEM, V98, P538, DOI 10.1002/jcb.20719; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giral H, 2009, AM J PHYSIOL-RENAL, V297, pF1466, DOI 10.1152/ajprenal.00279.2009; Hartner A, 2003, J MOL MED-JMM, V81, P32, DOI 10.1007/s00109-002-0403-x; HAUT LL, 1980, KIDNEY INT, V17, P722, DOI 10.1038/ki.1980.85; Hernando N, 2000, AM J PHYSIOL-RENAL, V278, pF361, DOI 10.1152/ajprenal.2000.278.3.F361; Hilfiker H, 1998, P NATL ACAD SCI USA, V95, P14564, DOI 10.1073/pnas.95.24.14564; Hill C, 2000, ENDOCRINOLOGY, V141, P1196, DOI 10.1210/en.141.3.1196; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishibashi K, 2011, AM J PHYSIOL-REG I, V300, pR566, DOI [10.1152/ajpregu.90464.2008, 10.1007/978-94-024-1057-0_2]; Ishibashi K, 2009, CLIN EXP NEPHROL, V13, P107, DOI 10.1007/s10157-008-0118-6; Kadota K, 2009, ALGORITHM MOL BIOL, V4, DOI 10.1186/1748-7188-4-7; Kirtane AJ, 2005, J AM COLL CARDIOL, V45, P1781, DOI 10.1016/j.jacc.2005.02.068; Lake J, 2010, COMP BIOCHEM PHYS D, V5, P24, DOI 10.1016/j.cbd.2009.09.002; LEVI M, 1994, AM J PHYSIOL-RENAL, V267, pF900, DOI 10.1152/ajprenal.1994.267.5.F900; Matsuzaki H, 2007, J CLIN BIOCHEM NUTR, V41, P179, DOI 10.3164/jcbn.2007025; Miyamoto KI, 2011, J PHARM SCI-US, V100, P3719, DOI 10.1002/jps.22614; Nakai Y, 2008, BIOSCI BIOTECH BIOCH, V72, P139, DOI 10.1271/bbb.70508; Nakamura A, 2000, J EXP MED, V191, P899, DOI 10.1084/jem.191.5.899; Okada S, 2008, FASEB J, V22, P3672, DOI 10.1096/fj.08-111872; R Development Core Team, 2006, R LANG ENV STAT COMP; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Sabbagh Y, 2009, J AM SOC NEPHROL, V20, P2348, DOI 10.1681/ASN.2009050559; Segawa H, 2007, AM J PHYSIOL-RENAL, V292, pF395, DOI 10.1152/ajprenal.00100.2006; Segawa H, 2009, AM J PHYSIOL-RENAL, V297, pF671, DOI 10.1152/ajprenal.00156.2009; Shibasaki Y, 2009, BIOCHEM BIOPH RES CO, V381, P482, DOI 10.1016/j.bbrc.2009.02.067; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Takeda E, 2002, J NUTR SCI VITAMINOL, V48, P102, DOI 10.3177/jnsv.48.102; Tani Y, 2007, J CLIN BIOCHEM NUTR, V40, P221, DOI 10.3164/jcbn.40.221; Wang X, 1999, J SURG RES, V87, P194, DOI 10.1006/jsre.1999.5757; Xu YX, 2003, BIOL REPROD, V69, P1135, DOI 10.1095/biolreprod.103.018028	39	27	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29483	10.1371/journal.pone.0029483	http://dx.doi.org/10.1371/journal.pone.0029483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235299	gold, Green Submitted, Green Published			2022-12-27	WOS:000301123400061
J	Swatantran, A; Dubayah, R; Goetz, S; Hofton, M; Betts, MG; Sun, M; Simard, M; Holmes, R				Swatantran, Anu; Dubayah, Ralph; Goetz, Scott; Hofton, Michelle; Betts, Matthew G.; Sun, Mindy; Simard, Marc; Holmes, Richard			Mapping Migratory Bird Prevalence Using Remote Sensing Data Fusion	PLOS ONE			English	Article							SMALL-FOOTPRINT LIDAR; VEGETATION STRUCTURE; QUANTILE REGRESSION; FOLIAGE STRUCTURE; DECIDUOUS FOREST; HABITAT; CLASSIFICATION; VOLUME; HETEROGENEITY; ABUNDANCE	Background: Improved maps of species distributions are important for effective management of wildlife under increasing anthropogenic pressures. Recent advances in lidar and radar remote sensing have shown considerable potential for mapping forest structure and habitat characteristics across landscapes. However, their relative efficacies and integrated use in habitat mapping remain largely unexplored. We evaluated the use of lidar, radar and multispectral remote sensing data in predicting multi-year bird detections or prevalence for 8 migratory songbird species in the unfragmented temperate deciduous forests of New Hampshire, USA. Methodology and Principal Findings: A set of 104 predictor variables describing vegetation vertical structure and variability from lidar, phenology from multispectral data and backscatter properties from radar data were derived. We tested the accuracies of these variables in predicting prevalence using Random Forests regression models. All data sets showed more than 30% predictive power with radar models having the lowest and multi-sensor synergy ("fusion'') models having highest accuracies. Fusion explained between 54% and 75% variance in prevalence for all the birds considered. Stem density from discrete return lidar and phenology from multispectral data were among the best predictors. Further analysis revealed different relationships between the remote sensing metrics and bird prevalence. Spatial maps of prevalence were consistent with known habitat preferences for the bird species. Conclusion and Significance: Our results highlight the potential of integrating multiple remote sensing data sets using machine-learning methods to improve habitat mapping. Multi-dimensional habitat structure maps such as those generated from this study can significantly advance forest management and ecological research by facilitating fine-scale studies at both stand and landscape level.	[Swatantran, Anu; Dubayah, Ralph; Hofton, Michelle] Univ Maryland, College Pk, MD 20742 USA; [Goetz, Scott; Sun, Mindy] Woods Hole Res Ctr, Falmouth, MA USA; [Betts, Matthew G.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Simard, Marc] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Holmes, Richard] Dartmouth Coll, Hanover, NH 03755 USA	University System of Maryland; University of Maryland College Park; Woods Hole Research Center; Oregon State University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Dartmouth College	Swatantran, A (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	aswatan@umd.edu	Beckley, Matthew/D-4547-2013; Hofton, Michelle/A-1186-2019; Betts, Matthew G/Q-2978-2019; Goetz, Scott J/A-3393-2015; Simard, Marc/H-3516-2013; Swatantran, Anu/B-8786-2016	Betts, Matthew G/0000-0002-7100-2551; Goetz, Scott J/0000-0002-6326-4308; Simard, Marc/0000-0002-9442-4562; 	NASA [NNX08AP55G, NNX09AK20G]; National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF))	The avian ecology research at HBEF has been supported primarily by multiple grants from the National Science Foundation. Dr. Swatantran, Dr. Dubayah, Dr. Goetz and Dr. Simard were supported by grants from NASA's Terrestrial Ecology and Biodiversity Programs (NASA Grants http://www.nasa.gov/ NNX08AP55G; NNX09AK20G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J, 2006, REMOTE SENS ENVIRON, V105, P248, DOI 10.1016/j.rse.2006.07.001; Antonarakis AS, 2011, ECOL APPL, V21, P1120, DOI 10.1890/10-0274.1; Bergen KM, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000883; Bergen KM, 2007, ECOL INFORM, V2, P9, DOI 10.1016/j.ecoinf.2007.01.001; Berk R, 2008, INTRO STAT LEARNING, P1; Betts MG, 2008, ECOGRAPHY, V31, P592, DOI 10.1111/j.0906-7590.2008.05490.x; Betts MG, 2006, ECOL MODEL, V191, P197, DOI 10.1016/j.ecolmodel.2005.04.027; Blair JB, 1999, ISPRS J PHOTOGRAMM, V54, P115, DOI 10.1016/S0924-2716(99)00002-7; Bradbury RB, 2005, IBIS, V147, P443, DOI 10.1111/j.1474-919x.2005.00438.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cablk ME, 2002, PREDICTING SPECIES O; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Caillaud D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015002; Clark ML, 2004, REMOTE SENS ENVIRON, V91, P68, DOI 10.1016/j.rse.2004.02.008; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; DeGraaf RM, 1998, FOREST ECOL MANAG, V103, P217, DOI 10.1016/S0378-1127(97)00213-2; Doran PJ, 2005, CAN J ZOOL, V83, P1297, DOI 10.1139/Z05-127; Doran PJ, 2003, THESIS DARTMOUTH COL; Drake JB, 2002, REMOTE SENS ENVIRON, V79, P305, DOI 10.1016/S0034-4257(01)00281-4; Dubayah RO, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG000933; Dubayah RO, 2000, J FOREST, V98, P44; Fahey TJ, 2005, BIOGEOCHEMISTRY, V75, P109, DOI 10.1007/s10533-004-6321-y; Goetz S, 2007, REMOTE SENS ENVIRON, V108, P254, DOI 10.1016/j.rse.2006.11.016; Goetz SJ, 2010, ECOLOGY, V91, P1569, DOI 10.1890/09-1670.1; Goetz SJ, 1997, INT J REMOTE SENS, V18, P71, DOI 10.1080/014311697219286; Goncalves FG, 2011, INT J REMOTE SENS, V32, P503, DOI 10.1080/01431160903475217; Gustafson EJ, 1998, ECOSYSTEMS, V1, P143, DOI 10.1007/s100219900011; Hall DL, 1997, P IEEE, V85, P6, DOI 10.1109/5.554205; Holmes RT, 2011, FOREST ECOL MANAG, V262, P20, DOI 10.1016/j.foreco.2010.06.021; Holmes RT, 2001, AUK, V118, P589, DOI 10.1642/0004-8038(2001)118[0589:TYBPTI]2.0.CO;2; HOLMES RT, 1979, ECOLOGY, V60, P512, DOI 10.2307/1936071; Hyde P, 2006, REMOTE SENS ENVIRON, V102, P63, DOI 10.1016/j.rse.2006.01.021; Imhoff ML, 1997, REMOTE SENS ENVIRON, V60, P217, DOI 10.1016/S0034-4257(96)00116-2; Lefsky MA, 2002, BIOSCIENCE, V52, P19, DOI 10.1641/0006-3568(2002)052[0019:LRSFES]2.0.CO;2; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Magness DR, 2008, STUD COMPUT INTELL, V122, P209; McDermid GJ, 2005, PROG PHYS GEOG, V29, P449, DOI 10.1191/0309133305pp455ra; Meinshausen N, 2006, J MACH LEARN RES, V7, P983; Moody A, 2001, REMOTE SENS ENVIRON, V75, P305, DOI 10.1016/S0034-4257(00)00175-9; Ni-Meister W, 2001, IEEE T GEOSCI REMOTE, V39, P1943, DOI 10.1109/36.951085; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Pang Y, 2008, CAN J REMOTE SENS, V34, pS471, DOI 10.5589/m08-074; Pohl C, 1998, INT J REMOTE SENS, V19, P823, DOI 10.1080/014311698215748; Popescu SC, 2003, CAN J REMOTE SENS, V29, P564, DOI 10.5589/m03-027; Popescu SC, 2004, FOREST SCI, V50, P551; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Ralph JC, 1995, PSWGTR149; ROBINSON SK, 1984, AUK, V101, P672, DOI 10.2307/4086894; Rosen PA, 2006, IEEE RAD CONF, P22, DOI 10.1109/RADAR.2006.1631770; Saatchi SS, 2000, IEEE T GEOSCI REMOTE, V38, P697, DOI 10.1109/36.841999; Schwarz PA, 2003, ECOLOGY, V84, P1862, DOI 10.1890/0012-9658(2003)084[1862:FCSVOT]2.0.CO;2; Schwarz PA, 2001, FOREST ECOL MANAG, V144, P201, DOI 10.1016/S0378-1127(00)00371-6; Simental E, 2005, PEC 16 GLOB PRIOR LA; Treuhaft RN, 2004, BIOSCIENCE, V54, P561, DOI 10.1641/0006-3568(2004)054[0561:FAFRIS]2.0.CO;2; Vierling KT, 2008, FRONT ECOL ENVIRON, V6, P90, DOI 10.1890/070001; Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323; Whelan CJ, 2001, ECOLOGY, V82, P219, DOI 10.1890/0012-9658(2001)082[0219:FSIFOI]2.0.CO;2; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016	59	53	54	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28922	10.1371/journal.pone.0028922	http://dx.doi.org/10.1371/journal.pone.0028922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235254	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400015
J	Vinopal, S; Cernohorska, M; Sulimenko, V; Sulimenko, T; Vosecka, V; Flemr, M; Draberova, E; Draber, P				Vinopal, Stanislav; Cernohorska, Marketa; Sulimenko, Vadym; Sulimenko, Tetyana; Vosecka, Vera; Flemr, Matyas; Draberova, Eduarda; Draber, Pavel			gamma-Tubulin 2 Nucleates Microtubules and Is Downregulated in Mouse Early Embryogenesis	PLOS ONE			English	Article							CELL-CYCLE; DIFFERENTIAL EXPRESSION; CHROMOSOME SEGREGATION; PROTEIN COMPLEXES; RING COMPLEX; RECRUITMENT; CENTROSOME; DUPLICATION; GENERATION; MATURATION	gamma-Tubulin is the key protein for microtubule nucleation. Duplication of the gamma-tubulin gene occurred several times during evolution, and in mammals gamma-tubulin genes encode proteins which share similar to 97% sequence identity. Previous analysis of Tubg1 and Tubg2 knock-out mice has suggested that gamma-tubulins are not functionally equivalent. Tubg1 knock-out mice died at the blastocyst stage, whereas Tubg2 knock-out mice developed normally and were fertile. It was proposed that gamma-tubulin 1 represents ubiquitous gamma-tubulin, while gamma-tubulin 2 may have some specific functions and cannot substitute for gamma-tubulin 1 deficiency in blastocysts. The molecular basis of the suggested functional difference between gamma-tubulins remains unknown. Here we show that exogenous gamma-tubulin 2 is targeted to centrosomes and interacts with gamma-tubulin complex proteins 2 and 4. Depletion of gamma-tubulin 1 by RNAi in U2OS cells causes impaired microtubule nucleation and metaphase arrest. Wild-type phenotype in gamma-tubulin 1-depleted cells is restored by expression of exogenous mouse or human gamma-tubulin 2. Further, we show at both mRNA and protein levels using RT-qPCR and 2D-PAGE, respectively, that in contrast to Tubg1, the Tubg2 expression is dramatically reduced in mouse blastocysts. This indicates that gamma-tubulin 2 cannot rescue gamma-tubulin 1 deficiency in knock-out blastocysts, owing to its very low amount. The combined data suggest that gamma-tubulin 2 is able to nucleate microtubules and substitute for gamma-tubulin 1. We propose that mammalian gamma-tubulins are functionally redundant with respect to the nucleation activity.	[Vinopal, Stanislav; Cernohorska, Marketa; Sulimenko, Vadym; Sulimenko, Tetyana; Vosecka, Vera; Draberova, Eduarda; Draber, Pavel] Acad Sci Czech Republ, Inst Mol Genet, Dept Biol Cytoskeleton, Prague, Czech Republic; [Flemr, Matyas] Acad Sci Czech Republ, Inst Mol Genet, Dept Epigenet Regulat, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Vinopal, S (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Dept Biol Cytoskeleton, Prague, Czech Republic.	paveldra@img.cas.cz	Draber, Pavel/C-7735-2012; Vinopal, Stanislav/GLR-3200-2022; Sulimenko, Vadym/E-8215-2012; Cernohorska, Marketa/J-4199-2014; Vinopal, Stanislav/ABG-4322-2021; Draberova, Eduarda/G-3547-2014; Sulimenko, Vadym/G-3549-2014; Cernohorska, Marketa Schmidt/AAB-5448-2020	Vinopal, Stanislav/0000-0001-9352-4580; Cernohorska, Marketa Schmidt/0000-0001-9053-8928; Sulimenko, Vadym/0000-0003-2153-4485; Draber, Pavel/0000-0001-9625-5013	Grant Agency of the Czech Republic [204/09/H084, 204/09/1777, P302/10/1759]; Ministry of Education, Youth and Sports of the Czech Republic [LC545, 1M6837805001]; Grant Agency of the Czech Academy of Sciences [KAN200520701]; Grant Agency of Charles University [11109]; Institutional Research Support Grant [AVOZ50520514]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Academy of Sciences(Grant Agency of the Czech Republic); Grant Agency of Charles University; Institutional Research Support Grant	This work was supported in part by Grants 204/09/H084 (SV, MC.), 204/09/1777 (PD), and P302/10/1759 (ED) from the Grant Agency of the Czech Republic, Grants LC545 (TS) and 1M6837805001 (VV) from Ministry of Education, Youth and Sports of the Czech Republic, KAN200520701 (VS) from the Grant Agency of the Czech Academy of Sciences, Grant 11109 from the Grant Agency of Charles University (SV), and by the Institutional Research Support Grant AVOZ50520514 (PD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouissou A, 2009, J CELL BIOL, V187, P327, DOI 10.1083/jcb.200905060; Carson AR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-156; Cuschieri L, 2006, MOL BIOL CELL, V17, P4420, DOI 10.1091/mbc.E06-03-0245; Dammermann A, 2008, J CELL BIOL, V180, P771, DOI 10.1083/jcb.200709102; DeLuna A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000347; DRABER P, 1991, ELECTROPHORESIS, V12, P453, DOI 10.1002/elps.1150120617; DRABEROVA E, 1993, J CELL SCI, V106, P1263; Draberova E, 1999, FOLIA BIOL-PRAGUE, V45, P163; Guillet V, 2011, NAT STRUCT MOL BIOL, V18, P915, DOI 10.1038/nsmb.2083; Hajkova Z, 2011, J IMMUNOL, V186, P913, DOI 10.4049/jimmunol.1002074; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Hendrickson TW, 2001, MOL BIOL CELL, V12, P2469, DOI 10.1091/mbc.12.8.2469; Horejsi B, 2012, J CELL PHYSIOL, V227, P367, DOI 10.1002/jcp.22772; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; JOSHI HC, 1992, NATURE, V356, P80, DOI 10.1038/356080a0; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Katsetos CD, 2006, J NEUROPATH EXP NEUR, V65, P465, DOI 10.1097/01.jnen.0000229235.20995.6e; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kollman JM, 2010, NATURE, V466, P879, DOI 10.1038/nature09207; Kukharskyy V, 2004, EXP CELL RES, V298, P218, DOI 10.1016/j.yexcr.2004.04.016; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lam EWF, 2000, J BIOL CHEM, V275, P3479, DOI 10.1074/jbc.275.5.3479; LIU B, 1994, PLANT CELL, V6, P303, DOI 10.1105/tpc.6.2.303; Loh JK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-268; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Lynch M, 2000, GENETICS, V154, P459; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; Moudjou M, 1996, J CELL SCI, V109, P875; Nayak T, 2010, J CELL BIOL, V190, P317, DOI 10.1083/jcb.201002105; Novakova M, 1996, CELL MOTIL CYTOSKEL, V33, P38, DOI 10.1002/(SICI)1097-0169(1996)33:1<38::AID-CM5>3.0.CO;2-E; OAKLEY BR, 1990, CELL, V61, P1289, DOI 10.1016/0092-8674(90)90693-9; Piehl M, 2004, P NATL ACAD SCI USA, V101, P1584, DOI 10.1073/pnas.0308205100; PIKO L, 1982, DEV BIOL, V89, P362, DOI 10.1016/0012-1606(82)90325-6; Raynaud-Messina B, 2007, CURR OPIN CELL BIOL, V19, P24, DOI 10.1016/j.ceb.2006.12.008; Rodriguez AS, 2008, CELL CYCLE, V7, P1246, DOI 10.4161/cc.7.9.5808; Ruiz F, 1999, CURR BIOL, V9, P43, DOI 10.1016/S0960-9822(99)80045-1; SCHULTZ RM, 1977, J CELL SCI, V24, P167; SELLENS MH, 1981, J REPROD FERTIL, V61, P307, DOI 10.1530/jrf.0.0610307; STEARNS T, 1991, CELL, V65, P825, DOI 10.1016/0092-8674(91)90390-K; Sulimenko V, 2002, BIOCHEM J, V365, P889, DOI 10.1042/BJ20020175; Tan M, 1998, GENE, V210, P53, DOI 10.1016/S0378-1119(98)00068-7; Uehara R, 2010, J CELL BIOL, V191, P259, DOI 10.1083/jcb.201004150; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Wilson PG, 1997, DEV BIOL, V184, P207, DOI 10.1006/dbio.1997.8545; Wise DO, 2000, GENOMICS, V67, P164, DOI 10.1006/geno.2000.6247; Yuba-Kubo A, 2005, DEV BIOL, V282, P361, DOI 10.1016/j.ydbio.2005.03.031; Zimmerman S, 2005, MOL BIOL CELL, V16, P2719, DOI 10.1091/mbc.E04-08-0676	50	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29919	10.1371/journal.pone.0029919	http://dx.doi.org/10.1371/journal.pone.0029919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235350	gold, Green Submitted, Green Published			2022-12-27	WOS:000301123400112
J	Muszewska, A; Hoffman-Sommer, M; Grynberg, M				Muszewska, Anna; Hoffman-Sommer, Marta; Grynberg, Marcin			LTR Retrotransposons in Fungi	PLOS ONE			English	Article							GENOME SEQUENCE; TRANSPOSABLE ELEMENTS; CHAETOMIUM-GLOBOSUM; EVOLUTION; INSIGHTS; FAMILIES; TOOL; TRANSCRIPTOME; TRANSPOSITION; MECHANISMS	Transposable elements with long terminal direct repeats (LTR TEs) are one of the best studied groups of mobile elements. They are ubiquitous elements present in almost all eukaryotic genomes. Their number and state of conservation can be a highlight of genome dynamics. We searched all published fungal genomes for LTR-containing retrotransposons, including both complete, functional elements and remnant copies. We identified a total of over 66,000 elements, all of which belong to the Ty1/Copia or Ty3/Gypsy superfamilies. Most of the detected Gypsy elements represent Chromoviridae, i.e. they carry a chromodomain in the pol ORF. We analyzed our data from a genome-ecology perspective, looking at the abundance of various types of LTR TEs in individual genomes and at the highest-copy element from each genome. The TE content is very variable among the analyzed genomes. Some genomes are very scarce in LTR TEs (<50 elements), others demonstrate huge expansions (>8000 elements). The data shows that transposon expansions in fungi usually involve an increase both in the copy number of individual elements and in the number of element types. The majority of the highest-copy TEs from all genomes are Ty3/Gypsy transposons. Phylogenetic analysis of these elements suggests that TE expansions have appeared independently of each other, in distant genomes and at different taxonomical levels. We also analyzed the evolutionary relationships between protein domains encoded by the transposon pol ORF and we found that the protease is the fastest evolving domain whereas reverse transcriptase and RNase H evolve much slower and in correlation with each other.	[Muszewska, Anna; Hoffman-Sommer, Marta; Grynberg, Marcin] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Muszewska, A (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	musze@icm.edu.pl	Muszewska, Anna/S-9406-2019	Muszewska, Anna/0000-0002-4578-844X; Hoffman-Sommer, Marta/0000-0002-1451-5967; Grynberg, Marcin/0000-0003-1887-7209				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Baker SE, 2006, MED MYCOL, V44, pS17, DOI 10.1080/13693780600921037; Balajee SA, 2009, MED MYCOL, V47, pS42, DOI 10.1080/13693780802562092; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blandin G, 2000, FEBS LETT, V487, P91, DOI 10.1016/S0014-5793(00)02287-0; Bruckner S, 2012, FEMS MICROBIOL REV, V36, P25, DOI 10.1111/j.1574-6976.2011.00275.x; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; CAMERON JR, 1979, CELL, V16, P739, DOI 10.1016/0092-8674(79)90090-4; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Capy P, 1997, GENETICA, V100, P63, DOI 10.1023/A:1018300721953; Chaturvedi V, 2011, TRENDS MICROBIOL, V19, P564, DOI 10.1016/j.tim.2011.07.010; Chicas A, 2004, NUCLEIC ACIDS RES, V32, P4237, DOI 10.1093/nar/gkh764; Cleveland TE, 2009, TRENDS BIOTECHNOL, V27, P151, DOI 10.1016/j.tibtech.2008.11.008; Clutterbuck AJ, 2011, FUNGAL GENET BIOL, V48, P306, DOI 10.1016/j.fgb.2010.09.002; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Craig NL, 2002, MOBILE DNA, pxviii; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Daboussi MJ, 2003, ANNU REV MICROBIOL, V57, P275, DOI 10.1146/annurev.micro.57.030502.091029; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Desnos-Ollivier M, 2008, J CLIN MICROBIOL, V46, P3237, DOI 10.1128/JCM.01451-08; Dobinson K F, 1993, Trends Microbiol, V1, P348, DOI 10.1016/0966-842X(93)90076-4; Dorn B, 2011, J APPL MICROBIOL, V111, P693, DOI 10.1111/j.1365-2672.2011.05091.x; Dutta Shuchismita, 2007, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0109s20; Eddy Sean R, 2009, Genome Inform, V23, P205; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Favel A, 2003, DIAGN MICR INFEC DIS, V47, P331, DOI 10.1016/S0732-8893(03)00094-4; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Gao X, 2008, GENOME RES, V18, P359, DOI 10.1101/gr.7146408; Goodwin SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002070; Gorinsek B, 2004, MOL BIOL EVOL, V21, P781, DOI 10.1093/molbev/msh057; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hughes SE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000233; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kapitonov VV, 2007, TRENDS GENET, V23, P521, DOI 10.1016/j.tig.2007.08.004; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kejnovsky E, 2006, MOL GENET GENOMICS, V276, P254, DOI 10.1007/s00438-006-0140-x; Kordis D, 2005, GENE, V347, P161, DOI 10.1016/j.gene.2004.12.017; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Lannoo MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022211; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Llorens C, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-3; Llorens C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-276; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P374, DOI 10.1128/JCM.01790-07; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; Malik HS, 2005, CYTOGENET GENOME RES, V110, P392, DOI 10.1159/000084971; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Morse AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004332; Nakayashiki H, 1999, GENETICS, V153, P693; Neuveglise C, 2002, GENOME RES, V12, P930, DOI 10.1101/gr.219202; NORTHAM BE, 1951, J GEN MICROBIOL, V5, P502, DOI 10.1099/00221287-5-3-502; Novikova O S, 2010, Genetika, V46, P725; Nowacki M, 2009, SCIENCE, V324, P935, DOI 10.1126/science.1170023; Oliver RP, 2010, CURR OPIN PLANT BIOL, V13, P415, DOI 10.1016/j.pbi.2010.05.003; Olson Sue A, 2002, Brief Bioinform, V3, P87, DOI 10.1093/bib/3.1.87; Pantou MP, 2008, GENE, V419, P7, DOI 10.1016/j.gene.2008.04.009; Paoletti M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-223; Pelizza SA, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.7001; Piriyapongsa J, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-31; Plett JM, 2011, TRENDS GENET, V27, P14, DOI 10.1016/j.tig.2010.10.005; Pritham EJ, 2007, GENE, V390, P3, DOI 10.1016/j.gene.2006.08.008; Rachidi N, 1999, MOL GEN GENET, V261, P841, DOI 10.1007/s004380050028; Reissinger A, 2003, MYCOL RES, V107, P1094, DOI 10.1017/S0953756203008189; Replansky T, 2008, TRENDS ECOL EVOL, V23, P494, DOI 10.1016/j.tree.2008.05.005; Rokas A, 2009, TRENDS GENET, V25, P60, DOI 10.1016/j.tig.2008.11.003; Sasaki T, 2008, P NATL ACAD SCI USA, V105, P4220, DOI 10.1073/pnas.0709398105; SCHMIDBERGER N, 1994, J BACTERIOL, V176, P2477, DOI 10.1128/JB.176.9.2477-2482.1994; Sharpton TJ, 2009, GENOME RES, V19, P1722, DOI 10.1101/gr.087551.108; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Turgeon BG, 2007, ADV GENET, V57, P219, DOI 10.1016/S0065-2660(06)57006-3; Wang XY, 2010, GENE DEV, V24, P2566, DOI 10.1101/gad.1970910; Wicker T, 2007, GENOME RES, V17, P1072, DOI 10.1101/gr.6214107; Windhofer F, 2000, CURR GENET, V37, P194, DOI 10.1007/s002940050519; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yu J, 2006, MED MYCOL, V44, P541, DOI 10.1080/13693780500525235; Yukawa M., 1931, B SCI FALKULTATO TER, V4, P218; Zemojtel T, 2009, TRENDS GENET, V25, P63, DOI 10.1016/j.tig.2008.11.005	88	63	69	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29425	10.1371/journal.pone.0029425	http://dx.doi.org/10.1371/journal.pone.0029425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242120	gold, Green Published, Green Submitted			2022-12-27	WOS:000300677000032
J	Qiao, SL; Jiang, ZZ; Tian, XH; Wang, R; Xing, GX; Wan, B; Bao, DK; Liu, YH; Hao, HF; Guo, JQ; Zhang, GP				Qiao, Songlin; Jiang, Zhizheng; Tian, Xiaohui; Wang, Rui; Xing, Guangxu; Wan, Bo; Bao, Dengke; Liu, Yonghui; Hao, Huifang; Guo, Junqing; Zhang, Gaiping			Porcine Fc gamma RIIb Mediates Enhancement of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Infection	PLOS ONE			English	Article							ANTIBODY-DEPENDENT ENHANCEMENT; ROSS RIVER VIRUS; DENGUE VIRUS; LELYSTAD VIRUS; PIGS; DISEASE; SWINE; MECHANISMS; EXPRESSION; RECEPTORS	Antibody-dependent enhancement (ADE) of virus infection caused by the uptake of virus-antibody complexes by Fc gamma Rs is a significant obstacle to the development of effective vaccines to control certain human and animal viral diseases. The activation Fc gamma Rs, including Fc gamma RI and Fc gamma RIIa have been shown to mediate ADE infection of virus. In the present paper, we showed that pocine Fc gamma RIIb, an inhibitory Fc gamma R, mediates ADE of PRRSV infection. Stable Marc-145 cell lines expressing poFc gamma RIIb (Marc-poFc gamma RII) were established. The relative yield of progeny virus was significantly increased in the presence of sub-neutralization anti-PRRSV antibody. The Fab fragment and normal porcine sera had no effect. Anti-poFc gamma RII antibody inhibited the enhancement of infection when cells were infected in the presence of anti-PRRSV antibody, but not when cells were infected in the absence of antibody. These results indicate that enhancement of infection in these cells by anti-PRRSV virus antibody is Fc gamma RII-mediated. Identification of the inhibitory Fc gamma R mediating ADE infection should expand our understanding of the mechanisms of pathogenesis for a broad range of infectious diseases and may open many approaches for improvements to the treatment and prevention of such diseases.	[Qiao, Songlin; Jiang, Zhizheng; Tian, Xiaohui; Wang, Rui; Xing, Guangxu; Wan, Bo; Bao, Dengke; Liu, Yonghui; Hao, Huifang; Guo, Junqing; Zhang, Gaiping] Henan Acad Agr Sci, Key Lab Anim Immunol, Minist Agr, Henan Prov Key Lab Anim Immunol, Zhengzhou, Peoples R China	Henan Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Qiao, SL (corresponding author), Henan Acad Agr Sci, Key Lab Anim Immunol, Minist Agr, Henan Prov Key Lab Anim Immunol, Zhengzhou, Peoples R China.	zhanggaiping2003@yahoo.com.cn	Liu, Yong/GWQ-6163-2022	Qiao, Songlin/0000-0001-9731-4943	National Natural Science Foundation of China [30730068, 31072122]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 30730068 and 31072122) (http://www.nsfc.gov.cn/Portal0/default106.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHRISTIANSON WT, 1993, CAN J VET RES, V57, P262; COLLINS JE, 1992, J VET DIAGN INVEST, V4, P117, DOI 10.1177/104063879200400201; Duan X, 1997, VET MICROBIOL, V56, P9, DOI 10.1016/S0378-1135(96)01347-8; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; KONTNY U, 1988, J VIROL, V62, P3928, DOI 10.1128/JVI.62.11.3928-3933.1988; Lemke CD, 2004, J IMMUNOL, V172, P1916, DOI 10.4049/jimmunol.172.3.1916; Lidbury BA, 2000, J VIROL, V74, P8376, DOI 10.1128/JVI.74.18.8376-8381.2000; LITTAUA R, 1990, J IMMUNOL, V144, P3183; Mahalingam S, 2002, P NATL ACAD SCI USA, V99, P13819, DOI 10.1073/pnas.202415999; Mateu E, 2008, VET J, V177, P345, DOI 10.1016/j.tvjl.2007.05.022; MEULENBERG JJM, 1993, VIROLOGY, V192, P62, DOI 10.1006/viro.1993.1008; Meyer K, 2008, J VIROL, V82, P2140, DOI 10.1128/JVI.01867-07; Mulupuri P, 2008, J VIROL, V82, P358, DOI 10.1128/JVI.01023-07; Murtaugh MP, 2002, VIRAL IMMUNOL, V15, P533, DOI 10.1089/088282402320914485; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nimmerjahn F, IMMUNOL REV, V236, P265; Qiao SL, 2006, VET IMMUNOL IMMUNOP, V114, P178, DOI 10.1016/j.vetimm.2006.06.012; Qiao SL, 2011, VET MICROBIOL, V149, P213, DOI 10.1016/j.vetmic.2010.11.006; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Rodrigo WWSI, 2006, J VIROL, V80, P10128, DOI 10.1128/JVI.00792-06; Shibata I, 1998, J VET MED SCI, V60, P1285, DOI 10.1292/jvms.60.1285; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Tian XH, 2009, PROTEIN EXPRES PURIF, V68, P12, DOI 10.1016/j.pep.2009.06.020; Tirado SMC, 2003, VIRAL IMMUNOL, V16, P69, DOI 10.1089/088282403763635465; Ubol S, 2010, CLIN VACCINE IMMUNOL, V17, P1829, DOI 10.1128/CVI.00316-10; Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Yoon KJ, 1997, VET MICROBIOL, V55, P277, DOI 10.1016/S0378-1135(96)01338-7; Yoon KJ, 1996, VIRAL IMMUNOL, V9, P51, DOI 10.1089/vim.1996.9.51	29	20	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e28721	10.1371/journal.pone.0028721	http://dx.doi.org/10.1371/journal.pone.0028721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220194	Green Submitted, Green Published, gold			2022-12-27	WOS:000300677000006
J	Castillo-Gomez, E; Varea, E; Blasco-Ibanez, JM; Crespo, C; Nacher, J				Castillo-Gomez, Esther; Varea, Emilio; Miguel Blasco-Ibanez, Jose; Crespo, Carlos; Nacher, Juan			Polysialic Acid Is Required for Dopamine D2 Receptor-Mediated Plasticity Involving Inhibitory Circuits of the Rat Medial Prefrontal Cortex	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; PSA-NCAM EXPRESSION; ADULT-RAT; GABAERGIC INTERNEURONS; STRUCTURAL PLASTICITY; SCHIZOPHRENIA; NEURONS; ASSOCIATION; INVOLVEMENT; INCREASES	Decreased expression of dopamine D2 receptors (D2R), dysfunction of inhibitory neurotransmission and impairments in the structure and connectivity of neurons in the medial prefrontal cortex (mPFC) are involved in the pathogenesis of schizophrenia and major depression, but the relationship between these changes remains unclear. The polysialylated form of the neural cell adhesion molecule (PSA-NCAM), a plasticity-related molecule, may serve as a link. This molecule is expressed in cortical interneurons and dopamine, via D2R, modulates its expression in parallel to that of proteins related to synapses and inhibitory neurotransmission, suggesting that D2R-targeted antipsychotics/antidepressants may act by affecting the plasticity of mPFC inhibitory circuits. To understand the role of PSA-NCAM in this plasticity, rats were chronically treated with a D2R agonist (PPHT) after cortical PSA depletion. PPHT-induced increases in GAD67 and synaptophysin (SYN) neuropil expression were blocked when PSA was previously removed, indicating a role for PSA-NCAM in this plasticity. The number of PSA-NCAM expressing interneuron somata also increased after PPHT treatment, but the percentages of these cells belonging to different interneuronal subpopulations did not change. Cortical pyramidal neurons did not express PSA-NCAM, but puncta co-expressing this molecule and parvalbumin could be found surrounding their somata. PPHT treatment increased the number of PSA-NCAM and parvalbumin expressing perisomatic puncta, but decreased the percentage of parvalbumin puncta that co-expressed SYN. PSA depletion did not block these effects on the perisomatic region, but increased further the number of parvalbumin expressing puncta and increased the percentage of puncta co-expressing SYN and parvalbumin, suggesting that the polysialylation of NCAM may regulate perisomatic inhibition of mPFC principal neurons. Summarizing, the present results indicate that dopamine acting on D2R influences structural plasticity of mPFC interneurons and point to PSA-NCAM as a key player in this remodeling.	[Castillo-Gomez, Esther; Varea, Emilio; Miguel Blasco-Ibanez, Jose; Crespo, Carlos; Nacher, Juan] Univ Valencia, Neurobiol Unit, Valencia, Spain; [Castillo-Gomez, Esther; Varea, Emilio; Miguel Blasco-Ibanez, Jose; Crespo, Carlos; Nacher, Juan] Univ Valencia, Program Basic & Appl Neurosci, Dept Cell Biol, Valencia, Spain; [Castillo-Gomez, Esther; Varea, Emilio; Miguel Blasco-Ibanez, Jose; Crespo, Carlos; Nacher, Juan] INCLIVA, Fdn Invest Hosp Clin Valencia, Valencia, Spain	University of Valencia; University of Valencia	Castillo-Gomez, E (corresponding author), Univ Valencia, Neurobiol Unit, Valencia, Spain.	nacher@uv.es	Blasco Ibáñez, Jose Miguel/H-9164-2015; Varea, Emilio/ABF-6367-2021; CASTILLO-GÓMEZ, ESTHER/ABG-2340-2020; Nacher, Juan/AAA-4714-2020; Nacher, Juan/ABE-5734-2020	CASTILLO-GÓMEZ, ESTHER/0000-0002-7566-0340; Nacher, Juan/0000-0001-7599-3957; Crespo, Carlos/0000-0003-1069-0861; Varea, Emilio/0000-0002-1996-2870	Spanish Ministry of Science and Innovation [MICINN-FEDER BFU2009-12284/BFI, MICINN-PIM2010ERN-00577/NEUCONNECT]; Generalitat Valenciana [CS2009-AP-127, ACOMP2009/271]; Stanley Medical Research Institute; Spanish Ministry of Education and Science [AP2006-01953]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Stanley Medical Research Institute; Spanish Ministry of Education and Science(Spanish Government)	This study was financially supported by Spanish Ministry of Science and Innovation (www.micinn.es; grant numbers: MICINN-FEDER BFU2009-12284/BFI and MICINN-PIM2010ERN-00577/NEUCONNECT in the frame of ERA-NET NEURON), Generalitat Valenciana (www.gva.es; grant numbers: CS2009-AP-127 and ACOMP2009/271) and the Stanley Medical Research Institute (www.stanleyresearch.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Esther Castillo-Gomez had a FPU ("Formacion de Profesorado Universitario") pre-doctoral fellowship from the Spanish Ministry of Education and Science (www.mec.es; fellowship number: AP2006-01953).	Gomez-Climent MA, 2011, CEREB CORTEX, V21, P1028, DOI 10.1093/cercor/bhq177; Arai M, 2004, BIOL PSYCHIAT, V55, P804, DOI 10.1016/j.biopsych.2004.01.009; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Castillo-Gomez E, 2008, EXP NEUROL, V214, P97, DOI 10.1016/j.expneurol.2008.07.018; Castren E, 2005, NAT REV NEUROSCI, V6, P241, DOI 10.1038/nrn1629; Daskalakis ZJ, 2007, BRAIN RES REV, V56, P427, DOI 10.1016/j.brainresrev.2007.09.006; Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008; Di Forti M, 2007, EUR NEUROPSYCHOPHARM, V17, pS101, DOI 10.1016/j.euroneuro.2007.02.005; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Knable MB, 2001, BRAIN RES BULL, V55, P651, DOI 10.1016/S0361-9230(01)00521-4; LeMoine C, 1998, MOL BRAIN RES, V58, P231, DOI 10.1016/S0169-328X(98)00118-1; Lewis DA, 2008, NEUROPSYCHOPHARMACOL, V33, P141, DOI 10.1038/sj.npp.1301563; Nacher J, 2010, NEUROSCIENCE, V167, P825, DOI 10.1016/j.neuroscience.2010.02.067; Nacher J, 2002, BRAIN RES, V927, P111, DOI 10.1016/S0006-8993(01)03241-3; Rajkowska G, 2007, NEUROPSYCHOPHARMACOL, V32, P471, DOI 10.1038/sj.npp.1301234; RETAUX S, 1994, EUR J NEUROSCI, V6, P1782, DOI 10.1111/j.1460-9568.1994.tb00571.x; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Saegusa T, 2004, NEUROSCI RES, V48, P185, DOI 10.1016/j.neures.2003.10.010; Sandi C, 2004, NAT REV NEUROSCI, V5, P917, DOI 10.1038/nrn1555; Santana N, 2009, CEREB CORTEX, V19, P849, DOI 10.1093/cercor/bhn134; Schiavone S, 2009, BIOL PSYCHIAT, V66, P384, DOI 10.1016/j.biopsych.2009.04.033; Seki T, 1999, J COMP NEUROL, V410, P115, DOI 10.1002/(SICI)1096-9861(19990719)410:1<115::AID-CNE10>3.0.CO;2-C; Sugahara M, 1999, NEUROSCI LETT, V259, P141, DOI 10.1016/S0304-3940(98)00920-3; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tao R, 2007, SCHIZOPHR RES, V90, P108, DOI 10.1016/j.schres.2006.09.029; Tseng KY, 2007, SYNAPSE, V61, P843, DOI 10.1002/syn.20432; Varea E, 2007, EUR NEUROPSYCHOPHARM, V17, P546, DOI 10.1016/j.euroneuro.2007.01.001; Varea E, 2005, NEUROSCIENCE, V136, P435, DOI 10.1016/j.neuroscience.2005.08.009; Varea E, 2007, J CHEM NEUROANAT, V33, P202, DOI 10.1016/j.jchemneu.2007.03.006; Varea E, 2007, NEUROPSYCHOPHARMACOL, V32, P803, DOI 10.1038/sj.npp.1301183; Varea E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00017; Varea E, 2009, NEUROBIOL AGING, V30, P808, DOI 10.1016/j.neurobiolaging.2007.08.016; Vawter MP, 2000, EUR J PHARMACOL, V405, P385, DOI 10.1016/S0014-2999(00)00568-9; Volk DW, 2002, PHYSIOL BEHAV, V77, P501, DOI 10.1016/S0031-9384(02)00936-8; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Xiao MF, 2009, J NEUROSCI, V29, P14752, DOI 10.1523/JNEUROSCI.4860-09.2009; Zhang JP, 2010, AM J PSYCHIAT, V167, P763, DOI 10.1176/appi.ajp.2009.09040598	41	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29516	10.1371/journal.pone.0029516	http://dx.doi.org/10.1371/journal.pone.0029516			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216301	gold, Green Published, Green Submitted			2022-12-27	WOS:000300676300063
J	Curtis, N; Jones, MEH; Shi, JF; O'Higgins, P; Evans, SE; Fagan, MJ				Curtis, Neil; Jones, Marc E. H.; Shi, Junfen; O'Higgins, Paul; Evans, Susan E.; Fagan, Michael J.			Functional Relationship between Skull Form and Feeding Mechanics in Sphenodon, and Implications for Diapsid Skull Development	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; LOWER TEMPORAL ARCADE; VIVO BONE STRAIN; IN-VIVO; ESTROGEN-RECEPTOR; ZYGOMATIC ARCH; INVIVO STRESS; HORSE EQUUS; PERFORMANCE; ADAPTATION	The vertebrate skull evolved to protect the brain and sense organs, but with the appearance of jaws and associated forces there was a remarkable structural diversification. This suggests that the evolution of skull form may be linked to these forces, but an important area of debate is whether bone in the skull is minimised with respect to these forces, or whether skulls are mechanically "over-designed'' and constrained by phylogeny and development. Mechanical analysis of diapsid reptile skulls could shed light on this longstanding debate. Compared to those of mammals, the skulls of many extant and extinct diapsids comprise an open framework of fenestrae (window-like openings) separated by bony struts (e.g., lizards, tuatara, dinosaurs and crocodiles), a cranial form thought to be strongly linked to feeding forces. We investigated this link by utilising the powerful engineering approach of multibody dynamics analysis to predict the physiological forces acting on the skull of the diapsid reptile Sphenodon. We then ran a series of structural finite element analyses to assess the correlation between bone strain and skull form. With comprehensive loading we found that the distribution of peak von Mises strains was particularly uniform throughout the skull, although specific regions were dominated by tensile strains while others were dominated by compressive strains. Our analyses suggest that the frame-like skulls of diapsid reptiles are probably optimally formed (mechanically ideal: sufficient strength with the minimal amount of bone) with respect to functional forces; they are efficient in terms of having minimal bone volume, minimal weight, and also minimal energy demands in maintenance.	[Curtis, Neil; Shi, Junfen; Fagan, Michael J.] Univ Hull, Dept Engn, Med & Biol Engn Res Grp, Kingston Upon Hull HU6 7RX, N Humberside, England; [Jones, Marc E. H.; Evans, Susan E.] UCL, Res Dept Cell & Dev Biol, London, England; [O'Higgins, Paul] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England	University of Hull; University of London; University College London; University of Hull; University of York - UK	Curtis, N (corresponding author), Univ Hull, Dept Engn, Med & Biol Engn Res Grp, Kingston Upon Hull HU6 7RX, N Humberside, England.	n.curtis@hull.ac.uk	Huw, Emyr/C-1516-2010; Evans, Susan/C-1888-2008; Evans, Susan/C-1888-2008	Huw, Emyr/0000-0002-0146-9623; Evans, Susan/0000-0002-1633-158X; O'Higgins, Paul/0000-0002-9797-0809; Evans, Susan/0000-0002-0799-4154	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E007465/1, BB/E009204/1, BB/E007813/1]; Biotechnology and Biological Sciences Research Council [BB/E007813/1, BB/E009204/1, BB/E007465/1] Funding Source: researchfish; BBSRC [BB/E009204/1, BB/E007813/1, BB/E007465/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by the Biotechnology and Biological Sciences Research Council (BBSRC-http://www.bbsrc.ac.uk) - grant numbers: BB/E007465/1, BB/E009204/1 and BB/E007813/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre LF, 2003, FUNCT ECOL, V17, P201, DOI 10.1046/j.1365-2435.2003.00721.x; Bickel R, 2002, BIOL J LINN SOC, V76, P91, DOI 10.1046/j.1095-8312.2002.00051.x; Biewener A. A., 1992, American Zoologist, V32, p155A; BIEWENER AA, 1986, J EXP BIOL, V123, P383; BIEWENER AA, 1983, J ZOOL, V201, P67, DOI 10.1111/j.1469-7998.1983.tb04261.x; BIEWENER AA, 1988, J ZOOL, V214, P547, DOI 10.1111/j.1469-7998.1988.tb03759.x; Blob RW, 1999, J EXP BIOL, V202, P1023; Burr DB, 1996, BONE, V18, P405, DOI 10.1016/8756-3282(96)00028-2; Burr DB, 2002, BONE, V30, P781, DOI 10.1016/S8756-3282(02)00707-X; CARTER DR, 1984, CALCIFIED TISSUE INT, V36, pS19, DOI 10.1007/BF02406129; CHURCHES AE, 1982, CLIN ORTHOP RELAT R, P265; COWIN SC, 1985, J BIOMECH, V18, P665, DOI 10.1016/0021-9290(85)90022-3; Currey JD, BONES STRUCTURE MECH; Curtis N, 2010, J BIOMECH, V43, P3132, DOI 10.1016/j.jbiomech.2010.08.001; Curtis N, 2010, J BIOMECH, V43, P2804, DOI 10.1016/j.jbiomech.2010.05.037; Curtis N, ANATOMICAL IN PRESS; Curtis N, 2009, PALAEONTOLOGIA ELECT, V12, p37T; Curtis N, 2008, ANAT REC, V291, P491, DOI 10.1002/ar.20689; Curtis N, 2011, J ANAT, V218, P16, DOI 10.1111/j.1469-7580.2010.01317.x; Curtis N, 2010, J R SOC INTERFACE, V7, P153, DOI 10.1098/rsif.2009.0139; Degrange FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011856; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Dumont ER, 2011, J ANAT, V218, P151, DOI 10.1111/j.1469-7580.2010.01247.x; Erickson GM, 1996, NATURE, V382, P706, DOI 10.1038/382706a0; Evans SE, 2010, ORIGIN EARLY HIST DI, P27; Evans Susan E., 2008, Contributions to Herpetology, V23, P1; FARLOW JO, 1975, EVOLUTION, V29, P353, DOI 10.1111/j.1558-5646.1975.tb00214.x; FRAZZETTA TH, 1968, J MORPHOL, V125, P145, DOI 10.1002/jmor.1051250203; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; GORNIAK GC, 1982, J MORPHOL, V171, P321, DOI 10.1002/jmor.1051710307; Haapasalo H, 2000, BONE, V27, P351, DOI 10.1016/S8756-3282(00)00331-8; HAMMER WR, 1994, SCIENCE, V264, P828, DOI 10.1126/science.264.5160.828; HEIFETZ MD, 1981, J NEUROSURG, V55, P811, DOI 10.3171/jns.1981.55.5.0811; Herrel A, 1997, J HERPETOL, V31, P189; Herring SW, 2005, J EXP BIOL, V208, P4509, DOI 10.1242/jeb.01923; HERRING SW, 1991, J MORPHOL, V207, P225, DOI 10.1002/jmor.1052070302; Hsieh YF, 2001, J BONE MINER RES, V16, P2291, DOI 10.1359/jbmr.2001.16.12.2291; Hylander WL, 1997, AM J PHYS ANTHROPOL, V102, P203, DOI 10.1002/(SICI)1096-8644(199702)102:2<203::AID-AJPA5>3.0.CO;2-Z; HYLANDER WL, 1979, J MORPHOL, V159, P253, DOI 10.1002/jmor.1051590208; Jones MEH, 2008, J MORPHOL, V269, P945, DOI 10.1002/jmor.10634; Jones MEH, 2011, PALAEONTOL ELECTRON, V14; Jones MEH, 2009, J ROY SOC NEW ZEAL, V39, P71, DOI 10.1080/03014220909510565; Jones MEH, 2010, J VERTEBR PALEONTOL, V2010, p113A; Jones MEH, 2009, PALAEONTOLOGIA ELECT, V12; Koolstra JH, 2004, J BIOMECH, V37, P1387, DOI 10.1016/j.jbiomech.2003.12.021; Lanyon L, 2001, J BONE MINER RES, V16, P1937, DOI 10.1359/jbmr.2001.16.11.1937; LANYON LE, 1979, J BONE JOINT SURG AM, V61, P263, DOI 10.2106/00004623-197961020-00019; Lanyon LE, 1982, BONE CLIN ORTHOPAEDI; Lanyon LE, 1985, FUNCTIONAL VERTEBRAT; Lee K, 2003, NATURE, V424, P389, DOI 10.1038/424389a; Lieberman DE, 2001, AM J PHYS ANTHROPOL, V116, P266, DOI 10.1002/ajpa.1123; Madsen JH., 1976, UTAH GEOLOGICAL MINI, V109, P1; Martin RB, 2000, BONE, V26, P1, DOI 10.1016/S8756-3282(99)00241-0; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; MIKIC B, 1995, J BIOMECH, V28, P465, DOI 10.1016/0021-9290(94)00085-I; Moazen M, 2008, J BIOMECH, V41, P1274, DOI 10.1016/j.jbiomech.2008.01.012; Moazen M, 2009, P NATL ACAD SCI USA, V106, P8273, DOI 10.1073/pnas.0813156106; MOORE W. J., 1965, J ZOOL PROC ZOOL SOC LONDON, V146, P123; MOSS ML, 1954, AM J ANAT, V94, P333, DOI 10.1002/aja.1000940302; Moss ML, 1960, AM J PHYS ANTHROPLOG, V74, P305; Muller J, 2003, NATURWISSENSCHAFTEN, V90, P473, DOI 10.1007/s00114-003-0461-0; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; NUNAMAKER DM, 1990, J ORTHOPAED RES, V8, P604, DOI 10.1002/jor.1100080417; OCONNOR JA, 1982, J BIOMECH, V15, P767, DOI 10.1016/0021-9290(82)90092-6; OLSON EC, 1961, AM ZOOL, V1, P205; Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155; Preuschoft Holger, 2002, Senckenbergiana Lethaea, V82, P207; Ravosa MJ, 2000, J HUM EVOL, V38, P667, DOI 10.1006/jhev.1999.0380; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; RIEPPEL O, 1981, ZOOL J LINN SOC-LOND, V72, P203, DOI 10.1111/j.1096-3642.1981.tb01570.x; Rieppel O, 1997, J ZOOL, V243, P351, DOI 10.1111/j.1469-7998.1997.tb02788.x; Robinson PL, MORPHOLOGY BIOL REPT, P43; Robling AG, 2002, J BONE MINER RES, V17, P1545, DOI 10.1359/jbmr.2002.17.8.1545; Ross CF, 2011, J ANAT, V218, P112, DOI 10.1111/j.1469-7580.2010.01322.x; Ross CF, 2004, ANN ANAT, V186, P387, DOI 10.1016/S0940-9602(04)80070-0; Roux W., 1881, ZUCHTENDE KAMPF TEIL; RUBIN CT, 1982, J EXP BIOL, V101, P187; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Sun ZY, 2004, ANAT REC PART A, V276A, P150, DOI 10.1002/ar.a.20002; Suuriniemi M, 2004, J BONE MINER RES, V19, P1758, DOI 10.1359/JBMR.040918; SWARTZ SM, 1992, NATURE, V359, P726, DOI 10.1038/359726a0; Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5; Ussher GT, 1999, NEW ZEAL J ZOOL, V26, P117, DOI 10.1080/03014223.1999.9518183; Walls G.Y., 1978, New Zealand Journal of Ecology, V1, P91; WALLS GY, 1981, NEW ZEAL J ECOL, V4, P89; Wang Q, 2010, ANAT REC, V293, P607, DOI 10.1002/ar.21123; WHITESIDE DI, 1986, PHILOS T ROY SOC B, V312, P379, DOI 10.1098/rstb.1986.0014; Witzel U, 2005, ANAT REC PART A, V283A, P391, DOI 10.1002/ar.a.20174; Witzel U, 2011, VERTEBR PALEOBIOL PA, P203, DOI 10.1007/978-94-007-0492-3_18; WOLFF JL, 1986, GESETZ TRANSFORMATIO	91	32	32	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29804	10.1371/journal.pone.0029804	http://dx.doi.org/10.1371/journal.pone.0029804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216358	Green Published, Green Submitted, gold			2022-12-27	WOS:000300676300086
J	Ferlin, A; Perilli, L; Gianesello, L; Taglialavoro, G; Foresta, C				Ferlin, Alberto; Perilli, Lisa; Gianesello, Lisa; Taglialavoro, Giuseppe; Foresta, Carlo			Profiling Insulin Like Factor 3 (INSL3) Signaling in Human Osteoblasts	PLOS ONE			English	Article							BONE-FORMATION; REGULATES BASAL; PROTEIN-KINASES; EXPRESSION; RECEPTOR; HORMONE; CELLS; DIFFERENTIATION; PROLIFERATION; OSTEOPOROSIS	Background: Young men with mutations in the gene for the INSL3 receptor (Relaxin family peptide 2, RXFP2) are at risk of reduced bone mass and osteoporosis. Consistent with the human phenotype, bone analyses of Rxfp2(-/-) mice showed decreased bone volume, alterations of the trabecular bone, reduced mineralizing surface, bone formation, and osteoclast surface. The aim of this study was to elucidate the INSL3/RXFP2 signaling pathways and targets in human osteoblasts. Methodology/Principal Findings: Alkaline phosphatase (ALP) production, protein phosphorylation, intracellular calcium, gene expression, and mineralization studies have been performed. INSL3 induced a significant increase in ALP production, and Western blot and ELISA analyses of multiple intracellular signaling pathway molecules and their phosphorylation status revealed that the MAPK was the major pathway influenced by INSL3, whereas it does not modify intracellular calcium concentration. Quantitative Real Time PCR and Western blotting showed that INSL3 regulates the expression of different osteoblast markers. Alizarin red-S staining confirmed that INSL3-stimulated osteoblasts are fully differentiated and able to mineralize the extracellular matrix. Conclusions/Significance: Together with previous findings, this study demonstrates that the INSL3/RXFP2 system is involved in bone metabolism by acting on the MAPK cascade and stimulating transcription of important genes of osteoblast maturation/differentiation and osteoclastogenesis.	[Ferlin, Alberto; Perilli, Lisa; Gianesello, Lisa; Foresta, Carlo] Univ Padua, Dept Histol Microbiol & Med Biotechnol, Sect Clin Pathol, Padua, Italy; [Taglialavoro, Giuseppe] Univ Padua, Orthopaed & Traumatol Clin, Padua, Italy	University of Padua; University of Padua	Ferlin, A (corresponding author), Univ Padua, Dept Histol Microbiol & Med Biotechnol, Sect Clin Pathol, Padua, Italy.	carlo.foresta@unipd.it	Ferlin, Alberto/AAO-3541-2020; Gianesello, Lisa/B-5030-2013; GIANESELLO, Lisa/R-6064-2019; Perilli, Lisa/I-4332-2014	Ferlin, Alberto/0000-0001-5817-8141; Gianesello, Lisa/0000-0001-9327-397X; GIANESELLO, Lisa/0000-0001-9327-397X; Perilli, Lisa/0000-0002-7441-4463				Agoulnik AI, 2007, ADV EXP MED BIOL, V612, P49; BAILEY AJ, 1993, CONNECT TISSUE RES, V29, P119, DOI 10.3109/03008209309014239; Barrett MG, 1997, J BIOL CHEM, V272, P26346, DOI 10.1074/jbc.272.42.26346; Bay K, 2006, J CLIN ENDOCR METAB, V91, P1108, DOI 10.1210/jc.2005-1865; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Bogatcheva NV, 2007, AM J PHYSIOL-ENDOC M, V292, pE138, DOI 10.1152/ajpendo.00228.2006; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Chau JFL, 2009, HISTOL HISTOPATHOL, V24, P1593, DOI 10.14670/HH-24.1593; Clarke BL, 2009, STEROIDS, V74, P296, DOI 10.1016/j.steroids.2008.10.003; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Echeverria V, 2008, NEUROSCI LETT, V444, P92, DOI 10.1016/j.neulet.2008.07.092; Feng S, 2009, ANN NY ACAD SCI, V1160, P197, DOI 10.1111/j.1749-6632.2009.03841.x; Ferlin A, 2008, J BONE MINER RES, V23, P683, DOI 10.1359/JBMR.080204; Ferlin A, 2006, J CLIN ENDOCR METAB, V91, P3426, DOI 10.1210/jc.2006-0821; Ferlin A, 2009, ANN NY ACAD SCI, V1160, P215, DOI 10.1111/j.1749-6632.2008.03787.x; Foresta C, 2004, J CLIN ENDOCR METAB, V89, P5952, DOI 10.1210/jc.2004-0575; Franke TF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe29; Fukami K, 2010, PROG LIPID RES, V49, P429, DOI 10.1016/j.plipres.2010.06.001; Gehart H, 2010, EMBO REP, V11, P834, DOI 10.1038/embor.2010.160; Gomez-Ambrosi J, 2008, OBES SURG, V18, P1134, DOI 10.1007/s11695-008-9548-1; Gustin JA, 2006, J BIOL CHEM, V281, P16473, DOI 10.1074/jbc.M507373200; Haylock DN, 2006, BRIT J HAEMATOL, V134, P467, DOI 10.1111/j.1365-2141.2006.06218.x; Kaftanovskaya EM, 2011, MOL ENDOCRINOL, V25, P170, DOI 10.1210/me.2010-0330; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Lian J B, 1995, Iowa Orthop J, V15, P118; Liu R, 2004, ARTHRITIS RHEUM, V50, P247, DOI 10.1002/art.11486; Milat F, 2009, MOL CELL ENDOCRINOL, V310, P52, DOI 10.1016/j.mce.2009.06.002; Notelovitz M, 2002, FERTIL STERIL, V77, pS34; Pepe A, 2009, ANN NY ACAD SCI, V1160, P219, DOI 10.1111/j.1749-6632.2008.03785.x; Raucci A, 2008, J CELL PHYSIOL, V215, P442, DOI 10.1002/jcp.21323; ROBEY PG, 1987, J CELL BIOL, V105, P457, DOI 10.1083/jcb.105.1.457; Rockel JS, 2009, MATRIX BIOL, V28, P354, DOI 10.1016/j.matbio.2009.05.005; Sadeghian H, 2005, MOL CELL ENDOCRINOL, V241, P10, DOI 10.1016/j.mce.2005.03.017; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Shahrara S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2318; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; St-Arnaud R, 2008, ARCH BIOCHEM BIOPHYS, V473, P225, DOI 10.1016/j.abb.2008.03.038; TERMINE JD, 1990, EXP GERONTOL, V25, P217, DOI 10.1016/0531-5565(90)90055-7; Vanderschueren D, 2004, ENDOCR REV, V25, P389, DOI 10.1210/er.2003-0003; Velasco J, 2010, OSTEOPOROSIS INT, V21, P109, DOI 10.1007/s00198-009-0931-0; Verheyen EM, 2010, DEV DYNAM, V239, P34, DOI 10.1002/dvdy.22019; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhang BC, 2011, BBA-MOL CELL RES, V1813, P73, DOI 10.1016/j.bbamcr.2010.10.001; Zhang H, 2005, J BIOMED MATER RES A, V75A, P98, DOI 10.1002/jbm.a.30400	44	40	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29733	10.1371/journal.pone.0029733	http://dx.doi.org/10.1371/journal.pone.0029733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216350	Green Published, Green Submitted, gold			2022-12-27	WOS:000300676300080
J	Krul, J; Blankers, M; Girbes, ARJ				Krul, Jan; Blankers, Matthijs; Girbes, Armand R. J.			Substance-Related Health Problems during Rave Parties in the Netherlands (1997-2008)	PLOS ONE			English	Article							SEROTONIN SYNDROME; EMERGENCY-DEPARTMENT; EXCITED DELIRIUM; POLICE CUSTODY; ECSTASY USE; MDMA USE; AMPHETAMINE; TOXICITY; DEATHS; HYPONATREMIA	The objective of this study was to describe a 12-year (1997-2008) observation of substance-related incidents occurring at rave parties in the Netherlands, including length of visits to first-aid stations, substances used, and severity of the incidents. During rave parties, specifically trained medical and paramedical personnel staffed first aid stations. Visitors were diagnosed and treated, and their data were recorded using standardized methods. During the 12-year period with 249 rave parties involving about 3,800,000 visitors, 27,897 people visited a first aid station, of whom 10,100 reported having a substance-related problem. The mean age of these people was 22.3+/25.4 years; 52.4% of them were male. Most (66.7%) substance-related problems were associated with ecstasy or alcohol use or both. Among 10,100 substance-related cases, 515 required professional medical care, and 16 of these cases were life threatening. People with a substance-related problem stayed 20 min at the first aid station, which was significantly longer than the 5 min that those without a substance-related health problem stayed. These unique data from the Netherlands identify a variety of acute health problems related to the use of alcohol, amphetamines, cannabis, cocaine, ecstasy, and GHB. Although most problems were minor, people using GHB more often required professional medical care those using the other substances. We recommended adherence to harm and risk reduction policy, and the use of first aid stations with specially trained staff for both minor and serious incidents.	[Krul, Jan] Educare Groningen, Groningen, Netherlands; [Blankers, Matthijs] Univ Amsterdam, Acad Med Ctr, Arkin & Amsterdam Inst Addict Res, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Girbes, Armand R. J.] Univ Hosp VU Med Ctr, Dept Intens Care, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Krul, J (corresponding author), Educare Groningen, Groningen, Netherlands.	jk13@home.nl						Abraham MD, 2002, LICIT ILLICIT DRUG U; Archer T, 2008, EMERG MED J, V25, P534, DOI 10.1136/emj.2007.054783; Benschop A, 2009, ANTENNE 2008; Bonell CP, 2010, INT J DRUG POLICY, V21, P244, DOI 10.1016/j.drugpo.2009.07.002; Chinet L, 2007, PHARMACOL BIOCHEM BE, V86, P284, DOI 10.1016/j.pbb.2006.07.025; de Boer J.Rampengeneeskunde, 2001, SAMENVATTEND OVERZIC; Degenhardt L, 2008, DRUG ALCOHOL REV, V27, P243, DOI 10.1080/09595230801950572; DiMaio T.G., 2006, EXCITED DELIRIUM SYN; Dunkley EJC, 2003, QJM-INT J MED, V96, P635, DOI 10.1093/qjmed/hcg109; Engels RCME, 2004, EUR ADDICT RES, V10, P156, DOI 10.1159/000079836; Galicia M, 2008, MED CLIN-BARCELONA, V130, P254, DOI 10.1157/13116549; Gillman PK, 1999, J PSYCHOPHARMACOL, V13, P100, DOI 10.1177/026988119901300111; Gram H, 2002, DANCE NEDERLAND BETE; Hall AP, 2006, BRIT J ANAESTH, V96, P678, DOI 10.1093/bja/ael078; Hsu YJ, 2005, J EMERG MED, V29, P369, DOI 10.1016/j.jemermed.2005.02.014; Krul J, 2009, PREHOSP DISASTER MED, V24, P133, DOI 10.1017/S1049023X00006695; Liechti ME, 2005, SWISS MED WKLY, V135, P652; Maalste N, 1998, GOED FOUT GAAN EERST; Martin TG, 1996, ANN EMERG MED, V28, P520, DOI 10.1016/S0196-0644(96)70116-6; Mason PJ, 2000, MEDICINE, V79, P201, DOI 10.1097/00005792-200007000-00001; McKetin R, 2006, ADDICTION, V101, P1473, DOI 10.1111/j.1360-0443.2006.01496.x; MORRIS JA, 1995, STAT CONFIDENCE CONF, P50; Pedal Ingo, 1999, Archiv fuer Kriminologie, V203, P1; Pijlman FTA, 2003, UITGAAN VEILIGHEID F; Pollanen MS, 1998, CAN MED ASSOC J, V158, P1603; Reingardiene Dagmara, 2006, Medicina (Kaunas), V42, P519; Reuter-Rice K, 2009, J PEDIATR HEALTH CAR, V23, P49, DOI 10.1016/j.pedhc.2008.09.002; Rogers G, 2009, Health Technol Assess, V13, piii, DOI 10.3310/hta13050; Rogers G, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13060; Rosenson J, 2007, ANN EMERG MED, V49, P164, DOI 10.1016/j.annemergmed.2006.09.018; Ross DL, 1998, MODERN PATHOL, V11, P1127; Sampson E, 1999, BRIT J GEN PRACT, V49, P867; Schifano F, 2003, BRIT MED J, V326, P80, DOI 10.1136/bmj.326.7380.80; Schifano F, 2010, NEUROPSYCHOBIOLOGY, V61, P122, DOI 10.1159/000279302; Tanabe P, 2004, ACAD EMERG MED, V11, P59, DOI 10.1197/S1069-6563(03)00585-2; Ter Bogt TFM, 2005, SUBST USE MISUSE, V40, P1479, DOI 10.1081/JA-200066822; ter Bogt TFM, 2006, ADDICT BEHAV, V31, P1240, DOI 10.1016/j.addbeh.2005.08.005; Topolski James M, 2007, Mo Med, V104, P82; van de Wijngaart, 1999, J DRUG ISSUES, V29, P679; van Laar M, 2008, NETHERLANDS DRUG SIT; van Laar M. W., 2011, NATL DRUG MONITOR JA; VANDEWIJNGAART G, 1997, ECSTASY UITGAANSCIRC; Weich L, 2009, AFR J PSYCHIATRY, V12, P213; White SR, 2002, SEMIN RESP CRIT CARE, V23, P27, DOI 10.1055/s-2002-20586; Wikipedia contributors, 2009, RAV; Yui K, 2000, ANN NY ACAD SCI, V914, P1, DOI 10.1111/j.1749-6632.2000.tb05178.x	46	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29620	10.1371/journal.pone.0029620	http://dx.doi.org/10.1371/journal.pone.0029620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216332	Green Published, gold, Green Submitted			2022-12-27	WOS:000300676300074
J	Shimoni, Y; Nudelman, G; Hayot, F; Sealfon, SC				Shimoni, Yishai; Nudelman, German; Hayot, Fernand; Sealfon, Stuart C.			Multi-Scale Stochastic Simulation of Diffusion-Coupled Agents and Its Application to Cell Culture Simulation	PLOS ONE			English	Article								Many biological systems consist of multiple cells that interact by secretion and binding of diffusing molecules, thus coordinating responses across cells. Techniques for simulating systems coupling extracellular and intracellular processes are very limited. Here we present an efficient method to stochastically simulate diffusion processes, which at the same time allows synchronization between internal and external cellular conditions through a modification of Gillespie's chemical reaction algorithm. Individual cells are simulated as independent agents, and each cell accurately reacts to changes in its local environment affected by diffusing molecules. Such a simulation provides time-scale separation between the intracellular and extra-cellular processes. We use our methodology to study how human monocyte-derived dendritic cells alert neighboring cells about viral infection using diffusing interferon molecules. A subpopulation of the infected cells reacts early to the infection and secretes interferon into the extra-cellular medium, which helps activate other cells. Findings predicted by our simulation and confirmed by experimental results suggest that the early activation is largely independent of the fraction of infected cells and is thus both sensitive and robust. The concordance with the experimental results supports the value of our method for overcoming the challenges of accurately simulating multiscale biological signaling systems.	[Shimoni, Yishai; Nudelman, German; Hayot, Fernand; Sealfon, Stuart C.] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Shimoni, Yishai; Nudelman, German; Hayot, Fernand; Sealfon, Stuart C.] Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY USA; [Shimoni, Yishai] Columbia Univ, Ctr Computat Biol & Bioinformat C2B2, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University	Shimoni, Y (corresponding author), Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA.	ys2559@c2b2.columbia.edu; german.nudelman@mssm.edu		SEALFON, Stuart/0000-0001-5791-1217	National Institute of Allergy and Infectious Diseases [HHSN272201000054C, U19 AI06231]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by contract HHSN272201000054C and grant U19 AI06231 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DF, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799998; [Anonymous], 2001, COM MOL BIO; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Chiam KH, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051910; Coppey M, 2007, BIOPHYS J, V93, P1917, DOI 10.1529/biophysj.107.109736; Drawert B, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3310809; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Friedman N, 2005, PLOS BIOL, V3, P1261, DOI 10.1371/journal.pbio.0030238; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; Gillespie D.T., 1977, J PHYS CHEM, V81; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; Hattne J, 2005, BIOINFORMATICS, V21, P2923, DOI 10.1093/bioinformatics/bti431; Hu J, 2009, BIOPHYS J, V97, P1984, DOI 10.1016/j.bpj.2009.05.067; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Hu J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl730; Indurkhya S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008125; Iyengar KA, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3310808; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kalantzis G, 2009, COMPUT BIOL CHEM, V33, P205, DOI 10.1016/j.compbiolchem.2009.03.002; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Marquez-Lago TT, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2771548; Phipps-Yonas H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000193; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; Ridwan AM, 2004, LECT NOTES COMPUT SC, V3037, P284; Shimoni Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005363; Slepoy A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2919546; YANG J, 2008, PHYS REV E, V78	28	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29298	10.1371/journal.pone.0029298	http://dx.doi.org/10.1371/journal.pone.0029298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216238	gold, Green Published, Green Submitted			2022-12-27	WOS:000299113600076
J	Corey, SM; Vizzard, MA; Bouffard, NA; Badger, GJ; Langevin, HM				Corey, Sarah M.; Vizzard, Margaret A.; Bouffard, Nicole A.; Badger, Gary J.; Langevin, Helene M.			Stretching of the Back Improves Gait, Mechanical Sensitivity and Connective Tissue Inflammation in a Rodent Model	PLOS ONE			English	Article							PROINFLAMMATORY GENE INDUCTION; HUMAN FIBROBLAST PROLIFERATION; REPETITIVE MOTION STRAIN; IYENGAR YOGA THERAPY; OPEN-FIELD; JOINT; TRANSCRIPTION; INJURY; PAIN; MICE	The role played by nonspecialized connective tissues in chronic non-specific low back pain is not well understood. In a recent ultrasound study, human subjects with chronic low back pain had altered connective tissue structure compared to human subjects without low back pain, suggesting the presence of inflammation and/or fibrosis in the low back pain subjects. Mechanical input in the form of static tissue stretch has been shown in vitro and in vivo to have anti-inflammatory and anti-fibrotic effects. To better understand the pathophysiology of lumbar nonspecialized connective tissue as well as potential mechanisms underlying therapeutic effects of tissue stretch, we developed a carrageenan-induced inflammation model in the low back of a rodent. Induction of inflammation in the lumbar connective tissues resulted in altered gait, increased mechanical sensitivity of the tissues of the low back, and local macrophage infiltration. Mechanical input was then applied to this model as in vivo tissue stretch for 10 minutes twice a day for 12 days. In vivo tissue stretch mitigated the inflammation-induced changes leading to restored stride length and intrastep distance, decreased mechanical sensitivity of the back and reduced macrophage expression in the nonspecialized connective tissues of the low back. This study highlights the need for further investigation into the contribution of connective tissue to low back pain and the need for a better understanding of how interventions involving mechanical stretch could provide maximal therapeutic benefit. This tissue stretch research is relevant to body-based treatments such as yoga or massage, and to some stretch techniques used with physical therapy.	[Corey, Sarah M.; Vizzard, Margaret A.; Bouffard, Nicole A.; Langevin, Helene M.] Univ Vermont, Dept Neurol, Burlington, VT 05405 USA; [Vizzard, Margaret A.] Univ Vermont, Dept Anat & Neurobiol, Burlington, VT USA; [Badger, Gary J.] Univ Vermont, Dept Med Biostat, Burlington, VT USA; [Langevin, Helene M.] Univ Vermont, Dept Movement & Rehabil Sci, Burlington, VT USA; [Corey, Sarah M.] Univ Vermont, Grad Program Neurosci, Burlington, VT USA	University of Vermont; University of Vermont; University of Vermont; University of Vermont; University of Vermont	Corey, SM (corresponding author), Univ Vermont, Dept Neurol, Burlington, VT 05405 USA.	coreys@ocim.ucsf.edu			National Center for Complementary and Alternative Medicine (NCCAM) [5F31AT005559-02]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [F31AT005559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060481, R01DK051369] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a National Center for Complementary and Alternative Medicine (NCCAM) Research grant 5F31AT005559-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KD, 2011, J ORTHOP RES, V29, P694, DOI 10.1002/jor.21309; Borg-Stein Joanne, 2006, Curr Pain Headache Rep, V10, P339, DOI 10.1007/s11916-006-0057-4; Bouffard NA, 2008, J CELL PHYSIOL, V214, P389, DOI 10.1002/jcp.21209; Branski RC, 2007, J VOICE, V21, P651, DOI 10.1016/j.jvoice.2006.06.005; Bulling DGS, 2001, J NEUROCHEM, V77, P372, DOI 10.1046/j.1471-4159.2001.00175.x; Chan MWC, 2010, METHOD CELL BIOL, V98, P179, DOI 10.1016/S0091-679X(10)98008-4; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen CH, 2010, MED SCI SPORTS EXERC; Corey SM, 2011, CELLS TISSUES ORGANS, V194, P521, DOI 10.1159/000323875; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Dossumbekova A, 2007, ARTHRITIS RHEUM, V56, P3284, DOI 10.1002/art.22933; Eagan TS, 2007, J MANIP PHYSIOL THER, V30, P584, DOI 10.1016/j.jmpt.2007.07.013; Ferretti M, 2006, AM J PHYSIOL-CELL PH, V290, pC1610, DOI 10.1152/ajpcell.00529.2005; Furlan AD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001929.pub2; HINES KL, 1993, IMMUNOMETHODS, V3, P13; Hoheisel U, 2011, EUROPEAN J IN PRESS; Jaworski DM, 2006, J NEUROBIOL, V66, P82, DOI 10.1002/neu.20205; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Langevin HM, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-151; Madhavan S, 2006, OSTEOARTHR CARTILAGE, V14, P1023, DOI 10.1016/j.joca.2006.03.016; Meltzer KR, 2010, J BODYW MOV THER, V14, P162, DOI 10.1016/j.jbmt.2010.01.002; Meltzer KR, 2007, J AM OSTEOPATH ASSOC, V107, P527; Millecamps M, 2004, PAIN, V109, P214, DOI 10.1016/j.pain.2003.12.028; Miyagi M, 2011, SPINE, V36, P1760, DOI 10.1097/BRS.0b013e3182269732; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Radhakrishnan R, 2003, PAIN, V104, P567, DOI 10.1016/S0304-3959(03)00114-3; Rosen A, 2000, BRAIN RES, V857, P212, DOI 10.1016/S0006-8993(99)02432-4; Ross MH, 2006, HISTOLOGY TEXT ATLAS, Vxvii; Sherman KJ, 2005, ANN INTERN MED, V143, P849, DOI 10.7326/0003-4819-143-12-200512200-00003; Sherman KJ, 2011, ARCH INTERNAL MED; Silver Frederick H, 2003, Crit Rev Biomed Eng, V31, P255, DOI 10.1615/CritRevBiomedEng.v31.i4.10; Standley PR, 2008, J BODYW MOV THER, V12, P201, DOI 10.1016/j.jbmt.2008.05.006; Staton PC, 2007, EUR J PAIN, V11, P283, DOI 10.1016/j.ejpain.2006.03.006; Swiergiel AH, 2007, PHARMACOL BIOCHEM BE, V86, P651, DOI 10.1016/j.pbb.2007.02.010; Taguchi T, 2008, PAIN, V138, P119, DOI 10.1016/j.pain.2007.11.015; Tesarz J, 2011, NEUROSCIENCE, V194, P302, DOI 10.1016/j.neuroscience.2011.07.066; Tilbrook HE, 2011, ANN INTERN MED, V155, P569, DOI 10.7326/0003-4819-155-9-201111010-00003; Tuon L, 2008, INTENS CARE MED, V34, P1724, DOI 10.1007/s00134-008-1129-1; Williams KA, 2005, PAIN, V115, P107, DOI 10.1016/j.pain.2005.02.016; Williams K, 2009, SPINE, V34, P2066, DOI 10.1097/BRS.0b013e3181b315cc; Xu ZF, 2000, J IMMUNOL, V165, P453, DOI 10.4049/jimmunol.165.1.453; Yuktasir B, 2009, J BODYW MOV THER, V13, P11, DOI 10.1016/j.jbmt.2007.10.001	42	34	34	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29831	10.1371/journal.pone.0029831	http://dx.doi.org/10.1371/journal.pone.0029831			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238664	Green Published, gold			2022-12-27	WOS:000301188800041
J	Damon, C; Lehembre, F; Oger-Desfeux, C; Luis, P; Ranger, J; Fraissinet-Tachet, L; Marmeisse, R				Damon, Coralie; Lehembre, Frederic; Oger-Desfeux, Christine; Luis, Patricia; Ranger, Jacques; Fraissinet-Tachet, Laurence; Marmeisse, Roland			Metatranscriptomics Reveals the Diversity of Genes Expressed by Eukaryotes in Forest Soils	PLOS ONE			English	Article							CYTOCHROME-P450 ENGINEERING DATABASE; GENOME SEQUENCE; PROTEIN; DEGRADATION; INSIGHTS; TOOL; GUT; CLASSIFICATION; ENDOGLUCANASE; METAGENOMICS	Eukaryotic organisms play essential roles in the biology and fertility of soils. For example the micro and mesofauna contribute to the fragmentation and homogenization of plant organic matter, while its hydrolysis is primarily performed by the fungi. To get a global picture of the activities carried out by soil eukaryotes we sequenced 2x10,000 cDNAs synthesized from polyadenylated mRNA directly extracted from soils sampled in beech (Fagus sylvatica) and spruce (Picea abies) forests. Taxonomic affiliation of both cDNAs and 18S rRNA sequences showed a dominance of sequences from fungi (up to 60%) and metazoans while protists represented less than 12% of the 18S rRNA sequences. Sixty percent of cDNA sequences from beech forest soil and 52% from spruce forest soil had no homologs in the GenBank/EMBL/DDJB protein database. A Gene Ontology term was attributed to 39% and 31.5% of the spruce and beech soil sequences respectively. Altogether 2076 sequences were putative homologs to different enzyme classes participating to 129 KEGG pathways among which several were implicated in the utilisation of soil nutrients such as nitrogen (ammonium, amino acids, oligopeptides), sugars, phosphates and sulfate. Specific annotation of plant cell wall degrading enzymes identified enzymes active on major polymers (cellulose, hemicelluloses, pectin, lignin) and glycoside hydrolases represented 0.5% (beech soil)-0.8% (spruce soil) of the cDNAs. Other sequences coding enzymes active on organic matter (extracellular proteases, lipases, a phytase, P450 monooxygenases) were identified, thus underlining the biotechnological potential of eukaryotic metatranscriptomes. The phylogenetic affiliation of 12 full-length carbohydrate active enzymes showed that most of them were distantly related to sequences from known fungi. For example, a putative GH45 endocellulase was closely associated to molluscan sequences, while a GH7 cellobiohydrolase was closest to crustacean sequences, thus suggesting a potentially significant contribution of non-fungal eukaryotes in the actual hydrolysis of soil organic matter.	[Damon, Coralie; Lehembre, Frederic; Luis, Patricia; Fraissinet-Tachet, Laurence; Marmeisse, Roland] Univ Lyon 1, CNRS, UMR 5557, USC INRA 1193, F-69622 Villeurbanne, France; [Oger-Desfeux, Christine] Univ Lyon 1, Univ Lyon, Pole Rhone Alpes Bioinformat, F-69622 Villeurbanne, France; [Ranger, Jacques] INRA Ctr Nancy, Biogeochim Ecosyst Forestiers, Champenoux, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE	Damon, C (corresponding author), Univ Lyon 1, CNRS, UMR 5557, USC INRA 1193, F-69622 Villeurbanne, France.	roland.marmeisse@univ-lyon1.fr		Luis, Patricia/0000-0001-7002-6212; Marmeisse, Roland/0000-0003-1653-3517	French ECosphere Contientale ECOGER program; French Agence Nationale de la Recherche Biodiversity [ANR-06-443 BDIV-006]	French ECosphere Contientale ECOGER program; French Agence Nationale de la Recherche Biodiversity(French National Research Agency (ANR))	This work was funded by the French ECosphere Contientale ECOGER program AO 2005 (project Microger) and the French Agence Nationale de la Recherche Biodiversity program (project ANR-06-443 BDIV-006 Fundiv). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Coutinho PM, 2009, FUNGAL GENET BIOL, V46, pS161, DOI 10.1016/j.fgb.2008.07.020; Damon C, 2011, ISME J, V5, P1871, DOI 10.1038/ismej.2011.67; Damon C, 2010, FEMS MICROBIOL ECOL, V74, P693, DOI 10.1111/j.1574-6941.2010.00983.x; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Findley SD, 2011, APPL ENVIRON MICROB, V77, P8106, DOI 10.1128/AEM.05925-11; Fischer M, 2003, NUCLEIC ACIDS RES, V31, P319, DOI 10.1093/nar/gkg015; Fischer M, 2007, BIOINFORMATICS, V23, P2015, DOI 10.1093/bioinformatics/btm268; Frankland JC, 1998, MYCOL RES, V102, P1, DOI 10.1017/S0953756297005364; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grant S, 2006, APPL ENVIRON MICROB, V72, P135, DOI 10.1128/AEM.72.1.135-143.2006; He SM, 2010, NAT METHODS, V7, P807, DOI [10.1038/nmeth.1507, 10.1038/NMETH.1507]; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Huson DH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S12; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jeon S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-222; Kellner H, 2011, MICROBIOL RES, V166, P360, DOI 10.1016/j.micres.2010.07.006; King AJ, 2010, P NATL ACAD SCI USA, V107, P5345, DOI 10.1073/pnas.0914228107; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu GD, 2010, J GEN APPL MICROBIOL, V56, P223, DOI 10.2323/jgam.56.223; Lopez-Garcia P, 2008, RES MICROBIOL, V159, P67, DOI 10.1016/j.resmic.2007.11.019; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Meier CL, 2008, P NATL ACAD SCI USA, V105, P19780, DOI 10.1073/pnas.0805600105; Moukoumi J, 2006, ANN FOREST SCI, V63, P763, DOI 10.1051/forest:2006057; Nielsen UN, 2010, J BIOGEOGR, V37, P1317, DOI 10.1111/j.1365-2699.2010.02281.x; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Qi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020521; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Sakamoto K, 2009, COMP BIOCHEM PHYS B, V152, P390, DOI 10.1016/j.cbpb.2009.01.010; SALOHEIMO A, 1994, MOL MICROBIOL, V13, P219, DOI 10.1111/j.1365-2958.1994.tb00417.x; Sarkar N, 1997, ANNU REV BIOCHEM, V66, P173, DOI 10.1146/annurev.biochem.66.1.173; Sarkar P, 2009, J EXP BOT, V60, P3615, DOI 10.1093/jxb/erp245; Schadel C, 2010, PLANT PHYSIOL BIOCH, V48, P1, DOI 10.1016/j.plaphy.2009.09.008; Sharma VK, 2010, NUCLEIC ACIDS RES, V38, pD468, DOI 10.1093/nar/gkp1001; Shrestha PM, 2009, ENVIRON MICROBIOL, V11, P960, DOI 10.1111/j.1462-2920.2008.01821.x; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Sirim D, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-27; Stephenson SL, 2011, SOIL BIOL BIOCHEM, V43, P2237, DOI 10.1016/j.soilbio.2011.07.007; Stewart FJ, 2010, ISME J, V4, P896, DOI 10.1038/ismej.2010.18; Tartar A, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-25; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Xu BZ, 2000, EUR J BIOCHEM, V267, P4970, DOI 10.1046/j.1432-1327.2000.01533.x; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019950	67	110	120	2	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e28967	10.1371/journal.pone.0028967	http://dx.doi.org/10.1371/journal.pone.0028967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238585	Green Submitted, Green Published, gold			2022-12-27	WOS:000301188800003
J	Xu, YD; Qian, CX; Pan, L; Wang, BB; Lou, C				Xu, Yidong; Qian, Chunxiang; Pan, Lei; Wang, Bingbing; Lou, Chi			Comparing Monofractal and Multifractal Analysis of Corrosion Damage Evolution in Reinforcing Bars	PLOS ONE			English	Article							STEEL BARS; FRACTURE SURFACES	Based on fractal theory and damage mechanics, the aim of this paper is to describe the monofractal and multifractal characteristics of corrosion morphology and develop a new approach to characterize the nonuniform corrosion degree of reinforcing bars. The relationship between fractal parameters and tensile strength of reinforcing bars are discussed. The results showed that corrosion mass loss ratio of a bar cannot accurately reflect the damage degree of the bar. The corrosion morphology of reinforcing bars exhibits both monofractal and multifractal features. The fractal dimension and the tensile strength of corroded steel bars exhibit a power function relationship, while the width of multifractal spectrum and tensile strength of corroded steel bars exhibit a linear relationship. By comparison, using width of multifractal spectrum as multifractal damage variable not only reflects the distribution of corrosion damage in reinforcing bars, but also reveals the influence of nonuniform corrosion on the mechanical properties of reinforcing bars. The present research provides a new approach for the establishment of corrosion damage constitutive models of reinforcing bars.	[Xu, Yidong; Qian, Chunxiang] Southeast Univ, Sch Mat Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Xu, Yidong; Pan, Lei; Wang, Bingbing; Lou, Chi] Zhejiang Univ, Ningbo Inst Technol, Res Ctr Green Bldg Mat & Waste Resources Reuse, Ningbo, Zhejiang, Peoples R China	Southeast University - China; Zhejiang University	Xu, YD (corresponding author), Southeast Univ, Sch Mat Sci & Engn, Nanjing, Jiangsu, Peoples R China.	30397604@163.com	徐, 亦冬/J-6680-2019	徐, 亦冬/0000-0003-3756-032X; Qian, Chunxiang/0000-0002-7547-5890	National Key Basic Research and Development Plan of China [2009CB623203]; National Natural Science Foundation of China [51008276]; Natural Science Foundation of Ningbo [2011A610075]	National Key Basic Research and Development Plan of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Ningbo	Funding was provided by the National Key Basic Research and Development Plan of China, 2009CB623203 (http://973concrete.seu.edu.cn/topic/feblog.do?method=index), the National Natural Science Foundation of China, 51008276 (http://159.226.244.23/portal/Proj_List.asp), and the Natural Science Foundation of Ningbo, 2011A610075 (http://www.nbsti.gov.cn/gb/Project/ContentForProject.aspx?CID=00452&CID1=00441&CID2=00442&CID3=00452&ProjectID=53a0895e-2cf6-4848-9150-c67101feb23b). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almusallam AA, 2001, CONSTR BUILD MATER, V15, P361, DOI 10.1016/S0950-0618(01)00009-5; Apostolopoulos CA, 2008, CONSTR BUILD MATER, V22, P2316, DOI 10.1016/j.conbuildmat.2007.10.006; Apostolopoulos CA, 2006, CONSTR BUILD MATER, V20, P782, DOI 10.1016/j.conbuildmat.2005.01.065; Azevedo CRF, 2010, ENG FAIL ANAL, V17, P286, DOI 10.1016/j.engfailanal.2009.06.010; COSTA JM, 1991, CORROS SCI, V32, P665, DOI 10.1016/0010-938X(91)90114-5; Dlouhy I, 2008, ENG FRACT MECH, V75, P726, DOI 10.1016/j.engfracmech.2007.03.038; Du YG, 2005, MAG CONCRETE RES, V57, P135, DOI 10.1680/macr.57.3.135.60482; Guan J, 2010, SIGNAL PROCESS, V90, P523, DOI 10.1016/j.sigpro.2009.07.021; Jimenez-Hornero FJ, 2009, GEODERMA, V150, P196, DOI 10.1016/j.geoderma.2009.02.006; Kitowski CJ, 1997, CORROSION, V53, P216, DOI 10.5006/1.3280463; Krajcinovic D, 2000, INT J SOLIDS STRUCT, V37, P267, DOI 10.1016/S0020-7683(99)00081-5; Liu C, 2009, APPL SURF SCI, V255, P4239, DOI 10.1016/j.apsusc.2008.11.014; Lopes R, 2009, MED IMAGE ANAL, V13, P634, DOI 10.1016/j.media.2009.05.003; MANDELBROT BB, 1984, NATURE, V308, P721, DOI 10.1038/308721a0; Mehta PK, 1991, P 2 INT C CONCR DUR, P1; Pidaparti RM, 2010, CORROS SCI, V52, P3661, DOI 10.1016/j.corsci.2010.07.017; Xie HP, 1996, PHYS LETT A, V218, P275, DOI 10.1016/0375-9601(96)00390-8; Xie SY, 2010, MAR PETROL GEOL, V27, P476, DOI 10.1016/j.marpetgeo.2009.10.010; Xu SJ, 2006, PATTERN RECOGN LETT, V27, P1942, DOI 10.1016/j.patrec.2006.05.005; Xu YD, 2011, ADV MATER RES-SWITZ, V255-260, P569, DOI 10.4028/www.scientific.net/AMR.255-260.569; Xu YD, 2011, ADV MATER RES-SWITZ, V163-167, P3118, DOI 10.4028/www.scientific.net/AMR.163-167.3118; Yuan YS, 2009, CONSTR BUILD MATER, V23, P2461, DOI 10.1016/j.conbuildmat.2008.09.026	22	36	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29956	10.1371/journal.pone.0029956	http://dx.doi.org/10.1371/journal.pone.0029956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238682	Green Published, gold, Green Submitted			2022-12-27	WOS:000301188800052
J	Wang, XJ; Hao, JQ; Metzger, DL; Ao, ZL; Chen, LP; Ou, DW; Verchere, CB; Mui, A; Warnock, GL				Wang, Xiaojie; Hao, Jianqiang; Metzger, Daniel L.; Ao, Ziliang; Chen, Lieping; Ou, Dawei; Verchere, C. Bruce; Mui, Alice; Warnock, Garth L.			B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation	PLOS ONE			English	Article							B7 FAMILY-MEMBER; PROTEIN-KINASE-B; ANTIGEN RECEPTOR; EXPRESSION; SIGNAL; SURVIVAL; IL-2; PHOSPHORYLATION; TRANSDUCTION; MOLECULE	B7-H4 is a newly identified B7 homolog that plays an important role in maintaining T-cell homeostasis by inhibiting T-cell proliferation and lymphokine-secretion. In this study, we investigated the signal transduction pathways inhibited by B7-H4 engagement in mouse T cells. We found that treatment of CD3(+) T cells with a B7-H4.Ig fusion protein inhibits anti-CD3 elicited T-cell receptor (TCR)/CD28 signaling events, including phosphorylation of the MAP kinases, ERK, p38, and JNK. B7-H4.Ig treatment also inhibited the phosphorylation of AKT kinase and impaired its kinase activity as assessed by the phosphorylation of its endogenous substrate GSK-3. Expression of IL-2 is also reduced by B7-H4. In contrast, the phosphorylation state of the TCR proximal tyrosine kinases ZAP70 and lymphocyte-specific protein tyrosine kinase (LCK) are not affected by B7-H4 ligation. These results indicate that B7-H4 inhibits T-cell proliferation and IL-2 production through interfering with activation of ERK, JNK, and AKT, but not of ZAP70 or LCK.	[Wang, Xiaojie; Hao, Jianqiang; Ao, Ziliang; Ou, Dawei; Mui, Alice; Warnock, Garth L.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada; [Metzger, Daniel L.] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; [Verchere, C. Bruce] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Chen, Lieping] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA	University of British Columbia; University of British Columbia; University of British Columbia; Yale University	Wang, XJ (corresponding author), Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada.	Garth.Warnock@vch.ca		Verchere, Cameron Bruce/0000-0002-9262-0586; Metzger, Daniel/0000-0002-1715-4319	Canadian Institutes of Health Research/Michael Smith Foundation; Canadian Institutes of Health Research [MOP-79414]; University of British Columbia	Canadian Institutes of Health Research/Michael Smith Foundation(Michael Smith Foundation for Health ResearchCanadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of British Columbia	XW was the recipient of fellowships from the Canadian Institutes of Health Research/Michael Smith Foundation for Health Research Strategic Training Program in Transplantation Research and University of British Columbia Graduate program. This project was funded by the Canadian Institutes of Health Research (MOP-79414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Awadallah NS, 2008, PANCREAS, V36, P200, DOI 10.1097/MPA.0b013e318150e4e0; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Calvo CR, 1997, J EXP MED, V186, P1645, DOI 10.1084/jem.186.10.1645; Chiang GG, 2000, J BIOL CHEM, V275, P6055, DOI 10.1074/jbc.275.9.6055; Choi IH, 2003, J IMMUNOL, V171, P4650, DOI 10.4049/jimmunol.171.9.4650; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Honstettre A, 2006, INFECT IMMUN, V74, P1800, DOI 10.1128/IAI.74.3.1800-1808.2006; IRVING BA, 1993, J EXP MED, V177, P1093, DOI 10.1084/jem.177.4.1093; Jones RG, 2002, J EXP MED, V196, P335, DOI 10.1084/jem.20020307; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; KARNITZ L, 1992, MOL CELL BIOL, V12, P4521, DOI 10.1128/MCB.12.10.4521; Kelly E, 2002, J IMMUNOL, V168, P597, DOI 10.4049/jimmunol.168.2.597; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; Kong GH, 1996, MOL CELL BIOL, V16, P5026; Krambeck AE, 2006, P NATL ACAD SCI USA, V103, P10391, DOI 10.1073/pnas.0600937103; Kryczek I, 2006, J EXP MED, V203, P871, DOI 10.1084/jem.20050930; Kryczek I, 2006, J IMMUNOL, V177, P40, DOI 10.4049/jimmunol.177.1.40; Meagher C, 2008, J IMMUNOL, V180, P7793, DOI 10.4049/jimmunol.180.12.7793; Ou DW, 2006, CELL TRANSPLANT, V15, P399, DOI 10.3727/000000006783981837; OWAKI H, 1993, EMBO J, V12, P4367, DOI 10.1002/j.1460-2075.1993.tb06121.x; Parry RV, 1997, EUR J IMMUNOL, V27, P2495, DOI 10.1002/eji.1830271006; Prasad DVR, 2003, IMMUNITY, V18, P863, DOI 10.1016/S1074-7613(03)00147-X; Salceda S, 2005, EXP CELL RES, V306, P128, DOI 10.1016/j.yexcr.2005.01.018; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Toyooka K, 1996, INT IMMUNOL, V8, P159, DOI 10.1093/intimm/8.2.159; Tringler B, 2005, CLIN CANCER RES, V11, P1842, DOI 10.1158/1078-0432.CCR-04-1658; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Wang XJ, 2009, TRANSPLANTATION, V87, P482, DOI 10.1097/TP.0b013e318195e5fa; WEISS A, 1987, ADV IMMUNOL, V41, P1, DOI 10.1016/S0065-2776(08)60029-2; WHITEHURST CE, 1995, J BIOL CHEM, V270, P5594, DOI 10.1074/jbc.270.10.5594; Whitehurst CE, 1996, J IMMUNOL, V156, P1020; Yuan CL, 2009, TRANSPL IMMUNOL, V21, P143, DOI 10.1016/j.trim.2009.03.007; Zang XX, 2003, P NATL ACAD SCI USA, V100, P10388, DOI 10.1073/pnas.1434299100; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	40	58	77	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28232	10.1371/journal.pone.0028232	http://dx.doi.org/10.1371/journal.pone.0028232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238573	gold, Green Published, Green Submitted			2022-12-27	WOS:000301070200005
J	Yang, XH; Yao, Y; Chen, MF; Yang, X; Xie, YD; Liu, YF; Zhao, XY; Gao, Y; Wei, L				Yang, XiaoHua; Yao, Yao; Chen, MeiFang; Yang, Xia; Xie, YanDi; Liu, YaFen; Zhao, XiuYing; Gao, Yan; Wei, Lai			Etiology and Clinical Characteristics of Influenza-Like Illness (ILI) in Outpatients in Beijing, June 2010 to May 2011	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; CASE-DEFINITION; CHILDREN; INFECTIONS; DIAGNOSIS; SURVEILLANCE; EPIDEMICS; SEASON; IMPACT	Background: Since May 2009, exposure of the population of Beijing, China to pH1N1 has resulted in an increase in respiratory illnesses. Limited information is available on the etiology and clinical characteristics of the influenza-like illness (ILI) that ensued in adults following the pH1N1 pandemic. Methods: Clinical and epidemiological data of ILI in adults was collected. A total of 279 throat swabs were tested for twelve respiratory viruses using multiplex RT-PCR. Clinical characteristics of influenza A in outpatients versus test-negative patients were compared using Pearson's chi(2) and the Mann-Whitney U test. 190 swabs were tested for pH1N1 by virus isolation. Consultation rates for ILI were compared between 2009 and 2010. Results: One or two virus were detected in 29% of the samples. Influenza A virus (FLU-A) accounted for 22.9% (64/279). Other viruses were present at a frequency less than 3.0%. Cough was significantly associated with Influenza A virus infection (chi(2), p<0.001). The positive rate of FLU-A was consistent with changes in the ILI rate during the same period and there was a significant reduction in the incidence of ILI in 2010 when compared to 2009. During the 2010-2011 influenza season, the incidence peaked in January 2011 in Beijing and north China. Conclusions: Exposure to pH1N1 had no impact on typical influenza seasonal peaks, although FLU-A remained the predominant virus for 2010 in Beijing. Symptomatically, cough was associated with FLU-A infection. The positive rate of influenza virus was consistent with changes in the ILI rate during the same period and there was a significant reduction in the incidence of ILI in 2010 when compared to that of 2009.	[Yang, XiaoHua; Chen, MeiFang; Yang, Xia; Xie, YanDi; Liu, YaFen; Gao, Yan; Wei, Lai] Peking Univ, Peoples Hosp, Inst Hepatol, Dept Infect Dis, Beijing 100871, Peoples R China; [Yao, Yao; Zhao, XiuYing] Capital Med Univ, Beijing YouAn Hosp, Ctr Clin Lab, Beijing, Peoples R China	Peking University; Capital Medical University	Yang, XH (corresponding author), Peking Univ, Peoples Hosp, Inst Hepatol, Dept Infect Dis, Beijing 100871, Peoples R China.	zhaoxiuying2001@163.com; gaoyan6384@163.com			National Science and Technology Major Special Funding, People's Republic of China [2009ZX10004-110]	National Science and Technology Major Special Funding, People's Republic of China	This study was funded by the National Science and Technology Major Special Funding (www.nmp.gov.cn), People's Republic of China, grant number 2009ZX10004-110. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Laguna-Torres VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011719; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Cao B, 2009, EMERG INFECT DIS, V15, P1418, DOI 10.3201/eid1509.090794; Cao Bin, 2008, Zhonghua Jiehe He Huxi Zazhi, V31, P483; Centers for Disease Control and Prevention, 2009, OV INFL SURV US 2007; Chinese Center for Disease Control and Prevention (China CDC), 2011, REP NOT DIS; Chinese National Influenza Center (CNIC), 2009, CHIN FLU WEEKL REP; Chu YH, 2007, CAPITAL J PUBLIC HLT, V1, P0197; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; Fleming D M, 2000, Commun Dis Public Health, V3, P32; Forgie SE, 2011, CLIN INFECT DIS, V52, P10, DOI 10.1093/cid/ciq030; Gao Yan, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1097; Gordon A, 2009, EMERG INFECT DIS, V15, P408, DOI 10.3201/eid1503.080238; Hasman H, 2009, J MED MICROBIOL, V58, P408, DOI 10.1099/jmm.0.006098-0; Huang Fang, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P494; Kasper MR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-320; Kim SR, 2009, J VIROL METHODS, V156, P111, DOI 10.1016/j.jviromet.2008.11.007; Kniss Krista, 2011, Morbidity and Mortality Weekly Report, V60, P705; Monto AS, 2002, AM J MED, V112, p4S; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Noyola DE, 2005, PEDIATR INFECT DIS J, V24, P1049, DOI 10.1097/01.inf.0000190026.58557.93; Ohmit SE, 2006, CLIN INFECT DIS, V43, P564, DOI 10.1086/506352; Peltola V, 2005, CLIN INFECT DIS, V41, P1198, DOI 10.1086/444508; Petric M, 2006, J INFECT DIS, V194, pS98, DOI 10.1086/507554; Puzelli S, 2009, J MED VIROL, V81, P2066, DOI 10.1002/jmv.21610; Rodriguez-Noriega E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010658; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; Yang P, 2009, EMERG INFECT DIS, V15, P1603, DOI 10.3201/eid1510.081040; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X; Zhang Jing, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P461; Zhu Ru-nan, 2010, Zhonghua Weishengwuxue He Mianyixue Zazhi, V30, P420, DOI 10.3760/cma.j.issn.0254-5101.2010.05.008	32	26	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28786	10.1371/journal.pone.0028786	http://dx.doi.org/10.1371/journal.pone.0028786			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238581	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200011
J	D'Ippolito, S; Marana, R; Di Nicuolo, F; Castellani, R; Veglia, M; Stinson, J; Scambia, G; Di Simone, N				D'Ippolito, Silvia; Marana, Riccardo; Di Nicuolo, Fiorella; Castellani, Roberta; Veglia, Manuela; Stinson, John; Scambia, Giovanni; Di Simone, Nicoletta			Effect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL) - Mediated Inhibition of Endometrial Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VITRO TROPHOBLAST INVASIVENESS; ANTI-BETA-2-GLYCOPROTEIN-I ANTIBODIES; FACTOR EXPRESSION; PATHOGENIC ROLE; FETAL LOSS; PREGNANCY; BINDING; BETA-2-GLYCOPROTEIN-I; ACTIVATION	Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by vascular thrombosis and/or pregnancy morbidity in the presence of circulating antiphospholipid antibodies (aPL). Different pathogenic mechanisms for aPL-mediated pregnancy failure have been proposed. In particular a direct effect of aPL on both maternal and fetal side of the placental tissue has been reported, since their reactivity with beta 2-glycoprotein I (beta 2GPI) makes them adhere to trophoblast and human endometrial endothelial cell (HEEC) membranes. beta 2GPI can be recognized by aPL that, once bound, interfere with both trophoblast functions and with the HEEC differentiation. APS patients can be successfully treated with Low Molecular Weight Heparin (LMWH). Recent reports suggest that LMWH acts through mechanisms alternative to its well known anticoagulant effect, because of its ability to bind beta 2GPI. In our previous studies, we showed that LMWH is able to reduce the aPL binding to trophoblasts and restore cell invasiveness and differentiation. So far, however, no study has described its effects on endometrial angiogenesis. The aim of our research was to evaluate whether two LMWHs, tinzaparin and enoxaparin, have an effect on the aPL-inhibited endometrial angiogenesis. This prompted us to investigate: (i) in vitro HEEC angiogenesis through a Matrigel assay; (ii) VEGF secretion by ELISA; (iii) matrix metalloproteinase-2 (MMP-2) activity by gelatin zymography; (iv) Nuclear Factor-kappa B (NF-kappa B) DNA binding activity by colorimetric assay; (v) STAT-3 activation by a sandwich-ELISA kit. Furthermore, using an in vivo murine model we investigated the LMWHs effects on angiogenesis. We demonstrated that the addition of LMWHs prevents aPL-inhibited HEEC angiogenesis, both in vitro and in vivo, and is able to restore the aPL inhibited NF-kappa B and/or STAT-3 activity, the VEGF secretion and the MMPs activity. The demonstration of a beneficial role for LMWHs on the aPL-inhibited HEEC angiogenesis might provide additional mechanisms whereby this treatment protects early pregnancy in APS.	[D'Ippolito, Silvia; Marana, Riccardo; Di Nicuolo, Fiorella; Castellani, Roberta; Veglia, Manuela; Scambia, Giovanni; Di Simone, Nicoletta] Univ Cattolica Sacro Cuore, Dept Obstet & Gynecol, Rome, Italy; [Marana, Riccardo] Univ Cattolica Sacro Cuore, Ist Sci Int Paolo VI, Rome, Italy; [Stinson, John] LEO Pharma, Ballerup, Denmark	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; LEO Pharma	D'Ippolito, S (corresponding author), Univ Cattolica Sacro Cuore, Dept Obstet & Gynecol, Rome, Italy.	nicolettadisimone@rm.unicatt.it	D'IPPOLITO, SILVIA/L-1879-2019; Stinson, John/HCJ-0195-2022	D'IPPOLITO, SILVIA/0000-0002-6160-0558; DI SIMONE, NICOLETTA/0000-0003-1273-3335	LEO Pharma A/S Dept [54807]; Istituto Scientifico Internazionale, Paolo VI Institute, Catholic University of Sacred Heart, Rome, Italy	LEO Pharma A/S Dept; Istituto Scientifico Internazionale, Paolo VI Institute, Catholic University of Sacred Heart, Rome, Italy	The research was supported by LEO Pharma A/S Dept 54807, Industriparken 55, DK-2750 Ballerup Denmark and by Istituto Scientifico Internazionale, Paolo VI Institute, Catholic University of Sacred Heart, Rome, Italy. The funders contributed to purchase reagents and materials required to perform experiments.	Berman J, 2005, J IMMUNOL, V174, P485, DOI 10.4049/jimmunol.174.1.485; Branch W, 2011, LUPUS, V20, P158, DOI 10.1177/0961203310395054; Buteau-Lozano H, 2002, CANCER RES, V62, P4977; Cohen D, 2011, J PATHOL, V225, P502, DOI 10.1002/path.2893; Cohen D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2541; Collen A, 2000, CANCER RES, V60, P6196; Cugno M, 2010, J AUTOIMMUN, V34, P105, DOI 10.1016/j.jaut.2009.07.004; CULLINANBOVE K, 1993, ENDOCRINOLOGY, V133, P829, DOI 10.1210/en.133.2.829; de Groot PG, 2011, J THROMB HAEMOST, V9, P1275, DOI 10.1111/j.1538-7836.2011.04327.x; Dendrinos S, 2009, INT J GYNECOL OBSTET, V104, P223, DOI 10.1016/j.ijgo.2008.11.010; Di Simone N, 1999, HUM REPROD, V14, P489, DOI 10.1093/humrep/14.2.489; Di Simone N, 2007, HUM REPROD UPDATE, V13, P189, DOI 10.1093/humupd/dml051; Di Simone N, 2007, PLACENTA, V28, P298, DOI 10.1016/j.placenta.2006.04.001; Di Simone N, 2005, ANN RHEUM DIS, V64, P462, DOI 10.1136/ard.2004.021444; Di Simone N, 2010, BIOL REPROD, V83, P212, DOI 10.1095/biolreprod.110.083410; DiSimone N, 1997, HUM REPROD, V12, P2061, DOI 10.1093/humrep/12.9.2061; Empson M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002859.pub2; Gharavi AE, 2004, LUPUS, V13, P17, DOI 10.1191/0961203304lu484oa; Giannakopoulos B, 2009, BLOOD, V113, P985, DOI 10.1182/blood-2007-12-129627; Girardi G, 2005, J REPROD IMMUNOL, V66, P45, DOI 10.1016/j.jri.2005.01.006; Girardi G, 2004, NAT MED, V10, P1222, DOI 10.1038/nm1121; Guerin J, 2002, J BIOL CHEM, V277, P2644, DOI 10.1074/jbc.M110176200; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; LOZIER J, 1984, P NATL ACAD SCI-BIOL, V81, P3640, DOI 10.1073/pnas.81.12.3640; Meroni PL, 2008, CLIN REV ALLERG IMMU, V34, P332, DOI 10.1007/s12016-007-8055-9; Meroni PL, 2008, J AUTOIMMUN, V30, P99, DOI 10.1016/j.jaut.2007.11.014; Meroni PL, 2011, NAT REV RHEUMATOL, V7, P330, DOI 10.1038/nrrheum.2011.52; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Moon DO, 2010, TOXICOL IN VITRO, V24, P1927, DOI 10.1016/j.tiv.2010.08.002; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pandey MK, 2009, MOL PHARMACOL, V75, P525, DOI 10.1124/mol.108.052548; Passam FH, 2010, J AUTOIMMUN, V30, P1; Racine E, 2001, PHARMACOTHERAPY, V21, p62S, DOI 10.1592/phco.21.8.62S.34594; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Ruiz-Irastorza G, 2010, LANCET, V376, P1498, DOI 10.1016/S0140-6736(10)60709-X; Smorenburg SM, 2001, PHARMACOL REV, V53, P93; SOKER S, 1994, BIOCHEM BIOPH RES CO, V203, P1339, DOI 10.1006/bbrc.1994.2329; Staun-Ram E, 2004, REPROD BIOL ENDOCRIN, V4, P2; Takahashi H, 2005, BRIT J PHARMACOL, V146, P333, DOI 10.1038/sj.bjp.0706344; Wang ZL, 2010, EUR J CANCER, V46, P2996, DOI 10.1016/j.ejca.2010.07.008; Willems GM, 1996, BIOCHEMISTRY-US, V35, P13833, DOI 10.1021/bi960657q; Yagel S, 2011, THROMB RES, V127, pS64, DOI 10.1016/S0049-3848(11)70018-4; Zhu M, 1999, BRIT J HAEMATOL, V105, P102, DOI 10.1111/j.1365-2141.1999.01292.x	44	27	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29660	10.1371/journal.pone.0029660	http://dx.doi.org/10.1371/journal.pone.0029660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235321	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400083
J	Hughes, LC; Ralston, KS; Hill, KL; Zhou, ZH				Hughes, Louise C.; Ralston, Katherine S.; Hill, Kent L.; Zhou, Z. Hong			Three-Dimensional Structure of the Trypanosome Flagellum Suggests that the Paraflagellar Rod Functions as a Biomechanical Spring	PLOS ONE			English	Article							CENTRAL PAIR MICROTUBULES; SEA-URCHIN SPERM; AFRICAN TRYPANOSOMES; CRYOELECTRON TOMOGRAPHY; ELECTRON-MICROSCOPY; CELL MOTILITY; DYNEIN ARMS; BRUCEI; PROTEIN; CILIA	Flagellum motility is critical for normal human development and for transmission of pathogenic protozoa that cause tremendous human suffering worldwide. Biophysical principles underlying motility of eukaryotic flagella are conserved from protists to vertebrates. However, individual cells exhibit diverse waveforms that depend on cell-specific elaborations on basic flagellum architecture. Trypanosoma brucei is a uniflagellated protozoan parasite that causes African sleeping sickness. The T. brucei flagellum is comprised of a 9+2 axoneme and an extra-axonemal paraflagellar rod (PFR), but the three-dimensional (3D) arrangement of the underlying structural units is poorly defined. Here, we use dual-axis electron tomography to determine the 3D architecture of the T. brucei flagellum. We define the T. brucei axonemal repeating unit. We observe direct connections between the PFR and axonemal dyneins, suggesting a mechanism by which mechanochemical signals may be transmitted from the PFR to axonemal dyneins. We find that the PFR itself is comprised of overlapping laths organized into distinct zones that are connected through twisting elements at the zonal interfaces. The overall structure has an underlying 57nm repeating unit. Biomechanical properties inferred from PFR structure lead us to propose that the PFR functions as a biomechanical spring that may store and transmit energy derived from axonemal beating. These findings provide insight into the structural foundations that underlie the distinctive flagellar waveform that is a hallmark of T. brucei cell motility.	[Hughes, Louise C.; Ralston, Katherine S.; Hill, Kent L.; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA; [Hughes, Louise C.; Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA; [Hill, Kent L.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Hughes, LC (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA.	kenthill@mednet.ucla.edu; Hong.Zhou@ucla.edu	Zhou, Z Hong/HDN-0747-2022	Ralston, Katherine/0000-0002-1604-7634; Hughes, Louise/0000-0002-7505-202X	National Institutes of Health (NIH) [GM071940, AI069015, AI052348, 1S10RR23057]; United States Public Health Service National Research Service [GM07104]; University of California Los Angeles graduate division; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI052348, R01AI052348, R01AI069015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007104, R01GM071940] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service National Research Service; University of California Los Angeles graduate division; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project is supported in part by grants from the National Institutes of Health (NIH) (GM071940 and AI069015 to ZZ, and AI052348 to KH). KR is the recipient of a United States Public Health Service National Research Service Award (GM07104) and a Dissertation Year Fellowship from the University of California Los Angeles graduate division. The authors acknowledge the use of the cryoEM facilities at the Electron Imaging Center for NanoMachines supported in part by NIH (1S10RR23057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFZELIUS B, 1959, J BIOPHYS BIOCHEM CY, V5, P269, DOI 10.1083/jcb.5.2.269; ANDERSON WA, 1965, J PROTOZOOL, V12, P483, DOI 10.1111/j.1550-7408.1965.tb03247.x; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Baron DM, 2007, J CELL SCI, V120, P1513, DOI 10.1242/jcs.004846; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Bastin P, 2010, CURR OPIN MICROBIOL, V13, P450, DOI 10.1016/j.mib.2010.05.013; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; CACHON J, 1988, BIOL CELL, V63, P169, DOI 10.1016/0248-4900(88)90056-1; DESOUZA W, 1980, J PARASITOL, V66, P229, DOI 10.2307/3280809; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; FARINA M, 1986, J PROTOZOOL, V33, P552, DOI 10.1111/j.1550-7408.1986.tb05661.x; FUGE H, 1969, J PROTOZOOL, V16, P460, DOI 10.1111/j.1550-7408.1969.tb02301.x; Gadelha C, 2006, J CELL SCI, V119, P2405, DOI 10.1242/jcs.02969; Ginger ML, 2008, NAT REV MICROBIOL, V6, P838, DOI 10.1038/nrmicro2009; Griffiths S, 2007, EUKARYOT CELL, V6, P1248, DOI 10.1128/EC.00110-07; Gruby D., 1843, CR HEBD ACAD SCI, V17, P1134; HEMPHILL A, 1991, J STRUCT BIOL, V107, P211, DOI 10.1016/1047-8477(91)90046-Y; HEMPHILL A, 1991, J PARASITOL, V77, P603, DOI 10.2307/3283167; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Hill KL, 2003, EUKARYOT CELL, V2, P200, DOI 10.1128/EC.2.2.200-208.2003; Hunger-Glaser I, 1997, MOL BIOCHEM PARASIT, V90, P347, DOI 10.1016/S0166-6851(97)00139-4; Hutchings NR, 2002, J CELL BIOL, V156, P867, DOI 10.1083/jcb.200201036; Ibanez-Tallon I, 2003, HUM MOL GENET, V12, pR27, DOI 10.1093/hmg/ddg061; King SM, 2000, J CELL SCI, V113, P2521; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Koyfman AY, 2011, P NATL ACAD SCI USA, V108, P11105, DOI 10.1073/pnas.1103634108; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; LARSEN J, 1991, J PROTOZOOL, V38, P55, DOI 10.1111/j.1550-7408.1991.tb04801.x; Maga JA, 1999, J CELL SCI, V112, P2753; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; MASTRONARDE DN, 1992, J CELL BIOL, V118, P1145, DOI 10.1083/jcb.118.5.1145; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Moreira-Leite FF, 2001, SCIENCE, V294, P610, DOI 10.1126/science.1063775; Movassagh T, NATURE STRUCTURAL MO, V17, P761; Nicastro D, 2005, P NATL ACAD SCI USA, V102, P15889, DOI 10.1073/pnas.0508274102; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Oberholzer M, 2007, FASEB J, V21, P720, DOI 10.1096/fj.06-6818com; Oberholzer M, 2009, METHOD CELL BIOL, V93, P21, DOI 10.1016/S0091-679X(08)93002-8; OLSON GE, 1977, J ULTRA MOL STRUCT R, V61, P21, DOI 10.1016/S0022-5320(77)90004-1; Peng L, 2010, STRUCTURE, V18, P47, DOI 10.1016/j.str.2009.10.017; Porter ME, 2000, J CELL BIOL, V151, pF37, DOI 10.1083/jcb.151.5.F37; Portman N, 2010, INT J PARASITOL, V40, P135, DOI 10.1016/j.ijpara.2009.10.005; Portman N, 2009, J BIOL CHEM, V284, P5610, DOI 10.1074/jbc.M808859200; Pullen TJ, 2004, MOL BIOL CELL, V15, P3257, DOI 10.1091/mbc.E04-03-0217; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; ROBINSON D, 1991, METHOD ENZYMOL, V196, P285; Rocha GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011407; Rodriguez JA, 2009, P NATL ACAD SCI USA, V106, P19322, DOI 10.1073/pnas.0907001106; RUSSELL DG, 1983, EUR J CELL BIOL, V30, P137; SALE WS, 1986, J CELL BIOL, V102, P2042, DOI 10.1083/jcb.102.6.2042; Santrich C, 1997, MOL BIOCHEM PARASIT, V90, P95, DOI 10.1016/S0166-6851(97)00149-7; SATIR P, 1968, J CELL BIOL, V39, P77, DOI 10.1083/jcb.39.1.77; SUMMERS KE, 1971, P NATL ACAD SCI USA, V68, P3092, DOI 10.1073/pnas.68.12.3092; TETLEY L, 1985, J CELL SCI, V74, P1; VICKERMAN K., 1962, TRANS ROY SOC TROP MED AND HYG, V56, P487, DOI 10.1016/0035-9203(62)90072-X; WALKER PJ, 1961, NATURE, V189, P1017, DOI 10.1038/1891017a0; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	61	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e25700	10.1371/journal.pone.0025700	http://dx.doi.org/10.1371/journal.pone.0025700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235240	gold, Green Published, Green Submitted			2022-12-27	WOS:000301123400001
J	Shirasuna, K; Jiemtaweeboon, S; Raddatz, S; Nitta, A; Schuberth, HJ; Bollwein, H; Shimizu, T; Miyamoto, A				Shirasuna, Koumei; Jiemtaweeboon, Sineenard; Raddatz, Sybille; Nitta, Akane; Schuberth, Hans-Joachim; Bollwein, Heinrich; Shimizu, Takashi; Miyamoto, Akio			Rapid Accumulation of Polymorphonuclear Neutrophils in the Corpus luteum during Prostaglandin F-2 alpha-Induced Luteolysis in the Cow	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; HISTOCOMPATIBILITY COMPLEX ANTIGENS; MESSENGER-RNA EXPRESSION; ENDOTHELIAL P-SELECTIN; NECROSIS-FACTOR-ALPHA; BOVINE NEUTROPHIL; INTERFERON-GAMMA; ESTROUS-CYCLE; GROWTH-FACTOR; IMMUNE CELLS	Prostaglandin F-2 alpha (PGF(2 alpha)) induces luteolysis within a few days in cows, and immune cells increase in number in the regressing corpus luteum (CL), implying that luteolysis is an inflammatory-like immune response. We investigated the rapid change in polymorphonuclear neutrophil (PMN) numbers in response to PGF(2 alpha) administration as the first cells recruited to inflammatory sites, together with mRNA of interleukin-8 (IL-8: neutrophil chemoattractant) and P-selectin (leukocyte adhesion molecule) in the bovine CL. CLs were collected by ovariectomy at various times after PGF(2 alpha) injection. The number of PMNs was increased at 5 min after PGF(2 alpha) administration, whereas IL-8 and P-selectin mRNA increased at 30 min and 2 h, respectively. PGF(2 alpha) directly stimulated P-selectin protein expression at 5-30 min in luteal endothelial cells (LECs). Moreover, PGF(2 alpha) enhanced PMN adhesion to LECs, and this enhancement by PGF(2 alpha) was inhibited by anti-P-selectin antibody, suggesting that P-selectin expression by PGF(2 alpha) is crucial in PMN migration. In conclusion, PGF(2 alpha) rapidly induces the accumulation of PMNs into the bovine CL at 5 min and enhances PMN adhesion via P-selectin expression in LECs. It is suggested that luteolytic cascade by PGF(2 alpha) may involve an acute inflammatory-like response due to rapidly infiltrated PMNs.	[Shirasuna, Koumei; Jiemtaweeboon, Sineenard; Nitta, Akane; Shimizu, Takashi; Miyamoto, Akio] Obihiro Univ Agr & Vet Med, Grad Sch Anim & Food Hyg, Obihiro, Hokkaido 080, Japan; [Raddatz, Sybille; Schuberth, Hans-Joachim] Univ Vet Med Hannover, Clin Cattle, Hannover, Germany; [Bollwein, Heinrich] Univ Vet Med Hannover, Inst Immunol, Hannover, Germany	Obihiro University of Agriculture & Veterinary Medicine; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Miyamoto, A (corresponding author), Obihiro Univ Agr & Vet Med, Grad Sch Anim & Food Hyg, Obihiro, Hokkaido 080, Japan.	akiomiya@obihiro.ac.jp	Schuberth, Hans-Joachim/AAE-4845-2020; Bollwein, Heinrich J/A-4964-2013	Bollwein, Heinrich/0000-0003-1982-5101	Japanese Ministry of Education, Science, Sports, Culture and Technology; Japan Society for the Promotion of Science (JSPS), Japan	Japanese Ministry of Education, Science, Sports, Culture and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a grant from Global Centers of Excellence (GCOE) Program from Japanese Ministry of Education, Science, Sports, Culture and Technology and by the Grant-in-Aid for Scientific Research of the Japan Society for the Promotion of Science (JSPS), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-zi'abi MO, 2002, REPRODUCTION, V123, P67, DOI 10.1530/rep.0.1230067; Arici A, 1996, ENDOCRINOLOGY, V137, P3762, DOI 10.1210/en.137.9.3762; Bauer M, 2001, REPRODUCTION, V121, P297, DOI 10.1530/rep.0.1210297; Belayet HM, 2000, CYTOKINE, V12, P361; BENYO DF, 1991, BIOL REPROD, V45, P229, DOI 10.1095/biolreprod45.2.229; Bowen JM, 1999, BIOL REPROD, V60, P740, DOI 10.1095/biolreprod60.3.740; Brannstrom M, 1995, J REPROD IMMUNOL, V29, P265, DOI 10.1016/0165-0378(95)00941-D; Brannstrom M, 1997, SEMIN REPROD ENDOCR, V15, P363, DOI 10.1055/s-2008-1068374; CARLOS TM, 1994, BLOOD, V84, P2068; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; de Menezes GB, 2005, INFLAMMATION, V29, P163, DOI 10.1007/s10753-006-9013-z; Diez-Fraile A, 2004, CAN J VET RES, V68, P232; FAIRCHILD DL, 1989, BIOL REPROD, V40, P453, DOI 10.1095/biolreprod40.3.453; FLINT APF, 1982, NATURE, V297, P587, DOI 10.1038/297587a0; Goto J, 2002, CYTOKINE, V20, P168, DOI 10.1006/cyto.2002.1987; Hojo T, 2010, J REPROD DEVELOP, V56, P515, DOI 10.1262/jrd.10-056T; Jiemtaweeboon S, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-79; JUENGEL JL, 1993, ENDOCRINOLOGY, V132, P249, DOI 10.1210/en.132.1.249; Kaur J, 2001, AM J PHYSIOL-HEART C, V281, pH784, DOI 10.1152/ajpheart.2001.281.2.H784; KHOURY EL, 1990, CELL TISSUE RES, V262, P217, DOI 10.1007/BF00309876; Klipper E, 2004, REPRODUCTION, V128, P463, DOI 10.1530/rep.1.00271; Kumar V, 2002, ROBBINS BASIC PATHOL; Liptak AR, 2005, BIOL REPROD, V72, P1169, DOI 10.1095/biolreprod.104.032953; Maliba R, 2008, J LEUKOCYTE BIOL, V83, P352, DOI 10.1189/jlb.0107056; MCCRACKEN JA, 1981, ACTA VET SCAND, P71; Meidan R, 2005, DOMEST ANIM ENDOCRIN, V29, P318, DOI 10.1016/j.domaniend.2005.04.003; Minegishi K, 2002, AM J PHYSIOL-ENDOC M, V283, pE1308, DOI 10.1152/ajpendo.00240.2002; MIYAMOTO A, 1992, J ENDOCRINOL, V135, P103, DOI 10.1677/joe.0.1350103; Murayama C, 2010, CELL BIOL INT, V34, P531, DOI 10.1042/CBI20090498; MURDOCH WJ, 1988, MED HYPOTHESES, V27, P197, DOI 10.1016/0306-9877(88)90141-7; NETT TM, 1976, BIOL REPROD, V15, P66, DOI 10.1095/biolreprod15.1.66; Okuda Kiyoshi, 2003, Reprod Biol Endocrinol, V1, P95, DOI 10.1186/1477-7827-1-95; Paape MJ, 2003, VET RES, V34, P597, DOI 10.1051/vetres:2003024; Pate JL, 2001, REPRODUCTION, V122, P665, DOI 10.1530/rep.0.1220665; PATE JL, 1995, J REPROD FERTIL, P365; Penny LA, 1999, J REPROD FERTIL, V115, P87, DOI 10.1530/jrf.0.1150087; PEPPERELL JR, 1992, ENDOCRINOLOGY, V130, P1001, DOI 10.1210/en.130.2.1001; Runesson E, 2000, J CLIN ENDOCR METAB, V85, P4387, DOI 10.1210/jc.85.11.4387; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Sales KJ, 2009, BBA-MOL CELL RES, V1793, P1917, DOI 10.1016/j.bbamcr.2009.09.018; SAWYER HR, 1990, DOMEST ANIM ENDOCRIN, V7, P229, DOI 10.1016/0739-7240(90)90029-Y; Schruefer R, 2005, AM J PHYSIOL-HEART C, V288, pH1186, DOI 10.1152/ajpheart.00237.2004; Shirasuna K, 2008, REPRODUCTION, V135, P527, DOI 10.1530/REP-07-0496; Shirasuna K, 2010, J REPROD DEVELOP, V56, P428, DOI 10.1262/jrd.10-004O; Sohn EJ, 2007, VET RES, V38, P809, DOI 10.1051/vetres:2007033; SPANELBOROWSKI K, 1991, CELL TISSUE RES, V266, P37, DOI 10.1007/BF00678709; SUGAMA Y, 1992, J CELL BIOL, V119, P935, DOI 10.1083/jcb.119.4.935; Sugino N, 2007, J REPROD DEVELOP, V53, P977, DOI 10.1262/jrd.19047; Townson DH, 2002, BIOL REPROD, V66, P361, DOI 10.1095/biolreprod66.2.361; Watanabe S, 2006, J REPROD DEVELOP, V52, P551, DOI 10.1262/jrd.18018; Yasuda M, 2000, LIFE SCI, V66, P2113, DOI 10.1016/S0024-3205(00)00537-3	51	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29054	10.1371/journal.pone.0029054	http://dx.doi.org/10.1371/journal.pone.0029054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235260	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000301123400021
J	Singh, H; Hansen, TM; Patel, N; Brindle, NPJ				Singh, Harprit; Hansen, Tania M.; Patel, Nisha; Brindle, Nicholas P. J.			The Molecular Balance between Receptor Tyrosine Kinases Tie1 and Tie2 Is Dynamically Controlled by VEGF and TNF alpha and Regulates Angiopoietin Signalling	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; ECTODOMAIN CLEAVAGE; SURFACE-RECEPTOR; SOLUBLE TIE; EXPRESSION; ANGIOGENESIS; CYTOKINES; HYPOXIA; RELEASE; LIGAND	Angiopoietin-1 (Ang1) signals via the receptor tyrosine kinase Tie2 which exists in complex with the related protein Tie1 at the endothelial cell surface. Tie1 undergoes regulated ectodomain cleavage in response to phorbol esters, vascular endothelial growth factor (VEGF) and tumour necrosis factor-alpha (TNF alpha). Recently phorbol esters and VEGF were found also to stimulate ectodomain cleavage of Tie2. Here we investigate for the first time the effects of factors activating ectodomain cleavage on both Tie1 and Tie2 within the same population of cells, and their impact on angiopoietin signalling. We find that phorbol ester and VEGF activated Tie1 cleavage within minutes followed by restoration to control levels by 24 h. However, several hours of PMA and VEGF treatment were needed to elicit a detectable decrease in cellular Tie2, with complete loss seen at 24 h of PMA treatment. TNF alpha stimulated Tie1 cleavage, and induced a sustained decrease in cellular Tie1 over 24 h whilst increasing cellular Tie2. These differential effects of agonists on Tie1 and Tie2 result in dynamic modulation of the cellular Tie2: Tie1 ratio. To assess the impact of this on Ang1 signalling cells were stimulated with VEGF and TNF alpha for differing times and Ang1-induced Tie2 phosphorylation examined. Elevated Tie2: Tie1, in response to acute VEGF treatment or chronic TNF alpha, was associated with increased Ang1-activated Tie2 in cells. These data demonstrate cellular levels of Tie1 and Tie2 are differentially regulated by pathophysiologically relevant agonists resulting in dynamic control of the cellular Tie2: Tie1 balance and modulation of Ang1 signalling. These findings highlight the importance of regulation of signalling at the level of the receptor. Such control may be an important adaptation to allow modulation of cellular signalling responses in systems in which the activating ligand is normally present in excess or where the ligand provides a constitutive maintenance signal.	[Singh, Harprit; Hansen, Tania M.; Patel, Nisha; Brindle, Nicholas P. J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England	University of Leicester	Singh, H (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.	npjb1@le.ac.uk		Brindle, Nicholas/0000-0002-4221-677X	British Heart Foundation [PG/07/029/22656, PG/08/123/26405]	British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation (www.bhf.org.uk) grants PG/07/029/22656 and PG/08/123/26405. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Cabrera N, 1996, J CELL BIOL, V132, P427, DOI 10.1083/jcb.132.3.427; Chen-Konak L, 2003, FASEB J, V17, P2121, DOI 10.1096/fj.02-1151fje; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DUMONT DJ, 1993, ONCOGENE, V8, P1293; DUMONT DJ, 1992, ONCOGENE, V7, P71; Findley CM, 2007, ARTERIOSCL THROM VAS, V27, P2619, DOI 10.1161/ATVBAHA.107.150482; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Jones PF, 2003, J PATHOL, V201, P515, DOI 10.1002/path.1452; Linggi B, 2006, ONCOGENE, V25, P160, DOI 10.1038/sj.onc.1209003; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; MAISONPIERRE PC, 1993, ONCOGENE, V8, P1631; Mandriota SJ, 1998, CIRC RES, V83, P852, DOI 10.1161/01.RES.83.8.852; Marron MB, 2007, J BIOL CHEM, V282, P30509, DOI 10.1074/jbc.M702535200; Marron MB, 2000, J BIOL CHEM, V275, P39741, DOI 10.1074/jbc.M007189200; MATTHEWS JA, 1985, ANAL BIOCHEM, V151, P205, DOI 10.1016/0003-2697(85)90073-9; McCarthy MJ, 1999, LAB INVEST, V79, P889; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Oh H, 1999, J BIOL CHEM, V274, P15732, DOI 10.1074/jbc.274.22.15732; Onimaru M, 2010, ARTERIOSCL THROM VAS, V30, P818, DOI 10.1161/ATVBAHA.109.201111; PARTANEN J, 1992, MOL CELL BIOL, V12, P1698, DOI 10.1128/MCB.12.4.1698; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Reusch Petra, 2001, Angiogenesis, V4, P123, DOI 10.1023/A:1012226627813; RUNTING AS, 1993, GROWTH FACTORS, V9, P99; Singh H, 2009, CELL SIGNAL, V21, P1346, DOI 10.1016/j.cellsig.2009.04.002; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tadros A, 2003, BLOOD, V102, P4407, DOI 10.1182/blood-2003-05-1602; Tsiamis AC, 2002, MICROVASC RES, V63, P149, DOI 10.1006/mvre.2001.2377; Wilhelmsen K, 2004, MOL CELL BIOL, V24, P454, DOI 10.1128/MCB.24.1.454-464.2004; Willam C, 2000, CIRC RES, V87, P370; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Yabkowitz R, 1999, BLOOD, V93, P1969, DOI 10.1182/blood.V93.6.1969.406k14_1969_1979; Yabkowitz R, 1997, BLOOD, V90, P706, DOI 10.1182/blood.V90.2.706.706_706_715; Yuan HT, 2007, FASEB J, V21, P3171, DOI 10.1096/fj.07-8487com; ZIEGLER SF, 1993, ONCOGENE, V8, P663	36	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29319	10.1371/journal.pone.0029319	http://dx.doi.org/10.1371/journal.pone.0029319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235284	Green Submitted, gold, Green Published			2022-12-27	WOS:000301123400045
J	Cuttica, MJ; Shah, SJ; Rosenberg, SR; Orr, R; Beussink, L; Dematte, JE; Smith, LJ; Kalhan, R				Cuttica, Michael J.; Shah, Sanjiv J.; Rosenberg, Sharon R.; Orr, Randy; Beussink, Lauren; Dematte, Jane E.; Smith, Lewis J.; Kalhan, Ravi			Right Heart Structural Changes Are Independently Associated with Exercise Capacity in Non-Severe COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ARTERIAL-HYPERTENSION; EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY; RIGHT VENTRICLE; 6-MINUTE WALK; LUNG; ECHOCARDIOGRAPHY; STANDARDIZATION; GUIDELINES	Background: Pulmonary hypertension (PH) occurs frequently and results in functional limitation in advanced COPD. Data regarding the functional consequence of PH in less severe COPD are limited. Whether echocardiographic evidence of right sided heart pathology is associated with functional outcomes in patients with non-severe COPD is unknown. Methods: We evaluated pulmonary function, six minute walk distance, and echocardiography in 74 consecutive patients with non-severe COPD. We performed multivariable linear regression to evaluate the association between right heart echocardiographic parameters and six minute walk distance adjusting for lung function, age, sex, race, and BMI. Main Results: The mean six minute walk distance was 324+/-106 meters. All subjects had preserved left ventricular (LV) systolic function (LV ejection fraction 62.3%+/-6.1%). 54.1% had evidence of some degree of diastolic dysfunction. 17.6% of subjects had evidence of right ventricular enlargement and 36.5% had right atrial enlargement. In univariate analysis RV wall thickness (beta = -68.6; p = 0.002), log right atrial area (beta = -297.9; p = 0.004), LV mass index (beta = -1.3; p = 0.03), E/E' ratio (beta = -5.5; p = 0.02), and degree of diastolic dysfunction (beta = -42.8; p = 0.006) were associated with six minute walk distance. After adjustment for co-variables, the associations between right atrial area (log right atrial area beta = -349.8; p = 0.003) and right ventricular wall thickness (beta = 243.8; p = 0.04) with lower six minute walk distance remained significant independent of forced expiratory volume in one second (FEV1). LV mass index, E/E' ratio, and degree of diastolic dysfunction were not independent predictors of six minute walk distance. Conclusion: In patients with non-severe COPD right sided cardiac structural changes are associated with lower six minute walk distance independent of lung function. These findings may indicate that echocardiographic evidence of pulmonary hypertension is present in patients with non-severe COPD and has important functional consequences.	[Cuttica, Michael J.; Shah, Sanjiv J.; Orr, Randy; Dematte, Jane E.] Northwestern Univ, Pulm Hypertens Program, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Rosenberg, Sharon R.; Smith, Lewis J.; Kalhan, Ravi] Northwestern Univ, Asthma & COPD Program, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Shah, Sanjiv J.; Beussink, Lauren] Northwestern Univ, Dept Med, Div Cardiol, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University	Cuttica, MJ (corresponding author), Northwestern Univ, Pulm Hypertens Program, Div Pulm & Crit Care Med, Chicago, IL 60611 USA.	m-cuttica@northwestern.edu	Shah, Sanjiv J./AFQ-9480-2022	Kalhan, Ravi/0000-0003-2443-0876; Smith, Lewis J/0000-0002-4728-1562; Beussink-Nelson, MHS, RDCS, Lauren/0000-0002-7260-6912	Northwestern University [1 K12 HL 083790-01A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL083790] Funding Source: NIH RePORTER	Northwestern University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This manuscript was supported by the Vascular Medicine at Northwestern University Grant (1 K12 HL 083790-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badano LP, 2010, EUR J ECHOCARDIOGR, V11, P27, DOI 10.1093/ejechocard/jep152; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Cuttica M. J., 2010, RESP MED; Cuttica MJ, 2010, RESP MED, V104, P1877, DOI 10.1016/j.rmed.2010.05.009; Decramer M, 2009, LANCET, V374, P1171, DOI 10.1016/S0140-6736(09)61298-8; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; Fan VS, 2007, ARCH INTERN MED, V167, P2345, DOI 10.1001/archinte.167.21.2345; Ghio S, 2011, AM J CARDIOL, V107, P628, DOI 10.1016/j.amjcard.2010.10.027; Han MK, 2007, CIRCULATION, V116, P2992, DOI 10.1161/CIRCULATIONAHA.106.685206; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Higham MA, 2001, EUR RESPIR J, V17, P350, DOI 10.1183/09031936.01.17303500; Holtzman D, 2011, ANN NONINVAS ELECTRO, V16, P30, DOI 10.1111/j.1542-474X.2010.00404.x; Kessler R, 2001, AM J RESP CRIT CARE, V164, P219, DOI 10.1164/ajrccm.164.2.2006129; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lindqvist P, 2005, CHEST, V128, P755, DOI 10.1378/chest.128.2.755; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Minino A., 2010, NATL VITAL STAT REPO; OSWALDMAMMOSSER M, 1995, CHEST, V107, P1193, DOI 10.1378/chest.107.5.1193; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Raymond RJ, 2002, J AM COLL CARDIOL, V39, P1214, DOI 10.1016/S0735-1097(02)01744-8; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Santos S, 2002, EUR RESPIR J, V19, P632, DOI 10.1183/09031936.02.00245902; Scharf SM, 2002, AM J RESP CRIT CARE, V166, P314, DOI 10.1164/rccm.2107027; Simon MA, 2009, CTS-CLIN TRANSL SCI, V2, P294, DOI 10.1111/j.1752-8062.2009.00134.x; Sims MW, 2009, CHEST, V136, P412, DOI 10.1378/chest.08-2739; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Thabut G, 2005, CHEST, V127, P1531, DOI 10.1378/chest.127.5.1531; Vondracek Sheryl F, 2009, Int J Chron Obstruct Pulmon Dis, V4, P267; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005	32	36	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29069	10.1371/journal.pone.0029069	http://dx.doi.org/10.1371/journal.pone.0029069			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220201	Green Published, gold, Green Submitted			2022-12-27	WOS:000300677000014
J	Fernandez, P; Maier, M; Lindauer, M; Kuffer, C; Storchova, Z; Bausch, AR				Fernandez, Pablo; Maier, Matthias; Lindauer, Martina; Kuffer, Christian; Storchova, Zuzana; Bausch, Andreas R.			Mitotic Spindle Orients Perpendicular to the Forces Imposed by Dynamic Shear	PLOS ONE			English	Article							ASYMMETRIC CELL-DIVISION; C-ELEGANS; SHAPE; CHECKPOINT; MECHANISM; POSITION; TENSION	Orientation of the division axis can determine cell fate in the presence of morphogenetic gradients. Understanding how mitotic cells integrate directional cues is therefore an important question in embryogenesis. Here, we investigate the effect of dynamic shear forces on confined mitotic cells. We found that human epithelial cells (hTERT-RPE1) as well as MC3T3 osteoblasts align their mitotic spindle perpendicular to the external force. Spindle orientation appears to be a consequence of cell elongation along the zero-force direction in response to the dynamic shear. This process is a nonlinear response to the strain amplitude, requires actomyosin activity and correlates with redistribution of myosin II. Mechanosteered cells divide normally, suggesting that this mechanism is compatible with biological functions.	[Fernandez, Pablo; Maier, Matthias; Lindauer, Martina; Bausch, Andreas R.] Tech Univ Munich, D-8046 Garching, Germany; [Kuffer, Christian; Storchova, Zuzana] Max Planck Inst Biochem, Garching, Germany	Technical University of Munich; Max Planck Society	Fernandez, P (corresponding author), Tech Univ Munich, D-8046 Garching, Germany.	pablo.fernandez@mytum.de	Kuffer, Christian CK/D-9314-2015	Kuffer, Christian CK/0000-0003-3798-8959; Storchova, Zuzana/0000-0003-2376-7047	Deutsche Forschungsgemeinschaft [SFB 863]; German Excellence Initiative "International Graduate School for Science and Engineering''; Nanosystems Initiative Munich	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Excellence Initiative "International Graduate School for Science and Engineering''; Nanosystems Initiative Munich	Funding for this work comes from the Deutsche Forschungsgemeinschaft in the framework of the SFB 863, from the German Excellence Initiative "International Graduate School for Science and Engineering'' and the "Nanosystems Initiative Munich''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abal M, 2005, BIOL CELL, V97, P425, DOI 10.1042/BC20040112; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bloom K, 2010, CURR BIOL, V20, pR1040, DOI 10.1016/j.cub.2010.10.055; Effler JC, 2007, CELL CYCLE, V6, P30, DOI 10.4161/cc.6.1.3674; Fernandez P, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/419; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; FISHKIND DJ, 1995, CURR OPIN CELL BIOL, V7, P23, DOI 10.1016/0955-0674(95)80041-7; Gachet Y, 2004, EMBO J, V23, P1289, DOI 10.1038/sj.emboj.7600156; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; HONDA H, 1983, INT REV CYTOL, V81, P191, DOI 10.1016/S0074-7696(08)62339-6; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; HU M, 1962, IRE T INFORM THEOR, V8, P179, DOI 10.1109/tit.1962.1057692; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Schmoller KM, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1134; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Strauss B, 2006, DEVELOPMENT, V133, P3883, DOI 10.1242/dev.02578; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2008, HFSP J, V2, P65, DOI 10.2976/1.2895661; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Tsou MFB, 2002, DEVELOPMENT, V129, P4469	27	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e28965	10.1371/journal.pone.0028965	http://dx.doi.org/10.1371/journal.pone.0028965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220200	gold, Green Submitted, Green Published			2022-12-27	WOS:000300677000012
J	Garcia, SP; Pinho, AJ				Garcia, Sara P.; Pinho, Armando J.			Minimal Absent Words in Four Human Genome Assemblies	PLOS ONE			English	Article							SEQUENCE	Minimal absent words have been computed in genomes of organisms from all domains of life. Here, we aim to contribute to the catalogue of human genomic variation by investigating the variation in number and content of minimal absent words within a species, using four human genome assemblies. We compare the reference human genome GRCh37 assembly, the HuRef assembly of the genome of Craig Venter, the NA12878 assembly from cell line GM12878, and the YH assembly of the genome of a Han Chinese individual. We find the variation in number and content of minimal absent words between assemblies more significant for large and very large minimal absent words, where the biases of sequencing and assembly methodologies become more pronounced. Moreover, we find generally greater similarity between the human genome assemblies sequenced with capillary-based technologies (GRCh37 and HuRef) than between the human genome assemblies sequenced with massively parallel technologies (NA12878 and YH). Finally, as expected, we find the overall variation in number and content of minimal absent words within a species to be generally smaller than the variation between species.	[Garcia, Sara P.; Pinho, Armando J.] Univ Aveiro, Signal Proc Lab, Inst Elect & Telemat Engn Aveiro, P-3800 Aveiro, Portugal; [Pinho, Armando J.] Univ Aveiro, Dept Elect Telecommun & Informat, P-3800 Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro	Garcia, SP (corresponding author), Univ Aveiro, Signal Proc Lab, Inst Elect & Telemat Engn Aveiro, P-3800 Aveiro, Portugal.	spgarcia@ua.pt	Pinho, Armando J/A-2309-2012	Pinho, Armando/0000-0002-9164-0016; Garcia, Sara/0000-0003-3312-6454	Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e a Tecnologia) [FCOMP-01-0124-FEDER-010095]; COMPETE; QREN (Quadro de Referencia Estrategico Nacional); FEDER (Fundo Europeu de Desenvolvimento Regional); European Social Fund; Portuguese Ministry of Education and Science	Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); COMPETE; QREN (Quadro de Referencia Estrategico Nacional); FEDER (Fundo Europeu de Desenvolvimento Regional)(European Commission); European Social Fund(European Social Fund (ESF)); Portuguese Ministry of Education and Science(Portuguese Foundation for Science and Technology)	This work was supported by project grant FCOMP-01-0124-FEDER-010095, funded by the Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e a Tecnologia) and co-funded by COMPETE (Programa Operacional Factores de Competitividade), QREN (Quadro de Referencia Estrategico Nacional), and FEDER (Fundo Europeu de Desenvolvimento Regional). SPG acknowledges funding from the European Social Fund and the Portuguese Ministry of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouelhoda MI, 2002, LECT NOTES COMPUT SC, V2452, P449; Acquisti C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001022; Burrows M, 1994, SRCRR124; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dembo A., 1992, ANN APPL PROBAB, V2, P329, DOI DOI 10.1214/aoap/1177005707; Garcia SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016065; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gusfield D., 1997, ALGORITHMS STRINGS T; Hampikian G, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P355; Herold J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-167; Jaccard P., 1901, B SOC VAUD SCI N, V37, P241, DOI DOI 10.5169/SEALS-266450; Kasai T, 2001, P 12 ANN S COMB PATT, V2089, P182; Khan Z, 2009, BIOINFORMATICS, V25, P1609, DOI 10.1093/bioinformatics/btp275; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lupski JR, 2010, CELL, V141, P1110, DOI 10.1016/j.cell.2010.06.014; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Ning K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012047; Pinho AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-137	20	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29344	10.1371/journal.pone.0029344	http://dx.doi.org/10.1371/journal.pone.0029344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220210	Green Published, gold, Green Submitted			2022-12-27	WOS:000300677000027
J	Bertrand, A; Chaigneau, A; Peraltilla, S; Ledesma, J; Graco, M; Monetti, F; Chavez, FP				Bertrand, Arnaud; Chaigneau, Alexis; Peraltilla, Salvador; Ledesma, Jesus; Graco, Michelle; Monetti, Florian; Chavez, Francisco P.			Oxygen: A Fundamental Property Regulating Pelagic Ecosystem Structure in the Coastal Southeastern Tropical Pacific	PLOS ONE			English	Article							ANCHOVY ENGRAULIS-RINGENS; SARDINE SARDINOPS-SAGAX; HUMBOLDT CURRENT SYSTEM; MINIMUM ZONE; CLIMATE VARIABILITY; PERU; HYPOXIA; TROPHODYNAMICS; COMMUNITIES; POPULATIONS	Background: In the southeastern tropical Pacific anchovy (Engraulis ringens) and sardine (Sardinops sagax) abundance have recently fluctuated on multidecadal scales and food and temperature have been proposed as the key parameters explaining these changes. However, ecological and paleoecological studies, and the fact that anchovies and sardines are favored differently in other regions, raise questions about the role of temperature. Here we investigate the role of oxygen in structuring fish populations in the Peruvian upwelling ecosystem that has evolved over anoxic conditions and is one of the world's most productive ecosystems in terms of forage fish. This study is particularly relevant given that the distribution of oxygen in the ocean is changing with uncertain consequences. Methodology/Principal Findings: A comprehensive data set is used to show how oxygen concentration and oxycline depth affect the abundance and distribution of pelagic fish. We show that the effects of oxygen on anchovy and sardine are opposite. Anchovy flourishes under relatively low oxygen conditions while sardine avoid periods/areas with low oxygen concentration and restricted habitat. Oxygen consumption, trophic structure and habitat compression play a fundamental role in fish dynamics in this important ecosystem. Conclusions/Significance: For the ocean off Peru we suggest that a key process, the need to breathe, has been neglected previously. Inclusion of this missing piece allows the development of a comprehensive conceptual model of pelagic fish populations and change in an ocean ecosystem impacted by low oxygen. Should current trends in oxygen in the ocean continue similar effects may be evident in other coastal upwelling ecosystems.	[Bertrand, Arnaud] IRD, EME IFEREMER IRD UM2 UMR212, Sete, France; [Bertrand, Arnaud; Chaigneau, Alexis; Peraltilla, Salvador; Ledesma, Jesus; Graco, Michelle; Monetti, Florian] Inst Mar Peru, Lima, Peru; [Chaigneau, Alexis] IRD, UMR LEGOS, Toulouse, France; [Monetti, Florian] UPMC CNRS IRD MNHN, IPSL LOCEAN, IRD, Paris, France; [Chavez, Francisco P.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA	Institut de Recherche pour le Developpement (IRD); Instituto del Mar del Peru; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Monterey Bay Aquarium Research Institute	Bertrand, A (corresponding author), IRD, EME IFEREMER IRD UM2 UMR212, Sete, France.	Arnaud.Bertrand@ird.fr	Chaigneau, Alexis/E-4324-2010; Bertrand, Arnaud/E-4251-2010	Bertrand, Arnaud/0000-0003-4723-179X; Graco, Michelle Ivette/0000-0002-6193-3256; chaigneau, alexis/0000-0001-6770-0114; Ledesma, Jesus/0000-0003-4919-7089				Alheit J, 2004, PROG OCEANOGR, V60, P201, DOI 10.1016/j.pocean.2004.02.006; Arntz Wolf E., 1991, Geological Society Special Publication, V58, P131, DOI 10.1144/GSL.SP.1991.058.01.10; Ayon P, 2011, MAR ECOL PROG SER, V422, P211, DOI 10.3354/meps08918; Bakun A, 2008, PROG OCEANOGR, V79, P290, DOI 10.1016/j.pocean.2008.10.027; Ballon M, 2011, PROG OCEANOGR, V91, P360, DOI 10.1016/j.pocean.2011.03.001; Bertrand A, 2004, FISH FISH, V5, P296, DOI 10.1111/j.1467-2679.2004.00165.x; Bertrand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010330; Bertrand A, 2008, PROG OCEANOGR, V79, P264, DOI 10.1016/j.pocean.2008.10.018; Brochier T, 2011, FISH FISH, V12, P94, DOI 10.1111/j.1467-2979.2010.00385.x; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Chavez FP, 2011, ANNU REV MAR SCI, V3, P227, DOI 10.1146/annurev.marine.010908.163917; Chavez FP, 2008, PROG OCEANOGR, V79, P95, DOI 10.1016/j.pocean.2008.10.012; Csirke Jorge, 1996, Boletin Instituto del Mar del Peru (Callao), V15, P1; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dunn PK, 2005, STAT COMPUT, V15, P267, DOI 10.1007/s11222-005-4070-y; Ekau W, 2005, AFR J MAR SCI, V27, P629, DOI 10.2989/18142320509504123; Ekau W, 2010, BIOGEOSCIENCES, V7, P1669, DOI 10.5194/bg-7-1669-2010; Espinoza P, 2009, PROG OCEANOGR, V83, P242, DOI 10.1016/j.pocean.2009.07.045; Espinoza P, 2008, PROG OCEANOGR, V79, P215, DOI 10.1016/j.pocean.2008.10.022; *FAO FISH AQ DEP, 2009, STAT WORLD FISH AQ 2; Field DB, 2009, CLIMATE CHANGE AND SMALL PELAGIC FISH, P45; Finney BP, 2010, J MARINE SYST, V79, P316, DOI 10.1016/j.jmarsys.2008.12.010; Freon P, 2009, PROG OCEANOGR, V83, P1, DOI 10.1016/j.pocean.2009.08.001; Fuenzalida R, 2009, DEEP-SEA RES PT II, V56, P1027, DOI 10.1016/j.dsr2.2008.11.001; GALLARDO VA, 1977, NATURE, V268, P331, DOI 10.1038/268331a0; Garcia H. E., 2010, WORLD OCEAN ATLAS 20, V3; Gutierrez D, 2009, BIOGEOSCIENCES, V6, P835, DOI 10.5194/bg-6-835-2009; Gutierrez D, 2008, PROG OCEANOGR, V79, P177, DOI 10.1016/j.pocean.2008.10.025; Gutierrez M, 2007, FISH OCEANOGR, V16, P155, DOI 10.1111/j.1365-2419.2006.00422.x; JAMES AG, 1989, J EXP MAR BIOL ECOL, V131, P81, DOI 10.1016/0022-0981(89)90001-4; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; Lluch-Belda D., 1992, Fisheries Oceanography, V1, P339, DOI 10.1111/j.1365-2419.1992.tb00006.x; McFarlane GA, 2002, AM FISH S S, V32, P195; Paulmier A, 2008, CONT SHELF RES, V28, P2746, DOI 10.1016/j.csr.2008.09.012; Pauly D., 2010, GASPING FISH PANTING; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Prince ED, 2010, FISH OCEANOGR, V19, P448, DOI 10.1111/j.1365-2419.2010.00556.x; REINIGER RF, 1968, DEEP-SEA RES, V15, P185, DOI 10.1016/0011-7471(68)90040-5; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rykaczewski RR, 2008, P NATL ACAD SCI USA, V105, P1965, DOI 10.1073/pnas.0711777105; Schwartzlose RA, 1999, S AFR J MARINE SCI, V21, P289; Seibel BA, 2011, J EXP BIOL, V214, P326, DOI 10.1242/jeb.049171; Serra R, 1998, GLOBAL VERSUS LOCAL CHANGES IN UPWELLING SYSTEMS, P267; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Swartzman G, 2008, PROG OCEANOGR, V79, P228, DOI 10.1016/j.pocean.2008.10.021; Valdes J, 2008, PROG OCEANOGR, V79, P198, DOI 10.1016/j.pocean.2008.10.002; van der Lingen CD, 2006, AFR J MAR SCI, V28, P465, DOI 10.2989/18142320609504199; vanderLingen CD, 1995, MAR ECOL PROG SER, V129, P41, DOI 10.3354/meps129041; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105	50	99	109	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29558	10.1371/journal.pone.0029558	http://dx.doi.org/10.1371/journal.pone.0029558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216315	Green Submitted, Green Published, gold			2022-12-27	WOS:000300676300066
J	Bollinger, T; Leutz, A; Leliavski, A; Skrum, L; Kovac, J; Bonacina, L; Benedict, C; Lange, T; Westermann, J; Oster, H; Solbach, W				Bollinger, Thomas; Leutz, Anton; Leliavski, Alexei; Skrum, Ludmila; Kovac, Judit; Bonacina, Luigi; Benedict, Christian; Lange, Tanja; Westermann, Juergen; Oster, Henrik; Solbach, Werner			Circadian Clocks in Mouse and Human CD4+T Cells	PLOS ONE			English	Article							GENE-EXPRESSION; T-CELLS; TNF-ALPHA; NK CELLS; RHYTHMS; SLEEP; GAMMA; TRANSCRIPTION; OSCILLATIONS; MACROPHAGES	Though it has been shown that immunological functions of CD4+ T cells are time of day-dependent, the underlying molecular mechanisms remain largely obscure. To address the question whether T cells themselves harbor a functional clock driving circadian rhythms of immune function, we analyzed clock gene expression by qPCR in unstimulated CD4+ T cells and immune responses of PMA/ionomycin stimulated CD4+ T cells by FACS analysis purified from blood of healthy subjects at different time points throughout the day. Molecular clock as well as immune function was further analyzed in unstimulated T cells which were cultured in serum-free medium with circadian clock reporter systems. We found robust rhythms of clock gene expression as well as, after stimulation, IL-2, IL-4, IFN-gamma production and CD40L expression in freshly isolated CD4+ T cells. Further analysis of IFN-gamma and CD40L in cultivated T cells revealed that these parameters remain rhythmic in vitro. Moreover, circadian luciferase reporter activity in CD4+ T cells and in thymic sections from PER2::LUCIFERASE reporter mice suggest that endogenous T cell clock rhythms are self-sustained under constant culture conditions. Microarray analysis of stimulated CD4+ T cell cultures revealed regulation of the NF-kappa B pathway as a candidate mechanism mediating circadian immune responses. Collectively, these data demonstrate for the first time that CD4+ T cell responses are regulated by an intrinsic cellular circadian oscillator capable of driving rhythmic CD4+ T cell immune responses.	[Bollinger, Thomas; Leutz, Anton; Skrum, Ludmila; Solbach, Werner] Univ Lubeck, Inst Med Microbiol & Hyg, Lubeck, Germany; [Benedict, Christian; Lange, Tanja] Univ Lubeck, Dept Neuroendocrinol, Lubeck, Germany; [Westermann, Juergen] Univ Lubeck, Inst Anat, Lubeck, Germany; [Leliavski, Alexei; Kovac, Judit; Oster, Henrik] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Bonacina, Luigi] Univ Geneva, GAP Biophoton, Geneva, Switzerland; [Bollinger, Thomas] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland	University of Lubeck; University of Lubeck; University of Lubeck; Max Planck Society; University of Geneva; University of Geneva	Bollinger, T (corresponding author), Univ Lubeck, Inst Med Microbiol & Hyg, Lubeck, Germany.	Thomas.Bollinger@uk-sh.de	Solbach, Werner/F-9217-2012; Bonacina, Luigi/A-6705-2009; Oster, Henrik/O-4426-2019; Solbach, Werner/O-8582-2015; Oster, Henrik/D-2335-2013; Benedict, Christian/K-2190-2017; Leliavski, Alexei/N-9333-2017; Lange, Tanja/Z-1688-2018	Bonacina, Luigi/0000-0003-0476-4473; Oster, Henrik/0000-0002-1414-7068; Solbach, Werner/0000-0002-3608-8652; Oster, Henrik/0000-0002-1414-7068; Benedict, Christian/0000-0002-8911-4068; Leliavski, Alexei/0000-0003-0279-9226; Lange, Tanja/0000-0001-8309-2112	DFG [FB 654, BO 3646/1-1]; University of Lubeck [E37-2008]	DFG(German Research Foundation (DFG)); University of Lubeck	This work was supported by the DFG SFB 654, project B5, B7, C4, C6, and C8, DFG BO 3646/1-1, the E37-2008 funding of the University of Lubeck. HO is an Emmy Noether fellow of the DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SN, 2008, SLEEP, V31, P608, DOI 10.1093/sleep/31.5.608; Arjona A, 2005, J IMMUNOL, V174, P7618, DOI 10.4049/jimmunol.174.12.7618; Arjona A, 2006, BRAIN BEHAV IMMUN, V20, P469, DOI 10.1016/j.bbi.2005.10.002; Arjona A, 2008, NEUROCHEM RES, V33, P708, DOI 10.1007/s11064-007-9501-z; Arjona A, 2006, J INTERF CYTOK RES, V26, P645, DOI 10.1089/jir.2006.26.645; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Boivin DB, 2003, BLOOD, V102, P4143, DOI 10.1182/blood-2003-03-0779; Bollinger T, 2009, CLIN EXP IMMUNOL, V155, P231, DOI 10.1111/j.1365-2249.2008.03822.x; Bollinger T, 2010, IMMUNOLOGY IN PRESS; Bollinger T, 2010, GERONTOLOGY, V56, P574, DOI 10.1159/000281827; Born J, 1997, J IMMUNOL, V158, P4454; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Dimitrov S, 2009, BLOOD, V113, P5134, DOI 10.1182/blood-2008-11-190769; Graham CM, 2007, IMMUNOLOGY, V121, P238, DOI 10.1111/j.1365-2567.2007.02563.x; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; HALBERG F, 1960, P SOC EXP BIOL MED, V103, P142; Hashiramoto A, 2010, J IMMUNOL, V184, P1560, DOI 10.4049/jimmunol.0903284; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Hayashi M, 2007, BIOL PHARM BULL, V30, P621, DOI 10.1248/bpb.30.621; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kashiwada M, 2011, EMBO J, V30, P2071, DOI 10.1038/emboj.2011.111; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Krappmann D, 2004, MOL CELL BIOL, V24, P6488, DOI 10.1128/MCB.24.14.6488-6500.2004; Liu JG, 2006, INFECT IMMUN, V74, P4750, DOI 10.1128/IAI.00287-06; Logan RW, 2011, BRAIN BEHAV IMMUN, V25, P101, DOI 10.1016/j.bbi.2010.08.007; Maier B, 2009, GENE DEV, V23, P708, DOI 10.1101/gad.512209; Motomura Y, 2011, NAT IMMUNOL, V12, P450, DOI 10.1038/ni.2020; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; OhAinle M, 2006, J VIROL, V80, P3853, DOI 10.1128/JVI.80.8.3853-3862.2006; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Phillips AC, 2008, PSYCHOPHYSIOLOGY, V45, P663, DOI 10.1111/j.1469-8986.2008.00662.x; Poellman L, 1988, ARBEITSMEDIZIN GESUN, P83; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sierakowski S, 2011, SCAND J RHEUMATOL, V40, P1, DOI 10.3109/03009742.2011.566433; Terazono H, 2003, P NATL ACAD SCI USA, V100, P6795, DOI 10.1073/pnas.0936797100; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	44	119	121	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29801	10.1371/journal.pone.0029801	http://dx.doi.org/10.1371/journal.pone.0029801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216357	Green Published, gold, Green Submitted			2022-12-27	WOS:000300676300085
J	Cornett, JC; Landrette, SF; Xu, T				Cornett, Jonathan C.; Landrette, Sean F.; Xu, Tian			Characterization of Fluorescent Eye Markers for Mammalian Transgenic Studies	PLOS ONE			English	Article							MICE; PROTEINS; COINJECTION; EXPRESSION; GENE; IDENTIFICATION; STRATEGIES; CRYSTALLIN; TYROSINASE; CELLS	Genotyping mice by DNA based methods is both laborious and costly. As an alternative, we systematically examined fluorescent proteins expressed in the lens as transgenic markers for mice. A set of eye markers has been selected such that double and triple transgenic animals can be visually identified and that fluorescence intensity in the eyes can be used to distinguish heterozygous from homozygous mice. Taken together, these eye markers dramatically reduce the time and cost of genotyping transgenics and empower analysis of genetic interaction.	[Cornett, Jonathan C.; Landrette, Sean F.; Xu, Tian] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Boyer Ctr Mol Med, New Haven, CT 06510 USA; [Xu, Tian] Fudan Univ, Inst Dev Biol & Mol Med, Fudan Yale Ctr Biomed Res, Sch Life Sci, Shanghai 200433, Peoples R China	Howard Hughes Medical Institute; Yale University; Fudan University	Cornett, JC (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Boyer Ctr Mol Med, New Haven, CT 06510 USA.	tian.xu@yale.edu			Howard Hughes Medical Institute; National Cancer Institute [F32CA132320]; Anna Fuller Fund Fellowship in Molecular Oncology; American Cancer Society [PF-08-256-01-GMC]; NATIONAL CANCER INSTITUTE [F32CA132320] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Anna Fuller Fund Fellowship in Molecular Oncology; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Howard Hughes Medical Institute as well as the following sources: JCC was supported by a fellowship from the National Cancer Institute (F32CA132320); SFL was supported by an Anna Fuller Fund Fellowship in Molecular Oncology and an American Cancer Society New England Division Fellowship (PF-08-256-01-GMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEERMANN F, 1991, NUCLEIC ACIDS RES, V19, P958, DOI 10.1093/nar/19.4.958; CALDERONE L, 1986, EXP EYE RES, V42, P331, DOI 10.1016/0014-4835(86)90026-6; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Fu LZ, 2002, MOL REPROD DEV, V62, P470, DOI 10.1002/mrd.10137; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Landrette SF, PLOS ONE, V6, pe2; Langenau DM, 2008, ONCOGENE, V27, P4242, DOI 10.1038/onc.2008.56; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; METHOT D, 1995, NUCLEIC ACIDS RES, V23, P4551, DOI 10.1093/nar/23.22.4551; Overbeek Paul A., 1991, Transgenic Research, V1, P31, DOI 10.1007/BF02512994; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; YAMADA T, 1990, CURR EYE RES, V9, P31, DOI 10.3109/02713689009000052; Yang Y, 2006, EMBO J, V25, P2107, DOI 10.1038/sj.emboj.7601114; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhu HX, 2005, GENESIS, V42, P86, DOI 10.1002/gene.20129	21	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29486	10.1371/journal.pone.0029486	http://dx.doi.org/10.1371/journal.pone.0029486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216292	Green Submitted, Green Published, gold			2022-12-27	WOS:000300676300061
J	Zhao, YN; Mangalmurti, NS; Xiong, ZY; Prakash, B; Guo, FL; Stolz, DB; Lee, JS				Zhao, Yani; Mangalmurti, Nilam S.; Xiong, Zeyu; Prakash, Bharat; Guo, Fengli; Stolz, Donna B.; Lee, Janet S.			Duffy Antigen Receptor for Chemokines Mediates Chemokine Endocytosis through a Macropinocytosis-Like Process in Endothelial Cells	PLOS ONE			English	Article							AGONIST-INDUCED ENDOCYTOSIS; CIRCULAR DORSAL RUFFLES; EPIDERMAL-GROWTH-FACTOR; BLOOD-GROUP ANTIGEN; LIVING CELLS; A431 CELLS; INTERNALIZATION; CAVEOLAE; DYNAMIN; MECHANISMS	Background: The Duffy antigen receptor for chemokines (DARC) shows high affinity binding to multiple inflammatory CC and CXC chemokines and is expressed by erythrocytes and endothelial cells. Recent evidence suggests that endothelial DARC facilitates chemokine transcytosis to promote neutrophil recruitment. However, the mechanism of chemokine endocytosis by DARC remains unclear. Methodology/Principal Findings: We investigated the role of several endocytic pathways in DARC-mediated ligand internalization. Here we report that, although DARC co-localizes with caveolin-1 in endothelial cells, caveolin-1 is dispensable for DARC-mediated I-125-CXCL1 endocytosis as knockdown of caveolin-1 failed to inhibit ligand internalization. I-125-CXCL1 endocytosis by DARC was also independent of clathrin and flotillin-1 but required cholesterol and was, in part, inhibited by silencing Dynamin II expression. I-125-CXCL1 endocytosis was inhibited by amiloride, cytochalasin D, and the PKC inhibitor Go6976 whereas Platelet Derived Growth Factor (PDGF) enhanced ligand internalization through DARC. The majority of DARC-ligand interactions occurred on the endothelial surface, with DARC identified along plasma membrane extensions with the appearance of ruffles, supporting the concept that DARC provides a high affinity scaffolding function for surface retention of chemokines on endothelial cells. Conclusions/Significance: These results show DARC-mediated chemokine endocytosis occurs through a macropinocytosis-like process in endothelial cells and caveolin-1 is dispensable for CXCL1 internalization.	[Zhao, Yani; Xiong, Zeyu; Prakash, Bharat; Lee, Janet S.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Mangalmurti, Nilam S.] Univ Penn, Dept Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Guo, Fengli; Stolz, Donna B.] Univ Pittsburgh, Dept Cell Biol & Physiol, Ctr Biol Imaging, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhao, YN (corresponding author), Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.	leejs3@upmc.edu	Zhao, Yani/A-1968-2013	Lee, Janet/0000-0002-6812-6043; Mangalmurti, Nilam/0000-0002-9146-1608	National Institutes of Health [HL086884, HL086884-S1]; Institute for Transfusion Medicine (JSL); Vascular Medicine Institute Hemostasis and Vascular Biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Transfusion Medicine (JSL); Vascular Medicine Institute Hemostasis and Vascular Biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant HL086884, HL086884-S1, Vascular Medicine Institute Hemostasis and Vascular Biology Grant from the Institute for Transfusion Medicine (JSL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Anton IM, 2003, J CELL SCI, V116, P2443, DOI 10.1242/jcs.00433; BRENNER SL, 1980, J BIOL CHEM, V255, P841; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Chakera A, 2008, MOL PHARMACOL, V73, P1362, DOI 10.1124/mol.107.040915; Chaudhuri A, 1997, BLOOD, V89, P701, DOI 10.1182/blood.V89.2.701; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DARBONNE WC, 1991, J CLIN INVEST, V88, P1362, DOI 10.1172/JCI115442; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; DRAZNIN B, 1985, ENDOCRINOLOGY, V117, P960, DOI 10.1210/endo-117-3-960; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Grimmer S, 2002, J CELL SCI, V115, P2953; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; HADLEY TJ, 1994, J CLIN INVEST, V94, P985, DOI 10.1172/JCI117465; HAIGLER HT, 1980, J BIOL CHEM, V255, P1239; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hogan A, 2004, J BIOL CHEM, V279, P53717, DOI 10.1074/jbc.M410654200; HORUK R, 1994, J BIOL CHEM, V269, P17730; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Larsen EC, 2000, J IMMUNOL, V165, P2809, DOI 10.4049/jimmunol.165.5.2809; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Lee JS, 2006, J IMMUNOL, V177, P8086, DOI 10.4049/jimmunol.177.11.8086; Lee JS, 2003, J IMMUNOL, V170, P5244, DOI 10.4049/jimmunol.170.10.5244; Lee JS, 2003, J HISTOCHEM CYTOCHEM, V51, P159, DOI 10.1177/002215540305100204; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Liberali P, 2008, EMBO J, V27, P970, DOI 10.1038/emboj.2008.59; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Mangalmurti NS, 2009, BLOOD, V113, P1158, DOI 10.1182/blood-2008-07-166264; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Miaczynska M, 2008, J CELL BIOL, V180, P7, DOI 10.1083/jcb.200711073; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Muro S, 2003, J CELL SCI, V116, P1599, DOI 10.1242/jcs.00367; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; NEOTE K, 1994, BLOOD, V84, P44; NEOTE K, 1993, J BIOL CHEM, V268, P12247; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Orth JD, 2006, CANCER RES, V66, P11094, DOI 10.1158/0008-5472.CAN-06-3397; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; PEIPER SC, 1995, J EXP MED, V181, P1311, DOI 10.1084/jem.181.4.1311; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Reutershan J, 2009, EUR J IMMUNOL, V39, P1597, DOI 10.1002/eji.200839089; Rose JJ, 2004, J BIOL CHEM, V279, P24372, DOI 10.1074/jbc.M401364200; Rot Antal, 1996, Pathol Oncol Res, V2, P16; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Signoret N, 2005, MOL BIOL CELL, V16, P902, DOI 10.1091/mbc.e04-08-0687; SMART EJ, 1994, J CELL BIOL, V127, P1185, DOI 10.1083/jcb.127.5.1185; Stamatovic SM, 2009, J BIOL CHEM, V284, P19053, DOI 10.1074/jbc.M109.000521; Stolz DB, 2002, HEPATOLOGY, V36, P81, DOI 10.1053/jhep.2002.33716; SWANSON JA, 1989, J CELL SCI, V94, P135; SZABO MC, 1995, J BIOL CHEM, V270, P25348, DOI 10.1074/jbc.270.43.25348; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731	58	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29624	10.1371/journal.pone.0029624	http://dx.doi.org/10.1371/journal.pone.0029624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216333	Green Accepted, gold, Green Published			2022-12-27	WOS:000300674900047
J	Gallet, P; Phulpin, B; Merlin, JL; Leroux, A; Bravetti, P; Mecellem, H; Tran, N; Dolivet, G				Gallet, Patrice; Phulpin, Berengere; Merlin, Jean-Louis; Leroux, Agnes; Bravetti, Pierre; Mecellem, Hinda; Nguyen Tran; Dolivet, Gilles			Long-Term Alterations of Cytokines and Growth Factors Expression in Irradiated Tissues and Relation with Histological Severity Scoring	PLOS ONE			English	Article							INDUCED LUNG INJURY; RADIATION PNEUMONITIS; IONIZING-RADIATION; STROMAL CELLS; INFLAMMATORY CYTOKINES; THORACIC RADIOTHERAPY; FACTOR-BETA; HYPOXIA; FIBROSIS; RAT	Purpose: Beside its efficacy in cancer treatment, radiotherapy induces degeneration of healthy tissues within the irradiated area. The aim of this study was to analyze the variations of proinflammatory (IL-1 alpha, IL-2, IL-6, TNF-alpha, IFN-gamma), profibrotic (TGF-beta 1), proangiogneic (VEGF) and stem cell mobilizing (GM-CSF) cytokines and growth factors in an animal model of radiation-induced tissue degeneration. Materials and Methods: 24 rats were irradiated unilaterally on the hindlimb at a monodose of 30 Gy. Six weeks (n = 8), 6 months (n = 8) and 1 year (n = 8) after irradiation the mediators expression in skin and muscle were analyzed using Western blot and the Bio-Plex (R) protein array (BPA) technology. Additional histological severity for fibrosis, inflammation, vascularity and cellularity alterations scoring was defined from histology and immnunohistochemistry analyses. Results: A significant increase of histological severity scoring was found in irradiated tissue. Skin tissues were more radiosensitive than muscle. A high level of TGF-beta 1 expression was found throughout the study and a significant relation was evidenced between TGF-beta 1 expression and fibrosis scoring. Irradiated tissue showed a chronic inflammation (IL-2 and TNF-alpha significantly increased). Moreover a persistent expression of GM-CSF and VEGF was found in all irradiated tissues. The vascular score was related to TGF-beta 1 expression and the cellular alterations score was significantly related with the level of IL-2, VEGF and GM-CSF. Conclusion: The results achieved in the present study underline the complexity and multiplicity of radio-induced alterations of cytokine network. It offers many perspectives of development, for the comprehension of the mechanisms of late injuries or for the histological and molecular evaluation of the mode of action and the efficacy of rehabilitation techniques.	[Gallet, Patrice; Phulpin, Berengere; Merlin, Jean-Louis; Leroux, Agnes; Dolivet, Gilles] Nancy Univ, SiGReTO, EA4421, Fac Med, Vandoeuvre Les Nancy, France; [Phulpin, Berengere; Dolivet, Gilles] Ctr Alexis Vautrin, Dept Surg Oncol, Head & Neck Surg Unit, Vandoeuvre Les Nancy, France; [Phulpin, Berengere; Dolivet, Gilles] Ctr Alexis Vautrin, Dept Surg Oncol, Dent Unit, Vandoeuvre Les Nancy, France; [Merlin, Jean-Louis; Leroux, Agnes] Ctr Alexis Vautrin, Pathol & Tumor Biol Dept, Vandoeuvre Les Nancy, France; [Bravetti, Pierre] Nancy Univ, Fac Dent, Dept Oral Surg, Nancy, France; [Mecellem, Hinda] Ctr Alexis Vautrin, Dept Radiotherapy, Vandoeuvre Les Nancy, France; [Nguyen Tran] Nancy Univ, Fac Med, INSERM, Sch Surg,U961, Vandoeuvre Les Nancy, France	Universite de Lorraine; UNICANCER; Institut de cancerologie de Lorraine (ICL); UNICANCER; Institut de cancerologie de Lorraine (ICL); UNICANCER; Institut de cancerologie de Lorraine (ICL); Universite de Lorraine; UNICANCER; Institut de cancerologie de Lorraine (ICL); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine	Gallet, P (corresponding author), Nancy Univ, SiGReTO, EA4421, Fac Med, Vandoeuvre Les Nancy, France.	b.phulpin@nancy.unicancer.fr			French Ligue contre le cancer, Comites Lorrains	French Ligue contre le cancer, Comites Lorrains	This work was granted by the French Ligue contre le cancer, Comites Lorrains. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anscher MS, 1998, INT J RADIAT ONCOL, V41, P1029, DOI 10.1016/S0360-3016(98)00154-0; Arpin D, 2005, J CLIN ONCOL, V23, P8748, DOI 10.1200/JCO.2005.01.7145; Barthelemy-Brichant N, 2004, INT J RADIAT ONCOL, V58, P758, DOI 10.1016/S0360-3016(03)01614-6; Calveley VL, 2005, INT J RADIAT BIOL, V81, P887, DOI 10.1080/09553000600568002; Castro SV, 2010, BIOMARK MED, V4, P133, DOI 10.2217/BMM.09.79; Cha C, 2004, ANN SURG, V239, P903, DOI 10.1097/01.sla.0000128686.51815.8b; Chen YY, 2005, INT J RADIAT ONCOL, V62, P260, DOI 10.1016/j.ijrobp.2005.01.041; Coppes RP, 2009, SEMIN RADIAT ONCOL, V19, P112, DOI 10.1016/j.semradonc.2008.11.005; Dantzer D, 2003, J SURG ONCOL, V83, P185, DOI 10.1002/jso.10242; Denham JW, 2002, RADIOTHER ONCOL, V63, P129, DOI 10.1016/S0167-8140(02)00060-9; Dorr W, 2001, RADIOTHER ONCOL, V61, P223, DOI 10.1016/S0167-8140(01)00429-7; Ebrahimian TG, 2009, ARTERIOSCL THROM VAS, V29, P503, DOI 10.1161/ATVBAHA.108.178962; Fajardo LF, 2005, ACTA ONCOL, V44, P13, DOI 10.1080/02841860510007440; Fedorocko P, 2002, INT J RADIAT BIOL, V78, P305, DOI 10.1080/09553000110104614; Fleckenstein K, 2007, SEMIN RADIAT ONCOL, V17, P89, DOI 10.1016/j.semradonc.2006.11.004; Fong ELS, 2011, BIOMATERIALS, V32, P395, DOI 10.1016/j.biomaterials.2010.08.101; Fu XL, 2001, INT J RADIAT ONCOL, V50, P899, DOI 10.1016/S0360-3016(01)01524-3; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gaugler M-H, 2005, BRIT J RADIOL, V78, P100, DOI [10.1259/bjr/24511652, DOI 10.1259/BJR/24511652]; Girinsky T, 2000, J MAL VASCUL, V25, P321; Han SK, 2006, INT J RADIAT BIOL, V82, P686, DOI 10.1080/09553000600930699; Hart JP, 2005, INT J RADIAT ONCOL, V63, P1448, DOI 10.1016/j.ijrobp.2005.05.032; Hill RP, 2001, INT J RADIAT ONCOL, V49, P353, DOI 10.1016/S0360-3016(00)01484-X; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Hogle William P, 2006, Semin Oncol Nurs, V22, P212, DOI 10.1016/j.soncn.2006.07.004; HOPEWELL JW, 1989, FRONT RADIAT THER ON, V23, P85; Lefaix JL, 1998, HEALTH PHYS, V75, P375, DOI 10.1097/00004032-199810000-00003; Li YQ, 2001, CANCER RES, V61, P3348; Linard C, 2004, INT J RADIAT ONCOL, V58, P427, DOI 10.1016/j.ijrobp.2003.09.039; Liu Y, 2008, J RADIAT RES, V49, P261, DOI 10.1269/jrr.07099; Liu YB, 2006, J SURG RES, V136, P336, DOI 10.1016/j.jss.2006.07.037; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; Martin M, 1997, ONCOGENE, V15, P981, DOI 10.1038/sj.onc.1201433; Martin M, 2000, Cancer Radiother, V4, P369, DOI 10.1016/S1278-3218(00)00010-X; McFarlin K, 2006, WOUND REPAIR REGEN, V14, P471, DOI 10.1111/j.1743-6109.2006.00153.x; Milliat F., 2008, Annales de Cardiologie et d'Angeiologie, V57, P139, DOI 10.1016/j.ancard.2008.02.015; Okunieff P, 2005, INT J RADIAT ONCOL, V62, P273, DOI 10.1016/j.ijrobp.2005.01.034; Phulpin B, 2009, PLAST RECONSTR SURG, V123, P1187, DOI 10.1097/PRS.0b013e31819f2928; Rabbani ZN, 2010, RADIAT RES, V173, P165, DOI 10.1667/RR1816.1; RANDALL K, 1995, INT J RADIAT BIOL, V68, P301, DOI 10.1080/09553009514551231; Rieder F, 2011, INFLAMM BOWEL DIS; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x; Roy H, 2006, FEBS LETT, V580, P2879, DOI 10.1016/j.febslet.2006.03.087; Rube CE, 2005, INT J RADIAT ONCOL, V61, P1482, DOI 10.1016/j.ijrobp.2004.12.072; Rube CE, 2000, INT J RADIAT ONCOL, V47, P1033, DOI 10.1016/S0360-3016(00)00482-X; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; Schultze-Mosgau S, 2005, INT J RADIAT ONCOL, V61, P1189, DOI 10.1016/j.ijrobp.2004.12.008; Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4; Travis EL, 2001, SEMIN RADIAT ONCOL, V11, P184, DOI 10.1053/srao.2001.25243; von Bultzingslowen I, 2006, SUPPORT CARE CANCER, V14, P519, DOI 10.1007/s00520-006-0052-7; Vujaskovic Z, 2001, INT J RADIAT ONCOL, V50, P851, DOI 10.1016/S0360-3016(01)01593-0; Wang W, 2001, AM J PHYSIOL-HEART C, V280, pH434, DOI 10.1152/ajpheart.2001.280.1.H434; Williams J, 2003, SEMIN RADIAT ONCOL, V13, P182, DOI 10.1016/S1053-4296(03)00045-6; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	56	57	61	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29399	10.1371/journal.pone.0029399	http://dx.doi.org/10.1371/journal.pone.0029399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216271	Green Published, gold, Green Submitted			2022-12-27	WOS:000299684700052
J	Julien, S; Biesemeier, A; Kokkinou, D; Eibl, O; Schraermeyer, U				Julien, Sylvie; Biesemeier, Antje; Kokkinou, Despina; Eibl, Oliver; Schraermeyer, Ulrich			Zinc Deficiency Leads to Lipofuscin Accumulation in the Retinal Pigment Epithelium of Pigmented Rats	PLOS ONE			English	Article							SENILE MACULAR DEGENERATION; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; OCULAR MELANIN; ORAL ZINC; HUMAN RPE; MELANOSOMES; COPPER; CELLS; EXPRESSION	Background: Age-related macular degeneration (AMD) is associated with lipofuscin accumulation whereas the content of melanosomes decreases. Melanosomes are the main storage of zinc in the pigmented tissues. Since the elderly population, as the most affected group for AMD, is prone to zinc deficit, we investigated the chemical and ultrastructural effects of zinc deficiency in pigmented rat eyes after a six-month zinc penury diet. Methodology/Principal Findings: Adult Long Evans (LE) rats were investigated. The control animals were fed with a normal alimentation whereas the zinc-deficiency rats (ZD-LE) were fed with a zinc deficient diet for six months. Quantitative Energy Dispersive X-ray (EDX) microanalysis yielded the zinc mole fractions of melanosomes in the retinal pigment epithelium (RPE). The lateral resolution of the analysis was 100 nm. The zinc mole fractions of melanosomes were significantly smaller in the RPE of ZD-LE rats as compared to the LE control rats. Light, fluorescence and electron microscopy, as well as immunohistochemistry were performed. The numbers of lipofuscin granules in the RPE and of infiltrated cells (empty set > 3 mu m) found in the choroid were quantified. The number of lipofuscin granules significantly increased in ZD-LE as compared to control rats. Infiltrated cells bigger than 3 mu m were only detected in the choroid of ZD-LE animals. Moreover, the thickness of the Bruch's membrane of ZD-LE rats varied between 0.4-3 mu m and thin, rangy ED1 positive macrophages were found attached at these sites of Bruch's membrane or even inside it. Conclusions/Significance: In pigmented rats, zinc deficiency yielded an accumulation of lipofuscin in the RPE and of large pigmented macrophages in the choroids as well as the appearance of thin, rangy macrophages at Bruch's membrane. Moreover, we showed that a zinc diet reduced the zinc mole fraction of melanosomes in the RPE and modulated the thickness of the Bruch's membrane.	[Julien, Sylvie; Biesemeier, Antje; Kokkinou, Despina; Schraermeyer, Ulrich] Ctr Ophthalmol, Sect Expt Vitreoretinal Surg, Inst Ophthalm Res, Tubingen, Germany; [Eibl, Oliver] Univ Tubingen, Inst Appl Phys, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Julien, S (corresponding author), Ctr Ophthalmol, Sect Expt Vitreoretinal Surg, Inst Ophthalm Res, Tubingen, Germany.	Ulrich.Schraermeyer@med.uni-tuebingen.de		Julien-Schraermeyer, Sylvie/0000-0002-2322-511X; Biesemeier, Antje/0000-0002-3462-8803	Deutsche Forschungsgesellschaft DFG SCHR [436/12-2]	Deutsche Forschungsgesellschaft DFG SCHR	This work was supported by a grant from the Deutsche Forschungsgesellschaft DFG SCHR 436/12-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames BN, 1999, ANN NY ACAD SCI, V889, P87, DOI 10.1111/j.1749-6632.1999.tb08727.x; Bailey TA, 2001, EXP EYE RES, V73, P851, DOI 10.1006/exer.2001.1089; Berger A, 2002, BMJ-BRIT MED J, V325, P1062, DOI 10.1136/bmj.325.7372.1062; Biesemeier A, 2011, EXP EYE RES, V93, P29, DOI 10.1016/j.exer.2011.04.004; Biesemeier A, 2011, MICRON, V42, P461, DOI 10.1016/j.micron.2011.01.004; BOULTON M, 1993, J PHOTOCH PHOTOBIO B, V19, P201, DOI 10.1016/1011-1344(93)87085-2; Brewer G J, 1983, Prog Clin Biol Res, V129, P35; DOREY CK, 1989, INVEST OPHTH VIS SCI, V30, P1691; Eibl O, 2006, MICRON, V37, P262, DOI 10.1016/j.micron.2005.08.006; Erie JC, 2009, AM J OPHTHALMOL, V147, P276, DOI 10.1016/j.ajo.2008.08.014; FEENEY L, 1978, INVEST OPHTH VIS SCI, V17, P583; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; FELIX CC, 1978, BIOCHEM BIOPH RES CO, V84, P335, DOI 10.1016/0006-291X(78)90175-4; Friedman DS, 1999, OPHTHALMOLOGY, V106, P1049, DOI 10.1016/S0161-6420(99)90267-1; GLICKMAN RD, 1993, FREE RADICAL BIO MED, V15, P453, DOI 10.1016/0891-5849(93)90045-V; Gottschall PE, 1996, NEUROIMMUNOMODULAT, V3, P69, DOI 10.1159/000097229; GREEN WR, 1985, OPHTHALMOLOGY, V92, P615; GREGOR Z, 1978, BRIT J OPHTHALMOL, V62, P547, DOI 10.1136/bjo.62.8.547; HAMMERMUELLER JD, 1987, J NUTR, V117, P894, DOI 10.1093/jn/117.5.894; HILL HZ, 1992, BIOESSAYS, V14, P49, DOI 10.1002/bies.950140111; HORCICKO J, 1973, H-S Z PHYSIOL CHEM, V354, P203; HUBER AM, 1975, J NUTR, V105, P1486, DOI 10.1093/jn/105.11.1486; Hyun HJ, 2000, BRAIN RES, V869, P39, DOI 10.1016/S0006-8993(00)02340-4; KATZ ML, 1993, INVEST OPHTH VIS SCI, V34, P3161; KATZ ML, 1982, EXP EYE RES, V34, P339, DOI 10.1016/0014-4835(82)90082-3; KENNEDY CJ, 1994, EXP CELL RES, V210, P209, DOI 10.1006/excr.1994.1031; Kokkinou D, 2005, GRAEF ARCH CLIN EXP, V243, P1050, DOI 10.1007/s00417-005-1197-7; Kokkinou D, 2004, PIGM CELL RES, V17, P515, DOI 10.1111/j.1600-0749.2004.00177.x; KORYTOWSKI W, 1987, PHOTOCHEM PHOTOBIOL, V45, P185, DOI 10.1111/j.1751-1097.1987.tb05362.x; LEUREDUPREE AE, 1982, INVEST OPHTH VIS SCI, V23, P425; LEUREDUPREE AE, 1982, RETINA-J RET VIT DIS, V2, P294, DOI 10.1097/00006982-198202040-00015; LEUREDUPREE AE, 1981, INVEST OPHTH VIS SCI, V21, P1; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; MARTUZA RL, 1985, J INVEST DERMATOL, V85, P347, DOI 10.1111/1523-1747.ep12276952; MCCLAIN CJ, 1985, PROG FOOD NUTR SCI, V9, P185; Miceli MV, 1999, INVEST OPHTH VIS SCI, V40, P1238; NEWSOME DA, 1988, ARCH OPHTHALMOL-CHIC, V106, P192; Nicolas MG, 1996, EXP EYE RES, V62, P399, DOI 10.1006/exer.1996.0045; Pauleikhoff D., 1996, Ophthalmologe, V93, P299; Peters S, 1999, GRAEF ARCH CLIN EXP, V237, P976, DOI 10.1007/s004170050333; Rozanowska M, 1997, PHOTOCHEM PHOTOBIOL, V65, P472, DOI 10.1111/j.1751-1097.1997.tb08593.x; SAKINA N L, 1990, Radiobiologiya, V30, P28; SAMUELSON DA, 1993, EXP EYE RES, V56, P63, DOI 10.1006/exer.1993.1009; Samuelson Don A., 1999, Veterinary Ophthalmology, V2, P35; Samuelson Don A., 1999, Veterinary Ophthalmology, V2, P27; Sarangarajan R, 2006, MELANOMA RES, V16, P3, DOI 10.1097/01.cmr.0000195699.35143.df; SARNA T, 1992, J PHOTOCH PHOTOBIO B, V12, P215, DOI 10.1016/1011-1344(92)85027-R; Schraermeyer U, 1999, EXP EYE RES, V68, P237, DOI 10.1006/exer.1998.0596; Stur M, 1996, INVEST OPHTH VIS SCI, V37, P1225; TATE DJ, 1995, CURR EYE RES, V14, P897, DOI 10.3109/02713689508995129; TATE DJ, 1993, INVEST OPHTH VIS SCI, V34, P2348; WEISS LW, 1977, ARCH DERMATOL, V113, P491, DOI 10.1001/archderm.113.4.491; WEITER JJ, 1986, INVEST OPHTH VIS SCI, V27, P145; WEITER JJ, 1985, AM J OPHTHALMOL, V99, P185, DOI 10.1016/0002-9394(85)90230-2; WOLBARSHT ML, 1981, APPL OPTICS, V20, P2184, DOI 10.1364/AO.20.002184; Wu L, 1994, Metab Pediatr Syst Ophthalmol (1985), V17, P38	56	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29245	10.1371/journal.pone.0029245	http://dx.doi.org/10.1371/journal.pone.0029245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216222	Green Published, gold, Green Submitted			2022-12-27	WOS:000299684700043
J	Hosni-Ahmed, A; Barnes, JD; Wan, J; Jones, TS				Hosni-Ahmed, Amira; Barnes, Joseph D.; Wan, Jim; Jones, Terreia S.			Thiopurine Methyltransferase Predicts the Extent of Cytotoxicty and DNA Damage in Astroglial Cells after Thioguanine Exposure	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; INFLAMMATORY-BOWEL-DISEASE; SECONDARY BRAIN-TUMORS; S-METHYLTRANSFERASE; BIOCHEMICAL-PROPERTIES; MOLECULAR-MECHANISMS; TRANSPLANT RECIPIENT; MALIGNANT NEOPLASMS; MISMATCH REPAIR; AZATHIOPRINE	Thiopurine methyltransferase (Tpmt) is the primary enzyme responsible for deactivating thiopurine drugs. Thiopurine drugs (i.e., thioguanine [TG], mercaptopurine, azathioprine) are commonly used for the treatment of cancer, organ transplant, and autoimmune disorders. Chronic thiopurine therapy has been linked to the development of brain cancer (most commonly astrocytomas), and Tpmt status has been associated with this risk. Therefore, we investigated whether the level of Tpmt protein activity could predict TG-associated cytotoxicity and DNA damage in astrocytic cells. We found that TG induced cytotoxicity in a dose-dependent manner in Tpmt(+/+), Tpmt(+/-) and Tpmt(-/-) primary mouse astrocytes and that a low Tpmt phenotype predicted significantly higher sensitivity to TG than did a high Tpmt phenotype. We also found that TG exposure induced significantly more DNA damage in the form of single strand breaks (SSBs) and double strand breaks (DSBs) in primary astrocytes with low Tpmt versus high Tpmt. More interestingly, we found that Tpmt(+/-) astrocytes had the highest degree of cytotoxicity and genotoxicity (i.e., IC50, SSBs and DSBs) after TG exposure. We then used human glioma cell lines as model astroglial cells to represent high (T98) and low (A172) Tpmt expressers and found that A172 had the highest degree of cytoxicity and SSBs after TG exposure. When we over-expressed Tpmt in the A172 cell line, we found that TG IC50 was significantly higher and SSB's were significantly lower as compared to mock transfected cells. This study shows that low Tpmt can lead to greater sensitivity to thiopurine therapy in astroglial cells. When Tpmt deactivation at the germ-line is considered, this study also suggests that heterozygosity may be subject to the greatest genotoxic effects of thiopurine therapy.	[Hosni-Ahmed, Amira; Jones, Terreia S.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Barnes, Joseph D.; Jones, Terreia S.] Univ Tennessee, Hlth Sci Ctr, Dept Clin Pharm, Memphis, TN USA; [Jones, Terreia S.] Univ Tennessee, Hlth Sci Ctr, Dept Neurosurg, Memphis, TN USA; [Wan, Jim] Univ Tennessee, Hlth Sci Ctr, Div Biostat & Epidemiol, Memphis, TN USA; [Hosni-Ahmed, Amira] Fayoum Univ, Coll Sci, Dept Chem, Al Fayyum, Egypt	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Egyptian Knowledge Bank (EKB); Fayoum University	Hosni-Ahmed, A (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Memphis, TN 38163 USA.	tjones@uthsc.edu			Center for Translational Science Institute, University of Tennessee Health Science Center	Center for Translational Science Institute, University of Tennessee Health Science Center	The work was funded by the Center for Translational Science Institute, University of Tennessee Health Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chalastanis A, 2010, J NATL CANCER I, V102, P1731, DOI 10.1093/jnci/djq389; CHRISTIE NT, 1984, CANCER RES, V44, P3665; Cooley N, 2010, TOXICOLOGY, V268, P111, DOI 10.1016/j.tox.2009.12.008; Evans WE, 2001, J CLIN ONCOL, V19, P2293, DOI 10.1200/JCO.2001.19.8.2293; EVANS WE, 1991, J PEDIATR-US, V119, P985, DOI 10.1016/S0022-3476(05)83063-X; Guenova E, 2009, MELANOMA RES, V19, P271, DOI 10.1097/CMR.0b013e32831bc44a; Hartford C, 2007, CANCER RES, V67, P4965, DOI 10.1158/0008-5472.CAN-06-3508; HIESSE C, 1995, TRANSPLANT P, V27, P2450; Hijiya N, 2007, JAMA-J AM MED ASSOC, V297, P1207, DOI 10.1001/jama.297.11.1207; Kandiel A, 2005, GUT, V54, P1121, DOI 10.1136/gut.2004.049460; Karran P, 2001, CARCINOGENESIS, V22, P1931, DOI 10.1093/carcin/22.12.1931; Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292; Katyal S, 2007, EMBO J, V26, P4720, DOI 10.1038/sj.emboj.7601869; Kinsella TJ, 2009, CLIN CANCER RES, V15, P1853, DOI 10.1158/1078-0432.CCR-08-1307; Krynetski EY, 1996, PHARMACOGENETICS, V6, P279, DOI 10.1097/00008571-199608000-00001; MCLEOD HL, 1995, BLOOD, V85, P1897, DOI 10.1182/blood.V85.7.1897.bloodjournal8571897; NYGAARD R, 1991, ACTA PAEDIATR SCAND, V80, P1220, DOI 10.1111/j.1651-2227.1991.tb11812.x; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Otterness D, 1997, CLIN PHARMACOL THER, V62, P60, DOI 10.1016/S0009-9236(97)90152-1; Overall RW, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.15.003.2009; PENN I, 1993, J HEART LUNG TRANSPL, V12, pS328; Relling MV, 1999, JNCI-J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Relling MV, 1999, LANCET, V354, P34, DOI 10.1016/S0140-6736(98)11079-6; REMY CN, 1963, J BIOL CHEM, V238, P1078; ROSSO P, 1994, INT J CANCER, V59, P451, DOI 10.1002/ijc.2910590402; Schaeffeler E, 2004, PHARMACOGENETICS, V14, P407, DOI 10.1097/01.fpc.0000114745.08559.db; SCHUTZ E, 1993, LANCET, V341, P436, DOI 10.1016/0140-6736(93)93028-Y; Smith MA, 2010, ALIMENT PHARM THER, V32, P119, DOI 10.1111/j.1365-2036.2010.04330.x; Snanoudj R, 2003, TRANSPLANTATION, V76, P930, DOI 10.1097/01.TP.0000079253.06061.52; Stanulla M, 2009, BLOOD, V114, P1314, DOI 10.1182/blood-2008-12-193250; SZUMLANSKI CL, 1992, PHARMACOGENETICS, V2, P148, DOI 10.1097/00008571-199208000-00002; Tai HL, 1996, AM J HUM GENET, V58, P694; Tassaneeyakul W, 2003, TRANSPLANTATION, V76, P265, DOI 10.1097/01.TP.0000070521.22024.F1; Thomsen JB, 1999, CANCER-AM CANCER SOC, V86, P1080, DOI 10.1002/(SICI)1097-0142(19990915)86:6<1080::AID-CNCR26>3.0.CO;2-5; TIDD DM, 1974, CANCER RES, V34, P738; Vancura RW, 2006, SURG NEUROL, V65, P490, DOI 10.1016/j.surneu.2005.06.047; VANLOON JA, 1982, BIOCHEM GENET, V20, P637, DOI 10.1007/BF00483962; VANLOON JA, 1992, BIOCHEM PHARMACOL, V44, P775, DOI 10.1016/0006-2952(92)90416-G; Walter AW, 1998, J CLIN ONCOL, V16, P3761, DOI 10.1200/JCO.1998.16.12.3761; WEINSHILBOUM RM, 1980, AM J HUM GENET, V32, P651; WEINSHILBOUM RM, 1978, CLIN CHIM ACTA, V85, P323, DOI 10.1016/0009-8981(78)90311-X; Yan T, 2003, CLIN CANCER RES, V9, P2327; Yuan BF, 2008, J BIOL CHEM, V283, P23665, DOI 10.1074/jbc.M804047200; Yuan BF, 2010, ACS CHEM BIOL, V5, P1021, DOI 10.1021/cb100214b; Yue JM, 2010, BIOCHEM BIOPH RES CO, V394, P667, DOI 10.1016/j.bbrc.2010.03.047	45	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29163	10.1371/journal.pone.0029163	http://dx.doi.org/10.1371/journal.pone.0029163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216194	Green Published, Green Submitted, gold			2022-12-27	WOS:000299113600061
J	Chen, HM; Rosebrock, AP; Khan, SR; Futcher, B; Leatherwood, JK				Chen, Huei-Mei; Rosebrock, Adam P.; Khan, Sohail R.; Futcher, Bruce; Leatherwood, Janet K.			Repression of Meiotic Genes by Antisense Transcription and by Fkh2 Transcription Factor in Schizosaccharomyces pombe	PLOS ONE			English	Article							DNA-BINDING DOMAIN; FISSION YEAST; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; SELECTIVE ELIMINATION; EXPRESSION PROGRAM; ASCOSPORE WALL; BUDDING YEAST; MOUSE OOCYTES; 2ND DIVISION	In S. pombe, about 5% of genes are meiosis-specific and accumulate little or no mRNA during vegetative growth. Here we use Affymetrix tiling arrays to characterize transcripts in vegetative and meiotic cells. In vegetative cells, many meiotic genes, especially those induced in mid-meiosis, have abundant antisense transcripts. Disruption of the antisense transcription of three of these mid-meiotic genes allowed vegetative sense transcription. These results suggest that antisense transcription represses sense transcription of meiotic genes in vegetative cells. Although the mechanism(s) of antisense mediated transcription repression need to be further explored, our data indicates that RNAi machinery is not required for repression. Previously, we and others used non-strand specific methods to study splicing regulation of meiotic genes and concluded that 28 mid-meiotic genes are spliced only in meiosis. We now demonstrate that the "unspliced" signal in vegetative cells comes from the antisense RNA, not from unspliced sense RNA, and we argue against the idea that splicing regulates these mid-meiotic genes. Most of these mid-meiotic genes are induced in mid-meiosis by the forkhead transcription factor Mei4. Interestingly, deletion of a different forkhead transcription factor, Fkh2, allows low levels of sense expression of some mid-meiotic genes in vegetative cells. We propose that vegetative expression of mid-meiotic genes is repressed at least two independent ways: antisense transcription and Fkh2 repression.	[Chen, Huei-Mei; Rosebrock, Adam P.; Khan, Sohail R.; Futcher, Bruce; Leatherwood, Janet K.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Chen, HM (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	bfutcher@ms.cc.sunysb.edu; jleatherwood@ms.cc.sunysb.edu			National Institutes of Health [1060114-1-41911, 1063668-1-43264]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM088297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health grants 1060114-1-41911 and 1063668-1-43264. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2000, GENETICS, V154, P1497; ADHYA S, 1982, CELL, V29, P939, DOI 10.1016/0092-8674(82)90456-1; Almeida R, 2005, TRENDS CELL BIOL, V15, P251, DOI 10.1016/j.tcb.2005.03.006; Amorim MJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.38; Aranda A, 1999, MOL CELL BIOL, V19, P1251; Averbeck N, 2005, MOL CELL, V18, P491, DOI 10.1016/j.molcel.2005.04.007; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; Buske FA, 2010, BIOINFORMATICS, V26, P860, DOI 10.1093/bioinformatics/btq049; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Cervantes MD, 2000, MOL CELL, V5, P883, DOI 10.1016/S1097-2765(00)80328-7; Chen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026804; Cremona N, 2011, MOL BIOL CELL, V22, P66, DOI 10.1091/mbc.E10-05-0448; Darieva Z, 2006, NATURE, V444, P494, DOI 10.1038/nature05339; Darieva Z, 2010, MOL CELL, V38, P29, DOI 10.1016/j.molcel.2010.02.030; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Garcia I, 2006, MOL MICROBIOL, V59, P836, DOI 10.1111/j.1365-2958.2005.04995.x; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Ge XJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-27; Gelfand B, 2011, MOL CELL BIOL, V31, P1701, DOI 10.1128/MCB.01071-10; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; Huber W, 2006, BIOINFORMATICS, V22, P1963, DOI 10.1093/bioinformatics/btl289; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Juneau K, 2007, P NATL ACAD SCI USA, V104, P1522, DOI 10.1073/pnas.0610354104; KAUFMANN E, 1994, EUR J BIOCHEM, V223, P329, DOI 10.1111/j.1432-1033.1994.tb18998.x; KISHIDA M, 1994, CURR GENET, V25, P497, DOI 10.1007/BF00351668; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; Leatherwood J, 2010, MOL CELL, V38, P1, DOI 10.1016/j.molcel.2010.03.011; Li W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S20; Liu JH, 2000, FEBS LETT, V478, P105, DOI 10.1016/S0014-5793(00)01828-7; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Martin V, 2000, MOL MICROBIOL, V38, P308, DOI 10.1046/j.1365-2958.2000.02118.x; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556; Moldon A, 2008, NATURE, V455, P997, DOI 10.1038/nature07325; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; MULLER WEG, 1971, NATURE-NEW BIOL, V232, P143, DOI 10.1038/newbio232143a0; Nakamura T, 2000, GENES CELLS, V5, P463, DOI 10.1046/j.1365-2443.2000.00343.x; Nakamura T, 2002, MOL CELL BIOL, V22, P309, DOI 10.1128/MCB.22.1.309-320.2002; Ni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015271; Numata K, 2007, GENE, V392, P134, DOI 10.1016/j.gene.2006.12.005; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Reynolds D, 2003, GENE DEV, V17, P1789, DOI 10.1101/gad.1074103; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Rudra D, 2005, EMBO J, V24, P533, DOI 10.1038/sj.emboj.7600553; RUPRECHT RM, 1973, BIOCHIM BIOPHYS ACTA, V294, P192, DOI 10.1016/0005-2787(73)90292-X; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; SPIEGELMAN S, 1970, NATURE, V227, P1029, DOI 10.1038/2271029a0; St-Andre O, 2010, J BIOL CHEM, V285, P27859, DOI 10.1074/jbc.M110.150748; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Wade JT, 2004, NATURE, V432, P1054, DOI 10.1038/nature03175; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Werner A, 2009, CURR OPIN NEPHROL HY, V18, P343, DOI 10.1097/MNH.0b013e32832cb982; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Xu ZY, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.1; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87; Zhang LY, 2011, GENOME RES, V21, P875, DOI 10.1101/gr.117465.110	71	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29917	10.1371/journal.pone.0029917	http://dx.doi.org/10.1371/journal.pone.0029917			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238674	Green Submitted, Green Published, gold			2022-12-27	WOS:000301188800046
J	Gomes-Santos, CSS; Itoe, MA; Afonso, C; Henriques, R; Gardner, R; Sepulveda, N; Simoes, PD; Raquel, H; Almeida, AP; Moita, LF; Frischknecht, F; Mota, MM				Gomes-Santos, Carina S. S.; Itoe, Maurice A.; Afonso, Cristina; Henriques, Ricardo; Gardner, Rui; Sepulveda, Nuno; Simoes, Pedro D.; Raquel, Helena; Almeida, Antonio Paulo; Moita, Luis F.; Frischknecht, Friedrich; Mota, Maria M.			Highly Dynamic Host Actin Reorganization around Developing Plasmodium Inside Hepatocytes	PLOS ONE			English	Article							LIVER STAGE; CELL; MEMBRANE; PARASITE; CYTOSKELETON; LYSOSOMES; PATHOGEN	Plasmodium sporozoites are transmitted by Anopheles mosquitoes and infect hepatocytes, where a single sporozoite replicates into thousands of merozoites inside a parasitophorous vacuole. The nature of the Plasmodium-host cell interface, as well as the interactions occurring between these two organisms, remains largely unknown. Here we show that highly dynamic hepatocyte actin reorganization events occur around developing Plasmodium berghei parasites inside human hepatoma cells. Actin reorganization is most prominent between 10 to 16 hours post infection and depends on the actin severing and capping protein, gelsolin. Live cell imaging studies also suggest that the hepatocyte cytoskeleton may contribute to parasite elimination during Plasmodium development in the liver.	[Gomes-Santos, Carina S. S.; Itoe, Maurice A.; Afonso, Cristina; Mota, Maria M.] Univ Lisbon, Fac Med, Inst Mol Med, Malaria Unit, Lisbon, Portugal; [Gomes-Santos, Carina S. S.] Univ Coimbra, PhD Programme Expt Biol & Biomed, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Henriques, Ricardo] Univ Lisbon, Cell Biol Unit, Inst Mol Med, Lisbon, Portugal; [Gardner, Rui; Sepulveda, Nuno] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Sepulveda, Nuno] Univ Lisbon, Ctr Stat & Applicat, P-1699 Lisbon, Portugal; [Simoes, Pedro D.; Raquel, Helena; Moita, Luis F.] Univ Lisbon, Cell Biol Immune Syst Unit, Inst Mol Med, Lisbon, Portugal; [Almeida, Antonio Paulo] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Entomol Med UPMM, P-1200 Lisbon, Portugal; [Frischknecht, Friedrich] Heidelberg Univ, Dept Infect Dis, Sch Med, Heidelberg, Germany	Universidade de Lisboa; Universidade de Coimbra; Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Universidade de Lisboa; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Ruprecht Karls University Heidelberg	Gomes-Santos, CSS (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, Malaria Unit, Lisbon, Portugal.	freddy.frischknecht@med.uni-heidelberg.de; mmota@fm.ul.pt	Moita, Luis F./L-1296-2013; Sepulveda, Nuno/S-9936-2019; de almeida, antonio paulo gouveia/I-2541-2012; Mota, Maria/AAF-2048-2019; Gardner, Rui/F-6052-2012; Moita, Luis/HCI-2793-2022; Henriques, Ricardo/T-4004-2018; Itoe, Maurice A./AAQ-5634-2020; Sepulveda, Nuno/AAA-5544-2021	Moita, Luis F./0000-0003-0707-315X; Gardner, Rui/0000-0002-7270-5136; Moita, Luis/0000-0003-0707-315X; Henriques, Ricardo/0000-0002-2043-5234; Sepulveda, Nuno/0000-0002-8542-1706; Afonso, Cristina/0000-0003-2021-6856; Frischknecht, Friedrich/0000-0002-8332-6668; Raquel, Helena/0000-0001-6008-6852; Itoe, Maurice/0000-0002-1356-0168; Mota, Maria Manuel/0000-0002-2858-1041	Fundacao para a Ciencia e Tecnologia (FCT) of the Portuguese Ministry of Science [PTDC/SAU-GMG/100313/2008]; Federal German Ministry of education and Science (Biofuture); FCT [SFRH/BD/15888/2005]; EU Marie Curie Initial Training Network [215281]; Fundacao Luso-Americana para o Desenvolvimento; Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-MII/69280/2006, PTDC/SAU-MII/78333/2006]; Chica and Heinz Schaller Foundation; Fundação para a Ciência e a Tecnologia [PTDC/SAU-MII/69280/2006, PTDC/SAU-GMG/100313/2008, PTDC/SAU-MII/78333/2006] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT) of the Portuguese Ministry of Science(Portuguese Foundation for Science and Technology); Federal German Ministry of education and Science (Biofuture); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); EU Marie Curie Initial Training Network; Fundacao Luso-Americana para o Desenvolvimento; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Chica and Heinz Schaller Foundation; Fundação para a Ciência e a Tecnologia	The work was supported by Fundacao para a Ciencia e Tecnologia (FCT) of the Portuguese Ministry of Science (PTDC/SAU-GMG/100313/2008), the Federal German Ministry of education and Science (Biofuture) C.S.S.G-S. was supported by an FCT fellowship (SFRH/BD/15888/2005). M.A.I. was funded by the EU FP 7 Marie Curie Initial Training Network "Intervention Strategies against Malaria (InterMalTraining)", contract no. 215281. L.F.M. is a Young Investigator from the Human Frontier Science Program and receives support from Fundacao Luso-Americana para o Desenvolvimento and Fundacao para a Ciencia e a Tecnologia (PTDC/SAU-MII/69280/2006 and PTDC/SAU-MII/78333/2006). F.F. thanks the Chica and Heinz Schaller Foundation for support. M.M.M. and F.F. are members of the EU FP7 Network of Excellence EVIMalaR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque SS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-270; Anes E, 2003, NAT CELL BIOL, V5, P793, DOI 10.1038/ncb1036; Bano N, 2007, INT J PARASITOL, V37, P1329, DOI 10.1016/j.ijpara.2007.04.005; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Elliott DA, 2000, INFECT IMMUN, V68, P2315, DOI 10.1128/IAI.68.4.2315-2322.2000; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Frenal K, 2009, CELL HOST MICROBE, V5, P602, DOI 10.1016/j.chom.2009.05.013; Frischknecht F, 2006, CURR OPIN MICROBIOL, V9, P297, DOI 10.1016/j.mib.2006.04.007; Gonzalez V, 2009, CELL HOST MICROBE, V5, P259, DOI 10.1016/j.chom.2009.01.011; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Johnston SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001041; Kobayashi I, 2003, PLANTA, V217, P340, DOI 10.1007/s00425-003-1042-3; Ma HS, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-15; Mendes AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000069; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Millholland MG, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010678-1, 10.1074/mcp.M111.010678]; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mostowy S, 2010, CELL HOST MICROBE, V8, P433, DOI 10.1016/j.chom.2010.10.009; Munter Sylvia, 2006, Sci STKE, V2006, pre5, DOI 10.1126/stke.3352006re5; Oh SS, 2000, MOL BIOCHEM PARASIT, V108, P237, DOI 10.1016/S0166-6851(00)00227-9; Patel JC, 2005, CURR OPIN MICROBIOL, V8, P10, DOI 10.1016/j.mib.2004.09.001; Pei XH, 2007, J BIOL CHEM, V282, P26754, DOI 10.1074/jbc.M701612200; Prudencio M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000201; Ray K, 2010, CELL MICROBIOL, V12, P545, DOI 10.1111/j.1462-5822.2010.01428.x; Schaible U. E., 2009, INTRACELLULAR NICHES; Sturm A, 2009, PROTIST, V160, P51, DOI 10.1016/j.protis.2008.08.002; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Taunton J, 2001, CURR OPIN CELL BIOL, V13, P85, DOI 10.1016/S0955-0674(00)00178-2; Tian MY, 2009, PLANT PHYSIOL, V150, P815, DOI 10.1104/pp.109.137604; von Schubert C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000499; Yam PT, 2004, MOL BIOL CELL, V15, P5647, DOI 10.1091/mbc.E04-06-0509	31	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29408	10.1371/journal.pone.0029408	http://dx.doi.org/10.1371/journal.pone.0029408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238609	Green Published, Green Submitted, gold			2022-12-27	WOS:000301188800015
J	Vurgese, S; Panda-Jonas, S; Jonas, JB				Vurgese, Sujiv; Panda-Jonas, Songhomitra; Jonas, Jost B.			Scleral Thickness in Human Eyes	PLOS ONE			English	Article							CENTRAL CORNEAL THICKNESS; OPTIC-NERVE HEAD; LAMINA-CRIBROSA; PERIPAPILLARY SCLERA; INTRAOCULAR SPACE; HISTOMORPHOMETRY; BIOMECHANICS	Purpose: To obtain information about scleral thickness in different ocular regions and its associations. Methods: The histomorphometric study included 238 human globes which had been enucleated because of choroidal melanomas or due to secondary angle-closure glaucoma. Using light microscopy, anterior-posterior pupil-optic nerve sections were measured. Results: In the non-axially elongated group (axial length <= 26 mm), scleral thickness decreased from the limbus (0.50 +/- 0.11 mm) to the ora serrata (0.43 +/- 0.14 mm) and the equator (0.42 +/- 0.15 mm), and then increased to the midpoint between posterior pole and equator (0.65 +/- 0.15 mm) and to the posterior pole (0.94 +/- 0.18 mm), from where it decreased to the peri-optic nerve region (0.86 +/- 0.21 mm) and finally the peripapillary scleral flange (0.39 +/- 0.09 mm). Scleral thickness was significantly lower in the axially elongated group (axial length > 26 mm) than in the non-axially elongated group for measurements taken at and posterior to the equator. Scleral thickness measurements of the posterior pole and of the peripapillary scleral flange were correlated with lamina cribrosa thickness measurements. Scleral thickness measurements at any location of examination were not significantly (all P > 0.10) correlated with corneal thickness measurements. Scleral thickness was statistically independent of age, gender and presence of glaucoma. Conclusions: In non-axially elongated eyes, the sclera was thickest at the posterior pole, followed by the peri-optic nerve region, the midpoint between posterior pole and equator, the limbus, the ora serrata, the equator and finally the peripapillary scleral flange. In axially elongated eyes, scleral thinning occurred at and posterior to the equator, being more marked closer to the posterior pole and the longer the axial length was. Within the anterior and posterior segment respectively, scleral thickness measurements were correlated with each other. Posterior scleral thickness was correlated with lamina cribrosa thickness. Scleral thickness measurements at any location of examination were not significantly correlated with corneal thickness or with age, gender and presence of absolute secondary angler-closure glaucoma.	[Vurgese, Sujiv; Panda-Jonas, Songhomitra; Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Vurgese, S (corresponding author), Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany.	Jost.Jonas@umm.de						Burgoyne CF, 2001, J GLAUCOMA, V10, pS16, DOI 10.1097/00061198-200110001-00007; Downs JC, 2007, INVEST OPHTH VIS SCI, V48, P3195, DOI 10.1167/iovs.07-0021; Downs JC, 2001, INVEST OPHTH VIS SCI, V42, P3202; Elsheikh A, 2010, EXP EYE RES, V90, P624, DOI 10.1016/j.exer.2010.02.010; Girard MJA, 2009, INVEST OPHTH VIS SCI, V50, P5226, DOI 10.1167/iovs.08-3363; Girard MJA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3113683; Girard MJA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3113682; Jonas JB, 2005, INVEST OPHTH VIS SCI, V46, P1275, DOI 10.1167/iovs.04-0851; Jonas JB, 2005, AM J OPHTHALMOL, V139, P346, DOI 10.1016/j.ajo.2004.07.047; Jonas JB, 2004, INVEST OPHTH VIS SCI, V45, P2660, DOI 10.1167/iovs.03-1363; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; Jonas JB, 2011, AM J OPHTHALMOL 0805; Jonas JB, 2011, ACTA OPHTHALMOL, V89, pE423, DOI 10.1111/j.1755-3768.2011.02121.x; Jonas JB, 2009, ARCH OPHTHALMOL-CHIC, V127, P1395, DOI 10.1001/archophthalmol.2009.243; Jonas SB, 2011, ACTA OPHTHALMOL, V89, pe659, DOI 10.1111/j.1755-3768.2010.02034.x; Lam A, 2005, AM J OPHTHALMOL, V140, P329, DOI 10.1016/j.ajo.2005.02.014; Liu HH, 2010, OPHTHALMOLOGY, V117, P1763, DOI 10.1016/j.ophtha.2010.01.020; Mohamed-Noor J, 2009, J GLAUCOMA, V18, P32, DOI 10.1097/IJG.0b013e31816b2fd1; Norman RE, 2011, EXP EYE RES, V93, P4, DOI 10.1016/j.exer.2010.09.014; Norman RE, 2010, EXP EYE RES, V90, P277, DOI 10.1016/j.exer.2009.11.001; Oliveira C, 2006, J GLAUCOMA, V15, P190, DOI 10.1097/01.ijg.0000212220.42675.c5; Olsen TW, 1998, AM J OPHTHALMOL, V125, P237, DOI 10.1016/S0002-9394(99)80096-8; Ren RJ, 2010, GRAEF ARCH CLIN EXP, V248, P1579, DOI 10.1007/s00417-010-1369-y; Ren RJ, 2009, INVEST OPHTH VIS SCI, V50, P2175, DOI 10.1167/iovs.07-1429; Sigal IA, 2005, INVEST OPHTH VIS SCI, V46, P4189, DOI 10.1167/iovs.05-0541; Sigal IA, 2010, EXP EYE RES, V90, P70, DOI 10.1016/j.exer.2009.09.013; Taban M, 2010, OCUL IMMUNOL INFLAMM, V18, P305, DOI 10.3109/09273941003658292; Xu LA, 2010, ACTA OPHTHALMOL, V88, pe350, DOI 10.1111/j.1755-3768.2009.01770.x; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P4597, DOI 10.1167/iovs.07-0349; Yoo C, 2011, J GLAUCOMA, V20, P95, DOI 10.1097/IJG.0b013e3181dde051	30	155	159	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29692	10.1371/journal.pone.0029692	http://dx.doi.org/10.1371/journal.pone.0029692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238635	gold, Green Published, Green Submitted			2022-12-27	WOS:000301188800025
J	Buurman, BM; Hoogerduijn, JG; van Gemert, EA; de Haan, RJ; Schuurmans, MJ; de Rooij, SE				Buurman, Bianca M.; Hoogerduijn, Jita G.; van Gemert, Elisabeth A.; de Haan, Rob J.; Schuurmans, Marieke J.; de Rooij, Sophia E.			Clinical Characteristics and Outcomes of Hospitalized Older Patients with Distinct Risk Profiles for Functional Decline: A Prospective Cohort Study	PLOS ONE			English	Article							ACUTE MEDICAL ILLNESS; SCREENING TOOL; ADULTS; DISABILITY; FRAILTY; RECOVERY; INDEX; IDENTIFICATION; VALIDATION; HEALTH	Background: The aim of this research was to study the clinical characteristics and mortality and disability outcomes of patients who present distinct risk profiles for functional decline at admission. Methods: Multicenter, prospective cohort study conducted between 2006 and 2009 in three hospitals in the Netherlands in consecutive patients of >= 65 years, acutely admitted and hospitalized for at least 48 hours. Nineteen geriatric conditions were assessed at hospital admission, and mortality and functional decline were assessed until twelve months after admission. Patients were divided into risk categories for functional decline (low, intermediate or high risk) according to the Identification of Seniors at Risk-Hospitalized Patients. Results: A total of 639 patients were included, with a mean age of 78 years. Overall, 27%, 33% and 40% of the patients were at low, intermediate or high risk, respectively, for functional decline. Low-risk patients had fewer geriatric conditions (mean 2.2 [standard deviation [SD] 1.3]) compared with those at intermediate (mean 3.8 [SD 2.1]) or high risk (mean 5.1 [SD 1.8]) (p < 0.001). Twelve months after admission, 39% of the low-risk group had an adverse outcome, compared with 50% in the intermediate risk group and 69% in the high risk group (p < 0.001). Conclusion: By using a simple risk assessment instrument at hospital admission, patients at low, intermediate or high risk for functional decline could be identified, with distinct clinical characteristics and outcomes. This approach should be tested in clinical practice and research and might help appropriately tailor patient care.	[Buurman, Bianca M.; van Gemert, Elisabeth A.; de Rooij, Sophia E.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med & Geriatr, NL-1105 AZ Amsterdam, Netherlands; [Hoogerduijn, Jita G.; Schuurmans, Marieke J.] Univ Appl Sci Utrecht, Hgsk Utrecht, Fac Hlth Care, Res Grp Care Chronically 3, Utrecht, Netherlands; [Schuurmans, Marieke J.] Univ Med Ctr, Dept Nursing Sci, Utrecht, Netherlands; [de Haan, Rob J.] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Buurman, BM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med & Geriatr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	B.m.vanes@amc.uva.nl; s.e.derooij@amc.nl			Netherlands Organization for Health Research and Development (Zon MW) [13550004]	Netherlands Organization for Health Research and Development (Zon MW)(Netherlands Organization for Health Research and Development)	This study was financed by the Netherlands Organization for Health Research and Development (Zon MW), grant number 13550004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1718; Boltz M, 2010, INT J NURS PRACT, V16, P381, DOI 10.1111/j.1440-172X.2010.01855.x; Boyd CM, 2008, J AM GERIATR SOC, V56, P2171, DOI 10.1111/j.1532-5415.2008.02023.x; Buurman BM, 2011, J CLIN EPIDEMIOL, V64, P619, DOI 10.1016/j.jclinepi.2010.07.005; Buurman BM, 2008, J GEN INTERN MED, V23, P1883, DOI 10.1007/s11606-008-0741-7; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Counsell SR, 2000, J AM GERIATR SOC, V48, P1572, DOI 10.1111/j.1532-5415.2000.tb03866.x; Covinsky KE, 2000, J AM GERIATR SOC, V48, P164, DOI 10.1111/j.1532-5415.2000.tb03907.x; De Saint-Hubert M, 2010, J NUTR HEALTH AGING, V14, P394, DOI 10.1007/s12603-010-0086-x; Dendukuri N, 2004, J AM GERIATR SOC, V52, P290, DOI 10.1111/j.1532-5415.2004.52073.x; Ellis G, 2004, BRIT MED BULL, V71, P45, DOI 10.1093/bmb/ldh033; Ferrucci L, 2004, J AM GERIATR SOC, V52, P625, DOI 10.1111/j.1532-5415.2004.52174.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Hardy SE, 2005, ARCH INTERN MED, V165, P106, DOI 10.1001/archinte.165.1.106; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; Health Council of the Netherlands, 2009, PREV ELD FOC FUNCT D; Hoogerduijn JG, 2011, AGE AGEING IN PRESS; Hoogerduijn JG, 2010, J CLIN NURS, V19, P1219, DOI 10.1111/j.1365-2702.2009.03035.x; Inouye SK, 2007, J AM GERIATR SOC, V55, P780, DOI 10.1111/j.1532-5415.2007.01156.x; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Jones DM, 2004, J AM GERIATR SOC, V52, P1929, DOI 10.1111/j.1532-5415.2004.52521.x; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kircher TTJ, 2007, AGE AGEING, V36, P36, DOI 10.1093/ageing/afl102; Kruizenga HM, 2005, CLIN NUTR, V24, P75, DOI 10.1016/j.clnu.2004.07.015; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; McCusker J, 1999, J AM GERIATR SOC, V47, P1229, DOI 10.1111/j.1532-5415.1999.tb05204.x; McCusker J, 1998, ACAD EMERG MED, V5, P883, DOI 10.1111/j.1553-2712.1998.tb02818.x; McCusker J, 2002, J GERONTOL A-BIOL, V57, pM569, DOI 10.1093/gerona/57.9.M569; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Pulignano G, 2010, J CARDIOVASC MED, V11, P739, DOI 10.2459/JCM.0b013e328339d981; Sager MA, 1996, ARCH INTERN MED, V156, P645, DOI 10.1001/archinte.156.6.645; Sager MA, 1996, J AM GERIATR SOC, V44, P251, DOI 10.1111/j.1532-5415.1996.tb00910.x; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2987, DOI 10.1001/jama.285.23.2987	38	55	56	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29621	10.1371/journal.pone.0029621	http://dx.doi.org/10.1371/journal.pone.0029621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	902VE	22238628	Green Published, gold			2022-12-27	WOS:000301070200039
J	Christiansen, P				Christiansen, Per			The Making of a Monster: Postnatal Ontogenetic Changes in Craniomandibular Shape in the Great Sabercat Smilodon	PLOS ONE			English	Article							LEOPARD NEOFELIS-NEBULOSA; PREDATORY BEHAVIOR; SEXUAL-DIMORPHISM; LATE MIOCENE; AGE-DETERMINATION; BITE FORCES; EVOLUTION; GROWTH; INTEGRATION; CAT	Derived sabercats had craniomandibular morphologies that in many respects were highly different from those of extant felids, and this has often been interpreted functionally as adaptations for predation at extreme gape angles with hypertrophied upper canines. It is unknown how much of this was a result of intraspecific postnatal ontogeny, since juveniles of sabercats are rare and no quantitative study has been made of craniomandibular ontogeny. Postnatal ontogenetic craniomandibular shape changes in two morphologically derived sabercats, Smilodon fatalis and S. populator, were analysed using geometric morphometrics and compared to three species of extant pantherines, the jaguar, tiger, and Sunda clouded leopard. Ontogenetic shape changes in Smilodon usually involved the same areas of the cranium and mandible as in extant pantherines, and large-scale modularization was similar, suggesting that such may have been the case for all felids, since it followed the same trends previously observed in other mammals. However, in other respects Smilodon differed from extant pantherines. Their crania underwent much greater and more localised ontogenetic shape changes than did the mandibles, whereas crania and mandibles of extant pantherines underwent smaller, fewer and less localised shape changes. Ontogenetic shape changes in the two species of Smilodon are largely similar, but differences are also present, notably those which may be tied to the presence of larger upper canines in S. populator. Several of the specialized cranial characters differentiating adult Smilodon from extant felids in a functional context, which are usually regarded as evolutionary adaptations for achieving high gape angles, are ontogenetic, and in several instances ontogeny appears to recapitulate phylogeny to some extent. No such ontogenetic evolutionary adaptive changes were found in the extant pantherines. Evolution in morphologically derived sabercats involved greater cranial ontogenetic changes than among extant felids, resulting in greatly modified adult craniomandibular morphologies.	Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark	Aalborg University	Christiansen, P (corresponding author), Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark.	pc@bio.aau.dk			Aalborg University	Aalborg University	Funding received from Aalborg University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RR, 2005, J HUM EVOL, V48, P175, DOI 10.1016/j.jhevol.2004.11.001; Ackermann RR, 2002, J HUM EVOL, V43, P167, DOI 10.1006/jhev.2002.0569; AKERSTEN W A, 1985, Contributions in Science (Los Angeles), P1; Anton M, 2004, ZOOL J LINN SOC-LOND, V140, P207, DOI 10.1111/j.1096-3642.2003.00093.x; ATCHLEY WR, 1991, BIOL REV, V66, P101, DOI 10.1111/j.1469-185X.1991.tb01138.x; Bastir M, 2004, J HUM EVOL, V47, P359, DOI 10.1016/j.jhevol.2004.08.009; Benoit Matthew H., 2010, P165; BERTA A, 1987, Bulletin of the Florida State Museum Biological Sciences, V31, P1; BERTA A, 1985, Contributions in Science (Los Angeles), P1; Biknevicius AR, 1996, J VERTEBR PALEONTOL, V16, P510, DOI 10.1080/02724634.1996.10011336; Birch JM, 1997, J MAMMAL, V78, P1187, DOI 10.2307/1383062; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bookstein FL, 1996, NATO ADV SCI INST SE, V284, P131; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Christiansen P, 2005, J MORPHOL, V266, P369, DOI 10.1002/jmor.10384; Christiansen P, CLADISTICS IN PRESS; Christiansen P, 2008, J MAMM EVOL, V15, P155, DOI 10.1007/s10914-007-9069-z; Christiansen P, 2007, ZOOL J LINN SOC-LOND, V151, P423, DOI 10.1111/j.1096-3642.2007.00321.x; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; Christiansen P, 2006, J MORPHOL, V267, P1186, DOI 10.1002/jmor.10468; Christiansen P, 2011, ZOOL J LINN SOC-LOND, V162, P220, DOI 10.1111/j.1096-3642.2010.00675.x; CROWE DM, 1975, J MAMMAL, V56, P177, DOI 10.2307/1379615; Daegling DJ, 1996, J HUM EVOL, V30, P315, DOI 10.1006/jhev.1996.0026; EMERSON SB, 1980, PALEOBIOLOGY, V6, P295, DOI 10.1017/S0094837300006813; Ewer, 1998, CARNIVORES; GarciaPerea R, 1996, J MORPHOL, V229, P241, DOI 10.1002/(SICI)1097-4687(199609)229:3<241::AID-JMOR1>3.0.CO;2-1; Gay SW, 1996, J MAMMAL, V77, P191, DOI 10.2307/1382720; Giannini NP, 2010, MAMM BIOL, V75, P547, DOI 10.1016/j.mambio.2009.08.001; Gilbert SF, 2011, DEV BIOL; Gittleman JL, 1997, J ZOOL, V242, P97, DOI 10.1111/j.1469-7998.1997.tb02932.x; Goswami A, 2006, EVOLUTION, V60, P169; Gould S. J., 1977, ONTOGENY PHYLOGENY; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Gust S, 2003, PALEOBIOS S1, P2; Haeckel E, 1868, NATURLICHE SCHOPFUNG; JACKSON DL, 1988, J WILDLIFE MANAGE, V52, P515, DOI 10.2307/3801602; JOHNSON NF, 1981, WILDLIFE SOC B, V9, P202; Klingenberg CP, 2004, GENETICS, V166, P1909, DOI 10.1534/genetics.166.4.1909; Klingenberg CP, 2003, EVOL DEV, V5, P522, DOI 10.1046/j.1525-142X.2003.03057.x; Kurten B., 1990, Journal of Vertebrate Paleontology, V10, P158; LAIRD AK, 1966, GROWTH, V30, P349; LAIRD AK, 1965, GROWTH, V29, P233; Lund PW, 1842, THESIS VIDENSKABERNE, V4, P137; MAYR E, 1994, Q REV BIOL, V69, P223, DOI 10.1086/418541; Mazak JH, 2004, MAMM BIOL, V69, P392, DOI 10.1078/1616-5047-00161; Mazak V., 1983, TIGER; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Meachen-Samuels JA, 2010, J ZOOL, V280, P271, DOI 10.1111/j.1469-7998.2009.00659.x; Miller G. J., 1968, Contributions in Science, VNo. 131, P1; OPPENHEIMER JM, 1959, Q REV BIOL, V34, P271, DOI 10.1086/402827; Palmqvist P, 2007, J VERTEBR PALEONTOL, V27, P160, DOI 10.1671/0272-4634(2007)27[160:AROTDO]2.0.CO;2; Peigne S, 2003, ZOOL J LINN SOC-LOND, V138, P477, DOI 10.1046/j.1096-3642.2003.00066.x; PETERSEN MK, 1978, CARNIVORE, V1, P87; Pocock R. I., 1916, Annals & Magazine of Natural History, V18; Polanski JM., 2011, INT J EVOL BIOL, V2011, P1; Polanski JM, 2006, AM J PHYS ANTHROPOL, V131, P38, DOI 10.1002/ajpa.20421; Prevosti FJ, 2010, AMEGHINIANA, V47, P239, DOI 10.5710/AMGH.v47i2.9; Prieto A, 2010, REV CHIL HIST NAT, V83, P299; RADINSKY L, 1984, EVOLUTION, V38, P1, DOI 10.1111/j.1558-5646.1984.tb00254.x; RASMUSSEN N, 1991, J HIST BIOL, V24, P51; Ravosa MJ, 2010, AM J PRIMATOL, V72, P161, DOI 10.1002/ajp.20767; Ravosa MJ, 1998, AM J PRIMATOL, V45, P225, DOI 10.1002/(SICI)1098-2345(1998)45:3<225::AID-AJP1>3.3.CO;2-E; Rawn-Schatzinger V., 1983, Journal of Vertebrate Paleontology, V3, P49, DOI 10.1080/02724634.1983.10011958; Rawn-Schatzinger V., 1992, ILL STATE MUS REP IN, V47, P1; Rincon AD, 2006, AMEGHINIANA, V43, P499; Robb RC, 1935, J GENET, V31, P39; Robb RC, 1935, J GENET, V31, P47; Rohlf F.J., 2004, TPSSPLINE THIN PLATE; Rohlf F. James, 1993, Monografias del Museo Nacional de Ciencias Naturales, V1993, P131; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 2004, TPSRELW VER 1 39; Rohlf FJ, 2004, TPSDIG DIGITIZE LAND; Rusconi C., 1931, Anales de la Sociedad Cientifica Argentina, V111, P147; Salesa MJ, 2010, PALAEONTOLOGY, V53, P1369, DOI 10.1111/j.1475-4983.2010.01013.x; Salesa MJ, 2006, J ZOOL, V268, P243, DOI 10.1111/j.1469-7998.2005.00032.x; Salesa MJ, 2005, ZOOL J LINN SOC-LOND, V144, P363, DOI 10.1111/j.1096-3642.2005.00174.x; Segura Valentina, 2009, Mastozool. neotrop., V16, P169; Slater GJ, 2008, PALEOBIOLOGY, V34, P403, DOI 10.1666/07061.1; Slaughter B. H., 1963, Texas Journal of Science, V15, P68; SLAUGHTER BH, 1974, J MAMMAL, V55, P115, DOI 10.2307/1379261; SMITH MM, 1990, BIOL REV, V65, P277, DOI 10.1111/j.1469-185X.1990.tb01427.x; SMUTS GL, 1978, J ZOOL, V185, P115, DOI 10.1111/j.1469-7998.1978.tb03317.x; SMUTS GL, 1980, J ZOOL, V190, P365; SNEATH PHA, 1967, J ZOOL, V151, P65; Stander PE, 1997, AFR J ECOL, V35, P156, DOI 10.1111/j.1365-2028.1997.068-89068.x; STEHLIK J, 1971, INT ZOO YB, V11, P116; Stock, 1932, CARNEGIE I WASHINGTO, V422, P1; Stuart C.T., 1986, Saugetierkundliche Mitteilungen, V32, P217; Sunquist ME, 2002, WILD CATS WORLD; SWIDERSKI DL, 1993, EVOLUTION, V47, P1854, DOI 10.1111/j.1558-5646.1993.tb01274.x; Tejada-Flores A.E., 1984, Journal of Vertebrate Paleontology, V4, P114; Therrien F, 2005, ZOOL J LINN SOC-LOND, V145, P393, DOI 10.1111/j.1096-3642.2005.00194.x; Thompson D'Arcy W, 1917, GROWTH FORM; TURNER A, 1984, ANN ZOOL FENN, V21, P1; Turner A., 1997, BIG CATS THEIR FOSSI; VOLF J, 1972, Mammalia, V36, P683, DOI 10.1515/mamm.1972.36.4.683; Werdelin L., 2010, BIOL CONSERVATION WI, P60; WIIG O, 1986, ACTA THERIOL, V31, P147; Willmore KE, 2009, EVOL BIOL, V36, P19, DOI 10.1007/s11692-009-9056-9; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; Zelditch ML, 2000, SM S COMP E, P37; ZELDITCH ML, 1992, EVOLUTION, V46, P1164, DOI 10.1111/j.1558-5646.1992.tb00626.x; ZULLINGER EM, 1984, J MAMMAL, V65, P607, DOI 10.2307/1380844	104	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29699	10.1371/journal.pone.0029699	http://dx.doi.org/10.1371/journal.pone.0029699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235326	Green Published, gold			2022-12-27	WOS:000301123400088
J	Glass, TR; Rotger, M; Telenti, A; Decosterd, L; Csajka, C; Bucher, HC; Gunthard, HF; Rickenbach, M; Nicca, D; Hirschel, B; Bernasconi, E; Wandeler, G; Battegay, M; Marzolini, C				Glass, Tracy R.; Rotger, Margalida; Telenti, Amalio; Decosterd, Laurent; Csajka, Chantal; Bucher, Heiner C.; Guenthard, Huldrych F.; Rickenbach, Martin; Nicca, Dunja; Hirschel, Bernard; Bernasconi, Enos; Wandeler, Gilles; Battegay, Manuel; Marzolini, Catia		Swiss HIV Cohort Study	Determinants of Sustained Viral Suppression in HIV-Infected Patients with Self-Reported Poor Adherence to Antiretroviral Therapy	PLOS ONE			English	Article							PATIENTS RECEIVING LOPINAVIR/RITONAVIR; LESS-THAN 95-PERCENT; HIV-1-INFECTED PATIENTS; VIROLOGICAL OUTCOMES; INHIBITOR THERAPY; TREATMENT FAILURE; PLASMA-LEVELS; EFAVIRENZ; PHARMACOGENETICS; INDIVIDUALS	Background: Good adherence to antiretroviral therapy (ART) is critical for successful HIV treatment. However, some patients remain virologically suppressed despite suboptimal adherence. We hypothesized that this could result from host genetic factors influencing drug levels. Methods: Eligible individuals were Caucasians treated with efavirenz (EFV) and/or boosted lopinavir (LPV/r) with self-reported poor adherence, defined as missing doses of ART at least weekly for more than 6 months. Participants were genotyped for single nucleotide polymorphisms (SNPs) in candidate genes previously reported to decrease EFV (rs3745274, rs35303484, rs35979566 in CYP2B6) and LPV/r clearance (rs4149056 in SLCO1B1, rs6945984 in CYP3A, rs717620 in ABCC2). Viral suppression was defined as having HIV-1 RNA <400 copies/ml throughout the study period. Results: From January 2003 until May 2009, 37 individuals on EFV (28 suppressed and 9 not suppressed) and 69 on LPV/r (38 suppressed and 31 not suppressed) were eligible. The poor adherence period was a median of 32 weeks with 18.9% of EFV and 20.3% of LPV/r patients reporting missed doses on a daily basis. The tested SNPs were not determinant for viral suppression. Reporting missing >1 dose/week was associated with a lower probability of viral suppression compared to missing 1 dose/week (EFV: odds ratio (OR) 0.11, 95% confidence interval (CI): 0.01-0.99; LPV/r: OR 0.29, 95% CI: 0.09-0.94). In both groups, the probability of remaining suppressed increased with the duration of continuous suppression prior to the poor adherence period (EFV: OR 3.40, 95% CI: 0.62-18.75; LPV/r: OR 5.65, 95% CI: 1.82-17.56). Conclusions: The investigated genetic variants did not play a significant role in the sustained viral suppression of individuals with suboptimal adherence. Risk of failure decreased with longer duration of viral suppression in this population.	[Glass, Tracy R.; Bucher, Heiner C.] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Rotger, Margalida; Telenti, Amalio] Univ Lausanne Hosp, Inst Microbiol, Lausanne, Switzerland; [Decosterd, Laurent; Csajka, Chantal] Univ Lausanne Hosp, Div Clin Pharmacol & Toxicol, Lausanne, Switzerland; [Guenthard, Huldrych F.] Univ Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Guenthard, Huldrych F.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Rickenbach, Martin] Univ Lausanne Hosp, Swiss HIV Cohort Data Ctr, Lausanne, Switzerland; [Nicca, Dunja] Kantonsspital, Div Infect Dis, St Gallen, Switzerland; [Hirschel, Bernard] Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland; [Bernasconi, Enos] Reg Hosp Lugano, Div Infect Dis, Lugano, Switzerland; [Wandeler, Gilles] Univ Hosp Bern, Div Infect Dis, CH-3010 Bern, Switzerland; [Bucher, Heiner C.; Battegay, Manuel; Marzolini, Catia] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [Csajka, Chantal] Univ Geneva, Dept Pharmaceut Sci, Geneva, Switzerland; [Wandeler, Gilles] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich; University of Zurich; University Zurich Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; University of Geneva; University of Bern; University Hospital of Bern; University of Basel; University of Geneva; University of Bern	Glass, TR (corresponding author), Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland.	MarzoliniC@uhbs.ch; MarzoliniC@uhbs.ch	Telenti, Amalio/AAY-1674-2021; gunthard, huldrych f/F-1724-2011; Wandeler, Gilles/ABB-2961-2020; Pantaleo, Giuseppe/K-6163-2016; Marzolini, Catia/C-8253-2019; Glass, Tracy R/D-5046-2017; Decosterd, Laurent/E-8494-2019	gunthard, huldrych f/0000-0002-1142-6723; Glass, Tracy R/0000-0001-7075-9803; Decosterd, Laurent/0000-0002-9840-1325; Csajka, Chantal/0000-0002-0660-082X	Swiss HIV Cohort Study [619]; Swiss National Foundation (SNF) [33CS30_134277]; Stiftung Forschung Infektionskrankheiten, University Hospital Basel [35]; Santesuisse and Gottfried and Julia Bangerter-Rhyner-Foundation; GlaxoSmithKline; Bristol-Myers-Squibb; Merck Sharp Dohme; Gilead; Janssen; Roche; Abbott; Tibotec; Boehringer-Ingelheim; ViiV Healthcare; Bristol-Myers Squibb; Boehringer Ingelheim; Gilead Sciences	Swiss HIV Cohort Study; Swiss National Foundation (SNF)(Swiss National Science Foundation (SNSF)); Stiftung Forschung Infektionskrankheiten, University Hospital Basel; Santesuisse and Gottfried and Julia Bangerter-Rhyner-Foundation; GlaxoSmithKline(GlaxoSmithKline); Bristol-Myers-Squibb(Bristol-Myers Squibb); Merck Sharp Dohme(Merck & Company); Gilead(Gilead Sciences); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Roche(Roche Holding); Abbott(Abbott Laboratories); Tibotec; Boehringer-Ingelheim(Boehringer Ingelheim); ViiV Healthcare; Bristol-Myers Squibb(Bristol-Myers Squibb); Boehringer Ingelheim(Boehringer Ingelheim); Gilead Sciences(Gilead Sciences)	This study has been financed in the framework of the Swiss HIV Cohort Study (SHCS project 619) which is in turn supported by the Swiss National Foundation (SNF 33CS30_134277). CM has been supported by a grant from the Stiftung Forschung Infektionskrankheiten (project 35), University Hospital Basel. TRG and HCB are supported by Santesuisse and Gottfried and Julia Bangerter-Rhyner-Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: HCB has received travel grants, honoraria and unrestricted research grants from GlaxoSmithKline, Bristol-Myers-Squibb, Merck Sharp & Dohme, Gilead, Janssen, Roche, Abbott, Tibotec, Boehringer-Ingelheim and ViiV Healthcare. HFG has been an adviser and/or consultant for the following companies: GlaxoSmithKline, Abbott, Novartis, Boehringer Ingelheim, Roche, Tib tec and Bristol-Myers Squibb, and has received unrestricted research and educational grants from Roche, Abbott, Bristol-Myers Squibb, GlaxoSmithKline, Tibotec and Merck Sharp & Dohme (integral financial support went to the institution). EB received honoraria or travel grants from the following pharmaceutical companies: Abbott, Bristol-Myers Squibb, Boehringer Ingelheim, Gilead, ViiV Healthcare, Merck Sharp & Dohme, Janssen. MB has received speaker's honoraria from Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck Sharp & Dohme and Tibotec and has received unrestricted research grants from Boehringer Ingelheim, Gilead Sciences, GlaxoSmithKline and serves as a consultant for Boehringer Ingelheim Switzerland. TRG, MR, AT, LD, CC, MR, DN, BH, GW, and CM declare no competing interests. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Arab-Alameddine M, 2009, CLIN PHARMACOL THER, V85, P485, DOI 10.1038/clpt.2008.271; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Boffito M, 2008, ANTIVIR THER, V13, P901; Colombo S, 2005, J CHROMATOGR B, V819, P259, DOI 10.1016/j.jchromb.2005.02.010; Corbeau P, 2011, BLOOD, V117, P5582, DOI 10.1182/blood-2010-12-322453; Csajka C, 2003, CLIN PHARMACOL THER, V73, P20, DOI 10.1067/mcp.2003.22; Fayet A, 2008, THER DRUG MONIT, V30, P511, DOI 10.1097/FTD.0b013e3181817318; Glass TR, 2008, ANTIVIR THER, V13, P77; Haas DW, 2004, AIDS, V18, P2391; King MS, 2005, J INFECT DIS, V191, P2046, DOI 10.1086/430387; Lima VD, 2010, JAIDS-J ACQ IMM DEF, V55, P460, DOI 10.1097/QAI.0b013e3181f2ac87; Lima VD, 2008, AIDS, V22, P2371, DOI 10.1097/QAD.0b013e328315cdd3; Lubomirov R, 2010, PHARMACOGENET GENOM, V20, P217, DOI 10.1097/FPC.0b013e328336eee4; Maggiolo F, 2005, CLIN INFECT DIS, V40, P158, DOI 10.1086/426595; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; Marzolini C, 2001, THER DRUG MONIT, V23, P394, DOI 10.1097/00007691-200108000-00012; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pearson CR, 2007, AIDS BEHAV, V11, P161, DOI 10.1007/s10461-006-9133-3; Ribaudo HJ, 2006, CLIN INFECT DIS, V42, P401, DOI 10.1086/499364; Rosenblum M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007196; Rotger M, 2007, CLIN PHARMACOL THER, V81, P557, DOI 10.1038/sj.clpt.6100072; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Shuter J, 2007, JAIDS-J ACQ IMM DEF, V45, P4, DOI 10.1097/QAI.0b013e318050d8c2; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Telenti A, 2008, ANNU REV PHARMACOL, V48, P227, DOI 10.1146/annurev.pharmtox.48.113006.094753; Von Wyl V, 2007, ARCH INTERN MED, V167, P1782, DOI 10.1001/archinte.167.16.1782; Wagner G, 2004, JAIDS-J ACQ IMM DEF, V35, P203, DOI 10.1097/00126334-200402010-00016	29	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							10.1371	10.1371/journal.pone.0029186	http://dx.doi.org/10.1371/journal.pone.0029186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235271	Green Accepted, Green Published, gold			2022-12-27	WOS:000301123400032
J	Parsons, HA; Baracos, VE; Dhillon, N; Hong, DS; Kurzrock, R				Parsons, Henrique A.; Baracos, Vickie E.; Dhillon, Navjot; Hong, David S.; Kurzrock, Razelle			Body Composition, Symptoms, and Survival in Advanced Cancer Patients Referred to a Phase I Service	PLOS ONE			English	Article							QUALITY-OF-LIFE; SKELETAL-MUSCLE; ONCOLOGY TRIALS; SARCOPENIC-OBESITY; ADIPOSE-TISSUE; WEIGHT-LOSS; CYTOKINES; CHEMOTHERAPY; VALIDATION; PARADOX	Background: Body weight and body composition are relevant to the outcomes of cancer and antineoplastic therapy. However, their role in Phase I clinical trial patients is unknown. Methods: We reviewed symptom burden, body composition, and survival in 104 patients with advanced cancer referred to a Phase I oncology service. Symptom burden was analyzed using the MD Anderson Symptom Assessment Inventory(MDASI); body composition was evaluated utilizing computerized tomography(CT) images. A body mass index (BMI)>= 25 kg/m(2) was considered overweight. Sarcopenia, severe muscle depletion, was assessed using CT-based criteria. Results: Most patients were overweight (n = 65, 63%); 53 patients were sarcopenic (51%), including 79% of patients with a BMI, 25 kg/m(2) and 34% of those with BMI >= 25 kg/m(2). Sarcopenic patients were older and less frequently African-American. Symptom burden did not differ among patients classified according to BMI and presence of sarcopenia. Median (95% confidence interval) survival (days) varied according to body composition: 215 (71-358) (BMI, 25 kg/m(2); sarcopenic), 271 (99-443) (BMI<25 kg/m(2); non-sarcopenic), 484 (286-681) (BMI >= 25 kg/m(2); sarcopenic); 501 d (309-693) (BMI >= 25 kg/m(2); non-sarcopenic). Higher muscle index and gastrointestinal cancer diagnosis predicted longer survival in multivariate analysis after controlling for age, gender, performance status, and fat index. Conclusions: Patients referred to a Phase I clinic had a high frequency of sarcopenia and a BMI >= 25 kg/m(2), independent of symptom burden. Body composition variables were predictive of clinically relevant survival differences, which is potentially important in developing Phase I studies.	[Parsons, Henrique A.; Dhillon, Navjot; Hong, David S.; Kurzrock, Razelle] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA; [Baracos, Vickie E.] Univ Alberta, Dept Oncol, Div Palliat Care Med, Edmonton, AB, Canada	University of Texas System; UTMD Anderson Cancer Center; University of Alberta	Parsons, HA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA.	haparsons@gmail.com	Kurzrock, Razelle/AAU-9782-2020	Afonseca Parsons, Henrique/0000-0002-0436-4368; Baracos, Vickie/0000-0002-9609-1001	National Center for Research Resources, a component of the NIH Roadmap for Medical Research [RR024148]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	National Center for Research Resources, a component of the NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by Grant Number RR024148 from the National Center for Research Resources, a component of the NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Antoun S, 2010, J CLIN ONCOL, V28, P1054, DOI 10.1200/JCO.2009.24.9730; ARGILES JM, 1992, MED RES REV, V12, P637, DOI 10.1002/med.2610120605; Argiles JM, 2003, CURR OPIN CLIN NUTR, V6, P401, DOI 10.1097/01.mco.0000078983.18774.cc; Argiles JM, 2006, CANC TREAT, V130, P199; Arkenau HT, 2009, J CLIN ONCOL, V27, P2692, DOI 10.1200/JCO.2008.19.5081; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; BILLEWICZ WZ, 1962, BRIT J PREV SOC MED, V16, P183; Bouchard DR, 2009, OBESITY, V17, P2082, DOI 10.1038/oby.2009.109; Cleeland CS, 2000, CANCER-AM CANCER SOC, V89, P1634, DOI 10.1002/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V; Dahele M, 2007, J PAIN SYMPTOM MANAG, V33, P676, DOI 10.1016/j.jpainsymman.2006.09.024; Deans DAC, 2007, BRIT J SURG, V94, P1501, DOI 10.1002/bjs.5849; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Evans W, 1997, J NUTR, V127, pS998; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fearon KC, 2006, AM J CLIN NUTR, V83, P1345, DOI 10.1093/ajcn/83.6.1345; Finlay E, 2009, CANCER-AM CANCER SOC, V115, P446, DOI 10.1002/cncr.24025; Fouladiun M, 2007, CLIN CANCER RES, V13, P6379, DOI 10.1158/1078-0432.CCR-07-1147; Garrido-Laguna I, 2011, CANCER IN PRESS; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; Hinsley R, 2007, INT J PALLIAT NURS, V13, P84, DOI 10.12968/ijpn.2007.13.2.23068; Horstmann E, 2005, NEW ENGL J MED, V352, P895, DOI 10.1056/NEJMsa042220; Italiano A, 2008, ANN ONCOL, V19, P787, DOI 10.1093/annonc/mdm548; Jensen GL, 2008, JPEN-PARENTER ENTER, V32, P656, DOI 10.1177/0148607108324585; Kalantar-Zadeh K, 2006, CONTRIB NEPHROL, V151, P57, DOI 10.1159/000095319; Kamel HK, 2003, NUTR REV, V61, P157, DOI 10.1301/nr.2003.may.157-167; Kurzrock R, 2005, NEW ENGL J MED, V352, P930, DOI 10.1056/NEJMe058007; Ma G, 1998, TOPICS PALLIATIVE CA, P91; Miller KD, 1998, LANCET, V351, P871, DOI 10.1016/S0140-6736(97)11518-5; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115, DOI 10.1152/jappl.1998.85.1.115; Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; Murthy NS, 2009, J POSTGRAD MED, V55, P45, DOI 10.4103/0022-3859.43549; Myers JS, 2008, ONCOL NURS FORUM, V35, P802, DOI 10.1188/08.ONF.802-807; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Quinn J, 2008, WEST J EMERG MED, V9, P6; Reyes-Gibby CC, 2008, LANCET ONCOL, V9, P777, DOI 10.1016/S1470-2045(08)70197-9; Rolland Y, 2009, AM J CLIN NUTR, V89, P1895, DOI 10.3945/ajcn.2008.26950; Roubenoff R, 2003, J GERONTOL A-BIOL, V58, P1012; Roubenoff R, 2002, NES NUTR WS, V6, P151, DOI 10.1159/000061864; Roubenoff R, 2008, LANCET ONCOL, V9, P605, DOI 10.1016/S1470-2045(08)70160-8; Saini A, 2006, CYTOKINE GROWTH F R, V17, P475, DOI 10.1016/j.cytogfr.2006.09.006; Sarhill N, 2003, SUPPORT CARE CANCER, V11, P652, DOI 10.1007/s00520-003-0486-0; Schmidt D, 2007, NUTR CLIN PRACT, V22, P11, DOI 10.1177/011542650702200111; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; Shaffer JR, 2007, OSTEOPOROSIS INT, V18, P733, DOI 10.1007/s00198-006-0316-6; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Shen W, 2004, AM J CLIN NUTR, V80, P271, DOI 10.1093/ajcn/80.2.271; Tan BHL, 2009, CLIN CANCER RES, V15, P6973, DOI 10.1158/1078-0432.CCR-09-1525; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Wheler J, 2009, CANCER, V115, P1091, DOI 10.1002/cncr.24018; Wood LJ, 2006, ONCOL NURS FORUM, V33, P535, DOI 10.1188/06.ONF.535-542	52	78	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29330	10.1371/journal.pone.0029330	http://dx.doi.org/10.1371/journal.pone.0029330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235285	Green Submitted, Green Published, gold			2022-12-27	WOS:000301123400046
J	Sirieix, C; Gervasoni, D; Luppi, PH; Leger, L				Sirieix, Chrystelle; Gervasoni, Damien; Luppi, Pierre-Herve; Leger, Lucienne			Role of the Lateral Paragigantocellular Nucleus in the Network of Paradoxical (REM) Sleep: An Electrophysiological and Anatomical Study in the Rat	PLOS ONE			English	Article							C-FOS EXPRESSION; BRAIN-STEM NEURONS; ORAL MOTOR NUCLEI; LOCUS-COERULEUS; DORSAL RAPHE; PERIAQUEDUCTAL GRAY; PONTOMESENCEPHALIC TEGMENTUM; NORADRENERGIC NEURONS; VENTROLATERAL MEDULLA; AFFERENT-PROJECTIONS	The lateral paragigantocellular nucleus (LPGi) is located in the ventrolateral medulla and is known as a sympathoexcitatory area involved in the control of blood pressure. In recent experiments, we showed that the LPGi contains a large number of neurons activated during PS hypersomnia following a selective deprivation. Among these neurons, more than two-thirds are GABAergic and more than one fourth send efferent fibers to the wake-active locus coeruleus nucleus. To get more insight into the role of the LPGi in PS regulation, we combined an electrophysiological and anatomical approach in the rat, using extracellular recordings in the head-restrained model and injections of tracers followed by the immunohistochemical detection of Fos in control, PS-deprived and PS-recovery animals. With the head-restrained preparation, we showed that the LPGi contains neurons specifically active during PS (PS-On neurons), neurons inactive during PS (PS-Off neurons) and neurons indifferent to the sleep-waking cycle. After injection of CTb in the facial nucleus, the neurons of which are hyperpolarized during PS, the largest population of Fos/CTb neurons visualized in the medulla in the PS-recovery condition was observed in the LPGi. After injection of CTb in the LPGi itself and PS-recovery, the nucleus containing the highest number of Fos/CTb neurons, moreover bilaterally, was the sublaterodorsal nucleus (SLD). The SLD is known as the pontine executive PS area and triggers PS through glutamatergic neurons. We propose that, during PS, the LPGi is strongly excited by the SLD and hyperpolarizes the motoneurons of the facial nucleus in addition to local and locus coeruleus PS-Off neurons, and by this means contributes to PS genesis.	[Sirieix, Chrystelle; Gervasoni, Damien; Luppi, Pierre-Herve; Leger, Lucienne] Lyon Neurosci Res Ctr, Sleep Team, Lyon, France; [Sirieix, Chrystelle; Gervasoni, Damien; Luppi, Pierre-Herve; Leger, Lucienne] CNRS, UMR 5292, Lyon, France; [Sirieix, Chrystelle; Gervasoni, Damien; Luppi, Pierre-Herve; Leger, Lucienne] INSERM, U1028, F-69008 Lyon, France; [Sirieix, Chrystelle; Gervasoni, Damien; Luppi, Pierre-Herve; Leger, Lucienne] Univ Lyon 1, F-69365 Lyon, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Sirieix, C (corresponding author), Lyon Neurosci Res Ctr, Sleep Team, Lyon, France.	lucienne.leger@gmail.com	GERVASONI, Damien/N-9100-2017; Luppi, Pierre-Hervé/C-4333-2014	GERVASONI, Damien/0000-0003-1529-899X; Luppi, Pierre-Hervé/0000-0002-0503-423X	Centre National de la Recherche Scientifique; Universite Claude Bernard Lyon 1	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Claude Bernard Lyon 1	Funding provided by the Centre National de la Recherche Scientifique (URL:http://www.cnrs.fr) and Universite Claude Bernard Lyon 1 (URL: http://www.univ-lyon1.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MN, 2002, J PHYSIOL-LONDON, V538, P619, DOI 10.1113/jphysiol.2001.012888; Allers KA, 2003, NEUROSCIENCE, V122, P193, DOI 10.1016/S0306-4522(03)00518-9; ANDREZIK JA, 1981, ANAT EMBRYOL, V161, P373, DOI 10.1007/BF00316049; ANDREZIK JA, 1981, ANAT EMBRYOL, V161, P355, DOI 10.1007/BF00316048; ARLUISON M, 1984, BRAIN RES BULL, V13, P269, DOI 10.1016/0361-9230(84)90128-X; ASTONJONES G, 1981, J NEUROSCI, V1, P876; BLIWISE D, 1974, PSYCHOPHYSIOLOGY, V11, P497, DOI 10.1111/j.1469-8986.1974.tb00578.x; Boissard R, 2002, EUR J NEUROSCI, V16, P1959, DOI 10.1046/j.1460-9568.2002.02257.x; Boissard R, 2000, SLEEP S, V23, P107; Brooks PL, 2010, ADV EXP MED BIOL, V669, P259, DOI 10.1007/978-1-4419-5692-7_52; Buck HD, 2001, AUTON NEUROSCI-BASIC, V87, P187, DOI 10.1016/S1566-0702(00)00259-9; CARLI G, 1965, ARCH ITAL BIOL, V103, P751; CHASE MH, 1989, J NEUROSCI, V9, P743; Clement O, 2011, SLEEP, V34, P419, DOI 10.1093/sleep/34.4.419; DAMPNEY RAL, 1987, CAN J PHYSIOL PHARM, V65, P1572, DOI 10.1139/y87-247; DAMPNEY RAL, 1994, PHYSIOL REV, V74, P323, DOI 10.1152/physrev.1994.74.2.323; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; ENNIS M, 1988, J NEUROSCI, V8, P3644; Fay RA, 1997, BRAIN RES REV, V25, P276, DOI 10.1016/S0165-0173(97)00027-1; Fort P, 1998, Sleep Res Online, V1, P102; FORT P, 1989, J COMP NEUROL, V283, P285, DOI 10.1002/cne.902830209; Gervasoni D, 1998, EUR J NEUROSCI, V10, P964, DOI 10.1046/j.1460-9568.1998.00106.x; Gervasoni D, 2000, J NEUROSCI, V20, P4217; Goutagny R, 2008, NEUROSCIENCE, V152, P849, DOI 10.1016/j.neuroscience.2007.12.014; Goutagny R, 2005, NEUROREPORT, V16, P1069, DOI 10.1097/00001756-200507130-00008; GUYENET PG, 1987, BRAIN RES, V406, P171, DOI 10.1016/0006-8993(87)90781-5; Guyenet PG, 2000, RESP PHYSIOL, V121, P147, DOI 10.1016/S0034-5687(00)00125-0; GUYENET PG, 1990, AM J PHYSIOL, V259, pR1063, DOI 10.1152/ajpregu.1990.259.5.R1063; HASELTON JR, 1989, NEUROSCIENCE, V30, P199, DOI 10.1016/0306-4522(89)90365-5; Hassani OK, 2010, EUR J NEUROSCI, V32, P448, DOI 10.1111/j.1460-9568.2010.07295.x; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; HERBERT H, 1992, J COMP NEUROL, V315, P34, DOI 10.1002/cne.903150104; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; JONES BE, 1991, NEUROSCIENCE, V40, P637, DOI 10.1016/0306-4522(91)90002-6; JOUVET M, 1972, ERG PHYSIOL BIOL CH, V64, P166; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Koyama Y, 1998, NEUROSCIENCE, V83, P1105, DOI 10.1016/S0306-4522(97)00439-9; Koyama Y, 2003, NEUROSCIENCE, V119, P1209, DOI 10.1016/S0306-4522(03)00173-8; Lee HS, 2005, J COMP NEUROL, V481, P179, DOI 10.1002/cne.20365; Leger L, 2010, J CHEM NEUROANAT, V39, P262, DOI 10.1016/j.jchemneu.2010.03.001; Leger L, 2009, J CHEM NEUROANAT, V37, P149, DOI 10.1016/j.jchemneu.2008.12.008; Li YQ, 1997, J COMP NEUROL, V378, P283, DOI 10.1002/(SICI)1096-9861(19970210)378:2<283::AID-CNE10>3.0.CO;2-T; Li YQ, 1996, J COMP NEUROL, V373, P498, DOI 10.1002/(SICI)1096-9861(19960930)373:4<498::AID-CNE3>3.0.CO;2-X; LOVICK TA, 1988, BRAIN RES, V456, P183, DOI 10.1016/0006-8993(88)90361-7; Lu J, 2006, J NEUROSCI, V26, P193, DOI 10.1523/JNEUROSCI.2244-05.2006; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; LUCKMAN SM, 1994, J NEUROSCI, V14, P4825; Luppi PH, 2011, SLEEP MED REV, V15, P153, DOI 10.1016/j.smrv.2010.08.002; Maloney KJ, 1999, J NEUROSCI, V19, P3057; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MENDELSON WB, 1974, PHARMACOL BIOCHEM BE, V2, P553, DOI 10.1016/0091-3057(74)90018-5; MHAMED SB, 1993, NEUROSCI LETT, V164, P195, DOI 10.1016/0304-3940(93)90890-W; Morales FR, 1999, J NEUROSCI, V19, P9508; Rivera-Garcia AP, 2011, J SLEEP RES, V20, P82, DOI 10.1111/j.1365-2869.2010.00853.x; PETROV T, 1993, BRAIN RES, V609, P81, DOI 10.1016/0006-8993(93)90858-K; Peyron C., 1995, Society for Neuroscience Abstracts, V21, P373; RODER S, 1994, BRAIN RES, V638, P182, DOI 10.1016/0006-8993(94)90648-3; ROSS CA, 1985, J COMP NEUROL, V242, P511, DOI 10.1002/cne.902420405; ROSS CA, 1984, J NEUROSCI, V4, P474; RUGGIERO DA, 1989, PROG BRAIN RES, V81, P49; Saha S, 2005, CLIN EXP PHARMACOL P, V32, P450, DOI 10.1111/j.1440-1681.2005.04210.x; Sakai K, 2001, NEUROSCIENCE, V104, P1141, DOI 10.1016/S0306-4522(01)00103-8; SAKAI K, 1988, ARCH ITAL BIOL, V126, P239; Sakai K, 2001, ARCH ITAL BIOL, V139, P93; Sakai K, 1981, BRAIN MECH PERCEPTUA, P405; Sakai K., 1980, RETICULAR FORMATION, P427; Sapin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011766; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; Sastre JP, 1996, NEUROSCIENCE, V74, P415, DOI 10.1016/0306-4522(96)00190-X; SOJA PJ, 1987, EXP NEUROL, V96, P178, DOI 10.1016/0014-4886(87)90179-8; Sosulina L, 2010, J NEUROPHYSIOL, V104, P617, DOI 10.1152/jn.00207.2010; Souliere F, 2000, J NEUROSCI RES, V61, P88, DOI 10.1002/1097-4547(20000701)61:1<88::AID-JNR11>3.0.CO;2-5; Steininger TL, 1999, BRAIN RES, V840, P138, DOI 10.1016/S0006-8993(99)01648-0; Stornetta RL, 1999, J COMP NEUROL, V415, P482, DOI 10.1002/(SICI)1096-9861(19991227)415:4<482::AID-CNE5>3.0.CO;2-4; Stornetta RL, 2004, J COMP NEUROL, V479, P257, DOI 10.1002/cne.20332; TRAVERS JB, 1983, J COMP NEUROL, V220, P280, DOI 10.1002/cne.902200303; Travers JB, 2005, J COMP NEUROL, V488, P28, DOI 10.1002/cne.20604; TRULSON ME, 1979, BRAIN RES, V163, P135, DOI 10.1016/0006-8993(79)90157-4; Urbain N, 2000, EUR J NEUROSCI, V12, P3361, DOI 10.1046/j.1460-9568.2000.00199.x; VANBOCKSTAELE EJ, 1989, J COMP NEUROL, V290, P561, DOI 10.1002/cne.902900410; Verberne AJM, 1999, J PHYSIOL-LONDON, V517, P477, DOI 10.1111/j.1469-7793.1999.0477t.x; Verret L, 2006, J COMP NEUROL, V495, P573, DOI 10.1002/cne.20891; Verret L, 2005, EUR J NEUROSCI, V21, P2488, DOI 10.1111/j.1460-9568.2005.04060.x; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19; WEBSTER HH, 1988, BRAIN RES, V458, P285, DOI 10.1016/0006-8993(88)90471-4; Yamuy J, 1999, NEUROSCIENCE, V94, P11, DOI 10.1016/S0306-4522(99)00355-3	87	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28724	10.1371/journal.pone.0028724	http://dx.doi.org/10.1371/journal.pone.0028724			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235249	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400010
J	Bohan, DA; Caron-Lormier, G; Muggleton, S; Raybould, A; Tamaddoni-Nezhad, A				Bohan, David A.; Caron-Lormier, Geoffrey; Muggleton, Stephen; Raybould, Alan; Tamaddoni-Nezhad, Alireza			Automated Discovery of Food Webs from Ecological Data Using Logic-Based Machine Learning	PLOS ONE			English	Article							MODIFIED HERBICIDE-TOLERANT; FARM-SCALE EVALUATIONS; GENERALIST PREDATORS; INVERTEBRATE ABUNDANCE; INTRAGUILD PREDATION; BIOLOGICAL-CONTROL; ECOSYSTEM SERVICE; WEED SEEDBANK; MANAGEMENT; COLLEMBOLA	Networks of trophic links (food webs) are used to describe and understand mechanistic routes for translocation of energy (biomass) between species. However, a relatively low proportion of ecosystems have been studied using food web approaches due to difficulties in making observations on large numbers of species. In this paper we demonstrate that Machine Learning of food webs, using a logic-based approach called A/ILP, can generate plausible and testable food webs from field sample data. Our example data come from a national-scale Vortis suction sampling of invertebrates from arable fields in Great Britain. We found that 45 invertebrate species or taxa, representing approximately 25% of the sample and about 74% of the invertebrate individuals included in the learning, were hypothesized to be linked. As might be expected, detritivore Collembola were consistently the most important prey. Generalist and omnivorous carabid beetles were hypothesized to be the dominant predators of the system. We were, however, surprised by the importance of carabid larvae suggested by the machine learning as predators of a wide variety of prey. High probability links were hypothesized for widespread, potentially destabilizing, intra-guild predation; predictions that could be experimentally tested. Many of the high probability links in the model have already been observed or suggested for this system, supporting our contention that A/ILP learning can produce plausible food webs from sample data, independent of our preconceptions about "who eats whom." Well-characterised links in the literature correspond with links ascribed with high probability through A/ILP. We believe that this very general Machine Learning approach has great power and could be used to extend and test our current theories of agricultural ecosystem dynamics and function. In particular, we believe it could be used to support the development of a wider theory of ecosystem responses to environmental change.	[Bohan, David A.; Caron-Lormier, Geoffrey] W Common, Rothamsted Res, Harpenden, Herts, England; [Bohan, David A.] INRA, UMR Biol & Gest Adventices 1210, F-21034 Dijon, France; [Muggleton, Stephen; Tamaddoni-Nezhad, Alireza] Univ London Imperial Coll Sci Technol & Med, Dept Comp, Computat Bioinformat Lab, London, England; [Raybould, Alan] Syngenta, Jealotts Hill Int Res Ctr, Bracknell, Berks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; INRAE; Imperial College London; Syngenta	Bohan, DA (corresponding author), W Common, Rothamsted Res, Harpenden, Herts, England.	weed.dynamics@gmail.com	Bohan, David A/D-7992-2012; Caron-Lormier, Geoffrey/B-6677-2009	Bohan, David A/0000-0001-5656-775X; 	Syngenta Ltd; Imperial College	Syngenta Ltd(Syngenta); Imperial College	This research was partly supported by monies in support of Alireza Tamaddoni-Nezhad and Stephen Muggleton through a strategic link between Syngenta Ltd and Imperial College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Agusti N, 2003, MOL ECOL, V12, P3467, DOI 10.1046/j.1365-294X.2003.02014.x; Arim M, 2004, ECOL LETT, V7, P557, DOI 10.1111/j.1461-0248.2004.00613.x; Bell JR, 2010, ECOGRAPHY, V33, P64, DOI 10.1111/j.1600-0587.2009.06046.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bilde T, 2000, J APPL ECOL, V37, P672, DOI 10.1046/j.1365-2664.2000.00527.x; Bohan DA, 2007, B ENTOMOL RES, V97, P265, DOI 10.1017/S0007485307004890; Bohan DA, 2011, WEED RES, V51, P422, DOI 10.1111/j.1365-3180.2011.00860.x; Bohan DA, 2005, P ROY SOC B-BIOL SCI, V272, P463, DOI 10.1098/rspb.2004.3049; Bohan DA, 2011, J APPL ECOL, V48, P888, DOI 10.1111/j.1365-2664.2011.02008.x; Brooks DR, 2003, PHILOS T R SOC B, V358, P1847, DOI 10.1098/rstb.2003.1407; Caron-Lormier G, 2011, ECOL MODEL, V222, P1163, DOI 10.1016/j.ecolmodel.2010.11.028; Caron-Lormier G, 2009, ECOL MODEL, V220, P1935, DOI 10.1016/j.ecolmodel.2009.04.021; Champion GT, 2003, PHILOS T ROY SOC B, V358, P1801, DOI 10.1098/rstb.2003.1405; Cohen JE, 2009, P NATL ACAD SCI USA, V106, P22335, DOI 10.1073/pnas.0910582106; Dewar AM, 2003, P ROY SOC B-BIOL SCI, V270, P335, DOI 10.1098/rspb.2002.2248; Dickinson G., 1998, ECOSYSTEMS FUNCTIONA; Dietterich TG, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P8; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Eitzinger B, 2011, J APPL ECOL, V48, P591, DOI 10.1111/j.1365-2664.2010.01947.x; Firbank LG, 2003, J APPL ECOL, V40, P2, DOI 10.1046/j.1365-2664.2003.00787.x; Firbank LG., 2003, IMPLICATIONS SPRING; Flach PA, 2000, APPL LOGIC SERIES; Frank SD, 2010, ECOL ENTOMOL, V35, P61, DOI 10.1111/j.1365-2311.2009.01156.x; Haughton AJ, 2003, PHILOS T ROY SOC B, V358, P1863, DOI 10.1098/rstb.2003.1408; HAUSSLER D, 1994, MACH LEARN, V14, P83, DOI 10.1007/BF00993163; Hawes C, 2009, BASIC APPL ECOL, V10, P34, DOI 10.1016/j.baae.2007.11.007; IWDB, 2011, INTERACTION WEB DATA; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Macfadyen S, 2009, ECOL LETT, V12, P229, DOI 10.1111/j.1461-0248.2008.01279.x; Marcussen BM, 1999, ENTOMOL EXP APPL, V92, P29, DOI 10.1023/A:1003787208256; Muggleton S., 1991, New Generation Computing, V8, P295, DOI 10.1007/BF03037089; Muggleton S. H., 2000, Inductive Logic Programming. 10th International Conference, ILP 2000. Proceedings (Lecture Notes in Artificial Intelligence Vol.1866), P130; Muggleton Stephen, 1996, ADV INDUCTIVE LOGIC, V32, P254; ODUM E P, 1971, P574; Perry JN, 2003, J APPL ECOL, V40, P17, DOI 10.1046/j.1365-2664.2003.00786.x; Pons X, 2005, EUR J ENTOMOL, V102, P519, DOI 10.14411/eje.2005.074; Prasad RP, 2004, BIOL CONTROL, V31, P428, DOI 10.1016/j.biocontrol.2004.07.005; Riede JO, 2011, ECOL LETT, V14, P169, DOI 10.1111/j.1461-0248.2010.01568.x; Rosenheim JA, 1998, ANNU REV ENTOMOL, V43, P421, DOI 10.1146/annurev.ento.43.1.421; Rosenheim JA, 2005, BIOL CONTROL, V32, P172, DOI 10.1016/j.biocontrol.2004.09.007; Roy DB, 2003, PHILOS T ROY SOC B, V358, P1879, DOI 10.1098/rstb.2003.1404; Smith' V, 2008, ARTHROPOD-PLANT INTE, V2, P21, DOI 10.1007/s11829-007-9027-y; Snyder WE, 2001, ECOLOGY, V82, P705, DOI 10.1890/0012-9658(2001)082[0705:GPDBCB]2.0.CO;2; Squire GR, 2003, PHILOS T R SOC B, V358, P1779, DOI 10.1098/rstb.2003.1403; SUNDERLAND KD, 1975, J APPL ECOL, V12, P507, DOI 10.2307/2402171; SUNDERLAND KD, 1987, J APPL ECOL, V24, P907, DOI 10.2307/2403989; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Tamaddoni-Nezhad A, 2006, MACH LEARN, V64, P209, DOI 10.1007/s10994-006-8988-x; Toft S, 2005, EUR J ENTOMOL, V102, P371, DOI 10.14411/eje.2005.054; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Turchin P., 2003, MONOGRAPHS POPULATIO; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Weber DC, 2009, BIOL CONTROL, V51, P199, DOI 10.1016/j.biocontrol.2009.05.013	54	42	44	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29028	10.1371/journal.pone.0029028	http://dx.doi.org/10.1371/journal.pone.0029028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242111	Green Published, gold, Green Submitted			2022-12-27	WOS:000300677000013
J	McBride, DJ; Buckle, A; van Heyningen, V; Kleinjan, DA				McBride, David J.; Buckle, Adam; van Heyningen, Veronica; Kleinjan, Dirk A.			DNaseI Hypersensitivity and Ultraconservation Reveal Novel, Interdependent Long-Range Enhancers at the Complex Pax6 Cis-Regulatory Region	PLOS ONE			English	Article							GENE; EXPRESSION; EYE; ANIRIDIA; DIFFERENTIATION; ELEMENTS; LENS; OVEREXPRESSION; SEQUENCE; MICE	The PAX6 gene plays a crucial role in development of the eye, brain, olfactory system and endocrine pancreas. Consistent with its pleiotropic role the gene exhibits a complex developmental expression pattern which is subject to strict spatial, temporal and quantitative regulation. Control of expression depends on a large array of cis-elements residing in an extended genomic domain around the coding region of the gene. The minimal essential region required for proper regulation of this complex locus has been defined through analysis of human aniridia-associated breakpoints and YAC transgenic rescue studies of the mouse smalleye mutant. We have carried out a systematic DNase I hypersensitive site (HS) analysis across 200 kb of this critical region of mouse chromosome 2E3 to identify putative regulatory elements. Mapping the identified HSs onto a percent identity plot (PIP) shows many HSs correspond to recognisable genomic features such as evolutionarily conserved sequences, CpG islands and retrotransposon derived repeats. We then focussed on a region previously shown to contain essential long range cis-regulatory information, the Pax6 downstream regulatory region (DRR), allowing comparison of mouse HS data with previous human HS data for this region. Reporter transgenic mice for two of the HS sites, HS5 and HS6, show that they function as tissue specific regulatory elements. In addition we have characterised enhancer activity of an ultra-conserved cis-regulatory region located near Pax6, termed E60. All three cis-elements exhibit multiple spatio-temporal activities in the embryo that overlap between themselves and other elements in the locus. Using a deletion set of YAC reporter transgenic mice we demonstrate functional interdependence of the elements. Finally, we use the HS6 enhancer as a marker for the migration of precerebellar neuro-epithelium cells to the hindbrain precerebellar nuclei along the posterior and anterior extramural streams allowing visualisation of migratory defects in both pathways in Pax6(Sey/Sey) mice.	[McBride, David J.; Buckle, Adam; van Heyningen, Veronica; Kleinjan, Dirk A.] Univ Edinburgh, Western Gen Hosp, Med Res Council Human Genet Unit, Med Res Council Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland	University of Edinburgh	McBride, DJ (corresponding author), Illumina Cambridge Ltd, Chesterford Res Pk, Saffron Walden, Essex, England.	D.Kleinjan@hgu.mrc.ac.uk	van Heyningen, Veronica/B-8039-2008; VAN HEYNINGEN, Veronica/GYE-0531-2022	van Heyningen, Veronica/0000-0003-0359-0141; buckle, adam/0000-0002-9861-6959	Medical Research Council UK; MRC [MC_PC_U127527199, MC_U127527199] Funding Source: UKRI; Medical Research Council [MC_PC_U127527199, MC_U127527199] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by the Medical Research Council UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman J, 1997, DEV CEREBELLAR SYSTE; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Bayrakli F, 2009, J CLIN NEUROSCI, V16, P1610, DOI 10.1016/j.jocn.2009.03.022; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Benzing K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002099; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Chanas SA, 2009, INVEST OPHTH VIS SCI, V50, P4045, DOI 10.1167/iovs.07-1630; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Davidson EH, 2006, REG GEN GEN REG; Dohrmann C, 2000, MECH DEVELOP, V92, P47, DOI 10.1016/S0925-4773(99)00324-X; ELGIN SCR, 1988, J BIOL CHEM, V263, P19259; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; FELLUGA B, 1969, J NATL CANCER I, V43, P319; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Griffin C, 2002, MECH DEVELOP, V112, P89, DOI 10.1016/S0925-4773(01)00646-3; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hobert O, 2011, CURR BIOL, V21, pR146, DOI 10.1016/j.cub.2011.01.005; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; Kammandel B, 1999, DEV BIOL, V205, P79, DOI 10.1006/dbio.1998.9128; Kim J, 2006, DEV BIOL, V292, P486, DOI 10.1016/j.ydbio.2005.12.041; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kioussi C, 1999, P NATL ACAD SCI USA, V96, P14378, DOI 10.1073/pnas.96.25.14378; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kleinjan DA, 2004, DEV BIOL, V265, P462, DOI 10.1016/j.ydbio.2003.09.011; Kleinjan DA, 2001, HUM MOL GENET, V10, P2049, DOI 10.1093/hmg/10.19.2049; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Kleinjan DA, 2006, DEV BIOL, V299, P563, DOI 10.1016/j.ydbio.2006.08.060; Kleinjan Dirk-Jan, 2009, Briefings in Functional Genomics & Proteomics, V8, P317, DOI 10.1093/bfgp/elp022; Landsberg RL, 2005, NEURON, V48, P933, DOI 10.1016/j.neuron.2005.11.031; Lauderdale J, 2000, P NATL ACAD SCI USA, V97, P13755, DOI 10.1073/pnas.240398797; Manuel M, 2007, DEVELOPMENT, V134, P545, DOI 10.1242/dev.02764; Manuel M, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-59; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Mastick GS, 2001, MOL CELL NEUROSCI, V17, P190, DOI 10.1006/mcne.2000.0924; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; Meader S, 2010, GENOME RES, V20, P1335, DOI 10.1101/gr.108795.110; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; Pauler FM, 2005, GENOME RES, V15, P1379, DOI 10.1101/gr.3783805; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Shaham O, 2009, DEVELOPMENT, V136, P2567, DOI 10.1242/dev.032888; SIMOLA KOJ, 1983, HUM GENET, V63, P158, DOI 10.1007/BF00291536; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Sisodiya SM, 2001, NAT GENET, V28, P214, DOI 10.1038/90042; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Stoykova A, 1996, DEVELOPMENT, V122, P3453; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; Tyas DA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-21; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Warren N, 1999, CEREB CORTEX, V9, P627, DOI 10.1093/cercor/9.6.627; Warren N, 1997, DEVELOPMENT, V124, P1573; Williams SC, 1998, MECH DEVELOP, V73, P225, DOI 10.1016/S0925-4773(98)00057-4; Xu PX, 1999, DEVELOPMENT, V126, P383	62	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e28616	10.1371/journal.pone.0028616	http://dx.doi.org/10.1371/journal.pone.0028616			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220192	Green Published, Green Submitted, gold			2022-12-27	WOS:000300677000004
J	Ramos, EAS; Grochoski, M; Braun-Prado, K; Seniski, GG; Cavalli, IJ; Ribeiro, EMSF; Camargo, AA; Costa, FF; Klassen, G				Ramos, Edneia A. S.; Grochoski, Mariana; Braun-Prado, Karin; Seniski, Gerusa G.; Cavalli, Iglenir J.; Ribeiro, Enilze M. S. F.; Camargo, Anamaria A.; Costa, Fabricio F.; Klassen, Giseli			Epigenetic Changes of CXCR4 and Its Ligand CXCL12 as Prognostic Factors for Sporadic Breast Cancer	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; LYMPH-NODE METASTASIS; CPG ISLAND HYPERMETHYLATION; DNA METHYLATION; UP-REGULATION; EXPRESSION	Chemokines and their receptors are involved in the development and cancer progression. The chemokine CXCL12 interacts with its receptor, CXCR4, to promote cellular adhesion, survival, proliferation and migration. The CXCR4 gene is upregulated in several types of cancers, including skin, lung, pancreas, brain and breast tumors. In pancreatic cancer and melanoma, CXCR4 expression is regulated by DNA methylation within its promoter region. In this study we examined the role of cytosine methylation in the regulation of CXCR4 expression in breast cancer cell lines and also correlated the methylation pattern with the clinicopathological aspects of sixty-nine primary breast tumors from a cohort of Brazilian women. RT-PCR showed that the PMC-42, MCF7 and MDA-MB-436 breast tumor cell lines expressed high levels of CXCR4. Conversely, the MDA-MB-435 cell line only expressed CXCR4 after treatment with 5-Aza-CdR, which suggests that CXCR4 expression is regulated by DNA methylation. To confirm this hypothesis, a 184 bp fragment of the CXCR4 gene promoter region was cloned after sodium bisulfite DNA treatment. Sequencing data showed that cell lines that expressed CXCR4 had only 15% of methylated CpG dinucleotides, while the cell line that not have CXCR4 expression, had a high density of methylation (91%). Loss of DNA methylation in the CXCR4 promoter was detected in 67% of the breast cancer analyzed. The absence of CXCR4 methylation was associated with the tumor stage, size, histological grade, lymph node status, ESR1 methylation and CXCL12 methylation, metastasis and patient death. Kaplan-Meier curves demonstrated that patients with an unmethylated CXCR4 promoter had a poorer overall survival and disease-free survival. Furthermore, patients with both CXCL12 methylation and unmethylated CXCR4 had a shorter overall survival and disease-free survival. These findings suggest that the DNA methylation status of both CXCR4 and CXCL12 genes could be used as a biomarker for prognosis in breast cancer.	[Ramos, Edneia A. S.; Grochoski, Mariana; Braun-Prado, Karin; Seniski, Gerusa G.; Klassen, Giseli] Univ Fed Parana, Dept Basic Pathol, Epigenet & Mol Biol Lab, BR-80060000 Curitiba, Parana, Brazil; [Costa, Fabricio F.] Northwestern Univ, Canc Biol & Epigen Program, Childrens Mem Res Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Cavalli, Iglenir J.; Ribeiro, Enilze M. S. F.] Univ Fed Parana, Dept Genet, BR-80060000 Curitiba, Parana, Brazil; [Camargo, Anamaria A.] Ludwig Inst Canc Res, Lab Mol Biol & Genom, Sao Paulo, Brazil	Universidade Federal do Parana; Northwestern University; Feinberg School of Medicine; Universidade Federal do Parana; Ludwig Institute for Cancer Research	Ramos, EAS (corresponding author), Univ Fed Parana, Dept Basic Pathol, Epigenet & Mol Biol Lab, BR-80060000 Curitiba, Parana, Brazil.	fcosta@childrensmemorial.org; giseli@ufpr.br	Ribeiro, Enilze MSF/K-7319-2012; Camargo, Anamaria A/E-9388-2012; Cavalieri, Edneia ASR/Q-9636-2019; Braun-Prado, Karin/C-4282-2014; Klassen, Giseli/F-8753-2012; Costa, Fabricio/M-5309-2017; Klassen, Giseli/AAF-3962-2019	Camargo, Anamaria A/0000-0002-6076-9597; Cavalieri, Edneia ASR/0000-0002-8855-5988; Klassen, Giseli/0000-0001-5336-6178; Klassen, Giseli/0000-0001-5336-6178; braun prado, Karin/0000-0002-9652-0566	Brazilian Research Council (CNPq); Coordination of Improvement of Higher Education Personnel (CAPES); Maeve McNicholas Memorial Foundation; Avon Foundation [01-2009-037]	Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination of Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Maeve McNicholas Memorial Foundation; Avon Foundation	This work was supported by the Brazilian Research Council (CNPq) and Coordination of Improvement of Higher Education Personnel (CAPES). Dr. Costa is supported by the Maeve McNicholas Memorial Foundation and the Avon Foundation (grant # 01-2009-037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2006, ANN ONCOL, V17, P945, DOI 10.1093/annonc/mdl053; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Costa Fabricio F, 2010, Cancer Manag Res, V2, P255, DOI 10.2147/CMR.S7280; Costa FF, 2006, CANCER GENET CYTOGEN, V165, P135, DOI 10.1016/j.cancergencyto.2005.07.023; Dumitrescu RG, 2005, J CELL MOL MED, V9, P208, DOI 10.1111/j.1582-4934.2005.tb00350.x; Dworkin AM, 2009, SEMIN CANCER BIOL, V19, P165, DOI 10.1016/j.semcancer.2009.02.007; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Hamm CA, 2011, DRUG DISCOV TODAY, V16, P626, DOI 10.1016/j.drudis.2011.04.007; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hassan S, 2008, CLIN CANCER RES, V14, P446, DOI 10.1158/1078-0432.CCR-07-1189; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hiller DJ, 2011, J SURG RES, V166, P14, DOI 10.1016/j.jss.2010.04.045; Holm NT, 2007, J SURG RES, V141, P53, DOI 10.1016/j.jss.2007.03.015; INCA, 2012, INC CANC BRAS, P100; Jemal A, 2010, CANC STAT 2010; Jovanovic J, 2010, MOL ONCOL, V4, P242, DOI 10.1016/j.molonc.2010.04.002; Kang H, 2005, BREAST, V14, P360, DOI 10.1016/j.breast.2004.12.007; Kato M, 2003, BREAST CANCER RES, V5, pR144, DOI 10.1186/bcr627; Kubarek L, 2007, FEBS LETT, V581, P1441, DOI 10.1016/j.febslet.2007.02.070; Leu YW, 2004, CANCER RES, V64, P8184, DOI 10.1158/0008-5472.CAN-04-2045; Meier R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001016; Montero AJ, 2006, CANCER BIOL THER, V5, P1494, DOI 10.4161/cbt.5.11.3299; Mori T, 2005, CANCER RES, V65, P1800, DOI 10.1158/0008-5472.CAN-04-3531; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pathiraja TN, 2010, J MAMMARY GLAND BIOL, V15, P35, DOI 10.1007/s10911-010-9166-0; Ramos EAS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-23; Sambrook J., 2001, MOL CLONING LAB MANU; Sato N, 2005, CANCER BIOL THER, V4, P70, DOI 10.4161/cbt.4.1.1378; Shim H, 2006, BIOCHEM BIOPH RES CO, V346, P252, DOI 10.1016/j.bbrc.2006.05.110; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Su YC, 2006, BREAST, V15, P533, DOI 10.1016/j.breast.2005.08.034; Veronesi U, 2006, BREAST, V15, P3, DOI 10.1016/j.breast.2005.11.011; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wendt MK, 2006, ONCOGENE, V25, P4986, DOI 10.1038/sj.onc.1209505; Widschwendter M, 2002, ONCOGENE, V21, P5462, DOI 10.1038/sj.onc.1205606; Woo SU, 2008, ANN SURG ONCOL, V15, P281, DOI 10.1245/s10434-007-9595-1	37	48	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29461	10.1371/journal.pone.0029461	http://dx.doi.org/10.1371/journal.pone.0029461			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220212	Green Submitted, gold, Green Published			2022-12-27	WOS:000300677000036
J	Kadri, S; Hinman, VF; Benos, PV				Kadri, Sabah; Hinman, Veronica F.; Benos, Panayiotis V.			RNA Deep Sequencing Reveals Differential MicroRNA Expression during Development of Sea Urchin and Sea Star	PLOS ONE			English	Article							INTERFERENCE; EVOLUTION; NETWORK; GENOME; GENES; DICER	microRNAs (miRNAs) are small (20-23 nt), non-coding single stranded RNA molecules that act as post-transcriptional regulators of mRNA gene expression. They have been implicated in regulation of developmental processes in diverse organisms. The echinoderms, Strongylocentrotus purpuratus (sea urchin) and Patiria miniata (sea star) are excellent model organisms for studying development with well-characterized transcriptional networks. However, to date, nothing is known about the role of miRNAs during development in these organisms, except that the genes that are involved in the miRNA biogenesis pathway are expressed during their developmental stages. In this paper, we used Illumina Genome Analyzer (Illumina, Inc.) to sequence small RNA libraries in mixed stage population of embryos from one to three days after fertilization of sea urchin and sea star (total of 22,670,000 reads). Analysis of these data revealed the miRNA populations in these two species. We found that 47 and 38 known miRNAs are expressed in sea urchin and sea star, respectively, during early development (32 in common). We also found 13 potentially novel miRNAs in the sea urchin embryonic library. miRNA expression is generally conserved between the two species during development, but 7 miRNAs are highly expressed in only one species. We expect that our two datasets will be a valuable resource for everyone working in the field of developmental biology and the regulatory networks that affect it. The computational pipeline to analyze Illumina reads is available at http://www.benoslab.pitt.edu/services.html.	[Kadri, Sabah] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Hinman, Veronica F.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Benos, Panayiotis V.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kadri, S (corresponding author), Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA.	benos@pitt.edu		Kadri, Sabah/0000-0003-0365-6550; Benos, Panayiotis/0000-0003-3172-3132	National Institutes of Health [R01LM007994, R01LM009657]; National Science Foundation [IOS 1024811]; NATIONAL LIBRARY OF MEDICINE [R01LM009657, R01LM007994] Funding Source: NIH RePORTER; Direct For Biological Sciences [1024811] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institutes of Health grants R01LM007994, and R01LM009657 (PVB), and National Science Foundation grant IOS 1024811. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Cameron RA, 2009, NUCLEIC ACIDS RES, V37, pD750, DOI 10.1093/nar/gkn887; Campo-Paysaa F, 2011, EVOL DEV, V13, P15, DOI 10.1111/j.1525-142X.2010.00452.x; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Davidson EH, 2009, CURR OPIN GENET DEV, V19, P535, DOI 10.1016/j.gde.2009.10.007; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Hinman VF, 2007, P NATL ACAD SCI USA, V104, P19404, DOI 10.1073/pnas.0709994104; Hinman VF, 2003, P NATL ACAD SCI USA, V100, P13356, DOI 10.1073/pnas.2235868100; Hinman VF, 2003, MECH DEVELOP, V120, P1165, DOI 10.1016/j.mod.2003.08.002; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Oliveri P, 2002, DEV BIOL, V246, P209, DOI 10.1006/dbio.2002.0627; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Song JL, 2007, DEV DYNAM, V236, P3180, DOI 10.1002/dvdy.21353; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; WADA H, 1994, J MOL EVOL, V38, P41; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911	40	19	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29217	10.1371/journal.pone.0029217	http://dx.doi.org/10.1371/journal.pone.0029217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216218	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000300676300038
J	Leroy, S; Bouissou, F; Fernandez-Lopez, A; Gurgoze, MK; Karavanaki, K; Ulinski, T; Bressan, S; Vaos, G; Leblond, P; Coulais, Y; Cubells, CL; Aygun, AD; Stefanidis, CJ; Bensman, A; DaDalt, L; Gardikis, S; Bigot, S; Gendrel, D; Breart, G; Chalumeau, M				Leroy, Sandrine; Bouissou, Francois; Fernandez-Lopez, Anna; Gurgoze, Metin K.; Karavanaki, Kyriaki; Ulinski, Tim; Bressan, Silvia; Vaos, Geogios; Leblond, Pierre; Coulais, Yvon; Luaces Cubells, Carlos; Aygun, A. Denizmen; Stefanidis, Constantinos J.; Bensman, Albert; DaDalt, Liviana; Gardikis, Stefanos; Bigot, Sandra; Gendrel, Dominique; Breart, Gerard; Chalumeau, Martin			Prediction of High-Grade Vesicoureteral Reflux after Pediatric Urinary Tract Infection: External Validation Study of Procalcitonin-Based Decision Rule	PLOS ONE			English	Article							ACUTE PYELONEPHRITIS; ANTIBIOTIC-PROPHYLAXIS; BACTERIAL-INFECTIONS; FEBRILE INFANTS; CHILDREN; DIAGNOSIS; EMERGENCY; MULTICENTER; MARKERS	Background: Predicting vesico-ureteral reflux (VUR) >= 3 at the time of the first urinary tract infection (UTI) would make it possible to restrict cystography to high-risk children. We previously derived the following clinical decision rule for that purpose: cystography should be performed in cases with ureteral dilation and a serum procalcitonin level >= 0.17 ng/mL, or without ureteral dilatation when the serum procalcitonin level >= 0.63 ng/mL. The rule yielded a 86% sensitivity with a 46% specificity. We aimed to test its reproducibility. Study Design: A secondary analysis of prospective series of children with a first UTI. The rule was applied, and predictive ability was calculated. Results: The study included 413 patients (157 boys, VUR >= 3 in 11%) from eight centers in five countries. The rule offered a 46% specificity (95% CI, 41-52), not different from the one in the derivation study. However, the sensitivity significantly decreased to 64% (95% CI, 50-76), leading to a difference of 20% (95% CI, 17-36). In all, 16 (34%) patients among the 47 with VUR >= 3 were misdiagnosed by the rule. This lack of reproducibility might result primarily from a difference between derivation and validation populations regarding inflammatory parameters (CRP, PCT); the validation set samples may have been collected earlier than for the derivation one. Conclusions: The rule built to predict VUR >= 3 had a stable specificity (ie. 46%), but a decreased sensitivity (ie. 64%) because of the time variability of PCT measurement. Some refinement may be warranted.	[Leroy, Sandrine] Ctr Stat Med, Oxford, England; [Leroy, Sandrine] Inst Pasteur, Epidemiol Emerging Dis Unit, Paris, France; [Leroy, Sandrine; Breart, Gerard; Chalumeau, Martin] Inserm U953 Unit, Paris, France; [Leroy, Sandrine; Gendrel, Dominique; Chalumeau, Martin] Paris Descartes Univ, Necker Hosp, AP HP, Dept Pediat, Paris, France; [Bouissou, Francois; Coulais, Yvon] Univ Toulouse 3, CHU Purpan, Childrens Hosp, Dept Pediat, F-31062 Toulouse, France; [Fernandez-Lopez, Anna] Hosp Arnau Vilanova, Dept Pediat, Lleida, Spain; [Gurgoze, Metin K.; Aygun, A. Denizmen] Firat Univ, Fac Med, TR-23169 Elazig, Turkey; [Karavanaki, Kyriaki; Stefanidis, Constantinos J.] Dept Nephrol A&P Kyriakou Childens Hosp, Athens, Greece; [Ulinski, Tim; Bensman, Albert] Trousseau Hosp, Dept Pediat Nephrol, Paris, France; [Ulinski, Tim; Bensman, Albert] Univ Paris 06, Paris, France; [Bressan, Silvia; DaDalt, Liviana] Univ Padua, Dept Pediat, Padua, Italy; [Vaos, Geogios; Gardikis, Stefanos] Alexandroupolis Univ Hosp, Dept Pediat Surg, Thrace, Greece; [Leblond, Pierre; Bigot, Sandra] Jeanne de Flandre Hosp, Dept Pediat, Lille, France; [Luaces Cubells, Carlos] Hosp San Joan de Deu, Dept Pediat, Barcelona, Spain	University of Oxford; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University Hospital Arnau de Vilanova; Firat University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Padua; Universite de Lille - ISITE; CHU Lille	Leroy, S (corresponding author), Ctr Stat Med, Oxford, England.	Sandrine.Leroy@pasteur.fr	Stefanidis, Constantinos J./AEW-8891-2022; Chalumeau, Martin/F-4293-2017; Aygun, A. Denizmen/ABD-9791-2020; gürgöze, metin kaya/W-6665-2018; Luaces, Carlos/L-9791-2017	Stefanidis, Constantinos J./0000-0002-6342-4877; Chalumeau, Martin/0000-0001-8175-3706; Aygun, A. Denizmen/0000-0002-6450-9282; gürgöze, metin kaya/0000-0003-0645-8170; Luaces, Carlos/0000-0003-3015-4409; LEBLOND, Pierre/0000-0002-7088-2614; breart, gerard/0000-0003-3142-9128	French Society of Nephrology; la Fondation Bettencourt	French Society of Nephrology; la Fondation Bettencourt	Sandrine Leroy was funded by a post-doctoral fellowship grant from the French Society of Nephrology, and from la Fondation Bettencourt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreola B, 2007, PEDIATR INFECT DIS J, V26, P672, DOI 10.1097/INF.0b013e31806215e3; [Anonymous], 1991, J ROY COLL PHYS LOND, V25, P36; Belhadj-Tahar Hafid, 2008, Infect Drug Resist, V1, P17; Bergman DA, 1999, PEDIATRICS, V103, P843; Bigot S, 2005, ARCH PEDIATRIE, V12, P1075, DOI 10.1016/j.arcped.2005.03.058; Bressan S, 2009, PEDIATR NEPHROL, V24, P1199, DOI 10.1007/s00467-009-1125-x; Cohen AL, 2005, PEDIATRICS, V115, P1474, DOI 10.1542/peds.2004-1559; Espindol R, 2011, PEDIATR NEPHROL, V26, P1589; Fernandez Lopez A, 2001, An Esp Pediatr, V55, P321; Fettich J, 2003, EUR J NUCL MED MOL I, V30, pBP39, DOI 10.1007/s00259-003-1137-x; Garin EH, 2006, PEDIATRICS, V117, P626, DOI 10.1542/peds.2005-1362; GUIGNARD JP, 1979, LANCET, V1, P103; Gurgoze MK, 2005, PEDIATR NEPHROL, V20, P1445, DOI 10.1007/s00467-005-1941-6; Hoberman A, 2003, NEW ENGL J MED, V348, P195, DOI 10.1056/NEJMoa021698; Jodal U, 2000, ACTA PAEDIATR, V89, P767, DOI 10.1080/080352500750043594; Jodal U, 2006, PEDIATR NEPHROL, V21, P785, DOI 10.1007/s00467-006-0063-0; Karavanaki K, 2007, INFECT DIS CLIN PRAC, V15, P377, DOI 10.1097/IPC.0b013e318157d272; Kotoula A, 2009, INT UROL NEPHROL, V41, P393, DOI 10.1007/s11255-008-9472-2; Kotoula A, 2009, UROLOGY, V73, P782, DOI 10.1016/j.urology.2008.10.042; LEBOWITZ RL, 1985, PEDIATR RADIOL, V15, P105, DOI 10.1007/BF02388714; Leroy S, 2005, PEDIATRICS, V116, P1262, DOI 10.1542/peds.2005-1928; Leroy S, 2010, PEDIATR NEPHROL, V25, P1848; LEROY S, 2010, PEDIATR NEPHROL, V25, P1852; Leroy S, 2007, J PEDIATR-US, V150, P89, DOI 10.1016/j.jpeds.2006.08.066; Leroy S, 2011, J PEDIATR-US, V159, P644, DOI 10.1016/j.jpeds.2011.03.008; Leroy S, 2010, RADIOLOGY, V255, P890, DOI 10.1148/radiol.10091359; Lopez AF, 2003, PEDIATR INFECT DIS J, V22, P895, DOI 10.1097/01.inf.0000091360.11784.21; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Montini G, 2011, NEW ENGL J MED, V365, P239, DOI 10.1056/NEJMra1007755; Mori R, 2007, BRIT MED J, V335, P395, DOI 10.1136/bmj.39286.700891.AD; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Roussey-Kesler G, 2008, J UROLOGY, V179, P674, DOI 10.1016/j.juro.2007.09.090; Smellie JM, 2001, LANCET, V357, P1329, DOI 10.1016/S0140-6736(00)04520-7; Williams G, 2008, J AM SOC NEPHROL, V19, P847, DOI 10.1681/ASN.2007020245	34	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29556	10.1371/journal.pone.0029556	http://dx.doi.org/10.1371/journal.pone.0029556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216314	Green Published, Green Submitted, gold			2022-12-27	WOS:000300676300065
J	Rigor, RR; Damoc, C; Phinney, BS; Cala, PM				Rigor, Robert R.; Damoc, Catalina; Phinney, Brett S.; Cala, Peter M.			Phosphorylation and Activation of the Plasma Membrane Na+/H+ Exchanger (NHE1) during Osmotic Cell Shrinkage	PLOS ONE			English	Article							RED-BLOOD-CELLS; AMINO-ACIDS SER(770); VOLUME REGULATION; DEPENDENT ACTIVATION; SIGNAL-TRANSDUCTION; STATISTICAL-MODEL; MASS-SPECTROMETRY; GROWTH-FACTORS; OKADAIC ACID; ERM PROTEINS	The Na+/H+ Exchanger isoform 1 (NHE1) is a highly versatile, broadly distributed and precisely controlled transport protein that mediates volume and pH regulation in most cell types. NHE1 phosphorylation contributes to Na+/H+ exchange activity in response to phorbol esters, growth factors or protein phosphatase inhibitors, but has not been observed during activation by osmotic cell shrinkage (OCS). We examined the role of NHE1 phosphorylation during activation by OCS, using an ideal model system, the Amphiuma tridactylum red blood cell (atRBC). Na+/H+ exchange in atRBCs is mediated by an NHE1 homolog (atNHE1) that is 79% identical to human NHE1 at the amino acid level. NHE1 activity in atRBCs is exceptionally robust in that transport activity can increase more than 2 orders of magnitude from rest to full activation. Michaelis-Menten transport kinetics indicates that either OCS or treatment with the phosphatase inhibitor calyculin-A (CLA) increase Na+ transport capacity without affecting transport affinity (K-m = 44 mM) in atRBCs. CLA and OCS act non-additively to activate atNHE1, indicating convergent, phosphorylation-dependent signaling in atNHE1 activation. In situ P-32 labeling and immunoprecipitation demonstrates that the net phosphorylation of atNHE1 is increased 4-fold during OCS coinciding with a more than 2-order increase in Na+ transport activity. This is the first reported evidence of increased NHE1 phosphorylation during OCS in any vertebrate cell type. Finally, liquid chromatography and mass spectrometry (LC-MS/MS) analysis of atNHE1 immunoprecipitated from atRBC membranes reveals 9 phosphorylated serine/threonine residues, suggesting that activation of atNHE1 involves multiple phosphorylation and/or dephosphorylation events.	[Rigor, Robert R.; Cala, Peter M.] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Damoc, Catalina; Phinney, Brett S.] Univ Calif Davis, Genome Ctr, Prote Core Facil, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Rigor, RR (corresponding author), Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA.	robrigor@ucdavis.edu	Phinney, Brett/S-6404-2016	Phinney, Brett/0000-0003-3870-3302; Rigor, Robert/0000-0001-6234-1992	National Institutes of Health [R01 HL 21179]; American Heart Association Western States Affiliate; American Heart Association [AHA 0315035Y]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021179, R37HL021179] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Western States Affiliate(American Heart Association); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health research grant (NHLBI) R01 HL 21179 (to PMC). RRR was supported by the Joel Drillings Award for Excellence in Cardiovascular Disease Research from the American Heart Association Western States Affiliate, and an American Heart Association Predoctoral Fellowship (#AHA 0315035Y). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner M, 2006, P NATL ACAD SCI USA, V103, P13391, DOI 10.1073/pnas.0605950103; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; BIANCHINI L, 1995, AM J PHYSIOL-CELL PH, V269, pC998, DOI 10.1152/ajpcell.1995.269.4.C998; Bianchini L, 1997, J BIOL CHEM, V272, P271; BIANCHINI L, 1991, J BIOL CHEM, V266, P15406; CALA PM, 1983, MOL PHYSIOL, V4, P33; CALA PM, 1994, J GEN PHYSIOL, V103, P1035, DOI 10.1085/jgp.103.6.1035; CALA PM, 1985, FED PROC, V44, P2500; CALA PM, 1980, J GEN PHYSIOL, V76, P683, DOI 10.1085/jgp.76.6.683; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; Coccaro E, 2009, AM J PHYSIOL-HEART C, V297, pH846, DOI 10.1152/ajpheart.01231.2008; Grenier AL, 2008, AM J PHYSIOL-CELL PH, V295, pC883, DOI 10.1152/ajpcell.00574.2007; GRINSTEIN S, 1992, J BIOL CHEM, V267, P23823; Grinstein Sergio, 1992, News in Physiological Sciences, V7, P232; HERSCHLAG D, 1993, GENE DEV, V7, P173, DOI 10.1101/gad.7.2.173; Hoffmann EK, 2010, ACTA PHYSL OXF; Hoffmann EK, 2006, CONTRIB NEPHROL, V152, P54, DOI 10.1159/000096318; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Holt MEV, 2006, CELL BIOCHEM BIOPHYS, V45, P1, DOI 10.1385/CBB:45:1:1; Karmazyn M., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P323, DOI 10.2174/1568006054553417; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Koster S, 2011, J BIOL CHEM IN PRESS; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Lehoux S, 2001, J BIOL CHEM, V276, P15794, DOI 10.1074/jbc.M100410200; Li XJ, 2006, BIOCHEMISTRY-US, V45, P2414, DOI 10.1021/bi051132d; Liu HZ, 2004, ANAL CHEM, V76, P4223, DOI 10.1021/ac035231d; LIVNE AA, 1991, FEBS LETT, V284, P219, DOI 10.1016/0014-5793(91)80689-Z; Lytle C, 1997, J BIOL CHEM, V272, P15069, DOI 10.1074/jbc.272.24.15069; Malo ME, 2007, J BIOL CHEM, V282, P6292, DOI 10.1074/jbc.M611073200; Malo ME, 2006, CAN J PHYSIOL PHARM, V84, P1081, DOI 10.1139/Y06-065; McLean LA, 1999, AM J PHYSIOL-CELL PH, V276, pC1025, DOI 10.1152/ajpcell.1999.276.5.C1025; McSwine RL, 1996, J CELL PHYSIOL, V168, P8; Meima ME, 2009, J BIOL CHEM, V284, P26666, DOI 10.1074/jbc.M109.019448; Musch MW, 1999, J BIOL CHEM, V274, P7923, DOI 10.1074/jbc.274.12.7923; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ortiz-Acevedo A, 2010, AM J PHYSL CELL PHYS; Ortiz-Acevedo A, 2008, AM J PHYSIOL-CELL PH, V295, pC1316, DOI 10.1152/ajpcell.00160.2008; Pedersen SF, 2006, AM J PHYSIOL-REG I, V291, pR1, DOI 10.1152/ajpregu.00782.2005; Pedersen SF, 2004, J EXP ZOOL PART A, V301A, P569, DOI 10.1002/jez.a.47; Pedersen SF, 2001, COMP BIOCHEM PHYS A, V130, P385, DOI 10.1016/S1095-6433(01)00429-9; Pedersen SF, 2006, PFLUG ARCH EUR J PHY, V452, P249, DOI 10.1007/s00424-006-0044-y; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Rasmussen M, 2008, AM J PHYSIOL-CELL PH, V294, pC197, DOI 10.1152/ajpcell.00268.2007; Rowley A, 2000, METHODS, V20, P383, DOI 10.1006/meth.2000.0951; SARDET C, 1991, J BIOL CHEM, V266, P19166; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Snabaitis AK, 2008, CIRC RES, V103, P881, DOI 10.1161/CIRCRESAHA.108.175877; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Wakabayashi S, 1997, BIOCHEMISTRY-US, V36, P12854, DOI 10.1021/bi9715472; Yan WH, 2001, J BIOL CHEM, V276, P31349, DOI 10.1074/jbc.M102679200	51	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29210	10.1371/journal.pone.0029210	http://dx.doi.org/10.1371/journal.pone.0029210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216214	gold, Green Published, Green Submitted			2022-12-27	WOS:000300676300037
J	Abedi-Ardekani, B; Kamangar, F; Sotoudeh, M; Villar, S; Islami, F; Aghcheli, K; Nasrollahzadeh, D; Taghavi, N; Dawsey, SM; Abnet, CC; Hewitt, SM; Fahimi, S; Saidi, F; Brennan, P; Boffetta, P; Malekzadeh, R; Hainaut, P				Abedi-Ardekani, Behnoush; Kamangar, Farin; Sotoudeh, Masoud; Villar, Stephanie; Islami, Farhad; Aghcheli, Karim; Nasrollahzadeh, Dariush; Taghavi, Noushin; Dawsey, Sanford M.; Abnet, Christian C.; Hewitt, Stephen M.; Fahimi, Saman; Saidi, Farrokh; Brennan, Paul; Boffetta, Paolo; Malekzadeh, Reza; Hainaut, Pierre			Extremely High Tp53 Mutation Load in Esophageal Squamous Cell Carcinoma in Golestan Province, Iran	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; HIGH-RISK AREA; NORTHEASTERN IRAN; DNA-DAMAGE; TOBACCO-SMOKE; NORTHERN IRAN; P53 MUTATIONS; CANCER; POPULATION; CHINA	Background: Golestan Province in northeastern Iran has one of the highest incidences of esophageal squamous cell carcinoma (ESCC) in the world with rates over 50 per 100,000 person-years in both sexes. We have analyzed TP53 mutation patterns in tumors from this high-risk geographic area in search of clues to the mutagenic processes involved in causing ESCC. Methodology/Principal Findings: Biopsies of 119 confirmed ESCC tumor tissue from subjects enrolled in a case-control study conducted in Golestan Province were analyzed by direct sequencing of TP53 exons 2 through 11. Immunohistochemical staining for p53 was carried out using two monoclonal antibodies, DO7 and 1801. A total of 120 TP53 mutations were detected in 107/119 cases (89.9%), including 11 patients with double or triple mutations. The mutation pattern was heterogeneous with infrequent mutations at common TP53 "hotspots" but frequent transversions potentially attributable to environmental carcinogens forming bulky DNA adducts, including 40% at bases known as site of mutagenesis by polycyclic aromatic hydrocarbons (PAHs). Mutations showed different patterns according to the reported temperature of tea consumption, but no variation was observed in relation to ethnicity, tobacco or opium use, and alcoholic beverage consumption or urban versus rural residence. Conclusion/Significance: ESCC tumors in people from Golestan Province show the highest rate of TP53 mutations ever reported in any cancer anywhere. The heterogeneous mutation pattern is highly suggestive of a causative role for multiple environmental carcinogens, including PAHs. The temperature and composition of tea may also influence mutagenesis.	[Abedi-Ardekani, Behnoush; Sotoudeh, Masoud; Islami, Farhad; Aghcheli, Karim; Nasrollahzadeh, Dariush; Taghavi, Noushin; Fahimi, Saman; Saidi, Farrokh; Malekzadeh, Reza] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Ctr, Tehran, Iran; [Abedi-Ardekani, Behnoush; Villar, Stephanie; Islami, Farhad; Brennan, Paul; Hainaut, Pierre] Int Agcy Res Canc, F-69372 Lyon, France; [Abedi-Ardekani, Behnoush] Social Secur Org, Tehran, Iran; [Kamangar, Farin; Dawsey, Sanford M.; Abnet, Christian C.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Kamangar, Farin] Morgan State Univ, Sch Community Hlth & Policy, Dept Publ Hlth Anal, Baltimore, MD 21239 USA; [Islami, Farhad; Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Nasrollahzadeh, Dariush] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hewitt, Stephen M.] NCI, Tissue Array Res Program, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Fahimi, Saman] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Boffetta, Paolo] Int Prevent Res Inst, Lyon, France	Tehran University of Medical Sciences; World Health Organization; International Agency for Research on Cancer (IARC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Morgan State University; Icahn School of Medicine at Mount Sinai; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge	Abedi-Ardekani, B (corresponding author), Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Ctr, Tehran, Iran.	hainaut@iarc.fr	Hainaut, Pierre/B-6018-2012; Abnet, Christian C/C-4111-2015; Malekzadeh, Reza/U-1382-2017; Abedi-Ardekani, Behnoush/O-7829-2016; Boffetta, Paolo/AAI-7767-2021	Hainaut, Pierre/0000-0002-1303-1610; Abnet, Christian C/0000-0002-3008-7843; Malekzadeh, Reza/0000-0002-9820-6335; Abedi-Ardekani, Behnoush/0000-0002-0980-0587; Boffetta, Paolo/0000-0002-3811-2791; Islami, Farhad/0000-0002-7357-5994; Malekzadeh, Reza/0000-0003-1043-3814; Hewitt, Stephen/0000-0001-8283-1788	Division of Cancer Epidemiology; Genetics of the National Cancer Institute at the National Institutes of Health, Bethesda, Maryland, USA; International Agency for Research on Cancer, Lyon, France; Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran; NATIONAL CANCER INSTITUTE [ZICBC010923] Funding Source: NIH RePORTER	Division of Cancer Epidemiology; Genetics of the National Cancer Institute at the National Institutes of Health, Bethesda, Maryland, USA; International Agency for Research on Cancer, Lyon, France; Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran(Tehran University of Medical Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by intramural funds of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute at the National Institutes of Health, Bethesda, Maryland, USA and by regular budgets from the International Agency for Research on Cancer, Lyon, France and the Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi-Ardekani B, 2010, GUT, V59, P1178, DOI 10.1136/gut.2010.210609; Abnet CC, 2004, CANCER EPIDEM BIOMAR, V13, P1068; Biramijamal F, 2001, CANCER RES, V61, P3119; BLOT WJ, 2006, CANC EPIDEMIOLOGY PR, P697, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0036; Breton J, 2003, MUTAGENESIS, V18, P299, DOI 10.1093/mutage/18.3.299; Cao W, 2004, CANCER-AM CANCER SOC, V101, P834, DOI 10.1002/cncr.20437; Chang KF, 2006, ENVIRON POLLUT, V142, P388, DOI 10.1016/j.envpol.2005.09.025; Cloutier JF, 2001, J MOL BIOL, V313, P539, DOI 10.1006/jmbi.2001.4997; Eslick GD, 2009, GASTROENTEROL CLIN N, V38, pvii; Eslick GD, 2009, GASTROENTEROL CLIN N, V38, P1, DOI 10.1016/j.gtc.2009.01.003; FRIESEN M, 1985, MUTAT RES, V150, P177, DOI 10.1016/0027-5107(85)90114-9; Gouas D, 2009, CANCER LETT, V286, P29, DOI 10.1016/j.canlet.2009.02.057; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Hakami R, 2008, NUTR CANCER, V60, P216, DOI 10.1080/01635580701684831; Islami F, 2004, BRIT J CANCER, V90, P1402, DOI 10.1038/sj.bjc.6601737; Islami F, 2009, EUR J CANCER, V45, P3156, DOI 10.1016/j.ejca.2009.09.018; Islami F, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b929; Islami F, 2009, INT J EPIDEMIOL, V38, P978, DOI 10.1093/ije/dyp195; Islami F, 2009, INT J CANCER, V125, P491, DOI 10.1002/ijc.24445; Kamangar F, 2005, ANTICANCER RES, V25, P425; Kamangar F, 2007, ARCH IRAN MED, V10, P70; Kazerouni N, 2001, FOOD CHEM TOXICOL, V39, P423, DOI 10.1016/S0278-6915(00)00158-7; KMET J, 1972, SCIENCE, V175, P846, DOI 10.1126/science.175.4024.846; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; MALAVEILLE C, 1982, CARCINOGENESIS, V3, P577, DOI 10.1093/carcin/3.5.577; Mastrangelo G, 1996, ENVIRON HEALTH PERSP, V104, P1166, DOI 10.2307/3432909; Nasrollahzadeh D, 2008, BRIT J CANCER, V98, P1857, DOI 10.1038/sj.bjc.6604369; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Putz A, 2002, INT J CANCER, V98, P99, DOI 10.1002/ijc.10128; Rossini A, 2010, MUTAT RES-GEN TOX EN, V696, P10, DOI 10.1016/j.mrgentox.2009.11.005; Roth MJ, 1998, EUR J CANCER, V34, P757; Sepehr A, 2001, ONCOGENE, V20, P7368, DOI 10.1038/sj.onc.1204912; Smith LE, 2000, JNCI-J NATL CANCER I, V92, P803, DOI 10.1093/jnci/92.10.803; Stewart B. W., 2003, WORLD CANC REPORT, P223; Straif K, 2005, LANCET ONCOL, V6, P931, DOI 10.1016/S1470-2045(05)70458-7; Taniere P, 2001, BRIT J CANCER, V85, P721, DOI 10.1054/bjoc.2001.1990; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616	38	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29488	10.1371/journal.pone.0029488	http://dx.doi.org/10.1371/journal.pone.0029488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216294	Green Submitted, Green Published, gold			2022-12-27	WOS:000300674900040
J	Moessnang, C; Finkelmeyer, A; Vossen, A; Schneider, F; Habel, U				Moessnang, Carolin; Finkelmeyer, Andreas; Vossen, Alexandra; Schneider, Frank; Habel, Ute			Assessing Implicit Odor Localization in Humans Using a Cross-Modal Spatial Cueing Paradigm	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; OLFACTORY FUNCTION; SEX-DIFFERENCES; ATTENTION; PERCEPTION; STIMULI; SMELL; INFORMATION; ADAPTATION; RESPONSES	Background: Navigation based on chemosensory information is one of the most important skills in the animal kingdom. Studies on odor localization suggest that humans have lost this ability. However, the experimental approaches used so far were limited to explicit judgements, which might ignore a residual ability for directional smelling on an implicit level without conscious appraisal. Methods: A novel cueing paradigm was developed in order to determine whether an implicit ability for directional smelling exists. Participants performed a visual two-alternative forced choice task in which the target was preceded either by a side-congruent or a side-incongruent olfactory spatial cue. An explicit odor localization task was implemented in a second experiment. Results: No effect of cue congruency on mean reaction times could be found. However, a time by condition interaction emerged, with significantly slower responses to congruently compared to incongruently cued targets at the beginning of the experiment. This cueing effect gradually disappeared throughout the course of the experiment. In addition, participants performed at chance level in the explicit odor localization task, thus confirming the results of previous research. Conclusion: The implicit cueing task suggests the existence of spatial information processing in the olfactory system. Response slowing after a side-congruent olfactory cue is interpreted as a cross-modal attentional interference effect. In addition, habituation might have led to a gradual disappearance of the cueing effect. It is concluded that under immobile conditions with passive monorhinal stimulation, humans are unable to explicitly determine the location of a pure odorant. Implicitly, however, odor localization seems to exert an influence on human behaviour. To our knowledge, these data are the first to show implicit effects of odor localization on overt human behaviour and thus support the hypothesis of residual directional smelling in humans.	[Moessnang, Carolin; Finkelmeyer, Andreas; Schneider, Frank; Habel, Ute] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Finkelmeyer, Andreas] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Vossen, Alexandra] Maastricht Univ, Fac Psychol & Neurosci, Maastricht, Netherlands	RWTH Aachen University; Newcastle University - UK; Maastricht University	Moessnang, C (corresponding author), Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany.	camoessnang@ukaachen.de	Moessnang, Carolin/V-8095-2017	Moessnang, Carolin/0000-0003-4357-2706; Finkelmeyer, Andreas/0000-0001-7491-5113; Habel, Ute/0000-0003-0703-7722; Schneider, Frank/0000-0003-1557-7956; Vossen, Alexandra/0000-0001-9001-3486	German Research Foundation (DFG, International Research Training Group) [IRTG 1328]	German Research Foundation (DFG, International Research Training Group)(German Research Foundation (DFG))	C.M. is supported by the German Research Foundation (DFG, IRTG 1328, International Research Training Group). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bensafi M, 2002, NEUROPHYSIOL CLIN, V32, P335, DOI 10.1016/S0987-7053(02)00337-4; Bensafi M, 2002, NEUROPHYSIOL CLIN, V32, P326, DOI 10.1016/S0987-7053(02)00339-8; Bensafi M, 2002, NEUROSCI LETT, V319, P162, DOI 10.1016/S0304-3940(01)02572-1; Bensafi M, 2002, NEUROSCI LETT, V328, P309, DOI 10.1016/S0304-3940(02)00548-7; Bensafi M, 2002, CHEM SENSES, V27, P703, DOI 10.1093/chemse/27.8.703; Best AR, 2004, J NEUROSCI, V24, P652, DOI 10.1523/JNEUROSCI.4220-03.2004; Brand G, 2000, CR ACAD SCI III-VIE, V323, P959, DOI 10.1016/S0764-4469(00)01235-X; Brand G, 2001, Q J EXP PSYCHOL-B, V54, P259, DOI 10.1080/02724990143000045; Brand G, 2001, NEUROSCI LETT, V316, P91, DOI 10.1016/S0304-3940(01)02375-8; CAIN WS, 1982, CHEM SENSES, V7, P129, DOI 10.1093/chemse/7.2.129; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P403, DOI 10.1002/cne.903460306; Dalton P, 2000, CHEM SENSES, V25, P487, DOI 10.1093/chemse/25.4.487; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; Frasnelli J, 2011, CHEM SENSES, V36, P405, DOI 10.1093/chemse/bjr001; Frasnelli J, 2010, NEUROSCI LETT, V478, P102, DOI 10.1016/j.neulet.2010.04.074; Frasnelli J, 2009, CHEM SENSES, V34, P139, DOI 10.1093/chemse/bjn068; Gottfried JA, 2006, ADV OTO-RHINO-LARYNG, V63, P44, DOI 10.1159/000093750; Hummel T, 2003, TOXICOL LETT, V140, P273, DOI 10.1016/S0378-4274(03)00078-X; Kennett S, 2001, J COGNITIVE NEUROSCI, V13, P462, DOI 10.1162/08989290152001899; Kikuta S, 2010, P NATL ACAD SCI USA, V107, P12363, DOI 10.1073/pnas.1003999107; Kinsbourne M., 1993, UNILATERAL NEGLECT C, DOI DOI 10.4324/9780203765258; Kinsbourne M., 1975, ATTENTION PERFORM, VV, P81; Kleemann AM, 2009, PHYSIOL BEHAV, V97, P401, DOI 10.1016/j.physbeh.2009.03.013; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; KOBAL G, 1989, EXPERIENTIA, V45, P130, DOI 10.1007/BF01954845; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; KOELEGA HS, 1994, PERCEPT MOTOR SKILL, V78, P203, DOI 10.2466/pms.1994.78.1.203; Koster EP, 2002, CHEM SENSES, V27, P191, DOI 10.1093/chemse/27.3.191; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Lang J., 1989, CLIN ANATOMY NOSE NA; Leppanen JM, 2003, EMOTION, V3, P315, DOI 10.1037/1528-3542.3.4.315; Lundstrom JN, 2006, BEHAV BRAIN RES, V166, P197, DOI 10.1016/j.bbr.2005.07.015; Macaluso E, 2010, CORTEX, V46, P282, DOI 10.1016/j.cortex.2009.05.010; MARZI CA, 1991, NEUROPSYCHOLOGIA, V29, P1163, DOI 10.1016/0028-3932(91)90031-3; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; Mulckhuyse M, 2010, ACTA PSYCHOL, V134, P299, DOI 10.1016/j.actpsy.2010.03.002; Olofsson JK, 2004, CHEM SENSES, V29, P629, DOI 10.1093/chemse/bjh066; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Porter J, 2005, NEURON, V47, P581, DOI 10.1016/j.neuron.2005.06.028; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, ATTENTION PERFORM, P531; Price JL, 1990, HUMAN NERVOUS SYSTEM, P979; Rajan R, 2006, SCIENCE, V311, P666, DOI 10.1126/science.1122096; Schmidt K.-H., 1992, WST WORTSCHATZTEST; Seubert J, 2010, NEUROIMAGE, V53, P746, DOI 10.1016/j.neuroimage.2010.07.012; Seubert J, 2010, J PSYCHIATR NEUROSCI, V35, P185, DOI 10.1503/jpn.090094; Seubert J, 2009, CHEM SENSES, V34, P77, DOI 10.1093/chemse/bjn054; SHAFFER JP, 1986, J AM STAT ASSOC, V81, P826, DOI 10.2307/2289016; SLATTERY WH, 1994, HEARING RES, V75, P38, DOI 10.1016/0378-5955(94)90053-1; Spence C, 1998, PERCEPT PSYCHOPHYS, V60, P544, DOI 10.3758/BF03206045; Spence C, 2001, EXP BRAIN RES, V138, P432, DOI 10.1007/s002210100713; Spence C, 2010, ANN NY ACAD SCI, V1191, P182, DOI 10.1111/j.1749-6632.2010.05440.x; Stuck BA, 2006, CLIN NEUROPHYSIOL, V117, P1367, DOI 10.1016/j.clinph.2006.03.004; WALLACE P, 1977, PHYSIOL BEHAV, V19, P577, DOI 10.1016/0031-9384(77)90238-4; Wickens Thomas D., 2002, ELEMENTARY SIGNAL DE; Wysocki CJ, 2003, PERCEPT PSYCHOPHYS, V65, P115, DOI 10.3758/BF03194788; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	61	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29614	10.1371/journal.pone.0029614	http://dx.doi.org/10.1371/journal.pone.0029614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216331	Green Published, gold, Green Submitted			2022-12-27	WOS:000300674900046
J	Carp, J; Park, J; Hebrank, A; Park, DC; Polk, TA				Carp, Joshua; Park, Joonkoo; Hebrank, Andrew; Park, Denise C.; Polk, Thad A.			Age-Related Neural Dedifferentiation in the Motor System	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; BRAIN; CORTEX; ADULTS; GABA; NEUROMODULATION; REPRESENTATIONS; DEGRADATION; PERFORMANCE; COGNITION	Recent neuroimaging studies using multi-voxel pattern analysis (MVPA) show that distributed patterns of brain activation elicited by different visual stimuli are less distinctive in older adults than in young adults. However, less is known about the effects of aging on the neural representation of movement. The present study used MVPA to compare the distinctiveness of motor representations in young and older adults. We also investigated the contributions of brain structure to age differences in the distinctiveness of motor representations. We found that neural distinctiveness was reduced in older adults throughout the motor control network. Although aging was also associated with decreased gray matter volume in these regions, age differences in motor distinctiveness remained significant after controlling for gray matter volume. Our results suggest that age-related neural dedifferentiation is not restricted to sensory perception and is instead a more general feature of the aging brain.	[Carp, Joshua; Park, Joonkoo; Polk, Thad A.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Hebrank, Andrew; Park, Denise C.] Univ Texas Dallas, Ctr Vital Longev, Dallas, TX 75230 USA	University of Michigan System; University of Michigan; University of Texas System; University of Texas Dallas	Carp, J (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	jmcarp@umich.edu		Park, Joonkoo/0000-0002-6703-3961; Carp, Joshua/0000-0003-4706-3212	National Defense Science and Engineering Graduate fellowship; National Institute on Aging [5R37AG006265]; NATIONAL INSTITUTE ON AGING [R37AG006265] Funding Source: NIH RePORTER	National Defense Science and Engineering Graduate fellowship; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a National Defense Science and Engineering Graduate fellowship grant, which is administered by the U.S. Department of Defense, to Joshua Carp [http://ndseg.asee.org] and National Institute on Aging research grant 5R37AG006265 to Denise C. Park [http://www.nia.nih.gov]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett PJ, 2007, VISION RES, V47, P799, DOI 10.1016/j.visres.2007.01.001; Bernard J, 2011, NEUROBIOLOGY AGING; Boy F, 2010, CURR BIOL, V20, P1779, DOI 10.1016/j.cub.2010.09.003; CARP J, 2010, FRONTIERS HUMAN NEUR, V4; Carp J, 2011, NEUROIMAGE, V56, P736, DOI 10.1016/j.neuroimage.2010.04.267; David-Jurgens M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003399; Floel A, 2008, EUR J NEUROSCI, V27, P1301, DOI 10.1111/j.1460-9568.2008.06079.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goh JO, 2010, NEUROIMAGE, V51, P336, DOI 10.1016/j.neuroimage.2010.01.107; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Haushofer J, 2008, PLOS BIOL, V6, P1459, DOI 10.1371/journal.pbio.0060187; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Heuninckx S, 2005, J NEUROSCI, V25, P6787, DOI 10.1523/JNEUROSCI.1263-05.2005; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; Hua TM, 2008, BRAIN RES BULL, V75, P119, DOI 10.1016/j.brainresbull.2007.08.001; Kalpouzos G., 2011, NEUROBIOLOGY AGING; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Li SC, 2002, NEUROSCI BIOBEHAV R, V26, P795, DOI 10.1016/S0149-7634(02)00066-0; Li SC, 2001, TRENDS COGN SCI, V5, P479, DOI 10.1016/S1364-6613(00)01769-1; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; OWSLEY C, 1981, INVEST OPHTH VIS SCI, V21, P362; Park DC, 2004, P NATL ACAD SCI USA, V101, P13091, DOI 10.1073/pnas.0405148101; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Park J, NEURAL BROA IN PRESS; Park J, 2010, J NEUROSCI, V30, P9253, DOI 10.1523/JNEUROSCI.0853-10.2010; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Roudaia E, 2008, VISION RES, V48, P2767, DOI 10.1016/j.visres.2008.07.026; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; van Dyck CH, 2008, NEUROBIOL AGING, V29, P1237, DOI 10.1016/j.neurobiolaging.2007.02.012; Ward NS, 2003, BRAIN, V126, P873, DOI 10.1093/brain/awg071; Zhou XM, 2007, P NATL ACAD SCI USA, V104, P15935, DOI 10.1073/pnas.0707348104	34	85	85	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29411	10.1371/journal.pone.0029411	http://dx.doi.org/10.1371/journal.pone.0029411			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216274	gold, Green Published, Green Submitted			2022-12-27	WOS:000299684700053
J	Tzivelekidis, T; Jank, T; Pohl, C; Schlosser, A; Rospert, S; Knudsen, CR; Rodnina, MV; Belyi, Y; Aktories, K				Tzivelekidis, Tina; Jank, Thomas; Pohl, Corinna; Schlosser, Andreas; Rospert, Sabine; Knudsen, Charlotte R.; Rodnina, Marina V.; Belyi, Yury; Aktories, Klaus			Aminoacyl-tRNA-Charged Eukaryotic Elongation Factor 1A Is the Bona Fide Substrate for Legionella pneumophila Effector Glucosyltransferases	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; THERMOPHILUS EF-TU; TERNARY COMPLEX; TRAFFICKING PATHWAYS; STRUCTURAL BASIS; MAMMALIAN-CELLS; SHUTTLE VECTORS; RAB1 ACTIVATION; DOT/ICM SYSTEM; PROTEIN DRRA	Legionella pneumophila, which is the causative organism of Legionnaires disease, translocates numerous effector proteins into the host cell cytosol by a type IV secretion system during infection. Among the most potent effector proteins of Legionella are glucosyltransferases (Lgt's), which selectively modify eukaryotic elongation factor (eEF) 1A at Ser-53 in the GTP binding domain. Glucosylation results in inhibition of protein synthesis. Here we show that in vitro glucosylation of yeast and mouse eEF1A by Lgt3 in the presence of the factors Phe-tRNA(Phe) and GTP was enhanced 150 and 590-fold, respectively. The glucosylation of eEF1A catalyzed by Lgt1 and 2 was increased about 70-fold. By comparison of uncharged tRNA with two distinct aminoacyl-tRNAs (His-tRNA(His) and Phe-tRNA(Phe)) we could show that aminoacylation is crucial for Lgt-catalyzed glucosylation. Aminoacyl-tRNA had no effect on the enzymatic properties of Lgt's and did not enhance the glucosylation rate of eEF1A truncation mutants, consisting of the GTPase domain only or of a 5 kDa peptide covering Ser-53 of eEF1A. Furthermore, binding of aminoacyl-tRNA to eEF1A was not altered by glucosylation. Taken together, our data suggest that the ternary complex, consisting of eEF1A, aminoacyl-tRNA and GTP, is the bona fide substrate for Lgt's.	[Tzivelekidis, Tina; Jank, Thomas; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79106 Freiburg, Germany; [Tzivelekidis, Tina] Univ Freiburg, Fak Biol, D-79106 Freiburg, Germany; [Pohl, Corinna; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Gottingen, Germany; [Schlosser, Andreas] Univ Freiburg, Core Facil Prote, Zentrum Biosyst Anal, D-79106 Freiburg, Germany; [Rospert, Sabine] Univ Freiburg, ZBMZ, Inst Biochem & Mikrobiol, D-79106 Freiburg, Germany; [Knudsen, Charlotte R.] Univ Aarhus, Dept Mol Biol, Aarhus, Denmark; [Belyi, Yury] Gamaleya Res Inst, Moscow, Russia	University of Freiburg; University of Freiburg; Max Planck Society; University of Freiburg; University of Freiburg; Aarhus University; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS	Tzivelekidis, T (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Hugstetter Str 55, D-79106 Freiburg, Germany.	klaus.aktories@pharmakol.uni-freiburg.de	Belyi, Yury/AAU-8092-2020; Jank, Thomas/R-9627-2017; Aktories, Klaus/CAJ-5682-2022; Rodnina, Marina V./AAD-4667-2019	Aktories, Klaus/0000-0002-5397-0436; Rodnina, Marina V./0000-0003-0105-3879; Rospert, Sabine/0000-0002-3089-9614; Knudsen, Charlotte/0000-0003-2356-4821	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (to KA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Asahara H, 2005, BIOCHEMISTRY-US, V44, P11254, DOI 10.1021/bi050204y; Asahara H, 2002, P NATL ACAD SCI USA, V99, P3499, DOI 10.1073/pnas.052028599; Belyi I, 2003, INFECT IMMUN, V71, P181, DOI 10.1128/IAI.71.1.181-186.2003; Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; Belyi Y, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00076; Belyi Y, 2010, BBA-GEN SUBJECTS, V1800, P134, DOI 10.1016/j.bbagen.2009.07.022; Belyi Y, 2009, J BIOL CHEM, V284, P20167, DOI 10.1074/jbc.M109.008441; Dale T, 2004, BIOCHEMISTRY-US, V43, P6159, DOI 10.1021/bi036290o; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Fontana MF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001289; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Gromadski KB, 2007, J BIOL CHEM, V282, P35629, DOI 10.1074/jbc.M707245200; Harb OS, 2000, ENVIRON MICROBIOL, V2, P251, DOI 10.1046/j.1462-2920.2000.00112.x; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Hurtado-Guerrero R, 2010, BIOCHEM J, V426, P281, DOI 10.1042/BJ20091351; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Ivanov SS, 2009, CELL MICROBIOL, V11, P261, DOI 10.1111/j.1462-5822.2008.01251.x; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P17575, DOI 10.1073/pnas.1009598107; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; LOUIE A, 1984, J BIOL CHEM, V259, P5010; Lu W, 2010, J MOL BIOL, V396, P321, DOI 10.1016/j.jmb.2009.11.044; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; MUDER RR, 1986, ARCH INTERN MED, V146, P1607, DOI 10.1001/archinte.146.8.1607; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Nissen P, 1996, BIOCHIMIE, V78, P921, DOI 10.1016/S0300-9084(97)86714-4; OTT G, 1990, BIOCHIM BIOPHYS ACTA, V1050, P222, DOI 10.1016/0167-4781(90)90170-7; Pedersen GN, 1998, PROTEIN ENG, V11, P101, DOI 10.1093/protein/11.2.101; Pedersen L, 2001, ACTA CRYSTALLOGR D, V57, P159, DOI 10.1107/S0907444900015559; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Segal G, 2005, FEMS MICROBIOL REV, V29, P65, DOI 10.1016/j.femsre.2004.07.001; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; Shen XH, 2009, CELL MICROBIOL, V11, P911, DOI 10.1111/j.1462-5822.2009.01301.x; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; von der Haar F, 1979, Methods Enzymol, V59, P257; Weber SS, 2009, MOL MICROBIOL, V71, P1341, DOI 10.1111/j.1365-2958.2009.06608.x; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638; Zhu YQ, 2010, P NATL ACAD SCI USA, V107, P4699, DOI 10.1073/pnas.0914231107	56	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29525	10.1371/journal.pone.0029525	http://dx.doi.org/10.1371/journal.pone.0029525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216304	Green Published, gold			2022-12-27	WOS:000299684700064
J	Bernaudat, F; Frelet-Barrand, A; Pochon, N; Dementin, S; Hivin, P; Boutigny, S; Rioux, JB; Salvi, D; Seigneurin-Berny, D; Richaud, P; Joyard, J; Pignol, D; Sabaty, M; Desnos, T; Pebay-Peyroula, E; Darrouzet, E; Vernet, T; Rolland, N				Bernaudat, Florent; Frelet-Barrand, Annie; Pochon, Nathalie; Dementin, Sebastien; Hivin, Patrick; Boutigny, Sylvain; Rioux, Jean-Baptiste; Salvi, Daniel; Seigneurin-Berny, Daphne; Richaud, Pierre; Joyard, Jacques; Pignol, David; Sabaty, Monique; Desnos, Thierry; Pebay-Peyroula, Eva; Darrouzet, Elisabeth; Vernet, Thierry; Rolland, Norbert			Heterologous Expression of Membrane Proteins: Choosing the Appropriate Host	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; HIGH-THROUGHPUT CLONING; LARGE-SCALE PRODUCTION; HIGH-LEVEL EXPRESSION; LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; BACTERIAL EXPRESSION; NICOTIANA-BENTHAMIANA; FUNCTIONAL EXPRESSION; ENABLING TECHNOLOGIES	Background: Membrane proteins are the targets of 50% of drugs, although they only represent 1% of total cellular proteins. The first major bottleneck on the route to their functional and structural characterisation is their overexpression; and simply choosing the right system can involve many months of trial and error. This work is intended as a guide to where to start when faced with heterologous expression of a membrane protein. Methodology/Principal Findings: The expression of 20 membrane proteins, both peripheral and integral, in three prokaryotic (E. coli, L. lactis, R. sphaeroides) and three eukaryotic (A. thaliana, N. benthamiana, Sf9 insect cells) hosts was tested. The proteins tested were of various origins (bacteria, plants and mammals), functions (transporters, receptors, enzymes) and topologies (between 0 and 13 transmembrane segments). The Gateway system was used to clone all 20 genes into appropriate vectors for the hosts to be tested. Culture conditions were optimised for each host, and specific strategies were tested, such as the use of Mistic fusions in E. coli. 17 of the 20 proteins were produced at adequate yields for functional and, in some cases, structural studies. We have formulated general recommendations to assist with choosing an appropriate system based on our observations of protein behaviour in the different hosts. Conclusions/Significance: Most of the methods presented here can be quite easily implemented in other laboratories. The results highlight certain factors that should be considered when selecting an expression host. The decision aide provided should help both newcomers and old-hands to select the best system for their favourite membrane protein.	[Bernaudat, Florent; Pebay-Peyroula, Eva; Vernet, Thierry] CEA, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Bernaudat, Florent; Pebay-Peyroula, Eva; Vernet, Thierry] CNRS, UMR 5075, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Bernaudat, Florent; Pebay-Peyroula, Eva; Vernet, Thierry] Univ Grenoble 1, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Frelet-Barrand, Annie; Boutigny, Sylvain; Salvi, Daniel; Seigneurin-Berny, Daphne; Joyard, Jacques; Rolland, Norbert] CEA, DSV, iRTSV, Lab Physiol Cellulaire & Vegetale, Grenoble, France; [Frelet-Barrand, Annie; Boutigny, Sylvain; Salvi, Daniel; Seigneurin-Berny, Daphne; Joyard, Jacques; Rolland, Norbert] CNRS, UMR 5168, Lab Physiol Cellulaire & Vegetale, Grenoble, France; [Frelet-Barrand, Annie; Boutigny, Sylvain; Salvi, Daniel; Seigneurin-Berny, Daphne; Joyard, Jacques; Rolland, Norbert] INRA, UMR 1200, Lab Physiol Cellulaire & Vegetale, Grenoble, France; [Frelet-Barrand, Annie; Boutigny, Sylvain; Salvi, Daniel; Seigneurin-Berny, Daphne; Joyard, Jacques; Rolland, Norbert] Univ Grenoble 1, Lab Physiol Cellulaire & Vegetale, Grenoble, France; [Pochon, Nathalie; Desnos, Thierry] CEA, DSV, iBEB, Lab Biol Dev Plantes,SBVME, St Paul Les Durance, France; [Pochon, Nathalie; Desnos, Thierry] CNRS, UMR 6191, Lab Biol Dev Plantes, St Paul Les Durance, France; [Pochon, Nathalie; Desnos, Thierry] Univ Aix Marseille, Lab Biol Dev Plantes, St Paul Les Durance, France; [Dementin, Sebastien; Rioux, Jean-Baptiste; Pignol, David; Sabaty, Monique] CEA, DSV, iBEB, Lab Bioenerget Cellulaire,SBVME, St Paul Les Durance, France; [Dementin, Sebastien; Rioux, Jean-Baptiste; Pignol, David; Sabaty, Monique] CNRS, UMR 6191, Lab Bioenerget Cellulaire, St Paul Les Durance, France; [Dementin, Sebastien; Rioux, Jean-Baptiste; Pignol, David; Sabaty, Monique] Univ Aix Marseille, Lab Bioenerget Cellulaire, St Paul Les Durance, France; [Hivin, Patrick] CEA, DSV, iBEB, Lab Ingn Cellulaire & Biotechnol,SBTN, Bagnols Sur Ceze, France; [Richaud, Pierre] CEA, DSV, iBEB, Lab Echanges Membranaires & Signalisat,SBVME, St Paul Les Durance, France; [Richaud, Pierre] CNRS, UMR 6191, Lab Echanges Membranaires & Signalisat, St Paul Les Durance, France; [Richaud, Pierre] Univ Aix Marseille, Lab Echanges Membranaires & Signalisat, St Paul Les Durance, France; [Darrouzet, Elisabeth] CEA, DSV, iBEB,SBTN, Lab Transporteurs Imagerie & Radiotherapie Oncol,, Bagnols Sur Ceze, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA	Bernaudat, F (corresponding author), CEA, Inst Biol Struct Jean Pierre Ebel, Grenoble, France.	florent.bernaudat@ibs.fr	Vernet, Thierry/G-1118-2012; FRELET-BARRAND, Annie/AFX-2878-2022; sabaty, monique/K-4244-2013; Frelet-Barrand, Annie/S-1951-2017; ROLLAND, Norbert/B-4405-2012; frelet barrand, annie/E-5479-2015; SEIGNEURIN-BERNY, Daphne/C-8412-2017	FRELET-BARRAND, Annie/0000-0002-0849-9040; ROLLAND, Norbert/0000-0003-1959-6636; SEIGNEURIN-BERNY, Daphne/0000-0002-7436-9885; sabaty, monique/0000-0002-1399-6922; DESNOS, Thierry/0000-0002-6585-1362; Dementin, Sebastien/0000-0001-6168-5371; PIGNOL, David/0000-0002-8070-0319	CEA (Commissariat a l'Energie Atomique et aux Energies Alternatives); CNRS (Centre National de la Recherche Scientifique); University of Grenoble; European grant [LSMH-CT-EUR-INTAFAR 2004-512138]	CEA (Commissariat a l'Energie Atomique et aux Energies Alternatives)(French Atomic Energy Commission); CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); University of Grenoble; European grant	This work has been supported by the CEA (Commissariat a l'Energie Atomique et aux Energies Alternatives, funding of the CEA-PM project and PostDoc fellowships to F. Bernaudat, A. Frelet-Barrand, P. Hivin and S. Dementin), by the CNRS (Centre National de la Recherche Scientifique, Post-Doc fellowship to A. Frelet-Barrand) and by the University of Grenoble 1. This work was partly supported by the European grant LSMH-CT-EUR-INTAFAR 2004-512138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qarn M, 2008, CURR OPIN STRUC BIOL, V18, P544, DOI 10.1016/j.sbi.2008.06.010; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bechtel S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-399; Bensmihen S, 2004, FEBS LETT, V561, P127, DOI 10.1016/S0014-5793(04)00148-6; Berne C, 2007, APPL MICROBIOL BIOT, V77, P135, DOI 10.1007/s00253-007-1140-4; BLAIN KY, 2010, BIOCHEMISTRY; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bonander N, 2005, PROTEIN SCI, V14, P1729, DOI 10.1110/ps.051435705; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Bouhss A, 2004, J BIOL CHEM, V279, P29974, DOI 10.1074/jbc.M314165200; Brugiere S, 2004, PHYTOCHEMISTRY, V65, P1693, DOI 10.1016/j.phytochem.2004.03.028; Carvalho LC, 2008, J PLANT PHYSIOL, V165, P1300, DOI 10.1016/j.jplph.2007.04.009; Catty P, 2011, J BIOL CHEM, V286, P36188, DOI 10.1074/jbc.M111.241034; CLAYTON RK, 1960, BIOCHIM BIOPHYS ACTA, V37, P503, DOI 10.1016/0006-3002(60)90507-2; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colwill K, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-13; Condreay JP, 2007, CURR DRUG TARGETS, V8, P1126, DOI 10.2174/138945007782151351; Dahlroth SL, 2009, PROTEIN EXPRES PURIF, V68, P121, DOI 10.1016/j.pep.2009.07.010; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; del Rio B, 2010, VACCINE, V28, P6714, DOI 10.1016/j.vaccine.2010.07.084; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Deniaud A, 2011, BBA-BIOMEMBRANES, V1808, P2059, DOI 10.1016/j.bbamem.2011.04.011; Dobrovetsky Elena, 2005, Journal of Structural and Functional Genomics, V6, P33, DOI 10.1007/s10969-005-1363-5; DOUILLARD FP, 2011, PLASMID; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Dvir H, 2009, PROTEIN EXPRES PURIF, V68, P28, DOI 10.1016/j.pep.2009.06.007; Eifler N, 2007, J STRUCT BIOL, V159, P179, DOI 10.1016/j.jsb.2007.01.014; Eshaghi S, 2005, PROTEIN SCI, V14, P676, DOI 10.1110/ps.041127005; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Freigassner M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-69; Frelet-Barrand A, 2010, METHODS MOL BIOL, V601, P67, DOI 10.1007/978-1-60761-344-2_5; Frelet-Barrand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008746; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; Gonzalez E, 2005, PLANT CELL, V17, P3500, DOI 10.1105/tpc.105.036640; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Gordon E, 2008, PROTEIN EXPRES PURIF, V62, P1, DOI 10.1016/j.pep.2008.07.005; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Gravot A, 2004, FEBS LETT, V561, P22, DOI 10.1016/S0014-5793(04)00072-9; Griffith DA, 2003, FEBS LETT, V553, P45, DOI 10.1016/S0014-5793(03)00952-9; Haferkamp I, 2002, EUR J BIOCHEM, V269, P3172, DOI 10.1046/j.1432-1033.2002.02991.x; Hartley JL, 2006, CURR OPIN BIOTECH, V17, P359, DOI 10.1016/j.copbio.2006.06.011; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Huc-Brandt S, 2011, BBA-BIOMEMBRANES, V1808, P65, DOI 10.1016/j.bbamem.2010.08.013; Hunt I, 2005, PROTEIN EXPRES PURIF, V40, P1, DOI 10.1016/j.pep.2004.10.018; JARVIS DL, 1995, VIROLOGY, V212, P500, DOI 10.1006/viro.1995.1508; Junge F, 2008, CELL MOL LIFE SCI, V65, P1729, DOI 10.1007/s00018-008-8067-5; Keech O, 2005, PHYSIOL PLANTARUM, V124, P403, DOI 10.1111/j.1399-3054.2005.00521.x; Kefala Georgia, 2007, Journal of Structural and Functional Genomics, V8, P167, DOI 10.1007/s10969-007-9033-4; KILEY PJ, 1988, MICROBIOL REV, V52, P50, DOI 10.1128/MMBR.52.1.50-69.1988; Koehn Jim, 2009, V498, P1, DOI 10.1007/978-1-59745-196-3_1; Korepanova A, 2005, PROTEIN SCI, V14, P148, DOI 10.1110/ps.041022305; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Krammer EM, 2009, BIOPHYS J, V97, pL25, DOI 10.1016/j.bpj.2009.08.047; Kunji ERS, 2005, CURR OPIN BIOTECH, V16, P546, DOI 10.1016/j.copbio.2005.08.006; Kunji ERS, 2003, BBA-BIOMEMBRANES, V1610, P97, DOI 10.1016/S0005-2736(02)00712-5; Laage R, 2001, TRAFFIC, V2, P99, DOI 10.1034/j.1600-0854.2001.020204.x; Lacapere JJ, 2007, TRENDS BIOCHEM SCI, V32, P259, DOI 10.1016/j.tibs.2007.04.001; Laible Philip D., 2004, Journal of Structural and Functional Genomics, V5, P167, DOI 10.1023/B:JSFG.0000029201.33710.46; Le Loir Y, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-2; Leaver M, 2005, MOL MICROBIOL, V57, P1196, DOI 10.1111/j.1365-2958.2005.04736.x; Lee Min Woo, 2006, V323, P225; Lenoir G, 2002, BBA-BIOMEMBRANES, V1560, P67, DOI 10.1016/S0005-2736(01)00458-8; Lesley SA, 2009, METHOD ENZYMOL, V463, P767, DOI 10.1016/S0076-6879(09)63041-X; Leviatan S, 2010, J BIOL CHEM, V285, P23548, DOI 10.1074/jbc.M110.125492; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Lichty JJ, 2005, PROTEIN EXPRES PURIF, V41, P98, DOI 10.1016/j.pep.2005.01.019; Linares DM, 2010, J MOL BIOL, V401, P45, DOI 10.1016/j.jmb.2010.06.002; Liu HP, 1999, BIOSCI BIOTECH BIOCH, V63, P530, DOI 10.1271/bbb.63.530; Liu XJ, 2008, BBA-PROTEINS PROTEOM, V1784, P1742, DOI 10.1016/j.bbapap.2008.06.018; Lundstrom K, 2003, BBA-BIOMEMBRANES, V1610, P90, DOI 10.1016/S0005-2736(02)00721-6; Lundstrom Kenneth, 2006, Journal of Structural and Functional Genomics, V7, P77, DOI 10.1007/s10969-006-9011-2; Marreddy RKR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010317; Matsuyama A, 2009, METHODS MOL BIOL, V577, P11, DOI 10.1007/978-1-60761-232-2_2; McLuskey K, 2010, EUR BIOPHYS J BIOPHY, V39, P723, DOI 10.1007/s00249-009-0546-6; Midgett CR, 2007, J STRUCT BIOL, V160, P265, DOI 10.1016/j.jsb.2007.07.001; Mierau I, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-16; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Miras S, 2002, J BIOL CHEM, V277, P47770, DOI 10.1074/jbc.M207477200; Miras S, 2007, J BIOL CHEM, V282, P29482, DOI 10.1074/jbc.M611112200; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Misson J, 2004, PLANT MOL BIOL, V55, P727, DOI 10.1007/s11103-004-1965-5; Mizutani K, 2011, PROTEIN EXPRES PURIF, V77, P1, DOI 10.1016/j.pep.2010.12.009; Morello E, 2008, J MOL MICROB BIOTECH, V14, P48, DOI 10.1159/000106082; NEKRASOVA OV, 2010, J BIOTECHNOL; Neuhaus HE, 1997, PLANT J, V11, P73, DOI 10.1046/j.1365-313X.1997.11010073.x; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; Panneels V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018478; Pellet J, 2010, NUCLEIC ACIDS RES, V38, pD371, DOI 10.1093/nar/gkp1000; Petrovskaya LE, 2010, BIOCHEMISTRY-MOSCOW+, V75, P881, DOI 10.1134/S0006297910070102; Porter RK, 2008, J BIOENERG BIOMEMBR, V40, P457, DOI 10.1007/s10863-008-9172-8; Possee RD, 1997, CURR OPIN BIOTECH, V8, P569, DOI 10.1016/S0958-1669(97)80030-4; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Psakis G, 2007, PROTEIN SCI, V16, P2667, DOI 10.1110/ps.073104707; Rahman M, 2007, MOL MEMBR BIOL, V24, P407, DOI 10.1080/09687860701243998; Rajagopala SV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-470; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Reymond M, 2006, PLANT CELL ENVIRON, V29, P115, DOI 10.1111/j.1365-3040.2005.01405.x; Riedel C, 2001, TRENDS BIOCHEM SCI, V26, P490, DOI 10.1016/S0968-0004(01)01904-1; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Sabaty M, 2001, APPL ENVIRON MICROB, V67, P5122, DOI 10.1128/AEM.67.11.5122-5126.2001; Sahdev S, 2008, MOL CELL BIOCHEM, V307, P249, DOI 10.1007/s11010-007-9603-6; Sarramegna V, 2003, CELL MOL LIFE SCI, V60, P1529, DOI 10.1007/s00018-003-3168-7; Schmidt KL, 2004, J BACTERIOL, V186, P785, DOI 10.1128/JB.186.3.785-793.2004; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Seigneurin-Berny D, 2006, J BIOL CHEM, V281, P2882, DOI 10.1074/jbc.M508333200; Sorensen HP, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-27; STEEN A, 2010, MOL CELL PROTEOMICS; Surade S, 2006, PROTEIN SCI, V15, P2178, DOI 10.1110/ps.062312706; Tate CG, 2003, BBA-BIOMEMBRANES, V1610, P141, DOI 10.1016/S0005-2736(02)00719-8; Tate CG, 2001, FEBS LETT, V504, P94, DOI 10.1016/S0014-5793(01)02711-9; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Verret F, 2005, FEBS LETT, V579, P1515, DOI 10.1016/j.febslet.2005.01.065; Vezina LP, 2009, PLANT BIOTECHNOL J, V7, P442, DOI 10.1111/j.1467-7652.2009.00414.x; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; von Heijne G, 2007, J INTERN MED, V261, P543, DOI 10.1111/j.1365-2796.2007.01792.x; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]; Wise AA, 2006, METH MOL B, V343, P43; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y; Yashiroda Y, 2008, CURR OPIN CHEM BIOL, V12, P55, DOI 10.1016/j.cbpa.2008.01.024; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhou XX, 2006, BIOTECHNOL ADV, V24, P285, DOI 10.1016/j.biotechadv.2005.11.001	129	90	94	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29191	10.1371/journal.pone.0029191	http://dx.doi.org/10.1371/journal.pone.0029191			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216205	gold, Green Published, Green Submitted			2022-12-27	WOS:000299113600065
J	Heck, A; Vogler, C; Gschwind, L; Ackermann, S; Auschra, B; Spalek, K; Rasch, B; de Quervain, D; Papassotiropoulos, A				Heck, Angela; Vogler, Christian; Gschwind, Leo; Ackermann, Sandra; Auschra, Bianca; Spalek, Klara; Rasch, Bjoern; de Quervain, Dominique; Papassotiropoulos, Andreas			Statistical Epistasis and Functional Brain Imaging Support a Role of Voltage-Gated Potassium Channels in Human Memory	PLOS ONE			English	Article							DIFFERENTIAL AMYGDALA ACTIVATION; CASE-CONTROL ASSOCIATION; GENE-GENE INTERACTIONS; K+ CHANNEL; POPULATION STRATIFICATION; HIPPOCAMPAL-NEURONS; EXPRESSION; IDENTIFICATION; LOCALIZATION; METHYLATION	Despite the current progress in high-throughput, dense genome scans, a major portion of complex traits' heritability still remains unexplained, a phenomenon commonly termed "missing heritability." The negligence of analytical approaches accounting for gene-gene interaction effects, such as statistical epistasis, is probably central to this phenomenon. Here we performed a comprehensive two-way SNP interaction analysis of human episodic memory, which is a heritable complex trait, and focused on 120 genes known to show differential, memory-related expression patterns in rat hippocampus. Functional magnetic resonance imaging was also used to capture genotype-dependent differences in memory-related brain activity. A significant, episodic memory-related interaction between two markers located in potassium channel genes (KCNB2 and KCNH5) was observed (P-nominal combined = 0.000001). The epistatic interaction was robust, as it was significant in a screening (P-nominal = 0.0000012) and in a replication sample (P-nominal = 0.01). Finally, we found genotype-dependent activity differences in the parahippocampal gyrus (P-nominal = 0.001) supporting the behavioral genetics finding. Our results demonstrate the importance of analytical approaches that go beyond single marker statistics of complex traits.	[Heck, Angela; Vogler, Christian; Gschwind, Leo; Ackermann, Sandra; Auschra, Bianca; Rasch, Bjoern; Papassotiropoulos, Andreas] Univ Basel, Div Mol Neurosci, Dept Psychol, Basel, Switzerland; [Vogler, Christian; Papassotiropoulos, Andreas] Univ Basel, Div Mol Neurosci, Univ Psychiat Clin, Basel, Switzerland; [Papassotiropoulos, Andreas] Univ Basel, Life Sci Training Facil, Dept Biozentrum, Basel, Switzerland; [Spalek, Klara; Rasch, Bjoern; de Quervain, Dominique] Univ Basel, Div Cognit Neurosci, Dept Psychol, Basel, Switzerland; [de Quervain, Dominique] Univ Basel, Div Cognit Neurosci, Univ Psychiat Clin, Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University of Basel	Heck, A (corresponding author), Univ Basel, Div Mol Neurosci, Dept Psychol, Basel, Switzerland.	angela.heck@unibas.ch	Rasch, Björn/A-3119-2015	Rasch, Björn/0000-0001-7607-3415; Heck, Angela/0000-0002-1543-3197; de Quervain, Dominique/0000-0001-7131-2464; Vogler, Christian/0000-0003-3922-109X; Papassotiropoulos, Andreas/0000-0002-2210-9651; Spalek, Klara/0000-0002-4244-6495	Swiss National Science Foundation (SNSF) Sinergia [CRSIKO_122691, CRSI33_130080]; National Centre of Competence in Research (NCCR) Synapsy; European Union (ADAMS) [242257]	Swiss National Science Foundation (SNSF) Sinergia(Swiss National Science Foundation (SNSF)); National Centre of Competence in Research (NCCR) Synapsy(Swiss National Science Foundation (SNSF)); European Union (ADAMS)	This work was supported in part by the Swiss National Science Foundation (SNSF) Sinergia grants [CRSIKO_122691, CRSI33_130080 to D. Q. and A. P.]; the National Centre of Competence in Research (NCCR) Synapsy, and the 7th framework programme of the European Union (ADAMS) [242257, FP7-HEALTH-2009 to D. Q. and A. P.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolino A, 2008, BIOL PSYCHIAT, V64, P226, DOI 10.1016/j.biopsych.2008.02.001; Bertolino A, 2009, J NEUROSCI, V29, P1224, DOI 10.1523/JNEUROSCI.4858-08.2009; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cavallaro S, 2002, P NATL ACAD SCI USA, V99, P16279, DOI 10.1073/pnas.242597199; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945; Deng HW, 2001, GENETICS, V159, P1319; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Engel JE, 1998, J NEUROSCI, V18, P2254; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Giubilei F, 2008, AGE AGEING, V37, P640, DOI 10.1093/ageing/afn132; Greenwood PM, 2009, P NATL ACAD SCI USA, V106, P3633, DOI 10.1073/pnas.0807891106; GRIFFITH LC, 1994, P NATL ACAD SCI USA, V91, P10044, DOI 10.1073/pnas.91.21.10044; Guan D, 2007, J PHYSIOL-LONDON, V581, P941, DOI 10.1113/jphysiol.2007.128454; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; HWANG PM, 1992, NEURON, V8, P473, DOI 10.1016/0896-6273(92)90275-I; Ikeda M, 2010, BIOL PSYCHIAT, V67, P263, DOI 10.1016/j.biopsych.2009.08.030; Jeng CJ, 2005, NEUROREPORT, V16, P229, DOI 10.1097/00001756-200502280-00005; JESSELL TM, 1993, CELL, V72, P1, DOI 10.1016/S0092-8674(05)80025-X; LANG PJ, 2008, INT AFFECTICVE PICTU; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; Mandzia JL, 2004, HUM BRAIN MAPP, V21, P1, DOI 10.1002/hbm.10140; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Nyholt DR, 2008, HUM MOL GENET, V17, P3318, DOI 10.1093/hmg/ddn227; PAPASSOTIROPOUL.A, 2009, MOL PSYCHIAT; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Papassotiropoulos A, 2011, TRENDS COGN SCI, V15, P381, DOI 10.1016/j.tics.2011.07.005; Pollard KS, 2005, STAT BIOL HEALTH, P249; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasch B, 2010, NEUROIMAGE, V53, P870, DOI 10.1016/j.neuroimage.2010.01.001; Rasch B, 2010, NEUROIMAGE, V52, P1712, DOI 10.1016/j.neuroimage.2010.05.054; Rasch B, 2009, P NATL ACAD SCI USA, V106, P19191, DOI 10.1073/pnas.0907425106; Rombouts SARB, 2001, NEUROIMAGE, V14, P67, DOI 10.1006/nimg.2001.0799; Saganich MJ, 1999, J NEUROSCI, V19, P10789, DOI 10.1523/JNEUROSCI.19-24-10789.1999; Schonherr R, 2002, FEBS LETT, V514, P204, DOI 10.1016/S0014-5793(02)02365-7; Steffens M, 2010, HUM HERED, V69, P268, DOI 10.1159/000295896; Stelzel C, 2009, EUR J NEUROSCI, V29, P1056, DOI 10.1111/j.1460-9568.2009.06647.x; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; TAN HY, 2011, MOL PSYCHIAT; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; Ursini G, 2011, J NEUROSCI, V31, P6692, DOI 10.1523/JNEUROSCI.6631-10.2011; Vasan RS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S2; Wang YT, 2004, GENET EPIDEMIOL, V27, P14, DOI 10.1002/gepi.20003; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Zhong CB, 2005, NEUROSCI LETT, V373, P99, DOI 10.1016/j.neulet.2004.09.069	52	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29337	10.1371/journal.pone.0029337	http://dx.doi.org/10.1371/journal.pone.0029337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216252	gold, Green Published, Green Submitted			2022-12-27	WOS:000299113600079
J	Dolinska, MB; Wingfield, PT; Sergeev, YV				Dolinska, Monika B.; Wingfield, Paul T.; Sergeev, Yuri V.			beta B1-Crystallin: Thermodynamic Profiles of Molecular Interactions	PLOS ONE			English	Article							BETA-CRYSTALLINS; HUMAN LENS; ASSOCIATION; PROTEINS; HETEROOLIGOMERS; DEAMIDATION; STABILITY; SEQUENCE; COMPLEX; ALTERS	Backgroud: beta-Crystallins are structural proteins maintaining eye lens transparency and opacification. Previous work demonstrated that dimerization of both beta A3 and beta B2 crystallins (beta A3 and beta B2) involves endothermic enthalpy of association (similar to 8 kcal/mol) mediated by hydrophobic interactions. Methodology/Principal Findings: Thermodynamic profiles of the associations of dimeric beta A3 and beta B1 and tetrameric beta B1/beta A3 were measured using sedimentation equilibrium. The homo-and heteromolecular associations of beta B1 crystallin are dominated by exothermic enthalpy (-13.3 and -24.5 kcal/mol, respectively). Conclusions/Significance: Global thermodynamics of beta B1 interactions suggest a role in the formation of stable protein complexes in the lens via specific van der Waals contacts, hydrogen bonds and salt bridges whereas those b-crystallins which associate by predominately hydrophobic forces participate in a weaker protein associations.	[Dolinska, Monika B.; Sergeev, Yuri V.] NEI, NIH, Bethesda, MD 20892 USA; [Wingfield, Paul T.] NIAMSD, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Dolinska, MB (corresponding author), NEI, NIH, Bethesda, MD 20892 USA.	sergeevy@nei.nih.gov		Wingfield, Paul/0000-0002-9515-4752	National Institutes of Health [Z01-EY000476-01]; NATIONAL EYE INSTITUTE [ZIAEY000476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (Z01-EY000476-01 to Y.V.S.). No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman OA, 2003, EXP EYE RES, V77, P409, DOI 10.1016/S0014-4835(03)00173-8; Chan MP, 2008, BIOCHEMISTRY-US, V47, P11062, DOI 10.1021/bi8012438; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Datiles MB, 2008, ARCH OPHTHALMOL-CHIC, V126, P1687, DOI 10.1001/archophthalmol.2008.507; David LL, 1996, J BIOL CHEM, V271, P4273; Dey S, 2010, J MOL BIOL, V398, P146, DOI 10.1016/j.jmb.2010.02.020; Dolinska MB, 2009, BIOCHEMISTRY-US, V48, P9684, DOI 10.1021/bi9013984; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hejtmancik JF, 2004, EXP EYE RES, V79, P377, DOI 10.1016/j.exer.2004.06.011; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; Lampi KJ, 2001, EXP EYE RES, V72, P279, DOI 10.1006/exer.2000.0950; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liu BF, 2007, FEBS LETT, V581, P3936, DOI 10.1016/j.febslet.2007.07.022; Marin-Vinader L, 2006, FEBS J, V273, P3172, DOI 10.1111/j.1742-4658.2006.05326.x; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Roth CM, 1996, BIOPHYS J, V70, P977, DOI 10.1016/S0006-3495(96)79641-8; Sergeev YV, 2004, BIOCHEMISTRY-US, V43, P415, DOI 10.1021/bi034617f; Sergeev YV, 2000, BIOCHEMISTRY-US, V39, P15799, DOI 10.1021/bi001882h; Sinha D, 2008, MOL CELL NEUROSCI, V37, P85, DOI 10.1016/j.mcn.2007.08.016; SLINGSBY C, 1990, BIOCHEMISTRY-US, V29, P6592, DOI 10.1021/bi00480a007; Stein A, 2009, FEBS J, V276, P5390, DOI 10.1111/j.1742-4658.2009.07251.x; Takata T, 2009, MOL VIS, V15, P241; Werten PJL, 1999, BBA-PROTEIN STRUCT M, V1432, P286, DOI 10.1016/S0167-4838(99)00123-5; Yuan XL, 2010, MOL CELL PROTEOMICS, V9, P1031, DOI 10.1074/mcp.M900523-MCP200; Zigler JS, 2011, J CELL SCI, V124, P523, DOI 10.1242/jcs.078790	25	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29227	10.1371/journal.pone.0029227	http://dx.doi.org/10.1371/journal.pone.0029227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238594	Green Submitted, Green Published, gold			2022-12-27	WOS:000301188800007
J	Gayat, E; Aulagnier, J; Matthieu, E; Boisson, M; Fischler, M				Gayat, Etienne; Aulagnier, Jerome; Matthieu, Emmanuel; Boisson, Mireille; Fischler, Marc			Non-Invasive Measurement of Hemoglobin: Assessment of Two Different Point-of-Care Technologies	PLOS ONE			English	Article							ACCURACY	Background: Measurement of blood hemoglobin (Hb) concentration is a routine procedure. Using a non-invasive point-of-care device reduces pain and discomfort for the patient and allows time saving in patient care. The aims of the present study were to assess the concordance of Hb levels obtained non-invasively with the Pronto-7 monitor (version 2.1.9, Masimo Corporation, Irvine, USA) or with the NBM-200MP monitor (Orsense, Nes Ziona, Israel) and the values obtained from the usual colorimetric method using blood samples and to determine the source of discordance. Methods and Findings: We conducted two consecutive prospective open trials enrolling patients presenting in the emergency department of a university hospital. The first was designed to assess Pronto-7 (TM) and the second NBM-200MP (TM). In each study, the main outcome measure was the agreement between both methods. Independent factors associated with the bias were determined using multiple linear regression. Three hundred patients were prospectively enrolled in each study. For Pronto-7 (TM), the absolute mean difference was 0.56 g. L-1 (95% confidence interval [CI] 0.41 to 0.69) with an upper agreement limit at 2.94 g. L-1 (95% CI [2.70; 3.19]), a lower agreement limit at -1.84 g. L-1 (95% CI [-2.08;-1.58]) and an intraclass correlation coefficient at 0.80 (95% CI [0.74; 0.84]). The corresponding values for the NBM-200MP (TM) were 0.21 [0.02; 0.39], 3.42 [3.10; 3.74], -3.01 [-3.32;-2.69] and 0.69 [0.62; 0.75]. Multivariate analysis showed that age and laboratory values of hemoglobin were independently associated with the bias when using Pronto-7 (TM), while perfusion index and laboratory value of hemoglobin were independently associated with the bias when using NBM-200MP (TM). Conclusion: Despite a relatively limited bias in both cases, the large limits of agreement found in both cases render the clinical usefulness of such devices debatable. For both devices, the bias is independently and inversely associated with the true value of hemoglobin. Trial Registration: ClinicalTrials. gov NCT01321580 and NCT01321593	[Gayat, Etienne; Fischler, Marc] Hop Foch, Dept Anesthesia, Suresnes, France; [Gayat, Etienne] Hop St Louis, INSERM, U717, Paris, France; [Boisson, Mireille] Hop Foch, Dept Biol, Suresnes, France	Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hospital Foch	Gayat, E (corresponding author), Hop Foch, Dept Anesthesia, Suresnes, France.	etienne.gayat@9online.fr	Gayat, Etienne/ABG-5308-2021	GAYAT, Etienne/0000-0002-3334-3849; Fischler, Marc/0000-0003-0729-5430				BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Gayat E, 2011, ANN EMERG MED; Gayat E, 2011, ACTA ANAESTHESIOL SC; Gehring H, 2002, ACTA ANAESTH SCAND, V46, P980, DOI 10.1034/j.1399-6576.2002.460809.x; Hahn RG, 2010, ACTA ANAESTH SCAND, V54, P1233, DOI 10.1111/j.1399-6576.2010.02321.x; Khusun H, 1999, J NUTR, V129, P1669, DOI 10.1093/jn/129.9.1669; Lardi AM, 1998, ANAESTHESIA, V53, P349, DOI 10.1046/j.1365-2044.1998.00328.x; Macknet MR, 2010, ANESTH ANALG, V111, P1424, DOI 10.1213/ANE.0b013e3181fc74b9; Miller RD, 2011, ANESTH ANALG, V112, P858, DOI 10.1213/ANE.0b013e31820eecd1; Ricos C, 1999, SCAND J CLIN LAB INV, V59, P491; Severinghaus J W, 1986, J Clin Monit, V2, P270, DOI 10.1007/BF02851177; Shoukri MM, 2004, STAT METHODS MED RES, V13, P251, DOI 10.1191/0962280204sm365ra; VONSCHENCK H, 1986, CLIN CHEM, V32, P526; WHO, 1994, IND STRAT IR DEF AN	15	75	79	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e30065	10.1371/journal.pone.0030065	http://dx.doi.org/10.1371/journal.pone.0030065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238693	gold, Green Published, Green Submitted			2022-12-27	WOS:000301188800057
J	Liang, QY; Xu, ZF; Xu, RZ; Wu, LJ; Zheng, S				Liang, Qiaoyi; Xu, Zefeng; Xu, Rongzhen; Wu, Lijun; Zheng, Shu			Expression Patterns of Non-Coding Spliced Transcripts from Human Endogenous Retrovirus HERV-H Elements in Colon Cancer	PLOS ONE			English	Article							LONG TERMINAL REPEATS; PROMOTER ACTIVITY; FAMILY; GENES; SEQUENCES; ENVELOPE; TISSUE; DNA	Background: Up-regulation of the most abundant H family human endogenous retrovirus (HERV-H), especially env-related transcripts, correlates with colon cancer. However, expression pattern of spliced non-coding transcripts of HERV-H is not clear. Methodology/Principal Findings: In this study, expression of HERV-H spliced transcripts in colon cancer was investigated by a RT-PCR strategy using primers targeting the tRNA His primer-binding site and the R region in the 39 long terminal repeat (LTR), followed by cloning and sequencing of the amplicons. Sequences were then assigned to individual HERV-H loci by employing private nucleotide differences between loci. Different expression patterns of HERV-H spliced transcripts from distinct active elements were found in colon cancer cell lines HT29, LS 174T, RKO, SW480 and SW620. Furthermore, the expression patterns in SW480 and RKO were significantly changed by demethylation treatment. Interestingly, more HERV-H elements were found to be transcriptionally active in colon tumor tissues than in adjacent normal tissues (14 vs. 7). Conclusions/Significance: This is the first research to study the character of expression of non-coding spliced transcripts of HERV-H elements in colon cancer. Expression patterns of HERV-H spliced transcripts differed among colon cancer cell lines and could be affected by genomic DNA methylation levels. More importantly, besides the commonly accepted view of upregulation of HERV-H expression in colon tumor tissues, we found more active HERV-H loci in colon tumor as compared with adjacent normal tissues.	[Liang, Qiaoyi; Xu, Zefeng; Xu, Rongzhen; Wu, Lijun; Zheng, Shu] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc, Hangzhou 310003, Zhejiang, Peoples R China; [Liang, Qiaoyi] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Liang, Qiaoyi; Xu, Zefeng; Xu, Rongzhen; Wu, Lijun; Zheng, Shu] China Natl Minist Educ, Key Lab Canc Prevent & Intervent, Key Lab Mol Biol Med Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Chinese University of Hong Kong	Liang, QY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc, Hangzhou 310003, Zhejiang, Peoples R China.	zhengshu@zju.edu.cn	Liang, Qiaoyi Jessie/G-9612-2019	Liang, Qiaoyi Jessie/0000-0001-8496-3442	International Cooperation of Science and Technology Key Foundation of Zhejiang Province [2009C14010]; Zhejiang Provincial Natural Science Foundation [R2090353]; National Natural Science Foundation of China [30973382, 81101488]	International Cooperation of Science and Technology Key Foundation of Zhejiang Province; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the International Cooperation of Science and Technology Key Foundation of Zhejiang Province (2009C14010), Zhejiang Provincial Natural Science Foundation (R2090353), National Natural Science Foundation of China (30973382 and 81101488). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; de Parseval N, 2001, VIROLOGY, V279, P558, DOI 10.1006/viro.2000.0737; Forsman A, 2005, J VIROL METHODS, V129, P16, DOI 10.1016/j.jviromet.2005.04.016; HIROSE Y, 1993, VIROLOGY, V192, P52, DOI 10.1006/viro.1993.1007; Jern P, 2005, J VIROL, V79, P6325, DOI 10.1128/JVI.79.10.6325-6337.2005; Jern P, 2004, VIROLOGY, V327, P93, DOI 10.1016/j.virol.2004.06.023; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lettini AA, 2007, HISTOL HISTOPATHOL, V22, P1413, DOI 10.14670/HH-22.1413; Liang Q, 2009, GENET MOL BIOL; Liang Q, 2009, BIOCHEM BIOPH RES CO, V382, P470; Liang QY, 2010, INT J CANCER, V127, P1833, DOI 10.1002/ijc.25213; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; Mangeney M, 2001, J GEN VIROL, V82, P2515, DOI 10.1099/0022-1317-82-10-2515; Okahara G, 2004, GENOMICS, V84, P982, DOI 10.1016/j.ygeno.2004.09.004; Pichon JP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl086; Schon U, 2009, J VIROL, V83, P12643, DOI 10.1128/JVI.00858-09; Schon U, 2001, VIROLOGY, V279, P280, DOI 10.1006/viro.2000.0712; Sjottem E, 1996, J VIROL, V70, P188; Wentzensen N, 2004, INT J ONCOL, V24, P987; WILKINSON DA, 1993, J VIROL, V67, P2981, DOI 10.1128/JVI.67.6.2981-2989.1993	20	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29950	10.1371/journal.pone.0029950	http://dx.doi.org/10.1371/journal.pone.0029950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238681	Green Submitted, Green Published, gold			2022-12-27	WOS:000301188800051
J	Rothkamm, K; Crosbie, JC; Daley, F; Bourne, S; Barber, PR; Vojnovic, B; Cann, L; Rogers, PAW				Rothkamm, Kai; Crosbie, Jeffrey C.; Daley, Frances; Bourne, Sarah; Barber, Paul R.; Vojnovic, Borivoj; Cann, Leonie; Rogers, Peter A. W.			In situ Biological Dose Mapping Estimates the Radiation Burden Delivered to 'Spared' Tissue between Synchrotron X-Ray Microbeam Radiotherapy Tracks	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; INDUCED GAMMA-H2AX; MICROPLANAR BEAMS; CELLS; IRRADIATION; THERAPY; DOSIMETRY; REPAIR; DAMAGE	Microbeam radiation therapy (MRT) using high doses of synchrotron X-rays can destroy tumours in animal models whilst causing little damage to normal tissues. Determining the spatial distribution of radiation doses delivered during MRT at a microscopic scale is a major challenge. Film and semiconductor dosimetry as well as Monte Carlo methods struggle to provide accurate estimates of dose profiles and peak-to-valley dose ratios at the position of the targeted and traversed tissues whose biological responses determine treatment outcome. The purpose of this study was to utilise gamma-H2AX immunostaining as a biodosimetric tool that enables in situ biological dose mapping within an irradiated tissue to provide direct biological evidence for the scale of the radiation burden to 'spared' tissue regions between MRT tracks. Gamma-H2AX analysis allowed microbeams to be traced and DNA damage foci to be quantified in valleys between beams following MRT treatment of fibroblast cultures and murine skin where foci yields per unit dose were approximately five-fold lower than in fibroblast cultures. Foci levels in cells located in valleys were compared with calibration curves using known broadbeam synchrotron X-ray doses to generate spatial dose profiles and calculate peak-to-valley dose ratios of 30-40 for cell cultures and approximately 60 for murine skin, consistent with the range obtained with conventional dosimetry methods. This biological dose mapping approach could find several applications both in optimising MRT or other radiotherapeutic treatments and in estimating localised doses following accidental radiation exposure using skin punch biopsies.	[Rothkamm, Kai] Hlth Protect Agcy Ctr Radiat Chem & Environm Haza, Chilton, Oxon, England; [Rothkamm, Kai; Daley, Frances; Bourne, Sarah; Barber, Paul R.; Vojnovic, Borivoj] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England; [Crosbie, Jeffrey C.; Cann, Leonie; Rogers, Peter A. W.] Univ Melbourne, Dept Obstet & Gynaecol, Royal Womens Hosp, Parkville, Vic 3052, Australia; [Crosbie, Jeffrey C.] Alfred Hosp, William Buckland Radiotherapy Ctr, Melbourne, Vic, Australia; [Cann, Leonie] Monash Med Ctr, Victorian Canc Biobank, Clayton, Vic 3168, Australia	University of Oxford; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Monash University	Rothkamm, K (corresponding author), Hlth Protect Agcy Ctr Radiat Chem & Environm Haza, Chilton, Oxon, England.	kai.rothkamm@hpa.org.uk	Rothkamm, Kai/A-2164-2014; Rogers, Peter AW/C-2651-2008; Vojnovic, Borivoj/AAV-4756-2021; Crosbie, Jeffrey/F-8465-2010	Rothkamm, Kai/0000-0001-7414-5729; Rogers, Peter AW/0000-0002-7399-8997; Vojnovic, Borivoj/0000-0001-9013-3816; Crosbie, Jeffrey/0000-0002-8047-5465	Australian Nuclear Science & Technology Organisation; Cancer Council Victoria; National Health & Medical Research Council; Cancer Research UK; NIHR Centre for Research in Health Protection at the Health Protection Agency; Cancer Research UK [15677] Funding Source: researchfish	Australian Nuclear Science & Technology Organisation; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research UK(Cancer Research UK); NIHR Centre for Research in Health Protection at the Health Protection Agency; Cancer Research UK(Cancer Research UK)	This study was funded by the Australian Nuclear Science & Technology Organisation, Cancer Council Victoria, National Health & Medical Research Council, Cancer Research UK, and the NIHR Centre for Research in Health Protection at the Health Protection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health.	Barber PR, 2007, P SOC PHOTO-OPT INS, V6441, pM1; Barber RC, 2006, ONCOGENE, V25, P7336, DOI 10.1038/sj.onc.1209723; Belyakov OV, 2005, P NATL ACAD SCI USA, V102, P14203, DOI 10.1073/pnas.0505020102; Bencokova Z, 2008, J SYNCHROTRON RADIAT, V15, P74, DOI 10.1107/S0909049507044937; Bouchet A, 2010, INT J RADIAT ONCOL, V78, P1503, DOI 10.1016/j.ijrobp.2010.06.021; Brauer-Krisch E, 2010, MUTAT RES-REV MUTAT, V704, P160, DOI 10.1016/j.mrrev.2009.12.003; Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Chai Y., 2008, ACTA MED NAGASAKI, V53, pS65; Chua MLK, 2011, RADIOTHER ONCOL, V99, P225, DOI 10.1016/j.radonc.2011.04.009; Crosbie JC, 2008, PHYS MED BIOL, V53, P6861, DOI 10.1088/0031-9155/53/23/014; Crosbie JC, 2010, INT J RADIAT ONCOL, V77, P886, DOI 10.1016/j.ijrobp.2010.01.035; Dickey JS, 2009, CHROMOSOMA, V118, P683, DOI 10.1007/s00412-009-0234-4; Dickey JS, 2009, CARCINOGENESIS, V30, P1686, DOI 10.1093/carcin/bgp192; Dilmanian FA, 2007, EXP HEMATOL, V35, P69, DOI 10.1016/j.exphem.2007.01.014; Dilmanian FA, 2002, NEURO-ONCOLOGY, V4, P26, DOI 10.1093/neuonc/4.1.26; Han W, 2007, ONCOGENE, V26, P2330, DOI 10.1038/sj.onc.1210024; Laissue JA, 1998, INT J CANCER, V78, P654, DOI 10.1002/(SICI)1097-0215(19981123)78:5<654::AID-IJC21>3.0.CO;2-L; Nariyama N, 2009, APPL RADIAT ISOTOPES, V67, P155, DOI 10.1016/j.apradiso.2008.08.002; Nettelbeck H, 2009, MED PHYS, V36, P447, DOI 10.1118/1.3049786; Ohno Y, 2008, MED PHYS, V35, P3252, DOI 10.1118/1.2940157; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Rothkamm K, 2009, ANN I SUPER SANITA, V45, P265; Sedelnikova OA, 2007, CANCER RES, V67, P4295, DOI 10.1158/0008-5472.CAN-06-4442; Serduc R, 2006, INT J RADIAT ONCOL, V64, P1519, DOI 10.1016/j.ijrobp.2005.11.047; Serduc R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009028; Siegbahn EA, 2009, MED PHYS, V36, P1128, DOI 10.1118/1.3081934; SLATKIN DN, 1995, P NATL ACAD SCI USA, V92, P8783, DOI 10.1073/pnas.92.19.8783; Usami N, 2006, RADIAT PROT DOSIM, V122, P307, DOI 10.1093/rpd/ncl434; van der Sanden B, 2010, INT J RADIAT ONCOL, V77, P1545, DOI 10.1016/j.ijrobp.2010.02.019	30	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29853	10.1371/journal.pone.0029853	http://dx.doi.org/10.1371/journal.pone.0029853			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238667	Green Published, gold			2022-12-27	WOS:000301188800043
J	Wagenaar, DA				Wagenaar, Daniel A.			An Optically Stabilized Fast-Switching Light Emitting Diode as a Light Source for Functional Neuroimaging	PLOS ONE			English	Article							VOLTAGE-SENSITIVE DYES; ACTION-POTENTIALS; ELECTRICAL-ACTIVITY; NEURONS; LEECH; DENDRITES	Neuroscience research increasingly relies on optical methods for evoking neuronal activity as well as for measuring it, making bright and stable light sources critical building blocks of modern experimental setups. This paper presents a method to control the brightness of a high-power light emitting diode (LED) light source to an unprecedented level of stability. By continuously monitoring the actual light output of the LED with a photodiode and feeding the result back to the LED's driver by way of a proportional-integral controller, drift was reduced to as little as 0.007% per hour over a 12-h period, and short-term fluctuations to 0.005% root-mean-square over 10 seconds. The LED can be switched on and off completely within 100 mu s, a feature that is crucial when visual stimuli and light for optical recording need to be interleaved to obtain artifact-free recordings. The utility of the system is demonstrated by recording visual responses in the central nervous system of the medicinal leech Hirudo verbana using voltage-sensitive dyes.	[Wagenaar, Daniel A.] CALTECH, Broad Fellows Program, Pasadena, CA 91125 USA; [Wagenaar, Daniel A.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Wagenaar, DA (corresponding author), CALTECH, Broad Fellows Program, Pasadena, CA 91125 USA.	daw@caltech.edu	Wagenaar, Daniel A/B-4035-2010	Wagenaar, Daniel A/0000-0002-6222-761X	Broad Foundations	Broad Foundations	This work was supported by a Senior Research Fellowship from the Broad Foundations. The author holds a Career Award at the Scientic Interface from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baca SM, 2008, NEURON, V57, P276, DOI 10.1016/j.neuron.2007.11.028; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Bru-Chevallier C, 2005, PHYS STATUS SOLIDI A, V202, P1292, DOI 10.1002/pssa.200460909; Cacciatore TW, 1999, NEURON, V23, P449, DOI 10.1016/S0896-6273(00)80799-0; CHIEN CB, 1991, J NEUROSCI METH, V38, P93, DOI 10.1016/0165-0270(91)90159-W; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; FRANK E, 1975, J COMP NEUROL, V159, P1, DOI 10.1002/cne.901590102; GRINVALD A, 1981, P NATL ACAD SCI-BIOL, V78, P3245, DOI 10.1073/pnas.78.5.3245; Holthoff K, 2010, J PHYSIOL-LONDON, V588, P1085, DOI 10.1113/jphysiol.2009.184960; Knopfel T, 2010, J NEUROSCI, V30, P14998, DOI 10.1523/JNEUROSCI.4190-10.2010; KRETZ JR, 1976, J COMP PHYSIOL, V106, P1, DOI 10.1007/BF00606569; Momose-Sato Y, 1999, J MEMBRANE BIOL, V172, P145, DOI 10.1007/s002329900592; Mukai T, 1998, JAPANESE J APPL PH 2; Nishimura M, 2006, NEUROSCI RES, V54, P230, DOI 10.1016/j.neures.2005.12.002; Peterka DS, 2011, NEURON, V69, P9, DOI 10.1016/j.neuron.2010.12.010; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Sjulson L, 2007, PHYSIOLOGY, V22, P47, DOI 10.1152/physiol.00036.2006; THOMSON LA, 1975, APPL MICROBIOL, V30, P616, DOI 10.1128/AEM.30.4.616-624.1975; Wagenaar DA, 2010, CURR BIOL, V20, P487, DOI 10.1016/j.cub.2010.02.027; Wise F, 2011, IMAGING LAB MANUAL, P135; Zhou WL, 2007, J NEUROSCI METH, V164, P225, DOI 10.1016/j.jneumeth.2007.05.002	21	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29822	10.1371/journal.pone.0029822	http://dx.doi.org/10.1371/journal.pone.0029822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238663	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000301188800040
J	Capilla-Gonzalez, V; Gil-Perotin, S; Ferragud, A; Bonet-Ponce, L; Canales, JJ; Garcia-Verdugo, JM				Capilla-Gonzalez, Vivian; Gil-Perotin, Sara; Ferragud, Antonio; Bonet-Ponce, Luis; Canales, Juan Jose; Manuel Garcia-Verdugo, Jose			Exposure to N-Ethyl-N-Nitrosourea in Adult Mice Alters Structural and Functional Integrity of Neurogenic Sites	PLOS ONE			English	Article							ENU MOUSE MUTAGENESIS; HIPPOCAMPAL NEUROGENESIS; SUBVENTRICULAR ZONE; MAMMALIAN BRAIN; NERVOUS-SYSTEM; DENTATE GYRUS; CRANIAL IRRADIATION; CONTEXTUAL FEAR; GERMINAL ZONE; STEM-CELLS	Background: Previous studies have shown that prenatal exposure to the mutagen N-ethyl-N-nitrosourea (ENU), a N-nitroso compound (NOC) found in the environment, disrupts developmental neurogenesis and alters memory formation. Previously, we showed that postnatal ENU treatment induced lasting deficits in proliferation of neural progenitors in the subventricular zone (SVZ), the main neurogenic region in the adult mouse brain. The present study is aimed to examine, in mice exposed to ENU, both the structural features of adult neurogenic sites, incorporating the dentate gyrus (DG), and the behavioral performance in tasks sensitive to manipulations of adult neurogenesis. Methodology/Principal Findings: 2-month old mice received 5 doses of ENU and were sacrificed 45 days after treatment. Then, an ultrastructural analysis of the SVZ and DG was performed to determine cellular composition in these regions, confirming a significant alteration. After bromodeoxyuridine injections, an S-phase exogenous marker, the immunohistochemical analysis revealed a deficit in proliferation and a decreased recruitment of newly generated cells in neurogenic areas of ENU-treated animals. Behavioral effects were also detected after ENU-exposure, observing impairment in odor discrimination task (habituation-dishabituation test) and a deficit in spatial memory (Barnes maze performance), two functions primarily related to the SVZ and the DG regions, respectively. Conclusions/Significance: The results demonstrate that postnatal exposure to ENU produces severe disruption of adult neurogenesis in the SVZ and DG, as well as strong behavioral impairments. These findings highlight the potential risk of environmental NOC-exposure for the development of neural and behavioral deficits.	[Capilla-Gonzalez, Vivian; Gil-Perotin, Sara; Bonet-Ponce, Luis; Manuel Garcia-Verdugo, Jose] Univ Valencia, Lab Neurobiol Comparada, Inst Cavanilles Biodiversidad & Biol Evolut, Valencia, Spain; [Gil-Perotin, Sara] Hosp Univ La Fe, Serv Med Intens, Valencia, Spain; [Ferragud, Antonio; Canales, Juan Jose] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand; [Manuel Garcia-Verdugo, Jose] CIBERNED, Lab Morfol Celular, Unidad Mixta Ctr Invest Principe Felipe UVEG, Valencia, Spain	University of Valencia; Hospital Universitari i Politecnic La Fe; University of Canterbury; CIBERNED; Prince Felipe Research Center	Capilla-Gonzalez, V (corresponding author), Univ Valencia, Lab Neurobiol Comparada, Inst Cavanilles Biodiversidad & Biol Evolut, Valencia, Spain.	vivian.capilla@uv.es	Ferragud, Antonio/AAB-1592-2019; García-Verdugo, José Manuel/L-8421-2017; Bonet-Ponce, Luis/ADT-4664-2022; CAPILLA-GONZALEZ, VIVIAN/N-8838-2019; Gil-Perotin, Sara/AAK-9942-2021; Gil-Perotin, Sara/I-2467-2015; Bonet-Ponce, Luis/GPW-9357-2022; Ferragud, Antonio/AAD-8772-2019	García-Verdugo, José Manuel/0000-0001-9872-6499; CAPILLA-GONZALEZ, VIVIAN/0000-0003-2020-1662; Gil-Perotin, Sara/0000-0003-3793-0116; Gil-Perotin, Sara/0000-0003-3793-0116; Bonet-Ponce, Luis/0000-0001-9276-059X; Ferragud, Antonio/0000-0002-6739-007X; Canales, Juan J./0000-0003-2884-5227	University of Valencia (VCG); Centro de Investigacion Biomedica en Red para Enfermedades Neurodegenerativas (CIBERNED); Red de Terapia Celular TERCEL (RETICS) [RD06/0010/0022]; Instituto de Salud Carlos III; Spanish Ministry of Science, and Innovation [SAF2008-01274]	University of Valencia (VCG); Centro de Investigacion Biomedica en Red para Enfermedades Neurodegenerativas (CIBERNED); Red de Terapia Celular TERCEL (RETICS); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science, and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the University of Valencia (fellowship Cinc Segles) (VCG), by Centro de Investigacion Biomedica en Red para Enfermedades Neurodegenerativas (CIBERNED), Red de Terapia Celular TERCEL (RETICS RD06/0010/0022) from Instituto de Salud Carlos III and by a project from the Spanish Ministry of Science, and Innovation (SAF2008-01274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Acevedo-Arozena A, 2008, ANNU REV GENOM HUM G, V9, P49, DOI 10.1146/annurev.genom.9.081307.164224; Agustin-Pavon C, 2007, BEHAV NEUROSCI, V121, P920, DOI 10.1037/0735-7044.121.5.920; Altkofer W, 2005, MOL NUTR FOOD RES, V49, P235, DOI 10.1002/mnfr.200400050; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Anderson VA, 2000, BRIT J CANCER, V82, P255; Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; Bartsch H, 1991, IARC Sci Publ, P1; Belvindrah R, 2009, REV NEUROSCIENCE, V20, P331, DOI 10.1515/REVNEURO.2009.20.5-6.331; BILZER T, 1989, NEUROTOXICOL TERATOL, V11, P551, DOI 10.1016/0892-0362(89)90036-6; Bland ST, 2006, NEUROREPORT, V17, P593, DOI 10.1097/00001756-200604240-00008; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Briancon-Marjollet A, 2010, CARCINOGENESIS, V31, P1718, DOI 10.1093/carcin/bgq154; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Capilla-Gonzalez V, 2010, EUR J NEUROSCI; Capilla-Gonzalez V, 2011, PHARMACEUTICALS, V4, P915, DOI 10.3390/ph4060915; Cook MC, 2006, CURR OPIN IMMUNOL, V18, P627, DOI 10.1016/j.coi.2006.07.011; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Driscoll I, 2006, NEUROSCIENCE, V139, P1173, DOI 10.1016/j.neuroscience.2006.01.040; Eichenbaum H, 2006, CURR BIOL, V16, pR643, DOI 10.1016/j.cub.2006.07.026; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Ferragud A, 2010, BEHAV BRAIN RES; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Ghebranious N, 2011, CLIN MED RES, V9, P17, DOI 10.3121/cmr.2010.894; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Haorah J, 2001, J AGR FOOD CHEM, V49, P6068, DOI 10.1021/jf010602h; Harrison FE, 2006, LEARN MEMORY, V13, P809, DOI 10.1101/lm.334306; HECHT SS, 1989, CANCER SURV, V8, P273; Hernandez-Rabaza V, 2009, NEUROSCIENCE, V159, P59, DOI 10.1016/j.neuroscience.2008.11.054; Ho YC, 2010, NEUROSCIENCE, V171, P153, DOI 10.1016/j.neuroscience.2010.08.062; Hong SM, 2007, EXP NEUROL, V206, P24, DOI 10.1016/j.expneurol.2007.03.028; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jang TC, 2004, NEUROBIOL DIS, V15, P544, DOI 10.1016/j.nbd.2003.11.016; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; JONES EL, 1973, J PATHOL, V109, P123, DOI 10.1002/path.1711090206; Kikuchi A, 2008, PSYCHIAT CLIN NEUROS, V62, P713, DOI 10.1111/j.1440-1819.2008.01875.x; KOESTNER A, 1990, TOXICOL PATHOL, V18, P186, DOI 10.1177/019262339001800124; LANTOS PL, 1986, FOOD CHEM TOXICOL, V24, P121, DOI 10.1016/0278-6915(86)90346-7; Lazarini F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007017; Lemaire V, 2006, BIOL PSYCHIAT, V59, P786, DOI 10.1016/j.biopsych.2005.11.009; Leonard JR, 2001, ONCOGENE, V20, P8281, DOI 10.1038/sj.onc.1205024; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Luo AH, 2002, BRAIN RES, V941, P62, DOI 10.1016/S0006-8993(02)02566-0; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Mayer JL, 2006, J NEUROENDOCRINOL, V18, P629, DOI 10.1111/j.1365-2826.2006.01455.x; MIRVISH SS, 1975, TOXICOL APPL PHARM, V31, P325, DOI 10.1016/0041-008X(75)90255-0; Mukherjee J, 2004, TOXICOL LETT, V150, P239, DOI 10.1016/j.toxlet.2004.01.016; Nagel BJ, 2004, AM J NEURORADIOL, V25, P1575; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pilkington GF, 1993, PATHOLOGY EXPT BRAIN, P51; Pilkington GJ, 2005, CELL PROLIFERAT, V38, P423, DOI 10.1111/j.1365-2184.2005.00358.x; Preston-Martin S, 1991, IARC Sci Publ, P197; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Sakuraba Y, 2005, BIOCHEM BIOPH RES CO, V336, P609, DOI 10.1016/j.bbrc.2005.08.134; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Sareddy GR, 2009, NEUROCHEM RES, V34, P1278, DOI 10.1007/s11064-008-9906-3; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schothorst R. C., 2001, International Journal of Cosmetic Science, V23, P109, DOI 10.1046/j.1467-2494.2001.00062.x; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Shimazu K, 2006, LEARN MEMORY, V13, P307, DOI 10.1101/lm.76006; Sirerol-Piquer M, 2010, HIPPOCAMPUS; Slikker W, 2004, TOXICOL SCI, V81, P112, DOI 10.1093/toxsci/kfh177; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Soewarto D, 2009, CURR PHARM BIOTECHNO, V10, P198, DOI 10.2174/138920109787315079; Sunyer B, 2007, NATURE PROTOCOLS; Valley MT, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.003.2009; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Wojtowicz JM, 2008, EUR J NEUROSCI, V27, P1494, DOI 10.1111/j.1460-9568.2008.06128.x; YAMASAKI EF, 1992, MUTAT RES, V266, P241, DOI 10.1016/0027-5107(92)90192-5; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao W, 2003, CARDIOVASC RES, V57, P71, DOI 10.1016/S0008-6363(02)00609-0	79	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29891	10.1371/journal.pone.0029891	http://dx.doi.org/10.1371/journal.pone.0029891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238669	Green Published, Green Submitted, gold			2022-12-27	WOS:000301070200056
J	Cooper, DL; Martin, SG; Robinson, JI; Mackie, SL; Charles, CJ; Nam, J; Isaacs, JD; Emery, P; Morgan, AW				Cooper, Dawn L.; Martin, Stephen G.; Robinson, James I.; Mackie, Sarah L.; Charles, Christopher J.; Nam, Jackie; Isaacs, John D.; Emery, Paul; Morgan, Ann W.		YEAR Consortium	Fc gamma RIIIa Expression on Monocytes in Rheumatoid Arthritis: Role in Immune-Complex Stimulated TNF Production and Non-Response to Methotrexate Therapy	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PERIPHERAL-BLOOD MONOCYTES; RECEPTOR-TYPE IIIA; ANTIGEN PRESENTATION; CITRULLINATED PROTEINS; DENDRITIC CELLS; INFLAMMATION; MACROPHAGES; AUTOANTIBODIES	Objective: The expression of Fc gamma RIIIa/CD16 may render monocytes targets for activation by IgG-containing immune complexes (IC). We investigated whether Fc gamma RIIIa/CD16 was upregulated in rheumatoid arthritis (RA), associated with TNF production in response to IC-stimulation, and if this predicted response to methotrexate therapy. Methods: Fc gamma RIIIa/CD16 expression on CD14(low) and CD14(++) monocytes was measured by flow cytometry in healthy controls and RA patients (early and long-standing disease). Intracellular TNF-staining was carried out after in vitro LPS or heat-aggregated immunoglobulin (HAG) activation. Fc gamma RIIIa/CD16 expression pre- and post-steroid/methotrexate treatment was examined. Results: Increased Fc gamma RIIIa/CD16 expression on CD14(++) monocytes in long-standing RA patients compared to controls was demonstrated (p = 0.002) with intermediate levels in early-RA patients. HAG-induced TNF-production in RA patients was correlated with the percentage of CD14(++) monocytes expressing Fc gamma RIIIa/CD16 (p<0.001). The percentage of CD14(++) monocytes expressing Fc gamma RIIIa/CD16 at baseline in early DMARD-naive RA patients was negatively correlated with DAS28-ESR improvement 14-weeks post-methotrexate therapy (p = 0.003) and was significantly increased in EULAR non-responders compared to moderate (p = 0.01) or good responders (p = 0.003). Fc gamma RIIIa/CD16 expression was not correlated with age, presence of systemic inflammation or autoantibody titers. Conclusion: Increased Fc gamma RIIIa/CD16 expression on CD14(++) monocytes in RA may result in a cell that has increased responsiveness to IC-stimulation. This monocyte subset may contribute to non-response to methotrexate therapy.	[Cooper, Dawn L.; Martin, Stephen G.; Robinson, James I.; Mackie, Sarah L.; Charles, Christopher J.; Nam, Jackie; Emery, Paul; Morgan, Ann W.] Univ Leeds, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England; [Isaacs, John D.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Leeds Biomedical Research Centre; University of Leeds; Newcastle University - UK	Cooper, DL (corresponding author), Univ Leeds, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England.	a.w.morgan@leeds.ac.uk	Robinson, James/D-9096-2016; emery, paul/B-3560-2013	Robinson, James/0000-0001-5425-7520; Isaacs, John/0000-0002-6103-7056; Conaghan, Philip/0000-0002-3478-5665; Morgan, Ann/0000-0003-1109-624X; Hensor, Elizabeth/0000-0002-5245-4755	Arthritis Research Campaign, United Kingdom; Research into Ageing, United Kingdom; Leeds Teaching Hospitals Charitable Foundation; National Institute for Health Research; Medical Research Council [G1001518] Funding Source: researchfish; National Institute for Health Research [CL-2009-02-002, IS-BRC-0211-10046, NF-SI-0508-10299] Funding Source: researchfish; Versus Arthritis [19764, 18475] Funding Source: researchfish; NIHR Newcastle Biomedical Research Centre [BH120307] Funding Source: researchfish; MRC [G1001518] Funding Source: UKRI	Arthritis Research Campaign, United Kingdom(Versus Arthritis); Research into Ageing, United Kingdom; Leeds Teaching Hospitals Charitable Foundation; National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis); NIHR Newcastle Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Arthritis Research Campaign, United Kingdom; Research into Ageing, United Kingdom; the Leeds Teaching Hospitals Charitable Foundation and the National Institute for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2000, ARTHRITIS RHEUM-US, V43, P608, DOI 10.1002/1529-0131(200003)43:3<608::AID-ANR18>3.0.CO;2-G; Ancuta P, 2004, IMMUNOBIOLOGY, V209, P11, DOI 10.1016/j.imbio.2004.04.001; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Binstadt BA, 2006, NAT IMMUNOL, V7, P284, DOI 10.1038/ni1306; Blom AB, 2003, ANN RHEUM DIS, V62, P465, DOI 10.1136/ard.62.5.465; Blom AB, 2000, ARTHRITIS RES, V2, P489, DOI 10.1186/ar131; Burmester GR, 1997, ARTHRITIS RHEUM, V40, P5, DOI 10.1002/art.1780400104; Cairns AP, 2002, RHEUMATOL INT, V21, P189, DOI 10.1007/s00296-001-0165-8; Clavel C, 2008, ARTHRITIS RHEUM-US, V58, P678, DOI 10.1002/art.23284; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Danks L, 2002, ANN RHEUM DIS, V61, P916, DOI 10.1136/ard.61.10.916; de Stahl TD, 2002, EUR J IMMUNOL, V32, P2915, DOI 10.1002/1521-4141(2002010)32:10<2915::AID-IMMU2915>3.0.CO;2-4; Dijstelbloem HM, 2001, TRENDS IMMUNOL, V22, P510, DOI 10.1016/S1471-4906(01)02014-2; Edwards JCW, 1998, QUESTIONS UNCERTAINT; Evans HG, 2009, P NATL ACAD SCI USA, V106, P6232, DOI 10.1073/pnas.0808144106; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Fingerle-Rowson G, 1998, CLIN EXP IMMUNOL, V112, P501; Gerber JS, 2001, MICROBES INFECT, V3, P131, DOI 10.1016/S1286-4579(00)01360-5; Hamano Y, 2000, J IMMUNOL, V164, P6113, DOI 10.4049/jimmunol.164.12.6113; Hepburn AL, 2004, RHEUMATOLOGY, V43, P547, DOI 10.1093/rheumatology/keh112; Herrada AA, 2007, P NATL ACAD SCI USA, V104, P13402, DOI 10.1073/pnas.0700999104; Iwahashi M, 2004, ARTHRITIS RHEUM-US, V50, P1457, DOI 10.1002/art.20219; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Kawanaka N, 2002, ARTHRITIS RHEUM, V46, P2578, DOI 10.1002/art.10545; Kleinau S, 2003, CURR PHARM DESIGN, V9, P1861, DOI 10.2174/1381612033454414; Laurent L, 2011, ANN RHEUM DIS, V70, P1052, DOI 10.1136/ard.2010.142091; Marsh CB, 1999, J IMMUNOL, V162, P6217; Mathsson L, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1926; Mertens M, 2009, J RHEUMATOL, V36, P1118, DOI 10.3899/jrheum.090074; Mewar D, 2006, BIOMED PHARMACOTHER, V60, P648, DOI 10.1016/j.biopha.2006.09.002; Mobley JL, 2007, INFLAMMATION, V30, P189, DOI 10.1007/s10753-007-9036-0; Morgan AW, 2000, ARTHRITIS RHEUM, V43, P2328, DOI 10.1002/1529-0131(200010)43:10<2328::AID-ANR21>3.0.CO;2-Z; Morgan AW, 2003, RHEUMATOLOGY, V42, P528, DOI 10.1093/rheumatology/keg169; Mullazehi M, 2006, ARTHRITIS RHEUM-US, V54, P1759, DOI 10.1002/art.21892; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Robinson JI, 2010, ANN RHEUM DIS, V69, P1054, DOI 10.1136/ard.2009.110874; Scherberich JE, 1999, CLIN CHEM LAB MED, V37, P209, DOI 10.1515/CCLM.1999.039; Shahrara S, 2009, J IMMUNOL, V182, P3884, DOI 10.4049/jimmunol.0802246; Signorino E, 2007, CANCER BIOL THER, V6, P1932, DOI 10.4161/cbt.6.12.4973; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; VANLENT PLEM, 1995, SCAND J RHEUMATOL, P83, DOI 10.3109/03009749509100906; Wijngaarden S, 2005, RHEUMATOLOGY, V44, P729, DOI 10.1093/rheumatology/keh583; Wikaningrum R, 1998, ARTHRITIS RHEUM, V41, P1783, DOI 10.1002/1529-0131(199810)41:10<1783::AID-ART10>3.0.CO;2-W; Wipke BT, 2004, J IMMUNOL, V172, P7694, DOI 10.4049/jimmunol.172.12.7694; Ziegler-Heitbrock HWL, 2000, J LEUKOCYTE BIOL, V67, P603, DOI 10.1002/jlb.67.5.603; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	50	45	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28918	10.1371/journal.pone.0028918	http://dx.doi.org/10.1371/journal.pone.0028918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235253	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400014
J	Durfort, T; Tkach, M; Meschaninova, MI; Rivas, MA; Elizalde, PV; Venyaminova, AG; Schillaci, R; Francois, JC				Durfort, Tiphanie; Tkach, Mercedes; Meschaninova, Mariya I.; Rivas, Martin A.; Elizalde, Patricia V.; Venyaminova, Alya G.; Schillaci, Roxana; Francois, Jean-Christophe			Small Interfering RNA Targeted to IGF-IR Delays Tumor Growth and Induces Proinflammatory Cytokines in a Mouse Breast Cancer Model	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HUMAN-MELANOMA CELLS; FACTOR RECEPTOR; TNF-ALPHA; ANTISENSE OLIGODEOXYNUCLEOTIDES; THERAPEUTIC TARGET; CARCINOMA-CELLS; MESSENGER-RNA; P42/P44 MAPK; INSULIN	Insulin-like growth factor I (IGF-I) and its type I receptor (IGF-IR) play significant roles in tumorigenesis and in immune response. Here, we wanted to know whether an RNA interference approach targeted to IGF-IR could be used for specific antitumor immunostimulation in a breast cancer model. For that, we evaluated short interfering RNA (siRNAs) for inhibition of in vivo tumor growth and immunological stimulation in immunocompetent mice. We designed 2'-O-methyl-modified siRNAs to inhibit expression of IGF-IR in two murine breast cancer cell lines (EMT6, C4HD). Cell transfection of IGF-IR siRNAs decreased proliferation, diminished phosphorylation of downstream signaling pathway proteins, AKT and ERK, and caused a G0/G1 cell cycle block. The IGF-IR silencing also induced secretion of two proinflammatory cytokines, TNF-alpha and IFN-gamma. When we transfected C4HD cells with siRNAs targeting IGF-IR, mammary tumor growth was strongly delayed in syngenic mice. Histology of developing tumors in mice grafted with IGF-IR siRNA treated C4HD cells revealed a low mitotic index, and infiltration of lymphocytes and polymorphonuclear neutrophils, suggesting activation of an antitumor immune response. When we used C4HD cells treated with siRNA as an immunogen, we observed an increase in delayed-type hypersensitivity and the presence of cytotoxic splenocytes against wild-type C4HD cells, indicative of evolving immune response. Our findings show that silencing IGF-IR using synthetic siRNA bearing 2'-O-methyl nucleotides may offer a new clinical approach for treatment of mammary tumors expressing IGF-IR. Interestingly, our work also suggests that crosstalk between IGF-I axis and antitumor immune response can mobilize proinflammatory cytokines.	[Durfort, Tiphanie; Francois, Jean-Christophe] INSERM, U565, Paris, France; [Durfort, Tiphanie; Francois, Jean-Christophe] Museum Natl Hist Nat, Ctr Natl Rech, UMR 7196, F-75231 Paris, France; [Tkach, Mercedes; Rivas, Martin A.; Elizalde, Patricia V.; Schillaci, Roxana] Consejo Invest Cient Tecn CONICET, IBYME, Buenos Aires, DF, Argentina; [Meschaninova, Mariya I.; Venyaminova, Alya G.] Russian Acad Sci SB RAS, Siberian Div, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Museum National d'Histoire Naturelle (MNHN); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Durfort, T (corresponding author), INSERM, U565, Paris, France.	jean-christophe.francois@inserm.fr	Venyaminova, Alya/G-1720-2013; Meschaninova, Mariya I/G-3496-2013; FRANCOIS, Jean-Christophe/O-1659-2018; Rivas, Martin/F-2399-2012	Meschaninova, Mariya I/0000-0003-0045-2413; FRANCOIS, Jean-Christophe/0000-0003-4480-1822; Rivas, Martin/0000-0002-9603-6897; Schillaci, Roxana/0000-0002-7776-3378; Elizalde, Patricia V./0000-0002-5923-9898	INTAS (International Association for the promotion of cooperation with scientists from the new independent states of the former Soviet Union, Brussels, Belgium) [03-51-5281]; Hubert Curien partnership [18908VK]; Proyecto de Investigacion Cientifica y Tecnologica, National Agency of Scientific Promotion of Argentina [IDB 1728 OC/AR PICT, 0211]; Susan G. Komen for the Cure [KG090250]; Oncomed-Reno CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas), Henry Moore Institute of Argentina [1819/03]; Ministere delegue a l'enseignement superieur et a la recherche; Ligue Nationale Contre le Cancer	INTAS (International Association for the promotion of cooperation with scientists from the new independent states of the former Soviet Union, Brussels, Belgium); Hubert Curien partnership; Proyecto de Investigacion Cientifica y Tecnologica, National Agency of Scientific Promotion of Argentina; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Oncomed-Reno CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas), Henry Moore Institute of Argentina; Ministere delegue a l'enseignement superieur et a la recherche; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	The project was financed by INTAS (International Association for the promotion of cooperation with scientists from the new independent states of the former Soviet Union, Brussels, Belgium, Grant 03-51-5281) (J-CF), Hubert Curien partnership 18908VK (J-CF), IDB 1728 OC/AR PICT (Proyecto de Investigacion Cientifica y Tecnologica) 0211 (2006) from the National Agency of Scientific Promotion of Argentina (PVE), the Susan G. Komen for the Cure KG090250 investigator-initiated research grant (PVE), and Oncomed-Reno CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) 1819/03 from the Henry Moore Institute of Argentina (RS and PVE). TD was supported by Ministere delegue a l'enseignement superieur et a la recherche and Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews DW, 2001, J CLIN ONCOL, V19, P2189, DOI 10.1200/JCO.2001.19.8.2189; Balana ME, 2001, ONCOGENE, V20, P34, DOI 10.1038/sj.onc.1204050; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Balkwill F, 2010, CLIN PHARMACOL THER, V87, P401, DOI 10.1038/clpt.2009.312; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Baserga R, 2005, EXPERT OPIN THER TAR, V9, P753, DOI 10.1517/14728222.9.4.753; Baserga R, 1997, ENDOCRINE, V7, P99, DOI 10.1007/BF02778073; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; Baserga R, 1996, TRENDS BIOTECHNOL, V14, P150, DOI 10.1016/0167-7799(96)10023-8; Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; Blankenstein T, 2005, CURR OPIN IMMUNOL, V17, P180, DOI 10.1016/j.coi.2005.01.008; Burfeind P, 1996, P NATL ACAD SCI USA, V93, P7263, DOI 10.1073/pnas.93.14.7263; Casa AJ, 2012, BREAST CANCER RES TR, V132, P61, DOI 10.1007/s10549-011-1540-0; Chernicky CL, 2002, J CLIN PATHOL-MOL PA, V55, P102, DOI 10.1136/mp.55.2.102; Chernolovskaya EL, 2010, CURR OPIN MOL THER, V12, P158; Cornelie S, 2004, J BIOL CHEM, V279, P15124, DOI 10.1074/jbc.M313406200; Cubillos-Ruiz JR, 2009, J CLIN INVEST, V119, P2231, DOI 10.1172/JCI37716; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Eichbaum C, 2011, ANTICANCER RES, V31, P3219; Furukawa J, 2010, PROSTATE, V70, P206, DOI 10.1002/pros.21054; Gantier MP, 2010, MOL THER, V18, P785, DOI 10.1038/mt.2010.4; Garcia-Tunon I, 2006, CANCER SCI, V97, P1044, DOI 10.1111/j.1349-7006.2006.00277.x; Goes N, 1996, J AM SOC NEPHROL, V7, P710; Gualberto A, 2009, ONCOGENE, V28, P3009, DOI 10.1038/onc.2009.172; Institute of Laboratory Animal Resources Commission on Life Sciences National Research Council, 1996, GUID CAR US LAB AN, P1; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Khatib AM, 2005, AM J PATHOL, V167, P749, DOI 10.1016/S0002-9440(10)62048-2; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Kooijman R, 2006, CYTOKINE GROWTH F R, V17, P305, DOI 10.1016/j.cytogfr.2006.02.002; LafargeFrayssinet C, 1997, CANCER GENE THER, V4, P276; Lanari C, 2009, ENDOCR-RELAT CANCER, V16, P333, DOI 10.1677/ERC-08-0244; Lann D, 2008, J MAMMARY GLAND BIOL, V13, P371, DOI 10.1007/s10911-008-9100-x; Lecosnier S, 2011, FASEB J, V25, P2201, DOI 10.1096/fj.10-169540; Liu FY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016241; Liu XD, 1998, CANCER RES, V58, P5432; Lu Y, 2001, GENE THER, V8, P499, DOI 10.1038/sj.gt.3301429; Ly A, 2001, J CLIN PATHOL-MOL PA, V54, P230, DOI 10.1136/mp.54.4.230; Ly A, 2000, LIFE SCI, V68, P307, DOI 10.1016/S0024-3205(00)00936-X; McCusker RH, 2007, PSYCHONEUROIMMUNOLOGY, VOLS I AND II, 4TH EDITION, P171; O'Connor JC, 2008, CELL IMMUNOL, V252, P91, DOI 10.1016/j.cellimm.2007.09.010; Oussedik K, 2010, FASEB J, V24, P2235, DOI 10.1096/fj.09-132324; Pastor F, 2010, NATURE, V465, P227, DOI 10.1038/nature08999; Prevost-Blondel A, 2000, J IMMUNOL, V164, P3645, DOI 10.4049/jimmunol.164.7.3645; Proietti CJ, 2009, MOL CELL BIOL, V29, P1249, DOI 10.1128/MCB.00853-08; PUSZTAI L, 1993, BRIT J CANCER, V67, P290, DOI 10.1038/bjc.1993.55; Resnicoff M, 1998, INT J MOL MED, V1, P883; Resnicoff M, 1996, CANCER IMMUNOL IMMUN, V42, P64, DOI 10.1007/s002620050252; RESNICOFF M, 1994, CANCER RES, V54, P4848; RESNICOFF M, 1995, CANCER RES, V55, P3739; RESNICOFF M, 1995, CANCER RES, V55, P2463; Rivas MA, 2008, EXP CELL RES, V314, P509, DOI 10.1016/j.yexcr.2007.10.005; Robbins M, 2009, OLIGONUCLEOTIDES, V19, P89, DOI 10.1089/oli.2009.0180; Rochester MA, 2005, CANCER GENE THER, V12, P90, DOI 10.1038/sj.cgt.7700775; Sachdev D, 2007, MOL CANCER THER, V6, P1, DOI 10.1158/1535-7163.MCT-06-0080; Salatino M, 2004, ONCOGENE, V23, P5161, DOI 10.1038/sj.onc.1207659; Samani AA, 2001, HUM GENE THER, V12, P1969, DOI 10.1089/104303401753204544; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Schillaci R, 2006, J IMMUNOL, V176, P3426, DOI 10.4049/jimmunol.176.6.3426; Scotlandi K, 2002, CANCER GENE THER, V9, P296, DOI 10.1038/sj.cgt.7700442; Shalita-Chesner M, 2001, MOL CELL ENDOCRINOL, V176, P1, DOI 10.1016/S0303-7207(01)00484-1; Shaw LC, 2003, INVEST OPHTH VIS SCI, V44, P4105, DOI 10.1167/iovs.03-0295; Shen WH, 2002, CANCER RES, V62, P4746; Smith TJ, 2010, PHARMACOL REV, V62, P199, DOI 10.1124/pr.109.002469; Sprenger CCT, 2009, CLIN CANCER RES, V15, P7634, DOI 10.1158/1078-0432.CCR-09-0264; Takigami I, 2011, INT J CANCER, V128, P216, DOI 10.1002/ijc.25564; Trojan J, 2010, BIOMED PHARMACOTHER, V64, P576, DOI 10.1016/j.biopha.2010.01.019; Venters HD, 2000, ANN NY ACAD SCI, V917, P210; Warren MA, 2009, MOL CANCER THER, V8, P2655, DOI 10.1158/1535-7163.MCT-09-0358; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Yeh AH, 2006, ONCOGENE, V25, P6574, DOI 10.1038/sj.onc.1209674; Yu P, 2004, NAT IMMUNOL, V5, P141, DOI 10.1038/ni1029; Yuen JSP, 2008, EXPERT OPIN THER TAR, V12, P589, DOI 10.1517/14728222.12.5.589 ; Yuen JSP, 2009, MOL CANCER THER, V8, P1448, DOI 10.1158/1535-7163.MCT-09-0101	73	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29213	10.1371/journal.pone.0029213	http://dx.doi.org/10.1371/journal.pone.0029213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235273	gold, Green Published, Green Submitted			2022-12-27	WOS:000301123400034
J	Murray, JM; Watson, GJ; Giangrande, A; Licciano, M; Bentley, MG				Murray, Joanna M.; Watson, Gordon J.; Giangrande, Adriana; Licciano, Margherita; Bentley, Matt G.			Managing the Marine Aquarium Trade: Revealing the Data Gaps Using Ornamental Polychaetes	PLOS ONE			English	Article							SABELLASTARTE-SPECTABILIS; SABELLIDAE; REVISION; FISH	The marine aquarium industry has great potential to generate jobs in low-income coastal communities creating incentives for the maintenance of a healthy coral reef, if effectively managed. In the absence of current monitoring or legislation to govern the trade, baseline information regarding the species, number and source location of animals traded is missing despite being critical for its successful management and sustainability. An industry assessment to establish the number and provenance of species of ornamental polychaetes (sabellids and serpulids) traded was undertaken across UK wholesalers and retailers. Six geographical regions exporting fan worms were identified. Singapore contributed the highest percentage of imports, but of only one worm "type'' whereas Bali, the second largest source, supplied five different worm "types''. Over 50% of UK retailers were supplied by one wholesaler while the remainder were stocked by a mixture of one other wholesaler and/or direct imports from the source country. We estimate that up to 18,500 ornamental polychaetes (16,980 sabellids and 1,018 serpulids) are sold annually in the UK revealing a drastic underestimation of currently accepted trade figures. Incorrect identification (based on exporting region or visual characteristics) of traded animals exacerbates the inaccuracy in market quantification, although identification of preserved sabellids using published keys proved just as inconclusive with high within-species variability and the potential for new or cryptic species. A re-description of the polychaete groups traded using a combination of molecular and morphological techniques is necessary for effective identification and market quantification. This study provides the first assessment of ornamental polychaetes but more importantly highlights the issues surrounding the collection of baseline information necessary to manage the aquarium trade. We recommend that future management should be community based and site-specific with financial and educational support from NGOs, local governments and industry members.	[Murray, Joanna M.; Watson, Gordon J.] Univ Portsmouth, Sch Biol Sci, Inst Marine Sci, Portsmouth, Hants, England; [Giangrande, Adriana; Licciano, Margherita] Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy; [Bentley, Matt G.] Newcastle Univ, Sch Marine Sci & Technol, Dove Marine Lab, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Portsmouth; University of Salento; Newcastle University - UK	Murray, JM (corresponding author), Univ Portsmouth, Sch Biol Sci, Inst Marine Sci, Portsmouth, Hants, England.	Joanna.murray@port.ac.uk	Licciano, Margherita/L-2242-2019	Licciano, Margherita/0000-0001-8762-3179; Bentley, Matt/0000-0002-6494-2545; Giangrande, Adriana/0000-0003-4531-2377; Watson, Gordon/0000-0001-8274-7658	Leverhulme Trust;  [F/00 678/9]	Leverhulme Trust(Leverhulme Trust); 	This work was supported by a Leverhulme Trust grant to GW and a studentship for JM (grant number F/00 678/9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baquero J., 1999, QUALITY SUSTAINABILI, P1; Bell JD, 1997, AQUAC RES, V28, P121; Bunting BW, 2003, MARINE ORNAMENTAL SPECIES: COLLECTION, CULTURE & CONSERVATION, P109; Bybee DR, 2006, SCI MAR, V70, P279, DOI 10.3989/scimar.2006.70s3279; Bybee DR, 2007, MAR BIOL, V151, P639, DOI 10.1007/s00227-006-0504-0; Capa M, 2010, ORG DIVERS EVOL, P1; Costa-Paiva EM, 2007, J MAR BIOL ASSOC UK, V87, P1127, DOI 10.1017/S002531540705223X; Green E, 2003, MARINE ORNAMENTAL SPECIES: COLLECTION, CULTURE & CONSERVATION, P31; Green EP, 1999, CORAL REEFS, V18, P403, DOI 10.1007/s003380050218; Hardin MP, 2005, REV BIOL TROP, V53, P139; KENNEDY B, 1980, ZOOMORPHOLOGY, V96, P33, DOI 10.1007/BF00310075; Knight-Jones P, 1998, ZOOL J LINN SOC-LOND, V123, P385, DOI 10.1006/zjls.1997.0133; Knight-Jones P, 2003, J NAT HIST, V37, P2269, DOI 10.1080/00222930110120629; Murray JM, 2010, THESIS U PORTSMOUTH; Olivier K, 2003, MARINE ORNAMENTAL SPECIES: COLLECTION, CULTURE & CONSERVATION, P49, DOI 10.1002/9780470752722.ch4; Pomeroy R, 2004, ASIAN FISH SCI, V17, P365; Rhyne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008413; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tamaru C, 2008, REGIONAL NOTES CTR T, V19, P6; Tamaru C, 2004, AQUACULTURE HAWAIIAN; Tamaru CS, 2011, J WORLD AQUACULT SOC, V42, P12, DOI 10.1111/j.1749-7345.2010.00439.x; Tissot BN, 2010, MAR POLICY, V34, P1385, DOI 10.1016/j.marpol.2010.06.002; Tlusty M, 2002, AQUACULTURE, V205, P203, DOI 10.1016/S0044-8486(01)00683-4; Wabnitz Colette, 2003, P1; Wood E., 2001, COLLECTION CORAL REE; Wood E.M., 2001, AQUARIUM SCI CONSERV, V3, P65, DOI DOI 10.1023/A:1011391700880	26	36	36	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29543	10.1371/journal.pone.0029543	http://dx.doi.org/10.1371/journal.pone.0029543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235306	Green Published, Green Accepted, gold			2022-12-27	WOS:000301123400068
J	Sakuma, T; Tonne, JM; Malcolm, JA; Thatava, T; Ohmine, S; Peng, KW; Ikeda, Y				Sakuma, Toshie; Tonne, Jason M.; Malcolm, Jessica A.; Thatava, Tayaramma; Ohmine, Seiga; Peng, Kah-Whye; Ikeda, Yasuhiro			Long-Term Infection and Vertical Transmission of a Gammaretrovirus in a Foreign Host Species	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; PORCINE ENDOGENOUS RETROVIRUS; HORIZONTAL TRANSMISSION; NO EVIDENCE; XMRV; DISEASE; MICE; RESTRICTION; RECEPTOR; CELLS	Increasing evidence has indicated natural transspecies transmission of gammaretroviruses; however, viral-host interactions after initial xeno-exposure remain poorly understood. Potential association of xenotropic murine leukemia virus-related virus (XMRV) in patients with prostate cancer and chronic fatigue syndrome has attracted broad interests in this topic. Although recent studies have indicated that XMRV is unlikely a human pathogen, further understanding of XMRV xenoinfection would allow in vivo modeling of the initial steps of gammaretroviral interspecies transmission, evolution and dissemination in a new host population. In this study, we monitored the long-term consequences of XMRV infection and its possible vertical transmission in a permissive foreign host, wild-derived Mus pahari mice. One year post-infection, XMRV-infected mice showed no notable pathological changes, while proviral DNA was detected in three out of eight mice. XMRV-infected mice remained seropositive throughout the study although the levels of gp70 Env- and p30 capsid-specific antibodies gradually decreased. When vertical XMRV transmission was assessed, no viremia, humoral immune responses nor endogenization were observed in nine offspring from infected mothers, yet one offspring was found PCR-positive for XMRV-specific sequences. Amplified viral sequences from the offspring showed several mutations, including one amino acid deletion in the receptor binding domain of Env SU. Our results therefore demonstrate long-term asymptomatic infection, low incidence of vertical transmission and limited evolution of XMRV upon transspecies infection of a permissive new host, Mus pahari.	[Sakuma, Toshie; Tonne, Jason M.; Malcolm, Jessica A.; Thatava, Tayaramma; Ohmine, Seiga; Peng, Kah-Whye; Ikeda, Yasuhiro] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA	Mayo Clinic	Sakuma, T (corresponding author), Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA.	ikeda.yasuhiro@mayo.edu			National Institutes of Health [AI093186]; Mayo Clinic Career Development Project in Prostate SPORE [CA91956-080013]; Mayo Foundation; Mayo Clinic Prostate SPORE and Department of Molecular Medicine; NATIONAL CANCER INSTITUTE [P50CA091956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI093186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Career Development Project in Prostate SPORE; Mayo Foundation; Mayo Clinic Prostate SPORE and Department of Molecular Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (AI093186), Mayo Clinic Career Development Project in Prostate SPORE grant CA91956-080013, the Mayo Foundation (YI), and Mayo Clinic Prostate SPORE and Department of Molecular Medicine Grants (TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; BUFFETT RF, 1969, CANCER RES, V29, P588; BUFFETT RF, 1969, CANCER RES, V29, P596; Duggan J, 2004, VIRAL IMMUNOL, V17, P266, DOI 10.1089/0882824041310586; Duggan J, 2006, J GEN VIROL, V87, P2679, DOI 10.1099/vir.0.82015-0; Fass D, 1997, SCIENCE, V277, P1662, DOI 10.1126/science.277.5332.1662; Fiebig U, 2006, J VIROL, V80, P5651, DOI 10.1128/JVI.02597-05; GARDNER MB, 1979, J NATL CANCER I, V62, P63; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Hanger JJ, 2000, J VIROL, V74, P4264, DOI 10.1128/JVI.74.9.4264-4272.2000; HARDY WD, 1973, NATURE, V244, P266, DOI 10.1038/244266a0; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; IDA N, 1965, GANN, V56, P239; KAWAKAMI TG, 1972, NATURE-NEW BIOL, V235, P170, DOI 10.1038/newbio235170a0; KOZAK CA, 1987, J VIROL, V61, P3082, DOI 10.1128/JVI.61.10.3082-3088.1987; KOZAK CA, 1985, J VIROL, V55, P281, DOI 10.1128/JVI.55.2.281-285.1985; KOZAK CA, 1985, J VIROL, V55, P690, DOI 10.1128/JVI.55.3.690-695.1985; Kozak CA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-101; LIEBER MM, 1975, P NATL ACAD SCI USA, V72, P2315, DOI 10.1073/pnas.72.6.2315; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Lyu MS, 1996, J VIROL, V70, P830, DOI 10.1128/JVI.70.2.830-833.1996; Martin J, 1999, J VIROL, V73, P2442, DOI 10.1128/JVI.73.3.2442-2449.1999; Martin U, 1998, TRANSPLANT INT, V11, P247, DOI 10.1007/s001470050136; Martina Y, 2006, J VIROL, V80, P3135, DOI 10.1128/JVI.80.7.3135-3146.2006; MELIEF CJM, 1975, JNCI-J NATL CANCER I, V55, P691, DOI 10.1093/jnci/55.3.691; MIRAND EA, 1966, NATURE, V209, P696, DOI 10.1038/209696a0; MIRAND EA, 1962, VIROLOGY, V16, P344, DOI 10.1016/0042-6822(62)90257-X; Miyazawa T, 2011, J VET MED SCI, V73, P65, DOI 10.1292/jvms.10-0250; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Onlamoon N, 2011, J VIROL, V85, P4547, DOI 10.1128/JVI.02411-10; Paprotka T, 2010, J VIROL; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236; PARKS WP, 1973, INT J CANCER, V12, P129, DOI 10.1002/ijc.2910120114; Patience C, 1998, LANCET, V352, P699, DOI 10.1016/S0140-6736(98)04369-4; PORTIS JL, 1987, J VIROL, V61, P1037, DOI 10.1128/JVI.61.4.1037-1044.1987; RASHEED S, 1976, J VIROL, V19, P13, DOI 10.1128/JVI.19.1.13-18.1976; SAHA K, 1994, VIROLOGY, V198, P129, DOI 10.1006/viro.1994.1015; Sakuma R, 2010, VIROLOGY, V397, P1, DOI 10.1016/j.virol.2009.11.013; Sakuma T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-23; Sakuma T, 2010, HUM GENE THER, V21, P1665, DOI 10.1089/hum.2010.063; Sakuma T, 2011, J VIROL, V85, P1205, DOI 10.1128/JVI.00886-10; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; SHARPE AH, 1989, J VIROL, V63, P1049, DOI 10.1128/JVI.63.3.1049-1053.1989; SNYDER SP, 1973, JNCI-J NATL CANCER I, V51, P89, DOI 10.1093/jnci/51.1.89; STOYE JP, 1987, J VIROL, V61, P2659, DOI 10.1128/JVI.61.9.2659-2669.1987; Svoboda J, 2000, GENE, V261, P181, DOI 10.1016/S0378-1119(00)00481-9; Tarlinton R, 2005, J GEN VIROL, V86, P783, DOI 10.1099/vir.0.80547-0; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Yan Y, 2007, J VIROL, V81, P10550, DOI 10.1128/JVI.00933-07; Yan Y, 2009, P NATL ACAD SCI USA, V106, P3259, DOI 10.1073/pnas.0900181106	52	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29682	10.1371/journal.pone.0029682	http://dx.doi.org/10.1371/journal.pone.0029682			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235324	gold, Green Published, Green Submitted			2022-12-27	WOS:000301123400086
J	Kimura, T; Han, W; Pagel, P; Nairn, AC; Caplan, MJ				Kimura, Toru; Han, WonSun; Pagel, Philipp; Nairn, Angus C.; Caplan, Michael J.			Protein Phosphatase 2A Interacts with the Na+,K+-ATPase and Modulates Its Trafficking by Inhibition of Its Association with Arrestin	PLOS ONE			English	Article							ADRENERGIC-RECEPTOR KINASE; SITE-DIRECTED MUTAGENESIS; CELL-SURFACE EXPRESSION; SODIUM-POTASSIUM PUMP; SHORT-TERM REGULATION; NA+-K+-ATPASE; GAMMA-SUBUNIT; CRYSTAL-STRUCTURE; BETA-ARRESTINS; LEUCINE/ISOLEUCINE ZIPPERS	Background: The P-type ATPase family constitutes a collection of ion pumps that form phosphorylated intermediates during ion transport. One of the best known members of this family is the Na+, K+-ATPase. The catalytic subunit of the Na+, K+-ATPase includes several functional domains that determine its enzymatic and trafficking properties. Methodology/Principal Findings: Using the yeast two-hybrid system we found that protein phosphatase 2A (PP2A) catalytic C-subunit is a specific Na+, K+-ATPase interacting protein. PP-2A C-subunit interacted with the Na+, K+-ATPase, but not with the homologous sequences of the H+, K+-ATPase. We confirmed that the Na+, K+-ATPase interacts with a complex of A-and C-subunits in native rat kidney. Arrestins and G-protein coupled receptor kinases (GRKs) are important regulators of G-protein coupled receptor (GPCR) signaling, and they also regulate Na+, K+-ATPase trafficking through direct association. PP2A inhibits association between the Na+, K+-ATPase and arrestin, and diminishes the effect of arrestin on Na+, K+-ATPase trafficking. GRK phosphorylates the Na+, K+-ATPase and PP2A can at least partially reverse this phosphorylation. Conclusions/Significance: Taken together, these data demonstrate that the sodium pump belongs to a growing list of ion transport proteins that are regulated through direct interactions with the catalytic subunit of a protein phosphatase.	[Kimura, Toru] Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Mitaka, Tokyo 181, Japan; [Kimura, Toru; Han, WonSun; Pagel, Philipp; Caplan, Michael J.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Nairn, Angus C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA	Kyorin University; Yale University; Yale University	Kimura, T (corresponding author), Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Mitaka, Tokyo 181, Japan.	michael.caplan@yale.edu		Nairn, Angus/0000-0002-7075-0195; Caplan, Michael/0000-0001-5768-4405	National Institutes of Health [DK072612, DK17433, MH40899, MH074866]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK017433, R01DK072614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899, P50MH074866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health DK072612 and DK17433 (MJC), and MH40899 and MH074866 (ACN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arystarkhova E, 1999, J BIOL CHEM, V274, P33183, DOI 10.1074/jbc.274.47.33183; BASKIN DG, 1982, HISTOCHEMISTRY, V73, P535, DOI 10.1007/BF00493367; Bauman AL, 2000, J NEUROSCI, V20, P7571; BEAN BP, 1984, NATURE, V307, P371, DOI 10.1038/307371a0; BEGUIN P, 1994, J BIOL CHEM, V269, P24437; Beguin P, 1997, EMBO J, V16, P4250, DOI 10.1093/emboj/16.14.4250; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; BERTORELLO A, 1990, AM J HYPERTENS, V3, pS51, DOI 10.1093/ajh/3.6.51S; BERTORELLO AM, 1991, P NATL ACAD SCI USA, V88, P11359, DOI 10.1073/pnas.88.24.11359; BIEMESDERFER D, 1992, AM J PHYSIOL, V262, pF55, DOI 10.1152/ajprenal.1992.262.1.F55; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Blostein R, 2003, ANN NY ACAD SCI, V986, P420, DOI 10.1111/j.1749-6632.2003.tb07224.x; Brady AE, 2003, J BIOL CHEM, V278, P32405, DOI 10.1074/jbc.M304195200; Cheng XJ, 1997, AM J PHYSIOL-CELL PH, V273, pC893, DOI 10.1152/ajpcell.1997.273.3.C893; COUTRY N, 1995, J MEMBRANE BIOL, V145, P99; CRAMBERT G, 2003, SCI STKE, pRE1; Davare MA, 2000, J BIOL CHEM, V275, P39710, DOI 10.1074/jbc.M005462200; Dinudom A, 2004, P NATL ACAD SCI USA, V101, P11886, DOI 10.1073/pnas.0402178101; Dunbar LA, 2000, J CELL BIOL, V148, P769, DOI 10.1083/jcb.148.4.769; Feraille E, 2001, PHYSIOL REV, V81, P345, DOI 10.1152/physrev.2001.81.1.345; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Feschenko MS, 2000, J BIOL CHEM, V275, P34693, DOI 10.1074/jbc.M005869200; FESCHENKO MS, 1995, J BIOL CHEM, V270, P14072, DOI 10.1074/jbc.270.23.14072; FISONE G, 1994, J BIOL CHEM, V269, P9368; FISONE G, 1995, J BIOL CHEM, V270, P2427, DOI 10.1074/jbc.270.6.2427; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Geering K, 2003, ANN NY ACAD SCI, V986, P388, DOI 10.1111/j.1749-6632.2003.tb07219.x; Goodarzi AA, 2004, EMBO J, V23, P4451, DOI 10.1038/sj.emboj.7600455; GOTTARDI CJ, 1993, J BIOL CHEM, V268, P14342; HORIUCHI A, 1993, MOL PHARMACOL, V43, P281; Kimura T, 2007, MOL BIOL CELL, V18, P4508, DOI 10.1091/mbc.E06-08-0711; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Lecuona E, 2000, FEBS LETT, V481, P217, DOI 10.1016/S0014-5793(00)02009-3; Lecuona E, 2006, FASEB J, V20, P2618, DOI 10.1096/fj.06-6503fje; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Lubert EJ, 2003, BIOCHEM BIOPH RES CO, V303, P908, DOI 10.1016/S0006-291X(03)00434-0; Maeda M, 1998, CELL STRUCT FUNCT, V23, P315, DOI 10.1247/csf.23.315; Marks AR, 2002, TRENDS CARDIOVAS MED, V12, P166, DOI 10.1016/S1050-1738(02)00156-1; Marx SO, 2001, J CELL BIOL, V153, P699, DOI 10.1083/jcb.153.4.699; MEISTER B, 1993, SEMIN NEPHROL, V13, P41; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nestor NB, 1997, ANN NY ACAD SCI, V834, P579, DOI 10.1111/j.1749-6632.1997.tb52324.x; OHTSUBO M, 1990, BIOCHIM BIOPHYS ACTA, V1021, P157, DOI 10.1016/0005-2736(90)90028-M; Pagel P, 2003, ANN NY ACAD SCI, V986, P360, DOI 10.1111/j.1749-6632.2003.tb07215.x; Pedemonte CH, 2001, J BIOENERG BIOMEMBR, V33, P439, DOI 10.1023/A:1010675708820; PIETRINI G, 1992, P NATL ACAD SCI USA, V89, P8414, DOI 10.1073/pnas.89.18.8414; Scarborough GA, 2002, J BIOENERG BIOMEMBR, V34, P235, DOI 10.1023/A:1020211016696; SCHEINERBOBIS G, 1994, BBA-BIOMEMBRANES, V1193, P226, DOI 10.1016/0005-2736(94)90157-0; SCULPTOREANU A, 1993, NATURE, V364, P240, DOI 10.1038/364240a0; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; Smith FD, 1999, J BIOL CHEM, V274, P19894, DOI 10.1074/jbc.274.28.19894; Soares-da-Silva P, 1995, Hypertens Res, V18 Suppl 1, pS47, DOI 10.1291/hypres.18.SupplementI_S47; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Sweadner KJ, 2003, ANN NY ACAD SCI, V986, P382, DOI 10.1111/j.1749-6632.2003.tb07218.x; Szabo EZ, 2005, P NATL ACAD SCI USA, V102, P2790, DOI 10.1073/pnas.0407444102; TAKADA T, 1992, HISTOCHEMISTRY, V98, P183, DOI 10.1007/BF00315877; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; Therien AG, 2001, J BIOENERG BIOMEMBR, V33, P407, DOI 10.1023/A:1010619623841; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Turowski P, 1997, EUR J BIOCHEM, V248, P200, DOI 10.1111/j.1432-1033.1997.t01-1-00200.x; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Wang Q, 2002, J BIOL CHEM, V277, P50589, DOI 10.1074/jbc.M208503200; Yang CS, 2005, MOL CELL BIOL, V25, P1298, DOI 10.1128/MCB.25.4.1298-1308.2005; Yokoyama N, 2003, ARCH BIOCHEM BIOPHYS, V417, P87, DOI 10.1016/S0003-9861(03)00333-3; Zouzoulas A, 2003, J BIOL CHEM, V278, P40437, DOI 10.1074/jbc.M308610200	69	20	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29269	10.1371/journal.pone.0029269	http://dx.doi.org/10.1371/journal.pone.0029269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242112	Green Submitted, Green Published, gold			2022-12-27	WOS:000300677000023
J	del Campo, R; Martinez, E; del Fresno, C; Alenda, R; Gomez-Pina, V; Fernandez-Ruiz, I; Siliceo, M; Jurado, T; Toledano, V; Arnalich, F; Garcia-Rio, F; Lopez-Collazo, E				del Campo, Rosa; Martinez, Eriel; del Fresno, Carlos; Alenda, Raquel; Gomez-Pina, Vanesa; Fernandez-Ruiz, Irene; Siliceo, Maria; Jurado, Teresa; Toledano, Victor; Arnalich, Francisco; Garcia-Rio, Francisco; Lopez-Collazo, Eduardo			Translocated LPS Might Cause Endotoxin Tolerance in Circulating Monocytes of Cystic Fibrosis Patients	PLOS ONE			English	Article							INTESTINAL INFLAMMATION; M EXPRESSION; IRAK-M; BACTERIAL; RELEASE; PERMEABILITY; DYSFUNCTION; DISEASE; SEPSIS	Cystic Fibrosis (CF) is an inherited pleiotropic disease that results from abnormalities in the gene codes of a chloride channel. The lungs of CF patients are chronically infected by several pathogens but bacteraemia have rarely been reported in this pathology. Besides that, circulating monocytes in CF patients exhibit a patent Endotoxin Tolerance (ET) state since they show a significant reduction of the inflammatory response to bacterial stimulus. Despite a previous description of this phenomenon, the direct cause of ET in CF patients remains unknown. In this study we have researched the possible role of microbial/endotoxin translocation from a localized infection to the bloodstream as a potential cause of ET induction in CF patients. Plasma analysis of fourteen CF patients revealed high levels of LPS compared to healthy volunteers and patients who suffer from Chronic Obstructive Pulmonary Disease. Experiments in vitro showed that endotoxin concentrations found in plasma of CF patients were enough to induce an ET phenotype in monocytes from healthy controls. In agreement with clinical data, we failed to detect bacterial DNA in CF plasma. Our results suggest that soluble endotoxin present in bloodstream of CF patients causes endotoxin tolerance in their circulating monocytes.	[del Campo, Rosa] Hosp Univ Ramon y Cajal, Microbiol Serv, Madrid, Spain; [del Campo, Rosa] Hosp Univ Ramon y Cajal, IRYCIS, CIBERESP, Madrid, Spain; [Martinez, Eriel; Gomez-Pina, Vanesa] EMPIREO Res SL, Madrid, Spain; [Martinez, Eriel; del Fresno, Carlos; Gomez-Pina, Vanesa; Fernandez-Ruiz, Irene; Siliceo, Maria; Jurado, Teresa; Toledano, Victor; Lopez-Collazo, Eduardo] Hosp La Paz, IdiPAZ, Lab Tumor Immunol, Madrid, Spain; [Alenda, Raquel] Univ Hosp Ramon y Cajal, Dept Inmunol, Madrid, Spain; [Arnalich, Francisco] Hosp La Paz, Serv Internal Med, Madrid, Spain; [Garcia-Rio, Francisco] Hosp La Paz, Serv Resp Dis, Madrid, Spain	Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario Ramon y Cajal; Hospital Universitario La Paz; Hospital Universitario Ramon y Cajal; Hospital Universitario La Paz; Hospital Universitario La Paz	del Campo, R (corresponding author), Hosp Univ Ramon y Cajal, Microbiol Serv, Madrid, Spain.	elopezc.hulp@salud.madrid.org	Del Fresno Sánchez, CArlos/AAY-1525-2021; Garcia-Rio, Francisco/AAC-9981-2020; Arnalich, Francisco/AAF-5924-2021; Del Fresno, Carlos/F-2624-2016; Del Fresno, Carlos/ABD-7766-2020; Arnalich, Francisco/J-8184-2017; Arnalich, Francisco/K-7723-2014; Lopez-Collazo, Eduardo/U-6634-2018; del Campo, Rosa/M-9628-2013	Arnalich, Francisco/0000-0003-2943-0373; Del Fresno, Carlos/0000-0003-1771-7254; Del Fresno, Carlos/0000-0003-1771-7254; Lopez-Collazo, Eduardo/0000-0003-1957-877X; del Campo, Rosa/0000-0003-1147-7923; Fernandez Ruiz, Irene/0000-0001-5138-1649; Garcia-Rio, Francisco/0000-0002-7227-2238; Garcia, Felipe/0000-0002-4099-0120	Ministerio de Ciencia e Innovacion; Instituto de Salud Carlos III-FIS [CB05/137]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III-FIS(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by a "Ministerio de Ciencia e Innovacion" grant to EL-C. RdC has a contract from the Instituto de Salud Carlos III-FIS (CB05/137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AB, 2003, IMMUNOL REV, V196, P147, DOI 10.1046/j.1600-065X.2003.00082.x; Ammori BJ, 2003, PANCREAS, V26, P18, DOI 10.1097/00006676-200301000-00004; [Anonymous], 2009, CHEST; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; BRETT MM, 1990, ARCH DIS CHILD, V65, P259, DOI 10.1136/adc.65.3.259; Bruzzese E, 2004, ALIMENT PHARM THER, V20, P813, DOI 10.1111/j.1365-2036.2004.02174.x; Canton R, 2010, CLIN MICROBIOL INFEC, V16, P793, DOI 10.1111/j.1469-0691.2010.03261.x; Caradonna L, 2000, J ENDOTOXIN RES, V6, P205, DOI 10.1177/09680519000060030101; Cavaillon JM, 2003, J ENDOTOXIN RES, V9, P101, DOI 10.1179/096805103125001487; Cooke KR, 2002, J ENDOTOXIN RES, V8, P441, DOI 10.1179/096805102125001046; da Silva FP, 2007, NAT MED, V13, P1368, DOI 10.1038/nm1665; de las Heras B, 2007, BRIT J PHARMACOL, V152, P249, DOI 10.1038/sj.bjp.0707382; del Fresno C, 2005, J IMMUNOL, V174, P3032, DOI 10.4049/jimmunol.174.5.3032; del Fresno C, 2007, J ENDOTOXIN RES, V13, P39, DOI 10.1177/0968051907078623; del Fresno C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002667; del Fresno C, 2009, J IMMUNOL, V182, P6494, DOI 10.4049/jimmunol.0803350; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Escoll P, 2003, BIOCHEM BIOPH RES CO, V311, P465, DOI 10.1016/j.bbrc.2003.10.019; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; FAHY JV, 1991, J INFECTION, V22, P241, DOI 10.1016/S0163-4453(05)80005-2; Gomez-Pina V, 2007, J IMMUNOL, V179, P4065, DOI 10.4049/jimmunol.179.6.4065; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Haynes BF, 2006, NAT MED, V12, P1351, DOI 10.1038/nm1206-1351; Hernandez-Fuentes MP, 2003, IMMUNOL REV, V196, P247, DOI 10.1046/j.1600-065X.2003.00092.x; Holzheimer RG, 1998, INFECTION, V26, P77, DOI 10.1007/BF02767765; HURLEY JC, 1992, CLIN INFECT DIS, V15, P840, DOI 10.1093/clind/15.5.840; Lewindon PJ, 1998, J PAEDIATR CHILD H, V34, P79, DOI 10.1046/j.1440-1754.1998.00159.x; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Molloy Eleanor J, 2009, Recent Pat Antiinfect Drug Discov, V4, P51; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Muir A, 2004, AM J RESP CELL MOL, V30, P777, DOI 10.1165/rcmb.2003-0329OC; OBRIEN S, 1993, GUT, V34, P1137, DOI 10.1136/gut.34.8.1137; Paiardini M, 2008, AIDS REV, V10, P36; Pauwels R A, 2001, Respir Care, V46, P798; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Raia V, 2000, PEDIATR RES, V47, P344, DOI 10.1203/00006450-200003000-00010; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Schietroma M, 2007, HEPATO-GASTROENTEROL, V54, P342; Schietroma M, 2006, ANN SURG, V243, P359, DOI 10.1097/01.sla.0000201455.89037.f6; Smyth RL, 2000, ARCH DIS CHILD, V82, P394, DOI 10.1136/adc.82.5.394; STUMACHER RJ, 1973, NEW ENGL J MED, V288, P1261, DOI 10.1056/NEJM197306142882402; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7	46	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29577	10.1371/journal.pone.0029577	http://dx.doi.org/10.1371/journal.pone.0029577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216320	Green Submitted, gold, Green Published			2022-12-27	WOS:000300676300067
J	Kim, Y; Wood, J; Moghaddam, B				Kim, Yunbok; Wood, Jesse; Moghaddam, Bita			Coordinated Activity of Ventral Tegmental Neurons Adapts to Appetitive and Aversive Learning	PLOS ONE			English	Article							MIDBRAIN DOPAMINE NEURONS; LONG-TERM POTENTIATION; PREFRONTAL CORTEX; DENTATE GYRUS; PHASE-LOCKING; INFORMATION; AREA; OSCILLATIONS; RESPONSES; VTA	Our understanding of how value-related information is encoded in the ventral tegmental area (VTA) is based mainly on the responses of individual putative dopamine neurons. In contrast to cortical areas, the nature of coordinated interactions between groups of VTA neurons during motivated behavior is largely unknown. These interactions can strongly affect information processing, highlighting the importance of investigating network level activity. We recorded the activity of multiple single units and local field potentials (LFP) in the VTA during a task in which rats learned to associate novel stimuli with different outcomes. We found that coordinated activity of VTA units with either putative dopamine or GABA waveforms was influenced differently by rewarding versus aversive outcomes. Specifically, after learning, stimuli paired with a rewarding outcome increased the correlation in activity levels between unit pairs whereas stimuli paired with an aversive outcome decreased the correlation. Paired single unit responses also became more redundant after learning. These response patterns flexibly tracked the reversal of contingencies, suggesting that learning is associated with changing correlations and enhanced functional connectivity between VTA neurons. Analysis of LFP recorded simultaneously with unit activity showed an increase in the power of theta oscillations when stimuli predicted reward but not an aversive outcome. With learning, a higher proportion of putative GABA units were phase locked to the theta oscillations than putative dopamine units. These patterns also adapted when task contingencies were changed. Taken together, these data demonstrate that VTA neurons organize flexibly as functional networks to support appetitive and aversive learning.	[Kim, Yunbok; Wood, Jesse; Moghaddam, Bita] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kim, Y (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	bita@pitt.edu	Kim, Yunbok/C-9201-2012	Wood, Jesse/0000-0003-0206-6874	National Institute of Mental Health [R37 MH048404, R01 MH084906]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH048404, R01MH084906] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health grants R37 MH048404 and R01 MH084906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Averbeck BB, 2006, J NEUROPHYSIOL, V95, P3633, DOI 10.1152/jn.00919.2005; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; DeCoteau WE, 2007, P NATL ACAD SCI USA, V104, P5644, DOI 10.1073/pnas.0700818104; Dommett E, 2005, SCIENCE, V307, P1476, DOI 10.1126/science.1107026; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fujisawa S, 2011, NEURON, V72, P153, DOI 10.1016/j.neuron.2011.08.018; Gao M, 2007, J NEUROSCI, V27, P5414, DOI 10.1523/JNEUROSCI.5347-06.2007; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Glimcher P.W., 2011, P NATL ACAD SCI US; GREENSTEIN YJ, 1988, BRAIN RES, V438, P331, DOI 10.1016/0006-8993(88)91358-3; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; HUERTA PT, 1993, NATURE, V364, P723, DOI 10.1038/364723a0; Jung MW, 2000, J NEUROSCI, V20, P6166, DOI 10.1523/JNEUROSCI.20-16-06166.2000; Kim MJ, 2003, NEUROSCIENCE, V118, P205, DOI 10.1016/S0306-4522(02)00813-8; Kim YB, 2010, EUR J NEUROSCI, V32, P1564, DOI 10.1111/j.1460-9568.2010.07371.x; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman JE, 2010, BIOL PSYCHIAT, V68, P17, DOI 10.1016/j.biopsych.2010.04.007; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Narayanan NS, 2005, J NEUROSCI, V25, P4207, DOI 10.1523/JNEUROSCI.4697-04.2005; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Panzeri S, 1999, P ROY SOC B-BIOL SCI, V266, P1001, DOI 10.1098/rspb.1999.0736; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Paz R, 2008, LEARN MEMORY, V15, P524, DOI 10.1101/lm.932408; Peters Y, 2004, SYNAPSE, V52, P143, DOI 10.1002/syn.20015; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Rieke F., 1997, SPIKES EXPLORING NEU; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shi WX, 2005, J NEUROPHYSIOL, V94, P3516, DOI 10.1152/jn.00317.2005; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; van Wingerden M, 2010, J NEUROSCI, V30, P7078, DOI 10.1523/JNEUROSCI.3860-09.2010; VANKAN PLE, 1985, EXP BRAIN RES, V60, P559, DOI 10.1007/BF00236942; Volkow ND, 2007, ARCH NEUROL-CHICAGO, V64, P1575, DOI 10.1001/archneur.64.11.1575; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Womelsdorf T, 2006, J PHYSIOL-PARIS, V100, P182, DOI 10.1016/j.jphysparis.2007.01.005; Xia YF, 2011, J NEUROSCI, V31, P7811, DOI 10.1523/JNEUROSCI.1504-11.2011; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	62	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29766	10.1371/journal.pone.0029766	http://dx.doi.org/10.1371/journal.pone.0029766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238652	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000301188800036
J	Richard, P; West, K; Ku, L				Richard, Patrick; West, Kristina; Ku, Leighton			The Return on Investment of a Medicaid Tobacco Cessation Program in Massachusetts	PLOS ONE			English	Article							SMOKING-CESSATION; DEPENDENCE TREATMENTS; COST-EFFECTIVENESS; VARENICLINE; COVERAGE; MODELS	Background and Objective: A high proportion of low-income people insured by the Medicaid program smoke. Earlier research concerning a comprehensive tobacco cessation program implemented by the state of Massachusetts indicated that it was successful in reducing smoking prevalence and those who received tobacco cessation benefits had lower rates of in-patient admissions for cardiovascular conditions, including acute myocardial infarction, coronary atherosclerosis and nonspecific chest pain. This study estimates the costs of the tobacco cessation benefit and the short-term Medicaid savings attributable to the aversion of inpatient hospitalization for cardiovascular conditions. Methods: A cost-benefit analysis approach was used to estimate the program's return on investment. Administrative data were used to compute annual cost per participant. Data from the 2002-2008 Medical Expenditure Panel Survey and from the Behavioral Risk Factor Surveillance Surveys were used to estimate the costs of hospital inpatient admissions by Medicaid smokers. These were combined with earlier estimates of the rate of reduction in cardiovascular hospital admissions attributable to the tobacco cessation program to calculate the return on investment. Findings: Administrative data indicated that program costs including pharmacotherapy, counseling and outreach costs about $183 per program participant (2010 $). We estimated inpatient savings per participant of $571 (range $549 to $583). Every $1 in program costs was associated with $3.12 (range $3.00 to $3.25) in medical savings, for a $2.12 (range $2.00 to $2.25) return on investment to the Medicaid program for every dollar spent. Conclusions: These results suggest that an investment in comprehensive tobacco cessation services may result in substantial savings for Medicaid programs. Further federal and state policy actions to promote and cover comprehensive tobacco cessation services in Medicaid may be a cost-effective approach to improve health outcomes for low-income populations.	[Richard, Patrick; West, Kristina] George Washington Univ, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC USA; [Ku, Leighton] George Washington Univ, Ctr Hlth Policy Res, Sch Publ Hlth & Hlth Serv, Washington, DC USA	George Washington University; George Washington University	Richard, P (corresponding author), Uniformed Serv Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD USA.	lku@gwu.edu		Ku, Leighton/0000-0002-6154-9289	Partnership for Prevention	Partnership for Prevention	This study was supported with funding from the Partnership for Prevention. The funders had no role in study design, data collection and analysis, decision to public or preparation of the manuscript.	Aday L A, 1974, Health Serv Res, V9, P208; Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Adhikari B., 2009, Morbidity and Mortality Weekly Report, V58, P29; Agency for Healthcare Research and Quality, 2011, HCUP CLIN CLASS SOFT; Armour BS, 2009, PREV CHRONIC DIS, V6; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; *CDCP, 2009, AD CIG SMOK US CURR; Duan N., 1983, J BUS STAT, V1, P115, DOI DOI 10.2307/1391852; Dube S. R., 2010, Morbidity and Mortality Weekly Report, V59, P1135; Fiore MC, 2008, TREATING TOBACCO USE; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Hajek P, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003999.pub3, 10.1002/14651858.CD003999.pub4]; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Kahn R, 2008, CIRCULATION, V118, P576, DOI 10.1161/CIRCULATIONAHA.108.190186; Keating GM, 2010, PHARMACOECONOMICS, V28, P231, DOI 10.2165/11204380-000000000-00000; Ku L, 2010, HEALTH AFFAIR, V29, P1173, DOI 10.1377/hlthaff.2010.0417; Ladapo JA, 2011, ARCH INTERN MED, V171, P39, DOI 10.1001/archinternmed.2010.479; Land T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000375; Land T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009770; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Massachusetts Tobacco Cessation Program, MASSHEALTH TOB CESS; McMenamin S. B., 2010, Morbidity and Mortality Weekly Report, V59, P1340; Nides M, 2008, AM J MED, V121, pS20, DOI 10.1016/j.amjmed.2008.01.016; Office of the Surgeon General, HLTH PEOPL 2020 SUMM; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Zimovetz EA, 2011, J EVAL CLIN PRACT, V17, P288, DOI 10.1111/j.1365-2753.2010.01439.x	26	56	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29665	10.1371/journal.pone.0029665	http://dx.doi.org/10.1371/journal.pone.0029665			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	904IR	22238633	Green Published, gold			2022-12-27	WOS:000301188800024
J	Yang, Q; Liu, H; Low, HQ; Wang, HF; Yu, YX; Fu, XA; Yu, GQ; Chen, MF; Yan, XX; Chen, SM; Huang, W; Liu, JJ; Zhang, FR				Yang, Qing; Liu, Hong; Low, Hui-Qi; Wang, Haifeng; Yu, Yongxiang; Fu, Xi'an; Yu, Gongqi; Chen, Mingfei; Yan, Xiaoxiao; Chen, Shumin; Huang, Wei; Liu, Jianjun; Zhang, Furen			Chromosome 2p14 Is Linked to Susceptibility to Leprosy	PLOS ONE			English	Article							LOD SCORES; LINKAGE; GENETICS; ALLELE; GENES; MAPS	Background: A genetic component to the etiology of leprosy is well recognized but the mechanism of inheritance and the genes involved are yet to be fully established. Methodology: A genome-wide single nucleotide polymorphism (SNP) based linkage analysis was carried out using 23 pedigrees, each with 3 to 7 family members affected by leprosy. Multipoint parametric and non-parametric linkage analyses were performed using MERLIN 1.1.1. Principal Findings: Genome-wide significant evidence for linkage was identified on chromosome 2p14 with a heterogeneity logarithm of odds (HLOD) score of 3.51 (rs1106577) under a recessive model of inheritance, while suggestive evidence was identified on chr.4q22 (HLOD 2.92, rs1349350, dominant model), chr.8q24 (HLOD 2.74, rs1618523, recessive model) and chr.16q24 (HLOD 1.93, rs276990 dominant model). Our study also provided moderate evidence for a linkage locus on chromosome 6q24-26 by non-parametric linkage analysis (rs6570858, LOD 1.54, p = 0.004), overlapping a previously reported linkage region on chromosome 6q25-26. Conclusion: A genome-wide linkage analysis has identified a new linkage locus on chromosome 2p14 for leprosy in Pedigrees from China.	[Yang, Qing; Liu, Hong; Yu, Yongxiang; Fu, Xi'an; Yu, Gongqi; Chen, Mingfei; Yan, Xiaoxiao; Chen, Shumin; Zhang, Furen] Shandong Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan, Shandong, Peoples R China; [Yang, Qing; Liu, Hong; Yu, Yongxiang; Fu, Xi'an; Yu, Gongqi; Chen, Mingfei; Yan, Xiaoxiao; Chen, Shumin; Zhang, Furen] Shandong Prov Hosp Skin Dis, Jinan, Shandong, Peoples R China; [Yang, Qing; Liu, Hong; Yu, Yongxiang; Fu, Xi'an; Yu, Gongqi; Chen, Mingfei; Yan, Xiaoxiao; Chen, Shumin; Zhang, Furen] Shandong Prov Key Lab Dermatovenereol, Jinan, Shandong, Peoples R China; [Yang, Qing; Liu, Hong; Yu, Yongxiang; Fu, Xi'an; Yu, Gongqi; Chen, Mingfei; Yan, Xiaoxiao; Chen, Shumin; Zhang, Furen] Shandong Prov Med Ctr Dermatovenereol, Jinan, Shandong, Peoples R China; [Low, Hui-Qi; Liu, Jianjun] Genome Inst Singapore, Dept Human Genet, Singapore, Singapore; [Wang, Haifeng; Huang, Wei] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Yang, Q (corresponding author), Shandong Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan, Shandong, Peoples R China.	zhangfuren@hotmail.com	Liu, Jianjun/AAK-4989-2020	Liu, Jianjun/0000-0002-3255-3019; Wang, Haifeng/0000-0001-5022-0720	National Natural Science Foundation of China [81071288, 81072391]; Project of Medical leading scholar of Shandong Province; Project of Taishan scholar; Research Foundation of Shandong Provincial Institute of Dermatology and Venereology; Shandong Provincial Leprosy Control Special Financial Support	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Medical leading scholar of Shandong Province; Project of Taishan scholar; Research Foundation of Shandong Provincial Institute of Dermatology and Venereology; Shandong Provincial Leprosy Control Special Financial Support	This work was funded by a grant from the National Natural Science Foundation of China (81071288, 81072391), Project of Medical leading scholar of Shandong Province (2010-), Project of Taishan scholar (2008-), Project of Research Foundation of Shandong Provincial Institute of Dermatology and Venereology (2008-7) and the Shandong Provincial Leprosy Control Special Financial Support (2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; ABEL L, 1988, AM J HUM GENET, V42, P256; ABEL L, 1995, GENET EPIDEMIOL, V12, P63, DOI 10.1002/gepi.1370120107; Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; Alcais A, 2007, NAT GENET, V39, P517, DOI 10.1038/ng2000; Allen-Brady K, 2009, AM J HUM GENET, V84, P678, DOI 10.1016/j.ajhg.2009.04.002; Bochud PY, 2008, J INFECT DIS, V197, P253, DOI 10.1086/524688; Chakravartti MR, 1973, TOPICS HUMAN GENETIC, P1; GOLDIN LR, 1992, GENET EPIDEMIOL, V9, P61, DOI 10.1002/gepi.1370090107; HASTINGS RC, 1994, LEPROSY; Jamieson SE, 2004, GENES IMMUN, V5, P46, DOI 10.1038/sj.gene.6364029; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Mira MT, 2003, NAT GENET, V33, P412, DOI 10.1038/ng1096; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Moraes MO, 2006, LEPROSY REV, V77, P189; Quintana-Murci L, 2007, NAT IMMUNOL, V8, P1165, DOI 10.1038/ni1535; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Schuring RP, 2009, J INFECT DIS, V199, P1816, DOI 10.1086/599121; SHIELDS ED, 1987, J CLIN INVEST, V79, P1139, DOI 10.1172/JCI112930; Siddiqui MR, 2001, NAT GENET, V27, P439, DOI 10.1038/86958; Tosh K, 2002, J INFECT DIS, V186, P1190, DOI 10.1086/343806; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang FR, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-133	24	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29747	10.1371/journal.pone.0029747	http://dx.doi.org/10.1371/journal.pone.0029747			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238647	Green Published, Green Submitted, gold			2022-12-27	WOS:000301188800031
J	Hoeve, MA; Nash, AA; Jackson, D; Randall, RE; Dransfield, I				Hoeve, Marieke A.; Nash, Anthony A.; Jackson, David; Randall, Richard E.; Dransfield, Ian			Influenza Virus A Infection of Human Monocyte and Macrophage Subpopulations Reveals Increased Susceptibility Associated with Cell Differentiation	PLOS ONE			English	Article							BLOOD-DERIVED MACROPHAGES; HUMAN PERIPHERAL-BLOOD; A H5N1 VIRUSES; APOPTOTIC CELLS; NS1 PROTEIN; HUMAN ALVEOLAR; ALTERNATIVE ACTIVATION; DEPENDENT PHAGOCYTOSIS; EPITHELIAL-CELLS; GENE-EXPRESSION	Influenza virus infection accounts for significant morbidity and mortality world-wide. Interactions of the virus with host cells, particularly those of the macrophage lineage, are thought to contribute to various pathological changes associated with poor patient outcome. Development of new strategies to treat disease therefore requires a detailed understanding of the impact of virus infection upon cellular responses. Here we report that human blood-derived monocytes could be readily infected with the H3N2 influenza virus A/Udorn/72 (Udorn), irrespective of their phenotype (CD14(++)/CD16(-), CD14(++)/CD16(+) or CD14(dim)CD16(++)), as determined by multi-colour flow cytometry for viral haemagglutinin (HA) expression and cell surface markers 8-16 hours post infection. Monocytes are relatively resistant to influenza-induced cell death early in infection, as approximately 20% of cells showed influenza-induced caspase-dependent apoptosis. Infection of monocytes with Udorn also induced the release of IL-6, IL-8, TNF alpha and IP-10, suggesting that NS1 protein of Udorn does not (effectively) inhibit this host defence response in human monocytes. Comparative analysis of human monocyte-derived macrophages (Mph) demonstrated greater susceptibility to human influenza virus than monocytes, with the majority of both pro-inflammatory Mph1 and anti-inflammatory/regulatory Mph2 cells expressing viral HA after infection with Udorn. Influenza infection of macrophages also induced cytokine and chemokine production. However, both Mph1 and Mph2 phenotypes released comparable amounts of TNF alpha, IL-12p40 and IP-10 after infection with H3N2, in marked contrast to differential responses to LPS-stimulation. In addition, we found that influenza virus infection augmented the capacity of poorly phagocytic Mph1 cells to phagocytose apoptotic cells by a mechanism that was independent of either IL-10 or the Mer receptor tyrosine kinase/Protein S pathway. In summary, our data reveal that influenza virus infection of human macrophages causes functional alterations that may impact on the process of resolution of inflammation, with implications for viral clearance and lung pathology.	[Hoeve, Marieke A.; Dransfield, Ian] Univ Edinburgh, MRC Ctr Inflammat & Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Nash, Anthony A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Nash, Anthony A.] Univ Edinburgh, Roslin Inst, Ctr Infect Dis, Edinburgh, Midlothian, Scotland; [Jackson, David; Randall, Richard E.] Univ St Andrews, St Andrews, Fife, Scotland	University of Edinburgh; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of St Andrews	Hoeve, MA (corresponding author), Univ Edinburgh, MRC Ctr Inflammat & Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.	m.hoeve@ed.ac.uk; i.dransfield@ed.ac.uk		Randall, Richard/0000-0002-9304-6678; Dransfield, Ian/0000-0001-5848-7059	Scottish Funding Council; MRC [G0901697] Funding Source: UKRI; Medical Research Council [G0901697] Funding Source: researchfish	Scottish Funding Council; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Dr. Hoeve was supported by a grant to the Interscplinary Centre for Human and Avian Influenza Research (ICHAIR) from the Scottish Funding Council (http://www.sfc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDER A, 1993, J IMMUNOL, V151, P5416; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; Di Paolo NC, 2009, IMMUNITY, V31, P110, DOI 10.1016/j.immuni.2009.04.015; ETTENSOHN DB, 1984, J INFECT DIS, V149, P942, DOI 10.1093/infdis/149.6.942; FESQ H, 1994, IMMUNOBIOLOGY, V190, P175, DOI 10.1016/S0171-2985(11)80292-5; Franz S, 2009, AUTOIMMUNITY, V42, P275, DOI 10.1080/08916930902828080; Fujimoto I, 2000, J VIROL, V74, P3399, DOI 10.1128/JVI.74.7.3399-3403.2000; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Giles KM, 2000, BRIT J HAEMATOL, V109, P1, DOI 10.1046/j.1365-2141.2000.01805.x; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Hart SP, 2000, CELL DEATH DIFFER, V7, P493, DOI 10.1038/sj.cdd.4400680; Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448; HASKILL S, 1988, J IMMUNOL, V140, P1690; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Hayman A, 2006, VIROLOGY, V347, P52, DOI 10.1016/j.virol.2005.11.024; Herold S, 2008, J EXP MED, V205, P3065, DOI 10.1084/jem.20080201; Hoeve MA, 2006, EUR J IMMUNOL, V36, P661, DOI 10.1002/eji.200535239; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Jackson D, 2010, VIROLOGY, V396, P94, DOI 10.1016/j.virol.2009.10.004; JENNINGS ST, 1984, AM REV RESPIR DIS, V130, P98; Jersmann HPA, 2003, CLIN SCI, V105, P273, DOI 10.1042/CS20030126; Jersmann HPA, 2003, CYTOM PART A, V51A, P7, DOI 10.1002/cyto.a.10005; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P10096, DOI 10.1073/pnas.152327499; Le Goffic R, 2011, AM J RESP CELL MOL B; Leverrier Y, 2003, J BIOL CHEM, V278, P38437, DOI 10.1074/jbc.M306649200; Li YH, 2011, VIROLOGY, V415, P12, DOI 10.1016/j.virol.2011.03.024; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Matikainen S, 2000, VIROLOGY, V276, P138, DOI 10.1006/viro.2000.0542; McColl A, 2009, J IMMUNOL, V183, P2167, DOI 10.4049/jimmunol.0803503; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; MORI I, 1995, J GEN VIROL, V76, P2869, DOI 10.1099/0022-1317-76-11-2869; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; NAIN M, 1990, J IMMUNOL, V145, P1921; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Pauligk C, 2004, IMMUNOBIOLOGY, V209, P3, DOI 10.1016/j.imbio.2004.04.002; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Serbina NV, 2009, J IMMUNOL, V183, P2678, DOI 10.4049/jimmunol.0803398; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Stamatos NM, 2005, FEBS J, V272, P2545, DOI 10.1111/j.1742-4658.2005.04679.x; Sun K, 2010, J VIROL, V84, P5007, DOI 10.1128/JVI.02408-09; TAKIZAWA T, 1993, J GEN VIROL, V74, P2347, DOI 10.1099/0022-1317-74-11-2347; Takizawa T, 1999, MICROBIOL IMMUNOL, V43, P245, DOI 10.1111/j.1348-0421.1999.tb02400.x; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Turchiarelli V, 2011, ALLERGY, V66, P1099, DOI 10.1111/j.1398-9995.2011.02600.x; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Watanabe Y, 2005, BIOCHEM BIOPH RES CO, V337, P881, DOI 10.1016/j.bbrc.2005.09.133; Watanabe Y, 2004, MICROBIOL IMMUNOL, V48, P875, DOI 10.1111/j.1348-0421.2004.tb03619.x; Wu WX, 2010, VIROLOGY, V396, P178, DOI 10.1016/j.virol.2009.10.016; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; ZIEGLERHEITBROCK HWL, 1988, HYBRIDOMA, V7, P521, DOI 10.1089/hyb.1988.7.521; ZIEGLERHEITBROCK HWL, 1993, EUR J IMMUNOL, V23, P2053, DOI 10.1002/eji.1830230902	72	59	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29443	10.1371/journal.pone.0029443	http://dx.doi.org/10.1371/journal.pone.0029443			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238612	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200028
J	Johansson, DX; Ljungberg, K; Kakoulidou, M; Liljestrom, P				Johansson, Daniel X.; Ljungberg, Karl; Kakoulidou, Maria; Liljestrom, Peter			Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses	PLOS ONE			English	Article							DNA VACCINE DELIVERY; CD8(+) T-CELLS; MESSENGER-RNA; DENDRITIC CELLS; TRANSGENE EXPRESSION; GENETIC IMMUNIZATION; SKIN ELECTROPORATION; ENCEPHALITIS-VIRUS; IN-VIVO; IMMUNOGENICITY	RNA-based vaccines represent an interesting immunization modality, but suffer from poor stability and a lack of efficient and clinically feasible delivery technologies. This study evaluates the immunogenic potential of naked in vitro transcribed Semliki Forest virus replicon RNA (RREP) delivered intradermally in combination with electroporation. Replicon-immunized mice showed a strong cellular and humoral response, contrary to mice immunized with regular mRNA. RREP-elicited induction of interferon-gamma secreting CD8+ T cells and antibody responses were significantly increased by electroporation. CD8+ T cell responses remained substantial five weeks post vaccination, and antigen-specific CD8+ T cells with phenotypic characteristics of both effector and central memory cells were identified. The immune response during the contraction phase was further increased by a booster immunization, and the proportion of effector memory cells increased significantly. These results demonstrate that naked RREP delivered via intradermal electroporation constitute an immunogenic, safe and attractive alternative immunization strategy to DNA-based vaccines.	[Johansson, Daniel X.; Ljungberg, Karl; Kakoulidou, Maria; Liljestrom, Peter] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Karolinska Institutet	Johansson, DX (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	Daniel.johansson@ki.se		Ljungberg, Karl/0000-0001-7192-6204; Liljestrom, Peter/0000-0002-2132-0981	Swedish Research Council; Swedish International Development Cooperation Agency	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency	This work was supported by the Swedish Research Council (www.vr.se) and the Swedish International Development Cooperation Agency (www.sida.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Berglund P, 1998, NAT BIOTECHNOL, V16, P562, DOI 10.1038/nbt0698-562; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Brave A, 2010, VACCINE; CONRY RM, 1995, CANCER RES, V55, P1397; Fleeton MN, 2001, J INFECT DIS, V183, P1395, DOI 10.1086/319857; Fotin-Mleczek M, 2011, J IMMUNOTHER, V34, P1, DOI 10.1097/CJI.0b013e3181f7dbe8; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Garneau NL, 2008, J VIROL, V82, P880, DOI 10.1128/JVI.01205-07; Gilboa E, 2004, IMMUNOL REV, V199, P251, DOI 10.1111/j.0105-2896.2004.00139.x; Hallengard D, 2011, VACCINE, V29, P839, DOI 10.1016/j.vaccine.2010.10.083; Hayashi T, 2010, DEV DYNAM, V239, P2034, DOI 10.1002/dvdy.22344; Hoerr I, 2000, EUR J IMMUNOL, V30, P1; Kang KK, 2003, INTERVIROLOGY, V46, P270, DOI 10.1159/000073206; Karlsson Gunilla B, 2004, Methods Mol Biol, V246, P543; Kostense S, 2002, BLOOD, V99, P2505, DOI 10.1182/blood.V99.7.2505; Krebs P, 2005, J IMMUNOL, V174, P4559, DOI 10.4049/jimmunol.174.8.4559; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Ledwith B J, 2000, Dev Biol (Basel), V104, P33; Ledwith BJ, 2000, INTERVIROLOGY, V43, P258, DOI 10.1159/000053993; Leitner WW, 2000, CANCER RES, V60, P51; Ljungberg K, 2007, J VIROL, V81, P13412, DOI 10.1128/JVI.01799-07; Lorenzi JCC, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-77; Morris-Downes MM, 2001, VACCINE, V19, P1978, DOI 10.1016/S0264-410X(00)00428-X; Nordstrom EKL, 2005, J GEN VIROL, V86, P349, DOI 10.1099/vir.0.80481-0; Piggott JM, 2009, MOL MED REP, V2, P753, DOI 10.3892/mmr_00000168; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Qiu P, 1996, GENE THER, V3, P262; Rittig SM, 2010, MOL THER; Roesler E, 2009, J ALLERGY CLIN IMMUN, V124, P1070, DOI 10.1016/j.jaci.2009.06.036; Roos AK, 2006, MOL THER, V13, P320, DOI 10.1016/j.ymthe.2005.08.005; Roos AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007226; Roos AK, 2009, MOL THER, V17, P1637, DOI 10.1038/mt.2009.120; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Sokoloski KJ, 2010, CELL HOST MICROBE, V8, P196, DOI 10.1016/j.chom.2010.07.003; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; Thurner B, 1999, J EXP MED, V190, P1669, DOI 10.1084/jem.190.11.1669; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Weide B, 2008, J IMMUNOTHER, V31, P180, DOI 10.1097/CJI.0b013e31815ce501; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; Ying H, 1999, NAT MED, V5, P823, DOI 10.1038/10548; Yu Q, 1998, J BIOL CHEM, V273, P23524, DOI 10.1074/jbc.273.36.23524; ZHOU X, 1994, VACCINE, V12, P1510, DOI 10.1016/0264-410X(94)90074-4; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	47	54	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29732	10.1371/journal.pone.0029732	http://dx.doi.org/10.1371/journal.pone.0029732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238645	Green Submitted, Green Published, gold			2022-12-27	WOS:000301070200046
J	Kincses, ZT; Szabo, N; Valalik, I; Kopniczky, Z; Dezsi, L; Klivenyi, P; Jenkinson, M; Kiraly, A; Babos, M; Voros, E; Barzo, P; Vecsei, L				Kincses, Zsigmond Tamas; Szabo, Nikoletta; Valalik, Istvan; Kopniczky, Zsolt; Dezsi, Livia; Klivenyi, Peter; Jenkinson, Mark; Kiraly, Andras; Babos, Magor; Voeroes, Erika; Barzo, Pal; Vecsei, Laszlo			Target Identification for Stereotactic Thalamotomy Using Diffusion Tractography	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; ESSENTIAL TREMOR; PARKINSONS-DISEASE; THALAMIC-STIMULATION; MULTIPLE-SCLEROSIS; VIM THALAMOTOMY; HIGH-RESOLUTION; NUCLEUS; SEGMENTATION; VALIDATION	Background: Stereotactic targets for thalamotomy are usually derived from population-based coordinates. Individual anatomy is used only to scale the coordinates based on the location of some internal guide points. While on conventional MR imaging the thalamic nuclei are indistinguishable, recently it has become possible to identify individual thalamic nuclei using different connectivity profiles, as defined by MR diffusion tractography. Methodology and Principal Findings: Here we investigated the inter-individual variation of the location of target nuclei for thalamotomy: the putative ventralis oralis posterior (Vop) and the ventral intermedius (Vim) nucleus as defined by probabilistic tractography. We showed that the mean inter-individual distance of the peak Vop location is 7.33 mm and 7.42 mm for Vim. The mean overlap between individual Vop nuclei was 40.2% and it was 31.8% for Vim nuclei. As a proof of concept, we also present a patient who underwent Vop thalamotomy for untreatable tremor caused by traumatic brain injury and another patient who underwent Vim thalamotomy for essential tremor. The probabilistic tractography indicated that the successful tremor control was achieved with lesions in the Vop and Vim respectively. Conclusions: Our data call attention to the need for a better appreciation of the individual anatomy when planning stereotactic functional neurosurgery.	[Kincses, Zsigmond Tamas; Szabo, Nikoletta; Dezsi, Livia; Klivenyi, Peter; Kiraly, Andras; Vecsei, Laszlo] Univ Szeged, Albert Szent Gyorgy Clin Ctr, Dept Neurol, Szeged, Hungary; [Kincses, Zsigmond Tamas] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic; [Valalik, Istvan] St Johns Hosp, Dept Neurosurg, Budapest, Hungary; [Kopniczky, Zsolt; Barzo, Pal] Univ Szeged, Albert Szent Gyorgy Clin Ctr, Dept Neurosurg, Szeged, Hungary; [Jenkinson, Mark] Univ Oxford, John Radcliffe Hosp, FMRIB Ctr, Dept Clin Neurol, Oxford OX3 9DU, England; [Babos, Magor] Euromed Diagnost Hungary Ltd, Szeged, Hungary; [Voeroes, Erika] Univ Szeged, Albert Szent Gyorgy Clin Ctr, Dept Radiol, Szeged, Hungary	Szeged University; St Anne's University Hospital Brno (FNUSA-ICRC); Szeged University; University of Oxford; Szeged University	Kincses, ZT (corresponding author), Univ Szeged, Albert Szent Gyorgy Clin Ctr, Dept Neurol, Szeged, Hungary.	kincsesz@nepsy.szote.u-szeged.hu	Kincses, Zsigmond Tamas/A-6507-2012; Kopniczky, Zsolt/G-7771-2012; Vécsei, László/B-2066-2010; Jenkinson, Mark/AAC-8861-2019; Vecsei, Laszlo/ABA-6137-2021; Kincses, Zsigmond Tamás/N-4849-2015	Kincses, Zsigmond Tamas/0000-0002-1442-4475; Vécsei, László/0000-0001-8037-3672; Jenkinson, Mark/0000-0001-6043-0166; Kincses, Zsigmond Tamás/0000-0002-1442-4475; Kiraly, Andras/0000-0003-3729-3911; Klivenyi, Peter/0000-0002-5389-3266; Szabo, Nikoletta/0000-0003-1656-5121	Medical Research Council (ETT) [026-04]; Neuroscience Research Group of the Hungarian Academy of Sciences and University of Szeged; Hungarian Academy of Sciences; International Research Center (FNUSA-ICRC) [CZ.1.05/1.1.00/02.0123]; European Regional Development Fund; Creating the Center of Excellence at the University of Szeged [TAMOP-4.2.1/B-09/1/KONV-2010-0005]	Medical Research Council (ETT)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Neuroscience Research Group of the Hungarian Academy of Sciences and University of Szeged; Hungarian Academy of Sciences(Hungarian Academy of Sciences); International Research Center (FNUSA-ICRC); European Regional Development Fund(European Commission); Creating the Center of Excellence at the University of Szeged	Dr. Laszlo Vecsei was supported by the Medical Research Council (ETT 026-04) and the "Neuroscience Research Group of the Hungarian Academy of Sciences and University of Szeged.". Dr. Zsigmond Tamas Kincses was supported by the Bolyai Scholarship Programme of the Hungarian Academy of Sciences and by the project International Research Center (FNUSA-ICRC, no. CZ.1.05/1.1.00/02.0123) from the European Regional Development Fund. Dr. Vecsei, Dr. Kincses, Dr. Szabo and Dr. Klivenyi were supported by "TAMOP-4.2.1/B-09/1/KONV-2010-0005 - Creating the Center of Excellence at the University of Szeged'' grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alusi SH, 2001, BRAIN, V124, P1576, DOI 10.1093/brain/124.8.1576; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P344; Bittar RG, 2005, J CLIN NEUROSCI, V12, P638, DOI 10.1016/j.jocn.2004.09.008; Blomstedt P, 2007, BRIT J NEUROSURG, V21, P504, DOI 10.1080/02688690701552278; Broggi G, 2006, ACTA NEUROCHIR SUPPL, V99, P13, DOI 10.1007/978-3-211-35205-2_2; BROGGI G, 1993, MOVEMENT DISORD, V8, P206, DOI 10.1002/mds.870080217; Chen H, 2010, CHINESE MED J-PEKING, V123, P695, DOI 10.3760/cma.j.issn.0366-6999.2010.06.011; Critchley GR, 1998, BRIT J NEUROSURG, V12, P559, DOI 10.1080/02688699844439; Crum WR, 2006, IEEE T MED IMAGING, V25, P1451, DOI 10.1109/TMI.2006.880587; Deoni SCL, 2005, HUM BRAIN MAPP, V25, P353, DOI 10.1002/hbm.20117; Deoni SCL, 2007, NEUROIMAGE, V34, P117, DOI 10.1016/j.neuroimage.2006.09.016; Dormont D, 1997, AM J NEURORADIOL, V18, P1093; Flora ED, 2010, MOVEMENT DISORD, V25, P1550, DOI 10.1002/mds.23195; Foote KD, 2006, NEUROSURGERY, V58, P280, DOI 10.1227/01.NEU.0000192692.95455.FD; Franzini A, 2011, J NEURAL TRANSM; Gallay MN, 2008, BRAIN STRUCT FUNCT, V212, P443, DOI 10.1007/s00429-007-0170-0; GUIOT G, 1968, NEUROCHIRURGIE, V14, P553; Hamani C, 2006, NEUROSURGERY, V58, P146, DOI 10.1227/01.NEU.0000192166.62017.C1; Hassler R, 1954, NERVENARZT, V25, P441; Hooper AK, 2008, STEREOT FUNCT NEUROS, V86, P147, DOI 10.1159/000120426; Hyam JA, 2011, NEUROSURGERY; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Kim MC, 2002, J NEUROL NEUROSUR PS, V73, P453, DOI 10.1136/jnnp.73.4.453; Macchi G, 1997, J NEUROSURG, V86, P670, DOI 10.3171/jns.1997.86.4.0670; Molnar GF, 2005, J NEUROPHYSIOL, V93, P3094, DOI 10.1152/jn.00881.2004; Morel A, 1997, J COMP NEUROL, V387, P588, DOI 10.1002/(SICI)1096-9861(19971103)387:4<588::AID-CNE8>3.0.CO;2-Z; Muthusamy KA, 2007, J NEUROSURG, V107, P814, DOI 10.3171/JNS-07/10/0814; NARABAYASHI H, 1980, APPL NEUROPHYSIOL, V43, P222; Nowinski WL, 2005, STEREOT FUNCT NEUROS, V83, P190, DOI 10.1159/000091082; Nowinski WL, 2002, STEREOT FUNCT NEUROS, V79, P1, DOI 10.1159/000069499; Pahwa R, 2006, J NEUROSURG, V104, P506, DOI 10.3171/jns.2006.104.4.506; Sanborn MR, 2009, STEREOT FUNCT NEUROS, V87, P128, DOI 10.1159/000207201; Sedrak M, 2011, NEUROSURGERY; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Traynor C, 2010, NEUROIMAGE; Yamada K, 2010, AM J NEURORADIOL, V31, P732, DOI 10.3174/ajnr.A1870; Zesiewicz TA, 2005, NEUROLOGY, V64, P2008, DOI 10.1212/01.WNL.0000163769.28552.CD	42	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29969	10.1371/journal.pone.0029969	http://dx.doi.org/10.1371/journal.pone.0029969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238685	gold, Green Published			2022-12-27	WOS:000301070200062
J	Monteys, VSI; Acin, P; Rosell, G; Quero, C; Jimenez, MA; Guerrero, A				Sarto i Monteys, Victor; Acin, Patricia; Rosell, Gloria; Quero, Carmen; Jimenez, Miquel A.; Guerrero, Angel			Moths Behaving like Butterflies. Evolutionary Loss of Long Range Attractant Pheromones in Castniid Moths: A Paysandisia archon Model	PLOS ONE			English	Article							PYRROLIZIDINE ALKALOIDS; LEPIDOPTERA; NYMPHALIDAE; ITHOMIINAE; PHYLOGENY	Background: In the course of evolution butterflies and moths developed two different reproductive behaviors. Whereas butterflies rely on visual stimuli for mate location, moths use the 'female calling plus male seduction' system, in which females release long-range sex pheromones to attract conspecific males. There are few exceptions from this pattern but in all cases known female moths possess sex pheromone glands which apparently have been lost in female butterflies. In the day-flying moth family Castniidae ("butterfly-moths"), which includes some important crop pests, no pheromones have been found so far. Methodology/Principal Findings: Using a multidisciplinary approach we described the steps involved in the courtship of P. archon, showing that visual cues are the only ones used for mate location; showed that the morphology and fine structure of the antennae of this moth are strikingly similar to those of butterflies, with male sensilla apparently not suited to detect female-released long range pheromones; showed that its females lack pheromone-producing glands, and identified three compounds as putative male sex pheromone (MSP) components of P. archon, released from the proximal halves of male forewings and hindwings. Conclusions/Significance: This study provides evidence for the first time in Lepidoptera that females of a moth do not produce any pheromone to attract males, and that mate location is achieved only visually by patrolling males, which may release a pheromone at short distance, putatively a mixture of Z,E-farnesal, E,E-farnesal, and (E,Z)-2,13-octadecadienol. The outlined behavior, long thought to be unique to butterflies, is likely to be widespread in Castniidae implying a novel, unparalleled butterfly-like reproductive behavior in moths. This will also have practical implications in applied entomology since it signifies that the monitoring/control of castniid pests should not be based on the use of female-produced pheromones, as it is usually done in many moths.	[Sarto i Monteys, Victor; Jimenez, Miquel A.] Generalitat Catalunya, Direccio Gen Agr & Ramaderia, Barcelona, Catalonia, Spain; [Acin, Patricia; Quero, Carmen; Guerrero, Angel] CSIC, Inst Quim Avancada Catalunya, Dept Quim Biol & Modelitzacio Mol, Barcelona, Catalonia, Spain; [Rosell, Gloria] Univ Barcelona Barcelona, Dept Farmacol & Quim Terapeut, Catalonia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); University of Barcelona	Monteys, VSI (corresponding author), Generalitat Catalunya, Direccio Gen Agr & Ramaderia, Barcelona, Catalonia, Spain.	vsarto@gencat.cat	Acín, Patricia/GOK-1054-2022; Guerrero, Angel/AAW-3731-2020; Quero, Carmen/G-3088-2016; MONTEYS, VICTOR SARTO I/ABE-7326-2020; Guerrero, Angel/G-8495-2015	Quero, Carmen/0000-0003-3599-2778; Guerrero, Angel/0000-0003-2323-2691; SARTO I MONTEYS, VICTOR/0000-0003-2701-6558	Spanish Ministerio de Ciencia e Innovacion; Catalonian Government (Spain); Comision Interministerial de Ciencia y Tecnologia [AGL 2006-13489-C02-01/AGR, AGL2009-13452-C02-01]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Catalonian Government (Spain); Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT))	The authors thank the Spanish Ministerio de Ciencia e Innovacion for an I3P fellowship to PA and a Ramon y Cajal contract to CQ. This research was sponsored by the Servei de Sanitat Vegetal of the Catalonian Government (Spain), and the Comision Interministerial de Ciencia y Tecnologia (projects AGL 2006-13489-C02-01/AGR and AGL2009-13452-C02-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boppre M, 1984, 11 S R ENT SOC LOND, P259; Edwards ED, 1998, LEPIDOPTERA MOTHS BU, V1, P181; Eisner T., 1987, P251; El-Sayed AM, 2011, PHEROBASE DATABASE I; Faucheux MJ, 1999, B SOC SCI NAT OUEST, P1; FORSBERG J, 1989, BEHAV ECOL SOCIOBIOL, V25, P349, DOI 10.1007/BF00302992; Hallberg E, 2003, LEPIDOPTERA MOTHS BU, V2, P267, DOI DOI 10.1515/9783110893724.267; Hallberg E, 2003, LEPIDOPTERA MOTHS BU, V2, P361; HANSSON BS, 1995, EXPERIENTIA, V51, P1003, DOI 10.1007/BF01946910; Kristensen NP, 2007, ZOOTAXA, P699, DOI 10.11646/zootaxa.1668.1.30; Miller JY, 1986, THESIS U FLORIDA ANN, P569; MINET J, 1991, ENTOMOL SCAND, V22, P69; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Naumann C.M., 1988, Verhandlungen der Deutschen Zoologischen Gesellschaft, V81, P257; Naumann CM, 1999, W PALAEARCTIC ZYGAEN; Nieberding CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002751; Ollivier L, 2006, PHYTOMA, V594, P30; Percy-Cunningham J.E., 1987, P27; Reboucas LMC, 1999, QUIM NOVA, V22, P645, DOI 10.1590/S0100-40421999000500003; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Romero Montesino Francisco, 1998, Boletin de Entomologia Venezolana, V13, P91; SALT GEORGE, 1929, BULL ENT RES [LONDON], V20, P187, DOI 10.1017/S000748530002109X; Sarto i Monteys V, 2005, NACHRICHTEN ENTOMOLO, V26, P61; Schulz S, 2004, BIOCHEM SYST ECOL, V32, P699, DOI 10.1016/j.bse.2003.12.004; Scoble M.J., 1986, Bulletin of the British Museum (Natural History) Entomology, V53, P251; Seitz A, 1913, MACROLEPIDOPTERA WOR, V6, P5; SELLIER R, 1974, ANN SOC ENTOMOL FR, V10, P917; Tatjanskaite L., 1995, Pheromones, V5, P53; TRIGO JR, 1994, J CHEM ECOL, V20, P2883, DOI 10.1007/BF02098396; ZAGATTI P, 1987, J CHEM ECOL, V13, P1561, DOI 10.1007/BF00980200	30	25	25	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29282	10.1371/journal.pone.0029282	http://dx.doi.org/10.1371/journal.pone.0029282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238600	Green Published, Green Submitted, gold			2022-12-27	WOS:000301070200022
J	Brandman, R; Brandman, Y; Pande, VS				Brandman, Relly; Brandman, Yigal; Pande, Vijay S.			A-Site Residues Move Independently from P-Site Residues in all-Atom Molecular Dynamics Simulations of the 70S Bacterial Ribosome	PLOS ONE			English	Article							ELONGATION-FACTOR G; TRANSFER-RNA; PROTEIN DYNAMICS; L1 STALK; MOTIONS; TRANSLATION; TRANSITION; SELECTION; SUBUNIT; ACID	The ribosome is a large macromolecular machine, and correlated motion between residues is necessary for coordinating function across multiple protein and RNA chains. We ran two all-atom, explicit solvent molecular dynamics simulations of the bacterial ribosome and calculated correlated motion between residue pairs by using mutual information. Because of the short timescales of our simulation (ns), we expect that dynamics are largely local fluctuations around the crystal structure. We hypothesize that residues that show coupled dynamics are functionally related, even on longer timescales. We validate our model by showing that crystallographic B-factors correlate well with the entropy calculated as part of our mutual information calculations. We reveal that A-site residues move relatively independently from P-site residues, effectively insulating A-site functions from P-site functions during translation.	[Brandman, Relly; Brandman, Yigal; Pande, Vijay S.] Stanford Univ, Stanford, CA 94305 USA	Stanford University	Brandman, R (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	rbrandman@gmail.com	Pande, Vijay/ABE-8145-2020		Bio-X Graduate Student Fellowship	Bio-X Graduate Student Fellowship	RB was funded by a Bio-X Graduate Student Fellowship. Computer resources on the Stanford Bio-X2 cluster were provided by National Science Foundation award Division of Computer and Network Systems CNS-0619926. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon F, 2005, BIOL CHEM, V386, P833, DOI 10.1515/BC.2005.098; Bashan A, 2008, TRENDS MICROBIOL, V16, P326, DOI 10.1016/j.tim.2008.05.001; Belousoff MJ, 2010, BIOCHEM SOC T, V38, P422, DOI 10.1042/BST0380422; Berendsen HJC, 2000, CURR OPIN STRUC BIOL, V10, P165, DOI 10.1016/S0959-440X(00)00061-0; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Fei JY, 2009, P NATL ACAD SCI USA, V106, P15702, DOI 10.1073/pnas.0908077106; GAVRILOVA LP, 1976, J MOL BIOL, V101, P537, DOI 10.1016/0022-2836(76)90243-6; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamberaj H, 2009, BIOPHYS J, V96, P1307, DOI 10.1016/j.bpj.2008.11.019; Kavran JM, 2007, J MOL BIOL, V371, P1047, DOI 10.1016/j.jmb.2007.05.091; Korostelev A, 2008, CURR OPIN CHEM BIOL, V12, P674, DOI 10.1016/j.cbpa.2008.08.037; Lange OF, 2008, PROTEINS, V70, P1294, DOI 10.1002/prot.21618; Lata KR, 1996, J MOL BIOL, V262, P43, DOI 10.1006/jmbi.1996.0497; Li DW, 2009, BIOPHYS J, V96, P3074, DOI 10.1016/j.bpj.2009.01.011; McClendon CL, 2009, J CHEM THEORY COMPUT, V5, P2486, DOI 10.1021/ct9001812; Mitra K, 2006, ANNU REV BIOPH BIOM, V35, P299, DOI 10.1146/annurev.biophys.35.040405.101950; Munro JB, 2010, P NATL ACAD SCI USA, V107, P709, DOI 10.1073/pnas.0908597107; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; PESTKA S, 1969, J BIOL CHEM, V244, P1533; Ramakrishnan V, 2008, BIOCHEM SOC T, V36, P567, DOI 10.1042/BST0360567; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Sanbonmatsu KY, 2005, P NATL ACAD SCI USA, V102, P15854, DOI 10.1073/pnas.0503456102; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Steitz TA, 2008, NAT REV MOL CELL BIO, V9, P242, DOI 10.1038/nrm2352; Tama F, 2003, P NATL ACAD SCI USA, V100, P9319, DOI 10.1073/pnas.1632476100; Trylska J, 2005, BIOPHYS J, V89, P1455, DOI 10.1529/biophysj.104.058495; Trylska J, 2009, Q REV BIOPHYS, V42, P301, DOI 10.1017/S0033583510000028; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Wang YM, 2005, BIOPHYS J, V89, P3399, DOI 10.1529/biophysj.105.064840; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Whitford PC, 2010, RNA, V16, P1196, DOI 10.1261/rna.2035410	40	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29377	10.1371/journal.pone.0029377	http://dx.doi.org/10.1371/journal.pone.0029377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235290	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400051
J	Broor, S; Krishnan, A; Roy, DS; Dhakad, S; Kaushik, S; Mir, MA; Singh, Y; Moen, A; Chadha, M; Mishra, AC; Lal, RB				Broor, Shobha; Krishnan, Anand; Roy, Dipanjan S.; Dhakad, Shivram; Kaushik, Samander; Mir, Muneer A.; Singh, Yashpal; Moen, Ann; Chadha, Mandeep; Mishra, Akhilesh C.; Lal, Renu B.			Dynamic Patterns of Circulating Seasonal and Pandemic A(H1N1)pdm09 Influenza Viruses From 2007-2010 in and around Delhi, India	PLOS ONE			English	Article							H1N1 2009 VIRUS; TRANSMISSION; EMERGENCE; MORTALITY; EPIDEMIC; EMPHASIS; IMPACT; EAST; AGE	Influenza surveillance was carried out in a subset of patients with influenza-like illness (ILI) presenting at an Employee Health Clinic (EHS) at All India Institute of Medical Sciences (AIIMS), New Delhi (urban) and pediatric out patients department of civil hospital at Ballabhgarh (peri-urban), under the Comprehensive Rural Health Services Project (CRHSP) of AIIMS, in Delhi region from January 2007 to December 2010. Of the 3264 samples tested, 541 (17%) were positive for influenza viruses, of which 221 (41%) were pandemic Influenza A(H1N1)pdm09, 168 (31%) were seasonal influenza A, and 152 (28%) were influenza B. While the Influenza viruses were detected year-round, their types/subtypes varied remarkably. While there was an equal distribution of seasonal A(H1N1) and influenza B in 2007, predominance of influenza B was observed in 2008. At the beginning of 2009, circulation of influenza A(H3N2) viruses was observed, followed later by emergence of Influenza A(H1N1) pdm09 with co-circulation of influenza B viruses. Influenza B was dominant subtype in early 2010, with second wave of Influenza A(H1N1) pdm09 in August-September, 2010. With the exception of pandemic H1N1 emergence in 2009, the peaks of influenza activity coincided primarily with monsoon season, followed by minor peak in winter at both urban and rural sites. Age group analysis of influenza positivity revealed that the percent positivity of Influenza A(H1N1) pdm09 influenza virus was highest in >5-18 years age groups (OR 2.5; CI = 1.2-5.0; p = 0.009) when compared to seasonal influenza. Phylogenetic analysis of Influenza A(H1N1) pdm09 from urban and rural sites did not reveal any major divergence from other Indian strains or viruses circulating worldwide. Continued surveillance globally will help define regional differences in influenza seasonality, as well as, to determine optimal periods to implement influenza vaccination programs among priority populations.	[Broor, Shobha; Krishnan, Anand; Dhakad, Shivram; Kaushik, Samander; Mir, Muneer A.; Singh, Yashpal] All India Inst Med Sci, Delhi, India; [Roy, Dipanjan S.; Moen, Ann; Lal, Renu B.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Chadha, Mandeep; Mishra, Akhilesh C.] Natl Inst Virol, Pune, Maharashtra, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Centers for Disease Control & Prevention - USA; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Broor, S (corresponding author), All India Inst Med Sci, Delhi, India.	shobha.broor@gmail.com	Broor, Shobha/AAX-4163-2021; Krishnan, Anand/D-8537-2012	Broor, Shobha/0000-0001-9679-4180; Krishnan, Anand/0000-0002-9173-7811; Kaushik, Samander/0000-0003-4835-6383	Indian Council of Medical Research, New Delhi, India; Centers for Disease Control and Prevention, Atlanta, USA [5U50 CI 024407, IU51 IP 00033301]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U50CI024407] Funding Source: NIH RePORTER	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR)); Centers for Disease Control and Prevention, Atlanta, USA(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported in part by Indian Council of Medical Research, New Delhi, India and a cooperative agreement 5U50 CI 024407 and IU51 IP 00033301 from the Centers for Disease Control and Prevention, Atlanta, USA. The study is part of collaborative activity between AIIMS, New Delhi, and US CDC, whereby investigators from both side are involved in study design, implementation and data analysis.	[Anonymous], 2010, INFL UPD; [Anonymous], 2009, CDC PROTOCOL REAL TI; Anupam Mukherjee, 2010, Journal of Public Health and Epidemiology, V2, P171; Bansal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009360; Blair PJ, 2010, EPIDEMIOL INFECT, V138, P199, DOI 10.1017/S095026880999063X; Brooks WA, 2010, PEDIATR INFECT DIS J, V29, P216, DOI 10.1097/INF.0b013e3181bc23fd; Broor S, 2011, INFLUENZA OTHER RESP, DOI [10.1111/j.1750-2659.00274.x, DOI 10.1111/J.1750-2659.00274.X]; Chadha MS, 2012, INFLUENZA OTHER RESP, V6, P196, DOI 10.1111/j.1750-2659.2011.00293.x; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Greer AL, 2010, EPIDEMIOL INFECT, V138, P1542, DOI 10.1017/S0950268810000579; Koul PA, 2011, INFLUENZA OTHER RESP, V5, pR521, DOI 10.1111/j.1750-2659.2011.00261.x; Leo YS, 2010, EMERG INFECT DIS, V16, P103, DOI 10.3201/eid1601.091164; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Mathews JD, 2009, INFLUENZA OTHER RESP, V3, P143, DOI 10.1111/j.1750-2659.2009.00089.x; Mir MA, 2011, J MED VIROL IN PRESS; Moura FEA, 2010, CURR OPIN INFECT DIS, V23, P415, DOI 10.1097/QCO.0b013e32833cc955; Mullick J, 2011, INFECT GENET EVOL, V11, P997, DOI 10.1016/j.meegid.2011.03.015; Nelson M., 2009, PLOS CURR, V1, DOI [DOI 10.1371/CURRENTS.RRN1126, 10.1371/currents.RRN1126]; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Sami A, 2010, INDIAN PEDIAT; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Simmerman JM, 2008, INFLUENZA OTHER RESP, V2, P81, DOI 10.1111/j.1750-2659.2008.00045.x; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Tang JLWT, 2010, ANN ACAD MED SINGAP, V39, P291; van Riet E, 2007, J INFECT DIS, V196, P1671, DOI 10.1086/522010; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; World Health Organization, 2007, AC RESP INF INFL; [No title captured]	36	55	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29129	10.1371/journal.pone.0029129	http://dx.doi.org/10.1371/journal.pone.0029129			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235265	Green Published, gold			2022-12-27	WOS:000301123400026
J	Kawahara, T; Ito, H; Terao, H; Yamagishi, T; Ogawa, T; Uemura, H; Kubota, Y; Matsuzaki, J				Kawahara, Takashi; Ito, Hiroki; Terao, Hideyuki; Yamagishi, Takuya; Ogawa, Takehiko; Uemura, Hiroji; Kubota, Yoshinobu; Matsuzaki, Junichi			Ureteral Stent Retrieval Using the Crochet Hook Technique in Females	PLOS ONE			English	Article							FLUOROSCOPIC GUIDANCE; MANAGEMENT; EXCHANGE; FORGOTTEN; REMOVAL	Introduction: We developed a method for ureteral stent removal in female patients that requires no cystoscopy or fluoroscopic guidance using a crochet hook. In addition, we also investigated the success rate, complications and pain associated with this procedure. Methods: A total of 40 female patients (56 stents) underwent the removal of ureteral stents. All procedures were carried out with the patients either under anesthesia, conscious sedation, or analgesic suppositories as deemed appropriate for each procedure including Shock Wave Lithotripsy (SWL), Ureteroscopy (URS), Percutaneous Nephrolithotomy (PCNL), and ureteral stent removal. At the time of these procedures, fluoroscopy and/or cystoscopy were prepared, but they were not used unless we failed to successfully remove the ureteral stent using the crochet hook. In addition, matched controls (comprising 50 stents) which were removed by standard ureteral stent removal using cystoscopy were used for comparison purposes. Results: A total of 47 of the 56 stents (83.9%) were successfully removed. In addition, 47 of 52 (90.4%) were successfully removed except for two migrated stents and two heavily encrusted stents which could not be removed using cystoscopy. Ureteral stent removal using the crochet hook technique was unsuccessful in nine patients, including two encrustations and two migrations. Concerning pain, ureteral stent removal using the crochet hook technique showed a lower visual analogue pain scale (VAPS) score than for the standard technique using cystoscopy. Conclusions: Ureteral stent removal using a crochet hook is considered to be easy, safe, and cost effective. This technique is also easy to learn and is therefore considered to be suitable for use on an outpatient basis.	[Kawahara, Takashi; Ito, Hiroki; Terao, Hideyuki; Yamagishi, Takuya; Matsuzaki, Junichi] Ohguchi Higashi Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan; [Kawahara, Takashi; Ito, Hiroki; Ogawa, Takehiko; Uemura, Hiroji; Kubota, Yoshinobu] Yokohama City Univ, Dept Urol, Grad Sch Med, Yokohama, Kanagawa 232, Japan	Yokohama City University	Kawahara, T (corresponding author), Ohguchi Higashi Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan.	takashi_tk2001@yahoo.co.jp						Borboroglu PG, 2000, J UROLOGY, V164, P648, DOI 10.1016/S0022-5347(05)67272-2; Bukkapatnam R, 2003, J UROLOGY, V170, P1111, DOI 10.1097/01.ju.0000086042.36616.1b; Bultitude MF, 2003, UROLOGY, V62, P622, DOI 10.1016/S0090-4295(03)00506-5; Chang RS, 2008, AM J ROENTGENOL, V190, P1665, DOI 10.2214/AJR.07.3216; DEBAERE T, 1994, RADIOLOGY, V190, P887, DOI 10.1148/radiology.190.3.8115645; ELFAQIH SR, 1991, J UROLOGY, V146, P1487, DOI 10.1016/S0022-5347(17)38146-6; Ho CH, 2009, UROL INT, V83, P70, DOI 10.1159/000224872; Kawahara T, 2011, J ENDOUROL; Kim BM, 2008, ABDOM IMAGING, V33, P237, DOI 10.1007/s00261-007-9233-1; Mohan-Pillai K, 1999, J ENDOUROL, V13, P377, DOI 10.1089/end.1999.13.377; Ozkan O, 2009, DIAGN INTERV RADIOL, V15, P51; Park SW, 2007, J VASC INTERV RADIOL, V18, P251, DOI 10.1016/j.jvir.2006.12.722; SCHULZE KA, 1985, UROLOGY, V25, P616, DOI 10.1016/0090-4295(85)90293-6; Singh I, 2001, UROLOGY, V58, P526, DOI 10.1016/S0090-4295(01)01317-6; Somers WJ, 1996, UROLOGY, V47, P431, DOI 10.1016/S0090-4295(99)80468-3; Taylor WN, 2002, J UROLOGY, V168, P2020, DOI 10.1016/S0022-5347(05)64286-3; Xu CL, 2009, LASER MED SCI, V24, P140, DOI 10.1007/s10103-007-0537-8; ZIMSKIND PD, 1967, J UROLOGY, V97, P840, DOI 10.1016/S0022-5347(17)63130-6	18	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29292	10.1371/journal.pone.0029292	http://dx.doi.org/10.1371/journal.pone.0029292			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235282	Green Submitted, Green Published, gold			2022-12-27	WOS:000301123400043
J	Manfe, V; Biskup, E; Rosbjerg, A; Kamstrup, M; Skov, AG; Lerche, CM; Lauenborg, BT; Odum, N; Gniadecki, R				Manfe, Valentina; Biskup, Edyta; Rosbjerg, Anne; Kamstrup, Maria; Skov, Anne Guldhammer; Lerche, Catharina Margrethe; Lauenborg, Britt Thyssing; Odum, Niels; Gniadecki, Robert			miR-122 Regulates p53/Akt Signalling and the Chemotherapy-Induced Apoptosis in Cutaneous T-Cell Lymphoma	PLOS ONE			English	Article							THERAPEUTIC TARGET; CYCLIN G1; NOTCH; CANCER; MICRORNA; P53; EXPRESSION; ACTIVATION; PATHWAY; LINES	Advanced cutaneous T-cell lymphoma (CTCL) is resistant to chemotherapy and presents a major area of medical need. In view of the known role of microRNAs (miRNAs) in the regulation of cellular signalling, we aimed to identify the functionally important miRNA species, which regulate apoptosis in CTCL. Using a recently established model in which apoptosis of CTCL cell lines is induced by Notch-1 inhibition by gamma-secretase inhibitors (GSIs), we found that miR-122 was significantly increased in the apoptotic cells. miR-122 up-regulation was not specific for GSI-1 but was also seen during apoptosis induced by chemotherapies including doxorubicin and proteasome blockers (bortezomib, MG132). miR-122 was not expressed in quiescent T-cells, but was detectable in CTCL: in lesional skin in mycosis fungoides and in Sezary cells purified from peripheral blood. In situ hybridization results showed that miR-122 was expressed in the malignant T-cell infiltrate and increased in the advanced stage mycosis fungoides. Surprisingly, miR-122 overexpression decreased the sensitivity to the chemotherapy-induced apoptosis via a signaling circuit involving the activation of Akt and inhibition of p53. We have also shown that induction of miR-122 occurred via p53 and that p53 post-transcriptionally up-regulated miR-122. miR-122 is thus an amplifier of the antiapoptotic Akt/p53 circuit and it is conceivable that a pharmacological intervention in this pathway may provide basis for novel therapies for CTCL.	[Manfe, Valentina; Biskup, Edyta; Rosbjerg, Anne; Kamstrup, Maria; Skov, Anne Guldhammer; Lerche, Catharina Margrethe; Lauenborg, Britt Thyssing; Gniadecki, Robert] Bispebjerg Hosp, Dept Dermatol, DK-2400 Copenhagen, Denmark; [Lauenborg, Britt Thyssing; Odum, Niels] Univ Copenhagen, Inst Med Microbiol & Immunol, Copenhagen, Denmark; [Odum, Niels; Gniadecki, Robert] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen	Manfe, V (corresponding author), Bispebjerg Hosp, Dept Dermatol, DK-2400 Copenhagen, Denmark.	valentinamanfe@libero.it	Lerche, Catharina/C-8671-2012; Lerche, Catharina Margrethe/AAG-7506-2022; Gniadecki, Robert/A-5696-2010; Biskup, Edyta/O-4632-2015; Lerche, Catharina Margrethe/AFL-7571-2022	Lerche, Catharina Margrethe/0000-0003-3653-6424; Gniadecki, Robert/0000-0002-2310-8300; Biskup, Edyta/0000-0002-5510-2712; Lerche, Catharina Margrethe/0000-0003-3653-6424; Rosbjerg, Anne/0000-0001-6736-3138	Aage Bangs Foundation; Novo Nordisk Foundation; Kraeftens Bekaempelse	Aage Bangs Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Kraeftens Bekaempelse	This study was supported by grants from Aage Bangs Foundation, Novo Nordisk Foundation and Kr ae ftens Bek ae mpelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek WK, 2003, AM J OBSTET GYNECOL, V188, P634, DOI 10.1067/mob.2003.140; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; Garofalo M, 2010, ANN REV PHARM TOXICO; GAZDAR AF, 1980, BLOOD, V55, P409; Gniadecki R, 2003, BLOOD, V102, P3797, DOI 10.1182/blood-2003-03-0899; GOOTENBERG JE, 1981, J EXP MED, V154, P1403, DOI 10.1084/jem.154.5.1403; Holst LM, 2010, EXP DERMATOL, V19, pE201, DOI 10.1111/j.1600-0625.2009.01049.x; Jorgensen S, 2010, METHODS, V52, P375, DOI 10.1016/j.ymeth.2010.07.002; KALTOFT K, 1987, ARCH DERMATOL RES, V279, P293, DOI 10.1007/BF00431220; Kamstrup MR, 2008, BRIT J DERMATOL, V158, P747, DOI 10.1111/j.1365-2133.2007.08427.x; Kamstrup MR, 2010, BLOOD, V116, P2504, DOI 10.1182/blood-2009-12-260216; Kimura SH, 2001, ONCOGENE, V20, P3290, DOI 10.1038/sj.onc.1204270; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li GQ, 1998, J INVEST DERMATOL, V110, P767, DOI 10.1046/j.1523-1747.1998.00167.x; Luistro L, 2009, CANCER RES, V69, P7672, DOI 10.1158/0008-5472.CAN-09-1843; Manfe V, 2010, LEUKEMIA RES, V34, pE235, DOI 10.1016/j.leukres.2010.03.035; Marchi E, 2010, CLIN CANCER RES, V16, P3648, DOI 10.1158/1078-0432.CCR-10-0671; Marrogi AJ, 1999, J CUTAN PATHOL, V26, P369, DOI 10.1111/j.1600-0560.1999.tb01860.x; Marzec M, 2008, BLOOD, V111, P2181, DOI 10.1182/blood-2007-06-095182; Nair P, 2003, J VIROL, V77, P7106, DOI 10.1128/JVI.77.12.7106-7112.2003; Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758; Olsen E, 2007, BLOOD, V110, P1713, DOI 10.1182/blood-2007-03-055749; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Querfeld C, 2006, J INVEST DERMATOL, V126, P1641, DOI 10.1038/sj.jid.5700322; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Ri M, 2008, CANC SCI; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sors A, 2006, BLOOD, V107, P2354, DOI 10.1182/blood-2005-06-2536; Stenvang J, 2008, SEMIN CANCER BIOL, V18, P89, DOI 10.1016/j.semcancer.2008.01.004; Uddin S, 2005, CLIN CANCER RES, V11, P3102, DOI 10.1158/1078-0432.CCR-04-1857; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Wollina U, 2003, CANCER, V98, P993, DOI 10.1002/cncr.11593; Yin L, 2010, BIOCHEM PHARMACOL, V80, P690, DOI 10.1016/j.bcp.2010.03.026; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhao L, 2003, MOL CANCER RES, V1, P195; Zinzani PL, 2000, J CLIN ONCOL, V18, P2603, DOI 10.1200/JCO.2000.18.13.2603	51	85	91	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29541	10.1371/journal.pone.0029541	http://dx.doi.org/10.1371/journal.pone.0029541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235305	Green Submitted, Green Published, gold			2022-12-27	WOS:000301123400067
J	Peltola, T; Marttinen, P; Jula, A; Salomaa, V; Perola, M; Vehtari, A				Peltola, Tomi; Marttinen, Pekka; Jula, Antti; Salomaa, Veikko; Perola, Markus; Vehtari, Aki			Bayesian Variable Selection in Searching for Additive and Dominant Effects in Genome-Wide Data	PLOS ONE			English	Article							MODEL SELECTION; ASSOCIATION; LOCI; REGRESSION	Although complex diseases and traits are thought to have multifactorial genetic basis, the common methods in genome-wide association analyses test each variant for association independent of the others. This computational simplification may lead to reduced power to identify variants with small effect sizes and requires correcting for multiple hypothesis tests with complex relationships. However, advances in computational methods and increase in computational resources are enabling the computation of models that adhere more closely to the theory of multifactorial inheritance. Here, a Bayesian variable selection and model averaging approach is formulated for searching for additive and dominant genetic effects. The approach considers simultaneously all available variants for inclusion as predictors in a linear genotype-phenotype mapping and averages over the uncertainty in the variable selection. This leads to naturally interpretable summary quantities on the significances of the variants and their contribution to the genetic basis of the studied trait. We first characterize the behavior of the approach in simulations. The results indicate a gain in the causal variant identification performance when additive and dominant variation are simulated, with a negligible loss of power in purely additive case. An application to the analysis of high- and low-density lipoprotein cholesterol levels in a dataset of 3895 Finns is then presented, demonstrating the feasibility of the approach at the current scale of single-nucleotide polymorphism data. We describe a Markov chain Monte Carlo algorithm for the computation and give suggestions on the specification of prior parameters using commonly available prior information. An open-source software implementing the method is available at http://www.lce.hut.fi/research/mm/bmagwa/ and https://github.com/to-mi/.	[Peltola, Tomi; Marttinen, Pekka; Vehtari, Aki] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, Espoo, Finland; [Jula, Antti] Natl Inst Hlth & Welf, Dept Hlth & Funct Capac, Turku, Finland; [Perola, Markus] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Publ Hlth Genom Unit, Helsinki, Finland; [Perola, Markus] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Perola, Markus] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia	Aalto University; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki; University of Tartu	Peltola, T (corresponding author), Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, Espoo, Finland.	tomi.peltola@aalto.fi	Vehtari, Aki/A-7584-2008; Peltola, Tomi/G-6858-2012; Marttinen, Pekka E/N-6234-2015	Vehtari, Aki/0000-0003-2164-9469; Marttinen, Pekka E/0000-0001-7078-7927; Perola, Markus/0000-0003-4842-1667	Finnish Doctoral Programme in Computational Sciences; Finnish Foundation for Cardiovascular Research; Academy of Finland [218248, 129230, 129322, 129494]	Finnish Doctoral Programme in Computational Sciences; Finnish Foundation for Cardiovascular Research; Academy of Finland(Academy of Finland)	This work was supported by the Finnish Doctoral Programme in Computational Sciences (http://fics.hiit.fi/; TP); the Finnish Foundation for Cardiovascular Research (http://www.sydantutkimussaatio.fi/; MP); and the Academy of Finland (http://www.aka.fi/; grant 218248 to AV, and Pubgensens project grants 129230 to AV, 129322 to MP, 129494 to VS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee S, 2008, GENETICS, V179, P2275, DOI 10.1534/genetics.108.088427; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bottolo L, 2010, BAYESIAN ANAL, V5, P583, DOI 10.1214/10-BA523; Brown PJ, 2002, J R STAT SOC B, V64, P519, DOI 10.1111/1467-9868.00348; Clyde MA, 2011, J COMPUT GRAPH STAT, V20, P80, DOI 10.1198/jcgs.2010.09049; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GELMAN A, 2004, BAYESIAN DATA ANAL, P294; Gelman A, 2011, MISSING DATA IMPUTAT, P009; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; George EI, 1997, STAT SINICA, V7, P339; Guan YT, 2011, ANN APPL STAT, V5, P1780, DOI 10.1214/11-AOAS455; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Kohn R, 2001, STAT COMPUT, V11, P313, DOI 10.1023/A:1011916902934; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Logsdon BA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-58; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Nott DJ, 2005, BIOMETRIKA, V92, P747, DOI 10.1093/biomet/92.4.747; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Perttila J, 2009, J MOL MED, V87, P825, DOI 10.1007/s00109-009-0490-z; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RICHARDSON S, 2011, BAYESIAN STAT, V9; Scott JG, 2010, ANN STAT, V38, P2587, DOI 10.1214/10-AOS792; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Surakka I, 2010, GENOME RES, V20, P1344, DOI 10.1101/gr.106534.110; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Wilson MA, 2010, ANN APPL STAT, V4, P1342, DOI 10.1214/09-AOAS322; Yi NJ, 2007, GENETICS, V176, P1865, DOI 10.1534/genetics.107.071365; Yi NJ, 2005, GENETICS, V170, P1333, DOI 10.1534/genetics.104.040386; Zellner, 1986, BAYESIAN INFERENCE D, P233, DOI DOI 10.4236/OJS.2013.34031	37	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29115	10.1371/journal.pone.0029115	http://dx.doi.org/10.1371/journal.pone.0029115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235263	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400024
J	Matthews, KRW; Calhoun, KM; Lo, N; Ho, V				Matthews, Kirstin R. W.; Calhoun, Kara M.; Lo, Nathan; Ho, Vivian			The Aging of Biomedical Research in the United States	PLOS ONE			English	Article							YOUNG; SCIENTISTS; AGE	In the past 30 years, the average age of biomedical researchers has steadily increased. The average age of an investigator at the National Institutes of Health (NIH) rose from 39 to 51 between 1980 and 2008. The aging of the biomedical workforce was even more apparent when looking at first-time NIH grantees. The average age of a new investigator was 42 in 2008, compared to 36 in 1980. To determine if the rising barriers at NIH for entry in biomedical research might impact innovative ideas and research, we analyzed the research and publications of Nobel Prize winners from 1980 to 2010 to assess the age at which their pioneering research occurred. We established that in the 30-year period, 96 scientists won the Nobel Prize in medicine or chemistry for work related to biomedicine, and that their groundbreaking research was conducted at an average age of 41-one year younger than the average age of a new investigator at NIH. Furthermore, 78% of the Nobel Prize winners conducted their research before the age of 51, the average age of an NIH principal investigator. This suggested that limited access to NIH might inhibit research potential and novel projects, and could impact biomedicine and the next generation scientists in the United States.	[Matthews, Kirstin R. W.; Calhoun, Kara M.; Lo, Nathan; Ho, Vivian] Rice Univ, Sci & Technol Policy Program, James A Baker III Inst Publ Policy, Houston, TX 77251 USA; [Ho, Vivian] Rice Univ, Dept Econ, Houston, TX USA	Rice University; Rice University	Matthews, KRW (corresponding author), Rice Univ, Sci & Technol Policy Program, James A Baker III Inst Publ Policy, Houston, TX 77251 USA.	krwm@rice.edu	Matthews, Kirstin RW/D-2496-2017	Matthews, Kirstin RW/0000-0002-3702-0414; Ho, Vivian/0000-0002-5979-8155	James A. Baker III Institute for Public Policy's Science and Technology Program and Health Policy Forum	James A. Baker III Institute for Public Policy's Science and Technology Program and Health Policy Forum	This work was funded by the James A. Baker III Institute for Public Policy's Science and Technology Program and Health Policy Forum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Acad, 2008, ARISE ADV RES SCI EN; [Anonymous], 2011, NATURE, V472, P259, DOI 10.1038/472259b; [Anonymous], 2011, NIH NEWS        0427; Collins F, 2010, NATURE, V467, P635, DOI 10.1038/467635a; Costas R, 2010, J AM SOC INF SCI TEC, V61, P1564, DOI 10.1002/asi.21348; Costello L, 2009, SCIENTIST, V23, P27; Cyranoski D, 2011, NATURE, V472, P276, DOI 10.1038/472276a; Falagas ME, 2008, FASEB J, V22, P4067, DOI 10.1096/fj.08-117606; Fox MF, 2001, SOC STUD SCI, V31, P109, DOI 10.1177/030631201031001006; Gingras Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004048; Goldman E, 2002, SCIENCE, V298, P40, DOI 10.1126/science.298.5591.40; Holden C, 2008, SCIENCE, V31, P391, DOI DOI 10.1126/SCIENCE.319.5862.391D; Juliano RL, 2001, ACAD MED, V76, P1005, DOI 10.1097/00001888-200110000-00007; Kaiser J, 2008, SCIENCE, V322, P848, DOI 10.1126/science.322.5903.848; Kaiser J, 2008, SCIENCE, V322, P834, DOI 10.1126/science.322.5903.834; Lee Marlene A., 2008, POPULATION B, V63; LEVIN SG, 1989, RES HIGH EDUC, V30, P531, DOI 10.1007/BF00992202; Mandel HG, 2008, SCIENCE, V322, P189, DOI 10.1126/science.322.5899.189a; MANNICHE E, 1957, BEHAV SCI, V2, P301; National Science Board, 2018, SCI ENG IND; NIH, 2011, NIH RES PORTF ONL RE; NIH, 2011, NEW EARL STAG INV PO; Obama B., 2009, COMMUNICATION; STEPHAN PE, 1993, SCIENTOMETRICS, V28, P387, DOI 10.1007/BF02026517; Stroebe W, 2010, AM PSYCHOL, V65, P660, DOI 10.1037/a0021086; Tatsioni A, 2010, FASEB J, V24, P1335, DOI 10.1096/fj.09-148239; Taylor MC, 2011, NATURE, V472, P261, DOI 10.1038/472261a; US GAO, 2009, NAT I HLTH COMPL COM; Wolinsky H, 2010, EMBO REP, V11, P741, DOI 10.1038/embor.2010.140; Wray KB, 2004, SCIENTOMETRICS, V61, P117, DOI 10.1023/B:SCIE.0000037367.99073.bb; Wray KB, 2003, SOC STUD SCI, V33, P137, DOI 10.1177/0306312703033001961; Zerhouni E, 2008, BREAKFAST E ZERHOUNI; Zuckerman H, 1996, SCI ELITE NOBEL LAUR; Zumeta W, 2002, ISSUES SCI TECHNOL, V19, P36; Zumeta W, 2002, BEST BRIGHTEST SCI I	35	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29738	10.1371/journal.pone.0029738	http://dx.doi.org/10.1371/journal.pone.0029738			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	897SK	22216352	Green Published, gold			2022-12-27	WOS:000300676300082
J	Wang, XD; Morgan, SC; Loeken, MR				Wang, Xiao Dan; Morgan, Sarah C.; Loeken, Mary R.			Pax3 Stimulates p53 Ubiquitination and Degradation Independent of Transcription	PLOS ONE			English	Article							CARDIAC NEURAL CREST; EMBRYONIC STEM-CELLS; DOWNSTREAM TARGET GENES; OUTFLOW TRACT SEPTATION; TUBE DEFECTS; DNA-BINDING; WAARDENBURG-SYNDROME; MICROARRAY ANALYSIS; DIABETIC PREGNANCY; HUMAN MELANOMAS	Background: Pax3 is a developmental transcription factor that is required for neural tube and neural crest development. We previously showed that inactivating the p53 tumor suppressor protein prevents neural tube and cardiac neural crest defects in Pax3-mutant mouse embryos. This demonstrates that Pax3 regulates these processes by blocking p53 function. Here we investigated the mechanism by which Pax3 blocks p53 function. Methodology/Principal Findings: We employed murine embryonic stem cell (ESC)-derived neuronal precursors as a cell culture model of embryonic neuroepithelium or neural crest. Pax3 reduced p53 protein stability, but had no effect on p53 mRNA levels or the rate of p53 synthesis. Full length Pax3 as well as fragments that contained either the DNA-binding paired box or the homeodomain, expressed as GST or FLAG fusion proteins, physically associated with p53 and Mdm2 both in vitro and in vivo. In contrast, Splotch Pax3, which causes neural tube and neural crest defects in homozygous embryos, bound weakly, or not at all, to p53 or Mdm2. The paired domain and homeodomain each stimulated Mdm2-mediated ubiquitination of p53 and p53 degradation in the absence of the Pax3 transcription regulatory domains, whereas Splotch Pax3 did not stimulate p53 ubiquitination or degradation. Conclusions/Significance: Pax3 inactivates p53 function by stimulating its ubiquitination and degradation. This process utilizes the Pax3 paired domain and homeodomain but is independent of DNA-binding and transcription regulation. Because inactivating p53 is the only required Pax3 function during neural tube closure and cardiac neural crest development, and inactivating p53 does not require Pax3-dependent transcription regulation, this indicates that Pax3 is not required to function as a transcription factor during neural tube closure and cardiac neural crest development. These findings further suggest novel explanations for PAX3 functions in human diseases, such as in neural crest-derived cancers and Waardenburg syndrome types 1 and 3.	[Wang, Xiao Dan; Morgan, Sarah C.; Loeken, Mary R.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Dev & Stem Cell Biol,Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Wang, XD (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Dev & Stem Cell Biol,Dept Med, Boston, MA 02115 USA.	mary.loeken@joslin.harvard.edu	Loeken, Mary R./AAC-2450-2022	Loeken, Mary R./0000-0002-8056-9816	Diabetes Endocrine Research Center of the Joslin Diabetes Center; DNA sequencing Core of the Dana Farber/Harvard Cancer Center;  [RO1 DK52865]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052865] Funding Source: NIH RePORTER	Diabetes Endocrine Research Center of the Joslin Diabetes Center; DNA sequencing Core of the Dana Farber/Harvard Cancer Center; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by RO1 DK52865 (to MRL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We appreciate the assistance of Jennifer Waters and other members of the Nikon Imaging Center at Harvard Medical School. Dr. Wei Gu provided plasmids encoding GST fusion proteins of human p53 and HDM2 and helpful advice. We acknowledge the contributions of core laboratories supported by the Diabetes Endocrine Research Center of the Joslin Diabetes Center, and the DNA sequencing Core of the Dana Farber/Harvard Cancer Center.	AUERBACH R, 1954, J EXP ZOOL, V127, P305, DOI 10.1002/jez.1401270206; Bardeesy N, 2001, MOL CELL BIOL, V21, P2144, DOI 10.1128/MCB.21.6.2144-2153.2001; Bendall AJ, 1999, DEVELOPMENT, V126, P4965; BOBER E, 1994, DEVELOPMENT, V120, P603; Cai J, 1998, DIABETES, V47, P1803, DOI 10.2337/diabetes.47.11.1803; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P12745, DOI 10.1073/pnas.91.26.12745; CHALEPAKIS G, 1994, NUCLEIC ACIDS RES, V22, P3131, DOI 10.1093/nar/22.15.3131; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P3685, DOI 10.1073/pnas.91.9.3685; CHALEPAKIS G, 1995, GENE, V162, P267, DOI 10.1016/0378-1119(95)00345-7; Chang TI, 2003, DIABETOLOGIA, V46, P538, DOI 10.1007/s00125-003-1063-2; EPSTEIN DJ, 1993, P NATL ACAD SCI USA, V90, P532, DOI 10.1073/pnas.90.2.532; Epstein JA, 2000, DEVELOPMENT, V127, P1869; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; Fenby BT, 2008, BBA-GENE REGUL MECH, V1779, P115, DOI 10.1016/j.bbagrm.2007.11.008; Galibert MD, 1999, J BIOL CHEM, V274, P26894, DOI 10.1074/jbc.274.38.26894; Gershon TR, 2005, NEOPLASIA, V7, P575, DOI 10.1593/neo.04637; GOULDING M, 1993, GENOMICS, V17, P355, DOI 10.1006/geno.1993.1332; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Harris RG, 2002, J BIOL CHEM, V277, P34815, DOI 10.1074/jbc.M109609200; Hill AL, 1998, DEV GENES EVOL, V208, P128, DOI 10.1007/s004270050163; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kwang SJ, 2002, DEVELOPMENT, V129, P527; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lynch MP, 1998, J CELL BIOCHEM, V68, P31; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; MAULBECKER CC, 1993, EMBO J, V12, P2361, DOI 10.1002/j.1460-2075.1993.tb05890.x; Mayanil CSK, 2006, J BIOL CHEM, V281, P24544, DOI 10.1074/jbc.M512449200; Mayanil CSK, 2001, J BIOL CHEM, V276, P49299, DOI 10.1074/jbc.M107933200; Morgan SC, 2008, MECH DEVELOP, V125, P757, DOI 10.1016/j.mod.2008.07.003; Musi N, 2001, DIABETES, V50, P921, DOI 10.2337/diabetes.50.5.921; Olaopa M, 2011, DEV BIOL, V356, P308, DOI 10.1016/j.ydbio.2011.05.583; Pani L, 2002, GENE DEV, V16, P676, DOI 10.1101/gad.969302; Perry P, 2004, CELL CYCLE, V3, P1645; Phelan SA, 1998, J BIOL CHEM, V273, P19153, DOI 10.1074/jbc.273.30.19153; Phelan SA, 1997, DIABETES, V46, P1189, DOI 10.2337/diabetes.46.7.1189; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Relaix F, 2003, GENE DEV, V17, P2950, DOI 10.1101/gad.281203; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; Scholl FA, 2001, CANCER RES, V61, P823; Schulte TW, 1997, BIOCHEM MOL MED, V60, P121, DOI 10.1006/bmme.1997.2567; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Stamataki D, 2001, FEBS LETT, V499, P274, DOI 10.1016/S0014-5793(01)02556-X; STUART ET, 1994, ANNU REV GENET, V28, P219, DOI 10.1146/annurev.ge.28.120194.001251; STUART ET, 1995, EMBO J, V14, P5638, DOI 10.1002/j.1460-2075.1995.tb00251.x; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Toda I, 1998, CLIN IMMUNOL IMMUNOP, V86, P59, DOI 10.1006/clin.1997.4466; Underwood TJ, 2007, FEBS LETT, V581, P5831, DOI 10.1016/j.febslet.2007.11.056; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Vachtenheim J, 1999, CELL MOL BIOL, V45, P1075; VOGAN K, 1993, CANCER RES, V53, P5269; Wang QY, 2007, INT J CANCER, V120, P1223, DOI 10.1002/ijc.22316; Watanabe A, 1998, NAT GENET, V18, P283, DOI 10.1038/ng0398-283; Wheat W, 1999, MOL CELL BIOL, V19, P2231; Wiggan O, 1998, ONCOGENE, V16, P227, DOI 10.1038/sj.onc.1201534	59	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29379	10.1371/journal.pone.0029379	http://dx.doi.org/10.1371/journal.pone.0029379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216266	Green Submitted, Green Published, gold			2022-12-27	WOS:000300676300051
J	Bai, F; Xie, CM; Watson, DR; Shi, YM; Yuan, YG; Wang, Y; Yue, CX; Teng, YH; Wu, D; Zhang, ZJ				Bai, Feng; Xie, Chunming; Watson, David R.; Shi, Yongmei; Yuan, Yonggui; Wang, Yi; Yue, Chunxian; Teng, Yuhuan; Wu, Di; Zhang, Zhijun			Aberrant Hippocampal Subregion Networks Associated with the Classifications of aMCI Subjects: A Longitudinal Resting-State Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; POSTERIOR CINGULATE CORTEX; ALZHEIMERS-DISEASE; FUNCTIONAL CONNECTIVITY; ENTORHINAL CORTEX; SPATIAL MEMORY; ATROPHY; CONVERSION; CA3; MRI	Background: Altered hippocampal structure and function is a valuable indicator of possible conversion from amnestic type mild cognitive impairment (aMCI) to Alzheimer's disease (AD). However, little is known about the disrupted functional connectivity of hippocampus subregional networks in aMCI subjects. Methodology/Principal Findings: aMCI group-1 (n = 26) and controls group-1 (n = 18) underwent baseline and after approximately 20 months follow up resting-state fMRI scans. Integrity of distributed functional connectivity networks incorporating six hippocampal subregions (i.e. cornu ammonis, dentate gyrus and subicular complex, bilaterally) was then explored over time and comparisons made between groups. The ability of these extent longitudinal changes to separate unrelated groups of 30 subjects (aMCI-converters, n = 6; aMCI group-2, n = 12; controls group-2, n = 12) were further assessed. Six longitudinal hippocampus subregional functional connectivity networks showed similar changes in aMCI subjects over time, which were mainly associated with medial frontal gyrus, lateral temporal cortex, insula, posterior cingulate cortex (PCC) and cerebellum. However, the disconnection of hippocampal subregions and PCC may be a key factor of impaired episodic memory in aMCI, and the functional index of these longitudinal changes allowed well classifying independent samples of aMCI converters from non-converters (sensitivity was 83.3%, specificity was 83.3%) and controls (sensitivity was 83.3%, specificity was 91.7%). Conclusions/Significance: It demonstrated that the functional changes in resting-state hippocampus subregional networks could be an important and early indicator for dysfunction that may be particularly relevant to early stage changes and progression of aMCI subjects.	[Bai, Feng; Xie, Chunming; Wang, Yi; Yue, Chunxian; Teng, Yuhuan; Wu, Di; Zhang, Zhijun] Southeast Univ, Sch Med, Nanjing, Jiangsu, Peoples R China; [Bai, Feng; Shi, Yongmei; Yuan, Yonggui; Zhang, Zhijun] Southeast Univ, Affiliated ZhongDa Hosp, Inst Neuropsychiat, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Xie, Chunming] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Watson, David R.] Univ Ulster, Derry, North Ireland	Southeast University - China; Southeast University - China; Medical College of Wisconsin; Ulster University	Bai, F (corresponding author), Southeast Univ, Sch Med, Nanjing, Jiangsu, Peoples R China.	zhijunzhang838@yahoo.com.cn	Yuan, Yonggui/AFA-0807-2022	Yuan, Yonggui/0000-0001-6496-3998; Wu, Di/0000-0003-3014-9087	National Natural Science Foundation of China [30825014, 30971016, 81010063]; National Basic Research Program of China (973 Program) [2007CB512308]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This project was supported by the National Natural Science Foundation of China (No. 30825014; No. 30971016; No. 81010063), and the National Basic Research Program of China (973 Program) (No. 2007CB512308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisen PS, 2010, ALZHEIMERS DEMENT, V6, P239, DOI 10.1016/j.jalz.2010.03.006; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Apostolova LG, 2006, ARCH NEUROL-CHICAGO, V63, P693, DOI 10.1001/archneur.63.5.693; Apostolova LG, 2010, HUM BRAIN MAPP, V31, P786, DOI 10.1002/hbm.20905; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bai F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024271; Bai F, 2009, BRAIN RES, V1302, P167, DOI 10.1016/j.brainres.2009.09.028; Bai F, 2009, BIOL PSYCHIAT, V65, P951, DOI 10.1016/j.biopsych.2008.10.017; Baker Mary, 2008, Open Neuroimag J, V2, P52, DOI 10.2174/1874440000802010052; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Burggren AC, 2008, NEUROIMAGE, V41, P1177, DOI 10.1016/j.neuroimage.2008.03.039; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Frisoni GB, 2009, NEUROLOGY, V72, P1504, DOI 10.1212/WNL.0b013e3181a2e896; Gilbert PE, 2009, PROG NEURO-PSYCHOPH, V33, P774, DOI 10.1016/j.pnpbp.2009.03.037; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hirao K, 2005, NEUROIMAGE, V28, P1014, DOI 10.1016/j.neuroimage.2005.06.066; Jack CR, 2000, NEUROLOGY, V55, P484, DOI 10.1212/WNL.55.4.484; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones BF, 2006, CEREB CORTEX, V16, P1701, DOI 10.1093/cercor/bhj105; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Langston RF, 2010, BEHAV BRAIN RES, V215, P275, DOI 10.1016/j.bbr.2010.07.006; Li S, 2007, AM J NEURORADIOL, V28, P1339, DOI 10.3174/ajnr.A0620; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; MCNEIL BJ, 1984, MED DECIS MAKING, V4, P137, DOI 10.1177/0272989X8400400203; Miller SL, 2008, J NEUROL NEUROSUR PS, V79, P630, DOI 10.1136/jnnp.2007.124149; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Mueller SG, 2008, NEUROIMAGE, V42, P42, DOI 10.1016/j.neuroimage.2008.04.174; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Okada K, 2009, BEHAV BRAIN RES, V200, P181, DOI 10.1016/j.bbr.2009.01.011; Pennanen C, 2004, NEUROBIOL AGING, V25, P303, DOI 10.1016/S0197-4580(03)00084-8; Petersen RC, 2000, NEUROLOGY, V54, P581, DOI 10.1212/WNL.54.3.581; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2008, CNS SPECTRUMS, V13, P45, DOI 10.1017/S1092852900016151; Petrella JR, 2006, RADIOLOGY, V240, P177, DOI 10.1148/radiol.2401050739; Rombouts Serge, 2005, Current Alzheimer Research, V2, P115, DOI 10.2174/1567205053585783; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Suthana NA, 2010, NEUROIMAGE, V53, P1077, DOI 10.1016/j.neuroimage.2009.12.014; Walhovd KB, 2010, AM J NEURORADIOL, V31, P347, DOI 10.3174/ajnr.A1809; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yassa MA, 2010, NEUROIMAGE, V51, P1242, DOI 10.1016/j.neuroimage.2010.03.040; Zhou YX, 2008, ALZHEIMERS DEMENT, V4, P265, DOI 10.1016/j.jalz.2008.04.006	48	45	46	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29288	10.1371/journal.pone.0029288	http://dx.doi.org/10.1371/journal.pone.0029288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216234	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000300674900024
J	Khatri, M; Saif, YM				Khatri, Mahesh; Saif, Yehia M.			Epithelial Cells Derived from Swine Bone Marrow Express Stem Cell Markers and Support Influenza Virus Replication In Vitro	PLOS ONE			English	Article							CYTOKINE RESPONSES; H5N1 VIRUSES; LUNG; MODEL; INFECTION; IDENTIFICATION; POPULATION; TRANSPLANTATION; ENGRAFTMENT; PATHOLOGY	The bone marrow contains heterogeneous population of cells that are involved in the regeneration and repair of diseased organs, including the lungs. In this study, we isolated and characterized progenitor epithelial cells from the bone marrow of 4- to 5-week old germ-free pigs. Microscopically, the cultured cells showed epithelial-like morphology. Phenotypically, these cells expressed the stem cell markers octamer-binding transcription factor (Oct4) and stage-specific embryonic antigen-1 (SSEA-1), the alveolar stem cell marker Clara cell secretory protein (Ccsp), and the epithelial cell markers pan-cytokeratin (Pan-K), cytokeratin-18 (K-18), and occludin. When cultured in epithelial cell growth medium, the progenitor epithelial cells expressed type I and type II pneumocyte markers. Next, we examined the susceptibility of these cells to influenza virus. Progenitor epithelial cells expressed sialic acid receptors utilized by avian and mammalian influenza viruses and were targets for influenza virus replication. Additionally, differentiated type II but not type I pneumocytes supported the replication of influenza virus. Our data indicate that we have identified a unique population of progenitor epithelial cells in the bone marrow that might have airway reconstitution potential and may be a useful model for cell-based therapies for infectious and non-infectious lung diseases.	[Khatri, Mahesh; Saif, Yehia M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA	University System of Ohio; Ohio State University	Khatri, M (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA.	khatri.14@osu.edu	Saif, Yehia/E-4004-2011					Awad HA, 2003, J ORTHOP RES, V21, P420, DOI 10.1016/S0736-0266(02)00163-8; Chang C, 2008, CYTOTHERAPY, V10, P796, DOI 10.1080/14653240802461924; Chen JW, 2004, LAB INVEST, V84, P727, DOI 10.1038/labinvest.3700095; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Comite P, 2010, TRANSPL P, V42, P1341, DOI 10.1016/j.transproceed.2010.03.080; Cozzi E, 1997, TRANSPLANTATION, V64, P1383, DOI 10.1097/00007890-199711270-00002; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Garten RJ, 2009, SCIENCE; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Ibrahim Z, 2006, XENOTRANSPLANTATION, V13, P488, DOI 10.1111/j.1399-3089.2006.00346.x; Khatri M, 2010, J VIROL, V84, P11210, DOI 10.1128/JVI.01211-10; Khatri M, 2009, STEM CELLS DEV, V18, P1485, DOI 10.1089/scd.2008.0223; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kotton DN, 2001, DEVELOPMENT, V128, P5181; Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025; Lim JH, 2010, CELL REPROGRAM, V12, P689, DOI 10.1089/cell.2010.0039; Ling TY, 2006, P NATL ACAD SCI USA, V103, P9530, DOI 10.1073/pnas.0510232103; MacPherson H, 2005, J CELL SCI, V118, P2441, DOI 10.1242/jcs.02375; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Noel Daniele, 2002, Curr Opin Investig Drugs, V3, P1000; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Otani A, 2002, NAT MED, V8, P1004, DOI 10.1038/nm744; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reynolds SD, 2007, AM J PHYSIOL-LUNG C, V292, pL972, DOI 10.1152/ajplung.00090.2006; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, AM J PHYSIOL-LUNG C, V295, pL240, DOI 10.1152/ajplung.90203.2008; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Sueblinvong V, 2008, AM J RESP CRIT CARE, V177, P701, DOI 10.1164/rccm.200706-859OC; Summer R, 2003, AM J PHYSIOL-LUNG C, V285, pL97, DOI 10.1152/ajplung.00009.2003; Suzuki K, 2009, J VIROL; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; van Haaften T, 2009, AM J RESP CRIT CARE, V180, P1131, DOI 10.1164/rccm.200902-0179OC; Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102; Wong AP, 2009, J CLIN INVEST, V119, P336, DOI 10.1172/JCI36882; World Health Organization, 2009, INFL SEAS FACT SHEET; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07; Zhang ZF, 2009, HUM PATHOL, V40, P735, DOI 10.1016/j.humpath.2008.08.015; Zhou L, 2011, STEM CELLS, V29, P972, DOI 10.1002/stem.637	58	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29567	10.1371/journal.pone.0029567	http://dx.doi.org/10.1371/journal.pone.0029567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216319	gold, Green Published, Green Submitted			2022-12-27	WOS:000299684700071
J	Geng, HF; Whiteley, G; Ribbens, J; Zheng, W; Southall, N; Hu, X; Marugan, JJ; Ferrer, M; Maegawa, GHB				Geng, Haifeng; Whiteley, Grace; Ribbens, Jameson; Zheng, Wei; Southall, Noel; Hu, Xin; Marugan, Juan J.; Ferrer, Marc; Maegawa, Gustavo H. B.			Novel Patient Cell-Based HTS Assay for Identification of Small Molecules for a Lysosomal Storage Disease	PLOS ONE			English	Article							THROUGHPUT SCREENING ASSAYS; METACHROMATIC LEUKODYSTROPHY; ARYLSULFATASE-A; PHARMACOLOGICAL CHAPERONES; BETA-HEXOSAMINIDASE; GAUCHER-DISEASE; ENZYME; INHIBITORS; FIBROBLASTS; DISORDERS	Small molecules have been identified as potential therapeutic agents for lysosomal storage diseases (LSDs), inherited metabolic disorders caused by defects in proteins that result in lysosome dysfunctional. Some small molecules function assisting the folding of mutant misfolded lysosomal enzymes that are otherwise degraded in ER-associated degradation. The ultimate result is the enhancement of the residual enzymatic activity of the deficient enzyme. Most of the high throughput screening (HTS) assays developed to identify these molecules are single-target biochemical assays. Here we describe a cell-based assay using patient cell lines to identify small molecules that enhance the residual arylsulfatase A (ASA) activity found in patients with metachromatic leukodystrophy (MLD), a progressive neurodegenerative LSD. In order to generate sufficient cell lines for a large scale HTS, primary cultured fibroblasts from MLD patients were transformed using SV40 large T antigen. These SV40 transformed (SV40t) cells showed to conserve biochemical characteristics of the primary cells. Using a specific colorimetric substrate para-nitrocatechol sulfate (pNCS), detectable ASA residual activity were observed in primary and SV40t fibroblasts from a MLD patient (ASA-I179S) cultured in multi-well plates. A robust fluorescence ASA assay was developed in high-density 1,536-well plates using the traditional colorimetric pNCS substrate, whose product (pNC) acts as "plate fluorescence quencher" in white solid-bottom plates. The quantitative cell-based HTS assay for ASA generated strong statistical parameters when tested against a diverse small molecule collection. This cell-based assay approach can be used for several other LSDs and genetic disorders, especially those that rely on colorimetric substrates which traditionally present low sensitivity for assay-miniaturization. In addition, the quantitative cell-based HTS assay here developed using patient cells creates an opportunity to identify therapeutic small molecules in a disease-cellular environment where potentially disrupted pathways are exposed and available as targets.	[Geng, Haifeng; Ribbens, Jameson; Maegawa, Gustavo H. B.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA; [Maegawa, Gustavo H. B.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Whiteley, Grace; Zheng, Wei; Southall, Noel; Hu, Xin; Marugan, Juan J.; Ferrer, Marc] NIH, NIH Chem Genom Ctr, Rockville, MD USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Geng, HF (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	gmaegaw1@jhmmi.edu	Zheng, Wei/J-8889-2014; Zheng, Wei/GOE-5990-2022; Geng, Haifeng/A-9681-2012; Southall, Noel T/H-8991-2012	Zheng, Wei/0000-0003-1034-0757; Southall, Noel T/0000-0003-4500-880X; Maegawa, Gustavo/0000-0001-6933-4138	NIH-NINDS [1R21NS071535-01]; National Tay-Sachs and Allied Diseases Association (NTSAD); Kennedy Krieger Intellectual and Developmental Disabilities Research Center (IDDRC) [HD024061]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071535] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Tay-Sachs and Allied Diseases Association (NTSAD); Kennedy Krieger Intellectual and Developmental Disabilities Research Center (IDDRC); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by funds from NIH-NINDS grant 1R21NS071535-01 and National Tay-Sachs and Allied Diseases Association (NTSAD) Research Grant and Kennedy Krieger Intellectual and Developmental Disabilities Research Center (IDDRC, grant #HD024061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WF, 2010, MOL BIOTECHNOL, V45, P180, DOI 10.1007/s12033-010-9251-z; BAUM H, 1959, CLIN CHIM ACTA, V4, P453, DOI 10.1016/0009-8981(59)90119-6; Beck M, 2010, EXPERT OPIN EMERG DR, V15, P495, DOI 10.1517/14728214.2010.498580; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; Chambers C, 2003, COMB CHEM HIGH T SCR, V6, P355; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; FLUHARTY AL, 1991, AM J HUM GENET, V49, P1340; FRATANTONI JC, 1968, SCIENCE, V162, P570, DOI 10.1126/science.162.3853.570; FURUYA T, 1985, J INHERIT METAB DIS, V8, P143, DOI 10.1007/BF01819299; Gieselmann V, 2008, ACTA PAEDIATR, V97, P15, DOI 10.1111/j.1651-2227.2008.00648.x; Gort L, 1999, HUM MUTAT, V14, P240, DOI 10.1002/(SICI)1098-1004(1999)14:3<240::AID-HUMU7>3.3.CO;2-C; Grabowski GA, 2003, ANNU REV GENOM HUM G, V4, P403, DOI 10.1146/annurev.genom.4.070802.110415; Gribbon P, 2003, DRUG DISCOV TODAY, V8, P1035, DOI 10.1016/S1359-6446(03)02895-2; Hampton SL, 2010, CELL BIOL TOXICOL, V26, P43, DOI 10.1007/s10565-009-9140-z; HARZER K, 1973, J NEUROCHEM, V20, P279, DOI 10.1111/j.1471-4159.1973.tb12127.x; HASILIK A, 1980, J BIOL CHEM, V255, P4937; Hodder P, 2004, J BIOMOL SCREEN, V9, P417, DOI 10.1177/1087057104264038; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Lavery P, 2001, J BIOMOL SCREEN, V6, P3, DOI 10.1089/108705701750066971; LEINEKUGEL P, 1992, HUM GENET, V88, P513, DOI 10.1007/BF00219337; Li XP, 2007, EUR J PHARM BIOPHARM, V67, P284, DOI 10.1016/j.ejpb.2007.01.004; Maegawa GHB, 2007, J BIOL CHEM, V282, P9150, DOI 10.1074/jbc.M609304200; Maegawa GHB, 2009, J BIOL CHEM, V284, P23502, DOI 10.1074/jbc.M109.012393; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; MONTI E, 1992, BIOCHIM BIOPHYS ACTA, V1124, P80, DOI 10.1016/0005-2760(92)90129-J; Motabar O, 2009, ANAL BIOCHEM, V390, P79, DOI 10.1016/j.ab.2009.04.010; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; NEUFELD EF, 1989, J BIOL CHEM, V264, P10927; Poeppel P, 2005, FEBS J, V272, P1179, DOI 10.1111/j.1742-4658.2005.04553.x; Rauschka H, 2006, NEUROLOGY, V67, P859, DOI 10.1212/01.wnl.0000234129.97727.4d; Schroeter T, 2008, J BIOMOL SCREEN, V13, P17, DOI 10.1177/1087057107310806; Simeonov A, 2008, J MED CHEM, V51, P2363, DOI 10.1021/jm701301m; Smid BE, 2010, EXPERT OPIN INV DRUG, V19, P1367, DOI 10.1517/13543784.2010.524205; Tropak MB, 2007, CHEM BIOL, V14, P153, DOI 10.1016/j.chembiol.2006.12.006; Walkley SU, 2009, J INHERIT METAB DIS, V32, P181, DOI 10.1007/s10545-008-1040-5; Williams KP, 2009, METHODS MOL BIOL, V565, P107, DOI 10.1007/978-1-60327-258-2_5; Yarrow JC, 2005, CHEM BIOL, V12, P385, DOI 10.1016/j.chembiol.2005.01.015; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng W, 2007, P NATL ACAD SCI USA, V104, P13192, DOI 10.1073/pnas.0705637104; Zuck P, 2005, ANAL BIOCHEM, V342, P254, DOI 10.1016/j.ab.2005.04.029	40	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29504	10.1371/journal.pone.0029504	http://dx.doi.org/10.1371/journal.pone.0029504			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216298	Green Submitted, Green Published, gold			2022-12-27	WOS:000299113600084
J	Saunders, DGO; Win, J; Cano, LM; Szabo, LJ; Kamoun, S; Raffaele, S				Saunders, Diane G. O.; Win, Joe; Cano, Liliana M.; Szabo, Les J.; Kamoun, Sophien; Raffaele, Sylvain			Using Hierarchical Clustering of Secreted Protein Families to Classify and Rank Candidate Effectors of Rust Fungi	PLOS ONE			English	Article							THAUMATIN-LIKE PROTEINS; AVIRULENCE PROTEINS; PHYTOPHTHORA-SOJAE; DISEASE-RESISTANCE; GENOME SEQUENCE; REPEAT PROTEIN; FLAX RUST; EXPRESSION; VIRULENCE; HAUSTORIA	Rust fungi are obligate biotrophic pathogens that cause considerable damage on crop plants. Puccinia graminis f. sp. tritici, the causal agent of wheat stem rust, and Melampsora larici-populina, the poplar leaf rust pathogen, have strong deleterious impacts on wheat and poplar wood production, respectively. Filamentous pathogens such as rust fungi secrete molecules called disease effectors that act as modulators of host cell physiology and can suppress or trigger host immunity. Current knowledge on effectors from other filamentous plant pathogens can be exploited for the characterisation of effectors in the genome of recently sequenced rust fungi. We designed a comprehensive in silico analysis pipeline to identify the putative effector repertoire from the genome of two plant pathogenic rust fungi. The pipeline is based on the observation that known effector proteins from filamentous pathogens have at least one of the following properties: (i) contain a secretion signal, (ii) are encoded by in planta induced genes, (iii) have similarity to haustorial proteins, (iv) are small and cysteine rich, (v) contain a known effector motif or a nuclear localization signal, (vi) are encoded by genes with long intergenic regions, (vii) contain internal repeats, and (viii) do not contain PFAM domains, except those associated with pathogenicity. We used Markov clustering and hierarchical clustering to classify protein families of rust pathogens and rank them according to their likelihood of being effectors. Using this approach, we identified eight families of candidate effectors that we consider of high value for functional characterization. This study revealed a diverse set of candidate effectors, including families of haustorial expressed secreted proteins and small cysteine-rich proteins. This comprehensive classification of candidate effectors from these devastating rust pathogens is an initial step towards probing plant germplasm for novel resistance components.	[Saunders, Diane G. O.; Win, Joe; Cano, Liliana M.; Kamoun, Sophien; Raffaele, Sylvain] Sainsbury Lab, Norwich, Norfolk, England; [Szabo, Les J.] Agr Res Serv, Cereal Dis Lab, USDA, St Paul, MN USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; United States Department of Agriculture (USDA)	Saunders, DGO (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England.	sophien.kamoun@tsl.ac.uk; sylvain.raffaele@tsl.ac.uk	Raffaele, Sylvain/F-7187-2012; Saunders, Diane GO/N-1916-2015; Kamoun, Sophien/B-3529-2009; Raffaele, Sylvain/K-6673-2019; Cano, Liliana M/O-7041-2016; Win, Joe/H-2557-2014	Raffaele, Sylvain/0000-0002-2442-9632; Kamoun, Sophien/0000-0002-0290-0315; Raffaele, Sylvain/0000-0002-2442-9632; Cano, Liliana M/0000-0002-7996-4181; Win, Joe/0000-0002-9851-2404; Szabo, Les J./0000-0002-0477-7808	Gatsby Charitable Foundation; Leverhulme; Marie Curie IEF	Gatsby Charitable Foundation; Leverhulme; Marie Curie IEF(European Commission)	This project was funded by the Gatsby Charitable Foundation, a Leverhulme early career fellowship to D.G.O.S. and a Marie Curie IEF Fellowship to S. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BLAST2GO WEB SERVER; [Anonymous], PUCC GROUP DAT; [Anonymous], MELAMPSORA LARICIS P; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Boutemy LS, 2011, J BIOL CHEM, DOI 101074/jbc.M111.262303; Catanzariti AM, 2006, PLANT CELL, V18, P243, DOI 10.1105/tpc.105.035980; Ceroni A, 2006, NUCLEIC ACIDS RES, V34, pW177, DOI 10.1093/nar/gkl266; de Oliveira AL, 2011, J BIOL CHEM, V286, P17560, DOI 10.1074/jbc.M111.223644; Dodds PN, 2009, NEW PHYTOL, V183, P993, DOI 10.1111/j.1469-8137.2009.02922.x; Dodds PN, 2004, PLANT CELL, V16, P755, DOI 10.1105/tpc.020040; Doehlemann G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000290; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Duplessis S, 2011, P NATL ACAD SCI USA, V108, P9166, DOI 10.1073/pnas.1019315108; Ellis J, 2006, TRENDS PLANT SCI, V11, P61, DOI 10.1016/j.tplants.2005.12.008; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Godfrey D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-317; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hacquard S, 2010, MOL PLANT MICROBE IN, V23, P1275, DOI 10.1094/MPMI-05-10-0111; Hodson DP, 2011, EUPHYTICA, V179, P93, DOI 10.1007/s10681-010-0335-4; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Joly DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-422; Jorda J, 2009, BIOINFORMATICS, V25, P2632, DOI 10.1093/bioinformatics/btp482; Kamoun S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/j.pbi.2007.04.017; Kang SC, 1995, MOL PLANT MICROBE IN, V8, P939, DOI 10.1094/MPMI-8-0939; Kanneganti TD, 2007, PLANT J, V50, P149, DOI 10.1111/j.1365-313X.2007.03029.x; Kemen E, 2005, MOL PLANT MICROBE IN, V18, P1130, DOI 10.1094/MPMI-18-1130; Khang CH, 2010, PLANT CELL, V22, P1388, DOI 10.1105/tpc.109.069666; Kolmer JA, 2009, RUST FUNGI; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Larous L, 2008, J PLANT PATHOL, V90, P185; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li W, 2009, MOL PLANT MICROBE IN, V22, P411, DOI 10.1094/MPMI-22-4-0411; Liu JJ, 2010, PLANT CELL REP, V29, P419, DOI 10.1007/s00299-010-0826-8; Liu TL, 2011, PLANT PHYSIOL, V155, P490, DOI 10.1104/pp.110.166470; Liu XY, 2010, ACTA BIOCH BIOPH SIN, V42, P793, DOI 10.1093/abbs/gmq093; Milne TJ, 2003, J BIOL CHEM, V278, P31105, DOI 10.1074/jbc.M304843200; Nair R, 2003, PROTEINS, V53, P917, DOI 10.1002/prot.10507; Newton HJ, 2007, INFECT IMMUN, V75, P5575, DOI 10.1128/IAI.00443-07; Petre B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-33; PIETERSE CMJ, 1994, MOL GEN GENET, V244, P269, DOI 10.1007/BF00285454; Pinon J, 1997, EUR J PLANT PATHOL, V103, P159, DOI 10.1023/A:1008650128568; Pretorius Z. A., 2000, Plant Disease, V84, P203, DOI 10.1094/PDIS.2000.84.2.203B; Raffaele S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-637; Rafiqi M, 2010, PLANT CELL, V22, P2017, DOI 10.1105/tpc.109.072983; Rep M, 2005, FEMS MICROBIOL LETT, V253, P19, DOI 10.1016/j.femsle.2005.09.014; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; Rouxel T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1189; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Shim WB, 2006, MOL PLANT MICROBE IN, V19, P725, DOI 10.1094/MPMI-19-0725; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; Singh RP, 2011, ANN REV PHYTOPATHOLO, V49; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Szeto CYY, 2007, GENE, V393, P87, DOI 10.1016/j.gene.2007.01.030; Tompa P, 2010, BIOCHEM CELL BIOL, V88, P167, DOI [10.1139/O09-163, 10.1139/o09-163]; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Vleeshouwers V. G., 2011, ANNU REV PHYTOPATHOL, V49, P2521; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Wang XQ, 1996, P NATL ACAD SCI USA, V93, P2598, DOI 10.1073/pnas.93.6.2598; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Xu JH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-161; Yin CT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-626; Yoshida K, 2009, PLANT CELL, V21, P1573, DOI 10.1105/tpc.109.066324	67	172	181	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29847	10.1371/journal.pone.0029847	http://dx.doi.org/10.1371/journal.pone.0029847			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238666	gold, Green Submitted, Green Published			2022-12-27	WOS:000301188800042
J	Djebali, S; Lagarde, J; Kapranov, P; Lacroix, V; Borel, C; Mudge, JM; Howald, C; Foissac, S; Ucla, C; Chrast, J; Ribeca, P; Martin, D; Murray, RR; Yang, XP; Ghamsari, L; Lin, CW; Bell, I; Dumais, E; Drenkow, J; Tress, ML; Gelpi, JL; Orozco, M; Valencia, A; van Berkum, NL; Lajoie, BR; Vidal, M; Stamatoyannopoulos, J; Batut, P; Dobin, A; Harrow, J; Hubbard, T; Dekker, J; Frankish, A; Salehi-Ashtiani, K; Reymond, A; Antonarakis, SE; Guigo, R; Gingeras, TR				Djebali, Sarah; Lagarde, Julien; Kapranov, Philipp; Lacroix, Vincent; Borel, Christelle; Mudge, Jonathan M.; Howald, Cedric; Foissac, Sylvain; Ucla, Catherine; Chrast, Jacqueline; Ribeca, Paolo; Martin, David; Murray, Ryan R.; Yang, Xinping; Ghamsari, Lila; Lin, Chenwei; Bell, Ian; Dumais, Erica; Drenkow, Jorg; Tress, Michael L.; Lluis Gelpi, Josep; Orozco, Modesto; Valencia, Alfonso; van Berkum, Nynke L.; Lajoie, Bryan R.; Vidal, Marc; Stamatoyannopoulos, John; Batut, Philippe; Dobin, Alex; Harrow, Jennifer; Hubbard, Tim; Dekker, Job; Frankish, Adam; Salehi-Ashtiani, Kourosh; Reymond, Alexandre; Antonarakis, Stylianos E.; Guigo, Roderic; Gingeras, Thomas R.			Evidence for Transcript Networks Composed of Chimeric RNAs in Human Cells	PLOS ONE			English	Article							REVERSE TRANSCRIPTION; HUMAN GENOME; GENE FUSION; ANNOTATION; DISCOVERY; SITES; CLONING; RACE	The classic organization of a gene structure has followed the Jacob and Monod bacterial gene model proposed more than 50 years ago. Since then, empirical determinations of the complexity of the transcriptomes found in yeast to human has blurred the definition and physical boundaries of genes. Using multiple analysis approaches we have characterized individual gene boundaries mapping on human chromosomes 21 and 22. Analyses of the locations of the 5' and 3' transcriptional termini of 492 protein coding genes revealed that for 85% of these genes the boundaries extend beyond the current annotated termini, most often connecting with exons of transcripts from other well annotated genes. The biological and evolutionary importance of these chimeric transcripts is underscored by (1) the non-random interconnections of genes involved, (2) the greater phylogenetic depth of the genes involved in many chimeric interactions, (3) the coordination of the expression of connected genes and (4) the close in vivo and three dimensional proximity of the genomic regions being transcribed and contributing to parts of the chimeric RNAs. The non-random nature of the connection of the genes involved suggest that chimeric transcripts should not be studied in isolation, but together, as an RNA network.	[Djebali, Sarah; Lagarde, Julien; Lacroix, Vincent; Foissac, Sylvain; Ribeca, Paolo; Martin, David; Guigo, Roderic] Ctr Genom Regulat, Barcelona, Catalonia, Spain; [Guigo, Roderic] Univ Pompeu Fabra, Dept Ciences Expt & Salut, Barcelona, Catalonia, Spain; [Kapranov, Philipp; Foissac, Sylvain; Bell, Ian; Dumais, Erica; Gingeras, Thomas R.] Affymetrix Inc, Santa Clara, CA USA; [Borel, Christelle; Ucla, Catherine; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, Univ Hosp Geneva, CH-1211 Geneva, Switzerland; [Mudge, Jonathan M.; Harrow, Jennifer; Hubbard, Tim; Frankish, Adam] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Howald, Cedric; Chrast, Jacqueline; Reymond, Alexandre] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Murray, Ryan R.; Yang, Xinping; Ghamsari, Lila; Lin, Chenwei; Vidal, Marc; Salehi-Ashtiani, Kourosh] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Murray, Ryan R.; Yang, Xinping; Ghamsari, Lila; Lin, Chenwei; Vidal, Marc; Salehi-Ashtiani, Kourosh] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Murray, Ryan R.; Yang, Xinping; Ghamsari, Lila; Lin, Chenwei; Vidal, Marc; Salehi-Ashtiani, Kourosh] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Drenkow, Jorg; Batut, Philippe; Dobin, Alex; Gingeras, Thomas R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Tress, Michael L.; Valencia, Alfonso] Spanish Natl Canc Res Ctr, Struct Biol & Biocomp Programme, Madrid, Spain; [Lluis Gelpi, Josep; Orozco, Modesto] Univ Barcelona, Fac Biol, Inst Res Biomed, Barcelona, Catalonia, Spain; [Lluis Gelpi, Josep; Orozco, Modesto] Univ Barcelona, Fac Biol, Barcelona Supercomp Ctr, Joint Program Computat Biol, Barcelona, Catalonia, Spain; [Stamatoyannopoulos, John] Univ Washington, Seattle, WA 98195 USA; [van Berkum, Nynke L.; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA; [Salehi-Ashtiani, Kourosh] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Salehi-Ashtiani, Kourosh] New York Univ Abu Dhabi, Abu Dhabi, U Arab Emirates	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Affymetrix; University of Geneva; Wellcome Trust Sanger Institute; University of Lausanne; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Cold Spring Harbor Laboratory; Centro Nacional de Investigaciones Oncologicas (CNIO); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; University of Barcelona; University of Washington; University of Washington Seattle; University of Massachusetts System; University of Massachusetts Worcester; New York University	Djebali, S (corresponding author), Ctr Genom Regulat, Barcelona, Catalonia, Spain.	Stylianos.Antonarakis@unige.ch; roderic.guigo@crg.cat; gingeras@cshl.edu	Yang, Xinping/HGA-6104-2022; Kutalik, Zoltan/HHZ-5697-2022; borel, christelle/AAC-9645-2019; Valencia, Alfonso/I-3127-2015; Guigo, Roderic/D-1303-2010; Lacroix, Vincent/M-2906-2015; Gelpí, Josep Ll./M-6401-2013; Antonarakis, Stylianos E/N-8866-2014; Djebali, Sarah/O-9817-2014; Hubbard, Tim J.P./AAT-4571-2020; Hubbard, Tim J/C-2567-2008; Lagarde, Julien/AAI-1686-2020	Kutalik, Zoltan/0000-0001-8285-7523; Valencia, Alfonso/0000-0002-8937-6789; Guigo, Roderic/0000-0002-5738-4477; Lacroix, Vincent/0000-0002-4235-8524; Gelpí, Josep Ll./0000-0002-0566-7723; Antonarakis, Stylianos E/0000-0001-8907-5823; Djebali, Sarah/0000-0002-0599-1267; Hubbard, Tim J.P./0000-0002-1767-9318; Hubbard, Tim J/0000-0002-1767-9318; Lagarde, Julien/0000-0002-0290-7445; Orozco Lopez, Modesto/0000-0002-8608-3278; Salehi-Ashtiani, Kourosh/0000-0002-6521-5243; Foissac, Sylvain/0000-0002-2631-5356; Frankish, Adam/0000-0002-4333-628X; Kapranov, Philipp/0000-0003-2647-4856; Dobin, Alexander/0000-0002-4115-9128; Gingeras, Thomas/0000-0001-9106-3573; Yang, Xinping/0000-0003-4086-4180; Tress, Michael/0000-0001-9046-6370; Harrow, Jennifer/0000-0003-0338-3070; Mudge, Jonathan/0000-0003-4789-7495; Reymond, Alexandre/0000-0003-1030-8327; Batut, Philippe/0000-0003-4250-0663	National Human Genome Research for the ENCODE [U01HG003150, U01HG003147]; Spanish Ministry of Education and Science; Ellison Foundation; Dana Farber Cancer Institute Strategic Initiative; Swiss National Science Foundation; European Commission; National Center of Excellence; ChildCare Foundation; European Union; Wellcome Trust; Spanish Ministry of Science [CTQ2005-09365-C02-02, BIO2009-10964]; Instituto Nacional de Bioinformatica; Consolider E-science project [CSD2007-00050]; COMBIOMED RETICS; Fundacion Marcelino Botin; National Institutes of Health [HG003143, U54 HG004592]; Consolider E-Science [CSD2007-00050]; Fonds de la Recherche Scientifique (FRS-FNRS, French Community of Belgium); NHGRI [U54HG004557]; W.M. Keck Foundation; Affymetrix Inc.; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143, U54HG004557, U54HG004592, U01HG003150, U01HG003147] Funding Source: NIH RePORTER	National Human Genome Research for the ENCODE; Spanish Ministry of Education and Science(Spanish Government); Ellison Foundation(Lawrence Ellison Foundation); Dana Farber Cancer Institute Strategic Initiative; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); National Center of Excellence; ChildCare Foundation; European Union(European Commission); Wellcome Trust(Wellcome Trust); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto Nacional de Bioinformatica; Consolider E-science project; COMBIOMED RETICS; Fundacion Marcelino Botin; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consolider E-Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fonds de la Recherche Scientifique (FRS-FNRS, French Community of Belgium)(Fonds de la Recherche Scientifique - FNRS); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); W.M. Keck Foundation(W.M. Keck Foundation); Affymetrix Inc.; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work has been supported by grants U01HG003150 and U01HG003147 from the National Human Genome Research for the ENCODE project (http://www.genome.gov/10005107) to RG (CRG, Lausanne and Geneva) and TG (Affymetrix and Cold Spring Harbor). RG was also supported by a grant from the Spanish Ministry of Education and Science (http://www.educacion.gob.es/portada.html). In addition, KS-A, RM, XY, CL, LG and MV were supported by a grant from the Ellison Foundation (http://www.ellisonfoundation.org/index.jsp) (to MV) and as Institute Sponsored Research from the Dana Farber Cancer Institute Strategic Initiative. They wish to thank Changyu Fan and Yun Shen for providing informatics support. The laboratories of SA and AR were supported by grants from the Swiss National Science Foundation (http://www.snf.ch/E/Pages/default.aspx), and the European Commission AnEUploidy Integrated Project (http://www.tigem.it/scientific-office/eu-funded-projects-1/aneuploidy). SA was also supported by the National Center of Excellence "Frontiers in Genetics" (http://www.frontiers-ingenetics.org/page.php?id=profile_en), ChildCare Foundation (http://www.projectchildcarefoundation.org/) and an ERC grant from the European Union (http://erc.europa.eu/). AF, TH and JM acknowledge support from the Wellcome Trust (http://www.wellcome.ac.uk/). The work of JLG and MO has been supported by the Spanish Ministry of Science (CTQ2005-09365-C02-02, BIO2009-10964), Instituto Nacional de Bioinformatica (http://www.inab.org/), the Consolider E-science project (CSD2007-00050), COMBIOMED RETICS and the Fundacion Marcelino Botin (http://www.fundacionmbotin.org/). JD is supported by a grant from the National Institutes of Health (HG003143) and a W.M. Keck Foundation Distinguished Young Scholar Award. JS is supported by a grant from the National Institutes of Health (U54 HG004592). The work of MT and AV was supported by Consolider E-Science (CSD2007-00050) and the Instituto Nacional de Bioinformatica (http://www.inab.org/). MV (Center for Cancer Systems Biology, CCSB) is a "Chercheur Qualifie Honoraire'' from the Fonds de la Recherche Scientifique (FRS-FNRS, French Community of Belgium). This work has also been funded by grant to TG by NHGRI (U54HG004557) (http://www.genome.gov/10005107) and partially by Affymetirix, Corp (http://www.affymetrix.com/estore/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Affymetrix manufactured the arrays used and these were purchased at the sale price agreed to in the reported grant.; The study was partially funded by Affymetrix Inc. PK, SF, IB, ED, J.Drenkow, AD and TG were employees of Affymetrix Inc. at the time of the study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bowman RR, 1998, J VIROL, V72, P5198, DOI 10.1128/JVI.72.6.5198-5206.1998; Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; Collins JE, 2003, GENOME RES, V13, P27, DOI 10.1101/gr.695703; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Djebali S, 2008, NAT METHODS, V5, P629, DOI 10.1038/nmeth.1216; Dobin A, 2011, STAR MAPPING N UNPUB; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Durbin R, 2005, ONLINE ENCY GENETICS; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; Gingeras TR, 2009, NATURE, V461, P206, DOI 10.1038/nature08452; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Houseley J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012271; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kannan K, 2011, P NATL ACAD SCI USA, V108, P9172, DOI 10.1073/pnas.1100489108; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khanin R, 2006, J COMPUT BIOL, V13, P810, DOI 10.1089/cmb.2006.13.810; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Krzywinski MI, 2009, GENOME RES; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Li X, 2009, J MOL EVOL, V68, P56, DOI 10.1007/s00239-008-9187-0; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; McManus CJ, 2010, P NATL ACAD SCI USA, V107, P12975, DOI 10.1073/pnas.1007586107; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; Pombo A, 1996, EXP CELL RES, V229, P201, DOI 10.1006/excr.1996.0360; Qu Yongxia, 2007, Methods Mol Biol, V366, P145; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Roy SW, 2008, BIOESSAYS, V30, P601, DOI 10.1002/bies.20749; Rozen S, 2000, Methods Mol Biol, V132, P365; Salehi-Ashtiani K, 2008, NAT METHODS, V5, P597, DOI 10.1038/nmeth.1224; Searle SMJ, 2004, GENOME RES, V14, P963, DOI 10.1101/gr.1864804; Sonnhammer ELL, 2001, PROTEINS, V45, P262, DOI 10.1002/prot.1146; TEMIN HM, 1993, P NATL ACAD SCI USA, V90, P6900, DOI 10.1073/pnas.90.15.6900; Thorvaldsen JL, 2001, METH MOL B, V181, P133; Unneberg P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000254; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; Wu XM, 2009, SCI CHINA SER C, V52, P560, DOI 10.1007/s11427-009-0078-4	45	47	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28213	10.1371/journal.pone.0028213	http://dx.doi.org/10.1371/journal.pone.0028213			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238572	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000301070200004
J	Giri, V; Jain, S				Giri, Varun; Jain, Sanjay			The Origin of Large Molecules in Primordial Autocatalytic Reaction Networks	PLOS ONE			English	Article							PREBIOTIC CHEMISTRY; RNA WORLD; INTERMEDIARY METABOLISM; AMINO-ACIDS; EMERGENCE; CATALYSIS; REPLICATORS; MODELS; LIFE; ORGANOCATALYSIS	Large molecules such as proteins and nucleic acids are crucial for life, yet their primordial origin remains a major puzzle. The production of large molecules, as we know it today, requires good catalysts, and the only good catalysts we know that can accomplish this task consist of large molecules. Thus the origin of large molecules is a chicken and egg problem in chemistry. Here we present a mechanism, based on autocatalytic sets (ACSs), that is a possible solution to this problem. We discuss a mathematical model describing the population dynamics of molecules in a stylized but prebiotically plausible chemistry. Large molecules can be produced in this chemistry by the coalescing of smaller ones, with the smallest molecules, the 'food set', being buffered. Some of the reactions can be catalyzed by molecules within the chemistry with varying catalytic strengths. Normally the concentrations of large molecules in such a scenario are very small, diminishing exponentially with their size. ACSs, if present in the catalytic network, can focus the resources of the system into a sparse set of molecules. ACSs can produce a bistability in the population dynamics and, in particular, steady states wherein the ACS molecules dominate the population. However to reach these steady states from initial conditions that contain only the food set typically requires very large catalytic strengths, growing exponentially with the size of the catalyst molecule. We present a solution to this problem by studying 'nested ACSs', a structure in which a small ACS is connected to a larger one and reinforces it. We show that when the network contains a cascade of nested ACSs with the catalytic strengths of molecules increasing gradually with their size (e.g., as a power law), a sparse subset of molecules including some very large molecules can come to dominate the system.	[Giri, Varun; Jain, Sanjay] Univ Delhi, Dept Phys & Astrophys, Delhi 110007, India; [Jain, Sanjay] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India; [Jain, Sanjay] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Delhi; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore; The Santa Fe Institute	Giri, V (corresponding author), Univ Delhi, Dept Phys & Astrophys, Delhi 110007, India.	jain@physics.du.ac.in			University Grants Commission, Government of India; Department of Biotechnology, Government of India	University Grants Commission, Government of India(University Grants Commission, India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	VG received a Senior Research Fellowship from the University Grants Commission, Government of India and from the Department of Biotechnology, Government of India. SJ received support from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli D, 2009, J DIFFER EQUATIONS, V246, P3058, DOI 10.1016/j.jde.2009.01.025; BAGLEY RJ, 1989, BIOSYSTEMS, V23, P113, DOI 10.1016/0303-2647(89)90016-6; BAGLEY RJ, 1992, ARTIF LIFE, V2, P141; BAGLEY RJ, 1992, ARTIF LIFE, V2, P93; Barbas CF, 2008, ANGEW CHEM INT EDIT, V47, P42, DOI 10.1002/anie.200702210; Bertelsen S, 2009, CHEM SOC REV, V38, P2178, DOI 10.1039/b903816g; Brack A, 2007, CHEM BIODIVERS, V4, P665, DOI 10.1002/cbdv.200790057; Budin I, 2010, ANNU REV BIOPHYS, V39, P245, DOI 10.1146/annurev.biophys.050708.133753; Carletti T, 2008, J THEOR BIOL, V254, P741, DOI 10.1016/j.jtbi.2008.07.008; CECH TR, 1986, ANNU REV BIOCHEM, V55, P599, DOI 10.1146/annurev.biochem.55.1.599; Chen X, 2007, CHEM BIODIVERS, V4, P633, DOI 10.1002/cbdv.200790055; Copley SD, 2007, BIOORG CHEM, V35, P430, DOI 10.1016/j.bioorg.2007.08.001; Craciun G, 2006, P NATL ACAD SCI USA, V103, P8697, DOI 10.1073/pnas.0602767103; Craciun G, 2011, DESIGN AND ANALYSIS OF BIOMOLECULAR CIRCUITS:ENGINEERING APPROACHES TO SYSTEMS AND SYNTHETIC BIOLOGY, P63, DOI 10.1007/978-1-4419-6766-4_3; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Ermentrout B., 2002, SIMULATING ANAL ANIM, P290; FARMER JD, 1986, PHYSICA D, V22, P50, DOI 10.1016/0167-2789(86)90233-2; Ferris JP, 2004, ADV SPACE RES, V33, P100, DOI 10.1016/j.asr.2003.02.010; FONTANA W, 1994, P NATL ACAD SCI USA, V91, P757, DOI 10.1073/pnas.91.2.757; Furusawa C, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011912; Hanel R, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036117; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Hordijk W, 2011, INT J MOL SCI, V12, P3085, DOI 10.3390/ijms12053085; Jain S, 1998, PHYS REV LETT, V81, P5684, DOI 10.1103/PhysRevLett.81.5684; Jain S, 2001, P NATL ACAD SCI USA, V98, P543, DOI 10.1073/pnas.021545098; Kamimura A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.268103; KAUFFMAN S A, 1971, Journal of Cybernetics, V1, P71, DOI 10.1080/01969727108545830; Kauffman S.A., 1993, ORIGINS ORDER; Kun A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r51; MacMillan DWC, 2008, NATURE, V455, P304, DOI 10.1038/nature07367; MILLER SL, 1959, SCIENCE, V130, P245, DOI 10.1126/science.130.3370.245; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; Morowitz Harold J., 1999, Complexity, V4, P39, DOI 10.1002/(SICI)1099-0526(199907/08)4:6<39::AID-CPLX8>3.0.CO;2-2; Morowitz HJ, 2000, P NATL ACAD SCI USA, V97, P7704, DOI 10.1073/pnas.110153997; Ohtsuki H, 2009, P ROY SOC B-BIOL SCI, V276, P3783, DOI 10.1098/rspb.2009.1136; Orgel LE, 2000, P NATL ACAD SCI USA, V97, P12503, DOI 10.1073/pnas.220406697; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; Orgel LE, 2008, PLOS BIOL, V6, P5, DOI 10.1371/journal.pbio.0060018; Parker ET, 2011, P NATL ACAD SCI USA, V108, P5526, DOI 10.1073/pnas.1019191108; Piedrafita G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000872; Powner MW, 2011, PHILOS T R SOC B, V366, P2870, DOI 10.1098/rstb.2011.0134; Powner MW, 2009, NATURE, V459, P239, DOI 10.1038/nature08013; Ramakrishnan N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000122; Ricardo A, 2004, SCIENCE, V303, P196, DOI 10.1126/science.1092464; Rode BM, 1999, PEPTIDES, V20, P773, DOI 10.1016/S0196-9781(99)00062-5; ROSSLER OE, 1971, Z NATURFORSCH PT B, VB 26, P741; Segre D, 2000, P NATL ACAD SCI USA, V97, P4112, DOI 10.1073/pnas.97.8.4112; Severin K, 1997, NATURE, V389, P706, DOI 10.1038/39556; Srinivasan V, 2009, BIOL BULL-US, V217, P222, DOI 10.1086/BBLv217n3p222; STADLER PF, 1993, PHYSICA D, V63, P378, DOI 10.1016/0167-2789(93)90118-K; Steel M, 2000, APPL MATH LETT, V13, P91, DOI 10.1016/S0893-9659(99)00191-3; SYMONS RH, 1992, ANNU REV BIOCHEM, V61, P641; Szathmary E, 2006, PHILOS T R SOC B, V361, P1761, DOI 10.1098/rstb.2006.1912; WACHTERSHAUSER G, 1990, P NATL ACAD SCI USA, V87, P200, DOI 10.1073/pnas.87.1.200; Wales DJ, 2004, ENERGY LANDSCAPES AP, DOI [10.2277/0521814154, DOI 10.2277/0521814154]; Wilhelm T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011911; Wolfram Research Inc., 2008, MATH VERS 7 0	58	10	10	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29546	10.1371/journal.pone.0029546	http://dx.doi.org/10.1371/journal.pone.0029546			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238620	gold, Green Published, Green Submitted			2022-12-27	WOS:000301070200032
J	Reed, C; Madhi, SA; Klugman, KP; Kuwanda, L; Ortiz, JR; Finelli, L; Fry, AM				Reed, Carrie; Madhi, Shabir A.; Klugman, Keith P.; Kuwanda, Locadiah; Ortiz, Justin R.; Finelli, Lyn; Fry, Alicia M.			Development of the Respiratory Index of Severity in Children (RISC) Score among Young Children with Respiratory Infections in South Africa	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; COMMUNITY-ACQUIRED PNEUMONIA; PAPUA-NEW-GUINEA; DEVELOPING-COUNTRIES; CLINICAL SIGNS; VALIDATION; MULTICENTER; MANAGEMENT; FACILITIES; DERIVATION	Objective: Pneumonia is a leading cause of death in children worldwide. A simple clinical score predicting the probability of death in a young child with lower respiratory tract infection (LRTI) could aid clinicians in case management and provide a standardized severity measure during epidemiologic studies. Methods: We analyzed 4,148 LRTI hospitalizations in children <24 months enrolled in a pneumococcal conjugate vaccine trial in South Africa from 1998-2001, to develop the Respiratory Index of Severity in Children (RISC). Using clinical data at admission, a multivariable logistic regression model for mortality was developed and statistically evaluated using bootstrap resampling techniques. Points were assigned to risk factors based on their coefficients in the multivariable model. A child's RISC score is the sum of points for each risk factor present. Separate models were developed for HIV-infected and noninfected children. Results: Significant risk factors for HIV-infected and non-infected children included low oxygen saturation, chest indrawing, wheezing, and refusal to feed. The models also included age and HIV clinical classification (for HIV-infected children) or weight-for-age (for non-infected children). RISC scores ranged up to 7 points for HIV-infected or 6 points for non-infected children and correlated with probability of death (0-47%, HIV-infected; 0-14%, non-infected). Final models showed good discrimination (area under the ROC curve) and calibration (goodness-of-fit). Conclusion: The RISC score incorporates a simple set of risk factors that accurately discriminate between young children based on their risk of death from LRTI, and may provide an objective means to quantify severity based on the risk of mortality.	[Reed, Carrie; Finelli, Lyn; Fry, Alicia M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Reed, Carrie; Ortiz, Justin R.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA USA; [Madhi, Shabir A.; Klugman, Keith P.; Kuwanda, Locadiah] Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, Dept Sci & Technol, Natl Res Fdn,Vaccine Preventable Dis & Med Res Co, Bertsham, South Africa; [Madhi, Shabir A.; Klugman, Keith P.] Emory Univ, Hubert Dept Publ Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Ortiz, Justin R.] Univ Washington, Seattle, WA 98195 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; National Research Foundation - South Africa; University of Witwatersrand; Emory University; Rollins School Public Health; University of Washington; University of Washington Seattle	Reed, C (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	creed1@cdc.gov	Finelli, Lyn/AAK-2360-2020	Ortiz, Justin/0000-0002-3138-5965				Aujesky D, 2008, CLIN INFECT DIS, V47, pS133, DOI 10.1086/591394; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Caldwell MB, 1994, MMWR-MORBID MORTAL W, V43, P1; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Chowdhury EK, 2008, LANCET, V372, P822, DOI 10.1016/S0140-6736(08)61166-6; Duke T, 2001, INT J TUBERC LUNG D, V5, P511; Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2; Enarson Penny M, 2010, Expert Rev Respir Med, V4, P211, DOI 10.1586/ers.10.14; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Gona P, 2006, JAMA-J AM MED ASSOC, V296, P292, DOI 10.1001/jama.296.3.292; Graham SM, 2007, ANN TROP PAEDIATR, V27, P243, DOI 10.1179/146532807X245625; Graham SM, 2002, BRIT MED BULL, V61, P133, DOI 10.1093/bmb/61.1.133; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hazir T, 2004, ARCH DIS CHILD, V89, P1049, DOI 10.1136/adc.2003.035741; Hazir T, 2008, LANCET, V371, P49, DOI 10.1016/S0140-6736(08)60071-9; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lozano JM, 2001, INT J TUBERC LUNG D, V5, P496; Madhi SA, 2006, PEDIATR INFECT DIS J, V25, P30, DOI 10.1097/01.inf.0000195787.99199.4a; Madhi SA, 2005, CLIN INFECT DIS, V40, P1511, DOI 10.1086/429828; Madhi SA, 2002, CLIN INFECT DIS, V35, P1120, DOI 10.1086/343049; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Opiyo N, 2011, ARCH DIS CHILD; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Simoes EAF, 2003, B WORLD HEALTH ORGAN, V81, P522; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Weber MW, 1998, LANCET, V351, P1589, DOI 10.1016/S0140-6736(05)61160-9; WHO, 2005, COUGH DIFF BREATH PO; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0	32	91	93	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e27793	10.1371/journal.pone.0027793	http://dx.doi.org/10.1371/journal.pone.0027793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238570	Green Submitted, Green Published, gold			2022-12-27	WOS:000301070200002
J	Wan, P; Huang, YX; Wu, HH; Huang, MS; Cong, SB; Tabashnik, BE; Wu, KM				Wan, Peng; Huang, Yunxin; Wu, Huaiheng; Huang, Minsong; Cong, Shengbo; Tabashnik, Bruce E.; Wu, Kongming			Increased Frequency of Pink Bollworm Resistance to Bt Toxin Cry1Ac in China	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; FIELD-EVOLVED RESISTANCE; YANGTZE-RIVER VALLEY; BACILLUS-THURINGIENSIS; INSECT RESISTANCE; TRANSGENIC COTTON; PECTINOPHORA-GOSSYPIELLA; PEST-MANAGEMENT; NOCTUIDAE; SUPPRESSION	Transgenic crops producing insecticidal proteins from Bacillus thuringiensis (Bt) kill some key insect pests, but evolution of resistance by pests can reduce their efficacy. The main approach for delaying pest adaptation to Bt crops uses non-Bt host plants as "refuges" to increase survival of susceptible pests. To delay evolution of pest resistance to transgenic cotton producing Bt toxin Cry1Ac, the United States and some other countries have required refuges of non-Bt cotton, while farmers in China have relied on "natural" refuges of non-Bt host plants other than cotton. The "natural" refuge strategy focuses on cotton bollworm (Helicoverpa armigera), the primary target of Bt cotton in China that attacks many crops, but it does not apply to another major pest, pink bollworm (Pectinophora gossypiella), which feeds almost entirely on cotton in China. Here we report data showing field-evolved resistance to Cry1Ac by pink bollworm in the Yangtze River Valley of China. Laboratory bioassay data from 51 field-derived strains show that the susceptibility to Cry1Ac was significantly lower during 2008 to 2010 than 2005 to 2007. The percentage of field populations yielding one or more survivors at a diagnostic concentration of Cry1Ac increased from 0% in 2005-2007 to 56% in 2008-2010. However, the median survival at the diagnostic concentration was only 1.6% from 2008 to 2010 and failure of Bt cotton to control pink bollworm has not been reported in China. The early detection of resistance reported here may promote proactive countermeasures, such as a switch to transgenic cotton producing toxins distinct from Cry1A toxins, increased planting of non-Bt cotton, and integration of other management tactics together with Bt cotton.	[Wan, Peng; Wu, Kongming] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Wan, Peng; Wu, Huaiheng; Huang, Minsong; Cong, Shengbo] Hubei Acad Agr Sci, Inst Plant Protect & Soil Sci, Wuhan, Peoples R China; [Huang, Yunxin] Hubei Univ, Fac Resources & Environm Sci, Wuhan 430062, Peoples R China; [Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Hubei Academy of Agricultural Sciences; Hubei University; University of Arizona	Wan, P (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	kmwu@ippcaas.cn			Ministry of Science and Technology of China [2007CB109204]; National Natural Science Foundation of China [30625028]; Key Project for Breeding Genetic Modified Organisms [2008ZX08012-004]; U.S. Department of Agriculture, Agriculture and Food Research Initiative [2008-35302-0390]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project for Breeding Genetic Modified Organisms; U.S. Department of Agriculture, Agriculture and Food Research Initiative	This research was supported by 973 Projects Grant (2007CB109204) from the Ministry of Science and Technology of China and the National Natural Science Foundation of China (30625028), the Key Project for Breeding Genetic Modified Organisms (2008ZX08012-004), and grant 2008-35302-0390 from the U.S. Department of Agriculture, Agriculture and Food Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bambawale M, 2010, INDIAN J AGR SCI, V80, P730; Bambawale OM, 2004, CURR SCI INDIA, V86, P1628; Carriere Y, 2005, PEST MANAG SCI, V61, P327, DOI 10.1002/ps.1039; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Downes S, 2010, EVOL APPL, V3, P574, DOI 10.1111/j.1752-4571.2010.00146.x; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Henneberry T. J., 1998, Integrated Pest Management Reviews, V3, P31, DOI 10.1023/A:1009673622862; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Kruger M, 2009, CROP PROT, V28, P684, DOI 10.1016/j.cropro.2009.04.001; Li GP, 2007, ECOL ENTOMOL, V32, P366, DOI 10.1111/j.1365-2311.2007.00891.x; Liu FY, 2010, PEST MANAG SCI, V66, P155, DOI 10.1002/ps.1849; Liu YB, 2001, J ECON ENTOMOL, V94, P1237, DOI 10.1603/0022-0493-94.5.1237; Ministry of Agriculture, 2000, AGR YB CHIN 2000 201; Monsanto, 2010, COTT IND; National Research Council, 2010, IMP GEN ENG CROPS FA; RUSSELL R M, 1977, Bulletin of the Entomological Society of America, V23, P209; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Stone GD, 2004, HUM ORGAN, V63, P127, DOI 10.17730/humo.63.2.jgvu7rlfafk9jwf9; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 2000, P NATL ACAD SCI USA, V97, P12980, DOI 10.1073/pnas.97.24.12980; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Tabashnik BE, 2005, J ECON ENTOMOL, V98, P635, DOI 10.1603/0022-0493-98.3.635; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; Tabashnik BE, 2002, APPL ENVIRON MICROB, V68, P3790, DOI 10.1128/AEM.68.8.3790-3794.2002; Tabashnik BE, 2002, J ECON ENTOMOL, V95, P1018, DOI 10.1603/0022-0493-95.5.1018; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P1525, DOI 10.1603/0022-0493-99.5.1525; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tabashnik BE, 2008, P NATL ACAD SCI USA, V105, P19029, DOI 10.1073/pnas.0810763106; US Environmental Protection Agency, 1998, BIOP REG ACT DOC BAC; Wan P, 2005, J ECON ENTOMOL, V98, P195, DOI 10.1603/0022-0493-98.1.195; Wan P, 2004, CROP PROT, V23, P463, DOI 10.1016/j.cropro.2003.09.017; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2002, J ECON ENTOMOL, V95, P832, DOI 10.1603/0022-0493-95.4.832; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Wu KM, 2007, J INVERTEBR PATHOL, V95, P220, DOI 10.1016/j.jip.2007.03.012; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874; Zhao JZ, 2003, NAT BIOTECHNOL, V21, P1493, DOI 10.1038/nbt907	44	72	87	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29975	10.1371/journal.pone.0029975	http://dx.doi.org/10.1371/journal.pone.0029975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238687	Green Published, Green Submitted, gold			2022-12-27	WOS:000301070200064
J	Core, A; Runckel, C; Ivers, J; Quock, C; Siapno, T; DeNault, S; Brown, B; DeRisi, J; Smith, CD; Hafernik, J				Core, Andrew; Runckel, Charles; Ivers, Jonathan; Quock, Christopher; Siapno, Travis; DeNault, Seraphina; Brown, Brian; DeRisi, Joseph; Smith, Christopher D.; Hafernik, John			A New Threat to Honey Bees, the Parasitic Phorid Fly Apocephalus borealis	PLOS ONE			English	Article							COLONY COLLAPSE DISORDER; PARALYSIS VIRUS; NOSEMA-CERANAE; APIS-MELLIFERA; FLIES DIPTERA; TRANSMISSION; HOST; BEHAVIOR; PATHOGEN; WORKERS	Honey bee colonies are subject to numerous pathogens and parasites. Interaction among multiple pathogens and parasites is the proposed cause for Colony Collapse Disorder (CCD), a syndrome characterized by worker bees abandoning their hive. Here we provide the first documentation that the phorid fly Apocephalus borealis, previously known to parasitize bumble bees, also infects and eventually kills honey bees and may pose an emerging threat to North American apiculture. Parasitized honey bees show hive abandonment behavior, leaving their hives at night and dying shortly thereafter. On average, seven days later up to 13 phorid larvae emerge from each dead bee and pupate away from the bee. Using DNA barcoding, we confirmed that phorids that emerged from honey bees and bumble bees were the same species. Microarray analyses of honey bees from infected hives revealed that these bees are often infected with deformed wing virus and Nosema ceranae. Larvae and adult phorids also tested positive for these pathogens, implicating the fly as a potential vector or reservoir of these honey bee pathogens. Phorid parasitism may affect hive viability since 77% of sites sampled in the San Francisco Bay Area were infected by the fly and microarray analyses detected phorids in commercial hives in South Dakota and California's Central Valley. Understanding details of phorid infection may shed light on similar hive abandonment behaviors seen in CCD.	[Core, Andrew; Ivers, Jonathan; Quock, Christopher; Siapno, Travis; DeNault, Seraphina; Smith, Christopher D.; Hafernik, John] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Runckel, Charles; DeRisi, Joseph] San Francisco State Univ, Dept Biochem & Biophys, San Francisco, CA 94132 USA; [Brown, Brian] Nat Hist Museum Los Angeles Cty, Plant Pathol & Entomol Sect, Entomol Sect, Los Angeles, CA USA	California State University System; San Francisco State University; California State University System; San Francisco State University	Core, A (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.	acore13@yahoo.com	Brown, Brian/K-6558-2019	Quock, Christopher/0000-0003-1025-6352	United States National Science Foundation [DEB-1025922]; Howard Hughes Medical Institute; Genetech; California State University; Direct For Biological Sciences [1025922] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Genetech; California State University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	United States National Science Foundation grant DEB-1025922 supported BB. JD was supported by the Howard Hughes Medical Institute. CR was supported by a Genetech Graduate Student Fellowship and Project Apis m. JH and CS were supported by a California State University Program for Education and Research in Biotechnology Faculty-Student Seed Research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Becnel James J., 1999, P447; Brooks Wayne M., 1993, P231; Brown Brian V., 1997, Contributions in Science (Los Angeles), V468, P1; Brown Brian V., 2006, Contributions in Science (Los Angeles), P1; Brown BV, 2004, ZOOL J LINN SOC-LOND, V140, P1, DOI 10.1111/j.1096-3642.2004.00086.x; BROWN BV, 1993, SYST ENTOMOL, V18, P191, DOI 10.1111/j.1365-3113.1993.tb00662.x; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2006, APPL ENVIRON MICROB, V72, P606, DOI 10.1128/AEM.72.1.606-611.2006; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; Chen YP, 2004, APIDOLOGIE, V35, P441, DOI 10.1051/apido:2004031; Cook DC, 2007, ECOL APPL, V17, P1832, DOI 10.1890/06-1632.1; Dawkins R., 1982, pi; Di Prisco G, 2011, J GEN VIROL, V92, P151, DOI 10.1099/vir.0.023853-0; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feener DH, 1997, ANNU REV ENTOMOL, V42, P73, DOI 10.1146/annurev.ento.42.1.73; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Futerman PH, 2006, PARASITOLOGY, V132, P479, DOI 10.1017/S0031182005009339; Genersch E, 2010, APPL MICROBIOL BIOT, V87, P87, DOI 10.1007/s00253-010-2573-8; Gonzalez L, 2004, ZOOTAXA, P1; Heinze J, 2010, CURR BIOL, V20, P249, DOI 10.1016/j.cub.2009.12.031; Henne DC, 2007, INSECT SOC, V54, P150, DOI 10.1007/s00040-007-0924-y; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Hoover K, 2011, SCIENCE, V333, P1401, DOI 10.1126/science.1209199; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Lambrechts L, 2006, TRENDS PARASITOL, V22, P12, DOI 10.1016/j.pt.2005.11.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Morrison LW, 2005, BIOL CONTROL, V33, P9, DOI 10.1016/j.biocontrol.2005.01.004; Morrison LW, 1997, ENVIRON ENTOMOL, V26, P716, DOI 10.1093/ee/26.3.716; MULLER CB, 1993, NATURE, V363, P65, DOI 10.1038/363065a0; Oi DH, 2009, BIOL CONTROL, V48, P310, DOI 10.1016/j.biocontrol.2008.11.003; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Orians G.H., 1979, P155; Otterstatter MC, 2002, ECOL ENTOMOL, V27, P229, DOI 10.1046/j.1365-2311.2002.00403.x; Otterstatter MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002771; Plischuk S, 2009, ENV MICROBIOL REP, V1, P131, DOI 10.1111/j.1758-2229.2009.00018.x; Porter SD, 2000, BIOL CONTROL, V19, P35, DOI 10.1006/bcon.2000.0843; Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Richard FJ, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-50; ROBINSON GE, 1982, BEE WORLD, V63, P117, DOI 10.1080/0005772X.1982.11097875; Rueppell O, 2010, J EVOLUTION BIOL, V23, P1538, DOI 10.1111/j.1420-9101.2010.02022.x; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Schmid-Hempel P, 1998, MONOGRAPHS BEHAV ECO; Santillan-Galicia MT, 2010, J APICULT RES, V49, P141, DOI 10.3896/IBRA.1.49.2.01; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Williams GR, 2010, BIOESSAYS, V32, P845, DOI 10.1002/bies.201000075	50	70	75	1	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29639	10.1371/journal.pone.0029639	http://dx.doi.org/10.1371/journal.pone.0029639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235317	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400079
J	Lawson, EL; Mills, DR; Brilliant, KE; Hixson, DC				Lawson, Erica L.; Mills, David R.; Brilliant, Kate E.; Hixson, Douglas C.			The Transmembrane Domain of CEACAM1-4S Is a Determinant of Anchorage Independent Growth and Tumorigenicity	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; BILIARY GLYCOPROTEIN; CYTOPLASMIC DOMAIN; TUMOR-SUPPRESSOR; CAM 105; SIGNAL-TRANSDUCTION; DIMERIZATION MOTIF; HELIX ASSOCIATION; ALTERED FORM; GXXXG MOTIF	CEACAM1 is a multifunctional Ig-like cell adhesion molecule expressed by epithelial cells in many organs. CEACAM1-4L and CEACAM1-4S, two isoforms produced by differential splicing, are predominant in rat liver. Previous work has shown that downregulation of both isoforms occurs in rat hepatocellular carcinomas. Here, we have isolated an anchorage dependent clone, designated 253T-NT that does not express detectable levels of CEACAM1. Stable transfection of 253-NT cells with a wild type CEACAM1-4S expression vector induced an anchorage independent growth in vitro and a tumorigenic phenotype in vivo. These phenotypes were used as quantifiable end points to examine the functionality of the CEACAM1-4S transmembrane domain. Examination of the CEACAM1 transmembrane domain showed N-terminal GXXXG dimerization sequences and C-terminal tyrosine residues shown in related studies to stabilize transmembrane domain helix-helix interactions. To examine the effects of transmembrane domain mutations, 253-NT cells were transfected with transmembrane domain mutants carrying glycine to leucine or tyrosine to valine substitutions. Results showed that mutation of transmembrane tyrosine residues greatly enhanced growth in vitro and in vivo. Mutation of transmembrane dimerization motifs, in contrast, significantly reduced anchorage independent growth and tumorigenicity. 253-NT cells expressing CEACAM1-4S with both glycine to leucine and tyrosine to valine mutations displayed the growth-enhanced phenotype of tyrosine mutants. The dramatic effect of transmembrane domain mutations constitutes strong evidence that the transmembrane domain is an important determinant of CEACAM1-4S functionality and most likely by other proteins with transmembrane domains containing dimerization sequences and/or C-terminal tyrosine residues.	[Lawson, Erica L.; Mills, David R.; Brilliant, Kate E.; Hixson, Douglas C.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Hematol & Oncol,Dept Med, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Lawson, EL (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Hematol & Oncol,Dept Med, Providence, RI 02903 USA.	DHixson@lifespan.edu	Mills, David/GXF-1821-2022		National Institutes of Health [CA42714]; NATIONAL CANCER INSTITUTE [R01CA042714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by Award Number CA42714 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUM O, 1995, EUR J BIOCHEM, V228, P316; BECKER FF, 1975, CANCER RES, V35, P3021; Biebermann H, 1998, FASEB J, V12, P1461, DOI 10.1096/fasebj.12.14.1461; Blagosklonny MV, 2000, FASEB J, V14, P1901, DOI 10.1096/fj.99-1078rev; Brosig B, 1998, PROTEIN SCI, V7, P1052; Bu ZM, 1999, BIOPHYS J, V77, P1064, DOI 10.1016/S0006-3495(99)76956-0; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; CHEUNG PH, 1993, J BIOL CHEM, V268, P24303; Comegys MM, 2004, J BIOL CHEM, V279, P35063, DOI 10.1074/jbc.M404431200; Comegys MM, 1999, ONCOGENE, V18, P3261, DOI 10.1038/sj.onc.1202666; CULIC O, 1992, BIOCHEM J, V285, P47, DOI 10.1042/bj2850047; EDLUND M, 1993, EUR J BIOCHEM, V213, P1109, DOI 10.1111/j.1432-1033.1993.tb17860.x; Estrera VT, 1999, BIOCHEM BIOPH RES CO, V263, P797, DOI 10.1006/bbrc.1999.1443; Estrera VT, 2001, J BIOL CHEM, V276, P15547, DOI 10.1074/jbc.M008156200; FARIS RA, 1991, CANCER RES, V51, P1308; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Gerber D, 2004, J BIOL CHEM, V279, P21177, DOI 10.1074/jbc.M400847200; Gomyo H, 1999, GENOMICS, V62, P139, DOI 10.1006/geno.1999.6001; HABU S, 1981, J IMMUNOL, V127, P34; HIXSON DC, 1989, CANCER RES, V49, P6788; HIXSON DC, 1983, CANCER RES, V43, P3874; HIXSON DC, 1985, CANCER RES, V45, P3742; Hunter I, 1996, BIOCHEM J, V320, P847, DOI 10.1042/bj3200847; IKEHARA S, 1984, P NATL ACAD SCI-BIOL, V81, P886, DOI 10.1073/pnas.81.3.886; Izzi L, 1999, ONCOGENE, V18, P5563, DOI 10.1038/sj.onc.1202935; Kim JH, 2007, INT IMMUNOL, V19, P1403, DOI 10.1093/intimm/dxm110; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Kleiger G, 2002, J MOL BIOL, V323, P69, DOI 10.1016/S0022-2836(02)00885-9; KLEINERMAN DI, 1995, CANCER RES, V55, P2831; Kunath T, 1995, ONCOGENE, V11, P2375; Laurie NA, 2005, CANCER RES, V65, P11010, DOI 10.1158/0008-5472.CAN-04-2841; LIN SH, 1991, BIOCHEM J, V278, P155, DOI 10.1042/bj2780155; LIN SH, 1989, J BIOL CHEM, V264, P14408; MCENTIRE KD, 1989, CANCER RES, V49, P6795; MOWERY J, 1991, HEPATOLOGY, V13, P47; NEUMAIER M, 1993, P NATL ACAD SCI USA, V90, P10744, DOI 10.1073/pnas.90.22.10744; Oliveira-Ferrer L, 2004, CANCER RES, V64, P8932, DOI 10.1158/0008-5472.CAN-04-0505; Orzaez M, 2000, PROTEIN SCI, V9, P1246, DOI 10.1110/ps.9.6.1246; Overton MC, 2005, EUKARYOT CELL, V4, P1963, DOI 10.1128/EC.4.12.1963-1970.2005; Overton MC, 2003, J BIOL CHEM, V278, P49369, DOI 10.1074/jbc.M308654200; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; Riethdorf L, 1997, J HISTOCHEM CYTOCHEM, V45, P957, DOI 10.1177/002215549704500705; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sal-Man N, 2007, J BIOL CHEM, V282, P19753, DOI 10.1074/jbc.M610368200; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schneider D, 2004, J BIOL CHEM, V279, P9840, DOI 10.1074/jbc.M312749200; Segalat L, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-30; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; SMALL SJ, 1987, J CELL BIOL, V105, P2335, DOI 10.1083/jcb.105.5.2335; STERNBERG MJE, 1990, PROTEIN ENG, V3, P245, DOI 10.1093/protein/3.4.245; STEVENS TL, 1994, J IMMUNOL, V152, P4397; Tan KM, 2002, EMBO J, V21, P2076, DOI 10.1093/emboj/21.9.2076; Tanaka K, 1997, INT J CANCER, V74, P15, DOI 10.1002/(SICI)1097-0215(19970220)74:1<15::AID-IJC3>3.0.CO;2-3; Turbide C, 1997, CANCER RES, V57, P2781; Watt SM, 2001, BLOOD, V98, P1469, DOI 10.1182/blood.V98.5.1469; Yokoyama S, 2007, ONCOGENE, V26, P7637, DOI 10.1038/sj.onc.1210577; ZAMBETTI GP, 1993, FASEB J, V7, P855, DOI 10.1096/fasebj.7.10.8344485; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008; Zimmermann W, 1998, CELL ADHES COMMUN S, V5, P31	60	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29606	10.1371/journal.pone.0029606	http://dx.doi.org/10.1371/journal.pone.0029606			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235309	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400071
J	Rodrigues, CE; Sanches, TR; Volpini, RA; Shimizu, MHM; Kuriki, PS; Camara, NOS; Seguro, AC; Andrade, L				Rodrigues, Camila E.; Sanches, Talita R.; Volpini, Rildo A.; Shimizu, Maria H. M.; Kuriki, Patricia S.; Camara, Niels O. S.; Seguro, Antonio C.; Andrade, Lucia			Effects of Continuous Erythropoietin Receptor Activator in Sepsis-Induced Acute Kidney Injury and Multi-Organ Dysfunction	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; RENAL SODIUM TRANSPORTERS; NECROSIS-FACTOR-ALPHA; DOWN-REGULATION; ANIMAL-MODELS; SEPTIC SHOCK; PHARMACOKINETICS; EXPRESSION; LIPOPOLYSACCHARIDE; PHARMACODYNAMICS	Background: Despite advances in supportive care, sepsis-related mortality remains high, especially in patients with acute kidney injury (AKI). Erythropoietin can protect organs against ischemia and sepsis. This effect has been linked to activation of intracellular survival pathways, although the mechanism remains unclear. Continuous erythropoietin receptor activator (CERA) is an erythropoietin with a unique pharmacologic profile and long half-life. We hypothesized that pretreatment with CERA would be renoprotective in the cecal ligation and puncture (CLP) model of sepsis-induced AKI. Methods: Rats were randomized into three groups: control; CLP; and CLP+CERA (5 mu g/kg body weight, i.p. administered 24 h before CLP). At 24 hours after CLP, we measured creatinine clearance, biochemical variables, and hemodynamic parameters. In kidney tissue, we performed immunoblotting-to quantify expression of the Na-K-2Cl cotransporter (NKCC2), aquaporin 2 (AQP2), Toll-like receptor 4 (TLR4), erythropoietin receptor (EpoR), and nuclear factor kappa B (NF-kappa B)-and immunohistochemical staining for CD68 (macrophage infiltration). Plasma interleukin (IL)-2, IL-1 beta, IL-6, IL-10, interferon gamma, and tumor necrosis factor alpha were measured by multiplex detection. Results: Pretreatment with CERA preserved creatinine clearance and tubular function, as well as the expression of NKCC2 and AQP2. In addition, CERA maintained plasma lactate at normal levels, as well as preserving plasma levels of transaminases and lactate dehydrogenase. Renal expression of TLR4 and NF-kappa B was lower in CLP+CERA rats than in CLP rats (p<0.05 and p<0.01, respectively), as were CD68-positive cell counts (p<0.01), whereas renal EpoR expression was higher (p<0.05). Plasma levels of all measured cytokines were lower in CLP+CERA rats than in CLP rats. Conclusion: CERA protects against sepsis-induced AKI. This protective effect is, in part, attributable to suppression of the inflammatory response.	[Rodrigues, Camila E.; Sanches, Talita R.; Volpini, Rildo A.; Shimizu, Maria H. M.; Seguro, Antonio C.; Andrade, Lucia] Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, Brazil; [Kuriki, Patricia S.; Camara, Niels O. S.] Univ Fed Sao Paulo, Dept Nephrol, Paulista Sch Med, Sao Paulo, Brazil; [Camara, Niels O. S.] Univ Sao Paulo, Dept Immunol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Rodrigues, CE (corresponding author), Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, Brazil.	camila.eleuterio@usp.br	Shimizu, Maria/B-7887-2013; Andrade, Lucia C/C-5223-2014; Semedo-Kuriki, Patricia/D-2429-2010; Sanches, Talita R/A-2953-2015; Camara, Niels OS/G-8336-2011; Complexos, INCT Fluidos/H-9172-2013; Rodrigues, Camila E/E-9483-2017; Volpini, Rildo Aparecido/L-5690-2019; Volpini, Rildo A/B-7521-2013; Rodrigues, Camila/HHN-2048-2022; camara, niels olsen saraiva/AAX-3269-2020	Andrade, Lucia C/0000-0002-3078-8957; Camara, Niels OS/0000-0001-5436-1248; Rodrigues, Camila E/0000-0003-0562-0893; Volpini, Rildo Aparecido/0000-0001-6611-2249; Volpini, Rildo A/0000-0001-6611-2249; camara, niels olsen saraiva/0000-0001-5436-1248; Semedo-Kuriki, Patricia/0000-0002-2136-3308	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo Research Foundation); Laboratorios de Investigacao Medica (LIMs, Medical Investigation Laboratories) of the Faculdade de Medicina da Universidade de Sao Paulo (FMUSP, University of Sao Paulo School of Medicine); Hospital das Clinicas; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Office for the Advancement of Higher Education); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Laboratorios de Investigacao Medica (LIMs, Medical Investigation Laboratories) of the Faculdade de Medicina da Universidade de Sao Paulo (FMUSP, University of Sao Paulo School of Medicine); Hospital das Clinicas; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Office for the Advancement of Higher Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The paper was supported, in part, by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo Research Foundation - www.fapesp.org) and the Laboratorios de Investigacao Medica (LIMs, Medical Investigation Laboratories) of the Faculdade de Medicina da Universidade de Sao Paulo (FMUSP, University of Sao Paulo School of Medicine - www.direxlim.fm.usp.br) Hospital das Clinicas, as well as by a grant from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Office for the Advancement of Higher Education - www.capes.gov.br) to CER and by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development - www.cnpq.br) to TRS, ACS, and LA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bagnis C, 2001, NEPHROL DIAL TRANSPL, V16, P932, DOI 10.1093/ndt/16.5.932; Bagshaw SM, 2007, CLIN J AM SOC NEPHRO, V2, P431, DOI 10.2215/CJN.03681106; Bernhardt WM, 2008, CURR OPIN CRIT CARE, V14, P621, DOI 10.1097/MCC.0b013e328317ee82; Buer J, 2003, NAT REV GENET, V4, P195, DOI 10.1038/nrg1019; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Chvojka J, 2010, PHYSIOL RES, V59, P859, DOI 10.33549/physiolres.931936; Cicerone RJ, 2011, GUIDE CARE USE LAB A; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Correa-Costa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014298; Daemen MARC, 1999, TRANSPLANTATION, V67, P792, DOI 10.1097/00007890-199903270-00003; Deng JP, 2001, KIDNEY INT, V60, P2118, DOI 10.1046/j.1523-1755.2001.00043.x; Doi K, 2008, KIDNEY INT, V73, P1266, DOI 10.1038/ki.2008.97; Doi K, 2009, J CLIN INVEST, V119, P2868, DOI 10.1172/JCI39421; du Cheyron D, 2005, INTENS CARE MED, V31, P1529, DOI 10.1007/s00134-005-2739-5; El-Achkar TM, 2006, AM J PHYSIOL-RENAL, V290, pF1034, DOI 10.1152/ajprenal.00414.2005; Endre ZH, 2010, KIDNEY INT, V77, P1020, DOI 10.1038/ki.2010.25; ESCALANTE BA, 1994, AM J PHYSIOL, V266, pC1568, DOI 10.1152/ajpcell.1994.266.6.C1568; Fliser D, 2006, NAT CLIN PRACT CARD, V3, P563, DOI 10.1038/ncpcardio0609; Fox AC, 2009, CRIT CARE MED, V37, P1138, DOI 10.1097/CCM.0b013e318196fd23; Fujiwara N, 2011, INTERNAL MED, V50, P1929, DOI 10.2169/internalmedicine.50.5145; Grenz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014812; Grinevich V, 2004, KIDNEY INT, V65, P54, DOI 10.1111/j.1523-1755.2004.00378.x; HALSTENSON CE, 1991, CLIN PHARMACOL THER, V50, P702, DOI 10.1038/clpt.1991.210; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Hocherl K, 2010, AM J PHYSIOL-RENAL, V298, pF196, DOI 10.1152/ajprenal.90607.2008; Hori O, 1996, J NEUROCHEM, V66, P973; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Husted RF, 1998, AM J PHYSIOL-RENAL, V275, pF946, DOI 10.1152/ajprenal.1998.275.6.F946; Jansen TC, 2009, J TRAUMA, V66, P377, DOI 10.1097/TA.0b013e3181648e2f; Johnson D.W., 2010, OPEN DRUG DISCOVERY, V2, P8, DOI [10.2174/1877381801002020008, DOI 10.2174/1877381801002020008]; Kaden J, 2000, Transpl Int, V13 Suppl 1, pS34, DOI 10.1111/j.1432-2277.2000.tb02055.x; Kalakeche R, 2011, J AM SOC NEPHROL, V22, P1505, DOI 10.1681/ASN.2011020203; Kao R, 2007, CRIT CARE, V11, DOI 10.1186/cc5920; KOHAN DE, 1994, J LAB CLIN MED, V123, P668; Langenberg C, 2008, CRIT CARE, V12, DOI [10.1186/cc6823, 10.1186/cc6863]; Leelahavanichkul A, 2008, AM J PHYSIOL-RENAL, V295, pF1825, DOI 10.1152/ajprenal.90442.2008; Lerolle N, 2010, INTENS CARE MED, V36, P471, DOI 10.1007/s00134-009-1723-x; Li X, 2009, CURR OPIN CRIT CARE, V15, P481, DOI 10.1097/MCC.0b013e328332f69e; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lopes JA, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-9; Macdougall IC, 2006, CLIN J AM SOC NEPHRO, V1, P1211, DOI 10.2215/CJN.00730306; Macdougall IC, 1999, J AM SOC NEPHROL, V10, P2392; Meerwein C, 2011, EUR J PHARMACOL, V671, P113, DOI 10.1016/j.ejphar.2011.09.166; Menne J, 2007, J AM SOC NEPHROL, V18, P2046, DOI 10.1681/ASN.2006070699; Messner UK, 1999, KIDNEY INT, V55, P2322, DOI 10.1046/j.1523-1755.1999.00473.x; Moore E, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-3; O'Sullivan AW, 2009, J SURG RES, V152, P46, DOI 10.1016/j.jss.2008.04.030; Olesen ETB, 2009, NEPHROL DIAL TRANSPL, V24, P2338, DOI 10.1093/ndt/gfp011; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Reinhart K, 2006, CRIT CARE CLIN, V22, P503, DOI 10.1016/j.ccc.2006.03.003; Santhanam AVR, 2005, STROKE, V36, P2731, DOI 10.1161/01.STR.0000190021.85035.5b; Schmidt C, 2007, J AM SOC NEPHROL, V18, P1072, DOI 10.1681/ASN.2006050454; Sharples EJ, 2006, NEPHRON EXP NEPHROL, V104, pE83, DOI 10.1159/000094546; Umegaki Takeshi, 2011, J Anaesthesiol Clin Pharmacol, V27, P180, DOI 10.4103/0970-9185.81816; VILLA P, 1995, CLIN DIAGN LAB IMMUN, V2, P549, DOI 10.1128/CDLI.2.5.549-553.1995; Volpini RA, 2003, DIABETES-METAB RES, V19, P43, DOI 10.1002/dmrr.336; Walden AP, 2010, CRIT CARE, V14, DOI 10.1186/cc9049; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Westenfelder C, 1999, KIDNEY INT, V55, P808, DOI 10.1046/j.1523-1755.1999.055003808.x; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2	63	50	51	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29893	10.1371/journal.pone.0029893	http://dx.doi.org/10.1371/journal.pone.0029893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235348	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400110
J	Rowan, SL; Rygiel, K; Purves-Smith, FM; Solbak, NM; Turnbull, DM; Hepple, RT				Rowan, Sharon L.; Rygiel, Karolina; Purves-Smith, Fennigje M.; Solbak, Nathan M.; Turnbull, Douglas M.; Hepple, Russell T.			Denervation Causes Fiber Atrophy and Myosin Heavy Chain Co-Expression in Senescent Skeletal Muscle	PLOS ONE			English	Article							AGE-RELATED-CHANGES; WHOLE VASTUS LATERALIS; MOTOR UNIT; SOLEUS MUSCLE; BROWN-NORWAY; FAST-TWITCH; MITOCHONDRIAL DYSFUNCTION; NEUROMUSCULAR-JUNCTION; TIBIALIS ANTERIOR; GENE-EXPRESSION	Although denervation has long been implicated in aging muscle, the degree to which it is causes the fiber atrophy seen in aging muscle is unknown. To address this question, we quantified motoneuron soma counts in the lumbar spinal cord using choline acetyl transferase immunhistochemistry and quantified the size of denervated versus innervated muscle fibers in the gastrocnemius muscle using the in situ expression of the denervation-specific sodium channel, Nav(1.5), in young adult (YA) and senescent (SEN) rats. To gain insights into the mechanisms driving myofiber atrophy, we also examined the myofiber expression of the two primary ubiquitin ligases necessary for muscle atrophy (MAFbx, MuRF1). MN soma number in lumbar spinal cord declined 27% between YA (638+/-34 MNsxmm(-1)) and SEN (46+/-13 MNsxmm(-1)). Nav(1.5) positive fibers (1548+/-70 mu m(2)) were 35% smaller than Nav(1.5) negative fibers (2367+/-78 mu m(2); P<0.05) in SEN muscle, whereas Nav(1.5) negative fibers in SEN were only 7% smaller than fibers in YA (2553+/-33 mu m(2); P<0.05) where no Nav(1.5) labeling was seen, suggesting denervation is the primary cause of aging myofiber atrophy. Nav(1.5) positive fibers had higher levels of MAFbx and MuRF1 (P<0.05), consistent with involvement of the proteasome proteolytic pathway in the atrophy of denervated muscle fibers in aging muscle. In summary, our study provides the first quantitative assessment of the contribution of denervation to myofiber atrophy in aging muscle, suggesting it explains the majority of the atrophy we observed. This striking result suggests a renewed focus should be placed on denervation in seeking understanding of the causes of and treatments for aging muscle atrophy.	[Rowan, Sharon L.; Purves-Smith, Fennigje M.; Solbak, Nathan M.] Univ Calgary, Fac Kinesiol, Muscle & Aging Lab, Calgary, AB, Canada; [Rygiel, Karolina; Turnbull, Douglas M.] Newcastle Univ, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Hepple, Russell T.] McGill Univ, Royal Victoria Hosp, Crit Care Div, Montreal, PQ H3A 1A1, Canada; [Hepple, Russell T.] McGill Univ, Dept Med, Montreal, PQ, Canada	University of Calgary; Newcastle University - UK; McGill University; Royal Victoria Hospital; McGill University	Rowan, SL (corresponding author), Univ Calgary, Fac Kinesiol, Muscle & Aging Lab, Calgary, AB, Canada.	russell.hepple@mcgill.ca		Turnbull, Doug/0000-0002-8878-9901; Hepple, Russell/0000-0003-3640-486X	Canadian Institutes of Health Research [MOP 57808, IAO 84673]; Alberta Heritage Foundation for Medical Research; Medical Research Council [MC_G0802536, G0800674, G0700718B, G0601943B, G0700718] Funding Source: researchfish; MRC [G0800674, G0700718, MC_G0802536] Funding Source: UKRI	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Operating Grants from the Canadian Institutes of Health Research (MOP 57808 and IAO 84673 to RTH), and a Senior Scholar Award from the Alberta Heritage Foundation for Medical Research (to RTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun M, 2010, J BIOL CHEM; Andersen JL, 2003, SCAND J MED SCI SPOR, V13, P40, DOI 10.1034/j.1600-0838.2003.00299.x; ANSVED T, 1991, ACTA PHYSIOL SCAND, V143, P345, DOI 10.1111/j.1748-1716.1991.tb09242.x; ANSVED T, 1990, ACTA PHYSIOL SCAND, V139, P297, DOI 10.1111/j.1748-1716.1990.tb08927.x; ANZIL AP, 1989, J NEUROCYTOL, V18, P833, DOI 10.1007/BF01187235; ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Austad SN, 2001, HDB BIOL AGING, P1; Awad SS, 2001, J NEUROSCI, V21, P8456, DOI 10.1523/JNEUROSCI.21-21-08456.2001; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P2660; Bartels Matthew N, 2005, Phys Med Rehabil Clin N Am, V16, P197, DOI 10.1016/j.pmr.2004.06.011; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Brette F, 2006, BIOCHEM BIOPH RES CO, V348, P1163, DOI 10.1016/j.bbrc.2006.07.189; Brown M, 1996, J GERONTOL A-BIOL, V51, pB117, DOI 10.1093/gerona/51A.2.B117; Butikofer L, 2011, FASEB J OFFICIAL PUB; Carter EE, 2010, EXP GERONTOL, V45, P662, DOI 10.1016/j.exger.2010.04.001; Chopek JW, 2010, MECH AGEING DEV, V131, P650, DOI 10.1016/j.mad.2010.09.001; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cruz-Jentoft AJ, 2010, CURR OPIN CLIN NUTR, V13, P1, DOI 10.1097/MCO.0b013e328333c1c1; DOHERTY TJ, 1993, J APPL PHYSIOL, V74, P868, DOI 10.1152/jappl.1993.74.2.868; Dorrens J, 2003, SCAND J MED SCI SPOR, V13, P26, DOI 10.1034/j.1600-0838.2003.00306.x; Dow DE, 2005, J GERONTOL A-BIOL, V60, P416, DOI 10.1093/gerona/60.4.416; Edstrom E, 2005, AGING CELL, V4, P65, DOI 10.1111/j.1474-9728.2005.00145.x; Edstrom E, 2007, PHYSIOL BEHAV, V92, P129, DOI 10.1016/j.physbeh.2007.05.040; EDSTROM L, 1987, J PHYSIOL-LONDON, V392, P129, DOI 10.1113/jphysiol.1987.sp016773; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; Glass D, 2010, ANN NY ACAD SCI, V1211, P25, DOI 10.1111/j.1749-6632.2010.05809.x; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gordon T, 2009, NEUROL RES, V31, P28, DOI 10.1179/174313208X332977; GUTMANN E, 1966, NATURE, V209, P921, DOI 10.1038/209921b0; Hagen JL, 2004, J GERONTOL A-BIOL, V59, P1099, DOI 10.1093/gerona/59.11.1099; HASHIZUME K, 1988, J COMP NEUROL, V269, P425, DOI 10.1002/cne.902690309; HASHIZUME K, 1990, NEUROSCI LETT, V113, P267, DOI 10.1016/0304-3940(90)90595-Z; HASHIZUME K, 1995, NEUROSCI RES, V22, P189, DOI 10.1016/0168-0102(95)00889-3; Hepple RT, 2004, J APPL PHYSIOL, V96, P2257, DOI 10.1152/japplphysiol.01309.2003; Hepple RT, 2004, J GERONTOL A-BIOL, V59, P108; Hepple RT, 2001, J APPL PHYSIOL, V91, P2150, DOI 10.1152/jappl.2001.91.5.2150; Hepple RT, 2003, SCI AGING KNOWLEDGE; Hepple RT, 2008, AM J PHYSIOL-REG I, V295, pR1231, DOI 10.1152/ajpregu.90478.2008; HUSSAIN H, 1987, EXP NEUROL, V97, P635, DOI 10.1016/0014-4886(87)90120-8; ISHIHARA A, 1987, BRAIN RES, V435, P355, DOI 10.1016/0006-8993(87)91624-6; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; KANDA K, 1989, J NEUROPHYSIOL, V61, P737, DOI 10.1152/jn.1989.61.4.737; LARSSON L, 1995, J GERONTOL A-BIOL, V50, P91; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; LEXELL J, 1991, J ANAT, V174, P239; Lexell J, 1997, J NUTR, V127, pS1011, DOI 10.1093/jn/127.5.1011S; LEXELL J, 1991, ACTA NEUROPATHOL, V81, P377, DOI 10.1007/BF00293457; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Lipman RD, 1996, J GERONTOL A-BIOL, V51, pB54, DOI 10.1093/gerona/51A.1.B54; LUPA MT, 1994, J CELL BIOL, V124, P139, DOI 10.1083/jcb.124.1.139; Lushaj EB, 2008, J GERONTOL A-BIOL, V63, P921, DOI 10.1093/gerona/63.9.921; Machida S, 2004, EXP GERONTOL, V39, P1521, DOI 10.1016/j.exger.2004.08.009; Marzetti E, 2010, BBA-GEN SUBJECTS, V1800, P235, DOI 10.1016/j.bbagen.2009.05.007; McNeil CJ, 2005, MUSCLE NERVE, V31, P461, DOI 10.1002/mus.20276; Monemi M, 1999, J MUSCLE RES CELL M, V20, P351, DOI 10.1023/A:1005421604314; ODA K, 1984, J NEUROL SCI, V66, P327, DOI 10.1016/0022-510X(84)90021-2; Rice KM, 2005, BIOGERONTOLOGY, V6, P335, DOI 10.1007/s10522-005-4808-0; Rowan SL, 2011, EXP GERONTOL, V46, P660, DOI 10.1016/j.exger.2011.03.005; SCELSI R, 1980, ACTA NEUROPATHOL, V51, P99, DOI 10.1007/BF00690450; SCHIAFFINO S, 1988, DEV BIOL, V127, P1, DOI 10.1016/0012-1606(88)90183-2; Snow LM, 2005, ANAT REC PART A, V286A, P866, DOI 10.1002/ar.a.20218; TOMLINSON BE, 1977, J NEUROL SCI, V34, P213, DOI 10.1016/0022-510X(77)90069-7; Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492; TYC F, 1995, J PHYSIOL-LONDON, V482, P651, DOI 10.1113/jphysiol.1995.sp020547; Urbanchek MG, 2001, J GERONTOL A-BIOL, V56, pB191, DOI 10.1093/gerona/56.5.B191; Wang ZM, 2005, J PHYSIOL-LONDON, V565, P757, DOI 10.1113/jphysiol.2005.087601; YANG JSJ, 1991, NEURON, V7, P421, DOI 10.1016/0896-6273(91)90294-A	70	152	155	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29082	10.1371/journal.pone.0029082	http://dx.doi.org/10.1371/journal.pone.0029082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235261	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400022
J	Zhao, M; Tai, HH; Sun, SZ; Zhang, FS; Xu, YB; Li, WX				Zhao, Meng; Tai, Huanhuan; Sun, Suzhen; Zhang, Fusuo; Xu, Yunbi; Li, Wen-Xue			Cloning and Characterization of Maize miRNAs Involved in Responses to Nitrogen Deficiency	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SHORT RNAS; ARABIDOPSIS; MICRORNAS; PLANT; IDENTIFICATION; NITRATE; GENE; TARGETS; NUTRIENT	Although recent studies indicated that miRNAs regulate plant adaptive responses to nutrient deprivation, the functional significance of miRNAs in adaptive responses to nitrogen (N) limitation remains to be explored. To elucidate the molecular biology underlying N sensing/signaling in maize, we constructed four small RNA libraries and one degradome from maize seedlings exposed to N deficiency. We discovered a total of 99 absolutely new loci belonging to 47 miRNA families by small RNA deep sequencing and degradome sequencing, as well as 9 new loci were the paralogs of previously reported miR169, miR171, and miR398, significantly expanding the reported 150 high confidence genes within 26 miRNA families in maize. Bioinformatic and subsequent small RNA northern blot analysis identified eight miRNA families (five conserved and three newly identified) differentially expressed under the N-deficient condition. Predicted and degradome-validated targets of the newly identified miRNAs suggest their involvement in a broad range of cellular responses and metabolic processes. Because maize is not only an important crop but is also a genetic model for basic biological research, our research contributes to the understanding of the regulatory roles of miRNAs in plant adaption to N-deficiency stress.	[Zhao, Meng; Tai, Huanhuan; Sun, Suzhen; Zhang, Fusuo; Li, Wen-Xue] China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China; [Xu, Yunbi; Li, Wen-Xue] Chinese Acad Agr Sci, Natl Key Facil Crop Genet Resources & Improvement, Inst Crop Sci, Beijing 100193, Peoples R China; [Xu, Yunbi] Int Maize & Wheat Improvement Ctr CIMMYT, El Batan, Texcoco, Mexico	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)		liwenxue@cau.edu.cn	Zhang, Fusuo/AAV-4517-2021	Xu, Yunbi/0000-0003-3361-4650	National Science Foundation of China [30970221, 31071139]; Ministry of Agriculture of China [2009ZX08009-131B]; China Agricultural University	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); China Agricultural University	This work was supported by the National Science Foundation of China (Grant number 30970221, 31071139), the Ministry of Agriculture of China for transgenic research (Grant number 2009ZX08009-131B) to W-XL, and the Innovation Fund for Graduate Student of China Agricultural University to MZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, RNA, V15, P2112, DOI 10.1261/rna.1774909; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bi YM, 2005, PLANT J, V44, P680, DOI 10.1111/j.1365-313X.2005.02568.x; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Castaings L, 2009, PLANT J, V57, P426, DOI 10.1111/j.1365-313X.2008.03695.x; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Devers EA, 2011, PLANT PHYSIOL, DOI 10.1104; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fode B, 2008, PLANT CELL, V20, P3122, DOI 10.1105/tpc.108.058974; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Gutierez RA, 2008, P NATL ACAD SCI USA, V105, P4939, DOI 10.1073/pnas.0800211105; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Ho CH, 2010, CURR OPIN PLANT BIOL, V13, P604, DOI 10.1016/j.pbi.2010.08.005; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kawashima CG, 2011, PLANT J, V66, P863, DOI 10.1111/j.1365-313X.2011.04547.x; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Klevebring D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-620; Lanet E, 2009, PLANT CELL, V21, P1762, DOI 10.1105/tpc.108.063412; Li T, 2011, NUCLEIC ACIDS RES, V39, P2821, DOI 10.1093/nar/gkq1047; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pant BD, 2009, PLANT PHYSIOL, V150, P1541, DOI 10.1104/pp.109.139139; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Peng MS, 2007, PLANT J, V50, P320, DOI 10.1111/j.1365-313X.2007.03050.x; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Vidal EA, 2008, CURR OPIN PLANT BIOL, V11, P521, DOI 10.1016/j.pbi.2008.07.003; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Yanagisawa S, 2004, P NATL ACAD SCI USA, V101, P7833, DOI 10.1073/pnas.0402267101; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhao M, 2011, NEW PHYTOL, V190, P906, DOI 10.1111/j.1469-8137.2011.03647.x; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	58	120	129	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29669	10.1371/journal.pone.0029669	http://dx.doi.org/10.1371/journal.pone.0029669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235323	Green Submitted, Green Published, gold			2022-12-27	WOS:000301123400085
J	Judge, J; McDonald, RA; Walker, N; Delahay, RJ				Judge, Johanna; McDonald, Robbie A.; Walker, Neil; Delahay, Richard J.			Effectiveness of Biosecurity Measures in Preventing Badger Visits to Farm Buildings	PLOS ONE			English	Article							TUBERCULOSIS MYCOBACTERIUM-BOVIS; MELES-MELES; POTENTIAL ROUTE; TRANSMISSION; CATTLE; RISK; BEHAVIOR; TB; CONTACT; TROUGHS	Background: Bovine tuberculosis caused by Mycobacterium bovis is a serious and economically important disease of cattle. Badgers have been implicated in the transmission and maintenance of the disease in the UK since the 1970s. Recent studies have provided substantial evidence of widespread and frequent visits by badgers to farm buildings during which there is the potential for close direct contact with cattle and contamination of cattle feed. Methodology: Here we evaluated the effectiveness of simple exclusion measures in improving farm biosecurity and preventing badger visits to farm buildings. In the first phase of the study, 32 farms were surveyed using motion-triggered infrared cameras on potential entrances to farm buildings to determine the background level of badger visits experienced by each farm. In the second phase, they were divided into four treatment groups; "Control", "Feed Storage", "Cattle Housing" and "Both", whereby no exclusion measures were installed, exclusion measures were installed on feed storage areas only, cattle housing only or both feed storage and cattle housing, respectively. Badger exclusion measures included sheet metal gates, adjustable metal panels for gates, sheet metal fencing, feed bins and electric fencing. Cameras were deployed for at least 365 nights in each phase on each farm. Results: Badger visits to farm buildings occurred on 19 of the 32 farms in phase one. In phase two, the simple exclusion measures were 100% effective in preventing badger entry into farm buildings, as long as they were appropriately deployed. Furthermore, the installation of exclusion measures also reduced the level of badger visits to the rest of the farmyard. The findings of the present study clearly demonstrate how relatively simple practical measures can substantially reduce the likelihood of badger visits to buildings and reduce some of the potential for contact and disease transmission between badgers and cattle.	[Judge, Johanna; McDonald, Robbie A.; Walker, Neil; Delahay, Richard J.] Food & Environm Res Agcy, York, Yorks, England; [McDonald, Robbie A.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	Food & Environment Research Agency; University of Exeter	Judge, J (corresponding author), Food & Environm Res Agcy, York, Yorks, England.	johanna.judge@fera.gsi.gov.uk	McDonald, Robbie/AAK-2718-2020; McDonald, Robbie A/A-2931-2012; Judge, Johanna/J-4443-2014; Delahay, Richard/J-2261-2014; Delahay, Richard/GSI-4663-2022	McDonald, Robbie/0000-0002-6922-3195; McDonald, Robbie A/0000-0002-6922-3195; 	Defra [SE3119]	Defra(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by Defra project number SE3119, http://www.defra.gov.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENHAM PFJ, 1989, BRIT VET J, V145, P226, DOI 10.1016/0007-1935(89)90075-4; Benham PFJ, 1985, STUDY CATTLE BADGER; Bennett R, 2005, VET REC, V156, P143, DOI 10.1136/vr.156.5.143; Birks JDS, 1998, BIOL CONSERV, V85, P233, DOI 10.1016/S0006-3207(97)00175-4; Bohm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005016; Bourne F., 2007, BOVINE TUBERCULOSIS; CHEESEMAN CL, 1981, J ZOOL, V194, P284, DOI 10.1111/j.1469-7998.1981.tb05780.x; CLIFTONHADLEY RS, 1993, EPIDEMIOL INFECT, V111, P9, DOI 10.1017/S0950268800056624; Collett D, 2002, MODELLING BINARY DAT; Daniels MJ, 2003, EPIDEMIOL INFECT, V130, P561, DOI 10.1017/S0950268803008483; DEFRA, 2011, BOV TB ER PROGR ENGL; Garnett BT, 2003, APPL ANIM BEHAV SCI, V80, P1, DOI 10.1016/S0168-1591(02)00204-6; Garnett BT, 2002, P ROY SOC B-BIOL SCI, V269, P1487, DOI 10.1098/rspb.2002.2072; Gehring Thomas M, 2006, Proceedings of the Vertebrate Pest Conference, V22, P2; GLUECK TF, 1988, WILDLIFE SOC B, V16, P6; Gortazar C, 2007, EUR J WILDLIFE RES, V53, P241, DOI 10.1007/s10344-007-0098-y; Greig A, 1997, VET REC, V140, P141, DOI 10.1136/vr.140.6.141; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; Hutchings MR, 1997, VET J, V153, P149, DOI 10.1016/S1090-0233(97)80035-4; Hutchings MR, 1999, EPIDEMIOL INFECT, V122, P167, DOI 10.1017/S0950268898001897; MAFF, 1979, 3 MAFF; MUIRHEAD RH, 1974, VET REC, V95, P552, DOI 10.1136/vr.95.24.552; Poole DW, 2002, CROP PROT, V21, P409, DOI 10.1016/S0261-2194(01)00123-5; Roper TJ, 2003, CATTLE PRACT, V11, P9; Seamans TW, 2006, WILDLIFE SOC B, V34, P8, DOI 10.2193/0091-7648(2006)34[8:EOEFAA]2.0.CO;2; Tolhurst BA, EUROPEAN J IN PRESS; Tolhurst BA, 2006, THESIS U SUSSEX; Tolhurst BA, 2008, APPL ANIM BEHAV SCI, V113, P224, DOI 10.1016/j.applanim.2007.11.006; Tolhurst BA, 2009, APPL ANIM BEHAV SCI, V117, P103, DOI 10.1016/j.applanim.2008.10.009; VerCauteren K. C., 2003, PROCEEDINGS OF THE 1, P146; VerCauteren KC, 2006, WILDLIFE SOC B, V34, P371, DOI 10.2193/0091-7648(2006)34[371:GABLAI]2.0.CO;2; Ward AI, 2008, VET REC, V163, P107, DOI 10.1136/vr.163.4.107; Ward AI, 2008, APPL ANIM BEHAV SCI, V115, P221, DOI 10.1016/j.applanim.2008.06.004; WEBSTER JP, 1995, PARASITOLOGY, V111, P247, DOI 10.1017/S0031182000081804	34	45	45	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e28941	10.1371/journal.pone.0028941	http://dx.doi.org/10.1371/journal.pone.0028941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220199	gold, Green Submitted, Green Published			2022-12-27	WOS:000300677000011
J	Sanchez, SA; Gratton, E; Zanocco, AL; Lemp, E; Gunther, G				Sanchez, Susana A.; Gratton, Enrico; Zanocco, Antonio L.; Lemp, Else; Gunther, German			Sucrose Monoester Micelles Size Determined by Fluorescence Correlation Spectroscopy (FCS)	PLOS ONE			English	Article							FATTY-ACID ESTER; AGGREGATION NUMBERS; AQUEOUS-SOLUTIONS; SURFACTANTS; SHAPE; ESTERIFICATION; SOLUBILIZATION; EXTRACTION	One of the several uses of sucrose detergents, as well as other micelle forming detergents, is the solubilization of different membrane proteins. Accurate knowledge of the micelle properties, including size and shape, are needed to optimize the surfactant conditions for protein purification and membrane characterization. We synthesized sucrose esters having different numbers of methylene subunits on the substituent to correlate the number of methylene groups with the size of the corresponding micelles. We used Fluorescence Correlation Spectroscopy (FCS) and two photon excitation to determine the translational D of the micelles and calculate their corresponding hydrodynamic radius, Rh. As a fluorescent probe we used LAURDAN (6-dodecanoyl-2-dimethylaminonaphthalene), a dye highly fluorescent when integrated in the micelle and non-fluorescent in aqueous media. We found a linear correlation between the size of the tail and the hydrodynamic radius of the micelle for the series of detergents measured.	[Sanchez, Susana A.; Gratton, Enrico] Univ Calif Irvine, Fluorescence Dynam Lab, Irvine, CA 92717 USA; [Sanchez, Susana A.] Fdn Carlos III CNIC, Microscopy & Dynam Imaging Unit, Madrid, Spain; [Zanocco, Antonio L.; Lemp, Else; Gunther, German] Univ Chile, Fac Ciencias Quim & Farmaceut, Lab Cinet & Fotoquim, Santiago, Chile	University of California System; University of California Irvine; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Universidad de Chile	Sanchez, SA (corresponding author), Univ Calif Irvine, Fluorescence Dynam Lab, Irvine, CA 92717 USA.	ggunther@ciq.uchile.cl	Sánchez, Susana/HII-3113-2022; Gunther, German/I-1028-2013	Gunther, German/0000-0002-4733-8426; ZANOCCO, ANTONIO/0000-0002-6521-5382	Fondecyt [1080412]; Division of Research Resources of the National Institutes of Health [PHS 5 P41 RR-03155]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003155] Funding Source: NIH RePORTER	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Division of Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	GG gratefully thanks Fondecyt grant 1080412. SAS and EG thank the Division of Research Resources of the National Institutes of Health (Grant PHS 5 P41 RR-03155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan F, 2003, INT J PHARMACEUT, V251, P195, DOI 10.1016/S0378-5173(02)00597-5; Alargova RG, 1998, LANGMUIR, V14, P5412, DOI 10.1021/la980565x; Alargova RG, 1998, LANGMUIR, V14, P1575, DOI 10.1021/la971008y; Baker IJA, 2000, J SURFACTANTS DETERG, V3, P1, DOI 10.1007/s11743-000-0107-2; Becerra N, 2008, COLLOID SURFACE A, V327, P134, DOI 10.1016/j.colsurfa.2008.06.012; Becerra N, 2006, COLLOID SURFACE A, V272, P2, DOI 10.1016/j.colsurfa.2005.04.024; BERLAND KM, 1995, BIOPHYS J, V68, P694, DOI 10.1016/S0006-3495(95)80230-4; Berrios E, 2008, J CHIL CHEM SOC, V53, P1728, DOI 10.4067/S0717-97072008000400021; Ferrer M, 2002, LANGMUIR, V18, P667, DOI 10.1021/la010727g; Gapinski J, 2010, LANGMUIR, V26, P9304, DOI 10.1021/la100181d; Garcia MT, 1997, CHEMOSPHERE, V35, P545; Garofalakis G, 2000, J COLLOID INTERF SCI, V229, P391, DOI 10.1006/jcis.2000.7035; Ghosh S, 2011, J COLLOID INTERF SCI, V360, P672, DOI 10.1016/j.jcis.2011.05.006; Hierrezuelo JM, 2004, LANGMUIR, V20, P10419, DOI 10.1021/la048278i; Hill K, 1999, FETT-LIPID, V101, P25; HINK M, 1999, APPL FLUORESCENCE CH, P101; Hohner A, 2006, EUR PHYS J E, V21, P41, DOI 10.1140/epje/i2006-10043-y; Johansson I, 2001, CURR OPIN COLLOID IN, V6, P178, DOI 10.1016/S1359-0294(01)00076-0; KAWAGUCHI T, 1991, J PHYS CHEM-US, V95, P3837, DOI 10.1021/j100162a073; Lakowickz JR, 1992, TOPICS FLUORESCENCE; Lipfert J, 2007, J PHYS CHEM B, V111, P12427, DOI 10.1021/jp073016l; Luschtinetz F, 2009, J COLLOID INTERF SCI, V338, P312, DOI 10.1016/j.jcis.2009.06.064; Meng J, 2009, Z PHYS CHEM, V223, P689, DOI 10.1524/zpch.2009.5450; Meng XX, 2005, MACROMOLECULES, V38, P593, DOI 10.1021/ma048968t; Miraglia DB, 2010, J COLLOID INTERF SCI, V351, P197, DOI 10.1016/j.jcis.2010.07.040; Molinier V, 2005, J COLLOID INTERF SCI, V286, P360, DOI 10.1016/j.jcis.2004.12.010; Molinier V, 2004, TETRAHEDRON-ASYMMETR, V15, P1753, DOI 10.1016/j.tetasy.2004.04.021; Noritomi H, 2006, COLLOID POLYM SCI, V284, P683, DOI 10.1007/s00396-005-1452-9; Noritomi H, 2006, COLLOID POLYM SCI, V284, P604, DOI 10.1007/s00396-005-1398-y; Noritomi H, 2006, COLLOID POLYM SCI, V284, P677, DOI 10.1007/s00396-005-1419-x; Pedersen NR, 2003, TETRAHEDRON-ASYMMETR, V14, P667, DOI 10.1016/S0957-4166(03)00086-7; Sanchez SA, 2001, BIOCHEMISTRY-US, V40, P6903, DOI 10.1021/bi001599i; Schuch H, 2000, MACROMOLECULES, V33, P1734, DOI 10.1021/ma991491e; SCHULTZ SG, 1961, J GEN PHYSIOL, V44, P1189, DOI 10.1085/jgp.44.6.1189; So P. T. C., 1995, Bioimaging, V3, P49, DOI 10.1002/1361-6374(199506)3:2<49::AID-BIO1>3.3.CO;2-5; SO PTC, 1996, FLUORESCENCE IMAGING, P351; Soultani S, 2003, COLLOID SURFACE A, V227, P35, DOI 10.1016/S0927-7757(03)00360-1; TANFORD C, 1972, J PHYS CHEM-US, V76, P3020, DOI 10.1021/j100665a018; Thevenet S, 1999, CARBOHYD RES, V318, P52, DOI 10.1016/S0008-6215(99)00079-8; Vlahov IR, 1997, J CARBOHYD CHEM, V16, P1, DOI 10.1080/07328309708006506; Ying JY, 1999, ANGEW CHEM INT EDIT, V38, P56, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<56::AID-ANIE56>3.0.CO;2-E; Youan BBC, 2003, AAPS PHARMSCI, V5; Yu LL, 2006, ANAL CHIM ACTA, V556, P216, DOI 10.1016/j.aca.2005.09.008	43	9	9	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29278	10.1371/journal.pone.0029278	http://dx.doi.org/10.1371/journal.pone.0029278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216230	Green Published, gold			2022-12-27	WOS:000300676300041
J	Cattaneo, MG; Cappellini, E; Benfante, R; Ragni, M; Omodeo-Sale, F; Nisoli, E; Borgese, N; Vicentini, LM				Cattaneo, Maria Grazia; Cappellini, Elisa; Benfante, Roberta; Ragni, Maurizio; Omodeo-Sale, Fausta; Nisoli, Enzo; Borgese, Nica; Vicentini, Lucia M.			Chronic Deficiency of Nitric Oxide Affects Hypoxia Inducible Factor-1 alpha (HIF-1 alpha) Stability and Migration in Human Endothelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR GENE; CYTOCHROME-C-OXIDASE; MITOCHONDRIAL BIOGENESIS; TRANSCRIPTIONAL REGULATION; IN-VITRO; HIF-1; EXPRESSION; ALPHA; ATHEROSCLEROSIS; INHIBITION	Background: Endothelial dysfunction in widely diffuse disorders, such as atherosclerosis, hypertension, diabetes and senescence, is associated with nitric oxide (NO) deficiency. Here, the behavioural and molecular consequences deriving from NO deficiency in human umbilical vein endothelial cells (HUVECs) were investigated. Results: Endothelial nitric oxide synthase (eNOS) was chronically inhibited either by N-G-Nitro-L-arginine methyl ester (L-NAME) treatment or its expression was down-regulated by RNA interference. After long-term L-NAME treatment, HUVECs displayed a higher migratory capability accompanied by an increased Vascular Endothelial Growth Factor (VEGF) and VEGF receptor-2 (kinase insert domain receptor, KDR) expression. Moreover, both pharmacological and genetic inhibition of eNOS induced a state of pseudohypoxia, revealed by the stabilization of hypoxia-inducible factor-1 alpha (HIF-1 alpha). Furthermore, NO loss induced a significant decrease in mitochondrial mass and energy production accompanied by a lower O-2 consumption. Notably, very low doses of chronically administered DETA/NO reverted the HIF-1 alpha accumulation, the increased VEGF expression and the stimulated migratory behaviour detected in NO deficient cells. Conclusion: Based on our results, we propose that basal release of NO may act as a negative controller of HIF-1 alpha levels with important consequences for endothelial cell physiology. Moreover, we suggest that our experimental model where eNOS activity was impaired by pharmacological and genetic inhibition may represent a good in vitro system to study endothelial dysfunction.	[Cattaneo, Maria Grazia; Cappellini, Elisa; Benfante, Roberta; Ragni, Maurizio; Nisoli, Enzo; Borgese, Nica; Vicentini, Lucia M.] Univ Milan, Sch Med, Dept Pharmacol, I-20122 Milan, Italy; [Benfante, Roberta; Borgese, Nica] Inst Neurosci, CNR, Milan, Italy; [Omodeo-Sale, Fausta] Univ Milan, Fac Pharm, Dept Mol Sci Appl Biosyst, I-20122 Milan, Italy; [Borgese, Nica] Univ Catanzaro Magna Graecia, Dept Pharmacobiol Sci, Roccelletta Di Borgia, Cz, Italy	University of Milan; Consiglio Nazionale delle Ricerche (CNR); University of Milan; Magna Graecia University of Catanzaro	Cattaneo, MG (corresponding author), Univ Milan, Sch Med, Dept Pharmacol, I-20122 Milan, Italy.	lucia.vicentini@unimi.it	Cattaneo, Maria Grazia/H-3067-2017; Ragni, Maurizio/AAB-1527-2020; Benfante, Roberta/C-1513-2015; Nisoli, Enzo/D-6526-2014; Borgese, Nica/GWZ-8895-2022	Cattaneo, Maria Grazia/0000-0002-1582-9933; Ragni, Maurizio/0000-0001-6548-741X; Benfante, Roberta/0000-0001-5396-5429; Nisoli, Enzo/0000-0002-6670-1630; Borgese, Nica/0000-0002-7537-3974; Vicentini, Lucia M./0000-0002-2446-1974	Ministero Universita e Ricerca; University of Milano (FIRST and PUR)	Ministero Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Milano (FIRST and PUR)	This work was supported by research grants from Ministero Universita e Ricerca (PRIN 2008) to LMV, and from University of Milano (FIRST and PUR) to MGC and LMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addabbo F, 2009, AM J PATHOL, V174, P34, DOI 10.2353/ajpath.2009.080650; Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63; BAUMGARTNERPARZER SM, 1995, DIABETES, V44, P1323, DOI 10.2337/diabetes.44.11.1323; Bilton RL, 2003, EUR J BIOCHEM, V270, P791, DOI 10.1046/j.1432-1033.2003.03446.x; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; Bulotta S, 2009, BIOCHEM BIOPH RES CO, V386, P744, DOI 10.1016/j.bbrc.2009.06.118; Cattaneo MG, 2008, BRIT J PHARMACOL, V153, P728, DOI 10.1038/sj.bjp.0707609; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Herman AG, 2005, EUR HEART J, V26, P1945, DOI 10.1093/eurheartj/ehi333; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kimura H, 2000, BLOOD, V95, P189, DOI 10.1182/blood.V95.1.189.001k05_189_197; Li HG, 2009, CURR PHARM DESIGN, V15, P3133, DOI 10.2174/138161209789058002; Liu YX, 1998, J BIOL CHEM, V273, P15257, DOI 10.1074/jbc.273.24.15257; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mateo J, 2003, BIOCHEM J, V376, P537, DOI 10.1042/BJ20031155; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892; Namiki A, 1995, J BIOL CHEM, V270, P31189, DOI 10.1074/jbc.270.52.31189; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Noiri E, 1997, J BIOL CHEM, V272, P1747, DOI 10.1074/jbc.272.3.1747; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Palmer LA, 2000, MOL PHARMACOL, V58, P1197, DOI 10.1124/mol.58.6.1197; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Sandau KB, 2001, J BIOL CHEM, V276, P39805, DOI 10.1074/jbc.M107689200; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Sessa WC, 2009, J THROMB HAEMOST, V7, P35, DOI 10.1111/j.1538-7836.2009.03424.x; Sogawa K, 1998, P NATL ACAD SCI USA, V95, P7368, DOI 10.1073/pnas.95.13.7368; Tacchini L, 2004, CARCINOGENESIS, V25, P2089, DOI 10.1093/carcin/bgh227; Tacchini L, 2008, J BIOL CHEM, V283, P20674, DOI 10.1074/jbc.M800365200; Takabuchi S, 2004, BIOCHEM BIOPH RES CO, V324, P417, DOI 10.1016/j.bbrc.2004.09.064; Taylor CT, 2010, ARTERIOSCL THROM VAS, V30, P643, DOI 10.1161/ATVBAHA.108.181628; Triggle CR, 2010, J AM SOC HYPERTENS, V4, P102, DOI 10.1016/j.jash.2010.02.004; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; Vasa M, 2000, CIRC RES, V87, P540, DOI 10.1161/01.RES.87.7.540; ZICHE M, 1994, J CLIN INVEST, V94, P2036, DOI 10.1172/JCI117557	43	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29680	10.1371/journal.pone.0029680	http://dx.doi.org/10.1371/journal.pone.0029680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216344	gold, Green Published			2022-12-27	WOS:000300674900053
J	Yu, RJ; Zhou, W; Zhou, XL				Yu, Rongjun; Zhou, Wu; Zhou, Xiaolin			Rapid Processing of Both Reward Probability and Reward Uncertainty in the Human Anterior Cingulate Cortex	PLOS ONE			English	Article							FEEDBACK-RELATED NEGATIVITY; ERROR-RELATED NEGATIVITY; MEDIAL FRONTAL-CORTEX; BRAIN POTENTIALS; ELECTROPHYSIOLOGICAL RESPONSES; PREDICTION ERRORS; BAD OUTCOMES; RISK; REFLECTS; INFORMATION	Reward probability and uncertainty are two fundamental parameters of decision making. Whereas reward probability indicates the prospect of winning, reward uncertainty, measured as the variance of probability, indicates the degree of risk. Several lines of evidence have suggested that the anterior cingulate cortex (ACC) plays an important role in reward processing. What is lacking is a quantitative analysis of the encoding of reward probability and uncertainty in the human ACC. In this study, we addressed this issue by analyzing the feedback-related negativity (FRN), an event-related potential (ERP) component that reflects the ACC activity, in a simple gambling task in which reward probability and uncertainty were parametrically manipulated through predicting cues. Results showed that at the outcome evaluation phase, while both win and loss-related FRN amplitudes increased as the probability of win or loss decreased, only the win-related FRN was modulated by reward uncertainty. This study demonstrates the rapid encoding of reward probability and uncertainty in the human ACC and offers new insights into the functions of the ACC.	[Yu, Rongjun] S China Normal Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China; [Yu, Rongjun; Zhou, Xiaolin] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Yu, Rongjun; Zhou, Xiaolin] Peking Univ, Ctr Brain & Cognit Sci, Beijing 100871, Peoples R China; [Zhou, Wu] Univ Mississippi, Med Ctr, Dept Otolaryngol & Commun Sci, Jackson, MS 39216 USA; [Zhou, Wu] Univ Mississippi, Med Ctr, Dept Neurol & Anat, Jackson, MS 39216 USA; [Zhou, Xiaolin] Peking Univ, Minist Educ, Key Lab Machine Percept, Beijing 100871, Peoples R China	South China Normal University; Peking University; Peking University; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Peking University	Yu, RJ (corresponding author), S China Normal Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China.	xz104@pku.edu.cn	Yu, Rongjun/AAV-2615-2020	Yu, Rongjun/0000-0003-0123-1524	Natural Science Foundation of China [60435010, 30770712]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Natural Science Foundation of China (60435010, 30770712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, J NEUROPHYSIOL, V92, P1144, DOI 10.1152/jn.01209.2003; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bellebaum C, 2008, EUR J NEUROSCI, V27, P1823, DOI 10.1111/j.1460-9568.2008.06138.x; Bellebaum C, 2010, NEUROPSYCHOLOGIA, V48, P3343, DOI 10.1016/j.neuropsychologia.2010.07.023; Carlson JM, 2011, NEUROIMAGE, V57, P1608, DOI 10.1016/j.neuroimage.2011.05.037; Cohen MX, 2007, NEUROIMAGE, V35, P968, DOI 10.1016/j.neuroimage.2006.11.056; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Donkers FCL, 2005, COGNITIVE BRAIN RES, V25, P777, DOI 10.1016/j.cogbrainres.2005.09.007; Dreher JC, 2006, CEREB CORTEX, V16, P561, DOI 10.1093/cercor/bhj004; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Frank MJ, 2005, NEURON, V47, P495, DOI 10.1016/j.neuron.2005.06.020; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P161, DOI 10.1111/j.1469-8986.2005.00278.x; Han MH, 2010, NEUROSCIENCE, V30, P16453; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2008, PSYCHOPHYSIOLOGY, V45, P688, DOI 10.1111/j.1469-8986.2008.00668.x; Holroyd CB, 2006, BRAIN RES, V1105, P93, DOI 10.1016/j.brainres.2005.12.015; Holroyd CB, 2011, NEUROREPORT, V22, P249, DOI 10.1097/WNR.0b013e328345441d; Jessup RK, 2010, J NEUROSCI, V30, P3467, DOI 10.1523/JNEUROSCI.4130-09.2010; LEVY H, 1979, AM ECON REV, V69, P308; Luu P, 2003, PSYCHOL SCI, V14, P47, DOI 10.1111/1467-9280.01417; Marco-Pallares J, 2010, PSYCHOPHYSIOLOGY; Martin LE, 2009, NEUROREPORT, V20, P1140, DOI 10.1097/WNR.0b013e32832f0dca; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Moser JS, 2009, PSYCHOPHYSIOLOGY, V46, P313, DOI 10.1111/j.1469-8986.2008.00760.x; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Potts GF, 2006, J COGNITIVE NEUROSCI, V18, P1112, DOI 10.1162/jocn.2006.18.7.1112; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; REAL LA, 1991, SCIENCE, V253, P980, DOI 10.1126/science.1887231; Rolls ET, 2008, CEREB CORTEX, V18, P652, DOI 10.1093/cercor/bhm097; Sallet J, 2007, COGN AFFECT BEHAV NE, V7, P327, DOI 10.3758/CABN.7.4.327; Scherg M., 1990, BESA BRAIN ELECT SOU; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; van Veen V, 2004, BRAIN COGNITION, V56, P267, DOI 10.1016/j.bandc.2004.06.007; Williams ZM, 2004, NAT NEUROSCI, V7, P1370, DOI 10.1038/nn1354; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Yasuda A, 2004, NEUROREPORT, V15, P2561, DOI 10.1097/00001756-200411150-00027; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153; Yu RJ, 2009, J COGNITIVE NEUROSCI, V21, P684, DOI 10.1162/jocn.2009.21034; Zhou ZH, 2010, NEUROPSYCHOLOGIA, V48, P3606, DOI 10.1016/j.neuropsychologia.2010.08.010	47	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29633	10.1371/journal.pone.0029633	http://dx.doi.org/10.1371/journal.pone.0029633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	897SB	22216335	Green Published, gold			2022-12-27	WOS:000300674900048
J	Calabrese, JM; Brunner, JL; Ostfeld, RS				Calabrese, Justin M.; Brunner, Jesse L.; Ostfeld, Richard S.			Partitioning the Aggregation of Parasites on Hosts into Intrinsic and Extrinsic Components via an Extended Poisson-Gamma Mixture Model	PLOS ONE			English	Article							IXODES-SCAPULARIS ACARI; PEROMYSCUS-LEUCOPUS; TICK; IXODIDAE; POPULATIONS; TRANSMISSION; INFECTION; ABUNDANCE; PATTERNS; DAMMINI	It is well known that parasites are often highly aggregated on their hosts such that relatively few individuals host the large majority of parasites. When the parasites are vectors of infectious disease, a key consequence of this aggregation can be increased disease transmission rates. The cause of this aggregation, however, is much less clear, especially for parasites such as arthropod vectors, which generally spend only a short time on their hosts. Regression-based analyses of ticks on various hosts have focused almost exclusively on identifying the intrinsic host characteristics associated with large burdens, but these efforts have had mixed results; most host traits examined have some small influence, but none are key. An alternative approach, the Poisson-gamma mixture distribution, has often been used to describe aggregated parasite distributions in a range of host/macroparasite systems, but lacks a clear mechanistic basis. Here, we extend this framework by linking it to a general model of parasite accumulation. Then, focusing on blacklegged ticks (Ixodes scapularis) on mice (Peromyscus leucopus), we fit the extended model to the best currently available larval tick burden datasets via hierarchical Bayesian methods, and use it to explore the relative contributions of intrinsic and extrinsic factors on observed tick burdens. Our results suggest that simple bad luck-inhabiting a home range with high vector density-may play a much larger role in determining parasite burdens than is currently appreciated.	[Calabrese, Justin M.] Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA; [Calabrese, Justin M.] UFZ Helmholtz Ctr Environm Res, Leipzig, Germany; [Brunner, Jesse L.; Ostfeld, Richard S.] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Brunner, Jesse L.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Cary Institute of Ecosystem Studies; Washington State University	Calabrese, JM (corresponding author), Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA.	CalabreseJ@si.edu	Brunner, Jesse L./B-1692-2013; Calabrese, Justin/B-9131-2012	Brunner, Jesse L./0000-0003-4894-8274; Calabrese, Justin/0000-0003-0575-6408; Ostfeld, Richard/0000-0002-3707-9301	NSF [DEB 0075277, DEB 0444585]; NIH [R01 AI40076]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040076] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The data collection for this research was supported by NSF grants DEB 0075277 and DEB 0444585, and NIH grant R01 AI40076 (www.nsf.gov,www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1982, PARASITOLOGY, V85, P373, DOI 10.1017/S0031182000055347; Boswell M., 1970, RANDOM COUNTS SCI WO, V1, P3; Boyer N, 2010, J ANIM ECOL, V79, P538, DOI 10.1111/j.1365-2656.2010.01659.x; Brunner JL, 2008, ECOLOGY, V89, P2259, DOI 10.1890/07-0665.1; BUSH AO, 1993, CAN J ZOOL, V71, P1358, DOI 10.1139/z93-186; Case T, 2000, ILLUSTRATED GUIDE TH, V44; Clark J. S, 2007, MODELS ECOLOGICAL DA; CROFTON HD, 1971, PARASITOLOGY, V62, P179, DOI 10.1017/S0031182000071420; FALCO RC, 1991, J MED ENTOMOL, V28, P726, DOI 10.1093/jmedent/28.5.726; FALCO RC, 1992, EXP APPL ACAROL, V14, P165, DOI 10.1007/BF01219108; Fish Durland, 1993, P25; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Hilborn Ray, 1997, V28; Hubbard A, 2002, PARASITOLOGY, V125, P221, DOI 10.1017/S003118200200207X; JANOVY J, 1988, J THEOR BIOL, V134, P391, DOI 10.1016/S0022-5193(88)80069-9; JONES LD, 1987, SCIENCE, V237, P775, DOI 10.1126/science.3616608; KEYMER AE, 1979, PARASITOLOGY, V79, P195, DOI 10.1017/S0031182000053282; Kiffner C, 2011, MED VET ENTOMOL, V25, P39, DOI 10.1111/j.1365-2915.2010.00929.x; Kiffner C, 2011, PARASITOL RES, V108, P323, DOI 10.1007/s00436-010-2065-x; LABUDA M, 1993, J MED ENTOMOL, V30, P295, DOI 10.1093/jmedent/30.1.295; Lindsay LR, 1998, J MED ENTOMOL, V35, P189, DOI 10.1093/jmedent/35.3.189; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Markowski D, 1997, J PARASITOL, V83, P207, DOI 10.2307/3284440; Mouchet J, 1996, LANCET, V348, P1735, DOI 10.1016/S0140-6736(05)65860-6; Paterson S, 2003, TRENDS PARASITOL, V19, P370, DOI 10.1016/S1471-4922(03)00149-1; Perkins SE, 2003, INT J PARASITOL, V33, P909, DOI 10.1016/S0020-7519(03)00128-0; PETNEY TN, 1990, ONDERSTEPOORT J VET, V57, P123; SCHAD GA, 1985, SCIENCE, V228, P1537, DOI 10.1126/science.4012307; Schmidt KA, 1999, J MED ENTOMOL, V36, P749, DOI 10.1093/jmedent/36.6.749; Shaw DJ, 1995, PARASITOLOGY, V111, pS111, DOI 10.1017/S0031182000075855; Shaw DJ, 1998, PARASITOLOGY, V117, P597, DOI 10.1017/S0031182098003448; Wilson K, 2002, ECOLOGY WILDLIFE DIS, P644; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	36	42	42	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29215	10.1371/journal.pone.0029215	http://dx.doi.org/10.1371/journal.pone.0029215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216216	Green Submitted, gold, Green Published			2022-12-27	WOS:000299684700041
J	Trivino, M; Thuiller, W; Cabeza, M; Hickler, T; Araujo, MB				Trivino, Maria; Thuiller, Wilfried; Cabeza, Mar; Hickler, Thomas; Araujo, Miguel B.			The Contribution of Vegetation and Landscape Configuration for Predicting Environmental Change Impacts on Iberian Birds	PLOS ONE			English	Article							LAND-USE CHANGE; MODELING SPECIES DISTRIBUTIONS; CLIMATE-CHANGE; HABITAT; ACCURACY; COVER; TREE; BIODIVERSITY; UNCERTAINTY; DIVERSITY	Although climate is known to be one of the key factors determining animal species distributions amongst others, projections of global change impacts on their distributions often rely on bioclimatic envelope models. Vegetation structure and landscape configuration are also key determinants of distributions, but they are rarely considered in such assessments. We explore the consequences of using simulated vegetation structure and composition as well as its associated landscape configuration in models projecting global change effects on Iberian bird species distributions. Both present-day and future distributions were modelled for 168 bird species using two ensemble forecasting methods: Random Forests (RF) and Boosted Regression Trees (BRT). For each species, several models were created, differing in the predictor variables used (climate, vegetation, and landscape configuration). Discrimination ability of each model in the present-day was then tested with four commonly used evaluation methods (AUC, TSS, specificity and sensitivity). The different sets of predictor variables yielded similar spatial patterns for well-modelled species, but the future projections diverged for poorly-modelled species. Models using all predictor variables were not significantly better than models fitted with climate variables alone for ca. 50% of the cases. Moreover, models fitted with climate data were always better than models fitted with landscape configuration variables, and vegetation variables were found to correlate with bird species distributions in 26-40% of the cases with BRT, and in 1-18% of the cases with RF. We conclude that improvements from including vegetation and its landscape configuration variables in comparison with climate only variables might not always be as great as expected for future projections of Iberian bird species.	[Trivino, Maria; Cabeza, Mar; Araujo, Miguel B.] CSIC, Natl Museum Nat Sci, Dept Biodivers & Evolutionary Biol, Madrid, Spain; [Thuiller, Wilfried] Univ Grenoble 1, CNRS, UMR 5553, Lab Ecol Alpine, Grenoble, France; [Cabeza, Mar] Univ Helsinki, Dept Biol & Environm Sci, Metapopulat Res Grp, Helsinki, Finland; [Hickler, Thomas] Lund Univ, Geobiosphere Sci Ctr, Dept Phys Geog & Ecosyst Anal, Lund, Sweden; [Hickler, Thomas] Goethe Univ Frankfurt, Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Hickler, Thomas] Goethe Univ Frankfurt, Dept Phys Geog, Frankfurt, Germany; [Hickler, Thomas] Senckenberg Gesell Nat Forsch, Frankfurt, Germany; [Araujo, Miguel B.] Univ Evora, CIBIO, Rui Nabeiro Biodivers Chair, Evora, Portugal; [Araujo, Miguel B.] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark	Consejo Superior de Investigaciones Cientificas (CSIC); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; University of Helsinki; Lund University; Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Evora; University of Copenhagen	Trivino, M (corresponding author), CSIC, Natl Museum Nat Sci, Dept Biodivers & Evolutionary Biol, Madrid, Spain.	m.trivino@mncn.csic.es	Triviño, María/H-7740-2019; Thuiller, Wilfried/G-3283-2010; Hickler, Thomas/S-6287-2016; Araújo, Miguel B/B-6117-2008; Cabeza, Mar/ABC-4297-2020	Triviño, María/0000-0002-2420-3537; Thuiller, Wilfried/0000-0002-5388-5274; Hickler, Thomas/0000-0002-4668-7552; Araújo, Miguel B/0000-0002-5107-7265; Cabeza, Mar/0000-0002-7410-7631	Spanish Ministry of Science and Innovation (MICINN) [BES-2007-17331]; European Commission [244092, 036866-GOCE]; Landesinitiative zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE); Spanish Ministry of Science and Innovation [CGL2008-01198-E/BOS]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); Landesinitiative zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	MT was funded by predoctoral research grant FPI (Formacion de Personal Investigador) from the Spanish Ministry of Science and Innovation (MICINN) (BES-2007-17331) URL: http://www.micinn.es/portal/site/MICINN/menuitem.dbc68b34d11ccbd5d52ffeb801432ea0/?vgnextoid=2d161e84ed136210VgnVCM1000001d04140aRCRD. MC and MBA were funded by the European Commission Seventh Framework Program project European RESPONSES to climate change (grant agreement number 244092). URL: http://www.responsesproject.eu/. WT, TH and MBA were funded by the European Commission Sixth Framework Program ECOCHANGE project (Challenges in Assessing and Forecasting Biodiversity and Ecosystem Changes in Europe, contract no. 036866-GOCE). URL: http://www.ecochange-project.eu/. TH was also supported by the Landesinitiative zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE)-initiative for scientific and economic excellence of the German federal state of Hesse (http://www.hessen.de/irj/HMWK_Internet?cid=a2396939885f8c8c0a3ba39bda517cbd). MBA was further supported by the Spanish Ministry of Science and Innovation (complementary action no. CGL2008-01198-E/BOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Alvim A, 2008, EQUIPA ATLAS ATLAS A; Araujo MB, 2008, ENVIRON SCI POLICY, V11, P38, DOI 10.1016/j.envsci.2007.07.002; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Araujo MB, 2009, P NATL ACAD SCI USA, V106, pE45, DOI 10.1073/pnas.0813294106; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Bohn U, 2003, MAP NATURAL VEGETATI; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brommer JE, 2004, ANN ZOOL FENN, V41, P391; Brotons L, 2007, DIVERS DISTRIB, V13, P276, DOI 10.1111/j.1472-4642.2007.00339.x; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dendoncker N, 2006, J LAND USE SCI, V1, P63, DOI 10.1080/17474230601058302; Dendoncker N, 2007, COMPUT ENVIRON URBAN, V31, P188, DOI 10.1016/j.compenvurbsys.2006.06.004; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; European Commission, 1993, COR LAND COV MAP TEC; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Fronzek S, 2012, GLOBAL ECOL BIOGEOGR, V21, P19, DOI 10.1111/j.1466-8238.2011.00695.x; Gerten D, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024247; Gregory RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004678; Hampe A, 2004, GLOBAL ECOL BIOGEOGR, V13, P469, DOI 10.1111/j.1466-822X.2004.00090.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hickler T, 2004, ECOLOGY, V85, P519, DOI 10.1890/02-0344; Hickler T, 2008, GLOBAL CHANGE BIOL, V14, P1531, DOI 10.1111/j.1365-2486.2008.01598.x; Hickler T, 2012, GLOBAL ECOL BIOGEOGR, V21, P50, DOI 10.1111/j.1466-8238.2010.00613.x; Hickler T, 2009, GLOBAL ECOL BIOGEOGR, V18, P304, DOI 10.1111/j.1466-8238.2009.00455.x; Hughes GO, 2008, BIOL CONSERV, V141, P23, DOI 10.1016/j.biocon.2007.08.004; Huntley B., 2007, CLIMATIC ATLAS EUROP; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Kaplan JO, 2009, QUATERNARY SCI REV, V28, P3016, DOI 10.1016/j.quascirev.2009.09.028; KARR JR, 1971, AM NAT, V105, P423, DOI 10.1086/282735; Kissling WD, 2010, PHILOS T R SOC B, V365, P2035, DOI 10.1098/rstb.2010.0008; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Lee PY, 2005, J BIOGEOGR, V32, P1139, DOI 10.1111/j.1365-2699.2005.01254.x; Lehikoinen E, 2004, ADV ECOL RES, V35, P1, DOI 10.1016/S0065-2504(04)35001-4; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Luoto M, 2008, GLOBAL CHANGE BIOL, V14, P483, DOI 10.1111/j.1365-2486.2007.01527.x; Luoto M, 2007, GLOBAL ECOL BIOGEOGR, V16, P34, DOI 10.1111/j.1466-8238.2006.00262.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Martui R., 2003, ATLAS AVES REPRODUCT; McPherson JM, 2007, ECOGRAPHY, V30, P135, DOI 10.1111/j.2006.0906-7590.04823.x; Melles SJ, 2011, GLOBAL CHANGE BIOL, V17, P17, DOI 10.1111/j.1365-2486.2010.02214.x; MOller A. P., 2004, BIRDS CLIMATE CHANGE; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; PEARSON SM, 1993, LANDSCAPE ECOL, V8, P3, DOI 10.1007/BF00129863; Peterson AT, 2002, IBIS, V144, pE27, DOI 10.1046/j.0019-1019.2001.00031.x; Pompe S, 2008, BIOL LETTERS, V4, P564, DOI 10.1098/rsbl.2008.0231; Poyry J, 2008, GLOBAL ECOL BIOGEOGR, V17, P403, DOI 10.1111/j.1466-8238.2007.00373.x; Preston K, 2008, GLOBAL CHANGE BIOL, V14, P2501, DOI 10.1111/j.1365-2486.2008.01671.x; R Core Team, 2021, R LANGUAGE ENV STAT; ROOT T, 1988, J BIOGEOGR, V15, P489, DOI 10.2307/2845278; ROTENBERRY JT, 1980, ECOLOGY, V61, P1228, DOI 10.2307/1936840; Rounsevell MDA, 2006, AGR ECOSYST ENVIRON, V114, P57, DOI 10.1016/j.agee.2005.11.027; Saab V, 1999, ECOL APPL, V9, P135, DOI 10.1890/1051-0761(1999)009[0135:IOSSTH]2.0.CO;2; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Seoane J, 2005, ECOL MODEL, V185, P299, DOI 10.1016/j.ecolmodel.2004.12.012; Seoane J, 2004, ECOL MODEL, V171, P209, DOI 10.1016/j.ecolmodel.2003.08.006; Seoane J, 2008, GLOBAL ECOL BIOGEOGR, V17, P111, DOI 10.1111/j.1466-8238.2007.00351.x; Smith B, 2001, GLOBAL ECOL BIOGEOGR, V10, P621, DOI 10.1046/j.1466-822X.2001.00256.x; Spangenberg JH, 2007, SUSTAIN DEV, V15, P343, DOI 10.1002/sd.320; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thuiller W, 2004, NATURE, V430, DOI 10.1038/nature02716; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Villanueva JA, 2004, TERCER INVENTARIO FO; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Whittaker RJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P76, DOI 10.1111/j.1466-8238.2006.00268.x	83	44	46	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29373	10.1371/journal.pone.0029373	http://dx.doi.org/10.1371/journal.pone.0029373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216263	Green Published, gold			2022-12-27	WOS:000299684700051
J	Bouillard, K; Nordez, A; Hug, F				Bouillard, Killian; Nordez, Antoine; Hug, Francois			Estimation of Individual Muscle Force Using Elastography	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; TRANSIENT ELASTOGRAPHY; SURFACE ELECTROMYOGRAM; ELASTIC PROPERTIES; SHEAR; STIFFNESS; MOVEMENTS; EMG	Background: Estimation of an individual muscle force still remains one of the main challenges in biomechanics. In this way, the present study aimed: (1) to determine whether an elastography technique called Supersonic Shear Imaging (SSI) could be used to estimate muscle force, (2) to compare this estimation to that one provided by surface electromyography (EMG), and (3) to determine the effect of the pennation of muscle fibers on the accuracy of the estimation. Methods and Results: Eleven subjects participated in two experimental sessions; one was devoted to the shear elastic modulus measurements and the other was devoted to the EMG recordings. Each session consisted in: (1) two smooth linear torque ramps from 0 to 60% and from 0 to 30% of maximal voluntary contraction, for the first dorsal interosseous and the abductor digiti minimi, respectively (referred to as "ramp contraction''); (2) two contractions done with the instruction to freely change the torque (referred to as "random changes contraction''). Multi-channel surface EMG recordings were obtained from a linear array of eight electrodes and the shear elastic modulus was measured using SSI. For ramp contractions, significant linear relationships were reported between EMG activity level and torque (R-2 = 0.949 +/- 0.036), and between shear elastic modulus and torque (R-2 = 0.982 +/- 0.013). SSI provided significant lower RMSdeviation between measured torque and estimated torque than EMG activity level for both types of contraction (1.460.7 vs. 2.861.4% of maximal voluntary contraction for "ramp contractions'', p < 0.01; 4.5 +/- 2.3 vs. 7.9 +/- 5.9% of MVC for "random changes contractions'', p < 0.05). No significant difference was reported between muscles. Conclusion: The shear elastic modulus measured using SSI can provide a more accurate estimation of individual muscle force than surface EMG. In addition, pennation of muscle fibers does not influence the accuracy of the estimation.	[Bouillard, Killian; Nordez, Antoine; Hug, Francois] Univ Nantes, Lab Motricite Interact Performance EA 4334, Nantes, France	Nantes Universite	Bouillard, K (corresponding author), Univ Nantes, Lab Motricite Interact Performance EA 4334, Nantes, France.	antoine.nordez@univ-nantes.fr	Hug, François/AAV-2415-2020; HUG, Francois/A-5540-2011	Hug, François/0000-0002-6432-558X; 	Association Francaise contre les Myopathies (AFM) [14597]; Region des Pays de la Loire [2010_11120]; Fonds Europeen de Developpement Regional	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Region des Pays de la Loire(Region Pays de la Loire); Fonds Europeen de Developpement Regional	This work was supported by the Association Francaise contre les Myopathies (AFM - contract 14597), the Region des Pays de la Loire (2010_11120), and the Fonds Europeen de Developpement Regional. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basford JR, 2002, ARCH PHYS MED REHAB, V83, P1530, DOI 10.1053/apmr.2002.35472; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Buchanan TS, 2004, J APPL BIOMECH, V20, P367, DOI 10.1123/jab.20.4.367; Catheline S, 2004, J ACOUST SOC AM, V116, P3734, DOI 10.1121/1.1815075; Chao E.Y., 1989, BIOMECHANICS HAND BA; Cornu C, 2001, J PHYSIOL-LONDON, V533, P605, DOI 10.1111/j.1469-7793.2001.0605a.x; Deffieux T, 2009, IEEE T MED IMAGING, V28, P313, DOI 10.1109/TMI.2008.925077; Del Santo F, 2007, BRAIN RES, V1163, P79, DOI 10.1016/j.brainres.2007.06.012; Dresner MA, 2001, J MAGN RESON IMAGING, V13, P269, DOI 10.1002/1522-2586(200102)13:2<269::AID-JMRI1039>3.3.CO;2-T; Erdemir A, 2007, CLIN BIOMECH, V22, P131, DOI 10.1016/j.clinbiomech.2006.09.005; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; FORD LE, 1981, J PHYSIOL-LONDON, V311, P219, DOI 10.1113/jphysiol.1981.sp013582; Fung Y.C., 1993, BIOMECHANICS MECH PR; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Gennisson JL, 2003, J ACOUST SOC AM, V114, P536, DOI 10.1121/1.1579008; Hug F, 2011, J ELECTROMYOGR KINES, V21, P1, DOI 10.1016/j.jelekin.2010.08.009; Infantolino BW, 2010, J ANAT, V216, P463, DOI 10.1111/j.1469-7580.2009.01196.x; Keenan KG, 2005, J APPL PHYSIOL, V98, P120, DOI 10.1152/japplphysiol.00894.2004; LAWRENCE JH, 1983, J APPL PHYSIOL, V54, P1653, DOI 10.1152/jappl.1983.54.6.1653; Lebreton E, 2010, CHIR MAIN, V29, P213, DOI 10.1016/j.main.2010.04.003; MASON P, 1978, BIOPHYS STRUCT MECH, V4, P15, DOI 10.1007/BF00538837; MILNERBROWN HS, 1975, J PHYSIOL-LONDON, V246, P549, DOI 10.1113/jphysiol.1975.sp010904; Nordez A, 2008, J BIOMECH, V41, P2305, DOI 10.1016/j.jbiomech.2008.03.033; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; Orizio C, 2010, J ELECTROMYOGR KINES, V20, P732, DOI 10.1016/j.jelekin.2010.03.005; Shinohara M, 2010, MUSCLE NERVE, V42, P438, DOI 10.1002/mus.21723; WEISS PL, 1988, J BIOMECH, V21, P539, DOI 10.1016/0021-9290(88)90217-5; Zajac FE, 2003, GAIT POSTURE, V17, P1, DOI 10.1016/S0966-6362(02)00069-3	28	114	121	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29261	10.1371/journal.pone.0029261	http://dx.doi.org/10.1371/journal.pone.0029261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22229057	gold, Green Published, Green Submitted			2022-12-27	WOS:000299113600070
J	Hsiang, MS; Hwang, J; Kunene, S; Drakeley, C; Kandula, D; Novotny, J; Parizo, J; Jensen, T; Tong, M; Kemere, J; Dlamini, S; Moonen, B; Angov, E; Dutta, S; Ockenhouse, C; Dorsey, G; Greenhouse, B				Hsiang, Michelle S.; Hwang, Jimee; Kunene, Simon; Drakeley, Chris; Kandula, Deepika; Novotny, Joseph; Parizo, Justin; Jensen, Trevor; Tong, Marcus; Kemere, Jordan; Dlamini, Sabelo; Moonen, Bruno; Angov, Evelina; Dutta, Sheetij; Ockenhouse, Christian; Dorsey, Grant; Greenhouse, Bryan			Surveillance for Malaria Elimination in Swaziland: A National Cross-Sectional Study Using Pooled PCR and Serology	PLOS ONE			English	Article							DRIED BLOOD SPOTS; TRANSMISSION; FEASIBILITY; PLASMODIUM; COMMUNITY; MARKERS	Background: To guide malaria elimination efforts in Swaziland and other countries, accurate assessments of transmission are critical. Pooled-PCR has potential to efficiently improve sensitivity to detect infections; serology may clarify temporal and spatial trends in exposure. Methodology/Principal Findings: Using a stratified two-stage cluster, cross-sectional design, subjects were recruited from the malaria endemic region of Swaziland. Blood was collected for rapid diagnostic testing (RDT), pooled PCR, and ELISA detecting antibodies to Plasmodium falciparum surface antigens. Of 4330 participants tested, three were RDT-positive yet false positives by PCR. Pooled PCR led to the identification of one P. falciparum and one P. malariae infection among RDT-negative participants. The P. falciparum-infected participant reported recent travel to Mozambique. Compared to performing individual testing on thousands of samples, PCR pooling reduced labor and consumable costs by 95.5%. Seropositivity was associated with age >= 20 years (11.7% vs 1.9%, P < 0.001), recent travel to Mozambique (OR 4.4 [95% CI 1.0-19.0]) and residence in southeast Swaziland (RR 3.78, P < 0.001). Conclusions: The prevalence of malaria infection and recent exposure in Swaziland are extremely low, suggesting elimination is feasible. Future efforts should address imported malaria and target remaining foci of transmission. Pooled PCR and ELISA are valuable surveillance tools for guiding elimination efforts.	[Hsiang, Michelle S.; Hwang, Jimee; Kandula, Deepika; Novotny, Joseph] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Hsiang, Michelle S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Hwang, Jimee] Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA USA; [Kunene, Simon; Dlamini, Sabelo] Dept Hlth, Malaria Control Program, Manzini, Swaziland; [Drakeley, Chris] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Kandula, Deepika; Novotny, Joseph; Moonen, Bruno] Clinton Hlth Access Initiat, Boston, MA USA; [Parizo, Justin; Jensen, Trevor] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Tong, Marcus] Univ Calif Los Angeles, Sch Engn & Appl Sci, Los Angeles, CA 90024 USA; [Kemere, Jordan] Univ N Carolina, Chapel Hill, NC USA; [Angov, Evelina; Dutta, Sheetij; Ockenhouse, Christian] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD USA; [Dorsey, Grant; Greenhouse, Bryan] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of California System; University of California San Francisco	Hsiang, MS (corresponding author), Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.	HsiangM@peds.ucsf.edu	Dlamini, Sabelo Nick/AAC-2213-2020	Dlamini, Sabelo Nick/0000-0002-4165-580X; Greenhouse, Bryan/0000-0003-0287-9111	Global Fund to Fight AIDS, Tuberculosis and Malaria; Southern Africa Roll Back Malaria Network through Swaziland Ministry of Health [A115545]; Pediatric Infectious Diseases Society [A112604]; Bill and Melinda Gates Foundation [A108197]	Global Fund to Fight AIDS, Tuberculosis and Malaria; Southern Africa Roll Back Malaria Network through Swaziland Ministry of Health; Pediatric Infectious Diseases Society; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Global Fund to Fight AIDS, Tuberculosis and Malaria and Southern Africa Roll Back Malaria Network through Swaziland Ministry of Health (grant A115545); Pediatric Infectious Diseases Society (grant A112604); and the Bill and Melinda Gates Foundation (grant A108197). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000400; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000396; Alves FP, 2005, J MED ENTOMOL, V42, P777, DOI 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; [Anonymous], SWAZ NAT MAL EL POL; [Anonymous], 3 SESS AFR UN C MIN; [Anonymous], 2010, 2010 SWAZ MAL REP; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; BRUCECHWATT LJ, 1973, LANCET, V2, P547; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Eng JLV, 2007, AM J TROP MED HYG, V77, P393, DOI 10.4269/ajtmh.2007.77.393; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hlongwana KW, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-29; Hsiang MS, 2010, J CLIN MICROBIOL, V48, P3539, DOI 10.1128/JCM.00522-10; Ishengoma DS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-176; Jima D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-58; Keating J, 2009, ACTA TROP, V112, P277, DOI 10.1016/j.actatropica.2009.08.011; Maude RJ, 2011, LANCET, V377, P638, DOI 10.1016/S0140-6736(11)60229-8; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Murray CK, 2003, TROP MED INT HEALTH, V8, P876, DOI 10.1046/j.1365-3156.2003.01115.x; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Roll Back Malaria Monitoring and Evaluation Reference Group, 2005, MAL IND SURV BAS DOC; Sabot O, 2010, LANCET, V376, P1604, DOI 10.1016/S0140-6736(10)61355-4; *SADC MIN HLTH, 2007, STRAT PLAN FIGHT MAL; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Steenkeste N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-108; Steenkeste N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-86; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Swaziland Malaria Control Unit, 1990, ANN REP 1989 90 SWAZ; WHO Global Malaria Programme, 2010, WORLD MAL REP 2010; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119	33	65	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29550	10.1371/journal.pone.0029550	http://dx.doi.org/10.1371/journal.pone.0029550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238621	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000301188800020
J	Romanel, A; Jensen, LJ; Cardelli, L; Csikasz-Nagy, A				Romanel, Alessandro; Jensen, Lars Juhl; Cardelli, Luca; Csikasz-Nagy, Attila			Transcriptional Regulation Is a Major Controller of Cell Cycle Transition Dynamics	PLOS ONE			English	Article							POSITIVE FEEDBACK; MITOTIC EXIT; MORPHOGENESIS CHECKPOINT; MATHEMATICAL-MODEL; SIGNALING PATHWAYS; NEGATIVE FEEDBACK; LEVEL; ANAPHASE; CDK; PHOSPHORYLATION	DNA replication, mitosis and mitotic exit are critical transitions of the cell cycle which normally occur only once per cycle. A universal control mechanism was proposed for the regulation of mitotic entry in which Cdk helps its own activation through two positive feedback loops. Recent discoveries in various organisms showed the importance of positive feedbacks in other transitions as well. Here we investigate if a universal control system with transcriptional regulation(s) and post-translational positive feedback(s) can be proposed for the regulation of all cell cycle transitions. Through computational modeling, we analyze the transition dynamics in all possible combinations of transcriptional and post-translational regulations. We find that some combinations lead to 'sloppy' transitions, while others give very precise control. The periodic transcriptional regulation through the activator or the inhibitor leads to radically different dynamics. Experimental evidence shows that in cell cycle transitions of organisms investigated for cell cycle dependent periodic transcription, only the inhibitor OR the activator is under cyclic control and never both of them. Based on these observations, we propose two transcriptional control modes of cell cycle regulation that either STOP or let the cycle GO in case of a transcriptional failure. We discuss the biological relevance of such differences.	[Romanel, Alessandro; Csikasz-Nagy, Attila] Microsoft Res Univ Trento, Ctr Computat & Syst Biol, Trento, Italy; [Jensen, Lars Juhl] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark; [Cardelli, Luca] Microsoft Res Cambridge, Cambridge, England	Microsoft; University of Trento; University of Copenhagen; Microsoft	Romanel, A (corresponding author), Univ Trento, Ctr Integrat Biol, Trento, Italy.	csikasz@cosbi.eu	Csikasz-Nagy, Attila/A-3487-2009; Romanel, Alessandro/J-8864-2018; Jensen, Lars Juhl/C-6492-2008	Csikasz-Nagy, Attila/0000-0002-2919-5601; Romanel, Alessandro/0000-0003-4855-8620; Jensen, Lars Juhl/0000-0001-7885-715X; Cardelli, Luca/0000-0002-8705-8488; Romanel, Alessandro/0000-0002-2376-8552	Italian Research Fund FIRB [RBPR0523C3]; Novo Nordisk Foundation Center for Protein Research	Italian Research Fund FIRB; Novo Nordisk Foundation Center for Protein Research	The work carried out in this study was in part supported by the Italian Research Fund FIRB (RBPR0523C3) and the Novo Nordisk Foundation Center for Protein Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, INTRO SYSTEMS BIOL D; Amon A, 1997, EMBO J, V16, P2693, DOI 10.1093/emboj/16.10.2693; Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Charvin G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000284; Ciliberto A, 2003, J CELL BIOL, V163, P1243, DOI 10.1083/jcb.200306139; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Csikasz-Nagy A, 2007, CURR GENET, V51, P245, DOI 10.1007/s00294-007-0123-4; Csikasz-Nagy A, 2006, BIOPHYS J, V90, P4361, DOI 10.1529/biophysj.106.081240; Csikasz-Nagy A, 2011, J R SOC INTERFACE, V8, P480, DOI 10.1098/rsif.2010.0336; Csikasz-Nagy A, 2009, BRIEF BIOINFORM, V10, P424, DOI 10.1093/bib/bbp005; Csikasz-Nagy A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.73; Deibler RW, 2010, MOL CELL, V37, P753, DOI 10.1016/j.molcel.2010.02.023; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Dematte L, 2008, BRIEF BIOINFORM, V9, P437, DOI 10.1093/bib/bbn023; Dematte L, 2010, SYST BIO, V1, P777, DOI 10.1007/978-1-4419-5797-9_31; Dissmeyer N, 2010, PLANT SIGNAL BEHAV, V5, P1613, DOI 10.4161/psb.5.12.13969; Domingo-Sananes MR, 2010, CHAOS, V20, DOI 10.1063/1.3526967; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Enders GH, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-12; Ferrell JE, 2008, CURR BIOL, V18, pR244, DOI 10.1016/j.cub.2008.02.035; Ferrell JE, 2011, CELL, V144, P874, DOI 10.1016/j.cell.2011.03.006; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gauthier NP, 2010, NUCLEIC ACIDS RES, V38, pD699, DOI 10.1093/nar/gkp1044; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107; He E, 2011, P NATL ACAD SCI USA, V108, P10016, DOI 10.1073/pnas.1102106108; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; Kapuy O, 2009, FEBS LETT, V583, P3992, DOI 10.1016/j.febslet.2009.08.023; Khodjakov Alexey, 2009, Journal of Biology (London), V8, P1, DOI 10.1186/jbiol195; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Lopez-Aviles S, 2009, NATURE, V459, P592, DOI 10.1038/nature07984; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Morgan DO, CELL CYCLE PRINCIPLE; Nasmyth K, 2001, CELL, V107, P689, DOI 10.1016/S0092-8674(01)00604-3; NOVAK B, 1993, J CELL SCI, V106, P1153; Novak B, 2007, NAT CELL BIOL, V9, P724, DOI 10.1038/ncb0707-724; Novak B, 2010, CURR OPIN CELL BIOL, V22, P801, DOI 10.1016/j.ceb.2010.07.001; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; O'Farrell PH, 2001, TRENDS CELL BIOL, V11, P512, DOI 10.1016/S0962-8924(01)02142-0; Orlando DA, 2008, NATURE, V453, P944, DOI 10.1038/nature06955; Pal G, 2008, J CELL BIOL, V180, P931, DOI 10.1083/jcb.200711014; Perry JA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-12; Pomerening JR, 2009, FEBS LETT, V583, P3388, DOI 10.1016/j.febslet.2009.10.001; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Rupes I, 2002, TRENDS GENET, V18, P479, DOI 10.1016/S0168-9525(02)02745-2; Savageau MA, 1998, GENETICS, V149, P1665; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Sia RAL, 1998, EMBO J, V17, P6678, DOI 10.1093/emboj/17.22.6678; Sia RAL, 1996, MOL BIOL CELL, V7, P1657, DOI 10.1091/mbc.7.11.1657; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Sveiczer A, 1996, J CELL SCI, V109, P2947; Trunnell NB, 2011, MOL CELL, V41, P263, DOI 10.1016/j.molcel.2011.01.012; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tyson JJ, 2002, BIOESSAYS, V24, P1095, DOI 10.1002/bies.10191; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Tyson JJ, 2008, CURR BIOL, V18, pR759, DOI 10.1016/j.cub.2008.07.001; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149	69	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29716	10.1371/journal.pone.0029716	http://dx.doi.org/10.1371/journal.pone.0029716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238641	Green Published, Green Submitted, gold			2022-12-27	WOS:000301188800030
J	Filipovic, B; Matak, I; Bach-Rojecky, L; Lackovic, Z				Filipovic, Boris; Matak, Ivica; Bach-Rojecky, Lidija; Lackovic, Zdravko			Central Action of Peripherally Applied Botulinum Toxin Type A on Pain and Dural Protein Extravasation in Rat Model of Trigeminal Neuropathy	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; SENSORY NEURONS; SUBSTANCE-P; STIMULATION; NERVE; ALLODYNIA; RESPONSES; GANGLION; SUMATRIPTAN; NEUROTOXIN	Background: Infraorbital nerve constriction (IoNC) is an experimental model of trigeminal neuropathy. We investigated if IoNC is accompanied by dural extravasation and if botulinum toxin type A (BoNT/A) can reduce pain and dural extravasation in this model. Methodology/Principal Findings: Rats which developed mechanical allodynia 14 days after the IoNC were injected with BoNT/A (3.5 U/kg) into vibrissal pad. Allodynia was tested by von Frey filaments and dural extravasation was measured as colorimetric absorbance of Evans blue - plasma protein complexes. Presence of dural extravasation was also examined in orofacial formalin-induced pain. Unilateral IoNC, as well as formalin injection, produced bilateral dural extravasation. Single unilateral BoNT/A injection bilaterally reduced IoNC induced dural extravasation, as well as allodynia (lasting more than 2 weeks). Similarly, BoNT/A reduced formalin-induced pain and dural extravasation. Effects of BoNT/A on pain and dural extravasation in IoNC model were dependent on axonal transport through sensory neurons, as evidenced by colchicine injections (5 mM, 2 mu l) into the trigeminal ganglion completely preventing BoNT/A effects. Conclusions/Significance: Two different types of pain, IoNC and formalin, are accompanied by dural extravasation. The lasting effect of a unilateral injection of BoNT/A in experimental animals suggests that BoNT/A might have a long-term beneficial effect in craniofacial pain associated with dural neurogenic inflammation. Bilateral effects of BoNT/A and dependence on retrograde axonal transport suggest a central site of its action.	[Filipovic, Boris; Matak, Ivica; Lackovic, Zdravko] Univ Zagreb, Sch Med, Lab Mol Neuropharmacol, Dept Pharmacol, Zagreb 41001, Croatia; [Filipovic, Boris; Matak, Ivica; Lackovic, Zdravko] Univ Zagreb, Sch Med, Croatian Brain Res Inst, Zagreb 41001, Croatia; [Bach-Rojecky, Lidija] Univ Zagreb, Sch Pharm & Biochem, Dept Pharmacol, Zagreb 41000, Croatia; [Filipovic, Boris] Univ Hosp Sveti Duh, Dept Otorhinolaryngol Head & Neck Surg, Zagreb, Croatia	University of Zagreb; University of Zagreb; University of Zagreb	Filipovic, B (corresponding author), Univ Zagreb, Sch Med, Lab Mol Neuropharmacol, Dept Pharmacol, Zagreb 41001, Croatia.	lac@mef.hr	Bach, Lidija/AAR-6305-2020	Bach, Lidija/0000-0003-4580-833X; Lackovic, Zdravko/0000-0001-6338-3609	Croatian Ministry of Science, Education and Sport [108-1080003-0001]; Deutscher Akademischer Austausch Dienst (DAAD)	Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); Deutscher Akademischer Austausch Dienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This study was supported by the Croatian Ministry of Science, Education and Sport (Project No. 108-1080003-0001) and Deutscher Akademischer Austausch Dienst (DAAD) project awarded to Professors Peter Riederer, Jurgen Deckert and Zdravko Lackovic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir R, 2000, NEUROSCIENCE, V95, P189; Antonucci F, 2008, J NEUROSCI, V28, P3689, DOI 10.1523/JNEUROSCI.0375-08.2008; Bach-Rojecky L, 2005, CROAT MED J, V46, P201; Bach-Rojecky L, 2005, J NEURAL TRANSM, V112, P215, DOI 10.1007/s00702-004-0265-1; Bach-Rojecky L, 2008, FUND CLIN PHARMACOL, V22, P503, DOI 10.1111/j.1472-8206.2008.00615.x; Bach-Rojecky L, 2010, EUR J PHARMACOL, V633, P10, DOI 10.1016/j.ejphar.2010.01.020; Bach-Rojecky L, 2009, PHARMACOL BIOCHEM BE, V94, P234, DOI 10.1016/j.pbb.2009.08.012; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Burstein R, 1998, J NEUROPHYSIOL, V79, P964, DOI 10.1152/jn.1998.79.2.964; BUZZI MG, 1989, EUR J PHARMACOL, V165, P251; BUZZI MG, 1991, CEPHALALGIA, V11, P165, DOI 10.1046/j.1468-2982.1991.1104165.x; Christensen D, 2001, PAIN, V93, P147, DOI 10.1016/S0304-3959(01)00305-0; Chuang YC, 2008, J UROLOGY, V180, P742, DOI 10.1016/j.juro.2007.07.120; Cui ML, 2004, PAIN, V107, P125, DOI 10.1016/j.pain.2003.10.008; Doods H, 2007, TRENDS PHARMACOL SCI, V28, P580, DOI 10.1016/j.tips.2007.10.005; Durham PL, 2004, HEADACHE, V44, P35, DOI 10.1111/j.1526-4610.2004.04007.x; Favre-Guilmard C, 2009, EUR J PHARMACOL, V617, P48, DOI 10.1016/j.ejphar.2009.06.047; Filipovic B, 2010, FUND CLIN PHARMACOL, V24, P43, DOI 10.1111/j.1472-8206.2009.00767.x; GREGG JM, 1973, J DENT RES, V52, P392, DOI 10.1177/00220345730520024001; Ishikawa H, 2000, JPN J OPHTHALMOL, V44, P106, DOI 10.1016/S0021-5155(99)00197-5; JACQUIN MF, 1990, SOMATOSENS MOT RES, V7, P153, DOI 10.3109/08990229009144705; Kayser V, 2002, BRIT J PHARMACOL, V137, P1287, DOI 10.1038/sj.bjp.0704979; Kitamura Y, 2009, NEUROSCIENCE, V159, P1422, DOI 10.1016/j.neuroscience.2009.01.066; Knotkova H, 2007, PAIN MED, V8, P383, DOI 10.1111/j.1526-4637.2006.00197.x; KOLSTON J, 1993, MICROVASC RES, V46, P143, DOI 10.1006/mvre.1993.1043; Kumada A, 2012, J ORAL REHABIL, V39, P63, DOI 10.1111/j.1365-2842.2011.02236.x; Larrier D, 2003, OTOLARYNG CLIN N AM, V36, P1041, DOI 10.1016/S0030-6665(03)00127-0; LEE WS, 1995, BRIT J PHARMACOL, V116, P1661, DOI 10.1111/j.1476-5381.1995.tb16388.x; Luvisetto S, 2007, NEUROSCIENCE, V145, P1, DOI 10.1016/j.neuroscience.2006.12.004; MARKOWITZ S, 1987, J NEUROSCI, V7, P4129, DOI 10.1523/jneurosci.07-12-04129.1987; Matak I, 2011, NEUROSCIENCE, V186, P201, DOI 10.1016/j.neuroscience.2011.04.026; Meng JH, 2007, J CELL SCI, V120, P2864, DOI 10.1242/jcs.012211; Meng JH, 2009, J NEUROSCI, V29, P4981, DOI 10.1523/JNEUROSCI.5490-08.2009; MOSKOWITZ MA, 1990, NEUROL CLIN, V8, P801, DOI 10.1016/S0733-8619(18)30318-9; Nelson DL, 2010, CEPHALALGIA, V30, P1159, DOI 10.1177/0333102410370873; Neubert JK, 2005, BRAIN RES PROTOC, V15, P119, DOI 10.1016/j.brainresprot.2005.05.003; Park HJ, 2006, CAN J ANAESTH, V53, P470, DOI 10.1007/BF03022619; Raboisson P, 2004, NEUROSCI BIOBEHAV R, V28, P219, DOI 10.1016/j.neubiorev.2003.12.003; SAITO K, 1988, ANN NEUROL, V24, P732, DOI 10.1002/ana.410240607; Samsam M, 2001, J CHEM NEUROANAT, V21, P161, DOI 10.1016/S0891-0618(01)00088-6; Smith CP, 2004, UROLOGY, V64, P871, DOI 10.1016/j.urology.2004.06.073; Thalakoti S, 2007, HEADACHE, V47, P1008, DOI 10.1111/j.1526-4610.2007.00854.x; Villalon CM, 2009, PHARMACOL THERAPEUT, V124, P309, DOI 10.1016/j.pharmthera.2009.09.003; VOS BP, 1994, J NEUROSCI, V14, P2708; YAMAMOTO T, 1993, PAIN, V55, P227, DOI 10.1016/0304-3959(93)90151-E; Yamamura H, 1999, J NEUROPHYSIOL, V81, P479, DOI 10.1152/jn.1999.81.2.479	46	68	69	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29803	10.1371/journal.pone.0029803	http://dx.doi.org/10.1371/journal.pone.0029803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238656	Green Accepted, Green Published, gold			2022-12-27	WOS:000301070200047
J	Angueyra, JM; Pulido, C; Malagon, G; Nasi, E; Gomez, MD				Angueyra, Juan Manuel; Pulido, Camila; Malagon, Gerardo; Nasi, Enrico; del Pilar Gomez, Maria			Melanopsin-Expressing Amphioxus Photoreceptors Transduce Light via a Phospholipase C Signaling Cascade	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; PROTEIN-KINASE-C; CYCLIC-GMP; 2-AMINOETHOXYDIPHENYL BORATE; INSP(3) RECEPTOR; CALCIUM-RELEASE; FINE-STRUCTURE; LIVER-CELLS; DROSOPHILA; MEMBRANE	Melanopsin, the receptor molecule that underlies light sensitivity in mammalian 'circadian' receptors, is homologous to invertebrate rhodopsins and has been proposed to operate via a similar signaling pathway. Its downstream effectors, however, remain elusive. Melanopsin also expresses in two distinct light-sensitive cell types in the neural tube of amphioxus. This organism is the most basal extant chordate and can help outline the evolutionary history of different photoreceptor lineages and their transduction mechanisms; moreover, isolated amphioxus photoreceptors offer unique advantages, because they are unambiguously identifiable and amenable to single-cell physiological assays. In the present study whole-cell patch clamp recording, pharmacological manipulations, and immunodetection were utilized to investigate light transduction in amphioxus photoreceptors. A G(q) was identified and selectively localized to the photosensitive microvillar membrane, while the pivotal role of phospholipase C was established pharmacologically. The photocurrent was profoundly depressed by IP3 receptor antagonists, highlighting the importance of IP3 receptors in light signaling. By contrast, surrogates of diacylglycerol (DAG), as well as poly-unsaturated fatty acids failed to activate a membrane conductance or to alter the light response. The results strengthen the notion that calcium released from the ER via IP3-sensitive channels may fulfill a key role in conveying - directly or indirectly - the melanopsin-initiated light signal to the photoconductance; moreover, they challenge the dogma that microvillar photoreceptors and phoshoinositide-based light transduction are a prerogative of invertebrate eyes.	[Angueyra, Juan Manuel; Nasi, Enrico; del Pilar Gomez, Maria] Marine Biol Lab, Woods Hole, MA 02543 USA; [Pulido, Camila; Malagon, Gerardo; del Pilar Gomez, Maria] Univ Nacl Colombia, Dept Biol, Bogota, Colombia; [Nasi, Enrico] Univ Nacl Colombia, Inst Genet, Bogota, Colombia	Marine Biological Laboratory - Woods Hole; Universidad Nacional de Colombia; Universidad Nacional de Colombia	Angueyra, JM (corresponding author), Univ Washington, Seattle, WA 98195 USA.	mgomez@mbl.edu	Angueyra, Juan/HCI-8722-2022	Pulido, Camila/0000-0002-5648-066X; Angueyra, Juan/0000-0002-9217-3069	National Science Foundation of the USA [0918930]	National Science Foundation of the USA(National Science Foundation (NSF))	This work was supported by the National Science Foundation of the USA (grant 0918930). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; Arendt D, 2001, PHILOS T R SOC B, V356, P1545, DOI 10.1098/rstb.2001.0971; BACIGALUPO J, 1995, J NEUROSCI, V15, P7196; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bilmen JG, 2002, EUR J BIOCHEM, V269, P3678, DOI 10.1046/j.1432-1033.2002.03060.x; Brown JE, 1996, BIOCHEM BIOPH RES CO, V224, P684, DOI 10.1006/bbrc.1996.1084; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Gomez MD, 2009, P NATL ACAD SCI USA, V106, P9081, DOI 10.1073/pnas.0900708106; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; EAKIN RM, 1962, J ULTRA MOL STRUCT R, V6, P531, DOI 10.1016/S0022-5320(62)80007-0; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Fahrenkrug J, 2009, BIOCHEMISTRY-US, V48, P5142, DOI 10.1021/bi900249n; Fein A, 2003, J GEN PHYSIOL, V121, P441, DOI 10.1085/jgp.200208778; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Gehring WJ, 2002, INT J DEV BIOL, V46, P65; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Gomez MD, 1998, J NEUROSCI, V18, P5253, DOI 10.1523/JNEUROSCI.18-14-05253.1998; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Gregory RB, 2001, BIOCHEM J, V354, P285, DOI 10.1042/0264-6021:3540285; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HILL TD, 1987, BIOCHEM BIOPH RES CO, V149, P897, DOI 10.1016/0006-291X(87)90492-X; JOHNSON EC, 1986, NATURE, V324, P468, DOI 10.1038/324468a0; KHORANA HG, 1988, P NATL ACAD SCI USA, V85, P7917, DOI 10.1073/pnas.85.21.7917; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Koyanagi M, 2008, PHOTOCHEM PHOTOBIOL, V84, P1024, DOI 10.1111/j.1751-1097.2008.00369.x; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Nagy K, 1997, VISUAL NEUROSCI, V14, P995, DOI 10.1017/S0952523800011706; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; NAKAO T, 1964, TOHOKU J EXP MED, V82, P349, DOI 10.1620/tjem.82.349; Nasi Enrico, 2009, Communicative & Integrative Biology, V2, P441; Newman LA, 2003, BIOCHEMISTRY-US, V42, P12734, DOI 10.1021/bi035418z; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Peirson SN, 2007, CURR BIOL, V17, P1363, DOI 10.1016/j.cub.2007.07.045; Plachetzki DC, 2005, TRENDS ECOL EVOL, V20, P465, DOI 10.1016/j.tree.2005.07.001; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Raghu P, 2000, MOL CELL NEUROSCI, V15, P429, DOI 10.1006/mcne.2000.0846; ROBINSON PR, 1989, VISUAL NEUROSCI, V3, P1, DOI 10.1017/S0952523800012451; Ruiz S, 1991, J HIRNFORSCH, V32, P159; SALVINIPLAWEN LV, 1977, EVOLUTIONARY BIOL, V10, P207; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Sekaran S, 2007, J NEUROSCI, V27, P3981, DOI 10.1523/JNEUROSCI.4716-06.2007; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; THOMPSON AK, 1991, J BIOL CHEM, V266, P23856; Warren EJ, 2006, EUR J NEUROSCI, V23, P2477, DOI 10.1111/j.1460-9568.2006.04777.x; WATANABE T, 1986, EXP BIOL, V46, P67; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567	52	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29813	10.1371/journal.pone.0029813	http://dx.doi.org/10.1371/journal.pone.0029813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235344	gold, Green Published			2022-12-27	WOS:000301123400106
J	Lenglet, C; Abosch, A; Yacoub, E; De Martino, F; Sapiro, G; Harel, N				Lenglet, Christophe; Abosch, Aviva; Yacoub, Essa; De Martino, Federico; Sapiro, Guillermo; Harel, Noam			Comprehensive in vivo Mapping of the Human Basal Ganglia and Thalamic Connectome in Individuals Using 7T MRI	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; PROBABILISTIC DIFFUSION TRACTOGRAPHY; EXTERNAL GLOBUS-PALLIDUS; SUBTHALAMIC NUCLEUS; FUNCTIONAL CONNECTIVITY; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; THALAMOCORTICAL CIRCUITRY; CEREBRAL-CORTEX; IMAGE-ANALYSIS	Basal ganglia circuits are affected in neurological disorders such as Parkinson's disease (PD), essential tremor, dystonia and Tourette syndrome. Understanding the structural and functional connectivity of these circuits is critical for elucidating the mechanisms of the movement and neuropsychiatric disorders, and is vital for developing new therapeutic strategies such as deep brain stimulation (DBS). Knowledge about the connectivity of the human basal ganglia and thalamus has rapidly evolved over recent years through non-invasive imaging techniques, but has remained incomplete because of insufficient resolution and sensitivity of these techniques. Here, we present an imaging and computational protocol designed to generate a comprehensive in vivo and subject-specific, three-dimensional model of the structure and connections of the human basal ganglia. High-resolution structural and functional magnetic resonance images were acquired with a 7-Tesla magnet. Capitalizing on the enhanced signal-to-noise ratio (SNR) and enriched contrast obtained at high-field MRI, detailed structural and connectivity representations of the human basal ganglia and thalamus were achieved. This unique combination of multiple imaging modalities enabled the in-vivo visualization of the individual human basal ganglia and thalamic nuclei, the reconstruction of seven white-matter pathways and their connectivity probability that, to date, have only been reported in animal studies, histologically, or group-averaged MRI population studies. Also described are subject-specific parcellations of the basal ganglia and thalamus into sub-territories based on their distinct connectivity patterns. These anatomical connectivity findings are supported by functional connectivity data derived from resting-state functional MRI (R-fMRI). This work demonstrates new capabilities for studying basal ganglia circuitry, and opens new avenues of investigation into the movement and neuropsychiatric disorders, in individual human subjects.	[Lenglet, Christophe; Yacoub, Essa; De Martino, Federico; Harel, Noam] Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Abosch, Aviva; Harel, Noam] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA; [De Martino, Federico] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Sapiro, Guillermo] Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Maastricht University; University of Minnesota System; University of Minnesota Twin Cities	Lenglet, C (corresponding author), Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA.	clenglet@umn.edu	De Martino, Federico/ABF-9850-2021; De Martino, Federico/I-1817-2012; Harel, Noam/R-7391-2018; Yacoub, Essa/AAS-7757-2021; Abosch, Aviva/U-7963-2019	De Martino, Federico/0000-0002-0352-0648; De Martino, Federico/0000-0002-0352-0648; Harel, Noam/0000-0002-6034-3801; 	16 NIH Institutes and Centers [U54 MH091657]; NIH [R01 EB008645, R01 EB008432, K12 RR023247, S10 RR026783, P30 NS057091, P41 RR008079]; W.M. Keck Foundation; ONR; NGA; NSF; DARPA; NSSEFF; ARO; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026783, K12RR023247, P41RR008079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008432, R01EB008645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057091] Funding Source: NIH RePORTER	16 NIH Institutes and Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Clinical Center (CC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Foundation(W.M. Keck Foundation); ONR(Office of Naval Research); NGA; NSF(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSSEFF; ARO; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Human Connectome Project (U54 MH091657) from the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research, NIH grants R01 EB008645, R01 EB008432, K12 RR023247, S10 RR026783, P30 NS057091 and P41 RR008079, the W.M. Keck Foundation, and by ONR, NGA, NSF, DARPA, NSSEFF, and ARO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abosch A, 2010, NEUROSURGERY, V67, P1745, DOI 10.1227/NEU.0b013e3181f74105; ALBIN RL, 1995, TRENDS NEUROSCI, V18, P63; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Aravamuthan BR, 2007, NEUROIMAGE, V37, P694, DOI 10.1016/j.neuroimage.2007.05.050; Babalola KO, 2009, NEUROIMAGE, V47, P1435, DOI 10.1016/j.neuroimage.2009.05.029; Bagary MS, 2002, J NEUROPSYCH CLIN N, V14, P443, DOI 10.1176/appi.neuropsych.14.4.443; Bar-Gad I, 2001, CURR OPIN NEUROBIOL, V11, P689, DOI 10.1016/S0959-4388(01)00270-7; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BECKSTEAD RM, 1979, BRAIN RES, V175, P191, DOI 10.1016/0006-8993(79)91001-1; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; CARPENTER MB, 1972, J COMP NEUROL, V144, P93, DOI 10.1002/cne.901440105; Carrillo-Ruiz JD, 2007, ACTA NEUROCHIR SUPPL, V97, P185; Chaddock L, 2010, DEV NEUROSCI-BASEL, V32, P249, DOI 10.1159/000316648; Colpan ME, 2010, PARKINSONISM RELAT D, V16, P398, DOI 10.1016/j.parkreldis.2010.03.008; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; Deriche R, 2009, MED IMAGE ANAL, V13, P564, DOI 10.1016/j.media.2009.05.008; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Francois C, 2004, BRAIN, V127, P2055, DOI 10.1093/brain/awh239; Gallay MN, 2008, BRAIN STRUCT FUNCT, V212, P443, DOI 10.1007/s00429-007-0170-0; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hamani C, 2004, BRAIN, V127, P4, DOI 10.1093/brain/awh029; HARMAN PJ, 1950, J COMP NEUROL, V93, P125, DOI 10.1002/cne.900930107; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Joe BN, 1999, RADIOLOGY, V212, P811, DOI 10.1148/radiology.212.3.r99se22811; Joel D, 2001, MOVEMENT DISORD, V16, P407, DOI 10.1002/mds.1096; Joel D, 1997, BRAIN RES REV, V23, P62, DOI 10.1016/S0165-0173(96)00018-5; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Johnson MD, 2009, EXP NEUROL, V219, P359, DOI 10.1016/j.expneurol.2009.04.022; Kelly RM, 2004, PROG BRAIN RES, V143, P449, DOI 10.1016/S0079-6123(03)43042-2; KEMP JM, 1971, PHILOS T R SOC B, V262, P441, DOI 10.1098/rstb.1971.0106; Klein JC, 2010, NEUROIMAGE, V51, P555, DOI 10.1016/j.neuroimage.2010.02.062; Krack P, 2002, MOVEMENT DISORD, V17, pS2, DOI 10.1002/mds.10136; KUO JS, 1973, J COMP NEUROL, V151, P201, DOI 10.1002/cne.901510302; Kusnoor SV, 2009, PARKINSONISM RELAT D, V15, pS162, DOI 10.1016/S1353-8020(09)70806-5; Leh SE, 2007, NEUROSCI LETT, V419, P113, DOI 10.1016/j.neulet.2007.04.049; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Macchi G, 1997, J NEUROSURG, V86, P77, DOI 10.3171/jns.1997.86.1.0077; Mallet L, 2007, P NATL ACAD SCI USA, V104, P10661, DOI 10.1073/pnas.0610849104; Mars RB, 2011, J NEUROSCI, V31, P4087, DOI 10.1523/JNEUROSCI.5102-10.2011; Massey LA, 2010, NEUROIMAG CLIN N AM, V20, P7, DOI 10.1016/j.nic.2009.10.001; Menke RA, 2010, NEUROIMAGE, V52, P1175, DOI 10.1016/j.neuroimage.2010.05.086; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Nakano K, 2000, J NEUROL, V247, P1; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nowinski WL, 2005, NEUROSURGERY, V57, P319, DOI 10.1227/01.NEU.0000180960.75347.11; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Plaha P, 2006, BRAIN, V129, P1732, DOI 10.1093/brain/awl127; Plenz D, 1999, NATURE, V400, P677, DOI 10.1038/23281; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Rico AJ, 2010, NEUROBIOL DIS, V39, P381, DOI 10.1016/j.nbd.2010.05.004; ROUILLER EM, 1994, J COMP NEUROL, V345, P185, DOI 10.1002/cne.903450204; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spoletini I, 2011, SCHIZOPHRENIA BULL, V37, P118, DOI 10.1093/schbul/sbp058; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Takada M, 1998, EXP BRAIN RES, V120, P114, DOI 10.1007/s002210050384; Takada M, 1998, BRAIN RES, V791, P335, DOI 10.1016/S0006-8993(98)00198-X; Tseng K.Y., 2010, HDB BASAL GANGLIA ST; VONBONIN G, 1951, J COMP NEUROL, V94, P427, DOI 10.1002/cne.900940306; Whone AL, 2003, ANN NEUROL, V53, P206, DOI 10.1002/ana.10427; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yelnik J, 2002, MOVEMENT DISORD, V17, pS15, DOI 10.1002/mds.10138; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182	71	117	121	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29153	10.1371/journal.pone.0029153	http://dx.doi.org/10.1371/journal.pone.0029153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235267	gold, Green Published, Green Submitted			2022-12-27	WOS:000301123400028
J	Neggers, SFW; van Diepen, RM; Zandbelt, BB; Vink, M; Mandl, RCW; Gutteling, TP				Neggers, Sebastiaan F. W.; van Diepen, Rosanne M.; Zandbelt, Bram B.; Vink, Matthijs; Mandl, Rene C. W.; Gutteling, Tjerk P.			A Functional and Structural Investigation of the Human Fronto-Basal Volitional Saccade Network	PLOS ONE			English	Article							FRONTAL EYE FIELDS; VISUALLY GUIDED SACCADES; BASAL GANGLIA; RETROSPECTIVE CORRECTION; BRAIN ACTIVATION; ANTI-SACCADES; PRO-SACCADES; FMRI; MOVEMENTS; TASK	Almost all cortical areas are connected to the subcortical basal ganglia (BG) through parallel recurrent inhibitory and excitatory loops, exerting volitional control over automatic behavior. As this model is largely based on non-human primate research, we used high resolution functional MRI and diffusion tensor imaging (DTI) to investigate the functional and structural organization of the human (pre)frontal cortico-basal network controlling eye movements. Participants performed saccades in darkness, pro- and antisaccades and observed stimuli during fixation. We observed several bilateral functional subdivisions along the precentral sulcus around the human frontal eye fields (FEF): a medial and lateral zone activating for saccades in darkness, a more fronto-medial zone preferentially active for ipsilateral antisaccades, and a large anterior strip along the precentral sulcus activating for visual stimulus presentation during fixation. The supplementary eye fields (SEF) were identified along the medial wall containing all aforementioned functions. In the striatum, the BG area receiving almost all cortical input, all saccade related activation was observed in the putamen, previously considered a skeletomotor striatal subdivision. Activation elicited by the cue instructing pro or antisaccade trials was clearest in the medial FEF and right putamen. DTI fiber tracking revealed that the subdivisions of the human FEF complex are mainly connected to the putamen, in agreement with the fMRI findings. The present findings demonstrate that the human FEF has functional subdivisions somewhat comparable to non-human primates. However, the connections to and activation in the human striatum preferentially involve the putamen, not the caudate nucleus as is reported for monkeys. This could imply that fronto-striatal projections for the oculomotor system are fundamentally different between humans and monkeys. Alternatively, there could be a bias in published reports of monkey studies favoring the caudate nucleus over the putamen in the search for oculomotor functions.	[Neggers, Sebastiaan F. W.; van Diepen, Rosanne M.; Zandbelt, Bram B.; Vink, Matthijs; Mandl, Rene C. W.; Gutteling, Tjerk P.] UMC Utrecht, Dept Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Neggers, SFW (corresponding author), UMC Utrecht, Dept Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	b.neggers@umcutrecht.nl	Zandbelt, Bram/A-3326-2009; Gutteling, Tjerk/J-3440-2012; Mandl, René C.W./AAU-7037-2020	Zandbelt, Bram/0000-0002-6491-1247; Gutteling, Tjerk/0000-0002-0934-418X; Vink, Matthijs/0000-0002-1235-8347	Netherlands Foundation for Scientific Research (NWO) [NWO 400-05-134]	Netherlands Foundation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was in part supported by a Netherlands Foundation for Scientific Research (NWO, http://www.nwo.nl/) Open Competition Grant (NWO 400-05-134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Amiez C, 2006, J NEUROSCI, V26, P2724, DOI 10.1523/JNEUROSCI.4739-05.2006; Amiez C, 2009, PROG NEUROBIOL, V89, P220, DOI 10.1016/j.pneurobio.2009.07.010; Andersson JLR, 2002, NEUROIMAGE, V16, P177, DOI 10.1006/nimg.2001.1039; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Balslev D, 2011, HUM BRAIN MAPP, V32, P624, DOI 10.1002/hbm.21050; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Ben-Yakov A, 2011, J NEUROSCI, V31, P9032, DOI 10.1523/JNEUROSCI.0702-11.2011; Beurze SM, 2009, J NEUROPHYSIOL, V101, P3053, DOI 10.1152/jn.91194.2008; Brown MRG, 2006, NEUROIMAGE, V33, P644, DOI 10.1016/j.neuroimage.2006.07.002; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Cameron IGM, 2009, EUR J NEUROSCI, V29, P2413, DOI 10.1111/j.1460-9568.2009.06776.x; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Crinion J, 2007, NEUROIMAGE, V37, P866, DOI 10.1016/j.neuroimage.2007.04.065; Curtis CE, 2008, J NEUROPHYSIOL, V99, P133, DOI 10.1152/jn.00899.2007; Darby DG, 1996, NEUROIMAGE, V3, P53, DOI 10.1006/nimg.1996.0006; de Weijer AD, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00041; Dejardin S, 1998, EUR J NEUROSCI, V10, P2328, DOI 10.1046/j.1460-9568.1998.00245.x; DeLong M R, 1984, Hum Neurobiol, V2, P235; DeSouza JFX, 2003, J NEUROPHYSIOL, V89, P1016, DOI 10.1152/jn.00562.2002; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Ford KA, 2005, J NEUROPHYSIOL, V94, P429, DOI 10.1152/jn.00471.2004; Ford KA, 2009, J NEUROPHYSIOL, V102, P2334, DOI 10.1152/jn.00125.2009; Ford KA, 2009, NEUROIMAGE, V45, P470, DOI 10.1016/j.neuroimage.2008.12.009; Friederici AD, 2006, NAT NEUROSCI, V9, P991, DOI 10.1038/nn0806-991; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Goutte C, 2000, IEEE T MED IMAGING, V19, P1188, DOI 10.1109/42.897811; Grosbras MH, 1999, CEREB CORTEX, V9, P705, DOI 10.1093/cercor/9.7.705; Grosbras MH, 2003, EUR J NEUROSCI, V18, P3121, DOI 10.1111/j.1460-9568.2003.03055.x; Gutteling TP, 2010, J COGNITIVE NEUROSCI, V22, P1931, DOI 10.1162/jocn.2009.21342; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P292, DOI 10.1152/jn.1985.53.1.292; Hodgson TL, 2004, J COGNITIVE NEUROSCI, V16, P318, DOI 10.1162/089892904322984599; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; Ikkai A, 2008, CEREB CORTEX, V18, P1384, DOI 10.1093/cercor/bhm171; Kastner S, 2007, J NEUROPHYSIOL, V97, P3494, DOI 10.1152/jn.00010.2007; Krebs RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008691; Leh SE, 2007, NEUROSCI LETT, V419, P113, DOI 10.1016/j.neulet.2007.04.049; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mandl RCW, 2010, SCHIZOPHRENIA BULL, V36, P778, DOI 10.1093/schbul/sbn161; Matsuda T, 2004, PSYCHIAT RES-NEUROIM, V131, P147, DOI 10.1016/j.pscychresns.2003.12.007; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Neggers SFW, 2007, J NEUROPHYSIOL, V98, P2765, DOI 10.1152/jn.00357.2007; Neggers SFW, 2005, EUR J NEUROSCI, V21, P2853, DOI 10.1111/j.1460-9568.2005.04129.x; ODRISCOLL GA, 1995, P NATL ACAD SCI USA, V92, P925, DOI 10.1073/pnas.92.3.925; PETIT L, 1993, J NEUROPHYSIOL, V69, P1009, DOI 10.1152/jn.1993.69.4.1009; Raemaekers M, 2002, ARCH GEN PSYCHIAT, V59, P313, DOI 10.1001/archpsyc.59.4.313; Sato TR, 2003, NEURON, V38, P637, DOI 10.1016/S0896-6273(03)00237-X; SCHALL JD, 1991, J NEUROPHYSIOL, V66, P559, DOI 10.1152/jn.1991.66.2.559; Silvanto J, 2006, J NEUROPHYSIOL, V96, P941, DOI 10.1152/jn.00015.2006; Simo LS, 2005, CEREB CORTEX, V15, P1982, DOI 10.1093/cercor/bhi073; Sommer MA, 2000, J NEUROPHYSIOL, V83, P1979, DOI 10.1152/jn.2000.83.4.1979; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; STANTON GB, 1988, J COMP NEUROL, V271, P473, DOI 10.1002/cne.902710402; SUZUKI H, 1983, EXP BRAIN RES, V53, P47; Vermersch AI, 1996, J NEUROL NEUROSUR PS, V60, P179, DOI 10.1136/jnnp.60.2.179; Vink M, 2005, HUM BRAIN MAPP, V25, P336, DOI 10.1002/hbm.20111; Vink M, 2006, BIOL PSYCHIAT, V60, P32, DOI 10.1016/j.biopsych.2005.11.026; Watanabe M, 2010, J NEUROSCI, V30, P10144, DOI 10.1523/JNEUROSCI.1738-10.2010; Zandbelt BB, BIOL PSYCHI IN PRESS; Zandbelt BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013848	67	44	45	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29517	10.1371/journal.pone.0029517	http://dx.doi.org/10.1371/journal.pone.0029517			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235303	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400065
J	Tomasovic, A; Traub, S; Tikkanen, R				Tomasovic, Ana; Traub, Stephanie; Tikkanen, Ritva			Molecular Networks in FGF Signaling: Flotillin-1 and Cbl-Associated Protein Compete for the Binding to Fibroblast Growth Factor Receptor Substrate 2	PLOS ONE			English	Article							TYROSINE KINASE; PC12 CELLS; REGGIE/FLOTILLIN PROTEINS; NEURONAL DIFFERENTIATION; GLUT4 TRANSLOCATION; AXON REGENERATION; ADAPTER PROTEINS; DOCKING PROTEINS; ERK ACTIVATION; RAFT DOMAINS	Fibroblast growth factor receptor substrate 2 (FRS2 alpha) is a signaling adaptor protein that regulates downstream signaling of many receptor tyrosine kinases. During signal transduction, FRS2 can be both tyrosine and threonine phosphorylated and forms signaling complexes with other adaptor proteins and tyrosine phosphatases. We have here identified flotillin-1 and the cbl-associated protein/ponsin (CAP) as novel interaction partners of FRS2. Flotillin-1 binds to the phosphotyrosine binding domain (PTB) of FRS2 and competes for the binding with the fibroblast growth factor receptor. Flotillin-1 knockdown results in increased Tyr phosphorylation of FRS2, in line with the inhibition of ERK activity in the absence of flotillin-1. CAP directly interacts with FRS2 by means of its sorbin homology (SoHo) domain, which has previously been shown to interact with flotillin-1. In addition, the third SH3 domain in CAP binds to FRS2. Due to the overlapping binding domains, CAP and flotillin-1 appear to compete for the binding to FRS2. Thus, our results reveal a novel signaling network containing FRS2, CAP and flotillin-1, whose successive interactions are most likely required to regulate receptor tyrosine kinase signaling, especially the mitogen activated protein kinase pathway.	[Tomasovic, Ana; Tikkanen, Ritva] Univ Giessen, Inst Biochem, Giessen, Germany; [Tomasovic, Ana; Traub, Stephanie; Tikkanen, Ritva] Univ Clin Frankfurt, Inst Biochem 2, Frankfurt, Germany	Justus Liebig University Giessen	Tomasovic, A (corresponding author), Univ Giessen, Inst Biochem, Giessen, Germany.	Ritva.Tikkanen@biochemie.med.uni-giessen.de	Traub, Stephanie/M-1709-2013	Tikkanen, Ritva/0000-0002-8393-1825	Deutsche Forschungsgemeinschaft DFG [Ti 291/6-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	Funds were received from Deutsche Forschungsgemeinschaft DFG (www.dfg.de), personal grant to RT (Ti 291/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Burgar HR, 2002, J BIOL CHEM, V277, P4018, DOI 10.1074/jbc.M107785200; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Delahaye L, 2000, ENDOCRINOLOGY, V141, P621, DOI 10.1210/en.141.2.621; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Dixon SJ, 2006, BBA-MOL CELL RES, V1763, P366, DOI 10.1016/j.bbamcr.2006.02.009; Fernow I, 2007, EUR J CELL BIOL, V86, P345, DOI 10.1016/j.ejcb.2007.03.004; Fernow I, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-80; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gotoh N, 2005, MOL CELL BIOL, V25, P4105, DOI 10.1128/MCB.25.10.4105-4116.2005; Gotoh N, 2004, FEBS LETT, V564, P14, DOI 10.1016/S0014-5793(04)00287-X; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hadari YR, 2001, P NATL ACAD SCI USA, V98, P8578, DOI 10.1073/pnas.161259898; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hopfer U, 2006, J BIOL CHEM, V281, P8645, DOI 10.1074/jbc.M513751200; Huang L, 2006, ONCOGENE, V25, P6457, DOI 10.1038/sj.onc.1209656; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kato N, 2006, J IMMUNOL, V177, P147, DOI 10.4049/jimmunol.177.1.147; Kimura A, 2001, P NATL ACAD SCI USA, V98, P9098, DOI 10.1073/pnas.151252898; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Kurokawa K, 2001, ONCOGENE, V20, P1929, DOI 10.1038/sj.onc.1204290; Langhorst MF, 2008, EUR J CELL BIOL, V87, P921, DOI 10.1016/j.ejcb.2008.07.001; Lax I, 2002, MOL CELL, V10, P709, DOI 10.1016/S1097-2765(02)00689-5; Limpert AS, 2007, MOL CELL BIOL, V27, P5686, DOI 10.1128/MCB.01109-06; Liu J, 2002, MOL CELL BIOL, V22, P3599, DOI 10.1128/MCB.22.11.3599-3609.2002; McDougall K, 2001, MECH DEVELOP, V103, P145, DOI 10.1016/S0925-4773(01)00337-9; Meakin SO, 1999, J BIOL CHEM, V274, P9861, DOI 10.1074/jbc.274.14.9861; Melillo RM, 2001, MOL CELL BIOL, V21, P4177, DOI 10.1128/MCB.21.13.4177-4187.2001; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Munderloh C, 2009, J NEUROSCI, V29, P6607, DOI 10.1523/JNEUROSCI.0870-09.2009; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Ong SH, 2000, MOL CELL BIOL, V20, P979, DOI 10.1128/MCB.20.3.979-989.2000; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; RABIN SJ, 1993, MOL CELL BIOL, V13, P2203, DOI 10.1128/MCB.13.4.2203; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Ridyard MS, 2003, J BIOL CHEM, V278, P13803, DOI 10.1074/jbc.M210245200; Schulte T, 1997, DEVELOPMENT, V124, P577; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Sugawara Y, 2007, CELL SIGNAL, V19, P1301, DOI 10.1016/j.cellsig.2007.01.012; Vomastek T, 2004, P NATL ACAD SCI USA, V101, P6981, DOI 10.1073/pnas.0305894101; Wong A, 2002, P NATL ACAD SCI USA, V99, P6684, DOI 10.1073/pnas.052138899; Wu YJ, 2003, BIOL CHEM, V384, P1215, DOI 10.1515/BC.2003.134; Xu H, 1998, J BIOL CHEM, V273, P17987, DOI 10.1074/jbc.273.29.17987; Xu H, 2001, J BIOL CHEM, V276, P13049, DOI 10.1074/jbc.M009925200; Zhang M, 2006, EMBO J, V25, P5284, DOI 10.1038/sj.emboj.7601406; Zhang YY, 2008, MOL ENDOCRINOL, V22, P167, DOI 10.1210/me.2007-0140	52	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29739	10.1371/journal.pone.0029739	http://dx.doi.org/10.1371/journal.pone.0029739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235335	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400097
J	Banrezes, B; Sainte-Beuve, T; Canon, E; Schultz, RM; Cancela, J; Ozil, JP				Banrezes, Bernadette; Sainte-Beuve, Thierry; Canon, Eugenie; Schultz, Richard M.; Cancela, Jose; Ozil, Jean-Pierre			Adult Body Weight Is Programmed by a Redox-Regulated and Energy-Dependent Process during the Pronuclear Stage in Mouse	PLOS ONE			English	Article							EGG ACTIVATION; CA2+ OSCILLATIONS; INTRACELLULAR PH; PREIMPLANTATION DEVELOPMENT; MITOCHONDRIAL-FUNCTION; OOCYTE MATURATION; GENE-EXPRESSION; FERTILIZATION; EMBRYOS; SIGNAL	In mammals fertilization triggers a series of Ca2+ oscillations that not only are essential for events of egg activation but also stimulate oxidative phosphorylation. Little is known, however, about the relationship between quantitative changes in egg metabolism and specific long-term effects in offspring. This study assessed whether post-natal growth is modulated by early transient changes in NAD(P) H and FAD(2+) in zygotes. We report that experimentally manipulating the redox potential of fertilized eggs during the pronuclear (PN) stage affects post-natal body weight. Exogenous pyruvate induces NAD(P) H oxidation and stimulates mitochondrial activity with resulting offspring that are persistently and significantly smaller than controls. Exogenous lactate stimulates NAD(+) reduction and impairs mitochondrial activity, and produces offspring that are smaller than controls at weaning but catch up after weaning. Cytosolic alkalization increases NAD(P)(+) reduction and offspring of normal birth-weight become significantly and persistently larger than controls. These results constitute the first report that post-natal growth rate is ultimately linked to modulation of NAD(P) H and FAD(2+) concentration as early as the PN stage.	[Banrezes, Bernadette; Sainte-Beuve, Thierry; Canon, Eugenie; Ozil, Jean-Pierre] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Banrezes, Bernadette; Sainte-Beuve, Thierry; Canon, Eugenie; Ozil, Jean-Pierre] ENVA, Maisons Alfort, France; [Schultz, Richard M.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Cancela, Jose] Univ Paris 11, CNRS, UMR 8195, CNPS, F-91405 Orsay, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA); University of Pennsylvania; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet	Banrezes, B (corresponding author), INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France.	Jean-Pierre.Ozil@jouy.inra.fr		Cancela, Jose-Manuel/0000-0002-6234-1500	INRA (Animal Physiology and Livestock Systems Division); NIH [HD022732]; BRACER BIOTECH [B05806]	INRA (Animal Physiology and Livestock Systems Division); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BRACER BIOTECH	This research was supported by INRA (Animal Physiology and Livestock Systems Division) to JPO and grant from the NIH (HD022732) to RMS. BRACER BIOTECH supported the development of the microfluidic device and the software (contract B05806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JF, 1993, FEBS LETT, V332, P203, DOI 10.1016/0014-5793(93)80631-4; Amirand C, 2000, BIOL CELL, V92, P409, DOI 10.1016/S0248-4900(00)01080-7; Blackstone NW, 2008, CURR BIOL, V18, pR351, DOI 10.1016/j.cub.2008.03.039; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Coffman JA, 2009, SEMIN CELL DEV BIOL, V20, P321, DOI 10.1016/j.semcdb.2009.02.002; Coffman JA, 2009, SEMIN CELL DEV BIOL, V20, P320, DOI 10.1016/j.semcdb.2009.03.009; DEAMER DW, 1987, J BIOENERG BIOMEMBR, V19, P457; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Ducibella T, 2002, DEV BIOL, V250, P280, DOI 10.1006/dbio.2002.0788; Dumollard R, 2004, DEVELOPMENT, V131, P3057, DOI 10.1242/dev.01181; Dumollard R, 2008, DEV BIOL, V316, P431, DOI 10.1016/j.ydbio.2008.02.004; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Dumollard R, 2007, DEVELOPMENT, V134, P455, DOI 10.1242/dev.02744; Ecker DJ, 2004, P NATL ACAD SCI USA, V101, P1595, DOI 10.1073/pnas.0306846101; Ferguson EM, 2006, MOL REPROD DEV, V73, P1195, DOI 10.1002/mrd.20494; Gardner DK, 2010, MOL HUM REPROD, V16, P539, DOI 10.1093/molehr/gaq042; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Khosla S, 2001, BIOL REPROD, V64, P918, DOI 10.1095/biolreprod64.3.918; Kwong WY, 2004, REPROD BIOMED ONLINE, V8, P574, DOI 10.1016/S1472-6483(10)61105-4; Lane M, 2005, J BIOL CHEM, V280, P18361, DOI 10.1074/jbc.M500174200; Lane M, 1998, BIOL REPROD, V59, P1483, DOI 10.1095/biolreprod59.6.1483; Lane M, 2000, BIOL REPROD, V62, P16, DOI 10.1095/biolreprod62.1.16; Leese HJ, 1995, HUM REPROD UPDATE, V1, P63, DOI 10.1093/humupd/1.1.63; Marangos P, 2003, DEVELOPMENT, V130, P1461, DOI 10.1242/dev.00340; Mitchell M, 2009, BIOL REPROD, V80, P295, DOI 10.1095/biolreprod.108.069864; MIYAZAKI S, 1995, CIBA F SYMP, V188, P235; Mostoslavsky R, 2010, CELL CYCLE, V9, P1907, DOI 10.4161/cc.9.10.11481; Nixon VL, 2000, BIOL CELL, V92, P187, DOI 10.1016/S0248-4900(00)01068-6; Ozil JP, 2006, DEV BIOL, V300, P534, DOI 10.1016/j.ydbio.2006.08.041; Ozil JP, 2005, DEV BIOL, V282, P39, DOI 10.1016/j.ydbio.2005.02.035; Phillips KP, 1996, MOL REPROD DEV, V45, P52, DOI 10.1002/(SICI)1098-2795(199609)45:1&lt;52::AID-MRD8&gt;3.0.CO;2-R; Rogers NT, 2006, REPRODUCTION, V132, P45, DOI 10.1530/rep.1.01059; Schomer B, 1998, DEV BIOL, V203, P1, DOI 10.1006/dbio.1998.9044; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Toth S, 2006, REPRODUCTION, V131, P27, DOI 10.1530/rep.1.00764; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Van Blerkom J, 2009, SEMIN CELL DEV BIOL, V20, P354, DOI 10.1016/j.semcdb.2008.12.005; Vaquero A, 2009, INT J DEV BIOL, V53, P303, DOI 10.1387/ijdb.082675av; Watkins AJ, 2008, J PHYSIOL-LONDON, V586, P2231, DOI 10.1113/jphysiol.2007.149229; WHITAKER MJ, 1981, CELL, V25, P95, DOI 10.1016/0092-8674(81)90234-8; Whittingham D G, 1971, J Reprod Fertil Suppl, V14, P7; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155; Zander DL, 2006, BIOL REPROD, V74, P288, DOI 10.1095/biolreprod.105.046235; Zhang T, 2009, BIOCH BIOPHYS ACTA	45	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29388	10.1371/journal.pone.0029388	http://dx.doi.org/10.1371/journal.pone.0029388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216268	Green Published, Green Submitted, gold			2022-12-27	WOS:000300676300053
J	Adu, B; Dodoo, D; Adukpo, S; Gyan, BA; Hedley, PL; Goka, B; Adjei, GO; Larsen, SO; Christiansen, M; Theisen, M				Adu, Bright; Dodoo, Daniel; Adukpo, Selorme; Gyan, Ben A.; Hedley, Paula L.; Goka, Bamenla; Adjei, George O.; Larsen, Severin O.; Christiansen, Michael; Theisen, Michael			Polymorphisms in the RNASE3 Gene Are Associated with Susceptibility to Cerebral Malaria in Ghanaian Chil7dren	PLOS ONE			English	Article							EOSINOPHIL CATIONIC PROTEIN; INTERCELLULAR-ADHESION MOLECULE-1; PLASMODIUM-FALCIPARUM INFECTION; WEST-AFRICAN POPULATION; SCHISTOSOMA-MANSONI; CLINICAL-FEATURES; GRANULE PROTEINS; INDIAN ADULTS; CELLS; PROMOTER	Background: Cerebral malaria (CM) is the most severe outcome of Plasmodium falciparum infection and a major cause of death in children from 2 to 4 years of age. A hospital based study in Ghana showed that P. falciparum induces eosinophilia and found a significantly higher serum level of eosinophil cationic protein (ECP) in CM patients than in uncomplicated malaria (UM) and severe malaria anemia (SA) patients. Single nucleotide polymorphisms (SNPs) have been described in the ECP encoding-gene (RNASE3) of which the c.371G > C polymorphism (rs2073342) results in an arginine to threonine amino acid substitution p.R124T in the polypeptide and abolishes the cytotoxicity of ECP. The present study aimed to investigate the potential association between polymorphisms in RNASE3 and CM. Methodology/Principal Findings: The RNASE3 gene and flanking regions were sequenced in 206 Ghanaian children enrolled in a hospital based malaria study. An association study was carried out to assess the significance of five SNPs in CM (n = 45) and SA (n = 56) cases, respectively. The two severe case groups (CM and SA) were compared with the non-severe control group comprising children suffering from UM (n = 105). The 371G allele was significantly associated with CM (p = 0.00945, OR = 2.29, 95% Cl = 1.22-4.32) but not with SA. Linkage disequilibrium analysis demonstrated significant linkage between three SNPs and the haplotype combination 371G/*16G/*94A was strongly associated with susceptibility to CM (p = 0.000913, OR = 4.14, 95% Cl = 1.79-9.56), thus, defining a risk haplotype. The RNASE3 371GG genotype was found to be under frequency-dependent selection. Conclusions/Significance: The 371G allele of RNASE3 is associated with susceptibility to CM and forms part of a risk associated haplotype GGA defined by the markers: rs2073342 (G-allele), rs2233860 (G-allele) and rs8019343 (A-allele) respectively. Collectively, these results suggest a hitherto unrecognized role for eosinophils in CM pathogenesis.	[Adu, Bright; Adukpo, Selorme; Hedley, Paula L.; Larsen, Severin O.; Christiansen, Michael; Theisen, Michael] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Dodoo, Daniel; Gyan, Ben A.] Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana; [Hedley, Paula L.] Univ Stellenbosch, Dept Biomed Sci, Cape Town, South Africa; [Goka, Bamenla] Univ Ghana, Coll Hlth Sci, Sch Med, Dept Child Hlth, Accra, Ghana; [Adjei, George O.] Univ Ghana, Coll Hlth Sci, Sch Med, Ctr Trop Clin Pharmacol & Therapeut, Accra, Ghana	Statens Serum Institut; University of Ghana; Stellenbosch University; University of Ghana; University of Ghana	Adu, B (corresponding author), Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark.	mth@ssi.dk	Christiansen, Michael/B-4588-2009; Adu, Bright/ABA-8631-2020; Hedley, Paula L/E-6156-2011	Christiansen, Michael/0000-0003-4713-755X; Adu, Bright/0000-0002-3622-2137; Hedley, Paula L/0000-0001-5801-960X; Theisen, Michael/0000-0003-4412-1392	European and Developing Countries Clinical Trials Partnership [TA.2007.40200.012]; Multilateral Initiative on Malaria-Training in Tropical Diseases (MIM-TDR) [A11034]	European and Developing Countries Clinical Trials Partnership; Multilateral Initiative on Malaria-Training in Tropical Diseases (MIM-TDR)	The study was funded by the European and Developing Countries Clinical Trials Partnership (TA.2007.40200.012) and Multilateral Initiative on Malaria-Training in Tropical Diseases (MIM-TDR project A11034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo AA, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-38; ALTMAN LC, 1993, J ALLERGY CLIN IMMUN, V92, P527, DOI 10.1016/0091-6749(93)90077-S; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellamy R, 1998, T ROY SOC TROP MED H, V92, P312, DOI 10.1016/S0035-9203(98)91026-4; Brown HC, 2000, NEUROLOGY, V55, P104, DOI 10.1212/WNL.55.1.104; Dhangadamajhi G, 2009, PARASITOL RES, V104, P1315, DOI 10.1007/s00436-009-1329-9; Dhangadamajhi G, 2009, INFECT GENET EVOL, V9, P908, DOI 10.1016/j.meegid.2009.06.010; Dhangadamajhi G, 2009, INFECT IMMUN, V77, P2943, DOI 10.1128/IAI.00083-09; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Eriksson J, 2007, INT J PARASITOL, V37, P1359, DOI 10.1016/j.ijpara.2007.04.001; Flori L, 2003, GENES IMMUN, V4, P265, DOI 10.1038/sj.gene.6363960; FREDENS K, 1982, J ALLERGY CLIN IMMUN, V70, P361, DOI 10.1016/0091-6749(82)90025-2; Gyan B, 2002, SCAND J IMMUNOL, V56, P619, DOI 10.1046/j.1365-3083.2002.01161.x; Hananantachai H, 2001, AM J MED GENET, V102, P391, DOI 10.1002/ajmg.1486; Hirayama Kenji, 2002, Korean Journal of Parasitology, V40, P165, DOI 10.3347/kjp.2002.40.4.165; Holloway JW, 2001, GENES IMMUN, V2, P20, DOI 10.1038/sj.gene.6363723; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Jonsson UB, 2002, CLIN EXP ALLERGY, V32, P1092, DOI 10.1046/j.1365-2222.2002.01410.x; Jonsson UB, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-36; Kang I, 2010, EUR ARCH OTO-RHINO-L, V267, P391, DOI 10.1007/s00405-009-1103-8; Kim YJ, 2005, AM J TROP MED HYG, V73, P125, DOI 10.4269/ajtmh.2005.73.125; KIMANI G, 1988, J IMMUNOL, V140, P3161; Kurtzhals JAL, 1998, CLIN EXP IMMUNOL, V112, P303; Kusi KA, 2008, CLIN VACCINE IMMUNOL, V15, P1456, DOI 10.1128/CVI.00506-07; LATTER BDH, 1972, GENETICS, V70, P475; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maeda T, 2002, EUR J BIOCHEM, V269, P307, DOI 10.1046/j.0014-2956.2001.02653.x; MAEGRAITH B, 1948, T ROY SOC TROP MED H, V41, P687, DOI 10.1016/S0035-9203(48)90678-6; Marchiafava E., 1894, FEBBRI ESTIVO AUMNAL; Mazier D, 2000, PARASITE IMMUNOL, V22, P613, DOI 10.1046/j.1365-3024.2000.00342.x; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; MCLAREN DJ, 1981, PARASITE IMMUNOL, V3, P359, DOI 10.1111/j.1365-3024.1981.tb00414.x; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; MOLYNEUX ME, 1989, Q J MED, V71, P441; Munthe-Kaas MC, 2007, ALLERGY, V62, P429, DOI 10.1111/j.1398-9995.2007.01327.x; Naka I, 2009, INFECT GENET EVOL, V9, P1406, DOI 10.1016/j.meegid.2009.08.004; Neves JS, 2009, CURR OPIN IMMUNOL, V21, P694, DOI 10.1016/j.coi.2009.07.011; Noguchi E, 2003, AM J RESP CRIT CARE, V167, P180, DOI 10.1164/rccm.200204-292OC; Ohashi J, 2001, JPN J INFECT DIS, V54, P114; PERLMANN H, 1994, CLIN EXP IMMUNOL, V97, P284, DOI 10.1111/j.1365-2249.1994.tb06082.x; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Rubin J, 2009, J IMMUNOL, V183, P445, DOI 10.4049/jimmunol.0803912; Sanderson C J, 1988, Dev Biol Stand, V69, P23; Takafuji S, 2000, ALLERGY, V55, P1170, DOI 10.1034/j.1398-9995.2000.00623.x; Takafuji S, 1998, ALLERGY, V53, P951, DOI 10.1111/j.1398-9995.1998.tb03795.x; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Trautmann A, 2002, J ALLERGY CLIN IMMUN, V109, P329, DOI 10.1067/mai.2002.121460; Trulson A, 2007, CLIN EXP ALLERGY, V37, P208, DOI 10.1111/j.1365-2222.2007.02644.x; Turner G, 1997, BRAIN PATHOL, V7, P569, DOI 10.1111/j.1750-3639.1997.tb01075.x; TURNER GDH, 1994, AM J PATHOL, V145, P1057; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Walsh GM, 2001, CURR OPIN HEMATOL, V8, P28, DOI 10.1097/00062752-200101000-00006; WATERS LS, 1987, INFECT IMMUN, V55, P877, DOI 10.1128/IAI.55.4.877-881.1987; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Zhang J, 2000, GENETICS, V156, P1949	55	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29465	10.1371/journal.pone.0029465	http://dx.doi.org/10.1371/journal.pone.0029465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216286	Green Published, gold			2022-12-27	WOS:000300674900037
J	Hecker, M; Paap, BK; Goertsches, RH; Kandulski, O; Fatum, C; Koczan, D; Hartung, HP; Thiesen, HJ; Zettl, UK				Hecker, Michael; Paap, Brigitte Katrin; Goertsches, Robert Hermann; Kandulski, Ole; Fatum, Christian; Koczan, Dirk; Hartung, Hans-Peter; Thiesen, Hans-Juergen; Zettl, Uwe Klaus			Reassessment of Blood Gene Expression Markers for the Prognosis of Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							INTERFERON-BETA THERAPY; IL-1 RECEPTOR ANTAGONIST; NEUTRALIZING ANTIBODIES; BREAKTHROUGH DISEASE; FOLLOW-UP; MRI; PREDICTS; PROTEIN; DISABILITY; SIGNATURE	Despite considerable advances in the treatment of multiple sclerosis, current drugs are only partially effective. Most patients show reduced disease activity with therapy, but still experience relapses, increasing disability, and new brain lesions. Since there are no reliable clinical or biological markers of disease progression, long-term prognosis is difficult to predict for individual patients. We identified 18 studies that suggested genes expressed in blood as predictive biomarkers. We validated the prognostic value of those genes with three different microarray data sets comprising 148 patients in total. Using these data, we tested whether the genes were significantly differentially expressed between patients with good and poor courses of the disease. Poor progression was defined by relapses and/or increase of disability during a two-year follow-up, independent of the administered therapy. Of 110 genes that have been proposed as predictive biomarkers, most could not be confirmed in our analysis. However, the G protein-coupled membrane receptor GPR3 was expressed at significantly lower levels in patients with poor disease progression in all data sets. GPR3 has therefore a high potential to be a biomarker for predicting future disease activity. In addition, we examined the IL17 cytokines and receptors in more detail and propose IL17RC as a new, promising, transcript-based biomarker candidate. Further studies are needed to better understand the roles of these receptors in multiple sclerosis and its treatment and to clarify the utility of GPR3 and IL17RC expression levels in the blood as markers of long-term prognosis.	[Hecker, Michael; Goertsches, Robert Hermann] Steinbeis Transfer Ctr Proteome Anal, Rostock, Germany; [Paap, Brigitte Katrin; Kandulski, Ole; Fatum, Christian; Zettl, Uwe Klaus] Univ Rostock, Dept Neurol, Rostock, Germany; [Koczan, Dirk; Thiesen, Hans-Juergen] Univ Rostock, Inst Immunol, Rostock, Germany; [Hartung, Hans-Peter] Univ Dusseldorf, Dept Neurol, Dusseldorf, Germany	University of Rostock; University of Rostock; Heinrich Heine University Dusseldorf	Hecker, M (corresponding author), Steinbeis Transfer Ctr Proteome Anal, Rostock, Germany.	michael.hecker@rocketmail.com		Hecker, Michael/0000-0001-7015-3094	Bayer HealthCare and Biogen Idec	Bayer HealthCare and Biogen Idec	The Affymetrix microarray experiments were partially funded by Bayer HealthCare and Biogen Idec. The funders had to role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no additional external sources of funding.	Achiron A, 2007, CLIN EXP IMMUNOL, V149, P235, DOI 10.1111/j.1365-2249.2007.03405.x; Achiron A, 2010, United States patent, Patent No. 20100074864; Achiron A, 2010, NEUROBIOL DIS, V38, P201, DOI 10.1016/j.nbd.2009.12.029; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Baranzini SE, 2005, PLOS BIOL, V3, P166, DOI 10.1371/journal.pbio.0030002; Bartosik-Psujek H, 2006, CLIN NEUROL NEUROSUR, V108, P644, DOI 10.1016/j.clineuro.2005.10.011; Burger D, 2009, P NATL ACAD SCI USA, V106, P4355, DOI 10.1073/pnas.0812183106; Bustamante MF, 2011, ANN NEUROL, V70, P634, DOI 10.1002/ana.22511; Caggiula M, 2005, SCAND J IMMUNOL, V62, P176, DOI 10.1111/j.1365-3083.2005.01649.x; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Comabella M, 2009, BRAIN, V132, P3353, DOI 10.1093/brain/awp228; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Debouverie M, 2008, EUR J NEUROL, V15, P916, DOI 10.1111/j.1468-1331.2008.02241.x; Deisenhammer F, 2004, J NEUROL, V251, P31, DOI 10.1007/s00415-004-1206-5; DeLuca GC, 2007, P NATL ACAD SCI USA, V104, P20896, DOI 10.1073/pnas.0707731105; Di Padova Franco, 2009, P1; Drulovic J, 2009, J NEUROIMMUNOL, V215, P90, DOI 10.1016/j.jneuroim.2009.07.010; Eikelenboom MJ, 2005, J NEUROIMMUNOL, V158, P222, DOI 10.1016/j.jneuroim.2004.09.005; Fernald GH, 2007, J IMMUNOL, V178, P5076, DOI 10.4049/jimmunol.178.8.5076; Ferrari F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-446; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Freedman MS, 2009, MULT SCLER, V15, P422, DOI 10.1177/1352458508101944; Furlan R, 2007, GENE THER, V14, P93, DOI 10.1038/sj.gt.3302805; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gandhi KS, 2010, HUM MOL GENET, V19, P2134, DOI 10.1093/hmg/ddq090; Gilli F, 2011, ARCH NEUROL-CHICAGO, V68, P879, DOI 10.1001/archneurol.2011.32; Giovannoni G, 2002, J NEUROL NEUROSUR PS, V73, P465, DOI 10.1136/jnnp.73.5.465; Goertsches RH, 2011, PHARMACOGENOMICS, V12, P423, DOI [10.2217/PGS.10.190, 10.2217/pgs.10.190]; Goertsches RH, 2010, PHARMACOGENOMICS, V11, P147, DOI [10.2217/pgs.09.152, 10.2217/PGS.09.152]; Goertsches RH, 2008, J NEUROL, V255, P48, DOI 10.1007/s00415-008-6010-1; Gow JW, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-38; Graber JJ, 2007, J NEUROIMMUNOL, V185, P168, DOI 10.1016/j.jneuroim.2007.01.011; Graber JJ, 2011, J NEUROL SCI, V305, P1, DOI 10.1016/j.jns.2011.03.026; Gurevich M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-46; Hagman S, 2011, J NEUROIMMUNOL, V234, P141, DOI 10.1016/j.jneuroim.2011.02.009; Haudenschild D, 2002, J BIOL CHEM, V277, P4309, DOI 10.1074/jbc.M109372200; Hecker M, 2012, PHARMACOGENOMICS J, V12, P134, DOI 10.1038/tpj.2010.77; Hesse D, 2011, EUR J NEUROL, V18, P266, DOI 10.1111/j.1468-1331.2010.03116.x; Hesse D, 2010, NEUROLOGY, V74, P1455, DOI 10.1212/WNL.0b013e3181dc1a94; Ho AW, 2010, SEMIN IMMUNOPATHOL, V32, P33, DOI 10.1007/s00281-009-0185-0; Hu Y, 2011, ANN NY ACAD SCI, V1217, P60, DOI 10.1111/j.1749-6632.2010.05825.x; Kemppinen AK, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000053; Khademi M, 2011, MULT SCLER J, V17, P335, DOI 10.1177/1352458510389102; Killestein J, 2011, NAT REV NEUROL, V7, P221, DOI 10.1038/nrneurol.2011.22; Koczan D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2419; Kostenis E, 2004, J CELL BIOCHEM, V92, P923, DOI 10.1002/jcb.20092; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Langer-Gould A, 2006, ARCH NEUROL-CHICAGO, V63, P1686, DOI 10.1001/archneur.63.12.1686; Lee LF, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002400; Lopatinskaya L, 2006, MULT SCLER, V12, P704, DOI 10.1177/1352458506070826; Malucchi S, 2008, NEUROLOGY, V70, P1119, DOI 10.1212/01.wnl.0000304040.29080.7b; Mendes A, 2011, ARQ NEURO-PSIQUIAT, V69, P536, DOI 10.1590/S0004-282X2011000400024; Mowry EM, 2009, NEUROLOGY, V72, P602, DOI 10.1212/01.wnl.0000342458.39625.91; Neema M, 2007, NEUROTHERAPEUTICS, V4, P602, DOI 10.1016/j.nurt.2007.08.001; Power C, 2008, United States patent, Patent No. 20080305078; Rudick RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019262; Rudick RA, 2009, LANCET NEUROL, V8, P545, DOI 10.1016/S1474-4422(09)70082-1; Sailer M, 2008, ROFO-FORTSCHR RONTG, V180, P994, DOI 10.1055/s-2008-1027817; Satoh J, 2006, J NEUROIMMUNOL, V174, P108, DOI 10.1016/j.jneuroim.2006.02.004; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sbardella E, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-54; Serrano-Fernandez P, 2010, AUTOIMMUNITY, V43, P172, DOI 10.3109/08916930903219040; SHARIEF MK, 1991, NEW ENGL J MED, V325, P467, DOI 10.1056/NEJM199108153250704; Simpson S, 2010, ANN NEUROL, V68, P193, DOI 10.1002/ana.22043; Singh MK, 2007, J NEUROL SCI, V258, P52, DOI 10.1016/j.jns.2007.02.034; Soilu-Hanninen M, 2005, J NEUROIMMUNOL, V167, P175, DOI 10.1016/j.jneuroim.2005.06.022; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Spulber S, 2009, BRAIN BEHAV IMMUN, V23, P573, DOI 10.1016/j.bbi.2009.02.015; Sturzebecher S, 2003, BRAIN, V126, P1419, DOI 10.1093/brain/awg147; Tanaka S, 2007, J BIOL CHEM, V282, P10506, DOI 10.1074/jbc.M700911200; Thamilarasan M, 2012, AUTOIMMUN REV, V11, P174, DOI 10.1016/j.autrev.2011.05.009; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; Tintore M, 2006, NEUROLOGY, V67, P968, DOI 10.1212/01.wnl.0000237354.10144.ec; Uhlenbrock K, 2002, CELL SIGNAL, V14, P941, DOI 10.1016/S0898-6568(02)00041-4; van Baarsen LGM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001927; van Boxel-Dezaire AHH, 2000, ANN NEUROL, V48, P313, DOI 10.1002/1531-8249(200009)48:3<313::AID-ANA5>3.0.CO;2-9; van der Voort LF, 2010, NEUROLOGY, V75, P1228, DOI 10.1212/WNL.0b013e3181f6c556; Vandenbroeck K, 2010, PHARMACOGENOMICS, V11, P1137, DOI [10.2217/pgs.10.108, 10.2217/PGS.10.108]; Villar LM, 2005, J CLIN INVEST, V115, P187, DOI 10.1172/JCI200522833; Villar LM, 2003, ANN NEUROL, V53, P222, DOI 10.1002/ana.10441; Vogt MHJ, 2004, J NEUROIMMUNOL, V155, P155, DOI 10.1016/j.jneuroim.2004.06.007; Vosoughi R, 2010, CLIN NEUROL NEUROSUR, V112, P365, DOI 10.1016/j.clineuro.2010.03.010; Wandinger KP, 2003, LANCET, V361, P2036, DOI 10.1016/S0140-6736(03)13641-0; Waubant E, 1999, NEUROLOGY, V53, P1397, DOI 10.1212/WNL.53.7.1397; Weinstock-Guttman B, 2008, J NEUROIMMUNOL, V205, P113, DOI 10.1016/j.jneuroim.2008.09.004; Young N, 2006, THESCIENTIFICWORLDJO, V6, P946, DOI 10.1100/tsw.2006.182; Zrioual S, 2008, J IMMUNOL, V180, P655, DOI 10.4049/jimmunol.180.1.655	88	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29648	10.1371/journal.pone.0029648	http://dx.doi.org/10.1371/journal.pone.0029648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216338	Green Submitted, gold, Green Published			2022-12-27	WOS:000300674900050
J	Beck, CR; McKenzie, BC; Hashim, AB; Harris, RC; Zanuzdana, A; Agboado, G; Orton, E; Bechard-Evans, L; Morgan, G; Stevenson, C; Weston, R; Mukaigawara, M; Enstone, J; Augustine, G; Butt, M; Kim, S; Puleston, R; Dabke, G; Howard, R; O'Boyle, J; O'Brien, M; Ahyow, L; Denness, H; Farmer, S; Figureroa, J; Fisher, P; Greaves, F; Haroon, M; Haroon, S; Hird, C; Isba, R; Ishola, DA; Kerac, M; Parish, V; Roberts, J; Rosser, J; Theaker, S; Wallace, D; Wigglesworth, N; Lingard, L; Vinogradova, Y; Horiuchi, H; Penalver, J; Nguyen-Van-Tam, JS				Beck, Charles R.; McKenzie, Bruce C.; Hashim, Ahmed B.; Harris, Rebecca C.; Zanuzdana, Arina; Agboado, Gabriel; Orton, Elizabeth; Bechard-Evans, Laura; Morgan, Gemma; Stevenson, Charlotte; Weston, Rachel; Mukaigawara, Mitsuru; Enstone, Joanne; Augustine, Glenda; Butt, Mobasher; Kim, Sophie; Puleston, Richard; Dabke, Girija; Howard, Robert; O'Boyle, Julie; O'Brien, Mary; Ahyow, Lauren; Denness, Helene; Farmer, Siobhan; Figureroa, Jose; Fisher, Paul; Greaves, Felix; Haroon, Munib; Haroon, Sophie; Hird, Caroline; Isba, Rachel; Ishola, David A.; Kerac, Marko; Parish, Vivienne; Roberts, Jonathan; Rosser, Julia; Theaker, Sarah; Wallace, Dean; Wigglesworth, Neil; Lingard, Liz; Vinogradova, Yana; Horiuchi, Hiroshi; Penalver, Javier; Nguyen-Van-Tam, Jonathan S.			Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-Analysis from a Public Health Policy Perspective	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMORAL IMMUNE-RESPONSE; SERUM ANTIBODY-RESPONSE; KIDNEY-TRANSPLANT RECIPIENTS; HIV-INFECTED INDIVIDUALS; ACUTE LYMPHOBLASTIC-LEUKEMIA; T-CELL-ACTIVATION; H1N1 2009 VACCINE; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND	Background: Immunocompromised patients are vulnerable to severe or complicated influenza infection. Vaccination is widely recommended for this group. This systematic review and meta-analysis assesses influenza vaccination for immunocompromised patients in terms of preventing influenza-like illness and laboratory confirmed influenza, serological response and adverse events. Methodology/Principal Findings: Electronic databases and grey literature were searched and records were screened against eligibility criteria. Data extraction and risk of bias assessments were performed in duplicate. Results were synthesised narratively and meta-analyses were conducted where feasible. Heterogeneity was assessed using I-2 and publication bias was assessed using Begg's funnel plot and Egger's regression test. Many of the 209 eligible studies included an unclear or high risk of bias. Meta-analyses showed a significant effect of preventing influenza-like illness (odds ratio [OR] = 0.23; 95% confidence interval [CI] = 0.16-0.34; p < 0.001) and laboratory confirmed influenza infection (OR = 0.15; 95% CI = 0.03-0.63; p = 0.01) through vaccinating immunocompromised patients compared to placebo or unvaccinated controls. We found no difference in the odds of influenza-like illness compared to vaccinated immunocompetent controls. The pooled odds of seroconversion were lower in vaccinated patients compared to immunocompetent controls for seasonal influenza A(H1N1), A(H3N2) and B. A similar trend was identified for seroprotection. Meta-analyses of seroconversion showed higher odds in vaccinated patients compared to placebo or unvaccinated controls, although this reached significance for influenza B only. Publication bias was not detected and narrative synthesis supported our findings. No consistent evidence of safety concerns was identified. Conclusions/Significance: Infection prevention and control strategies should recommend vaccinating immunocompromised patients. Potential for bias and confounding and the presence of heterogeneity mean the evidence reviewed is generally weak, although the directions of effects are consistent. Areas for further research are identified.	[Beck, Charles R.; McKenzie, Bruce C.; Hashim, Ahmed B.; Enstone, Joanne; Puleston, Richard; Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Harris, Rebecca C.; Mukaigawara, Mitsuru] World Hlth Org, Global Influenza Programme, Geneva, Switzerland; [Zanuzdana, Arina] Univ Bielefeld, Dept Publ Hlth Med, D-33615 Bielefeld, Germany; [Agboado, Gabriel] Natl Hlth Serv Blackpool, Publ Hlth Directorate, Blackpool, Lancs, England; [Orton, Elizabeth; Vinogradova, Yana] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; [Morgan, Gemma; Roberts, Jonathan] Hlth Protect Agcy, SW N Hlth Protect Unit, Gloucester, England; [Stevenson, Charlotte] Hlth Protect Agcy, Cumbria & Lancashire Hlth Protect Unit, Chorley, Lancs, England; [Weston, Rachel] Hlth Protect Agcy, Hlth Protect Agcy Yorkshire & Humber, Leeds, W Yorkshire, England; [Augustine, Glenda; Ahyow, Lauren] Natl Hlth Serv Leicestershire Cty, Publ Hlth Directorate, Leicester, Leics, England; [Butt, Mobasher] Brighton & Sussex Univ Hosp Natl Hlth Serv Trust, Dept Med, Brighton, E Sussex, England; [Kim, Sophie] Harvard Univ, Sch Law, Cambridge, MA 02138 USA; [Dabke, Girija] Hlth Protect Agcy, Hampshire & Isle Wight Hlth Protect Unit, Fareham, Hants, England; [Howard, Robert; O'Boyle, Julie] Natl Hlth Serv, Publ Hlth Directorate, Nottingham, England; [O'Brien, Mary] Wessex Deanery, Publ Hlth, Winchester, Hants, England; [Denness, Helene] Natl Hlth Serv Derbyshire Cty, Publ Hlth Directorate, Chesterfield, Derby, England; [Farmer, Siobhan] Mersey Deanery, Publ Hlth, Liverpool, Merseyside, England; [Figureroa, Jose] Harvard Univ, Sch Med, Boston, MA USA; [Fisher, Paul] Solihull Natl Hlth Serv Primary Care Trust, Publ Hlth Directorate, Solihull, W Midlands, England; [Greaves, Felix] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Haroon, Munib] Leicester Partnership Trust, Childrens Serv, Leicester, Leics, England; [Haroon, Sophie; Hird, Caroline] Hlth Protect Agcy, Hlth Protect Agcy E Midlands, Nottingham, England; [Isba, Rachel] Univ Lancaster, Sch Med, Lancaster, England; [Ishola, David A.] UCL, Dept Infect & Populat Hlth, London, England; [Kerac, Marko] UCL, Ctr Int Hlth & Dev, London, England; [Parish, Vivienne] Natl Hlth Serv Northamptonshire, Publ Hlth Directorate, Northampton, England; [Rosser, Julia] Natl Hlth Serv Halton & St Helens, Publ Hlth Directorate, Widnes, Cheshire, England; [Theaker, Sarah; Wallace, Dean] NHS Nottinghamshire Cty, Publ Hlth Directorate, Mansfield, Notts, England; [Wigglesworth, Neil] NHS E Lancashire, Publ Hlth Directorate, Nelson, Lancs, England; [Lingard, Liz] Hlth Protect Agcy, Hlth Protect Agcy NE, Newcastle Upon Tyne, Tyne & Wear, England; [Horiuchi, Hiroshi] Tokyo Med & Dent Univ, Fac Med, Tokyo 113, Japan	University of Nottingham; World Health Organization; University of Bielefeld; University of Nottingham; Health Protection Agency; Health Protection Agency; Health Protection Agency; University of Sussex; Harvard University; Health Protection Agency; NHS Blood & Transplant (NHSBT); Harvard University; Harvard Medical School; Imperial College London; Health Protection Agency; Lancaster University; University of London; University College London; University of London; University College London; Health Protection Agency; Tokyo Medical & Dental University (TMDU)	Beck, CR (corresponding author), Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England.	charles.beck@nottingham.ac.uk	Mukaigawara, Mitsuru/L-2144-2016; Orton, Elizabeth/J-6550-2013; Orton, Elizabeth/AAI-1377-2021; Greaves, Felix/AAL-5891-2021; Farmer, Siobhan/K-8035-2015; Nguyen-Van-Tam, Jonathan/I-2162-2019; Kerac, Marko/GQR-1136-2022; Greaves, Felix/A-1324-2012; Harris, Rebecca/E-5764-2016; Kerac, Marko/G-1777-2010	Mukaigawara, Mitsuru/0000-0001-6530-2083; Orton, Elizabeth/0000-0002-2531-8846; Greaves, Felix/0000-0001-9393-3122; Farmer, Siobhan/0000-0001-9442-5322; Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Greaves, Felix/0000-0001-9393-3122; Harris, Rebecca/0000-0002-2636-1520; Kerac, Marko/0000-0002-3745-7317; Isba, Rachel/0000-0002-2896-4309	WHO; National Institute for Health Research [ACF-2008-18-010, ACF-2009-21-030] Funding Source: researchfish	WHO(World Health Organization); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was commissioned by the Global Influenza Programme, World Health Organization. The University of Nottingham Health Protection Research Group (JSN-V-T, CRB, BCM, ABH, JE, RP) is an official WHO Collaborating Centre for pandemic influenza and research. It receives limited funding from WHO in support of specific activities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Shakra M, 2002, CLIN RHEUMATOL, V21, P369, DOI 10.1007/s100670200099; Admon D, 1997, VACCINE, V15, P1518, DOI 10.1016/S0264-410X(97)00193-X; ALLISON JE, 1977, J INFECT DIS, V136, pS672, DOI 10.1093/infdis/136.Supplement_3.S672; Altamirano-Diaz L, 2011, PEDIATR TRANSPLANT, V15, P172, DOI 10.1111/j.1399-3046.2010.01433.x; Amendola A, 2001, J MED VIROL, V65, P644, DOI 10.1002/jmv.2085; Anderson H, 1999, BRIT J CANCER, V80, P219, DOI 10.1038/sj.bjc.6690342; Anema A, 2008, HIV MED, V9, P57, DOI 10.1111/j.1468-1293.2008.00515.x; [Anonymous], 2010, WHO GUID PHARM MAN P; Antonio R, 2010, PEDIATR BLOOD CANCER, V55, P973; Atashili J, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-138; Avetisyan G, 2008, TRANSPLANTATION, V86, P257, DOI 10.1097/TP.0b013e3181772a75; Ballet C, 2006, AM J TRANSPLANT, V6, P2796, DOI 10.1111/j.1600-6143.2006.01533.x; Banic S, 2001, ACTA VIROL, V45, P39; Bate J, 2010, PEDIATR BLOOD CANCER, V55, P823; Bate J, 2010, CLIN INFECT DIS, V51, pE95, DOI 10.1086/657403; Beck C, 2011, CRD REGISTER; Bedognetti D, 2010, CLIN IMMUNOL, V135, pS84, DOI 10.1016/j.clim.2010.03.252; Bedognetti D, 2009, J IMMUNOTHER, V32, P992; Bektas O, 2007, PEDIATR BLOOD CANCER, V49, P914, DOI 10.1002/pbc.21106; Bellei N.C.J., 2006, Braz J Infect Dis, V10, P269, DOI 10.1590/S1413-86702006000400011; Benne CA, 1998, CLIN DIAGN LAB IMMUN, V5, P114, DOI 10.1128/CDLI.5.1.114-117.1998; Bergeron A, 2010, THESIS U ALBERTA EDM, P158; Bickel M, 2010, AIDS, V24, pF31, DOI 10.1097/QAD.0b013e3283398da1; BISELLI R, 1995, GERONTOLOGY, V41, P3; Blumberg EA, 1998, J HEART LUNG TRANSPL, V17, P1075; Blumberg EA, 1996, CLIN INFECT DIS, V22, P295, DOI 10.1093/clinids/22.2.295; BORELLA L, 1971, CANCER RES, V31, P420; Brakemeier S, 2010, TRANSPL INT, V23, P49; BRIGGS WA, 1980, ANN INTERN MED, V92, P471, DOI 10.7326/0003-4819-92-4-471; BROWN AE, 1982, J INFECT DIS, V145, P126, DOI 10.1093/infdis/145.1.126; Brunell PA, 1977, MMWR-MORBID MORTAL W, V26, P54; Brydak LB, 1999, CLIN DRUG INVEST, V17, P441, DOI 10.2165/00044011-199917060-00004; Brydak LB, 1999, LEUKEMIA LYMPHOMA, V32, P369, DOI 10.3109/10428199909167399; Brydak LB, 1998, PEDIATR INFECT DIS J, V17, P125, DOI 10.1097/00006454-199802000-00009; Brydak LB, 2004, J CLIN IMMUNOL, V24, P225, DOI 10.1023/B:JOCI.0000025444.24160.d5; Brydak LB, 2001, SUPPORT CARE CANCER, V9, P65, DOI 10.1007/s005200000186; Brydak LB, 2000, INT J PEDIAT HEM ONC, V7, P29; Brydak LB, 2006, VACCINE, V24, P6620, DOI 10.1016/j.vaccine.2006.05.100; BUCALOSSI A, 1995, ACTA HAEMATOL-BASEL, V93, P56; Burbach G, 1999, TRANSPLANTATION, V67, P753, DOI 10.1097/00007890-199903150-00019; Campbell CNJ, 2011, EPIDEMIOL INFECT, V139, P1560, DOI 10.1017/S0950268810002657; Candon S, 2009, AM J TRANSPLANT, V9, P2346, DOI 10.1111/j.1600-6143.2009.02787.x; Candon S, 2009, AM J TRANSPLANT, V9, P658; Canestri A, 2010, AIDS, V24, P2887, DOI 10.1097/QAD.0b013e3283402bc1; CARROLL RNP, 1974, BRIT MED J, V2, P701, DOI 10.1136/bmj.2.5921.701; Cavdar C, 2003, SCAND J UROL NEPHROL, V37, P71, DOI 10.1080/00365590310008749; Centkowski P, 2007, J CLIN IMMUNOL, V27, P339, DOI 10.1007/s10875-007-9073-3; Chadha MK, 2009, J CLIN ONCOL, V27; CHADWICK EG, 1994, PEDIATR INFECT DIS J, V13, P206, DOI 10.1097/00006454-199403000-00008; CHALMERS A, 1994, J RHEUMATOL, V21, P1203; Chebotareva T. A., 2009, Pediatriya (Moscow), V88, P104; Chironna M, 2010, EURO SURVEILL, V15, pii=; Chisholm J, 2005, EUR J CANCER, V41, P2280, DOI 10.1016/j.ejca.2005.07.006; Chisholm JC, 2001, ARCH DIS CHILD, V84, P496, DOI 10.1136/adc.84.6.496; Committee for Human Medicinal Products, 2007, EMEACHMPVWP263499200; Committee for Proprietary Medicinal Products, 1997, CPMPBWP21496 EUR AG; Danziger-Isakov L, 2010, TRANSPLANTATION, V89, P838, DOI 10.1097/TP.0b013e3181ca56f8; de Lavallade H, 2011, HAEMATOL-HEMATOL J, V96, P307, DOI 10.3324/haematol.2010.032664; de Roux A, 2006, VACCINE, V24, P1537, DOI 10.1016/j.vaccine.2005.10.007; DeBruyn JCC, 2010, THESIS U CALGARY CAL; Vazquez-Alvarez MD, 2010, J HEART LUNG TRANSPL, V29, P1318, DOI 10.1016/j.healun.2010.07.011; Del Porto F, 2006, VACCINE, V24, P3217, DOI 10.1016/j.vaccine.2006.01.028; Delafond P, 1990, MED DOUCE, P18; Dengler TJ, 1998, TRANSPLANTATION, V66, P1340, DOI 10.1097/00007890-199811270-00014; Dopp JM, 2009, PROG TRANSPLANT, V19, P153; Dorrell L, 1997, INT J STD AIDS, V8, P776, DOI 10.1258/0956462971919264; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Duchini A, 2001, LIVER TRANSPLANT, V7, P311, DOI 10.1053/jlts.2001.23010; Durando P, 2008, CLIN VACCINE IMMUNOL, V15, P253, DOI 10.1128/CVI.00316-07; Edvardsson VO, 1996, CLIN TRANSPLANT, V10, P556; ENGELHARD D, 1993, BONE MARROW TRANSPL, V11, P1; Enstone JE, 2011, EMERG INFECT DIS, V17, P592, DOI 10.3201/eid1704.101679; Esposito S, 2010, VACCINE, V28, P1558, DOI 10.1016/j.vaccine.2009.11.055; Falchetti Magnani, 2000, ITALIAN HEART J O S6, V1, P25; FEERY BJ, 1977, MED J AUSTRALIA, V1, P292, DOI 10.5694/j.1326-5377.1977.tb130704.x; Fine AD, 2001, CLIN INFECT DIS, V32, P1784, DOI 10.1086/320747; Fomin I, 2006, ANN RHEUM DIS, V65, P191, DOI 10.1136/ard.2005.036434; Fowke KR, 1997, AIDS, V11, P1013, DOI 10.1097/00002030-199708000-00010; Fraund S, 1999, J HEART LUNG TRANSPL, V18, P220, DOI 10.1016/S1053-2498(98)00013-8; Fuller JD, 1999, CLIN INFECT DIS, V28, P541, DOI 10.1086/515170; FURTH SL, 1995, PEDIATR NEPHROL, V9, P566, DOI 10.1007/BF00860934; Gabay C, 2010, SWISS MED WKLY, V140, p7S; Gandhi MK, 2001, BONE MARROW TRANSPL, V28, P775, DOI 10.1038/sj.bmt.1703239; GANZ PA, 1978, CANCER, V42, P2244, DOI 10.1002/1097-0142(197811)42:5<2244::AID-CNCR2820420523>3.0.CO;2-7; Gelinck LBS, 2008, ANN RHEUM DIS, V67, P713, DOI 10.1136/ard.2007.077552; Gelinck LBS, 2007, ANN RHEUM DIS, V66, P1402, DOI 10.1136/ard.2007.071878; Giannella M, 2011, CLIN MICROBIOL INFEC, V17, P1160, DOI 10.1111/j.1469-0691.2010.03399.x; Glesby MJ, 1996, J INFECT DIS, V174, P1332, DOI 10.1093/infdis/174.6.1332; Goossen GM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006484.pub2; GREKAS D, 1993, INT J CLIN PHARM TH, V31, P553; GRIBABIS DA, 1994, ACTA HAEMATOL-BASEL, V91, P115; GROSS PA, 1978, J PEDIATR-US, V92, P30, DOI 10.1016/S0022-3476(78)80065-1; Gunthard HF, 2000, J INFECT DIS, V181, P522, DOI 10.1086/315260; Hajiabdolbaghi Mahboube, 2010, Acta Med Iran, V48, P95; Halasa N, 2009, ACTA PAEDIATR, V98, P151; Hanania NA, 2004, J ALLERGY CLIN IMMUN, V113, P717, DOI 10.1016/j.jaci.2003.12.584; Hanania NA, 2002, AM J RESP CRIT CARE, pA561; Haroon M, 2010, JOINT BONE SPINE; Hayney MS, 2008, VACCINE, V26, P2596, DOI 10.1016/j.vaccine.2008.03.012; Hayney Mary S, 2004, Prog Transplant, V14, P346; HODGES GR, 1979, SOUTHERN MED J, V72, P29, DOI 10.1097/00007611-197901000-00010; Holvast A, 2009, RHEUMATOLOGY, V48, P1294, DOI 10.1093/rheumatology/kep200; Holvast A, 2009, ARTHRITIS RHEUM, V60, P2438, DOI 10.1002/art.24679; Hsieh YC, 2002, J FORMOS MED ASSOC, V101, P700; HUANG KL, 1983, INFECT IMMUN, V40, P421, DOI 10.1128/IAI.40.1.421-424.1983; HUANG KL, 1987, JAMA-J AM MED ASSOC, V257, P2047, DOI 10.1001/jama.257.15.2047; HUENGSBERG M, 1995, GENITOURIN MED, V71, P355; Human Development Report 2010 team, 2010, REAL WEALTH NAT PATH; ICH Expert Working Group, ICH HARM TRIP GUID G; Ionita E, 1998, Roum Arch Microbiol Immunol, V57, P53; Iorio AM, 1997, VACCINE, V15, P97, DOI 10.1016/S0264-410X(96)00057-6; Isbel NM, 1997, NEPHROLOGY, V3, pS327; Issa NC, 2011, BIOL BLOOD MARROW TR, V17, P434, DOI 10.1016/j.bbmt.2010.10.002; Kaine JL, 2007, J RHEUMATOL, V34, P272; Kanakoudi-Tsakalidou F, 2001, CLIN EXP RHEUMATOL, V19, P589; Kapetanovic MC, 2007, RHEUMATOLOGY, V46, P608, DOI 10.1093/rheumatology/kel366; Keshtkar-Jahromi M, 2008, AM J NEPHROL, V28, P654, DOI 10.1159/000119742; Kharfan-Dabaja MA, 2010, INT J HEMATOL, V91, P124, DOI 10.1007/s12185-009-0464-5; Kimball P, 2000, TRANSPLANTATION, V69, P2449, DOI 10.1097/00007890-200006150-00042; Kimball P, 2001, TRANSPLANT P, V33, P1785, DOI 10.1016/S0041-1345(00)02679-8; King JC, 2000, J INFECT DIS, V181, P725, DOI 10.1086/315246; King JC, 2001, PEDIATR INFECT DIS J, V20, P1124, DOI 10.1097/00006454-200112000-00006; Knysz B, 2001, PROBLEMY HIV AIDS, V7, P29; Kosalaraksa P, 2009, 2 THAIL HUM INFL RES; Kostyanaya IE, 2002, B VAKZINAZIJA, P1; KROON FP, 1994, AIDS, V8, P469, DOI 10.1097/00002030-199404000-00008; Kroon FP, 1998, AIDS, V12, pF217, DOI 10.1097/00002030-199817000-00002; Kroon FP, 2000, VACCINE, V18, P3040, DOI 10.1016/S0264-410X(00)00079-7; Kubiet MA, 1996, CHEST, V110, P367, DOI 10.1378/chest.110.2.367; Kubota Tetsuo, 2007, Mod Rheumatol, V17, P531, DOI 10.1007/s10165-007-0632-5; Kudo M, 2005, NIHON SHONI JINZOBYO, V18, P21; KUMAR D, 2010, AM J TRANSPLANT S, V10, P207; KUMAR SS, 1978, JAMA-J AM MED ASSOC, V239, P840; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Lalayanni C, 2010, J INFECTION, V61, P270, DOI 10.1016/j.jinf.2010.06.013; LANGE B, 1979, J INFECT DIS, V140, P402, DOI 10.1093/infdis/140.3.402; Lawal A, 2004, AM J TRANSPLANT, V4, P1805, DOI 10.1111/j.1600-6143.2004.00564.x; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Leekha S, 2007, INFECT CONT HOSP EP, V28, P1071, DOI 10.1086/520101; LO W, 1993, EUR J CLIN MICROBIOL, V12, P778, DOI 10.1007/BF02098469; LOUIE JS, 1978, ANN INTERN MED, V88, P790, DOI 10.7326/0003-4819-88-6-790; Lu CC, 2011, VACCINE, V29, P444, DOI 10.1016/j.vaccine.2010.10.081; Lu Y, 2009, AM J GASTROENTEROL, V104, P444, DOI 10.1038/ajg.2008.120; Lyall EGH, 1997, ARCH DIS CHILD, V76, P215, DOI 10.1136/adc.76.3.215; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Macias J, 2001, EUR J CLIN MICROBIOL, V20, P46, DOI 10.1007/s100960000421; Madan RP, 2008, CLIN INFECT DIS, V46, P712, DOI 10.1086/527391; Magnani G, 2005, J HEART LUNG TRANSPL, V24, P588, DOI 10.1016/j.healun.2004.03.004; Malaspina A, 2005, J INFECT DIS, V191, P1442, DOI 10.1086/429298; MALLESON PN, 1993, J RHEUMATOL, V20, P1769; Mamula P, 2007, CLIN GASTROENTEROL H, V5, P851, DOI 10.1016/j.cgh.2007.02.035; Marczynska M, 2001, ACTA PAEDIATR, V90, P466; Matsuzaki A, 2005, PEDIATR BLOOD CANCER, V45, P831, DOI 10.1002/pbc.20470; MAUCH TJ, 1995, J PEDIATR-US, V127, P957, DOI 10.1016/S0022-3476(95)70037-4; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mazza JJ, 2005, CLIN MED RES, V3, P214, DOI 10.3121/cmr.3.4.214; Mazzone PJ, 2001, EUR RESPIR J, V18, P971, DOI 10.1183/09031936.01.00215201; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Mercado U, 2004, REV INVEST CLIN, V56, P16; Mercado U, 2003, J RHEUMATOL, V30, P2295; Mesle F, 1999, DOSSIERS RECHERCHE; Meyer S, 2010, TRANSPL INT, V23, P64; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; MIOTTI PG, 1989, JAMA-J AM MED ASSOC, V262, P779, DOI 10.1001/jama.262.6.779; Miyamae T, 2002, J PEDIAT INFECT DIS, V14, P121; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mohty B, 2011, BONE MARROW TRANSPL, DOI [10.1038/bmt.2011.1057, DOI 10.1038/BMT.2011.1057]; Montomoli Emanuele, 2008, P139, DOI 10.1007/978-3-7643-8371-8_7; Montoya CJ, 2007, MEM I OSWALDO CRUZ, V102, P501, DOI 10.1590/S0074-02762007005000055; Mulder SF, 2009, EJC SUPPL, V7, P116, DOI 10.1016/S1359-6349(09)70397-0; Nailescu C, 2011, PEDIATR NEPHROL, V26, P459, DOI 10.1007/s00467-010-1729-1; NELSON KE, 1988, ANN INTERN MED, V109, P383, DOI 10.7326/0003-4819-109-5-383; Nicholson KG, 1998, LANCET, V351, P326, DOI 10.1016/S0140-6736(97)07468-0; Nordoy T, 2002, MED ONCOL, V19, P71, DOI 10.1385/MO:19:2:71; OBRIEN WA, 1995, BLOOD, V86, P1082; Oren S, 2008, ANN RHEUM DIS, V67, P937, DOI 10.1136/ard.2007.077461; Orlando G, 2010, AIDS, V24, P2142, DOI 10.1097/QAD.0b013e32833cfcb0; ORTBALS DW, 1977, ANN INTERN MED, V87, P552, DOI 10.7326/0003-4819-87-5-552; PABICO RC, 1976, ANN INTERN MED, V85, P431, DOI 10.7326/0003-4819-85-4-431; Park CL, 1996, PEDIATRICS, V98, P196; Pebody RG, 2010, EUROSURVEILLANCE, V15; Pereira G, 2009, ARCH MED INTERNA, V31, P20; Pinto LA, 2001, J INFECT DIS, V183, P1000, DOI 10.1086/319277; Porter CC, 2004, PEDIATR BLOOD CANCER, V42, P36, DOI 10.1002/pbc.10459; RAGNI MV, 1987, J LAB CLIN MED, V109, P545; Rambal V, 2010, AM J TRANSPLANT, V10, P564; Ramilo O, 1996, PEDIATR INFECT DIS J, V15, P197, DOI 10.1097/00006454-199603000-00004; Ranieri R, 2005, AIDS RES HUM RETROV, V21, P407, DOI 10.1089/aid.2005.21.407; Rapezzi D, 2003, EUR J HAEMATOL, V70, P225, DOI 10.1034/j.1600-0609.2003.00028.x; Reboli AC, 1996, CLIN INFECT DIS, V23, P257; Reid DW, 1998, RESP MED, V92, P1010, DOI 10.1016/S0954-6111(98)90346-8; Reilly A, 2010, J PEDIAT HEMATOL ONC, V32, pE177, DOI 10.1097/MPH.0b013e3181d869f3; Ring A, 2002, SUPPORT CARE CANCER, V10, P462, DOI 10.1007/s00520-001-0337-9; RISTOW SC, 1978, ANN INTERN MED, V88, P786, DOI 10.7326/0003-4819-88-6-786; Robertson JD, 2000, BRIT J CANCER, V82, P1261, DOI 10.1054/bjoc.1999.1088; Romanowska M, 2010, MED SCI MONITOR, V16, pCR433; Rosok B, 1996, CLIN EXP IMMUNOL, V104, P203, DOI 10.1046/j.1365-2249.1996.25732.x; Rucker RP, 2004, ANN ALLERG ASTHMA IM, V93, P272, DOI 10.1016/S1081-1206(10)61500-1; Rytel M W, 1977, Dev Biol Stand, V39, P225; Salassa B, 1996, INT C AIDS, V11, P121; Salemi S, 2010, CLIN IMMUNOL, V134, P113, DOI 10.1016/j.clim.2009.09.014; Salisbury D, 2006, IMMUNISATION INFECT, P185; Salles MJC, 2010, CLIN TRANSPLANT, V24, pE17, DOI 10.1111/j.1399-0012.2009.01095.x; Sanchez-Fructuoso AI, 2000, TRANSPLANTATION, V69, P436, DOI 10.1097/00007890-200002150-00023; SCHAFER AI, 1979, CANCER-AM CANCER SOC, V43, P25, DOI 10.1002/1097-0142(197901)43:1<25::AID-CNCR2820430103>3.0.CO;2-Q; Scharpe J, 2008, AM J TRANSPLANT, V8, P332, DOI 10.1111/j.1600-6143.2007.02066.x; Schneider MME, 1996, INT J ANTIMICROB AG, V6, P195, DOI 10.1016/0924-8579(95)00038-0; Shahgholi E, 2010, PEDIATR BLOOD CANCER, V54, P716, DOI 10.1002/pbc.22421; SHILDT RA, 1979, CANCER-AM CANCER SOC, V44, P1629, DOI 10.1002/1097-0142(197911)44:5<1629::AID-CNCR2820440514>3.0.CO;2-7; Soesman NMR, 2000, J MED VIROL, V61, P85, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;85::AID-JMV14&gt;3.0.CO;2-H; Spies CD, 2008, J INT MED RES, V36, P296, DOI 10.1177/147323000803600212; Spitaleri G, 2010, J THORAC ONCOL, V5, P752, DOI 10.1097/JTO.0b013e3181d6b8a1; STAPRANS SI, 1995, J EXP MED, V182, P1727, DOI 10.1084/jem.182.6.1727; STEINHERZ PG, 1980, CANCER, V45, P750, DOI 10.1002/1097-0142(19800215)45:4<750::AID-CNCR2820450423>3.0.CO;2-Z; STIVER HG, 1978, CAN MED ASSOC J, V119, P733; STIVER HG, 1977, INFECT IMMUN, V16, P738, DOI 10.1128/IAI.16.3.738-741.1977; SUMAYA CV, 1977, J INFECT DIS, V136, pS656, DOI 10.1093/infdis/136.Supplement_3.S656; Takata T, 2009, J CLIN EXP HEMATOP, V49, P9, DOI 10.3960/jslrt.49.9; Tanzi E, 2006, J MED VIROL, V78, P440, DOI 10.1002/jmv.20559; Tarasova AA, 2006, DETSKIE INFEKZII, V3, P43; Tasker SA, 1999, ANN INTERN MED, V131, P430, DOI 10.7326/0003-4819-131-6-199909210-00006; Tasker SA, 1998, VACCINE, V16, P1039, DOI 10.1016/S0264-410X(97)00275-2; Tebas P, 2010, AIDS, V24, P2187, DOI 10.1097/QAD.0b013e32833c6d5c; Thibault F, 2010, SAFETY EFFICACY INAC, pP573; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tremblay CL, 2011, VACCINE, V29, P1359, DOI 10.1016/j.vaccine.2010.12.023; Tsuru T, 2008, NIHON RINSHO MENEKI, V36, P124; van Assen S, 2008, CLIN EXP IMMUNOL, V154, P117; van Assen S, 2010, CLIN IMMUNOL, V136, P228, DOI 10.1016/j.clim.2010.03.430; van Assen S, 2010, ARTHRITIS RHEUM-US, V62, P75, DOI 10.1002/art.25033; van der Velden A M.T., 2001, Eur J Intern Med, V12, P420, DOI 10.1016/S0953-6205(01)00149-2; Vaziri S., 2009, Iranian Journal of Clinical Infectious Diseases, V4, P19; VERSLUIS DJ, 1986, TRANSPLANTATION, V42, P376, DOI 10.1097/00007890-198610000-00009; VERSLUIS DJ, 1986, TRANSPLANT P, V18, P1348; VERSLUIS DJ, 1985, ANTIVIR RES, P289; Viboud C, 2010, PLOS CURR; Vigano A, 1998, AIDS RES HUM RETROV, V14, P727, DOI 10.1089/aid.1998.14.727; Vigano A, 2008, JAIDS-J ACQ IMM DEF, V48, P289, DOI 10.1097/QAI.0b013e3181632cda; Weinberg Geoffrey A., 2001, Pediatric Research, V49, p242A; West S, 2002, 47 AG HEALTHC RES QU; Wiesik-Szewczyk E, 2010, CLIN RHEUMATOL, V29, P605, DOI 10.1007/s10067-010-1373-y; Wilking H, 2010, EURO SURVEILL, V15, pii; Willcocks LC, 2007, AM J TRANSPLANT, V7, P2006, DOI 10.1111/j.1600-6143.2007.01869.x; Winer RL, 1978, DIALYSIS TRANSPLANT, V7, P207; Wyzgal J, 2002, TRANSPLANT P, V34, P572, DOI 10.1016/S0041-1345(01)02849-4; Xu Y, 2009, 48 ANN M INF DIS SOC; Yalcin S, 2010, BONE MARROW TRANSPL, V45, pS204; Yalcin SS, 2010, ANN HEMATOL, V89, P913, DOI 10.1007/s00277-009-0897-1; YAMADA A, 1982, BIKEN J, V25, P89; Yamanaka H, 2005, JAIDS-J ACQ IMM DEF, V39, P167; YERLY S, 1994, AIDS, V8, P1503, DOI 10.1097/00002030-199410000-00022; Zuccotti GV, 2004, J INT MED RES, V32, P492, DOI 10.1177/147323000403200506; Zuccotti GV, 2002, ACTA PAEDIATR, V91, P486, DOI 10.1080/080352502317371779; Zykov MP, 1980, PROBLEMY TUBERKULEZA, V58, P3; Zykov MP, 1983, PROBLEMY TUBERKULEZA, V61, P17	256	48	48	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29249	10.1371/journal.pone.0029249	http://dx.doi.org/10.1371/journal.pone.0029249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216224	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000299684700044
J	Notch, EG; Shaw, JR; Coutermarsh, BA; Dzioba, M; Stanton, BA				Notch, Emily G.; Shaw, Joseph R.; Coutermarsh, Bonita A.; Dzioba, Marisa; Stanton, Bruce A.			Morpholino Gene Knockdown in Adult Fundulus heteroclitus: Role of SGK1 in Seawater Acclimation	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL NA+ CHANNEL; CYSTIC-FIBROSIS; SALINITY ADAPTATION; ESTUARINE TELEOST; XENOPUS-LAEVIS; CL-TRANSPORT; KINASE SGK1; EXPRESSION; KILLIFISH	The Atlantic killifish (Fundulus heteroclitus) is an environmental sentinel organism used extensively for studies on environmental toxicants and salt (NaCl) homeostasis. Previous research in our laboratory has shown that rapid acclimation of killifish to seawater is mediated by trafficking of CFTR chloride channels from intracellular vesicles to the plasma membrane in the opercular membrane within the first hour in seawater, which enhances chloride secretion into seawater, thereby contributing to salt homeostasis. Acute transition to seawater is also marked by an increase in both mRNA and protein levels of serum glucocorticoid kinase 1 (SGK1) within 15 minutes of transfer. Although the rise in SGK1 in gill and its functional analog, the opercular membrane, after seawater transfer precedes the increase in membrane CFTR, a direct role of SGK1 in elevating membrane CFTR has not been established in vivo. To test the hypothesis that SGK1 mediates the increase in plasma membrane CFTR we designed two functionally different vivo-morpholinos to knock down SGK1 in gill, and developed and validated a vivo-morpholino knock down technique for adult killifish. Injection (intraperitoneal, IP) of the splice blocking SGK1 vivo-morpholino reduced SGK1 mRNA in the gill after transition from fresh to seawater by 66%. The IP injection of the translational blocking and splice blocking vivo-morpholinos reduced gill SGK1 protein abundance in fish transferred from fresh to seawater by 64% and 53%, respectively. Moreover, knock down of SGK1 completely eliminated the seawater induced rise in plasma membrane CFTR, demonstrating that the increase in SGK1 protein is required for the trafficking of CFTR from intracellular vesicles in mitochondrion rich cells to the plasma membrane in the gill during acclimation to seawater. This is the first report of the use of vivo-morpholinos in adult killifish and demonstrates that vivo-morpholinos are a valuable genetic tool for this environmentally relevant model organism.	[Notch, Emily G.; Coutermarsh, Bonita A.; Stanton, Bruce A.] Dartmouth Med Sch, Dept Microbiol & Immunol & Physiol, Hanover, NH 03755 USA; [Notch, Emily G.; Shaw, Joseph R.; Dzioba, Marisa; Stanton, Bruce A.] Mt Desert Isl Biol Lab, Salsbury Cove, ME USA; [Shaw, Joseph R.] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN USA; [Shaw, Joseph R.] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN USA	Dartmouth College; Mount Desert Island Biological Laboratory; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Notch, EG (corresponding author), Dartmouth Med Sch, Dept Microbiol & Immunol & Physiol, Hanover, NH 03755 USA.	emily.notch@dartmouth.edu			National Institutes of Health from National Institute of Environmental Health Sciences [P42 ES007373]; DOD-SERDP [ER1503]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373] Funding Source: NIH RePORTER	National Institutes of Health from National Institute of Environmental Health Sciences; DOD-SERDP; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The project described herein was supported by National Institutes of Health Grant Number P42 ES007373 from the National Institute of Environmental Health Sciences. JRS was supported by funds from DOD-SERDP grant ER1503. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ASTM, 1985, ANN BOOK ASTM STAND; Burnett KG, 2007, COMP BIOCHEM PHYS D, V2, P257, DOI 10.1016/j.cbd.2007.09.001; de la Rosa DA, 1999, J BIOL CHEM, V274, P37834, DOI 10.1074/jbc.274.53.37834; Evans TG, 2010, J FISH BIOL, V76, P1903, DOI 10.1111/j.1095-8649.2010.02590.x; FLIK G, 1985, BIOL CELL, V55, P265, DOI 10.1111/j.1768-322X.1985.tb00436.x; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Hoffmann EK, 2002, BBA-BIOMEMBRANES, V1566, P129, DOI 10.1016/S0005-2736(02)00587-4; Keren A, 2010, METHODS MOL BIOL, V661, P409, DOI 10.1007/978-1-60761-795-2_25; Kim S, 2010, BLOOD CELL MOL DIS, V44, P169, DOI 10.1016/j.bcmd.2009.12.004; Lang F, 2003, CELL PHYSIOL BIOCHEM, V13, P41, DOI 10.1159/000070248; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; Maki N, 2010, FASEB J, V24, P3462, DOI 10.1096/fj.10-159285; Mancera JM, 2000, J EXP ZOOL, V287, P263, DOI 10.1002/1097-010X(20000901)287:4&lt;263::AID-JEZ1&gt;3.0.CO;2-I; Marshall WS, 1999, J EXP BIOL, V202, P1535; Marshall WS, 2003, BBA-BIOMEMBRANES, V1618, P95, DOI 10.1016/j.bbamem.2003.10.015; Marshall WS, 2002, J EXP ZOOL, V293, P264, DOI 10.1002/jez.10127; Marshall WS, 2002, BBA-BIOMEMBRANES, V1566, P16, DOI 10.1016/S0005-2736(02)00584-9; Matson CW, 2008, AQUAT TOXICOL, V87, P289, DOI 10.1016/j.aquatox.2008.02.010; Morcos PA, 2008, BIOTECHNIQUES, V45, P613, DOI 10.2144/000113005; Moulton JD, 2008, CURRENT PROTOCOLS MO; Ohnishi E, 2010, MOL CELL BIOL, V30, P675, DOI 10.1128/MCB.00576-09; Oleksiak MF, 2008, AQUAT TOXICOL, V90, P161, DOI 10.1016/j.aquatox.2008.08.010; Sato JD, 2007, CELL PHYSIOL BIOCHEM, V20, P91, DOI 10.1159/000104157; Scott GR, 2004, AM J PHYSIOL-CELL PH, V287, pC300, DOI 10.1152/ajpcell.00054.2004; Scott GR, 2005, J EXP BIOL, V208, P2719, DOI 10.1242/jeb.01688; Shaw JR, 2008, CELL PHYSIOL BIOCHEM, V22, P69, DOI 10.1159/000149784; Shaw JR, 2007, AM J PHYSIOL-REG I, V292, pR1052, DOI 10.1152/ajpregu.00328.2006; Shigaev A, 2000, AM J PHYSIOL-RENAL, V278, pF613, DOI 10.1152/ajprenal.2000.278.4.F613; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Vallon V, 2005, AM J PHYSIOL-REG I, V288, pR4, DOI 10.1152/ajpregu.00369.2004; Wagner CA, 2001, CELL PHYSIOL BIOCHEM, V11, P209, DOI 10.1159/000051935; Whitehead A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r13; Whitehead A, 2010, EVOLUTION, V64, P2070, DOI 10.1111/j.1558-5646.2010.00957.x; Wilson JM, 2002, J EXP ZOOL, V293, P192, DOI 10.1002/jez.10124; Wood CA, 2003, BBA-BIOMEMBRANES, V1618, P106, DOI 10.1016/j.bbamem.2003.08.014; Zecevic M, 2004, PFLUG ARCH EUR J PHY, V448, P29, DOI 10.1007/s00424-003-1222-9	37	19	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29462	10.1371/journal.pone.0029462	http://dx.doi.org/10.1371/journal.pone.0029462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216285	Green Submitted, Green Published, gold			2022-12-27	WOS:000299684700058
J	Schmidt, M; Creutziger, M; Lenz, P				Schmidt, Mischa; Creutziger, Martin; Lenz, Peter			Influence of Molecular Noise on the Growth of Single Cells and Bacterial Populations	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; ESCHERICHIA-COLI; FLUCTUATING ENVIRONMENTS; BACILLUS-SUBTILIS; DIVISION; PROTEIN; INDIVIDUALITY; CYTOKINESIS; SPORULATION; KINETICS	During the last decades experimental studies have revealed that single cells of a growing bacterial population are significantly exposed to molecular noise. Important sources for noise are low levels of metabolites and enzymes that cause significant statistical variations in the outcome of biochemical reactions. In this way molecular noise affects biological processes such as nutrient uptake, chemotactic tumbling behavior, or gene expression of genetically identical cells. These processes give rise to significant cell-to-cell variations of many directly observable quantities such as protein levels, cell sizes or individual doubling times. In this study we theoretically explore if there are evolutionary benefits of noise for a growing population of bacteria. We analyze different situations where noise is either suppressed or where it affects single cell behavior. We consider two specific examples that have been experimentally observed in wild-type Escherichia coli cells: (i) the precision of division site placement (at which molecular noise is highly suppressed) and (ii) the occurrence of noise-induced phenotypic variations in fluctuating environments. Surprisingly, our analysis reveals that in these specific situations both regulatory schemes [i. e. suppression of noise in example (i) and allowance of noise in example (ii)] do not lead to an increased growth rate of the population. Assuming that the observed regulatory schemes are indeed caused by the presence of noise our findings indicate that the evolutionary benefits of noise are more subtle than a simple growth advantage for a bacterial population in nutrient rich conditions.	[Schmidt, Mischa; Creutziger, Martin; Lenz, Peter] Univ Marburg, Fachbereich Phys, D-3550 Marburg, Germany; [Lenz, Peter] Univ Marburg, Zentrum Synthet Mikrobiol, Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Schmidt, M (corresponding author), Univ Marburg, Fachbereich Phys, Renthof 5, D-3550 Marburg, Germany.	peter.lenz@Physik.Uni-Marburg.DE	Lenz, Peter/L-5980-2013	Lenz, Peter/0000-0001-7705-3950	University of Marburg; LOEWE	University of Marburg; LOEWE	This work was financed by the University of Marburg and the LOEWE programm of Hessen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bremer H, 1996, ESCHERICHIA COLI SAL; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; COOPER S, 1988, J BACTERIOL, V170, P5001, DOI 10.1128/jb.170.11.5001-5005.1988; Davidson CJ, 2008, ANNU REV GENET, V42, P253, DOI 10.1146/annurev.genet.42.110807.091601; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; DONACHIE WD, 1989, J BACTERIOL, V171, P4633, DOI 10.1128/jb.171.9.4633-4639.1989; ECKER RE, 1969, J BACTERIOL, V98, P1219, DOI 10.1128/JB.98.3.1219-1226.1969; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; ERRINGTON J, 1993, MICROBIOL REV, V57, P1; Guberman JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000233; HARVEY RJ, 1967, J BACTERIOL, V93, P605, DOI 10.1128/JB.93.2.605-617.1967; KOCH AL, 1983, J MOL EVOL, V19, P455, DOI 10.1007/BF02102321; Koch AL, 1995, MICROBIOL-SGM, V141, P3171, DOI 10.1099/13500872-141-12-3171; Koch AL, 2000, APPL ENVIRON MICROB, V66, P3657, DOI 10.1128/AEM.66.9.3657-3663.2000; Koch AL, BACTERIAL GROWTH FOR; KOPPES LJH, 1978, J BACTERIOL, V134, P423, DOI 10.1128/JB.134.2.423-433.1978; Kovarova-Kovar K, 1998, MICROBIOL MOL BIOL R, V62, P646; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; LENDENMANN U, 1995, MICROBIOL-SGM, V141, P71, DOI 10.1099/00221287-141-1-71; Levin BR, 2004, SCIENCE, V305, P1578, DOI 10.1126/science.1103077; Margolin W, 2001, CURR OPIN MICROBIOL, V4, P647, DOI 10.1016/S1369-5274(01)00264-8; Maughan H, 2004, J BACTERIOL, V186, P2212, DOI 10.1128/JB.186.7.2212-2214.2004; Megerle JA, 2008, BIOPHYS J, V95, P2103, DOI 10.1529/biophysj.107.127191; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; PHILIPPI T, 1989, TRENDS ECOL EVOL, V4, P41, DOI 10.1016/0169-5347(89)90138-9; POWELL EO, 1956, J GEN MICROBIOL, V15, P492, DOI 10.1099/00221287-15-3-492; SCHAECHTER M, 1962, J GEN MICROBIOL, V29, P421, DOI 10.1099/00221287-29-3-421; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Smukalla S, 2008, CELL, V135, P726, DOI 10.1016/j.cell.2008.09.037; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; TRUEBA FJ, 1982, ARCH MICROBIOL, V131, P55, DOI 10.1007/BF00451499; Veening JW, 2006, J APPL MICROBIOL, V101, P531, DOI 10.1111/j.1365-2672.2006.02911.x; WOLDRINGH CL, 1991, RES MICROBIOL, V142, P309, DOI 10.1016/0923-2508(91)90046-D; Yu XC, 1999, MOL MICROBIOL, V32, P315, DOI 10.1046/j.1365-2958.1999.01351.x	39	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29932	10.1371/journal.pone.0029932	http://dx.doi.org/10.1371/journal.pone.0029932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238678	Green Published, Green Submitted, gold			2022-12-27	WOS:000301188800049
J	Aditama, TY; Samaan, G; Kusriastuti, R; Sampurno, OD; Purba, W; Misriyah; Santoso, H; Bratasena, A; Maruf, A; Sariwati, E; Setiawaty, V; Glass, K; Lokuge, K; Kelly, PM; Kandun, IN				Aditama, Tjandra Y.; Samaan, Gina; Kusriastuti, Rita; Sampurno, Ondri Dwi; Purba, Wilfried; Misriyah; Santoso, Hari; Bratasena, Arie; Maruf, Anas; Sariwati, Elvieda; Setiawaty, Vivi; Glass, Kathryn; Lokuge, Kamalini; Kelly, Paul M.; Kandun, I. Nyoman			Avian Influenza H5N1 Transmission in Households, Indonesia	PLOS ONE			English	Article							TO-PERSON TRANSMISSION; A H5N1; VIRUS-INFECTION; RISK-FACTORS; EPIDEMIOLOGY; CAMBODIA; MODELS	Background: Disease transmission patterns are needed to inform public health interventions, but remain largely unknown for avian influenza H5N1 virus infections. A recent study on the 139 outbreaks detected in Indonesia between 2005 and 2009 found that the type of exposure to sources of H5N1 virus for both the index case and their household members impacted the risk of additional cases in the household. This study describes the disease transmission patterns in those outbreak households. Methodology/Principal Findings: We compared cases (n = 177) and contacts (n = 496) in the 113 sporadic and 26 cluster outbreaks detected between July 2005 and July 2009 to estimate attack rates and disease intervals. We used final size household models to fit transmission parameters to data on household size, cases and blood-related household contacts to assess the relative contribution of zoonotic and human-to-human transmission of the virus, as well as the reproduction number for human virus transmission. The overall household attack rate was 18.3% and secondary attack rate was 5.5%. Secondary attack rate remained stable as household size increased. The mean interval between onset of subsequent cases in outbreaks was 5.6 days. The transmission model found that human transmission was very rare, with a reproduction number between 0.1 and 0.25, and the upper confidence bounds below 0.4. Transmission model fit was best when the denominator population was restricted to blood-related household contacts of index cases. Conclusions/Significance: The study only found strong support for human transmission of the virus when a single large cluster was included in the transmission model. The reproduction number was well below the threshold for sustained transmission. This study provides baseline information on the transmission dynamics for the current zoonotic virus and can be used to detect and define signatures of a virus with increasing capacity for human-to-human transmission.	[Aditama, Tjandra Y.; Kusriastuti, Rita; Purba, Wilfried; Misriyah; Santoso, Hari; Bratasena, Arie; Maruf, Anas; Sariwati, Elvieda; Kandun, I. Nyoman] Minist Hlth, Directorate Gen Dis Control & Environm Hlth, Jakarta, Indonesia; [Samaan, Gina; Glass, Kathryn; Lokuge, Kamalini; Kelly, Paul M.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Sampurno, Ondri Dwi; Setiawaty, Vivi] Minist Hlth, Natl Inst Hlth Res & Dev, Jakarta, Indonesia; [Kelly, Paul M.] Australian Capital Terr Govt Hlth Directorate, Populat Hlth Div, Canberra, ACT, Australia	Ministry of Health - Indonesia; Australian National University; Ministry of Health - Indonesia; National Institute of Health Research & Development - Indonesia	Aditama, TY (corresponding author), Minist Hlth, Directorate Gen Dis Control & Environm Hlth, Jakarta, Indonesia.	ginasamaan@yahoo.com		Glass, Kathryn/0000-0001-5905-1310; Setiawaty, Vivi/0000-0002-1196-7909; Lokuge, Kamalini/0000-0002-6287-1296	Ministry of Agriculture and laboratory	Ministry of Agriculture and laboratory	We would like to acknowledge the support of the provincial and district health offices, the Ministry of Agriculture and laboratory staff in the outbreak investigation and data collection. We thank Alex Richard Cook for input on the statistical analyses in the study.	Aditama TY, 2011, CLIN INFECT DIS, V53, P1237, DOI 10.1093/cid/cir740; [Anonymous], WHO GUID INV HUM CAS; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Blair PJ, 2010, EPIDEMIOL INFECT, V138, P199, DOI 10.1017/S095026880999063X; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; COPAS JB, 1989, J R STAT SOC C-APPL, V38, P71; Horby P, 2010, EPIDEMIOL INFECT, V138, P1550, DOI 10.1017/S0950268810000518; Hosmer DW, 1997, STAT MED, V16, P965; Jefferson T, 2010, HEALTH TECHNOL ASSES, V14, P347; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; LECESSIE S, 1991, BIOMETRICS, V47, P1267, DOI 10.2307/2532385; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Olsen SJ, 2005, EMERG INFECT DIS, V11, P1799; Santhia K, 2009, INFLUENZA OTHER RESP, V3, P81, DOI 10.1111/j.1750-2659.2009.00069.x; Sedyaningsih ER, 2007, J INFECT DIS, V196, P522, DOI 10.1086/519692; Shu YL, 2010, EMERG INFECT DIS, V16, P725, DOI 10.3201/eid1604.091578; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; van Boven M, 2007, PLOS COMPUT BIOL, V3, P1394, DOI 10.1371/journal.pcbi.0030145; Van Kerkhove MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014582; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; Vongphrachanh P, 2010, INFLUENZA OTHER RESP, V4, P47, DOI 10.1111/j.1750-2659.2009.00120.x; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; Wendelboe AM, AM J MED SCI, V340, P181; *WHO, 2006, WHO CAS DEF HUM INF; WHO, 2007, REC LAB PROC DET AV; *WHO, 2010, WKLY EPIDEMIOL REC, V85, P13; *WHO, 2004, WHO GUID GLOB SURV I; World Health Organization [WHO], 2010, AV INFL SIT IND; Yang Y, 2007, EMERG INFECT DIS, V13, P1348, DOI 10.3201/eid1309.070111	31	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29971	10.1371/journal.pone.0029971	http://dx.doi.org/10.1371/journal.pone.0029971			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238686	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200063
J	Liggins, J; Pihl, RO; Benkelfat, C; Leyton, M				Liggins, John; Pihl, Robert O.; Benkelfat, Chawki; Leyton, Marco			The Dopamine Augmenter L-DOPA Does Not Affect Positive Mood in Healthy Human Volunteers	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; NUCLEUS-ACCUMBENS DOPAMINE; PIMOZIDE-INDUCED EXTINCTION; D-AMPHETAMINE; EXTRACELLULAR DOPAMINE; MENSTRUAL-CYCLE; SMOKED COCAINE; SUBJECTIVE EXPERIENCE; PREPULSE INHIBITION; INTRAVENOUS COCAINE	Dopamine neurotransmission influences approach toward rewards and reward-related cues. The best cited interpretation of this effect proposes that dopamine mediates the pleasure that commonly accompanies reward. This hypothesis has received support in some animal models and a few studies in humans. However, direct assessments of the effect of transiently increasing dopamine neurotransmission have been largely limited to the use of psychostimulant drugs, which elevate brain levels of multiple neurotransmitters in addition to dopamine. In the present study we tested the effect of more selectively elevating dopamine neurotransmission, as produced by administration of the immediate dopamine precursor, L-DOPA (0, 100/25, 200/50 mg, Sinemet), in healthy human volunteers. Neither dose altered positive mood. The results suggest that dopamine neurotransmission does not directly influence positive mood in humans.	[Liggins, John; Pihl, Robert O.; Benkelfat, Chawki; Leyton, Marco] McGill Univ, Dept Psychiat, Montreal, PQ, Canada	McGill University	Liggins, J (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.	marco.leyton@mcgill.ca	Leyton, Marco/AAY-7557-2020	Leyton, Marco/0000-0002-1243-2252	Canadian Institutes of Health Research [MOP-36429]; McGill University	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McGill University	This work was funded by an operating grant from the Canadian Institutes of Health Research (MOP-36429) < www.cihr-irsc.gc.ca/e/193.html > and William Dawson fund from McGill University < www.mcgill.ca/ap-facultyaffairs/mcgilldawson >, both to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abduljawad KAJ, 1998, J PSYCHOPHARMACOL, V12, P239, DOI 10.1177/026988119801200302; Abi-Dargham A, 2003, EUR NEUROPSYCHOPHARM, V13, P459, DOI 10.1016/j.euroneuro.2003.08.007; Acheson A, 2008, EXP CLIN PSYCHOPHARM, V16, P113, DOI 10.1037/1064-1297.16.2.113; Andreu N, 1999, CLIN NEUROPHARMACOL, V22, P15, DOI 10.1097/00002826-199901000-00004; Apud JA, 2007, NEUROPSYCHOPHARMACOL, V32, P1011, DOI 10.1038/sj.npp.1301227; Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Barrett SP, 2008, EUR NEUROPSYCHOPHARM, V18, P439, DOI 10.1016/j.euroneuro.2008.01.008; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; BERRIDGE KC, 1989, BEHAV NEUROSCI, V103, P36, DOI 10.1037/0735-7044.103.1.36; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; BLIN O, 1990, CLIN NEUROPHARMACOL, V13, P426, DOI 10.1097/00002826-199010000-00004; Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226; Boileau I, 2007, J NEUROSCI, V27, P3998, DOI 10.1523/JNEUROSCI.4370-06.2007; Brauer LH, 1996, BIOL PSYCHIAT, V39, P26, DOI 10.1016/0006-3223(95)00110-7; Brauer LH, 1997, PHARMACOL BIOCHEM BE, V56, P265, DOI 10.1016/S0091-3057(96)00240-7; Brauer LH, 1995, EXP CLIN PSYCHOPHARM, V3, P371, DOI 10.1037/1064-1297.3.4.371; Breitenstein C, 2006, NEUROPSYCHOPHARMACOL, V31, P2552, DOI 10.1038/sj.npp.1301167; Bressan RA, 2002, SCHIZOPHR RES, V56, P31, DOI 10.1016/S0920-9964(01)00185-2; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; Buckholtz JW, 2010, NAT NEUROSCI, V13, P419, DOI 10.1038/nn.2510; Burgdorf J, 2006, NEUROSCI BIOBEHAV R, V30, P173, DOI 10.1016/j.neubiorev.2005.06.001; Casey KF, 2006, EUR NEUROPSYCHOPHARM, V16, P512, DOI 10.1016/j.euroneuro.2006.02.002; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; Cools R, 2007, J NEUROSCI, V27, P5506, DOI 10.1523/JNEUROSCI.0601-07.2007; Costa PT, 2007, REVISED NEO PERSONAL; de Haan L, 2000, AM J PSYCHIAT, V157, P1019, DOI 10.1176/appi.ajp.157.6.1019; de la Fuente-Fernandez R, 2004, BRAIN, V127, P2747, DOI 10.1093/brain/awh290; de Wit H, 2002, NEUROPSYCHOPHARMACOL, V27, P813, DOI 10.1016/S0893-133X(02)00343-3; Dreher JC, 2007, P NATL ACAD SCI USA, V104, P2465, DOI 10.1073/pnas.0605569104; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; Eisenegger C, 2010, BIOL PSYCHIAT, V67, P702, DOI 10.1016/j.biopsych.2009.09.021; Evans AH, 2006, ANN NEUROL, V59, P852, DOI 10.1002/ana.20822; Evans SM, 2002, PSYCHOPHARMACOLOGY, V159, P397, DOI 10.1007/s00213-001-0944-7; Evans SM, 2001, DRUG ALCOHOL DEPEN, V64, P271, DOI 10.1016/S0376-8716(01)00129-6; First MB, 1995, AXIS 1 DISORDERS; Floel A, 2008, NEUROBIOL AGING, V29, P267, DOI 10.1016/j.neurobiolaging.2006.10.009; FOURIEZOS G, 1976, BRAIN RES, V103, P377, DOI 10.1016/0006-8993(76)90809-X; FOURIEZOS G, 1978, J COMP PHYSIOL PSYCH, V92, P661, DOI 10.1037/h0077500; Franken IHA, 2008, PSYCHOPHARMACOLOGY, V195, P537, DOI 10.1007/s00213-007-0941-6; FRANKLIN KBJ, 1979, PHARMACOL BIOCHEM BE, V11, P71, DOI 10.1016/0091-3057(79)90299-5; GAWIN FH, 1986, PSYCHOPHARMACOLOGY, V90, P142; Giakoumaki SG, 2008, NEUROPSYCHOPHARMACOL, V33, P3058, DOI 10.1038/npp.2008.82; GRATTON A, 1994, J NEUROSCI, V14, P4130; Gratton A, 1996, J PSYCHIATR NEUROSCI, V21, P264; GUNNE LM, 1972, PSYCHIAT NEUROL NEUR, V75, P225; Hamidovic A, 2008, J CLIN PSYCHOPHARM, V28, P45, DOI 10.1097/jcp.0b013e3181602fab; Hamidovic A, 2009, EXP CLIN PSYCHOPHARM, V17, P374, DOI 10.1037/a0017840; Haney M, 2001, PSYCHOPHARMACOLOGY, V155, P330, DOI 10.1007/s002130100725; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; JONSSON LE, 1971, CLIN PHARMACOL THER, V12, P889; JONSSON LE, 1972, EUR J CLIN PHARMACOL, V4, P206, DOI 10.1007/BF00635797; KIYATKIN EA, 1994, BRAIN RES, V652, P225, DOI 10.1016/0006-8993(94)90231-3; Kumakura Y, 2004, ACTA NEUROL SCAND, V110, P188, DOI 10.1111/j.1600-0404.2004.00299.x; LARUELLE M, 1995, J NUCL MED, V36, P1182; Leyton M, 2002, NEUROPSYCHOPHARMACOL, V27, P1027, DOI 10.1016/S0893-133X(02)00366-4; Leyton M, 2005, BEHAV NEUROSCI, V119, P1619, DOI 10.1037/0735-7044.119.6.1619; Leyton M, 2000, ALCOHOL CLIN EXP RES, V24, P459; Leyton M, 2009, PLEASURES BRAIN, P222; Leyton M, 2007, J PSYCHIATR NEUROSCI, V32, P129; LORR M, 1982, J PERS ASSESS, V46, P432, DOI 10.1207/s15327752jpa4604_16; Lorr M., 1988, MANUAL PROFILE MOOD; Mahler SV, 2007, NEUROPSYCHOPHARMACOL, V32, P2267, DOI 10.1038/sj.npp.1301376; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; Mehta MA, 2001, PSYCHOPHARMACOLOGY, V159, P10, DOI 10.1007/s002130100851; Micallef J, 2009, BRIT J CLIN PHARMACO, V67, P333, DOI 10.1111/j.1365-2125.2008.03310.x; Mizrahi R, 2007, AM J PSYCHIAT, V164, P630, DOI 10.1176/appi.ajp.164.4.630; Morcom AM, 2010, CEREB CORTEX, V20, P743, DOI 10.1093/cercor/bhp139; Muller U, 1998, J NEUROSCI, V18, P2720; Munro CA, 2006, BIOL PSYCHIAT, V59, P966, DOI 10.1016/j.biopsych.2006.01.008; MURPHY DL, 1971, NATURE, V229, P135, DOI 10.1038/229135a0; Nann-Vernotica E, 2001, PSYCHOPHARMACOLOGY, V155, P338, DOI 10.1007/s002130100724; Oswald LM, 2005, NEUROPSYCHOPHARMACOL, V30, P821, DOI 10.1038/sj.npp.1300667; Oswald LM, 2007, NEUROIMAGE, V36, P153, DOI 10.1016/j.neuroimage.2007.01.055; Pecina S, 2006, NEUROSCIENTIST, V12, P500, DOI 10.1177/1073858406293154; PHILLIPS AG, 1973, SCIENCE, V179, P575, DOI 10.1126/science.179.4073.575; PHILLIPS AG, 1991, MESOLIMBIC DOPAMINE SYSTEM : FROM MOTIVATION TO ACTION, P199; Pine A, 2010, J NEUROSCI, V30, P8888, DOI 10.1523/JNEUROSCI.6028-09.2010; Pizzagalli DA, 2008, PSYCHOPHARMACOLOGY, V196, P221, DOI 10.1007/s00213-007-0957-y; Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004; Raftopoulos C, 1996, MOVEMENT DISORD, V11, P59, DOI 10.1002/mds.870110111; Richard JM, 2011, EUR J NEUROSCI, V33, P736, DOI 10.1111/j.1460-9568.2010.07553.x; Rodriguez M, 2007, SYNAPSE, V61, P61, DOI 10.1002/syn.20342; Roesch-Ely D, 2005, PSYCHOPHARMACOLOGY, V178, P420, DOI 10.1007/s00213-004-2027-z; Romach MK, 1999, ARCH GEN PSYCHIAT, V56, P1101, DOI 10.1001/archpsyc.56.12.1101; Rothman RB, 2001, SYNAPSE, V39, P32, DOI 10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3; Roussos P, 2009, BIOL PSYCHIAT, V66, P997, DOI 10.1016/j.biopsych.2009.07.008; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Salamone JD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.013.2009; SCHULTZ W, 1990, J NEUROPHYSIOL, V63, P607, DOI 10.1152/jn.1990.63.3.607; Scott DJ, 2006, J NEUROSCI, V26, P10789, DOI 10.1523/JNEUROSCI.2577-06.2006; Setiawan E, 2011, ALCOHOL CLIN EXP RES, V35, P1134, DOI 10.1111/j.1530-0277.2011.01446.x; SINGH MM, 1973, COMPR PSYCHIAT, V14, P393, DOI 10.1016/0010-440X(73)90013-8; Sofuoglu M, 1999, EXP CLIN PSYCHOPHARM, V7, P274, DOI 10.1037/1064-1297.7.3.274; Steeves TDL, 2009, BRAIN, V132, P1376, DOI 10.1093/brain/awp054; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; Stine SM, 1997, BIOL PSYCHIAT, V42, P181, DOI 10.1016/S0006-3223(96)00331-9; Treadway MT, 2011, NEUROSCI BIOBEHAV R, V35, P537, DOI 10.1016/j.neubiorev.2010.06.006; Upadhyaya HP, 2003, PSYCHOPHARMACOLOGY, V166, P95, DOI 10.1007/s00213-002-1303-z; van der Post J, 2004, J PSYCHOPHARMACOL, V18, P109, DOI 10.1177/0269881104042832; Venugopalan VV, 2011, NEUROPSYCHOPHARMACOL, V36, P2469, DOI 10.1038/npp.2011.135; Volkow ND, 1999, J PHARMACOL EXP THER, V291, P409; Willner P, 1985, DEPRESSION PSYCHOBIO, P597; WISE RA, 1982, BEHAV BRAIN SCI, V5, P39, DOI 10.1017/S0140525X00010372; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; WISE RA, 1978, BRAIN RES, V152, P215, DOI 10.1016/0006-8993(78)90253-6; Wise RA, 2008, NEUROTOX RES, V14, P169, DOI 10.1007/BF03033808; Woicik PA, 2009, ADDICT BEHAV, V34, P1042, DOI 10.1016/j.addbeh.2009.07.001; YOKEL RA, 1976, PSYCHOPHARMACOLOGY, V48, P311, DOI 10.1007/BF00496868; YOKEL RA, 1975, SCIENCE, V187, P547, DOI 10.1126/science.1114313; Young SN, 2002, PHARMACOL BIOCHEM BE, V71, P857, DOI 10.1016/S0091-3057(01)00670-0	111	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28370	10.1371/journal.pone.0028370	http://dx.doi.org/10.1371/journal.pone.0028370			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238577	Green Published, Green Submitted, gold			2022-12-27	WOS:000301070200008
J	Pochon, X; Putnam, HM; Burki, F; Gates, RD				Pochon, Xavier; Putnam, Hollie M.; Burki, Fabien; Gates, Ruth D.			Identifying and Characterizing Alternative Molecular Markers for the Symbiotic and Free-Living Dinoflagellate Genus Symbiodinium	PLOS ONE			English	Article							SEQUENCE TAG ANALYSIS; MULTIGENE PHYLOGENY; INDO-PACIFIC; DNA-CONTENT; DIVERSITY; GENOME; EVOLUTION; ACTIN; ZOOXANTHELLAE; DINOPHYCEAE	Dinoflagellates in the genus Symbiodinium are best known as endosymbionts of corals and other invertebrate as well as protist hosts, but also exist free-living in coastal environments. Despite their importance in marine ecosystems, less than 10 loci have been used to explore phylogenetic relationships in this group, and only the multi-copy nuclear ribosomal Internal Transcribed Spacer (ITS) regions 1 and 2 have been used to characterize fine-scale genetic diversity within the nine clades (A-I) that comprise the genus. Here, we describe a three-step molecular approach focused on 1) identifying new candidate genes for phylogenetic analysis of Symbiodinium spp., 2) characterizing the phylogenetic relationship of these candidate genes from DNA samples spanning eight Symbiodinium clades (A-H), and 3) conducting in-depth phylogenetic analyses of candidate genes displaying genetic divergences equal or higher than those within the ITS-2 of Symbiodinium clade C. To this end, we used bioinformatics tools and reciprocal comparisons to identify homologous genes from 55,551 cDNA sequences representing two Symbiodinium and six additional dinoflagellate EST libraries. Of the 84 candidate genes identified, 7 Symbiodinium genes (elf2, coI, coIII, cob, calmodulin, rad24, and actin) were characterized by sequencing 23 DNA samples spanning eight Symbiodinium clades (A-H). Four genes displaying higher rates of genetic divergences than ITS-2 within clade C were selected for in-depth phylogenetic analyses, which revealed that calmodulin has limited taxonomic utility but that coI, rad24, and actin behave predictably with respect to Symbiodinium lineage C and are potential candidates as new markers for this group. The approach for targeting candidate genes described here can serve as a model for future studies aimed at identifying and testing new phylogenetically informative genes for taxa where transcriptomic and genomics data are available.	[Pochon, Xavier; Putnam, Hollie M.; Gates, Ruth D.] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Burki, Fabien] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of Hawaii System; University of British Columbia	Pochon, X (corresponding author), Univ Hawaii, Sch Ocean & Earth Sci & Technol, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA.	pochon@hawaii.edu	Burki, Fabien/F-4818-2010; Pochon, Xavier/K-5844-2019	Burki, Fabien/0000-0002-8248-8462; Pochon, Xavier/0000-0001-9510-0407; Putnam, Hollie/0000-0003-2322-3269	United States National Science Foundation [OCE-0752604]; Swiss National Science Foundation [PBGEA-115118]; School of Ocean and Earth Science and Technology, University of Hawai'i	United States National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); School of Ocean and Earth Science and Technology, University of Hawai'i	This work was supported by the United States National Science Foundation (OCE-0752604 to RDG), the Swiss National Science Foundation (PBGEA-115118 to XP), and the School of Ocean and Earth Science and Technology, University of Hawai'i. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachvaroff TR, 2004, PROTIST, V155, P65, DOI 10.1078/1434461000165; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Barbrook AC, 2000, MOL GEN GENET, V263, P152, DOI 10.1007/s004380050042; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; Bongaerts P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010871; Brown BE, 1999, MAR ECOL PROG SER, V191, P53, DOI 10.3354/meps191053; Burki F, 2008, BIOL LETTERS, V4, P366, DOI 10.1098/rsbl.2008.0224; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Burki F, 2006, MOL BIOL EVOL, V23, P1922, DOI 10.1093/molbev/msl055; CASTRESANA J, 1994, EMBO J, V13, P2516, DOI 10.1002/j.1460-2075.1994.tb06541.x; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Correa AMS, 2009, CORAL REEFS, V28, P81, DOI 10.1007/s00338-008-0456-6; Fedorova L, 2005, CURR GENOMICS, V6, P589, DOI 10.2174/138920205775811416; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Franklin EC, 2012, MOL ECOL RESOUR, V12, P369, DOI 10.1111/j.1755-0998.2011.03081.x; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Hackett JD, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-80; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hoppenrath M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013220; Howe CJ, 2008, J EXP BOT, V59, P1035, DOI 10.1093/jxb/erm292; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JACOBSON DM, 1986, J PHYCOL, V22, P249, DOI 10.1111/j.1529-8817.1986.tb00021.x; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Jones A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010437; Kim S, 2011, MOL BIOL EVOL, V28, P1469, DOI 10.1093/molbev/msq332; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; LaJeunesse TC, 2009, P ROY SOC B-BIOL SCI, V276, P4139, DOI 10.1098/rspb.2009.1405; Leggat W, 2007, J PHYCOL, V43, P1010, DOI 10.1111/j.1529-8817.2007.00387.x; Lidie KB, 2005, MAR BIOTECHNOL, V7, P481, DOI 10.1007/s10126-004-4110-6; Lin SJ, 2011, RES MICROBIOL, V162, P551, DOI 10.1016/j.resmic.2011.04.006; Magalon H, 2006, MAR BIOL, V148, P913, DOI 10.1007/s00227-005-0133-z; Mieog JC, 2009, MOL ECOL RESOUR, V9, P74, DOI 10.1111/j.1755-0998.2008.02222.x; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Muller J, 2005, MOL BIOL CELL, V16, P5736, DOI 10.1091/mbc.E05-06-0508; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Oota S, 1999, MOL BIOL EVOL, V16, P856, DOI 10.1093/oxfordjournals.molbev.a026170; Patron NJ, 2005, J MOL BIOL, V348, P1015, DOI 10.1016/j.jmb.2005.03.030; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Pochon X, 2007, CORAL REEFS, V26, P867, DOI 10.1007/s00338-007-0279-x; Pochon X, 2006, MOL PHYLOGENET EVOL, V38, P20, DOI 10.1016/j.ympev.2005.04.028; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Pochon X, 2010, J PHYCOL, V46, P53, DOI 10.1111/j.1529-8817.2009.00797.x; RAE PMM, 1970, J CELL BIOL, V46, P106, DOI 10.1083/jcb.46.1.106; Reichman JR, 2003, MOL BIOL EVOL, V20, P2143, DOI 10.1093/molbev/msg233; RIZZO PJ, 1991, J PROTOZOOL, V38, P246, DOI 10.1111/j.1550-7408.1991.tb04437.x; Rodriguez-Lanetty M, 2003, MOL PHYLOGENET EVOL, V28, P152, DOI 10.1016/S1055-7903(03)00033-2; Rooney AP, 2004, MOL BIOL EVOL, V21, P1704, DOI 10.1093/molbev/msh178; ROWAN R, 1992, P NATL ACAD SCI USA, V89, P3639, DOI 10.1073/pnas.89.8.3639; Rowan R, 1996, PLANT CELL, V8, P539, DOI 10.1105/tpc.8.3.539; Rowan R, 1998, J PHYCOL, V34, P407, DOI 10.1046/j.1529-8817.1998.340407.x; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Shalchian-Tabrizi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002098; Shinohara M, 2003, GENETICS, V164, P855; Siano R, 2010, PROTIST, V161, P385, DOI 10.1016/j.protis.2010.01.002; Stat M, 2009, CORAL REEFS, V28, P709, DOI 10.1007/s00338-009-0509-5; Stat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015854; Stat M, 2009, MAR ECOL PROG SER, V386, P83, DOI 10.3354/meps08080; Stern RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013991; Takabayashi M, 2004, J PHYCOL, V40, P160, DOI 10.1111/j.0022-3646.2003.03-097.x; Takishita K, 2003, PROTIST, V154, P443, DOI 10.1078/143446103322454176; Takishita K, 2003, PHYCOLOGIA, V42, P285, DOI 10.2216/i0031-8884-42-3-285.1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanikawa N, 2004, PHOTOCHEM PHOTOBIOL, V80, P31, DOI 10.1562/2004-03-12-RA-110.1; Taylor F.J.R., 1987, BOT MONOGRAPHS; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Oppen MJH, 2005, CORAL REEFS, V24, P482, DOI 10.1007/s00338-005-0487-1; Veldhuis MJW, 1997, J PHYCOL, V33, P527, DOI 10.1111/j.0022-3646.1997.00527.x; Voolstra CR, 2009, COMP BIOCHEM PHYS D, V4, P67, DOI 10.1016/j.cbd.2008.11.001; Waller RF, 2009, BIOESSAYS, V31, P237, DOI 10.1002/bies.200800164; Watanabe T, 2006, J APPL PHYCOL, V18, P219, DOI 10.1007/s10811-006-9106-y; Zhang H, 2006, J EUKARYOT MICROBIOL, V53, P142, DOI 10.1111/j.1550-7408.2005.00085.x; Zhang H, 2005, J PHYCOL, V41, P411, DOI 10.1111/j.1529-8817.2005.04168.x	77	64	66	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29816	10.1371/journal.pone.0029816	http://dx.doi.org/10.1371/journal.pone.0029816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238660	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200051
J	Rauch, U; Shami, A; Zhang, F; Carmignac, V; Durbeej, M; Hultgardh-Nilsson, A				Rauch, Uwe; Shami, Annelie; Zhang, Feng; Carmignac, Virginie; Durbeej, Madeleine; Hultgardh-Nilsson, Anna			Increased Neointimal Thickening in Dystrophin-Deficient mdx Mice	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; SARCOGLYCAN-SARCOSPAN COMPLEX; CELLS IN-VITRO; MUSCULAR-DYSTROPHY; GLYCOPROTEIN COMPLEX; EXTRACELLULAR-MATRIX; LAMININ ISOFORMS; AORTIC-CELLS; EXPRESSION; PROLIFERATION	Background: The dystrophin gene, which is mutated in Duchenne muscular dystrophy (DMD), encodes a large cytoskeletal protein present in muscle fibers. While dystrophin in skeletal muscle has been extensively studied, the function of dystrophin in vascular smooth muscle is less clear. Here, we have analyzed the role of dystrophin in injury-induced arterial neointima formation. Methodology/Principal Findings: We detected a down-regulation of dystrophin, dystroglycan and beta-sarcoglycan mRNA expression when vascular smooth muscle cells de-differentiate in vitro. To further mimic development of intimal lesions, we performed a collar-induced injury of the carotid artery in the mdx mouse, a model for DMD. As compared with control mice, mdx mice develop larger lesions with increased numbers of proliferating cells. In vitro experiments demonstrate increased migration of vascular smooth muscle cells from mdx mice whereas the rate of proliferation was similar in cells isolated from wild-type and mdx mice. Conclusions/Significance: These results show that dystrophin deficiency stimulates neointima formation and suggest that expression of dystrophin in vascular smooth muscle cells may protect the artery wall against injury-induced intimal thickening.	[Rauch, Uwe; Shami, Annelie; Zhang, Feng; Carmignac, Virginie; Durbeej, Madeleine; Hultgardh-Nilsson, Anna] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Rauch, U (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	madeleine.durbeej-hjalt@med.lu.se		Durbeej Hjalt, Madeleine/0000-0002-5491-2457	Swedish Heart and Lung Foundation; Swedish Research Council; Craaford Foundation; Alfred Osterlund Foundation; Thelma Zoega Foundation; Kock Foundation at Medical Faculty, Lund University; Vascular Wall program at Medical Faculty, Lund University	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Craaford Foundation; Alfred Osterlund Foundation; Thelma Zoega Foundation; Kock Foundation at Medical Faculty, Lund University; Vascular Wall program at Medical Faculty, Lund University	Supported by The Swedish Heart and Lung Foundation, The Swedish Research Council, The Craaford Foundation, The Alfred Osterlund Foundation, The Thelma Zoega Foundation, The Kock Foundation and The Vascular Wall program at Medical Faculty, Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barresi R, 2000, J BIOL CHEM, V275, P38554, DOI 10.1074/jbc.M007799200; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; Dingemans KP, 2000, ANAT REC, V258, P1; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; Dye WW, 2007, J APPL PHYSIOL, V103, P664, DOI 10.1152/japplphysiol.00118.2007; Engel AG, 2004, DYSTROPHINOPATHIES, V2004, P961; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; FRITZ KE, 1970, EXP MOL PATHOL, V12, P354, DOI 10.1016/0014-4800(70)90066-3; Gawlik K, 2004, HUM MOL GENET, V13, P1775, DOI 10.1093/hmg/ddh190; Gawlik KI, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-9; HARRICANE MC, 1994, CELL BIOL INT, V18, P947, DOI 10.1006/cbir.1994.1015; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hou R, 2006, J CELL BIOL, V173, P417, DOI 10.1083/jcb.200508121; HOUZELSTEIN D, 1992, J CELL BIOL, V119, P811, DOI 10.1083/jcb.119.4.811; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inoue T, 2009, CIRC J, V73, P615, DOI 10.1253/circj.CJ-09-0059; Ito K, 2006, HUM MOL GENET, V15, P2266, DOI 10.1093/hmg/ddl151; Kokubo T, 2007, J VASC SURG, V45, p33A, DOI 10.1016/j.jvs.2007.02.069; Loufrani L, 2001, CIRCULATION, V103, P864, DOI 10.1161/01.CIR.103.6.864; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Poling J, 2011, ARTERIOSCL THROM VAS, V31, P2297, DOI 10.1161/ATVBAHA.111.232835; Quignard JF, 2001, CARDIOVASC RES, V49, P177, DOI 10.1016/S0008-6363(00)00210-8; Ramirez-Sanchez I, 2005, J VASC RES, V42, P1, DOI 10.1159/000082528; Rauch U, 2011, HISTOL HISTOPATHOL, V26, P711, DOI 10.14670/HH-26.711; Rzucidlo EM, 2007, J VASC SURG, V45, p25A, DOI 10.1016/j.jvs.2007.03.001; SCHULER F, 1995, J CELL SCI, V108, P3795; Straub V, 1999, J BIOL CHEM, V274, P27989, DOI 10.1074/jbc.274.39.27989; Stroem A, 2007, CIRC RES, V101, pE83, DOI 10.1161/CIRCRESAHA.107.160705; Strom A, 2007, ATHEROSCLEROSIS, V190, P298, DOI 10.1016/j.atherosclerosis.2006.03.032; Thyberg J, 1996, INT REV CYTOL, V169, P183, DOI 10.1016/S0074-7696(08)61987-7; Tran PK, 2004, CIRC RES, V94, P550, DOI 10.1161/01.RES.0000117772.86853.34; Wheeler MT, 2004, J CLIN INVEST, V113, P668, DOI 10.1172/JCI200420410; Willmann R, 2009, NEUROMUSCULAR DISORD, V19, P241, DOI 10.1016/j.nmd.2008.11.015; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Zahradka P, 2006, J PHARMACOL EXP THER, V317, P651, DOI 10.1124/jpet.105.096271	40	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29904	10.1371/journal.pone.0029904	http://dx.doi.org/10.1371/journal.pone.0029904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238670	gold, Green Published, Green Submitted			2022-12-27	WOS:000301070200057
J	Shiu, JH; Chen, CY; Chen, YC; Chang, YT; Chang, YS; Huang, CH; Chuang, WJ				Shiu, Jia-Hau; Chen, Chiu-Yueh; Chen, Yi-Chun; Chang, Yao-Tsung; Chang, Yung-Sheng; Huang, Chun-Hao; Chuang, Woei-Jer			Effect of P to A Mutation of the N-Terminal Residue Adjacent to the Rgd Motif on Rhodostomin: Importance of Dynamics in Integrin Recognition	PLOS ONE			English	Article							PLATELET-AGGREGATION INHIBITOR; GLYCOPROTEIN-IIB-IIIA; CELL-ADHESION; 3-DIMENSIONAL STRUCTURE; BACKBONE DYNAMICS; PROLINE MUTATIONS; CRYSTAL-STRUCTURE; HUMAN LYSOZYME; BETA 3; DISINTEGRINS	Rhodostomin (Rho) is an RGD protein that specifically inhibits integrins. We found that Rho mutants with the P48A mutation 4.4-11.5 times more actively inhibited integrin alpha 5 beta 1. Structural analysis showed that they have a similar 3D conformation for the RGD loop. Docking analysis also showed no difference between their interactions with integrin alpha 5 beta 1. However, the backbone dynamics of RGD residues were different. The values of the R-2 relaxation parameter for Rho residues R49 and D51 were 39% and 54% higher than those of the P48A mutant, which caused differences in S-2, R-ex, and tau(e). The S-2 values of the P48A mutant residues R49, G50, and D51 were 29%, 14%, and 28% lower than those of Rho. The R-ex values of Rho residues R49 and D51 were 0.91 s(-1) and 1.42 s(-1); however, no Rex was found for those of the P48A mutant. The te values of Rho residues R49 and D51 were 9.5 and 5.1 times lower than those of P48A mutant. Mutational study showed that integrin alpha 5 beta 1 prefers its ligands to contain (G/A) RGD but not PRGD sequences for binding. These results demonstrate that the N-terminal proline residue adjacent to the RGD motif affect its function and dynamics, which suggests that the dynamic properties of the RGD motif may be important in Rho's interaction with integrin alpha 5 beta 1.	[Shiu, Jia-Hau; Chen, Chiu-Yueh; Chen, Yi-Chun; Chang, Yao-Tsung; Huang, Chun-Hao; Chuang, Woei-Jer] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Chang, Yung-Sheng; Chuang, Woei-Jer] Natl Cheng Kung Univ, Coll Med, Inst Biopharmaceut Sci, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University	Shiu, JH (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Dept Biochem & Mol Biol, Tainan 70101, Taiwan.	wjcnmr@mail.ncku.edu.tw			National Research Program for Genomic Medicine; National Science Council, Taiwan, Republic of China [NSC-1002325-B-006-006, NSC-99-2323-B-006-001-CC2]	National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by the National Research Program for Genomic Medicine, the research grants from the National Science Council (NSC-1002325-B-006-006 and NSC-99-2323-B-006-001-CC2), Taiwan, Republic of China (URL:http://web1.nsc.gov.tw/mp.aspx?mp=7). Funding for this article's open access publication was provided by National Science Council, Taiwan, Republic of China. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBER T, 1988, SCIENCE, V239, P631, DOI 10.1126/science.3277275; Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Blobel Carl P., 1992, Current Opinion in Cell Biology, V4, P760; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; Calvete JJ, 2005, CURR PHARM DESIGN, V11, P829, DOI 10.2174/1381612053381783; Carr PA, 1997, STRUCTURE, V5, P949, DOI 10.1016/S0969-2126(97)00248-7; CHEN BL, 1992, BIOCHEMISTRY-US, V31, P1464, DOI 10.1021/bi00120a025; Chen CY, 2009, PROTEINS, V76, P808, DOI 10.1002/prot.22387; Chen CY, 2003, J BIOL CHEM, V278, P17336, DOI 10.1074/jbc.M209038200; CHEN Y, 1994, J BIOMOL NMR, V4, P307; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; DENNIS MS, 1993, PROTEINS, V15, P312, DOI 10.1002/prot.340150308; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fujii Y, 2003, J MOL BIOL, V332, P1115, DOI 10.1016/S0022-2836(03)00991-4; GREEN JDF, 1992, J BIOL CHEM, V267, P23484; Guo RT, 2001, PROTEINS, V43, P499, DOI 10.1002/prot.1061; HERNING T, 1991, BIOCHEMISTRY-US, V30, P9882, DOI 10.1021/bi00105a011; HERNING T, 1992, BIOCHEMISTRY-US, V31, P7077, DOI 10.1021/bi00146a008; Hohenester E, 2002, MATRIX BIOL, V21, P115, DOI 10.1016/S0945-053X(01)00191-3; Huang TF, 1998, CELL MOL LIFE SCI, V54, P527, DOI 10.1007/s000180050181; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krieger F, 2005, J AM CHEM SOC, V127, P3346, DOI 10.1021/ja042798i; Lu X., 2003, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V1, P189, DOI 10.2174/1568016033477522; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Mans BJ, 2002, J BIOL CHEM, V277, P21371, DOI 10.1074/jbc.M112060200; McLane MA, 1998, P SOC EXP BIOL MED, V219, P109, DOI 10.3181/00379727-219-44322; McLane MA, 1996, FEBS LETT, V391, P139, DOI 10.1016/0014-5793(96)00716-8; McLane MA, 2008, FRONT BIOSCI-LANDMRK, V13, P6617, DOI 10.2741/3177; Monleon D, 2005, BIOCHEM J, V387, P57, DOI 10.1042/BJ20041343; NAKANO T, 1993, BIOCHEMISTRY-US, V32, P2534, DOI 10.1021/bi00061a010; NIEWIAROWSKI S, 1994, SEMIN HEMATOL, V31, P289; Ogasahara K, 1997, BIOCHEMISTRY-US, V36, P932, DOI 10.1021/bi961660c; PIELA L, 1987, BIOPOLYMERS, V26, P1587, DOI 10.1002/bip.360260910; Rahman S, 1998, BIOCHEM J, V335, P247, DOI 10.1042/bj3350247; Rata IA, 2010, J PHYS CHEM B, V114, P1859, DOI 10.1021/jp909874g; REIDHAAROLSON JF, 1990, PROTEINS, V7, P306, DOI 10.1002/prot.340070403; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1058; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; SENN H, 1993, J MOL BIOL, V232, P907, DOI 10.1006/jmbi.1993.1439; SEYMOUR JL, 1990, J BIOL CHEM, V265, P10143; Shin J, 2003, BIOCHEMISTRY-US, V42, P14408, DOI 10.1021/bi0300276; Shiu JH, 2004, PROTEINS, V57, P839, DOI 10.1002/prot.20269; Smith KJ, 1996, INT J PEPT PROT RES, V48, P220; Swenson S, 2007, CURR PHARM DESIGN, V13, P2860, DOI 10.2174/138161207782023793; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; VALE R, 1999, GUIDEBOOK EXTRACELLU; Wang FZ, 2003, J VIROL, V77, P3131, DOI 10.1128/JVI.77.5.3131-3147.2003; Wattam B, 2001, BIOCHEM J, V356, P11, DOI 10.1042/0264-6021:3560011; Williams Janice A., 1993, Biochemical Society Transactions, V21, p73S; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zhang XP, 1998, J BIOL CHEM, V273, P7345, DOI 10.1074/jbc.273.13.7345	54	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28833	10.1371/journal.pone.0028833	http://dx.doi.org/10.1371/journal.pone.0028833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238583	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200013
J	Li, H; Liu, H; Shi, AM; Stys, P; Zhou, XG; Cai, WZ				Li, Hu; Liu, Hui; Shi, Aimin; Stys, Pavel; Zhou, Xuguo; Cai, Wanzhi			The Complete Mitochondrial Genome and Novel Gene Arrangement of the Unique-Headed Bug Stenopirates sp (Hemiptera: Enicocephalidae)	PLOS ONE			English	Article							TRANSFER-RNA GENES; COMPLETE SEQUENCE; PHYLOGENETIC ANALYSIS; APIS-MELLIFERA; CONTROL REGION; WEB SERVER; EVOLUTION; INSECTA; DNA; ORGANIZATION	Many of true bugs are important insect pests to cultivated crops and some are important vectors of human diseases, but few cladistic analyses have addressed relationships among the seven infraorders of Heteroptera. The Enicocephalomorpha and Nepomorpha are consider the basal groups of Heteroptera, but the basal-most lineage remains unresolved. Here we report the mitochondrial genome of the unique-headed bug Stenopirates sp., the first mitochondrial genome sequenced from Enicocephalomorpha. The Stenopirates sp. mitochondrial genome is a typical circular DNA molecule of 15, 384 bp in length, and contains 37 genes and a large non-coding fragment. The gene order differs substantially from other known insect mitochondrial genomes, with rearrangements of both tRNA genes and protein-coding genes. The overall AT content (82.5%) of Stenopirates sp. is the highest among all the known heteropteran mitochondrial genomes. The strand bias is consistent with other true bugs with negative GC-skew and positive AT-skew for the J-strand. The heteropteran mitochondrial atp8 exhibits the highest evolutionary rate, whereas cox1 appears to have the lowest rate. Furthermore, a negative correlation was observed between the variation of nucleotide substitutions and the GC content of each protein-coding gene. A microsatellite was identified in the putative control region. Finally, phylogenetic reconstruction suggests that Enicocephalomorpha is the sister group to all the remaining Heteroptera.	[Li, Hu; Shi, Aimin; Cai, Wanzhi] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Liu, Hui] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Entomol Lab, Fukuoka 812, Japan; [Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	China Agricultural University; Kyushu University; University of Kentucky	Li, H (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	xuguozhou@uky.edu; caiwz@cau.edu.cn	li, hu/N-7159-2013; SHI, AIMIN/L-7480-2019	SHI, AIMIN/0000-0001-8275-3185	National Natural Science Foundation of China [30825006, 30970394, 31061160186]; Beijing Natural Science Foundation [6112013]; Doctoral Program of Higher Education of China [200800190015]; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences [O529YX5105]; China Agricultural University [15059211]; Grant Agency of Czech Academy of Sciences [601110706]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences; China Agricultural University; Grant Agency of Czech Academy of Sciences(Grant Agency of the Czech Republic)	This study was supported by grants from the National Natural Science Foundation of China (Nos. 30825006, 30970394, 31061160186), Beijing Natural Science Foundation (No. 6112013), the Doctoral Program of Higher Education of China (No. 200800190015), the Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences (No. O529YX5105) to Wanzhi Cai, the Innovation Program for Ph.D. Students of China Agricultural University (No. 15059211) to Hu Li and Grant Agency of Czech Academy of Sciences (IAA. 601110706) to Pavel Stys. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; BARRETTE RJ, 1994, GENOME, V37, P858, DOI 10.1139/g94-121; Boore JL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-182; Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2005, METHOD ENZYMOL, V395, P311, DOI 10.1016/S0076-6879(05)95019-2; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Boore JL, 2001, MOL BIOL EVOL, V18, P1413, DOI 10.1093/oxfordjournals.molbev.a003925; Cameron SL, 2004, CLADISTICS, V20, P534, DOI 10.1111/j.1096-0031.2004.00040.x; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cameron SL, 2007, J MOL EVOL, V65, P589, DOI 10.1007/s00239-007-9042-8; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; CROZIER RH, 1993, GENETICS, V133, P97; Curole JP, 1999, TRENDS ECOL EVOL, V14, P394, DOI 10.1016/S0169-5347(99)01660-2; Dermauw W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-107; Dotson EM, 2001, INSECT MOL BIOL, V10, P205, DOI 10.1046/j.1365-2583.2001.00258.x; Dowton M, 2002, INVERTEBR SYST, V16, P345, DOI 10.1071/IS02003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fumagalli L, 1996, MOL BIOL EVOL, V13, P31, DOI 10.1093/oxfordjournals.molbev.a025568; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Goldstein D, 1999, MICROSATELLITES EVOL; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; He Y, 2005, J MOL EVOL, V61, P819, DOI 10.1007/s00239-005-0102-7; Hua JM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-134; Hua JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-610; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Lee W, 2009, MOL CELLS, V28, P155, DOI 10.1007/s10059-009-0125-9; LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li H, 2011, INT J BIOL SCI, V7, P792, DOI 10.7150/ijbs.7.792; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin CP, 2004, MOL PHYLOGENET EVOL, V30, P686, DOI 10.1016/S1055-7903(03)00241-0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-156; Mahner M, 1993, ZOOLOGICA, V143, pix+302; Masta SE, 2004, MOL BIOL EVOL, V21, P893, DOI 10.1093/molbev/msh096; Masta SE, 2008, MOL BIOL EVOL, V25, P949, DOI 10.1093/molbev/msn051; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Oliveira DCSG, 2008, MOL BIOL EVOL, V25, P2167, DOI 10.1093/molbev/msn159; Oliveira MT, 2008, MOL PHYLOGENET EVOL, V48, P850, DOI 10.1016/j.ympev.2008.05.022; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roques S, 2006, GENE, V383, P12, DOI 10.1016/j.gene.2006.06.018; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; Schuh R. T., 1995, True bugs of the world (Hemiptera: Heteroptera): classification and natural history.; Schuh RT, 2009, SYST ENTOMOL, V34, P15, DOI 10.1111/j.1365-3113.2008.00436.x; SCHUH RT, 1986, ANNU REV ENTOMOL, V31, P67, DOI 10.1146/annurev.en.31.010186.000435; SCHUH RT, 1991, J NEW YORK ENTOMOL S, V99, P298; Shao RF, 2003, MOL BIOL EVOL, V20, P362, DOI 10.1093/molbev/msg045; Shao RF, 2001, MOL BIOL EVOL, V18, P1828, DOI 10.1093/oxfordjournals.molbev.a003970; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Song N, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.7601; STYS P, 1975, ACTA ENTOMOL BOHEMOS, V72, P65; Stys P., 1984, International Congress of Entomology Proceedings, V17, P12; Stys P, 1995, TRUE BUGS WORLD HEMI, P67; Stys P., 1989, PRA CE SLOVENSKEJ EN, V8, P69; Stys P, 2008, B INSECTOL, V61, P137; Sweet M. H., 2006, Denisia, P225; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thao ML, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-25; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian Y, 2008, MOL PHYLOGENET EVOL, V47, P581, DOI 10.1016/j.ympev.2008.01.034; Usinger Robert L, 1943, ANN ENT SOC AMERICA, V36, P602; Wei SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012708; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Weirauch C, 2011, ANNU REV ENTOMOL, V56, P487, DOI 10.1146/annurev-ento-120709-144833; WHEELER WC, 1993, ENTOMOL SCAND, V24, P121; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Xie Q, 2008, MOL PHYLOGENET EVOL, V47, P463, DOI 10.1016/j.ympev.2008.01.024; Yuan ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-597; Yue GH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-242; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; Zhou ZJ, 2007, GENOME, V50, P855, DOI 10.1139/G07-057; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	84	95	105	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29419	10.1371/journal.pone.0029419	http://dx.doi.org/10.1371/journal.pone.0029419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235294	Green Submitted, gold, Green Published			2022-12-27	WOS:000301123400055
J	Matzinger, SR; Carroll, TD; Fritts, L; McChesney, MB; Miller, CJ				Matzinger, Shannon R.; Carroll, Timothy D.; Fritts, Linda; McChesney, Michael B.; Miller, Christopher J.			Exogenous IFN-alpha Administration Reduces Influenza A Virus Replication in the Lower Respiratory Tract of Rhesus Macaques	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; MX-PROTEINS; INTERFERON; GENE; EXPRESSION; MORBIDITY; INFECTION; CYTOKINES; EFFECTORS; INHIBIT	To determine the role of innate immune responses in controlling influenza A virus replication, rhesus macaques (RM) were administered pegylated IFN-alpha prior to virus challenge. Systemic and mucosal pegylated IFN-alpha administration induced expression of the interferon-stimulated genes (ISG) MxA and OAS in the airways. RM treated with IFN-alpha 24 hours prior to influenza virus challenge had significantly lower peak vRNA levels in the trachea compared to untreated animals. In addition to blunting viral replication, IFN-alpha treatment minimized the weight loss and spike in body temperature after influenza infection of RM. These results confirm the importance of IFN-alpha induced innate immune responses in the rapid control of influenza A virus replication in primates.	[Matzinger, Shannon R.; Carroll, Timothy D.; Fritts, Linda; McChesney, Michael B.; Miller, Christopher J.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Matzinger, Shannon R.; Carroll, Timothy D.; Fritts, Linda; Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Matzinger, SR (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	cjmiller@ucdavis.edu	Carroll, Timothy D/A-4605-2013	Carroll, Timothy D/0000-0002-3459-3364	Public Health Service from National Center for Research Resources [P51RR00169]; National Institute of Allergy and Infectious Disease [U01AI57624, U01AI5726]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI057264] Funding Source: NIH RePORTER	Public Health Service from National Center for Research Resources; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant P51RR00169 from the National Center for Research Resources and grants U01AI57624 and U01AI5726 from the National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2005, J VIROL, V79, P12164, DOI 10.1128/JVI.79.19.12164-12172.2005; Asmuth DM, 2008, J MED PRIMATOL, V37, P26, DOI 10.1111/j.1600-0684.2007.00221.x; Brydon EWA, 2005, FEMS MICROBIOL REV, V29, P837, DOI 10.1016/j.femsre.2004.12.003; Carroll TD, 2008, J IMMUNOL, V180, P2385, DOI 10.4049/jimmunol.180.4.2385; Haasbach E, 2011, J INTERF CYTOK RES, V31, P515, DOI 10.1089/jir.2010.0071; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; HORISBERGER MA, 1983, P NATL ACAD SCI-BIOL, V80, P1910, DOI 10.1073/pnas.80.7.1910; Kugel D, 2009, J VIROL; Kugel D, 2009, J VIROL, V83, P3843, DOI 10.1128/JVI.02453-08; MURPHY BR, 1973, J INFECT DIS, V128, P488, DOI 10.1093/infdis/128.4.488; PAVLOVIC J, 1992, J VIROL, V66, P2564, DOI 10.1128/JVI.66.4.2564-2569.1992; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shaker O, 2010, J VIRAL HEPATITIS, V17, P794, DOI 10.1111/j.1365-2893.2009.01241.x; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; Tumpey TM, 2007, J VIROL, V81, P10818, DOI 10.1128/JVI.01116-07; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; Wang YC, 2005, J VIROL, V79, P14355, DOI 10.1128/JVI.79.22.14355-14370.2005	20	19	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29255	10.1371/journal.pone.0029255	http://dx.doi.org/10.1371/journal.pone.0029255			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220209	Green Published, gold			2022-12-27	WOS:000300677000022
J	Yang, T; Liu, NN				Yang, Ting; Liu, Nannan			Genome Analysis of Cytochrome P450s and Their Expression Profiles in Insecticide Resistant Mosquitoes, Culex quinquefasciatus	PLOS ONE			English	Article							PYRETHROID-RESISTANT; GENE-EXPRESSION; DETOXIFICATION ENZYMES; METABOLIC RESISTANCE; HOUSE-FLIES; CYP4 FAMILY; SUPPRESSION; STRAINS; OVEREXPRESSION; BIOSYNTHESIS	Here we report a study of the 204 P450 genes in the whole genome sequence of larvae and adult Culex quinquefasciatus mosquitoes. The expression profiles of the P450 genes were compared for susceptible (S-Lab) and resistant mosquito populations, two different field populations of mosquitoes (HAmCq and MAmCq), and field parental mosquitoes (HAmCq (G0) and MAmCq(G0)) and their permethrin selected offspring (HAmCq (G8) and MAmCq(G6)). While the majority of the P450 genes were expressed at a similar level between the field parental strains and their permethrin selected offspring, an up-or down-regulation feature in the P450 gene expression was observed following permethrin selection. Compared to their parental strains and the susceptible S-Lab strain, HAmCq(G8) and MAmCq(G6) were found to up-regulate 11 and 6% of total P450 genes in larvae and 7 and 4% in adults, respectively, while 5 and 11% were down-regulated in larvae and 4 and 2% in adults. Although the majority of these up- and down-regulated P450 genes appeared to be developmentally controlled, a few were either up-or down-regulated in both the larvae and adult stages. Interestingly, a different gene set was found to be up- or down-regulated in the HAmCq(G8) and MAmCq(G6) mosquito populations in response to insecticide selection. Several genes were identified as being up-or down-regulated in either the larvae or adults for both HAmCq(G8) and MAmCq(G6); of these, CYP6AA7 and CYP4C52v1 were up-regulated and CYP6BY3 was down-regulated across the life stages and populations of mosquitoes, suggesting a link with the permethrin selection in these mosquitoes. Taken together, the findings from this study indicate that not only are multiple P450 genes involved in insecticide resistance but up-or down-regulation of P450 genes may also be co-responsible for detoxification of insecticides, insecticide selection, and the homeostatic response of mosquitoes to changes in cellular environment.	[Yang, Ting; Liu, Nannan] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA	Auburn University System; Auburn University	Yang, T (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	liunann@auburn.edu			National Institute of Allergy and Infectious Diseases [R21AI076893]; AAES [ALA08-045, ALA015-1-10026]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076893] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AAES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by award number R21AI076893 to N.L. from the National Institute of Allergy and Infectious Diseases, AAES Hatch/Multistate Grants ALA08-045 and ALA015-1-10026 to N.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aerts JL, 2004, BIOTECHNIQUES, V36, P84, DOI 10.2144/04361ST04; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Berenbaum M.R., 1991, P221; CARINO F, 1992, ACS SYM SER, V505, P31; CARINO FA, 1994, INSECT BIOCHEM MOLEC, V24, P411, DOI 10.1016/0965-1748(94)90034-5; Carvalho RA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-695; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Cui PH, 2010, BRIT J PHARMACOL, V159, P1440, DOI 10.1111/j.1476-5381.2009.00628.x; Davies L, 2006, INSECT BIOCHEM MOLEC, V36, P801, DOI 10.1016/j.ibmb.2006.08.001; Festucci-Buselli RA, 2005, INSECT MOL BIOL, V14, P69, DOI 10.1111/j.1365-2583.2005.00532.x; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R., 2005, P1; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Hardstone MC, 2010, INSECT MOL BIOL, V19, P717, DOI 10.1111/j.1365-2583.2010.01030.x; HODGSON E, 1983, INSECT BIOCHEM, V13, P237, DOI 10.1016/0020-1790(83)90044-6; Itokawa K, 2010, INSECT BIOCHEM MOLEC, V40, P631, DOI 10.1016/j.ibmb.2010.06.001; Kasai S, 2000, INSECT BIOCHEM MOLEC, V30, P163, DOI 10.1016/S0965-1748(99)00114-9; Komagata O, 2010, INSECT BIOCHEM MOLEC, V40, P146, DOI 10.1016/j.ibmb.2010.01.006; Lee SH, 2010, INSECT MOL BIOL, V19, P599, DOI 10.1111/j.1365-2583.2010.01024.x; Li B, 2005, SCI CHINA SER C, V48, P414, DOI 10.1360/04yc0057; Li T, 2010, J MED ENTOMOL, V47, P1127, DOI 10.1603/ME10142; Li XC, 2002, INSECT BIOCHEM MOLEC, V32, P311, DOI 10.1016/S0965-1748(01)00092-3; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lin RY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014557; Liu HQ, 2004, J MED ENTOMOL, V41, P408, DOI 10.1603/0022-2585-41.3.408; Liu N, 1998, INSECT BIOCHEM MOLEC, V28, P531, DOI 10.1016/S0965-1748(98)00039-3; Liu N, 1997, INSECT MOL BIOL, V6, P77, DOI 10.1046/j.1365-2583.1997.00160.x; Liu NN, 2007, GENE, V394, P61, DOI 10.1016/j.gene.2007.01.032; Liu NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023403; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LU AYH, 1979, PHARMACOL REV, V31, P277; Marinotti O, 2005, INSECT MOL BIOL, V14, P365, DOI 10.1111/j.1365-2583.2005.00567.x; Morgan ET, 1997, DRUG METAB REV, V29, P1129, DOI 10.3109/03602539709002246; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; MORGAN ET, 1989, MOL PHARMACOL, V36, P699; Nelson David R., 2009, Human Genomics, V4, P59; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; REED JR, 1994, P NATL ACAD SCI USA, V91, P10000, DOI 10.1073/pnas.91.21.10000; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Riddick DS, 2004, DRUG METAB DISPOS, V32, P367, DOI 10.1124/dmd.32.4.367; Schuler MA, 1996, PLANT PHYSIOL, V112, P1411, DOI 10.1104/pp.112.4.1411; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Shen B, 2003, PESTIC BIOCHEM PHYS, V75, P19, DOI 10.1016/S0048-3575(03)00014-2; SNYDER MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P13, DOI 10.1006/abbi.1995.1362; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Sutherland TD, 1998, P NATL ACAD SCI USA, V95, P12884, DOI 10.1073/pnas.95.22.12884; TERRIERE LC, 1984, ANNU REV ENTOMOL, V29, P71, DOI 10.1146/annurev.en.29.010184.000443; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Wen ZM, 2003, INSECT BIOCHEM MOLEC, V33, P937, DOI 10.1016/S0965-1748(03)00100-0; WHITE RE, 1980, ANNU REV BIOCHEM, V49, P315, DOI 10.1146/annurev.bi.49.070180.001531; *WHO, 1957, WHO TECH RPT SER; Winter J, 2001, BIOL CHEM, V382, P1541, DOI 10.1515/BC.2001.188; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; Xu Q, 2005, PEST MANAG SCI, V61, P1096, DOI 10.1002/ps.1090; Xu Q, 2006, BIOCHEM BIOPH RES CO, V345, P774, DOI 10.1016/j.bbrc.2006.04.155; Zhu F, 2008, ARCH INSECT BIOCH PH, V34, P147; Zhu F., 2008, INSECT MOL BIOL, V20, P1365, DOI DOI 10.1186/1472-6793-8-18; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107; Zhu Fang, 2008, BMC Physiology, V8, P18, DOI 10.1186/1472-6793-8-18	65	98	104	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29418	10.1371/journal.pone.0029418	http://dx.doi.org/10.1371/journal.pone.0029418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242119	Green Submitted, gold, Green Published			2022-12-27	WOS:000300677000031
J	Goodman, AL; Blagborough, AM; Biswas, S; Wu, YM; Hill, AV; Sinden, RE; Draper, SJ				Goodman, Anna L.; Blagborough, Andrew M.; Biswas, Sumi; Wu, Yimin; Hill, Adrian V.; Sinden, Robert E.; Draper, Simon J.			A Viral Vectored Prime-Boost Immunization Regime Targeting the Malaria Pfs25 Antigen Induces Transmission-Blocking Activity	PLOS ONE			English	Article							SUBUNIT VACCINE IMMUNOGENICITY; MEROZOITE SURFACE PROTEIN-1; PLASMODIUM-FALCIPARUM; FUNCTIONAL IMMUNOGENICITY; ADJUVANT VACCINES; SEXUAL STAGE; IN-VITRO; ANTIBODIES; CANDIDATE; IMMUNITY	The ookinete surface protein Pfs25 is a macrogamete-to-ookinete/ookinete stage antigen of Plasmodium falciparum, capable of exerting high-level anti-malarial transmission-blocking activity following immunization with recombinant protein-in-adjuvant formulations. Here, this antigen was expressed in recombinant chimpanzee adenovirus 63 (ChAd63), human adenovirus serotype 5 (AdHu5) and modified vaccinia virus Ankara (MVA) viral vectored vaccines. Two immunizations were administered to mice in a heterologous prime-boost regime. Immunization of mice with AdHu5 Pfs25 at week 0 and MVA Pfs25 at week 10 (Ad-MVA Pfs25) resulted in high anti-Pfs25 IgG titers, consisting of predominantly isotypes IgG1 and IgG2a. A single priming immunization with ChAd63 Pfs25 was as effective as AdHu5 Pfs25 with respect to ELISA titers at 8 weeks post-immunization. Sera from Ad-MVA Pfs25 immunized mice inhibited the transmission of P. falciparum to the mosquito both ex vivo and in vivo. In a standard membrane-feeding assay using NF54 strain P. falciparum, oocyst intensity in Anopheles stephensi mosquitoes was significantly reduced in an IgG concentration-dependent manner when compared to control feeds (96% reduction of intensity, 78% reduction in prevalence at a 1 in 5 dilution of sera). In addition, an in vivo transmission-blocking effect was also demonstrated by direct feeding of immunized mice infected with Pfs25DR3, a chimeric P. berghei line expressing Pfs25 in place of endogenous Pbs25. In this assay the density of Pfs25DR3 oocysts was significantly reduced when mosquitoes were fed on vaccinated as compared to control mice (67% reduction of intensity, 28% reduction in prevalence) and specific IgG titer correlated with efficacy. These data confirm the utility of the adenovirus-MVA vaccine platform for the induction of antibodies with transmission-blocking activity, and support the continued development of this alternative approach to transmission-blocking malaria subunit vaccines.	[Goodman, Anna L.; Biswas, Sumi; Hill, Adrian V.; Sinden, Robert E.; Draper, Simon J.] Univ Oxford, Jenner Inst, Oxford, England; [Blagborough, Andrew M.; Sinden, Robert E.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London, England; [Wu, Yimin] NIAID, Lab Malaria Immunol & Vaccinol, Rockville, MD USA	University of Oxford; Jenner Institute; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Goodman, AL (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	anna.goodman@nhs.net	Draper, Simon J/F-1758-2011	Draper, Simon J/0000-0002-9415-1357; Goodman, Anna/0000-0003-0643-9017	Medical Research Council [G0600424]; Transmolbloc (EU); BBSRC [LDAD_P15820]; Medical Research Council [G1000527] Funding Source: researchfish; MRC [G1000527, G0600424] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Transmolbloc (EU); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported primarily by grant G0600424 from the Medical Research Council (ALG) and in addition by Transmolbloc (EU FP7) and BBSRC (award number LDAD_P15820). SJD and AVH are Jenner Investigators. SJD is a MRC Career Development Fellow. AVH is a Wellcome Trust Principal Research Fellow. ALG was an MRC clinical training fellow whilst she undertook this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.mrc.ac.uk/index.htm. http://www.bbsrc.ac.uk/. http://www.wellcome.ac.uk/.	Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; [Anonymous], 2004, COCHRANE DB SYST REV; Arakawa T, 2005, INFECT IMMUN, V73, P7375, DOI 10.1128/IAI.73.11.7375-7380.2005; Arakawa T, 2009, INFECT IMMUN, V77, P5496, DOI 10.1128/IAI.00640-09; Bejon P, 2009, INFECT IMMUN, V77, P1917, DOI 10.1128/IAI.01358-08; Biswas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020977; Blagborough AM, 2010, VACCINE, V28, P6014, DOI 10.1016/j.vaccine.2010.06.100; Blagborough AM, 2009, VACCINE, V27, P5187, DOI 10.1016/j.vaccine.2009.06.069; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Butler D, 2009, NATURE, V462, P19, DOI 10.1038/462017a; Carter R, 2001, VACCINE, V19, P2309, DOI 10.1016/S0264-410X(00)00521-1; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; Cheru L, 2010, VACCINE, V28, P4423, DOI 10.1016/j.vaccine.2010.04.036; de Cassan SC, 2011, J IMMUNOL, V187, P2602, DOI 10.4049/jimmunol.1101004; de Koning-Ward TF, 2000, ANNU REV MICROBIOL, V54, P157, DOI 10.1146/annurev.micro.54.1.157; Diallo M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-248; Dinglasan RR, 2007, P NATL ACAD SCI USA, V104, P13461, DOI 10.1073/pnas.0702239104; Douglas AD, 2010, VACCINE, V28, P7167, DOI 10.1016/j.vaccine.2010.08.068; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Draper SJ, 2010, J IMMUNOL, V185, P7583, DOI 10.4049/jimmunol.1001760; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Draper SJ, 2009, CELL HOST MICROBE, V5, P95, DOI 10.1016/j.chom.2008.12.004; Farrance CE, 2011, CLIN VACCINE IMMUNOL, V18, P1351, DOI 10.1128/CVI.05105-11; Farrance CE, 2011, HUM VACCINES, V7, P191, DOI 10.4161/hv.7.0.14588; Forbes EK, 2011, J IMMUNOL, V187, P3738, DOI 10.4049/jimmunol.1003783; Goodman AL, 2010, ANN TROP MED PARASIT, V104, P189, DOI 10.1179/136485910X12647085215534; Goodman AL, 2010, INFECT IMMUN, V78, P4601, DOI 10.1128/IAI.00315-10; Healer J, 1997, INFECT IMMUN, V65, P3017, DOI 10.1128/IAI.65.8.3017-3023.1997; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; KASLOW DC, 1991, SCIENCE, V252, P1310, DOI 10.1126/science.1925544; KASLOW DC, 1988, NATURE, V333, P74, DOI 10.1038/333074a0; Kubler-Kielb J, 2007, P NATL ACAD SCI USA, V104, P293, DOI 10.1073/pnas.0609885104; Kumar KA, 2004, J IMMUNOL METHODS, V292, P157, DOI 10.1016/j.jim.2004.06.017; LeBlanc R, 2008, VACCINE, V26, P185, DOI 10.1016/j.vaccine.2007.10.066; Lobo CA, 1999, INFECT IMMUN, V67, P1688; Malkin EM, 2005, VACCINE, V23, P3131, DOI 10.1016/j.vaccine.2004.12.019; Mambo G, 2008, INFECT IMMUN, V76, P2018, DOI 10.1128/IAI.01409-07; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Miura K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-107; Miyata T, 2011, VACCINE, V29, P2720, DOI 10.1016/j.vaccine.2011.01.083; Mlambo G, 2008, EUKARYOT CELL, V7, P1875, DOI 10.1128/EC.00242-08; Mlambo G, 2010, VACCINE, V28, P7025, DOI 10.1016/j.vaccine.2010.08.022; Outchkourov N, 2007, J BIOL CHEM, V282, P17148, DOI 10.1074/jbc.M700948200; Qian F, 2008, VACCINE, V26, P2521, DOI 10.1016/j.vaccine.2008.03.005; Ramjanee S, 2007, VACCINE, V25, P886, DOI 10.1016/j.vaccine.2006.09.035; Sheehy SH, 2011, MOL THER; Sinden RE, 2002, CELL MICROBIOL, V4, P713, DOI 10.1046/j.1462-5822.2002.00229.x; Sinden RE, 2010, HUM VACCINES, V6, P3, DOI 10.4161/hv.6.1.9604; Stowers A, 2001, EXPERT OPIN BIOL TH, V1, P619, DOI 10.1517/14712598.1.4.619; Tomas AM, 2001, EMBO J, V20, P3975, DOI 10.1093/emboj/20.15.3975; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VERMEULEN AN, 1985, J EXP MED, V162, P1460, DOI 10.1084/jem.162.5.1460; Vincent AA, 1999, PARASITE IMMUNOL, V21, P573, DOI 10.1046/j.1365-3024.1999.00255.x; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wu YM, 2006, P NATL ACAD SCI USA, V103, P18243, DOI 10.1073/pnas.0608545103; Wu YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002636	57	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29428	10.1371/journal.pone.0029428	http://dx.doi.org/10.1371/journal.pone.0029428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216279	Green Submitted, Green Published, gold			2022-12-27	WOS:000300676300059
J	Kalvelage, T; Jensen, MM; Contreras, S; Revsbech, NP; Lam, P; Gunter, M; LaRoche, J; Lavik, G; Kuypers, MMM				Kalvelage, Tim; Jensen, Marlene M.; Contreras, Sergio; Revsbech, Niels Peter; Lam, Phyllis; Guenter, Marcel; LaRoche, Julie; Lavik, Gaute; Kuypers, Marcel M. M.			Oxygen Sensitivity of Anammox and Coupled N-Cycle Processes in Oxygen Minimum Zones	PLOS ONE			English	Article							ANAEROBIC AMMONIUM OXIDATION; NITROUS-OXIDE; AEROBIC DENITRIFICATION; NITRATE REDUCTASES; DEFICIENT WATERS; FRESH-WATER; MARINE; NITRIFICATION; BACTERIAL; INHIBITORS	Nutrient measurements indicate that 30-50% of the total nitrogen (N) loss in the ocean occurs in oxygen minimum zones (OMZs). This pelagic N-removal takes place within only similar to 0.1% of the ocean volume, hence moderate variations in the extent of OMZs due to global warming may have a large impact on the global N-cycle. We examined the effect of oxygen (O-2) on anammox, NH3 oxidation and NO3- reduction in N-15-labeling experiments with varying O-2 concentrations (0-25 mu mol L-1) in the Namibian and Peruvian OMZs. Our results show that O-2 is a major controlling factor for anammox activity in OMZ waters. Based on our O-2 assays we estimate the upper limit for anammox to be similar to 20 mu mol L-1. In contrast, NH3 oxidation to NO2- and NO3- reduction to NO2- as the main NH4+ and NO2- sources for anammox were only moderately affected by changing O-2 concentrations. Intriguingly, aerobic NH3 oxidation was active at non-detectable concentrations of O-2, while anaerobic NO3- reduction was fully active up to at least 25 mu mol L-1 O-2. Hence, aerobic and anaerobic N-cycle pathways in OMZs can co-occur over a larger range of O-2 concentrations than previously assumed. The zone where N-loss can occur is primarily controlled by the O-2(-) sensitivity of anammox itself, and not by any effects of O-2 on the tightly coupled pathways of aerobic NH3 oxidation and NO3- reduction. With anammox bacteria in the marine environment being active at O-2 levels similar to 20 times higher than those known to inhibit their cultured counterparts, the oceanic volume potentially acting as a N-sink increases tenfold. The predicted expansion of OMZs may enlarge this volume even further. Our study provides the first robust estimates of O-2 sensitivities for processes directly and indirectly connected with N-loss. These are essential to assess the effects of ocean de-oxygenation on oceanic N-cycling.	[Kalvelage, Tim; Jensen, Marlene M.; Contreras, Sergio; Lam, Phyllis; Guenter, Marcel; Lavik, Gaute; Kuypers, Marcel M. M.] Max Planck Inst Marine Microbiol, Dept Biogeochem, Bremen, Germany; [Revsbech, Niels Peter] Univ Aarhus, Dept Biol Sci, DK-8000 Aarhus C, Denmark; [LaRoche, Julie] Leibniz Inst Marine Sci IFM GEOMAR, Dept Marine Biogeochem, Kiel, Germany	Max Planck Society; Aarhus University; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Kalvelage, T (corresponding author), Max Planck Inst Marine Microbiol, Dept Biogeochem, Bremen, Germany.	tkalvela@mpi-bremen.de	Contreras, Sergio/I-1858-2014; Lavik, Gaute/F-6578-2013; LaRoche, Julie/A-1109-2010; Revsbech, Niels P/I-8040-2013; Lam, Phyllis/D-9574-2011	Contreras, Sergio/0000-0001-7192-6810; Lam, Phyllis/0000-0003-2067-171X; Revsbech, Niels Peter/0000-0002-2193-262X; LaRoche, Julie/0000-0003-4809-6411; Jensen, Marlene Mark/0000-0002-9711-763X	Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 754]; European Research Council [267233]; Danish Council for Independent Research: Natural Sciences [10-083140]	Max-Planck-Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Danish Council for Independent Research: Natural Sciences(Det Frie Forskningsrad (DFF))	The study was funded by the Max-Planck-Gesellschaft (www.mpg.de), Deutsche Forschungsgemeinschaft (DFG) (www.dfg.de), the DFG-funded Sonderforschungsbereich 754 "Climate-Biogeochemistry Interactions in the Tropical Ocean" (www.sfb754.de), the European Research Council, grant 267233 (www.erc.europa.eu) and the Danish Council for Independent Research: Natural Sciences, grant 10-083140 (http://en.fi.dk/councils-commissions/the-danish-council-for-independent-research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDARD C, 1989, MICROBIOL REV, V53, P68; Bohlen L, 2011, GEOCHIM COSMOCHIM AC, V75, P6094, DOI 10.1016/j.gca.2011.08.010; CARLUCCI AF, 1969, LIMNOL OCEANOGR, V14, P736, DOI 10.4319/lo.1969.14.5.0736; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; CHAPMAN P, 1985, OCEANOGR MAR BIOL, V23, P183; CLINE JD, 1972, LIMNOL OCEANOGR, V17, P885, DOI 10.4319/lo.1972.17.6.0885; CODISPOTI LA, 1980, J MAR RES, V38, P453; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; COYNE MS, 1990, FEMS MICROBIOL ECOL, V73, P263, DOI 10.1016/0378-1097(90)90738-C; Dalsgaard T, 2003, NATURE, V422, P606, DOI 10.1038/nature01526; Deutsch C, 2011, SCIENCE, V333, P336, DOI 10.1126/science.1202422; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fuenzalida R, 2009, DEEP-SEA RES PT II, V56, P1027, DOI 10.1016/j.dsr2.2008.11.001; Fussel J, 2011, ISME J IN PRESS; Galan A, 2009, DEEP-SEA RES PT II, V56, P1125, DOI 10.1016/j.dsr2.2008.09.016; Gao H, 2010, ISME J, V4, P417, DOI 10.1038/ismej.2009.127; Gonzalez PJ, 2006, J INORG BIOCHEM, V100, P1015, DOI 10.1016/j.jinorgbio.2005.11.024; GOREAU TJ, 1980, APPL ENVIRON MICROB, V40, P526, DOI 10.1128/AEM.40.3.526-532.1980; Granger J, 2006, LIMNOL OCEANOGR-METH, V4, P205, DOI 10.4319/lom.2006.4.205; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; GUNDERSEN K, 1966, J GEN MICROBIOL, V42, P387, DOI 10.1099/00221287-42-3-387; HALL GH, 1984, MICROB ECOL, V10, P25, DOI 10.1007/BF02011592; HALL GH, 1984, MICROB ECOL, V10, P37, DOI 10.1007/BF02011593; Hamersley MR, 2007, LIMNOL OCEANOGR, V52, P923, DOI 10.4319/lo.2007.52.3.0923; Hansen H.P., 2007, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984, DOI 10.1002/9783527613984.CH10]; Hartsock A, 2011, J BACTERIOL, V193, P6483, DOI 10.1128/JB.05324-11; Helly JJ, 2004, DEEP-SEA RES PT I, V51, P1159, DOI 10.1016/j.dsr.2004.03.009; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Holtappels M, 2011, METHOD ENZYMOL, V486, P223, DOI [10.1016/S0076-6879(11)86010-6, 10.1016/B978-0-12-381294-0.00010-9]; Jensen MM, 2008, LIMNOL OCEANOGR, V53, P23, DOI 10.4319/lo.2008.53.1.0023; Jensen MM, 2007, APPL ENVIRON MICROB, V73, P3151, DOI 10.1128/AEM.01898-06; KAMYKOWSKI D, 1990, DEEP-SEA RES, V37, P1861, DOI 10.1016/0198-0149(90)90082-7; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; KORNER H, 1989, APPL ENVIRON MICROB, V55, P1670; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Lam P, 2011, BIOGEOSCIENCES, V8, P1565, DOI 10.5194/bg-8-1565-2011; Lam P, 2007, P NATL ACAD SCI USA, V104, P7104, DOI 10.1073/pnas.0611081104; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Lavik G, 2009, NATURE, V457, P581, DOI 10.1038/nature07588; LIPSCHULTZ F, 1990, DEEP-SEA RES, V37, P1513, DOI 10.1016/0198-0149(90)90060-9; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; McIlvin MR, 2005, ANAL CHEM, V77, P5589, DOI 10.1021/ac050528s; MCKENNEY DJ, 1994, SOIL BIOL BIOCHEM, V26, P901, DOI 10.1016/0038-0717(94)90306-9; Molina V, 2009, DEEP-SEA RES PT II, V56, P1009, DOI 10.1016/j.dsr2.2008.09.006; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; Nicholls JC, 2007, LIMNOL OCEANOGR, V52, P156, DOI 10.4319/lo.2007.52.1.0156; Paulmier A, 2009, BIOGEOSCIENCES, V6, P923, DOI 10.5194/bg-6-923-2009; Ploug H, 2001, LIMNOL OCEANOGR, V46, P1624, DOI 10.4319/lo.2001.46.7.1624; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; ROBERTSON LA, 1984, ARCH MICROBIOL, V139, P351, DOI 10.1007/BF00408378; ROBERTSON LA, 1995, FEMS MICROBIOL ECOL, V18, P113, DOI 10.1111/j.1574-6941.1995.tb00168.x; Schmidt I, 1997, ARCH MICROBIOL, V167, P106, DOI 10.1007/s002030050422; SMETHIE WM, 1987, DEEP-SEA RES, V34, P983, DOI 10.1016/0198-0149(87)90049-5; Stolper DA, 2010, P NATL ACAD SCI USA, V107, P18755, DOI 10.1073/pnas.1013435107; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Strous M, 1997, APPL ENVIRON MICROB, V63, P2446, DOI 10.1128/AEM.63.6.2446-2448.1997; Thamdrup B, 2006, LIMNOL OCEANOGR, V51, P2145, DOI 10.4319/lo.2006.51.5.2145; WARD BB, 1988, DEEP-SEA RES, V35, P1127, DOI 10.1016/0198-0149(88)90005-2; WARD BB, 1989, DEEP-SEA RES, V36, P1031, DOI 10.1016/0198-0149(89)90076-9; Woebken D, 2007, APPL ENVIRON MICROB, V73, P4648, DOI 10.1128/AEM.02774-06; WYRTKI K, 1962, DEEP-SEA RES, V9, P11, DOI 10.1016/0011-7471(62)90243-7; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	67	179	185	6	152	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29299	10.1371/journal.pone.0029299	http://dx.doi.org/10.1371/journal.pone.0029299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216239	Green Published, gold, Green Accepted			2022-12-27	WOS:000300676300043
J	Zaller, JG; Heigl, F; Grabmaier, A; Lichtenegger, C; Piller, K; Allabashi, R; Frank, T; Drapela, T				Zaller, Johann G.; Heigl, Florian; Grabmaier, Andrea; Lichtenegger, Claudia; Piller, Katja; Allabashi, Roza; Frank, Thomas; Drapela, Thomas			Earthworm-Mycorrhiza Interactions Can Affect the Diversity, Structure and Functioning of Establishing Model Grassland Communities	PLOS ONE			English	Article							PLANT BIOMASS PRODUCTION; TIERRA-DEL-FUEGO; LUMBRICUS-TERRESTRIS; ARBUSCULAR MYCORRHIZAE; CALCAREOUS GRASSLAND; WATER INFILTRATION; FEN ECOSYSTEM; ELEVATED CO2; SOIL; FUNGI	Both earthworms and arbuscular mycorrhizal fungi (AMF) are important ecosystem engineers co-occurring in temperate grasslands. However, their combined impacts during grassland establishment are poorly understood and have never been studied. We used large mesocosms to study the effects of different functional groups of earthworms (i.e., vertically burrowing anecics vs. horizontally burrowing endogeics) and a mix of four AMF taxa on the establishment, diversity and productivity of plant communities after a simulated seed rain of 18 grassland species comprising grasses, non-leguminous forbs and legumes. Moreover, effects of earthworms and/or AMF on water infiltration and leaching of ammonium, nitrate and phosphate were determined after a simulated extreme rainfall event (40 l m 22). AMF colonisation of all three plant functional groups was altered by earthworms. Seedling emergence and diversity was reduced by anecic earthworms, however only when AMF were present. Plant density was decreased in AMF-free mesocosms when both anecic and endogeic earthworms were active; with AMF also anecics reduced plant density. Plant shoot and root biomass was only affected by earthworms in AMF-free mesocosms: shoot biomass increased due to the activity of either anecics or endogeics; root biomass increased only when anecics were active. Water infiltration increased when earthworms were present in the mesocosms but remained unaffected by AMF. Ammonium leaching was increased only when anecics or a mixed earthworm community was active but was unaffected by AMF; nitrate and phosphate leaching was neither affected by earthworms nor AMF. Ammonium leaching decreased with increasing plant density, nitrate leaching decreased with increasing plant diversity and density. In order to understand the underlying processes of these interactions further investigations possibly under field conditions using more diverse belowground communities are required. Nevertheless, this study demonstrates that belowground-aboveground linkages involving earthworms and AMF are important mediators of the diversity, structure and functioning of plant communities.	[Zaller, Johann G.; Heigl, Florian; Grabmaier, Andrea; Lichtenegger, Claudia; Piller, Katja; Frank, Thomas; Drapela, Thomas] Univ Nat Resources & Life Sci Vienna, Inst Zool, Dept Integrat Biol & Biodivers Res, Vienna, Austria; [Allabashi, Roza] Univ Nat Resources & Life Sci Vienna, Inst Sanit Engn & Water Pollut Control, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Zaller, JG (corresponding author), Univ Nat Resources & Life Sci Vienna, Inst Zool, Dept Integrat Biol & Biodivers Res, Vienna, Austria.	johann.zaller@boku.ac.at	Heigl, Florian/W-9142-2019; Zaller, Johann G./AFE-0349-2022; Zaller, Johann G/A-9914-2009	Heigl, Florian/0000-0002-0083-4908; Zaller, Johann G./0000-0001-7744-7378; Zaller, Johann G/0000-0001-7744-7378	Austrian Science Fund (FWF) [P20171-B16]; Austrian Science Fund (FWF) [P 20171] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by the Austrian Science Fund (FWF), project no. P20171-B16 (www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aira M, 2009, APPL SOIL ECOL, V41, P360, DOI 10.1016/j.apsoil.2008.11.007; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Bardgett RD, 2001, ECOSYSTEMS, V4, P421, DOI 10.1007/s10021-001-0020-5; Bastardie F, 2003, APPL SOIL ECOL, V24, P3, DOI 10.1016/S0929-1393(03)00071-4; BOHLEN PJ, 1995, SOIL BIOL BIOCHEM, V27, P341, DOI 10.1016/0038-0717(94)00184-3; Bonkowski M, 2000, PEDOBIOLOGIA, V44, P666, DOI 10.1078/S0031-4056(04)70080-3; Bouche MB, 1997, SOIL BIOL BIOCHEM, V29, P441, DOI 10.1016/S0038-0717(96)00272-6; Bouche MB, 1977, ECOL B STOCKHOLM, V25, P122, DOI DOI 10.2307/20112572; Cameron DD, 2010, PLANT SOIL, V333, P1, DOI 10.1007/s11104-010-0361-y; Capowiez Y, 2000, BIOL FERT SOILS, V31, P494, DOI 10.1007/s003740000198; Curry JP, 2007, PEDOBIOLOGIA, V50, P463, DOI 10.1016/j.pedobi.2006.09.001; Decaens T, 2008, APPL SOIL ECOL, V39, P321, DOI 10.1016/j.apsoil.2008.01.007; Dijkstra FA, 2007, ECOLOGY, V88, P490, DOI 10.1890/06-0733; Dominguez J, 2004, ECOSYSTEMS, V7, P672, DOI 10.1007/s10021-004-0150-7; Edwards CA, 1996, BIOL ECOLOGY EARTHWO, DOI DOI 10.1016/S0167-8809(97)88859-7; Eisenhauer N, 2008, SOIL BIOL BIOCHEM, V40, P2650, DOI 10.1016/j.soilbio.2008.07.010; Eisenhauer N, 2010, PEDOBIOLOGIA, V53, P343, DOI 10.1016/j.pedobi.2010.04.003; Eisenhauer N, 2010, SOIL BIOL BIOCHEM, V42, P1418, DOI 10.1016/j.soilbio.2010.05.001; Eisenhauer N, 2010, SOIL BIOL BIOCHEM, V42, P1245, DOI 10.1016/j.soilbio.2010.04.012; Eisenhauer N, 2009, OECOLOGIA, V161, P291, DOI 10.1007/s00442-009-1374-1; Eisenhauer N, 2009, SOIL BIOL BIOCHEM, V41, P561, DOI 10.1016/j.soilbio.2008.12.017; Ellenberg H., 1986, VEGETATION MITTELEUR, V4th ed.; Ernst G, 2009, EUR J SOIL BIOL, V45, P207, DOI 10.1016/j.ejsobi.2009.01.001; GANGE AC, 1993, SOIL BIOL BIOCHEM, V25, P1021, DOI 10.1016/0038-0717(93)90149-6; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gormsen D, 2004, APPL SOIL ECOL, V27, P211, DOI 10.1016/j.apsoil.2004.06.001; GRIME JP, 1987, NATURE, V328, P420, DOI 10.1038/328420a0; Hartnett DC, 1999, ECOLOGY, V80, P1187, DOI 10.1890/0012-9658(1999)080[1187:MIPCSA]2.0.CO;2; Heiner B, 2011, PEDOBIOLOGIA, V54, P169, DOI 10.1016/j.pedobi.2011.02.002; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; IPCC, 2007, CLIM CHANG 2007 PHYS; Jegou D, 1999, BIOL FERT SOILS, V29, P314, DOI 10.1007/s003740050558; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Klironomos JN, 2000, ECOL LETT, V3, P137, DOI 10.1046/j.1461-0248.2000.00131.x; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Kreuzer K, 2004, SOIL BIOL BIOCHEM, V36, P2005, DOI 10.1016/j.soilbio.2004.05.019; Laossi KR, 2008, PEDOBIOLOGIA, V51, P397, DOI 10.1016/j.pedobi.2007.11.001; Laossi KR, 2011, PEDOBIOLOGIA, V54, P127, DOI 10.1016/j.pedobi.2010.12.001; Laossi KR, 2010, PLANT SOIL, V328, P109, DOI 10.1007/s11104-009-0086-y; LAVELLE P, 1988, BIOL FERT SOILS, V6, P237, DOI 10.1007/BF00260820; Le Bayon RC, 2006, SOIL BIOL BIOCHEM, V38, P235, DOI 10.1016/j.soilbio.2005.05.013; Lee KK, 1996, APPL SOIL ECOL, V3, P177, DOI 10.1016/0929-1393(95)00082-8; Leishman MR, 2001, OIKOS, V93, P294, DOI 10.1034/j.1600-0706.2001.930212.x; Ma Y, 2006, SOIL BIOL BIOCHEM, V38, P1403, DOI 10.1016/j.soilbio.2005.10.016; MCKENZIE BM, 1993, GEODERMA, V56, P233, DOI 10.1016/0016-7061(93)90113-Y; Milcu A, 2006, FUNCT ECOL, V20, P261, DOI 10.1111/j.1365-2435.2006.01098.x; Milleret R, 2009, PLANT SOIL, V316, P1, DOI 10.1007/s11104-008-9753-7; Monard C, 2008, APPL ENVIRON MICROB, V74, P5589, DOI 10.1128/AEM.00333-08; Niklaus PA, 2001, OECOLOGIA, V127, P540, DOI 10.1007/s004420000612; Ortiz-Ceballos AI, 2007, BIOL FERT SOILS, V44, P181, DOI 10.1007/s00374-007-0193-y; PIEARCE TG, 1994, J BIOL EDUC, V28, P195, DOI 10.1080/00219266.1994.9655392; Putz B, 2011, METHODS ECOL EVOL, V2, P326, DOI 10.1111/j.2041-210X.2010.00072.x; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; REDDELL P, 1991, SOIL BIOL BIOCHEM, V23, P767, DOI 10.1016/0038-0717(91)90147-C; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Scherer-Lorenzen M, 2003, ECOLOGY, V84, P1539, DOI 10.1890/0012-9658(2003)084[1539:TROPDA]2.0.CO;2; Scheu S, 2003, PEDOBIOLOGIA, V47, P846, DOI 10.1016/s0031-4056(04)70279-6; SHIPITALO MJ, 1994, J ENVIRON QUAL, V23, P1345, DOI 10.2134/jeq1994.00472425002300060031x; Shipitalo MJ, 1999, PEDOBIOLOGIA, V43, P782; Spehn EM, 2000, PLANT SOIL, V224, P217, DOI 10.1023/A:1004891807664; THOMPSON K, 1994, FUNCT ECOL, V8, P29, DOI 10.2307/2390108; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 2010, ECOLOGY, V91, P1163, DOI 10.1890/09-0336.1; van der Heijden MGA, 2004, ECOL LETT, V7, P293, DOI 10.1111/j.1461-0248.2004.00577.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; WILLEMS JH, 1994, ECOGRAPHY, V17, P124, DOI 10.1111/j.1600-0587.1994.tb00084.x; Willoughby GL, 2002, J SOIL WATER CONSERV, V57, P82; WOLTERS V, 1992, SOIL BIOL BIOCHEM, V24, P171, DOI 10.1016/0038-0717(92)90274-2; Wurst S, 2005, PLANT SOIL, V271, P123, DOI 10.1007/s11104-004-2201-4; Wurst S, 2004, NEW PHYTOL, V163, P169, DOI 10.1111/j.1469-8137.2004.01106.x; Yu XZ, 2005, SOIL BIOL BIOCHEM, V37, P195, DOI 10.1016/j.soilbio.2004.07.029; Zaller JG, 2011, PLANT SOIL ENVIRON, V57, P499, DOI 10.17221/189/2011-PSE; Zaller JG, 1999, ECOLOGY, V80, P873; Zaller JG, 1999, PLANT SOIL, V208, P1, DOI 10.1023/A:1004424720523; Zaller JG, 1999, SOIL BIOL BIOCHEM, V31, P517, DOI 10.1016/S0038-0717(98)00126-6; Zaller JG, 2002, GLOBAL CHANGE BIOL, V8, P867, DOI 10.1046/j.1365-2486.2002.00524.x; Zaller JG, 1997, OECOLOGIA, V111, P249, DOI 10.1007/PL00008817; Zaller JG, 2007, EUR J SOIL BIOL, V43, pS86, DOI 10.1016/j.ejsobi.2007.08.010; Zaller JG, 2011, EUR J SOIL BIOL, V47, P175, DOI 10.1016/j.ejsobi.2011.03.001; Zaller JG, 2009, GLOBAL CHANGE BIOL, V15, P2493, DOI 10.1111/j.1365-2486.2009.01970.x; Zar, 2011, BIOSTAT ANAL; Zarea MJ, 2009, PEDOBIOLOGIA, V52, P223, DOI 10.1016/j.pedobi.2008.10.004	85	34	35	3	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29293	10.1371/journal.pone.0029293	http://dx.doi.org/10.1371/journal.pone.0029293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216236	Green Submitted, gold, Green Published			2022-12-27	WOS:000300676300042
J	Zhang, YH; Zhou, CJ; Zhou, ZR; Song, AX; Hu, HY				Zhang, Yu-Hang; Zhou, Chen-Jie; Zhou, Zi-Ren; Song, Ai-Xin; Hu, Hong-Yu			Domain Analysis Reveals That a Deubiquitinating Enzyme USP13 Performs Non-Activating Catalysis for Lys63-Linked Polyubiquitin	PLOS ONE			English	Article							UBIQUITIN-BINDING DOMAINS; ISOPEPTIDASE-T; PROTEIN-DEGRADATION; ENDOPLASMIC-RETICULUM; CHAINS; PROTEASOME; ZINC; UBP; RECOGNITION; MECHANISM	Deubiquitination is a reverse process of cellular ubiquitination important for many biological events. Ubiquitin (Ub)-specific protease 13 (USP13) is an ortholog of USP5 implicated in catalyzing hydrolysis of various Ub chains, but its enzymatic properties and catalytic regulation remain to be explored. Here we report studies of the roles of the Ub-binding domains of USP13 in regulatory catalysis by biochemical and NMR structural approaches. Our data demonstrate that USP13, distinct from USP5, exhibits a weak deubiquitinating activity preferring to Lys63-linked polyubiquitin (K63-polyUb) in a non-activation manner. The zinc finger (ZnF) domain of USP13 shares a similar fold with that of USP5, but it cannot bind with Ub, so that USP13 has lost its ability to be activated by free Ub. Substitution of the ZnF domain with that of USP5 confers USP13 the property of catalytic activation. The tandem Ub-associated (UBA) domains of USP13 can bind with different types of diUb but preferentially with K63-linked, providing a possible explanation for the weak activity preferring to K63-polyUb. USP13 can also regulate the protein level of CD3 delta in cells, probably depending on its weak deubiquitinating activity and the Ub-binding properties of the UBA domains. Thus, the non-activating catalysis of USP13 for K63-polyUb chains implies that it may function differently from USP5 in cellular deubiquitination processes.	[Zhang, Yu-Hang; Zhou, Chen-Jie; Zhou, Zi-Ren; Song, Ai-Xin; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhang, YH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China.	hyhu@sibs.ac.cn	Hu, Hong-Yu/AAQ-2633-2020; Chou, Steven Ziren/M-1995-2014		National Natural Science Foundation of China [30870485, 10979070]; Sino Swiss Science and Technology Cooperation Program [GJHZ0909]; National Basic Research Program of China [2011CB911100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sino Swiss Science and Technology Cooperation Program; National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the grants from the National Natural Science Foundation of China (30870485, 10979070), the Sino Swiss Science and Technology Cooperation Program (GJHZ0909), and the National Basic Research Program of China (2011CB911100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2007, PROTEIN SCI, V16, P2072, DOI 10.1110/ps.072967807; Amerik AY, 1997, EMBO J, V16, P4826; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Bonnet J, 2008, TRENDS BIOCHEM SCI, V33, P369, DOI 10.1016/j.tibs.2008.05.005; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000679; Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Dayal S, 2009, J BIOL CHEM, V284, P5030, DOI 10.1074/jbc.M805871200; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Fontaine JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007632; Gabriel JM, 2002, BIOCHEMISTRY-US, V41, P13755, DOI 10.1021/bi026096m; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; HADARI T, 1992, J BIOL CHEM, V267, P719; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hochstrasser M, 1996, CELL, V84, P813, DOI 10.1016/S0092-8674(00)81058-2; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Luna-Vargas MPA, 2011, EMBO REP, V12, P365, DOI 10.1038/embor.2011.33; McElhinny AS, 2002, J CELL BIOL, V157, P125, DOI 10.1083/jcb.200108089; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Pai MT, 2007, J MOL BIOL, V370, P290, DOI 10.1016/j.jmb.2007.04.015; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Raasi Shahri, 2005, V301, P47; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; Scortegagna M, 2011, J BIOL CHEM, V286, P27333, DOI 10.1074/jbc.M111.218214; Song AX, 2010, PROTEIN SCI, V19, P1104, DOI 10.1002/pro.386; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; STEIN RL, 1995, BIOCHEMISTRY-US, V34, P12616, DOI 10.1021/bi00039a017; Timms KM, 1998, GENE, V217, P101, DOI 10.1016/S0378-1119(98)00341-2; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wilkinson KD, 2009, J CELL SCI, V122, P2325, DOI 10.1242/jcs.041046; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Ye Y, 2009, MOL BIOSYST, V5, P1797, DOI 10.1039/b907669g; Zhao XS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1421; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	50	19	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29362	10.1371/journal.pone.0029362	http://dx.doi.org/10.1371/journal.pone.0029362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216260	Green Submitted, gold, Green Published			2022-12-27	WOS:000300676300050
J	Fang, F; Chen, HL; Wirdefeldt, K; Ronnevi, LO; Al-Chalabi, A; Peters, TL; Kamel, F; Ye, WM				Fang, Fang; Chen, Honglei; Wirdefeldt, Karin; Ronnevi, Lars-Olof; Al-Chalabi, Ammar; Peters, Tracy L.; Kamel, Freya; Ye, Weimin			Infection of the Central Nervous System, Sepsis and Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MOTOR-NEURON DISEASE; INFLAMMATORY RESPONSE; UNITED-STATES; ALS PATIENTS; SPINAL-CORD; DEATH; MORTALITY; NEURODEGENERATION; PROGRESSION; MICROGLIA	Background: Severe infections may lead to chronic inflammation in the central nervous system (CNS) which may in turn play a role in the etiopathogenesis of amyotrophic lateral sclerosis (ALS). The relentless progression and invasive supportive treatments of ALS may on the other hand induce severe infections among ALS patients. Methodology and Principal Findings: The present study included 4,004 ALS patients identified from the Swedish Patient Register during 1991-2007 and 20,020 age and sex matched general population controls. Conditional logistic regression was used to estimate the odds ratios (ORs) of ALS given a previous hospitalization for CNS infection or sepsis. Cox models were used to estimate the hazard ratios (HRs) of hospitalization for CNS infection or sepsis after ALS diagnosis. Overall, previous CNS infection (OR: 1.3, 95% confidence interval [CI]: 0.8, 2.4) or sepsis (OR: 1.2, 95% CI: 0.9, 1.6) was not associated with ALS risk. However, compared to ALS free individuals, ALS cases were more likely to be hospitalized for sepsis after diagnosis (HR: 2.6, 95% CI: 1.9, 3.5). We did not observe a higher risk of CNS infection after ALS diagnosis. Conclusions/Significance: Our results suggest that acute and severe infections unlikely contribute to the development of ALS; however, ALS patients are at a higher risk of sepsis after diagnosis, compared to ALS free individuals.	[Fang, Fang; Wirdefeldt, Karin; Peters, Tracy L.; Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Chen, Honglei; Kamel, Freya] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; [Wirdefeldt, Karin; Ronnevi, Lars-Olof] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Al-Chalabi, Ammar] Kings Coll London, MRC Ctr Neurodegenerat Res, Inst Psychiat, London, England	Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Karolinska Institutet; University of London; King's College London	Fang, F (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	fang.fang@ki.se	Al-Chalabi, Ammar/E-5361-2010	Al-Chalabi, Ammar/0000-0002-4924-7712; Chen, Honglei/0000-0003-3446-7779; Kamel, Freya/0000-0001-5052-6615; ye, weimin/0000-0002-6859-4648; Fang, Fang/0000-0002-3310-6456	Swedish Research Council (SIMSAM) [80748301]; Hjarnfonden; Svenska Sallskapet for Medicinsk Forskning (SSMF); National Institutes of Health, the National Institute of Environmental Health Sciences of the United States; European Community [FP7/2007-2013, 259867]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049005] Funding Source: NIH RePORTER	Swedish Research Council (SIMSAM)(Swedish Research Council); Hjarnfonden; Svenska Sallskapet for Medicinsk Forskning (SSMF); National Institutes of Health, the National Institute of Environmental Health Sciences of the United States; European Community(European Commission); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Swedish Research Council (SIMSAM grant number 80748301). Drs. Fang Fang and Karin Wirdefeldt were supported by Hjarnfonden and the Svenska Sallskapet for Medicinsk Forskning (SSMF). Drs. Honglei Chen and Freya Kamel were supported by the intramural research program of National Institutes of Health, the National Institute of Environmental Health Sciences of the United States. We also thank the NIHR specialist Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust (SLaM) and the Institute of Psychiatry, King's College London. The research leading to these results also received funding from the European Community's Health Seventh Framework Programme (FP7/2007-2013) under grant agreement no 259867. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 2010, J NEUROL NEUROSUR PS, V81, P1324, DOI 10.1136/jnnp.2010.207464; Al-Chalabi A, 2011, HUM HERED, V71, P281, DOI 10.1159/000330167; Andersen PM, 2011, NAT REV NEUROL; ANDERSSON PB, 1992, NEUROSCIENCE, V48, P169, DOI 10.1016/0306-4522(92)90347-5; Berger MM, 2000, NEUROLOGY, V54, P20, DOI 10.1212/WNL.54.1.20; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Corcia P, 2008, AMYOTROPH LATERAL SC, V9, P59, DOI 10.1080/17482960701656940; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Dunn N, 2005, ALZ DIS ASSOC DIS, V19, P91, DOI 10.1097/01.wad.0000165511.52746.1f; Ebert S, 2010, J NEUROSCI RES, V88, P1124, DOI 10.1002/jnr.22270; Gedeborg R, 2007, J CLIN EPIDEMIOL, V60, P155, DOI 10.1016/j.jclinepi.2006.05.013; Gil J, 2008, EUR J NEUROL, V15, P1245, DOI 10.1111/j.1468-1331.2008.02307.x; Giraud P, 2001, NEUROLOGY, V56, P1777, DOI 10.1212/WNL.56.12.1777; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Holmes C, 2003, J NEUROL NEUROSUR PS, V74, P788, DOI 10.1136/jnnp.74.6.788; JOKELAINEN M, 1976, J NEUROL SCI, V29, P55, DOI 10.1016/0022-510X(76)90080-0; JUBELT B, 1992, CURR OPIN NEUROL NEU, V5, P655; Kurian KM, 2009, J NEUROL NEUROSUR PS, V80, P84, DOI 10.1136/jnnp.2008.149708; LEONE M, 1987, NEUROLOGY, V37, P1339, DOI 10.1212/WNL.37.8.1339; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; SalazarGrueso EF, 1996, CLIN NEUROSCI, V3, P360; Sejvar JJ, 2005, NEUROEPIDEMIOLOGY, V25, P144, DOI 10.1159/000086679; TROOST D, 1990, NEUROPATH APPL NEURO, V16, P401, DOI 10.1111/j.1365-2990.1990.tb01276.x; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919	29	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29749	10.1371/journal.pone.0029749	http://dx.doi.org/10.1371/journal.pone.0029749			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216353	Green Submitted, gold, Green Published			2022-12-27	WOS:000300674900058
J	Zhang, Y; Heermann, DW				Zhang, Yang; Heermann, Dieter W.			Loops Determine the Mechanical Properties of Mitotic Chromosomes	PLOS ONE			English	Article							HIGHER-ORDER STRUCTURE; TOPOISOMERASE-II; CHROMATIN; ELASTICITY; MODEL; VISUALIZATION; CONDENSIN; DYNAMICS; LENGTH	We introduce a new polymer model for mitotic chromosomes. The key assumption of the model is the ability of the chromatin fibre to cross-link to itself due to binding proteins. These protein-chromatin interactions are included by a probabilistic and dynamic mechanism. The hypothesis is motivated by the observation of high repulsive forces between ring polymers. We performed computer simulations to validate our model. Our results show that the presence of loops leads to a tight compaction and contributes significantly to the bending rigidity of chromosomes. Moreover, our qualitative prediction of the force elongation behaviour is close to experimental findings. The Dynamic Loop Model presented here indicates that the internal structure of mitotic chromosomes is based on self-organization of the chromatin fibre rather than attachment of chromatin to a protein scaffold. It also shows that the number and size of loops have a strong influence on the mechanical properties. We suggest that changes in the mechanical characteristics of chromosomes in different stages of the cell cycle, for example, can be explained by an altered internal loop structure.	[Zhang, Yang; Heermann, Dieter W.] Heidelberg Univ, Inst Theoret Phys, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Zhang, Y (corresponding author), Heidelberg Univ, Inst Theoret Phys, Heidelberg, Germany.	y.zhang@tphys.uni-heidelberg.de			Institute for Theoretical Physics of the Heidelberg University; Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences (HGS MathComp)	Institute for Theoretical Physics of the Heidelberg University; Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences (HGS MathComp)	YZ appreciates partial support by the Institute for Theoretical Physics of the Heidelberg University and the Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences (HGS MathComp). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro S, 2004, J BIOL CHEM, V279, P5118, DOI 10.1074/jbc.M307221200; BAK AL, 1977, P NATL ACAD SCI USA, V74, P1595, DOI 10.1073/pnas.74.4.1595; Belmont AS, 2006, CURR OPIN CELL BIOL, V18, P632, DOI 10.1016/j.ceb.2006.09.007; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; Belmont AS, 2002, P NATL ACAD SCI USA, V99, P15855, DOI 10.1073/pnas.262672799; Bohn M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051805; Bohn M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012218; Bohn M, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3302812; Bruce A., 2002, MOL BIOL CELL, V4th ed.; CARMESIN I, 1988, MACROMOLECULES, V21, P2819, DOI 10.1021/ma00187a030; Chiu A, 2004, J BIOL CHEM, V279, P26233, DOI 10.1074/jbc.M402439200; Christensen MO, 2002, J CELL BIOL, V157, P31, DOI 10.1083/jcb.200112023; CLAUSSEN U, 1994, CYTOGENET CELL GENET, V66, P120, DOI 10.1159/000133681; Cocco S, 2003, EUR PHYS J E, V10, P249, DOI 10.1140/epje/i2002-10113-2; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DEUTSCH HP, 1991, J CHEM PHYS, V94, P2294, DOI 10.1063/1.459901; EARNSHAW WC, 1985, J CELL BIOL, V100, P1706, DOI 10.1083/jcb.100.5.1706; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Fraser P, 2006, CURR OPIN GENET DEV, V16, P490, DOI 10.1016/j.gde.2006.08.002; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Houchmandzadeh B, 1997, J CELL BIOL, V139, P1, DOI 10.1083/jcb.139.1.1; Houchmandzadeh B, 1999, J CELL BIOL, V145, P215, DOI 10.1083/jcb.145.2.215; Kawamura R, 2010, J CELL BIOL, V188, P653, DOI 10.1083/jcb.200910085; Kireeva N, 2004, J CELL BIOL, V166, P775, DOI 10.1083/jcb.200406049; Landau L.D., 1948, COURSE THEORETICAL P, P207, DOI 10.1016/B978-0-08-010586-4.50070-5; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Marko JF, 2003, BIOCHEM CELL BIOL, V81, P209, DOI 10.1139/o03-047; Marko JF, 1997, MOL BIOL CELL, V8, P2217, DOI 10.1091/mbc.8.11.2217; Marko JF, 2008, CHROMOSOME RES, V16, P469, DOI 10.1007/s10577-008-1233-7; Marko JF, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051905; MARSDEN MPF, 1979, CELL, V17, P849, DOI 10.1016/0092-8674(79)90325-8; Marshall WF, 2001, CURR BIOL, V11, P569, DOI 10.1016/S0960-9822(01)00180-4; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; MICHELI G, 1993, CHROMOSOMA, V102, P478, DOI 10.1007/BF00357103; Oliveira RA, 2007, CHROMOSOMA, V116, P259, DOI 10.1007/s00412-007-0097-5; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Poirier M, 2000, MOL BIOL CELL, V11, P269, DOI 10.1091/mbc.11.1.269; Poirier MG, 2002, P NATL ACAD SCI USA, V99, P15393, DOI 10.1073/pnas.232442599; Poirier MG, 2002, MOL BIOL CELL, V13, P2170, DOI 10.1091/mbc.01-08-0401; Poirier MG, 2001, PHYS REV LETT, V86, P360, DOI 10.1103/PhysRevLett.86.360; Pope LH, 2006, MOL BIOL CELL, V17, P104, DOI 10.1091/mbc.e05-04-0321; Sakai A, 2003, EMBO J, V22, P2764, DOI 10.1093/emboj/cdg247; SEDAT J, 1977, COLD SPRING HARB SYM, V42, P331, DOI 10.1101/SQB.1978.042.01.035; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Sokal A, MONTE CARLO METHODS; Strobl G, 1997, PHYS POLYM, VXI; Strukov YG, 2003, J CELL BIOL, V162, P23, DOI 10.1083/jcb.200303098; Sun MX, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015003; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; vanHolde K, 1996, P NATL ACAD SCI USA, V93, P10548, DOI 10.1073/pnas.93.20.10548; WILLIAMS SP, 1986, BIOPHYS J, V49, P233, DOI 10.1016/S0006-3495(86)83637-2; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6	53	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29225	10.1371/journal.pone.0029225	http://dx.doi.org/10.1371/journal.pone.0029225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216220	Green Published, gold, Green Submitted			2022-12-27	WOS:000300674900021
J	Coll, RC; O'Neill, LAJ				Coll, Rebecca C.; O'Neill, Luke A. J.			The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes	PLOS ONE			English	Article							TRANSFERASE OMEGA 1-1; SPECK-LIKE PROTEIN; CELL-DEATH; NALP3 INFLAMMASOME; INDEPENDENT ROLE; CYTOPLASMIC DNA; CARD ASC; ACTIVATION; CASPASE-1; IDENTIFICATION	Background: The Inflammasomes are multi-protein complexes that regulate caspase-1 activation and the production of the pro-inflammatory cytokine IL-1 beta. Previous studies identified a class of diarylsulfonylurea containing compounds called Cytokine Release Inhibitory Drugs (CRIDs) that inhibited the post-translational processing of IL-1 beta. Further work identified Glutathione S-Transferase Omega 1 (GSTO1) as a possible target of these CRIDs. This study aimed to investigate the mechanism of the inhibitory activity of the CRID CP-456,773 (termed CRID3) in light of recent advances in the area of inflammasome activation, and to clarify the potential role of GSTO1 in the regulation of IL-1 beta production. Methodology and Results: In murine bone marrow derived macrophages, CRID3 inhibited IL-1 beta secretion and caspase 1 processing in response to stimulation of NLRP3 and AIM2 but not NLRC4. CRID3 also prevented AIM2 dependent pyroptosis in contrast to the NLRP3 inhibitors glyburide and parthenolide, which do not inhibit AIM2 activation. Confocal microscopy and Western blotting assays indicated that CRID3 inhibited the formation of ASC complexes or 'specks' in response to NLRP3 and AIM2 stimulation. Co-immunoprecipitation assays show that GSTO1 interacted with ASC. Significance: These results identify CRID3 as a novel inhibitor of the NLRP3 and AIM2 inflammasomes and provide an insight into the mechanism of action of this small molecule. In addition GSTO1 may be a component of the inflammasome that is required for ASC complex formation.	[Coll, Rebecca C.; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland	Trinity College Dublin	Coll, RC (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland.	collr@tcd.ie	Robertson, Avril/A-4043-2012; Coll, Rebecca/J-2124-2014; Cooper, Matthew A./C-7988-2009	Robertson, Avril/0000-0002-9652-8357; Coll, Rebecca/0000-0002-7359-6023; Cooper, Matthew A./0000-0003-3147-3460	Science Foundation Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was funded by Science Foundation Ireland (www.sfi.ie). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Bauernfeind F, 2011, CELL MOL LIFE SCI, V68, P765, DOI 10.1007/s00018-010-0567-4; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Burmeister C, 2008, FASEB J, V22, P343, DOI 10.1096/fj.06-7426com; Capurso C, 2010, REJUV RES, V13, P645, DOI 10.1089/rej.2010.1052; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Ellebedy AH, 2011, P NATL ACAD SCI USA, V108, P2927, DOI 10.1073/pnas.1012455108; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Ippagunta SK, 2010, J BIOL CHEM, V285, P12454, DOI 10.1074/jbc.M109.093252; Jin CC, 2011, P NATL ACAD SCI USA, V108, P14867, DOI 10.1073/pnas.1111101108; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Pan S, 2007, CIRC RES, V100, P213, DOI 10.1161/01.RES.0000256089.30318.20; Perregaux DG, 2001, J PHARMACOL EXP THER, V299, P187; Piaggi S, 2010, CARCINOGENESIS, V31, P804, DOI 10.1093/carcin/bgq031; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shaw PJ, 2010, J IMMUNOL, V184, P4610, DOI 10.4049/jimmunol.1000217; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wu Y, 2006, ONCOGENE, V25, P5787, DOI 10.1038/sj.onc.1209576; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	39	106	109	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29539	10.1371/journal.pone.0029539	http://dx.doi.org/10.1371/journal.pone.0029539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216309	Green Published, gold			2022-12-27	WOS:000299684700066
J	Fujimura, K; Conte, MA; Kocher, TD				Fujimura, Koji; Conte, Matthew A.; Kocher, Thomas D.			Circular DNA Intermediate in the Duplication of Nile Tilapia vasa Genes	PLOS ONE			English	Article							OREOCHROMIS-NILOTICUS PISCES; GREEN FLUORESCENT PROTEIN; GERM-CELLS; SEX DETERMINATION; TELEOST FISH; DIFFERENTIAL EXPRESSION; RAINBOW-TROUT; CICHLID FISH; GENOME; EVOLUTION	vasa is a highly conserved RNA helicase involved in animal germ cell development. Among vertebrate species, it is typically present as a single copy per genome. Here we report the isolation and sequencing of BAC clones for Nile tilapia vasa genes. Contrary to a previous report that Nile tilapia have a single copy of the vasa gene, we find evidence for at least three vasa gene loci. The vasa gene locus was duplicated from the original site and integrated into two distant novel sites. For one of these insertions we find evidence that the duplication was mediated by a circular DNA intermediate. This mechanism of gene duplication may explain the origin of isolated gene duplicates during the evolution of fish genomes. These data provide a foundation for studying the role of multiple vasa genes in the development of tilapia gonads, and will contribute to investigations of the molecular mechanisms of sex determination and evolution in cichlid fishes.	[Fujimura, Koji; Conte, Matthew A.; Kocher, Thomas D.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Fujimura, K (corresponding author), Jikei Univ, Sch Med, Dept Anat, Minato Ku, Tokyo, Japan.	tdk@umd.edu	Fujimura, Koji/O-5355-2019; Kocher, Thomas D/B-3089-2013	Kocher, Thomas/0000-0002-7547-0133; Conte, Matthew/0000-0003-2712-7960	National Institutes of Health [R01HD058635]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058635] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [11J09181] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grant R01HD058635 from the National Institutes of Health (URL: http://www.nichd.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartfai R, 2003, DNA CELL BIOL, V22, P47, DOI 10.1089/104454903321112497; Borneman AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001287; Cnaani A, 2008, SEX DEV, V2, P43, DOI 10.1159/000117718; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Durkin K, 2011, CHROMOSOME RES, V19, pS18; Eichler EE, 1996, HUM MOL GENET, V5, P899, DOI 10.1093/hmg/5.7.899; FAO, 2020, STAT WORLD FISH AQ, DOI 10.4060/ca9229-n; Farrell J, 1996, COMP BIOCHEM PHYS A, V115, P103, DOI 10.1016/0300-9629(96)00015-1; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Fryer G, 1972, CICHLID FISHES GREAT; Fujimura K, 2008, DEV GROWTH DIFFER, V50, P653, DOI 10.1111/j.1440-169X.2008.01063.x; Fujimura K, 2008, DEV GROWTH DIFFER, V50, P339, DOI [10.1111/j.1440-169x.2008.01032.x, 10.1111/j.1440-169X.2008.01032.x]; Fujimura K, 2007, DEV GROWTH DIFFER, V49, P301, DOI [10.1111/j.1440-169x.2007.00926.x, 10.1111/j.1440-169X.2007.00926.x]; Fujimura K, 2011, AQUACULTURE, V319, P342, DOI 10.1016/j.aquaculture.2011.07.021; HAYASHIDA H, 1983, P NATL ACAD SCI-BIOL, V80, P2671, DOI 10.1073/pnas.80.9.2671; Ijiri S, 2008, BIOL REPROD, V78, P333, DOI 10.1095/biolreprod.107.064246; Katagiri T, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-89; Katagiri T, 2001, ANIM GENET, V32, P200, DOI 10.1046/j.1365-2052.2001.00764.x; Knaut H, 2002, CURR BIOL, V12, P454, DOI 10.1016/S0960-9822(02)00723-6; Kobayashi T, 2002, MECH DEVELOP, V111, P167, DOI 10.1016/S0925-4773(01)00613-X; Kobayashi T, 2000, MECH DEVELOP, V99, P139, DOI 10.1016/S0925-4773(00)00464-0; Kocher TD, 1998, GENETICS, V148, P1225; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Krovel AV, 2002, MECH DEVELOP, V116, P141, DOI 10.1016/S0925-4773(02)00154-5; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; MAJUMDAR KC, 1986, GENETICA, V68, P175, DOI 10.1007/BF02424441; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MCCORMICK SD, 1992, P NATL ACAD SCI USA, V89, P3635, DOI 10.1073/pnas.89.8.3635; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Oliveira C, 1998, CHROMOSOME RES, V6, P205, DOI 10.1023/A:1009211701829; Parhar IS, 2000, ENDOCRINOLOGY, V141, P1618, DOI 10.1210/en.141.5.1618; Raz E, 2000, GENOME BIOL, V1, P1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Robinson-Rechavi M, 2001, CURR BIOL, V11, pR458, DOI 10.1016/S0960-9822(01)00280-9; Santini S, 2005, GENE, V346, P51, DOI 10.1016/j.gene.2004.10.027; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Ser JR, 2010, EVOLUTION, V64, P486, DOI 10.1111/j.1558-5646.2009.00871.x; Strussmann CA, 2002, FISH PHYSIOL BIOCHEM, V26, P13, DOI 10.1023/A:1023343023556; Tanaka M, 2001, P NATL ACAD SCI USA, V98, P2544, DOI 10.1073/pnas.041315498; Volff JN, 1999, MOL BIOL EVOL, V16, P1427, DOI 10.1093/oxfordjournals.molbev.a026055; Yoshizaki G, 2000, INT J DEV BIOL, V44, P323	42	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29477	10.1371/journal.pone.0029477	http://dx.doi.org/10.1371/journal.pone.0029477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216289	Green Published, gold, Green Submitted			2022-12-27	WOS:000299684700060
J	Prosperi, JR; Khramtsov, AI; Khramtsova, GF; Goss, KH				Prosperi, Jenifer R.; Khramtsov, Andrey I.; Khramtsova, Galina F.; Goss, Kathleen H.			Apc Mutation Enhances PyMT-Induced Mammary Tumorigenesis	PLOS ONE			English	Article							FOCAL ADHESION KINASE; ADENOMATOUS-POLYPOSIS-COLI; EPITHELIAL-MESENCHYMAL TRANSITION; WNT/BETA-CATENIN PATHWAY; BREAST-CANCER; TUMOR-SUPPRESSOR; SIGNAL-TRANSDUCTION; TYROSINE KINASE; MOUSE MODEL; ACTIVATION	The Adenomatous Polyposis Coli (APC) tumor suppressor gene is silenced by hypermethylation or mutated in up to 70% of human breast cancers. In mouse models, Apc mutation disrupts normal mammary development and predisposes to mammary tumor formation; however, the cooperation between APC and other mutations in breast tumorigenesis has not been studied. To test the hypothesis that loss of one copy of APC promotes oncogene-mediated mammary tumorigenesis, Apc(Min/+) mice were crossed with the mouse mammary tumor virus(MMTV)-Polyoma virus middle T antigen (PyMT) or MMTV-c-Neu transgenic mice. In the PyMT tumor model, the Apc(Min/+) mutation significantly decreased survival and tumor latency, promoted a squamous adenocarcinoma phenotype, and enhanced tumor cell proliferation. In tumor-derived cell lines, the proliferative advantage was a result of increased FAK, Src and JNK signaling. These effects were specific to the PyMT model, as no changes were observed in MMTV-c-Neu mice carrying the Apc(Min/+) mutation. Our data indicate that heterozygosity of Apc enhances tumor development in an oncogene-specific manner, providing evidence that APC-dependent pathways may be valuable therapeutic targets in breast cancer. Moreover, these preclinical model systems offer a platform for dissection of the molecular mechanisms by which APC mutation enhances breast carcinogenesis, such as altered FAK/Src/JNK signaling.	[Prosperi, Jenifer R.; Goss, Kathleen H.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Khramtsov, Andrey I.; Khramtsova, Galina F.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Prosperi, JR (corresponding author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	kgoss@uchicago.edu	Khramtsova, Galina/CAJ-0147-2022; Khramtsov, Andrey I/H-8701-2018	Khramtsova, Galina/0000-0001-9625-1549; Khramtsov, Andrey I/0000-0001-6301-4619; Prosperi, Jenifer/0000-0001-8439-4411; Goss, Kathleen/0000-0002-7379-5639	American Cancer Society New England Division [PF-10-225-01-TBG]; American Cancer Society [RSG 04-251-01-CCG]	American Cancer Society New England Division(American Cancer Society); American Cancer Society(American Cancer Society)	JRP was supported by the American Cancer Society New England Division - SpinOdyssey Postdoctoral Fellowship (PF-10-225-01-TBG). This work was funded by RSG 04-251-01-CCG from the American Cancer Society to KHG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriance MC, 2004, ONCOGENE, V23, P697, DOI 10.1038/sj.onc.1207165; Amundadottir LT, 1998, ONCOGENE, V16, P737, DOI 10.1038/sj.onc.1201829; Andrechek ER, 2000, BREAST CANCER RES, V2, P211, DOI 10.1186/bcr56; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; DAbaco GM, 1996, MOL CELL BIOL, V16, P884; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fluck MM, 2009, MICROBIOL MOL BIOL R, V73, P542, DOI 10.1128/MMBR.00009-09; Gallagher RCJ, 2002, ONCOGENE, V21, P6446, DOI 10.1038/sj.onc.1205892; Gaspar C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000547; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; GUY CT, 1994, GENE DEV, V8, P23, DOI 10.1101/gad.8.1.23; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hayes MJ, 2008, CLIN CANCER RES, V14, P4038, DOI 10.1158/1078-0432.CCR-07-4379; Heinen CD, 2002, GASTROENTEROLOGY, V123, P751, DOI 10.1053/gast.2002.35382; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Imaoka T, 2006, RADIAT RES, V165, P165, DOI 10.1667/RR3502.1; Khramtsov AI, 2010, AM J PATHOL; Klemm F, 2011, CARCINOGENESIS, V32, P434, DOI 10.1093/carcin/bgq269; Kuraguchi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000367; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Lark AL, 2005, MODERN PATHOL, V18, P1289, DOI 10.1038/modpathol.3800424; Li WM, 2003, DEVELOPMENT, V130, P6143, DOI 10.1242/dev.00820; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu B, 2008, NEOPLASIA, V10, P1004, DOI 10.1593/neo.08548; LUONGO C, 1994, CANCER RES, V54, P5947; Marcotte R, 2011, P NATL ACAD SCI USA; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; Meniel V, 2005, CANCER RES, V65, P410; Miyoshi K, 2002, ONCOGENE, V21, P5548, DOI 10.1038/sj.onc.1205686; Miyoshi K, 2002, P NATL ACAD SCI USA, V99, P219, DOI 10.1073/pnas.012414099; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nakayama T, 2007, RADIAT RES, V168, P433, DOI 10.1667/RR0869.1; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Oktay M, 1999, J CELL BIOL, V145, P1461, DOI 10.1083/jcb.145.7.1461; Pecina-Slaus N, 2011, BRAIN TUMOR PATHOL, V28, P223, DOI 10.1007/s10014-011-0030-8; Pirkmaier A, 2003, ONCOGENE, V22, P4425, DOI 10.1038/sj.onc.1206488; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Prasad CP, 2008, LIFE SCI, V83, P318, DOI 10.1016/j.lfs.2008.06.019; Previdi S, 2010, EUR J CANCER, V46, P1679, DOI 10.1016/j.ejca.2010.02.036; Prosperi J.R., 2011, WNT PATHWAY INDEPEND; Prosperi JR, 2010, CURR DRUG TARGETS, V11, P1074; Prosperi JR, 2009, J CELL PHYSIOL, V220, P319, DOI 10.1002/jcp.21766; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Renou JP, 2003, ONCOGENE, V22, P4594, DOI 10.1038/sj.onc.1206596; SARKAR FH, 1993, BIOTECHNIQUES, V15, P36; Sasai H, 2000, CARCINOGENESIS, V21, P953, DOI 10.1093/carcin/21.5.953; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schmitz KJ, 2005, BREAST CANCER RES, V7, pR194, DOI 10.1186/bcr977; Sieg DJ, 1999, J CELL SCI, V112, P2677; SPICER AP, 1995, J BIOL CHEM, V270, P30093; Troyer KL, 2001, J MAMMARY GLAND BIOL, V6, P7, DOI 10.1023/A:1009560330359; Van der Auwera I, 2008, BRIT J CANCER, V99, P1735, DOI 10.1038/sj.bjc.6604705; van Oordt CWVH, 1999, GENE CHROMOSOME CANC, V24, P191; vanOordt CWV, 1997, CARCINOGENESIS, V18, P2197, DOI 10.1093/carcin/18.11.2197; Wang H, 2007, CANCER RES, V67, P11226, DOI 10.1158/0008-5472.CAN-07-2487; Wang JH, 2010, MOL CANCER RES, V8, P266, DOI 10.1158/1541-7786.MCR-09-0221; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhang Y, 1999, J BIOL CHEM, V274, P35247, DOI 10.1074/jbc.274.49.35247; Zhou BP, 2003, SEMIN ONCOL, V30, P38, DOI 10.1053/j.seminoncol.2003.08.006	65	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29339	10.1371/journal.pone.0029339	http://dx.doi.org/10.1371/journal.pone.0029339			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216254	Green Submitted, gold, Green Published			2022-12-27	WOS:000299684700050
J	Li, F; Ma, JX; Ma, Y; Hu, YY; Tian, SJ; White, RE; Han, GC				Li, Fen; Ma, Jixian; Ma, Yu; Hu, Yanyan; Tian, Shujuan; White, Richard E.; Han, Guichun			hElp3 Directly Modulates the Expression of HSP70 Gene in HeLa Cells via HAT Activity	PLOS ONE			English	Article							RNA-POLYMERASE; ELONGATOR COMPLEX; HISTONE ACETYLTRANSFERASE; ELP3 SUBUNIT; HEAT-SHOCK; TRANSCRIPTION; PROTEIN; POLYMORPHISMS; BINDING; IDENTIFICATION	Human Elongator complex, which plays a key role in transcript elongation in vitro assay, is incredibly similar in either components or function to its yeast counterpart. However, there are only a few studies focusing on its target gene characterization in vivo. We studied the effect of down-regulation of the human elongation protein 3 (hELP3) on the expression of HSP70 through antisense strategy. Transfecting antisense plasmid p1107 into HeLa cells highly suppressed hELP3 expression, and substantially reduced expression of HSP70 mRNA and protein. Furthermore, chromatin immunoprecipitation assay (ChIP Assay) revealed that hElp3 participates in the transcription elongation of HSPA1A in HeLa cells. Finally, complementation and ChIP Assay in yeast showed that hElp3 can not only complement the growth and slow activation of HSP70 (SSA3) gene transcription, but also directly regulates the transcription of SSA3. On the contrary, these functions are lost when the HAT domain is deleted from hElp3. These data suggest that hElp3 can regulate the transcription of HSP70 gene, and the HAT domain of hElp3 is essential for this function. These findings now provide novel insights and evidence of the functions of hELP3 in human cells.	[Li, Fen; Ma, Jixian; Ma, Yu; Hu, Yanyan; Tian, Shujuan] Henan Normal Univ, Coll Life Sci, Xinxiang, Peoples R China; [Li, Fen; Han, Guichun] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [White, Richard E.] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA	Henan Normal University; Texas A&M University System; Texas A&M University College Station; University System of Georgia; Augusta University	Li, F (corresponding author), Henan Normal Univ, Coll Life Sci, Xinxiang, Peoples R China.	lifen2001@yahoo.com; ghan@cvm.tamu.edu			Chinese National Natural Science Foundation [30600343]; Key Problem Tackling Project in Henan [092102310026]; Construct Program of the Key Discipline in Henan Province in China	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key Problem Tackling Project in Henan; Construct Program of the Key Discipline in Henan Province in China	This work was supported by the Chinese National Natural Science Foundation (No. 30600343), the Key Problem Tackling Project in Henan (092102310026) and the Construct Program of the Key Discipline in Henan Province in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinenov Y, 2002, TRENDS BIOCHEM SCI, V27, P115, DOI 10.1016/S0968-0004(02)02058-3; Chuong SDX, 2004, MOL CELL PROTEOMICS, V3, P970, DOI 10.1074/mcp.M400053-MCP200; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Cohen-Kupiec R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019147; Collum RG, 2000, P NATL ACAD SCI USA, V97, P10120, DOI 10.1073/pnas.170192197; Colvis CM, 2005, J NEUROSCI, V25, P10379, DOI 10.1523/JNEUROSCI.4119-05.2005; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Daugaard M, 2005, CELL CYCLE, V4, P877, DOI 10.4161/cc.4.7.1838; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Frohloff F, 2001, EMBO J, V20, P1993, DOI 10.1093/emboj/20.8.1993; Giacconi R, 2005, MECH AGEING DEV, V126, P866, DOI 10.1016/j.mad.2005.03.007; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; Han QJ, 2008, BIOCHEM J, V409, P779, DOI 10.1042/BJ20070578; Han QJ, 2007, ACTA BIOCH BIOPH SIN, V39, P453, DOI 10.1111/j.1745-7270.2007.00293.x; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Klausz G, 2005, SCAND J GASTROENTERO, V40, P1197, DOI 10.1080/00365520510023350; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Kristjuhan A, 2002, MOL CELL, V10, P925, DOI 10.1016/S1097-2765(02)00647-0; Li F, 2005, MOL GENET GENOMICS, V273, P264, DOI 10.1007/s00438-005-1120-2; Li Q, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000684; Lipardi C, 2009, P NATL ACAD SCI USA, V106, P15645, DOI 10.1073/pnas.0904984106; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mukhopadhyay A, 2008, NAT PROTOC, V3, P698, DOI 10.1038/nprot.2008.38; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Pae CU, 2005, NEUROSCI RES, V53, P8, DOI 10.1016/j.neures.2005.05.004; Paraskevopoulou C, 2006, MOL MICROBIOL, V59, P795, DOI 10.1111/j.1365-2958.2005.04989.x; Petrakis TG, 2004, J BIOL CHEM, V279, P32087, DOI 10.1074/jbc.M403361200; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; Simpson CL, 2009, HUM MOL GENET, V18, P472, DOI 10.1093/hmg/ddn375; Trotter EW, 2002, J BIOL CHEM, V277, P44817, DOI 10.1074/jbc.M204686200; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Wittschieben BO, 2000, EMBO J, V19, P3060, DOI 10.1093/emboj/19.12.3060; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Wu YR, 2004, HUM GENET, V114, P236, DOI 10.1007/s00439-003-1050-1	38	4	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29303	10.1371/journal.pone.0029303	http://dx.doi.org/10.1371/journal.pone.0029303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216241	gold, Green Published, Green Submitted			2022-12-27	WOS:000299113600077
J	Luke, L; Vicens, A; Serra, F; Luque-Larena, JJ; Dopazo, H; Roldan, ERS; Gomendio, M				Lueke, Lena; Vicens, Alberto; Serra, Francois; Jose Luque-Larena, Juan; Dopazo, Hernan; Roldan, Eduardo R. S.; Gomendio, Montserrat			Sexual Selection Halts the Relaxation of Protamine 2 among Rodents	PLOS ONE			English	Article							ADAPTIVE EVOLUTION; POSITIVE SELECTION; SPERM COMPETITION; RAPID EVOLUTION; MOLECULAR PHYLOGENY; GENES; PROTEINS; NUCLEAR; SIZE; MOUSE	Sexual selection has been proposed as the driving force promoting the rapid evolutionary changes observed in some reproductive genes including protamines. We test this hypothesis in a group of rodents which show marked differences in the intensity of sexual selection. Levels of sperm competition were not associated with the evolutionary rates of protamine 1 but, contrary to expectations, were negatively related to the evolutionary rate of cleaved- and mature-protamine 2. Since both domains were found to be under relaxation, our findings reveal an unforeseen role of sexual selection: to halt the degree of degeneration that proteins within families may experience due to functional redundancy. The degree of relaxation of protamine 2 in this group of rodents is such that in some species it has become dysfunctional and it is not expressed in mature spermatozoa. In contrast, protamine 1 is functionally conserved but shows directed positive selection on specific sites which are functionally relevant such as DNA-anchoring domains and phosphorylation sites. We conclude that in rodents protamine 2 is under relaxation and that sexual selection removes deleterious mutations among species with high levels of sperm competition to maintain the protein functional and the spermatozoa competitive.	[Lueke, Lena; Vicens, Alberto; Roldan, Eduardo R. S.; Gomendio, Montserrat] Museo Nacl Ciencias Nat CSIC, Reprod Ecol & Biol Grp, Madrid, Spain; [Serra, Francois; Dopazo, Hernan] Ctr Invest Principe Felipe CIPF, Bioinformat & Genom Dept, Evolutionary Genom Lab, Valencia, Spain; [Jose Luque-Larena, Juan] Univ Valladolid, Area Zool, Dept Ciencias Agroforestales, ETS Ingn Agr, Palencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Prince Felipe Research Center; Universidad de Valladolid	Luke, L (corresponding author), Museo Nacl Ciencias Nat CSIC, Reprod Ecol & Biol Grp, Madrid, Spain.	montseg@mncn.csic.es	Roldan, Eduardo R.S./M-7947-2014; Arévalo, Lena/AAM-5277-2020; Dopazo, Hernan/AAY-5419-2020; Luque-Larena, Juan Jose/D-6454-2014; Arévalo, Lena/D-8757-2013; Serra, Francois Jose/A-8789-2011	Roldan, Eduardo R.S./0000-0002-7545-4248; Arévalo, Lena/0000-0002-0681-0392; Dopazo, Hernan/0000-0001-6125-2357; Luque-Larena, Juan Jose/0000-0001-6425-637X; Arévalo, Lena/0000-0002-0681-0392; Serra, Francois Jose/0000-0003-3895-4742	Ministry of Science and Innovation [CGL2008-04090/BOS, BFU2009-13409-C02-01]	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Ministry of Science and Innovation (grants number CGL2008-04090/BOS to MG and BFU2009-13409-C02-01 to HD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Balhorn R., 1989, P366; Balhorn R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-227; Birkhead TR, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P1; Birkhead TR, 1998, SPERM COMPETITION SE; Brewer LR, 1999, SCIENCE, V286, P120, DOI 10.1126/science.286.5437.120; CARREEUSEBE D, 1991, BIOCHEM J, V277, P39, DOI 10.1042/bj2770039; Corzett M, 2002, MOL REPROD DEV, V61, P519, DOI 10.1002/mrd.10105; Corzett M, 1999, MOL REPROD DEV, V54, P273, DOI 10.1002/(SICI)1098-2795(199911)54:3&lt;273::AID-MRD8&gt;3.0.CO;2-X; Dean MD, 2008, MOL BIOL EVOL, V25, P383, DOI 10.1093/molbev/msm265; Dean MD, 2009, MOL BIOL EVOL, V26, P1733, DOI 10.1093/molbev/msp094; Dorus S, 2004, NAT GENET, V36, P1326, DOI 10.1038/ng1471; Dorus S, 2010, MOL BIOL EVOL, V27, P1235, DOI 10.1093/molbev/msq007; Findlay GD, 2010, BIOESSAYS, V32, P26, DOI 10.1002/bies.200900127; Findlay GD, 2009, GENOME RES, V19, P886, DOI 10.1101/gr.089391.108; Finn S, 2010, J MOL EVOL, V71, P231, DOI 10.1007/s00239-010-9382-7; Galewski T, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-80; GOMENDIO M, 1991, P ROY SOC B-BIOL SCI, V243, P181, DOI 10.1098/rspb.1991.0029; Gomendio M, 2008, INT J DEV BIOL, V52, P439, DOI 10.1387/ijdb.082595mg; Gomendio M, 2006, P NATL ACAD SCI USA, V103, P15113, DOI 10.1073/pnas.0605795103; Gomenido Montserrat, 1998, P667, DOI 10.1016/B978-012100543-6/50041-6; Montoto LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018173; Good JM, 2005, MOL BIOL EVOL, V22, P1044, DOI 10.1093/molbev/msi087; Guenet JL, 2003, TRENDS GENET, V19, P24, DOI 10.1016/S0168-9525(02)00007-0; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Jaarola M, 2004, MOL PHYLOGENET EVOL, V33, P647, DOI 10.1016/j.ympev.2004.07.015; KENAGY GJ, 1986, J MAMMAL, V67, P1, DOI 10.2307/1380997; Martin-Coello J, 2009, P ROY SOC B-BIOL SCI, V276, P2427, DOI 10.1098/rspb.2009.0257; Martins E. P., 2004, COMPARE VERSION 4 6B; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; Montgomery SH, 2011, MOL BIOL EVOL, V28, P625, DOI 10.1093/molbev/msq237; Neumann K, 2006, MOL PHYLOGENET EVOL, V39, P135, DOI 10.1016/j.ympev.2006.01.010; OLIVA R, 1991, PROG NUCLEIC ACID RE, V40, P25; Oliva R, 2006, HUM REPROD UPDATE, V12, P417, DOI 10.1093/humupd/dml009; PIRHONEN A, 1994, BIOL REPROD, V50, P981, DOI 10.1095/biolreprod50.5.981; Ramm SA, 2008, MOL BIOL EVOL, V25, P207, DOI 10.1093/molbev/msm242; Rooney AP, 1999, MOL BIOL EVOL, V16, P706, DOI 10.1093/oxfordjournals.molbev.a026153; Soulsbury CD, 2010, PLOS ONE, V5, pA152, DOI 10.1371/journal.pone.0009581; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Torgerson DG, 2002, MOL BIOL EVOL, V19, P1973, DOI 10.1093/oxfordjournals.molbev.a004021; Tourmente M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-12; Turner LM, 2008, INT J DEV BIOL, V52, P769, DOI 10.1387/ijdb.082577lt; Walters JR, 2011, EVOLUTION, V65, P2855, DOI 10.1111/j.1558-5646.2011.01351.x; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; YANG Z, 1997, MOL BIOL EVOL, V14; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	50	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29247	10.1371/journal.pone.0029247	http://dx.doi.org/10.1371/journal.pone.0029247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216223	Green Published, Green Submitted, gold			2022-12-27	WOS:000299113600069
J	Pall, T; Pink, A; Kasak, L; Turkina, M; Anderson, W; Valkna, A; Kogerman, P				Paell, Taavi; Pink, Anne; Kasak, Lagle; Turkina, Marina; Anderson, Wally; Valkna, Andres; Kogerman, Priit			Soluble CD44 Interacts with Intermediate Filament Protein Vimentin on Endothelial Cell Surface	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; MICE LACKING VIMENTIN; HYALURONAN-BINDING DOMAIN; MAMMARY-CARCINOMA CELLS; SERUM CD44; TUMOR ANGIOGENESIS; COLON-CANCER; IN-VIVO; MEMBRANE; GROWTH	CD44 is a cell surface glycoprotein that functions as hyaluronan receptor. Mouse and human serum contain substantial amounts of soluble CD44, generated either by shedding or alternative splicing. During inflammation and in cancer patients serum levels of soluble CD44 are significantly increased. Experimentally, soluble CD44 overexpression blocks cancer cell adhesion to HA. We have previously found that recombinant CD44 hyaluronan binding domain (CD44HABD) and its non-HA-binding mutant inhibited tumor xenograft growth, angiogenesis, and endothelial cell proliferation. These data suggested an additional target other than HA for CD44HABD. By using non-HA-binding CD44HABD Arg41Ala, Arg78Ser, and Tyr79Ser-triple mutant (CD443MUT) we have identified intermediate filament protein vimentin as a novel interaction partner of CD44. We found that vimentin is expressed on the cell surface of human umbilical vein endothelial cells (HUVEC). Endogenous CD44 and vimentin coprecipitate from HUVECs, and when overexpressed in vimentin-negative MCF-7 cells. By using deletion mutants, we found that CD44HABD and CD443MUT bind vimentin N-terminal head domain. CD443MUT binds vimentin in solution with a Kd in range of 12-37 nM, and immobilised vimentin with Kd of 74 nM. CD443MUT binds to HUVEC and recombinant vimentin displaces CD443MUT from its binding sites. CD44HABD and CD443MUT were internalized by wild-type endothelial cells, but not by lung endothelial cells isolated from vimentin knock-out mice. Together, these data suggest that vimentin provides a specific binding site for soluble CD44 on endothelial cells.	[Paell, Taavi; Pink, Anne; Kasak, Lagle; Valkna, Andres; Kogerman, Priit] Tallinn Univ Technol, Dept Gene Technol, Tallinn, Estonia; [Paell, Taavi; Pink, Anne; Kasak, Lagle; Turkina, Marina; Anderson, Wally; Valkna, Andres; Kogerman, Priit] Competence Ctr Canc Res, Tallinn, Estonia	Tallinn University of Technology; Competence Centre for Cancer Research	Pall, T (corresponding author), Tallinn Univ Technol, Dept Gene Technol, Tallinn, Estonia.	taavi.pall@ttu.ee	Pink, Anne/F-9531-2017	Pink, Anne/0000-0001-8292-8854	Enterprise Estonia [EU28138/EU28658, EU30013]; Estonian Science Fund [8116]	Enterprise Estonia; Estonian Science Fund(Estonian Research Council)	This work was supported by the European Regional Development Fund via Enterprise Estonia grants (EU28138/EU28658, EU30013) to Competence Center for Cancer Research and by Estonian Science Fund (grant 8116 to P. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens T, 2001, ONCOGENE, V20, P3399, DOI 10.1038/sj.onc.1204435; Aziz A, 2010, J BIOL CHEM, V285, P15278, DOI 10.1074/jbc.M109.075598; Bajorath J, 1998, J BIOL CHEM, V273, P338, DOI 10.1074/jbc.273.1.338; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Bartolazzi A, 1996, J CELL BIOL, V132, P1199, DOI 10.1083/jcb.132.6.1199; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Cao GY, 2006, AM J PATHOL, V169, P325, DOI 10.2353/ajpath.2006.060206; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cichy J, 2002, J BIOL CHEM, V277, P44440, DOI 10.1074/jbc.M207437200; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Ehnis T, 1996, EXP CELL RES, V229, P388, DOI 10.1006/excr.1996.0384; English NM, 1998, CANCER RES, V58, P3736; Faigle W, 2000, MOL BIOL CELL, V11, P3485, DOI 10.1091/mbc.11.10.3485; GEORGATOS SD, 1985, J CELL BIOL, V100, P1962, DOI 10.1083/jcb.100.6.1962; Griffioen AW, 1997, BLOOD, V90, P1150, DOI 10.1182/blood.V90.3.1150.1150_1150_1159; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; GUO YJ, 1994, CANCER RES, V54, P422; Henrion D, 1997, J CLIN INVEST, V100, P2909, DOI 10.1172/JCI119840; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Huet D, 2006, J IMMUNOL, V176, P652, DOI 10.4049/jimmunol.176.1.652; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; Janiszewska M, 2010, J BIOL CHEM, V285, P30548, DOI 10.1074/jbc.M109.075838; KATOH S, 1994, J IMMUNOL, V153, P3440; Kogerman P, 1997, ONCOGENE, V15, P1407, DOI 10.1038/sj.onc.1201306; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Krettek A, 2004, AM J PATHOL, V165, P1571, DOI 10.1016/S0002-9440(10)63414-1; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; LOPEZ JI, 2005, CANCER RES, P6755; Maenpaa H, 2000, LEUKEMIA LYMPHOMA, V37, P585, DOI 10.3109/10428190009058511; Mayer S, 2008, J CANCER RES CLIN, V134, P1229, DOI 10.1007/s00432-008-0397-z; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Nakamura H, 2004, CANCER RES, V64, P876, DOI 10.1158/0008-5472.CAN-03-3502; Niitsu N, 2002, LEUKEMIA RES, V26, P241, DOI 10.1016/S0145-2126(01)00122-9; Okamoto I, 1999, ONCOGENE, V18, P1435, DOI 10.1038/sj.onc.1202447; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Pall T, 2004, ONCOGENE, V23, P7874, DOI 10.1038/sj.onc.1208083; Peterson RM, 2000, AM J PATHOL, V156, P2159, DOI 10.1016/S0002-9440(10)65086-9; Podor TJ, 2002, J BIOL CHEM, V277, P7529, DOI 10.1074/jbc.M109675200; RISTAMAKI R, 1994, BLOOD, V84, P238; Ristamaki R, 1997, J IMMUNOL, V158, P3000; Ristamaki R, 1997, BLOOD, V90, P4039, DOI 10.1182/blood.V90.10.4039; Runembert I, 2002, J CELL SCI, V115, P713; Sokolova AV, 2006, P NATL ACAD SCI USA, V103, P16206, DOI 10.1073/pnas.0603629103; Styers ML, 2004, MOL BIOL CELL, V15, P5369, DOI 10.1091/mbc.E04-03-0272; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; Terzi F, 1997, J CLIN INVEST, V100, P1520, DOI 10.1172/JCI119675; van Beijnum JR, 2006, BLOOD, V108, P2339, DOI 10.1182/blood-2006-02-004291; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Yu Q, 1996, J BIOL CHEM, V271, P20603, DOI 10.1074/jbc.271.34.20603; Yu Q, 1997, J EXP MED, V186, P1985, DOI 10.1084/jem.186.12.1985; Zou YM, 2006, BIOCHEM BIOPH RES CO, V351, P625, DOI 10.1016/j.bbrc.2006.10.091	54	43	44	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29305	10.1371/journal.pone.0029305	http://dx.doi.org/10.1371/journal.pone.0029305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216242	Green Published, Green Submitted, gold			2022-12-27	WOS:000299113600078
J	Hara, E; Rivas, MV; Ward, JM; Okanoya, K; Jarvis, ED				Hara, Erina; Rivas, Miriam V.; Ward, James M.; Okanoya, Kazuo; Jarvis, Erich D.			Convergent Differential Regulation of Parvalbumin in the Brains of Vocal Learners	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; PARROT MELOPSITTACUS-UNDULATUS; FINCH TAENIOPYGIA-GUTTATA; DRIVEN GENE-EXPRESSION; NEURAL PATHWAYS; SONG SYSTEM; NEUROCHEMICAL SPECIALIZATIONS; FOXP2 EXPRESSION; ZEBRA FINCHES; AVIAN BRAINS	Spoken language and learned song are complex communication behaviors found in only a few species, including humans and three groups of distantly related birds - songbirds, parrots, and hummingbirds. Despite their large phylogenetic distances, these vocal learners show convergent behaviors and associated brain pathways for vocal communication. However, it is not clear whether this behavioral and anatomical convergence is associated with molecular convergence. Here we used oligo microarrays to screen for genes differentially regulated in brain nuclei necessary for producing learned vocalizations relative to adjacent brain areas that control other behaviors in avian vocal learners versus vocal non-learners. A top candidate gene in our screen was a calcium-binding protein, parvalbumin (PV). In situ hybridization verification revealed that PV was expressed significantly higher throughout the song motor pathway, including brainstem vocal motor neurons relative to the surrounding brain regions of all distantly related avian vocal learners. This differential expression was specific to PV and vocal learners, as it was not found in avian vocal non-learners nor for control genes in learners and non-learners. Similar to the vocal learning birds, higher PV up-regulation was found in the brainstem tongue motor neurons used for speech production in humans relative to a non-human primate, macaques. These results suggest repeated convergent evolution of differential PV up-regulation in the brains of vocal learners separated by more than 65-300 million years from a common ancestor and that the specialized behaviors of learned song and speech may require extra calcium buffering and signaling.	[Hara, Erina; Rivas, Miriam V.; Ward, James M.; Jarvis, Erich D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA; [Hara, Erina; Okanoya, Kazuo] Chiba Univ, Grad Sch Adv Integrat Sci, Chiba, Japan; [Okanoya, Kazuo] RIKEN BSI, Lab Biolinguist, Saitama, Japan	Duke University; Howard Hughes Medical Institute; Chiba University; RIKEN	Hara, E (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA.	hara@neuro.duke.edu; jarvis@neuro.duke.edu	Jarvis, Erich D/A-2319-2008	Jarvis, Erich D/0000-0001-8931-5049; Ward, James/0000-0002-9510-2848	NIH [RR00163]; HHMI; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Support was contributed by an NIH Director's Pioneer Award and HHMI to EDJ and macaque care was supported in part by NIH grant RR00163 to the Oregon National Primate Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adret P, 2002, J COMP NEUROL, V454, P409, DOI 10.1002/cne.10459; BALL GF, 1994, BRAIN BEHAV EVOLUT, V44, P234, DOI 10.1159/000113579; Balmer TS, 2009, J NEUROSCI, V29, P12878, DOI 10.1523/JNEUROSCI.2974-09.2009; Bottjer SW, 2000, J COMP NEUROL, V420, P244; Deacon TW, 2000, J COMMUN DISORD, V33, P273, DOI 10.1016/S0021-9924(00)00025-3; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Dubbeldam JL, 1998, ACTA ANAT, V163, P157; Durand SE, 1997, J COMP NEUROL, V377, P179, DOI 10.1002/(SICI)1096-9861(19970113)377:2<179::AID-CNE3>3.0.CO;2-0; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Fischer J, 2010, GENES BRAIN BEHAV; Fisher SE, 2006, NAT REV GENET, V7, P9, DOI 10.1038/nrg1747; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Fitch WT, 2010, NEURON, V65, P795, DOI 10.1016/j.neuron.2010.03.011; Gahr M, 2000, J COMP NEUROL, V426, P182; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hensch TK, 2005, CURR TOP DEV BIOL, V69, P215, DOI 10.1016/S0070-2153(05)69008-4; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hof PR, 1999, J CHEM NEUROANAT, V16, P77, DOI 10.1016/S0891-0618(98)00065-9; Horn D, 2010, HUM MUTAT, V31, pE1851, DOI 10.1002/humu.21362; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jarvis ED, 2000, NATURE, V406, P628, DOI 10.1038/35020570; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Jurgens U, 2002, NEUROSCI LETT, V328, P245, DOI 10.1016/S0304-3940(02)00525-6; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; KUYPERS HGJ, 1958, BRAIN, V81, P364, DOI 10.1093/brain/81.3.364; KUYPERS HGJM, 1958, J COMP NEUROL, V110, P221, DOI 10.1002/cne.901100205; Li XC, 2007, P NATL ACAD SCI USA, V104, P6834, DOI 10.1073/pnas.0701619104; Lovell PV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003440; Matsunaga E, 2008, BRAIN RES BULL, V75, P474, DOI 10.1016/j.brainresbull.2007.10.045; Matsunaga E, 2009, DEV GROWTH DIFFER, V51, P355, DOI 10.1111/j.1440-169X.2009.01091.x; Nomura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001454; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1972, AM NAT, V106, P116, DOI 10.1086/282756; Obal I, 2006, J COMP NEUROL, V499, P17, DOI 10.1002/cne.21041; Paizs M, 2010, J COMP NEUROL, V518, P1946, DOI 10.1002/cne.22312; Preuss TM, 1996, BRAIN RES, V712, P353, DOI 10.1016/0006-8993(95)01531-0; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; REINER A, 1995, EXP NEUROL, V131, P239, DOI 10.1016/0014-4886(95)90046-2; Roberts TF, 2002, J COMP NEUROL, V454, P383, DOI 10.1002/cne.10456; Roberts TF, 2007, J COMP NEUROL, V502, P157, DOI 10.1002/cne.21310; Roulhac PL, 2011, COLD SPRING HARB PRO; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Schwaller Beat, 2002, Cerebellum, V1, P241, DOI 10.1080/147342202320883551; Sherwood CC, 2004, BRAIN BEHAV EVOLUT, V63, P82, DOI 10.1159/000075673; Sherwood CC, 2007, BRAIN BEHAV EVOLUT, V69, P176, DOI 10.1159/000096986; Simonyan K, 2011, NEUROSCIENTIST, V17, P197, DOI 10.1177/1073858410386727; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; STRIEDTER GF, 1994, J COMP NEUROL, V343, P35, DOI 10.1002/cne.903430104; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Tyack PL, 2008, J COMP PSYCHOL, V122, P319, DOI 10.1037/a0013087; Wada K, 2004, J COMP NEUROL, V476, P44, DOI 10.1002/cne.20201; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Wild JM, 1997, J COMP NEUROL, V377, P392, DOI 10.1002/(SICI)1096-9861(19970120)377:3<392::AID-CNE7>3.0.CO;2-Y; WILD JM, 1994, BRAIN BEHAV EVOLUT, V44, P192, DOI 10.1159/000113577; Wild JM, 1997, J NEUROBIOL, V33, P653, DOI 10.1002/(SICI)1097-4695(19971105)33:5<653::AID-NEU11>3.0.CO;2-A; Wild JM, 2005, J COMP NEUROL, V483, P76, DOI 10.1002/cne.20403; Wild JM, 2001, BRAIN RES, V917, P235; Wild JM, 2000, J COMP NEUROL, V423, P413, DOI 10.1002/1096-9861(20000731)423:3<413::AID-CNE5>3.0.CO;2-7	65	38	38	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29457	10.1371/journal.pone.0029457	http://dx.doi.org/10.1371/journal.pone.0029457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238614	Green Published, gold			2022-12-27	WOS:000301188800016
J	Franzkowiak, S; Pollok, B; Biermann-Ruben, K; Sudmeyer, M; Paszek, J; Thomalla, G; Jonas, M; Orth, M; Munchau, A; Schnitzler, A				Franzkowiak, Stephanie; Pollok, Bettina; Biermann-Ruben, Katja; Suedmeyer, Martin; Paszek, Jennifer; Thomalla, Goetz; Jonas, Melanie; Orth, Michael; Muenchau, Alexander; Schnitzler, Alfons			Motor-Cortical Interaction in Gilles de la Tourette Syndrome	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; ENHANCED COGNITIVE CONTROL; BASAL GANGLIA VOLUMES; SUPPLEMENTARY MOTOR; TIC SEVERITY; HUMAN-BRAIN; VOLUNTARY MOVEMENTS; POSTMORTEM ANALYSIS; FUNCTIONAL MRI; RATING-SCALE	Background: In Gilles de la Tourette syndrome (GTS) increased activation of the primary motor cortex (M1) before and during movement execution followed by increased inhibition after movement termination was reported. The present study aimed at investigating, whether this activation pattern is due to altered functional interaction between motor cortical areas. Methodology/Principal Findings: 10 GTS-patients and 10 control subjects performed a self-paced finger movement task while neuromagnetic brain activity was recorded using Magnetoencephalography (MEG). Cerebro-cerebral coherence as a measure of functional interaction was calculated. During movement preparation and execution coherence between contralateral M1 and supplementary motor area (SMA) was significantly increased at beta-frequency in GTS-patients. After movement termination no significant differences between groups were evident. Conclusions/Significance: The present data suggest that increased M1 activation in GTS-patients might be due to increased functional interaction between SMA and M1 most likely reflecting a pathophysiological marker of GTS. The data extend previous findings of motor-cortical alterations in GTS by showing that local activation changes are associated with alterations of functional networks between premotor and primary motor areas. Interestingly enough, alterations were evident during preparation and execution of voluntary movements, which implies a general theme of increased motor-cortical interaction in GTS.	[Franzkowiak, Stephanie; Pollok, Bettina; Biermann-Ruben, Katja; Suedmeyer, Martin; Paszek, Jennifer; Schnitzler, Alfons] Univ Dusseldorf, Fac Med, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany; [Franzkowiak, Stephanie; Pollok, Bettina; Biermann-Ruben, Katja; Suedmeyer, Martin; Paszek, Jennifer; Schnitzler, Alfons] Univ Dusseldorf, Dept Neurol, Fac Med, Dusseldorf, Germany; [Thomalla, Goetz; Jonas, Melanie; Muenchau, Alexander] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Orth, Michael] Univ Hosp Ulm, Dept Neurol, Ulm, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University	Franzkowiak, S (corresponding author), Univ Dusseldorf, Fac Med, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany.	Bettina.pollok@uni-duesseldorf.de	Pollok, Bettina/B-5290-2012; Schnitzler, Alfons/AAT-1054-2021; Schnitzler, Alfons/Q-5520-2019	Schnitzler, Alfons/0000-0002-6414-7939; Thomalla, Gotz/0000-0002-4785-1449	Deutsche Forschungsgemeinschaft (DFG) [SCHN592/1-2, MU1692/2-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG; grant numbers SCHN592/1-2 to AS, MU1692/2-2 to AM; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LA, 2003, ADULT ADHD SELF REPO; Akkal D, 2007, J NEUROSCI, V27, P10659, DOI 10.1523/JNEUROSCI.3134-07.2007; Albin RL, 2006, TRENDS NEUROSCI, V29, P175, DOI 10.1016/j.tins.2006.01.001; Biswal B, 1998, AM J NEURORADIOL, V19, P1509; Bohlhalter S, 2006, BRAIN, V129, P2029, DOI 10.1093/brain/awl050; Chen R, 1998, ANN NEUROL, V44, P317, DOI 10.1002/ana.410440306; DEECKE L, 1982, EXP BRAIN RES, V48, P144; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Fattapposta F, 2005, PSYCHIAT RES-NEUROIM, V138, P269, DOI 10.1016/j.pscychresns.2005.02.001; Franzkowiak S, 2010, MOVEMENT DISORD, V25, P1960, DOI 10.1002/mds.23186; GEORGIOU N, 1995, J NEUROL NEUROSUR PS, V58, P184, DOI 10.1136/jnnp.58.2.184; Gerloff C, 1998, BRAIN, V121, P1513, DOI 10.1093/brain/121.8.1513; Gilbert DL, 2006, NEUROLOGY, V67, P1695, DOI 10.1212/01.wnl.0000242733.18534.2c; Gilbert DL, 2004, MOVEMENT DISORD, V19, P416, DOI 10.1002/mds.20044; Goetz CG, 1999, MOVEMENT DISORD, V14, P502, DOI 10.1002/1531-8257(199905)14:3<502::AID-MDS1020>3.0.CO;2-G; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Hall SD, 2011, NEUROIMAGE, V56, P1506, DOI 10.1016/j.neuroimage.2011.02.025; Hampson M, 2009, BIOL PSYCHIAT, V65, P594, DOI 10.1016/j.biopsych.2008.11.012; Heise KF, 2010, BRAIN, V133, P580, DOI 10.1093/brain/awp299; HOLM S, 1979, SCAND J STAT, V6, P65; Jackson GM, 2007, EXP BRAIN RES, V182, P357, DOI 10.1007/s00221-007-0999-8; Jurkiewicz MT, 2006, NEUROIMAGE, V32, P1281, DOI 10.1016/j.neuroimage.2006.06.005; Kwak C, 2003, MOVEMENT DISORD, V18, P1530, DOI 10.1002/mds.10618; Leckman JF, 2010, J CHILD ADOL PSYCHOP, V20, P237, DOI 10.1089/cap.2009.0118; Leckman JF, 2000, NEURON, V28, P349, DOI 10.1016/S0896-6273(00)00114-8; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; MALISON RT, 1995, AM J PSYCHIAT, V152, P1359; Mantovani A, 2006, INT J NEUROPSYCHOPH, V9, P95, DOI 10.1017/S1461145705005729; Mantovani A, 2007, CLIN NEUROPHYSIOL, V118, P2314, DOI 10.1016/j.clinph.2007.07.011; Mink Jonathan W, 2006, Adv Neurol, V99, P89; Mink JW, 2003, ARCH NEUROL-CHICAGO, V60, P1365, DOI 10.1001/archneur.60.10.1365; Mink JW, 2001, PEDIATR NEUROL, V25, P190, DOI 10.1016/S0887-8994(01)00262-4; Minzer K, 2004, J NEUROL SCI, V219, P55, DOI 10.1016/j.jns.2003.12.006; Moll GH, 1999, NEUROSCI LETT, V272, P37, DOI 10.1016/S0304-3940(99)00575-3; Mueller SC, 2006, CURR BIOL, V16, P570, DOI 10.1016/j.cub.2006.01.064; Myers LJ, 2004, P ANN INT IEEE EMBS, V26, P4669; Ohara S, 2001, J NEUROSCI, V21, P9377, DOI 10.1523/JNEUROSCI.21-23-09377.2001; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orth M, 2005, BRAIN, V128, P1292, DOI 10.1093/brain/awh473; Orth M, 2008, BIOL PSYCHIAT, V64, P248, DOI 10.1016/j.biopsych.2007.12.009; Paszek J, 2010, MOVEMENT DISORD, V25, P1106, DOI 10.1002/mds.23053; PETERSON B, 1993, NEUROLOGY, V43, P941, DOI 10.1212/WNL.43.5.941; Peterson BS, 2003, ARCH GEN PSYCHIAT, V60, P415, DOI 10.1001/archpsyc.60.4.415; Praamstra P, 1996, ELECTROEN CLIN NEURO, V98, P468, DOI 10.1016/0013-4694(96)95643-6; Retz-Junginger P, 2002, NERVENARZT, V73, P830, DOI 10.1007/s00115-001-1215-x; Ritter P, 2009, HUM BRAIN MAPP, V30, P1168, DOI 10.1002/hbm.20585; Robertson MM, 1999, NEUROLOGY, V53, P2108, DOI 10.1212/WNL.53.9.2108; Rosenblum MG, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.045202; Salmelin R, 1995, NEUROIMAGE, V2, P237, DOI 10.1006/nimg.1995.1031; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Serrien DJ, 2005, BRAIN, V128, P116, DOI 10.1093/brain/awh318; Serrien DJ, 2002, BRAIN, V125, P290, DOI 10.1093/brain/awf024; SINGER HS, 1994, BRAIN DEV-JPN, V16, P353, DOI 10.1016/0387-7604(94)90122-8; Singer HS, 2002, AM J PSYCHIAT, V159, P1329, DOI 10.1176/appi.ajp.159.8.1329; Sowell ER, 2008, NAT NEUROSCI, V11, P637, DOI 10.1038/nn.2121; Steeves TDL, 2010, ANN NEUROL, V67, P170, DOI 10.1002/ana.21809; Stern E, 2000, ARCH GEN PSYCHIAT, V57, P741, DOI 10.1001/archpsyc.57.8.741; Thomalla G, 2009, BRAIN, V132, P765, DOI 10.1093/brain/awn339; Yoon DY, 2007, J NEUROL SCI, V255, P50, DOI 10.1016/j.jns.2007.01.069; Ziemann U, 1997, AM J PSYCHIAT, V154, P1277	60	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e27850	10.1371/journal.pone.0027850	http://dx.doi.org/10.1371/journal.pone.0027850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238571	gold, Green Submitted, Green Published			2022-12-27	WOS:000301070200003
J	Marcus, MW; Muskens, RPHM; Ramdas, WD; Wolfs, RCW; De Jong, PTVM; Vingerling, JR; Hofman, A; Stricker, BH; Jansonius, NM				Marcus, Michael W.; Muskens, Rogier P. H. M.; Ramdas, Wishal D.; Wolfs, Roger C. W.; De Jong, Paulus T. V. M.; Vingerling, Johannes R.; Hofman, Albert; Stricker, Bruno H.; Jansonius, Nomdo M.			Cholesterol-Lowering Drugs and Incident Open-Angle Glaucoma: A Population-Based Cohort Study	PLOS ONE			English	Article							VISUAL-FIELD LOSS; PSEUDOEXFOLIATION SYNDROME; STATIN USE; NEUROPROTECTIVE PROPERTIES; ASSOCIATION; SIMVASTATIN; CATARACT; RISK; PROGRESSION; EXPOSURE	Background: Open-angle glaucoma (OAG) is a progressive neurodegenerative disease that may lead to blindness. An elevated intraocular pressure (IOP) is its major risk factor. OAG treatment is currently exclusively directed towards the lowering of the IOP. IOP lowering does not prevent disease progression in all patients and thus other treatment modalities are needed. Earlier studies reported cholesterol-lowering drugs to have neuroprotective properties. The aim of this study was to determine the associations between the use of cholesterol-lowering drugs and incident OAG. Methodology/Principal Findings: Participants in a prospective population-based cohort study underwent ophthalmic examinations, including IOP measurements and perimetry, at baseline and follow-up. The use of statins and non-statin cholesterol-lowering drugs was monitored continuously during the study. Associations between the use of cholesterol-lowering drugs and incident OAG were analyzed with Cox regression; associations between cholesterol-lowering drugs and IOP at follow-up were analyzed with multiple linear regression. During a mean follow-up of 9.8 years, 108 of 3939 eligible participants (2.7%) developed OAG. The hazard ratio for statin use was 0.54 (95% confidence interval 0.31-0.96; P = 0.034) and for non-statin cholesterol-lowering drugs 2.07 (0.81-5.33; P = 0.13). The effect of statins was more pronounced with prolonged use (hazard ratio 0.89 [0.41-1.94; P = 0.77] for use two years or less; 0.46 [0.23-0.94; P = 0.033] for use more than two years; P-value for trend 0.10). The analyzes were adjusted for age and gender, baseline IOP and IOP-lowering treatment, the family history of glaucoma, and myopia. There was no effect of statins on the IOP. Conclusions/Significance: Long-term use of statins appears to be associated with a reduced risk of OAG. The observed effect was independent of the IOP. These findings are in line with the idea that statins have neuroprotective properties and may open a way to a new OAG treatment modality.	[Marcus, Michael W.; Muskens, Rogier P. H. M.; Jansonius, Nomdo M.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Ramdas, Wishal D.; Wolfs, Roger C. W.; Vingerling, Johannes R.; Hofman, Albert; Stricker, Bruno H.; Jansonius, Nomdo M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Ramdas, Wishal D.; Wolfs, Roger C. W.; Vingerling, Johannes R.] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [De Jong, Paulus T. V. M.] Netherlands Inst Neurosci, Dept Ophthalmogenet, Amsterdam, Netherlands; [De Jong, Paulus T. V. M.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands; [Stricker, Bruno H.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Stricker, Bruno H.] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands	University of Groningen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Marcus, MW (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	b.stricker@erasmusmc.nl	Ramdas, Wishal D/H-5062-2018	Ramdas, Wishal D/0000-0002-1780-5281; Jansonius, Nomdo/0000-0002-6495-6568	Stichting Lijf en Leven, Krimpen aan de Lek; MD Fonds, Utrecht; Rotterdamse Vereniging Blindenbelangen, Rotterdam; Stichting Oogfonds Nederland, Utrecht; Blindenpenning, Amsterdam; Blindenhulp, The Hague; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (ANVVB), Doorn; Landelijke Stichting voor Blinden en Slechtzienden, Utrecht; Swart van Essen, Rotterdam; Stichting Winckel-Sweep, Utrecht; Henkes Stichting, Rotterdam; Professor Mulder Stichting, Groningen; Stichting Nederlands Oogheelkundig Onderzoek, Rotterdam; Lameris Ootech BV, Nieuwegein; Medical Workshop, de Meern; Topcon Europe BV; Capelle aan de IJssel in the Netherlands; Heidelberg Engineering, Dossenheim, Germany; Lameris Ootech BV; Medical Workshop; Heidelberg Engineering	Stichting Lijf en Leven, Krimpen aan de Lek; MD Fonds, Utrecht; Rotterdamse Vereniging Blindenbelangen, Rotterdam; Stichting Oogfonds Nederland, Utrecht; Blindenpenning, Amsterdam; Blindenhulp, The Hague; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (ANVVB), Doorn; Landelijke Stichting voor Blinden en Slechtzienden, Utrecht; Swart van Essen, Rotterdam; Stichting Winckel-Sweep, Utrecht; Henkes Stichting, Rotterdam; Professor Mulder Stichting, Groningen; Stichting Nederlands Oogheelkundig Onderzoek, Rotterdam; Lameris Ootech BV, Nieuwegein; Medical Workshop, de Meern; Topcon Europe BV; Capelle aan de IJssel in the Netherlands; Heidelberg Engineering, Dossenheim, Germany; Lameris Ootech BV; Medical Workshop; Heidelberg Engineering	Stichting Lijf en Leven, Krimpen aan de Lek; MD Fonds, Utrecht; Rotterdamse Vereniging Blindenbelangen, Rotterdam; Stichting Oogfonds Nederland, Utrecht; Blindenpenning, Amsterdam; Blindenhulp, The Hague; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (ANVVB), Doorn; Landelijke Stichting voor Blinden en Slechtzienden, Utrecht; Swart van Essen, Rotterdam; Stichting Winckel-Sweep, Utrecht; Henkes Stichting, Rotterdam; Professor Mulder Stichting, Groningen; Stichting Nederlands Oogheelkundig Onderzoek, Rotterdam; Lameris Ootech BV, Nieuwegein; Medical Workshop, de Meern; Topcon Europe BV, Capelle aan de IJssel, all in the Netherlands and Heidelberg Engineering, Dossenheim, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by the following companies: Lameris Ootech BV, Medical Workshop, Topcon Europe BV and Heidelberg Engineering. The funding was unrestricted and did not, in any way, interfere with the conception and/or design and/or outcome and/or publication of the study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andrikopoulos GK, 2009, EYE, V23, P442, DOI 10.1038/sj.eye.6702992; Chodick G, 2010, ANN EPIDEMIOL, V20, P136, DOI 10.1016/j.annepidem.2009.10.007; Citirik M, 2007, EYE, V21, P11, DOI 10.1038/sj.eye.6702177; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2003, LANCET, V361, P2005; Corsini A, 1999, PHARMACOL THERAPEUT, V84, P413, DOI 10.1016/S0163-7258(99)00045-5; Czudowska MA, 2010, OPHTHALMOLOGY, V117, P1705, DOI 10.1016/j.ophtha.2010.01.034; De Backer G, 2004, ATHEROSCLEROSIS, V173, P379, DOI 10.1016/j.atherosclerosis.2004.02.014; De Castro DK, 2007, CLIN EXP OPHTHALMOL, V35, P506, DOI 10.1111/j.1442-9071.2007.01529.x; DIELEMANS I, 1994, GRAEF ARCH CLIN EXP, V232, P141, DOI 10.1007/BF00176782; Ekstrom C., 2010, ACTA OPHTHALMOL, DOI [DOI 10.1111/J.1755-3768.2010.01943.X, 10.1111/j.1755-3768.2010.01943.x]; ENDO A, 1992, J LIPID RES, V33, P1569; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; GRUNDY SM, 1988, NEW ENGL J MED, V319, P24; Hofman A, 2009, EUR J EPIDEMIOL, V24, P553, DOI 10.1007/s10654-009-9386-z; Iskedjian M, 2009, CURR MED RES OPIN, V25, P1879, DOI 10.1185/03007990903035083; Klein BEK, 2006, JAMA-J AM MED ASSOC, V295, P2752, DOI 10.1001/jama.295.23.2752; Leung DYL, 2010, OPHTHALMOLOGY, V117, P471, DOI 10.1016/j.ophtha.2009.08.016; Li JM, 2009, EXP EYE RES, V89, P71, DOI 10.1016/j.exer.2009.02.013; Marcus MW, 2011, OPHTHALMOLO IN PRESS; McGuinness B, 2010, COCHRANE DB SYST REV, V4; McGwin G, 2004, ARCH OPHTHALMOL-CHIC, V122, P822, DOI 10.1001/archopht.122.6.822; McGwin G, 2003, BRIT J OPHTHALMOL, V87, P1121, DOI 10.1136/bjo.87.9.1121; Mitchell P, 1997, AM J OPHTHALMOL, V124, P685, DOI 10.1016/S0002-9394(14)70908-0; Nagaoka T, 2006, ARCH OPHTHALMOL-CHIC, V124, P665, DOI 10.1001/archopht.124.5.665; Owen CG, 2010, INVEST OPHTH VIS SCI, V51, P3524, DOI 10.1167/iovs.09-4821; Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x; Sen K, 2002, DIABETES RES CLIN PR, V56, P1, DOI 10.1016/S0168-8227(01)00341-2; Sierra S, 2011, J ALZHEIMERS DIS, V23, P307, DOI 10.3233/JAD-2010-101179; Skenduli-Bala E, 2005, ARCH OPHTHALMOL-CHIC, V123, P233, DOI 10.1001/archopht.123.2.233; Stepien K, 2005, PHARMACOL REP, V57, P561; Stricker BHC, 2010, EUR J EPIDEMIOL, V25, P245, DOI 10.1007/s10654-010-9451-7; Tan JSL, 2007, AM J OPHTHALMOL, V143, P687, DOI 10.1016/j.ajo.2006.11.027; van der Most PJ, 2009, PROG NEUROBIOL, V88, P64, DOI 10.1016/j.pneurobio.2009.02.002; van Leeuwen R, 2003, BRIT MED J, V326, P255, DOI 10.1136/bmj.326.7383.255; Vaughan CJ, 1999, STROKE, V30, P1969, DOI 10.1161/01.STR.30.9.1969; Walley T, 2004, BRIT MED J, V328, P385, DOI 10.1136/bmj.328.7436.385; Wolfs RCW, 2000, INVEST OPHTH VIS SCI, V41, P3309; Wood WG, 2010, ANN NY ACAD SCI, V1199, P69, DOI 10.1111/j.1749-6632.2009.05359.x	40	57	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29724	10.1371/journal.pone.0029724	http://dx.doi.org/10.1371/journal.pone.0029724			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238644	Green Published, gold			2022-12-27	WOS:000301070200045
J	Zhao, HJ; Ho, PC; Lo, YH; Espejo, A; Bedford, MT; Hung, MC; Wang, SC				Zhao, Huajun; Ho, Po-Chun; Lo, Yuan-Hung; Espejo, Alexsandra; Bedford, Mark T.; Hung, Mien-Chie; Wang, Shao-Chun			Interaction of Proliferation Cell Nuclear Antigen (PCNA) with c-Abl in Cell Proliferation and Response to DNA Damages in Breast Cancer	PLOS ONE			English	Article							TYROSINE KINASE; REPLICATION; REPAIR; PHOSPHORYLATION; INHIBITION; ACTIVATION; UBIQUITIN; PROTEIN; GROWTH; SUMO	Cell proliferation in primary and metastatic tumors is a fundamental characteristic of advanced breast cancer. Further understanding of the mechanism underlying enhanced cell growth will be important in identifying novel prognostic markers and therapeutic targets. Here we demonstrated that tyrosine phosphorylation of the proliferating cell nuclear antigen (PCNA) is a critical event in growth regulation of breast cancer cells. We found that phosphorylation of PCNA at tyrosine 211 (Y211) enhanced its association with the non-receptor tyrosine kinase c-Abl. We further demonstrated that c-Abl facilitates chromatin association of PCNA and is required for nuclear foci formation of PCNA in cells stressed by DNA damage as well as in unperturbed cells. Targeting Y211 phosphorylation of PCNA with a cell-permeable peptide inhibited the phosphorylation and reduced the PCNA-Abl interaction. These results show that PCNA signal transduction has an important impact on the growth regulation of breast cancer cells.	[Zhao, Huajun; Ho, Po-Chun; Lo, Yuan-Hung; Wang, Shao-Chun] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45221 USA; [Espejo, Alexsandra; Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Hung, Mien-Chie] China Med Univ & Hosp, Ctr Mol Med, Taichung, Taiwan; [Hung, Mien-Chie] China Med Univ & Hosp, Grad Inst Canc Biol, Taichung, Taiwan	University System of Ohio; University of Cincinnati; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Zhao, HJ (corresponding author), Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45221 USA.	wangsc@ucmail.uc.edu		Wang, Shao-Chun/0000-0002-5477-1682; Hung, Mien-Chie/0000-0003-4317-4740; Espejo, Alexsandra/0000-0002-8841-7219	Susan G. Komen Research Award [KG080540]; Department of Defense [PC073951]; University of Cincinnati Center for Clinical and Translational Science; Marlene Harris-Ride Cincinnati Pilot Grant; Public Health Service [P30 DK078392]; Sister Institute Fund of China Medical University Hospital; M. D. Anderson Cancer Center; National Institute of Environmental Health Sciences [ES007784]; Cancer Prevention and Research Institute of Texas [RP110471]; NATIONAL CANCER INSTITUTE [R01CA109311] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	Susan G. Komen Research Award(Susan G. Komen Breast Cancer Foundation); Department of Defense(United States Department of Defense); University of Cincinnati Center for Clinical and Translational Science; Marlene Harris-Ride Cincinnati Pilot Grant; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Sister Institute Fund of China Medical University Hospital; M. D. Anderson Cancer Center; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study was supported in part by: the Susan G. Komen Research Award KG080540, the Department of Defense Prostate Cancer Research Award PC073951, University of Cincinnati Center for Clinical and Translational Science and Training Junior Investigator Pilot Grant, the Marlene Harris-Ride Cincinnati Pilot Grant, and the Public Health Service Grant P30 DK078392 (to S-CW), the Sister Institute Fund of China Medical University Hospital and M. D. Anderson Cancer Center (to M-CH), and the institutional grant National Institute of Environmental Health Sciences ES007784 and Cancer Prevention and Research Institute of Texas funding RP110471 (to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; He X, 2009, APOPTOSIS, V14, P268, DOI 10.1007/s10495-009-0313-2; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Komatsu K, 2000, ONCOGENE, V19, P5291, DOI 10.1038/sj.onc.1203901; Lehmann AR, 2006, EXP CELL RES, V312, P2673, DOI 10.1016/j.yexcr.2006.06.010; Lin J, 2008, ONCOGENE, V27, P4385, DOI 10.1038/onc.2008.86; Lin J, 2007, ONCOGENE, V26, P6989, DOI 10.1038/sj.onc.1210500; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Marti TM, 2002, J CELL PHYSIOL, V191, P28, DOI 10.1002/jcp.10077; Matunis MJ, 2002, MOL CELL, V10, P441, DOI 10.1016/S1097-2765(02)00653-6; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Paunesku T, 2001, INT J RADIAT BIOL, V77, P1007, DOI 10.1080/09553000110069335; Sirvent A, 2007, ONCOGENE, V26, P7313, DOI 10.1038/sj.onc.1210543; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Ulrich HD, 2004, CELL CYCLE, V3, P15; Wadia JS, 2005, ADV DRUG DELIVER REV, V57, P579, DOI 10.1016/j.addr.2004.10.005; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Zhao HJ, 2011, MOL CANCER THER, V10, P29, DOI 10.1158/1535-7163.MCT-10-0778; Zhao HJ, 2010, NEOPLASIA, V12, P214, DOI 10.1593/neo.91576	23	36	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29416	10.1371/journal.pone.0029416	http://dx.doi.org/10.1371/journal.pone.0029416			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238610	Green Published, Green Submitted, gold			2022-12-27	WOS:000301070200027
J	Barandeh, F; Nguyen, PL; Kumar, R; Iacobucci, GJ; Kuznicki, ML; Kosterman, A; Bergey, EJ; Prasad, PN; Gunawardena, S				Barandeh, Farda; Phuong-Lan Nguyen; Kumar, Rajiv; Iacobucci, Gary J.; Kuznicki, Michelle L.; Kosterman, Andrew; Bergey, Earl J.; Prasad, Paras N.; Gunawardena, Shermali			Organically Modified Silica Nanoparticles Are Biocompatible and Can Be Targeted to Neurons In Vivo	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; AXONAL-TRANSPORT; GENE DELIVERY; DRUG; DISRUPTION; EXPRESSION; MUTATIONS; INSIGHT; SYSTEM; PROBES	The application of nanotechnology in biological research is beginning to have a major impact leading to the development of new types of tools for human health. One focus of nanobiotechnology is the development of nanoparticle-based formulations for use in drug or gene delivery systems. However most of the nano probes currently in use have varying levels of toxicity in cells or whole organisms and therefore are not suitable for in vivo application or long-term use. Here we test the potential of a novel silica based nanoparticle (organically modified silica, ORMOSIL) in living neurons within a whole organism. We show that feeding ORMOSIL nanoparticles to Drosophila has no effect on viability. ORMOSIL nanoparticles penetrate into living brains, neuronal cell bodies and axonal projections. In the neuronal cell body, nanoparticles are present in the cytoplasm, but not in the nucleus. Strikingly, incorporation of ORMOSIL nanoparticles into the brain did not induce aberrant neuronal death or interfered with normal neuronal processes. Our results in Drosophila indicate that these novel silica based nanoparticles are biocompatible and not toxic to whole organisms, and has potential for the development of long-term applications.	[Barandeh, Farda; Phuong-Lan Nguyen; Iacobucci, Gary J.; Kuznicki, Michelle L.; Kosterman, Andrew; Gunawardena, Shermali] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Kumar, Rajiv; Bergey, Earl J.; Prasad, Paras N.; Gunawardena, Shermali] SUNY Buffalo, Inst Lasers Photon & Biophoton, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Barandeh, F (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	sg99@buffalo.edu	Prasad, Paras N/U-2269-2019; Kumar, Rajiv/A-1457-2011	Kumar, Rajiv/0000-0002-2363-3930; gunawardena, shermali/0000-0001-8776-9397	State University of New York at Buffalo; John R. Oishei Foundation; Center for Undergraduate Research and Creative Activities (CURCA) from State University of New York (SUNY) at Buffalo; College of Arts and Sciences, SUNY at Buffalo	State University of New York at Buffalo; John R. Oishei Foundation; Center for Undergraduate Research and Creative Activities (CURCA) from State University of New York (SUNY) at Buffalo; College of Arts and Sciences, SUNY at Buffalo	This work is supported by funds from the State University of New York at Buffalo and from John R. Oishei Foundation to SG. GJI and MK were funded by a fellowship from the Center for Undergraduate Research and Creative Activities (CURCA) from State University of New York (SUNY) at Buffalo. An award from the Julian Park Publication Fund (College of Arts and Sciences, SUNY at Buffalo) helped defray publication costs for this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Affleck JG, 2008, CYTOTECHNOLOGY, V57, P1, DOI 10.1007/s10616-008-9124-5; Altinoglu EI, 2008, ACS NANO, V2, P2075, DOI 10.1021/nn800448r; Ashburner M, 2005, DROSOPHILA LAB HDB, P1408; Ashburner M., 1978, GENETICS BIOL DROS A, P1; Bharali DJ, 2005, P NATL ACAD SCI USA, V102, P11539, DOI 10.1073/pnas.0504926102; Deissler V, 2008, SMALL, V4, P1240, DOI 10.1002/smll.200701069; DEJONG G, 1990, CLIN CHIM ACTA, V190, P1, DOI 10.1016/0009-8981(90)90278-Z; Fye S, 2010, JOVE-J VIS EXP, P2128; Ghoroghchian PP, 2005, P NATL ACAD SCI USA, V102, P2922, DOI 10.1073/pnas.0409394102; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Gunawardena S, 2005, ARCH NEUROL-CHICAGO, V62, P46, DOI 10.1001/archneur.62.1.46; Gunawardena S, 2004, J NEUROBIOL, V58, P258, DOI 10.1002/neu.10319; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Han L, 2009, CHEM-EUR J, V15, P2818, DOI 10.1002/chem.200801688; Hewes RS, 1998, J NEUROSCI, V18, P7138; Hsich G, 2002, HUM GENE THER, V13, P579, DOI 10.1089/10430340252837198; Hulchanskyy TY, 2007, NANO LETT, V7, P2835, DOI 10.1021/nl0714637; Hurd DD, 1996, GENETICS, V144, P1075; Josephson L, 2002, BIOCONJUGATE CHEM, V13, P554, DOI 10.1021/bc015555d; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Kells AP, 2004, MOL THER, V9, P682, DOI 10.1016/j.ymthe.2004.02.016; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; Kim S, 2007, J AM CHEM SOC, V129, P2669, DOI 10.1021/ja0680257; Kraft R, 1998, J NEUROSCI, V18, P8886; Kumar R, 2008, ACS NANO, V2, P449, DOI 10.1021/nn700370b; Kumar R, 2010, ACS NANO, V4, P699, DOI 10.1021/nn901146y; Kuznicki Michelle L, 2010, J Vis Exp, DOI 10.3791/2151; Lee J, 2002, J NEUROSCI, V22, P11065; Lessing D, 2009, NAT REV GENET, V10, P359, DOI 10.1038/nrg2563; Mayer F, 2009, J NEUROSCI, V29, P3538, DOI 10.1523/JNEUROSCI.5564-08.2009; Meeusen T, 2002, P NATL ACAD SCI USA, V99, P15363, DOI 10.1073/pnas.252339599; Nichols CD, 2006, PHARMACOL THERAPEUT, V112, P677, DOI 10.1016/j.pharmthera.2006.05.012; Nyk M, 2008, NANO LETT, V8, P3834, DOI 10.1021/nl802223f; Ow H, 2005, NANO LETT, V5, P113, DOI [10.1021/nl0482478, 10.1012/nl0482478]; Park JH, 2008, ANGEW CHEM INT EDIT, V47, P7284, DOI 10.1002/anie.200801810; PAVLIDIS P, 1995, J NEUROSCI, V15, P5810; Pereanu W, 2007, DEV NEUROBIOL, V67, P1669, DOI 10.1002/dneu.20538; Pluskota A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006622; Qian J, 2008, OPT EXPRESS, V16, P19568, DOI 10.1364/OE.16.019568; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Qu L, 2009, J COMP NEUROL, V514, P343, DOI 10.1002/cne.22007; Rand MD, 2010, NEUROTOXICOL TERATOL, V32, P74, DOI 10.1016/j.ntt.2009.06.004; Roy I, 2003, J AM CHEM SOC, V125, P7860, DOI 10.1021/ja0343095; Santra S, 2004, CHEM COMMUN, P2810, DOI 10.1039/b411916a; Santra S, 2005, J NANOSCI NANOTECHNO, V5, P899, DOI 10.1166/jnn.2005.146; Satpute-Krishnan P, 2006, P NATL ACAD SCI USA, V103, P16532, DOI 10.1073/pnas.0607527103; Sharma RK, 2004, J COLLOID INTERF SCI, V277, P342, DOI 10.1016/j.jcis.2004.04.019; Slowing II, 2009, SMALL, V5, P57, DOI 10.1002/smll.200800926; Walcarius A, 2006, LANGMUIR, V22, P469, DOI 10.1021/la051916s; Zhao XJ, 2004, P NATL ACAD SCI USA, V101, P15027, DOI 10.1073/pnas.0404806101	51	99	101	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29424	10.1371/journal.pone.0029424	http://dx.doi.org/10.1371/journal.pone.0029424			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22238611	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400057
J	Cabral, FJ; Fotoran, WL; Wunderlich, G				Cabral, Fernanda J.; Fotoran, Wesley L.; Wunderlich, Gerhard			Dynamic Activation and Repression of the Plasmodium falciparum rif Gene Family and Their Relation to Chromatin Modification	PLOS ONE			English	Article							ANTIGENIC VARIATION; VARIANT PROTEINS; VIRULENCE GENES; MALARIA; TRANSCRIPTION; EXPRESSION; IDENTIFICATION; PHENOTYPES; REVEALS; SURFACE	The regulation of variant gene expression in Plasmodium falciparum is still only partially understood. Regulation of var genes, the most studied gene family involved in antigenic variation, is orchestrated by a dynamic pattern of inherited chromatin states. Although recent evidence pointed to epigenetic regulation of transcribed and repressed rif loci, little is known about specific on/off associated histone modifications of individual rif genes. To investigate the chromatin marks for transcribed and repressed rif loci, we cultivated parasites and evaluated the transcriptional status of chosen rif targets by qRT-PCR and performed ChIP assays using H3K9ac and H3K9me3 antibodies. We then monitored changes in the epigenetic patterns in parasites after several reinvasions and also evaluated the "poised'' mark in trophozoites and schizonts of the same erythrocytic cycle by ChIP using H3K4me2 specific antibodies. Our results show that H3K9 is acetylated in transcribed rif loci and trimethylated or even unmodified in repressed rif loci. These transcriptional and epigenetic states are inherited after several reinvasions. The poised modification H3K4me2 showed a tendency to be more present in loci in trophozoites that upon progression to schizonts strongly transcribe the respective locus. However, this effect was not consistently observed for all monitored loci. While our data show important similarities to var transcription-associated chromatin modifications, the observed swiftly occurring modifications at rif loci and the absence of H3K9 modification point to a different dynamic of recruitment of chromatin modifying enzymes.	[Cabral, Fernanda J.; Fotoran, Wesley L.; Wunderlich, Gerhard] Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Sao Paulo, Brazil	Universidade de Sao Paulo	Cabral, FJ (corresponding author), Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Sao Paulo, Brazil.	gwunder@usp.br	Wunderlich, Gerhard/G-8245-2012; Cabral, Fernanda Janku/W-5797-2019; Fotoran, Wesley/N-2545-2016; Janku Cabral, Fernanda/K-1317-2014	Wunderlich, Gerhard/0000-0003-1724-0337; Cabral, Fernanda Janku/0000-0001-9263-5553; Fotoran, Wesley/0000-0001-8203-8384; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, www.fapesp.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, METHODS MALARIA RES; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Cabral FJ, 2009, MOL BIOCHEM PARASIT, V168, P186, DOI 10.1016/j.molbiopara.2009.08.002; Chaal BK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000737; Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103; Claessens A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-180; Cui LW, 2010, EUKARYOT CELL, V9, P1138, DOI 10.1128/EC.00036-10; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Dzikowski R, 2006, PLOS PATHOG, V2, P184, DOI 10.1371/journal.ppat.0020022; Flueck C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000784; Golnitz U, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-14; Howitt CA, 2009, MOL MICROBIOL, V73, P1171, DOI 10.1111/j.1365-2958.2009.06846.x; Joannin N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-19; Kerppola TK, 2009, TRENDS CELL BIOL, V19, P692, DOI 10.1016/j.tcb.2009.10.001; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lelievre J, 2005, EXP PARASITOL, V109, P195, DOI 10.1016/j.exppara.2004.11.012; Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Mancio-Silva L, 2010, P NATL ACAD SCI USA, V107, P15117, DOI 10.1073/pnas.1001045107; Painter HJ, 2011, MOL BIOCHEM PARASIT, V176, P1, DOI 10.1016/j.molbiopara.2010.11.014; Perez-Toledo K, 2009, NUCLEIC ACIDS RES, V37, P2596, DOI 10.1093/nar/gkp115; Peters J, 2002, P NATL ACAD SCI USA, V99, P10689, DOI 10.1073/pnas.162349899; Petter M, 2007, MOL BIOCHEM PARASIT, V156, P51, DOI 10.1016/j.molbiopara.2007.07.011; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salcedo-Amaya AM, 2009, P NATL ACAD SCI USA, V106, P9655, DOI 10.1073/pnas.0902515106; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tonkin CJ, 2009, PLOS BIOL, V7, P771, DOI 10.1371/journal.pbio.1000084; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trelle MB, 2009, J PROTEOME RES, V8, P3439, DOI 10.1021/pr9000898; Volz J, 2010, INT J PARASITOL, V40, P109, DOI 10.1016/j.ijpara.2009.09.002; Wang CW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-147; Wang CW, 2009, INT J PARASITOL, V39, P655, DOI 10.1016/j.ijpara.2008.11.014; Westenberger SJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-610	37	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29881	10.1371/journal.pone.0029881	http://dx.doi.org/10.1371/journal.pone.0029881			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235345	gold, Green Published, Green Submitted			2022-12-27	WOS:000301123400107
J	Lando, D; Balmer, J; Laue, ED; Kouzarides, T				Lando, David; Balmer, Jenny; Laue, Ernest D.; Kouzarides, Tony			The S. pombe Histone H2A Dioxygenase Ofd2 Regulates Gene Expression during Hypoxia	PLOS ONE			English	Article							OXIDATIVE DEMETHYLATION; DEPENDENT OXYGENASES; LYSYL HYDROXYLASE; FISSION YEAST; HIF-ALPHA; DNA; PROTEINS; FAMILY; DAMAGE; ALKB	Post-translational modification of histone proteins are known to play an important role in regulating chromatin structure. In an effort to find additional histone modifications we set out to screen enzymes of the 2-oxoglutarate and Fe(II)-dependent (2-OG-Fe(II)) dioxygenase family for activity towards histones. Here we show that the Schizosaccharomyces pombe 2-OG-Fe(II) dioxygenase domain containing protein-2 (Ofd2) is a histone H2A dioxygenase enzyme. Using a combination of peptide screening and alanine scanning substitution analysis, we identify an HxxLR motif in H2A as a substrate for Ofd2 activity. Transcriptional profiling indicates that Ofd2 regulates the repression of oxidative phosphorylation genes during hypoxic stress. We show that Ofd2 is recruited to the 59 end of oxidative phosphorylation genes specifically during hypoxia and that it uses its dioxygenase activity to regulate their transcription. Together, these data uncover a novel histone H2A modifying activity involved in the regulation of gene expression during hypoxia.	[Lando, David; Kouzarides, Tony] Univ Cambridge, Gurdon Inst, Cambridge, England; [Lando, David; Kouzarides, Tony] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Balmer, Jenny; Laue, Ernest D.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge; University of Cambridge; University of Cambridge	Lando, D (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge, England.	t.kouzarides@gurdon.cam.ac.uk	Lando, David/AAH-3052-2019	Lando, David/0000-0001-5783-8769; Balmer, Jennifer/0000-0002-8469-4382; Kouzarides, Tony/0000-0002-8918-4162; Laue, Ernest/0000-0002-7476-4148	Wellcome Trust; Cancer Research United Kingdom	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research United Kingdom(Cancer Research UK)	Funding from Wellcome Trust (EL) and Cancer Research United Kingdom (TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow JN, 1997, BIOCHEM SOC T, V25, P86, DOI 10.1042/bst0250086; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Clifton IJ, 2001, EUR J BIOCHEM, V268, P6625, DOI 10.1046/j.0014-2956.2001.02617.x; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Falnes PO, 2003, RES MICROBIOL, V154, P531, DOI 10.1016/S0923-2508(03)00150-5; HAUTALA T, 1992, GENOMICS, V13, P62, DOI 10.1016/0888-7543(92)90202-4; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer LM, 2001, GENOME BIOL, V2; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MYLLYLA R, 1984, J BIOL CHEM, V259, P5403; Pan ZS, 2008, DEV DYNAM, V237, P316, DOI 10.1002/dvdy.21418; PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prescott AG, 1996, ANNU REV PLANT PHYS, V47, P245, DOI 10.1146/annurev.arplant.47.1.245; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tasto JJ, 2001, YEAST, V18, P657, DOI 10.1002/yea.713; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Welford RWD, 2003, J BIOL CHEM, V278, P10157, DOI 10.1074/jbc.M211058200; Zhang JH, 1999, ANAL BIOCHEM, V271, P137, DOI 10.1006/abio.1999.4135; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6	31	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29765	10.1371/journal.pone.0029765	http://dx.doi.org/10.1371/journal.pone.0029765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235339	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400101
J	Rajski, M; Vogel, B; Baty, F; Rochlitz, C; Buess, M				Rajski, Michal; Vogel, Brigitte; Baty, Florent; Rochlitz, Christoph; Buess, Martin			Global Gene Expression Analysis of the Interaction between Cancer Cells and Osteoblasts to Predict Bone Metastasis in Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR; SERUM-LEVELS; STEM-CELLS; INTERLEUKIN-6; IL-6; DISEASE; SIGNATURE; CARCINOMA; RESOURCE; SUBTYPES	Background: Bone metastasis is a main cause of morbidity in breast cancer. Since breast cancer is a heterogeneous disease, the interactions of cancer cells with the skeletal host cells might also be diverse. We hypothesized that gene expression signatures induced by heterotypic interaction of breast cancer cells and osteoblasts might be of clinical relevance. Methodology/Principal Findings: We established an ex vivo co-culture model using benign breast epithelial cells or a panel of 5 malignant breast epithelial cells in combination with primary human osteoblasts and determined associated gene expression changes with HEEBO microarrays. Pretreatment gene expression profiles of 295 early stage breast cancers published from the Netherlands Cancer Institute with a median follow up of 12.6 years allowed evaluating in vitro effects in the in vivo situation. The effects of the interaction between osteoblasts and breast cancer cell lines of different origin were very heterogeneous. Hs578T cells started to proliferate in co-culture with osteoblasts, SKBR-3 induced a TGF-beta response and MDA-MB231 cells showed two distinct sets of up-regulated genes: A set of interferon response genes associated with an up-regulation of STAT1 was in vivo remarkably coherent providing a basis for segregation of tumors into two groups. In a univariate analysis, early stage tumors with high expression levels (n = 136) of this gene set had a significantly lower overall survival rate (p = 0.005) (63% at 10 years) than tumors with low expression levels (n = 159) (overall survival: 77% at 10 years). The second gene set was associated with IL-6 and did not significantly change the overall survival rate (p = 0.165), but was significantly associated with a shorter time to bone metastasis (p = 0.049; 74% vs. 83% at 10 years). Conclusion/Significance: An IL-6 gene expression pattern induced by heterotypic interaction of breast cancer cells with osteoblasts in vitro is associated with a higher rate of bone metastasis in vivo.	[Rajski, Michal; Vogel, Brigitte; Rochlitz, Christoph; Buess, Martin] Univ Basel, Dept Biomed, Div Med Oncol, Basel, Switzerland; [Rajski, Michal] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Baty, Florent] Cantonal Hosp St Gallen, Div Pneumol, St Gallen, Switzerland; [Rochlitz, Christoph] Univ Basel Hosp, Div Med Oncol, CH-4031 Basel, Switzerland; [Buess, Martin] St Clara Hosp, Div Oncol, Basel, Switzerland	University of Basel; University of Zurich; Kantonsspital St. Gallen; University of Basel	Rajski, M (corresponding author), Univ Basel, Dept Biomed, Div Med Oncol, Basel, Switzerland.	Martin.Buess@claraspital.ch			Krebsliga beider Basel; Swiss National Science Foundation [320000-112794/1]; Oncosuisse	Krebsliga beider Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Oncosuisse	MB is a fellow of the Schoenmakers-Muller Foundation, Basel, Switzerland. MR was supported by the Krebsliga beider Basel (http://www.klbb.ch). This work was supported in part by the Swiss National Science Foundation grant 320000-112794/1(http://www.snf.ch) and a grant from Oncosuisse(http://www.oncosuisse.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bachelot T, 2003, BRIT J CANCER, V88, P1721, DOI 10.1038/sj.bjc.6600956; BATAILLE R, 1989, J CLIN INVEST, V84, P2008, DOI 10.1172/JCI114392; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Buess M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r191; Buess M, 2009, NEOPLASIA, V11, P987, DOI 10.1593/neo.09670; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; COLEMAN RE, 1987, BRIT J CANCER, V55, P61, DOI 10.1038/bjc.1987.13; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; Devlin RD, 1996, J CLIN ENDOCR METAB, V81, P1893, DOI 10.1210/jc.81.5.1893; Dhurjati R, 2008, CLIN EXP METASTAS, V25, P741, DOI 10.1007/s10585-008-9185-z; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Egeblad M, 2005, COLD SH Q B, V70, P383, DOI 10.1101/sqb.2005.70.007; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; HOYLAND JA, 1994, J BONE MINER RES, V9, P75; Iiizumi M, 2007, MICROVASC RES, V74, P114, DOI 10.1016/j.mvr.2007.04.002; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Karrison TG, 1999, JNCI-J NATL CANCER I, V91, P80, DOI 10.1093/jnci/91.1.80; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Li LH, 2006, CANCER RES, V66, P4553, DOI 10.1158/0008-5472.CAN-05-3986; Mauri D, 2010, J NATL COMPR CANC NE, V8, P279, DOI 10.6004/jnccn.2010.0020; Mourskaia AA, 2009, ONCOGENE, V28, P1005, DOI 10.1038/onc.2008.454; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nikiteas NI, 2005, WORLD J GASTROENTERO, V11, P1639; Paget S, 1889, CANCER METAST REV, V1, P98; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Rajski M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-1; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Rusciano D, 2000, IN VIVO CANC METASTA, P207; Safran M, 2010, GENECARDS VERSION 3; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Smid M, 2006, J CLIN ONCOL, V24, P2261, DOI 10.1200/JCO.2005.03.8802; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; UDAGAWA N, 1995, J EXP MED, V182, P1461, DOI 10.1084/jem.182.5.1461; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Zumsteg A, 2009, CURR OPIN ONCOL, V21, P60, DOI 10.1097/CCO.0b013e32831bed7e	53	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29743	10.1371/journal.pone.0029743	http://dx.doi.org/10.1371/journal.pone.0029743			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235336	gold, Green Published, Green Submitted			2022-12-27	WOS:000301123400098
J	Colvin, EK; Susanto, JM; Kench, JG; Ong, VN; Mawson, A; Pinese, M; Chang, DK; Rooman, I; O'Toole, SA; Segara, D; Musgrove, EA; Sutherland, RL; Apte, MV; Scarlett, CJ; Biankin, AV				Colvin, Emily K.; Susanto, Johana M.; Kench, James G.; Ong, Vivienna N.; Mawson, Amanda; Pinese, Mark; Chang, David K.; Rooman, Ilse; O'Toole, Sandra A.; Segara, Davendra; Musgrove, Elizabeth A.; Sutherland, Robert L.; Apte, Minoti V.; Scarlett, Christopher J.; Biankin, Andrew V.			Retinoid Signaling in Pancreatic Cancer, Injury and Regeneration	PLOS ONE			English	Article							BINDING-PROTEIN-I; GENE-EXPRESSION; CELLULAR RETINOL-BINDING-PROTEIN-1; HEDGEHOG; DIFFERENTIATION; METHYLATION; HYPERMETHYLATION; ADENOCARCINOMA; GENERATION; RECEPTORS	Background: Activation of embryonic signaling pathways quiescent in the adult pancreas is a feature of pancreatic cancer (PC). These discoveries have led to the development of novel inhibitors of pathways such as Notch and Hedgehog signaling that are currently in early phase clinical trials in the treatment of several cancer types. Retinoid signaling is also essential for pancreatic development, and retinoid therapy is used successfully in other malignancies such as leukemia, but little is known concerning retinoid signaling in PC. Methodology/Principal Findings: We investigated the role of retinoid signaling in vitro and in vivo in normal pancreas, pancreatic injury, regeneration and cancer. Retinoid signaling is active in occasional cells in the adult pancreas but is markedly augmented throughout the parenchyma during injury and regeneration. Both chemically induced and genetically engineered mouse models of PC exhibit a lack of retinoid signaling activity compared to normal pancreas. As a consequence, we investigated Cellular Retinoid Binding Protein 1 (CRBP1), a key regulator of retinoid signaling known to play a role in breast cancer development, as a potential therapeutic target. Loss, or significant downregulation of CRBP1 was present in 70% of human PC, and was evident in the very earliest precursor lesions (PanIN-1A). However, in vitro gain and loss of function studies and CRBP1 knockout mice suggested that loss of CRBP1 expression alone was not sufficient to induce carcinogenesis or to alter PC sensitivity to retinoid based therapies. Conclusions/Significance: In conclusion, retinoid signalling appears to play a role in pancreatic regeneration and carcinogenesis, but unlike breast cancer, it is not mediated directly by CRBP1.	[Colvin, Emily K.; Susanto, Johana M.; Kench, James G.; Ong, Vivienna N.; Mawson, Amanda; Pinese, Mark; Chang, David K.; Rooman, Ilse; O'Toole, Sandra A.; Segara, Davendra; Musgrove, Elizabeth A.; Sutherland, Robert L.; Scarlett, Christopher J.; Biankin, Andrew V.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia; [Kench, James G.; O'Toole, Sandra A.] Univ Sydney, Dept Tissue Pathol & Diagnost Oncol, Royal Prince Alfred Hosp, Cent Clin Sch, Camperdown, NSW, Australia; [Chang, David K.; Biankin, Andrew V.] Bankstown Hosp, Div Surg, Sydney, NSW, Australia; [O'Toole, Sandra A.; Sutherland, Robert L.; Apte, Minoti V.; Biankin, Andrew V.] Univ New S Wales, St Vincents Clin Sch, Fac Med, Sydney, NSW 2052, Australia; [Apte, Minoti V.] Univ New S Wales, Pancreat Res Grp, S Western Sydney Clin Sch, Sch Med Sci, Sydney, NSW 2052, Australia; [Scarlett, Christopher J.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia	Garvan Institute of Medical Research; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Newcastle	Colvin, EK (corresponding author), Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia.	a.biankin@garvan.org.au	Sutherland, Robert L/A-8378-2008; Apte, Minoti/X-2864-2019	Apte, Minoti/0000-0003-0194-8939; Biankin, Andrew/0000-0002-0362-5597; Colvin, Emily/0000-0002-5435-5902; Scarlett, Christopher/0000-0002-4140-7785; Chang, David/0000-0002-4821-3078; Rooman, Ilse/0000-0001-7264-2246; Kench, James Geoffrey/0000-0001-8687-4988; Pinese, Mark/0000-0001-5078-6687	Cancer Institute New South Wales (CINSW) [06/RSA/1-05, 08/RSA/1-15, 07/CDF/1-28, 09/CDF/2-40, 10/CRF/1-01]; National Health and Medical Research Council of Australia [427655]; Cancer Council New South Wales; St. Vincent's Clinic Foundation; Royal Australian College of Surgeons; Australian Cancer Research Foundation; Avner Nahmani Pancreatic Cancer Foundation; R. T. Hall Trust	Cancer Institute New South Wales (CINSW); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council New South Wales(Cancer Council New South Wales); St. Vincent's Clinic Foundation; Royal Australian College of Surgeons; Australian Cancer Research Foundation; Avner Nahmani Pancreatic Cancer Foundation; R. T. Hall Trust	This work was supported by the Cancer Institute New South Wales (CINSW), the National Health and Medical Research Council of Australia (#427655), The Cancer Council New South Wales, the St. Vincent's Clinic Foundation, the Royal Australian College of Surgeons, the Australian Cancer Research Foundation, The Avner Nahmani Pancreatic Cancer Foundation, and the R. T. Hall Trust. AVB, CJS, DKC, EAM and EKC are supported by fellowships from the CINSW (06/RSA/1-05; 08/RSA/1-15; 07/CDF/1-28; 09/CDF/2-40; 10/CRF/1-01). RLS is a Senior Principal Fellow of the NHMRC and holds the Petre Chair of Breast Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianifahanana M, 2001, CLIN CANCER RES, V7, P4033; BALAGUE C, 1995, GASTROENTEROLOGY, V109, P953, DOI 10.1016/0016-5085(95)90406-9; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Biankin AV, 2009, GASTROENTEROLOGY, V137, P558, DOI 10.1053/j.gastro.2009.04.009; Biankin AV, 2002, J CLIN ONCOL, V20, P4531, DOI 10.1200/JCO.2002.12.063; Bistulfi G, 2006, CANCER RES, V66, P10308, DOI 10.1158/0008-5472.CAN-06-1052; Crnogorac-Jurcevic T, 2003, J PATHOL, V201, P63, DOI 10.1002/path.1418; Cvetkovic D, 2003, CLIN CANCER RES, V9, P1013; Eads CA, 1999, CANCER RES, V59, P2302; Esteller M, 2002, CANCER RES, V62, P5902; Farias EF, 2005, J NATL CANCER I, V97, P21, DOI 10.1093/jnci/dji004; Fendrich V, 2008, GASTROENTEROLOGY, V135, P621, DOI 10.1053/j.gastro.2008.04.011; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; Froeling FE, 2011, GASTROENTEROLOGY; Furukawa T, 1996, AM J PATHOL, V148, P1763; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Gong YL, 2000, J SURG ONCOL, V73, P95, DOI 10.1002/(SICI)1096-9098(200002)73:2<95::AID-JSO7>3.3.CO;2-I; Heiser PW, 2004, CELL CYCLE, V3, P270; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Jeronimo C, 2004, J CLIN PATHOL, V57, P872, DOI 10.1136/jcp.2003.014555; Kimura K, 2007, CANCER SCI, V98, P155, DOI 10.1111/j.1349-7006.2006.00369.x; Kuppumbatti YS, 2000, J NATL CANCER I, V92, P475, DOI 10.1093/jnci/92.6.475; Lotan R, 2005, JNCI-J NATL CANCER I, V97, P3, DOI 10.1093/jnci/dji031; Maeda S, 2007, BRIT J CANCER, V97, P405, DOI 10.1038/sj.bjc.6603879; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Michalski CW, 2007, NAT CLIN PRACT ONCOL, V4, P526, DOI 10.1038/ncponc0925; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; Neoptolemos JP, 2001, LANCET, V358, P1576, DOI 10.1016/S0140-6736(01)06651-X; Neuschwander-Tetri BA, 2006, INT J BIOCHEM CELL B, V38, P102, DOI 10.1016/j.biocel.2005.08.008; Neuschwander-Tetri BA, 2000, DIGEST DIS SCI, V45, P665, DOI 10.1023/A:1005423122127; Ostrom M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002841; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Segara D, 2005, CLIN CANCER RES, V11, P3587, DOI 10.1158/1078-0432.CCR-04-1813; Shutoh M, 2005, CANCER-AM CANCER SOC, V104, P1609, DOI 10.1002/cncr.21392; Soprano DR, 2004, ANNU REV NUTR, V24, P201, DOI 10.1146/annurev.nutr.24.012003.132407; Sun SY, 2002, CRIT REV ONCOL HEMAT, V41, P41, DOI 10.1016/S1040-8428(01)00144-5; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Yeo CJ, 1997, ANN SURG, V226, P248, DOI 10.1097/00000658-199709000-00004	44	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29075	10.1371/journal.pone.0029075	http://dx.doi.org/10.1371/journal.pone.0029075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220202	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000300677000015
J	Iwata, NG; Pham, M; Rizzo, NO; Cheng, AM; Maloney, E; Kim, F				Iwata, Naomi G.; Pham, Matilda; Rizzo, Norma O.; Cheng, Andrew M.; Maloney, Ezekiel; Kim, Francis			Trans Fatty Acids Induce Vascular Inflammation and Reduce Vascular Nitric Oxide Production in Endothelial Cells	PLOS ONE			English	Article							KAPPA-B; ACTIVATION; GLUCOSE; SUPEROXIDE; BETA; FLOW	Intake of trans fatty acids (TFA), which are consumed by eating foods made from partially hydrogenated vegetable oils, is associated with a higher risk of cardiovascular disease. This relation can be explained by many factors including TFA's negative effect on endothelial function and reduced nitric oxide (NO) bioavailability. In this study we investigated the effects of three different TFA (2 common isomers of C18 found in partially hydrogenated vegetable oil and a C18 isomer found from ruminant-derived-dairy products and meat) on endothelial NF-kappa B activation and nitric oxide (NO) production. Human endothelial cells were treated with increasing concentrations of Elaidic (trans-C18: 1 (9 trans)), Linoelaidic (trans-C18: 2 (9 trans, 12 trans)), and Transvaccenic (trans-C18: 1 (11 trans)) for 3 h. Both Elaidic and Linoelaidic acids were associated with increasing NF-kappa B activation as measured by IL-6 levels and phosphorylation of I kappa B alpha, and impairment of endothelial insulin signaling and NO production, whereas Transvaccenic acid was not associated with these responses. We also measured superoxide production, which has been hypothesized to be necessary in fatty acid-dependent activation of NF-kappa B. Both Elaidic acid and Linoelaidic acid are associated with increased superoxide production, whereas Transvaccenic acid (which did not induce inflammatory responses) did not increase superoxide production. We observed differential activation of endothelial superoxide production, NF-kappa B activation, and reduction in NO production by different C18 isomers suggesting that the location and number of trans double bonds effect endothelial NF-kappa B activation.	[Iwata, Naomi G.; Pham, Matilda; Rizzo, Norma O.; Cheng, Andrew M.; Maloney, Ezekiel; Kim, Francis] Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Iwata, NG (corresponding author), Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA 98195 USA.	fkim@u.washington.edu		Maloney, Ezekiel/0000-0002-7614-4399	National Institute of Health [RO1 DK073878]; John Locke Jr. Charitable Trust; Kenneth H. Cooper Endowed Professorship in Preventive Cardiology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073878] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Locke Jr. Charitable Trust; Kenneth H. Cooper Endowed Professorship in Preventive Cardiology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant Support: National Institute of Health RO1 DK073878, John Locke Jr. Charitable Trust and Kenneth H. Cooper Endowed Professorship in Preventive Cardiology. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1999, J AM DIET ASSOC, V99, P166, DOI 10.1016/S0002-8223(99)00041-3; Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P445, DOI 10.1161/01.ATV.0000115637.48689.77; Baer DJ, 2004, AM J CLIN NUTR, V79, P969; Cai Hua, 2007, V139, P293; Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102; Cousin SP, 2001, ENDOCRINOLOGY, V142, P229, DOI 10.1210/en.142.1.229; Dikalov SI, 2007, BIOCHEM PHARMACOL, V73, P972, DOI 10.1016/j.bcp.2006.12.012; Dlouhy P, 2008, ANN NUTR METAB, V53, P129, DOI 10.1159/000162679; Gallis B, 1999, J BIOL CHEM, V274, P30101, DOI 10.1074/jbc.274.42.30101; Harvey KA, 2008, BRIT J NUTR, V99, P723, DOI 10.1017/S0007114507842772; Hingorani AD, 2000, CIRCULATION, V102, P994, DOI 10.1161/01.CIR.102.9.994; Kim F, 2005, J MOL CELL CARDIOL, V39, P327, DOI 10.1016/j.yjmcc.2005.05.009; Kim F, 2005, ARTERIOSCL THROM VAS, V25, P989, DOI 10.1161/01.ATV.0000160549.60980.a8; Kim F, 2001, AM J PHYSIOL-CELL PH, V280, pC1057, DOI 10.1152/ajpcell.2001.280.5.C1057; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kleschyov AL, 2000, BIOCHEM BIOPH RES CO, V275, P672, DOI 10.1006/bbrc.2000.3361; Kleschyov AL, 2002, METHOD ENZYMOL, V359, P42; Landmesser U, 2002, HYPERTENSION, V40, P511, DOI 10.1161/01.HYP.0000032100.23772.98; Lemaitre RN, 2006, CIRCULATION, V114, P209, DOI 10.1161/CIRCULATIONAHA.106.620336; Lopez-Garcia E, 2005, J NUTR, V135, P562, DOI 10.1093/jn/135.3.562; Maloney E, 2009, ARTERIOSCL THROM VAS, V29, P1370, DOI 10.1161/ATVBAHA.109.188813; Montagnani M, 2002, MOL ENDOCRINOL, V16, P1931, DOI 10.1210/me.2002-0074; Pieper GM, 1997, J CARDIOVASC PHARM, V30, P528, DOI 10.1097/00005344-199710000-00019; Steinberg HO, 1997, J CLIN INVEST, V100, P1230, DOI 10.1172/JCI119636; Steinberg HO, 2000, DIABETES, V49, P1231, DOI 10.2337/diabetes.49.7.1231; Sun Q, 2007, CIRCULATION, V115, P1858, DOI 10.1161/CIRCULATIONAHA.106.679985; Tardy AL, 2011, NUTR RES REV, P1; Vogel RA, 1997, AM J CARDIOL, V79, P350, DOI 10.1016/S0002-9149(96)00760-6; Young VM, 1998, METABOLISM, V47, P566, DOI 10.1016/S0026-0495(98)90241-4	29	70	73	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29600	10.1371/journal.pone.0029600	http://dx.doi.org/10.1371/journal.pone.0029600			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216328	Green Published, gold, Green Submitted			2022-12-27	WOS:000300676300071
J	Balakrishnan, T; Bela-Ong, DB; Toh, YX; Flamand, M; Devi, S; Koh, MB; Hibberd, ML; Ooi, EE; Low, JG; Leo, YS; Gu, F; Fink, K				Balakrishnan, Thavamalar; Bela-Ong, Dennis B.; Toh, Ying Xiu; Flamand, Marie; Devi, Shamala; Koh, Mickey B.; Hibberd, Martin L.; Ooi, Eng Eong; Low, Jenny G.; Leo, Yee Sin; Gu, Feng; Fink, Katja			Dengue Virus Activates Polyreactive, Natural IgG B Cells after Primary and Secondary Infection	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; PLASMA-CELLS; ANTIBODIES; PATHOGENESIS; RESPONSES; SURVIVAL; DISEASE; TARGETS; MEMORY; BAFF	Background: Dengue virus is transmitted by mosquitoes and has four serotypes. Cross-protection to other serotypes lasting for a few months is observed following infection with one serotype. There is evidence that low-affinity T and/or B cells from primary infections contribute to the severe syndromes often associated with secondary dengue infections. such pronounced immune-mediated enhancement suggests a dengue-specific pattern of immune cell activation. This study investigates the acute and early convalescent B cell response leading to the generation of cross-reactive and neutralizing antibodies following dengue infection. Methodology/Principal Findings: We assayed blood samples taken from dengue patients with primary or secondary infection during acute disease and convalescence and compared them to samples from patients presenting with non-dengue related fever. Dengue induced massive early plasmablast formation, which correlated with the appearance of polyclonal, cross-reactive IgG for both primary and secondary infection. Surprisingly, the contribution of IgG to the neutralizing titer 4-7 days after fever onset was more than 50% even after primary infection. Conclusions/Significance: Poly-reactive and virus serotype cross-reactive IgG are an important component of the innate response in humans during both primary and secondary dengue infection, and "innate specificities'' seem to constitute part of the adaptive response in dengue. While of potential importance for protection during secondary infection, cross-reactive B cells will also compete with highly neutralizing B cells and possibly interfere with their development.	[Balakrishnan, Thavamalar; Toh, Ying Xiu; Fink, Katja] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Bela-Ong, Dennis B.; Gu, Feng] Novartis Inst Trop Dis, Singapore, Singapore; [Flamand, Marie] Inst Pasteur, Dept Virol, Paris, France; [Devi, Shamala] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Koh, Mickey B.] Singapore Gen Hosp, Hlth Sci Author, Blood Serv Grp, Singapore 0316, Singapore; [Hibberd, Martin L.] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Ooi, Eng Eong] Duke NUS Grad Med Sch, Singapore, Singapore; [Low, Jenny G.; Leo, Yee Sin] Tock Seng Hosp, Communicable Dis Ctr, Dept Infect Dis, Singapore, Singapore; [Koh, Mickey B.] St George Hosp, Dept Haematol, London, England	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Novartis; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universiti Malaya; Health Sciences Authority (HSA); Singapore General Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; St Georges University London	Balakrishnan, T (corresponding author), ASTAR, Singapore Immunol Network, Singapore, Singapore.	Katja_Fink@immunol.a-star.edu.sg	Bela-ong, Dennis/H-6782-2019; Devi, Shamala Devi/B-9735-2010; Hibberd, Martin L/D-5050-2009; Sekaran, Shamala Devi/B-8482-2008; Fink, Katja/AAI-1881-2021	Bela-ong, Dennis/0000-0002-9483-3542; Devi, Shamala Devi/0000-0002-0478-0425; Sekaran, Shamala Devi/0000-0002-0478-0425; Fink, Katja/0000-0002-3571-0390; Ooi, Eng Eong/0000-0002-0520-1544; Hibberd, Martin/0000-0001-8587-1849	Agency for Science, Technology and Research A*STAR; National Research Foundation NRF, Singapore	Agency for Science, Technology and Research A*STAR(Agency for Science Technology & Research (A*STAR)); National Research Foundation NRF, Singapore(National Research Foundation, Singapore)	This study was supported by the Agency for Science, Technology and Research A*STAR, and the National Research Foundation NRF, Singapore (Translational and Clinical Research Program STOP Dengue). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bombardieri M, 2011, ANN RHEUM DIS, V70, P1857, DOI 10.1136/ard.2011.150219; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188; De Vita S, 2008, AUTOIMMUN REV, V8, P95, DOI 10.1016/j.autrev.2008.05.005; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Donati D, 2004, INFECT IMMUN, V72, P5412, DOI 10.1128/IAI.72.9.5412-5418.2004; FALCONAR AKI, 1990, J VIROL METHODS, V30, P323, DOI 10.1016/0166-0934(90)90075-Q; Gorelik L, 2003, J EXP MED, V198, P937, DOI 10.1084/jem.20030789; Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Hammond SN, 2005, AM J TROP MED HYG, V73, P1063; Hubert B, 2009, EMERG INFECT DIS, V15, P1265, DOI 10.3201/eid1508.081500; Ittah M, 2009, EUR J IMMUNOL, V39, P1271, DOI 10.1002/eji.200839086; Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07; Lacroix-Desmazes S, 1998, J IMMUNOL METHODS, V216, P117, DOI 10.1016/S0022-1759(98)00074-X; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Lee FEH, 2011, J IMMUNOL, V186, P5514, DOI 10.4049/jimmunol.1002932; Lin CF, 2003, J MED VIROL, V69, P82, DOI 10.1002/jmv.10261; Low JGH, 2006, ANN ACAD MED SINGAP, V35, P783; Lutz HU, 2009, TRENDS IMMUNOL, V30, P43, DOI 10.1016/j.it.2008.10.002; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Marovich M, 2001, J INVEST DERM SYMP P, V6, P219, DOI 10.1046/j.0022-202x.2001.00037.x; Mathew A, 2011, J INFECT DIS, V204, P1514, DOI 10.1093/infdis/jir607; McBride W. J. H., 1995, Communicable Diseases Intelligence, V19, P522; Meffre E, 2008, CURR OPIN IMMUNOL, V20, P632, DOI 10.1016/j.coi.2008.09.001; Mei HE, 2009, BLOOD, V113, P2461, DOI 10.1182/blood-2008-04-153544; Mei Henrik E., 2007, V136, P3; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; Recher M, 2004, NAT IMMUNOL, V5, P934, DOI 10.1038/ni1102; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Schieffelin JS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-28; Stoiber H, 2009, CURR OPIN HIV AIDS, V4, P394, DOI 10.1097/COH.0b013e32832f0108; TAMURA M, 1994, J VIROL, V68, P3499, DOI 10.1128/JVI.68.6.3499-3504.1994; Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407; Woods A, 2007, J VIROL, V81, P12525, DOI 10.1128/JVI.00839-07; Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553; Yoksan S, 2009, J CLIN VIROL, V46, pS13, DOI 10.1016/S1386-6532(09)70289-6	47	63	63	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29430	10.1371/journal.pone.0029430	http://dx.doi.org/10.1371/journal.pone.0029430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216280	Green Published, gold, Green Accepted			2022-12-27	WOS:000299684700055
J	Arkun, Y; Gur, M				Arkun, Yaman; Gur, Mert			Combining Optimal Control Theory and Molecular Dynamics for Protein Folding	PLOS ONE			English	Article							ENERGY LANDSCAPE; SIMULATIONS; MODEL; PATHWAYS; ENTROPY; MOTIONS	A new method to develop low-energy folding routes for proteins is presented. The novel aspect of the proposed approach is the synergistic use of optimal control theory with Molecular Dynamics (MD). In the first step of the method, optimal control theory is employed to compute the force field and the optimal folding trajectory for the C-alpha atoms of a Coarse-Grained (CG) protein model. The solution of this CG optimization provides an harmonic approximation of the true potential energy surface around the native state. In the next step CG optimization guides the MD simulation by specifying the optimal target positions for the C-alpha atoms. In turn, MD simulation provides an all-atom conformation whose C-alpha positions match closely the reference target positions determined by CG optimization. This is accomplished by Targeted Molecular Dynamics (TMD) which uses a bias potential or harmonic restraint in addition to the usual MD potential. Folding is a dynamical process and as such residues make different contacts during the course of folding. Therefore CG optimization has to be reinitialized and repeated over time to accomodate these important changes. At each sampled folding time, the active contacts among the residues are recalculated based on the all-atom conformation obtained from MD. Using the new set of contacts, the CG potential is updated and the CG optimal trajectory for the C-alpha atoms is recomputed. This is followed by MD. Implementation of this repetitive CG optimization - MD simulation cycle generates the folding trajectory. Simulations on a model protein Villin demonstrate the utility of the method. Since the method is founded on the general tools of optimal control theory and MD without any restrictions, it is widely applicable to other systems. It can be easily implemented with available MD software packages.	[Arkun, Yaman] Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey; [Gur, Mert] Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey	Koc University; Koc University	Arkun, Y (corresponding author), Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey.	yarkun@ku.edu.tr	Gur, Mert/O-5304-2015; Gur, Mert/P-6408-2014	Gur, Mert/0000-0003-0983-4397; 				ADOLF DB, 1991, MACROMOLECULES, V24, P5834, DOI 10.1021/ma00021a018; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amadei A, 1999, PROTEINS, V35, P283, DOI 10.1002/(SICI)1097-0134(19990515)35:3<283::AID-PROT2>3.0.CO;2-R; Arkun Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013275; Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; Christen M, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2187488; Clementi C, 2007, CURR OPIN STRUC BIOL, V17, P1; Colombo G, 2006, THEOR CHEM ACC, V116, P75, DOI 10.1007/s00214-005-0026-8; Das P, 2005, P NATL ACAD SCI USA, V102, P10141, DOI 10.1073/pnas.0409471102; Das P, 2006, P NATL ACAD SCI USA, V103, P9885, DOI 10.1073/pnas.0603553103; De Mori GMS, 2005, PROTEINS, V58, P459, DOI 10.1002/prot.20313; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Duan Y, 1998, SCIENCE, V282, P740, DOI 10.1126/science.282.5389.740; Erman B, 2000, J CHEM PHYS, V112, P1050, DOI 10.1063/1.480629; Faller R, 2004, POLYMER, V45, P3869, DOI 10.1016/j.polymer.2003.11.053; Ferrara P, 2000, J PHYS CHEM B, V104, P4511, DOI 10.1021/jp9943878; Freddolino PL, 2009, BIOPHYS J, V97, P2338, DOI 10.1016/j.bpj.2009.08.012; GO N, 1983, ANNU REV BIOPHYS BIO, V12, P183, DOI 10.1146/annurev.bb.12.060183.001151; Guner U, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2181976; Hinsen K, 1998, PROTEINS, V33, P417, DOI 10.1002/(SICI)1097-0134(19981115)33:3<417::AID-PROT10>3.0.CO;2-8; Izvekov S, 2005, J PHYS CHEM B, V109, P2469, DOI 10.1021/jp044629q; Kwakernaak H., 1972, LINEAR OPTIMAL CONTR; Lee IH, 2010, J COMPUT CHEM, V31, P57, DOI 10.1002/jcc.21288; Lei HX, 2007, P NATL ACAD SCI USA, V104, P4925, DOI 10.1073/pnas.0608432104; Lyman E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028105; Merris R, 1994, LIN ALGEBRA APPL, V143, P197; Muller-Plathe F, 2002, CHEMPHYSCHEM, V3, P754, DOI 10.1002/1439-7641(20020916)3:9<754::AID-CPHC754>3.0.CO;2-U; Neri M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.218102; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Palazoglu A, 2004, J COMPUT BIOL, V11, P1149, DOI 10.1089/cmb.2004.11.1149; Passerone D, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.108302; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Praprotnik M, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2132286; SCHLITTER J, 1993, MOL SIMULAT, V10, P291, DOI 10.1080/08927029308022170; Shen MY, 2002, PROTEINS, V49, P439, DOI 10.1002/prot.10230; Weikl TR, 2003, J MOL BIOL, V329, P585, DOI 10.1016/S0022-2836(03)00436-4	36	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29628	10.1371/journal.pone.0029628	http://dx.doi.org/10.1371/journal.pone.0029628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238629	Green Published, gold, Green Submitted			2022-12-27	WOS:000301188800021
J	Lowry, H; Lill, A; Wong, BBM				Lowry, Helene; Lill, Alan; Wong, Bob B. M.			How Noisy Does a Noisy Miner Have to Be? Amplitude Adjustments of Alarm Calls in an Avian Urban 'Adapter'	PLOS ONE			English	Article							ACOUSTIC COMMUNICATION; SONG AMPLITUDE; HIGHER PITCH; BIRDS; URBANIZATION; EVOLUTION; VARIES	Background: Urban environments generate constant loud noise, which creates a formidable challenge for many animals relying on acoustic communication. Some birds make vocal adjustments that reduce auditory masking by altering, for example, the frequency (kHz) or timing of vocalizations. Another adjustment, well documented for birds under laboratory and natural field conditions, is a noise level-dependent change in sound signal amplitude (the 'Lombard effect'). To date, however, field research on amplitude adjustments in urban environments has focused exclusively on bird song. Methods: We investigated amplitude regulation of alarm calls using, as our model, a successful urban 'adapter' species, the Noisy miner, Manorina melanocephala. We compared several different alarm calls under contrasting noise conditions. Results: Individuals at noisier locations (arterial roads) alarm called significantly more loudly than those at quieter locations (residential streets). Other mechanisms known to improve sound signal transmission in 'noise', namely use of higher perches and in-flight calling, did not differ between site types. Intriguingly, the observed preferential use of different alarm calls by Noisy miners inhabiting arterial roads and residential streets was unlikely to have constituted a vocal modification made in response to sound-masking in the urban environment because the calls involved fell within the main frequency range of background anthropogenic noise. Conclusions: The results of our study suggest that a species, which has the ability to adjust the amplitude of its signals, might have a 'natural' advantage in noisy urban environments.	[Lowry, Helene; Lill, Alan; Wong, Bob B. M.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Monash University	Lowry, H (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	Helene.Lowry@monash.edu		Wong, Bob/0000-0001-9352-6500	Stuart Leslie Bird Research Award (Birds Australia)	Stuart Leslie Bird Research Award (Birds Australia)	This project was funded by a Stuart Leslie Bird Research Award (Birds Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, TRAFF VOL DAT INF MA; Blair R, 2004, ECOL SOC, V9; BRACKENBURY JH, 1979, J EXP BIOL, V78, P163; Bradbury Jack W., 1998, pi; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Brumm H, 2004, AN ACAD BRAS CIENC, V76, P289, DOI 10.1590/S0001-37652004000200017; Brumm H, 2004, J EXP BIOL, V207, P443, DOI 10.1242/jeb.00768; Brumm H, 2002, ANIM BEHAV, V63, P891, DOI 10.1006/anbe.2001.1968; Brumm H, 2004, J ANIM ECOL, V73, P434, DOI 10.1111/j.0021-8790.2004.00814.x; Brumm H, 2009, ANIM BEHAV, V78, P741, DOI 10.1016/j.anbehav.2009.07.004; Cynx J, 1998, ANIM BEHAV, V56, P107, DOI 10.1006/anbe.1998.0746; DABELSTEEN T, 1993, J ACOUST SOC AM, V93, P2206, DOI 10.1121/1.406682; Dooling R.J., 1980, P261; Dooling RJ, 2000, SPR HDB AUD, V13, P308; DOW D D, 1979, Ibis, V121, P423, DOI 10.1111/j.1474-919X.1979.tb06683.x; Faeth SH, 2005, BIOSCIENCE, V55, P399, DOI 10.1641/0006-3568(2005)055[0399:TDIUC]2.0.CO;2; Fernandez-Juricic Esteban, 2005, Urban Habitats, V3, P49; Fuller RA, 2007, BIOLOGY LETT, V3, P368, DOI 10.1098/rsbl.2007.0134; Higgins P. J., 2001, HDB AUSTR NZ ANTARCT, V5, P626; Hochachka WM, 2009, CONDOR, V111, P349, DOI 10.1525/cond.2009.080086; JURISEVIC MA, 1994, EMU, V94, P67; Kirschel ANG, 2009, BEHAV ECOL, V20, P1089, DOI 10.1093/beheco/arp101; Leader N, 2005, AUK, V122, P231, DOI 10.1642/0004-8038(2005)122[0231:APOTUS]2.0.CO;2; Lohr B, 2003, ANIM BEHAV, V65, P763, DOI 10.1006/anbe.2003.2093; Luther D, 2010, P R SOC B, V277, P469, DOI 10.1098/rspb.2009.1571; Manabe K, 1998, J ACOUST SOC AM, V103, P1190, DOI 10.1121/1.421227; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Nemeth E, 2010, AM NAT, V176, P465, DOI 10.1086/656275; Nemeth E, 2009, ANIM BEHAV, V78, P637, DOI 10.1016/j.anbehav.2009.06.016; Oberweger K, 2001, J EXP BIOL, V204, P3379; Parris KM, 2009, ECOL SOC, V14; Parris KM, 2009, ECOL SOC, V14; Penna M, 2007, ANIM BEHAV, V74, P45, DOI 10.1016/j.anbehav.2006.11.010; Potvin DA, 2011, P R SOC B IN PRESS; Pytte CL, 2003, ANIM BEHAV, V66, P703, DOI 10.1006/anbe.2003.2257; Rabin LA, 2002, J COMP PSYCHOL, V116, P137, DOI 10.1037//0735-7036.116.2.137; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Slabbekoorn H, 2007, CONDOR, V109, P67, DOI 10.1650/0010-5422(2007)109[67:STASDA]2.0.CO;2; Slabbekoorn H, 2006, CURR BIOL, V16, P2326, DOI 10.1016/j.cub.2006.10.008; Slabbekoorn Hans, 2004, P178, DOI 10.1016/B978-012473070-0/50009-8; Warren PS, 2006, ANIM BEHAV, V71, P491, DOI 10.1016/j.anbehav.2005.07.014; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047; Wood WE, 2006, AUK, V123, P650, DOI 10.1642/0004-8038(2006)123[650:SSMMSV]2.0.CO;2	46	38	38	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29960	10.1371/journal.pone.0029960	http://dx.doi.org/10.1371/journal.pone.0029960			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238684	Green Submitted, Green Published, gold			2022-12-27	WOS:000301070200061
J	Mothe, B; Llano, A; Ibarrondo, J; Zamarreno, J; Schiaulini, M; Miranda, C; Ruiz-Riol, M; Berger, CT; Herrero, MJ; Palou, E; Plana, M; Rolland, M; Khatri, A; Heckerman, D; Pereyra, F; Walker, BD; Weiner, D; Paredes, R; Clotet, B; Felber, BK; Pavlakis, GN; Mullins, JI; Brander, C				Mothe, Beatriz; Llano, Anuska; Ibarrondo, Javier; Zamarreno, Jennifer; Schiaulini, Mattia; Miranda, Cristina; Ruiz-Riol, Marta; Berger, Christoph T.; Jose Herrero, M.; Palou, Eduard; Plana, Montse; Rolland, Morgane; Khatri, Ashok; Heckerman, David; Pereyra, Florencia; Walker, Bruce D.; Weiner, David; Paredes, Roger; Clotet, Bonaventura; Felber, Barbara K.; Pavlakis, George N.; Mullins, James I.; Brander, Christian			CTL Responses of High Functional Avidity and Broad Variant Cross-Reactivity Are Associated with HIV Control	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD8(+) T-CELLS; VIRAL LOAD; INFECTION; EPITOPE; GAG; LYMPHOCYTES; IMMUNE; POLYFUNCTIONALITY; IMMUNODOMINANCE	Cytotoxic T lymphocyte (CTL) responses targeting specific HIV proteins, in particular Gag, have been associated with relative control of viral replication in vivo. However, Gag-specific CTL can also be detected in individuals who do not control the virus and it remains thus unclear how Gag-specific CTL may mediate the beneficial effects in some individuals but not in others. Here, we used a 10mer peptide set spanning HIV Gag-p24 to determine immunogen-specific T-cell responses and to assess functional properties including functional avidity and cross-reactivity in 25 HIV-1 controllers and 25 non-controllers without protective HLA class I alleles. Our data challenge the common belief that Gag-specific T cell responses dominate the virus-specific immunity exclusively in HIV-1 controllers as both groups mounted responses of comparable breadths and magnitudes against the p24 sequence. However, responses in controllers reacted to lower antigen concentrations and recognized more epitope variants than responses in non-controllers. These cross-sectional data, largely independent of particular HLA genetics and generated using direct ex-vivo samples thus identify T cell responses of high functional avidity and with broad variant reactivity as potential functional immune correlates of relative HIV control.	[Mothe, Beatriz; Llano, Anuska; Ibarrondo, Javier; Zamarreno, Jennifer; Schiaulini, Mattia; Ruiz-Riol, Marta; Paredes, Roger; Clotet, Bonaventura; Brander, Christian] Hosp Badalona Germans Trias & Pujol, IrsiCaixa AIDS Res Inst HIVACAT, Barcelona, Spain; [Mothe, Beatriz; Miranda, Cristina; Paredes, Roger; Clotet, Bonaventura] Hosp Badalona Germans Trias & Pujol, Lluita Sida Fdn, Barcelona, Spain; [Mothe, Beatriz; Schiaulini, Mattia] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Berger, Christoph T.; Pereyra, Florencia; Walker, Bruce D.] MIT & Harvard, Ragon Inst MGH, Boston, MA USA; [Jose Herrero, M.; Palou, Eduard] Hosp Badalona Germans Trias & Pujol, Dept Immunol, LIRAD Banc Sang & Teixits, Barcelona, Spain; [Plana, Montse] Univ Barcelona, HIVACAT, Hosp Clin, AIDS Res Grp IDIBAPS, Barcelona, Spain; [Rolland, Morgane; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Khatri, Ashok] Massachusetts Gen Hosp, Peptide Prot Core Facil, Boston, MA 02114 USA; [Heckerman, David] Microsoft Res, Redmond, WA USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Weiner, David] Univ Penn, Philadelphia, PA 19104 USA; [Felber, Barbara K.; Pavlakis, George N.] NCI Frederick, Frederick, MD USA; [Brander, Christian] ICREA, Barcelona, Spain	Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Hospital Germans Trias i Pujol; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Microsoft; Howard Hughes Medical Institute; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); ICREA	Mothe, B (corresponding author), Hosp Badalona Germans Trias & Pujol, IrsiCaixa AIDS Res Inst HIVACAT, Barcelona, Spain.	cbrander@irsicaixa.es	Plana, Montserrat/AAA-5124-2020; Ruiz-Riol, Marta/AAL-7837-2021; Berger, Christoph T/I-6126-2019	Berger, Christoph T/0000-0002-1730-8824; Palou, Eduard/0000-0003-1544-1485; Brander, Christian/0000-0002-0548-5778; Mothe, Beatriz/0000-0001-9975-407X	Bill and Melinda Gates Foundation; Red de Investigacion de Sida (RIS) [RD06/04]; Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Spanish FIPSE [36-0737-09]; NATIONAL CANCER INSTITUTE [ZIABC010749, ZIABC010350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, P30AI060354] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Red de Investigacion de Sida (RIS); Instituto de Salud Carlos III (ISCIII), Madrid, Spain(Instituto de Salud Carlos III); Spanish FIPSE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICREA(ICREA)	This work was funded by Bill and Melinda Gates Foundation and was supported in part by the Red de Investigacion de Sida (RIS) (RD06/04), Instituto de Salud Carlos III (ISCIII), Madrid, Spain and the Spanish FIPSE 36-0737-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlexanderMiller MA, 1996, P NATL ACAD SCI USA, V93, P4102, DOI 10.1073/pnas.93.9.4102; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Bennett MS, 2010, AIDS; Berger CT, 2011, J VIROL, V85, P9334, DOI 10.1128/JVI.00460-11; Betts MR, 2004, J IMMUNOL, V172, P6407, DOI 10.4049/jimmunol.172.10.6407; Bihl F, 2006, J IMMUNOL, V176, P4094, DOI 10.4049/jimmunol.176.7.4094; Brander C, 1999, J IMMUNOL, V162, P4796; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Dinges WL, 2010, J VIROL, V84, P4461, DOI 10.1128/JVI.02438-09; Draenert R, 2003, J IMMUNOL METHODS, V275, P19, DOI 10.1016/S0022-1759(02)00541-0; Dubey S, 2007, JAIDS-J ACQ IMM DEF, V45, P20, DOI 10.1097/QAI.0b013e3180377b5b; Dzutsev AH, 2007, INT IMMUNOL, V19, P497, DOI 10.1093/intimm/dxm016; Elahi S, 2011, NAT MED, V17, P989, DOI 10.1038/nm.2422; Fomsgaard A, VACCINE; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Frahm N, 2007, J IMMUNOL, V179, P6638, DOI 10.4049/jimmunol.179.10.6638; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; Gea-Banacloche JC, 2000, J IMMUNOL, V165, P1082, DOI 10.4049/jimmunol.165.2.1082; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Li F, 2001, PLOS ONE; Lichterfeld M, 2007, J VIROL, V81, P4199, DOI 10.1128/JVI.01388-06; Llano A, 2009, HIV MOL IMMUNOLOGY D; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Mothe B, 2009, DIS MARKERS, V27, P105, DOI [10.1155/2009/360362, 10.3233/DMA-2009-0655]; Oxenius A, 2001, EUR J IMMUNOL, V31, P1115, DOI 10.1002/1521-4141(200104)31:4<1115::AID-IMMU1115>3.0.CO;2-9; Pereyra F, 2008, AIDS VACC M CAP TOWN; Prado JG, 2011, CURR MED CHEM; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Schneidewind A, 2008, J VIROL, V82, P5594, DOI 10.1128/JVI.02356-07; Sedlik C, 2000, J VIROL, V74, P5769, DOI 10.1128/JVI.74.13.5769-5775.2000; Snyder JT, 2003, CURR HIV RES, V1, P287, DOI 10.2174/1570162033485230; Turnbull EL, 2006, J IMMUNOL, V176, P6130, DOI 10.4049/jimmunol.176.10.6130; Weekes MP, 2006, IMMUNOLOGY, V118, P25, DOI 10.1111/j.1365-2567.2006.02334.x; Yerly D, 2008, J VIROL, V82, P3147, DOI 10.1128/JVI.02252-07; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	42	104	111	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29717	10.1371/journal.pone.0029717	http://dx.doi.org/10.1371/journal.pone.0029717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238642	gold, Green Published, Green Submitted			2022-12-27	WOS:000301070200043
J	Shen, SH; Wertz, DL; Klinman, JP				Shen, Sam H.; Wertz, Diana L.; Klinman, Judith P.			Implication for Functions of the Ectopic Adipocyte Copper Amine Oxidase (AOC3) from Purified Enzyme and Cell-Based Kinetic Studies	PLOS ONE			English	Article							VASCULAR ADHESION PROTEIN-1; L-THREONINE DEHYDROGENASE; LEUKOCYTE-ENDOTHELIUM INTERACTIONS; WHITE ADIPOSE-TISSUE; HANSENULA-POLYMORPHA; MONOAMINE OXIDASES; SUBSTRATE-SPECIFICITY; INFLAMMATORY RESPONSE; LIQUID-CHROMATOGRAPHY; REGULATED EXPRESSION	AOC3 is highly expressed in adipocytes and smooth muscle cells, but its function in these cells is currently unknown. The in vivo substrate(s) of AOC3 is/are also unknown, but could provide an invaluable clue to the enzyme's function. Expression of untagged, soluble human AOC3 in insect cells provides a relatively simple means of obtaining pure enzyme. Characterization of enzyme indicates a 6% titer for the active site 2,4,5-trihydroxyphenylalanine quinone (TPQ) cofactor and corrected k(cat) values as high as 7 s(-1). Substrate kinetic profiling shows that the enzyme accepts a variety of primary amines with different chemical features, including nonphysiological branched-chain and aliphatic amines, with measured k(cat)/K-m values between 10(2) and 10(4) M-1 s(-1). K-m(O-2) approximates the partial pressure of oxygen found in the interstitial space. Comparison of the properties of purified murine to human enzyme indicates k(cat)/K-m values that are within 3 to 4-fold, with the exception of methylamine and aminoacetone that are ca. 10-fold more active with human AOC3. With drug development efforts investigating AOC3 as an anti-inflammatory target, these studies suggest that caution is called for when screening the efficacy of inhibitors designed against human enzymes in non-transgenic mouse models. Differentiated murine 3T3-L1 adipocytes show a uniform distribution of AOC3 on the cell surface and whole cell K-m values that are reasonably close to values measured using purified enzymes. The latter studies support a relevance of the kinetic parameters measured with isolated AOC3 variants to adipocyte function. From our studies, a number of possible substrates with relatively high k(cat)/K-m have been discovered, including dopamine and cysteamine, which may implicate a role for adipocyte AOC3 in insulin-signaling and fatty acid metabolism, respectively. Finally, the demonstrated AOC3 turnover of primary amines that are non-native to human tissue suggests possible roles for the adipocyte enzyme in subcutaneous bacterial infiltration and obesity.	[Shen, Sam H.; Wertz, Diana L.; Klinman, Judith P.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Klinman, Judith P.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Klinman, Judith P.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Shen, SH (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	klinman@berkeley.edu			National Institutes of Health [GM039296, T32GM8352, T32GM20202]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020202, T32GM008352, R01GM039296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health, GM039296 to JK, T32GM8352 to SS, and T32GM20202 to DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airenne TT, 2005, PROTEIN SCI, V14, P1964, DOI 10.1110/ps.051438105; ALLISON C, 1989, APPL ENVIRON MICROB, V55, P2894, DOI 10.1128/AEM.55.11.2894-2898.1989; Andres N, 2001, J HISTOCHEM CYTOCHEM, V49, P209, DOI 10.1177/002215540104900208; AOYAMA Y, 1981, J BIOL CHEM, V256, P2367; BALLEVRE O, 1990, AM J PHYSIOL, V259, pE483, DOI 10.1152/ajpendo.1990.259.4.E483; Bamshad M, 1998, AM J PHYSIOL-REG I, V275, pR291, DOI 10.1152/ajpregu.1998.275.1.R291; Barreiro O, 2009, REV ESP CARDIOL, V62, P552, DOI 10.1016/S0300-8932(09)71035-8; Bickel PE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1, DOI 10.1152/ajpendo.2002.282.1.E1; BIRD MI, 1983, BIOCHEM J, V214, P687, DOI 10.1042/bj2140687; BIRD MI, 1984, BIOCHIM BIOPHYS ACTA, V802, P229, DOI 10.1016/0304-4165(84)90166-1; Bonaiuto E, 2010, BIOCHIMIE, V92, P858, DOI 10.1016/j.biochi.2010.03.006; Boomsma F, 2000, EUR HEART J, V21, P1859, DOI 10.1053/euhj.2000.2176; Boomsma F, 1999, DIABETOLOGIA, V42, P233, DOI 10.1007/s001250051143; Booth RE, 2003, PROTEIN EXPRES PURIF, V32, P141, DOI 10.1016/S1046-5928(03)00226-2; Bouwman JJM, 2008, INT J OBESITY, V32, P892, DOI 10.1038/ijo.2008.36; BOYLAN SA, 1981, J BIOL CHEM, V256, P1809; Brazeau BJ, 2004, ARCH BIOCHEM BIOPHYS, V428, P22, DOI 10.1016/j.abb.2004.03.034; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; Caesar R, 2010, J INTERN MED, V268, P320, DOI 10.1111/j.1365-2796.2010.02270.x; Cai DY, 1997, J BIOL CHEM, V272, P19277, DOI 10.1074/jbc.272.31.19277; Carpene C, 2007, PHARMACOL RES, V56, P522, DOI 10.1016/j.phrs.2007.09.016; Carpene C, 2005, J PHYSIOL BIOCHEM, V61, P405, DOI 10.1007/BF03167058; Chang CM, 2010, BIOCHEMISTRY-US, V49, P2540, DOI 10.1021/bi901933d; DAVIS EJ, 1961, NATURE, V190, P636, DOI 10.1038/190636a0; DuBois JL, 2005, ARCH BIOCHEM BIOPHYS, V433, P255, DOI 10.1016/j.abb.2004.08.036; DUPRE S, 1970, EUR J BIOCHEM, V16, P571, DOI 10.1111/j.1432-1033.1970.tb01119.x; Edgar AJ, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-18; Elmore BO, 2002, J BIOL INORG CHEM, V7, P565, DOI 10.1007/s00775-001-0331-1; Elovaara H, 2011, BIOCHEMISTRY-US, V50, P5507, DOI 10.1021/bi200117z; Enrique-Tarancon G, 2000, BIOCHEM J, V350, P171, DOI 10.1042/0264-6021:3500171; Ernberg K, 2010, ACTA CRYSTALLOGR F, V66, P1572, DOI 10.1107/S1744309110041515; Ferrer I, 2002, NEUROSCI LETT, V321, P21, DOI 10.1016/S0304-3940(01)02465-X; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; GHENGHESH KS, 1989, BRAZ J MED BIOL RES, V22, P653; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Heuts DPHM, 2011, J BIOL CHEM, V286, P29584, DOI 10.1074/jbc.M111.232850; Iffiu-Soltesz Z, 2011, J NEURAL TRANSM, V118, P1071, DOI 10.1007/s00702-011-0586-9; Jakobsson E, 2005, ACTA CRYSTALLOGR F, V61, P274, DOI 10.1107/S1744309105002678; Jalkanen S, 2001, EMBO J, V20, P3893, DOI 10.1093/emboj/20.15.3893; JANES SM, 1990, SCIENCE, V248, P981, DOI 10.1126/science.2111581; JOHANSEN H, 1989, GENE DEV, V3, P882, DOI 10.1101/gad.3.6.882; Kaitaniemi S, 2009, CELL MOL LIFE SCI, V66, P2743, DOI 10.1007/s00018-009-0076-5; Kao AW, 1999, J BIOL CHEM, V274, P17742, DOI 10.1074/jbc.274.25.17742; Kivi E, 2009, BLOOD, V114, P5385, DOI 10.1182/blood-2009-04-219253; KOMATSUBARA S, 1978, J BACTERIOL, V135, P318, DOI 10.1128/JB.135.2.318-323.1978; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Kurkijarvi R, 1998, J IMMUNOL, V161, P1549; Leach RM, 1998, BRIT MED J, V317, P1370, DOI 10.1136/bmj.317.7169.1370; Lee TL, 1998, J AUTONOM NERV SYST, V74, P86, DOI 10.1016/S0165-1838(98)00120-9; Li H, 2004, J CHROMATOGR B, V810, P277, DOI 10.1016/j.jchromb.2004.08.011; Mahadev K, 2001, J BIOL CHEM, V276, P48662, DOI 10.1074/jbc.M105061200; Mao SY, 2009, ANAL BIOCHEM, V384, P20, DOI 10.1016/j.ab.2008.09.029; Marti L, 2004, J MED CHEM, V47, P4865, DOI 10.1021/jm0499211; Marttila-Ichihara F, 2009, CANCER RES, V69, P7875, DOI 10.1158/0008-5472.CAN-09-1205; Maula SM, 2005, EUR J IMMUNOL, V35, P2718, DOI 10.1002/eji.200526351; Merinen M, 2005, AM J PATHOL, V166, P793, DOI 10.1016/S0002-9440(10)62300-0; Mitchell SC, 2000, CLIN CHIM ACTA, V302, P69, DOI 10.1016/S0009-8981(00)00355-7; Miura Yumiko, 2000, Kurume Medical Journal, V47, P267; Morris NJ, 1997, J BIOL CHEM, V272, P9388; Mure M, 2002, BIOCHEMISTRY-US, V41, P9269, DOI 10.1021/bi020246b; NEUMANN R, 1975, J BIOL CHEM, V250, P6362; Nurminen EM, 2010, J MED CHEM, V53, P6301, DOI 10.1021/jm100337z; O'Sullivan J, 2004, NEUROTOXICOLOGY, V25, P303, DOI 10.1016/S0161-813X(03)00117-7; Olivieri A, 2007, J NEURAL TRANSM, V114, P747, DOI 10.1007/s00702-007-0682-z; Rea G, 1998, FEBS LETT, V437, P177, DOI 10.1016/S0014-5793(98)01219-8; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; Salmi M, 2001, IMMUNITY, V14, P265, DOI 10.1016/S1074-7613(01)00108-X; SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341; SCHAYER RW, 1952, J BIOL CHEM, V198, P545; Scherer PE, 1998, NAT BIOTECHNOL, V16, P581, DOI 10.1038/nbt0698-581; SINGER TP, 1995, FASEB J, V9, P605, DOI 10.1096/fasebj.9.8.7768351; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; SUZUKI S, 1983, BIOCHEMISTRY-US, V22, P1630, DOI 10.1021/bi00276a016; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; TRESSEL T, 1986, J BIOL CHEM, V261, P6428; Ucar G, 2005, LIFE SCI, V78, P421, DOI 10.1016/j.lfs.2005.04.064; Welford RWD, 2007, BIOCHEMISTRY-US, V46, P10817, DOI 10.1021/bi700943r; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Yegutkin GG, 2004, EUR J IMMUNOL, V34, P2276, DOI 10.1002/eji.200424932; Yu PH, 2003, BBA-PROTEINS PROTEOM, V1647, P193, DOI 10.1016/S1570-9639(03)00101-8; Yuan B, 2010, WOUND REPAIR REGEN, V18, P202, DOI 10.1111/j.1524-475X.2010.00577.x; Zorzano A, 2003, BBA-PROTEINS PROTEOM, V1647, P3, DOI 10.1016/S1570-9639(03)00039-6	85	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29270	10.1371/journal.pone.0029270	http://dx.doi.org/10.1371/journal.pone.0029270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238597	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200021
J	Khoo, AL; Koenen, HJPM; Chai, LYA; Sweep, FCGJ; Netea, MG; van der Ven, AJAM; Joosten, I				Khoo, Ai-Leng; Koenen, Hans J. P. M.; Chai, Louis Y. A.; Sweep, Fred C. G. J.; Netea, Mihai G.; van der Ven, Andre J. A. M.; Joosten, Irma			Seasonal Variation in Vitamin D-3 Levels Is Paralleled by Changes in the Peripheral Blood Human T Cell Compartment	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; 1,25-DIHYDROXYVITAMIN D-3; 25-HYDROXYVITAMIN D; IMMUNE-SYSTEM; D DEFICIENCY; TH2 CELLS; RECEPTOR; RISK; PROLIFERATION; INDIVIDUALS	It is well-recognized that vitamin D-3 has immune-modulatory properties and that the variation in ultraviolet (UV) exposure affects vitamin D-3 status. Here, we investigated if and to what extent seasonality of vitamin D-3 levels are associated with changes in T cell numbers and phenotypes. Every three months during the course of the entire year, human PBMC and whole blood from 15 healthy subjects were sampled and analyzed using flow cytometry. We observed that elevated serum 25(OH)D-3 and 1,25(OH)(2)D-3 levels in summer were associated with a higher number of peripheral CD4(+) and CD8(+) T cells. In addition, an increase in naive CD4(+)CD45RA(+) T cells with a reciprocal drop in memory CD4(+)CD45RO(+) T cells was observed. The increase in CD4(+)CD45RA(+) T cell count was a result of heightened proliferative capacity rather than recent thymic emigration of T cells. The percentage of Treg dropped in summer, but not the absolute Treg numbers. Notably, in the Treg population, the levels of forkhead box protein 3 (Foxp3) expression were increased in summer. Skin, gut and lymphoid tissue homing potential was increased during summer as well, exemplified by increased CCR4, CCR6, CLA, CCR9 and CCR7 levels. Also, in summer, CD4(+) and CD8(+) T cells revealed a reduced capacity to produce pro-inflammatory cytokines. In conclusion, seasonal variation in vitamin D-3 status in vivo throughout the year is associated with changes in the human peripheral T cell compartment and may as such explain some of the seasonal variation in immune status which has been observed previously. Given that the current observations are limited to healthy adult males, larger population-based studies would be useful to validate these findings.	[Khoo, Ai-Leng; Koenen, Hans J. P. M.; Sweep, Fred C. G. J.; Joosten, Irma] Radboud Univ Nijmegen, Dept Lab Med, Lab Med Immunol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Khoo, Ai-Leng; Chai, Louis Y. A.; Netea, Mihai G.; van der Ven, Andre J. A. M.] Radboud Univ Nijmegen, Dept Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Khoo, Ai-Leng; Koenen, Hans J. P. M.; Chai, Louis Y. A.; Netea, Mihai G.; van der Ven, Andre J. A. M.; Joosten, Irma] Nijmegen Inst Infect Inflammat & Immun, Nijmegen, Netherlands; [Chai, Louis Y. A.] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; National University of Singapore	Khoo, AL (corresponding author), Radboud Univ Nijmegen, Dept Lab Med, Lab Med Immunol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	louisaileng@gmail.com	Sweep, C.G.J./H-8096-2014; Netea, Mihai/N-5155-2014; van der Ven, A.J.A.M./H-8102-2014; Joosten, Irma/N-4418-2013; Koenen, Hans J.P.M./A-2852-2014	Sweep, C.G.J./0000-0003-1103-3070; van der Ven, A.J.A.M./0000-0003-1833-3391; Joosten, Irma/0000-0003-2950-4977; 	Nutricia Research Foundation, The Netherlands; National Medical Research Council (NMRC), Singapore; Netherlands Organization for Scientific Research	Nutricia Research Foundation, The Netherlands(Netherlands Government); National Medical Research Council (NMRC), Singapore(National Medical Research Council, Singapore); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by The Nutricia Research Foundation, The Netherlands. LYAC was supported by the NIG and CSA grants from the National Medical Research Council (NMRC), Singapore. MGN was supported by a Vici grant of the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Alonso A, 2008, NEUROLOGY, V71, P129, DOI 10.1212/01.wnl.0000316802.35974.34; [Anonymous], 2011, SEASONAL VARIATION U; Baeke F, 2010, J STEROID BIOCHEM, V121, P221, DOI 10.1016/j.jsbmb.2010.03.037; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; de Abreu DAF, 2009, MULT SCLER J, V15, P1146, DOI 10.1177/1352458509106780; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Hollis BW, 1996, CALCIFIED TISSUE INT, V58, P4, DOI 10.1007/s002239900002; Imazeki I, 2006, BIOMED RES-TOKYO, V27, P1, DOI 10.2220/biomedres.27.1; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Khoo AL, 2011, CLIN EXP IMMUNOL, V164, P72, DOI 10.1111/j.1365-2249.2010.04315.x; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; LEMIRE JM, 1995, J NUTR, V125, pS1704, DOI 10.1093/jn/125.suppl_6.1704S; LEMIRE JM, 1984, J CLIN INVEST, V74, P657, DOI 10.1172/JCI111465; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; LIPS P, 2010, J STEROID BIOCH MOL; Mahon BD, 2003, J CELL BIOCHEM, V89, P922, DOI 10.1002/jcb.10580; Marelli-Berg FM, 2008, J PATHOL, V214, P179, DOI 10.1002/path.2269; Moan J, 2009, J STEROID BIOCHEM, V113, P217, DOI 10.1016/j.jsbmb.2009.01.001; Moltchanova EV, 2009, DIABETIC MED, V26, P673, DOI 10.1111/j.1464-5491.2009.02743.x; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Morales-Tirado V, 2011, CLIN IMMUNOL, V138, P212, DOI 10.1016/j.clim.2010.11.003; MULLER K, 1992, AUTOIMMUNITY, V14, P37; Ponsoby AL, 2002, TOXICOLOGY, V181, P71, DOI 10.1016/S0300-483X(02)00257-3; Radke KJ, 2010, J HUM HYPERTENS, V24, P410, DOI 10.1038/jhh.2009.75; RIGBY WFC, 1984, J CLIN INVEST, V74, P1451, DOI 10.1172/JCI111557; Sabetta JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011088; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Simpson Jr. S, 2011, J NEUROL NEUROSURG P; Simpson S, 2010, ANN NEUROL, V68, P193, DOI 10.1002/ana.22043; Smolders J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006635; Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543; Topilski I, 2004, EUR J IMMUNOL, V34, P1068, DOI 10.1002/eji.200324532; Van Den Bout-Van Den Beukel CJP, 2008, AIDS RES HUM RETROV, V24, P1375, DOI 10.1089/aid.2008.0058; VANHOOF HJC, 1993, J CHROMATOGR-BIOMED, V621, P33, DOI 10.1016/0378-4347(93)80073-D; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605; WALTERVANCAUTER E, 1981, INT J PEPT PROT RES, V17, P3; WEBB AR, 1988, ANNU REV NUTR, V8, P375, DOI 10.1146/annurev.nu.08.070188.002111; Willer CJ, 2005, BMJ-BRIT MED J, V330, P120, DOI 10.1136/bmj.38301.686030.63; Yamanaka KI, 2008, J ALLERGY CLIN IMMUN, V121, P148, DOI 10.1016/j.jaci.2007.08.014; Zold E, 2011, VITAM HORM, V86, P261, DOI 10.1016/B978-0-12-386960-9.00011-3	46	54	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29250	10.1371/journal.pone.0029250	http://dx.doi.org/10.1371/journal.pone.0029250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235276	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400037
J	Mastroyiannopoulos, NP; Nicolaou, P; Anayasa, M; Uney, JB; Phylactou, LA				Mastroyiannopoulos, Nikolaos P.; Nicolaou, Paschalis; Anayasa, Mustafa; Uney, James B.; Phylactou, Leonidas A.			Down-Regulation of Myogenin Can Reverse Terminal Muscle Cell Differentiation	PLOS ONE			English	Article							SKELETAL-MUSCLE; CYCLE ARREST; MYOBLAST DIFFERENTIATION; GENE MYF-5; IN-VIVO; MYOD; REGENERATION; EXPRESSION; DEDIFFERENTIATION; D1	Certain higher vertebrates developed the ability to reverse muscle cell differentiation (dedifferentiation) as an additional mechanism to regenerate muscle. Mammals, on the other hand, show limited ability to reverse muscle cell differentiation. Myogenic Regulatory Factors (MRFs), MyoD, myogenin, Myf5 and Myf6 are basic-helix-loop-helix (bHLH) transcription factors essential towards the regulation of myogenesis. Our current interest is to investigate whether down-regulation of MRFs in terminally differentiated mouse myotubes can induce reversal of muscle cell differentiation. Results from this work showed that reduction of myogenin levels in terminally differentiated mouse myotubes can reverse their differentiation state. Down-regulation of myogenin in terminally differentiated mouse myotubes induces cellular cleavage into mononucleated cells and cell cycle re-entry, as shown by re-initiation of DNA synthesis and increased cyclin D1 and cyclin E2 levels. Finally, we provide evidence that down-regulation of myogenin causes cell cycle re-entry (via down-regulation of MyoD) and cellularisation through separate pathways. These data reveal the important role of myogenin in maintaining terminal muscle cell differentiation and point to a novel mechanism by which muscle cells could be reactivated through its down-regulation.	[Mastroyiannopoulos, Nikolaos P.; Nicolaou, Paschalis; Anayasa, Mustafa; Phylactou, Leonidas A.] Cyprus Inst Neurol & Genet, Dept Mol Genet Funct & Therapy, Nicosia, Cyprus; [Uney, James B.] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England	University of Bristol	Mastroyiannopoulos, NP (corresponding author), Cyprus Inst Neurol & Genet, Dept Mol Genet Funct & Therapy, Nicosia, Cyprus.	laphylac@cing.ac.cy		Nicolaou, Paschalis/0000-0002-1425-2917	A.G. Leventis Foundation; Biotechnology and Biological Sciences Research Council [BB/J016489/1, BB/F022298/1] Funding Source: researchfish; BBSRC [BB/F022298/1, BB/J016489/1] Funding Source: UKRI	A.G. Leventis Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a research grant from the A.G. Leventis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; BUCKINGHAM M, 1994, CURR BIOL, V4, P61, DOI 10.1016/S0960-9822(00)00014-2; Camarda G, 2004, J CELL BIOL, V167, P417, DOI 10.1083/jcb.200408164; Cenciarelli C, 1999, MOL CELL BIOL, V19, P5203; CRESCENZI M, 1990, P NATL ACAD SCI USA, V87, P8442, DOI 10.1073/pnas.87.21.8442; de la Serna IL, 2001, J BIOL CHEM, V276, P41486, DOI 10.1074/jbc.M107281200; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Dedieu S, 2002, INT J DEV BIOL, V46, P235; Duckmanton A, 2005, CHEM BIOL, V12, P1117, DOI 10.1016/j.chembiol.2005.07.011; Echeverri K, 2002, SEMIN CELL DEV BIOL, V13, P353, DOI 10.1016/S1084952102000915; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; GUO K, 1995, MOL CELL BIOL, V15, P3823; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hjiantoniou E, 2008, DIFFERENTIATION, V76, P182, DOI 10.1111/j.1432-0436.2007.00195.x; Jung DW, 2011, ACS CHEM BIOL; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; McGann CJ, 2001, P NATL ACAD SCI USA, V98, P13699, DOI 10.1073/pnas.221297398; Meech R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011612; Megeney LA, 1995, BIOCHEM CELL BIOL, V73, P723, DOI 10.1139/o95-080; Mohun Tim, 1992, Current Opinion in Cell Biology, V4, P923, DOI 10.1016/0955-0674(92)90119-W; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; Mu XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016699; Myer A, 1997, DEV BIOL, V185, P127, DOI 10.1006/dbio.1997.8565; Myer A, 2001, DEV BIOL, V229, P340, DOI 10.1006/dbio.2000.9985; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Olson EN, 1998, DEV BIOL, V202, P153, DOI 10.1006/dbio.1998.9020; OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P; OLSON EN, 1991, MOL CELL BIOCHEM, V104, P7; Pajalunga D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011559; Perez OD, 2002, CHEM BIOL, V9, P475, DOI 10.1016/S1074-5521(02)00131-X; Qin RF, 2007, MOL CELL BIOCHEM, V302, P233, DOI 10.1007/s11010-007-9446-1; RAO SS, 1995, J BIOL CHEM, V270, P4093, DOI 10.1074/jbc.270.8.4093; RAO SS, 1994, MOL CELL BIOL, V14, P5259, DOI 10.1128/MCB.14.8.5259; RAWLS A, 1995, DEV BIOL, V172, P37, DOI 10.1006/dbio.1995.0004; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; Rosania GR, 2000, NAT BIOTECHNOL, V18, P304, DOI 10.1038/73753; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; THORBURN AM, 1993, MOL BIOL CELL, V4, P705, DOI 10.1091/mbc.4.7.705; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7	50	47	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29896	10.1371/journal.pone.0029896	http://dx.doi.org/10.1371/journal.pone.0029896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235349	gold, Green Published, Green Submitted			2022-12-27	WOS:000301123400111
J	Sille, FCM; Thomas, R; Smith, MT; Conde, L; Skibola, CF				Sille, Fenna C. M.; Thomas, Reuben; Smith, Martyn T.; Conde, Lucia; Skibola, Christine F.			Post-GWAS Functional Characterization of Susceptibility Variants for Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC SUSCEPTIBILITY; FOLLICULAR LYMPHOMA; MESSENGER-RNA; NUCLEAR-BODY; B-CELLS; RISK; SNPS; TRANSFORMATION; TRANSCRIPTION	Recent genome-wide association studies (GWAS) have identified several gene variants associated with sporadic chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Many of these CLL/SLL susceptibility loci are located in non-coding or intergenic regions, posing a significant challenge to determine their potential functional relevance. Here, we review the literature of all CLL/SLL GWAS and validation studies, and apply eQTL analysis to identify putatively functional SNPs that affect gene expression that may be causal in the pathogenesis of CLL/SLL. We tested 12 independent risk loci for their potential to alter gene expression through cis-acting mechanisms, using publicly available gene expression profiles with matching genotype information. Sixteen SNPs were identified that are linked to differential expression of SP140, a putative tumor suppressor gene previously associated with CLL/SLL. Three additional SNPs were associated with differential expression of DACT3 and GNG8, which are involved in the WNT/beta-catenin- and G protein-coupled receptor signaling pathways, respectively, that have been previously implicated in CLL/SLL pathogenesis. Using in silico functional prediction tools, we found that 14 of the 19 significant eQTL SNPs lie in multiple putative regulatory elements, several of which have prior implications in CLL/SLL or other hematological malignancies. Although experimental validation is needed, our study shows that the use of existing GWAS data in combination with eQTL analysis and in silico methods represents a useful starting point to screen for putatively causal SNPs that may be involved in the etiology of CLL/SLL.	[Sille, Fenna C. M.; Thomas, Reuben; Smith, Martyn T.; Conde, Lucia; Skibola, Christine F.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Sille, FCM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA.	chrisfs@berkeley.edu	Sille, Fenna/ABB-9495-2021; Conde, Lucia/D-9295-2011; Pillay, Nischalan/F-9536-2012	Conde, Lucia/0000-0001-5180-543X; Sille, Fenna/0000-0003-4305-2049	National Cancer Institute (NCI), National Institutes of Health (NIH) [CA122663, CA104682, R01 CA154643-01A1]; NATIONAL CANCER INSTITUTE [R01CA104682, R01CA154643, R01CA122663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705] Funding Source: NIH RePORTER	National Cancer Institute (NCI), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants CA122663, CA104682 and R01 CA154643-01A1 from the National Cancer Institute (NCI), National Institutes of Health (NIH) (C.F.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040005; Barrett Tanya, 2006, V338, P175; Battle TE, 2003, BLOOD, V102, P3016, DOI 10.1182/blood-2002-09-2972; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett LB, 2010, EPIGENOMICS-UK, V2, P53, DOI 10.2217/EPI.09.43; Bloch DB, 1996, J BIOL CHEM, V271, P29198, DOI 10.1074/jbc.271.46.29198; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Castle JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020660; Castro JE, 2005, BLOOD, V106, P2506, DOI 10.1182/blood-2005-03-1099; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; Crowther-Swanepoel D, 2011, BRIT J HAEMATOL, V154, P229, DOI 10.1111/j.1365-2141.2011.08706.x; Crowther-Swanepoel D, 2010, BRIT J HAEMATOL, V150, P473, DOI 10.1111/j.1365-2141.2010.08270.x; Crowther-Swanepoel D, 2010, HUM MOL GENET, V19, P1840, DOI 10.1093/hmg/ddq044; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; De Thonel Aurelie, 2011, Cancers (Basel), V3, P1158, DOI 10.3390/cancers3011158; Dent AL, 1996, BLOOD, V88, P1423, DOI 10.1182/blood.V88.4.1423.bloodjournal8841423; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Dolcetti Riccardo, 2010, Infect Agent Cancer, V5, P22, DOI 10.1186/1750-9378-5-22; Gaboli M, 2001, GENE DEV, V15, P1625, DOI 10.1101/gad.902301; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goldin LR, 2007, BRIT J HAEMATOL, V139, P774, DOI 10.1111/j.1365-2141.2007.06810.x; Gosling J., 2000, JAVA LANGUAGE SPECIF, V7th; Harner EJ, 2009, COMPUTATION STAT, V24, P295, DOI 10.1007/s00180-008-0131-y; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; Howlader N, 2011, SEER CANC STAT REV 1; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kharas MG, 2007, BLOOD, V109, P747, DOI 10.1182/blood-2006-03-011106; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Lan Q, 2010, EUR J HAEMATOL, V85, P492, DOI 10.1111/j.1600-0609.2010.01518.x; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lee PH, 2009, BIOINFORMATICS, V25, P1048, DOI 10.1093/bioinformatics/btp103; Lin CH, 2007, FEBS J, V274, P2946, DOI 10.1111/j.1742-4658.2007.05828.x; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Macintyre G, 2010, BIOINFORMATICS, V26, pi524, DOI 10.1093/bioinformatics/btq378; Madani N, 2002, J VIROL, V76, P11133, DOI 10.1128/JVI.76.21.11133-11138.2002; McCauley JL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-266; Negorev DG, 2010, CANCER RES, V70, P9991, DOI 10.1158/0008-5472.CAN-10-1483; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nuckel H, 2003, LEUKEMIA LYMPHOMA, V44, P1739, DOI 10.1080/1042819031000111017; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pollard KS, 2010, MULTTEST RESAMPLING; Rush LJ, 2004, CANCER RES, V64, P2424, DOI 10.1158/0008-5472.CAN-03-2870; Saad Hussam, 2007, Journal de la Societe de Biologie, V201, P307, DOI 10.1051/jbio:2007029; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Skibola CF, 2009, NAT GENET, V41, P873, DOI 10.1038/ng.419; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Slager SL, 2010, CANCER EPIDEM BIOMAR, V19, P1098, DOI 10.1158/1055-9965.EPI-09-1217; SONENBERG N, 1988, PROG NUCLEIC ACID RE, V35, P173, DOI 10.1016/S0079-6603(08)60614-5; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Team RDC, 2009, R LANG ENV STAT COMP; WEIS L, 1992, FASEB J, V6, P3300, DOI 10.1096/fasebj.6.14.1426767; Weller JI, 1998, GENETICS, V150, P1699	56	28	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29632	10.1371/journal.pone.0029632	http://dx.doi.org/10.1371/journal.pone.0029632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235315	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400077
J	Zhang, H; Yin, YB; Olman, V; Xu, Y				Zhang, Han; Yin, Yanbin; Olman, Victor; Xu, Ying			Genomic Arrangement of Regulons in Bacterial Genomes	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; TRANSCRIPTIONAL REGULATION; BACILLUS-SUBTILIS; ORGANIZATION; PATTERNS; DATABASE; OPERONS	Regulons, as groups of transcriptionally co-regulated operons, are the basic units of cellular response systems in bacterial cells. While the concept has been long and widely used in bacterial studies since it was first proposed in 1964, very little is known about how its component operons are arranged in a bacterial genome. We present a computational study to elucidate of the organizational principles of regulons in a bacterial genome, based on the experimentally validated regulons of E. coli and B. subtilis. Our results indicate that (1) genomic locations of transcriptional factors (TFs) are under stronger evolutionary constraints than those of the operons they regulate so changing a TF's genomic location will have larger impact to the bacterium than changing the genomic position of any of its target operons; (2) operons of regulons are generally not uniformly distributed in the genome but tend to form a few closely located clusters, which generally consist of genes working in the same metabolic pathways; and (3) the global arrangement of the component operons of all the regulons in a genome tends to minimize a simple scoring function, indicating that the global arrangement of regulons follows simple organizational principles.	[Zhang, Han; Yin, Yanbin; Olman, Victor; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; [Zhang, Han; Yin, Yanbin; Olman, Victor; Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Zhang, Han] Nankai Univ, Coll Informat Tech Sci, Dept Automat & Intelligent Sci, Tianjin 300071, Peoples R China; [Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun, Jilin, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Nankai University; Jilin University	Zhang, H (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA.	xyn@bmb.uga.edu	Yin, Yanbin/AAH-2665-2020; Yin, Yanbin/C-9788-2010	Yin, Yanbin/0000-0001-7667-881X; Yin, Yanbin/0000-0001-7667-881X; Zhang, Hao/0000-0002-2155-0592	DOE of the US, BioEnergy Science Center [DE-PS02-06ER64304]; NSF of the US [DEB-0830024]; Division Of Environmental Biology [0830024] Funding Source: National Science Foundation	DOE of the US, BioEnergy Science Center; NSF of the US; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	DOE of the US, BioEnergy Science Center grant (DE-PS02-06ER64304) NSF of the US, DEB-0830024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TE, 2006, PLOS COMPUT BIOL, V2, P13, DOI 10.1371/journal.pcbi.0020002; Carpentier AS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-84; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Janga SC, 2009, NUCLEIC ACIDS RES, V37, P3680, DOI 10.1093/nar/gkp231; Jeong KS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r86; Lawrence JG, 1996, GENETICS, V143, P1843; MAAS WK, 1964, J MOL BIOL, V8, P365, DOI 10.1016/S0022-2836(64)80200-X; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Rocha EPC, 2008, ANNU REV GENET, V42, P211, DOI 10.1146/annurev.genet.42.110807.091653; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Wright MA, 2007, P NATL ACAD SCI USA, V104, P10559, DOI 10.1073/pnas.0610776104; Yin YB, 2010, P NATL ACAD SCI USA, V107, P6310, DOI 10.1073/pnas.0911237107	17	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29496	10.1371/journal.pone.0029496	http://dx.doi.org/10.1371/journal.pone.0029496			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235300	gold, Green Submitted, Green Published			2022-12-27	WOS:000301123400062
J	Miyazawa, S				Miyazawa, Sanzo			Advantages of a Mechanistic Codon Substitution Model for Evolutionary Analysis of Protein-Coding Sequences	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; NUCLEOTIDE SUBSTITUTION; MITOCHONDRIAL-DNA; SYNONYMOUS SUBSTITUTIONS; PHYLOGENETIC ANALYSIS; SELECTION; RATES; FREQUENCY; MATRIX; SITES	Background: A mechanistic codon substitution model, in which each codon substitution rate is proportional to the product of a codon mutation rate and the average fixation probability depending on the type of amino acid replacement, has advantages over nucleotide, amino acid, and empirical codon substitution models in evolutionary analysis of protein-coding sequences. It can approximate a wide range of codon substitution processes. If no selection pressure on amino acids is taken into account, it will become equivalent to a nucleotide substitution model. If mutation rates are assumed not to depend on the codon type, then it will become essentially equivalent to an amino acid substitution model. Mutation at the nucleotide level and selection at the amino acid level can be separately evaluated. Results: The present scheme for single nucleotide mutations is equivalent to the general time-reversible model, but multiple nucleotide changes in infinitesimal time are allowed. Selective constraints on the respective types of amino acid replacements are tailored to each gene in a linear function of a given estimate of selective constraints. Their good estimates are those calculated by maximizing the respective likelihoods of empirical amino acid or codon substitution frequency matrices. Akaike and Bayesian information criteria indicate that the present model performs far better than the other substitution models for all five phylogenetic trees of highly-divergent to highly-homologous sequences of chloroplast, mitochondrial, and nuclear genes. It is also shown that multiple nucleotide changes in infinitesimal time are significant in long branches, although they may be caused by compensatory substitutions or other mechanisms. The variation of selective constraint over sites fits the datasets significantly better than variable mutation rates, except for 10 slow-evolving nuclear genes of 10 mammals. An critical finding for phylogenetic analysis is that assuming variable mutation rates over sites lead to the overestimation of branch lengths.	Gunma Univ, Grad Sch Engn, Kiryu, Gunma 376, Japan	Gunma University	Miyazawa, S (corresponding author), Gunma Univ, Grad Sch Engn, Kiryu, Gunma 376, Japan.	sanzo.miyazawa@gmail.com	Miyazawa, Sanzo/V-5550-2017	Miyazawa, Sanzo/0000-0002-5063-3661				Abdo Z, 2005, MOL BIOL EVOL, V22, P691, DOI 10.1093/molbev/msi050; Adachi J, 2000, J MOL EVOL, V50, P348, DOI 10.1007/s002399910038; Adachi J, 1996, J MOL EVOL, V42, P459; Adachi J, 1996, MOL BIOL EVOL, V13, P200, DOI 10.1093/oxfordjournals.molbev.a025556; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Averof M, 2000, SCIENCE, V287, P1283, DOI 10.1126/science.287.5456.1283; Bazykin GA, 2004, NATURE, V429, P558, DOI 10.1038/nature02601; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Delport W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000885; Delport W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011587; Dimmic M W, 2000, Pac Symp Biocomput, P18; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; Galtier N, 2001, MOL BIOL EVOL, V18, P866, DOI 10.1093/oxfordjournals.molbev.a003868; GO M, 1980, INT J PEPT PROT RES, V15, P211; GOJOBORI T, 1982, J MOL EVOL, V18, P360, DOI 10.1007/BF01733904; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halpern AL, 1998, MOL BIOL EVOL, V15, P910, DOI 10.1093/oxfordjournals.molbev.a025995; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Huelsenbeck JP, 2008, PHILOS T R SOC B, V363, P3941, DOI 10.1098/rstb.2008.0175; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kosiol C, 2007, MOL BIOL EVOL, V24, P1464, DOI 10.1093/molbev/msm064; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lopez P, 2002, MOL BIOL EVOL, V19, P1; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; MIYAZAWA S, 1993, PROTEIN ENG, V6, P267, DOI 10.1093/protein/6.3.267; Miyazawa S, 2011, PLOS ONE, V10, P1371; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Nikaido M, 2003, MOL PHYLOGENET EVOL, V28, P276, DOI 10.1016/S1055-7903(03)00120-9; Nishihara H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r199; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Schneider A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-134; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seo TK, 2008, SYST BIOL, V57, P367, DOI 10.1080/10635150802158670; Seo TK, 2009, SYST BIOL, V58, P199, DOI 10.1093/sysbio/syp015; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Stuart A, 1996, KENDALLS ADV THEORY, V2; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Wakeley J, 1996, TRENDS ECOL EVOL, V11, P158, DOI 10.1016/0169-5347(96)10009-4; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Whelan S, 2004, GENETICS, V167, P2027, DOI 10.1534/genetics.103.023226; YANG ZH, 1995, GENETICS, V139, P993; YANG ZH, 1994, MOL BIOL EVOL, V11, P316; Yang ZH, 2000, GENETICS, V155, P431; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 1999, J MOL EVOL, V48, P274, DOI 10.1007/PL00006470; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284; Zhong B, 2010, MOL BIOL EVOL, V10, P1093; Zuckerkandl E, 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	59	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e28892	10.1371/journal.pone.0028892	http://dx.doi.org/10.1371/journal.pone.0028892			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220197	Green Published, Green Submitted, gold			2022-12-27	WOS:000300677000009
J	Agrawal, P; Verma, D; Daniell, H				Agrawal, Pankaj; Verma, Dheeraj; Daniell, Henry			Expression of Trichoderma reesei beta-Mannanase in Tobacco Chloroplasts and Its Utilization in Lignocellulosic Woody Biomass Hydrolysis	PLOS ONE			English	Article							CELL-WALL; TRANSGENE CONTAINMENT; ENZYMATIC-HYDROLYSIS; PURIFICATION; PROTEIN; GALACTOGLUCOMANNAN; PROINSULIN; BIOFUELS; SOFTWOOD; LETTUCE	Lignocellulosic ethanol offers a promising alternative to conventional fossil fuels. One among the major limitations in the lignocellulosic biomass hydrolysis is unavailability of efficient and environmentally biomass degrading technologies. Plant-based production of these enzymes on large scale offers a cost-effective solution. Cellulases, hemicellulases including mannanases and other accessory enzymes are required for conversion of lignocellulosic biomass into fermentable sugars. beta-mannanase catalyzes endo-hydrolysis of the mannan backbone, a major constituent of woody biomass. In this study, the man1 gene encoding beta-mannanase was isolated from Trichoderma reesei and expressed via the chloroplast genome. PCR and Southern hybridization analysis confirmed site-specific transgene integration into the tobacco chloroplast genomes and homoplasmy. Transplastomic plants were fertile and set viable seeds. Germination of seeds in the selection medium showed inheritance of transgenes into the progeny without any Mendelian segregation. Expression of endo-beta-mannanase for the first time in plants facilitated its characterization for use in enhanced lignocellulosic biomass hydrolysis. Gel diffusion assay for endo-beta-mannanase showed the zone of clearance confirming functionality of chloroplast-derived mannanase. Endo-beta-mannanase expression levels reached up to 25 units per gram of leaf (fresh weight). Chloroplast-derived mannanase had higher temperature stability (40 degrees C to 70 degrees C) and wider pH optima (pH 3.0 to 7.0) than E. coli enzyme extracts. Plant crude extracts showed 6-7 fold higher enzyme activity than E. coli extracts due to the formation of disulfide bonds in chloroplasts, thereby facilitating their direct utilization in enzyme cocktails without any purification. Chloroplast-derived mannanase when added to the enzyme cocktail containing a combination of different plant-derived enzymes yielded 20% more glucose equivalents from pinewood than the cocktail without mannanase. Our results demonstrate that chloroplast-derived mannanase is an important component of enzymatic cocktail for woody biomass hydrolysis and should provide a cost-effective solution for its diverse applications in the biofuel, paper, oil, pharmaceutical, coffee and detergent industries.	[Agrawal, Pankaj; Verma, Dheeraj; Daniell, Henry] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Agrawal, P (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA.	Henry.Daniell@ucf.edu	Daniell, Henry/L-3655-2019	Daniell, Henry/0000-0003-4485-1176	USDA CSREES [2009-39200-19972]; USDA-NIFA [2010-39200-21704]; NIH [R01 GM 63879]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063879] Funding Source: NIH RePORTER	USDA CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA-NIFA(United States Department of Agriculture (USDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These investigations were supported in part by grants from USDA CSREES 2009-39200-19972, USDA-NIFA 2010-39200-21704 (http://www.csrees.usda.gov/) and NIH R01 GM 63879 (http://www.nih.gov/) to Henry Daniell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson M, 2010, PLANT SCI, V178, P61, DOI 10.1016/j.plantsci.2009.11.003; Ademark P, 1998, J BIOTECHNOL, V63, P199, DOI 10.1016/S0168-1656(98)00086-8; An XP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001179; ARISANATAC I, 1993, APPL MICROBIOL BIOT, V39, P58, DOI 10.1007/BF00166849; Arlen PA, 2007, PLANT BIOTECHNOL J, V5, P511, DOI 10.1111/j.1467-7652.2007.00258.x; Bally J, 2008, PLANT BIOTECHNOL J, V6, P46, DOI 10.1111/j.1467-7652.2007.00298.x; Bally J, 2009, PLANT PHYSIOL, V150, P1474, DOI 10.1104/pp.109.139816; Banerjee G, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-22; Boyhan D, 2011, PLANT BIOTECHNOL J, V9, P585, DOI 10.1111/j.1467-7652.2010.00582.x; Capek P, 2000, CARBOHYD RES, V329, P635, DOI 10.1016/S0008-6215(00)00210-X; CHRISTGAU S, 1994, BIOCHEM MOL BIOL INT, V33, P917; Cramer CL, 1999, CURR TOP MICROBIOL, V240, P95; Daniell H, 2005, METH MOL B, V286, P111; Daniell H, 2001, J MOL BIOL, V311, P1001, DOI 10.1006/jmbi.2001.4921; Daniell H, 1998, NAT BIOTECHNOL, V16, P345, DOI 10.1038/nbt0498-345; Daniell H, 2007, P NATL ACAD SCI USA, V104, P6879, DOI 10.1073/pnas.0702219104; De Cosa B, 2001, NAT BIOTECHNOL, V19, P71, DOI 10.1038/83559; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; DORMANN P, 1995, PLANT CELL, V7, P1801, DOI 10.1105/tpc.7.11.1801; DOWNIE B, 1994, PHYTOCHEMISTRY, V36, P829, DOI 10.1016/S0031-9422(00)90446-1; Dunn EK, 2007, PLANT CELL PHYSIOL, V48, P122, DOI 10.1093/pcp/pcl053; Glenz K, 2006, NAT BIOTECHNOL, V24, P76, DOI 10.1038/nbt1170; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Hagglund P, 2003, J BIOTECHNOL, V101, P37, DOI 10.1016/S0168-1656(02)00290-0; Hannon M, 2010, BIOFUELS-UK, V1, P763, DOI 10.4155/BFS.10.44; Jin SX, 2011, PLANT PHYSIOL, V155, P222, DOI 10.1104/pp.110.160754; JONES JKN, 1950, J CHEM SOC, P3292, DOI 10.1039/jr9500003292; Jorgensen H, 2010, APPL BIOCHEM BIOTECH, V161, P318, DOI 10.1007/s12010-009-8814-6; Klaus D, 2002, PLANT PHYSIOL, V128, P885, DOI 10.1104/pp.010780; Marcus SE, 2010, PLANT J, V64, P191, DOI 10.1111/j.1365-313X.2010.04319.x; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Oksanen T, 2000, J BIOTECHNOL, V78, P39, DOI 10.1016/S0168-1656(99)00232-1; Oraby H, 2007, TRANSGENIC RES, V16, P739, DOI 10.1007/s11248-006-9064-9; Pereira H, 2003, WOOD QUALITY ITS BIO, P53; Petersen K, 2011, PLANT MOL BIOL, V76, P311, DOI 10.1007/s11103-011-9742-8; RATTO M, 1993, APPL MICROBIOL BIOT, V40, P449; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Ruf S, 2007, P NATL ACAD SCI USA, V104, P6998, DOI 10.1073/pnas.0700008104; Ruhlman T, 2007, PLANT BIOTECHNOL J, V5, P495, DOI 10.1111/j.1467-7652.2007.00259.x; Ruhlman T, 2010, PLANT PHYSIOL, V152, P2088, DOI 10.1104/pp.109.152017; Sabini E, 2000, ACTA CRYSTALLOGR D, V56, P3, DOI 10.1107/S0907444999013943; Sainz MB, 2009, IN VITRO CELL DEV-PL, V45, P314, DOI 10.1007/s11627-009-9210-1; Salmen L, 2004, CR BIOL, V327, P873, DOI 10.1016/j.crvi.2004.03.010; Singh ND, 2008, PLANT CELL, V20, P3405, DOI 10.1105/tpc.108.063172; STALBRAND H, 1993, J BIOTECHNOL, V29, P229, DOI 10.1016/0168-1656(93)90055-R; STALBRAND H, 1995, APPL ENVIRON MICROB, V61, P1090; Staub JM, 2000, NAT BIOTECHNOL, V18, P333, DOI 10.1038/73796; Sticklen M, 2006, CURR OPIN BIOTECH, V17, P315, DOI 10.1016/j.copbio.2006.05.003; Still DW, 1997, PLANT PHYSIOL, V113, P13, DOI 10.1104/pp.113.1.13; Taylor LE, 2008, TRENDS BIOTECHNOL, V26, P413, DOI 10.1016/j.tibtech.2008.05.002; Tenkanen M, 1997, J BIOTECHNOL, V57, P191, DOI 10.1016/S0168-1656(97)00099-0; Pham TA, 2010, J BIOTECHNOL, V148, P163, DOI 10.1016/j.jbiotec.2010.05.012; van Zyl WH, 2010, PROCESS BIOCHEM, V45, P1203, DOI 10.1016/j.procbio.2010.05.011; Verma D, 2008, NAT PROTOC, V3, P739, DOI 10.1038/nprot.2007.522; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Verma D, 2010, PLANT BIOTECHNOL J, V8, P332, DOI 10.1111/j.1467-7652.2009.00486.x; WOOD PJ, 1980, CARBOHYD RES, V85, P271, DOI 10.1016/S0008-6215(00)84676-5; Yang B, 2011, BIOFUELS-UK, V2, P421, DOI 10.4155/BFS.11.116; Yu Hong-Ying, 2003, Sheng Wu Gong Cheng Xue Bao, V19, P327; Ziegelhoffer T, 2009, PLANT BIOTECHNOL J, V7, P527, DOI 10.1111/j.1467-7652.2009.00421.x	61	39	42	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29302	10.1371/journal.pone.0029302	http://dx.doi.org/10.1371/journal.pone.0029302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216240	Green Published, Green Submitted, gold			2022-12-27	WOS:000300676300044
J	Lee, BY; Song, Y; Bartsch, SM; Kim, DS; Singh, A; Avery, TR; Brown, ST; Yilmaz, SL; Wong, KF; Potter, MA; Burke, DS; Platt, R; Huang, SS				Lee, Bruce Y.; Song, Yeohan; Bartsch, Sarah M.; Kim, Diane S.; Singh, Ashima; Avery, Taliser R.; Brown, Shawn T.; Yilmaz, S. Levent; Wong, Kim F.; Potter, Margaret A.; Burke, Donald S.; Platt, Richard; Huang, Susan S.			Long-Term Care Facilities: Important Participants of the Acute Care Facility Social Network?	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ORANGE-COUNTY; HOSPITALS; CALIFORNIA; CONTINUUM; SPREAD	Background: Acute care facilities are connected via patient sharing, forming a network. However, patient sharing extends beyond this immediate network to include sharing with long-term care facilities. The extent of long-term care facility patient sharing on the acute care facility network is unknown. The objective of this study was to characterize and determine the extent and pattern of patient transfers to, from, and between long-term care facilities on the network of acute care facilities in a large metropolitan county. Methods/Principal Findings: We applied social network constructs principles, measures, and frameworks to all 2007 annual adult and pediatric patient transfers among the healthcare facilities in Orange County, California, using data from surveys and several datasets. We evaluated general network and centrality measures as well as individual ego measures and further constructed sociograms. Our results show that over the course of a year, 66 of 72 long-term care facilities directly sent and 67 directly received patients from other long-term care facilities. Long-term care facilities added 1,524 ties between the acute care facilities when ties represented at least one patient transfer. Geodesic distance did not closely correlate with the geographic distance among facilities. Conclusions/Significance: This study demonstrates the extent to which long-term care facilities are connected to the acute care facility patient sharing network. Many long-term care facilities were connected by patient transfers and further added many connections to the acute care facility network. This suggests that policy-makers and health officials should account for patient sharing with and among long-term care facilities as well as those among acute care facilities when evaluating policies and interventions.	[Lee, Bruce Y.; Song, Yeohan; Bartsch, Sarah M.; Singh, Ashima] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Lee, Bruce Y.; Song, Yeohan; Bartsch, Sarah M.] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA USA; [Lee, Bruce Y.; Song, Yeohan; Bartsch, Sarah M.; Singh, Ashima] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Kim, Diane S.; Huang, Susan S.] Univ Calif Irvine, Div Infect Dis, Irvine, CA USA; [Kim, Diane S.; Huang, Susan S.] Univ Calif Irvine, Hlth Policy Res Inst, Irvine, CA USA; [Singh, Ashima; Potter, Margaret A.] Univ Pittsburgh, Grad Sch Publ Hlth, Ctr Publ Hlth Practice, Dept Hlth Management & Policy, Pittsburgh, PA USA; [Avery, Taliser R.; Platt, Richard] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Avery, Taliser R.; Platt, Richard] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Brown, Shawn T.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Brown, Shawn T.] Carnegie Mellon Univ, Pittsburgh Supercomp Ctr, Pittsburgh, PA 15213 USA; [Yilmaz, S. Levent; Wong, Kim F.] Univ Pittsburgh, Ctr Simulat & Modeling, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Irvine; University of California System; University of California Irvine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lee, BY (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.	BYL1@pitt.edu		Brown, Shawn/0000-0001-6980-8372; /0000-0002-5704-8094	National Institute General Medical Sciences Models of Infectious Agent Study (MIDAS) [5U54GM088491-02, 1U01 GM076672]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM076672, U54GM088491] Funding Source: NIH RePORTER	National Institute General Medical Sciences Models of Infectious Agent Study (MIDAS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institute General Medical Sciences Models of Infectious Agent Study (MIDAS) grants 5U54GM088491-02 and 1U01 GM076672. The funders had no role study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[American College of Cardiology American Heart Association Task Force], 2007, CARDIOLOGY, V50; [Anonymous], MIRCAL INP DAT REP M; Cano SB, 1996, AM J HEALTH-SYST PH, V53, P270, DOI 10.1093/ajhp/53.3.270; Centers for Medicare and Medicaid Services, 2007, MIN DAT SET; Chhabra PT, 2011, RES SOCIAL ADM PHARM; Furuno JP, 2004, AM J INFECT CONTROL, V32, P436, DOI 10.1016/j.ajic.2004.03.009; Gittell JH, 2004, J MANAGE STUD, V41, P127, DOI 10.1111/j.1467-6486.2004.00424.x; Huang S, 2010, INFECT CONT HOSP EP, V31, P1160, DOI 10.1086/656747; LaMantia MA, 2010, J AM GERIATR SOC, V58, P777, DOI 10.1111/j.1532-5415.2010.02776.x; Lee BY, 2011, INFECT CONT HOSP EP, V32, P562, DOI 10.1086/660014; Lee BY, 2011, AM J PUBLIC HEALTH, V101, P707, DOI 10.2105/AJPH.2010.202754; Naylor Mary D, 2009, Policy Polit Nurs Pract, V10, P187, DOI 10.1177/1527154409355710; PHILLIPSHARRIS C, 1995, CLIN GERIATR MED, V11, P481, DOI 10.1016/S0749-0690(18)30281-7; Poulou A, 2010, J ANTIMICROB CHEMOTH, V65, P2538, DOI 10.1093/jac/dkq363; TERESI JA, 1991, GERONTOLOGIST, V31, P795, DOI 10.1093/geront/31.6.795; Zimarino M, 2010, AM HEART J, V160, DOI 10.1016/j.ahj.2010.10.015	16	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29342	10.1371/journal.pone.0029342	http://dx.doi.org/10.1371/journal.pone.0029342			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	897SB	22216255	gold, Green Published			2022-12-27	WOS:000300674900028
J	Hasegawa, T; Konno, M; Baba, T; Sugeno, N; Kikuchi, A; Kobayashi, M; Miura, E; Tanaka, N; Tamai, K; Furukawa, K; Arai, H; Mori, F; Wakabayashi, K; Aoki, M; Itoyama, Y; Takeda, A				Hasegawa, Takafumi; Konno, Masatoshi; Baba, Toru; Sugeno, Naoto; Kikuchi, Akio; Kobayashi, Michiko; Miura, Emiko; Tanaka, Nobuyuki; Tamai, Keiichi; Furukawa, Katsutoshi; Arai, Hiroyuki; Mori, Fumiaki; Wakabayashi, Koichi; Aoki, Masashi; Itoyama, Yasuto; Takeda, Atsushi			The AAA-ATPase VPS4 Regulates Extracellular Secretion and Lysosomal Targeting of alpha-Synuclein	PLOS ONE			English	Article							NEURONAL CELL-DEATH; PARKINSONS-DISEASE; LEWY BODY; MULTIVESICULAR BODY; ESCRT MACHINERY; PRION PROTEIN; EXOSOMES; AGGREGATION; VESICLE; TRANSMISSION	Many neurodegenerative diseases share a common pathological feature: the deposition of amyloid-like fibrils composed of misfolded proteins. Emerging evidence suggests that these proteins may spread from cell-to-cell and encourage the propagation of neurodegeneration in a prion-like manner. Here, we demonstrated that alpha-synuclein (alpha SYN), a principal culprit for Lewy pathology in Parkinson's disease (PD), was present in endosomal compartments and detectably secreted into the extracellular milieu. Unlike prion protein, extracellular alpha SYN was mainly recovered in the supernatant fraction rather than in exosome-containing pellets from the neuronal culture medium and cerebrospinal fluid. Surprisingly, impaired biogenesis of multivesicular body (MVB), an organelle from which exosomes are derived, by dominant-negative mutant vacuolar protein sorting 4 (VPS4) not only interfered with lysosomal targeting of alpha SYN but facilitated alpha SYN secretion. The hypersecretion of alpha SYN in VPS4-defective cells was efficiently restored by the functional disruption of recycling endosome regulator Rab11a. Furthermore, both brainstem and cortical Lewy bodies in PD were found to be immunoreactive for VPS4. Thus, VPS4, a master regulator of MVB sorting, may serve as a determinant of lysosomal targeting or extracellular secretion of alpha SYN and thereby contribute to the intercellular propagation of Lewy pathology in PD.	[Hasegawa, Takafumi; Konno, Masatoshi; Baba, Toru; Sugeno, Naoto; Kikuchi, Akio; Kobayashi, Michiko; Miura, Emiko; Aoki, Masashi; Itoyama, Yasuto; Takeda, Atsushi] Tohoku Univ, Grad Sch Med, Div Neurol, Dept Neurosci & Sensory Organs, Sendai, Miyagi 980, Japan; [Tanaka, Nobuyuki; Tamai, Keiichi] Miyagi Canc Ctr Res Inst, Div Canc Biol & Therapeut, Natori, Miyagi, Japan; [Furukawa, Katsutoshi; Arai, Hiroyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Geriatr & Gerontol, Sendai, Miyagi 980, Japan; [Mori, Fumiaki; Wakabayashi, Koichi] Hirosaki Univ, Sch Med, Inst Brain Sci, Dept Neuropathol, Hirosaki, Aomori 036, Japan; [Itoyama, Yasuto] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp Mental Nervous & Muscular Disorders, Kodaira, Tokyo, Japan	Tohoku University; Miyagi Cancer Center; Tohoku University; Hirosaki University; National Center for Neurology & Psychiatry - Japan	Hasegawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Div Neurol, Dept Neurosci & Sensory Organs, Sendai, Miyagi 980, Japan.	thasegawa@med.tohoku.ac.jp	Tamai, Keiichi/AAW-8261-2021; Perry, George/A-8611-2009	Perry, George/0000-0002-6547-0172; Baba, Toru/0000-0003-0936-2510; Tamai, Keiichi/0000-0003-0813-5885	The Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23591228]; Research Committee for Ataxic Diseases, Ministry of Health, Labor, and Welfare, Japan; Grants-in-Aid for Scientific Research [23500424, 23592521] Funding Source: KAKEN	The Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Committee for Ataxic Diseases, Ministry of Health, Labor, and Welfare, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (C) (23591228) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT), and a Grant from the Research Committee for Ataxic Diseases, the Ministry of Health, Labor, and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Baba M, 1998, AM J PATHOL, V152, P879; Beyer A, 2003, GENE, V305, P47, DOI 10.1016/S0378-1119(02)01205-2; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Davies BA, 2011, TRAFFIC; Denzer K, 2000, J CELL SCI, V113, P3365; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fevrier B, 2005, TRAFFIC, V6, P10, DOI 10.1111/j.1600-0854.2004.00247.x; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Furukawa K, 2006, J NEUROCHEM, V97, P1071, DOI 10.1111/j.1471-4159.2006.03803.x; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hasegawa T, 2001, BIOCHEM BIOPH RES CO, V280, P726, DOI 10.1006/bbrc.2000.4186; Hasegawa T, 2006, FEBS LETT, V580, P2147, DOI 10.1016/j.febslet.2006.03.018; Hasegawa T, 2004, BRAIN RES, V1013, P51, DOI 10.1016/j.brainres.2004.04.018; Hasegawa T, 2003, J NEUROCHEM, V87, P470, DOI 10.1046/j.1471-4159.2003.02008.x; Hasegawa T, 2008, J NEUROCHEM, V105, P1700, DOI 10.1111/j.1471-4159.2008.05277.x; HAYASHIDA K, 1993, ACTA NEUROPATHOL, V85, P445, DOI 10.1007/BF00334457; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kordower JH, 2008, MOVEMENT DISORD, V23, P2303, DOI 10.1002/mds.22369; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee HJ, 2011, BIOCH BIOPHYS RES CO; Lee SJ, 2008, J MOL NEUROSCI, V34, P17, DOI 10.1007/s12031-007-0012-9; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Liu J, 2009, J NEUROSCI, V29, P1480, DOI 10.1523/JNEUROSCI.6202-08.2009; Lowe R, 2004, PROTEIN SCI, V13, P3245, DOI 10.1110/ps.04879704; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Matsuzaki M, 2004, BRAIN RES, V1004, P83, DOI 10.1016/j.brainres.2004.01.017; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Peters PJ, 2003, J CELL BIOL, V162, P703, DOI 10.1083/jcb.200304140; Porto-Carreiro I, 2005, BLOOD CELL MOL DIS, V35, P143, DOI 10.1016/j.bcmd.2005.06.013; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Robertson C, 2006, BLOOD, V107, P3907, DOI 10.1182/blood-2005-02-0802; Scheuring S, 2001, J MOL BIOL, V312, P469, DOI 10.1006/jmbi.2001.4917; Schroter CJ, 1999, J IMMUNOL METHODS, V227, P161, DOI 10.1016/S0022-1759(99)00079-4; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sugeno N, 2008, J BIOL CHEM, V283, P23179, DOI 10.1074/jbc.M802223200; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Takeda A, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/19365; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Vella LJ, 2008, VET IMMUNOL IMMUNOP, V124, P385, DOI 10.1016/j.vetimm.2008.04.002; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Vogiatzi T, 2008, J BIOL CHEM; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Wikstrom K, 2008, CELL SIGNAL, V20, P2332, DOI 10.1016/j.cellsig.2008.09.003; Yamazaki T, 1996, J CELL SCI, V109, P999; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	76	108	113	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29460	10.1371/journal.pone.0029460	http://dx.doi.org/10.1371/journal.pone.0029460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216284	Green Submitted, Green Published, gold			2022-12-27	WOS:000299684700057
J	Yamamoto, K; Kawabata, H				Yamamoto, Kosuke; Kawabata, Hideaki			Temporal Recalibration in Vocalization Induced by Adaptation of Delayed Auditory Feedback	PLOS ONE			English	Article							SUPPLEMENTARY MOTOR AREA; SPEECH PRODUCTION; PERCEPTION; TIME; PRESUPPLEMENTARY; DIRECTION; EXPOSURE; SYSTEM; SOUND; MT	Background: We ordinarily perceive our voice sound as occurring simultaneously with vocal production, but the sense of simultaneity in vocalization can be easily interrupted by delayed auditory feedback (DAF). DAF causes normal people to have difficulty speaking fluently but helps people with stuttering to improve speech fluency. However, the underlying temporal mechanism for integrating the motor production of voice and the auditory perception of vocal sound remains unclear. In this study, we investigated the temporal tuning mechanism integrating vocal sensory and voice sounds under DAF with an adaptation technique. Methods and Findings: Participants produced a single voice sound repeatedly with specific delay times of DAF ( 0, 66, 133 ms) during three minutes to induce 'Lag Adaptation'. They then judged the simultaneity between motor sensation and vocal sound given feedback. We found that lag adaptation induced a shift in simultaneity responses toward the adapted auditory delays. This indicates that the temporal tuning mechanism in vocalization can be temporally recalibrated after prolonged exposure to delayed vocal sounds. Furthermore, we found that the temporal recalibration in vocalization can be affected by averaging delay times in the adaptation phase. Conclusions: These findings suggest vocalization is finely tuned by the temporal recalibration mechanism, which acutely monitors the integration of temporal delays between motor sensation and vocal sound.	[Yamamoto, Kosuke; Kawabata, Hideaki] Keio Univ, Dept Psychol, Minato Ku, Tokyo, Japan	Keio University	Yamamoto, K (corresponding author), Keio Univ, Dept Psychol, Minato Ku, Tokyo, Japan.	kawabata@flet.keio.ac.jp			Ministry of Education, Science, and Culture, Japan [D029, 19001004]	Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Program of Global Centers of Excellence (# D029) and Specially Promoted Research (19001004) of the Ministry of Education, Science, and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; Amano K, 2009, J VISION, V9, DOI 10.1167/9.3.4; Black JW, 1951, J SPEECH HEAR DISORD, V16, P56, DOI 10.1044/jshd.1601.56; Bliss CI, 1934, SCIENCE, V79, P409, DOI 10.1126/science.79.2053.409; BORDEN GJ, 1979, BRAIN LANG, V7, P307, DOI 10.1016/0093-934X(79)90025-7; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; BRIDGEMAN B, 1995, ANN BIOMED ENG, V23, P409, DOI 10.1007/BF02584441; DIXON NF, 1980, PERCEPTION, V9, P719, DOI 10.1068/p090719; Fairbanks G, 1955, J SPEECH HEAR DISORD, V20, P333, DOI 10.1044/jshd.2004.333; Fletcher H, 1918, 19412 W EL CO; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; Hanson JVM, 2008, EXP BRAIN RES, V185, P347, DOI 10.1007/s00221-008-1282-3; Harrar V, 2008, EXP BRAIN RES, V186, P517, DOI 10.1007/s00221-007-1253-0; Hashimoto Y, 2003, HUM BRAIN MAPP, V20, P22, DOI 10.1002/hbm.10119; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Howell P, 2002, J ACOUST SOC AM, V111, P2842, DOI 10.1121/1.1474444; Howell P, 1983, LANGUAGE PRODUCTION, V2, P203; KATZ DI, 1977, PERCEPT PSYCHOPHYS, V22, P476, DOI 10.3758/BF03199514; Khuu SK, 2002, VISION RES, V42, P3031, DOI 10.1016/S0042-6989(02)00384-X; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; LEE BS, 1950, J ACOUST SOC AM, V22, P824, DOI 10.1121/1.1906696; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Macar F, 1999, EXP BRAIN RES, V125, P271, DOI 10.1007/s002210050683; MARR D, 1981, PROC R SOC SER B-BIO, V211, P151, DOI 10.1098/rspb.1981.0001; Mita A, 2009, NAT NEUROSCI, V12, P502, DOI 10.1038/nn.2272; Miyazaki M, 2006, NAT NEUROSCI, V9, P875, DOI 10.1038/nn1712; Movshon JA, 1985, EXP BRAIN RES, V32, P1015; Norwich KH, 1981, PERCEPT PSYCHOPHYS, V42, P286; Pfordresher PQ, 2007, HUM MOVEMENT SCI, V26, P742, DOI 10.1016/j.humov.2007.07.006; Pfordresher PQ, 2011, J EXP PSYCHOL HUMAN, V37, P949, DOI 10.1037/a0021435; Postma A, 2000, COGNITION, V77, P97, DOI 10.1016/S0010-0277(00)00090-1; Roseboom W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018309; Shiller DM, 2009, J ACOUST SOC AM, V22, P824; Shima K, 1998, J NEUROPHYSIOL, V80, P3247, DOI 10.1152/jn.1998.80.6.3247; Spence C, 2003, CURR BIOL, V13, pR519, DOI 10.1016/S0960-9822(03)00445-7; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Sugano Y, 2010, EXP BRAIN RES, V201, P393, DOI 10.1007/s00221-009-2047-3; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; Takaso H, 2010, J SPEECH LANG HEAR R, V53, P226, DOI 10.1044/1092-4388(2009/09-0009); Tourville JA, 2008, NEUROIMAGE, V39, P1429, DOI 10.1016/j.neuroimage.2007.09.054; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; WARD LM, 1991, PERCEPT PSYCHOPHYS, V50, P117, DOI 10.3758/BF03212213; Wible CG, 2009, BRAIN IMAGING BEHAV, V3, P85, DOI 10.1007/s11682-008-9052-1; Williams SR, 1998, J NEUROPHYSIOL, V79, P947, DOI 10.1152/jn.1998.79.2.947; Winter R, 2008, BRAIN RES, V1242, P54, DOI 10.1016/j.brainres.2008.06.090; Yang J, 2009, J NEUROPHYSIOL, V101, P2693, DOI 10.1152/jn.00061.2009	48	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29414	10.1371/journal.pone.0029414	http://dx.doi.org/10.1371/journal.pone.0029414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216275	Green Published, Green Submitted, gold			2022-12-27	WOS:000299684700054
J	Harada, E; Nakagawa, J; Asano, T; Taoka, M; Sorimachi, H; Ito, Y; Aigaki, T; Matsuo, T				Harada, Eriko; Nakagawa, Jun; Asano, Tsunaki; Taoka, Masato; Sorimachi, Hiroyuki; Ito, Yoshihiro; Aigaki, Toshiro; Matsuo, Takashi			Functional Evolution of Duplicated Odorant-Binding Protein Genes, Obp57d and Obp57e, in Drosophila	PLOS ONE			English	Article							PHEROMONE-BINDING; BETA-OXIDATION; GYPSY-MOTH; FAMILY; EXPRESSION; KINETICS; RECOGNITION; SPECIFICITY; RECEPTORS; MECHANISM	Odorant-binding proteins (OBPs) are extracellular proteins found in insect chemosensilla, where they participate in the sensing of odors, tastes, and pheromones. Although a large number of OBP genes have been identified in insect genomes, their molecular functions and biological roles have been clarified in limited cases. Two OBP genes, Obp57d and Obp57e, were involved in the evolution of host-plant preference in Drosophila sechellia. Comparative analyses of the Obp57d/e genomic sequences from 27 closely related species suggested that the two genes arose by tandem gene duplication and functionally diverged from each other. In this study, the functional evolution of Obp57d and Obp57e was examined by in vitro binding assays using recombinant proteins synthesized in a bacterial system. Compared to the ancestral Dpse\OBP57de, Dmel\OBP57d was more specialized to tridecanoic acid while Dmel\OBP57e was generalized regarding their binding affinity, suggesting that the two OBP genes underwent subfunctionalization and neofunctionalization. A behavioral analysis using knockout flies supported that the biological role is different between OBP57d and OBP57e in vivo. Site-directed mutagenesis of the evolutionarily conserved amino acids revealed that these residues play an important role in protein folding. These findings provide a clue to understanding how the repertoire of OBP genes is maintained in a genome under natural selection.	[Harada, Eriko; Asano, Tsunaki; Aigaki, Toshiro] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo, Japan; [Nakagawa, Jun] Tokyo Metropolitan Inst Med Sci, Dept Mol Dev Biol, Tokyo 113, Japan; [Taoka, Masato] Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo 19203, Japan; [Sorimachi, Hiroyuki] Tokyo Metropolitan Inst Med Sci, Calpain Project, Tokyo 113, Japan; [Ito, Yoshihiro] RIKEN Adv Sci Inst, Nano Med Engn Lab, Saitama, Japan; [Matsuo, Takashi] Univ Tokyo, Dept Agr & Environm Biol, Tokyo, Japan	Tokyo Metropolitan University; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan University; Tokyo Metropolitan Institute of Medical Science; RIKEN; University of Tokyo	Harada, E (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo, Japan.	matsuo@utlae.org	Ito, Yoshihiro/F-4370-2012; Sorimachi, Hiroyuki/Q-6956-2017; Matsuo, Takashi/AAR-8291-2021; Sorimachi, Hiroyuki/C-6448-2009; Ito, Yoshihiro/T-1095-2019	Sorimachi, Hiroyuki/0000-0001-9509-6727; Matsuo, Takashi/0000-0002-4185-6740; Sorimachi, Hiroyuki/0000-0001-9509-6727; Ito, Yoshihiro/0000-0002-1154-253X; Taoka, Masato/0000-0001-5554-4951	Japan Society for the Promotion of Science [21688003]; Grants-in-Aid for Scientific Research [21688003, 09J06539] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS Research Fellowship for Young Scientists to EH and Grant-in-Aid for Young Scientists (A) 21688003 from the Japan Society for the Promotion of Science to TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Alvarez HM, 2003, INT BIODETER BIODEGR, V52, P35, DOI 10.1016/S0964-8305(02)00120-8; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Callaghan AV, 2009, APPL ENVIRON MICROB, V75, P1339, DOI 10.1128/AEM.02491-08; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Davrazou F, 2011, J BIOL CHEM, V286, P34175, DOI 10.1074/jbc.M111.274712; Gong YM, 2010, BIOCHEMISTRY-US, V49, P793, DOI 10.1021/bi901145a; Gong Y, 2009, CHEM BIOL, V16, P162, DOI 10.1016/j.chembiol.2009.01.005; Harada E, 2008, GENES GENET SYST, V83, P257, DOI 10.1266/ggs.83.257; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Honjo K, 2005, J NEUROSCI, V25, P7905, DOI 10.1523/JNEUROSCI.2135-05.2005; Ikematsu M, 2006, SANYO TECH REV, V37, P112; Jiang QY, 2009, INSECT BIOCHEM MOLEC, V39, P440, DOI 10.1016/j.ibmb.2009.04.004; Koganezawa M, 2010, CURR BIOL, V20, P1, DOI 10.1016/j.cub.2009.11.038; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007235; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Leite NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008006; Marchesini S, 2003, J BIOL CHEM, V278, P32596, DOI 10.1074/jbc.M305574200; Matsunaga I, 2000, LIPIDS, V35, P365, DOI 10.1007/s11745-000-533-y; Matsuo T, 2008, GENETICS, V178, P1061, DOI 10.1534/genetics.107.079046; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Michel E, 2011, J MOL BIOL, V408, P922, DOI 10.1016/j.jmb.2011.03.008; Pedrini N, 2010, MICROBIOL-SGM, V156, P2549, DOI 10.1099/mic.0.039735-0; Pesenti ME, 2008, J MOL BIOL, V380, P158, DOI 10.1016/j.jmb.2008.04.048; Qiao HL, 2011, CELL MOL LIFE SCI, V68, P1799, DOI 10.1007/s00018-010-0539-8; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Vieira FG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r235; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Yasukawa J, 2010, GENE, V467, P25, DOI 10.1016/j.gene.2010.07.006	36	28	30	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29710	10.1371/journal.pone.0029710	http://dx.doi.org/10.1371/journal.pone.0029710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238638	Green Submitted, gold, Green Published			2022-12-27	WOS:000301188800027
J	Ng, V; Sargeant, JM				Ng, Victoria; Sargeant, Jan M.			A Stakeholder-Informed Approach to the Identification of Criteria for the Prioritization of Zoonoses in Canada	PLOS ONE			English	Article							INFECTIOUS-DISEASES; PUBLIC-HEALTH	Background: Zoonotic diseases account for over 60% of all communicable diseases causing illness in humans and 75% of recently emerging infectious diseases. As limited resources are available for the control and prevention of zoonotic diseases, it is necessary to prioritize diseases in order to direct resources into those with the greatest needs. The selection of criteria for prioritization has traditionally been on the basis of expert opinion; however, details of the methods used to identify criteria from expert opinion often are not published and a full range of criteria may not be captured by expert opinion. Methodology/Principal Findings: This study used six focus groups to identify criteria for the prioritization of zoonotic diseases in Canada. Focus groups included people from the public, animal health professionals and human health professionals. A total of 59 criteria were identified for prioritizing zoonotic diseases. Human-related criteria accounted for the highest proportion of criteria identified (55%), followed by animal-related criteria (26%) then pathogen/disease-related criteria (19%). Similarities and differences were observed in the identification and scoring of criteria for disease prioritization between groups; the public groups were strongly influenced by the individual-level of disease burden, the responsibility of the scientific community in disease prioritization and the experiences of recent events while the professional groups were influenced by the societal- and population-level of disease burden and political and public pressure. Conclusions/Significance: This was the first study to describe a mixed semi-quantitative and qualitative approach to deriving criteria for disease prioritization. This was also the first study to involve the opinion of the general public regarding disease prioritization. The number of criteria identified highlights the difficulty in prioritizing zoonotic diseases. The method presented in this paper has formulated a comprehensive list of criteria that can be used to inform future disease prioritization studies.	[Ng, Victoria] Univ Guelph, Ontario Vet Coll, Ctr Publ Hlth & Zoonoses, Guelph, ON N1G 2W1, Canada; Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Ng, V (corresponding author), Univ Guelph, Ontario Vet Coll, Ctr Publ Hlth & Zoonoses, Guelph, ON N1G 2W1, Canada.	vng03@uoguelph.ca		Ng, Victoria/0000-0002-7619-541X	Canadian Institute of Health Research/Public Health Agency of Canada	Canadian Institute of Health Research/Public Health Agency of Canada(Canadian Institutes of Health Research (CIHR))	VN is supported by the Canadian Institute of Health Research/Public Health Agency of Canada, Applied Public Health Research Chair Program. JMS holds the Canadian Institute of Health Research/Public Health Agency of Canada, Applied Public Health Research Chair. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], COMMUN DIS REP CDR S; Balabanova Y., 2011, PLOS ONE, V6; Butler D, 2009, NATURE, V458, P1082, DOI 10.1038/4581082a; Cardoen S, 2009, FOODBORNE PATHOG DIS, V6, P1083, DOI 10.1089/fpd.2009.0291; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Doherty J A, 2000, Can J Infect Dis, V11, P21; Doherty J A, 2006, Can Commun Dis Rep, V32, P211; Gilsdorf A, 2011, EUROSURVEILLANCE, V16, P15; Havelaar AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013965; Heymann DL, 2008, CONTROL COMMUNICABLE; Horby P, 2001, Commun Dis Public Health, V4, P8; Institut de Veille Sanitaire, 2010, DEF PRIOR DOM ZOON N; Institut de Veille Sanitaire, 2002, DEF PRIOR DOM ZOON N; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Krause G, 2009, EUROSURVEILLANCE, V14, P5; Krause G, 2008, EMBO REP, V9, pS22, DOI 10.1038/embor.2008.76; Krueger RA, 2009, FOCUS GROUPS PRACTIC; Leach MJ, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-221; Lewis-Beck MS, 2004, SAGE ENCY SOCIAL SCI, V1; McCance T, 2012, J CLIN NURS, V21, P1145, DOI 10.1111/j.1365-2702.2011.03820.x; PHAC, 2010, LESS LEARN REV PUBL; Sampietro-Colom L, 2008, MED DECIS MAKING, V28, P554, DOI 10.1177/0272989X08315235; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Weinberg J, 1999, EUR J PUBLIC HEALTH, V9, P236, DOI 10.1093/eurpub/9.3.236; World Health Organization, 2003, WHO M BUCH ROM 21 23	27	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29752	10.1371/journal.pone.0029752	http://dx.doi.org/10.1371/journal.pone.0029752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238648	Green Published, gold, Green Submitted			2022-12-27	WOS:000301188800032
J	Woodroffe, R; Prager, KC; Munson, L; Conrad, PA; Dubovi, EJ; Mazet, JAK				Woodroffe, Rosie; Prager, Katherine C.; Munson, Linda; Conrad, Patricia A.; Dubovi, Edward J.; Mazet, Jonna A. K.			Contact with Domestic Dogs Increases Pathogen Exposure in Endangered African Wild Dogs (Lycaon pictus)	PLOS ONE			English	Article							CANINE PARVOVIRUS; NATIONAL-PARK; GROUP-SIZE; RABIES; POPULATION; DISEASE; INFECTION; TRANSMISSION; VIRUS; VACCINATION	Background: Infectious diseases have contributed to the decline and local extinction of several wildlife species, including African wild dogs (Lycaon pictus). Mitigating such disease threats is challenging, partly because uncertainty about disease dynamics makes it difficult to identify the best management approaches. Serious impacts on susceptible populations most frequently occur when generalist pathogens are maintained within populations of abundant (often domestic) "reservoir'' hosts, and spill over into less abundant host species. If this is the case, disease control directed at the reservoir host might be most appropriate. However, pathogen transmission within threatened host populations may also be important, and may not be controllable by managing another host species. Methodology/Principal Findings: We investigated interspecific and intraspecific transmission routes, by comparing African wild dogs' exposure to six canine pathogens with behavioural measures of their opportunities for contact with domestic dogs and with other wild dogs. Domestic dog contact was associated with exposure to canine parvovirus, Ehrlichia canis, Neospora caninum and perhaps rabies virus, but not with exposure to canine distemper virus or canine coronavirus. Contact with other wild dogs appeared not to increase the risk of exposure to any of the pathogens. Conclusions/Significance: These findings, combined with other data, suggest that management directed at domestic dogs might help to protect wild dog populations from rabies virus, but not from canine distemper virus. However, further analyses are needed to determine the management approaches - including no intervention - which are most appropriate for each pathogen.	[Woodroffe, Rosie] Zool Soc London, Inst Zool, London NW1 4RY, England; [Woodroffe, Rosie; Prager, Katherine C.; Munson, Linda; Conrad, Patricia A.; Mazet, Jonna A. K.] Univ Calif Davis, Wildlife Hlth Ctr, Davis, CA 95616 USA; [Munson, Linda; Conrad, Patricia A.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Dubovi, Edward J.] Cornell Univ, Coll Vet Med, Anim Hlth Diagnost Ctr, Ithaca, NY 14853 USA	Zoological Society of London; University of California System; University of California Davis; University of California System; University of California Davis; Cornell University	Woodroffe, R (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	rosie.woodroffe@ioz.ac.uk	Prager, Katherine/ABH-3784-2020		Morris Animal Foundation; African Wildlife Foundation; Columbus Zoo; Denver Zoo; Disney Wildlife Conservation Fund; National Geographic Society; Philadelphia Zoo; SeaWorld-Busch Gardens Conservation Fund; Wildlife Conservation Society; Medical Research Council [G0600719B] Funding Source: researchfish	Morris Animal Foundation; African Wildlife Foundation; Columbus Zoo; Denver Zoo; Disney Wildlife Conservation Fund; National Geographic Society(National Geographic Society); Philadelphia Zoo; SeaWorld-Busch Gardens Conservation Fund; Wildlife Conservation Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Morris Animal Foundation, African Wildlife Foundation, Columbus Zoo, Denver Zoo, Disney Wildlife Conservation Fund, National Geographic Society, Philadelphia Zoo, SeaWorld-Busch Gardens Conservation Fund and the Wildlife Conservation Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KA, 1994, J WILDLIFE DIS, V30, P481, DOI 10.7589/0090-3558-30.4.481; Alexander KA, 1996, J ZOO WILDLIFE MED, V27, P426; ALEXANDER KA, 1994, J WILDLIFE DIS, V30, P486, DOI 10.7589/0090-3558-30.4.486; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; APPEL M, 1973, AM J VET RES, V34, P1459; APPEL M. J., 1987, VIRUS INFECT CARNIVO, P133; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; CARMICHAEL LE, 1980, AM J VET RES, V41, P784; Cleaveland S, 1999, EPIDEMIOL INFECT, V123, P157, DOI 10.1017/S0950268899002563; Cleaveland S., 2002, P139; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Courtenay O, 2001, VET MICROBIOL, V81, P9, DOI 10.1016/S0378-1135(01)00326-1; Craft ME, 2008, J ANIM ECOL, V77, P1257, DOI 10.1111/j.1365-2656.2008.01410.x; Creel S, 1997, J WILDLIFE DIS, V33, P823, DOI 10.7589/0090-3558-33.4.823; Creel S., 2002, AFRICAN WILD DOG BEH; Dubey JP, 2007, CLIN MICROBIOL REV, V20, P323, DOI 10.1128/CMR.00031-06; East ML, 2001, P NATL ACAD SCI USA, V98, P15026, DOI 10.1073/pnas.261411898; Fekadu M., 1991, The natural history of rabies. 2nd Edition.., P367; Formenty P, 1999, J INFECT DIS, V179, pS120, DOI 10.1086/514296; Fuller TK, 1992, WILDLIFE 2001 POPULA; GASCOYNE SC, 1993, ONDERSTEPOORT J VET, V60, P415; Goller KV, 2010, VET MICROBIOL, V146, P245, DOI 10.1016/j.vetmic.2010.05.018; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Hofmeyr M, 2004, ANIM CONSERV, V7, P193, DOI 10.1017/S1367943004001234; Hofmeyr M, 2000, VET REC, V146, P50, DOI 10.1136/vr.146.2.50; Holmberg TA, 2006, VET CLIN PATH, V35, P235, DOI 10.1111/j.1939-165X.2006.tb00121.x; Hudson P, 1998, TRENDS ECOL EVOL, V13, P387, DOI 10.1016/S0169-5347(98)01475-X; KAT PW, 1995, P ROY SOC B-BIOL SCI, V262, P229, DOI 10.1098/rspb.1995.0200; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Leendertz FH, 2006, BIOL CONSERV, V131, P325, DOI 10.1016/j.biocon.2006.05.002; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; Mech LD, 2008, J WILDLIFE DIS, V44, P824, DOI 10.7589/0090-3558-44.4.824; Mills MGL, 1997, CONSERV BIOL, V11, P1397, DOI 10.1046/j.1523-1739.1997.96252.x; Prager KC, 2011, BIOL CONSERV, V144, P1940, DOI 10.1016/j.biocon.2011.03.025; PRAGER K. C., 2011, INVESTIGATION INFECT; Prager KC, RABIES CANI IN PRESS; Prager KC, EFFECT PROT IN PRESS; Randall DA, 2006, BIOL CONSERV, V131, P151, DOI 10.1016/j.biocon.2006.04.004; Richomme C, 2006, EPIDEMIOL INFECT, V134, P21, DOI 10.1017/S0950268805004693; RISTIC M, 1972, INFECT IMMUN, V6, P226, DOI 10.1128/IAI.6.3.226-231.1972; Ruttimann S, 2008, EUR J WILDLIFE RES, V54, P110, DOI 10.1007/s10344-007-0118-y; Scheepers JL, 1995, S AFR J WILDL RES, V25, P138; SilleroZubiri C, 1996, J WILDLIFE DIS, V32, P80, DOI 10.7589/0090-3558-32.1.80; SMITH JS, 1973, B WORLD HEALTH ORGAN, V48, P535; STEVENSON-HAMILTON J., 1939, Journal of the South African Veterinary Medical Association, V10, P56; Stich RW, 2008, VET PARASITOL, V158, P256, DOI 10.1016/j.vetpar.2008.09.013; THORNE E T, 1988, Conservation Biology, V2, P66, DOI 10.1111/j.1523-1739.1988.tb00336.x; Tompkins DM, 2002, P ROY SOC B-BIOL SCI, V269, P529, DOI 10.1098/rspb.2001.1897; VANHEERDEN J, 1995, J S AFR VET ASSOC, V66, P18; Woodroffe R, 2011, J ZOOL, V283, P88, DOI 10.1111/j.1469-7998.2010.00747.x; Woodroffe R, 2001, ORYX, V35, P234, DOI 10.1017/S0030605300031902; Woodroffe R, 2006, AFRICAN WILD DOGS AF; Woodroffe R., 2013, AFRICAN WILD DOG STA, P7; Woodroffe R, 2009, AFRICAN WILD DOGS AF; Woodroffe R, 2011, J APPL ECOL, V48, P1345, DOI 10.1111/j.1365-2664.2011.02059.x; Woodroffe R, 2011, J MAMMAL, V92, P305, DOI 10.1644/10-MAMM-A-157.1; Woodroffe R, 2009, J ANIM ECOL, V78, P818, DOI 10.1111/j.1365-2656.2009.01545.x; Woodroffe R, 1999, ANIM CONSERV, V2, P185, DOI 10.1111/j.1469-1795.1999.tb00064.x; Woodroffe R, 2007, J MAMMAL, V88, P181, DOI 10.1644/05-MAMM-A-405R1.1	61	86	89	4	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e30099	10.1371/journal.pone.0030099	http://dx.doi.org/10.1371/journal.pone.0030099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238695	Green Published, Green Submitted, gold			2022-12-27	WOS:000301188800059
J	Gibert, B; Eckel, B; Fasquelle, L; Moulin, M; Bouhallier, F; Gonin, V; Mellier, G; Simon, S; Kretz-Remy, C; Arrigo, AP; Diaz-Latoud, C				Gibert, Benjamin; Eckel, Benedicte; Fasquelle, Lydie; Moulin, Maryline; Bouhallier, Frantz; Gonin, Vincent; Mellier, Gregory; Simon, Stephanie; Kretz-Remy, Carole; Arrigo, Andre-Patrick; Diaz-Latoud, Chantal			Knock Down of Heat Shock Protein 27 (HspB1) Induces Degradation of Several Putative Client Proteins	PLOS ONE			English	Article							INDUCED APOPTOSIS; CELL-DEATH; CYTOCHROME-C; ANDROGEN ABLATION; DEACETYLASE HDAC6; PROSTATE-CANCER; AKT ACTIVATION; TUMOR-CELLS; HSP27; INHIBITION	Hsp27 belongs to the heat shock protein family and displays chaperone properties in stress conditions by holding unfolded polypeptides, hence avoiding their inclination to aggregate. Hsp27 is often referenced as an anti-cancer therapeutic target, but apart from its well-described ability to interfere with different stresses and apoptotic processes, its role in non-stressed conditions is still not well defined. In the present study we report that three polypeptides (histone deacetylase HDAC6, transcription factor STAT2 and procaspase-3) were degraded in human cancerous cells displaying genetically decreased levels of Hsp27. In addition, these proteins interacted with Hsp27 complexes of different native size. Altogether, these findings suggest that HDAC6, STAT2 and procaspase-3 are client proteins of Hsp27. Hence, in non stressed cancerous cells, the structural organization of Hsp27 appears to be a key parameter in the regulation by this chaperone of the level of specific polypeptides through client-chaperone type of interactions.	[Gibert, Benjamin; Eckel, Benedicte; Fasquelle, Lydie; Moulin, Maryline; Mellier, Gregory; Simon, Stephanie; Kretz-Remy, Carole; Arrigo, Andre-Patrick; Diaz-Latoud, Chantal] Univ Lyon 1, CNRS UMR5534, Ctr Genet Mol & Cellulaire, F-69622 Villeurbanne, France; [Fasquelle, Lydie] Hop St Eloi, Inserm U583, Inst Neurosci, Montpellier, France; [Fasquelle, Lydie] Univ Montpellier 1, Montpellier, France; [Moulin, Maryline] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Eckel, Benedicte; Gonin, Vincent; Diaz-Latoud, Chantal] Univ Lyon 1, INSERM U664, F-69622 Villeurbanne, France; [Bouhallier, Frantz] Univ Lyon 1, UMR5242, UMR1288, Inst Genom Fonctionnelle Lyon,CNRS,INRA,ENS Lyon, F-69365 Lyon, France; [Gibert, Benjamin; Arrigo, Andre-Patrick] Univ Lyon, Apoptosis Canc & Dev Lab, Ctr Leon Berard, CRCL UMR INSERM CNRS UMR5286 U1052, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; La Trobe University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Gibert, B (corresponding author), Univ Lyon 1, CNRS UMR5534, Ctr Genet Mol & Cellulaire, F-69622 Villeurbanne, France.	benjamin.gibert@lyon.unicancer.fr; chantal.diaz@univ-lyon1.fr	Kretz-Remy, Carole/J-7850-2019; Stephanie, Simon/A-3845-2013	Kretz-Remy, Carole/0000-0002-9553-5598; GIBERT, Benjamin/0000-0002-5295-3124; Moulin, Maryline/0000-0002-1851-8727	Comite du Rhone of la Ligue Contre le Cancer; Rhone-Alpes	Comite du Rhone of la Ligue Contre le Cancer; Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was supported by a research grant from the Comite du Rhone of la Ligue Contre le Cancer and by the Rhone-Alpes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy MT, 2008, INT J RADIAT ONCOL, V70, P543, DOI 10.1016/j.ijrobp.2007.08.061; Andrieu C, 2010, ONCOGENE, V29, P1883, DOI 10.1038/onc.2009.479; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Arrigo AP, 2001, IUBMB LIFE, V52, P303, DOI 10.1080/152165401317291156; Blagosklonny MV, 2002, LEUKEMIA, V16, P455, DOI 10.1038/sj.leu.2402415; Bluyssen HAR, 1997, J BIOL CHEM, V272, P4600, DOI 10.1074/jbc.272.7.4600; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Bruey JM, 2000, ONCOGENE, V19, P4855, DOI 10.1038/sj.onc.1203850; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Charette SJ, 2000, ANN NY ACAD SCI, V926, P126; Chauhan D, 2003, CANCER RES, V63, P6174; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Diaz-Latoud C, 2005, ANTIOXID REDOX SIGN, V7, P436, DOI 10.1089/ars.2005.7.436; Doshi BM, 2009, CELL STRESS CHAPERON, V14, P445, DOI 10.1007/s12192-008-0098-1; Gibert B, 2011, ONCOGENE, V30, P3672, DOI 10.1038/onc.2011.73; Hageman J, MOL CELL, V37, P355; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Huot J, 1996, CANCER RES, V56, P273; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Javouhey E, 2008, VIROLOGY, V376, P31, DOI 10.1016/j.virol.2008.02.031; Jaya N, 2009, P NATL ACAD SCI USA, V26, P26; Jomary C, 2006, INVEST OPHTH VIS SCI, V47, P1620, DOI 10.1167/iovs.05-1176; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Lelj-Garolla B, 2006, J BIOL CHEM, V281, P8169, DOI 10.1074/jbc.M512553200; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; Moulin M, 2006, EXP CELL RES, V312, P1765, DOI 10.1016/j.yexcr.2006.02.008; O'Callaghan-Sunol C, 2007, CANCER RES, V67, P11779, DOI 10.1158/0008-5472.CAN-07-2441; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Paul C, 2010, EXP CELL RES, V316, P1535, DOI 10.1016/j.yexcr.2010.03.006; Plescia J, 2005, CANCER CELL, V7, P457, DOI 10.1016/j.ccr.2005.03.035; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Rocchi P, 2005, CANCER RES, V65, P11083, DOI 10.1158/0008-5472.CAN-05-1840; Song H, 2004, BIOCHEM BIOPH RES CO, V314, P143, DOI 10.1016/j.bbrc.2003.12.048; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Voss OH, 2007, J BIOL CHEM, V282, P25088, DOI 10.1074/jbc.M701740200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Zhang Y, 2007, CLIN CANCER RES, V13, P2855, DOI 10.1158/1078-0432.CCR-06-2090; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	49	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29719	10.1371/journal.pone.0029719	http://dx.doi.org/10.1371/journal.pone.0029719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238643	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200044
J	Godart, N; Berthoz, S; Curt, F; Perdereau, F; Rein, Z; Wallier, J; Horreard, AS; Kaganski, I; Lucet, R; Atger, F; Corcos, M; Fermanian, J; Falissard, B; Flament, M; Eisler, I; Jeammet, P				Godart, Nathalie; Berthoz, Sylvie; Curt, Florence; Perdereau, Fabienne; Rein, Zoe; Wallier, Jenny; Horreard, Anne-Sophie; Kaganski, Irene; Lucet, Rejane; Atger, Frederic; Corcos, Maurice; Fermanian, Jacques; Falissard, Bruno; Flament, Martine; Eisler, Ivan; Jeammet, Philippe			A Randomized Controlled Trial of Adjunctive Family Therapy and Treatment as Usual Following Inpatient Treatment for Anorexia Nervosa Adolescents	PLOS ONE			English	Article							BODY-MASS INDEX; INDIVIDUAL THERAPY; EATING-DISORDERS; MEDICAL COMPLICATIONS; SOCIAL-ADJUSTMENT; PREDICTORS; TERM; COMORBIDITY; HOSPITALIZATION; PREVALENCE	Research on treatments in anorexia nervosa (AN) is scarce. Although most of the therapeutic programs used in 'real world practice' in AN treatment resort to multidisciplinary approaches, they have rarely been evaluated. Objective: To compare two multidimensional post-hospitalization outpatients treatment programs for adolescents with severe AN: Treatment as Usual (TAU) versus this treatment plus family therapy (TAU+FT). Method: Sixty female AN adolescents, aged 13 to 19 years, were included in a randomized parallel controlled trial conducted from 1999 to 2002 for the recruitment, and until 2004 for the 18 months follow-up. Allocation to one of the two treatment groups (30 in each arm) was randomised. The TAU program included sessions for the patient alone as well as sessions with a psychiatrist for the patient and her parents. The TAU+FT program was identical to the usual one but also included family therapy sessions targeting intra-familial dynamics, but not eating disorder symptoms. The main Outcome Measure was the Morgan and Russell outcome category (Good or Intermediate versus Poor outcome). Secondary outcome indicators included AN symptoms or their consequences (eating symptoms, body mass index, amenorrhea, number of hospitalizations in the course of follow-up, social adjustment). The evaluators, but not participants, were blind to randomization. Results: At 18 months follow-up, we found a significant group effect for the Morgan and Russell outcome category in favor of the program with family therapy (Intention-to-treat: TAU+FT : 12/30 (40%); TAU : 5/29 (17.2%) p = 0.05; Per Protocol analysis: respectively 12/26 (46.2%); 4/27 (14.8%), p = 0.01). Similar group effects were observed in terms of achievement of a healthy weight (i.e., BMI >= 10th percentile) and menstrual status. Conclusions: Adding family therapy sessions, focusing on intra-familial dynamics rather than eating symptomatology, to a multidimensional program improves treatment effectiveness in girls with severe AN. Trial Registration: Controlled-trials.com ISRCTN71142875	[Godart, Nathalie; Berthoz, Sylvie; Curt, Florence; Perdereau, Fabienne; Rein, Zoe; Wallier, Jenny; Horreard, Anne-Sophie; Kaganski, Irene; Lucet, Rejane; Atger, Frederic; Corcos, Maurice; Jeammet, Philippe] Inst Mutualiste Montsouris, Dept Adolescents & Young Adults Psychiat, Paris, France; [Godart, Nathalie; Berthoz, Sylvie; Perdereau, Fabienne; Wallier, Jenny; Atger, Frederic; Corcos, Maurice; Falissard, Bruno; Jeammet, Philippe] Natl Inst Hlth & Med Res Inserm, Unit UMR S0669, Paris, France; [Godart, Nathalie; Berthoz, Sylvie; Curt, Florence; Perdereau, Fabienne; Rein, Zoe; Wallier, Jenny; Kaganski, Irene; Lucet, Rejane; Atger, Frederic; Corcos, Maurice; Fermanian, Jacques; Falissard, Bruno; Jeammet, Philippe] Paris Descartes Univ, Paris, France; [Godart, Nathalie; Berthoz, Sylvie; Curt, Florence; Perdereau, Fabienne; Rein, Zoe; Wallier, Jenny; Kaganski, Irene; Lucet, Rejane; Atger, Frederic; Corcos, Maurice; Fermanian, Jacques; Falissard, Bruno; Jeammet, Philippe] Univ Paris 11, Paris, France; [Wallier, Jenny; Eisler, Ivan] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Fermanian, Jacques] Hop Necker Enfants Malad, Dept Biostat, Paris, France; [Flament, Martine] Univ Ottawa, Royal Ottawa Hosp, Mental Hlth Res Inst, Ottawa, ON, Canada	Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; University of London; King's College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Ottawa	Godart, N (corresponding author), Inst Mutualiste Montsouris, Dept Adolescents & Young Adults Psychiat, Paris, France.	nathalie.godart@imm.fr	Flament, Martine/D-4550-2013; Berthoz Landron, Sylvie/M-4517-2018; Eisler, Ivan/C-8386-2009; godart, nathalie/I-9553-2014	Eisler, Ivan/0000-0002-8211-7514; godart, nathalie/0000-0002-7233-6991; Berthoz, Sylvie/0000-0002-6862-2362	Hospitalier de Recherche Clinique (CRC-PHRC) [AOM97133]; Assistance Publique des Hopitaux de Paris (AP-HP)	Hospitalier de Recherche Clinique (CRC-PHRC); Assistance Publique des Hopitaux de Paris (AP-HP)	This study was funded by the Projet Hospitalier de Recherche Clinique (CRC-PHRC, 1997, AOM97133 AP-HP French Ministry of Health); and promoted by Assistance Publique des Hopitaux de Paris (AP-HP). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	American Psychiatric Association, 2006, PRACT GUID TREATM PA; Ball Jillian, 2004, Eat Disord, V12, P303, DOI 10.1080/10640260490521389; Berkman ND, 2007, INT J EAT DISORDER, V40, P293, DOI 10.1002/eat.20369; Bulik CM, 2007, INT J EAT DISORDER, V40, P310, DOI 10.1002/eat.20367; CASAGRANDE JT, 1978, BIOMETRICS, V34, P483, DOI 10.2307/2530613; Criquillon-Doublet S, 1995, PSYCHOPATHOLOGIE QUA, P249; Diem K, 1971, SCI TABLES; Eisler I, 2000, J CHILD PSYCHOL PSYC, V41, P727, DOI 10.1111/1469-7610.00660; Eisler I, 1997, ARCH GEN PSYCHIAT, V54, P1025; Eisler I, 2007, J CHILD PSYCHOL PSYC, V48, P552, DOI 10.1111/j.1469-7610.2007.01726.x; Fairburn CG, 2005, INT J EAT DISORDER, V37, pS26, DOI 10.1002/eat.20112; Flament M F, 2001, Eat Weight Disord, V6, P99; Fleiss J.L., 1994, HDB RES SYNTHESIS, P245; GARNER DM, 1993, LANCET, V341, P1631, DOI 10.1016/0140-6736(93)90768-C; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Godart N, 2006, EAT WEIGHT DISORD-ST, V11, P185, DOI 10.1007/BF03327570; Godart N, 2004, Eat Weight Disord, V9, P224; Godart N, 2005, ARCH PEDIATRIE, V12, P1544, DOI 10.1016/j.arcped.2005.02.030; Godart N, 2009, EAT WEIGHT DISORD-ST, V14, pE176, DOI 10.1007/BF03325114; Godart N, 2007, MANUEL PSYCHIAT, P424; Godart NT, 2007, J AFFECT DISORDERS, V97, P37, DOI 10.1016/j.jad.2006.06.023; Godart N T, 2004, Eat Weight Disord, V9, P249; Godart NT, 2002, INT J EAT DISORDER, V32, P253, DOI 10.1002/eat.10096; Gowers SG, 2000, BRIT J PSYCHIAT, V176, P138, DOI 10.1192/bjp.176.2.138; Gowers SG, 2007, BRIT J PSYCHIAT, V191, P427, DOI 10.1192/bjp.bp.107.036764; Halmi KA, 2005, ARCH GEN PSYCHIAT, V62, P776, DOI 10.1001/archpsyc.62.7.776; Halmi KA, 2008, AM J PSYCHIAT, V165, P1227, DOI 10.1176/appi.ajp.2008.08060957; Hebebrand J, 1996, INT J EAT DISORDER, V19, P359, DOI 10.1002/(SICI)1098-108X(199605)19:4&lt;359::AID-EAT4&gt;3.0.CO;2-K; Hoek HW, 2003, INT J EAT DISORDER, V34, P383, DOI 10.1002/eat.10222; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; JEAMMET P, 1991, PSYCHIAT ENFANT, V34, P381; Kaganski I., 2005, ENFANCE PSY, V2, P45; Kaganski I., 1999, PRISME, V30, P106; Kaganski I., 2004, GUERIR SOUFFRANCES F, P477; Katzman DK, 2005, INT J EAT DISORDER, V37, pS52, DOI 10.1002/eat.20118; Keel PK, 2003, ARCH GEN PSYCHIAT, V60, P179, DOI 10.1001/archpsyc.60.2.179; Keski-Rahkonen A, 2007, AM J PSYCHIAT, V164, P1259, DOI 10.1176/appi.ajp.2007.06081388; Lay B, 2002, EUR EAT DISORD REV, V10, P22, DOI 10.1002/erv.432; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; LEGRANGE D, 1992, INT J EAT DISORDER, V12, P347, DOI 10.1002/1098-108X(199212)12:4&lt;347::AID-EAT2260120402&gt;3.0.CO;2-W; Lock J, 2005, J AM ACAD CHILD PSY, V44, P632, DOI 10.1097/01.chi.0000161647.82775.0a; Lock J, 2001, J Psychother Pract Res, V10, P253; Lock J, 2006, J AM ACAD CHILD PSY, V45, P666, DOI 10.1097/01.chi.0000215152.61400.ca; Loeb KL, 2007, J AM ACAD CHILD PSY, V46, P792, DOI 10.1097/chi.0b013e318058a98e; Mitchell JE, 2006, CURR OPIN PSYCHIATR, V19, P438, DOI 10.1097/01.yco.0000228768.79097.3e; MORGAN HG, 1988, BRIT J PSYCHIAT, V152, P367, DOI 10.1192/bjp.152.3.367; MORGAN HG, 1975, PSYCHOL MED, V5, P355, DOI 10.1017/S0033291700056981; National Institute for Clinical Excellence, 2004, NAT I CLIN EXC CLIN, V9; Pike KM, 2003, AM J PSYCHIAT, V160, P2046, DOI 10.1176/appi.ajp.160.11.2046; ROBIN AL, 1995, INT J EAT DISORDER, V17, P313, DOI 10.1002/1098-108X(199505)17:4<313::AID-EAT2260170402>3.0.CO;2-8; ROBIN AL, 1994, J DEV BEHAV PEDIATR, V15, P111; Robin AL, 1999, J AM ACAD CHILD PSY, V38, P1482, DOI 10.1097/00004583-199912000-00008; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; RUSSELL GFM, 1987, ARCH GEN PSYCHIAT, V44, P1047; Schmidt U, 2006, BRIT J CLIN PSYCHOL, V45, P343, DOI 10.1348/014466505X53902; STEINHAUSEN HC, 1993, INT J EAT DISORDER, V14, P487, DOI 10.1002/1098-108X(199312)14:4<487::AID-EAT2260140412>3.0.CO;2-7; Strober M, 1997, INT J EAT DISORDER, V22, P339, DOI 10.1002/(SICI)1098-108X(199712)22:4&lt;339::AID-EAT1&gt;3.0.CO;2-N; WAINTRAUD L, 1995, ANN MED-PSYCHOL, V153, P274; WEISSMAN MM, 1976, ARCH GEN PSYCHIAT, V33, P1111	59	60	63	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e28249	10.1371/journal.pone.0028249	http://dx.doi.org/10.1371/journal.pone.0028249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	902VE	22238574	gold, Green Submitted, Green Published			2022-12-27	WOS:000301070200006
J	Krishnan, A; Almen, MS; Fredriksson, R; Schioth, HB				Krishnan, Arunkumar; Almen, Markus Sallman; Fredriksson, Robert; Schioth, Helgi B.			The Origin of GPCRs: Identification of Mammalian like Rhodopsin, Adhesion, Glutamate and Frizzled GPCRs in Fungi	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTORS; PHYLOGENETIC ANALYSIS; GENOME; REPERTOIRE; FAMILIES; TRENDS	G protein-coupled receptors (GPCRs) in humans are classified into the five main families named Glutamate, Rhodopsin, Adhesion, Frizzled and Secretin according to the GRAFS classification. Previous results show that these mammalian GRAFS families are well represented in the Metazoan lineages, but they have not been shown to be present in Fungi. Here, we systematically mined 79 fungal genomes and provide the first evidence that four of the five main mammalian families of GPCRs, namely Rhodopsin, Adhesion, Glutamate and Frizzled, are present in Fungi and found 142 novel sequences between them. Significantly, we provide strong evidence that the Rhodopsin family emerged from the cAMP receptor family in an event close to the split of Opisthokonts and not in Placozoa, as earlier assumed. The Rhodopsin family then expanded greatly in Metazoans while the cAMP receptor family is found in 3 invertebrate species and lost in the vertebrates. We estimate that the Adhesion and Frizzled families evolved before the split of Unikonts from a common ancestor of all major eukaryotic lineages. Also, the study highlights that the fungal Adhesion receptors do not have N-terminal domains whereas the fungal Glutamate receptors have a broad repertoire of mammalian-like N-terminal domains. Further, mining of the close unicellular relatives of the Metazoan lineage, Salpingoeca rosetta and Capsaspora owczarzaki, obtained a rich group of both the Adhesion and Glutamate families, which in particular provided insight to the early emergence of the N-terminal domains of the Adhesion family. We identified 619 Fungi specific GPCRs across 79 genomes and revealed that Blastocladiomycota and Chytridiomycota phylum have Metazoan-like GPCRs rather than the GPCRs specific for Fungi. Overall, this study provides the first evidence of the presence of four of the five main GRAFS families in Fungi and clarifies the early evolutionary history of the GPCR superfamily.	[Krishnan, Arunkumar; Almen, Markus Sallman; Fredriksson, Robert; Schioth, Helgi B.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University	Krishnan, A (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	helgi.schioth@neuro.uu.se	Schioth, Helgi/AAQ-7239-2020; Fredriksson, Robert/AAH-3921-2019	Fredriksson, Robert/0000-0002-2810-3226; Sallman Almen, Markus/0000-0001-9591-9228; Krishnan, Arunkumar/0000-0002-9677-9092	Swedish Research Council; Novo Nordisk Foundation, Swedish Royal Academy of Sciences; Magnus Bergvall Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation, Swedish Royal Academy of Sciences; Magnus Bergvall Foundation	The study was supported by the Swedish Research Council, The Novo Nordisk Foundation, Swedish Royal Academy of Sciences, and Magnus Bergvall Foundation. RF was supported by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; ATTWOOD TK, 1994, PROTEIN ENG, V7, P195, DOI 10.1093/protein/7.2.195; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carr M, 2008, P NATL ACAD SCI USA, V105, P16641, DOI 10.1073/pnas.0801667105; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; James TY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000458; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kamesh N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-129; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KLEIN PS, 1988, SCIENCE, V241, P1467, DOI 10.1126/science.3047871; Kulkarni RD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r24; Lafon A, 2006, FUNGAL GENET BIOL, V43, P490, DOI 10.1016/j.fgb.2006.02.001; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Medina M, 2001, P NATL ACAD SCI USA, V98, P9707, DOI 10.1073/pnas.171316998; Meersseman W, 2007, CLIN INFECT DIS, V45, P205, DOI 10.1086/518852; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Nordstrom KJV, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-9; Nordstrom KJV, 2009, MOL BIOL EVOL, V26, P71, DOI 10.1093/molbev/msn228; Nordstrom KJ, 2011, MOL BIOL EVOL; O'Day DH, 2011, BIOL REV CAMB PHILOS; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Ruiz-Trillo I, 2007, TRENDS GENET, V23, P113, DOI 10.1016/j.tig.2007.01.005; Ruiz-Trillo I, 2006, J EUKARYOT MICROBIOL, V53, P379, DOI 10.1111/j.1550-7408.2006.00118.x; Silveira F, 2005, CURR OPIN PULM MED, V11, P242, DOI 10.1097/01.mcp.0000159832.20648.70; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Wang Y, 2011, DEV GROWTH DIFFER, V53, P495, DOI 10.1111/j.1440-169X.2011.01265.x; Warnock DW, 2006, MED MYCOL, V44, P697, DOI 10.1080/13693780601009493; Xu JR, 2006, ANNU REV PHYTOPATHOL, V44, P337, DOI 10.1146/annurev.phyto.44.070505.143412; Xue CY, 2008, FEMS MICROBIOL REV, V32, P1010, DOI 10.1111/j.1574-6976.2008.00131.x; Yu JH, 2006, J MICROBIOL, V44, P145	46	116	119	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29817	10.1371/journal.pone.0029817	http://dx.doi.org/10.1371/journal.pone.0029817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238661	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200052
J	Saha, S; Bhanja, P; Liu, LB; Alfieri, AA; Yu, D; Kandimalla, ER; Agrawal, S; Guha, C				Saha, Subhrajit; Bhanja, Payel; Liu, Laibin; Alfieri, Alan A.; Yu, Dong; Kandimalla, Ekambar R.; Agrawal, Sudhir; Guha, Chandan			TLR9 Agonist Protects Mice from Radiation-Induced Gastrointestinal Syndrome	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; TOLL-LIKE RECEPTORS; GROWTH-FACTOR; STEM-CELL; INDUCED APOPTOSIS; IMMUNOMODULATORY OLIGONUCLEOTIDES; IMMUNOSTIMULATORY ACTIVITY; ENDOTHELIAL APOPTOSIS; IN-VIVO; TOLL-LIKE-RECEPTOR-9	Purpose: Radiation-induced gastrointestinal syndrome (RIGS) is due to the clonogenic loss of crypt cells and villi depopulation, resulting in disruption of mucosal barrier, bacterial invasion, inflammation and sepsis. Intestinal macrophages could recognize invading bacterial DNA via TLR9 receptors and transmit regenerative signals to the neighboring crypt. We therefore investigated whether systemic administration of designer TLR9 agonist could ameliorate RIGS by activating TLR9. Methods and Materials: Male C57Bl6 mice were distributed in four experimental cohorts, whole body irradiation (WBI) (8.4-10.4 Gy), TLR9 agonist (1 mg/kg s.c.), 1 h pre- or post-WBI and TLR9 agonist+WBI+iMyd88 (pretreatment with inhibitory peptide against Myd88). Animals were observed for survival and intestine was harvested for histological analysis. BALB/c mice with CT26 colon tumors in abdominal wall were irradiated with 14 Gy single dose of whole abdominal irradiation (AIR) for tumor growth study. Results: Mice receiving pre-WBI TLR9 agonist demonstrated improvement of survival after 10.4 Gy (p<0.03), 9.4 Gy (p<0.008) and 8.4 Gy (p<0.002) of WBI, compared to untreated or iMyd88-treated controls. Post-WBI TLR9 agonist mitigates up to 8.4 Gy WBI (p<0.01). Histological analysis and xylose absorption test demonstrated significant structural and functional restitution of the intestine in WBI+TLR9 agonist cohorts. Although, AIR reduced tumor growth, all animals died within 12 days from RIGS. TLR9 agonist improved the survival of mice beyond 28 days post-AIR (p<0.008) with significant reduction of tumor growth (p<0.0001). Conclusions: TLR9 agonist treatment could serve both as a prophylactic or mitigating agent against acute radiation syndrome and also as an adjuvant therapy to increase the therapeutic ratio of abdominal Radiation Therapy for Gastro Intestinal malignancies.	[Saha, Subhrajit; Bhanja, Payel; Liu, Laibin; Alfieri, Alan A.; Guha, Chandan] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA; [Guha, Chandan] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Yu, Dong; Kandimalla, Ekambar R.; Agrawal, Sudhir] Idera Pharmaceut Inc, Cambridge, MA USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Saha, S (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA.	cguhamd@pol.net	SAHA, SUBHRAJIT/AAJ-9272-2021	SAHA, SUBHRAJIT/0000-0002-7287-073X; Agrawal, Sudhir/0000-0003-4275-2510	National Institutes of Health (NIH) [RC2 AI087612, U19AI091175]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI091175, RC2AI087612] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health (NIH) grants RC2 AI087612 and U19AI091175 to CG. No other external funding was received for this study. Part of the findings of the manuscript has been presented in the 51st Annual Meeting of ASTRO in Chicago and was selected for the Poster Recognition Award in Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apontes P, 2011, ONCOTARGET, V2, P222, DOI 10.18632/oncotarget.248; Bhanja P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008014; Booth D, 2001, J Natl Cancer Inst Monogr, P16; Booth D, 2000, INT J CANCER, V86, P53, DOI 10.1002/(SICI)1097-0215(20000401)86:1<53::AID-IJC8>3.0.CO;2-Z; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Crawford PA, 2005, P NATL ACAD SCI USA, V102, P13254, DOI 10.1073/pnas.0504830102; Damiano V, 2006, CLIN CANCER RES, V12, P577, DOI 10.1158/1078-0432.CCR-05-1943; Damiano V, 2007, P NATL ACAD SCI USA, V104, P12468, DOI 10.1073/pnas.0705226104; Damiano V, 2009, CLIN CANCER RES, V15, P6921, DOI 10.1158/1078-0432.CCR-09-1599; Daroczi B, 2009, MOL CANCER THER, V8, P2625, DOI 10.1158/1535-7163.MCT-09-0198; Demidenko ZN, 2006, CELL DEATH DIFFER, V13, P1434, DOI 10.1038/sj.cdd.4401812; EBERTS TJ, 1979, CLIN CHEM, V25, P1440; Egan LJ, 2004, P NATL ACAD SCI USA, V101, P2452, DOI 10.1073/pnas.0306734101; Garin-Laflam MP, 2009, AM J PHYSIOL-GASTR L, V296, pG740, DOI 10.1152/ajpgi.90268.2008; Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636; Gudkov AV, 2010, J CLIN INVEST, V120, P2270, DOI 10.1172/JCI43794; Kandimalla ER, 2005, P NATL ACAD SCI USA, V102, P6925, DOI 10.1073/pnas.0501729102; Kandimalla ER, 2003, NUCLEIC ACIDS RES, V31, P2393, DOI 10.1093/nar/gkg343; Kandimalla ER, 2002, BIOCONJUGATE CHEM, V13, P966, DOI 10.1021/bc0200374; Kandimalla ER, 2011, MODULATION ENDOSOMAL; Khan WB, 1997, RADIAT RES, V148, P248, DOI 10.2307/3579609; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Maj JG, 2003, CANCER RES, V63, P4338; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Milas L, 2004, CANCER RES, V64, P5074, DOI 10.1158/0008-5472.CAN-04-0926; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Okunieff P, 1998, RADIAT RES, V150, P204, DOI 10.2307/3579856; Packey CD, 2010, CURR OPIN GASTROEN, V26, P88, DOI 10.1097/MOG.0b013e3283361927; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; POTTEN CS, 1990, INT J RADIAT BIOL, V58, P925, DOI 10.1080/09553009014552281; Potten CS, 1997, BRIT J CANCER, V75, P1454, DOI 10.1038/bjc.1997.249; POTTEN CS, 1994, INT J RADIAT BIOL, V65, P71, DOI 10.1080/09553009414550101; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; POTTEN CS, 1992, CANCER METAST REV, V11, P179, DOI 10.1007/BF00048063; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Putta MR, 2010, BIOCONJUGATE CHEM, V21, P39, DOI 10.1021/bc900425s; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Raffaghello L, 2010, CELL CYCLE, V9, P4474, DOI 10.4161/cc.9.22.13954; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rao B, 2010, ONCOTARGET, V1, P639; Rosa R, 2011, CLIN CANCER RES, V17, P6531, DOI 10.1158/1078-0432.CCR-10-3376; Rotolo JA, 2008, INT J RADIAT ONCOL, V70, P804, DOI 10.1016/j.ijrobp.2007.11.043; Stenson WF, 2008, CURR OPIN GASTROEN, V24, P103, DOI 10.1097/MOG.0b013e3282f44a2a; Tavana O, 2010, CELL CYCLE, V9, P3328, DOI 10.4161/cc.9.16.12688; Wang DQ, 2004, INT J ONCOL, V24, P901; Yu D, 2000, BIOORG MED CHEM LETT, V10, P2585, DOI 10.1016/S0960-894X(00)00537-0; Yu D, 2002, NUCLEIC ACIDS RES, V30, P4460, DOI 10.1093/nar/gkf582; Yu D, 2007, J MED CHEM, V50, P6411, DOI 10.1021/jm070881l; Zhang LR, 2010, INT J RADIAT ONCOL, V77, P261, DOI 10.1016/j.ijrobp.2009.11.026	49	49	54	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29357	10.1371/journal.pone.0029357	http://dx.doi.org/10.1371/journal.pone.0029357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238604	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200023
J	Lavoie, JP; Lefebvre-Lavoie, J; Leclere, M; Lavoie-Lamoureux, A; Chamberland, A; Laprise, C; Lussier, J				Lavoie, Jean-Pierre; Lefebvre-Lavoie, Josiane; Leclere, Mathilde; Lavoie-Lamoureux, Anouk; Chamberland, Annie; Laprise, Catherine; Lussier, Jacques			Profiling of Differentially Expressed Genes Using Suppression Subtractive Hybridization in an Equine Model of Chronic Asthma	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-I; SERUM RESPONSE FACTOR; AIRWAY INFLAMMATION; CALCINEURIN PATHWAY; CARDIAC-HYPERTROPHY; GRANULOSA-CELLS; ANIMAL-MODELS; TRANSCRIPTION; ACTIVATION	Background: Gene expression analyses are used to investigate signaling pathways involved in diseases. In asthma, they have been primarily derived from the analysis of bronchial biopsies harvested from mild to moderate asthmatic subjects and controls. Due to ethical considerations, there is currently limited information on the transcriptome profile of the peripheral lung tissues in asthma. Objective: To identify genes contributing to chronic inflammation and remodeling in the peripheral lung tissue of horses with heaves, a naturally occurring asthma-like condition. Methods: Eleven adult horses (6 heaves-affected and 5 controls) were studied while horses with heaves were in clinical remission (Pasture), and during disease exacerbation induced by a 30-day natural antigen challenge during stabling (Challenge). Large peripheral lung biopsies were obtained by thoracoscopy at both time points. Using suppression subtractive hybridization (SSH), lung cDNAs of controls (Pasture and Challenge) and asymptomatic heaves-affected horses (Pasture) were subtracted from cDNAs of horses with heaves in clinical exacerbation (Challenge). The differential expression of selected genes of interest was confirmed using quantitative PCR assay. Results: Horses with heaves, but not controls, developed airway obstruction when challenged. Nine hundred and fifty cDNA clones isolated from the subtracted library were screened by dot blot array and 224 of those showing the most marked expression differences were sequenced. The gene expression pattern was confirmed by quantitative PCR in 15 of 22 selected genes. Novel genes and genes with an already defined function in asthma were identified in the subtracted cDNA library. Genes of particular interest associated with asthmatic airway inflammation and remodeling included those related to PPP3CB/NFAT, RhoA, and LTB4/GPR44 signaling pathways. Conclusions: Pathways representing new possible targets for anti-inflammatory and anti-remodeling therapies for asthma were identified. The findings of genes previously associated with asthma validate this equine model for gene expression studies.	[Lavoie, Jean-Pierre; Lefebvre-Lavoie, Josiane; Leclere, Mathilde; Lavoie-Lamoureux, Anouk] Univ Montreal, Fac Vet Med, Dept Clin Sci, St Hyacinthe, PQ J2S 7C6, Canada; [Chamberland, Annie; Laprise, Catherine] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Saguenay, PQ, Canada; [Lussier, Jacques] Univ Montreal, Fac Med Vet, Dept Biomed, St Hyacinthe, PQ J2S 7C6, Canada	Universite de Montreal; University of Quebec; University of Quebec Chicoutimi; Universite de Montreal	Lavoie, JP (corresponding author), Univ Montreal, Fac Vet Med, Dept Clin Sci, St Hyacinthe, PQ J2S 7C6, Canada.	jean-pierre.lavoie@umontreal.ca	Leclere, Mathilde/X-7150-2018	Leclere, Mathilde/0000-0002-3910-0370; Laprise, Catherine/0000-0001-5526-9945	Canadian Institutes of Health Research [MIF79636]; AllerGen NCE Inc.	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AllerGen NCE Inc.	Funding was provided by the Canadian Institutes of Health Research (MIF79636) and AllerGen NCE Inc., a member of the Networks of Centers of Excellence Canada program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Bai TR, 2010, CURR OPIN ALLERGY CL, V10, P82, DOI 10.1097/ACI.0b013e32833363b2; Balakumar P, 2010, PHARMACOL RES, V62, P365, DOI 10.1016/j.phrs.2010.07.003; Bao YX, 2008, MOL CELL BIOCHEM, V317, P189, DOI 10.1007/s11010-008-9848-8; Bedard J, 2003, MOL REPROD DEV, V64, P152, DOI 10.1002/mrd.10239; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cao WX, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-26; Chetty A, 2006, PEDIATR RES, V60, P389, DOI 10.1203/01.pdr.0000238257.15502.f4; Clement MR, 2006, J UROLOGY, V176, P1225, DOI 10.1016/j.juro.2006.04.027; Costa LRR, 2009, J VET INTERN MED, V23, P1239, DOI 10.1111/j.1939-1676.2009.0385.x; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Dai ZQ, 2010, GROWTH HORM IGF RES, V20, P275, DOI 10.1016/j.ghir.2010.03.005; Dutsch-Wicherek M, 2010, AM J REPROD IMMUNOL, V63, P181, DOI 10.1111/j.1600-0897.2009.00803.x; Ekberg-Jansson A, 2001, RESP MED, V95, P363, DOI 10.1053/rmed.2001.1050; Elias JA, 2000, AM J RESP CRIT CARE, V161, pS168, DOI 10.1164/ajrccm.161.supplement_2.a1q4-4; Fayad T, 2004, BIOL REPROD, V70, P523, DOI 10.1095/biolreprod.103.021709; Hansel Nadia N, 2007, Proc Am Thorac Soc, V4, P32, DOI 10.1513/pats.200606-132JG; Hayashi K, 1999, J CELL BIOL, V145, P727, DOI 10.1083/jcb.145.4.727; Herszberg B, 2006, J ALLERGY CLIN IMMUN, V118, P382, DOI 10.1016/j.jaci.2006.03.044; Hirota JA, 2009, PULM PHARMACOL THER, V22, P370, DOI 10.1016/j.pupt.2008.12.004; Homer RJ, 2005, PHYSIOLOGY, V20, P28, DOI 10.1152/physiol.00035.2004; James A, 2005, CURR OPIN PULM MED, V11, P1, DOI 10.1097/01.mcp.0000146779.26339.d8; JAMES AL, 1989, AM REV RESPIR DIS, V139, P242, DOI 10.1164/ajrccm/139.1.242; Jeffery PK, 1998, EUR RESPIR J, V11, P524; Kakita T, 2001, CIRC RES, V88, P1239, DOI 10.1161/hh1201.091794; KAROL MH, 1994, EUR RESPIR J, V7, P555, DOI 10.1183/09031936.94.07030555; Kawaguchi M, 2010, CLIN EXP ALLERGY, V40, P1036, DOI 10.1111/j.1365-2222.2010.03527.x; KAY AB, 1991, J EXP MED, V173, P775, DOI 10.1084/jem.173.3.775; Leclere M, 2010, AM J RESP CELL MOL B; Lee SM, 2010, J BIOL CHEM, V285, P22036, DOI 10.1074/jbc.M110.108878; Leguillette R, 2009, AM J RESP CRIT CARE, V179, P194, DOI 10.1164/rccm.200609-1367OC; LOWELL FC, 1964, J ALLERGY, V35, P322, DOI 10.1016/0021-8707(64)90095-4; Luster AD, 2004, NAT REV IMMUNOL, V4, P711, DOI 10.1038/nri1438; MAGNO M, 1990, EUR RESPIR J, V3, pS557; Magno M, 1990, EUR RESPIR J, V12, p562S; Mao JH, 1998, P NATL ACAD SCI USA, V95, P12973, DOI 10.1073/pnas.95.22.12973; McClintock TS, 2002, CHEM SENSES, V27, P289, DOI 10.1093/chemse/27.3.289; MCLAUGHLIN RF, 1983, AM REV RESPIR DIS, V128, pS57; McWhinnie R, 2007, AM J PHYSIOL-LUNG C, V292, pL278, DOI 10.1152/ajplung.00111.2006; Montuschi P, 2002, J ALLERGY CLIN IMMUN, V109, P615, DOI 10.1067/mai.2002.122461; Nozaki K, 2003, J UROLOGY, V170, P2077, DOI 10.1097/01.ju.0000081460.23737.63; Ohkawa Y, 2003, BIOCHEM BIOPH RES CO, V301, P78, DOI 10.1016/S0006-291X(02)02965-0; Peroni JF, 2001, EQUINE VET J, V33, P231, DOI 10.2746/042516401776249688; Pettipher R, 2007, NAT REV DRUG DISCOV, V6, P313, DOI 10.1038/nrd2266; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Qin MH, 2003, ARTERIOSCL THROM VAS, V23, P425, DOI 10.1161/01.ATV.0000059303.94760.5C; Range F, 2007, VET PATHOL, V44, P901, DOI 10.1354/vp.44-6-901; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rao NL, 2010, AM J RESP CRIT CARE, V181, P899, DOI 10.1164/rccm.200807-1158OC; Relave F, 2008, VET SURG, V37, P232, DOI 10.1111/j.1532-950X.2008.00371.x; Schaafsma D, 2008, EUR J PHARMACOL, V585, P398, DOI 10.1016/j.ejphar.2008.01.056; SNAPPER JR, 1986, AM REV RESPIR DIS, V133, P351; Snelgrove RJ, 2010, SCIENCE, V330, P90, DOI 10.1126/science.1190594; Trakada G, 2000, RESP MED, V94, P992, DOI 10.1053/rmed.2000.0890; Ulven T, 2010, EXPERT OPIN THER PAT, V20, P1505, DOI 10.1517/13543776.2010.525506; van Erck E, 2003, AM J VET RES, V64, P1414, DOI 10.2460/ajvr.2003.64.1414; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veraldi KL, 2009, AM J RESP CRIT CARE; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Watanabe S, 2009, J ALLERGY CLIN IMMUN, V124, P59, DOI 10.1016/j.jaci.2009.03.024; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Winkler GS, 2006, EMBO J, V25, P3089, DOI 10.1038/sj.emboj.7601194; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Xin XP, 2004, AM J PHYSIOL-GASTR L, V286, pG777, DOI 10.1152/ajpgi.00293.2003; Yamashita N, 2005, CELL IMMUNOL, V235, P85, DOI 10.1016/j.cellimm.2005.07.006; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Yoshii A, 1999, AM J RESP CELL MOL, V20, P1190, DOI 10.1165/ajrcmb.20.6.3441; Zhu G, 2008, GENES IMMUN, V9, P23, DOI 10.1038/sj.gene.6364441	70	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29440	10.1371/journal.pone.0029440	http://dx.doi.org/10.1371/journal.pone.0029440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235296	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000301123400058
J	Velinov, M; Dolzhanskaya, N; Gonzalez, M; Powell, E; Konidari, I; Hulme, W; Staropoli, JF; Xin, WN; Wen, GY; Barone, R; Coppel, SH; Sims, K; Brown, WT; Zuchner, S				Velinov, Milen; Dolzhanskaya, Natalia; Gonzalez, Michael; Powell, Eric; Konidari, Ioanna; Hulme, William; Staropoli, John F.; Xin, Winnie; Wen, Guang Y.; Barone, Rosemary; Coppel, Scott H.; Sims, Katherine; Brown, W. Ted; Zuechner, Stephan			Mutations in the Gene DNAJC5 Cause Autosomal Dominant Kufs Disease in a Proportion of Cases: Study of the Parry Family and 8 Other Families	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; FORM	Background: The Neuronal Ceroid Lipofuscinoses (NCL) comprise at least nine progressive neurodegenerative genetic disorders. Kufs disease, an adult-onset form of NCL may be recessively or dominantly inherited. Our study aimed to identify genetic mutations associated with autosomal dominant Kufs disease (ADKD). Methodology and Principal Findings: We have studied the family first reported with this phenotype in the 1970s, the Parry family. The proband had progressive psychiatric manifestations, seizures and cognitive decline starting in her mid 20 s. Similarly affected relatives were observed in seven generations. Several of the affected individuals had post-mortem neuropathological brain study confirmatory for NCL disease. We conducted whole exome sequencing of three affected family members and identified a pLeu116del mutation in the gene DNAJC5, which segregated with the disease phenotype. An additional eight unrelated affected individuals with documented autosomal dominant or sporadic inheritance were studied. All had diagnostic confirmation with neuropathological studies of brain tissue. Among them we identified an additional individual with a p. Leu115Arg mutation in DNAJC5. In addition, a pAsn477Ser change in the neighboring gene PRPF6, a gene previously found to be associated with retinitis pigmentosa, segregated with the ADKD phenotype. Interestingly, two individuals of the Parry family did report visual impairment. Conclusions: Our study confirmed the recently reported association of DNAJC5 mutations with ADKD in two out of nine well-defined families. Sequence changes in PRPF6 have not been identified in other unrelated cases. The association of vision impairment with the expected PRPF6 dysfunction remains possible but would need further clinical studies in order to confirm the co-segregation of the visual impairment with this sequence change.	[Velinov, Milen; Dolzhanskaya, Natalia; Wen, Guang Y.; Brown, W. Ted] New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA; [Velinov, Milen] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Gonzalez, Michael; Powell, Eric; Konidari, Ioanna; Hulme, William; Zuechner, Stephan] Univ Miami, Miller Sch Med, Hussman Inst Human Genet, Miami, FL 33136 USA; [Staropoli, John F.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Staropoli, John F.; Xin, Winnie; Barone, Rosemary; Coppel, Scott H.; Sims, Katherine] Massachusetts Gen Hosp, Dept Neurol, Neurogenet DNA Diagnost Lab, Ctr Human Genet Res, Boston, MA 02114 USA; [Staropoli, John F.; Sims, Katherine] Harvard Univ, Sch Med, Boston, MA USA	Institute for Basic Research in Developmental Disabilities; Yeshiva University; Albert Einstein College of Medicine; University of Miami; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Velinov, M (corresponding author), New York State Inst Basic Res Dev Disabil, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	milen.velinov@opwdd.ny.gov	Brown, William/GXN-2777-2022	Wen, Guang Gary/0000-0001-6844-7528	New York State Office of People with Developmental Disabilities, Batten Disease Support and Research Association; National Institute of Neurological Disorders and Stroke [RO1-NS072248, RO1NS054132]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072248, R01NS054132] Funding Source: NIH RePORTER	New York State Office of People with Developmental Disabilities, Batten Disease Support and Research Association; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by the New York State Office of People with Developmental Disabilities, Batten Disease Support and Research Association and the National Institute of Neurological Disorders and Stroke (RO1-NS072248, RO1NS054132 to SZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsov T, 2011, AM J HUM GENET, V88, P566, DOI 10.1016/j.ajhg.2011.04.004; BOEHME DH, 1971, BRAIN, V94, P745, DOI 10.1093/brain/94.4.745; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Hobert JA, 2006, BBA-MOL BASIS DIS, V1762, P945, DOI 10.1016/j.bbadis.2006.08.004; Mole SE, 2010, GENE REV; Noskova L, 2011, AM J HUM GENET, V89, P1; Sims KB, 2011, NEW ENGL J MED, V364, P1062, DOI 10.1056/NEJMcpc1013927; Tanackovic G, 2011, AM J HUM GENET, V88, P643, DOI 10.1016/j.ajhg.2011.04.008; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5	9	61	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29729	10.1371/journal.pone.0029729	http://dx.doi.org/10.1371/journal.pone.0029729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235333	Green Published, gold			2022-12-27	WOS:000301123400095
J	Wang, S; Guo, X; Wu, XM; Lammi, MJ				Wang, Shuang; Guo, Xiong; Wu, Xiao-ming; Lammi, Mikko J.			Genome-Wide Gene Expression Analysis Suggests an Important Role of Suppressed Immunity in Pathogenesis of Kashin-Beck Disease	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; ARTICULAR CHONDROCYTES; RHEUMATOID-ARTHRITIS; MICROARRAY ANALYSIS; CC-CHEMOKINE; OSTEOARTHRITIS; PROTEIN; SPONDYLOARTHROPATHY; BIOMARKERS; CARTILAGE	Objective: To investigate the differences between the gene expression profiles in peripheral blood mononuclear cells (PBMC) from normal controls and patients with Kashin-Beck disease (KBD). Methods: Twenty KBD patients and 12 normal subjects were selected from a KBD-endemic area and divided into four pairs of KBD vs. control (KBD, n = 5 per pair; control, n = 3 per pair). RNAs were respectively isolated from KBD PBMCs and normal PBMCs. Gene expression profiles were analyzed by oligonucleotide microarray. The gene expression profiles in PBMCs from KBD patients and normal controls were compared and the differentially expressed genes were identified. The obtained microarray data was further confirmed by using quantitative real-time reverse transcription polymerase chain reaction (qRTPCR). Results: Approximately 501 genes, corresponding to 2.4% of the total probe transcripts, showed a 2-fold change in differential expression. 19.4% (97 out of 501) of the differentially expressed genes were commonly detected in all the four pairs. Among the 97 differentially expressed genes, 83 genes were up-regulated and 14 genes were down-regulated, compared with those in the normal controls. Some differentially expressed genes were found to be related to functions such as immunity, metabolism, apoptosis, cystoskeleton and cell movement, and extracellular matrix. The validity of our microarray data were supported by the results of qRT-PCR assay. Conclusion: Differences in the PBMC gene expression profile between the KBD patients and the normal controls exhibited a similar pattern among all the four pairs of microarrays examined, indicating that the suppressed immunity may play an important role in the pathogenesis of KBD.	[Wang, Shuang; Guo, Xiong] Xi An Jiao Tong Univ, Minist Educ, Coll Med,Dept Publ Hlth, Dept Orthodont,Stomatol Hosp,Key Lab Environm & G, Xian, Shaanxi, Peoples R China; [Wu, Xiao-ming] Xi An Jiao Tong Univ, Minist Educ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn, Xian, Peoples R China; [Lammi, Mikko J.] Univ Eastern Finland, Dept Biosci, Kuopio, Finland	Xi'an Jiaotong University; Xi'an Jiaotong University; University of Eastern Finland	Wang, S (corresponding author), Xi An Jiao Tong Univ, Minist Educ, Coll Med,Dept Publ Hlth, Dept Orthodont,Stomatol Hosp,Key Lab Environm & G, Xian, Shaanxi, Peoples R China.	guox@mail.xjtu.edu.cn	Lammi, Mikko/B-9291-2008	Lammi, Mikko/0000-0002-6181-9904	National Natural Scientific Foundation of China [30972556, 30630058]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090201110049]; Key Scientific and Technological Innovation Special Projects of Shaanxi "13115" of China [2009ZDKG-79]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Scientific and Technological Innovation Special Projects of Shaanxi "13115" of China	This work was supported by the National Natural Scientific Foundation of China ( 30972556, 30630058), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20090201110049), and the Key Scientific and Technological Innovation Special Projects of Shaanxi "13115" of China (2009ZDKG-79). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSALAMEH S, 1991, J RHEUMATOL, V18, P414; BANERJEE S, 1992, J RHEUMATOL, V19, P36; Barnes MG, 2004, RHEUMATOLOGY, V43, P973, DOI 10.1093/rheumatology/keh224; Bull TM, 2004, AM J RESP CRIT CARE, V170, P911, DOI 10.1164/rccm.200312-1686OC; [曹春霞 Cao Chunxia], 2004, [中国地方病学杂志, Chinese Journal of Endemiology], V23, P121; Chen Jing-hong, 2006, Sichuan Da Xue Xue Bao Yi Xue Ban, V37, P583; Fan HT, 2005, CURR MOL MED, V5, P3, DOI 10.2174/1566524053152861; GarciaZepeda EA, 1996, J IMMUNOL, V157, P5613; Gu J, 2002, RHEUMATOLOGY, V41, P759, DOI 10.1093/rheumatology/41.7.759; Guerassimov A, 1999, ARTHRITIS RHEUM, V42, P527, DOI 10.1002/1529-0131(199904)42:3<527::AID-ANR18>3.0.CO;2-M; Guo X, 2006, J BONE MINER METAB, V24, P319, DOI 10.1007/s00774-006-0690-3; GUO X, 1998, CHINESE J PATHOL, V27, P19; Guo X, 1992, J XIAN JIAOTONG U ME, V4, P99; Hikichi Y, 2009, BIOCHEM BIOPH RES CO, V386, P294, DOI 10.1016/j.bbrc.2009.06.052; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; [康龙丽 Kang Longli], 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P790; Liang ST, 1982, COMPILATION RES ENDE, P62; Liu JT, 2010, OSTEOARTHR CARTILAGE, V18, P1218, DOI 10.1016/j.joca.2010.07.003; Ma J, 2003, J MOL CELL CARDIOL, V35, P993, DOI 10.1016/S0022-2828(03)00179-2; Marshall KW, 2005, OSTEOARTHR CARTILAGE, V13, P861, DOI 10.1016/j.joca.2005.06.002; National Kashin-Beck Disease Surveillance Group, 1994, CHIN J ENDEMIOL, V13, P24; National Kashin-Beck disease surveillance group, 2003, J ENDEMIOL, V23, P147; Olsen NJ, 2004, ANN RHEUM DIS, V63, P1387, DOI 10.1136/ard.2003.017194; POWER CA, 1995, J BIOL CHEM, V270, P19495, DOI 10.1074/jbc.270.33.19495; Sakata M, 2001, J RHEUMATOL, V28, P1492; STADTMAN TC, 1991, J BIOL CHEM, V266, P16257; Sun TZH, 1991, CHIN J CTRL ENDEM DI, V6, P349; Twine NC, 2003, CANCER RES, V63, P6069; Xue LM, 1982, COMPILATION RES ENDE, P78; YANG J B, 1995, CHINESE JOURANL CNDE, V14, P201; [杨珺 Yang Jun], 2002, [中国地方病学杂志, Chinese Journal of Endemiology], V21, P341; Yin PP, 1984, CHIN J ENDEMIOL, V3, P48; Zhang BaoDi, 2004, Chinese Journal of Endemiology, V23, P172	34	18	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28439	10.1371/journal.pone.0028439	http://dx.doi.org/10.1371/journal.pone.0028439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235245	gold, Green Published, Green Submitted			2022-12-27	WOS:000301123400006
J	Carcamo, WC; Satoh, M; Kasahara, H; Terada, N; Hamazaki, T; Chan, JYF; Yao, B; Tamayo, S; Covini, G; von Muhlen, CA; Chan, EKL				Carcamo, Wendy C.; Satoh, Minoru; Kasahara, Hideko; Terada, Naohiro; Hamazaki, Takashi; Chan, Jason Y. F.; Yao, Bing; Tamayo, Stephanie; Covini, Giovanni; von Muehlen, Carlos A.; Chan, Edward K. L.			Induction of Cytoplasmic Rods and Rings Structures by Inhibition of the CTP and GTP Synthetic Pathway in Mammalian Cells	PLOS ONE			English	Article							MYCOPHENOLIC-ACID; PROTEIN; TARGET; AUTOANTIBODIES; IDENTIFICATION; DEHYDROGENASE; AUTOANTIGENS; REPRESSION; COMPONENTS; ANTITUMOR	Background: Cytoplasmic filamentous rods and rings (RR) structures were identified using human autoantibodies as probes. In the present study, the formation of these conserved structures in mammalian cells and functions linked to these structures were examined. Methodology/Principal Findings: Distinct cytoplasmic rods (similar to 3-10 mu m in length) and rings (similar to 2-5 mu m in diameter) in HEp-2 cells were initially observed in immunofluorescence using human autoantibodies. Co-localization studies revealed that, although RR had filament-like features, they were not enriched in actin, tubulin, or vimentin, and not associated with centrosomes or other known cytoplasmic structures. Further independent studies revealed that two key enzymes in the nucleotide synthetic pathway cytidine triphosphate synthase 1 (CTPS1) and inosine monophosphate dehydrogenase 2 (IMPDH2) were highly enriched in RR. CTPS1 enzyme inhibitors 6-diazo-5-oxo-L-norleucine and Acivicin as well as the IMPDH2 inhibitor Ribavirin exhibited dose-dependent induction of RR in >95% of cells in all cancer cell lines tested as well as mouse primary cells. RR formation by lower concentration of Ribavirin was enhanced in IMPDH2-knockdown HeLa cells whereas it was inhibited in GFP-IMPDH2 overexpressed HeLa cells. Interestingly, RR were detected readily in untreated mouse embryonic stem cells (>95%); upon retinoic acid differentiation, RR disassembled in these cells but reformed when treated with Acivicin. Conclusions/Significance: RR formation represented response to disturbances in the CTP or GTP synthetic pathways in cancer cell lines and mouse primary cells and RR are the convergence physical structures in these pathways. The availability of specific markers for these conserved structures and the ability to induce formation in vitro will allow further investigations in structure and function of RR in many biological systems in health and diseases.	[Carcamo, Wendy C.; Yao, Bing; Tamayo, Stephanie; Chan, Edward K. L.] Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; [Satoh, Minoru; Chan, Jason Y. F.] Univ Florida, Dept Med, Gainesville, FL USA; [Satoh, Minoru; Terada, Naohiro; Hamazaki, Takashi] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Kasahara, Hideko] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA; [Covini, Giovanni] Ist Clinico Humanitas, Dept Gastroenterol, Milan, Italy; [von Muehlen, Carlos A.] Rheuma Clin Rheumat Dis, Porto Alegre, RS, Brazil	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; IRCCS Humanitas Research Hospital	Chan, EKL (corresponding author), Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA.	echan@ufl.edu	Chan, Edward K. L./B-5671-2009	Chan, Edward K. L./0000-0003-3938-9503; von Muhlen, Carlos/0000-0002-2864-2633; Covini, Giovanni/0000-0003-1632-3907; Yao, Bing/0000-0002-3205-8130	National Institutes of Health [Al47859]; Bridges to Doctorate, University of Florida Graduate School; University of Florida; University Scholars Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bridges to Doctorate, University of Florida Graduate School; University of Florida(University of Florida); University Scholars Program	This work was supported in part by a grant from the National Institutes of Health grant Al47859. WCC is supported by Bridges to Doctorate, University of Florida Graduate School, and University of Florida Alumni Graduate Fellowship. ST is supported by the University Scholars Program. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALLISON AC, 1993, ANN NY ACAD SCI, V696, P63; ANDRADE LEC, 1991, J EXP MED, V173, P1407, DOI 10.1084/jem.173.6.1407; Bluthner M, 2009, P 9 DRESD S AUT, P125; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; CARR SF, 1993, J BIOL CHEM, V268, P27286; CASIANO CA, 1995, J AUTOIMMUN, V8, P575, DOI 10.1016/0896-8411(95)90009-8; CASIANO CA, 1993, J CELL SCI, V106, P1045; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Chen KN, 2011, J GENET GENOMICS, V38, P391, DOI 10.1016/j.jgg.2011.08.004; Christensen ST, 2008, CURR TOP DEV BIOL, V85, P261, DOI 10.1016/S0070-2153(08)00810-7; Covini G, 2012, ANTIVIRAL T IN PRESS; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Franchetti P, 1999, CURR MED CHEM, V6, P599; FRITZLER MJ, 1993, J EXP MED, V178, P49, DOI 10.1084/jem.178.1.49; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Hamazaki T, 2004, J CELL SCI, V117, P5681, DOI 10.1242/jcs.01489; He YJ, 2009, INT J COLORECTAL DIS, V24, P1271, DOI 10.1007/s00384-009-0759-2; Hofer A, 2001, P NATL ACAD SCI USA, V98, P6412, DOI 10.1073/pnas.111139498; Ingerson-Mahar M, 2010, NAT CELL BIOL, V12, P739, DOI 10.1038/ncb2087; Jakymiw A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1959; Ji YS, 2006, J BIOL CHEM, V281, P206, DOI 10.1074/jbc.M507056200; Kaur R, 2005, AIDS RES HUM RETROV, V21, P116, DOI 10.1089/aid.2005.21.116; Kursula P, 2006, ACTA CRYSTALLOGR F, V62, P613, DOI 10.1107/S1744309106018136; Lian S, 2007, MOL BIOL CELL, V18, P3375, DOI 10.1091/mbc.E07-01-0070; Liu JL, 2011, BIOESSAYS, V33, P159, DOI 10.1002/bies.201000129; Liu JL, 2010, J GENET GENOMICS, V37, P281, DOI 10.1016/S1673-8527(09)60046-1; Moser JJ, 2009, NAT PROTOC, V4, P674, DOI 10.1038/nprot.2009.34; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; Nozawa K, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar422; Pauley KM, 2010, IMMUNOL CELL BIOL, V88, P205, DOI 10.1038/icb.2009.84; Pinkus L M, 1977, Methods Enzymol, V46, P414; Ramer MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010872; Robertson CM, 2004, ANTIVIR RES, V64, P55, DOI 10.1016/j.antiviral.2004.05.004; Satoh M, 1996, J CLIN INVEST, V97, P2619, DOI 10.1172/JCI118711; Shan G, 2008, NAT BIOTECHNOL, V26, P933, DOI 10.1038/nbt.1481; Southwick FS, 2003, CELL MOTIL CYTOSKEL, V54, P41, DOI 10.1002/cm.10083; TAN EM, 1991, CELL, V67, P841, DOI 10.1016/0092-8674(91)90356-4; WILLINGHAM MC, 1987, EXP CELL RES, V171, P284, DOI 10.1016/0014-4827(87)90162-5; Wu F, 1999, EUR J CANCER, V35, P1155, DOI 10.1016/S0959-8049(99)00099-4; Zhou SF, 2003, VIROLOGY, V310, P333, DOI 10.1016/S0042-6822(03)00152-1	40	132	140	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29690	10.1371/journal.pone.0029690	http://dx.doi.org/10.1371/journal.pone.0029690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220215	gold, Green Published			2022-12-27	WOS:000300677000055
J	Karn, T; Pusztai, L; Holtrich, U; Iwamoto, T; Shiang, CY; Schmidt, M; Muller, V; Solbach, C; Gaetje, R; Hanker, L; Ahr, A; Liedtke, C; Ruckhaberle, E; Kaufmann, M; Rody, A				Karn, Thomas; Pusztai, Lajos; Holtrich, Uwe; Iwamoto, Takayuki; Shiang, Christine Y.; Schmidt, Marcus; Mueller, Volkmar; Solbach, Christine; Gaetje, Regine; Hanker, Lars; Ahr, Andre; Liedtke, Cornelia; Ruckhaeberle, Eugen; Kaufmann, Manfred; Rody, Achim			Homogeneous Datasets of Triple Negative Breast Cancers Enable the Identification of Novel Prognostic and Predictive Signatures	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; MOLECULAR PORTRAITS; GENE SIGNATURE; CYCLOPHOSPHAMIDE; DOXORUBICIN; RESISTANCE; DOCETAXEL; SURVIVAL; THERAPY; SUBTYPE	Background: Current prognostic gene signatures for breast cancer mainly reflect proliferation status and have limited value in triple-negative (TNBC) cancers. The identification of prognostic signatures from TNBC cohorts was limited in the past due to small sample sizes. Methodology/Principal Findings: We assembled all currently publically available TNBC gene expression datasets generated on Affymetrix gene chips. Inter-laboratory variation was minimized by filtering methods for both samples and genes. Supervised analysis was performed to identify prognostic signatures from 394 cases which were subsequently tested on an independent validation cohort (n = 261 cases). Conclusions/Significance: Using two distinct false discovery rate thresholds, 25% and <3.5%, a larger (n = 264 probesets) and a smaller (n = 26 probesets) prognostic gene sets were identified and used as prognostic predictors. Most of these genes were positively associated with poor prognosis and correlated to metagenes for inflammation and angiogenesis. No correlation to other previously published prognostic signatures (recurrence score, genomic grade index, 70-gene signature, wound response signature, 7-gene immune response module, stroma derived prognostic predictor, and a medullary like signature) was observed. In multivariate analyses in the validation cohort the two signatures showed hazard ratios of 4.03 (95% confidence interval [CI] 1.71-9.48; P = 0.001) and 4.08 (95% CI 1.79-9.28; P = 0.001), respectively. The 10-year event-free survival was 70% for the good risk and 20% for the high risk group. The 26-gene signatures had modest predictive value (AUC = 0.588) to predict response to neoadjuvant chemotherapy, however, the combination of a B-cell metagene with the prognostic signatures increased its response predictive value. We identified a 264-gene prognostic signature for TNBC which is unrelated to previously known prognostic signatures.	[Karn, Thomas; Holtrich, Uwe; Solbach, Christine; Gaetje, Regine; Hanker, Lars; Ahr, Andre; Ruckhaeberle, Eugen; Kaufmann, Manfred] Goethe Univ Frankfurt, Dept Obstet & Gynecol, Frankfurt, Germany; [Pusztai, Lajos; Iwamoto, Takayuki; Shiang, Christine Y.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Schmidt, Marcus] Johannes Gutenberg Univ Mainz, Dept Obstet & Gynecol, Mainz, Germany; [Mueller, Volkmar] Univ Hosp Hamburg Eppendorf, Dept Obstet & Gynecol, Hamburg, Germany; [Liedtke, Cornelia] Univ Munster, Dept Obstet & Gynecol, Munster, Germany; [Rody, Achim] Univ Saarland, Dept Obstet & Gynecol, D-6650 Homburg, Germany	Goethe University Frankfurt; University of Texas System; UTMD Anderson Cancer Center; Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; Saarland University	Karn, T (corresponding author), Goethe Univ Frankfurt, Dept Obstet & Gynecol, Frankfurt, Germany.	t.karn@em.uni-frankfurt.de	Schmidt, Marcus/H-3383-2013; Pusztai, Lajos/AAB-2901-2019; karn, t/C-7452-2013; Karn, Thomas/AAE-7723-2019	Schmidt, Marcus/0000-0003-1365-2414; karn, t/0000-0002-3264-6573; Karn, Thomas/0000-0002-3264-6573	H. W. and J. Hector-Stiftung; Margarete Bonifer-Stiftung; BANSS-Stiftung	H. W. and J. Hector-Stiftung; Margarete Bonifer-Stiftung; BANSS-Stiftung	This work was supported by grants from the H. W. and J. Hector-Stiftung, the Margarete Bonifer-Stiftung and the BANSS-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix, 2001, STAT ALG REF GUID; Ahr A, 2002, LANCET, V359, P131, DOI 10.1016/S0140-6736(02)07337-3; Angelo LS, 2007, CLIN CANCER RES, V13, P2825, DOI 10.1158/1078-0432.CCR-06-2416; [Anonymous], 2011, GENEFU R PACKAGE REL; Bianchini G, 2010, J CLIN ONCOL, V28, P4316, DOI 10.1200/JCO.2009.27.2419; Bieche I, 2007, ENDOCR-RELAT CANCER, V14, P1039, DOI 10.1677/erc.1.01301; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Desmedt C, 2011, J CLIN ONCOL, V29, P1578, DOI 10.1200/JCO.2010.31.2231; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Eklund AC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r26; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Foulkes WD, 2010, NAT REV CLIN ONCOL, V7, P348, DOI 10.1038/nrclinonc.2010.39; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Goldhirsch A, 2011, ANN ONCOL       0627; Gong Y, 2007, LANCET ONCOL, V8, P203, DOI 10.1016/S1470-2045(07)70042-6; Haibe-Kains B, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r18; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Hu ZY, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-9; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Karn T, 2011, EUR J CANC      0707; Karn T, 2010, BREAST CANCER RES TR, V120, P567, DOI 10.1007/s10549-009-0416-z; Kaufmann M, 2011, CANCER-AM CANCER SOC, V117, P1575, DOI 10.1002/cncr.25660; Korkaya H, 2011, CLIN CANC RES   0617; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-310; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; R Project, 2011, R PROJ STAT COMP; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Rody A, 2007, BREAST, V16, P235, DOI 10.1016/j.breast.2007.02.006; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; Sabatier R, 2011, BREAST CANCER RES TR, V126, P407, DOI 10.1007/s10549-010-0897-9; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Tabchy A, 2010, CLIN CANC RES   0909; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499	60	63	65	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e28403	10.1371/journal.pone.0028403	http://dx.doi.org/10.1371/journal.pone.0028403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220191	gold, Green Published, Green Submitted			2022-12-27	WOS:000300677000003
J	Hata, H; Yasugi, M; Hori, M				Hata, Hiroki; Yasugi, Masaki; Hori, Michio			Jaw Laterality and Related Handedness in the Hunting Behavior of a Scale-Eating Characin, Exodon paradoxus	PLOS ONE			English	Article							PERISSODUS-MICROLEPIS CICHLIDAE; FISH BETTA-SPLENDENS; FRESH-WATER GOBY; LAKE TANGANYIKA; FORAGING BEHAVIOR; FUNCTIONAL-MORPHOLOGY; CEREBRAL ASYMMETRY; AGGRESSIVE MIMICRY; MEASUREMENT ERROR; LARGEMOUTH BASS	Background: Asymmetry in animal bodies and behavior has evolved several times, but our knowledge of their linkage is limited. Tanganyikan scale-eating cichlids have well-known antisymmetry in their bodies and behavior; individuals open their mouths leftward (righty) or rightward (lefty), and righties always attack the right flank of the prey, whereas lefties attack the left. This study analyzed the morphological asymmetry in a scale-eating characiform, Exodon paradoxus, and its behavioral handedness. Methodology/Principal Findings: Each eight E. paradoxus was observed for 1-h with a prey goldfish in an aquarium to detect the behavioral handedness. Following the experiment, the lateral differences in the mandibles and head-inclination of these eight and ten additional specimens were analyzed. Both measurements on the morphology showed a bimodal distribution, and the laterality identified by these two methods was always consistent within a given individual, indicating that the characin has morphological antisymmetry. Furthermore, this laterality significantly corresponded to behavioral handedness; that is, lefties more often rasped scales from the right flank of the prey and vice versa. However, the correlation between laterality and handedness is the opposite of that in the cichlids. This is due to differences in the feeding apparatus and technique. The characin has cuspids pointing forward on the external side of the premaxilla, and it thrusts its dominant body side outward from its body axis on the flank of the prey to tear off scales. By contrast, the cichlids draw their dominant body side inward toward the axis or rotate it to scrape or wrench off scales with the teeth lined in the opened mouth. Conclusions/Significance: This study demonstrated that the antisymmetry in external morphology and the corresponding behavioral handedness have evolved in two lineages of scale-eating fishes independently, and these fishes adopt different utilization of their body asymmetry to tear off scales.	[Hata, Hiroki] Ehime Univ, Grad Sch Sci & Technol, Matsuyama, Ehime, Japan; [Yasugi, Masaki; Hori, Michio] Kyoto Univ, Grad Sch Sci, Kyoto, Japan	Ehime University; Kyoto University	Hata, H (corresponding author), Ehime Univ, Grad Sch Sci & Technol, Matsuyama, Ehime, Japan.	hata@sci.ehime-u.ac.jp		Hata, Hiroki/0000-0001-9438-0646; Yasugi, Masaki/0000-0001-7876-405X	Ministry of Education, Culture, Sports, Science and Technology, Japan [22770024, 21370010]; Global COE Program, Japan [A06]; Grants-in-Aid for Scientific Research [20405007] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.mext.go.jp/english/) for Young Scientists (B, 22770024), Scientific Research B (21370010) and the Global COE Program, Japan (A06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102; BAILEY RC, 1990, SYST ZOOL, V39, P124, DOI 10.2307/2992450; Bisazza A, 1997, PHYSIOL BEHAV, V61, P31, DOI 10.1016/S0031-9384(96)00308-3; Bisazza A, 1996, Laterality, V1, P161, DOI 10.1080/713754231; Bisazza A, 1996, NATURE, V379, P408, DOI 10.1038/379408a0; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; Cantalupo C, 1996, PHYSIOL BEHAV, V60, P249, DOI 10.1016/0031-9384(96)00015-7; COLLINS RL, 1993, BEHAV GENET, V23, P413, DOI 10.1007/BF01067444; COLLINS RL, 1985, CEREBRAL LATERALIZAT, P41; Concha ML, 2001, J ANAT, V199, P63, DOI 10.1046/j.1469-7580.2001.19910063.x; Corballis MC, 2009, PHILOS T R SOC B, V364, P867, DOI 10.1098/rstb.2008.0232; ECCLES DH, 1976, ZOOL J LINN SOC-LOND, V58, P165, DOI 10.1111/j.1096-3642.1976.tb00826.x; FABRETHORPE M, 1993, CORTEX, V29, P15, DOI 10.1016/S0010-9452(13)80208-0; Facchin L, 2009, PHILOS T R SOC B, V364, P1021, DOI 10.1098/rstb.2008.0234; Froese R., 2012, FISHBASE; Fryer G, 1972, CICHLID FISHES GREAT; Hata H, 2011, LATERALITY IN PRESS; Hata H, 2012, ZOOL SCI, V29, P49, DOI 10.2108/zsj.29.49; Hori M., 1987, P219; Hori M, 2000, ENVIRON BIOL FISH, V59, P111, DOI 10.1023/A:1007657419083; HORI M, 1993, SCIENCE, V260, P216, DOI 10.1126/science.260.5105.216; Hori M., 1991, INTECOL B, V19, P89; Hori M, 2007, ECOLOGY ENV, P51; Hori M, 2007, ZOOL SCI, V24, P486, DOI 10.2108/zsj.24.486; Janovetz J, 2005, J EXP BIOL, V208, P4757, DOI 10.1242/jeb.01938; Lee HJ, 2010, J FISH BIOL, V76, P1940, DOI 10.1111/j.1095-8649.2010.02620.x; McGrew WC, 1999, PRIMATES, V40, P509, DOI 10.1007/BF02557586; MERILA J, 1995, SYST BIOL, V44, P97, DOI 10.2307/2413486; Muller J., 1845, HORAE ICHTHYOLOGICAE, V1, P1; Nakae M, 2002, ICHTHYOL RES, V49, P7, DOI 10.1007/s102280200001; Nakajima M, 2007, ZOOL SCI, V24, P855, DOI 10.2108/zsj.24.855; Novakowski Gisele Caroline, 2004, Neotrop. ichthyol., V2, P157, DOI 10.1590/S1679-62252004000300008; NSHOMBO M, 1985, JPN J ICHTHYOL, V32, P66; NSHOMBO M, 1994, J ETHOL, V12, P141, DOI 10.1007/BF02350059; NSHOMBO M, 1994, ENVIRON BIOL FISH, V39, P59, DOI 10.1007/BF00004757; Palmer A. Richard, 2005, P359, DOI 10.1016/B978-012088777-4/50018-1; Palmer A. Richard, 2010, Journal of Biology (London), V9, P11, DOI 10.1186/jbiol218; Poliana RP, 2007, NEOTROP ICHTYOL, V5, P399; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roberts T, 1970, P CALIFORNIA ACAD SC, V37, P383; SAZIMA I, 1983, ENVIRON BIOL FISH, V9, P87, DOI 10.1007/BF00690855; SAZIMA I, 1977, NATURE, V270, P510, DOI 10.1038/270510a0; Schaafsma SM, 2009, PHILOS T R SOC B, V364, P915, DOI 10.1098/rstb.2008.0244; Seki S, 2000, ZOOL SCI, V17, P1321, DOI 10.2108/zsj.17.1321; Stewart TA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-8; Takahashi R, 2007, J FISH BIOL, V70, P1458, DOI 10.1111/j.1095-8649.2007.01423.x; Takahashi R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-195; Takeuchi Y, 2008, ANIM BEHAV, V75, P1359, DOI 10.1016/j.anbehav.2007.09.008; Takeuchi Y, 2010, BEHAV BRAIN RES, V208, P106, DOI 10.1016/j.bbr.2009.11.021; Tommasi L, 2009, PHILOS T R SOC B, V364, P855, DOI 10.1098/rstb.2008.0293; Van Dooren TJM, 2010, EVOLUTION, V64, P2159, DOI 10.1111/j.1558-5646.2010.00977.x; WESTNEAT MW, 1990, J MORPHOL, V205, P269, DOI 10.1002/jmor.1052050304; Westneat MW, 2004, INTEGR COMP BIOL, V44, P378, DOI 10.1093/icb/44.5.378; Yasugi M, 2011, ZOOL SCI, V28, P869, DOI 10.2108/zsj.28.869; [No title captured]	55	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29349	10.1371/journal.pone.0029349	http://dx.doi.org/10.1371/journal.pone.0029349			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216256	gold, Green Published, Green Submitted			2022-12-27	WOS:000300676300049
J	Kitano, J; Kawagishi, Y; Mori, S; Peichel, CL; Makino, T; Kawata, M; Kusakabe, M				Kitano, Jun; Kawagishi, Yui; Mori, Seiichi; Peichel, Catherine L.; Makino, Takashi; Kawata, Masakado; Kusakabe, Makoto			Divergence in Sex Steroid Hormone Signaling between Sympatric Species of Japanese Threespine Stickleback	PLOS ONE			English	Article							MALE 3-SPINED STICKLEBACK; IMMUNOCOMPETENCE HANDICAP HYPOTHESIS; ACUTE REGULATORY PROTEIN; 2 MIGRATORY FORMS; GASTEROSTEUS-ACULEATUS; RAINBOW-TROUT; REPRODUCTIVE ISOLATION; NATURAL-SELECTION; SEASONAL-CHANGES; MESSENGER-RNAS	Sex steroids mediate the expression of sexually dimorphic or sex-specific traits that are important both for mate choice within species and for behavioral isolation between species. We investigated divergence in sex steroid signaling between two sympatric species of threespine stickleback (Gasterosteus aculeatus): the Japan Sea form and the Pacific Ocean form. These sympatric forms diverge in both male display traits and female mate choice behaviors, which together contribute to asymmetric behavioral isolation in sympatry. Here, we found that plasma levels of testosterone and 17 beta-estradiol differed between spawning females of the two sympatric forms. Transcript levels of follicle-stimulating hormone-beta (FSH beta) gene were also higher in the pituitary gland of spawning Japan Sea females than in the pituitary gland of spawning Pacific Ocean females. By contrast, none of the sex steroids examined were significantly different between nesting males of the two forms. However, combining the plasma sex steroid data with testis transcriptome data suggested that the efficiency of the conversion of testosterone into 11-ketotestosterone has likely diverged between forms. Within forms, plasma testosterone levels in males were significantly correlated with male body size, a trait important for female mate choice in the two sympatric species. These results demonstrate that substantial divergence in sex steroid signaling can occur between incipient sympatric species. We suggest that investigation of the genetic and ecological mechanisms underlying divergence in hormonal signaling between incipient sympatric species will provide a better understanding of the mechanisms of speciation in animals.	[Kitano, Jun] Natl Inst Genet, Ecol Genet Lab, Mishima, Shizuoka 411, Japan; [Kitano, Jun] Grad Univ Adv Studies Sokendai, Dept Genet, Mishima, Shizuoka, Japan; [Kitano, Jun] Japan Sci & Technol Agcy, PRESTO, Honcho Kawaguchi, Saitama, Japan; [Kitano, Jun; Kawagishi, Yui; Makino, Takashi; Kawata, Masakado] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Kawagishi, Yui] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Mori, Seiichi] Gifu Keizai Univ, Biol Lab, Ogaki, Gifu, Japan; [Peichel, Catherine L.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Kusakabe, Makoto] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); Tohoku University; Baylor College of Medicine; Fred Hutchinson Cancer Center; University of Tokyo	Kitano, J (corresponding author), Natl Inst Genet, Ecol Genet Lab, Mishima, Shizuoka 411, Japan.	jkitano@lab.nig.ac.jp	Kawata, Masakado/E-3962-2012; Makino, Takashi/AAC-5181-2019	Makino, Takashi/0000-0003-4600-9353; Kawata, Masakado/0000-0001-8716-5438	Uehara Memorial Foundation, Japan Science and Technology PRESTO; Takeda Science Foundation; Naito Foundation; Ministry of Education, Science, Sports, and Culture [22770075, 23113007, 23113001]	Uehara Memorial Foundation, Japan Science and Technology PRESTO; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Uehara Memorial Foundation, Japan Science and Technology PRESTO program, Takeda Science Foundation, Naito Foundation, and Grant-in-Aid for Young Scientist (B) (22770075) and Grant-in-Aid for Scientific Research on Innovative Areas (23113007 and 23113001) from the Ministry of Education, Science, Sports, and Culture to JK and a Burroughs Wellcome Fund Career Award in the Biomedical Sciences to CP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E, 1998, AM ZOOL, V38, P166; Alvergne A, 2010, TRENDS ECOL EVOL, V25, P171, DOI 10.1016/j.tree.2009.08.003; Andersson Malte, 1994; Arnqvist Goran, 2005, pUnpaginated; Arterbery AS, 2010, GEN COMP ENDOCR, V167, P44, DOI 10.1016/j.ygcen.2010.02.021; Bell AM, 2001, ANIM BEHAV, V62, P775, DOI 10.1006/anbe.2001.1824; Bell M.A., 1994, EVOLUTIONARY BIOL TH; BLOUW DM, 1990, BIOL J LINN SOC, V39, P195, DOI 10.1111/j.1095-8312.1990.tb00512.x; BORG B, 1981, GEN COMP ENDOCR, V44, P177, DOI 10.1016/0016-6480(81)90245-8; Borg B, 1995, BEHAVIOUR, V132, P1025, DOI 10.1163/156853995X00432; BORG B, 1987, EXP BIOL, V47, P63; Borg Bertil, 2007, P225; Boughman Janette Wenrick, 2007, P83; Boughman JW, 2005, EVOLUTION, V59, P361; Callewaert F, 2010, J ENDOCRINOL, V207, P127, DOI 10.1677/JOE-10-0209; Cox RM, 2009, J EVOLUTION BIOL, V22, P1586, DOI 10.1111/j.1420-9101.2009.01772.x; Coyne J.A., 2004, SPECIATION; Cresko WA, 2007, GENETICA, V129, P105, DOI 10.1007/s10709-006-0036-z; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Gabor CR, 2010, HORM BEHAV, V57, P427, DOI 10.1016/j.yhbeh.2010.01.012; Hau M, 2007, BIOESSAYS, V29, P133, DOI 10.1002/bies.20524; Hellqvist A, 2004, GEN COMP ENDOCR, V135, P167, DOI 10.1016/j.ygcen.2003.09.003; Hibbeler S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-18; Jiang JQ, 2003, J MOL ENDOCRINOL, V31, P305, DOI 10.1677/jme.0.0310305; Katsiadaki Ioanna, 2007, P319; Ketterson ED, 2005, AM NAT, V166, pS85, DOI 10.1086/444602; Ketterson ED, 1999, AM NAT, V154, pS4, DOI 10.1086/303280; Kingsley David M., 2007, P41; Kitano J, 2011, ENV BIOL FI IN PRESS; Kitano J, 2008, BEHAVIOUR, V145, P443, DOI 10.1163/156853908792451430; Kitano J, 2007, BIOL J LINN SOC, V91, P671, DOI 10.1111/j.1095-8312.2007.00824.x; Kitano J, 2010, CURR BIOL, V20, P2124, DOI 10.1016/j.cub.2010.10.050; Kitano J, 2009, NATURE, V461, P1079, DOI 10.1038/nature08441; Knapp R, 2003, INTEGR COMP BIOL, V43, P658, DOI 10.1093/icb/43.5.658; Kume M, 2005, ICHTHYOL RES, V52, P189, DOI 10.1007/s10228-005-0269-3; Kume M, 2010, J EVOLUTION BIOL, V23, P1436, DOI 10.1111/j.1420-9101.2010.02009.x; Kume M, 2011, ZOOL STUD, V50, P309; Kurtz J, 2007, AM NAT, V170, P509, DOI 10.1086/521316; Kusakabe M, 2006, J ENDOCRINOL, V189, P541, DOI 10.1677/joe.1.06684; Kusakabe M, 2003, ENDOCRINOLOGY, V144, P2534, DOI 10.1210/en.2002-220446; Kusakabe M, 2002, MOL REPROD DEV, V62, P456, DOI 10.1002/mrd.10145; Leal E, 2009, J COMP PHYSIOL B, V179, P77, DOI 10.1007/s00360-008-0285-5; Leder EH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-426; LONE KP, 1989, FISH PHYSIOL BIOCHEM, V6, P149, DOI 10.1007/BF01874771; LUNDQVIST H, 1989, CAN J ZOOL, V67, P1733, DOI 10.1139/z89-248; MacColl ADC, 2009, BIOL J LINN SOC, V96, P425, DOI 10.1111/j.1095-8312.2008.01123.x; Mank JE, 2007, AM NAT, V169, P142, DOI 10.1086/510103; Maunder RJ, 2007, BIOL REPROD, V77, P999, DOI 10.1095/biolreprod.107.062240; MAYER I, 1990, GEN COMP ENDOCR, V79, P23, DOI 10.1016/0016-6480(90)90084-Y; Mayer Ian, 2007, P249; MCBRIDE JR, 1982, AQUACULTURE, V28, P201, DOI 10.1016/0044-8486(82)90023-0; McGlothlin JW, 2008, PHILOS T R SOC B, V363, P1611, DOI 10.1098/rstb.2007.0002; McGlothlin JW, 2004, P ROY SOC B-BIOL SCI, V271, P1377, DOI 10.1098/rspb.2004.2741; McKinnon JS, 2004, NATURE, V429, P294, DOI 10.1038/nature02556; McKinnon JS, 2002, TRENDS ECOL EVOL, V17, P480, DOI 10.1016/S0169-5347(02)02579-X; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; McPhail J.D., 1994, P399; Moore MC, 1998, AM ZOOL, V38, P133; Munakata A, 2002, FISHERIES SCI, V68, P49, DOI 10.2331/fishsci.68.sup1_49; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; Nakamura I, 2005, GEN COMP ENDOCR, V144, P224, DOI 10.1016/j.ygcen.2005.06.004; Oliveira RF, 2005, HORM BEHAV, V48, P430, DOI 10.1016/j.yhbeh.2005.06.002; Oliveira RF, 2001, GEN COMP ENDOCR, V121, P278, DOI 10.1006/gcen.2001.7596; Pall MK, 2002, HORM BEHAV, V42, P337, DOI 10.1006/hbeh.2002.1820; Ramsey ME, 2011, GEN COMP ENDOCR, V170, P381, DOI 10.1016/j.ygcen.2010.10.012; Rhen T, 2002, J NEUROENDOCRINOL, V14, P517, DOI 10.1046/j.1365-2826.2002.00820.x; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; Rice WR, 2001, J EVOLUTION BIOL, V14, P685, DOI 10.1046/j.1420-9101.2001.00319.x; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schroderus E, 2010, AM NAT, V176, pE90, DOI 10.1086/656264; Staub NL, 1997, GEN COMP ENDOCR, V108, P1, DOI 10.1006/gcen.1997.6962; WAI EVELYN HUI, 1963, CANADIAN JOUR ZOOL, V41, P611, DOI 10.1139/z63-034; WEDEKIND C, 1994, AM NAT, V143, P936, DOI 10.1086/285641; Wibe AE, 2002, ENVIRON RES, V90, P136, DOI 10.1006/enrs.2002.4392; Williams TM, 2009, NAT REV GENET, V10, P883, DOI 10.1038/nrg2710; Wootton R.J., 1976, BIOL STICKLEBACKS; YOUNG G, 1982, J EXP ZOOL, V224, P265, DOI 10.1002/jez.1402240217	81	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29253	10.1371/journal.pone.0029253	http://dx.doi.org/10.1371/journal.pone.0029253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216225	Green Published, Green Submitted, gold			2022-12-27	WOS:000300676300040
J	Podtelezhnikov, AA; Tanis, KQ; Nebozhyn, M; Ray, WJ; Stone, DJ; Loboda, AP				Podtelezhnikov, Alexei A.; Tanis, Keith Q.; Nebozhyn, Michael; Ray, William J.; Stone, David J.; Loboda, Andrey P.			Molecular Insights into the Pathogenesis of Alzheimer's Disease and Its Relationship to Normal Aging	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NEURODEGENERATIVE DISEASES; IDENTIFIES VARIANTS; HUMAN BRAIN; HYPOTHESIS; CLU	Alzheimer's disease (AD) is a complex neurodegenerative disorder that diverges from the process of normal brain aging by unknown mechanisms. We analyzed the global structure of age-and disease-dependent gene expression patterns in three regions from more than 600 brains. Gene expression variation could be almost completely explained by four transcriptional biomarkers that we named BioAge (biological age), Alz (Alzheimer), Inflame (inflammation), and NdStress (neurodegenerative stress). BioAge captures the first principal component of variation and includes genes statistically associated with neuronal loss, glial activation, and lipid metabolism. Normally BioAge increases with chronological age, but in AD it is prematurely expressed as if some of the subjects were 140 years old. A component of BioAge, Lipa, contains the AD risk factor APOE and reflects an apparent early disturbance in lipid metabolism. The rate of biological aging in AD patients, which cannot be explained by BioAge, is associated instead with NdStress, which includes genes related to protein folding and metabolism. Inflame, comprised of inflammatory cytokines and microglial genes, is broadly activated and appears early in the disease process. In contrast, the disease-specific biomarker Alz was selectively present only in the affected areas of the AD brain, appears later in pathogenesis, and is enriched in genes associated with the signaling and cell adhesion changes during the epithelial to mesenchymal (EMT) transition. Together these biomarkers provide detailed description of the aging process and its contribution to Alzheimer's disease progression.	[Podtelezhnikov, Alexei A.; Tanis, Keith Q.; Nebozhyn, Michael; Stone, David J.; Loboda, Andrey P.] Merck Inc, Merck Res Labs, Exploratory & Translat Sci, West Point, PA USA; [Ray, William J.] Merck Inc, Merck Res Labs, Neurosci, West Point, PA USA	Merck & Company; Merck & Company	Podtelezhnikov, AA (corresponding author), Merck Inc, Merck Res Labs, Exploratory & Translat Sci, West Point, PA USA.	andrey_loboda@merck.com	Ray, William J/E-9834-2016	Tanis, Keith/0000-0001-6744-1183; Ray, William/0000-0002-4491-167X	federal grant [R24 MH/NS068855]; Merck Co., Inc.; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER	federal grant; Merck Co., Inc.(Merck & Company); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The Harvard Brain Tissue Resource Center, which generously provided the tissue samples, is supported by federal grant # R24 MH/NS068855. The profiling and the analysis were funded by Merck & Co., Inc. The manuscript was reviewed and approved for publication by Merck. The funders had no other role in study design, data collection and analysis, or preparation of the manuscript.	Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bonda DJ, 2010, NEUROPATH APPL NEURO, V36, P157, DOI 10.1111/j.1365-2990.2010.01064.x; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cao KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013098; Casserly I, 2004, LANCET, V363, P1139, DOI 10.1016/S0140-6736(04)15900-X; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Drachman DA, 2006, NEUROLOGY, V67, P1340, DOI 10.1212/01.wnl.0000240127.89601.83; Eikelenboom P, 2006, J NEURAL TRANSM, V113, P1685, DOI 10.1007/s00702-006-0575-6; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Jakob-Roetne R, 2009, ANGEW CHEM INT EDIT, V48, P3030, DOI 10.1002/anie.200802808; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kleiman T, 2006, DEMENT GERIATR COGN, V22, P73, DOI 10.1159/000093316; Kronenberg G, 2009, CURR MOL MED, V9, P315, DOI 10.2174/156652409787847146; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; McCampbell A, 2011, J NEUROCHEM, V116, P82, DOI 10.1111/j.1471-4159.2010.07087.x; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Rosner B, 2010, FUNDAMENTALS BIOSTAT; Schmitt FA, 2000, NEUROLOGY, V55, P370, DOI 10.1212/WNL.55.3.370; Stone DJ, 2010, PHARMACOGENOMICS J, V10, P161, DOI 10.1038/tpj.2009.58; Tamayo P, 2007, P NATL ACAD SCI USA, V104, P5959, DOI 10.1073/pnas.0701068104; Van Dam F, 2009, ARCH GERONTOL GERIAT, V48, P425, DOI 10.1016/j.archger.2008.03.009; Waring SC, 2008, ARCH NEUROL-CHICAGO, V65, P329, DOI 10.1001/archneur.65.3.329; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; Woods J, 2007, BBA-MOL BASIS DIS, V1772, P503, DOI 10.1016/j.bbadis.2006.12.004; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	40	55	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29610	10.1371/journal.pone.0029610	http://dx.doi.org/10.1371/journal.pone.0029610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216330	Green Published, Green Submitted, gold			2022-12-27	WOS:000300676300073
J	Zhang, SZ; Dai, HH; Wan, N; Moore, Y; Dai, ZH				Zhang, Shuzi; Dai, Hehua; Wan, Ni; Moore, Yolonda; Dai, Zhenhua			Promoting Long-Term Survival of Insulin-Producing Cell Grafts That Differentiate from Adipose Tissue-Derived Stem Cells to Cure Type 1 Diabetes	PLOS ONE			English	Article							CD8(+) T-CELLS; ANTI-CD40 MONOCLONAL-ANTIBODY; SUPPRESS ALLOGRAFT-REJECTION; IN-VITRO; FAS-LIGAND; COSTIMULATORY BLOCKADE; SECRETING CELLS; GENE-TRANSFER; CD40 LIGAND; TRANSPLANTATION	Background: Insulin-producing cell clusters (IPCCs) have recently been generated in vitro from adipose tissue-derived stem cells (ASCs) to circumvent islet shortage. However, it is unknown how long they can survive upon transplantation, whether they are eventually rejected by recipients, and how their long-term survival can be induced to permanently cure type 1 diabetes. IPCC graft survival is critical for their clinical application and this issue must be systematically addressed prior to their in-depth clinical trials. Methodology/Principal Findings: Here we found that IPCC grafts that differentiated from murine ASCs in vitro, unlike their freshly isolated islet counterparts, did not survive long-term in syngeneic mice, suggesting that ASC-derived IPCCs have intrinsic survival disadvantage over freshly isolated islets. Indeed, beta cells retrieved from IPCC syngrafts underwent faster apoptosis than their islet counterparts. However, blocking both Fas and TNF receptor death pathways inhibited their apoptosis and restored their long-term survival in syngeneic recipients. Furthermore, blocking CD40-CD154 costimulation and Fas/TNF signaling induced long-term IPCC allograft survival in overwhelming majority of recipients. Importantly, Fasdeficient IPCC allografts exhibited certain immune privilege and enjoyed long-term survival in diabetic NOD mice in the presence of CD28/CD40 joint blockade while their islet counterparts failed to do so. Conclusions/Significance: Long-term survival of ASC-derived IPCC syngeneic grafts requires blocking Fas and TNF death pathways, whereas blocking both death pathways and CD28/CD40 costimulation is needed for long-term IPCC allograft survival in diabetic NOD mice. Our studies have important clinical implications for treating type 1 diabetes via ASC-derived IPCC transplantation.	[Zhang, Shuzi; Dai, Hehua; Wan, Ni; Moore, Yolonda; Dai, Zhenhua] Univ Texas Hlth Sci Ctr, Ctr Biomed Res, Dept Microbiol & Immunol, Tyler, TX USA	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Zhang, SZ (corresponding author), Univ Texas Hlth Sci Ctr, Ctr Biomed Res, Dept Microbiol & Immunol, Tyler, TX USA.	zhenhua.dai@uthct.edu			Juvenile Diabetes Research Foundation International (JDRF) [1-2008-583]	Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation)	This work was supported by a research grant from Juvenile Diabetes Research Foundation International (JDRF 1-2008-583, www.jdrf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi T, 2009, AM J TRANSPLANT, V9, P1732, DOI 10.1111/j.1600-6143.2009.02693.x; Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691; Boyd AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010965; Chandra V, 2009, STEM CELLS, V27, P1941, DOI 10.1002/stem.117; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dai ZH, 2004, J CLIN INVEST, V113, P310, DOI 10.1172/JCI200419727; Demirci G, 2003, J IMMUNOL, V171, P3878, DOI 10.4049/jimmunol.171.7.3878; Di Rocco G, 2006, J CELL SCI, V119, P2945, DOI 10.1242/jcs.03029; Giannoukakis N, 1999, DIABETES, V48, P1730, DOI 10.2337/diabetes.48.9.1730; Gilson CR, 2009, J IMMUNOL, V183, P1625, DOI 10.4049/jimmunol.0900339; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Judge TA, 1998, TRANSPLANTATION, V66, P426, DOI 10.1097/00007890-199808270-00003; Kajiyama H, 2010, INT J DEV BIOL, V54, P699, DOI 10.1387/ijdb.092953hk; Kang HM, 2009, STEM CELLS, V27, P1999, DOI 10.1002/stem.127; Kanmaz T, 2004, TRANSPLANTATION, V77, P914, DOI 10.1097/01.TP.0000116392.72152.75; Kawai T, 2000, NAT MED, V6, P114, DOI 10.1038/72162; Kim SC, 2010, CURR STEM CELL RES T, V5, P190; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; Lee J, 2008, BIOCHEM BIOPH RES CO, V375, P547, DOI 10.1016/j.bbrc.2008.08.064; Li XC, 2009, IMMUNOL REV, V229, P271, DOI 10.1111/j.1600-065X.2009.00781.x; Lin GT, 2009, STEM CELLS DEV, V18, P1399, DOI 10.1089/scd.2009.0010; Liu ZW, 2007, J IMMUNOL, V178, P4260, DOI 10.4049/jimmunol.178.7.4260; Lui KO, 2010, STEM CELLS, V28, P1905, DOI 10.1002/stem.506; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Nanji SA, 2006, DIABETES, V55, P27, DOI 10.2337/diabetes.55.01.06.db04-1154; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Pearl-Yafe M, 2006, BIOESSAYS, V28, P211, DOI 10.1002/bies.20356; Rigby MR, 2008, DIABETES, V57, P2672, DOI 10.2337/db07-1712; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Silva DG, 2003, J IMMUNOL, V170, P4996, DOI 10.4049/jimmunol.170.10.4996; Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157; Tang DQ, 2004, DIABETES, V53, P1721, DOI 10.2337/diabetes.53.7.1721; Timper K, 2006, BIOCHEM BIOPH RES CO, V341, P1135, DOI 10.1016/j.bbrc.2006.01.072; Wan N, 2008, J IMMUNOL, V180, P113, DOI 10.4049/jimmunol.180.1.113; Wang HS, 2011, CELL TRANSPLANT, V20, P455, DOI 10.3727/096368910X522270; Wang T, 2008, J IMMUNOL, V180, P2886, DOI 10.4049/jimmunol.180.5.2886; Wang Y, 2006, AM J TRANSPLANT, V6, P2851, DOI 10.1111/j.1600-6143.2006.01550.x; Wekerle T, 2002, CURR OPIN IMMUNOL, V14, P592, DOI 10.1016/S0952-7915(02)00378-3; Wu DC, 2008, STEM CELLS, V26, P1939, DOI 10.1634/stemcells.2008-0078; Yang LJ, 2002, P NATL ACAD SCI USA, V99, P8078, DOI 10.1073/pnas.122210699; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	42	3	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29706	10.1371/journal.pone.0029706	http://dx.doi.org/10.1371/journal.pone.0029706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216347	Green Submitted, gold, Green Published			2022-12-27	WOS:000300676300079
J	Ranzinger, J; Rustom, A; Abel, M; Leyh, J; Kihm, L; Witkowski, M; Scheurich, P; Zeier, M; Schwenger, V				Ranzinger, Julia; Rustom, Amin; Abel, Marcus; Leyh, Julia; Kihm, Lars; Witkowski, Margarete; Scheurich, Peter; Zeier, Martin; Schwenger, Vedat			Nanotube Action between Human Mesothelial Cells Reveals Novel Aspects of Inflammatory Responses	PLOS ONE			English	Article							INCREASES FIBRINOLYTIC-ACTIVITY; TUNNELING NANOTUBES; TNF-ALPHA; PERITONEAL; CYTOKINES; EXPOSURE; CATHETER; STATINS	A well-known role of human peritoneal mesothelial cells (HPMCs), the resident cells of the peritoneal cavity, is the generation of an immune response during peritonitis by activation of T-cells via antigen presentation. Recent findings have shown that intercellular nanotubes (NTs) mediate functional connectivity between various cell types including immune cells - such as T-cells, natural killer (NK) cells or macrophages - by facilitating a spectrum of long range cell-cell interactions. Although of medical interest, the relevance of NT-related findings for human medical conditions and treatment, e.g. in relation to inflammatory processes, remains elusive, particularly due to a lack of appropriate in vivo data. Here, we show for the first time that primary cultures of patient derived HPMCs are functionally connected via membranous nanotubes. NT formation appears to be actin cytoskeleton dependent, mediated by the action of filopodia. Importantly, significant variances in NT numbers between different donors as a consequence of pathophysiological alterations were observable. Furthermore, we show that TNF-alpha induces nanotube formation and demonstrate a strong correlation of NT connectivity in accordance with the cellular cholesterol level and distribution, pointing to a complex involvement of NTs in inflammatory processes with potential impact for clinical treatment.	[Ranzinger, Julia; Leyh, Julia; Kihm, Lars; Zeier, Martin; Schwenger, Vedat] Univ Heidelberg, Dept Nephrol, Heidelberg, Germany; [Rustom, Amin; Abel, Marcus] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Rustom, Amin; Abel, Marcus] Univ Heidelberg, Dept Biophys Chem, Heidelberg, Germany; [Witkowski, Margarete; Scheurich, Peter] Univ Stuttgart, Inst Cell Biol & Immunol, Stuttgart, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Ruprecht Karls University Heidelberg; University of Stuttgart	Ranzinger, J (corresponding author), Univ Heidelberg, Dept Nephrol, Heidelberg, Germany.	Julia.Ranzinger@med.uni-heidelberg.de						Aarons CB, 2007, ANN SURG, V245, P176, DOI 10.1097/01.sla.0000236627.07927.7c; Abel MP, 2011, BIOINTERPHASES, V6, P22, DOI 10.1116/1.3567416; Araujo FA, 2011, CLIN EXP PHARMACOL P, V38, P262, DOI 10.1111/j.1440-1681.2011.05496.x; Bukoreshtliev NV, 2009, FEBS LETT, V583, P1481, DOI 10.1016/j.febslet.2009.03.065; Chauveau A, 2010, P NATL ACAD SCI USA, V107, P5545, DOI 10.1073/pnas.0910074107; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; Eugenin EA, 2009, CELL IMMUNOL, V254, P142, DOI 10.1016/j.cellimm.2008.08.005; Flessner MF, 2007, J AM SOC NEPHROL, V18, P2294, DOI 10.1681/ASN.2006121417; Flessner MF, 2010, PERITON DIALYSIS INT, V30, P284, DOI 10.3747/pdi.2009.00100; Gousset K, 2009, PRION, V3, P94, DOI 10.4161/pri.3.2.8917; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; Haslinger B, 2003, KIDNEY INT, V63, P2065, DOI 10.1046/j.1523-1755.2003.t01-2-00004.x; Haslinger B, 2002, KIDNEY INT, V62, P1611, DOI 10.1046/j.1523-1755.2002.00601.x; Hurtig J, 2011, WILEY INTERDISCIP RE, V2, P260; Koukouritaki SB, 1999, MOL MED, V5, P382, DOI 10.1007/BF03402127; Kumar S, 2007, PERITON DIALYSIS INT, V27, P283; Lee JE, 2011, NEPHROL DIAL TRANSPL; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Puls A, 1999, J CELL SCI, V112, P2983; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Wang X, 2010, P NATL ACAD SCI USA, V107, P17194, DOI 10.1073/pnas.1006785107; Wang Y, 2011, CELL DEATH DIFFER, V18, P732, DOI 10.1038/cdd.2010.147; Witowski J, 2000, J AM SOC NEPHROL, V11, P729, DOI 10.1681/ASN.V114729; Yonemura Y, 1997, INT J ONCOL, V11, P349	26	25	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29537	10.1371/journal.pone.0029537	http://dx.doi.org/10.1371/journal.pone.0029537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216308	Green Published, gold, Green Submitted			2022-12-27	WOS:000300674900042
J	Vignes, M; Vandel, J; Allouche, D; Ramadan-Alban, N; Cierco-Ayrolles, C; Schiex, T; Mangin, B; de Givry, S				Vignes, Matthieu; Vandel, Jimmy; Allouche, David; Ramadan-Alban, Nidal; Cierco-Ayrolles, Christine; Schiex, Thomas; Mangin, Brigitte; de Givry, Simon			Gene Regulatory Network Reconstruction Using Bayesian Networks, the Dantzig Selector, the Lasso and Their Meta-Analysis	PLOS ONE			English	Article							INFERENCE; GENOMICS; BIOLOGY	Modern technologies and especially next generation sequencing facilities are giving a cheaper access to genotype and genomic data measured on the same sample at once. This creates an ideal situation for multifactorial experiments designed to infer gene regulatory networks. The fifth "Dialogue for Reverse Engineering Assessments and Methods" (DREAM5) challenges are aimed at assessing methods and associated algorithms devoted to the inference of biological networks. Challenge 3 on "Systems Genetics" proposed to infer causal gene regulatory networks from different genetical genomics data sets. We investigated a wide panel of methods ranging from Bayesian networks to penalised linear regressions to analyse such data, and proposed a simple yet very powerful meta-analysis, which combines these inference methods. We present results of the Challenge as well as more in-depth analysis of predicted networks in terms of structure and reliability. The developed meta-analysis was ranked first among the 16 teams participating in Challenge 3A. It paves the way for future extensions of our inference method and more accurate gene network estimates in the context of genetical genomics.	[Vignes, Matthieu; Vandel, Jimmy; Allouche, David; Ramadan-Alban, Nidal; Cierco-Ayrolles, Christine; Schiex, Thomas; Mangin, Brigitte; de Givry, Simon] INRA Toulouse, SaAB Team, BIA Unit, Castanet Tolosan, France	INRAE	Vignes, M (corresponding author), INRA Toulouse, SaAB Team, BIA Unit, Castanet Tolosan, France.	matthieu.vignes@toulouse.inra.fr			Alpha Natural Resource Research Grant FRAGENOMICS	Alpha Natural Resource Research Grant FRAGENOMICS	This work was partly supported by the Alpha Natural Resource Research Grant FRAGENOMICS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aten J, 2008, BMC BIOINFORMATICS, P2; Bach F, 2008, ACM INT C P SERIES, V307, P25; Bansal M, 2007, IET SYST BIOL, V1, P306, DOI 10.1049/iet-syb:20060079; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bickel PJ, 2009, ANN STAT, V37, P1705, DOI 10.1214/08-AOS620; Brazhnik P, 2002, TRENDS BIOTECHNOL, V20, P467, DOI 10.1016/S0167-7799(02)02053-X; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Candes E, 2007, ANN STAT, V35, P2313, DOI 10.1214/009053606000001523; Chaves M, 2006, IEEE DECIS CONTR P, P2358, DOI 10.1109/CDC.2006.376804; Chickering DM, 2004, J MACH LEARN RES, V5, P1287; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; de Campos C.P., 2009, P 26 ANN INT C MACHI, P113; de Campos CP, 2010, AAAI CONF ARTIF INTE, P431; de la Fuente A, D5C3 DREAM INITIATIV; Dhaeseleerl P, 2000, BIOINFORMATICS; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Elidan G, 2007, J MACH LEARN RES, V8, P1799; FISHER R. A., 1935, The design of experiments.; FRIEDMAN J, 2010, J STAT SOFTWARE, V33; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Friedman N, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P196; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Hartemink AJ, 2005, NAT BIOTECHNOL, V23, P554, DOI 10.1038/nbt0505-554; Hastie T, 2009, SERIES STAT; Hecht J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000025; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; James GM, 2009, J R STAT SOC B, V71, P127, DOI 10.1111/j.1467-9868.2008.00668.x; Jansen RC, 2003, NAT REV GENET, V4, P145, DOI 10.1038/nrg996; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; KARMARKAR N, 1984, COMBINATORICA, V4, P373, DOI 10.1007/BF02579150; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Keurentjes JJB, 2007, P NATL ACAD SCI USA, V104, P1708, DOI 10.1073/pnas.0610429104; Lan H, 2006, PLOS GENET, V2, P51, DOI 10.1371/journal.pgen.0020006; Li Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-520; Lippert C, 2009, P 12 INT C ART INT S, P358; Liu B, 2008, GENETICS, V178, P1763, DOI 10.1534/genetics.107.080069; Marbach D, 2009, ANN NY ACAD SCI, V1158, P234, DOI 10.1111/j.1749-6632.2008.03944.x; Pinna A, 2011, BIOINFORMATICS, V27, P2459, DOI 10.1093/bioinformatics/btr407; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Rau A, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1513; Rocha G, 2008, 769 UC BERK STAT DEP; Scholkopf B., 2004, KERNEL METHODS COMPU; Siegal ML, 2007, GENETICA, V129, P83, DOI 10.1007/s10709-006-0035-0; Silander T., 2007, P 23 C UNC ART INT U, P360; Steck H., 2008, P 24 C UNC ART INT U, P511; Stegle O., 2010, ADV NEURAL INF PROCE, V23, P1687; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wainwright MJ, 2009, IEEE T INFORM THEORY, V55, P5728, DOI 10.1109/TIT.2009.2032816; Wang J, 2010, PLANT J, V63, P1063, DOI 10.1111/j.1365-313X.2010.04303.x; Weir BS, 2007, EUPHYTICA, V154, P355, DOI 10.1007/s10681-006-9283-4; Werhli Adriano V., 2008, Journal of Bioinformatics and Computational Biology, V6, P543, DOI 10.1142/S0219720008003539; Xiong MM, 2004, GENETICS, V166, P1037, DOI 10.1534/genetics.166.2.1037; Yu J., 2002, INT C SYST BIOL, V2002; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhu J, 2007, PLOS COMPUT BIOL, V3, P692, DOI 10.1371/journal.pcbi.0030069; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	63	63	65	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29165	10.1371/journal.pone.0029165	http://dx.doi.org/10.1371/journal.pone.0029165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216195	gold, Green Published			2022-12-27	WOS:000300674900018
J	Butler, DC; Messer, A				Butler, David C.; Messer, Anne			Bifunctional Anti-Huntingtin Proteasome-Directed Intrabodies Mediate Efficient Degradation of Mutant Huntingtin Exon 1 Protein Fragments	PLOS ONE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; IN-VIVO; INTRACELLULAR ANTIBODIES; POLYGLUTAMINE PROTEINS; AGGREGATE FORMATION; MOUSE MODELS; HD MUTATION; DISEASE; EXPRESSION; CELLS	Huntington's disease (HD) is a fatal autosomal dominant neurodegenerative disorder caused by a trinucleotide (CAG)(n) repeat expansion in the coding sequence of the huntingtin gene, and an expanded polyglutamine (>37Q) tract in the protein. This results in misfolding and accumulation of huntingtin protein (htt), formation of neuronal intranuclear and cytoplasmic inclusions, and neuronal dysfunction/degeneration. Single-chain Fv antibodies (scFvs), expressed as intrabodies that bind htt and prevent aggregation, show promise as immunotherapeutics for HD. Intrastriatal delivery of anti-N-terminal htt scFv-C4 using an adeno-associated virus vector (AAV2/1) significantly reduces the size and number of aggregates in HDR6/1 transgenic mice; however, this protective effect diminishes with age and time after injection. We therefore explored enhancing intrabody efficacy via fusions to heterologous functional domains. Proteins containing a PEST motif are often targeted for proteasomal degradation and generally have a short half life. In ST14A cells, fusion of the C-terminal PEST region of mouse ornithine decarboxylase (mODC) to scFv-C4 reduces htt exon 1 protein fragments with 72 glutamine repeats (httex1-72Q) by similar to 80-90% when compared to scFv-C4 alone. Proteasomal targeting was verified by either scrambling the mODC-PEST motif, or via proteasomal inhibition with epoxomicin. For these constructs, the proteasomal degradation of the scFv intrabody proteins themselves was reduced <25% by the addition of the mODC-PEST motif, with or without antigens. The remaining intrabody levels were amply sufficient to target N-terminal httex1-72Q protein fragment turnover. Critically, scFv-C4-PEST prevents aggregation and toxicity of httex1-72Q fragments at significantly lower doses than scFv-C4. Fusion of the mODC-PEST motif to intrabodies is a valuable general approach to specifically target toxic antigens to the proteasome for degradation.	[Butler, David C.; Messer, Anne] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12237 USA; [Butler, David C.; Messer, Anne] SUNY Albany, Dept Biomed Sci, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Butler, DC (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12237 USA.	messer@wadsworth.org			National Institutes of Health/NINDS, Hereditary Disease Foundation [NS053912, NS 073415, NS061257]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053912, R21NS073415, R21NS061257] Funding Source: NIH RePORTER	National Institutes of Health/NINDS, Hereditary Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health/NINDS NS053912, NS 073415 and NS061257 Hereditary Disease Foundation (http://www.hdfoundation.org/home.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Auerbach W, 2001, HUM MOL GENET, V10, P2515, DOI 10.1093/hmg/10.22.2515; Barkhordarian H, 2006, PROTEIN ENG DES SEL, V19, P497, DOI 10.1093/protein/gzl036; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bett JS, 2006, HUM MOL GENET, V15, P33, DOI 10.1093/hmg/ddi423; Butler DC, 2011, PROGR NEURO IN PRESS; Cardinale A, 2008, TRENDS MOL MED, V14, P373, DOI 10.1016/j.molmed.2008.07.004; Colby DW, 2004, J MOL BIOL, V342, P901, DOI 10.1016/j.jmb.2004.07.054; Colby DW, 2004, P NATL ACAD SCI USA, V101, P17616, DOI 10.1073/pnas.0408134101; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Greiner ER, NAT CHEM BIOL, V7, P412; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Holt L J, 2000, Nucleic Acids Res, V28, pE72, DOI 10.1093/nar/28.15.e72; Jach G, 2006, NAT METHODS, V3, P597, DOI 10.1038/NMETH901; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Khoshnan A, 2002, P NATL ACAD SCI USA, V99, P1002, DOI 10.1073/pnas.022631799; Kvam E, 2010, PROTEIN ENG DES SEL, V23, P489, DOI 10.1093/protein/gzq022; Kvam E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005727; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lecerf JM, 2001, P NATL ACAD SCI USA, V98, P4764, DOI 10.1073/pnas.071058398; Leclerc GM, 2000, BIOTECHNIQUES, V29, P590, DOI 10.2144/00293rr02; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Martineau P, 1998, J MOL BIOL, V280, P117, DOI 10.1006/jmbi.1998.1840; McLear JA, 2008, FASEB J, V22, P2003, DOI 10.1096/fj.07-099689; Melchionna T, 2007, J MOL BIOL, V374, P641, DOI 10.1016/j.jmb.2007.09.053; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Messer A, 2006, BIODRUGS, V20, P327, DOI 10.2165/00063030-200620060-00002; Messer A, 2009, EXPERT OPIN BIOL TH, V9, P1189, DOI 10.1517/14712590903176387; Miller TW, 2005, MOL THER, V12, P394, DOI 10.1016/j.ymthe.2005.04.003; Miller TW, 2005, NEUROBIOL DIS, V19, P47, DOI 10.1016/j.nbd.2004.11.003; Murakami Y, 1999, MOL CELL BIOL, V19, P7216; Murphy RC, 2004, MOL BRAIN RES, V121, P141, DOI 10.1016/j.molbrainres.2003.11.011; Omi K, 2008, NEUROSCI LETT, V431, P45, DOI 10.1016/j.neulet.2007.11.018; Perez-Martinez D, 2010, BIOESSAYS, V32, P589, DOI 10.1002/bies.201000009; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Sarkar S, 2008, FEBS J, V275, P4263, DOI 10.1111/j.1742-4658.2008.06562.x; Schiefner A, J MOL BIOL; Sheets MD, 1998, P NATL ACAD SCI USA, V95, P6157, DOI 10.1073/pnas.95.11.6157; Sibler AP, 2005, FEBS J, V272, P2878, DOI 10.1111/j.1742-4658.2005.04709.x; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Snyder-Keller A, J NEUROPATHOL EXP NE, V69, P1078; Southwell AL, 2008, J NEUROSCI, V28, P9013, DOI 10.1523/JNEUROSCI.2747-08.2008; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Tomlinson I, 2000, METHOD ENZYMOL, V326, P461; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Wolfgang WJ, 2005, P NATL ACAD SCI USA, V102, P11563, DOI 10.1073/pnas.0505321102; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	59	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29199	10.1371/journal.pone.0029199	http://dx.doi.org/10.1371/journal.pone.0029199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216210	Green Published, Green Submitted, gold			2022-12-27	WOS:000299684700038
J	Untereiner, AA; Dhar, A; Liu, JH; Wu, LY				Untereiner, Ashley A.; Dhar, Arti; Liu, Jianghai; Wu, Lingyun			Increased Renal Methylglyoxal Formation with Down-Regulation of PGC-1 alpha-FBPase Pathway in Cystathionine gamma-Lyase Knockout Mice	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; HYDROGEN-SULFIDE; OXIDATIVE STRESS; COACTIVATOR-1-ALPHA PGC-1-ALPHA; FRUCTOSE 1,6-BISPHOSPHATASE; HYPERTENSION DEVELOPMENT; INSULIN-RELEASE; NITRIC-OXIDE; RAT; METABOLISM	We have previously reported that hydrogen sulfide (H2S), a gasotransmitter and vasodilator has cytoprotective properties against methylglyoxal (MG), a reactive glucose metabolite associated with diabetes and hypertension. Recently, H2S was shown to up-regulate peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1 alpha, a key gluconeogenic regulator that enhances the gene expression of the rate-limiting gluconeogenic enzyme, fructose-1,6-bisphosphatase (FBPase). Thus, we sought to determine whether MG levels and gluconeogenic enzymes are altered in kidneys of 6-22 week-old cystathionine gamma-lyase knockout (CSE-/-; H2S-producing enzyme) male mice. MG levels were determined by HPLC. Plasma glucose levels were measured by an assay kit. Q-PCR was used to measure mRNA levels of PGC-1 alpha and FBPase-1 and -2. Coupled-enzymatic assays were used to determine FBPase activity, or triosephosphate levels. Experimental controls were either age-matched wild type mice or untreated rat A-10 cells. Interestingly, we observed a significant decrease in plasma glucose levels along with a significant increase in plasma MG levels in all three age groups (6-8, 14-16, and 20-22 week-old) of the CSE-/- mice. Indeed, renal MG and triosephosphates were increased, whereas renal FBPase activity, along with its mRNA levels, were decreased in the CSE-/- mice. The decreased FBPase activity was accompanied by lower levels of its product, fructose-6-phosphate, and higher levels of its substrate, fructose-1,6-bisphosphate in renal extracts from the CSE-/- mice. In agreement, PGC-1 alpha mRNA levels were also significantly down-regulated in 6-22 week-old CSE-/- mice. Furthermore, FBPase-1 and -2 mRNA levels were reduced in aorta tissues from CSE-/- mice. Administration of NaHS, a H2S donor, increased the gene expression of PGC-1 alpha and FBPase-1 and -2 in cultured rat A-10 cells. In conclusion, overproduction of MG in CSE-/- mice is due to a H2S-mediated down-regulation of the PGC-1 alpha-FBPase pathway, further suggesting the important role of H2S in the regulation of glucose metabolism and MG generation.	[Untereiner, Ashley A.; Dhar, Arti; Liu, Jianghai; Wu, Lingyun] Univ Saskatchewan, Coll Med, Dept Pharmacol, Saskatoon, SK S7N 0W0, Canada; [Untereiner, Ashley A.; Wu, Lingyun] Lakehead Univ, Dept Hlth Sci, Thunder Bay, ON P7B 5E1, Canada; [Untereiner, Ashley A.; Wu, Lingyun] Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada	University of Saskatchewan; Lakehead University; Northern Ontario School of Medicine	Untereiner, AA (corresponding author), Univ Saskatchewan, Coll Med, Dept Pharmacol, Saskatoon, SK S7N 0W0, Canada.	lily.wu@usask.ca		Untereiner, Ashley/0000-0002-1994-6651	Canadian Institutes of Health Research; Heart and Stroke Foundation of Saskatchewan; College of Medicine from University of Saskatchewan	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Saskatchewan; College of Medicine from University of Saskatchewan	This work was supported by operating grants from Canadian Institutes of Health Research and the Heart and Stroke Foundation of Saskatchewan to Dr. Wu. Ms. Ashley Untereiner and Mr. Jianghai Liu were both supported by a College of Medicine Graduate Scholarship from the University of Saskatchewan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MY, 2007, J ENDOCRINOL, V195, P105, DOI 10.1677/JOE-07-0184; Brancaleone V, 2008, BRIT J PHARMACOL, V155, P673, DOI 10.1038/bjp.2008.296; Chang TJ, 2006, CAN J PHYSIOL PHARM, V84, P1229, DOI 10.1139/Y06-077; Chang TJ, 2010, ANTIOXID REDOX SIGN, V12, P1093, DOI 10.1089/ars.2009.2918; Dhar A, 2011, DIABETES, V60, P899, DOI 10.2337/db10-0627; Dhar A, 2009, J CHROMATOGR B, V877, P1093, DOI 10.1016/j.jchromb.2009.02.055; Eid A, 2006, J AM SOC NEPHROL, V17, P398, DOI 10.1681/ASN.2005070742; Feng XJ, 2009, BIOCHEM BIOPH RES CO, V380, P153, DOI 10.1016/j.bbrc.2009.01.059; FURUYA E, 1981, J BIOL CHEM, V256, P7109; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; HARGROVE JL, 1989, METABOLISM, V38, P666, DOI 10.1016/0026-0495(89)90105-4; Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200; Jacobs RL, 1998, DIABETES, V47, P1967, DOI 10.2337/diabetes.47.12.1967; Kaneko Y, 2006, DIABETES, V55, P1391, DOI 10.2337/db05-1082; KIKAWA Y, 1994, BIOCHEM BIOPH RES CO, V199, P687, DOI 10.1006/bbrc.1994.1283; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; LANG G, 1974, METHOD ENZYMAT AN, V3, P1238; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liu Jianghai, 2011, CARDIOVAS R IN PRESS; Lu M, 2010, J AM SOC NEPHROL, V21, P993, DOI 10.1681/ASN.2009090949; Michal G., 1984, METHOD ENZYMAT AN, VVI, P342; MIZUNUMA H, 1986, J BIOCHEM-TOKYO, V99, P1781, DOI 10.1093/oxfordjournals.jbchem.a135656; Nieman KM, 2004, J BIOL CHEM, V279, P45708, DOI 10.1074/jbc.M408664200; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; PONTREMO.S, 1965, J BIOL CHEM, V240, P3459; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Suliman HB, 2006, SCIENCE, V120, P299; Tomaschitz A, 2010, NAT REV ENDOCRINOL, V6, P83, DOI 10.1038/nrendo.2009.263; Vasdev Sudesh, 1998, Artery, V23, P10; Wang H, 2007, CLIN BIOCHEM, V40, P1232, DOI 10.1016/j.clinbiochem.2007.07.016; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang X, 2006, KIDNEY INT, V69, P281, DOI 10.1038/sj.ki.5000043; Wang XX, 2008, J HYPERTENS, V26, P765, DOI 10.1097/HJH.0b013e3282f4a13c; Wang XX, 2005, J HYPERTENS, V23, P1565, DOI 10.1097/01.hjh.0000173778.85233.1b; Wang XX, 2004, KIDNEY INT, V66, P2315, DOI 10.1111/j.1523-1755.2004.66034.x; Willy PJ, 2004, P NATL ACAD SCI USA, V101, P8912, DOI 10.1073/pnas.0401420101; Wu LY, 2009, LAB INVEST, V89, P59, DOI 10.1038/labinvest.2008.109; Wu LY, 2002, HYPERTENSION, V39, P809, DOI 10.1161/hy0302.105207; Wu LY, 2006, CAN J PHYSIOL PHARM, V84, P129, DOI 10.1139/Y05-137; Yan SK, 2006, BIOCHEM BIOPH RES CO, V351, P485, DOI 10.1016/j.bbrc.2006.10.058; Yanez AJ, 2005, J CELL PHYSIOL, V202, P743, DOI 10.1002/jcp.20183; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2007, J BIOL CHEM, V282, P16567, DOI 10.1074/jbc.M700605200; Yang GD, 2011, AM J PATHOL, V179, P869, DOI 10.1016/j.ajpath.2011.04.028; Yang GD, 2010, CARDIOVASC RES, V86, P487, DOI 10.1093/cvr/cvp420; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yusuf M, 2005, BIOCHEM BIOPH RES CO, V333, P1146, DOI 10.1016/j.bbrc.2005.06.021; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje	49	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29592	10.1371/journal.pone.0029592	http://dx.doi.org/10.1371/journal.pone.0029592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216325	Green Published, Green Submitted, gold			2022-12-27	WOS:000299684700072
J	Yu, W; Jin, CM; Lou, XY; Han, X; Li, LS; He, YH; Zhang, HY; Ma, KL; Zhu, JD; Cheng, LH; Lin, BY				Yu, Wei; Jin, Chengmeng; Lou, Xiaoyan; Han, Xu; Li, Lisha; He, Yinghua; Zhang, Hongyu; Ma, Kelong; Zhu, Jingde; Cheng, Lihua; Lin, Biaoyang			Global Analysis of DNA Methylation by Methyl-Capture Sequencing Reveals Epigenetic Control of Cisplatin Resistance in Ovarian Cancer Cell	PLOS ONE			English	Article							PROTEIN-KINASE-C; HIGH-THROUGHPUT; IN-VITRO; GENE; EXPRESSION; MICRORNA; GENOME; DEATH; IDENTIFICATION; ACTIVATION	Cisplatin resistance is one of the major reasons leading to the high death rate of ovarian cancer. Methyl-Capture sequencing (MethylCap-seq), which combines precipitation of methylated DNA by recombinant methyl-CpG binding domain of MBD2 protein with NGS, global and unbiased analysis of global DNA methylation patterns. We applied MethylCap-seq to analyze genome-wide DNA methylation profile of cisplatin sensitive ovarian cancer cell line A2780 and its isogenic derivative resistant line A2780CP. We obtained 21,763,035 raw reads for the drug resistant cell line A2780CP and 18,821,061reads for the sensitive cell line A2780. We identified 1224 hyper-methylated and 1216 hypomethylated DMRs (differentially methylated region) in A2780CP compared to A2780. Our MethylCap-seq data on this ovarian cancer cisplatin resistant model provided a good resource for the research community. We also found that A2780CP, compared to A2780, has lower observed to expected methylated CpG ratios, suggesting a lower global CpG methylation in A2780CP cells. Methylation specific PCR and bisulfite sequencing confirmed hypermethylation of PTK6, PRKCE and BCL2L1 in A2780 compared with A2780CP. Furthermore, treatment with the demethylation reagent 5-aza-dC in A2780 cells demethylated the promoters and restored the expression of PTK6, PRKCE and BCL2L1.	[Yu, Wei; Jin, Chengmeng; Lou, Xiaoyan; Han, Xu; Li, Lisha; Cheng, Lihua; Lin, Biaoyang] Zhejiang Univ, Zhejiang Calif Int Nanosyst Inst ZCNI, Syst Biol Div, Hangzhou 310003, Zhejiang, Peoples R China; [Yu, Wei] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany; [He, Yinghua; Zhang, Hongyu; Ma, Kelong; Zhu, Jingde] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, Shanghai 200030, Peoples R China; [Lin, Biaoyang] Swedish Med Ctr, Swedish Neurosci Inst, Seattle, WA USA; [Lin, Biaoyang] Univ Washington, Dept Urol, Seattle, WA 98195 USA	Zhejiang University; Technical University of Darmstadt; Shanghai Jiao Tong University; Swedish Medical Center; University of Washington; University of Washington Seattle	Yu, W (corresponding author), Zhejiang Univ, Zhejiang Calif Int Nanosyst Inst ZCNI, Syst Biol Div, Hangzhou 310003, Zhejiang, Peoples R China.	chenglihua75@gmail.com; bylin@u.washington.edu	Lin, Biaoyang/AAA-1258-2020	Lin, Biaoyang/0000-0002-2189-0407; YU, WEI/0000-0002-1777-5254	Ministry of Science and Technology of China [2006AA02A303, 2006AA02Z4A2, 2006DFA32950, 2007DFC30360]; National Science Foundation [30921140312]; National Research Program for Basic Research [2009CB825606, 2009CB825607, 2010CB912802]; International Collaboration Grant [2009DFA31010]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation(National Science Foundation (NSF)); National Research Program for Basic Research; International Collaboration Grant	This work was supported by the funds to BL by the Ministry of Science and Technology of China [2006AA02A303, 2006AA02Z4A2, 2006DFA32950, 2007DFC30360]. This work is supported by the funds to JZ from National Science Foundation (30921140312), National Research Program for Basic Research (2009CB825606, 2009CB825607 and 2010CB912802) and International Collaboration Grant (2009DFA31010) to XD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibes A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-9; Amundson SA, 2000, CANCER RES, V60, P6101; Anisowicz Anthony, 2008, BMC Cancer, V8, P222, DOI 10.1186/1471-2407-8-222; Bestor TH, 2005, CELL, V122, P322, DOI 10.1016/j.cell.2005.07.024; Boettcher M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011002; Bram EE, 2009, NEOPLASIA, V11, P1359, DOI 10.1593/neo.91314; Brinkman AB, 2010, METHODS, V52, P232, DOI 10.1016/j.ymeth.2010.06.012; Chang XF, 2010, CANCER RES, V70, P2870, DOI 10.1158/0008-5472.CAN-09-3427; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Dong Z, 2004, J BIOL CHEM, V279, P9215, DOI 10.1074/jbc.M312225200; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Einhorn LH, 1997, CLIN CANCER RES, V3, P2630; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; GATELY DP, 1994, BRIT J CANCER, V70, P1102, DOI 10.1038/bjc.1994.455; Gebauer G, 2000, INT J ONCOL, V16, P321; Green JA, 2006, EUR J CANCER, V42, P2539, DOI 10.1016/j.ejca.2006.06.015; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Hu S, 2010, CANCER BIOL THER, V10, P788, DOI 10.4161/cbt.10.8.12913; Jaaskelainen M, 2010, MOL CELL ENDOCRINOL, V330, P17, DOI 10.1016/j.mce.2010.07.020; KIDO Y, 1993, ANTI-CANCER DRUG, V4, P251, DOI 10.1097/00001813-199304000-00018; Kim EH, 2010, ONCOGENE, V29, P4725, DOI 10.1038/onc.2010.223; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Marx D, 1998, EUR J CANCER, V34, P845, DOI 10.1016/S0959-8049(97)10169-1; MICHALOWSKY LA, 1987, MOL CELL BIOL, V7, P3076, DOI 10.1128/MCB.7.9.3076; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ohka F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023332; Ohmori T, 1998, CELL GROWTH DIFFER, V9, P345; OZOLS RF, 1991, CANCER TREAT REV, V18, P77, DOI 10.1016/0305-7372(91)90027-W; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Ruike Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-137; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Staub J, 2007, ONCOGENE, V26, P4969, DOI 10.1038/sj.onc.1210300; Su HY, 2010, INT J CANCER, V127, P555, DOI 10.1002/ijc.25083; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Vento MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015636; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Yan Pearlly S, 2002, Methods Mol Biol, V200, P87; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zheng Y, 2010, MOL CELL BIOL, V30, P4280, DOI 10.1128/MCB.00024-10; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	48	47	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29450	10.1371/journal.pone.0029450	http://dx.doi.org/10.1371/journal.pone.0029450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216282	Green Published, Green Submitted, gold			2022-12-27	WOS:000299684700056
J	Harding, P; Gwynne, S; Amos, M				Harding, Peter; Gwynne, Steve; Amos, Martyn			Mutual Information for the Detection of Crush	PLOS ONE			English	Article							EVACUATION; MODEL	Fatal crush conditions occur in crowds with tragic frequency. Event organizers and architects are often criticised for failing to consider the causes and implications of crush, but the reality is that both the prediction and prevention of such conditions offer a significant technical challenge. Full treatment of physical force within crowd simulations is precise but often computationally expensive; the more common method of human interpretation of results is computationally "cheap'' but subjective and time-consuming. This paper describes an alternative method for the analysis of crowd behaviour, which uses information theory to measure crowd disorder. We show how this technique may be easily incorporated into an existing simulation framework, and validate it against an historical event. Our results show that this method offers an effective and efficient route towards automatic detection of the onset of crush.	[Harding, Peter; Amos, Martyn] Manchester Metropolitan Univ, Sch Comp Math & Digital Technol, Manchester M15 6BH, Lancs, England; [Gwynne, Steve] Hughes Associates, London, England	Manchester Metropolitan University	Harding, P (corresponding author), Manchester Metropolitan Univ, Sch Comp Math & Digital Technol, Manchester M15 6BH, Lancs, England.	M.Amos@mmu.ac.uk		Harding, Peter John/0000-0002-6801-1166; Gwynne, Steve/0000-0002-2758-3897; Amos, Martyn/0000-0003-1680-5535	Dalton Research Institute, Manchester Metropolitan University	Dalton Research Institute, Manchester Metropolitan University	This work was partially supported by a studentship from the Dalton Research Institute, Manchester Metropolitan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Fruin J.J., 1993, 1 INT C ENG CROWD SA; Galea ER, 2003, AERONAUT J, V107, P207; Grosshandler W.L., 2005, REPORT TECHNICAL INV; Gwynne S, 1999, BUILD ENVIRON, V34, P741, DOI 10.1016/S0360-1323(98)00057-2; Gwynne S, 2003, FIRE TECHNOL, V39, P225, DOI 10.1023/A:1024189414319; Gwynne S, 2001, FIRE SAFETY J, V36, P327, DOI 10.1016/S0379-7112(00)00060-6; Harding PJ, 2010, PEDESTRIAN AND EVACUATION DYNAMICS 2008, P233, DOI 10.1007/978-3-642-04504-2_18; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Helbing D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046109; Hostikka S., 2009, FIRE DYNAMICS SIMULA; KISKO TM, 1985, FIRE SAFETY J, V9, P211, DOI 10.1016/0379-7112(85)90009-8; Korhonen T., 2007, P INTERFLAM2007 11 I, V3, P1443; Kukla R, 2001, TRANSPORT RES REC, P11, DOI 10.3141/1774-02; Kuligowski ED., 2005, REV BUILDING EVACUAT; Owen M., 1996, J FIRE PROT ENG, V8, P65, DOI [10.1177/104239159600800202, DOI 10.1177/104239159600800202]; Quinn M.J., 2003, PROC 2 INT C PEDESTR, P63; Ryder NL, 2004, J HAZARD MATER, V115, P149, DOI 10.1016/j.jhazmat.2004.06.018; Taylor LJ, 1989, HILLSBOROUGH STADIUM; THOMPSON PA, 1995, FIRE SAFETY J, V24, P149, DOI 10.1016/0379-7112(95)00020-T; Wicks RT, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051125	21	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e28747	10.1371/journal.pone.0028747	http://dx.doi.org/10.1371/journal.pone.0028747			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22229055	Green Submitted, Green Published, gold			2022-12-27	WOS:000299113600030
J	Wei, XM; Ju, XC; Yi, X; Zhu, Q; Qu, N; Liu, TF; Chen, Y; Jiang, H; Yang, GH; Zhen, R; Lan, ZZ; Qi, M; Wang, JM; Yang, Y; Chu, YX; Li, XY; Guang, YF; Huang, J				Wei, Xiaoming; Ju, Xiangchun; Yi, Xin; Zhu, Qian; Qu, Ning; Liu, Tengfei; Chen, Yang; Jiang, Hui; Yang, Guanghui; Zhen, Ruan; Lan, Zhangzhang; Qi, Ming; Wang, Jinming; Yang, Yi; Chu, Yuxing; Li, Xiaoyan; Guang, Yanfang; Huang, Jian			Identification of Sequence Variants in Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing	PLOS ONE			English	Article							BETA-THALASSEMIA; CAPTURE; ENRICHMENT; MUTATIONS	Background: Identification of gene variants plays an important role in research on and diagnosis of genetic diseases. A combination of enrichment of targeted genes and next-generation sequencing (targeted DNA-HiSeq) results in both high efficiency and low cost for targeted sequencing of genes of interest. Methodology/Principal Findings: To identify mutations associated with genetic diseases, we designed an array-based gene chip to capture all of the exons of 193 genes involved in 103 genetic diseases. To evaluate this technology, we selected 7 samples from seven patients with six different genetic diseases resulting from six disease-causing genes and 100 samples from normal human adults as controls. The data obtained showed that on average, 99.14% of 3,382 exons with more than 30-fold coverage were successfully detected using Targeted DNA-HiSeq technology, and we found six known variants in four disease-causing genes and two novel mutations in two other disease-causing genes (the STS gene for XLI and the FBN1 gene for MFS) as well as one exon deletion mutation in the DMD gene. These results were confirmed in their entirety using either the Sanger sequencing method or real-time PCR. Conclusions/Significance: Targeted DNA-HiSeq combines next-generation sequencing with the capture of sequences from a relevant subset of high-interest genes. This method was tested by capturing sequences from a DNA library through hybridization to oligonucleotide probes specific for genetic disorder-related genes and was found to show high selectivity, improve the detection of mutations, enabling the discovery of novel variants, and provide additional indel data. Thus, targeted DNA-HiSeq can be used to analyze the gene variant profiles of monogenic diseases with high sensitivity, fidelity, throughput and speed.	[Wei, Xiaoming; Ju, Xiangchun; Yi, Xin; Zhu, Qian; Qu, Ning; Liu, Tengfei; Chen, Yang; Jiang, Hui; Yang, Guanghui; Zhen, Ruan; Lan, Zhangzhang; Qi, Ming; Wang, Jinming; Yang, Yi; Chu, Yuxing; Li, Xiaoyan; Guang, Yanfang; Huang, Jian] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Huang, Jian] Natl Engn Ctr Biochip Shanghai, Shanghai Minist Key Lab Dis & Hlth Genom, Shanghai, Peoples R China	Beijing Genomics Institute (BGI)	Wei, XM (corresponding author), Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China.	huangjchgc@hotmail.com		Ju, xiangchun/0000-0003-3309-4595; lan, zhangzhang/0000-0001-5237-8150	National High Technology Research and Development Program of China (863 Program) [2006AA02A302]; Chinese National Key Program on Basic Research [2010CB529206]; Shenzhen Development and Reform Commission; International Innovation Team on the Cancer Genome Research of Guangdong province	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Chinese National Key Program on Basic Research; Shenzhen Development and Reform Commission; International Innovation Team on the Cancer Genome Research of Guangdong province	The authors gratefully acknowledge support from the National High Technology Research and Development Program of China (863 Program, 2006AA02A302), the Chinese National Key Program on Basic Research (2010CB529206). The authors also gratefully acknowledge support from the Shenzhen Development and Reform Commission project, and the project of International Innovation Team on the Cancer Genome Research of Guangdong province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISSANI B, 1991, GENE, V106, P173, DOI 10.1016/0378-1119(91)90197-J; Arezi B, 2003, ANAL BIOCHEM, V321, P226, DOI 10.1016/S0003-2697(03)00465-2; Bansal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018353; Bansal V, 2010, GENOME RES, V20, P537, DOI 10.1101/gr.100040.109; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Berg JS, 2011, GENET MED, V13, P218, DOI 10.1097/GIM.0b013e318203cff2; Bonnefond A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013630; Buehler B, 2010, METHODS, V50, pS15, DOI 10.1016/j.ymeth.2010.01.004; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; CHENG TC, 1984, P NATL ACAD SCI-BIOL, V81, P2821, DOI 10.1073/pnas.81.9.2821; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Deguti MM, 2004, HUM MUTAT, V23, P398, DOI 10.1002/humu.9227; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; *ILL, 2006, PROT WHOL GEN SEQ US; Jimenez-Sanchez G, 2001, NATURE, V409, P853, DOI 10.1038/35057050; Levin JZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r115; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 1999, ELECTROPHORESIS, V20, P1258, DOI 10.1002/(SICI)1522-2683(19990101)20:6<1258::AID-ELPS1258>3.0.CO;2-V; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liao SS, 2008, J NEUROL SCI, V275, P92, DOI 10.1016/j.jns.2008.07.038; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; Shen PD, 2011, P NATL ACAD SCI USA, V108, P6549, DOI 10.1073/pnas.1018981108; SHIH YL, 2001, CANCER, V107, P579; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Wan L, 2010, HEPATOLOGY, V52, P1662, DOI 10.1002/hep.23865; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Xu XM, 2004, J CLIN PATHOL, V57, P517, DOI 10.1136/jcp.2003.014456	33	116	127	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29500	10.1371/journal.pone.0029500	http://dx.doi.org/10.1371/journal.pone.0029500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216297	Green Published, gold, Green Submitted			2022-12-27	WOS:000299113600083
J	Yucel, EB; Ulgen, KO				Yucel, Esra Borklu; Ulgen, Kutlu O.			A Network-Based Approach on Elucidating the Multi-Faceted Nature of Chronological Aging in S-cerevisiae	PLOS ONE			English	Article							SENSITIVE PHOSPHOPROTEOME REVEALS; PROTEIN-INTERACTION NETWORKS; REPLICATIVE LIFE-SPAN; ACTIN CYTOSKELETON; STRESS RESISTANCE; CYTOSCAPE PLUGIN; OXIDATIVE STRESS; TELOMERE LENGTH; CELL-DEATH; KINASE-A	Background: Cellular mechanisms leading to aging and therefore increasing susceptibility to age-related diseases are a central topic of research since aging is the ultimate, yet not understood mechanism of the fate of a cell. Studies with model organisms have been conducted to ellucidate these mechanisms, and chronological aging of yeast has been extensively used as a model for oxidative stress and aging of postmitotic tissues in higher eukaryotes. Methodology/Principal Findings: The chronological aging network of yeast was reconstructed by integrating protein-protein interaction data with gene ontology terms. The reconstructed network was then statistically "tuned'' based on the betweenness centrality values of the nodes to compensate for the computer automated method. Both the originally reconstructed and tuned networks were subjected to topological and modular analyses. Finally, an ultimate "heart'' network was obtained via pooling the step specific key proteins, which resulted from the decomposition of the linear paths depicting several signaling routes in the tuned network. Conclusions/Significance: The reconstructed networks are of scale-free and hierarchical nature, following a power law model with c = 1.49. The results of modular and topological analyses verified that the tuning method was successful. The significantly enriched gene ontology terms of the modular analysis confirmed also that the multifactorial nature of chronological aging was captured by the tuned network. The interplay between various signaling pathways such as TOR, Akt/PKB and cAMP/Protein kinase A was summarized in the "heart'' network originated from linear path analysis. The deletion of four genes, TCB3, SNA3, PST2 and YGR130C, was found to increase the chronological life span of yeast. The reconstructed networks can also give insight about the effect of other cellular machineries on chronological aging by targeting different signaling pathways in the linear path analysis, along with unraveling of novel proteins playing part in these pathways.	[Yucel, Esra Borklu; Ulgen, Kutlu O.] Bogazici Univ, Dept Chem Engn, Istanbul, Turkey	Bogazici University	Yucel, EB (corresponding author), Bogazici Univ, Dept Chem Engn, Istanbul, Turkey.	esra.yucel1@boun.edu.tr	Ulgen, Kutlu/AAF-3350-2020	Ulgen, Kutlu/0000-0003-3668-3467	Bogazici Research Fund [5681]; TUBITAK [110M428]	Bogazici Research Fund(Bogazici University); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was financially supported by Bogazici Research Fund through project 5681 and also by TUBITAK through project 110M428. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts AM, 2009, FEBS LETT, V583, P113, DOI 10.1016/j.febslet.2008.11.028; Ahmed SSSJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-6; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], INT J INFORM TECHNOL; Aragon AD, 2008, MOL BIOL CELL, V19, P1271, DOI 10.1091/mbc.E07-07-0666; Arga KY, 2007, BIOTECHNOL BIOENG, V97, P1246, DOI 10.1002/bit.21317; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barea F, 2009, MECH AGEING DEV, V130, P444, DOI 10.1016/j.mad.2009.04.005; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Batada NN, 2006, PLOS COMPUT BIOL, V2, P748, DOI 10.1371/journal.pcbi.0020088; Bell R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000414; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Bharucha N, 2008, MOL BIOL CELL, V19, P2708, DOI 10.1091/mbc.E07-11-1199; BHATTACHARYA S, 1995, P NATL ACAD SCI USA, V92, P2984, DOI 10.1073/pnas.92.7.2984; Braun EL, 1996, J BACTERIOL, V178, P6865, DOI 10.1128/jb.178.23.6865-6872.1996; Brown CR, 2010, J BIOL CHEM, V285, P1516, DOI 10.1074/jbc.M109.028241; Budovsky A, 2007, MECH AGEING DEV, V128, P117, DOI 10.1016/j.mad.2006.11.018; Burtner CR, 2011, CELL CYCLE, V10, P1385, DOI 10.4161/cc.10.9.15464; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Charville GW, 2011, PHILOS T R SOC B, V366, P85, DOI 10.1098/rstb.2010.0279; Chautard E, 2010, BIOGERONTOLOGY, V11, P463, DOI 10.1007/s10522-010-9268-5; Chen QH, 2006, FREE RADICAL BIO MED, V40, P120, DOI 10.1016/j.freeradbiomed.2005.08.048; Colombo S, 1998, EMBO J, V17, P3326, DOI 10.1093/emboj/17.12.3326; Creutz CE, 2004, CELL MOL LIFE SCI, V61, P1208, DOI 10.1007/s00018-004-4029-8; de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Demczuk A, 2008, EUKARYOT CELL, V7, P967, DOI 10.1128/EC.00438-07; Dezso Z, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-36; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Enserink JM, 2009, J CELL BIOL, V185, P423, DOI 10.1083/jcb.200811083; ERASO P, 2006, YEAST, V1758, P164; Estrada E, 1996, J BIOL CHEM, V271, P32064, DOI 10.1074/jbc.271.50.32064; Evans DS, 2011, AGEING RES REV, V10, P225, DOI 10.1016/j.arr.2010.04.001; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fabrizio P, 2008, BBA-MOL CELL RES, V1783, P1280, DOI 10.1016/j.bbamcr.2008.03.017; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goldberg AA, 2010, AGING-US, V2, P393, DOI 10.18632/aging.100168; Goldberg AA, 2009, EXP GERONTOL, V44, P555, DOI 10.1016/j.exger.2009.06.001; Gourlay CW, 2005, FEMS YEAST RES, V5, P1193, DOI 10.1016/j.femsyr.2005.08.001; Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148; Grandin N, 2003, MOL CELL BIOL, V23, P9162, DOI 10.1128/MCB.23.24.9162-9177.2003; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Harris N, 2001, MOL GENET GENOMICS, V265, P258, DOI 10.1007/s004380000409; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Hickman MA, 2010, P NATL ACAD SCI USA, V107, P19384, DOI 10.1073/pnas.1006436107; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hiraki T, 2010, FEBS LETT, V584, P55, DOI 10.1016/j.febslet.2009.11.076; Hlavata L, 2008, AGING CELL, V7, P148, DOI 10.1111/j.1474-9726.2007.00361.x; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Ito H, 2010, J BIOL CHEM, V285, P34616, DOI 10.1074/jbc.M110.175562; Jimenez-Hidalgo M, 2009, AGING CELL, V8, P140, DOI 10.1111/j.1474-9726.2009.00461.x; Kaeberlein M, 2007, AGING CELL, V6, P731, DOI 10.1111/j.1474-9726.2007.00341.x; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Kamenisch Y, 2010, J EXP MED, V207, P379, DOI 10.1084/jem.20091834; Korolchuk VI, 2009, AUTOPHAGY, V5, P862, DOI 10.4161/auto.8840; Krause SA, 2002, CURR BIOL, V12, P588, DOI 10.1016/S0960-9822(02)00760-1; Kriete A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000820; Li W, 2006, MOL BIOL CELL, V17, P1802, DOI 10.1091/mbc.E05-04-0333; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lorenz DR, 2009, P NATL ACAD SCI USA, V106, P1145, DOI 10.1073/pnas.0812551106; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Managbanag JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003802; Marisco G, 2011, YEAST, V28, P363, DOI 10.1002/yea.1844; Mesquita A, 2010, P NATL ACAD SCI USA, V107, P15123, DOI 10.1073/pnas.1004432107; Mitchell JR, 2003, CURR OPIN CELL BIOL, V15, P232, DOI 10.1016/S0955-0674(03)00018-8; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Murakami CJ, 2008, J GERONTOL A-BIOL, V63, P113, DOI 10.1093/gerona/63.2.113; NAKAFUKU M, 1988, P NATL ACAD SCI USA, V85, P1374, DOI 10.1073/pnas.85.5.1374; NALBANTOGLU B, 2011, CELL METABOLISM CELL; Nie K, 2009, BIOCHEM BIOPH RES CO, V378, P103, DOI 10.1016/j.bbrc.2008.11.010; Nozaki T, 1996, BIOCHEM BIOPH RES CO, V228, P452, DOI 10.1006/bbrc.1996.1681; Olivera-Couto A, 2011, MOL BIOL CELL, V22, P2360, DOI 10.1091/mbc.E10-12-1021; Osmani AH, 1999, J BIOL CHEM, V274, P23565, DOI 10.1074/jbc.274.33.23565; Peisker K, 2010, BBA-MOL CELL RES, V1803, P662, DOI 10.1016/j.bbamcr.2010.03.005; Ponnusamy S, 2008, J BIOL CHEM, V283, P27514, DOI 10.1074/jbc.M802980200; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Qi HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003520; Qin H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002670; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Reverter-Branchat G, 2007, MICROBIOL-SGM, V153, P3667, DOI 10.1099/mic.0.2007/009340-0; Ruckenstuhl C, 2010, AGING-US, V2, P643, DOI 10.18632/aging.100223; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031; Shi L, 2010, MOL BIOL CELL, V21, P1982, DOI 10.1091/mbc.E10-01-0056; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Simko GI, 2009, GENOME MED, V1, DOI 10.1186/gm90; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Staschke KA, 2010, J BIOL CHEM, V285, P16893, DOI 10.1074/jbc.M110.121947; Steffen M, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-34; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tabb MM, 2000, MOL CELL BIOL, V20, P6062, DOI 10.1128/MCB.20.16.6062-6073.2000; Tacutu R, 2010, BIOGERONTOLOGY, V11, P513, DOI 10.1007/s10522-010-9265-8; Tan Yuanyou, 2009, Adv Appl Bioinform Chem, V2, P49; Tekir SD, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/690925; Tekir SD, 2009, J BIOMED INFORM, V42, P228, DOI 10.1016/j.jbi.2008.08.008; Titorenko VI, 2011, TRAFFIC, V12, P252, DOI 10.1111/j.1600-0854.2010.01144.x; TIVECI S, 2011, CALCIUM SIGNALING SY; Toku AE, 2011, COMPUT BIOL CHEM, V35, P282, DOI 10.1016/j.compbiolchem.2011.07.002; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; Ungar L, 2009, NUCLEIC ACIDS RES, V37, P3840, DOI 10.1093/nar/gkp259; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; von Plehwe U, 2009, GENE DEV, V23, P2102, DOI 10.1101/gad.529409; Wang Y, 2004, PLOS BIOL, V2, P610, DOI 10.1371/journal.pbio.0020128; Wolfson M, 2009, INT J BIOCHEM CELL B, V41, P516, DOI 10.1016/j.biocel.2008.08.026; Yen WL, 2008, PHYSIOLOGY, V23, P248, DOI 10.1152/physiol.00013.2008; Zuin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002842	117	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29284	10.1371/journal.pone.0029284	http://dx.doi.org/10.1371/journal.pone.0029284			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216232	Green Submitted, Green Published, gold			2022-12-27	WOS:000299113600073
J	Liang, YH; Danzy, S; Dao, LD; Parslow, TG; Liang, YY				Liang, Yuhong; Danzy, Shamika; Dao, Luan Danh; Parslow, Tristram G.; Liang, Yuying			Mutational Analyses of the Influenza A Virus Polymerase Subunit PA Reveal Distinct Functions Related and Unrelated to RNA Polymerase Activity	PLOS ONE			English	Article							AMINO-ACID MUTATION; PB1 PROTEIN; PACKAGING SIGNALS; COMPLEX; LOCALIZATION; IDENTIFICATION; TRANSCRIPTION; GENERATION; SEGMENTS; DOMAINS	Influenza A viral polymerase is a heterotrimeric complex that consists of PA, PB1, and PB2 subunits. We previously reported that a di-codon substitution mutation (G507A-R508A), denoted J10, in the C-terminal half of PA had no apparent effect on viral RNA synthesis but prevented infectious virus production, indicating that PA may have a novel role independent of its polymerase activity. To further examine the roles of PA in the viral life cycle, we have now generated and characterized additional mutations in regions flanking the J10 site from residues 497 to 518. All tested di-codon mutations completely abolished or significantly reduced viral infectivity, but they did so through disparate mechanisms. Several showed effects resembling those of J10, in that the mutant polymerase supported normal levels of viral RNA synthesis but nonetheless failed to generate infectious viral particles. Others eliminated polymerase activity, in most cases by perturbing the normal nuclear localization of PA protein in cells. We also engineered single-codon mutations that were predicted to pack near the J10 site in the crystal structure of PA, and found that altering residues K378 or D478 each produced a J10-like phenotype. In further studies of J10 itself, we found that this mutation does not affect the formation and release of virion-like particles per se, but instead impairs the ability of those particles to incorporate each of the eight essential RNA segments (vRNAs) that make up the viral genome. Taken together, our analysis identifies mutations in the C-terminal region of PA that differentially affect at least three distinct activities: protein nuclear localization, viral RNA synthesis, and a trans-acting function that is required for efficient packaging of all eight vRNAs.	[Liang, Yuhong; Danzy, Shamika; Dao, Luan Danh; Parslow, Tristram G.; Liang, Yuying] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University	Liang, YH (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY USA.	yliang5@emory.edu			National Institutes of Health (NIH) [R01AI067704]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094133, R01AI067704] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant R01AI067704. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKKINA RK, 1987, J VIROL, V61, P2217, DOI 10.1128/JVI.61.7.2217-2224.1987; Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; BISWAS SK, 1994, J VIROL, V68, P1819, DOI 10.1128/JVI.68.3.1819-1826.1994; BLAAS D, 1982, VIROLOGY, V116, P339, DOI 10.1016/0042-6822(82)90425-1; BRAAM J, 1983, CELL, V34, P609; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; DIAS A, 2009, NATURE; Fodor E, 2003, J VIROL, V77, P5017, DOI 10.1128/JVI.77.8.5017-5020.2003; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gonzalez S, 1999, EMBO J, V18, P3767, DOI 10.1093/emboj/18.13.3767; Gonzalez S, 1996, NUCLEIC ACIDS RES, V24, P4456, DOI 10.1093/nar/24.22.4456; Guu TSY, 2008, VIROLOGY, V379, P135, DOI 10.1016/j.virol.2008.06.022; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hemerka J.N., 2009, J VIROL; Huarte M, 2003, J VIROL, V77, P6007, DOI 10.1128/JVI.77.10.6007-6013.2003; Huarte M, 2001, J VIROL, V75, P8597, DOI 10.1128/JVI.75.18.8597-8604.2001; Huet S, 2010, J VIROL, V84, P1254, DOI 10.1128/JVI.01533-09; Kawaguchi A, 2005, J VIROL, V79, P732, DOI 10.1128/JVI.79.2.732-744.2005; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Lamb RA, 2003, FIELDS VIROLOGY, P1487; Liang YH, 2008, J VIROL, V82, P229, DOI 10.1128/JVI.01541-07; Liang YY, 2005, J VIROL, V79, P10348, DOI 10.1128/JVI.79.16.10348-10355.2005; MAHY BWJ, 1983, GENETICS INFLUENZA V, P192; MURTI KG, 1988, VIROLOGY, V164, P562, DOI 10.1016/0042-6822(88)90574-0; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; NIETO A, 1992, VIRUS RES, V24, P65, DOI 10.1016/0168-1702(92)90031-4; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; PEREZ DR, 1995, J VIROL, V69, P6932; Regan JF, 2006, J VIROL, V80, P252, DOI 10.1128/JVI.80.1.252-261.2006; ULMANEN I, 1981, P NATL ACAD SCI-BIOL, V78, P7355, DOI 10.1073/pnas.78.12.7355; YUAN P, 2009, NATURE; Zurcher T, 1996, J GEN VIROL, V77, P1745, DOI 10.1099/0022-1317-77-8-1745	35	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29485	10.1371/journal.pone.0029485	http://dx.doi.org/10.1371/journal.pone.0029485			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238617	Green Submitted, gold, Green Published			2022-12-27	WOS:000301188800018
J	Colombo, G; Rossi, R; Gagliano, N; Portinaro, N; Clerici, M; Annibal, A; Giustarini, D; Colombo, R; Milzani, A; Dalle-Donne, I				Colombo, Graziano; Rossi, Ranieri; Gagliano, Nicoletta; Portinaro, Nicola; Clerici, Marco; Annibal, Andrea; Giustarini, Daniela; Colombo, Roberto; Milzani, Aldo; Dalle-Donne, Isabella			Red Blood Cells Protect Albumin from Cigarette Smoke-Induced Oxidation	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; SULFENIC ACID; DNA-DAMAGE; 2-CYS PEROXIREDOXIN; HYDROGEN-PEROXIDE; N-ACETYLCYSTEINE; NITRIC-OXIDE; HUMAN PLASMA; CYSTEINE; THIOL	Different studies reported the presence of oxidized (carbonylated) albumin in the extravascular pool, but not in the intravascular one of cigarette smokers. In this study we attempted to explain this apparent discrepancy exposing human serum albumin (HSA) to aqueous cigarette smoke extract (CSE). CSE induces HSA carbonylation and oxidation of the HSA Cys34 sulfhydryl group. An antioxidant action of glutathione, cysteine, and its synthetic derivative N-acetylcysteine was observed only at supra-physiological concentrations, suggesting that physiological (plasma) concentrations of glutathione and cysteine in the low micromolar range are ineffective in preventing cigarette smoke-induced oxidation of HSA. Differently, human erythrocytes resulted to be protective towards CSE-induced oxidation (carbonylation and thiol oxidation) of both HSA and total human plasma proteins.	[Colombo, Graziano; Clerici, Marco; Annibal, Andrea; Colombo, Roberto; Milzani, Aldo; Dalle-Donne, Isabella] Univ Milan, Dept Biol, Milan, Italy; [Rossi, Ranieri; Giustarini, Daniela] Univ Siena, Dept Evolutionary Biol, I-53100 Siena, Italy; [Gagliano, Nicoletta] Univ Milan, Dept Human Morphol & Biomed Sci Citta Studi, Milan, Italy; [Portinaro, Nicola] Ist Clin Humanitas, Dept Translat Med, Clin Ortoped & Traumatol, Milan, Italy	University of Milan; University of Siena; University of Milan; IRCCS Humanitas Research Hospital	Colombo, G (corresponding author), Univ Milan, Dept Biol, Milan, Italy.	quack@unimi.it	PORTINARO, NICOLA MARCELLO AGOSTINO/AAB-8274-2022; Giustarini, Daniela/AAV-6629-2021; Dalle-Donne, Isabella/K-1436-2018; Gagliano, Nicoletta/L-1485-2016; Dalle-Donne, Isabella/AHE-8993-2022; Annibal, Andrea/M-1753-2018; Milzani, Aldo/AHE-3364-2022; Rossi, Ranieri/C-8743-2011	PORTINARO, NICOLA MARCELLO AGOSTINO/0000-0002-7191-9837; Gagliano, Nicoletta/0000-0002-3393-3144; Annibal, Andrea/0000-0003-4311-5417; Milzani, Aldo/0000-0002-1496-6872; Rossi, Ranieri/0000-0002-0187-4530; Giustarini, Daniela/0000-0003-4929-5316; COLOMBO, GRAZIANO/0000-0001-8663-735X; Dalle-Donne, Isabella/0000-0001-7098-6213	PUR (Programma dell'Universita` per la Ricerca), University of Milan; Fondazione Ariel, Centro per le Disabilita Neuromotorie Infantili, Milan, Italy	PUR (Programma dell'Universita` per la Ricerca), University of Milan; Fondazione Ariel, Centro per le Disabilita Neuromotorie Infantili, Milan, Italy	This research was supported by PUR 2009 (Programma dell'Universita` per la Ricerca), University of Milan, and by Fondazione Ariel, Centro per le Disabilita Neuromotorie Infantili, Milan, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alayash AI, 2001, ANTIOXID REDOX SIGN, V3, P313, DOI 10.1089/152308601300185250; Aldini G, 2008, CHEM RES TOXICOL, V21, P824, DOI 10.1021/tx700349r; Barreiro E, 2010, AM J RESP CRIT CARE, V182, P477, DOI 10.1164/rccm.200908-1220OC; Baynes J. W., 2005, MED BIOCH, P497; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Boas FE, 1998, P NATL ACAD SCI USA, V95, P3077, DOI 10.1073/pnas.95.6.3077; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; Cha MK, 2000, BIOCHEMISTRY-US, V39, P6944, DOI 10.1021/bi000034j; Chiou WB, 2011, ADDICTION, V106, P2221, DOI 10.1111/j.1360-0443.2011.03545.x; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; Colombo G, 2010, ANTIOXID REDOX SIGN, V12, P349, DOI 10.1089/ars.2009.2806; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; De Flora S, 2001, CARCINOGENESIS, V22, P999, DOI 10.1093/carcin/22.7.999; Dennehy MK, 2006, CHEM RES TOXICOL, V19, P20, DOI 10.1021/tx050312l; Ditscheid B, 2005, EUR J CLIN NUTR, V59, P768, DOI 10.1038/sj.ejcn.1602138; Dubuisson M, 2004, FEBS LETT, V571, P161, DOI 10.1016/j.febslet.2004.06.080; Dumaswala UJ, 2001, AM J PHYSIOL-CELL PH, V280, pC867, DOI 10.1152/ajpcell.2001.280.4.C867; Eaton P, 2003, J AM SOC NEPHROL, V14, pS290, DOI 10.1097/01.ASN.0000078024.50060.C6; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Erhardt L, 2009, ATHEROSCLEROSIS, V205, P23, DOI 10.1016/j.atherosclerosis.2009.01.007; Giustarini D, 2006, J GERONTOL A-BIOL, V61, P1030, DOI 10.1093/gerona/61.10.1030; Hackett TL, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-180; Halliwell B., 2007, FREE RADICALS BIOL M; Hortin GL, 2006, CLIN CHEM, V52, P2258, DOI 10.1373/clinchem.2006.074302; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Johnson RM, 2005, FREE RADICAL BIO MED, V39, P1407, DOI 10.1016/j.freeradbiomed.2005.07.002; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Karatzi K, 2007, J AM COLL NUTR, V26, P10, DOI 10.1080/07315724.2007.10719580; Kawakami A, 2006, FEBS J, V273, P3346, DOI 10.1111/j.1742-4658.2006.05341.x; Kelly Greg, 2003, Altern Med Rev, V8, P43; Kelly Greg S, 2002, Altern Med Rev, V7, P370; Kelly Greg S, 2002, Altern Med Rev, V7, P500; Kim HJ, 2004, AM J RESP CELL MOL, V31, P483, DOI 10.1165/rcmb.2002-0300OC; Kinnula VL, 2005, THORAX, V60, P693, DOI 10.1136/thx.2004.037473; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Landar A, 2006, FREE RADICAL BIO MED, V40, P459, DOI 10.1016/j.freeradbiomed.2005.08.046; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; LIM YS, 1994, BIOCHEM BIOPH RES CO, V199, P199, DOI 10.1006/bbrc.1994.1214; Louhelainen Noora, 2009, BMC Pulm Med, V9, P25, DOI 10.1186/1471-2466-9-25; Low FM, 2008, ANTIOXID REDOX SIGN, V10, P1621, DOI 10.1089/ars.2008.2081; Low FM, 2007, BLOOD, V109, P2611, DOI 10.1182/blood-2006-09-048728; MANSOOR MA, 1992, ANAL BIOCHEM, V200, P218, DOI 10.1016/0003-2697(92)90456-H; Manta B, 2009, ARCH BIOCHEM BIOPHYS, V484, P146, DOI 10.1016/j.abb.2008.11.017; Marangon K, 1999, CLIN CHEM, V45, P577; Minetti M, 2006, ANTIOXID REDOX SIGN, V8, P1165, DOI 10.1089/ars.2006.8.1165; Minetti M, 2007, CARDIOVASC RES, V75, P21, DOI 10.1016/j.cardiores.2007.03.007; Moller P, 2004, EUR J NUTR, V43, P267, DOI 10.1007/s00394-004-0470-6; Moriarty SE, 2003, FREE RADICAL BIO MED, V35, P1582, DOI 10.1016/j.freeradbiomed.2003.09.006; Muscat JE, 2004, FREE RADICAL BIO MED, V36, P464, DOI 10.1016/j.freeradbiomed.2003.11.018; Nagai K, 2006, THORAX, V61, P496, DOI 10.1136/thx.2005.049148; Oettl K, 2007, BRIT J PHARMACOL, V151, P580, DOI 10.1038/sj.bjp.0707251; Oettl K, 2011, ACTA OPHTHALMOL, V89, pE174, DOI 10.1111/j.1755-3768.2009.01824.x; Oettl K, 2010, METHOD ENZYMOL, V474, P181, DOI 10.1016/S0076-6879(10)74011-8; Orosz Z, 2007, AM J PHYSIOL-HEART C, V292, pH130, DOI 10.1152/ajpheart.00599.2006; Patel RR, 2008, DRUGS, V68, P1511, DOI 10.2165/00003495-200868110-00004; PENDYALA L, 1995, CANCER EPIDEM BIOMAR, V4, P245; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Peters T., 1995, ALL ALBUMIN BIOCH GE, P9, DOI [10.1016/B978-012552110-9/50004-0, DOI 10.1016/B978-012552110-9/50004-0]; Pignatelli B, 2001, CANCER RES, V61, P778; Polidori MC, 2003, BRIT J NUTR, V90, P147, DOI 10.1079/BJN2003890; Quinlan GJ, 2005, HEPATOLOGY, V41, P1211, DOI 10.1002/hep.20720; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Rodgman A., 2013, CHEM COMPONENTS TOBA, V2nd; Romero N, 2006, IUBMB LIFE, V58, P572, DOI 10.1080/15216540600936549; Rossi R, 2009, J CELL MOL MED, V13, P3131, DOI 10.1111/j.1582-4934.2008.00417.x; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Sharma R, 2000, ACTA BIOCHIM POL, V47, P751, DOI 10.18388/abp.2000_3993; Stadler N, 2007, ARTERIOSCL THROM VAS, V27, P120, DOI 10.1161/01.ATV.0000250614.97896.4c; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Suzuki M, 2008, AM J RESP CELL MOL, V39, P673, DOI 10.1165/rcmb.2007-0424OC; Tsuchiya M, 2002, CIRCULATION, V105, P1155, DOI 10.1161/hc1002.105935; Turell L, 2009, BRAZ J MED BIOL RES, V42, P305, DOI 10.1590/S0100-879X2009000400001; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; Turell L, 2009, J CHROMATOGR B, V877, P3384, DOI 10.1016/j.jchromb.2009.03.035; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Yeh CC, 2008, ENVIRON RES, V106, P219, DOI 10.1016/j.envres.2007.09.008	81	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29930	10.1371/journal.pone.0029930	http://dx.doi.org/10.1371/journal.pone.0029930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238677	Green Published, gold			2022-12-27	WOS:000301070200059
J	Fan, YH; Pereira, RM; Kilic, E; Casella, G; Keyhani, NO				Fan, Yanhua; Pereira, Roberto M.; Kilic, Engin; Casella, George; Keyhani, Nemat O.			Pyrokinin beta-Neuropeptide Affects Necrophoretic Behavior in Fire Ants (S. invicta), and Expression of beta-NP in a Mycoinsecticide Increases Its Virulence	PLOS ONE			English	Article							FUNGUS BEAUVERIA-BASSIANA; SOLENOPSIS-INVICTA; ENTOMOPATHOGENIC FUNGUS; SCORPION NEUROTOXIN; HYMENOPTERA; FORMICIDAE; FAMILY; IDENTIFICATION; INVASION; IMPACT	Fire ants are one of the world's most damaging invasive pests, with few means for their effective control. Although ecologically friendly alternatives to chemical pesticides such as the insecticidal fungus Beauveria bassiana have been suggested for the control of fire ant populations, their use has been limited due to the low virulence of the fungus and the length of time it takes to kill its target. We present a means of increasing the virulence of the fungal agent by expressing a fire ant neuropeptide. Expression of the fire ant (Solenopsis invicta) pyrokinin beta -neuropeptide (beta-NP) by B. bassiana increased fungal virulence six-fold towards fire ants, decreased the LT50, but did not affect virulence towards the lepidopteran, Galleria mellonella. Intriguingly, ants killed by the beta-NP expressing fungus were disrupted in the removal of dead colony members, i.e. necrophoretic behavior. Furthermore, synthetic C-terminal amidated beta-NP but not the non-amidated peptide had a dramatic effect on necrophoretic behavior. These data link chemical sensing of a specific peptide to a complex social behavior. Our results also confirm a new approach to insect control in which expression of host molecules in an insect pathogen can by exploited for target specific augmentation of virulence. The minimization of the development of potential insect resistance by our approach is discussed.	[Fan, Yanhua] Southwest Univ, Biotechnol Res Ctr, Chongqing, Peoples R China; [Pereira, Roberto M.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Fan, Yanhua; Kilic, Engin; Casella, George; Keyhani, Nemat O.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA	Southwest University - China; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Fan, YH (corresponding author), Southwest Univ, Biotechnol Res Ctr, Chongqing, Peoples R China.	keyhani@ufl.edu	Pereira, Roberto/B-5008-2010; Keyhani, Nemat O/I-8150-2013	Pereira, Roberto/0000-0002-5618-7690; 	USDA [2010-34135-21095]; University of Florida IFAS; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	USDA(United States Department of Agriculture (USDA)); University of Florida IFAS(University of Florida); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by a USDA grant (2010-34135-21095) and a University of Florida IFAS Innovation Award to NOK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN CR, 1994, TEX J SCI, V46, P51; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; Bextine BR, 2004, SOUTHWEST ENTOMOL, V29, P47; Bidochka MJ, 2010, MICROBIOL-SGM, V156, P2164, DOI 10.1099/mic.0.038216-0; Borovsky D, 2003, J EXP BIOL, V206, P3869, DOI 10.1242/jeb.00602; Buhs JB, 2002, ISIS, V93, P377, DOI 10.1086/512523; Callcott AMA, 1996, FLA ENTOMOL, V79, P240, DOI 10.2307/3495821; Choe DH, 2009, P NATL ACAD SCI USA, V106, P8251, DOI 10.1073/pnas.0901270106; Choi MY, 2009, INSECT MOL BIOL, V18, P161, DOI 10.1111/j.1365-2583.2009.00867.x; Fan Y, 2011, NATURE BIOT IN PRESS; Fang WG, 2005, APPL ENVIRON MICROB, V71, P363, DOI 10.1128/AEM.71.1.363-370.2005; Gade G, 2005, PHYSIOL ENTOMOL, V30, P103, DOI 10.1111/j.1365-3032.2005.00442.x; Gade G, 2003, PEST MANAG SCI, V59, P1063, DOI 10.1002/ps.755; Harris M, 2003, SOUTHWEST ENTOMOL, P123; HOLMAN GM, 1986, COMP BIOCHEM PHYS C, V85, P219, DOI 10.1016/0742-8413(86)90077-0; HOWARD DF, 1976, BEHAVIOUR, V56, P157, DOI 10.1163/156853976X00334; JEMAL A, 1993, PREV VET MED, V17, P19, DOI 10.1016/0167-5877(93)90051-T; Lewis MW, 2009, MICROBIOL-SGM, V155, P3110, DOI 10.1099/mic.0.029165-0; Lin HM, 2011, J ECON ENTOMOL, V104, P225, DOI 10.1603/EC10298; Lu DD, 2008, APPL MICROBIOL BIOT, V81, P515, DOI 10.1007/s00253-008-1695-8; Nachman RJ, 1996, PEPTIDES, V17, P747, DOI 10.1016/0196-9781(96)00111-8; NACHMAN RJ, 1991, P NATL ACAD SCI USA, V88, P4518, DOI 10.1073/pnas.88.10.4518; Oi DH, 2009, BIOL CONTROL, V48, P310, DOI 10.1016/j.biocontrol.2008.11.003; OI DH, 1993, FLA ENTOMOL, V76, P63, DOI 10.2307/3496014; OI DH, 1994, J ECON ENTOMOL, V87, P623, DOI 10.1093/jee/87.3.623; PEREIRA RM, 1993, J INVERTEBR PATHOL, V61, P156, DOI 10.1006/jipa.1993.1028; Pereira RM, 2003, J AGR URBAN ENTOMOL, V20, P123; Rafaeli A, 2009, GEN COMP ENDOCR, V162, P69, DOI 10.1016/j.ygcen.2008.04.004; RAINA AK, 1989, SCIENCE, V244, P796, DOI 10.1126/science.244.4906.796; Riggs NL, 2002, SOUTHWEST ENTOMOL, P31; St Leger RJ, 2010, APPL MICROBIOL BIOT, V85, P901, DOI 10.1007/s00253-009-2306-z; STIMAC JL, 1993, J ECON ENTOMOL, V86, P1083, DOI 10.1093/jee/86.4.1083; Teal PEA, 1996, PEPTIDES, V17, P337, DOI 10.1016/0196-9781(95)02094-2; Wanchoo A, 2009, MICROBIOL-SGM, V155, P3121, DOI 10.1099/mic.0.029157-0; Wang CS, 2007, NAT BIOTECHNOL, V25, P1455, DOI 10.1038/nbt1357; Williams David F., 2003, American Entomologist, V49, P150; Williams David F., 2001, American Entomologist, V47, P146; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Zhang SZ, 2011, MOL MICROBIOL, V80, P811, DOI 10.1111/j.1365-2958.2011.07613.x; Zhang SZ, 2011, APPL ENVIRON MICROB, V77, P2676, DOI 10.1128/AEM.02747-10; Zhang SZ, 2010, APPL MICROBIOL BIOT, V87, P1151, DOI 10.1007/s00253-010-2636-x	41	26	26	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e26924	10.1371/journal.pone.0026924	http://dx.doi.org/10.1371/journal.pone.0026924			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238569	gold, Green Published, Green Submitted			2022-12-27	WOS:000301070200001
J	Rabello, MCD; Matsumoto, CK; de Almeida, LGP; Menendez, MC; de Oliveira, RS; Silva, RM; Garcia, MJ; Leao, SC				da Silva Rabello, Michelle Christiane; Matsumoto, Cristianne Kayoko; Paula de Almeida, Luiz Gonzaga; Carmen Menendez, Maria; de Oliveira, Rosangela Siqueira; Silva, Rosa Maria; Jesus Garcia, Maria; Leao, Sylvia Cardoso			First Description of Natural and Experimental Conjugation between Mycobacteria Mediated by a Linear Plasmid	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; AVIUM COMPLEX; HORIZONTAL TRANSFER; NONTUBERCULOUS MYCOBACTERIA; STREPTOMYCES-LIVIDANS; ESCHERICHIA-COLI; EUKARYOTIC GENES; IS1245; SEQUENCE; DNA	Background: In a previous study, we detected the presence of a Mycobacterium avium species-specific insertion sequence, IS1245, in Mycobacterium kansasii. Both species were isolated from a mixed M. avium-M. kansasii bone marrow culture from an HIV-positive patient. The transfer mechanism of this insertion sequence to M. kansasii was investigated here. Methodology/Principal Findings: A linear plasmid (pMA100) was identified in all colonies isolated from the M. avium-M. kansasii mixed culture carrying the IS1245 element. The linearity of pMA100 was confirmed. Other analyses suggested that pMA100 contained a covalently bound protein in the terminal regions, a characteristic of invertron linear replicons. Partial sequencing of pMA100 showed that it bears one intact copy of IS1245 inserted in a region rich in transposase-related sequences. These types of sequences have been described in other linear mycobacterial plasmids. Mating experiments were performed to confirm that pMA100 could be transferred in vitro from M. avium to M. kansasii. pMA100 was transferred by in vitro conjugation not only to the M. kansasii strain from the mixed culture, but also to two other unrelated M. kansasii clinical isolates, as well as to Mycobacterium bovis BCG Moreau. Conclusions/Significance: Horizontal gene transfer (HGT) is one of most important mechanisms leading to the evolution and diversity of bacteria. This work provides evidence for the first time on the natural occurrence of HGT between different species of mycobacteria. Gene transfer, mediated by a novel conjugative plasmid, was detected and experimentally reproduced.	[da Silva Rabello, Michelle Christiane; Matsumoto, Cristianne Kayoko; Silva, Rosa Maria; Leao, Sylvia Cardoso] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil; [Paula de Almeida, Luiz Gonzaga] Lab Nacl Comp Cient, Petropolis, Brazil; [Carmen Menendez, Maria; Jesus Garcia, Maria] Univ Autonoma Madrid, Fac Med, Dept Prevent Med, Madrid, Spain; [de Oliveira, Rosangela Siqueira] Adolfo Lutz Inst, Nucleo TB & Micobacterioses, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Laboratorio Nacional de Computacao Cientifica (LNCC); Autonomous University of Madrid; Instituto Adolfo Lutz	Rabello, MCD (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil.	sylvia.leao@unifesp.br	Garcia, Maria Jesus Garcia/B-7624-2014; Leao, Sylvia/O-9637-2016; Oliveira, Rosangela/H-6960-2012; Silva, Rosa Maria/J-6931-2015; Almeida, Luiz GP/G-5829-2012; Silva, Rosa Maria/AAQ-1510-2020; Leao, Sylvia/F-4431-2012	Leao, Sylvia/0000-0003-2083-0119; Silva, Rosa Maria/0000-0002-0452-5678; Almeida, Luiz GP/0000-0002-7124-2715; Silva, Rosa Maria/0000-0002-0452-5678; Leao, Sylvia/0000-0003-2083-0119; Oliveira, Rosangela Siqueira/0000-0002-5188-8367	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP - 06/01533-9]; Cooperacion Interuniversitaria UAM-Banco Santander con America Latina (CEAL), UAM, Spain; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Cooperacion Interuniversitaria UAM-Banco Santander con America Latina (CEAL), UAM, Spain; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study received financial support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br) (FAPESP - 06/01533-9) and from Cooperacion Interuniversitaria UAM-Banco Santander con America Latina (CEAL), UAM, Spain (http://www.uam.es/ss/Satellite/es/1234886374208/listado/CEAL_(Centro_de_Estudios_de_America_Latina).htm). MCSR was the recipient of fellowships from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (www.cnpq.br) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) (www.capes.gov.br). The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer J, 1999, J CLIN MICROBIOL, V37, P442; Becq J, 2007, MOL BIOL EVOL, V24, P1861, DOI 10.1093/molbev/msm111; Bhatt A, 2002, MOL MICROBIOL, V43, P135, DOI 10.1046/j.1365-2958.2002.02722.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; CHEN CW, 1993, MOL MICROBIOL, V7, P925, DOI 10.1111/j.1365-2958.1993.tb01183.x; Coleman NV, 2003, APPL ENVIRON MICROB, V69, P6041, DOI 10.1128/AEM.69.10.6041-6046.2003; CRESPI M, 1994, J BACTERIOL, V176, P2492, DOI 10.1128/JB.176.9.2492-2501.1994; DABROCK B, 1994, APPL ENVIRON MICROB, V60, P853, DOI 10.1128/AEM.60.3.853-860.1994; EISENACH KD, 1990, J INFECT DIS, V161, P977, DOI 10.1093/infdis/161.5.977; Fang Z, 1999, J BACTERIOL, V181, P1021, DOI 10.1128/JB.181.3.1021-1024.1999; Gamieldien J, 2002, TRENDS GENET, V18, P5, DOI 10.1016/S0168-9525(01)02529-X; GORMLEY EP, 1991, J BACTERIOL, V173, P6705, DOI 10.1128/jb.173.21.6705-6708.1991; GUERRERO C, 1995, J CLIN MICROBIOL, V33, P304, DOI 10.1128/JCM.33.2.304-307.1995; Guilhot C., 1999, MYCOBACTERIA MOL BIO, P17; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Hatfull Graham F., 1994, P165; Hosted TJ, 2004, MICROBIOL-SGM, V150, P1819, DOI 10.1099/mic.0.26994-0; INDERLIED CB, 1993, CLIN MICROBIOL REV, V6, P266, DOI 10.1128/CMR.6.3.266-310.1993; JUCKER MT, 1990, AM REV RESPIR DIS, V142, P858, DOI 10.1164/ajrccm/142.4.858; Keller AP, 2002, J CLIN MICROBIOL, V40, P1869, DOI 10.1128/JCM.40.5.1869-1872.2002; Kersulyte D, 2000, J BACTERIOL, V182, P5300, DOI 10.1128/JB.182.19.5300-5308.2000; Kinsella RJ, 2003, TRENDS GENET, V19, P687, DOI 10.1016/j.tig.2003.10.001; Kirby C, 2002, MOL MICROBIOL, V43, P173, DOI 10.1046/j.1365-2958.2002.02729.x; LABERGE S, 1995, J BACTERIOL, V177, P3133, DOI 10.1128/jb.177.11.3133-3142.1995; Le Dantec C, 2001, J BACTERIOL, V183, P2157, DOI 10.1128/JB.183.7.2157-2164.2001; MAAS R, 1983, PLASMID, V10, P296, DOI 10.1016/0147-619X(83)90045-8; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Mijs W, 2002, INT J SYST EVOL MICR, V52, P1505, DOI [10.1099/ijs.0.02037-0, 10.1099/00207713-52-5-1505]; Murcia MI, 2007, FEMS MICROBIOL LETT, V272, P229, DOI 10.1111/j.1574-6968.2007.00769.x; Murcia MI, 2006, INT J SYST EVOL MICR, V56, P2049, DOI 10.1099/ijs.0.64190-0; Oliveira RS, 2003, J CLIN MICROBIOL, V41, P44, DOI 10.1128/JCM.41.1.44-49.2003; Parsons LM, 1998, MOL MICROBIOL, V28, P571, DOI 10.1046/j.1365-2958.1998.00818.x; Pestel-Caron M, 1998, J CLIN MICROBIOL, V36, P1859, DOI 10.1128/JCM.36.7.1859-1863.1998; Picardeau M, 1997, J CLIN MICROBIOL, V35, P25, DOI 10.1128/JCM.35.1.25-32.1997; Picardeau M, 1998, MICROBIOL-UK, V144, P1981, DOI 10.1099/00221287-144-7-1981; Picardeau M, 1997, J BACTERIOL, V179, P2753, DOI 10.1128/jb.179.8.2753-2756.1997; Poelarends GJ, 2000, J BACTERIOL, V182, P2191, DOI 10.1128/JB.182.8.2191-2199.2000; Rabello MCDS, 2010, J CLIN MICROBIOL, V48, P2257, DOI 10.1128/JCM.02256-09; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; Ritacco V, 1998, INT J TUBERC LUNG D, V2, P242; Rosas-Magallanes V, 2006, MOL BIOL EVOL, V23, P1129, DOI 10.1093/molbev/msj120; Roth A, 2000, J CLIN MICROBIOL, V38, P1094, DOI 10.1128/JCM.38.3.1094-1104.2000; SAKAGUCHI K, 1990, MICROBIOL REV, V54, P66, DOI 10.1128/MMBR.54.1.66-74.1990; Sambrook J., 2001, MOL CLONING LAB MANU; Shimizu S, 2001, APPL ENVIRON MICROB, V67, P2021, DOI 10.1128/AEM.67.5.2021-2028.2001; SOBY S, 1993, PLASMID, V29, P135, DOI 10.1006/plas.1993.1015; Stinear TP, 2000, J BACTERIOL, V182, P6322, DOI 10.1128/JB.182.22.6322-6330.2000; Stinear TP, 2005, MICROBIOL-SGM, V151, P683, DOI 10.1099/mic.0.27674-0; Tortoli E, 2004, INT J SYST EVOL MICR, V54, P1277, DOI 10.1099/ijs.0.02777-0; Van Soolingen D, 1998, J CLIN MICROBIOL, V36, P3051, DOI 10.1128/JCM.36.10.3051-3054.1998; Viana-Niero C, 2008, J CLIN MICROBIOL, V46, P850, DOI 10.1128/JCM.02052-07; Wang J, 2003, NAT GENET, V34, P80, DOI 10.1038/ng1139; ZOTCHEV SB, 1992, RES MICROBIOL, V143, P839, DOI 10.1016/0923-2508(92)90071-U	53	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29884	10.1371/journal.pone.0029884	http://dx.doi.org/10.1371/journal.pone.0029884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235347	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400109
J	Li, Q; Yu, CH; Yu, JH; Liu, L; Xie, SS; Li, WW; Yang, X; Fan, WB; Gai, ZT; Chen, SJ; Kato, N				Li, Qiang; Yu, Cui-Hua; Yu, Jin-Hong; Liu, Li; Xie, Shuang-Shuang; Li, Wen-Wen; Yang, Xia; Fan, Wen-Bo; Gai, Zhong-Tao; Chen, Shi-Jun; Kato, Naoya			ABO Blood Group and the Risk of Hepatocellular Carcinoma: A Case-Control Study in Patients with Chronic Hepatitis B	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; CHRONIC LIVER-DISEASE; GROWTH-FACTOR GENE; GROUP ANTIGENS; FUNCTIONAL POLYMORPHISM; ENDOTHELIAL-CELLS; CIRRHOSIS; CANCER; INFLAMMATION; ASSOCIATION	Background: Studies have observed an association between the ABO blood group and risk of certain malignancies. However, no studies of the association with hepatocellular carcinoma (HCC) risk are available. We conducted this hospital-based case-control study to examine the association with HCC in patients with chronic hepatitis B (CHB). Methods: From January 2004 to December 2008, a total of 6275 consecutive eligible patients with chronic hepatitis B virus (HBV) infection were recruited. 1105 of them were patients with HBV-related HCC and 5,170 patients were CHB without HCC. Multivariate logistic regression models were used to investigate the association between the ABO blood group and HCC risk. Results: Compared with subjects with blood type O, the adjusted odds ratio (AOR) for the association of those with blood type A and HCC risk was 1.39 [95% confidence interval (CI), 1.05-1.83] after adjusting for age, sex, type 2 diabetes, cirrhosis, hepatitis B e antigen, and HBV DNA. The associations were only statistically significant [AOR (95% CI) = 1.56(1.14-2.13)] for men, for being hepatitis B e antigen positive [AOR (95% CI) = 4.92(2.83-8.57)], for those with cirrhosis [AOR (95% CI), 1.57(1.12-2.20)], and for those with HBV DNA <= 10(5) copies/mL [AOR (95% CI), 1.58(1.04-2.42)]. Stratified analysis by sex indicated that compared with those with blood type O, those with blood type B also had a significantly high risk of HCC among men, whereas, those with blood type AB or B had a low risk of HCC among women. Conclusions: The ABO blood type was associated with the risk of HCC in Chinese patients with CHB. The association was gender-related.	[Li, Qiang; Yu, Jin-Hong; Liu, Li; Xie, Shuang-Shuang; Chen, Shi-Jun] Shandong Univ, Div Liver Dis, Jinan Infect Dis Hosp, Jinan 250100, Peoples R China; [Yu, Cui-Hua] Shandong Univ, Dept Pharm, Jinan Infect Dis Hosp, Jinan 250100, Peoples R China; [Li, Wen-Wen; Kato, Naoya] Univ Tokyo, Inst Med Sci, Unit Dis Control Genome Med, Tokyo, Japan; [Yang, Xia] Shandong Prov Hosp, Unit Hyperbar Med, Jinan, Peoples R China; [Fan, Wen-Bo] Qihe Peoples Hosp, Dept Internal Med, Unit Digest Dis, Qihe, Shandong, Peoples R China; [Gai, Zhong-Tao] Shandong Univ, Dept Infect Dis, Jinan Infect Dis Hosp, Jinan 250100, Peoples R China	Shandong University; Shandong University; University of Tokyo; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Li, Q (corresponding author), Shandong Univ, Div Liver Dis, Jinan Infect Dis Hosp, Jinan 250100, Peoples R China.	gaizhongtao@sina.com; hepatology65@yahoo.com.cn	Li, Qiang/AAS-2836-2020		Jinan Infectious Disease Hospital, Shandong University	Jinan Infectious Disease Hospital, Shandong University	This study is supported by research fund of the authors' hospital (Jinan Infectious Disease Hospital, Shandong University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Dayyeh BK, 2011, GASTROENTEROLOGY, V141, P141, DOI 10.1053/j.gastro.2011.03.045; Afdhal N, 2008, J HEPATOL, V48, P1000, DOI 10.1016/j.jhep.2008.03.009; Barbalic M, 2010, HUM MOL GENET, V19, P1863, DOI 10.1093/hmg/ddq061; Berasain C, 2009, EXP BIOL MED, V234, P713, DOI 10.3181/0901-MR-12; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; ENGELMANN B, 1992, AM J HEMATOL, V39, P239, DOI 10.1002/ajh.2830390402; Evans AA, 2002, CANCER EPIDEM BIOMAR, V11, P369; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Greenwell P, 1997, GLYCOCONJUGATE J, V14, P159, DOI 10.1023/A:1018581503164; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; Hassan MM, 2009, HEPATOLOGY, V49, P1563, DOI 10.1002/hep.22793; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Jeng JE, 2007, NEOPLASIA, V9, P987, DOI 10.1593/neo.07781; LEEUWENBERG JFM, 1992, IMMUNOLOGY, V77, P543; Leevy CM, 1994, DIS LIVER BILIARY TR, P61; Li Q, 2007, HEPATOL INT, V1, pO; LOTAN R, 1988, J CELL BIOCHEM, V37, P107, DOI 10.1002/jcb.240370110; Lu SN, 2006, CANCER-AM CANCER SOC, V107, P2212, DOI 10.1002/cncr.22242; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Moriyama M, 2006, INTERVIROLOGY, V49, P327, DOI 10.1159/000095152; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; OKADA Y, 1987, J NATL CANCER I, V78, P19, DOI 10.1093/jnci/78.1.19; Otto VI, 2006, GLYCOBIOLOGY, V16, P1033, DOI 10.1093/glycob/cwl032; Pare G, 2008, PLOS GENET, V4; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Paterson AD, 2009, ARTERIOSCL THROM VAS, V29, P1958, DOI 10.1161/ATVBAHA.109.192971; Polgar J, 2005, J THROMB HAEMOST, V3, P1590, DOI 10.1111/j.1538-7836.2005.01373.x; Poujol-Robert A, 2006, DIGEST DIS SCI, V51, P1633, DOI 10.1007/s10620-006-9121-5; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Ravn V, 2000, APMIS, V108, P1, DOI 10.1034/j.1600-0463.2000.d01-1.x; Ripoche J, 2011, CLIN RES HEPATOL GAS, V35, P353, DOI 10.1016/j.clinre.2011.02.012; Schattenberg JM, 2011, J GASTROEN HEPATOL, V26, P213, DOI 10.1111/j.1440-1746.2010.06582.x; Schram MT, 2003, DIABETES CARE, V26, P2165, DOI 10.2337/diacare.26.7.2165; Sherman M, 2010, DIGEST LIVER DIS, V42, pS215, DOI 10.1016/S1590-8658(10)60508-7; SHIMIZU Y, 1995, HEPATOLOGY, V22, P525; Song YQ, 2007, DIABETES, V56, P1898, DOI 10.2337/db07-0250; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; Tanabe KK, 2008, JAMA-J AM MED ASSOC, V299, P53, DOI 10.1001/jama.2007.65; TERADA T, 1991, HUM PATHOL, V22, P486, DOI 10.1016/0046-8177(91)90136-D; TREVISANI F, 1993, CANCER, V72, P1557, DOI 10.1002/1097-0142(19930901)72:5<1557::AID-CNCR2820720512>3.0.CO;2-5; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yang Y, 2002, CHINESE FOOD COMPOST; Yu MC, 2004, GASTROENTEROLOGY, V127, pS72, DOI 10.1016/j.gastro.2004.09.018; Zhou XD, 2001, CANCER-AM CANCER SOC, V91, P1479, DOI 10.1002/1097-0142(20010415)91:8<1479::AID-CNCR1155>3.0.CO;2-0; ZOHRENS G, 1993, HEPATOLOGY, V18, P798, DOI 10.1002/hep.1840180408	51	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29928	10.1371/journal.pone.0029928	http://dx.doi.org/10.1371/journal.pone.0029928			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235351	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400113
J	Tuni, C; Goodacre, S; Bechsgaard, J; Bilde, T				Tuni, Cristina; Goodacre, Sara; Bechsgaard, Jesper; Bilde, Trine			Moderate Multiple Parentage and Low Genetic Variation Reduces the Potential for Genetic Incompatibility Avoidance Despite High Risk of Inbreeding	PLOS ONE			English	Article							STEGODYPHUS-LINEATUS ARANEAE; SEXUAL SELECTION; MATE CHOICE; MOLECULAR EVIDENCE; COMPUTER-PROGRAM; SPERM SELECTION; SPIDER; EVOLUTION; POLYANDRY; FEMALES	Background: Polyandry is widespread throughout the animal kingdom. In the absence of direct benefits of mating with different males, the underlying basis for polyandry is enigmatic because it can carry considerable costs such as elevated exposure to sexual diseases, physical injury or other direct fitness costs. Such costs may be balanced by indirect genetic benefits to the offspring of polyandrous females. We investigated polyandry and patterns of parentage in the spider Stegodyphus lineatus. This species experiences relatively high levels of inbreeding as a result of its spatial population structure, philopatry and limited male mating dispersal. Polyandry may provide an opportunity for post mating inbreeding avoidance that reduces the risk of genetic incompatibilities arising from incestuous matings. However, multiple mating carries direct fitness costs to females suggesting that genetic benefits must be substantial to counter direct costs. Methodology/Principal Findings: Genetic parentage analyses in two populations from Israel and a Greek island, showed mixed-brood parentage in approximately 50% of the broods. The number of fathers ranged from 1-2 indicating low levels of multiple parentage and there was no evidence for paternity bias in mixed-broods from both populations. Microsatellite loci variation suggested limited genetic variation within populations, especially in the Greek island population. Relatedness estimates among females in the maternal generation and potentially interacting individuals were substantial indicating full-sib and half-sib relationships. Conclusions/Significance: Three lines of evidence indicate limited potential to obtain substantial genetic benefits in the form of reduced inbreeding. The relatively low frequency of multiple parentage together with low genetic variation among potential mates and the elevated risk of mating among related individuals as corroborated by our genetic data suggest that there are limited actual outbreeding opportunities for polyandrous females. Polyandry in S. lineatus is thus unlikely to be maintained through adaptive female choice.	[Tuni, Cristina; Bechsgaard, Jesper; Bilde, Trine] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Goodacre, Sara] Univ Nottingham, Inst Genet, Nottingham NG7 2RD, England; [Goodacre, Sara] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England	Aarhus University; University of Nottingham; University of Nottingham	Tuni, C (corresponding author), Aarhus Univ, Dept Biosci, Aarhus, Denmark.	cristina.tuni@biology.au.dk	Bilde, Trine/J-2872-2013; Bilde, Trine/AAS-2098-2020	Bilde, Trine/0000-0002-0341-161X; Bilde, Trine/0000-0002-0341-161X; Goodacre, Sara L./0000-0002-0887-6563	Danish Research Council	Danish Research Council(Det Frie Forskningsrad (DFF))	This study was funded by the Danish Research Council to TB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 2005, AM NAT, V165, pS26, DOI 10.1086/429350; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist Goran, 2005, pUnpaginated; Bilde T, 2005, EVOLUTION, V59, P160, DOI 10.1111/j.0014-3820.2005.tb00903.x; Bilde T, 2009, MOL ECOL RESOUR, V9, P128, DOI 10.1111/j.1755-0998.2008.02296.x; Bilde T, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-295; Birkhead TR, 1998, SPERM COMPETITION SE; Bretman A, 2005, MOL ECOL, V14, P2169, DOI 10.1111/j.1365-294X.2005.02556.x; Bretman A, 2004, P ROY SOC B-BIOL SCI, V271, P159, DOI 10.1098/rspb.2003.2563; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; DALY M, 1978, AM NAT, V112, P771, DOI 10.1086/283319; Emery AM, 2001, MOL ECOL, V10, P1265, DOI 10.1046/j.1365-294X.2001.01258.x; Erez T, 2005, ETHOLOGY, V111, P693, DOI 10.1111/j.1439-0310.2005.01090.x; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; Fromhage L, 2009, EVOLUTION, V63, P684, DOI 10.1111/j.1558-5646.2008.00575.x; Garcia-Gonzalez F, 2005, J EVOLUTION BIOL, V18, P1097, DOI 10.1111/j.1420-9101.2005.00889.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Griffith SC, 2002, MOL ECOLOGY, V11; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Houle D, 2002, P ROY SOC B-BIOL SCI, V269, P97, DOI 10.1098/rspb.2001.1823; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jensen MP, 2006, MOL ECOL, V15, P2567, DOI 10.1111/j.1365-294X.2006.02951.x; Johannesen J, 1999, HEREDITY, V82, P677, DOI 10.1046/j.1365-2540.1999.00528.x; Johannesen J, 2001, J ARACHNOL, V29, P413, DOI 10.1636/0161-8202(2001)029[0413:EFKSGF]2.0.CO;2; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Knell RJ, 2004, BIOL REV, V79, P557, DOI 10.1017/S1464793103006365; Maklakov AA, 2005, AM NAT, V165, pS38, DOI 10.1086/429351; Maklakov AA, 2004, EVOLUTION, V58, P1135; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; Neff BD, 2002, J FISH BIOL, V61, P739, DOI 10.1111/j.1095-8649.2002.tb00908.x; Newcomer SD, 1999, P NATL ACAD SCI USA, V96, P10236, DOI 10.1073/pnas.96.18.10236; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; Petrie M, 1998, P NATL ACAD SCI USA, V95, P9390, DOI 10.1073/pnas.95.16.9390; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Puurtinen M, 2005, TRENDS ECOL EVOL, V20, P157, DOI 10.1016/j.tree.2005.02.005; Ramirez MG, 2009, J ARACHNOL, V37, P375, DOI 10.1636/Hi09-04SC.1; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Schneider JM, 1997, OIKOS, V79, P92, DOI 10.2307/3546094; Schneider JM, 1997, BIOL J LINN SOC, V60, P517; Schneider JM, 1996, NATURE, V381, P655, DOI 10.1038/381655a0; Schneider JM, 1997, ANIM BEHAV, V54, P305, DOI 10.1006/anbe.1996.0454; Sefc KM, 2009, J HERED, V100, P197, DOI 10.1093/jhered/esn095; Simmons LW, 2008, J HERED, V99, P610, DOI 10.1093/jhered/esn053; Simmons LW, 2006, MOL ECOL, V15, P3817, DOI 10.1111/j.1365-294X.2006.03035.x; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Simmons LW, 2007, MOL ECOLOGY, V16; Thornhill R., 1983, pi; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Villesen Palle, 2006, BMC Ecology, V6, P8, DOI 10.1186/1472-6785-6-8; Wade MJ, 2003, AM NAT, V162, P403, DOI 10.1086/378211; Yasui Y, 1997, AM NAT, V149, P573, DOI 10.1086/286006; Zeh JA, 2003, ETHOLOGY, V109, P929, DOI 10.1046/j.1439-0310.2003.00945.x; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250	61	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29636	10.1371/journal.pone.0029636	http://dx.doi.org/10.1371/journal.pone.0029636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235316	Green Published, gold			2022-12-27	WOS:000301123400078
J	Wolk, B; Trautwein, C; Buchele, B; Kersting, N; Blum, HE; Rammensee, HG; Cerny, A; Stevanovic, S; Moradpour, D; Brass, V				Woelk, Benno; Trautwein, Claudia; Buechele, Benjamin; Kersting, Nadine; Blum, Hubert E.; Rammensee, Hans-Georg; Cerny, Andreas; Stevanovic, Stefan; Moradpour, Darius; Brass, Volker			Identification of Naturally Processed Hepatitis C Virus-Derived Major Histocompatibility Complex Class I Ligands	PLOS ONE			English	Article							ADAPTIVE IMMUNE-RESPONSES; CELL-LINES; MEMBRANE ASSOCIATION; DETERMINANTS; INFECTION; PROTEINS; EPITOPES	Fine mapping of human cytotoxic T lymphocyte (CTL) responses against hepatitis C virus (HCV) is based on external loading of target cells with synthetic peptides which are either derived from prediction algorithms or from overlapping peptide libraries. These strategies do not address putative host and viral mechanisms which may alter processing as well as presentation of CTL epitopes. Therefore, the aim of this proof-of-concept study was to identify naturally processed HCV-derived major histocompatibility complex (MHC) class I ligands. To this end, continuous human cell lines were engineered to inducibly express HCV proteins and to constitutively express high levels of functional HLA-A2. These cell lines were recognized in an HLA-A2-restricted manner by HCV-specific CTLs. Ligands eluted from HLA-A2 molecules isolated from large-scale cultures of these cell lines were separated by high performance liquid chromatography and further analyzed by electrospray ionization quadrupole time of flight mass spectrometry (MS)/tandem MS. These analyses allowed the identification of two HLA-A2-restricted epitopes derived from HCV nonstructural proteins (NS) 3 and 5B (NS3(1406-1415) and NS5B(2594-2602)). In conclusion, we describe a general strategy that may be useful to investigate HCV pathogenesis and may contribute to the development of preventive and therapeutic vaccines in the future.	[Woelk, Benno; Buechele, Benjamin; Kersting, Nadine; Blum, Hubert E.; Moradpour, Darius; Brass, Volker] Univ Freiburg, Dept Med 2, D-79106 Freiburg, Germany; [Woelk, Benno] Hannover Med Sch, Inst Virol, D-3000 Hannover, Germany; [Trautwein, Claudia; Rammensee, Hans-Georg; Stevanovic, Stefan] Univ Tubingen, Dept Immunol, Tubingen, Germany; [Cerny, Andreas] Univ Bern, Inselspital, CH-3010 Bern, Switzerland; [Moradpour, Darius] Univ Lausanne, Div Gastroenterol & Hepatol, Ctr Hosp Univ Vaudois, Lausanne, Switzerland	University of Freiburg; Hannover Medical School; Eberhard Karls University of Tubingen; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Wolk, B (corresponding author), Univ Freiburg, Dept Med 2, Hugstetter Str 55, D-79106 Freiburg, Germany.	volker.brass@uniklinik-freiburg.de	Moradpour, Darius/G-7918-2017	Moradpour, Darius/0000-0003-1977-6792	German Bundesministerium fur Bildung und Forschung [01 KI 9951]; European Commission [QLK2-CT1999-00356, QLK2-CT2002-01329]; Swiss National Science Fondation [SNF 3200B0-103874, SNF 31003A-138484]; European Union; Deutsche Forschungsgemeinschaft [Forschergruppe FOR 1202, BR 3440/2-1, SFB 900]	German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Fondation(Swiss National Science Foundation (SNSF)); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	German Bundesministerium fur Bildung und Forschung (01 KI 9951) European Commission (QLK2-CT1999-00356 and QLK2-CT2002-01329) Swiss National Science Fondation (SNF 3200B0-103874) European Union INTERREG-IV-2009-FEDER-Hepato-Regio-Net Deutsche Forschungsgemeinschaft (Forschergruppe FOR 1202) Swiss National Science Foundation (SNF 31003A-138484) Deutsche Forschungsgemeinschaft (BR 3440/2-1) Deutsche Forschungsgemeinschaft (SFB 900) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NATURE, V474, pS1; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; CERNY A, 1995, J CLIN INVEST, V95, P521, DOI 10.1172/JCI117694; Crotzer VL, 2000, J IMMUNOL, V164, P6120, DOI 10.4049/jimmunol.164.12.6120; Gremion C, 2004, J VIROL, V78, P2152, DOI 10.1128/JVI.78.4.2152-2157.2004; Hillen N, 2006, EXPERT REV PROTEOMIC, V3, P653, DOI 10.1586/14789450.3.6.653; Jo J, 2009, GASTROENTEROLOGY, V136, P1391, DOI 10.1053/j.gastro.2008.12.034; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Lemmel C, 2004, NAT BIOTECHNOL, V22, P450, DOI 10.1038/nbt947; Miller FD, 2010, P NATL ACAD SCI USA, V107, P14757, DOI 10.1073/pnas.1008877107; Moradpour D, 1998, HEPATOLOGY, V28, P192, DOI 10.1002/hep.510280125; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Schmidt-Mende J, 2001, J BIOL CHEM, V276, P44052, DOI 10.1074/jbc.M103358200; Seeff LB, 2000, TRANSFUSION, V40, P1161, DOI 10.1046/j.1537-2995.2000.40101161.x; Stickel JS, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-1; Tellam J, 2007, J EXP MED, V204, P525, DOI 10.1084/jem.20062508; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Thimme R, 2008, BIOL CHEM, V389, P457, DOI 10.1515/BC.2008.061; Walker CM, 2010, ADV VIRUS RES, V78, P43, DOI 10.1016/S0065-3527(10)78002-7; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000	21	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29286	10.1371/journal.pone.0029286	http://dx.doi.org/10.1371/journal.pone.0029286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235280	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400041
J	Yao, C; Li, HD; Shen, XP; He, Z; He, L; Guo, Z				Yao, Chen; Li, Hongdong; Shen, Xiaopei; He, Zheng; He, Lang; Guo, Zheng			Reproducibility and Concordance of Differential DNA Methylation and Gene Expression in Cancer	PLOS ONE			English	Article							SAMPLE-SIZE; MICROARRAY; LEUKEMIA; IDENTIFICATION; NORMALIZATION; DISCOVERIES; PREDICTION; SIGNATURE; CONTRAST; DATABASE	Background: Hundreds of genes with differential DNA methylation of promoters have been identified for various cancers. However, the reproducibility of differential DNA methylation discoveries for cancer and the relationship between DNA methylation and aberrant gene expression have not been systematically analysed. Methodology/Principal Findings: Using array data for seven types of cancers, we first evaluated the effects of experimental batches on differential DNA methylation detection. Second, we compared the directions of DNA methylation changes detected from different datasets for the same cancer. Third, we evaluated the concordance between methylation and gene expression changes. Finally, we compared DNA methylation changes in different cancers. For a given cancer, the directions of methylation and expression changes detected from different datasets, excluding potential batch effects, were highly consistent. In different cancers, DNA hypermethylation was highly inversely correlated with the down-regulation of gene expression, whereas hypomethylation was only weakly correlated with the up-regulation of genes. Finally, we found that genes commonly hypomethylated in different cancers primarily performed functions associated with chronic inflammation, such as 'keratinization', 'chemotaxis' and 'immune response'. Conclusions: Batch effects could greatly affect the discovery of DNA methylation biomarkers. For a particular cancer, both differential DNA methylation and gene expression can be reproducibly detected from different studies with no batch effects. While DNA hypermethylation is significantly linked to gene down-regulation, hypomethylation is only weakly correlated with gene up-regulation and is likely to be linked to chronic inflammation.	[Yao, Chen; Li, Hongdong; Shen, Xiaopei; He, Zheng; He, Lang; Guo, Zheng] Univ Elect Sci & Technol China, Sch Life Sci, Bioinformat Ctr, Chengdu 610054, Peoples R China; [Yao, Chen; Li, Hongdong; Shen, Xiaopei; He, Zheng; He, Lang; Guo, Zheng] Univ Elect Sci & Technol China, Sch Life Sci, Educ Minist China, Key Lab NeuroInfomat, Chengdu 610054, Peoples R China; [Guo, Zheng] Harbin Med Univ, Coll Bioinformat Sci, Harbin, Peoples R China; [Guo, Zheng] Harbin Med Univ, Coll Bioinformat Technol, Harbin, Peoples R China	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China; Harbin Medical University; Harbin Medical University	Yao, C (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci, Bioinformat Ctr, Chengdu 610054, Peoples R China.	guoz@ems.hrbmu.edu.cn	Shen, Xiaopei/B-2773-2017	Shen, Xiaopei/0000-0002-0004-4228	National Natural Science Foundation of China [30370388, 81071646, 91029717]; Excellent Youth Foundation of Heilongjiang Province [JC200808]; Natural Science Foundation of Heilongjiang Province of China [QC2010012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province)	This work was supported by the National Natural Science Foundation of China (grant No: 30370388, 81071646, 91029717, URL: http://www.nsfc.gov.cn/Portal0/default152.htm), Excellent Youth Foundation of Heilongjiang Province (grant No. JC200808, URL: http://jj.hljkj.cn/qn/) and Natural Science Foundation of Heilongjiang Province of China (grant: QC2010012, URL: http://jj.hljkj.cn/zr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bediaga NG, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2721; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Calza S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-140; Carvajal-Rodriguez A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-209; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; De Bock M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/906082; Deng DJ, 2010, ADV GENET, V71, P125, DOI [10.1016/S0065-2660(10)71005-1, 10.1016/B978-0-12-380864-6.00005-5]; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; GASCHE JA, 2010, INT J CANC; Gong X, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-76; Grunau C, 2001, NUCLEIC ACIDS RES, V29, P270, DOI 10.1093/nar/29.1.270; Gupta S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-72; Hogan JM, 2006, OMICS, V10, P152, DOI 10.1089/omi.2006.10.152; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Kanduri M, 2010, BLOOD, V115, P296, DOI 10.1182/blood-2009-07-232868; Kim SY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-147; Lee MLT, 2002, STAT MED, V21, P3543, DOI 10.1002/sim.1335; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Lugthart S, 2011, BLOOD, V117, P234, DOI 10.1182/blood-2010-04-281337; Melnikov A, 2009, J MOL DIAGN, V11, P60, DOI 10.2353/jmoldx.2009.080072; Moody SE, 2010, CURR OPIN MOL THER, V12, P284; Movassagh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008564; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; O'Riain C, 2009, LEUKEMIA, V23, P1858, DOI 10.1038/leu.2009.114; Poon TCW, 2007, EXPERT REV PROTEOMIC, V4, P51, DOI 10.1586/14789450.4.1.51; Reinert T, 2011, CLIN CANCER RES, V17, P5582, DOI 10.1158/1078-0432.CCR-10-2659; Sadikovic B, 2009, HUM MOL GENET, V18, P1962, DOI 10.1093/hmg/ddp117; Shaknovich R, 2010, BLOOD, V116, pE81, DOI 10.1182/blood-2010-05-285320; Taylor KH, 2007, CANCER RES, V67, P2617, DOI 10.1158/0008-5472.CAN-06-3993; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ushijima T, 2010, CANCER SCI, V101, P300, DOI 10.1111/j.1349-7006.2009.01434.x; Wiedemeyer WR, 2010, P NATL ACAD SCI USA, V107, P11501, DOI 10.1073/pnas.1001613107; Yao CQ, 2010, PROTEOM CLIN APPL, V4, P4, DOI 10.1002/prca.200900050; Zernecke A, 2010, CARDIOVASC RES, V86, P192, DOI 10.1093/cvr/cvp391; Zhang M, 2008, BIOINFORMATICS, V24, P2057, DOI 10.1093/bioinformatics/btn365; Zhang M, 2009, BIOINFORMATICS, V25, P1662, DOI 10.1093/bioinformatics/btp295; Zhao YD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-28	43	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29686	10.1371/journal.pone.0029686	http://dx.doi.org/10.1371/journal.pone.0029686			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235325	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400087
J	Alonso-Peral, MM; Oliver, SN; Casao, MC; Greenup, AA; Trevaskis, B				Alonso-Peral, Maria M.; Oliver, Sandra N.; Cristina Casao, M.; Greenup, Aaron A.; Trevaskis, Ben			The Promoter of the Cereal VERNALIZATION1 Gene Is Sufficient for Transcriptional Induction by Prolonged Cold	PLOS ONE			English	Article							OPEN READING FRAMES; VEGETATIVE-PHASE; MOLECULAR-BASIS; BARLEY; EXPRESSION; TRANSITION; DAYLENGTH; UPSTREAM; VRN1; REPRESSOR	The VERNALIZATION1 (VRN1) gene of temperate cereals is transcriptionally activated by prolonged cold during winter (vernalization) to promote flowering. To investigate the mechanisms controlling induction of VRN1 by prolonged cold, different regions of the VRN1 gene were fused to the GREEN FLUORESCENT PROTEIN (GFP) reporter and expression of the resulting gene constructs was assayed in transgenic barley (Hordeum vulgare). A 2 kb segment of the promoter of VRN1 was sufficient for GFP expression in the leaves and shoot apex of transgenic barley plants. Fluorescence increased at the shoot apex prior to inflorescence initiation and was subsequently maintained in the developing inflorescence. The promoter was also sufficient for low-temperature induction of GFP expression. A naturally occurring insertion in the proximal promoter, which is associated with elevated VRN1 expression and early flowering in some spring wheats, did not abolish induction of VRN1 transcription by prolonged cold, however. A translational fusion of the promoter and transcribed regions of VRN1 to GFP, VRN1:: GFP, was localised to nuclei of cells at the shoot apex of transgenic barley plants. The distribution of VRN1:: GFP at the shoot apex was similar to the expression pattern of the VRN1 promoter-GFP reporter gene. Fluorescence from the VRN1:: GFP fusion protein increased in the developing leaves after prolonged cold treatment. These observations suggest that the promoter of VRN1 is targeted by mechanisms that trigger vernalization-induced flowering in economically important temperate cereal crops.	[Alonso-Peral, Maria M.; Oliver, Sandra N.; Cristina Casao, M.; Greenup, Aaron A.; Trevaskis, Ben] Commonwealth Sci & Ind Res Org, Div Plant Ind, Canberra, ACT, Australia; [Cristina Casao, M.] CSIC, Aula Expt Stn, Dept Genet & Plant Prod, Zaragoza, Aragon, Spain	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Aula Dei (EEAD)	Alonso-Peral, MM (corresponding author), Commonwealth Sci & Ind Res Org, Div Plant Ind, Canberra, ACT, Australia.	Ben.Trevaskis@csiro.au	Trevaskis, Ben/B-5350-2011; Alonso Peral, Maria/C-5123-2011	Trevaskis, Ben/0000-0001-7277-4994; 	Commonwealth Scientific and Industrial Research Organisation Office of the Chief Executive; Australian Grains Research and Development Corporation [CSP00131]	Commonwealth Scientific and Industrial Research Organisation Office of the Chief Executive(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Grains Research and Development Corporation(Grains R&D Corp)	This research was funded by a Commonwealth Scientific and Industrial Research Organisation Office of the Chief Executive postdoctoral fellowship to SNO, then MMA-P. Near-isogenic wheat lines were developed in the project CSP00131, funded by the Australian Grains Research and Development Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; CHOUARD P, 1960, ANNU REV PLANT PHYS, V11, P191, DOI 10.1146/annurev.pp.11.060160.001203; Cockram J, 2007, THEOR APPL GENET, V115, P993, DOI 10.1007/s00122-007-0626-x; Danilevskaya ON, 2008, PLANT PHYSIOL, V147, P2054, DOI 10.1104/pp.107.115261; Danyluk J, 2003, PLANT PHYSIOL, V132, P1849, DOI 10.1104/pp.103.023523; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Distelfeld A, 2010, MOL GENET GENOMICS, V283, P223, DOI 10.1007/s00438-009-0510-2; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Golovnina KA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-168; Greenup A, 2009, ANN BOT-LONDON, V103, P1165, DOI 10.1093/aob/mcp063; Greenup AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017900; Greenup AG, 2010, PLANT PHYSIOL, V153, P1062, DOI 10.1104/pp.109.152488; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Hemming MN, 2009, MOL GENET GENOMICS, V282, P107, DOI 10.1007/s00438-009-0449-3; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Jensen LB, 2005, THEOR APPL GENET, V110, P527, DOI 10.1007/s00122-004-1865-8; Kane NA, 2007, PLANT J, V51, P670, DOI 10.1111/j.1365-313X.2007.03172.x; Li CX, 2008, PLANT J, V55, P543, DOI 10.1111/j.1365-313X.2008.03526.x; Matthews PR, 2001, MOL BREEDING, V7, P195, DOI 10.1023/A:1011333321893; Murai K, 2003, PLANT CELL PHYSIOL, V44, P1255, DOI 10.1093/pcp/pcg171; Oliver SN, 2009, P NATL ACAD SCI USA, V106, P8386, DOI 10.1073/pnas.0903566106; Pidal B, 2009, J HERED, V100, P355, DOI 10.1093/jhered/esp002; Preston JC, 2008, PLANT PHYSIOL, V146, P265, DOI 10.1104/pp.107.109561; Sasani S, 2009, J EXP BOT, V60, P2169, DOI 10.1093/jxb/erp098; Schmitz J, 2000, PLANT MOL BIOL, V42, P899, DOI 10.1023/A:1006425619953; Seppanen MM, 2010, ANN BOT-LONDON, V106, P697, DOI 10.1093/aob/mcq174; Shitsukawa N, 2007, GENES GENET SYST, V82, P167, DOI 10.1266/ggs.82.167; Stockinger EJ, 2007, PLANT J, V51, P308, DOI 10.1111/j.1365-313X.2007.0141.x; Szucs P, 2007, MOL GENET GENOMICS, V277, P249, DOI 10.1007/s00438-006-0195-8; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Tingay S, 1997, PLANT J, V11, P1369, DOI 10.1046/j.1365-313X.1997.11061369.x; Trevaskis B, 2006, PLANT PHYSIOL, V140, P1397, DOI 10.1104/pp.105.073486; Trevaskis B, 2003, P NATL ACAD SCI USA, V100, P13099, DOI 10.1073/pnas.1635053100; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Trevaskis B, 2007, PLANT PHYSIOL, V143, P225, DOI 10.1104/pp.106.090860; Trevaskis B, 2010, FUNCT PLANT BIOL, V37, P479, DOI 10.1071/FP10056; von Zitzewitz J, 2005, PLANT MOL BIOL, V59, P449, DOI 10.1007/s11103-005-0351-2; Wang MB, 1998, ACTA HORTIC, P401, DOI 10.17660/ActaHortic.1998.461.46; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan L, 2004, THEOR APPL GENET, V109, P1677, DOI 10.1007/s00122-004-1796-4; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305	41	32	32	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29456	10.1371/journal.pone.0029456	http://dx.doi.org/10.1371/journal.pone.0029456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242122	gold, Green Published, Green Submitted			2022-12-27	WOS:000300677000035
J	Kang, J; Kim, J; Choi, KW				Kang, Jongkyun; Kim, Jaeseob; Choi, Kwang-Wook			Novel Cytochrome P450, cyp6a17, Is Required for Temperature Preference Behavior in Drosophila	PLOS ONE			English	Article							P450 ENZYMES; ECDYSONE; STRESS; MELANOGASTER; HOMEOSTASIS; PATHWAY; SYSTEMS	Perception of temperature is an important brain function for organisms to survive. Evidence suggests that temperature preference behavior (TPB) in Drosophila melanogaster, one of poikilothermal animals, is regulated by cAMP-dependent protein kinase (PKA) signaling in mushroom bodies of the brain. However, downstream targets for the PKA signaling in this behavior have not been identified. From a genome-wide search for the genes regulated by PKA activity in the mushroom bodies, we identified the cyp6a17 Cytochrome P450 gene as a new target for PKA. Our detailed analysis of mutants by genetic, molecular and behavioral assays shows that cyp6a17 is essential for temperature preference behavior. cyp6a17 expression is enriched in the mushroom bodies of the adult brain. Tissue-specific knockdown and rescue experiments demonstrate that cyp6a17 is required in the mushroom bodies for normal temperature preference behavior. This is the first study, to our knowledge, to show PKA-dependent expression of a cytochrome P450 gene in the mushroom bodies and its role as a key factor for temperature preference behavior. Taken together, this study reveals a new PKA-Cytochrome P450 pathway that regulates the temperature preference behavior.	[Kang, Jongkyun; Choi, Kwang-Wook] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Kim, Jaeseob] Aprogen Inc, Taejon, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Kang, J (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	kchoi100@kaist.ac.kr	Kang, Jongkyun/AAT-7581-2021; Choi, Kwang-Wook/C-1707-2011	Kang, Jongkyun/0000-0003-0259-110X; Choi, Kwang-Wook/0000-0002-8997-3065	World Class University through the National Research Foundation of Korea; Ministry of Education, Science Technology [R31-2008-000-10071-0]	World Class University through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by grants from the World Class University Program through the National Research Foundation of Korea funded by the Ministry of Education, Science & Technology, contract grant number R31-2008-000-10071-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando M, 1997, ENVIRON HEALTH PERSP, V105, P726, DOI 10.2307/3433728; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; Clark Andrew G., 1997, EXS, V83, P117; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Degtyarenko KN, 2001, BIOCHEM SOC T, V29, P139, DOI 10.1042/BST0290139; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Fujii S, 2008, GENETICS, V180, P179, DOI 10.1534/genetics.108.089177; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Hartenstein V, 2006, J ENDOCRINOL, V190, P555, DOI 10.1677/joe.1.06964; Hong ST, 2008, NATURE, V454, P771, DOI 10.1038/nature07090; Hong ST, 2006, J NEUROSCI, V26, P7245, DOI 10.1523/JNEUROSCI.5426-05.2006; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; Mansuy D, 1998, COMP BIOCHEM PHYS C, V121, P5, DOI 10.1016/S0742-8413(98)10026-9; Martin JR, 1998, LEARN MEMORY, V5, P179; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; NEBERT DW, 1991, MOL ENDOCRINOL, V5, P1203, DOI 10.1210/mend-5-9-1203; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Pedersen KS, 2008, GENETICS, V180, P1233, DOI 10.1534/genetics.108.089144; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x; Snyder MJ, 2001, ARCH ENVIRON CON TOX, V41, P22; Takeuchi K, 2009, SCIENCE, V323, P1740, DOI 10.1126/science.1165712; Thum AS, 2007, J NEUROSCI, V27, P11132, DOI 10.1523/JNEUROSCI.2712-07.2007; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Wang LM, 2008, P NATL ACAD SCI USA, V105, P5657, DOI 10.1073/pnas.0801327105; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194	39	76	89	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29800	10.1371/journal.pone.0029800	http://dx.doi.org/10.1371/journal.pone.0029800			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216356	Green Submitted, Green Published			2022-12-27	WOS:000300676300084
J	Melo, FHM; Butera, D; Junqueira, MD; Hsu, DK; da Silva, AMM; Liu, FT; Santos, MF; Chammas, R				Melo, Fabiana H. M.; Butera, Diego; Junqueira, Mara de Souza; Hsu, Daniel K.; Moura da Silva, Ana Maria; Liu, Fu-Tong; Santos, Marinilice F.; Chammas, Roger			The Promigratory Activity of the Matricellular Protein Galectin-3 Depends on the Activation of PI-3 Kinase	PLOS ONE			English	Article							FOCAL ADHESION KINASE; BREAST-CARCINOMA CELLS; N-GLYCOSYLATION; TYROSINE PHOSPHORYLATION; MESSENGER-RNA; IN-VITRO; EXPRESSION; INTEGRIN; SECRETION; MIGRATION	Expression of galectin-3 is associated with sarcoma progression, invasion and metastasis. Here we determined the role of extracellular galectin-3 on migration of sarcoma cells on laminin-111. Cell lines from methylcholanthrene-induced sarcomas from both wild type and galectin-3(-/-) mice were established. Despite the presence of similar levels of laminin-binding integrins on the cell surface, galectin-3(-/-) sarcoma cells were more adherent and less migratory than galectin-3+/+ sarcoma cells on laminin-111. When galectin-3 was transiently expressed in galectin-3(-/-) sarcoma cells, it inhibited cell adhesion and stimulated the migratory response to laminin in a carbohydrate-dependent manner. Extracellular galectin-3 led to the recruitment of SHP-2 phosphatase to focal adhesion plaques, followed by a decrease in the amount of phosphorylated FAK and phospho-paxillin in the lamellipodia of migrating cells. The promigratory activity of extracellular galectin-3 was inhibitable by wortmannin, implicating the activation of a PI-3 kinase dependent pathway in the galectin-3 triggered disruption of adhesion plaques, leading to sarcoma cell migration on laminin-111.	[Melo, Fabiana H. M.; Butera, Diego; Junqueira, Mara de Souza; Chammas, Roger] Univ Sao Paulo, Fac Med, Dept Radiol & Oncol, Sao Paulo, Brazil; [Butera, Diego; Moura da Silva, Ana Maria] Inst Butantan, Lab Imunopatol, Sao Paulo, Brazil; [Hsu, Daniel K.; Liu, Fu-Tong] Univ Calif Davis, Dept Dermatol, Davis, CA 95616 USA; [Santos, Marinilice F.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, BR-05508 Sao Paulo, Brazil; [Chammas, Roger] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto Butantan; University of California System; University of California Davis; Universidade de Sao Paulo	Melo, FHM (corresponding author), Univ Sao Paulo, Fac Med, Dept Radiol & Oncol, Sao Paulo, Brazil.	rchammas@lim24.fm.usp.br	Chammas, Roger/A-8004-2011; Santos, Marinilce F/G-9548-2011; Terapia celular, Cepid/I-4398-2013; Melo, Fabiana/M-6460-2013; Junqueira, Mara/AFL-8107-2022; da Silva, Ana/GXH-4851-2022; de Melo, Fabiana Henriques Machado/AAG-3096-2021; Junqueira, Mara/AAG-8053-2022; Liu, FU-TONG/A-5749-2019	Chammas, Roger/0000-0003-0342-8726; Santos, Marinilce F/0000-0002-3257-3327; Liu, FU-TONG/0000-0002-3354-1001; Junqueira, Mara de Souza/0000-0002-2404-6543	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP-Proc. 98/14247-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This project was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Proc. 98/14247-6) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; AVNUR Z, 1981, J MOL BIOL, V153, P361, DOI 10.1016/0022-2836(81)90283-7; Baptiste TA, 2007, EXP CELL RES, V313, P652, DOI 10.1016/j.yexcr.2006.11.005; BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0; Bresalier RS, 1997, CANCER, V80, P776; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Califice S, 2004, ONCOGENE, V23, P7527, DOI 10.1038/sj.onc.1207997; Cao ZY, 2002, J BIOL CHEM, V277, P42299, DOI 10.1074/jbc.M200981200; Carpi A, 2010, J CELL PHYSIOL, V224, P612, DOI 10.1002/jcp.22187; CHAMMAS R, 1993, P NATL ACAD SCI USA, V90, P1795, DOI 10.1073/pnas.90.5.1795; Danguy A, 2002, BBA-GEN SUBJECTS, V1572, P285, DOI 10.1016/S0304-4165(02)00315-X; de Melo FHM, 2007, J HISTOCHEM CYTOCHEM, V55, P1015, DOI 10.1369/jhc.7A7174.2007; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Friedrichs J, 2008, J BIOL CHEM, V283, P32264, DOI 10.1074/jbc.M803634200; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Goetz JG, 2009, CELL ADHES MIGR, V3, P185, DOI 10.4161/cam.3.2.7295; Gong HC, 1999, CANCER RES, V59, P6239; Granovsky M, 2000, NAT MED, V6, P306; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Gray RM, 2008, ARCH BIOCHEM BIOPHYS, V475, P100, DOI 10.1016/j.abb.2008.04.010; Guo HB, 2002, CANCER RES, V62, P6837; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Guvakova MA, 1999, EXP CELL RES, V251, P244, DOI 10.1006/excr.1999.4566; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hao X, 2010, VET PATHOL, V47, P434, DOI 10.1177/0300985810363705; HEBERT E, 1994, BIOL CELL, V81, P73, DOI 10.1016/0248-4900(94)90057-4; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Iglesias MM, 1998, GLYCOBIOLOGY, V8, P59, DOI 10.1093/glycob/8.1.59; Inohara H, 1998, EXP CELL RES, V245, P294, DOI 10.1006/excr.1998.4253; Jasiulionis MG, 1996, CANCER RES, V56, P1682; Jensen-Jarolim E, 2002, EUR J GASTROEN HEPAT, V14, P145, DOI 10.1097/00042737-200202000-00008; Jones PL, 2000, MATRIX BIOL, V19, P581, DOI 10.1016/S0945-053X(00)00106-2; Kariya Y, 2010, J BIOL CHEM, V285, P3330, DOI 10.1074/jbc.M109.038836; Kawachi K, 2000, HUM PATHOL, V31, P428, DOI 10.1053/hp.2000.6534; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Khanna C, 2001, CANCER RES, V61, P3750; Kwon M, 2006, ENDOCRINOLOGY, V147, P1458, DOI 10.1210/en.2005-1115; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Lampugnani MG, 1999, METH MOL B, V96, P177; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Levy Y, 2001, J BIOL CHEM, V276, P31285, DOI 10.1074/jbc.M100340200; LINDSTEDT R, 1993, J BIOL CHEM, V268, P11750; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Lukyanov P, 2005, BIOCHEM BIOPH RES CO, V338, P1031, DOI 10.1016/j.bbrc.2005.10.033; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; Nakamura M, 1999, INT J ONCOL, V15, P143; Nangia-Makker P, 2008, CANCER MICROENVIRON, V1, P43, DOI 10.1007/s12307-008-0003-6; Neder L, 2004, BRAIN PATHOL, V14, P399; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Ochieng J, 1998, BIOCHEM BIOPH RES CO, V246, P788, DOI 10.1006/bbrc.1998.8708; Openo KP, 2000, EXP CELL RES, V255, P278, DOI 10.1006/excr.1999.4782; Qin ZH, 2002, J EXP MED, V195, P1479, DOI 10.1084/jem.20011887; Rafiq K, 2006, J BIOL CHEM, V281, P19781, DOI 10.1074/jbc.M513040200; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Saravanan C, 2009, J CELL SCI, V122, P3684, DOI 10.1242/jcs.045674; Sato S, 2002, J IMMUNOL, V168, P1813, DOI 10.4049/jimmunol.168.4.1813; Schafer T, 2004, J BIOL CHEM, V279, P6244, DOI 10.1074/jbc.M310500200; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Silva-Monteiro E, 2007, AM J PATHOL, V170, P546, DOI 10.2353/ajpath.2007.060389; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; VEIGA SS, 1995, INT J CANCER, V61, P420, DOI 10.1002/ijc.2910610324; Villa-Verde DMS, 2002, EUR J IMMUNOL, V32, P1434, DOI 10.1002/1521-4141(200205)32:5<1434::AID-IMMU1434>3.0.CO;2-M; Wehrle-Haller B, 2003, J PATHOL, V200, P481, DOI 10.1002/path.1399; Zhu WQ, 2001, CANCER RES, V61, P1869; Zhuo Y, 2008, J BIOL CHEM	83	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29313	10.1371/journal.pone.0029313	http://dx.doi.org/10.1371/journal.pone.0029313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216245	Green Published, Green Submitted, gold			2022-12-27	WOS:000300676300046
J	Wu, JY; van Geen, A; Ahmed, KM; Alam, YAJ; Culligan, PJ; Escamilla, V; Feighery, J; Ferguson, AS; Knappett, P; Mailloux, BJ; McKay, LD; Serre, ML; Streatfield, PK; Yunus, M; Emch, M				Wu, Jianyong; van Geen, Alexander; Ahmed, Kazi Matin; Alam, Yasuyuki Akita Jahangir; Culligan, Patricia J.; Escamilla, Veronica; Feighery, John; Ferguson, Andrew S.; Knappett, Peter; Mailloux, Brian J.; McKay, Larry D.; Serre, Marc L.; Streatfield, P. Kim; Yunus, Mohammad; Emch, Michael			Increase in Diarrheal Disease Associated with Arsenic Mitigation in Bangladesh	PLOS ONE			English	Article							DRINKING-WATER; COMMUNITY WELLS; YOUNG-CHILDREN; TUBEWELL WATER; ARAIHAZAR; HEALTH; CONTAMINATION; INTERVENTIONS; GROUNDWATER; QUALITY	Background: Millions of households throughout Bangladesh have been exposed to high levels of arsenic (As) causing various deadly diseases by drinking groundwater from shallow tubewells for the past 30 years. Well testing has been the most effective form of mitigation because it has induced massive switching from tubewells that are high (>50 mu g/L) in As to neighboring wells that are low in As. A recent study has shown, however, that shallow low-As wells are more likely to be contaminated with the fecal indicator E. coli than shallow high-As wells, suggesting that well switching might lead to an increase in diarrheal disease. Methods: Approximately 60,000 episodes of childhood diarrhea were collected monthly by community health workers between 2000 and 2006 in 142 villages of Matlab, Bangladesh. In this cross-sectional study, associations between childhood diarrhea and As levels in tubewell water were evaluated using logistic regression models. Results: Adjusting for wealth, population density, and flood control by multivariate logistic regression, the model indicates an 11% (95% confidence intervals (CIs) of 4-19%) increase in the likelihood of diarrhea in children drinking from shallow wells with 10-50 mu g/L As compared to shallow wells with >50 mu g/L As. The same model indicates a 26% (95% CI: 9-42%) increase in diarrhea for children drinking from shallow wells with <= 10 mu g/L As compared to shallow wells with >50 mu g/L As. Conclusion: Children drinking water from shallow low As wells had a higher prevalence of diarrhea than children drinking water from high As wells. This suggests that the health benefits of reducing As exposure may to some extent be countered by an increase in childhood diarrhea.	[Wu, Jianyong; Alam, Yasuyuki Akita Jahangir; Serre, Marc L.] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27515 USA; [van Geen, Alexander] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Ahmed, Kazi Matin; Alam, Yasuyuki Akita Jahangir] Univ Dhaka, Dept Geol, Dhaka 1000, Bangladesh; [Culligan, Patricia J.; Ferguson, Andrew S.] Columbia Univ, Dept Civil Engn & Engn Mech, New York, NY 10027 USA; [Escamilla, Veronica; Emch, Michael] Univ N Carolina, Dept Geog, Chapel Hill, NC USA; [Feighery, John] Columbia Univ, Dept Earth & Environm Engn, New York, NY USA; [Knappett, Peter; McKay, Larry D.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN USA; [Mailloux, Brian J.] Columbia Univ Barnard Coll, Dept Environm Sci, New York, NY 10027 USA; [Streatfield, P. Kim; Yunus, Mohammad] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Emch, Michael] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Columbia University; University of Dhaka; Columbia University; University of North Carolina; University of North Carolina Chapel Hill; Columbia University; University of Tennessee System; University of Tennessee Knoxville; Columbia University; International Centre for Diarrhoeal Disease Research (ICDDR); University of North Carolina; University of North Carolina Chapel Hill	Wu, JY (corresponding author), Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27515 USA.	avangeen@ldeo.columbia.edu; emch@email.unc.edu	Wu, Jianyong/A-6854-2011; Culligan, Patricia/C-1407-2009	Wu, Jianyong/0000-0002-5864-3186; Culligan, Patricia/0000-0002-3647-0640; serre, marc laurent/0000-0003-3145-4024; Yunus, Mohammed/0000-0003-1116-4978; Ahmed, Kazi Matin/0000-0001-5188-4385	United States National Institutes of Health, Fogarty International Center [5 R01 TW008066]; International Centre for Diarrhoeal Disease Research (ICDDR), B; Government of the People's Republic of Bangladesh; Canadian International Development Agency; Embassy of the Kingdom of the Netherlands; Swedish International Development Cooperative Agency; Department for International Development, United Kingdom; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R01TW008066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	United States National Institutes of Health, Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); International Centre for Diarrhoeal Disease Research (ICDDR), B; Government of the People's Republic of Bangladesh; Canadian International Development Agency; Embassy of the Kingdom of the Netherlands; Swedish International Development Cooperative Agency; Department for International Development, United Kingdom; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Data analysis for this study was supported by grant 5 R01 TW008066 from the United States National Institutes of Health, Fogarty International Center. Data collection was supported by International Centre for Diarrhoeal Disease Research (ICDDR), B and its donors which provide unrestricted support to ICDDR, B for its operations and research. Current donors providing unrestricted support include: Government of the People's Republic of Bangladesh; Canadian International Development Agency, Embassy of the Kingdom of the Netherlands, Swedish International Development Cooperative Agency, and the Department for International Development, United Kingdom. The authors gratefully acknowledge these donors for their support and commitment to ICDDR, B's research efforts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MF, 2006, SCIENCE, V314, P1687, DOI 10.1126/science.1133146; Ahsan H, 2000, J OCCUP ENVIRON MED, V42, P1195, DOI 10.1097/00043764-200012000-00016; [Anonymous], 2009, DIARRH WHY CHILDR AR; Argos M, 2010, LANCET, V376, P252, DOI 10.1016/S0140-6736(10)60481-3; Aziz Z, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006000; BERN C, 1992, B WORLD HEALTH ORGAN, V70, P705; BRISCOE J, 1978, AM J CLIN NUTR, V31, P2100, DOI 10.1093/ajcn/31.11.2100; British Geological Survey Mott MacDonald, 2000, EXECUTIVE SUMMARY MA; Caldwell BK, 2003, SOC SCI MED, V56, P2089, DOI 10.1016/S0277-9536(02)00203-4; Chen Y, 2007, ENVIRON HEALTH PERSP, V115, P917, DOI 10.1289/ehp.9833; Cheng Z, 2005, ENVIRON SCI TECHNOL, V39, P4759, DOI 10.1021/es048065f; DEZOYSA I, 1985, B WORLD HEALTH ORGAN, V63, P569; DSOUZA S, 1982, POPUL DEV REV, V8, P753, DOI 10.2307/1972471; Emch M., 2010, ENV HLTH, V9; ESREY SA, 1985, B WORLD HEALTH ORGAN, V63, P757; Hoque BA, 2006, INT J HYG ENVIR HEAL, V209, P451, DOI 10.1016/j.ijheh.2006.04.008; Howard G, 2006, J HEALTH POPUL NUTR, V24, P346; Huttly SRA, 1997, B WORLD HEALTH ORGAN, V75, P163; Jakariya M, 2007, SCI TOTAL ENVIRON, V379, P167, DOI 10.1016/j.scitotenv.2006.11.053; Keusch GT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P371; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Leber J, 2011, GROUND WATER, V49, P111, DOI 10.1111/j.1745-6584.2010.00689.x; LEVINE RJ, 1976, LANCET, V2, P86; Lokuge KM, 2004, ENVIRON HEALTH PERSP, V112, P1172, DOI 10.1289/ehp.6866; Luby SP, 2008, J APPL MICROBIOL, V105, P1002, DOI 10.1111/j.1365-2672.2008.03826.x; Michael HA, 2008, P NATL ACAD SCI USA, V105, P8531, DOI 10.1073/pnas.0710477105; Opar A, 2007, HEALTH PLACE, V13, P164, DOI 10.1016/j.healthplace.2005.11.004; Stute M, 2007, WATER RESOUR RES, V43, DOI 10.1029/2005WR004499; van Geen A, 2003, B WORLD HEALTH ORGAN, V81, P632; van Geen A, 2002, B WORLD HEALTH ORGAN, V80, P732; Van Geen A, 2007, J ENVIRON SCI HEAL A, V42, P1729, DOI 10.1080/10934520701564236; van Geen A, 2011, ENVIRON SCI TECHNOL, V45, P1199, DOI 10.1021/es103192b; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; Winkel LHE, 2011, P NATL ACAD SCI USA, V108, P1246, DOI 10.1073/pnas.1011915108; World Health Organization (WHO), 2009, WORLD HLTH STAT	36	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29593	10.1371/journal.pone.0029593	http://dx.doi.org/10.1371/journal.pone.0029593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216326	Green Published, gold			2022-12-27	WOS:000300676300070
J	Buccigrossi, V; Laudiero, G; Nicastro, E; Miele, E; Esposito, F; Guarino, A				Buccigrossi, Vittoria; Laudiero, Gabriella; Nicastro, Emanuele; Miele, Erasmo; Esposito, Franca; Guarino, Alfredo			The HIV-1 Transactivator Factor (Tat) Induces Enterocyte Apoptosis through a Redox-Mediated Mechanism	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; OXIDATIVE STRESS; CELL-PROLIFERATION; INTESTINAL PERMEABILITY; INFECTED INDIVIDUALS; GLUTATHIONE; BARRIER; GROWTH; PROTEIN; GSH	The intestinal mucosa is an important target of human immunodeficiency virus (HIV) infection. HIV virus induces CD4+ T cell loss and epithelial damage which results in increased intestinal permeability. The mechanisms involved in nutrient malabsorption and alterations of intestinal mucosal architecture are unknown. We previously demonstrated that HIV-1 transactivator factor (Tat) induces an enterotoxic effect on intestinal epithelial cells that could be responsible for HIV-associated diarrhea. Since oxidative stress is implicated in the pathogenesis and morbidity of HIV infection, we evaluated whether Tat induces apoptosis of human enterocytes through oxidative stress, and whether the antioxidant N-acetylcysteine (NAC) could prevent it. Caco-2 and HT29 cells or human intestinal mucosa specimens were exposed to Tat alone or combined with NAC. In an in-vitro cell model, Tat increased the generation of reactive oxygen species and decreased antioxidant defenses as judged by a reduction in catalase activity and a reduced (GSH)/oxidized (GSSG) glutathione ratio. Tat also induced cytochrome c release from mitochondria to cytosol, and caspase-3 activation. Rectal dialysis samples from HIV-infected patients were positive for the oxidative stress marker 8-hydroxy-2'-deoxyguanosine. GSH/GSSG imbalance and apoptosis occurred in jejunal specimens from HIV-positive patients at baseline and from HIV-negative specimens exposed to Tat. Experiments with neutralizing anti-Tat antibodies showed that these effects were direct and specific. Pre-treatment with NAC prevented Tat-induced apoptosis and restored the glutathione balance in both the in-vitro and the ex-vivo model. These findings indicate that oxidative stress is one of the mechanism involved in HIV-intestinal disease.	[Buccigrossi, Vittoria; Laudiero, Gabriella; Nicastro, Emanuele; Miele, Erasmo; Guarino, Alfredo] Univ Naples Federico II, Dept Paediat, Naples, Italy; [Esposito, Franca] Univ Naples Federico II, Dept Biochem & Med Biotechnol, Naples, Italy	University of Naples Federico II; University of Naples Federico II	Buccigrossi, V (corresponding author), Univ Naples Federico II, Dept Paediat, Naples, Italy.	alfguari@unina.it	Guarino, Alfredo/AAC-4812-2022; Buccigrossi, Vittoria/AAA-1226-2020; Esposito, Franca/K-2024-2016; Nicastro, Emanuele/AAJ-2274-2020; Nicastro, Emanuele/K-1260-2018	Guarino, Alfredo/0000-0003-0199-0336; Esposito, Franca/0000-0001-9340-6875; Nicastro, Emanuele/0000-0002-4518-9375	University of Naples	University of Naples	The funder (University of Naples) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal L, 2007, VIROLOGY, V363, P462, DOI 10.1016/j.virol.2007.02.004; Allen Sara, 2000, Methods in Cell Science, V22, P305, DOI 10.1023/A:1017585308255; Attene-Ramos MS, 2005, AM J PHYSIOL-CELL PH, V289, pC1220, DOI 10.1152/ajpcell.00164.2005; Banerjee A, 2010, FREE RADICAL BIO MED, V48, P1388, DOI 10.1016/j.freeradbiomed.2010.02.023; Belmonte L, 2007, AIDS, V21, P2106, DOI 10.1097/QAD.0b013e3282efb74b; Brailoiu E, 2006, J NEUROVIROL, V12, P17, DOI 10.1080/13550280500516427; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Bruzzese E, 2004, ALIMENT PHARM THER, V20, P813, DOI 10.1111/j.1365-2036.2004.02174.x; Canani RB, 2006, AIDS, V20, P5, DOI 10.1097/01.aids.0000198088.85572.68; Canani RB, 2003, GASTROENTEROLOGY, V124, P368, DOI 10.1053/gast.2003.50056; Canani RB, 2002, AM J GASTROENTEROL, V97, P1574; Cello JP, 2009, GASTROENTEROLOGY, V136, P1952, DOI 10.1053/j.gastro.2008.12.073; Chen D, 2002, EMBO J, V21, P6801, DOI 10.1093/emboj/cdf683; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Circu ML, 2009, FREE RADICAL BIO MED, V47, P1190, DOI 10.1016/j.freeradbiomed.2009.07.032; Circu ML, 2009, BIOCHEM PHARMACOL, V77, P76, DOI 10.1016/j.bcp.2008.09.011; Critchfield JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003577; Epple HJ, 2009, GUT, V58, P220, DOI 10.1136/gut.2008.150425; Epple HJ, 2010, GASTROENTEROLOGY, V139, P1289, DOI 10.1053/j.gastro.2010.06.065; Fratemale A, 2008, ANTIVIR RES, V77, P120, DOI 10.1016/j.antiviral.2007.11.004; Fraternale A, 2009, MOL ASPECTS MED, V30, P99, DOI 10.1016/j.mam.2008.09.001; Gil L, 2010, BIOMED PHAR IN PRESS; Gotoh Y, 2002, CELL PROLIFERAT, V35, P221, DOI 10.1046/j.1365-2184.2002.00241.x; Herring TA, 2007, DIGEST DIS SCI, V52, P3005, DOI 10.1007/s10620-006-9663-6; Huo LH, 2011, J PATHOL, V223, P28, DOI 10.1002/path.2768; Kamat A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015533; KEATING J, 1995, GUT, V37, P623, DOI 10.1136/gut.37.5.623; Kline ER, 2008, J INVEST MED, V56, P752, DOI 10.1097/JIM.0b013e3181788d15; KOTLER DP, 1991, AM J PATHOL, V139, P823; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lafeuillade A, 2009, HIV CLIN TRIALS, V10, P324, DOI 10.1310/hct1005-324; Ledda M, 2011, EUR REV MED PHARMACO, V15, P61; Li QS, 2008, J INFECT DIS, V197, P420, DOI 10.1086/525046; LIM SG, 1993, SCAND J GASTROENTERO, V28, P573, DOI 10.3109/00365529309096090; MCCLOSKEY TW, 1995, CYTOMETRY, V22, P111, DOI 10.1002/cyto.990220206; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Papadia C, 2010, CLIN NUTR, V29, P795, DOI 10.1016/j.clnu.2010.04.008; Pierleoni R, 2010, MOL CELL BIOCHEM, V345, P105, DOI 10.1007/s11010-010-0564-9; Price TO, 2006, EXP NEUROL, V201, P193, DOI 10.1016/j.expneurol.2006.03.030; Rupinder SK, 2007, VASC PHARMACOL, V46, P383, DOI 10.1016/j.vph.2007.01.006; Sbrana E, 2004, ELECTROPHORESIS, V25, P1522, DOI 10.1002/elps.200305848; Sharpstone D, 1999, GUT, V45, P70, DOI 10.1136/gut.45.1.70; Shattock RJ, 2008, PLOS MED, V5, P537, DOI 10.1371/journal.pmed.0050081; Srinivas A, 2008, INDIAN J PEDIATR, V75, P347, DOI 10.1007/s12098-008-0036-3; Stehbens WE, 2004, EXP MOL PATHOL, V77, P121, DOI 10.1016/j.yexmp.2004.04.007; Stephensen CB, 2007, AM J CLIN NUTR, V85, P173, DOI 10.1093/ajcn/85.1.173; Stockmann M, 1998, AIDS, V12, P43, DOI 10.1097/00002030-199801000-00006; Stockmann M, 2000, ANN NY ACAD SCI, V915, P293, DOI 10.1111/j.1749-6632.2000.tb05257.x; Sundaram M, 2008, INT J INFECT DIS, V12, pE61, DOI 10.1016/j.ijid.2008.04.004; Taha R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011817; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Tsunada S, 2003, DIGEST DIS SCI, V48, P210, DOI 10.1023/A:1021775524062; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Wanchu A, 2009, AIDS RES HUM RETROV, V25, P1307, DOI 10.1089/aid.2009.0062; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0	55	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29436	10.1371/journal.pone.0029436	http://dx.doi.org/10.1371/journal.pone.0029436			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216281	Green Published, Green Submitted, gold			2022-12-27	WOS:000300674900035
J	Solomon, JA; Gianforcaro, A; Hamadeh, MJ				Solomon, Jesse A.; Gianforcaro, Alexandro; Hamadeh, Mazen J.			Vitamin D-3 Deficiency Differentially Affects Functional and Disease Outcomes in the G93A Mouse Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PROSTATE-CANCER RISK; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; D-RECEPTOR; 25-HYDROXYVITAMIN D-3-1-ALPHA-HYDROXYLASE; CONTROLLED-TRIAL; SKELETAL-MUSCLE; D SUPPLEMENTATION; CORTICAL-NEURONS; CREATINE SUPPLEMENTATION	Amyotrophic lateral sclerosis (ALS) is a neuromuscular disease characterized by motor neuron death in the central nervous system. Vitamin D supplementation increases antioxidant activity, reduces inflammation and improves motor neuron survival. We have previously demonstrated that vitamin D-3 supplementation at 10x the adequate intake improves functional outcomes in a mouse model of ALS. Objective: To determine whether vitamin D deficiency influences functional and disease outcomes in a mouse model of ALS. Methods: At age 25 d, 102 G93A mice (56 M, 46 F) were divided into two vitamin D-3 groups: 1) adequate (Al; 1 IU D-3/g feed) and 2) deficient (DEF; 0.025 IU D-3/g feed). At age 113 d, tibialis anterior (TA), quadriceps (quads) and brain were harvested from 42 mice (22 M and 20 F), whereas the remaining 60 mice (34 M and 26 F) were followed to endpoint. Results: During disease progression, DEF mice had 25% (P = 0.022) lower paw grip endurance AUC and 19% (P = 0.017) lower motor performance AUC vs. AI mice. Prior to disease onset (CS 2), DEF mice had 36% (P = 0.016) lower clinical score (CS) vs. Al mice. DEF mice reached CS 2 six days later vs. Al mice (P = 0.004), confirmed by a logrank test which revealed that DEF mice reached CS 2 at a 43% slower rate vs. Al mice (HR = 0.57; 95% Cl: 0.38, 1.74; P = 0.002). Body weight-adjusted TA (Al: r = 0.662, P = 0.001; DEF: r = 0.622, P = 0.006) and quads (Al: r = 0.661, P = 0.001; DEF: r = 0.768; P < 0.001) weights were strongly correlated with age at CS 2. Conclusion: Vitamin D-3 deficiency improves early disease severity and delays disease onset, but reduces performance in functional outcomes following disease onset, in the high-copy G93A mouse.	[Solomon, Jesse A.; Gianforcaro, Alexandro; Hamadeh, Mazen J.] York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Solomon, Jesse A.; Gianforcaro, Alexandro; Hamadeh, Mazen J.] York Univ, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada; [Hamadeh, Mazen J.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada	York University - Canada; York University - Canada; McMaster University	Solomon, JA (corresponding author), York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	hamadeh@yorku.ca		Hamadeh, Mazen/0000-0002-3511-4345	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/Index_ eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2005, CELL IMMUNOL, V233, P115, DOI 10.1016/j.cellimm.2005.04.013; Ahn J, 2009, CARCINOGENESIS, V30, P769, DOI 10.1093/carcin/bgp055; Ahonen MH, 2000, CANCER CAUSE CONTROL, V11, P847, DOI 10.1023/A:1008923802001; ALTHAUS HH, 1992, NEUROSCI LETT, V135, P219, DOI 10.1016/0304-3940(92)90440-I; Atif F, 2009, MOL MED, V15, P328, DOI 10.2119/molmed.2009.00016; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; BIRGE SJ, 1975, J CLIN INVEST, V56, P1100, DOI 10.1172/JCI108184; Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752; Bischoff-Ferrari HA, 2004, J BONE MINER RES, V19, P265, DOI 10.1359/jbmr.2004.19.2.265; Bland R, 2004, J STEROID BIOCHEM, V89-90, P121, DOI 10.1016/j.jsbmb.2004.03.115; BRAUN MM, 1995, CANCER CAUSE CONTROL, V6, P235, DOI 10.1007/BF00051795; Brewer LD, 2001, J NEUROSCI, V21, P98, DOI 10.1523/JNEUROSCI.21-01-00098.2001; Brown J, 2003, NEUROSCI LETT, V343, P139, DOI 10.1016/S0304-3940(03)00303-3; Cantorna MT, 2000, J NUTR, V130, P2648, DOI 10.1093/jn/130.11.2648; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Chung JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009011; Cohen RI, 1996, J NEUROSCI, V16, P6433; CURRY OB, 1974, NATURE, V249, P83, DOI 10.1038/249083a0; de Abreu DAF, 2010, J STEROID BIOCHEM, V121, P250, DOI 10.1016/j.jsbmb.2010.03.006; DEBOLAND AR, 1983, CALCIFIED TISSUE INT, V35, P798, DOI 10.1007/BF02405126; deCarvalho M, 1996, J NEUROL SCI, V139, P117, DOI 10.1016/0022-510X(96)00089-5; DeLuca HF, 2011, ARCH BIOCHEM BIOPHYS, V513, P140, DOI 10.1016/j.abb.2011.07.005; Derave W, 2003, NEUROBIOL DIS, V13, P264, DOI 10.1016/S0969-9961(03)00041-X; Dursun E, 2011, J ALZHEIMERS DIS, V23, P207, DOI 10.3233/JAD-2010-101377; Evatt ML, 2008, ARCH NEUROL-CHICAGO, V65, P1348, DOI 10.1001/archneur.65.10.1348; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; FELDMAN D, 1979, J BIOL CHEM, V254, P378; Fleet JC, 2008, J NUTR, V138, P1114, DOI 10.1093/jn/138.6.1114; Garland CF, 2007, J STEROID BIOCHEM, V103, P708, DOI 10.1016/j.jsbmb.2006.12.007; Gerdhem P, 2005, OSTEOPOROSIS INT, V16, P1425, DOI 10.1007/s00198-005-1860-1; Gianforcaro A, 2010, FASEB J, V24; Godar DE, 2009, MED HYPOTHESES, V72, P434, DOI 10.1016/j.mehy.2008.09.056; Gozdzik A, 2010, J NUTR, V140, P2213, DOI 10.3945/jn.110.126284; Griffin MD, 2003, ANNU REV NUTR, V23, P117, DOI 10.1146/annurev.nutr.23.011702.073114; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hamadeh MJ, 2006, MUSCLE NERVE, V34, P709, DOI 10.1002/mus.20630; Hamadeh MJ, 2005, MUSCLE NERVE, V31, P214, DOI 10.1002/mus.20255; Hamden K, 2009, J NUTR SCI VITAMINOL, V55, P215, DOI 10.3177/jnsv.55.215; Hoeck AD, 2011, MED HYPOTHESES, V76, P208, DOI 10.1016/j.mehy.2010.09.032; HOLICK MF, 1981, SCIENCE, V211, P590, DOI 10.1126/science.6256855; HOLICK MF, 2006, MODERN NUTR HLTH DIS, P376; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; HUGHES MR, 1977, ENDOCRINOLOGY, V100, P799, DOI 10.1210/endo-100-3-799; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Jaarsma D, 1998, ANN NEUROL, V44, P293, DOI 10.1002/ana.410440229; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Junger H, 1997, BRAIN RES, V762, P56, DOI 10.1016/S0006-8993(97)00347-8; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; Lambiase A, 2009, P NATL ACAD SCI USA, V106, P13469, DOI 10.1073/pnas.0906678106; LOUWERSE ES, 1995, ARCH NEUROL-CHICAGO, V52, P559, DOI 10.1001/archneur.1995.00540300031009; Mazzini L, 2001, J NEUROL SCI, V191, P139, DOI 10.1016/S0022-510X(01)00611-6; Miller RG, 2003, AMYOTROPH LATERAL SC, V4, P191; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; NEVEU I, 1994, MOL BRAIN RES, V24, P70, DOI 10.1016/0169-328X(94)90119-8; NIHEI K, 1993, ACTA NEUROPATHOL, V86, P55, DOI 10.1007/BF00454899; Nowson CA, 2002, MED J AUSTRALIA, V177, P149, DOI 10.5694/j.1326-5377.2002.tb04702.x; Patel BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009386; Patel BP, 2009, CLIN NUTR, V28, P604, DOI 10.1016/j.clnu.2009.06.002; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; PLEASURE D, 1979, J CLIN INVEST, V64, P1157, DOI 10.1172/JCI109569; Poduslo JF, 2000, ANN NEUROL, V48, P943, DOI 10.1002/1531-8249(200012)48:6<943::AID-ANA18>3.0.CO;2-1; Pongratz D, 1999, J NEUROL SCI, V165, pS10, DOI 10.1016/S0022-510X(99)00020-9; Prufer K, 1999, J CHEM NEUROANAT, V16, P135, DOI 10.1016/S0891-0618(99)00002-2; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reis JP, 2009, ATHEROSCLEROSIS, V207, P585, DOI 10.1016/j.atherosclerosis.2009.05.030; Rowling MJ, 2007, J NUTR, V137, P2608, DOI 10.1093/jn/137.12.2608; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; Segersten U, 2005, BREAST CANCER RES, V7, pR980, DOI 10.1186/bcr1332; Skinner HG, 2006, CANCER EPIDEM BIOMAR, V15, P1688, DOI 10.1158/1055-9965.EPI-06-0206; SMITH MC, 1960, J NEUROL NEUROSUR PS, V23, P269, DOI 10.1136/jnnp.23.4.269; Snow RJ, 2003, NEUROSCIENCE, V119, P661, DOI 10.1016/S0306-4522(03)00212-4; Solomon JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020582; Somjen D, 2005, CIRCULATION, V111, P1666, DOI 10.1161/01.CIR.0000160353.27927.70; Spach KM, 2005, J IMMUNOL, V175, P4119, DOI 10.4049/jimmunol.175.6.4119; Stockton KA, 2011, OSTEOPOROSIS INT, V22, P859, DOI 10.1007/s00198-010-1407-y; Stolzenberg-Solomon RZ, 2006, CANCER RES, V66, P10213, DOI 10.1158/0008-5472.CAN-06-1876; Stuiver BT, 1996, NEURODEGENERATION, V5, P153, DOI 10.1006/neur.1996.0022; Synofzik M, 2010, J NEUROL NEUROSUR PS, V81, P764, DOI 10.1136/jnnp.2009.181719; Tandan R, 1996, NEUROLOGY, V47, P1220, DOI 10.1212/WNL.47.5.1220; Taniura H, 2006, J NEUROSCI RES, V83, P1179, DOI 10.1002/jnr.20824; The Jackson Laboratory, 2011, B6SJL TG SODI G93A D; Tishkoff DX, 2008, ENDOCRINOLOGY, V149, P558, DOI 10.1210/en.2007-0805; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; USA American Institute of Nutrition, 1977, Journal of Nutrition, V107, P1340; Verschueren SMP, 2011, J BONE MINER RES, V26, P42, DOI 10.1002/jbmr.181; Vieth R, 2000, J NUTR, V130, P578, DOI 10.1093/jn/130.3.578; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang Y, 2000, NEUROPHARMACOLOGY, V39, P873, DOI 10.1016/S0028-3908(99)00255-5; Wang YJ, 2011, ENDOCRINOLOGY, V152, P354, DOI 10.1210/en.2010-1109; Weydt P, 2003, NEUROREPORT, V14, P1051, DOI 10.1097/01.wnr.0000073685.00308.89; WILLIAMS JH, 1995, MUSCLE NERVE, V18, P421, DOI 10.1002/mus.880180409; YANAGIHARA R, 1984, ANN NEUROL, V15, P42, DOI 10.1002/ana.410150108; Zang DW, 2002, NEUROSCI LETT, V332, P99, DOI 10.1016/S0304-3940(02)00944-8; Zehnder D, 1999, J AM SOC NEPHROL, V10, P2465; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888; Zhang ZL, 2011, ENDOCR RES, V36, P101, DOI 10.3109/07435800.2010.542415; Zwerina K, 2011, ANN RHEUM DIS, V70, P1122, DOI 10.1136/ard.2010.142331	100	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29354	10.1371/journal.pone.0029354	http://dx.doi.org/10.1371/journal.pone.0029354			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216257	Green Submitted, gold, Green Published			2022-12-27	WOS:000300674900029
J	Chen, XW; Lou, QY; He, JY; Yin, Z				Chen, Xiaowen; Lou, Qiyong; He, Jiangyan; Yin, Zhan			Role of Zebrafish Lbx2 in Embryonic Lateral Line Development	PLOS ONE			English	Article							TRANSCRIPTION FACTOR LBX1; MUSCLE PRECURSOR CELLS; DORSAL SPINAL-CORD; GENE LBX1; TRANSMITTER PHENOTYPES; TISSUE MIGRATION; DANIO-RERIO; HAIR-CELLS; IN-VIVO; EXPRESSION	Background: The zebrafish ladybird homeobox homologous gene 2 (lbx2) has been suggested to play a key role in the regulation of hypaxial myogenic precursor cell migration. Unlike their lbx counterparts in mammals, the function of teleost lbx genes beyond myogenesis during embryonic development remains unexplored. Principal Findings: Abrogation of lbx2 function using a specific independent morpholino oligonucleotide (MO) or truncated lbx2 mRNA with an engrailed domain deletion (lbx2(eh-)) resulted in defective formation of the zebrafish posterior lateral line (PLL). Migration of the PLL primordium was altered and accompanied by increased cell death in the primordium of lbx2-MO-injected embryos. A decreased number of muscle pioneer cells and impaired expression pattern of sdf1a in the horizontal myoseptum was observed in lbx2 morphants. Significance: Injection of lbx2 MO or lbx2(eh-) mRNA resulted in defective PPL formation and altered sdf1a expression, confirming an important function for lbx2 in sdf1a-dependent migration. In addition, the disassociation of PPL nerve extension with PLL primordial migration in some lbx2 morphants suggests that pathfinding of the PLL primordium and the lateral line nerve may be regulated independently.	[Chen, Xiaowen; Lou, Qiyong; He, Jiangyan; Yin, Zhan] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China; [Chen, Xiaowen; Lou, Qiyong; He, Jiangyan; Yin, Zhan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, XW (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China.	zyin@ihb.ac.cn			National Basic Research Program [2009CB118701, 2010CB126302]; Chinese Natural Science Foundation [30871402, 30925027]	National Basic Research Program(National Basic Research Program of China); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The work was supported by grants from National Basic Research Program 2009CB118701, 2010CB126302 for zebrafish facility support. The work also received a grant from Chinese Natural Science Foundation (No. 30871402, 30925027) for supporting the work on zebrafish lbx2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aman A, 2008, DEV CELL, V15, P749, DOI 10.1016/j.devcel.2008.10.002; Brohmann H, 2000, DEVELOPMENT, V127, P437; Chen F, 1999, MECH DEVELOP, V84, P181, DOI 10.1016/S0925-4773(99)00073-8; Cheng LP, 2005, NAT NEUROSCI, V8, P1510, DOI 10.1038/nn1569; Coffin AB, 2010, ZEBRAFISH, V7, P3, DOI 10.1089/zeb.2009.0639; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; COLLAZO A, 1994, SCIENCE, V264, P426, DOI 10.1126/science.8153631; COOMBS S, 1989, J ACOUST SOC AM, V85, P2185, DOI 10.1121/1.397867; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; DIJKGRAAF S, 1960, PROC R SOC SER B-BIO, V152, P51, DOI 10.1098/rspb.1960.0022; Feldner J, 2007, J NEUROSCI, V27, P4978, DOI 10.1523/JNEUROSCI.1132-07.2007; Flock A, 1971, Nord Med, V85, P438; Gallardo VE, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-120; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Gilmour D, 2004, NAT NEUROSCI, V7, P491, DOI 10.1038/nn1235; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Gross MK, 2000, DEVELOPMENT, V127, P413; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Haines L, 2004, DEVELOPMENT, V131, P4857, DOI 10.1242/dev.01374; Huang MG, 2008, DEV BIOL, V322, P394, DOI 10.1016/j.ydbio.2008.06.031; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kruger M, 2002, J NEUROCHEM, V82, P774, DOI 10.1046/j.1471-4159.2002.01078.x; Lecaudey V, 2008, DEVELOPMENT, V135, P2695, DOI 10.1242/dev.025981; Ma EY, 2008, J NEUROSCI, V28, P2261, DOI 10.1523/JNEUROSCI.4372-07.2008; Ma EY, 2009, CURR BIOL, V19, pR381, DOI 10.1016/j.cub.2009.03.057; Maqbool T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000122; Martin BL, 2006, DEVELOPMENT, V133, P195, DOI 10.1242/dev.02183; Matsuda M, 2010, DEVELOPMENT, V137, P3477, DOI 10.1242/dev.052761; Mennerich D, 1998, MECH DEVELOP, V73, P147, DOI 10.1016/S0925-4773(98)00046-X; Mennerich D, 2001, EMBO J, V20, P7174, DOI 10.1093/emboj/20.24.7174; Mizuhara E, 2005, J BIOL CHEM, V280, P3645, DOI 10.1074/jbc.M411652200; Moens Cecilia B., 2008, Briefings in Functional Genomics & Proteomics, V7, P454, DOI 10.1093/bfgp/eln046; Moisan V, 2010, J MOL HISTOL, V41, P289, DOI 10.1007/s10735-010-9291-5; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Nechiporuk A, 2008, SCIENCE, V320, P1774, DOI 10.1126/science.1156547; Ochi H, 2006, DEV BIOL, V297, P127, DOI 10.1016/j.ydbio.2006.05.001; Ochi H, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-13; Olivari FA, 2008, BRAIN RES, V1244, P1, DOI 10.1016/j.brainres.2008.09.050; Ou HC, 2010, DRUG DISCOV TODAY, V15, P265, DOI 10.1016/j.drudis.2010.01.001; Ou HC, 2009, JARO-J ASSOC RES OTO, V10, P191, DOI 10.1007/s10162-009-0158-y; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Pistocchi A, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-58; Schafer K, 1999, NAT GENET, V23, P213, DOI 10.1038/13843; Schafer K, 2003, CIRC RES, V92, P73, DOI 10.1161/01.RES.0000050587.76563.A5; SCHELLART NAM, 1992, BRAIN BEHAV EVOLUT, V39, P371, DOI 10.1159/000114132; Schubert FR, 2001, MECH DEVELOP, V101, P181, DOI 10.1016/S0925-4773(00)00537-2; Schweitzer J, 2005, DEV DYNAM, V234, P550, DOI 10.1002/dvdy.20525; Sieber MA, 2007, J NEUROSCI, V27, P4902, DOI 10.1523/JNEUROSCI.0717-07.2007; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Uchiyama K, 2000, J EXP ZOOL, V286, P270, DOI 10.1002/(SICI)1097-010X(20000215)286:3<270::AID-JEZ6>3.3.CO;2-G; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Watanabe S, 2007, J CELL SCI, V120, P4178, DOI 10.1242/jcs.011668; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wotton KR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-171	54	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29515	10.1371/journal.pone.0029515	http://dx.doi.org/10.1371/journal.pone.0029515			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216300	Green Submitted, Green Published, gold			2022-12-27	WOS:000299684700063
J	Vonk, WIM; Bartuzi, P; de Bie, P; Kloosterhuis, N; Wichers, CGK; Berger, R; Haywood, S; Klomp, LWJ; Wijmenga, C; van de Sluis, B				Vonk, Willianne I. M.; Bartuzi, Paulina; de Bie, Prim; Kloosterhuis, Niels; Wichers, Catharina G. K.; Berger, Ruud; Haywood, Susan; Klomp, Leo W. J.; Wijmenga, Cisca; van de Sluis, Bart			Liver-Specific Commd1 Knockout Mice Are Susceptible to Hepatic Copper Accumulation	PLOS ONE			English	Article							NF-KAPPA-B; WILSONS-DISEASE; BEDLINGTON TERRIERS; MURR1; GENE; TRANSPORT; TOXICOSIS; PROTEINS; MOUSE; IDENTIFICATION	Canine copper toxicosis is an autosomal recessive disorder characterized by hepatic copper accumulation resulting in liver fibrosis and eventually cirrhosis. We have identified COMMD1 as the gene underlying copper toxicosis in Bedlington terriers. Although recent studies suggest that COMMD1 regulates hepatic copper export via an interaction with the Wilson disease protein ATP7B, its importance in hepatic copper homeostasis is ill-defined. In this study, we aimed to assess the effect of Commd1 deficiency on hepatic copper metabolism in mice. Liver-specific Commd1 knockout mice (Commd1(Delta hep)) were generated and fed either a standard or a copper-enriched diet. Copper homeostasis and liver function were determined in Commd1(Delta hep) mice by biochemical and histological analyses, and compared to wild-type littermates. Commd1(Delta hep) mice were viable and did not develop an overt phenotype. At six weeks, the liver copper contents was increased up to a 3-fold upon Commd1 deficiency, but declined with age to concentrations similar to those seen in controls. Interestingly, Commd1(Delta hep) mice fed a copper-enriched diet progressively accumulated copper in the liver up to a 20-fold increase compared to controls. These copper levels did not result in significant induction of the copper-responsive genes metallothionein I and II, neither was there evidence of biochemical liver injury nor overt liver pathology. The biosynthesis of ceruloplasmin was clearly augmented with age in Commd1(Delta hep) mice. Although COMMD1 expression is associated with changes in ATP7B protein stability, no clear correlation between Atp7b levels and copper accumulation in Commd1(Delta hep) mice could be detected. Despite the absence of hepatocellular toxicity in Commd1(Delta hep) mice, the changes in liver copper displayed several parallels with copper toxicosis in Bedlington terriers. Thus, these results provide the first genetic evidence for COMMD1 to play an essential role in hepatic copper homeostasis and present a valuable mouse model for further understanding of the molecular mechanisms underlying hepatic copper homeostasis.	[Vonk, Willianne I. M.; de Bie, Prim; Wichers, Catharina G. K.; Berger, Ruud; Klomp, Leo W. J.] Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, Utrecht, Netherlands; [Vonk, Willianne I. M.; de Bie, Prim; Wichers, Catharina G. K.; Berger, Ruud; Klomp, Leo W. J.] Netherlands Metabol Ctr, Utrecht, Netherlands; [Vonk, Willianne I. M.; de Bie, Prim; Wijmenga, Cisca] Univ Med Ctr Utrecht, Complex Genet Sect, Utrecht, Netherlands; [Bartuzi, Paulina; Kloosterhuis, Niels; van de Sluis, Bart] Univ Groningen, Dept Pathol & Lab Med, Univ Med Ctr Groningen, Groningen, Netherlands; [Haywood, Susan] Univ Liverpool, Dept Vet Pathol, Fac Vet Sci, Liverpool L69 3BX, Merseyside, England; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Liverpool; University of Groningen	Vonk, WIM (corresponding author), Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, Utrecht, Netherlands.	a.j.a.van.de.sluis@umcg.nl	Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009	Wijmenga, Cisca/0000-0002-5635-1614; van de Sluis, Bart (A.J.A.)/0000-0003-3039-4365; Vonk, Willianne/0000-0002-5906-3933	Netherlands Organization for Scientific Research [40-00812-98-03106]; Pharmaceutical Department (University Medical Center Utrecht, Utrecht, The Netherlands)	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Pharmaceutical Department (University Medical Center Utrecht, Utrecht, The Netherlands)(Netherlands Government)	This work was supported by the Netherlands Organization for Scientific Research (grant number 40-00812-98-03106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the members of the Pharmaceutical Department (University Medical Center Utrecht, Utrecht, The Netherlands) for the use of the FAAS and their support. We acknowledge Dr. J. Gitlin for kindly providing the rabbit-anti-Atp7b antiserum. We thank Jackie Senior for critically reading the manuscript.	Allen KJ, 2006, BIOMETALS, V19, P555, DOI 10.1007/s10534-005-5918-5; Biasio W, 2004, J BIOL CHEM, V279, P5429, DOI 10.1074/jbc.M311155200; Burkhead JL, 2009, J BIOL CHEM, V284, P696, DOI 10.1074/jbc.M804766200; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Coronado VA, 2005, CLIN GENET, V68, P548, DOI 10.1111/j.1399-0004.2005.00524.x; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; He K, 2011, MAMM GENOME, V22, P703, DOI 10.1007/s00335-011-9359-x; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Huster D, 2007, MOL BIOSYST, V3, P816, DOI 10.1039/b711118p; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; Ke Y, 2010, AM J PHYSIOL-RENAL, V298, pF1445, DOI 10.1152/ajprenal.00257.2009; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; Lonnerdal B, 2007, ANNU REV NUTR, V27, P165, DOI 10.1146/annurev.nutr.27.061406.093809; Lutsenko S, 2010, CURR OPIN CHEM BIOL, V14, P211, DOI 10.1016/j.cbpa.2010.01.003; Maine GN, 2007, CELL MOL LIFE SCI, V64, P1997, DOI 10.1007/s00018-007-7078-y; Maine GN, 2007, CELL CYCLE, V6, P672, DOI 10.4161/cc.6.6.3989; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Maine GN, 2009, BIOCHEM J, V417, P601, DOI 10.1042/BJ20080854; MICHALSKA AE, 1993, P NATL ACAD SCI USA, V90, P8088, DOI 10.1073/pnas.90.17.8088; Miyayama T, 2010, BIOCHEM J, V429, P53, DOI 10.1042/BJ20100223; Muller PAJ, 2009, TRAFFIC, V10, P514, DOI 10.1111/j.1600-0854.2009.00892.x; Muller T, 2003, J HEPATOL, V38, P164, DOI 10.1016/S0168-8278(02)00356-2; Muller T, 1996, LANCET, V347, P877, DOI 10.1016/S0140-6736(96)91351-3; OWEN CA, 1982, AM J PATHOL, V106, P432; Pankit Anand N, 2002, J Gastroenterol Hepatol, V17 Suppl 3, pS403, DOI 10.1046/j.1440-1746.17.s3.35.x; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Prohaska JR, 2004, J NUTR, V134, P1003, DOI 10.1093/jn/134.5.1003; SCHOSINSKY KH, 1974, CLIN CHEM, V20, P1556; SU LC, 1982, AM J PHYSIOL, V243, pG226, DOI 10.1152/ajpgi.1982.243.3.G226; Tanner MS, 1998, AM J CLIN NUTR, V67, p1074S, DOI 10.1093/ajcn/67.5.1074S; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Thoms HC, 2010, CANCER RES, V70, P139, DOI 10.1158/0008-5472.CAN-09-1397; Thornburg LP, 2000, J VET DIAGN INVEST, V12, P101, DOI 10.1177/104063870001200201; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; van de Sluis B, 2007, MOL CELL BIOL, V27, P4142, DOI 10.1128/MCB.01932-06; van de Sluis B, 2010, J CLIN INVEST, V120, P2119, DOI 10.1172/JCI40583; van de Sluis B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007332; Vonk WI, 2011, CELL MOL LIFE SCI; Vonk WIM, 2010, J BIOL CHEM, V285, P28991, DOI 10.1074/jbc.M110.101477; Wijmenga C, 2004, P NUTR SOC, V63, P31, DOI 10.1079/PNS2003316	43	45	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29183	10.1371/journal.pone.0029183	http://dx.doi.org/10.1371/journal.pone.0029183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216203	Green Published, Green Submitted, gold			2022-12-27	WOS:000299684700036
J	Wang, X; Han, J; Han, HW				Wang, Xin; Han, Jing; Han, Huawei			Special Agents Can Promote Cooperation in the Population	PLOS ONE			English	Article							TIT-FOR-TAT; EVOLUTIONARY GAMES; RECIPROCITY; EMERGENCE; ALTRUISM; AUTOMATA; STRATEGY	Cooperation is ubiquitous in our real life but everyone would like to maximize her own profits. How does cooperation occur in the group of self-interested agents without centralized control? Furthermore, in a hostile scenario, for example, cooperation is unlikely to emerge. Is there any mechanism to promote cooperation if populations are given and play rules are not allowed to change? In this paper, numerical experiments show that complete population interaction is unfriendly to cooperation in the finite but end-unknown Repeated Prisoner's Dilemma (RPD). Then a mechanism called soft control is proposed to promote cooperation. According to the basic idea of soft control, a number of special agents are introduced to intervene in the evolution of cooperation. They comply with play rules in the original group so that they are always treated as normal agents. For our purpose, these special agents have their own strategies and share knowledge. The capability of the mechanism is studied under different settings. We find that soft control can promote cooperation and is robust to noise. Meanwhile simulation results demonstrate the applicability of the mechanism in other scenarios. Besides, the analytical proof also illustrates the effectiveness of soft control and validates simulation results. As a way of intervention in collective behaviors, soft control provides a possible direction for the study of reciprocal behaviors.	[Wang, Xin; Han, Jing; Han, Huawei] Chinese Acad Sci, Inst Syst Sci, Key Lab Syst & Control, Acad Math & Syst Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS	Wang, X (corresponding author), Chinese Acad Sci, Inst Syst Sci, Key Lab Syst & Control, Acad Math & Syst Sci, Beijing, Peoples R China.	hanjing@amss.ac.cn			National Natural Science Foundation of China [60574068, 60821091, 60804043]; Chinese Academy of Sciences [KJCX3-SYW-S01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work is supported by the National Natural Science Foundation of China (No. 60574068, No. 60821091, and No. 60804043) and the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. KJCX3-SYW-S01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1988, SCIENCE, V242, P1385, DOI 10.1126/science.242.4884.1385; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; AXTELL RL, RADICALS REVOLUTIONA; BINMORE K, 1987, ECON PHILOS, V3, P179, DOI 10.1017/S0266267100002893; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Brafman RI, 1996, J ARTIF INTELL RES, V4, P477, DOI 10.1613/jair.318; Cardillo A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103034; Cattaneo G, 2006, LECT NOTES COMPUT SC, V4173, P446; Chen Z, 2011, PHYSICA A, V390, P1615, DOI 10.1016/j.physa.2011.01.004; Cressman R, 1996, J ECON THEORY, V68, P234, DOI 10.1006/jeth.1996.0012; Darwen PJ, 2001, IEEE C EVOL COMPUTAT, P987, DOI 10.1109/CEC.2001.934298; dos Santos M, 2011, P ROY SOC B-BIOL SCI, V278, P371, DOI 10.1098/rspb.2010.1275; Droz M, 2009, EUR PHYS J B, V71, P579, DOI 10.1140/epjb/e2009-00160-1; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V422, P137, DOI 10.1038/nature01474; Fogel DB, 1993, EVOL COMPUT, V1, P77, DOI 10.1162/evco.1993.1.1.77; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; GREIG D, 2004, P ROY SOC LOND B BIO, V271, P525; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Hammond RA, 2006, THEOR POPUL BIOL, V69, P333, DOI 10.1016/j.tpb.2005.12.002; HAN J, 2006, J SYSTEMS SCI COMPLE, V19, P54; Helbing D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057104; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Han J, 2005, PROCEEDINGS OF THE 24TH CHINESE CONTROL CONFERENCE, VOLS 1 AND 2, P184; Krams I, 2008, BEHAV ECOL SOCIOBIOL, V62, P599, DOI 10.1007/s00265-007-0484-1; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; LOMBARDO MP, 1985, SCIENCE, V227, P1363, DOI 10.1126/science.227.4692.1363; Lozano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001892; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; Miller JH, 1996, J ECON BEHAV ORGAN, V29, P87, DOI 10.1016/0167-2681(95)00052-6; Moyano LG, 2009, J THEOR BIOL, V259, P84, DOI 10.1016/j.jtbi.2009.03.002; NOWAK M, 1990, J THEOR BIOL, V142, P237, DOI 10.1016/S0022-5193(05)80224-3; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK M, 1989, J THEOR BIOL, V137, P21, DOI 10.1016/S0022-5193(89)80146-8; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; NOWAK MA, 1994, P NATL ACAD SCI USA, V91, P4877, DOI 10.1073/pnas.91.11.4877; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Ogata K, 1997, MODERN CONTROL ENG; Ohtsuki H, 2004, J THEOR BIOL, V227, P299, DOI 10.1016/j.jtbi.2003.11.008; Ohtsuki H, 2007, J THEOR BIOL, V247, P462, DOI 10.1016/j.jtbi.2007.03.018; Ohtsuki H, 2009, NATURE, V457, P79, DOI 10.1038/nature07601; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Rand DG, 2010, J THEOR BIOL, V265, P624, DOI 10.1016/j.jtbi.2010.06.010; Riolo R, 1997, P 7 INT C GEN ALG IC, P378; Riolo RL, 2001, NATURE, V414, P441, DOI 10.1038/35106555; RUBINSTEIN A, 1986, J ECON THEORY, V39, P83, DOI 10.1016/0022-0531(86)90021-9; Sandholm TW, 1996, BIOSYSTEMS, V37, P147, DOI 10.1016/0303-2647(95)01551-5; Santos FC, 2006, P ROY SOC B-BIOL SCI, V273, P51, DOI 10.1098/rspb.2005.3272; SEGBROECK SV, 2009, PHYS REV LETT, V102; Sigmund K, 2010, PRINC SER THEOR COMP, P1; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Stephens DW, 2002, SCIENCE, V298, P2216, DOI 10.1126/science.1078498; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2009, EUR PHYS J B, V67, P337, DOI 10.1140/epjb/e2008-00470-8; Szolnoki A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50007; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Szolnoki A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093033; Szolnoki A, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30007; Vainstein MH, 2007, J THEOR BIOL, V244, P722, DOI 10.1016/j.jtbi.2006.09.012; Wang X, 2011, CHIN CONTR CONF, P5764; Woelfing B, 2009, J THEOR BIOL, V257, P689, DOI 10.1016/j.jtbi.2008.12.025; YAO X, 1994, INFORMATICA, V18, P435	66	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29182	10.1371/journal.pone.0029182	http://dx.doi.org/10.1371/journal.pone.0029182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	876NF	22216202	gold, Green Published, Green Submitted			2022-12-27	WOS:000299113600064
J	van Rijssel, J; Hoogenboezem, M; Wester, L; Hordijk, PL; Van Buul, JD				van Rijssel, Jos; Hoogenboezem, Mark; Wester, Lynn; Hordijk, Peter L.; Van Buul, Jaap D.			The N-Terminal DH-PH Domain of Trio Induces Cell Spreading and Migration by Regulating Lamellipodia Dynamics in a Rac1-Dependent Fashion	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; BINDING PROTEIN RHO; IN-VIVO; RAC; ADHESION; ACTIVATION; GROWTH; CYTOSKELETON; DOWNSTREAM; PATHWAY	The guanine-nucleotide exchange factor Trio encodes two DH-PH domains that catalyze nucleotide exchange on Rac1, RhoG and RhoA. The N-terminal DH-PH domain is known to activate Rac1 and RhoG, whereas the C-terminal DH-PH domain can activate RhoA. The current study shows that the N-terminal DH-PH domain, upon expression in HeLa cells, activates Rac1 and RhoG independently from each other. In addition, we show that the flanking SH3 domain binds to the proline-rich region of the C-terminus of Rac1, but not of RhoG. However, this SH3 domain is not required for Rac1 or RhoG GDP-GTP exchange. Rescue experiments in Trio-shRNA-expressing cells showed that the N-terminal DH-PH domain of Trio, but not the C-terminal DH-PH domain, restored fibronectin-mediated cell spreading and migration defects that are observed in Trio-silenced cells. Kymograph analysis revealed that the N-terminal DH-PH domain, independent of its SH3 domain, controls the dynamics of lamellipodia. Using siRNA against Rac1 or RhoG, we found that Trio-D1-induced lamellipodia formation required Rac1 but not RhoG expression. Together, we conclude that the GEF Trio is responsible for lamellipodia formation through its N-terminal DH-PH domain in a Rac1-dependent manner during fibronectin-mediated spreading and migration.	[van Rijssel, Jos; Hoogenboezem, Mark; Wester, Lynn; Hordijk, Peter L.; Van Buul, Jaap D.] Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	van Rijssel, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.vanbuul@sanquin.nl	van Buul, Jaap D/AAJ-4371-2021	van Buul, Jaap D/0000-0003-0054-7949; van Rijssel, Jos/0000-0001-8077-1371; Hordijk, Peter/0000-0002-3348-078X	Dutch Heart Foundation [2005T039]; NWO [916.76.053]; AMC Research B.V.	Dutch Heart Foundation(Netherlands Heart Foundation); NWO(Netherlands Organization for Scientific Research (NWO)); AMC Research B.V.	This work was funded by Dutch Heart Foundation (grant no. 2005T039), NWO-Veni grant 916.76.053 and AMC Research B.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bellanger JM, 1998, ONCOGENE, V16, P147, DOI 10.1038/sj.onc.1201532; Blangy A, 2000, J CELL SCI, V113, P729; de Kreu BJ, 2011, J CELL SCI, V124, P2375, DOI 10.1242/jcs.080630; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Ferraro F, 2007, MOL BIOL CELL, V18, P4813, DOI 10.1091/mbc.E07-05-0503; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; HALL A, 1993, PHILOS T ROY SOC B, V340, P267, DOI 10.1098/rstb.1993.0067; Hinz B, 1999, EXP CELL RES, V251, P234, DOI 10.1006/excr.1999.4541; Ho A, 2001, CANCER RES, V61, P474; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Medley QG, 2000, J BIOL CHEM, V275, P36116, DOI 10.1074/jbc.M003775200; Meller J, 2008, J CELL SCI, V121, P1981, DOI 10.1242/jcs.025130; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; Peng YJ, 2010, J BIOL CHEM, V285, P24834, DOI 10.1074/jbc.M109.096537; Pertz OC, 2008, P NATL ACAD SCI USA, V105, P1931, DOI 10.1073/pnas.0706545105; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Seipel K, 1999, J CELL SCI, V112, P1825; Skowronek KR, 2004, J BIOL CHEM, V279, P37895, DOI 10.1074/jbc.M312677200; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; van Buul JD, 2002, J IMMUNOL, V168, P588, DOI 10.4049/jimmunol.168.2.588; Yohe ME, 2008, BIOCHEMISTRY-US, V47, P6827, DOI 10.1021/bi702543p	32	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29912	10.1371/journal.pone.0029912	http://dx.doi.org/10.1371/journal.pone.0029912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238672	gold, Green Submitted, Green Published			2022-12-27	WOS:000301188800045
J	Feala, JD; Cortes, J; Duxbury, PM; McCulloch, AD; Piermarocchi, C; Paternostro, G				Feala, Jacob D.; Cortes, Jorge; Duxbury, Phillip M.; McCulloch, Andrew D.; Piermarocchi, Carlo; Paternostro, Giovanni			Statistical Properties and Robustness of Biological Controller-Target Networks	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; PROTEIN; CANCER; TOPOLOGY; PHOSPHORYLATION; ORGANIZATION; EXPRESSION; STABILITY; TOOL	Cells are regulated by networks of controllers having many targets, and targets affected by many controllers, in a "many-tomany" control structure. Here we study several of these bipartite (two-layer) networks. We analyze both naturally occurring biological networks (composed of transcription factors controlling genes, microRNAs controlling mRNA transcripts, and protein kinases controlling protein substrates) and a drug-target network composed of kinase inhibitors and of their kinase targets. Certain statistical properties of these biological bipartite structures seem universal across systems and species, suggesting the existence of common control strategies in biology. The number of controllers is,8% of targets and the density of links is 2.5%+/- 1.2%. Links per node are predominantly exponentially distributed. We explain the conservation of the mean number of incoming links per target using a mathematical model of control networks, which also indicates that the "many-to-many" structure of biological control has properties of efficient robustness. The drug-target network has many statistical properties similar to the biological networks and we show that drug-target networks with biomimetic features can be obtained. These findings suggest a completely new approach to pharmacological control of biological systems. Molecular tools, such as kinase inhibitors, are now available to test if therapeutic combinations may benefit from being designed with biomimetic properties, such as "many-to-many" targeting, very wide coverage of the target set, and redundancy of incoming links per target.	[Feala, Jacob D.; Paternostro, Giovanni] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Cortes, Jorge] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA; [Duxbury, Phillip M.; Piermarocchi, Carlo] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; [McCulloch, Andrew D.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Michigan State University; University of California System; University of California San Diego	Feala, JD (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA USA.	giovanni@burnham.org	Piermarocchi, Carlo/A-2427-2008; Cortes, Jorge/H-9135-2012; Piermarocchi, Carlo/AAH-2162-2019	Piermarocchi, Carlo/0000-0003-2762-8562; Cortes, Jorge/0000-0001-9582-5184; Piermarocchi, Carlo/0000-0003-2762-8562; duxbury, Phillip/0000-0003-4549-4764	National Science Foundation [0829891]; National Institutes of Health (NIH) [R21AG030685, P41-RR08605, P01-HL098053]; Division of Computing and Communication Foundations [0829891] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008605] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG030685] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Science Foundation grant 0829891 and National Institutes of Health (NIH) grant R21AG030685. Partial support was also received from NIH grants P41-RR08605 and P01-HL098053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 2007, J THEOR BIOL, V244, P670, DOI 10.1016/j.jtbi.2006.09.023; Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alberts B., 2008, MOL BIOL CELL, V5th, pxxxiii; Aldana M, 2003, P NATL ACAD SCI USA, V100, P8710, DOI 10.1073/pnas.1536783100; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bhardwaj N, 2010, PLOS COMPUTATIONAL B, V6; Bollobas B., 2001, RANDOM GRAPHS; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Calzolari D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000249; Choudhary A, 2006, BIOINFORMATICS, V22, P226, DOI 10.1093/bioinformatics/bti765; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Egerstedt M, 2011, NATURE, V473, P158, DOI 10.1038/473158a; Feala JD, 2010, WIRES SYST BIOL MED, V2, P181, DOI 10.1002/wsbm.51; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kauffman Stuart A., 1993; Klemm K, 2005, P NATL ACAD SCI USA, V102, P18414, DOI 10.1073/pnas.0509132102; Lau KY, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051907; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mencher Simon K, 2005, BMC Clin Pharmacol, V5, P3, DOI 10.1186/1472-6904-5-3; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Newman ME, 2001, PHYS REV E, V64; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Schlatter R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000595; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Varedi SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014029; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wong PK, 2008, P NATL ACAD SCI USA, V105, P5105, DOI 10.1073/pnas.0800823105; Yang CY, 2008, BIOINFORMATICS, V24, pI14, DOI 10.1093/bioinformatics/btn297; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zinner RG, 2009, MOL CANCER THER, V8, P521, DOI 10.1158/1535-7163.MCT-08-0937	52	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29374	10.1371/journal.pone.0029374	http://dx.doi.org/10.1371/journal.pone.0029374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235289	Green Submitted, gold, Green Published			2022-12-27	WOS:000301123400050
J	Huang, TC; Lu, KT; Wo, YYP; Wu, YJ; Yang, YL				Huang, Tai-Chun; Lu, Kwok-Tung; Wo, Yu-Yuan Peter; Wu, Yao-Ju; Yang, Yi-Ling			Resveratrol Protects Rats from A beta-induced Neurotoxicity by the Reduction of iNOS Expression and Lipid Peroxidation	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; HEME OXYGENASE-1 EXPRESSION; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; INFLAMMATORY RESPONSE; NEURONAL INJURY; MEMORY DEFICITS; BRAIN; INDUCTION	Alzheimer disease (AD) is an age-dependent neurodegenerative disease characterized by the formation of beta-amyloid (A beta)-containing senile plaque. The disease could be induced by the administration of A beta peptide, which was also known to upregulate inducible nitric oxide synthase (iNOS) and stimulate neuronal apoptosis. The present study is aimed to elucidate the cellular effect of resveratrol, a natural phytoestrogen with neuroprotective activities, on A beta-induced hippocampal neuron loss and memory impairment. On adult Sprague-Dawley rats, we found the injection of Ab could result in a significant impairment in spatial memory, a marked increase in the cellular level of iNOS and lipid peroxidation, and an apparent decrease in the expression of heme oxygenase-1 (HO-1). By combining the treatment with A beta, resveratrol was able to confer a significant improvement in spatial memory, and protect animals from A beta-induced neurotoxicity. These neurological protection effects of resveratrol were associated with a reduction in the cellular levels of iNOS and lipid peroxidation and an increase in the production of HO-1. Moreover, the similar neurological and cellular response were also observed when A beta treatment was combined with the administration of a NOS inhibitor, N(G)-nitro-L-arginine methyl ester hydrochloride (L-NAME). These findings strongly implicate that iNOS is involved in the A beta-induced lipid peroxidation and HO-1 downregulation, and resveratrol protects animals from A beta-induced neurotoxicity by suppressing iNOS production.	[Huang, Tai-Chun; Wo, Yu-Yuan Peter; Yang, Yi-Ling] Natl Chia Yi Univ, Dept Biochem Sci & Biotechnol, Chiayi, Taiwan; [Huang, Tai-Chun; Lu, Kwok-Tung; Wu, Yao-Ju] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan	National Chiayi University; National Taiwan Normal University	Huang, TC (corresponding author), Natl Chia Yi Univ, Dept Biochem Sci & Biotechnol, Chiayi, Taiwan.	ylyang@mail.ncyu.edu.tw			National Science Council, Taiwan [NSC 95-2321-B-415-002, 96-2321-B-415-002, 97-2321-B-415-002]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants NSC 95-2321-B-415-002; 96-2321-B-415-002, and 97-2321-B-415-002 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama KT, 2000, J BIOL CHEM, V275, P7918, DOI 10.1074/jbc.275.11.7918; Baranano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298; Butterfield DA, 2005, BBA-PROTEINS PROTEOM, V1703, P149, DOI 10.1016/j.bbapap.2004.10.014; Butterfield DA, 2011, INT J NEUROPSYCHOPH, P1; Cerny D, 2009, NITRIC OXIDE-BIOL CH, V20, P1, DOI 10.1016/j.niox.2008.08.006; Chen CY, 2005, BIOCHEM BIOPH RES CO, V331, P993, DOI 10.1016/j.bbrc.2005.03.237; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Chen K, 2000, J NEUROCHEM, V75, P304, DOI 10.1046/j.1471-4159.2000.0750304.x; Chen RS, 2002, J AGR FOOD CHEM, V50, P1665, DOI 10.1021/jf011134e; Cheng G, 2006, NEUROBIOL DIS, V23, P140, DOI 10.1016/j.nbd.2006.02.008; Diaz A, 2011, PHARMACOL BIOCHEM BE, V98, P67, DOI 10.1016/j.pbb.2010.12.005; Duncan Andrew J., 2005, Molecular Aspects of Medicine, V26, P67, DOI 10.1016/j.mam.2004.09.004; Ewing JF, 2006, J NEURAL TRANSM, V113, P439, DOI 10.1007/s00702-005-0408-z; Hui Y, 2011, J ALZHEIMERS DIS, V26, P299, DOI 10.3233/JAD-2011-102061; Hung SY, 2008, MOL PHARMACOL, V74, P1564, DOI 10.1124/mol.108.048611; Ishikawa K, 1997, J CLIN INVEST, V100, P1209, DOI 10.1172/JCI119634; Kim J, 2010, J NEUROCHEM, V112, P1415, DOI 10.1111/j.1471-4159.2009.06562.x; Kim TI, 2009, FREE RADICAL BIO MED, V47, P1601, DOI 10.1016/j.freeradbiomed.2009.09.008; Kim YA, 2006, INT J MOL MED, V17, P1069; Klinge CM, 2008, FASEB J, V22, P2185, DOI 10.1096/fj.07-103366; Le W, 1999, J NEUROSCI RES, V56, P652; Lee CL, 2007, J NEUROSCI RES, V85, P3171, DOI 10.1002/jnr.21428; Lee CL, 2011, APPL MICROBIOL BIOT, V91, P461, DOI 10.1007/s00253-011-3413-1; Li H, 2009, CARDIOVASC DRUG THER, V23, P425, DOI 10.1007/s10557-009-6209-0; Li J, 2010, BRAIN RES, V1328, P152, DOI 10.1016/j.brainres.2010.02.046; Liu RT, 2010, BEHAV BRAIN RES, V210, P24, DOI 10.1016/j.bbr.2010.01.041; Loh Kok Poh, 2006, Current Alzheimer Research, V3, P327; Lu KT, 2006, J AGR FOOD CHEM, V54, P3126, DOI [10.1021/jf053011q, 10.1021/JF053011Q]; Lu KT, 2008, J AGR FOOD CHEM, V56, P6910, DOI 10.1021/jf8007212; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Motterlini R, 2000, J BIOL CHEM, V275, P13613, DOI 10.1074/jbc.275.18.13613; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pappolla MA, 1998, AM J PATHOL, V152, P871; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Rottkamp CA, 2000, ALZ DIS ASSOC DIS, V14, pS62, DOI 10.1097/00002093-200000001-00010; Schipper HM, 2006, NEUROBIOL AGING, V27, P252, DOI 10.1016/j.neurobiolaging.2005.01.016; SCHIPPER HM, 1995, ANN NEUROL, V37, P758, DOI 10.1002/ana.410370609; Schipper HM, 2011, J NEURAL TRANSM, V118, P381, DOI 10.1007/s00702-010-0436-1; Schipper HM, 2009, J NEUROCHEM, V110, P469, DOI 10.1111/j.1471-4159.2009.06160.x; Schopfer FJ, 2003, TRENDS BIOCHEM SCI, V28, P646, DOI 10.1016/j.tibs.2003.10.006; Seyidova D, 2004, IN VIVO, V18, P325; Soleas GJ, 1997, J CLIN LAB ANAL, V11, P287, DOI 10.1002/(SICI)1098-2825(1997)11:5<287::AID-JCLA6>3.0.CO;2-4; Stepanichev M Yu, 2006, Neurosci Behav Physiol, V36, P101, DOI 10.1007/s11055-005-0167-1; Su B, 2008, CURR ALZHEIMER RES, V5, P525, DOI 10.2174/156720508786898451; Terai K, 1996, BRAIN RES, V735, P159; Tillerson JL, 2002, EXP NEUROL, V178, P80, DOI 10.1006/exnr.2002.8021; van Marum RJ, 2008, FUND CLIN PHARMACOL, V22, P265, DOI 10.1111/j.1472-8206.2008.00578.x; Wang QW, 2004, J NEUROSCI, V24, P6049, DOI 10.1523/JNEUROSCI.0233-04.2004; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Wimo A, 2003, ALZ DIS ASSOC DIS, V17, P63, DOI 10.1097/00002093-200304000-00002; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yet SF, 2003, FASEB J, V17, P1759, DOI 10.1096/fj.03-0187fje	55	60	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29102	10.1371/journal.pone.0029102	http://dx.doi.org/10.1371/journal.pone.0029102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220203	Green Published, Green Submitted, gold			2022-12-27	WOS:000300677000016
J	Lvovschi, V; Arnaud, L; Parizot, C; Freund, Y; Juillien, G; Ghillani-Dalbin, P; Bouberima, M; Larsen, M; Riou, B; Gorochov, G; Hausfater, P				Lvovschi, Virginie; Arnaud, Laurent; Parizot, Christophe; Freund, Yonathan; Juillien, Gaelle; Ghillani-Dalbin, Pascale; Bouberima, Mohammed; Larsen, Martin; Riou, Bruno; Gorochov, Guy; Hausfater, Pierre			Cytokine Profiles in Sepsis Have Limited Relevance for Stratifying Patients in the Emergency Department: A Prospective Observational Study	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SYSTEMIC INFLAMMATORY RESPONSE; C-REACTIVE PROTEIN; SEPTIC SHOCK; PLASMA CYTOKINE; PROCALCITONIN; SERUM; MARKER; MORTALITY; INFECTION	Introduction: Morbidity, mortality and social cost of sepsis are high. Previous studies have suggested that individual cytokines levels could be used as sepsis markers. Therefore, we assessed whether the multiplex technology could identify useful cytokine profiles in Emergency Department (ED) patients. Methods: ED patients were included in a single tertiary-care center prospective study. Eligible patients were >18 years and met at least one of the following criteria: fever, suspected systemic infection, >= 2 systemic inflammatory response syndrome (SIRS) criteria, hypotension or shock. Multiplex cytokine measurements were performed on serum samples collected at inclusion. Associations between cytokine levels and sepsis were assessed using univariate and multivariate logistic regressions, principal component analysis (PCA) and agglomerative hierarchical clustering (AHC). Results: Among the 126 patients (71 men, 55 women; median age: 54 years [19-96 years]) included, 102 had SIRS (81%), 55 (44%) had severe sepsis and 10 (8%) had septic shock. Univariate analysis revealed weak associations between cytokine levels and sepsis. Multivariate analysis revealed independent association between sIL-2R (p = 0.01) and severe sepsis, as well as between sIL-2R (p = 0.04), IL-1 beta (p = 0.046), IL-8 (p = 0.02) and septic shock. However, neither PCA nor AHC distinguished profiles characteristic of sepsis. Conclusions: Previous non-multiparametric studies might have reached inappropriate conclusions. Indeed, well-defined clinical conditions do not translate into particular cytokine profiles. Additional and larger trials are now required to validate the limited interest of expensive multiplex cytokine profiling for staging septic patients.	[Lvovschi, Virginie; Freund, Yonathan; Juillien, Gaelle; Riou, Bruno; Hausfater, Pierre] Hop La Pitie Salpetriere, AP HP, Emergency Dept, Paris, France; [Lvovschi, Virginie; Arnaud, Laurent; Larsen, Martin; Gorochov, Guy] INSERM, UMR S 945, Paris, France; [Lvovschi, Virginie; Arnaud, Laurent; Parizot, Christophe; Ghillani-Dalbin, Pascale; Larsen, Martin; Gorochov, Guy] Hop La Pitie Salpetriere, AP HP, Dept Immunol, Paris, France; [Freund, Yonathan; Larsen, Martin; Riou, Bruno; Gorochov, Guy; Hausfater, Pierre] Univ Paris 06, Paris, France; [Bouberima, Mohammed] Hop La Pitie Salpetriere, Emergency Biol Lab, Paris, France; [Riou, Bruno; Hausfater, Pierre] INSERM, UMR S 956, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lvovschi, V (corresponding author), Hop La Pitie Salpetriere, AP HP, Emergency Dept, Paris, France.	guy.gorochov@psl.aphp.fr; pierre.hausfater@psl.aphp.fr	Larsen, Martin/A-7316-2014; Gorochov, Guy/P-2911-2017	Larsen, Martin/0000-0003-1375-4816; PARIZOT, Christophe/0000-0001-5723-4471; ARNAUD, Laurent/0000-0002-8077-8394; Gorochov, Guy/0000-0003-2097-9677; Freund, Yonathan/0000-0002-0262-3848	Institut National de la Sante et de la Recherche Medicale, The Assistance Publique - Hopitaux de Paris; UPMC through "Leg Tessier"	Institut National de la Sante et de la Recherche Medicale, The Assistance Publique - Hopitaux de Paris; UPMC through "Leg Tessier"	This work was supported by Institut National de la Sante et de la Recherche Medicale, The Assistance Publique - Hopitaux de Paris and UPMC through "Leg Tessier". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto H, 2004, EUR J CLIN MICROBIOL, V23, P699, DOI 10.1007/s10096-004-1191-8; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; CALANDRA T, 1991, AM J MED, V91, P23, DOI 10.1016/0002-9343(91)90069-A; CALANDRA T, 1990, J INFECT DIS, V161, P982, DOI 10.1093/infdis/161.5.982; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Claeys R, 2002, CRIT CARE MED, V30, P757, DOI 10.1097/00003246-200204000-00006; Damas P, 1997, CRIT CARE MED, V25, P405, DOI 10.1097/00003246-199703000-00006; De Freitas I, 2004, CHEST, V125, P2238, DOI 10.1378/chest.125.6.2238; Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S; Feezor RJ, 2003, INFECT IMMUN, V71, P5803, DOI 10.1128/IAI.71.10.5803-5813.2003; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Hausfater P, 2002, CLIN INFECT DIS, V34, P895, DOI 10.1086/339198; Hausfater P, 2007, CRIT CARE, V11, DOI 10.1186/cc5926; Heffner AC, 2010, CLIN INFECT DIS, V50, P814, DOI 10.1086/650580; Heper Y, 2006, EUR J CLIN MICROBIOL, V25, P481, DOI 10.1007/s10096-006-0168-1; Kofoed K, 2006, CLIN CHEM, V52, P1284, DOI 10.1373/clinchem.2006.067595; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mauri T, 2010, INTENS CARE MED, V36, P621, DOI 10.1007/s00134-010-1752-5; Mera S, 2011, APMIS, V119, P155, DOI 10.1111/j.1600-0463.2010.02705.x; MICHIE HR, 1988, NEW ENGL J MED, V318, P1481, DOI 10.1056/NEJM198806093182301; Oberholzer A, 2005, SHOCK, V23, P488, DOI 10.1097/01.shk.0000163802.46355.59; PINSKY MR, 1993, CHEST, V103, P565, DOI 10.1378/chest.103.2.565; Reinhart K, 2000, INTENS CARE MED, V26, P1193, DOI 10.1007/s001340000624; Selberg O, 2000, CRIT CARE MED, V28, P2793, DOI 10.1097/00003246-200008000-00019; Shapiro NI, 2003, CRIT CARE MED, V31, P670, DOI 10.1097/01.CCM.0000054867.01688.D1; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; van Dissel JT, 1998, LANCET, V351, P950, DOI 10.1016/S0140-6736(05)60606-X; Vermont CL, 2006, CRIT CARE, V10, DOI 10.1186/cc4836; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	32	46	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e28870	10.1371/journal.pone.0028870	http://dx.doi.org/10.1371/journal.pone.0028870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220196	Green Submitted, Green Published, gold			2022-12-27	WOS:000300677000008
J	Drullion, D; Dubois, F				Drullion, Dominique; Dubois, Frederique			Neighbours' Breeding Success and the Sex Ratio of Their Offspring Affect the Mate Preferences of Female Zebra Finches	PLOS ONE			English	Article							CONSPECIFIC REPRODUCTIVE SUCCESS; WILD BIRD POPULATION; PUBLIC INFORMATION; HABITAT SELECTION; TAENIOPYGIA-GUTTATA; DIVORCE; TIT; ATTRACTIVENESS; PERFORMANCE; ALLOCATION	Several hypotheses on divorce predict that monogamous pairs should split up more frequently after a breeding failure. Yet, deviations from the expected pattern "success-stay, failure-leave" have been reported in several species. One possible explanation for these deviations would be that individuals do not use only their own breeding performance (i.e., private information) but also that of others (i.e., public information) to decide whether or not to divorce. To test this hypothesis, we investigated the relative importance of private and public information for mate choice decisions in female zebra finches (Taeniopygia guttata). We manipulated the reproductive performance of breeding pairs and measured females' preferences for their mate and the neighbouring male first following pair formation and then seven weeks later when all females had laid eggs and the young were independent. Although all females reduced their preference for their mate after a breeding failure, the decrease was significant only when the neighbouring pair had reproduced successfully. Furthermore, there was no evidence that females biased the sex ratio of their offspring according to their mate's attractiveness. On the other hand, after reproduction, both successful and unsuccessful females increased their preferences for males who had produced a larger proportion of sons. Despite the fact that other mechanisms may have also contributed to our findings, we suggest that females changed their mate preferences based on the proportion of sons produced by successful males, because offspring sex ratio reflects the male's testosterone level at the moment of fertilization and hence is an indicator of his immune condition.	[Drullion, Dominique; Dubois, Frederique] Univ Montreal, Dept Sci Biol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Drullion, D (corresponding author), Univ Montreal, Dept Sci Biol, CP 6128, Montreal, PQ H3C 3J7, Canada.	frederique.dubois@UMontreal.ca			Natural Sciences and Engineering Research Council (Canada) [R0013057]	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	D. Drullion was supported by research grants awarded to F. Dubois by the Natural Sciences and Engineering Research Council (Canada) http://www.nserc-crsng.gc.ca/Index_eng.asp (grant number: R0013057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Bonier F, 2007, BEHAV ECOL, V18, P1045, DOI 10.1093/beheco/arm075; Boulinier T, 1997, EVOL ECOL, V11, P505, DOI 10.1007/s10682-997-1507-0; BURLEY N, 1986, AM NAT, V127, P415, DOI 10.1086/284493; BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; CHOUDHURY S, 1995, ANIM BEHAV, V50, P413, DOI 10.1006/anbe.1995.0256; COULSON JC, 1966, J ANIM ECOL, V35, P269, DOI 10.2307/2394; Danchin E, 1998, ECOLOGY, V79, P2415, DOI 10.2307/176832; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Doligez B, 2003, ANIM BEHAV, V66, P973, DOI 10.1006/anbe.2002.2270; Doligez B, 2002, SCIENCE, V297, P1168, DOI 10.1126/science.1072838; Drullion D, 2008, BEHAV ECOL SOCIOBIOL, V63, P269, DOI 10.1007/s00265-008-0658-5; Dubois F, 2002, BEHAV ECOL SOCIOBIOL, V52, P357, DOI 10.1007/s00265-002-0521-z; Dubois F, 2007, MATE CHOICE COPYING; Ellegren H, 1996, P NATL ACAD SCI USA, V93, P11723, DOI 10.1073/pnas.93.21.11723; ENS BJ, 1993, ANIM BEHAV, V45, P1199, DOI 10.1006/anbe.1993.1142; Gam AE, 2011, J AVIAN BIOL, V42, P253, DOI 10.1111/j.1600-048X.2010.05251.x; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hatchwell BJ, 2000, P ROY SOC B-BIOL SCI, V267, P813, DOI 10.1098/rspb.2000.1076; James WH, 2008, J ENDOCRINOL, V198, P3, DOI 10.1677/JOE-07-0446; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Kolliker M, 1999, BEHAV ECOL, V10, P68, DOI 10.1093/beheco/10.1.68; Naves LC, 2006, OIKOS, V115, P263; ORELL M, 1994, ANIM BEHAV, V48, P1143, DOI 10.1006/anbe.1994.1347; Pike TW, 2006, P ROY SOC B-BIOL SCI, V273, P1093, DOI 10.1098/rspb.2005.3422; Rutkowska J, 2006, ANIM BEHAV, V71, P1283, DOI 10.1016/j.anbehav.2005.07.025; Rutstein AN, 2004, ANIM BEHAV, V68, P1087, DOI 10.1016/j.anbehav.2004.02.011; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; SULLIVAN MS, 1994, ANIM BEHAV, V47, P141, DOI 10.1006/anbe.1994.1016; Svensson E, 1996, P ROY SOC B-BIOL SCI, V263, P357, DOI 10.1098/rspb.1996.0055; Swaddle JP, 2005, P ROY SOC B-BIOL SCI, V272, P1053, DOI 10.1098/rspb.2005.3054; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Valone TJ, 2007, BEHAV ECOL SOCIOBIOL, V62, P1, DOI 10.1007/s00265-007-0439-6; Zann R. A., 1996, ZEBRA FINCHES SYNTHE; Zuk M, 1996, ECOLOGY, V77, P1037, DOI 10.2307/2265574	35	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29737	10.1371/journal.pone.0029737	http://dx.doi.org/10.1371/journal.pone.0029737			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216351	Green Published, Green Submitted, gold			2022-12-27	WOS:000300676300081
J	Dobler, CC; McDonald, SP; Marks, GB				Dobler, Claudia C.; McDonald, Stephen P.; Marks, Guy B.			Risk of Tuberculosis in Dialysis Patients: A Nationwide Cohort Study	PLOS ONE			English	Article							DENDRITIC CELL-FUNCTION; NOTIFICATIONS; AUSTRALIA; MONOCYTE	Background: The ability to identify individuals at increased risk of developing tuberculosis (TB) has important implications for public health policy and patient care. We conducted a general population historical cohort study in all Australian States and Territories to establish the risk of TB arising in people on chronic hemo- or peritoneal dialysis. Methodology/Principal Findings: Cases of TB disease in patients receiving chronic dialysis were identified by record linkage using the Australia & New Zealand Dialysis and Transplant Registry (ANZDATA) and State and Territory TB notification databases 2001 to 2006. Main outcome measure was the relative risk of TB in people on dialysis, adjusted for TB incidence in country of birth, sex, age and indigenous status. A total of 6,276 cases of active TB were reported among 19,855,283 people living in Australia between 2001 and 2006. Among 14,506 patients on dialysis, 37 had a notification for TB disease after commencing dialysis, of whom 28 were culture positive. The incidence of TB was 66.8/100,000/year (95% Cl 47.7 to 93.2) among people on dialysis and 5.7/100,000/year (95% Cl 5.5 to 5.8) in the general population. The adjusted relative risk (aRR) of TB in people on dialysis was 7.8 (95% Cl 3.3 to 18.7), and the aRR of culture positive TB was 8.6 (95% Cl 3.9 to 19.3). Conclusions/Significance: Patients on dialysis are at increased risk of TB. The final decision to screen for, and to treat, LTBI in individual dialysis patients will be influenced by a cumulative assessment of the risk of reactivation of TB and by assessment of risk factors for adverse effects of treatment.	[Dobler, Claudia C.; Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Dobler, Claudia C.; Marks, Guy B.] Liverpool Hosp, Dept Resp Med, Sydney, NSW, Australia; [McDonald, Stephen P.] Austrailia & New Zealand Dialysis & Transplant AN, Adelaide, SA, Australia; [McDonald, Stephen P.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia	University of Sydney; Woolcock Institute of Medical Research; Liverpool Hospital; University of Adelaide	Dobler, CC (corresponding author), Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia.	cdobler@med.usyd.edu.au	Marks, Guy B./F-5058-2013; McDonald, Stephen/G-4010-2013	Marks, Guy B./0000-0002-8976-8053; McDonald, Stephen/0000-0001-6103-1386; Dobler, Claudia/0000-0002-5460-0189	Sydney South West Research Foundation	Sydney South West Research Foundation	The study was funded by a grant from the Sydney South West Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AT, 2004, INT J TUBERC LUNG D, V8, P341; [Anonymous], 1995, MMWR Recomm Rep, V44, P19; Australian Bureau of Statistics (ABS), 2012, 47130 ABS; Barry C, 2009, COMMUN DIS INTELL, V33, P304; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; Chan TYK, 2000, CALCIFIED TISSUE INT, V66, P476, DOI 10.1007/s002230010095; Chia S, 1998, INT J TUBERC LUNG D, V2, P989; Chou KJ, 2001, NEPHRON, V88, P138, DOI 10.1159/000045974; Fleiss JL., 1981, STAT METHODS RATES P, P14; GIBBONS RAS, 1990, CLIN IMMUNOL IMMUNOP, V56, P66, DOI 10.1016/0090-1229(90)90170-U; Girndt M, 1999, NEPHROL DIAL TRANSPL, V14, P2807, DOI 10.1093/ndt/14.12.2807; Hussein MM, 2003, SEMIN DIALYSIS, V16, P38, DOI 10.1046/j.1525-139X.2003.03010.x; KAY N E, 1986, Blood Purification, V4, P120, DOI 10.1159/000169435; Lim WH, 2007, KIDNEY INT, V72, P1138, DOI 10.1038/sj.ki.5002425; Lim WH, 2007, KIDNEY INT, V71, P1122, DOI 10.1038/sj.ki.5002196; Lui SL, 2001, AM J KIDNEY DIS, V38, P1055, DOI 10.1053/ajkd.2001.28599; McDonald S, 2011, ANZDATA REGISTRY REP; Menzies D, 2008, INT J TUBERC LUNG D, V12, P498; Milburn H, 2010, THORAX, V65, P559, DOI 10.1136/thx.2009.133173; *NAT CTR HIV EP CL, 2006, HIV AIDS VIR HEP SEX; PRADHAN RP, 1974, JAMA-J AM MED ASSOC, V229, P798, DOI 10.1001/jama.229.7.798; Roche PW, 2008, COMMUN DIS INTELL, V32, P1; Simon TA, 1999, INFECT CONT HOSP EP, V20, P607, DOI 10.1086/501679; Singh M., 2002, AIHW B; Stewart JH, 2004, NEPHROLOGY, V9, P247, DOI 10.1111/j.1440-1797.2004.00258.x; Tubach F, 2009, ARTHRITIS RHEUM-US, V60, P1884, DOI 10.1002/art.24632; Tzanno-Martins C, 2000, NEPHRON, V84, P224, DOI 10.1159/000045581; WALTER SD, 1978, INT J EPIDEMIOL, V7, P175, DOI 10.1093/ije/7.2.175; World Health Organization, 2011, GLOB TUB DAT	29	49	53	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29563	10.1371/journal.pone.0029563	http://dx.doi.org/10.1371/journal.pone.0029563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216316	Green Published, Green Submitted, gold			2022-12-27	WOS:000300674900043
J	Ludgate, L; Adams, C; Hu, JM				Ludgate, Laurie; Adams, Christina; Hu, Jianming			Phosphorylation State-Dependent Interactions of Hepadnavirus Core Protein with Host Factors	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; STRAND DNA-SYNTHESIS; CAPSID PROTEIN; NUCLEOLAR PROTEIN; REVERSE TRANSCRIPTION; NUCLEAR-LOCALIZATION; C-TERMINUS; VIRAL REPLICATION; BINDING-ACTIVITY; COMPLEX	Dynamic phosphorylation and dephosphorylation of the hepadnavirus core protein C-terminal domain (CTD) are required for multiple steps of the viral life cycle. It remains unknown how the CTD phosphorylation state may modulate core protein functions but phosphorylation state-dependent viral or host interactions may play a role. In an attempt to identify host factors that may interact differentially with the core protein depending on its CTD phosphorylation state, pulldown assays were performed using the CTD of the duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) core protein, either with wild type (WT) sequences or with alanine or aspartic acid substitutions at the phosphorylation sites. Two host proteins, B23 and I2PP2A, were found to interact preferentially with the alanine-substituted CTD. Furthermore, the WT CTD became competent to interact with the host proteins upon dephosphorylation. Intriguingly, the binding site on the DHBV CTD for both B23 and I2PP2A was mapped to a region upstream of the phosphorylation sites even though B23 or I2PP2A binding to this site was clearly modulated by the phosphorylation state of the downstream and non-overlapping sequences. Together, these results demonstrate a novel mode of phosphorylation-regulated protein-protein interaction and provide new insights into virus-host interactions.	[Ludgate, Laurie; Adams, Christina; Hu, Jianming] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ludgate, L (corresponding author), Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA.	juh13@psu.edu			National Institutes of Health [R01AI43453]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043453, R01AI043453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Public Health Service grant, R01AI43453, from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basagoudanavar SH, 2007, J VIROL, V81, P1641, DOI 10.1128/JVI.01671-06; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; CHEN Y, 1994, J VIROL, V68, P5232, DOI 10.1128/JVI.68.8.5232-5238.1994; CROWTHER RA, 1994, CELL, V77, P943, DOI 10.1016/0092-8674(94)90142-2; Daub H, 2002, J VIROL, V76, P8124, DOI 10.1128/JVI.76.16.8124-8137.2002; FANKHAUSER C, 1991, MOL CELL BIOL, V11, P2567, DOI 10.1128/MCB.11.5.2567; Gazina EV, 2000, J VIROL, V74, P4721, DOI 10.1128/JVI.74.10.4721-4728.2000; HAKES DJ, 1992, ANAL BIOCHEM, V202, P293, DOI 10.1016/0003-2697(92)90108-J; HIRSCH RC, 1990, NATURE, V344, P552, DOI 10.1038/344552a0; Hu JM, 2000, J VIROL, V74, P11447, DOI 10.1128/JVI.74.24.11447-11455.2000; Hunt TA, 2007, CELL MICROBIOL, V9, P2756, DOI 10.1111/j.1462-5822.2007.01046.x; JILBERT AR, 1992, J VIROL, V66, P1377, DOI 10.1128/JVI.66.3.1377-1388.1992; Kann M, 1999, J CELL BIOL, V145, P45, DOI 10.1083/jcb.145.1.45; Kau JH, 1998, J VIROL, V72, P3796, DOI 10.1128/JVI.72.5.3796-3803.1998; Kock J, 2003, J BIOL CHEM, V278, P28123, DOI 10.1074/jbc.M300064200; Lan YT, 1999, VIROLOGY, V259, P342, DOI 10.1006/viro.1999.9798; Lewellyn EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017202; Li HC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001162; Li J, 2006, J BIOL CHEM, V281, P16536, DOI 10.1074/jbc.M601386200; LIAO W, 1995, J VIROL, V69, P1025, DOI 10.1128/JVI.69.2.1025-1029.1995; Mabit H, 2003, J VIROL, V77, P2157, DOI 10.1128/JVI.77.3.2157-2164.2003; Mabit H, 2001, J VIROL, V75, P1968, DOI 10.1128/JVI.75.4.1968-1977.2001; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nguyen DH, 2008, J VIROL, V82, P6852, DOI 10.1128/JVI.00465-08; Okuwaki M, 2002, MOL BIOL CELL, V13, P2016, DOI 10.1091/mbc.02-03-0036; Okuwaki M, 2001, J MOL BIOL, V311, P41, DOI 10.1006/jmbi.2001.4812; Okuwaki M, 1998, J BIOL CHEM, V273, P34511, DOI 10.1074/jbc.273.51.34511; Perlman DH, 2005, P NATL ACAD SCI USA, V102, P9020, DOI 10.1073/pnas.0502138102; Rabe B, 2003, P NATL ACAD SCI USA, V100, P9849, DOI 10.1073/pnas.1730940100; Scaglioni PP, 1997, J VIROL, V71, P345, DOI 10.1128/JVI.71.1.345-353.1997; SCHLICHT HJ, 1989, J VIROL, V63, P2995, DOI 10.1128/JVI.63.7.2995-3000.1989; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shim HY, 2011, VIROLOGY, V410, P161, DOI 10.1016/j.virol.2010.11.005; Sohn SY, 2006, J GEN VIROL, V87, P1883, DOI 10.1099/vir.0.81684-0; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Szebeni A, 1997, BIOCHEMISTRY-US, V36, P3941, DOI 10.1021/bi9627931; SZEBENI A, 1995, BIOCHEMISTRY-US, V34, P8037, DOI 10.1021/bi00025a009; Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1; VENKATESH LK, 1990, VIROLOGY, V176, P39, DOI 10.1016/0042-6822(90)90228-J; WANG DR, 1994, J BIOL CHEM, V269, P30994; Wang XT, 2002, J BIOL CHEM, V277, P24361, DOI 10.1074/jbc.M202198200; Weigand K, 2010, J GEN VIROL, V91, P59, DOI 10.1099/vir.0.013698-0; WINGFIELD PT, 1995, BIOCHEMISTRY-US, V34, P4919, DOI 10.1021/bi00015a003; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Yan N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000327; YU MS, 1991, J VIROL, V65, P2511, DOI 10.1128/JVI.65.5.2511-2517.1991; YU MS, 1994, J VIROL, V68, P2965, DOI 10.1128/JVI.68.5.2965-2969.1994; YU MS, 1994, J VIROL, V68, P4341, DOI 10.1128/JVI.68.7.4341-4348.1994; Zlotnick A, 1996, BIOCHEMISTRY-US, V35, P7412, DOI 10.1021/bi9604800	52	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29566	10.1371/journal.pone.0029566	http://dx.doi.org/10.1371/journal.pone.0029566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216318	gold, Green Published, Green Submitted			2022-12-27	WOS:000299684700070
J	Ren, DB; Xie, H; Zhang, WH; Hassan, F; Petralia, RS; Yu, SQ; Lim, DJ; Gu, XX				Ren, Dabin; Xie, Hang; Zhang, Wenhong; Hassan, Ferdaus; Petralia, Ronald S.; Yu, Shengqing; Lim, David J.; Gu, Xin-Xing			Intranasal Immunization of the Combined Lipooligosaccharide Conjugates Protects Mice from the Challenges with Three Serotypes of Moraxella catarrhalis	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; BRANHAMELLA-CATARRHALIS; MONOCLONAL-ANTIBODIES; VACCINE CANDIDATES; OTITIS-MEDIA; LIPOPOLYSACCHARIDE; OLIGOSACCHARIDES; INFECTIONS; RESPONSES; ANTIGENS	Background: There are no licensed vaccines available against Moraxella catarrhalis, a significant human respiratory pathogen. Lipooligosaccharide (LOS) based conjugate vaccines derived from individual serotype M. catarrhalis only showed partial protection coverage. A vaccine combining LOS conjugates of two or three serotypes might provide a broader protection. Methods: Mice were immunized intranasally with the combined conjugates consisting of LOS from serotype A and B or serotype A, B, and C followed by challenge with different M. catarrhalis strains of three serotypes. Mouse lungs, nasal washes, and sera were collected after each challenge for bacterial counts, histological evaluation, cytokine profiles, antibody level and binding activity determinations. Results: Intranasal administration of the combined LOS conjugates not only enhanced pulmonary bacterial clearance of all three serotypes of M. catarrhalis strains in vaccinated mice, but also elevated serotype-specific anti-LOS immunoglobulin (Ig)A and IgG titers in nasal wash and serum respectively. Mice vaccinated with the combined LOS conjugates also showed increased interferon (IFN)-gamma, interleukin (IL)-12, and IL-4 in the lungs after challenges. Compared to the control group, mice immunized with the combined LOS conjugates also showed reduced lung inflammation after M. catarrhalis infections. The hyperimmune sera induced by the combined conjugates exhibited a broad cross-reactivity toward all three serotypes of M. catarrhalis under transmission electron microscopy. Conclusions: The combined vaccine of serotype A and B LOS conjugates provides protection against most M. catarrhalis strains by eliciting humoral and cellular immune responses.	[Ren, Dabin; Zhang, Wenhong; Hassan, Ferdaus; Yu, Shengqing; Gu, Xin-Xing] NIDCD, Vaccine Res Sect, NIH, Rockville, MD USA; [Xie, Hang] US FDA, Lab Resp Viral Dis, Off Vaccines Res & Review, Div Viral Prod,Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Petralia, Ronald S.] NIDCD, Sect Neurotransmitter Receptor Biol, NIH, Bethesda, MD USA; [Lim, David J.] House Ear Res Inst, Sect Pathogenesis Ear Dis, Los Angeles, CA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); House Research Institute	Ren, DB (corresponding author), Mercer Univ, Sch Med, Div Basic Med Sci, Macon, GA 31207 USA.	guxx@mail.nih.gov	Ren, Dabin/H-6263-2013; Xie, Hang/AAC-9092-2019	Xie, Hang/0000-0001-8318-5554	National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), United States of America [NIH0010103632]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000003, ZICDC000081] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), United States of America; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by the Intramural Research Program of the National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), United States of America (#NIH0010103632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi C, 1998, INFECT IMMUN, V66, P540, DOI 10.1128/IAI.66.2.540-548.1998; Brandtzaeg P, 2003, INT J MED MICROBIOL, V293, P3, DOI 10.1078/1438-4221-00241; Chen DX, 1996, INFECT IMMUN, V64, P1900, DOI 10.1128/IAI.64.6.1900-1905.1996; EDEBRINK P, 1994, CARBOHYD RES, V257, P269, DOI 10.1016/0008-6215(94)80040-5; EDEBRINK P, 1995, CARBOHYD RES, V266, P237, DOI 10.1016/0008-6215(94)00276-L; Edebrink P, 1996, CARBOHYD RES, V295, P127, DOI 10.1016/S0008-6215(96)90132-9; GOLDBLUM RM, 1996, IMMUNOLOGIC DISORDER, P159; Gu XX, 1998, INFECT IMMUN, V66, P1891, DOI 10.1128/IAI.66.5.1891-1897.1998; Hu EG, 2000, INFECT IMMUN, V68, P4980, DOI 10.1128/IAI.68.9.4980-4985.2000; Hu WG, 1999, VACCINE, V18, P799, DOI 10.1016/S0264-410X(99)00335-7; Jiao XN, 2002, INFECT IMMUN, V70, P5982, DOI 10.1128/IAI.70.11.5982-5989.2002; KLEIN JO, 1994, CLIN INFECT DIS, V19, P823, DOI 10.1093/clinids/19.5.823; Lee CJ, 2005, CRIT REV MICROBIOL, V31, P137, DOI 10.1080/10408410591005093; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Mawas F, 2009, EXPERT REV VACCINES, V8, P77, DOI 10.1586/14760584.8.1.77; McGhee J.R.C., 1999, MUCOSAL IMMUNOL, Vsecond, P741; McMichael JC, 2000, MICROBES INFECT, V2, P561, DOI 10.1016/S1286-4579(00)00310-5; McMichael JC, 2000, VACCINE, V19, pS101, DOI 10.1016/S0264-410X(00)00287-5; MURPHY S, 1983, PEDIATRICS, V72, P1; Murphy TF, 2005, AM J RESP CRIT CARE, V172, P195, DOI 10.1164/rccm.200412-1747OC; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; OISHI K, 1992, J INFECT DIS, V165, P34, DOI 10.1093/infdis/165.1.34; Rahman M, 1998, MICROB PATHOGENESIS, V24, P299, DOI 10.1006/mpat.1997.0191; Tan TT, 2006, INFECT IMMUN, V74, P6377, DOI 10.1128/IAI.00702-06; Ton TT, 2007, EXPERT REV VACCINES, V6, P949, DOI 10.1586/14760584.6.6.949; VANEECHOUTTE M, 1990, J CLIN MICROBIOL, V28, P182, DOI 10.1128/JCM.28.2.182-187.1990; Welsh DA, 2001, MED CLIN N AM, V85, P1329, DOI 10.1016/S0025-7125(05)70383-7; Xie H, 2008, CELL MICROBIOL, V10, P1453, DOI 10.1111/j.1462-5822.2008.01138.x; Yu SQ, 2007, INFECT IMMUN, V75, P2974, DOI 10.1128/IAI.01915-06; Yu SQ, 2005, INFECT IMMUN, V73, P2790, DOI 10.1128/IAI.73.5.2790-2796.2005	30	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29553	10.1371/journal.pone.0029553	http://dx.doi.org/10.1371/journal.pone.0029553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216312	gold, Green Published, Green Submitted			2022-12-27	WOS:000299684700068
J	Barberi, TJ; Dunkle, A; He, YW; Racioppi, L; Means, AR				Barberi, Theresa J.; Dunkle, Alexis; He, You-Wen; Racioppi, Luigi; Means, Anthony R.			The Prolyl Isomerase Pin1 Modulates Development of CD8+cDC in Mice	PLOS ONE			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; COLONY-STIMULATING FACTOR; TRANSCRIPTION FACTOR; FLT3 LIGAND; PU.1; MACROPHAGE; EXPRESSION; CYCLE; ISOMERIZATION; SPECIFICATION	Background: Pin1 has previously been described to regulate cells that participate in both innate and adaptive immunity. Thus far, however, no role for Pin1 has been described in modulating conventional dendritic cells, innate antigen presenting cells that potently activate naive T cells, thereby bridging innate and adaptive immune responses. Methodology/Principal Findings: When challenged with LPS, Pin1-null mice failed to accumulate spleen conventional dendritic cells (cDC). Analysis of steady-state spleen DC populations revealed that Pin1-null mice had fewer CD8+ cDC. This defect was recapitulated by culturing Pin1-null bone marrow with the DC-instructive cytokine Flt3 Ligand. Additionally, injection of Flt3 Ligand for 9 days failed to induce robust expansion of CD8+ cDC in Pin1-null mice. Upon infection with Listeria monocytogenes, Pin1-null mice were defective in stimulating proliferation of adoptively transferred WT CD8+ T cells, suggesting that decreases in Pin1 null CD8+ cDC may affect T cell responses to infection in vivo. Finally, upon analyzing expression of proteins involved in DC development, elevated expression of PU.1 was detected in Pin1-null cells, which resulted from an increase in PU.1 protein half-life. Conclusions/Significance: We have identified a novel role for Pin1 as a modulator of CD8+ cDC development. Consistent with reduced numbers of CD8+ cDC in Pin1-null mice, we find that the absence of Pin1 impairs CD8+ T cell proliferation in response to infection with Listeria monocytogenes. These data suggest that, via regulation of CD8+ cDC production, Pin1 may serve as an important modulator of adaptive immunity.	[Barberi, Theresa J.; Means, Anthony R.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Dunkle, Alexis; He, You-Wen] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Racioppi, Luigi] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, Naples, Italy	Duke University; Duke University; University of Naples Federico II	Barberi, TJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.	tony.means@duke.edu	racioppi, luigi/GNP-0349-2022; racioppi, luigi/AGB-8665-2022	racioppi, luigi/0000-0002-9207-6752; 	National Institutes of Health [CA082846]; Department of Defense [W81XWH-08-1-0216]; NATIONAL CANCER INSTITUTE [R01CA082845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by National Institutes of Health (grant CA082846 to ARM http://www.nih.gov). Theresa Barberi received training support through a Department of Defense Breast Cancer Program pre-doctoral fellowship (W81XWH-08-1-0216, http://cdmrp.army.mil/bcrp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014656; Atchison FW, 2003, DEVELOPMENT, V130, P3579, DOI 10.1242/dev.00584; Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Busch DH, 1999, IMMUNOL LETT, V65, P93, DOI 10.1016/S0165-2478(98)00130-8; Carotta S, 2010, IMMUNOL REV, V238, P63, DOI 10.1111/j.1600-065X.2010.00955.x; Dahl R, 2007, J BIOL CHEM, V282, P6473, DOI 10.1074/jbc.M607613200; DeKoter RP, 2007, BLOOD CELL MOL DIS, V39, P316, DOI 10.1016/j.bcmd.2007.06.004; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Engel I, 2001, NAT REV IMMUNOL, V1, P193, DOI 10.1038/35105060; Esnault S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000226; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Gangenahalli GU, 2005, STEM CELLS DEV, V14, P140, DOI 10.1089/scd.2005.14.140; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hamdorf M, 2010, STEM CELLS; Hankey PA, 2009, FRONT BIOSCI-LANDMRK, V14, P5273, DOI 10.2741/3597; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hock H, 2006, CURR OPIN HEMATOL, V13, P1, DOI 10.1097/01.moh.0000190111.85284.8f; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Kapadia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019376; Kashiwada M, 2011, BLOOD, V117, P6193, DOI 10.1182/blood-2010-07-295873; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Liu WF, 2001, FEBS LETT, V496, P105, DOI 10.1016/S0014-5793(01)02411-5; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Mannel DN, 2007, INT J MED MICROBIOL, V297, P393, DOI 10.1016/j.ijmm.2007.03.005; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Marecki S, 2000, CELL BIOCHEM BIOPHYS, V33, P127, DOI 10.1385/CBB:33:2:127; McAleer JP, 2008, CRIT REV IMMUNOL, V28, P281; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Natoli G, 2011, GENE DEV, V25, P101, DOI 10.1101/gad.2018811; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; O'Keeffe M, 2002, BLOOD, V99, P2122, DOI 10.1182/blood.V99.6.2122; Phan RT, 2007, NAT IMMUNOL, V8, P1132, DOI 10.1038/ni1508; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Rankin L, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/281569; Rathinam C, 2005, IMMUNITY, V22, P717, DOI 10.1016/j.immuni.2005.04.007; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saito Y, 2010, BLOOD, V116, P3517, DOI 10.1182/blood-2010-03-277244; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Schmid MA, 2010, IMMUNOL REV, V234, P32, DOI 10.1111/j.0105-2896.2009.00877.x; Shen ZJ, 2008, J CLIN INVEST, V118, P479, DOI [10.1172/JC132789, 10.1172/JCI32789]; Shen ZJ, 2009, NAT IMMUNOL, V10, P257, DOI 10.1038/ni.1697; Shen ZJ, 2005, NAT IMMUNOL, V6, P1280, DOI 10.1038/ni1266; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Srinivasan S, 2010, CLIN VACCINE IMMUNOL, V17, P699, DOI 10.1128/CVI.00510-09; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Wang HS, 2009, IMMUNOL RES, V43, P109, DOI 10.1007/s12026-008-8055-8; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Watowich SS, 2010, IMMUNOL REV, V238, P76, DOI 10.1111/j.1600-065X.2010.00949.x; Winkler KE, 2000, SCIENCE, V287, P1644, DOI 10.1126/science.287.5458.1644; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Yeh ES, 2006, J BIOL CHEM, V281, P241, DOI 10.1074/jbc.M505770200; You H, 2002, J CELL BIOCHEM, V84, P211, DOI 10.1002/jcb.10037; Zanoni I, 2010, IMMUNOBIOLOGY, V215, P709, DOI 10.1016/j.imbio.2010.05.026; Zenke M, 2006, TRENDS IMMUNOL, V27, P140, DOI 10.1016/j.it.2005.12.007; Zhang N, 2008, J IMMUNOL, V180, P5506, DOI 10.4049/jimmunol.180.8.5506	69	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29808	10.1371/journal.pone.0029808	http://dx.doi.org/10.1371/journal.pone.0029808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	22238658	Green Published, gold, Green Submitted			2022-12-27	WOS:000301070200049
J	Caceres, N; Llopis, I; Marzo, E; Prats, C; Vilaplana, C; de Viedma, DG; Samper, S; Lopez, D; Cardona, PJ				Caceres, Neus; Llopis, Isaac; Marzo, Elena; Prats, Clara; Vilaplana, Cristina; Garcia de Viedma, Dario; Samper, Sofia; Lopez, Daniel; Cardona, Pere-Joan			Low Dose Aerosol Fitness at the Innate Phase of Murine Infection Better Predicts Virulence amongst Clinical Strains of Mycobacterium tuberculosis	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; LAG PHASE; GROWTH; RESISTANCE; EXPRESSION; EVOLUTION; SPREAD; AIR	Background: Evaluation of a quick and easy model to determine the intrinsic ability of clinical strains to generate active TB has been set by assuming that this is linked to the fitness of Mycobacterium tuberculosis strain at the innate phase of the infection. Thus, the higher the bacillary load, the greater the possibility of inducting liquefaction, and thus active TB, once the adaptive response is set. Methodology/Principal Findings: The virulence of seven clinical Mycobacterium tuberculosis strains isolated in Spain was tested by determining the bacillary concentration in the spleen and lung of mice at weeks 0, 1 and 2 after intravenous (IV) inoculation of 10(4) CFU, and by determining the growth in vitro until the stationary phase had been reached. Cord distribution automated analysis showed two clear patterns related to the high and low fitness in the lung after IV infection. This pattern was not seen in the in vitro fitness tests, which clearly favored the reference strain (H37Rv). Subsequent determination using a more physiological low-dose aerosol (AER) inoculation with 10(2) CFU showed a third pattern in which the three best values coincided with the highest dissemination capacity according to epidemiological data. Conclusions/Significance: The fitness obtained after low dose aerosol administration in the presence of the innate immune response is the most predictive factor for determining the virulence of clinical strains. This gives support to a mechanism of the induction of active TB derived from the dynamic hypothesis of latent tuberculosis infection.	[Caceres, Neus; Marzo, Elena; Vilaplana, Cristina; Cardona, Pere-Joan] Univ Autonoma Barcelona, Fundacio Inst Invest Ciencies Salut Germans Trias, Unitat TB Expt, Badalona, Catalonia, Spain; [Caceres, Neus; Marzo, Elena; Vilaplana, Cristina; Garcia de Viedma, Dario; Samper, Sofia; Cardona, Pere-Joan] CIBER Enfermedades Resp, Bunyola, Balears, Spain; [Llopis, Isaac; Prats, Clara; Lopez, Daniel] Univ Politecn Cataluna, Escola Super Agr Barcelona, Dept Fis & Engn Nucl, Castelldefels, Catalonia, Spain; [Garcia de Viedma, Dario] Hosp Gregorio Maranon, Serv Microbiol Clin & Enfermedades Infecciosas, Madrid, Spain; [Samper, Sofia] Inst Aragones Ciencias Salud, Zaragoza, Spain; [Samper, Sofia] Hosp Univ Miguel Servet, Zaragoza, Spain	Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universitat Politecnica de Catalunya; General University Gregorio Maranon Hospital; Miguel Servet University Hospital	Caceres, N (corresponding author), Univ Autonoma Barcelona, Fundacio Inst Invest Ciencies Salut Germans Trias, Unitat TB Expt, Badalona, Catalonia, Spain.	pjcardona@igtp.cat	Codina, Daniel Lopez/L-5309-2014; Prats, Clara/L-4797-2014; Marzo, Elena/AAG-7662-2020; Vilaplana, Cristina/K-7216-2012; de Viedma, Dario Garcia/D-6914-2018; Cardona, Pere-Joan/A-5258-2011; Codina, Daniel Lopez/Q-5959-2019	Codina, Daniel Lopez/0000-0002-0408-4526; Prats, Clara/0000-0002-1398-7559; Vilaplana, Cristina/0000-0002-2808-7270; de Viedma, Dario Garcia/0000-0003-3647-7110; Cardona, Pere-Joan/0000-0001-5623-7873; Codina, Daniel Lopez/0000-0002-0408-4526; Samper, Sofia/0000-0002-3011-2519	European Community [200999]	European Community(European Commission)	The research leading to these results has received funding from the European Community's 7th Framework Programme HEALTH-2007-2.3.2-2 (FP7/2007-2013: TOPLATENT-TB project under grant agreement 200999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar D, 2010, TUBERCULOSIS, V90, P319, DOI 10.1016/j.tube.2010.08.004; Alonso M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-151; BARNETT M, 1953, BRIT J EXP PATHOL, V34, P568; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Bishai WR, 1999, INFECT IMMUN, V67, P4931, DOI 10.1128/IAI.67.9.4931-4934.1999; BLOCH H, 1953, AM REV TUBERC PULM, V67, P629; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Caceres N, 2009, TUBERCULOSIS, V89, P175, DOI 10.1016/j.tube.2008.11.001; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; Cardona PJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/868246; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Chesney AM, 1916, J EXP MED, V24, P387, DOI 10.1084/jem.24.4.387; Converse PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010289; DARZINS E, 1956, DIS CHEST, V30, P642, DOI 10.1378/chest.30.6.642; Dietrich G, 2002, J BIOTECHNOL, V96, P259, DOI 10.1016/S0168-1656(02)00046-9; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Escombe AR, 2007, CLIN INFECT DIS, V44, P1349, DOI 10.1086/515397; Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC; Gao Q, 2004, TUBERCULOSIS, V84, P188, DOI 10.1016/j.tube.2003.12.013; Gillespie SH, 2001, INT J ANTIMICROB AG, V17, P171, DOI 10.1016/S0924-8579(00)00340-X; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003; Hall-Stoodley L, 2006, FEMS MICROBIOL LETT, V257, P43, DOI 10.1111/j.1574-6968.2006.00143.x; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Howard ST, 2006, MICROBIOL-SGM, V152, P1581, DOI 10.1099/mic.0.28625-0; Julian E, 2010, J BACTERIOL, V192, P1751, DOI 10.1128/JB.01485-09; Leemans JC, 2001, J IMMUNOL, V166, P4604, DOI 10.4049/jimmunol.166.7.4604; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Lodge RM, 1943, J CHEM SOC, P213, DOI 10.1039/jr9430000213; Lopez-Calleja Ana Isabel, 2009, BMC Pulm Med, V9, P3, DOI 10.1186/1471-2466-9-3; Louveau C, 2005, MICROBES INFECT, V7, P457, DOI 10.1016/j.micinf.2004.11.019; Martin A, 2007, CLIN MICROBIOL INFEC, V13, P1210, DOI 10.1111/j.1469-0691.2007.01820.x; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Mendelson M, 2005, TUBERCULOSIS, V85, P407, DOI 10.1016/j.tube.2005.08.004; Middelkoop K, 2009, J INFECT DIS, V200, P1207, DOI 10.1086/605930; MIDDLEBROOK G, 1947, J EXP MED, V86, P175, DOI 10.1084/jem.86.2.175; MIDDLEBROOK G, 1950, B NEW YORK ACAD MED, V26, P498; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; ORDWAY DJ, 1995, INFECT IMMUN, V63, P741, DOI 10.1128/IAI.63.2.741-743.1995; Palanisamy GS, 2008, TUBERCULOSIS, V88, P295, DOI 10.1016/j.tube.2007.12.003; Prats C, 2008, J THEOR BIOL, V252, P56, DOI 10.1016/j.jtbi.2008.01.019; RILEY RL, 1962, AM REV RESPIR DIS, V85, P511; Sleight SC, 2007, PHYSIOL BIOCHEM ZOOL, V80, P370, DOI 10.1086/518013; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Smith MA, 1998, CAN J MICROBIOL, V44, P351, DOI 10.1139/cjm-44-4-351; Toungoussova OS, 2004, FEMS IMMUNOL MED MIC, V42, P281, DOI 10.1016/j.femsim.2004.05.012; von Groll A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010191	48	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29010	10.1371/journal.pone.0029010	http://dx.doi.org/10.1371/journal.pone.0029010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235258	Green Published, gold			2022-12-27	WOS:000301123400019
J	Hirner, H; Gunes, C; Bischof, J; Wolff, S; Grothey, A; Kuh, M; Oswald, F; Wegwitz, F; Bosl, MR; Trauzold, A; Henne-Bruns, D; Peifer, C; Leithauser, F; Deppert, W; Knippschild, U				Hirner, Heidrun; Guenes, Cagatay; Bischof, Joachim; Wolff, Sonja; Grothey, Arnhild; Kueh, Marion; Oswald, Franz; Wegwitz, Florian; Boesl, Michael R.; Trauzold, Anna; Henne-Bruns, Doris; Peifer, Christian; Leithaeuser, Frank; Deppert, Wolfgang; Knippschild, Uwe			Impaired CK1 Delta Activity Attenuates SV40-Induced Cellular Transformation In Vitro and Mouse Mammary Carcinogenesis In Vivo	PLOS ONE			English	Article							LARGE-T-ANTIGEN; CASEIN-KINASE-I; SIMIAN-VIRUS-40 DNA-REPLICATION; WILD-TYPE P53; PROTEIN-KINASE; BREAST-CANCER; BETA-CATENIN; TRANSGENIC MICE; SV40-TRANSFORMED CELLS; MUTATIONAL ANALYSIS	Simian virus 40 (SV40) is a powerful tool to study cellular transformation in vitro, as well as tumor development and progression in vivo. Various cellular kinases, among them members of the CK1 family, play an important role in modulating the transforming activity of SV40, including the transforming activity of T-Ag, the major transforming protein of SV40, itself. Here we characterized the effects of mutant CK1 delta variants with impaired kinase activity on SV40-induced cell transformation in vitro, and on SV40-induced mammary carcinogenesis in vivo in a transgenic/bi-transgenic mouse model. CK1 delta mutants exhibited a reduced kinase activity compared to wtCK1 delta in in vitro kinase assays. Molecular modeling studies suggested that mutation N172D, located within the substrate binding region, is mainly responsible for impaired mutCK1 delta activity. When stably over-expressed in maximal transformed SV-52 cells, CK1 delta mutants induced reversion to a minimal transformed phenotype by dominant-negative interference with endogenous wtCK1 delta. To characterize the effects of CK1 delta on SV40-induced mammary carcinogenesis, we generated transgenic mice expressing mutant CK1 delta under the control of the whey acidic protein (WAP) gene promoter, and crossed them with SV40 transgenic WAP-T-antigen (WAP-T) mice. Both WAP-T mice as well as WAP-mutCK1 delta/WAP-T bi-transgenic mice developed breast cancer. However, tumor incidence was lower and life span was significantly longer in WAP-mutCK1 delta/WAP-T bi-transgenic animals. The reduced CK1 delta activity did not affect early lesion formation during tumorigenesis, suggesting that impaired CK1 delta activity reduces the probability for outgrowth of in situ carcinomas to invasive carcinomas. The different tumorigenic potential of SV40 in WAP-T and WAP-mutCK1 delta/WAP-T tumors was also reflected by a significantly different expression of various genes known to be involved in tumor progression, specifically of those involved in wnt-signaling and DNA repair. Our data show that inactivating mutations in CK1 delta impair SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo.	[Hirner, Heidrun; Bischof, Joachim; Wolff, Sonja; Grothey, Arnhild; Henne-Bruns, Doris; Knippschild, Uwe] Univ Ulm, Dept Gen Visceral & Transplantat Surg, Ulm, Germany; [Guenes, Cagatay] Univ Ulm, Inst Mol Med, Ulm, Germany; [Guenes, Cagatay] Univ Ulm, Max Planck Res Grp Stem Cell Aging, Ulm, Germany; [Kueh, Marion; Wegwitz, Florian; Deppert, Wolfgang] Leibniz Ctr Expt Virol, Heinrich Pette Inst, Dept Tumor Virol, Hamburg, Germany; [Oswald, Franz] Univ Ulm, Dept Internal Med 1, Ulm, Germany; [Boesl, Michael R.] Max Planck Inst, Max Planck Inst Neurobiol Transgen Mouse Models, Martinsried, Germany; [Trauzold, Anna] UK S H, CCCNorth, Inst Expt Canc Res, Div Mol Oncol, Kiel, Germany; [Peifer, Christian] Univ Kiel, Inst Pharm, Kiel, Germany; [Leithaeuser, Frank] Univ Kiel, Dept Pathol, D-2300 Kiel, Germany	Ulm University; Ulm University; Max Planck Society; Ulm University; Heinrich Pette Institute; Ulm University; Max Planck Society; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; University of Kiel	Hirner, H (corresponding author), Univ Gottingen, Dept Mol Oncol, Gottingen, Germany.	uwe.knippschild@uniklinik-ulm.de	Trauzold, Anna/P-4398-2014; Oswald, Franz/AAO-9584-2020		Deutsche Krebshilfe [102379, 108489]; Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit	Deutsche Krebshilfe(Deutsche Krebshilfe); Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit	This work was supported by grants from the Deutsche Krebshilfe, Dr. Mildred Scheel Stiftung, to Uwe Knippschild (102379 and 108489). The Heinrich-Pette-Institute is financially supported by the Freie und Hansestadt Hamburg and the Bundesministerium fur Gesundheit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali-Seyed M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-54; Alsheich-Bartok O, 2008, ONCOGENE, V27, P3653, DOI 10.1038/sj.onc.1211036; Barbanti-Brodano G, 2004, VIROLOGY, V318, P1, DOI 10.1016/j.virol.2003.09.004; BAUER M, 1987, J VIROL, V61, P1821, DOI 10.1128/JVI.61.6.1821-1827.1987; Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Boichuk S, 2010, J VIROL, V84, P8007, DOI 10.1128/JVI.00334-10; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Brockschmidt C, 2008, GUT, V57, P799, DOI 10.1136/gut.2007.123695; BURDON T, 1991, J BIOL CHEM, V266, P6909; CEGIELSKA A, 1994, J VIROL, V68, P269, DOI 10.1128/JVI.68.1.269-275.1994; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; CEGIELSKA A, 1993, MOL CELL BIOL, V13, P1202, DOI 10.1128/MCB.13.2.1202; Chen LH, 2005, MOL CELL BIOL, V25, P6509, DOI 10.1128/MCB.25.15.6509-6520.2005; DEPPERT W, 1991, ONCOGENE, V6, P1931; DEPPERT WR, 1992, J CHROMATOGR, V625, P13, DOI 10.1016/0021-9673(92)87216-U; Dumaz N, 1999, FEBS LETT, V463, P312, DOI 10.1016/S0014-5793(99)01647-6; Enam S, 2002, CANCER RES, V62, P7093; Farago M, 2005, CANCER RES, V65, P5792, DOI 10.1158/0008-5472.CAN-05-1021; Feng L, 2007, WORLD J GASTROENTERO, V13, P2218, DOI 10.3748/wjg.v13.i15.2218; Frierson HF, 2002, AM J PATHOL, V161, P1315, DOI 10.1016/S0002-9440(10)64408-2; Gan DD, 2004, ONCOGENE, V23, P483, DOI 10.1038/sj.onc.1207018; Giamas G, 2007, BIOCHEM J, V406, P389, DOI 10.1042/BJ20070091; GLINEUR C, 1990, GENE DEV, V4, P1663, DOI 10.1101/gad.4.10.1663; GRAESSMANN M, 1983, METHOD ENZYMOL, V101, P482; GRASSER FA, 1988, VIROLOGY, V165, P13, DOI 10.1016/0042-6822(88)90653-8; GURNEY EG, 1986, J VIROL, V57, P1168, DOI 10.1128/JVI.57.3.1168-1172.1986; Heinlein C, 2008, INT J CANCER, V122, P1701, DOI 10.1002/ijc.23317; Hermannstadter A, 2009, J VIROL, V83, P10106, DOI 10.1128/JVI.00174-09; Higashimoto Y, 2000, J BIOL CHEM, V275, P23199, DOI 10.1074/jbc.M002674200; Ho Y, 1997, P NATL ACAD SCI USA, V94, P581, DOI 10.1073/pnas.94.2.581; HOEKSTRA MF, 1991, SCIENCE, V253, P1031, DOI 10.1126/science.1887218; Honaker Y, 2010, ONCOGENE, V29, P3324, DOI 10.1038/onc.2010.96; Huart AS, 2009, J BIOL CHEM, V284, P32384, DOI 10.1074/jbc.M109.052647; Husler MR, 1998, TRANSGENIC RES, V7, P253, DOI 10.1023/A:1008865911660; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Jannasch K, 2009, INT J CANCER, V125, P62, DOI 10.1002/ijc.24332; Jiao XM, 2010, J BIOL CHEM, V285, P8218, DOI 10.1074/jbc.M110.100792; Knippschild U, 2005, ONKOLOGIE, V28, P508, DOI 10.1159/000087137; Knippschild U, 1996, ONCOGENE, V13, P1387; KNIPPSCHILD U, 1991, J VIROL, V65, P4414, DOI 10.1128/JVI.65.8.4414-4423.1991; Knippschild U, 1997, ONCOGENE, V15, P1727, DOI 10.1038/sj.onc.1201541; Li BL, 1998, ONCOGENE, V16, P997, DOI 10.1038/sj.onc.1201621; Li RH, 2000, P NATL ACAD SCI USA, V97, P3236, DOI 10.1073/pnas.040529797; Li RH, 1997, P NATL ACAD SCI USA, V94, P14506, DOI 10.1073/pnas.94.26.14506; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Longenecker KL, 1998, ACTA CRYSTALLOGR D, V54, P473, DOI 10.1107/S0907444997011724; LUSCHER B, 1990, NATURE, V344, P517, DOI 10.1038/344517a0; Mani M, 2009, CANCER RES, V69, P7577, DOI 10.1158/0008-5472.CAN-09-0773; Maritzen T, 2003, EUR J CELL BIOL, V82, P369, DOI 10.1078/0171-9335-00323; Mashhoon N, 2000, J BIOL CHEM, V275, P20052, DOI 10.1074/jbc.M001713200; MCKNIGHT RA, 1992, P NATL ACAD SCI USA, V89, P6943, DOI 10.1073/pnas.89.15.6943; Peifer C, 2009, J MED CHEM, V52, P7618, DOI 10.1021/jm9005127; PIPAS JM, 1983, MOL CELL BIOL, V3, P203, DOI 10.1128/MCB.3.2.203; Pise-Masison CA, 1998, J VIROL, V72, P6348, DOI 10.1128/JVI.72.8.6348-6355.1998; PITTIUS CW, 1988, P NATL ACAD SCI USA, V85, P5874, DOI 10.1073/pnas.85.16.5874; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Rampias T, 2010, MOL CANCER RES, V8, P433, DOI 10.1158/1541-7786.MCR-09-0345; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; Robles MTS, 2009, SEMIN CANCER BIOL, V19, P229, DOI 10.1016/j.semcancer.2009.02.002; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Sakanaka C, 2002, J BIOCHEM, V132, P697, DOI 10.1093/oxfordjournals.jbchem.a003276; SANDGREN EP, 1995, CANCER RES, V55, P3915; SCHEIDTMANN KH, 1990, J VIROL, V64, P672, DOI 10.1128/JVI.64.2.672-679.1990; SCHEIDTMANN KH, 1994, INT J ONCOL, V5, P1353; Schlosshauer PW, 2000, MODERN PATHOL, V13, P1066, DOI 10.1038/modpathol.3880196; Schlosshauer PW, 2000, CARCINOGENESIS, V21, P1453, DOI 10.1093/carcin/21.7.1453; Schulze-Garg C, 2000, ONCOGENE, V19, P1028, DOI 10.1038/sj.onc.1203281; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; TZENG YJ, 1993, ONCOGENE, V8, P1965; UMPHRESS JL, 1992, EUR J BIOCHEM, V203, P239, DOI 10.1111/j.1432-1033.1992.tb19852.x; Vleugel MM, 2006, HUM PATHOL, V37, P668, DOI 10.1016/j.humpath.2006.01.022; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Vousden KH, 2002, CANCER CELL, V2, P351, DOI 10.1016/S1535-6108(02)00186-1; Wang JY, 2004, J EXP CLIN CANC RES, V23, P373; Winter M, 2004, BIOCHEMISTRY-US, V43, P16356, DOI 10.1021/bi0489255; Wolff S, 2005, BBA-MOL CELL RES, V1745, P196, DOI 10.1016/j.bbamcr.2005.05.004; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; XU RM, 1995, EMBO J, V14, P1015, DOI 10.1002/j.1460-2075.1995.tb07082.x; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Zerrahn J, 1996, J IMMUNOL, V156, P3919; ZERRAHN J, 1993, EMBO J, V12, P4739, DOI 10.1002/j.1460-2075.1993.tb06162.x	82	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29709	10.1371/journal.pone.0029709	http://dx.doi.org/10.1371/journal.pone.0029709			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235331	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400093
J	Jeppesen, J; Jordy, AB; Sjoberg, KA; Fullekrug, J; Stahl, A; Nybo, L; Kiens, B				Jeppesen, Jacob; Jordy, Andreas B.; Sjoberg, Kim A.; Fuellekrug, Joachim; Stahl, Andreas; Nybo, Lars; Kiens, Bente			Enhanced Fatty Acid Oxidation and FATP4 Protein Expression after Endurance Exercise Training in Human Skeletal Muscle	PLOS ONE			English	Article							COA SYNTHETASE-ACTIVITY; LIPID-BINDING PROTEINS; TRANSPORT PROTEIN-1; METABOLISM; GENE; CARBOHYDRATE; FABPPM; LIPASE; ADIPOCYTES; DISRUPTION	FATP1 and FATP4 appear to be important for the cellular uptake and handling of long chain fatty acids (LCFA). These findings were obtained from loss- or gain of function models. However, reports on FATP1 and FATP4 in human skeletal muscle are limited. Aerobic training enhances lipid oxidation; however, it is not known whether this involves up-regulation of FATP1 and FATP4 protein. Therefore, the aim of this project was to investigate FATP1 and FATP4 protein expression in the vastus lateralis muscle from healthy human individuals and to what extent FATP1 and FATP4 protein expression were affected by an increased fuel demand induced by exercise training. Eight young healthy males were recruited to the study. All subjects were non smokers and did not participate in regular physical activity (<1 time per week for the past 6 months, VO2peak 3.4 +/- 0.1 vertical bar O-2 min(-1)). Subjects underwent an 8 week supervised aerobic training program. Training induced an increase in VO2peak from 3.4 +/- 0.1 to 3.9 +/- 0.1 vertical bar min(-1) and citrate synthase activity was increased from 53.7 +/- 2.5 to 80.8 +/- 3.7 mu mol g(-1) min(-1). The protein content of FATP4 was increased by 33%, whereas FATP1 protein content was reduced by 20%. Interestingly, at the end of the training intervention a significant association (r(2) = 0.74) between the observed increase in skeletal muscle FATP4 protein expression and lipid oxidation during a 120 min endurance exercise test was observed. In conclusion, based on the present findings it is suggested that FATP1 and FATP4 proteins perform different functional roles in handling LCFA in skeletal muscle with FATP4 apparently more important as a lipid transport protein directing lipids for lipid oxidation.	[Jeppesen, Jacob; Jordy, Andreas B.; Sjoberg, Kim A.; Kiens, Bente] Univ Copenhagen, Dept Exercise & Sport Sci, Mol Physiol Grp, Copenhagen, Denmark; [Fuellekrug, Joachim] Heidelberg Univ, Mol Cell Biol Lab, Heidelberg, Germany; [Stahl, Andreas] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of Copenhagen; Ruprecht Karls University Heidelberg; University of California System; University of California Berkeley	Jeppesen, J (corresponding author), Univ Copenhagen, Dept Exercise & Sport Sci, Mol Physiol Grp, Copenhagen, Denmark.	jjeppesen@ifi.ku.dk	Sjøberg, Kim/D-7612-2015; Füllekrug, Joachim/A-6581-2008; Kiens, Bente/B-1375-2015; Nybo, Lars/P-6153-2014	Sjøberg, Kim/0000-0001-6880-4804; Kiens, Bente/0000-0001-5705-5625; Nybo, Lars/0000-0002-9090-1958	European Commission [LSHM-CT-2004-005272]; Danish Agency of Science, Technology and Innovation; Ministry of Food, Agriculture and Fisheries; Novo Nordisk Foundation; German research foundation DFG [FU 340/5-1]; NIH/NIDDK [R56DK066336, R01DK066336]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK066336, R01DK066336] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Agency of Science, Technology and Innovation; Ministry of Food, Agriculture and Fisheries; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); German research foundation DFG(German Research Foundation (DFG)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The financial support from the Integrated Project Grant LSHM-CT-2004-005272 funded by the European Commission, the Danish Agency of Science, Technology and Innovation and the Ministry of Food, Agriculture and Fisheries and The Novo Nordisk Foundation (Bente Kiens) are acknowledged. Also, this work was supported in part by the German research foundation DFG (FU 340/5-1 to Joachim Fullekrug) and by NIH/NIDDK grants R56DK066336/R01DK066336 (Andreas Stahl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Alsted TJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE445, DOI 10.1152/ajpendo.90912.2008; Benton CR, 2006, J PHYSIOL-LONDON, V573, P199, DOI 10.1113/jphysiol.2006.106013; Binas B, 2003, AM J PHYSIOL-ENDOC M, V285, pE481, DOI 10.1152/ajpendo.00060.2003; Bonen A, 1999, CAN J APPL PHYSIOL, V24, P515, DOI 10.1139/h99-033; Bonen A, 1999, AM J PHYSIOL-ENDOC M, V276, pE642, DOI 10.1152/ajpendo.1999.276.4.E642; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Friedlander AL, 1998, J APPL PHYSIOL, V85, P1175, DOI 10.1152/jappl.1998.85.3.1175; Gimeno RE, 2003, J BIOL CHEM, V278, P49512, DOI 10.1074/jbc.M309759200; Guitart M, 2009, MITOCHONDRION, V9, P266, DOI 10.1016/j.mito.2009.03.007; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; Herrmann T, 2001, GENE, V270, P31, DOI 10.1016/S0378-1119(01)00489-9; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Jain SS, 2009, FEBS LETT, V583, P2294, DOI 10.1016/j.febslet.2009.06.020; Kiens B, 1996, AM J CLIN NUTR, V63, P47, DOI 10.1093/ajcn/63.1.47; Kiens B, 2004, J APPL PHYSIOL, V97, P1209, DOI 10.1152/japplphysiol.01278.2003; KIENS B, 1989, J CLIN INVEST, V83, P558, DOI 10.1172/JCI113918; KIENS B, 1993, J PHYSIOL-LONDON, V469, P459, DOI 10.1113/jphysiol.1993.sp019823; Kiens B, 1997, MED SCI SPORT EXER, V29, P640, DOI 10.1097/00005768-199705000-00009; Kiens B, 1997, BIOCHEM BIOPH RES CO, V231, P463, DOI 10.1006/bbrc.1997.6118; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; KLEINE AH, 1990, MOL CELL BIOCHEM, V98, P41, DOI 10.1007/BF00231366; Lewis SE, 2001, J BIOL CHEM, V276, P37042, DOI 10.1074/jbc.M105556200; Lobo Sandra, 2007, Novartis Found Symp, V286, P113; Lobo S, 2007, J LIPID RES, V48, P609, DOI 10.1194/jlr.M600441-JLR200; LOWRY CV, 1978, J BIOL CHEM, V253, P8269; Luiken JJFP, 2003, LIPIDS, V38, P491, DOI 10.1007/s11745-003-1089-6; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Neess D, 2011, J BIOL CHEM, V286, P3460, DOI 10.1074/jbc.M110.161109; Nickerson JG, 2009, J BIOL CHEM, V284, P16522, DOI 10.1074/jbc.M109.004788; Nybo L, 2009, ACTA PHYSIOL, V197, P117, DOI 10.1111/j.1748-1716.2009.01996.x; PASSONNEAU JV, 1967, ANAL BIOCHEM, V19, P315, DOI 10.1016/0003-2697(67)90167-4; Pohl J, 2004, BIOCHEMISTRY-US, V43, P4179, DOI 10.1021/bi035743m; Pohl R, 2004, P NUTR SOC, V63, P259, DOI 10.1079/PNS2004341; Roepstorff C, 2004, AM J PHYSIOL-ENDOC M, V287, pE696, DOI 10.1152/ajpendo.00001.2004; Roepstorff C, 2004, P NUTR SOC, V63, P239, DOI 10.1079/PNS2004332; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schubert W, 2001, J BIOL CHEM, V276, P48619, DOI 10.1074/jbc.C100613200; Sebastian D, 2009, J LIPID RES, V50, P1789, DOI 10.1194/jlr.M800535-JLR200; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Stahl A, 2001, TRENDS ENDOCRIN MET, V12, P266, DOI 10.1016/S1043-2760(01)00427-1; Stellingwerff T, 2007, AM J PHYSL ENDOCRINO; STREMMEL W, 1985, J CLIN INVEST, V75, P1068, DOI 10.1172/JCI111769; SVEDENHAG J, 1983, ATHEROSCLEROSIS, V49, P203, DOI 10.1016/0021-9150(83)90198-3; Talanian JL, 2006, J APPL PHYSL; Talanian JL, 2010, AM J PHYSL ENDOCRINO; Tunstall RJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE66, DOI 10.1152/ajpendo.00475.2001; TURCOTTE LP, 1992, AM J PHYSIOL, V262, pE791; Vistisen B, 2004, J LIPID RES, V45, P603, DOI 10.1194/jlr.M300424-JLR200; Watkins PA, 1998, J BIOL CHEM, V273, P18210, DOI 10.1074/jbc.273.29.18210; Watkins PA, 2000, CELL BIOCHEM BIOPHYS, V32, P333, DOI 10.1385/CBB:32:1-3:333; Wiczer BM, 2009, J LIPID RES, V50, P2502, DOI 10.1194/jlr.M900218-JLR200; Wu QW, 2006, DIABETES, V55, P3229, DOI 10.2337/db06-0749; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Yao-Borengasser A, 2010, METABOLISM	59	38	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29391	10.1371/journal.pone.0029391	http://dx.doi.org/10.1371/journal.pone.0029391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235293	gold, Green Submitted, Green Published			2022-12-27	WOS:000301123400054
J	Krupke, CH; Hunt, GJ; Eitzer, BD; Andino, G; Given, K				Krupke, Christian H.; Hunt, Greg J.; Eitzer, Brian D.; Andino, Gladys; Given, Krispn			Multiple Routes of Pesticide Exposure for Honey Bees Living Near Agricultural Fields	PLOS ONE			English	Article							APIS-MELLIFERA L; NEONICOTINOID INSECTICIDES; COLONY LOSSES; RESIDUES; TOXICITY; POLLEN	Populations of honey bees and other pollinators have declined worldwide in recent years. A variety of stressors have been implicated as potential causes, including agricultural pesticides. Neonicotinoid insecticides, which are widely used and highly toxic to honey bees, have been found in previous analyses of honey bee pollen and comb material. However, the routes of exposure have remained largely undefined. We used LC/MS-MS to analyze samples of honey bees, pollen stored in the hive and several potential exposure routes associated with plantings of neonicotinoid treated maize. Our results demonstrate that bees are exposed to these compounds and several other agricultural pesticides in several ways throughout the foraging period. During spring, extremely high levels of clothianidin and thiamethoxam were found in planter exhaust material produced during the planting of treated maize seed. We also found neonicotinoids in the soil of each field we sampled, including unplanted fields. Plants visited by foraging bees (dandelions) growing near these fields were found to contain neonicotinoids as well. This indicates deposition of neonicotinoids on the flowers, uptake by the root system, or both. Dead bees collected near hive entrances during the spring sampling period were found to contain clothianidin as well, although whether exposure was oral (consuming pollen) or by contact (soil/planter dust) is unclear. We also detected the insecticide clothianidin in pollen collected by bees and stored in the hive. When maize plants in our field reached anthesis, maize pollen from treated seed was found to contain clothianidin and other pesticides; and honey bees in our study readily collected maize pollen. These findings clarify some of the mechanisms by which honey bees may be exposed to agricultural pesticides throughout the growing season. These results have implications for a wide range of large-scale annual cropping systems that utilize neonicotinoid seed treatments.	[Krupke, Christian H.; Hunt, Greg J.; Andino, Gladys; Given, Krispn] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Eitzer, Brian D.] Connecticut Agr Expt Stn, Dept Analyt Chem, New Haven, CT 06504 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Connecticut Agricultural Experiment Station	Krupke, CH (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	ckrupke@purdue.edu	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216; Given, Krispn/0000-0002-0312-7782	North American Pollinator Protection Campaign; United States Department of Agriculture National Institute of Food and Agriculture [2009-8511805718]; Bayer Corporation; BASF; Syngenta	North American Pollinator Protection Campaign; United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Bayer Corporation(Bayer AG); BASF(BASF); Syngenta(Syngenta)	This research was funded by an award from the North American Pollinator Protection Campaign to CK, GH and BE and by an award from the Managed Pollinator Coordinated Agricultural Project (United States Department of Agriculture National Institute of Food and Agriculture 2009-8511805718) to GH. The funders had no role in study design, data collection or analysis, decision to publish or manuscript preparation.; CK has received funding in the past from agrochemical companies that manufacture and distribute a wide range of pesticides, including many of those mentioned in this manuscript. These entities include the Bayer Corporation, BASF and Syngenta. None of these entities were involved with this work or are aware of it in any way, financial or otherwise. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Anastassiades M, 2003, J AOAC INT, V86, P412; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bonmatin JM, 2005, J AGR FOOD CHEM, V53, P5336, DOI 10.1021/jf0479362; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Decourtye A, STEEVE HERVE THANY, P85; Deere & Company, DEER CO PUBL; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; GINSBERG HS, 1983, ECOLOGY, V64, P165, DOI 10.2307/1937338; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Girolami V, 2011, FATAL POWDERING BEES, DOI [10.1111/j.1439-0418.2011.01648.x, DOI 10.1111/J.1439-0418.2011.01648.X]; Greatti Moreno, 2006, Bulletin of Insectology, V59, P99; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Laurino D, 2011, B INSECTOL, V64, P107; Lydy M, 2004, ECOL SOC, V9; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; National Agriculture Statistics Service (NASS), 2010, CROP PROD 2010 SUMM; National Agriculture Statistics Service (NASS), 2010, IND CROP WEATH REP R; Paul PA, 2011, METAANALYIS YIELD RE, DOI [10.1094/phyto-03-11-0091, DOI 10.1094/PHYT0-03-11-0091]; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Schmuck R, 2003, PEST MANAG SCI, V59, P279, DOI 10.1002/ps.626; Thompson HM, 2010, PEST MANAG SCI, V66, P1157, DOI 10.1002/ps.1994; Tremolada P, 2010, B ENVIRON CONTAM TOX, V85, P229, DOI 10.1007/s00128-010-0066-1; UNITED STATES ENVIRONMENTAL PROTECTION AGENCY (EPA), 2003, EPA PUBL C; US Environmental Protection Agency Office of Chemical Safety and Pollution Prevention, 2011, PC CPD 044309 MEM CL; US Environmental Protection Agency Office of Pesticide Programs, 2003, DEC DOC ATR; Vanengelsdorp D, 2007, AM BEE J, V147, P599; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; [No title captured]	36	539	556	12	475	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29268	10.1371/journal.pone.0029268	http://dx.doi.org/10.1371/journal.pone.0029268			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235278	gold, Green Published, Green Submitted			2022-12-27	WOS:000301123400039
J	Loov, C; Fernqvist, M; Walmsley, A; Marklund, N; Erlandsson, A				Loov, Camilla; Fernqvist, Maria; Walmsley, Adrian; Marklund, Niklas; Erlandsson, Anna			Neutralization of LINGO-1 during In Vitro Differentiation of Neural Stem Cells Results in Proliferation of Immature Neurons	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; NOGO-A; GROWTH-FACTOR; FUNCTIONAL RECOVERY; SIGNALING PATHWAY; PRECURSOR CELLS; MOUSE-BRAIN; PROGENITORS; EXPRESSION	Identifying external factors that can be used to control neural stem cells division and their differentiation to neurons, astrocytes and oligodendrocytes is of high scientific and clinical interest. Here we show that the Nogo-66 receptor interacting protein LINGO-1 is a potent regulator of neural stem cell maturation to neurons. LINGO-1 is expressed by cortical neural stem cells from E14 mouse embryos and inhibition of LINGO-1 during the first days of neural stem cell differentiation results in decreased neuronal maturation. Compared to neurons in control cultures, which after 6 days of differentiation have long extending neurites, neurons in cultures treated with anti-LINGO-1 antibodies retain an immature, round phenotype with only very short processes. Furthermore, neutralization of LINGO-1 results in a threefold increase in beta III tubulin-positive cells compared to untreated control cultures. By using BrdU incorporation assays we show that the immature neurons in LINGO-1 neutralized cultures are dividing neuroblasts. In contrast to control cultures, in which no cells were double positive for beta III tubulin and BrdU, 36% of the neurons in cultures treated with anti-LINGO-1 antibodies were proliferating after three days of differentiation. TUNEL assays revealed that the amount of cells going through apoptosis during the early phase of differentiation was significantly decreased in cultures treated with anti-LINGO-1 antibodies compared to untreated control cultures. Taken together, our results demonstrate a novel role for LINGO-1 in neural stem cell differentiation to neurons and suggest a possibility to use LINGO-1 inhibitors to compensate for neuronal cell loss in the injured brain.	[Loov, Camilla; Fernqvist, Maria; Marklund, Niklas; Erlandsson, Anna] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Walmsley, Adrian] Novartis Inst Biomed Res, Autoimmune Transplantat & Inflammat DA, Basel, Switzerland	Uppsala University; Novartis	Loov, C (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	anna.erlandsson@neuro.uu.se		Marklund, Niklas/0000-0002-9797-5626	Uppsala University Hospital; Tore Nilsson's Foundation; Jeansson's Foundation; Lars Hierta's Memorial Foundation; Swedish Society of Medicine	Uppsala University Hospital; Tore Nilsson's Foundation; Jeansson's Foundation; Lars Hierta's Memorial Foundation; Swedish Society of Medicine	This study was supported by grants from the Uppsala University Hospital, Tore Nilsson's Foundation, Jeansson's Foundation, Lars Hierta's Memorial Foundation and The Swedish Society of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; BANDTLOW C, 2004, SCI STKE, pPE24, DOI DOI 10.1126/STKE.2352004PE24; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bourikas D, 2010, MOL CELL NEUROSCI, V45, P363, DOI 10.1016/j.mcn.2010.07.009; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Erlandsson A, 2001, J NEUROSCI, V21, P3483, DOI 10.1523/JNEUROSCI.21-10-03483.2001; Erlandsson A, 2006, CANCER RES, V66, P8042, DOI 10.1158/0008-5472.CAN-06-0900; Erlandsson A, 2006, CURR OPIN MOL THER, V8, P331; Fu QL, 2008, INVEST OPHTH VIS SCI, V49, P975, DOI 10.1167/iovs.07-1199; Gao Y, 2010, STEM CELLS DEV, V19, P53, DOI 10.1089/scd.2008.0357; Gao Y, 2009, NEUROSCI LETT, V458, P132, DOI 10.1016/j.neulet.2009.04.034; Glaser T, 2004, FASEB J, V18, P112, DOI 10.1096/fj.04-1931fje; Gritti A, 1996, J NEUROSCI, V16, P1091; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hou T, 2010, INT J NEUROSCI, V120, P201, DOI 10.3109/00207450903506502; Inoue H, 2007, P NATL ACAD SCI USA, V104, P14430, DOI 10.1073/pnas.0700901104; Ji B, 2006, MOL CELL NEUROSCI, V33, P311, DOI 10.1016/j.mcn.2006.08.003; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lee X, 2007, J NEUROSCI, V27, P220, DOI 10.1523/JNEUROSCI.4175-06.2007; Li X, 2009, NEUROREPORT, V20, P708, DOI 10.1097/WNR.0b013e32832aa942; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Llorens F, 2008, DEV NEUROBIOL, V68, P521, DOI 10.1002/dneu.20607; Llorens F, 2011, FASEB J, V25, P463, DOI 10.1096/fj.10-162792; Lv J, 2010, NEUROIMMUNOMODULAT, V17, P270, DOI 10.1159/000290043; Martin I, 2009, BRAIN RES, V1284, P22, DOI 10.1016/j.brainres.2009.05.070; Mathis C, 2010, CEREB CORTEX, V20, P2380, DOI 10.1093/cercor/bhp307; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mi S, 2008, INT J BIOCHEM CELL B, V40, P1971, DOI 10.1016/j.biocel.2008.03.018; Mi S, 2008, CYTOKINE GROWTH F R, V19, P245, DOI 10.1016/j.cytogfr.2008.04.007; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Mi S, 2009, ANN NEUROL, V65, P304, DOI 10.1002/ana.21581; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Muroyama Y, 2004, BIOCHEM BIOPH RES CO, V313, P915, DOI 10.1016/j.bbrc.2003.12.023; Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011; Pozniak CD, 2006, SCI STKE, V2006, ppe5; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rudick RA, 2008, EXPERT OPIN BIOL TH, V8, P1561, DOI [10.1517/14712598.8.10.1561, 10.1517/14712598.8.10.1561 ]; Satoh J, 2007, NEUROPATH APPL NEURO, V33, P99, DOI 10.1111/j.1365-2990.2006.00787.x; Walmsey AR, 2007, CURR PHARM DESIGN, V13, P2470; Wang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001856; Zhang ZH, 2009, J BIOL CHEM, V284, P15717, DOI 10.1074/jbc.M808751200	44	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29771	10.1371/journal.pone.0029771	http://dx.doi.org/10.1371/journal.pone.0029771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235341	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400103
J	Suman, P; Godbole, G; Thakur, R; Morales-Prieto, DM; Modi, DN; Markert, UR; Gupta, SK				Suman, Pankaj; Godbole, Geeta; Thakur, Ravi; Morales-Prieto, Diana M.; Modi, Deepak N.; Markert, Udo R.; Gupta, Satish K.			AP-1 Transcription Factors, Mucin-Type Molecules and MMPs Regulate the IL-11 Mediated Invasiveness of JEG-3 and HTR-8/SVneo Trophoblastic Cells	PLOS ONE			English	Article							INVASION; INTERLEUKIN-11; PROLIFERATION; EXPRESSION; MIGRATION; DECORIN; ACTIVATION; SECRETION; DECIDUA; LACKING	This study examines the IL-11 mediated activation of downstream signaling and expression of effector molecules to resolve the controversies associated with the IL-11 mediated regulation of the invasiveness of two commonly used trophoblastic cell models viz. JEG-3 and HTR-8/SVneo cells. It has been reported that IL-11 increases the invasiveness of JEG-3 cells while, reduces the invasiveness of HTR-8/SVneo cells. Invasion assay performed simultaneously for both the cell lines confirmed the above findings. In addition, HTR-8/SVneo cells showed a higher basal invasiveness than JEG-3 cells. Western blot showed the IL-11 mediated activation of STAT3(tyr705) and STAT1(tyr701) in both the cell lines. However, IL-11 activated the ERK1/2 phosphorylation in JEG-3 cells but, inhibited it in HTR-8/SVneo cells. Within 10 min of IL-11 treatment, p-STAT3(tyr705) was localized inside the nucleus of both the cell lines but, there was enhanced co-localization of protein inhibitor of activated STAT1/3 (PIAS1/3) and p-STAT3(tyr705) in HTR-8/SVneo cells and not in JEG-3 cells. This could be reason for the poor responsiveness of STAT3 responsive genes like mucin 1 (MUC1) in HTR-8/SVneo cells and not in JEG-3 cells. Further, microarray analysis of the IL-11 treated cells revealed differential responsiveness of JEG-3 as compared to HTR-8/SVneo cells. Several family of genes like activator protein-1 (AP-1) transcription factors (Jun and Fos), mucin-type molecules, MMP23B etc showed enhanced expression in IL-11 treated JEG-3 cells while, there was no response or decrease in their expression in IL-11 treated HTR-8/SVneo cells. Expression of these molecules was confirmed by quantitative RT-PCR. In addition, HTR-8/SVneo cells also showed a significant decrease in the expression of MMP2, MMP3 and MMP9 upon IL-11 treatment. Hence, IL-11 mediated differential activation of signaling and expression of effector molecules is responsible for the differential invasive response of JEG-3 and HTR-8/SVneo cells.	[Suman, Pankaj; Thakur, Ravi; Gupta, Satish K.] Natl Inst Immunol, Reprod Cell Biol Lab, New Delhi 110067, India; [Godbole, Geeta; Modi, Deepak N.] Natl Inst Res Reprod Hlth, Bombay, Maharashtra, India; [Morales-Prieto, Diana M.; Markert, Udo R.] Univ Jena, Fac Med, Dept Obstet, Placenta Lab, Jena, Germany	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Friedrich Schiller University of Jena	Suman, P (corresponding author), Natl Inst Immunol, Reprod Cell Biol Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	skgupta@nii.res.in	Gupta, Satish/B-9934-2009; MARKERT, UDO Rudolf/AAP-1663-2021; Prieto, Diana Maria Morales/AAU-6418-2020; Suman, Pankaj/C-7568-2016; Thakur, Ravi/AGH-8433-2022	Gupta, Satish/0000-0003-3717-0436; MARKERT, UDO Rudolf/0000-0001-5299-595X; Prieto, Diana Maria Morales/0000-0002-7348-059X; Suman, Pankaj/0000-0001-9887-6753; Thakur, Ravi/0000-0003-2505-9757; Godbole, Geeta/0000-0001-8724-681X; Modi, Deepak/0000-0002-4230-4219	National Institute of Immunology, New Delhi; Indian Council of Medical Research, Government of India; Council of Scientific and Industrial Research (CSIR), Government of India; Lady Tata Memorial Trust, Mumbai, India; CSIR; Friedrich-Schiller University, Jena	National Institute of Immunology, New Delhi; Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Lady Tata Memorial Trust, Mumbai, India; CSIR(Council of Scientific & Industrial Research (CSIR) - India); Friedrich-Schiller University, Jena	Financial support from the National Institute of Immunology, New Delhi and the Indian Council of Medical Research, Government of India is gratefully acknowledged. PS is recipient of Junior and Senior Research Fellowships of the Council of Scientific and Industrial Research (CSIR), Government of India, GG is grateful to Lady Tata Memorial Trust, Mumbai, India and CSIR, for Junior and Senior Research Fellowships respectively, and DM-P is supported by a Ph.D. grant from the Friedrich-Schiller University, Jena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilban M, 2010, PLACENTA, V31, P989, DOI 10.1016/j.placenta.2010.08.011; Bilinski P, 1998, GENE DEV, V12, P2234, DOI 10.1101/gad.12.14.2234; Chen HF, 2002, J CLIN ENDOCR METAB, V87, P2320, DOI 10.1210/jc.87.5.2320; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fitzgerald JS, 2005, INT J BIOCHEM CELL B, V37, P2284, DOI 10.1016/j.biocel.2005.02.025; Gao JC, 2009, INT J ONCOL, V35, P337, DOI 10.3892/ijo_00000345; Goldman-Wohl D, 2002, MOL CELL ENDOCRINOL, V187, P233, DOI 10.1016/S0303-7207(01)00687-6; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Guzelogiu-Kayisli Z, 2009, SEMIN REPROD MED, V27, P62, DOI 10.1055/s-0028-1108011; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iacob D, 2008, ENDOCRINOLOGY, V149, P6187, DOI 10.1210/en.2008-0780; Jovanovic M, 2010, REPRODUCTION, V139, P789, DOI 10.1530/REP-09-0341; Khachaturyan L, 2010, J REPRODUKTIONSMED E, V7, P120; Khan GA, 2011, MOL ENDOCRINOL, V25, P1431, DOI 10.1210/me.2010-0426; Koumantaki Y, 2001, EUR J OBSTET GYN R B, V98, P66, DOI 10.1016/S0301-2115(01)00289-5; LIBRACH CL, 1994, J BIOL CHEM, V269, P17125; Mossman BT, 2002, AM J RESP CELL MOL, V26, P167, DOI 10.1165/ajrcmb.26.2.f229; Paiva P, 2009, CYTOKINE GROWTH F R, V20, P319, DOI 10.1016/j.cytogfr.2009.07.001; Paiva P, 2009, BIOL REPROD, V80, P302, DOI 10.1095/biolreprod.108.071415; Pei DQ, 2000, J BIOL CHEM, V275, P33988, DOI 10.1074/jbc.M006493200; Pollheimer J, 2005, PLACENTA, V26, pS21, DOI 10.1016/j.placenta.2004.11.013; Qiu Q, 2004, REPRODUCTION, V128, P355, DOI 10.1530/rep.1.00234; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Schuringa JJ, 2001, CYTOKINE, V14, P78, DOI 10.1006/cyto.2001.0856; Suman P, 2009, J REPROD IMMUNOL, V82, P1, DOI 10.1016/j.jri.2009.07.002; Thirkill TL, 2007, BBA-MOL CELL RES, V1773, P1007, DOI 10.1016/j.bbamcr.2007.04.006; Velasco G, 1999, J BIOL CHEM, V274, P4570, DOI 10.1074/jbc.274.8.4570; Wells M, 2007, PATHOLOGY, V39, P88, DOI 10.1080/00313020601137367; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wicki A, 2007, BRIT J CANCER, V96, P1, DOI 10.1038/sj.bjc.6603518; Xu GX, 2003, BIOCHEM BIOPH RES CO, V300, P383, DOI 10.1016/S0006-291X(02)02845-0; Xu GX, 2002, BIOCHEM BIOPH RES CO, V294, P1079, DOI 10.1016/S0006-291X(02)00605-8; Xu GX, 2001, BIOCHEM BIOPH RES CO, V287, P47, DOI 10.1006/bbrc.2001.5533; Xu GX, 2002, BIOL REPROD, V67, P681, DOI 10.1095/biolreprod67.2.681; YAGEL S, 1988, J CELL PHYSIOL, V136, P455, DOI 10.1002/jcp.1041360309	36	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29745	10.1371/journal.pone.0029745	http://dx.doi.org/10.1371/journal.pone.0029745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235337	Green Published, gold, Green Submitted			2022-12-27	WOS:000301123400099
J	Nguyen, AV; Toepel, J; Burgess, S; Uhmeyer, A; Blifernez, O; Doebbe, A; Hankamer, B; Nixon, P; Wobbe, L; Kruse, O				Anh Vu Nguyen; Toepel, Joerg; Burgess, Steven; Uhmeyer, Andreas; Blifernez, Olga; Doebbe, Anja; Hankamer, Ben; Nixon, Peter; Wobbe, Lutz; Kruse, Olaf			Time-Course Global Expression Profiles of Chlamydomonas reinhardtii during Photo-Biological H-2 Production	PLOS ONE			English	Article							HYDROGEN PHOTOPRODUCTION; CHLOROPHYLL FLUORESCENCE; GENE; ELECTRON; CHLOROPLAST; METABOLISM; PROTEIN; STARCH; PHOSPHORYLATION; DEPRIVATION	We used a microarray study in order to compare the time course expression profiles of two Chlamydomonas reinhardtii strains, namely the high H-2 producing mutant stm6glc4 and its parental WT strain during H-2 production induced by sulfur starvation. Major cellular reorganizations in photosynthetic apparatus, sulfur and carbon metabolism upon H-2 production were confirmed as common to both strains. More importantly, our results pointed out factors which lead to the higher H-2 production in the mutant including a higher starch accumulation in the aerobic phase and a lower competition between the H(2)ase pathway and alternative electron sinks within the H-2 production phase. Key candidate genes of interest with differential expression pattern include LHCSR3, essential for efficient energy quenching (qE). The reduced LHCSR3 protein expression in mutant stm6glc4 could be closely related to the high-light sensitive phenotype. H-2 measurements carried out with the LHCSR3 knock-out mutant npq4 however clearly demonstrated that a complete loss of this protein has almost no impact on H-2 yields under moderate light conditions. The nuclear gene disrupted in the high H-2 producing mutant stm6glc4 encodes for the mitochondrial transcription termination factor (mTERF) MOC1, whose expression strongly increases during - S-induced H-2 production in WT strains. Studies under phototrophic high-light conditions demonstrated that the presence of functional MOC1 is a prerequisite for proper LHCSR3 expression. Furthermore knock-down of MOC1 in a WT strain was shown to improve the total H-2 yield significantly suggesting that this strategy could be applied to further enhance H-2 production in other strains already displaying a high H-2 production capacity. By combining our array data with previously published metabolomics data we can now explain some of the phenotypic characteristics which lead to an elevated H-2 production in stm6glc4.	[Anh Vu Nguyen; Toepel, Joerg; Uhmeyer, Andreas; Blifernez, Olga; Doebbe, Anja; Wobbe, Lutz; Kruse, Olaf] Univ Bielefeld, Fac Biol, Dept Algae Biotechnol & Bioenergy, D-33615 Bielefeld, Germany; [Burgess, Steven; Nixon, Peter] Univ London Imperial Coll Sci Technol & Med, Div Biol, Fac Nat Sci, London, England; [Hankamer, Ben] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 2, Australia	University of Bielefeld; Imperial College London; University of Queensland	Nguyen, AV (corresponding author), Univ Bielefeld, Fac Biol, Dept Algae Biotechnol & Bioenergy, D-33615 Bielefeld, Germany.	olaf.kruse@uni-bielefeld.de	Kruse, Olaf/O-1127-2015; Nguyen, Anh/C-5389-2013; Hankamer, Ben/C-9688-2015	Nguyen, Anh/0000-0001-6703-2291; Kruse, Olaf/0000-0001-9874-382X; Burgess, Steven/0000-0003-2353-7794; Wobbe, Lutz/0000-0001-5141-9897; Nixon, Peter/0000-0003-1952-6937; Hankamer, Ben/0000-0001-9284-4929	EU [212508]; German Federal Ministry of Science BMBF [0315265A]; Australian Research Council [DP0877147]; Engineering and Physical Sciences Research Council [EP/F00270X/1]; EPSRC [EP/F00270X/1] Funding Source: UKRI	EU(European Commission); German Federal Ministry of Science BMBF(Federal Ministry of Education & Research (BMBF)); Australian Research Council(Australian Research Council); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors would like to thank the EU/Energy FP7 project SOLAR-H2 (contract 212508, OK), the German Federal Ministry of Science BMBF-ForSys-Partner project (contract 0315265A, OK), the Australian Research Council (DP0877147, BH) as well as the Engineering and Physical Sciences Research Council (EP/F00270X/1, PN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Banet G, 2000, PLANTA, V210, P947, DOI 10.1007/s004250050702; BENAMOTZ A, 1983, PLANT PHYSIOL, V72, P593, DOI 10.1104/pp.72.3.593; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Cardol P, 2010, BBA-BIOENERGETICS, V1797, P177, DOI 10.1016/j.bbabio.2009.10.002; Chen M, 2010, J PROTEOME RES, V9, P3854, DOI 10.1021/pr100076c; Chochois V, 2009, PLANT PHYSIOL, V151, P631, DOI 10.1104/pp.109.144576; Dent RM, 2005, PLANT PHYSIOL, V137, P545, DOI 10.1104/pp.104.055244; Doebbe A, 2007, J BIOTECHNOL, V131, P27, DOI 10.1016/j.jbiotec.2007.05.017; Doebbe A, 2010, J BIOL CHEM, V285, P30247, DOI 10.1074/jbc.M110.122812; Eberhard S, 2006, CURR GENET, V49, P106, DOI 10.1007/s00294-005-0041-2; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Finazzi G, 2006, BIOCHEMISTRY-US, V45, P1490, DOI 10.1021/bi0521588; Fouchard S, 2005, APPL ENVIRON MICROB, V71, P6199, DOI 10.1128/AEM.71.10.6199-6205.2005; Ghirardi ML, 2007, ANNU REV PLANT BIOL, V58, P71, DOI 10.1146/annurev.arplant.58.032806.103848; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Happe T, 2002, EUR J BIOCHEM, V269, P1022, DOI 10.1046/j.0014-2956.2001.02743.x; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hemschemeier A, 2008, PLANTA, V227, P397, DOI 10.1007/s00425-007-0626-8; Hemschemeier A, 2011, BBA-BIOENERGETICS, V1807, P919, DOI 10.1016/j.bbabio.2011.02.010; Jans F, 2008, P NATL ACAD SCI USA, V105, P20546, DOI 10.1073/pnas.0806896105; KNAFF DB, 1991, BIOCHIM BIOPHYS ACTA, V1056, P93, DOI 10.1016/S0005-2728(05)80277-4; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; Kosourov S, 2003, PLANT CELL PHYSIOL, V44, P146, DOI 10.1093/pcp/pcg020; Kosourov S, 2007, J BIOTECHNOL, V128, P776, DOI 10.1016/j.jbiotec.2006.12.025; Kruse O, 2005, J BIOL CHEM, V280, P34170, DOI 10.1074/jbc.M503840200; Kruse O, 2010, CURR OPIN BIOTECH, V21, P238, DOI 10.1016/j.copbio.2010.03.012; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; LERS A, 1991, J BIOL CHEM, V266, P13698; Matthew T, 2009, J BIOL CHEM, V284, P23415, DOI 10.1074/jbc.M109.003541; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Molnar A, 2009, PLANT J, V58, P165, DOI 10.1111/j.1365-313X.2008.03767.x; Nakayama M, 2000, J INORG BIOCHEM, V82, P27, DOI 10.1016/S0162-0134(00)00138-0; Nguyen AV, 2008, EUKARYOT CELL, V7, P1965, DOI 10.1128/EC.00418-07; NISHIMAKI T, 1984, J BIOCHEM, V95, P1315, DOI 10.1093/oxfordjournals.jbchem.a134737; Niyogi KK, 1997, PLANT CELL, V9, P1369, DOI 10.2307/3870388; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Petroutsos D, 2011, PLANT CELL, V23, P2950, DOI 10.1105/tpc.111.087973; Posewitz MC, 2004, PLANT CELL, V16, P2151, DOI 10.1105/tpc.104.021972; Raghavendra AS, 2003, TRENDS PLANT SCI, V8, P546, DOI 10.1016/j.tplants.2003.09.015; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Ritte G, 2004, PLANT PHYSIOL, V135, P2068, DOI 10.1104/pp.104.041301; Ritte G, 2006, FEBS LETT, V580, P4872, DOI 10.1016/j.febslet.2006.07.085; Rupprecht J, 2006, APPL MICROBIOL BIOT, V72, P442, DOI 10.1007/s00253-006-0528-x; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schonfeld C, 2004, J BIOL CHEM, V279, P50366, DOI 10.1074/jbc.M408477200; Tolleter D, 2011, PLANT CELL, V23, P2619, DOI 10.1105/tpc.111.086876; Voss B, 2011, PLANT PHYSIOL, V155, P892, DOI 10.1104/pp.110.158683; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; White AL, 2006, INT J HYDROGEN ENERG, V31, P455, DOI 10.1016/j.ijhydene.2005.04.028; Wobbe L, 2009, P NATL ACAD SCI USA, V106, P13290, DOI 10.1073/pnas.0900670106; Wu SX, 2011, BIORESOURCE TECHNOL, V102, P2610, DOI 10.1016/j.biortech.2010.09.123; Wykoff DD, 1998, PLANT PHYSIOL, V117, P129, DOI 10.1104/pp.117.1.129; Zhang LP, 2002, PLANTA, V214, P552, DOI 10.1007/s004250100660; Zhang ZD, 2004, EUKARYOT CELL, V3, P1331, DOI 10.1128/EC.3.5.1331-1348.2004	56	25	27	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29364	10.1371/journal.pone.0029364	http://dx.doi.org/10.1371/journal.pone.0029364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242116	gold, Green Published, Green Submitted			2022-12-27	WOS:000300677000028
J	Cogni, R; Trigo, JR; Futuyma, DJ				Cogni, Rodrigo; Trigo, Jose R.; Futuyma, Douglas J.			Varying Herbivore Population Structure Correlates with Lack of Local Adaptation in a Geographic Variable Plant-Herbivore Interaction	PLOS ONE			English	Article							MARGINALE-MELAMPSORA-LINI; FREE AMINO-ACIDS; PYRROLIZIDINE ALKALOIDS; EXTRAFLORAL NECTARIES; HIBISCUS-PERNAMBUCENSIS; GENERALIST HERBIVORES; EVOLUTIONARY ECOLOGY; CHEMICAL DEFENSE; PARSNIP WEBWORMS; COEVOLUTION	Local adaptation of parasites to their hosts due to coevolution is a central prediction of many theories in evolutionary biology. However, empirical studies looking for parasite local adaptation show great variation in outcomes, and the reasons for such variation are largely unknown. In a previous study, we showed adaptive differentiation in the arctiid moth Utetheisa ornatrix to its host plant, the pyrrolizidine alkaloid-bearing legume Crotalaria pallida, at the continental scale, but found no differentiation at the regional scale. In the present study, we sampled the same sites to investigate factors that may contribute to the lack of differentiation at the regional scale. We performed field observations that show that specialist and non-specialist polyphagous herbivore incidence varies among populations at both scales. With a series of common-garden experiments we show that some plant traits that may affect herbivory (pyrrolizidine alkaloids and extrafloral nectaries) vary at the regional scale, while other traits (trichomes and nitrogen content) just vary at the continental scale. These results, combined with our previous evidence for plant population differentiation based on larval performance on fresh fruits, suggest that U. ornatrix is subjected to divergent selection even at the regional scale. Finally, with a microsatellite study we investigated population structure of U. ornatrix. We found that population structure is not stable over time: we found population differentiation at the regional scale in the first year of sampling, but not in the second year. Unstable population structure of the herbivore is the most likely cause of the lack of regional adaptation.	[Cogni, Rodrigo; Futuyma, Douglas J.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Trigo, Jose R.] Univ Estadual Campinas, Dept Biol Anim, Inst Biol, Campinas, SP, Brazil	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Universidade de Sao Paulo; Universidade Estadual de Campinas	Cogni, R (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.	rcogni@life.bio.sunysb.edu	Trigo, Jose R/B-8398-2012; Cogni, Rodrigo/C-3962-2016	Trigo, Jose R/0000-0003-3028-5353; Cogni, Rodrigo/0000-0001-9907-9297	NSF [DEB 0807418]; Stony Brook University; Lepidoptera Foundation; FAPESP; CNPq [98/01065-7, 304473/2009-0]	NSF(National Science Foundation (NSF)); Stony Brook University; Lepidoptera Foundation; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was provided by NSF (DEB 0807418) to RC and DJF, the Latin American and Caribbean Studies at Stony Brook University, and the Hovanitz Memorial Award from the Lepidoptera Foundation to RC, and FAPESP and CNPq grants (98/01065-7 and 304473/2009-0) to JRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Alleaume-Benharira M, 2006, J EVOLUTION BIOL, V19, P203, DOI 10.1111/j.1420-9101.2005.00976.x; Almeida E.C., 1986, REV CERES, V33, P529; Arab A, 2011, J CHEM ECOL, V37, P492, DOI 10.1007/s10886-011-9955-y; BARTON AM, 1986, ECOLOGY, V67, P495, DOI 10.2307/1938592; Berenbaum MR, 2006, ECOLOGY, V87, P3070, DOI 10.1890/0012-9658(2006)87[3070:PWAHPA]2.0.CO;2; Bezzerides A, 2004, MOL ECOL NOTES, V4, P566, DOI 10.1111/j.1471-8286.2004.00736.x; Bjorkman C, 2008, NEW PHYTOL, V179, P176, DOI 10.1111/j.1469-8137.2008.02442.x; Bowdish TI, 1998, OECOLOGIA, V113, P400, DOI 10.1007/s004420050392; Brenes-Arguedas T, 2008, J ECOL, V96, P127, DOI 10.1111/j.1365-2745.2007.01327.x; Brodie ED, 2002, EVOLUTION, V56, P2067; Burdon JJ, 1999, AM NAT, V153, pS15, DOI 10.1086/303209; Burdon JJ, 2000, EVOL ECOL, V14, P261, DOI 10.1023/A:1011042721274; Cobb Neil S., 1998, P37; COCKERHAM CC, 1973, GENETICS, V74, P679; Cogni R, 2003, ENTOMOL EXP APPL, V107, P125, DOI 10.1046/j.1570-7458.2003.00046.x; Cogni R, 2002, SOCIOBIOLOGY, V40, P373; Cogni R, 2010, THESIS STONY BROOK U; Cogni R, 2010, BIOTROPICA, V42, P188, DOI 10.1111/j.1744-7429.2009.00570.x; Cogni Rodrigo, 2000, Entomologist's Monthly Magazine, V136, P141; Cogni R, 2009, BIOL J LINN SOC, V97, P494, DOI 10.1111/j.1095-8312.2009.01234.x; Conner WE, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P248, DOI 10.1017/CBO9780511542664.008; Conner William E., 2009, P1; Cremieux L, 2008, NEW PHYTOL, V180, P524, DOI 10.1111/j.1469-8137.2008.02545.x; Dybdahl MF, 2003, TRENDS ECOL EVOL, V18, P523, DOI 10.1016/S0169-5347(03)00223-4; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; EISNER T, 1995, P NATL ACAD SCI USA, V92, P50, DOI 10.1073/pnas.92.1.50; Ferro VG., 2001, THESIS U ESTADUAL CA; Ferro VG, 2006, ENTOMOL EXP APPL, V121, P23, DOI 10.1111/j.1570-8703.2006.00450.x; FRITZ RS, 1992, PLANT RESISTANCE HER; Futuyma D.J., 1983, COEVOLUTION; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; Greischar MA, 2007, ECOL LETT, V10, P418, DOI 10.1111/j.1461-0248.2007.01028.x; Guimaraes PR, 2006, AUSTRAL ECOL, V31, P776, DOI 10.1111/j.1442-9993.2006.01639.x; Hanifin CT, 2008, PLOS BIOL, V6, P471, DOI 10.1371/journal.pbio.0060060; Hartmann T, 1999, PLANTA, V207, P483, DOI 10.1007/s004250050508; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Hoeksema JD, 2008, AM NAT, V171, P275, DOI 10.1086/527496; Joshi J, 2005, ECOL LETT, V8, P704, DOI 10.1111/j.1461-0248.2005.00769.x; Kaltz O, 1998, HEREDITY, V81, P361, DOI 10.1046/j.1365-2540.1998.00435.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Laine AL, 2009, J EXP BOT, V60, P2957, DOI 10.1093/jxb/erp168; Lankau RA, 2007, NEW PHYTOL, V175, P176, DOI 10.1111/j.1469-8137.2007.02090.x; Lively CM, 1999, AM NAT, V153, pS34, DOI 10.1086/303210; Macel M, 2005, J CHEM ECOL, V31, P1493, DOI 10.1007/s10886-005-5793-0; Macel M, 2011, PHYTOCHEM REV, V10, P75, DOI 10.1007/s11101-010-9181-1; Pando LA, 2004, PROTEIN J, V23, P437, DOI 10.1007/s10930-004-5219-9; Pereira MF, 2008, THESIS U ESTADUAL CA; Peters AD, 2007, J EVOLUTION BIOL, V20, P1206, DOI 10.1111/j.1420-9101.2006.01283.x; PILBEAM DJ, 1979, PHYTOCHEMISTRY, V18, P973, DOI 10.1016/S0031-9422(00)91460-2; PILBEAM DJ, 1979, BOT J LINN SOC, V79, P259, DOI 10.1111/j.1095-8339.1979.tb01518.x; POLHILL R. M., 1982, CROTALARIA AFRICA MA; Rego EJL, 2002, PHYTOCHEMISTRY, V60, P441, DOI 10.1016/S0031-9422(02)00132-2; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Siska EL, 2002, ECOLOGY, V83, P3369, DOI 10.1890/0012-9658(2002)083[3369:LVIPOS]2.0.CO;2; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Tewksbury JJ, 2008, P NATL ACAD SCI USA, V105, P11808, DOI 10.1073/pnas.0802691105; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JN, 2009, AM NAT, V173, P125, DOI 10.1086/595752; Thrall PH, 1997, J ECOL, V85, P743, DOI 10.2307/2960598; Thrall PH, 2002, EVOLUTION, V56, P1340; Toju H, 2006, AM NAT, V167, P105, DOI 10.1086/498277; Toju H, 2006, MOL ECOL, V15, P4161, DOI 10.1111/j.1365-294X.2006.03088.x; Trigo JR, 2011, PHYTOCHEM REV, V10, P83, DOI 10.1007/s11101-010-9191-z; Trigo JR, 2003, BIOCHEM SYST ECOL, V31, P1011, DOI 10.1016/S0305-1978(03)00038-3; TRIGO JR, 1993, J CHEM ECOL, V19, P669, DOI 10.1007/BF00985000; VANDAM NM, 1995, J CHEM ECOL, V21, P507, DOI 10.1007/BF02033698; vanderMeijden E, 1996, ENTOMOL EXP APPL, V80, P307, DOI 10.1007/BF00194780; Vos M, 2009, SCIENCE, V325, P833, DOI 10.1126/science.1174173; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir BS., 1996, GENETIC DATA ANAL; White T. C. R., 1993, INADEQUATE ENV NITRO; Wink M, 2003, BIOCHEM SYST ECOL, V31, P897, DOI 10.1016/S0305-1978(03)00085-1; Zangerl AR, 2008, P NATL ACAD SCI USA, V105, P4547, DOI 10.1073/pnas.0710280105; Zangerl AR, 2003, EVOLUTION, V57, P806, DOI 10.1111/j.0014-3820.2003.tb00292.x	79	16	16	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29220	10.1371/journal.pone.0029220	http://dx.doi.org/10.1371/journal.pone.0029220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22220208	Green Published, gold			2022-12-27	WOS:000300677000021
J	Delibes, M; Blazquez, MD; Soriano, L; Revilla, E; Godoy, JA				Delibes, Miguel; del Carmen Blazquez, Maria; Soriano, Laura; Revilla, Eloy; Antonio Godoy, Jose			High Antipredatory Efficiency of Insular Lizards: A Warning Signal of Excessive Specimen Collection?	PLOS ONE			English	Article							ESCAPE BEHAVIOR; BAJA-CALIFORNIA; PREDATION; POPULATIONS; SQUAMATA; TAMENESS; TRAITS; RISK	We live-captured lizards on islands in the Gulf of California and the Baja California peninsula mainland, and compared their ability to escape predation. Contrary to expectations, endemic lizard species from uninhabited islands fled from humans earlier and more efficiently than those from peninsular mainland areas. In fact, 58.2% (n = 146) of the lizards we tried to capture on the various islands escaped successfully, while this percentage was only 14.4% (n = 160) on the peninsular mainland. Separate evidence (e. g., proportion of regenerated tails, low human population at the collection areas, etc.) challenges several potential explanations for the higher antipredatory efficiency of insular lizards (e. g., more predation pressure on islands, habituation to humans on the peninsula, etc.). Instead, we suggest that the ability of insular lizards to avoid predators may be related to harvesting by humans, perhaps due to the value of endemic species as rare taxonomic entities. If this hypothesis is correct, predation-related behavioral changes in rare species could provide early warning signals of their over-exploitation, thus encouraging the adoption of conservation measures.	[Delibes, Miguel; Soriano, Laura; Revilla, Eloy] CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [del Carmen Blazquez, Maria] Ctr Invest Biol Noroeste, Dept Environm Planning & Conservat, La Paz, Baja California, Mexico; [Antonio Godoy, Jose] CSIC, Estn Biol Donana, Dept Integrat Ecol, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Delibes, M (corresponding author), CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain.	blazquez@cibnor.mx	Delibes, Miguel/K-2744-2014; Revilla, Eloy/B-5100-2008; Godoy, José Antonio/B-9288-2008	Delibes, Miguel/0000-0002-3569-567X; Revilla, Eloy/0000-0001-5534-5581; Godoy, José Antonio/0000-0001-7502-9471; Blazquez, M Carmen/0000-0002-0810-749X	Fondo Mixto Mexico-Espana FOMIX-CONACYT-AECI [J200-450/2004, 156/03/05]; AECID-CONACYT [J110-374/2007]	Fondo Mixto Mexico-Espana FOMIX-CONACYT-AECI; AECID-CONACYT	Financial support was through projects (ref. J200-450/2004 and ref. 156/03/05 Fondo Mixto Mexico-Espana FOMIX-CONACYT-AECI) and (AECID-CONACYT, ref. J110-374/2007.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2009, P NATL ACAD SCI USA, V106, P9987, DOI 10.1073/pnas.0901069106; Blazquez MC, 1997, ETHOLOGY, V103, P990; Blumstein DT, 2008, NATURAL SECURITY: A DARWINIAN APPROACH TO A DANGEROUS WORLD, P147; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Blumstein DT, 2005, P ROY SOC B-BIOL SCI, V272, P1663, DOI 10.1098/rspb.2005.3147; Blumstein DT, 2004, ETHOLOGY, V110, P919, DOI 10.1111/j.1439-0310.2004.01033.x; Blumstein DT, 2004, CONSERV BIOL, V18, P1175, DOI 10.1111/j.1523-1739.2004.00587.x; Case T.J., 2002, NEW ISLAND BIOGEOGRA, DOI DOI 10.1093/OSO/9780195133462.001.0001; Clobert J, 2000, FUNCT ECOL, V14, P675, DOI 10.1046/j.1365-2435.2000.00477.x; Cooper WE, 2006, CAN J ZOOL, V84, P495, DOI 10.1139/Z06-018; Cooper WE, 2009, CAN J ZOOL, V87, P912, DOI 10.1139/Z09-077; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Diego-Rasilla FJ, 2003, BEHAV PROCESS, V63, P1, DOI 10.1016/S0376-6357(03)00026-3; Grismer LL, 1999, HERPETOLOGICA, V55, P28; Hall RJ, 2008, CONSERV LETT, V1, P75, DOI 10.1111/j.1755-263X.2008.00013.x; Kothamasi D, 2009, CONSERV BIOL, V23, P1328, DOI 10.1111/j.1523-1739.2009.01252.x; Lecomte Nicolas, 2009, F1000 Biol Rep, V1, P26, DOI 10.3410/B1-26; Lovich RE, 2009, HERPETOL CONSERV BIO, V4, P358; Pinheiro J.C., 2000, MIXED EFFECTS MODELS, DOI [10.1007/0-387-22747-4_1, DOI 10.1007/B98882]; Punzo F, 2007, ETHOL ECOL EVOL, V19, P159, DOI 10.1080/08927014.2007.9522575; Rodriguez-Estrella R, 2006, BIODIVERS CONSERV, V15, P1621, DOI 10.1007/s10531-004-4308-6; Rodl T, 2007, P R SOC B, V274, P577, DOI 10.1098/rspb.2006.3755; Somerville MA, 2005, SCIENCE, V307, P1881, DOI 10.1126/science.1109279; Soule M.E., 1986, P1; STONE PA, 1994, CONSERV BIOL, V8, P569, DOI 10.1046/j.1523-1739.1994.08020569.x; Stuart BL, 2006, SCIENCE, V312, P1137, DOI 10.1126/science.312.5777.1137b; WALKER JM, 1968, AM MIDL NAT, V80, P1, DOI 10.2307/2423598; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1	29	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29312	10.1371/journal.pone.0029312	http://dx.doi.org/10.1371/journal.pone.0029312			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216244	Green Published, Green Submitted, gold			2022-12-27	WOS:000300676300045
J	Liu, H; Zhang, HX; Hou, HY; Lu, XF; Wei, JQ; Wang, CG; Zhang, LC; Zeng, YM; Wu, YP; Cao, JL				Liu, He; Zhang, Hong-Xing; Hou, Hui-Yan; Lu, Xian-Fu; Wei, Jing-Qiu; Wang, Chun-Guang; Zhang, Li-Cai; Zeng, Yin-Ming; Wu, Yong-Ping; Cao, Jun-Li			Acid Solution Is a Suitable Medium for Introducing QX-314 into Nociceptors through TRPV1 Channels to Produce Sensory-Specific Analgesic Effects	PLOS ONE			English	Article							LASTING LOCAL-ANESTHESIA; SENSING ION CHANNELS; MOLECULAR MECHANISMS; CAPSAICIN RECEPTOR; SENSITIVE METHOD; NERVE BLOCKADE; SCIATIC-NERVE; DORSAL-HORN; PAIN; MICE	Background: Previous studies have demonstrated that QX-314, an intracellular sodium channel blocker, can enter into nociceptors through capsaicin-activated TRPV1 or permeation of the membrane by chemical enhancers to produce a sensory-selective blockade. However, the obvious side effects of these combinations limit the application of QX-314. A new strategy for targeting delivery of QX-314 into nociceptors needs further investigation. The aim of this study is to test whether acidic QX-314, when dissolves in acidic solution directly, can enter into nociceptors through acid-activated TRPV1 and block sodium channels from the intracellular side to produce a sensory-specific analgesic effect. Methodology/Principal Findings: Acidic solution or noradrenaline was injected intraplantarly to induce acute pain behavior in mice. A chronic constrictive injury model was performed to induce chronic neuropathic pain. A sciatic nerve blockade model was used to evaluate the sensory-specific analgesic effects of acidic QX-314. Thermal and mechanical hyperalgesia were measured by using radiant heat and electronic von Frey filaments test. Spinal Fos protein expression was determined by immunohistochemistry. The expression of p-ERK was detected by western blot assay. Whole cell clamp recording was performed to measure action potentials and total sodium current in rats DRG neurons. We found that pH 5.0 PBS solution induced behavioral hyperalgesia accompanied with the increased expression of spinal Fos protein and p-ERK. Pretreatment with pH 5.0 QX-314, and not pH 7.4 QX-314, alleviated pain behavior, inhibited the increased spinal Fos protein and p-ERK expression induced by pH 5.0 PBS or norepinephrine, blocked sodium currents and abolished the production of action potentials evoked by current injection. The above effects were prevented by TRPV1 channel inhibitor SB366791, but not by ASIC channel inhibitor amiloride. Furthermore, acidic QX-314 employed adjacent to the sciatic nerve selectively blocked the sensory but not the motor functions in naive and CCI mice. Conclusions/Significance: Acid solution is a suitable medium for introducing QX-314 into nociceptors through TRPV1 channels to produce a sensory-specific analgesic effect.	[Liu, He; Zhang, Hong-Xing; Hou, Hui-Yan; Lu, Xian-Fu; Wei, Jing-Qiu; Wang, Chun-Guang; Zhang, Li-Cai; Zeng, Yin-Ming; Cao, Jun-Li] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Peoples R China; [Wu, Yong-Ping; Cao, Jun-Li] Jiangsu Prov Key Lab Anesthesia & Analgesia Appli, Xuzhou, Peoples R China; [Zeng, Yin-Ming; Cao, Jun-Li] Xuzhou Med Coll, Affiliated Hosp, Dept Anesthesiol, Xuzhou, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Liu, H (corresponding author), Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Peoples R China.	caojl0310@yahoo.com.cn	Liu, He/C-9799-2012	Liu, He/0000-0002-4103-312X; Cao, Jun-Li/0000-0002-8932-4743	National Nature Science Foundation of China [81070888, 30972834]; Jiangsu Province Department of Health, Jiangsu Province, China [RC2007094]; Jiangsu Province University Graduate Student Science and Technology, Jiangsu Province, China [CX10S-031Z]; Priority Academic Program Development of Jiangsu Higher Education Institutions, Jiangsu Province, China	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Department of Health, Jiangsu Province, China; Jiangsu Province University Graduate Student Science and Technology, Jiangsu Province, China; Priority Academic Program Development of Jiangsu Higher Education Institutions, Jiangsu Province, China	The study was supported by grants from National Nature Science Foundation of China (81070888) to JLC and grant 30972834 to XFL; "Xing-Wei" project of Jiangsu Province Department of Health, Jiangsu Province, China (RC2007094) to JLC; Jiangsu Province University Graduate Student Science and Technology Innovation Project, Jiangsu Province, China (CX10S-031Z) to HL. The Project was also Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, Jiangsu Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banik RK, 2001, NEUROSCI LETT, V299, P21, DOI 10.1016/S0304-3940(00)01770-5; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Binshtok AM, 2009, ANESTHESIOLOGY, V111, P127, DOI 10.1097/ALN.0b013e3181a915e7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUTTERWORTH JF, 1990, ANESTHESIOLOGY, V72, P711, DOI 10.1097/00000542-199004000-00022; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Coggeshall RE, 2005, PROG NEUROBIOL, V77, P299, DOI 10.1016/j.pneurobio.2005.11.002; Davies JW, 2010, BRIT J ANAESTH, V104, P596, DOI 10.1093/bja/aeq067; Drizin I, 2006, BIOORGAN MED CHEM, V14, P4740, DOI 10.1016/j.bmc.2006.03.027; Fuchs PYN, 2001, PAIN, V90, P15, DOI 10.1016/S0304-3959(00)00381-X; Gao Yong-Jing, 2009, Open Pain J, V2, P11; Gerner P, 2008, ANESTHESIOLOGY, V109, P872, DOI 10.1097/ALN.0b013e31818958f7; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Jhaveri MD, 2005, EUR J NEUROSCI, V22, P361, DOI 10.1111/j.1460-9568.2005.04227.x; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; Kim HY, 2010, PAIN, V150, P29, DOI 10.1016/j.pain.2010.02.016; Kissin I, 2008, ANESTH ANALG, V107, P271, DOI 10.1213/ane.0b013e318162cfa3; Leffler A, 2006, NEUROSCIENCE, V139, P699, DOI 10.1016/j.neuroscience.2005.12.020; LESZCZYNSKA K, 1992, J PHARMACOL TOXICOL, V27, P85, DOI 10.1016/1056-8719(92)90026-W; Levine JD, 2007, BBA-MOL BASIS DIS, V1772, P989, DOI 10.1016/j.bbadis.2007.01.008; Lim TKY, 2007, ANESTHESIOLOGY, V107, P305, DOI 10.1097/01.anes.0000270758.77314.b4; Munglani R, 1996, BRIT J ANAESTH, V76, P1; Pilcher J E, 1886, Ann Surg, V3, P51; Ries CR, 2009, ANESTHESIOLOGY, V111, P122, DOI 10.1097/ALN.0b013e3181a9160e; Sagie I, 2010, P NATL ACAD SCI USA, V107, P3740, DOI 10.1073/pnas.0911542107; Schwarz SKW, 2010, ANESTHESIOLOGY, V113, P438, DOI 10.1097/ALN.0b013e3181dfd31b; STRICHARTZ G, 1976, ANESTHESIOLOGY, V45, P421, DOI 10.1097/00000542-197610000-00012; Ugawa S, 2002, J CLIN INVEST, V110, P1185, DOI 10.1172/JCI200215709	30	13	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e29395	10.1371/journal.pone.0029395	http://dx.doi.org/10.1371/journal.pone.0029395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	22216270	Green Submitted, Green Published, gold			2022-12-27	WOS:000300676300054
J	Goel, N; Banks, S; Lin, L; Mignot, E; Dinges, DF				Goel, Namni; Banks, Siobhan; Lin, Ling; Mignot, Emmanuel; Dinges, David F.			Catechol-O-Methyltransferase Val158Met Polymorphism Associates with Individual Differences in Sleep Physiologic Responses to Chronic Sleep Loss	PLOS ONE			English	Article							PREDICTS INTERINDIVIDUAL DIFFERENCES; VAL(108/158) MET GENOTYPE; LOW ACTIVITY ALLELE; BIPOLAR DISORDER; DOSE-RESPONSE; VAL(158)MET POLYMORPHISM; DAYTIME SLEEPINESS; PARKINSON-DISEASE; COMT; SCHIZOPHRENIA	Background: The COMT Val158Met polymorphism modulates cortical dopaminergic catabolism, and predicts individual differences in prefrontal executive functioning in healthy adults and schizophrenic patients, and associates with EEG differences during sleep loss. We assessed whether the COMT Val158Met polymorphism was a novel marker in healthy adults of differential vulnerability to chronic partial sleep deprivation (PSD), a condition distinct from total sleep loss and one experienced by millions on a daily and persistent basis. Methodology/Principal Findings: 20 Met/Met, 64 Val/Met, and 45 Val/Val subjects participated in a protocol of two baseline 10h time in bed (TIB) nights followed by five consecutive 4 h TIB nights. Met/Met subjects showed differentially steeper declines in non-REM EEG slow-wave energy (SWE)-the putative homeostatic marker of sleep drive-during PSD, despite comparable baseline SWE declines. Val/Val subjects showed differentially smaller increases in slow-wave sleep and smaller reductions in stage 2 sleep during PSD, and had more stage 1 sleep across nights and a shorter baseline REM sleep latency. The genotypes, however, did not differ in performance across various executive function and cognitive tasks and showed comparable increases in subjective and physiological sleepiness in response to chronic sleep loss. Met/Met genotypic and Met allelic frequencies were higher in whites than African Americans. Conclusions/Significance: The COMT Val158Met polymorphism may be a genetic biomarker for predicting individual differences in sleep physiology-but not in cognitive and executive functioning-resulting from sleep loss in a healthy, racially-diverse adult population of men and women. Beyond healthy sleepers, our results may also provide insight for predicting sleep loss responses in patients with schizophrenia and other psychiatric disorders, since these groups repeatedly experience chronically-curtailed sleep and demonstrate COMT-related treatment responses and risk factors for symptom exacerbation.	[Goel, Namni; Banks, Siobhan; Dinges, David F.] Univ Penn, Sch Med, Dept Psychiat, Div Sleep & Chronobiol, Philadelphia, PA 19104 USA; [Lin, Ling; Mignot, Emmanuel] Stanford Univ, Howard Hughes Med Inst, Dept Psychiat & Behav Sci, Ctr Narcolepsy, Stanford, CA 94305 USA	University of Pennsylvania; Howard Hughes Medical Institute; Stanford University	Goel, N (corresponding author), Univ Penn, Sch Med, Dept Psychiat, Div Sleep & Chronobiol, Philadelphia, PA 19104 USA.	goel@mail.med.upenn.edu	Dinges, David/P-7183-2019; Banks, Siobhan/L-2149-2013	Banks, Siobhan/0000-0002-7489-0929; Goel, Namni/0000-0003-2602-1996	National Space Biomedical Research Institute through National Aeronautics and Space Administration (NASA) [NCC 9-58]; National Institutes of Health [NR004281, NS-23724]; Cancer Therapy and Research Center [UL1RR024134]; Institute for Translational Medicine and Therapeutics' (ITMAT); National Center for Research Resources [UL1RR024134]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS023724, P50NS023724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR004281] Funding Source: NIH RePORTER	National Space Biomedical Research Institute through National Aeronautics and Space Administration (NASA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Therapy and Research Center; Institute for Translational Medicine and Therapeutics' (ITMAT); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This research was supported by National Space Biomedical Research Institute through National Aeronautics and Space Administration (NASA) (NCC 9-58), National Institutes of Health (NR004281) and Cancer Therapy and Research Center (UL1RR024134) grants awarded to DFD, by the National Institutes of Health (NS-23724) grant to EM and by a grant from the Institute for Translational Medicine and Therapeutics' (ITMAT) Transdisciplinary Program in Translational Medicine and Therapeutics awarded to NG. The project described was supported in part by grant number UL1RR024134 from the National Center for Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. EM is a Howard Hughes Medical Institute Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hendy A, 2006, J SOC GYNECOL INVEST, V13, P136, DOI 10.1016/j.jsgi.2005.10.007; Banks S, 2010, SLEEP, V33, P1013, DOI 10.1093/sleep/33.8.1013; Barnett JH, 2007, MOL PSYCHIATR, V12, P502, DOI 10.1038/sj.mp.4001973; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Baune BT, 2008, NEUROPSYCHOPHARMACOL, V33, P924, DOI 10.1038/sj.npp.1301462; BEERSMA DGM, 1995, J SLEEP RES, V4, P23, DOI 10.1111/j.1365-2869.1995.tb00147.x; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Benedetti F, 2010, EUR PSYCHIAT, V25, P476, DOI 10.1016/j.eurpsy.2009.12.007; Benedetti F, 2010, J AFFECT DISORDERS, V125, P341, DOI 10.1016/j.jad.2010.01.005; Benedetti F, 2010, J AFFECT DISORDERS, V121, P68, DOI 10.1016/j.jad.2009.05.017; Bodenmann S, 2009, CLIN PHARMACOL THER, V85, P296, DOI 10.1038/clpt.2008.222; Bodenmann S, 2010, SLEEP, V33, P1027, DOI 10.1093/sleep/33.8.1027; Bodenmann S, 2009, J NEUROSCI, V29, P10855, DOI 10.1523/JNEUROSCI.1427-09.2009; Craddock N, 2001, BIPOLAR DISORD, V3, P284, DOI 10.1034/j.1399-5618.2001.30604.x; Dauvilliers Y., 2002, Pharmacogenomics Journal, V2, P65, DOI 10.1038/sj.tpj.6500088; Dauvilliers Y, 2001, MOL PSYCHIATR, V6, P367, DOI 10.1038/sj.mp.4000911; Dennis NA, 2010, CEREB CORTEX, V20, P672, DOI 10.1093/cercor/bhp132; Dickinson D, 2009, NEUROSCIENCE, V164, P72, DOI 10.1016/j.neuroscience.2009.05.014; Drake CL, 2001, PSYCHOPHYSIOLOGY, V38, P979, DOI 10.1111/1469-8986.3860979; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; FEINBERG I, 1979, PSYCHOPHYSIOLOGY, V16, P283, DOI 10.1111/j.1469-8986.1979.tb02991.x; Frauscher B, 2004, SLEEP, V27, P733, DOI 10.1093/sleep/27.4.733; Goel N, 2010, NEUROLOGY, V75, P1509, DOI 10.1212/WNL.0b013e3181f9615d; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Goel N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005874; Goghari VM, 2008, SCHIZOPHR RES, V103, P186, DOI 10.1016/j.schres.2008.05.015; Groeger JA, 2008, SLEEP, V31, P1159; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Li T, 1997, PHARMACOGENETICS, V7, P349, DOI 10.1097/00008571-199710000-00002; Mikolajczyk E, 2010, BRAIN RES, V1307, P142, DOI 10.1016/j.brainres.2009.10.035; Mollicone DJ, 2010, AVIAT SPACE ENVIR MD, V81, P735, DOI 10.3357/ASEM.2756.2010; O'Hara R, 2006, NEUROSCI LETT, V409, P205, DOI 10.1016/j.neulet.2006.09.047; Ohara K, 1998, NEUROREPORT, V9, P1305, DOI 10.1097/00001756-199805110-00009; Retey JV, 2007, CLIN PHARMACOL THER, V81, P692, DOI 10.1038/sj.clpt.6100102; Rissling I, 2006, SLEEP, V29, P108; Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x; Spronk D, 2011, J AFFECT DISORDERS, V128, P41, DOI 10.1016/j.jad.2010.06.021; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Wirgenes KV, 2010, SCHIZOPHR RES, V122, P31, DOI 10.1016/j.schres.2010.05.007; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Zhang ZZ, 2009, J NEURAL TRANSM, V116, P1193, DOI 10.1007/s00702-009-0260-7	44	39	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2011	6	12							e29283	10.1371/journal.pone.0029283	http://dx.doi.org/10.1371/journal.pone.0029283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SB	22216231	Green Submitted, Green Published, gold			2022-12-27	WOS:000300674900023
J	Kohler, D; Birk, P; Konig, K; Straub, A; Eldh, T; Morote-Garcia, JC; Rosenberger, P				Koehler, David; Birk, Philipp; Koenig, Klemens; Straub, Andreas; Eldh, Therese; Morote-Garcia, Julio C.; Rosenberger, Peter			Phosphorylation of Vasodilator-Stimulated Phosphoprotein (VASP) Dampens Hepatic Ischemia-Reperfusion Injury	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; PLATELET-NEUTROPHIL COMPLEXES; LIVER IN-VIVO; ISCHEMIA/REPERFUSION INJURY; PROSTAGLANDIN E-1; MOUSE-LIVER; RAT-LIVER; ACTIVATION; PROTECTS; ADHESION	Recent work has demonstrated that the formation of platelet neutrophil complexes (PNCs) affects inflammatory tissue injury. Vasodilator-stimulated phosphoprotein (VASP) is crucially involved into the control of PNC formation and myocardial reperfusion injury. Given the clinical importance of hepatic IR injury we pursued the role of VASP during hepatic ischemia followed by reperfusion. We report here that VASP(-/-) animals demonstrate reduced hepatic IR injury compared to wildtype (WT) controls. This correlated with serum levels of lactate dehydrogenase (LDH), aspartate (AST) and alanine (ALT) aminotransferase and the presence of PNCs within ischemic hepatic tissue and could be confirmed using repression of VASP through siRNA. In studies employing bone marrow chimeric mice we identified hematopoietic VASP to be of crucial importance for the extent of hepatic injury. Phosphorylation of VASP on Ser(153) through Prostaglandin E1 or on Ser(235) through atrial natriuretic peptide resulted in a significant reduction of hepatic IR injury. This was associated with a reduced presence of PNCs in ischemic hepatic tissue. Taken together, these studies identified VASP and VASP phosphorylation as crucial target for future hepatoprotective strategies.	[Koehler, David; Birk, Philipp; Straub, Andreas; Morote-Garcia, Julio C.; Rosenberger, Peter] Univ Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Koenig, Klemens; Rosenberger, Peter] Goethe Univ Frankfurt, Univ Hosp Frankfurt Main, Clin Anesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany; [Eldh, Therese] Univ Hosp, Dept Radiat Oncol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Kohler, D (corresponding author), Univ Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany.	peter.rosenberger@medizin.uni-tuebingen.de			Deutsche Forschungsgemeinschaft (DFG) [DFG-RO 3671/4-1, DFG-RO 3671/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a grant to P.R. from the Deutsche Forschungsgemeinschaft (DFG; grant number DFG-RO 3671/4-1 and DFG-RO 3671/5-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz PM, 2009, J CELL SCI; BILZER M, 1994, GASTROENTEROLOGY, V106, P143, DOI 10.1016/S0016-5085(94)94961-1; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Chen HJ, 2008, J BIOL CHEM, V283, P4439, DOI 10.1074/jbc.M709439200; Comerford KM, 2002, FASEB J; Cywes R, 1996, Liver Transpl Surg, V2, P23, DOI 10.1002/lt.500020106; FISHBEIN MC, 1981, AM HEART J, V101, P593, DOI 10.1016/0002-8703(81)90226-X; Gerwig T, 2003, J HEPATOL, V39, P341, DOI 10.1016/S0168-8278(03)00240-X; Hafez T, 2007, J SURG RES, V138, P88, DOI 10.1016/j.jss.2006.05.009; Hart ML, 2008, AM J PHYSIOL-GASTR L, V294, pG1431, DOI 10.1152/ajpgi.00083.2008; Hauser W, 1999, P NATL ACAD SCI USA, V96, P8120, DOI 10.1073/pnas.96.14.8120; Henes J, 2009, FASEB J, V23, P4244, DOI 10.1096/fj.09-138693; Hossain MA, 1999, BRIT J SURG, V86, P776, DOI 10.1046/j.1365-2168.1999.01098.x; Ibarra-Alvarado C, 2002, MOL PHARMACOL, V61, P312, DOI 10.1124/mol.61.2.312; JAESCHKE H, 1993, HEPATOLOGY, V17, P915, DOI 10.1016/0270-9139(93)90169-N; Khandoga A, 2002, SHOCK, V18, P529, DOI 10.1097/00024382-200212000-00008; Khandoga A, 2002, TRANSPLANTATION, V74, P681, DOI 10.1097/00007890-200209150-00016; Kiemer AK, 2002, HEPATOLOGY, V35, P88, DOI 10.1053/jhep.2002.30080; Kobayashi K, 2007, WORLD J GASTROENTERO, V13, P3487, DOI 10.3748/wjg.v13.i25.3487; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Kohler D, 2011, CIRCULATION; Kohler D, 2011, CIRCULATION IN PRESS; Kornerup KN, 2010, J APPL PHYSIOL, V109, P758, DOI 10.1152/japplphysiol.01086.2009; Kulhanek-Heinze S, 2004, J HEPATOL, V41, P414, DOI 10.1016/j.jhep.2004.05.017; Montalvo-Jave EE, 2008, J SURG RES, V147, P153, DOI 10.1016/j.jss.2007.06.015; Natori S, 1997, TRANSPLANTATION, V64, P1514, DOI 10.1097/00007890-199712150-00002; Peters MJ, 1999, BRIT J HAEMATOL, V106, P391, DOI 10.1046/j.1365-2141.1999.01553.x; Straub A, 2011, ARTERIOSCL THROM VAS, V31, P1607, DOI 10.1161/ATVBAHA.111.226373; Sugawara Y, 1998, J HEPATOL, V29, P969, DOI 10.1016/S0168-8278(98)80125-6; Vollmar B, 1997, LIVER, V17, P93; Walsh KB, 2009, EXP CLIN TRANSPLANT, V7, P78; WANG JH, 1995, AM J PHYSIOL-GASTR L, V269, pG297, DOI 10.1152/ajpgi.1995.269.2.G297; Weissmuller T, 2008, J CLIN INVEST, V118, P3682, DOI 10.1172/JCI35874; Xu YQ, 2006, AM J PHYSIOL-HEART C, V290, pH692, DOI 10.1152/ajpheart.00634.2005; Yadav SS, 1999, HEPATOLOGY, V29, P1494, DOI 10.1002/hep.510290505; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499	36	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29494	10.1371/journal.pone.0029494	http://dx.doi.org/10.1371/journal.pone.0029494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216296	gold, Green Published, Green Submitted			2022-12-27	WOS:000299684700062
J	Larsen, C; Chaix, ML; Le Strat, Y; Velter, A; Gervais, A; Auperin, I; Alric, L; Duval, X; Miailhes, P; Pioche, C; Pol, S; Piroth, L; Delarocque-Astagneau, E				Larsen, Christine; Chaix, Marie-Laure; Le Strat, Yann; Velter, Annie; Gervais, Anne; Auperin, Isabelle; Alric, Laurent; Duval, Xavier; Miailhes, Patrick; Pioche, Corinne; Pol, Stanislas; Piroth, Lionel; Delarocque-Astagneau, Elisabeth		Steering Comm HEPAIG Study	Gaining Greater Insight into HCV Emergence in HIV-Infected Men Who Have Sex with Men: The HEPAIG Study	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INJECTION-DRUG USERS; POSITIVE MEN; HOMOSEXUAL-MEN; TRANSMISSION; PREVALENCE; INCREASE; REINFECTION; OUTBREAK; THERAPY	Objectives: The HEPAIG study was conducted to better understand Hepatitis C virus (HCV) transmission among human immuno-deficiency (HIV)-infected men who have sex with men (MSM) and assess incidence of HCV infection among this population in France. Methods and Results: Acute HCV infection defined by anti-HCV or HCV ribonucleic acid (RNA) positivity within one year of documented anti-HCV negativity was notified among HIV-infected MSM followed up in HIV/AIDS clinics from a nationwide sampling frame. HIV and HCV infection characteristics, HCV potential exposures and sexual behaviour were collected by the physicians and via self-administered questionnaires. Phylogenetic analysis of the HCV-NS5B region was conducted. HCV incidence was 48/10 000 [95% Confidence Interval (CI): 43-54] and 36/10 000 [ 95% CI: 30-42] in 2006 and 2007, respectively. Among the 80 men enrolled (median age: 40 years), 55% were HIV-diagnosed before 2000, 56% had at least one sexually transmitted infection in the year before HCV diagnosis; 55% were HCV-infected with genotype 4 (15 men in one 4d-cluster), 32.5% with genotype 1 (three 1a-clusters); five men were HCV re-infected; in the six-month preceding HCV diagnosis, 92% reported having casual sexual partners sought online (75.5%) and at sex venues (79%), unprotected anal sex (90%) and fisting (65%); using recreational drugs (62%) and bleeding during sex (55%). Conclusions: This study emphasizes the role of multiple unprotected sexual practices and recreational drugs use during sex in the HCV emergence in HIV-infected MSM. It becomes essential to adapt prevention strategies and inform HIV-infected MSM with recent acute HCV infection on risk of re-infection and on risk-reduction strategies.	[Larsen, Christine; Le Strat, Yann; Velter, Annie; Pioche, Corinne; Delarocque-Astagneau, Elisabeth] Natl Inst Publ Hlth Surveillance InVS, St Maurice, France; [Chaix, Marie-Laure] Univ Paris 05, EA 3620, Dept Virol, APHP, Paris, France; [Gervais, Anne] Hop Xavier Bichat, Hepatol Dept, Paris, France; [Auperin, Isabelle] Community Hosp, Dept Internal Med, Montreuil, France; [Alric, Laurent] Univ Toulouse 3, Digest Dept, F-31062 Toulouse, France; [Duval, Xavier] Hop Xavier Bichat, Dept Infect Dis, Paris, France; [Miailhes, Patrick] Croix Rousse Hosp, Dept Infect Dis, Hosp Civiles Lyon, Lyon, France; [Pol, Stanislas] Univ Paris 05, Cochin Hosp, Assistance Publ Hop Paris, Inserm U1016,Liver Unit, Paris, France; [Piroth, Lionel] Univ Hosp, Dept Infect Dis, Dijon, France; [Delarocque-Astagneau, Elisabeth] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France	Institute of Public Health Surveillance; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; CHU Dijon Bourgogne; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Larsen, C (corresponding author), Natl Inst Publ Hlth Surveillance InVS, St Maurice, France.	c.larsen@invs.sante.fr	delarocque-astagneau, elisabeth/E-4706-2016; Le Strat, Yann/C-9848-2013	delarocque-astagneau, elisabeth/0000-0002-5129-9300; Le Strat, Yann/0000-0002-6180-4200	French Ministry of Health	French Ministry of Health	This study was performed within the surveillance activities of the Institut de veille sanitaire which is funded by the French Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron S, 2008, CLIN INFECT DIS, V47, P931, DOI 10.1086/591699; Albert M, 2011, AIDS, V25, P399, DOI 10.1097/QAD.0b013e328343443b; Briat A, 2005, AIDS, V19, P1827, DOI 10.1097/01.aids.0000189847.98569.2d; Browne R, 2004, SEX TRANSM INFECT, V80, P326, DOI 10.1136/sti.2003.008532; Cotte L, 2009, GASTROEN CLIN BIOL, V33, P977, DOI 10.1016/j.gcb.2009.06.011; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Danta M, 2008, J INFECT DIS, V197, P1558, DOI 10.1086/587843; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; den Hollander G, 2005, AIDS, V19, P639, DOI 10.1097/01.aids.0000163947.24059.68; Dore GJ, 2010, GASTROENTEROLOGY, V138, P123, DOI 10.1053/j.gastro.2009.09.019; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; Fierer DS, 2008, J INFECT DIS, V198, P683, DOI 10.1086/590430; Fierer Daniel S., 2011, Morbidity and Mortality Weekly Report, V60, P945; Gambotti L, 2005, Euro Surveill, V10, P115, DOI 10.2807/esm.10.05.00535-en; Giraudon I, 2008, SEX TRANSM INFECT, V84, P111, DOI 10.1136/sti.2007.027334; Gotz HM, 2005, AIDS, V19, P969, DOI 10.1097/01.aids.0000171412.61360.f8; Grebely J, 2010, J GASTROEN HEPATOL, V25, P1281, DOI 10.1111/j.1440-1746.2010.06238.x; Jin FY, 2010, SEX TRANSM INFECT, V86, P25, DOI 10.1136/sti.2009.038182; Lambers F, 2011, AIDS; Larsen C, 2008, Euro Surveill, V13; Lefrere JJ, 2004, J CLIN MICROBIOL, V42, P2027, DOI 10.1128/JCM.42.5.2027-2030.2004; Leobon A, 2011, AIDS CARE, V23, P25, DOI 10.1080/09540121.2010.498866; Macias J, 2008, LIVER INT, V28, P781, DOI 10.1111/j.1478-3231.2008.01688.x; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Matthews GV, 2011, CLIN INFECT DIS, V52, P803, DOI 10.1093/cid/ciq200; McGovern BH, 2009, CLIN INFECT DIS, V49, P1051, DOI 10.1086/605561; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Piroth L, 2010, HEPATOLOGY, V52, P1915, DOI 10.1002/hep.23959; Rauch A, 2005, CLIN INFECT DIS, V41, P395, DOI 10.1086/431486; Richardson D, 2008, J INFECT DIS, V197, P1213, DOI 10.1086/533454; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Russell M, 2009, AM J PUBLIC HEALTH, V99, pS173, DOI 10.2105/AJPH.2007.126383; Schmidt AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017781; Serpaggi J, 2006, AIDS, V20, P233, DOI 10.1097/01.aids.0000200541.40633.56; Thomson EC, 2011, GUT, V60, P837, DOI 10.1136/gut.2010.217166; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; Vandelli C, 2004, AM J GASTROENTEROL, V99, P855, DOI 10.1111/j.1572-0241.2004.04150.x	39	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2011	6	12							e29322	10.1371/journal.pone.0029322	http://dx.doi.org/10.1371/journal.pone.0029322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884DI	22216248	Green Published, gold, Green Submitted			2022-12-27	WOS:000299684700047
J	Burkhardt, NY; Baldridge, GD; Williamson, PC; Billingsley, PM; Heu, CC; Felsheim, RF; Kurtti, TJ; Munderloh, UG				Burkhardt, Nicole Y.; Baldridge, Gerald D.; Williamson, Phillip C.; Billingsley, Peggy M.; Heu, Chan C.; Felsheim, Roderick F.; Kurtti, Timothy J.; Munderloh, Ulrike G.			Development of Shuttle Vectors for Transformation of Diverse Rickettsia Species	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ANAPLASMA-PHAGOCYTOPHILUM; TRANSPOSON MUTAGENESIS; ESCHERICHIA-COLI; COPY-NUMBER; PROWAZEKII; EXPRESSION; GENE; IDENTIFICATION; MONACENSIS	Plasmids have been identified in most species of Rickettsia examined, with some species maintaining multiple different plasmids. Three distinct plasmids were demonstrated in Rickettsia amblyommii AaR/SC by Southern analysis using plasmid specific probes. Copy numbers of pRAM18, pRAM23 and pRAM32 per chromosome in AaR/SC were estimated by real-time PCR to be 2.0, 1.9 and 1.3 respectively. Cloning and sequencing of R. amblyommii AaR/SC plasmids provided an opportunity to develop shuttle vectors for transformation of rickettsiae. A selection cassette encoding rifampin resistance and a fluorescent marker was inserted into pRAM18 yielding a 27.6 kbp recombinant plasmid, pRAM18/Rif/GFPuv. Electroporation of Rickettsia parkeri and Rickettsia bellii with pRAM18/Rif/GFPuv yielded GFPuv-expressing rickettsiae within 2 weeks. Smaller vectors, pRAM18dRG, pRAM18dRGA and pRAM32dRGA each bearing the same selection cassette, were made by moving the parA and dnaA-like genes from pRAM18 or pRAM32 into a vector backbone. R. bellii maintained the highest numbers of pRAM18dRGA (13.3 - 28.1 copies), and R. parkeri, Rickettsia monacensis and Rickettsia montanensis contained 9.9, 5.5 and 7.5 copies respectively. The same species transformed with pRAM32dRGA maintained 2.6, 2.5, 3.2 and 3.6 copies. pRM, the plasmid native to R. monacensis, was still present in shuttle vector transformed R. monacensis at a level similar to that found in wild type R. monacensis after 15 subcultures. Stable transformation of diverse rickettsiae was achieved with a shuttle vector system based on R. amblyommii plasmids pRAM18 and pRAM32, providing a new research tool that will greatly facilitate genetic and biological studies of rickettsiae.	[Burkhardt, Nicole Y.; Baldridge, Gerald D.; Heu, Chan C.; Felsheim, Roderick F.; Kurtti, Timothy J.; Munderloh, Ulrike G.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; [Williamson, Phillip C.; Billingsley, Peggy M.] Univ N Texas Hlth Sci Ctr, Dept Forens & Invest Genet, Ft Worth, TX USA	University of Minnesota System; University of Minnesota Twin Cities; University of North Texas System; University of North Texas Health Science Center	Burkhardt, NY (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.	munde001@umn.edu		Heu, Chan/0000-0002-5235-288X	National Institutes of Health [R01 AI49424, R01 AI081690]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049424, R01AI081690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institutes of Health grants R01 AI49424 and R01 AI081690 to UM (http://www.grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldridge GD, 2005, APPL ENVIRON MICROB, V71, P2095, DOI 10.1128/AEM.71.4.2095-2105.2005; Baldridge GD, 2008, APPL ENVIRON MICROB, V74, P645, DOI 10.1128/AEM.02262-07; Baldridge GD, 2007, APPL ENVIRON MICROB, V73, P4984, DOI 10.1128/AEM.00988-07; Baldridge GD, 2010, APPL ENVIRON MICROB, V76, P1718, DOI 10.1128/AEM.02988-09; Barbet AF, 2005, GENE, V353, P89, DOI 10.1016/j.gene.2005.03.036; Blanc G, 2007, GENOME RES, V17, P1657, DOI 10.1101/gr.6742107; Clark TR, 2011, J BACTERIOL, V193, P4993, DOI 10.1128/JB.05279-11; Felsheim RF, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-42; Felsheim RF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008361; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Liu ZM, 2007, APPL ENVIRON MICROB, V73, P6644, DOI 10.1128/AEM.01727-07; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Qin AP, 2004, APPL ENVIRON MICROB, V70, P2816, DOI 10.1128/AEM.70.5.2816-2822.2004; Rachek LI, 1998, J BACTERIOL, V180, P2118, DOI 10.1128/JB.180.8.2118-2124.1998; Rachek LI, 2000, J BACTERIOL, V182, P3289, DOI 10.1128/JB.182.11.3289-3291.2000; Rahman MS, 2010, J BACTERIOL, V192, P3294, DOI 10.1128/JB.00155-10; Renesto P, 2002, MICROB PATHOGENESIS, V33, P17, DOI 10.1006/mpat.2002.0508; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Troyer JM, 1999, INFECT IMMUN, V67, P3308, DOI 10.1128/IAI.67.7.3308-3311.1999; Wood DO, 2000, INFECT IMMUN, V68, P6091, DOI 10.1128/IAI.68.11.6091-6093.2000	23	39	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29511	10.1371/journal.pone.0029511	http://dx.doi.org/10.1371/journal.pone.0029511			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216299	Green Published, gold, Green Submitted			2022-12-27	WOS:000299113600085
J	Mann, RS; Pelz-Stelinski, K; Hermann, SL; Tiwari, S; Stelinski, LL				Mann, Rajinder S.; Pelz-Stelinski, Kirsten; Hermann, Sara L.; Tiwari, Siddharth; Stelinski, Lukasz L.			Sexual Transmission of a Plant Pathogenic Bacterium, Candidatus Liberibacter asiaticus, between Conspecific Insect Vectors during Mating	PLOS ONE			English	Article							DIAPHORINA-CITRI HEMIPTERA; GREENING DISEASE; BEMISIA-TABACI; PSYLLIDAE; PCR; ACQUISITION; PROTEINS; ECOLOGY	Candidatus Liberibacter asiaticus is a fastidious, phloem-inhabiting, gram-negative bacterium transmitted by Asian citrus psyllid, Diaphorina citri Kuwayama (Hemiptera: Psyllidae). The bacterium is the presumed causal agent of huanglongbing (HLB), one of the most destructive and economically important diseases of citrus. We investigated whether Las is transmitted between infected and uninfected D. citri adults during courtship. Our results indicate that Las was sexually transmitted from Las-infected male D. citri to uninfected females at a low rate (< 4%) during mating. Sexual transmission was not observed following mating of infected females and uninfected males or among adult pairs of the same sex. Las was detected in genitalia of both sexes and also in eggs of infected females. A latent period of 7 days or more was required to detect the bacterium in recipient females. Rod shaped as well as spherical structures resembling Las were observed in ovaries of Las-infected females with transmission electron microscopy, but were absent in ovaries from uninfected D. citri females. The size of the rod shaped structures varied from 0.39 to 0.67 mm in length and 0.19 to 0.39 mm in width. The spherical structures measured from 0.61 to 0.80 mm in diameter. This investigation provides convincing evidence that a plant pathogenic bacterium is sexually transmitted from male to female insects during courtship and established evidence that bacteria persist in reproductive organs. Moreover, these findings provide an alternative sexually horizontal mechanism for the spread of Las within populations of D. citri, even in the absence of infected host trees.	[Mann, Rajinder S.; Pelz-Stelinski, Kirsten; Hermann, Sara L.; Tiwari, Siddharth; Stelinski, Lukasz L.] Univ Florida, Citrus Res & Educ Ctr, Dept Entomol & Nematol, Lake Alfred, FL USA	State University System of Florida; University of Florida	Mann, RS (corresponding author), Univ Florida, Citrus Res & Educ Ctr, Dept Entomol & Nematol, Lake Alfred, FL USA.	stelinski@ufl.edu			Citrus Research and Development Foundation Inc., Florida	Citrus Research and Development Foundation Inc., Florida	This research was supported by the Citrus Research and Development Foundation Inc., Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar E, 2011, ANN ENTOMOL SOC AM, V104, P526, DOI 10.1603/AN10134; [Anonymous], P 13 C INT ORG CITR; Aubert B., 1990, P 4 INT AS PAC CITR, P133; Bove JM, 2006, J PLANT PATHOL, V88, P7; Chen J, 2011, [植物病理学报, Acta Phytopathologica Sinica], V41, P113; Damiani C, 2008, CURR BIOL, V18, pR1087, DOI 10.1016/j.cub.2008.10.040; Damsteegt VD, 2010, PLANT DIS, V94, P528, DOI 10.1094/PDIS-94-5-0528; Dossi FCA, 2010, NEOTROP ENTOMOL, V39, P414, DOI 10.1590/S1519-566X2010000300015; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Garnier M., 1984, P 9 C INT ORG CITR V, V9, P115; Ghanim M, 2000, J VIROL, V74, P4738, DOI 10.1128/JVI.74.10.4738-4745.2000; Ghanim M, 2007, ARTHROPOD-PLANT INTE, V1, P195, DOI 10.1007/s11829-007-9018-z; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2009, J ECON ENTOMOL, V102, P446, DOI 10.1603/029.102.0158; HALL DG, 2008, TALLER INT HUANGLONG, V1, P1; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Hung TH, 2004, PLANT PATHOL, V53, P96, DOI 10.1111/j.1365-3059.2004.00948.x; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Knell RJ, 2004, BIOL REV, V79, P557, DOI 10.1017/S1464793103006365; LAFLECHE D., 1970, Fruits d'Outre Mer, V25, P455; LAFLECHE D, 1970, SCIENCES           D, V270, P1915; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Lung O, 2001, J INSECT PHYSIOL, V47, P617, DOI 10.1016/S0022-1910(00)00151-7; Manjunath KL, 2008, PHYTOPATHOLOGY, V98, P387, DOI 10.1094/PHYTO-98-4-0387; Meyer JM, 2008, FLA ENTOMOL, V91, P294, DOI 10.1653/0015-4040(2008)91[294:MSOEIF]2.0.CO;2; Moran NA, 2006, P NATL ACAD SCI USA, V103, P12803, DOI 10.1073/pnas.0605772103; Onagbola EO, 2008, MICRON, V39, P1184, DOI 10.1016/j.micron.2008.05.002; Otti O, 2009, AM NAT, V174, P292, DOI 10.1086/600099; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Raddadi N, 2011, ENVIRON MICROBIOL, V13, P414, DOI 10.1111/j.1462-2920.2010.02347.x; SAMAKOVLIS C, 1991, EMBO J, V10, P163, DOI 10.1002/j.1460-2075.1991.tb07932.x; Sechler A, 2009, PHYTOPATHOLOGY, V99, P480, DOI 10.1094/PHYTO-99-5-0480; Shokrollah H, 2010, AFR J BIOTECHNOL, V9, P5897; SHROYER DA, 1990, J MED ENTOMOL, V27, P334, DOI 10.1093/jmedent/27.3.334; Siva-Jothy MT, 2005, ADV INSECT PHYSIOL, V32, P1, DOI 10.1016/S0065-2806(05)32001-7; Tesh R.B., 1981, P122; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Wenninger EJ, 2007, FLA ENTOMOL, V90, P715, DOI 10.1653/0015-4040(2007)90[715:DTOMAA]2.0.CO;2; Wolfner MF, 2002, HEREDITY, V88, P85, DOI 10.1038/sj.hdy.6800017; Xu C.F., 1988, P 10 C INT ORG CITRU, P243	42	39	46	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29197	10.1371/journal.pone.0029197	http://dx.doi.org/10.1371/journal.pone.0029197			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216209	Green Published, gold			2022-12-27	WOS:000299113600066
J	Simoes, RD; Emmert-Streib, F				Simoes, Ricardo de Matos; Emmert-Streib, Frank			Influence of Statistical Estimators of Mutual Information and Data Heterogeneity on the Inference of Gene Regulatory Networks	PLOS ONE			English	Article							EXPRESSION DATA; ENTROPY ESTIMATION; NORMALIZATION	The inference of gene regulatory networks from gene expression data is a difficult problem because the performance of the inference algorithms depends on a multitude of different factors. In this paper we study two of these. First, we investigate the influence of discrete mutual information (MI) estimators on the global and local network inference performance of the C3NET algorithm. More precisely, we study 4 different MI estimators (Empirical, Miller-Madow, Shrink and Schurmann-Grassberger) in combination with 3 discretization methods (equal frequency, equal width and global equal width discretization). We observe the best global and local inference performance of C3NET for the Miller-Madow estimator with an equal width discretization. Second, our numerical analysis can be considered as a systems approach because we simulate gene expression data from an underlying gene regulatory network, instead of making a distributional assumption to sample thereof. We demonstrate that despite the popularity of the latter approach, which is the traditional way of studying MI estimators, this is in fact not supported by simulated and biological expression data because of their heterogeneity. Hence, our study provides guidance for an efficient design of a simulation study in the context of network inference, supporting a systems approach.	[Simoes, Ricardo de Matos; Emmert-Streib, Frank] Queens Univ Belfast, Computat Biol & Machine Learning Lab, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland	Queens University Belfast	Simoes, RD (corresponding author), Queens Univ Belfast, Computat Biol & Machine Learning Lab, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland.	v@bio-complexity.com	Conceição, Teresa/M-3449-2014; Emmert-Streib, Frank/AAF-2878-2020; da Costa, Paulo Martins/C-3080-2014; Emmert-Streib, Frank/G-8099-2011	Conceição, Teresa/0000-0002-9818-2767; Emmert-Streib, Frank/0000-0003-0745-5641; da Costa, Paulo Martins/0000-0001-6115-8811; Emmert-Streib, Frank/0000-0003-0745-5641; /0000-0001-6816-8932; de Matos Simoes, Ricardo/0000-0002-1700-5276; Antunes, Filipa/0000-0002-8472-078X; Aires-de-Sousa, Marta/0000-0001-5036-2446	Engineering and Physical Sciences Research Council (EPSRC); EPSRC [EP/H048871/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H048871/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Part of this work has been supported by the Engineering and Physical Sciences Research Council (EPSRC). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen K, 1955, AM DOCUMENTATION PRE, V6, P93, DOI [10.1002/, DOI 10.1002/ASI.5090060209]; Almudevar Anthony, 2006, NeuroRx, V3, P384, DOI 10.1016/j.nurx.2006.05.037; Alon U, 2007, INTRO SYSTEMS BIOL D; Altay G, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-31; Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bulashevska S, 2005, BIOINFORMATICS, V21, P2706, DOI 10.1093/bioinformatics/bti388; Butte A J, 2000, Pac Symp Biocomput, P418; COVER T. M., 2012, ELEMENTS INFORM THEO, DOI 10.1002/0471200611; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dehmer M, APPL STAT NETWORK BI; Dudoit S, 2008, SPRINGER SER STAT, P1; Emmert-Streib F, 2010, IET SYST BIOL, V4, P277, DOI 10.1049/iet-syb.2010.0028; Emmert-Streib F, 2011, WIRES SYST BIOL MED, V3, P379, DOI 10.1002/wsbm.134; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098; Harrell, 2010, HMISC HARRELL MISCEL; Hausser J, 2009, J MACH LEARN RES, V10, P1469; Husmeier D, 2003, BIOINFORMATICS, V19, P2271, DOI 10.1093/bioinformatics/btg313; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Khan S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026209; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; LI WT, 1990, J STAT PHYS, V60, P823, DOI 10.1007/BF01025996; Liang KC, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/253894; Liang S, 1998, Pac Symp Biocomput, P18; Luo WJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-467; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Miller GA., 1955, INF THEORY PSYCHOL P, V2, P95; Nemenman I, 2002, ADV NEURAL INFORM PR, V14, P569; Olsen C, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/308959; Palsson B O, 2006, SYSTEMS BIOL; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; R Core Team, 2021, R LANGUAGE ENV STAT; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schurmann T, 1996, CHAOS, V6, P414, DOI 10.1063/1.166191; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Sheskin D., 2011, HDB PARAMETRIC NONPA, V5th; Spirtes P., 2000, CAUSATION PREDICTION, Vsecond; Steinhoff C, 2006, BRIEF BIOINFORM, V7, P166, DOI 10.1093/bib/bbl002; Stolovitzky G, REVERSE ENG BIOL NET; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Stouffer S. A., 1949, AM SOLDIER, V1; Van den Bulcke T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-43; Verma T, 1990, P 4 WORKSH UNC ART I, P352; Vidal M, 2009, FEBS LETT, V583, P3891, DOI 10.1016/j.febslet.2009.11.024; von Bertalanffy Ludwig, 1950, BRIT J PHILOS SCI, V1, P134, DOI [DOI 10.1093/BJPS/I.2.134, 10.1093/bjps/I.2.134]; VONBERTALANFFY L, 1950, SCIENCE, V111, P23, DOI 10.1126/science.111.2872.23; Watkinson J, 2009, ANN NY ACAD SCI, V1158, P302, DOI 10.1111/j.1749-6632.2008.03757.x; Xing B, 2005, BIOINFORMATICS, V21, P4007, DOI 10.1093/bioinformatics/bti648; Yang Y, 2001, P EMCL 01 P 12 EUR C	56	74	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29279	10.1371/journal.pone.0029279	http://dx.doi.org/10.1371/journal.pone.0029279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242113	Green Published, gold, Green Submitted			2022-12-27	WOS:000300677000024
J	Wang, YL; An, LL; Jiang, YD; Hang, HY				Wang, Yulan; An, Lili; Jiang, Yuanda; Hang, Haiying			Effects of Simulated Microgravity on Embryonic Stem Cells	PLOS ONE			English	Article							MODELED MICROGRAVITY; DNA-DAMAGE; HUMAN-LYMPHOCYTES; NUCLEAR ANTIGEN; DIFFERENTIATION; PROLIFERATION; CULTURE; REPAIR; ESTABLISHMENT; SPACEFLIGHT	There have been many studies on the biological effects of simulated microgravity (SMG) on differentiated cells or adult stem cells. However, there has been no systematic study on the effects of SMG on embryonic stem (ES) cells. In this study, we investigated various effects (including cell proliferation, cell cycle distribution, cell differentiation, cell adhesion, apoptosis, genomic integrity and DNA damage repair) of SMG on mouse embryonic stem (mES) cells. Mouse ES cells cultured under SMG condition had a significantly reduced total cell number compared with cells cultured under 1 g gravity (1G) condition. However, there was no significant difference in cell cycle distribution between SMG and 1G culture conditions, indicating that cell proliferation was not impaired significantly by SMG and was not a major factor contributing to the total cell number reduction. In contrast, a lower adhesion rate cultured under SMG condition contributed to the lower cell number in SMG. Our results also revealed that SMG alone could not induce DNA damage in mES cells while it could affect the repair of radiation-induced DNA lesions of mES cells. Taken together, mES cells were sensitive to SMG and the major alterations in cellular events were cell number expansion, adhesion rate decrease, increased apoptosis and delayed DNA repair progression, which are distinct from the responses of other types of cells to SMG.	[Wang, Yulan; An, Lili; Hang, Haiying] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Wang, Yulan; An, Lili; Hang, Haiying] Chinese Acad Sci, Inst Biophys, Ctr Computat & Syst Biol, Beijing 100080, Peoples R China; [Jiang, Yuanda] Chinese Acad Sci, Ctr Space Sci & Appl Res, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences	Wang, YL (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	hh91@sun5.ibp.ac.cn	jiang, anyi/GPT-0379-2022	Huang, Yelin/0000-0002-2514-0144	Chinese Academy of Sciences [KSCX2-YW-R63]	Chinese Academy of Sciences(Chinese Academy of Sciences)	The study is supported by grants from Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-YW-R63). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Coinu R, 2006, FEBS LETT, V580, P2465, DOI 10.1016/j.febslet.2006.03.078; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; Degan P, 2005, J CELL BIOCHEM, V94, P460, DOI 10.1002/jcb.20302; Estrov Z, 2009, CLIN LYMPHOMA MYELOM, V9, pS319, DOI 10.3816/CLM.2009.s.031; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fridley KM, 2010, TISSUE ENG PT A, V16, P3285, DOI [10.1089/ten.tea.2010.0166, 10.1089/ten.TEA.2010.0166]; Guignandon A, 2001, FASEB J, V15, P2036, DOI 10.1096/fj.00-0837fje; Gundel A, 1997, J SLEEP RES, V6, P1, DOI 10.1046/j.1365-2869.1997.00028.x; Hammond TG, 2000, PHYSIOL GENOMICS, V3, P163, DOI 10.1152/physiolgenomics.2000.3.3.163; HANG HY, 2003, METH MOL B, V241, P23; Hatton DC, 2002, J APPL PHYSIOL, V92, P3, DOI 10.1152/jappl.2002.92.1.3; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Hopkins KM, 2004, MOL CELL BIOL, V24, P7235, DOI 10.1128/MCB.24.16.7235-7248.2004; JASKULSKI D, 1988, J BIOL CHEM, V263, P10175; [蒋远大 JIANG Yuanda], 2008, [航天医学与医学工程, Space Medicine & Medical Engineering], V21, P368; Kawahara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006343; Kumari R, 2009, J CELL BIOCHEM, V107, P723, DOI 10.1002/jcb.22171; Li J, 2009, PROTOPLASMA, V238, P23, DOI 10.1007/s00709-009-0068-1; LI YH, 2007, CELL PROLIFERAT, V40, P671; Lou YJ, 2011, ACTA PHARMACOL SIN, V32, P152, DOI 10.1038/aps.2010.194; MACGREGOR GR, 1995, DEVELOPMENT, V121, P1487; Makihira S, 2008, CELL BIOL INT, V32, P1176, DOI 10.1016/j.cellbi.2008.04.027; MATISE MP, 2000, GENE TARGETING, P111; Mognato M, 2005, MUTAT RES-FUND MOL M, V578, P417, DOI 10.1016/j.mrfmmm.2005.06.011; Mognato M, 2009, MUTAT RES-FUND MOL M, V663, P32, DOI 10.1016/j.mrfmmm.2009.01.002; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; Navran S, 2008, BIOTECHNOL ANN REV, V14, P275, DOI 10.1016/S1387-2656(08)00011-2; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Sarkar Devanand, 1999, Environmental Medicine (Nagoya), V43, P22; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sun LW, 2008, ACTA ASTRONAUT, V63, P968, DOI 10.1016/j.actaastro.2007.12.008; Takeda M, 2009, NEUROSCI LETT, V463, P54, DOI 10.1016/j.neulet.2009.07.045; Uva BM, 2002, EUR J HISTOCHEM, V46, P209; van Diest PJ, 1998, J CLIN PATHOL, V51, P716, DOI 10.1136/jcp.51.10.716; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; YUGE L, 2003, CELL DIFFER, V39, P89; Yuge L, 2006, STEM CELLS DEV, V15, P921, DOI 10.1089/scd.2006.15.921; Zhang CB, 2011, PROTEIN CELL, V2, P410, DOI 10.1007/s13238-011-1049-7	41	78	89	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29214	10.1371/journal.pone.0029214	http://dx.doi.org/10.1371/journal.pone.0029214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216215	gold, Green Published, Green Submitted			2022-12-27	WOS:000299113600067
J	Gupta, A; Nagilla, P; Le, HS; Bunney, C; Zych, C; Thalamuthu, A; Bar-Joseph, Z; Mathavan, S; Ayyavoo, V				Gupta, Ankit; Nagilla, Pruthvi; Le, Hai-Son; Bunney, Coulton; Zych, Courtney; Thalamuthu, Anbupalam; Bar-Joseph, Ziv; Mathavan, Sinnakaruppan; Ayyavoo, Velpandi			Comparative Expression Profile of miRNA and mRNA in Primary Peripheral Blood Mononuclear Cells Infected with Human Immunodeficiency Virus (HIV-1)	PLOS ONE			English	Article							GENE-EXPRESSION; GENOMEWIDE ASSOCIATION; DISEASE PROGRESSION; UP-REGULATION; MICRORNA; IMMUNE; IDENTIFICATION; TRANSLATION; RESISTANCE; APOPTOSIS	Host cells respond to exogenous infectious agents such as viruses, including HIV-1. Studies have evaluated the changes associated with virus infection at the transcriptional and translational levels of the cellular genes involved in specific pathways. While this approach is useful, in our view it provides only a partial view of genome-wide changes. Recently, technological advances in the expression profiling at the microRNA (miRNA) and mRNA levels have made it possible to evaluate the changes in the components of multiple pathways. To understand the role of miRNA and its interplay with host cellular gene expression (mRNA) during HIV-1 infection, we performed a comparative global miRNA and mRNA microarray using human PBMCs infected with HIV-1. The PBMCs were derived from multiple donors and were infected with virus generated from the molecular clone pNL4-3. The results showed that HIV-1 infection led to altered regulation of 21 miRNAs and 444 mRNA more than 2-fold, with a statistical significance of p<0.05. Furthermore, the differentially regulated miRNA and mRNA were shown to be associated with host cellular pathways involved in cell cycle/proliferation, apoptosis, T-cell signaling, and immune activation. We also observed a number of inverse correlations of miRNA and mRNA expression in infected PBMCs, further confirming the interrelationship between miRNA and mRNA regulation during HIV-1 infection. These results for the first time provide evidence that the miRNA profile could be an early indicator of host cellular dysfunction induced by HIV-1.	[Gupta, Ankit; Nagilla, Pruthvi; Bunney, Coulton; Zych, Courtney; Ayyavoo, Velpandi] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Le, Hai-Son; Bar-Joseph, Ziv] Carnegie Mellon Univ, Dept Machine Learning, Pittsburgh, PA 15213 USA; [Thalamuthu, Anbupalam; Mathavan, Sinnakaruppan] Genome Inst Singapore, Singapore, Singapore	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Gupta, A (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.	velpandi@pitt.edu	Bar-Joseph, Ziv/GWN-2754-2022; Thalamuthu, Anbupalam/Z-5545-2019	Thalamuthu, Anbupalam/0000-0002-7114-1260; Gupta, Amita/0000-0001-7036-2718	NIAID/NIH; ARRA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035041] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ARRA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by ARRA supplement to U01 U0-AI35041 by the NIAID/NIH to VA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Amariglio N, 2007, BLOOD CELL MOL DIS, V39, P151, DOI 10.1016/j.bcmd.2007.04.003; Asmuth DM, 2005, CYTOM PART A, V66A, P41, DOI 10.1002/cyto.a.20148; Backes C, 2010, NUCLEIC ACIDS RES, V38, P4476, DOI 10.1093/nar/gkq167; Ballana E, 2010, CLIN INFECT DIS, V50, P1022, DOI 10.1086/651114; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Barik S, 2005, J MOL MED, V83, P764, DOI 10.1007/s00109-005-0690-0; Barnes MR, 2007, EXPERT OPIN BIOL TH, V7, P1387, DOI 10.1517/14712598.7.9.1387; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Borjabad A, 2010, J NEUROIMMUNE PHARM, V5, P44, DOI 10.1007/s11481-009-9167-1; Brown JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003664; BURGENER A, CURR HIV AIDS REP, V7, P53; Carissimi C, 2009, AUTOIMMUN REV, V8, P520, DOI 10.1016/j.autrev.2009.01.008; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chan EY, 2007, J VIROL, V81, P7571, DOI 10.1128/JVI.00288-07; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Charurat M, 2004, J WOMENS HEALTH, V13, P719, DOI 10.1089/jwh.2004.13.719; Chua JH, 2009, CURR OPIN MOL THER, V11, P189; Ciccosanti F, 2010, ANTIVIR THER, V15, P377, DOI 10.3851/IMP1530; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Fabian MR, 2010, PROG MOL SUBCELL BIO, V50, P1, DOI 10.1007/978-3-642-03103-8_1; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fritz Jorg H, 2006, Sci STKE, V2006, ppe27; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Geiss GK, 2000, VIROLOGY, V266, P8, DOI 10.1006/viro.1999.0044; Gomase Virendra S, 2009, Int J Bioinform Res Appl, V5, P479, DOI 10.1504/IJBRA.2009.028678; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Herbeck JT, 2010, J INFECT DIS, V201, P618, DOI 10.1086/649842; Hirbod T, 2006, JAIDS-J ACQ IMM DEF, V43, P137, DOI 10.1097/01.qai.0000229016.85192.60; Hladik F, 2005, J VIROL, V79, P11677, DOI 10.1128/JVI.79.18.11677-11684.2005; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Huang JC, 2007, J COMPUT BIOL, V14, P550, DOI 10.1089/cmb.2007.R002; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; IMIG J, 2010, NUCL ACIDS RES; Imig J, 2011, NUCLEIC ACIDS RES, V39, P1880, DOI 10.1093/nar/gkq1043; JEANNET M, 1989, J ACQ IMMUN DEF SYND, V2, P28; Kaul D, 2009, MOL CELL BIOCHEM, V323, P143, DOI 10.1007/s11010-008-9973-4; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee JE, 2010, CELL PROLIFERAT, V43, P378, DOI 10.1111/j.1365-2184.2010.00687.x; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li QS, 2009, J IMMUNOL, V183, P1975, DOI 10.4049/jimmunol.0803222; Li Y, 2007, VIROLOGY, V366, P137, DOI 10.1016/j.virol.2007.04.020; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Liu XY, 2010, VIROLOGY, V398, P57, DOI 10.1016/j.virol.2009.11.036; Majumder B, 2005, J VIROL, V79, P7990, DOI 10.1128/JVI.79.13.7990-8003.2005; McMichael AJ, 2010, SCIENCE, V330, P1488, DOI 10.1126/science.1200035; Melendez LM, 2011, J NEUROIMMUNE PHARM, V6, P89, DOI 10.1007/s11481-010-9253-4; Mothe B, 2009, DIS MARKERS, V27, P105, DOI [10.1155/2009/360362, 10.3233/DMA-2009-0655]; Mummidi S, 1998, NAT MED, V4, P786, DOI 10.1038/nm0798-786; Narayanan A, 2011, EXPERT OPIN BIOL TH, V11, P17, DOI 10.1517/14712598.2011.540564; Nieto G, 2004, J STEROID BIOCHEM, V89-90, P199, DOI 10.1016/j.jsbmb.2004.03.086; Noorbakhsh F, 2010, FASEB J, V24, P1799, DOI 10.1096/fj.09-147819; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Paxton WA, 1998, SEMIN IMMUNOL, V10, P187, DOI 10.1006/smim.1998.0132; Poropatich K, 2011, J GEN VIROL, V92, P247, DOI 10.1099/vir.0.027102-0; Ringrose J, 2008, J VIROL, V82, P4320, DOI 10.1128/JVI.01819-07; Rotger M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000781; Ryo A, 2000, AIDS RES HUM RETROV, V16, P995, DOI 10.1089/08892220050058416; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Sundaravaradan V, 2010, VIROLOGY, V400, P32, DOI 10.1016/j.virol.2010.01.018; Sung TL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000263; Tatro ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010337; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vahey MT, 2002, AIDS RES HUM RETROV, V18, P179, DOI 10.1089/08892220252781239; Van den Bergh R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-53; van't Wout AB, 2003, J VIROL, V77, P1392, DOI 10.1128/JVI.77.2.1392-1402.2003; van 't Wout AB, 2005, J VIROL, V79, P10053, DOI 10.1128/JVI.79.15.10053-10058.2005; Venkatachari NJ, 2008, VIROLOGY, V376, P140, DOI 10.1016/j.virol.2008.03.015; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Weber J, 2003, J GEN VIROL, V84, P2217, DOI 10.1099/vir.0.19123-0; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wu JQ, 2008, VIROLOGY, V380, P124, DOI 10.1016/j.virol.2008.06.039; Xing HQ, 2009, NEUROPATHOLOGY, V29, P433, DOI 10.1111/j.1440-1789.2008.00996.x; Zaunders J, 2011, CURR OPIN HIV AIDS, V6, P151, DOI 10.1097/COH.0b013e3283454d5b; Zhang CX, 2009, CURR OPIN MOL THER, V11, P641; ZHANG L, PROTEOME SCI, V8, P12; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	81	186	189	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22730	10.1371/journal.pone.0022730	http://dx.doi.org/10.1371/journal.pone.0022730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	22220193	gold, Green Published, Green Submitted			2022-12-27	WOS:000293284600035
J	Qi, L; Li, J; Zhang, WJ; Liu, JN; Rong, CB; Li, Y; Wu, LF				Qi, Lei; Li, Jian; Zhang, WeiJia; Liu, Jiangning; Rong, Chengbo; Li, Ying; Wu, Longfei			Fur in Magnetospirillum gryphiswaldense Influences Magnetosomes Formation and Directly Regulates the Genes Involved in Iron and Oxygen Metabolism	PLOS ONE			English	Article							ESCHERICHIA-COLI; DNA-DAMAGE; HOMEOSTASIS; TRANSPORT; GROWTH; EXPRESSION	Magnetospirillum gryphiswaldense strain MSR-1 has the unique capability of taking up large amounts of iron and synthesizing magnetosomes (intracellular magnetic particles composed of Fe3O4). The unusual high iron content of MSR-1 makes it a useful model for studying biological mechanisms of iron uptake and homeostasis. The ferric uptake regulator (Fur) protein plays a key role in maintaining iron homeostasis in many bacteria. We identified and characterized a fur-homologous gene (MGR_1314) in MSR-1. MGR_1314 was able to complement a fur mutant of E. coli in iron-responsive manner in vivo. We constructed a fur mutant strain of MSR-1. In comparison to wild-type MSR-1, the mutant strain had lower magnetosome formation, and was more sensitive to hydrogen peroxide and streptonigrin, indicating higher intracellular free iron content. Quantitative real-time RT-PCR and chromatin immunoprecipitation analyses indicated that Fur protein directly regulates expression of several key genes involved in iron transport and oxygen metabolism, in addition it also functions in magnetosome formation in M. gryphiswaldense.	[Qi, Lei; Li, Jian; Zhang, WeiJia; Liu, Jiangning; Rong, Chengbo; Li, Ying] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Qi, Lei; Li, Jian; Zhang, WeiJia; Liu, Jiangning; Rong, Chengbo; Li, Ying] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Wu, Longfei] Univ Mediterranee Aix Marseille II, CNRS, Chim Bacterienne Lab, Inst Microbiol Mediterranee, Marseille, France; [Qi, Lei; Li, Jian; Zhang, WeiJia; Liu, Jiangning; Rong, Chengbo; Li, Ying; Wu, Longfei] France China Biomineralizat & Nanostruct Lab, Beijing, Peoples R China	China Agricultural University; China Agricultural University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Qi, L (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	yingli528@vip.sina.com	Zhang, Xingding/C-8780-2014	Zhang, Xingding/0000-0002-2759-5185	Chinese High Technology Research and Development Program [2007AA021805]; Chinese National Natural Science Foundation [30870043, 30970041]	Chinese High Technology Research and Development Program(National High Technology Research and Development Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	Chinese High Technology Research and Development Program (Grant No. 2007AA021805), and Chinese National Natural Science Foundation (Grants No. 30870043 and 30970041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Braun V, 1998, MET IONS BIOL SYST, V35, P67; Collas P, 2010, MOL BIOTECHNOL, V45, P87, DOI 10.1007/s12033-009-9239-8; Elgrably-Weiss M, 2002, J BACTERIOL, V184, P3774, DOI 10.1128/JB.184.14.3774-3784.2002; Escolar L, 1998, J MOL BIOL, V283, P537, DOI 10.1006/jmbi.1998.2119; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; FRANKEL RB, 1979, SCIENCE, V203, P1355, DOI 10.1126/science.203.4387.1355; GREGORY EM, 1973, J BACTERIOL, V114, P1193, DOI 10.1128/JB.114.3.1193-1197.1973; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; HANTKE K, 1987, MOL GEN GENET, V210, P135, DOI 10.1007/BF00337769; HASSETT DJ, 1987, J BIOL CHEM, V262, P13404; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kitphati W, 2007, APPL ENVIRON MICROB, V73, P4760, DOI 10.1128/AEM.00531-07; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lang C, 2009, APPL ENVIRON MICROB, V75, P4206, DOI 10.1128/AEM.02906-08; [李峰 Li Feng], 2004, [微生物学报, Acta Microbiologica Sinica], V44, P440; NIEDERHOFFER EC, 1990, J BACTERIOL, V172, P1930, DOI 10.1128/jb.172.4.1930-1938.1990; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Rong CB, 2008, RES MICROBIOL, V159, P530, DOI 10.1016/j.resmic.2008.06.005; Schuler D, 1998, J BACTERIOL, V180, P159; Schuler D, 1996, ARCH MICROBIOL, V166, P301, DOI 10.1007/s002030050387; Sun JB, 2008, APPL MICROBIOL BIOT, V79, P389, DOI 10.1007/s00253-008-1453-y; Suzuki T, 2006, J BACTERIOL, V188, P2275, DOI 10.1128/JB.188.6.2275-2279.2006; Suzuki T, 2007, FEBS LETT, V581, P3443, DOI 10.1016/j.febslet.2007.06.047; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Uebe R, 2010, J BACTERIOL, V192, P4192, DOI 10.1128/JB.00319-10; WHITE JR, 1982, BIOCHEM BIOPH RES CO, V106, P407, DOI 10.1016/0006-291X(82)91125-1; Wilson TJG, 1998, MOL MICROBIOL, V28, P961, DOI 10.1046/j.1365-2958.1998.00852.x; Woodmansee AN, 2002, J BIOL CHEM, V277, P34055, DOI 10.1074/jbc.M203977200; Yijun H, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1247, DOI 10.1134/S0006297907110119	32	88	90	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29572	10.1371/journal.pone.0029572	http://dx.doi.org/10.1371/journal.pone.0029572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	23071649	gold, Green Published, Green Submitted			2022-12-27	WOS:000301070200034
J	Simoes, RR; Aires-de-Sousa, M; Conceicao, T; Antunes, F; da Costa, PM; de Lencastre, H				Simoes, Romeo Rocha; Aires-de-Sousa, Marta; Conceicao, Teresa; Antunes, Filipa; da Costa, Paulo Martins; de Lencastre, Herminia			High Prevalence of EMRSA-15 in Portuguese Public Buses: A Worrisome Finding	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; PCR STRATEGY; COMMUNITY; STRAINS; CLONE; MRSA; TRANSPORT; INFECTIONS; EMERGENCE	Background: The nosocomial prevalence of methicillin resistant Staphylococcus aureus (MRSA) in Portugal remains one of highest in Europe and is currently around 50%. Transmission of S. aureus, including MRSA, occurs principally by direct human-to-human skin contact. However, S. aureus can survive for long periods on inanimate objects, which may represent an important reservoir for dissemination as well. Methodology/Principal Findings: Between May 2009 and February 2010, handrails of 85 public urban buses circulating in Oporto, Portugal, were screened for the occurrence of MRSA. Twenty-two (26%) buses showed MRSA contamination. The molecular characterization of a total of 55 MRSA, by pulsed-field gel electrophoresis (PFGE), staphylococcal cassette chromosome (SCC) mec typing, spa typing, and multilocus sequence typing (MLST), clustered the isolates into three clonal types. However, the overwhelming majority (n = 50; 91%) of the isolates belonged to a single clone (PFGE A, spa types t747, t032, t025 or t020, ST22, SCCmec type IVh) that exhibits the characteristics of the pandemic EMRSA-15, currently the major lineage circulating in Portuguese hospitals, namely in the Oporto region. Two additional clones were found but in much lower numbers: (i) PFGE B, ST5, spa type t002, SCCmec IVa (n = 3), and (ii) PFGE C, spa type t008, ST8, SCCmec IVa (n = 2). None of the 55 isolates was PVL positive. Conclusions/Significance: Public buses in Oporto seem to be an important reservoir of MRSA of nosocomial origin, providing evidence that the major hospital-associated MRSA clone in Portugal is escaping from the primary ecological niche of hospitals to the community environment. Infection control measures are urgently warranted to limit the spread of EMRSA-15 to the general population and future studies are required to assess the eventual increase of MRSA in the Portuguese community, which so far remains low.	[Simoes, Romeo Rocha; Conceicao, Teresa; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Simoes, Romeo Rocha; Antunes, Filipa; da Costa, Paulo Martins] Univ Porto, Inst Ciencias Biomed Abel Salazar, Oporto, Portugal; [Aires-de-Sousa, Marta] Escola Super Saude Cruz Vermelha Portuguesa, Lisbon, Portugal; [da Costa, Paulo Martins] CIIMAR Ctr Interdisciplinar Invest Marinha & Ambi, Oporto, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Universidade Nova de Lisboa; Universidade do Porto; Universidade do Porto; Rockefeller University	Simoes, RR (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal.	lencash@mail.rockefeller.edu	Conceição, Teresa/M-3449-2014; Emmert-Streib, Frank/AAF-2878-2020; da Costa, Paulo Martins/C-3080-2014; Emmert-Streib, Frank/G-8099-2011	Conceição, Teresa/0000-0002-9818-2767; Emmert-Streib, Frank/0000-0003-0745-5641; da Costa, Paulo Martins/0000-0001-6115-8811; Emmert-Streib, Frank/0000-0003-0745-5641; /0000-0001-6816-8932; de Matos Simoes, Ricardo/0000-0002-1700-5276; Antunes, Filipa/0000-0002-8472-078X; Aires-de-Sousa, Marta/0000-0001-5036-2446	European Community [TROCAR-HEALTH-F3-2008-223031, 095/BI-BI/2010]; EPSRC [EP/H048871/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H048871/1] Funding Source: researchfish	European Community(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was partially supported by Project TROCAR (TROCAR-HEALTH-F3-2008-223031) from the European Community to HL and by grant 095/BI-BI/2010 from the same Project to T. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Aires-De-Sousa M, 2007, APPL ENVIRON MICROB, V73, P3845, DOI 10.1128/AEM.00019-07; Allen KD, 1997, J HOSP INFECT, V35, P307, DOI 10.1016/S0195-6701(97)90225-5; Amorim ML, 2007, J CLIN MICROBIOL, V45, P2881, DOI 10.1128/JCM.00603-07; Bocher S, 2010, J ANTIMICROB CHEMOTH, V65, P717, DOI 10.1093/jac/dkq001; Cars O, 2001, LANCET, V357, P1851, DOI 10.1016/S0140-6736(00)04972-2; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; Clinical and Laboratory Standards Institute, 2018, METHODS DILUTION ANT, VEleventh; Conceicao T, 2011, EUR J CLIN MICROBIOL, V30, P293, DOI 10.1007/s10096-010-1087-8; Conceicao T, 2010, EUR J CLIN MICROBIOL, V29, P543, DOI 10.1007/s10096-010-0892-4; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; Faria NA, 2008, J CLIN MICROBIOL, V46, P136, DOI 10.1128/JCM.01684-07; Gonzalez BE, 2006, INFECT CONT HOSP EP, V27, P1051, DOI 10.1086/507923; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Kassem II, 2009, LETT APPL MICROBIOL, V48, P268, DOI 10.1111/j.1472-765X.2008.02518.x; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Manning N, 2004, J HOSP INFECT, V56, P250, DOI 10.1016/j.jhin.2003.12.021; McAdams RM, 2008, PEDIATR INT, V50, P810, DOI 10.1111/j.1442-200X.2008.02646.x; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Mollaghan AM, 2010, EPIDEMIOL INFECT, V138, P673, DOI 10.1017/S0950268810000191; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Neely AN, 2000, J CLIN MICROBIOL, V38, P724, DOI 10.1128/JCM.38.2.724-726.2000; O'Brien FG, 2004, J CLIN MICROBIOL, V42, P3185, DOI 10.1128/JCM.42.7.3185-3190.2004; Otter JA, 2009, LETT APPL MICROBIOL, V49, P803, DOI 10.1111/j.1472-765X.2009.02728.x; RAMALHINHO I, EVOLUCAO CONSUMO ANT; Roline CE, 2007, PREHOSP EMERG CARE, V11, P241, DOI 10.1080/10903120701205125; Sa-Leao R, 1999, J CLIN MICROBIOL, V37, P1913; Sa-Leao R, 2001, MICROB DRUG RESIST, V7, P237, DOI 10.1089/10766290152652783; Sexton JD, 2010, AM J INFECT CONTROL, V38, P368, DOI 10.1016/j.ajic.2010.01.004; Stepanovic S, 2008, LETT APPL MICROBIOL, V47, P339, DOI 10.1111/j.1472-765X.2008.02436.x; Tavares DA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-110; Tolba O, 2007, AM J INFECT CONTROL, V35, P342, DOI 10.1016/j.ajic.2006.10.015; Udo EE, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-31	36	74	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17630	10.1371/journal.pone.0017630	http://dx.doi.org/10.1371/journal.pone.0017630			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	22242113	Green Published, Green Submitted, gold			2022-12-27	WOS:000287933300037
J	Hu, AYC; Tseng, YF; Weng, TC; Liao, CC; Wu, J; Chou, AH; Chao, HJ; Gu, AN; Chen, J; Lin, SC; Hsiao, CH; Wu, SC; Chong, P				Hu, Alan Yung-Chih; Tseng, Yu-Fen; Weng, Tsai-Chuan; Liao, Chien-Chun; Wu, Johnson; Chou, Ai-Hsiang; Chao, Hsin-Ju; Gu, Anna; Chen, Janice; Lin, Su-Chen; Hsiao, Chia-Hsin; Wu, Suh-Chin; Chong, Pele			Production of Inactivated Influenza H5N1 Vaccines from MDCK Cells in Serum-Free Medium	PLOS ONE			English	Article							SCALE MICROCARRIER CULTURE; VIRUS PRODUCTION; ANIMAL-CELLS; VERO CELLS; RABIES VACCINE; WHOLE VIRUS; CULTIVATION; BIOREACTOR; SYSTEM; GROWTH	Background: Highly pathogenic influenza viruses pose a constant threat which could lead to a global pandemic. Vaccination remains the principal measure to reduce morbidity and mortality from such pandemics. The availability and surging demand for pandemic vaccines needs to be addressed in the preparedness plans. This study presents an improved high-yield manufacturing process for the inactivated influenza H5N1 vaccines using Madin-Darby canine kidney (MDCK) cells grown in a serum-free (SF) medium microcarrier cell culture system. Principal Finding: The current study has evaluated the performance of cell adaptation switched from serum-containing (SC) medium to several commercial SF media. The selected SF medium was further evaluated in various bioreactor culture systems for process scale-up evaluation. No significant difference was found in the cell growth in different sizes of bioreactors studied. In the 7.5 L bioreactor runs, the cell concentration reached to 2.3x10(6) cells/mL after 5 days. The maximum virus titers of 1024 Hemagglutinin (HA) units/50 mu L and 7.1 +/- 0.3x10(8) pfu/mL were obtained after 3 days infection. The concentration of HA antigen as determined by SRID was found to be 14.1 mu g/mL which was higher than those obtained from the SC medium. A mouse immunogenicity study showed that the formalin-inactivated purified SF vaccine candidate formulated with alum adjuvant could induce protective level of virus neutralization titers similar to those obtained from the SC medium. In addition, the H5N1 viruses produced from either SC or SF media showed the same antigenic reactivity with the NIBRG14 standard antisera. Conclusions: The advantages of this SF cell-based manufacturing process could reduce the animal serum contamination, the cost and lot-to-lot variation of SC medium production. This study provides useful information to manufacturers that are planning to use SF medium for cell-based influenza vaccine production.	[Hu, Alan Yung-Chih; Tseng, Yu-Fen; Weng, Tsai-Chuan; Liao, Chien-Chun; Wu, Johnson; Chou, Ai-Hsiang; Chao, Hsin-Ju; Gu, Anna; Chen, Janice; Lin, Su-Chen; Hsiao, Chia-Hsin; Wu, Suh-Chin; Chong, Pele] Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan, Taiwan; [Wu, Suh-Chin] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Chong, Pele] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; China Medical University Taiwan	Hu, AYC (corresponding author), Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan, Taiwan.	pelechong@nhri.org.tw	Chong, Pele/E-3855-2010; Hu, Alan Yung-Chih/G-3708-2011; Wu, Suh-Chin/AAV-6233-2021		Taiwan Pandemic Influenza Vaccine Research and Development Program [DOH95-DC-1408]	Taiwan Pandemic Influenza Vaccine Research and Development Program	This study was funded by the Taiwan Pandemic Influenza Vaccine Research and Development Program (Grant no. DOH95-DC-1408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler M, 2000, BIOTECHNOL PROGR, V16, P854, DOI 10.1021/bp000110+; Croughan MS, 2000, BIOTECHNOL BIOENG, V67, P841, DOI 10.1002/(SICI)1097-0290(20000320)67:6<841::AID-BIT19>3.0.CO;2-K; FISHBEIN DB, 1993, VACCINE, V11, P1390, DOI 10.1016/0264-410X(93)90167-V; Frazatti-Gallina NM, 2004, VACCINE, V23, P511, DOI 10.1016/j.vaccine.2004.06.014; Genzel Y, 2006, VACCINE, V24, P6074, DOI 10.1016/j.vaccine.2006.05.023; Genzel Y, 2006, VACCINE, V24, P3261, DOI 10.1016/j.vaccine.2006.01.019; Genzel Y, 2004, VACCINE, V22, P2202, DOI 10.1016/j.vaccine.2003.11.041; Genzel Y, 2009, EXPERT REV VACCINES, V8, P1681, DOI [10.1586/erv.09.128, 10.1586/ERV.09.128]; Hu AYC, 2008, VACCINE, V26, P5736, DOI 10.1016/j.vaccine.2008.08.015; Kistner O, 1999, WIEN KLIN WOCHENSCHR, V111, P207; Kistner O, 1998, VACCINE, V16, P960, DOI 10.1016/S0264-410X(97)00301-0; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Liu J, 2009, VACCINE, V27, P6460, DOI 10.1016/j.vaccine.2009.06.024; Merten O W, 2002, Dev Biol (Basel), V111, P233; Merten OW, 2000, CYTOTECHNOLOGY, V34, P181, DOI 10.1023/A:1008160817560; Merten OW, 1999, CYTOTECHNOLOGY, V30, pIX; Minor PD, 2009, VACCINE, V27, P2907, DOI 10.1016/j.vaccine.2009.02.064; Nerome K, 1999, Dev Biol Stand, V98, P53; Rourou S, 2007, VACCINE, V25, P3879, DOI 10.1016/j.vaccine.2007.01.086; Toriniwa H, 2007, BIOLOGICALS, V35, P221, DOI 10.1016/j.biologicals.2007.02.002; Tree JA, 2001, VACCINE, V19, P3444, DOI 10.1016/S0264-410X(01)00053-6; van der Pol L, 1998, TRENDS BIOTECHNOL, V16, P323, DOI 10.1016/S0167-7799(98)01209-8; WOOD JM, 1977, J BIOL STAND, V5, P237, DOI 10.1016/S0092-1157(77)80008-5; WOOD JM, 1989, VIROLOGY, V171, P214, DOI 10.1016/0042-6822(89)90528-X; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA; Wright PF, 2008, NEW ENGL J MED, V358, P2540, DOI 10.1056/NEJMp0803650; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; ZHANG S, 1992, J BIOTECHNOL, V25, P289, DOI 10.1016/0168-1656(92)90162-3	29	88	102	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e14578	10.1371/journal.pone.0014578	http://dx.doi.org/10.1371/journal.pone.0014578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	22216221	Green Published, Green Submitted, gold			2022-12-27	WOS:000286523400002
J	Li, ZF; Yang, YQ; Xie, DF; Zhu, LF; Zhang, ZG; Lin, WX				Li, Zhen-Fang; Yang, Yan-Qiu; Xie, Dong-Feng; Zhu, Lan-Fang; Zhang, Zi-Guan; Lin, Wen-Xiong			Identification of Autotoxic Compounds in Fibrous Roots of Rehmannia (Rehmannia glutinosa Libosch.)	PLOS ONE			English	Article							SEEDLING GROWTH; POPULATIONS; GERMINATION; PATHOGENS; EXTRACTS	Rehmannia is a medicinal plant in China. Autotoxicity has been reported to be one of the major problems hindering the consecutive monoculture of Rehmannia. However, potential autotoxins produced by the fibrous roots are less known. In this study, the autotoxicity of these fibrous roots was investigated. Four groups of autotoxic compounds from the aqueous extracts of the fibrous roots were isolated and characterized. The ethyl acetate extracts of these water-soluble compounds were further analyzed and separated into five fractions. Among them, the most autotoxic fraction (Fr 3) was subjected to GC/MS analysis, resulting in 32 identified compounds. Based on literature, nine compounds were selected for testing their autotoxic effects on radicle growth. Seven out of the nine compounds were phenolic, which significantly reduced radicle growth in a concentration-dependent manner. The other two were aliphatic compounds that showed a moderate inhibition effect at three concentrations. Concentration of these compounds in soil samples was determined by HPLC. Furthermore, the autotoxic compounds were also found in the top soil of the commercially cultivated Rehmannia fields. It appears that a close link exists between the autotoxic effects on the seedlings and the compounds extracted from fibrous roots of Rehmannia.	[Li, Zhen-Fang; Yang, Yan-Qiu; Xie, Dong-Feng; Zhu, Lan-Fang; Zhang, Zi-Guan; Lin, Wen-Xiong] Fujian Agr & Forestry Univ, Agroecol Inst, Fuzhou, Peoples R China	Fujian Agriculture & Forestry University	Li, ZF (corresponding author), Fujian Agr & Forestry Univ, Agroecol Inst, Fuzhou, Peoples R China.	wenxiong181@163.com			National Natural Science Foundation of China [30772729]; Provincial Natural Science Foundation of Fujian, China [2008J0051]; key discipline program of Fujian Province, China [20020F012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Fujian, China(Natural Science Foundation of Fujian Province); key discipline program of Fujian Province, China	This work was supported by The National Natural Science Foundation of China (No. 30772729), Provincial Natural Science Foundation of Fujian, China (No. 2008J0051), and the key discipline program of Fujian Province, China (grant No. 20020F012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogatek R, 2006, BIOL PLANTARUM, V50, P156, DOI 10.1007/s10535-005-0094-6; Canals RM, 2005, J THEOR BIOL, V235, P402, DOI 10.1016/j.jtbi.2005.01.020; Chon SU, 2005, J AGRON CROP SCI, V191, P75, DOI 10.1111/j.1439-037X.2004.00138.x; Chon SU, 2004, AGRON J, V96, P1673, DOI 10.2134/agronj2004.1673; Chou CH, 1976, J CHEM ECOL, V2, P353, DOI 10.1007/BF00988282; Cui YY, 2000, PLANT CELL TISS ORG, V62, P219, DOI 10.1023/A:1006412321864; Du Jia-fang, 2009, Shengtaixue Zazhi, V28, P445; Einhellig FA, 1996, AGRON J, V88, P886, DOI 10.2134/agronj1996.00021962003600060007x; Gao WW, 2006, CHINA J CHINESE MAT, V31, P1665; Hao ZP, 2007, SCI HORTIC-AMSTERDAM, V112, P315, DOI 10.1016/j.scienta.2006.12.030; Kalinova J, 2007, J AGR FOOD CHEM, V55, P6453, DOI 10.1021/jf070795u; Kong CH, 1999, J CHEM ECOL, V25, P2347, DOI 10.1023/A:1020882109682; Li Jing, 2010, Zhongguo Zhong Yao Za Zhi, V35, P1679; Lin WX, 2000, ALLELOPATHY J, V7, P215; Liu HY, 2006, J N CHINA AGR, V21, P131; Manici LM, 2003, PLANT SOIL, V256, P315, DOI 10.1023/A:1026103001592; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010; Wilson S, 2004, SCI HORTIC-AMSTERDAM, V102, P221, DOI 10.1016/j.scienta.2004.01.001; Wu HW, 2007, PLANT SOIL, V296, P85, DOI 10.1007/s11104-007-9292-7; [解红娥 XIE Hong'e], 2007, [山西农业科学, Journal of Shanxi Agricultural Sciences], V35, P59; Yu JQ, 2000, PLANT SOIL, V223, P149, DOI 10.1023/A:1004829512147; Zhang ZC, 2008, ARCH VIROL, V153, P595, DOI 10.1007/s00705-007-0002-9; Zhao HJ, 2007, PLANT GROWTH REGUL, V51, P255, DOI 10.1007/s10725-007-9167-1; Zhao YJ, 2005, ALLELOPATHY J, V15, P67	24	93	116	7	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e28806	10.1371/journal.pone.0028806	http://dx.doi.org/10.1371/journal.pone.0028806			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235251	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400012
J	Kim, J; Cho, YA; Choi, IJ; Lee, YS; Kim, SY; Shin, A; Cho, SJ; Kook, MC; Nam, JH; Ryu, KW; Lee, JH; Kim, YW				Kim, Jeongseon; Cho, Young Ae; Choi, Il Ju; Lee, Yeon-Su; Kim, Sook-Young; Shin, Aesun; Cho, Soo-Jeong; Kook, Myeong-Cherl; Nam, Ji Hyung; Ryu, Keun Won; Lee, Jun Ho; Kim, Young-Woo			Effects of Interleukin-10 Polymorphisms, Helicobacter pylori Infection, and Smoking on the Risk of Noncardia Gastric Cancer	PLOS ONE			English	Article							CYTOKINE GENE POLYMORPHISMS; MESSENGER-RNA; INFLAMMATION; ASSOCIATION; CARCINOMA; IL-10; CARCINOGENESIS; METAANALYSIS; EXPRESSION; DISEASES	Objective: Both variations in the interleukin-10 (IL10) gene and environmental factors are thought to influence inflammation and gastric carcinogenesis. Therefore, we investigated the associations between IL10 polymorphisms, Helicobacter pylori (H. pylori) infection, and smoking in noncardia gastric carcinogenesis in Koreans. Methods: We genotyped three promoter polymorphisms (-1082A>G, -819T>C, and -592 A>C) of IL10 in a case-control study of 495 noncardia gastric cancer patients and 495 sex-and age-matched healthy controls. Multiple logistic regression models were used to detect the effects of IL10 polymorphisms, H. pylori infection, and smoking on the risk of gastric cancer, which was stratified by the histological type of gastric cancer. Results: The IL10-819C and -592C alleles were found to have complete linkage disequilibrium, and all three IL10 polymorphisms were associated with an increased risk of intestinal-type noncardia gastric cancer. These associations were observed only in H. pylori-positive subjects and current smokers. A statistically significant interaction between the IL10-592 genotype and H. pylori infection on the risk of intestinal-type gastric cancer was observed (P for interaction = 0.047). In addition, H. pylori-positive smokers who were carriers of either the IL10-1082G (OR [95% CI] = 17.76 [6.17-51.06]) or the -592C (OR [95% CI] = 8.37 [2.79-25.16]) allele had an increased risk of intestinal-type gastric cancer compared to H. pylorinegative nonsmokers homozygous for IL10-1082A and -592A, respectively. The interaction between the IL10-1082 polymorphism and the combined effects of H. pylori infection and smoking tended towards significance (P for interaction = 0.080). Conclusions: Inflammation-related genetic variants may interact with H. pylori infection and smoking to increase the risk of noncardia gastric cancer, particularly the intestinal-type. These findings may be helpful in identifying individuals at an increased risk for developing noncardia gastric cancer.	[Kim, Jeongseon; Cho, Young Ae; Shin, Aesun] Natl Canc Ctr, Canc Epidemiol Branch, Goyang, South Korea; [Choi, Il Ju; Cho, Soo-Jeong; Kook, Myeong-Cherl; Ryu, Keun Won; Lee, Jun Ho; Kim, Young-Woo] Natl Canc Ctr, Ctr Gastr Canc, Goyang, South Korea; [Lee, Yeon-Su; Kim, Sook-Young] Natl Canc Ctr, Funct Genom Branch, Goyang, South Korea; [Nam, Ji Hyung] Ctr Canc Prevent & Detect, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Kim, J (corresponding author), Natl Canc Ctr, Canc Epidemiol Branch, Goyang, South Korea.	cij1224@ncc.re.kr	Shin, Aesun/E-9145-2014; Kim, Seongman/N-6910-2014; KIM, JEONGSEON/AAA-4643-2022	Shin, Aesun/0000-0002-6426-1969; Kim, Young-Woo/0000-0002-1559-9672; Kim, Hye Young/0000-0001-5978-512X; CHO, SOO-JEONG/0000-0001-7144-0589	National Cancer Center, Korea [1010190]	National Cancer Center, Korea	This study was supported by the National Cancer Center, Korea (Grant number:1010190). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger K, 1997, GUT, V40, P739, DOI 10.1136/gut.40.6.739; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Brenner H, 2002, INT J CANCER, V98, P446, DOI 10.1002/ijc.10201; Chang YW, 2002, INT J CANCER, V101, P469, DOI 10.1002/ijc.10637; CORREA P, 1992, CANCER RES, V52, P6735; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Vita F, 1999, CANCER, V86, P1936, DOI 10.1002/(SICI)1097-0142(19991115)86:10<1936::AID-CNCR9>3.0.CO;2-9; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; Epplein M, 2008, CANCER CAUSE CONTROL, V19, P869, DOI 10.1007/s10552-008-9149-2; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Garcia-Gonzalez MA, 2007, AM J GASTROENTEROL, V102, P1878, DOI 10.1111/j.1572-0241.2007.01423.x; Hamilton SR, 2000, PATHOLOGY GENETICS T; Howell WM, 2002, P NUTR SOC, V61, P447, DOI 10.1079/PNS2002186; Huang JQ, 2003, GASTROENTEROLOGY, V125, P1636, DOI 10.1053/j.gastro.2003.08.033; IWATA F, 1995, DIGEST DIS SCI, V40, P1118, DOI 10.1007/BF02064209; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamangar F, 2006, JNCI-J NATL CANCER I, V98, P1445, DOI 10.1093/jnci/djj393; Kang JM, 2009, J CLIN GASTROENTEROL, V43, P420, DOI 10.1097/MCG.0b013e318178d1d3; Kim CG, 2009, J GASTROEN HEPATOL, V24, P469, DOI 10.1111/j.1440-1746.2008.05679.x; Ko KP, 2009, J NUTR, V139, P1008, DOI 10.3945/jn.108.101865; Kraft P, 2007, HUM HERED, V63, P111, DOI 10.1159/000099183; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee JY, 2005, CANCER LETT, V225, P207, DOI 10.1016/j.canlet.2004.11.028; Levitzky YS, 2008, ATHEROSCLEROSIS, V201, P217, DOI 10.1016/j.atherosclerosis.2007.12.058; Lopez P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/838390; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x; Moy KA, 2010, CANCER EPIDEM BIOMAR, V19, P2287, DOI 10.1158/1055-9965.EPI-10-0362; Persson C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017404; Pyo CW, 2003, HUM IMMUNOL, V64, P979, DOI 10.1016/S0198-8859(03)00173-3; Rad R, 2004, GUT, V53, P1082, DOI 10.1136/gut.2003.029736; Shikata K, 2008, AM J EPIDEMIOL, V168, P1409, DOI 10.1093/aje/kwn276; Shimoyama T, 2001, J CLIN PATHOL, V54, P332, DOI 10.1136/jcp.54.4.332; Sipponen Pentti, 2002, Gastric Cancer, V5, P213, DOI 10.1007/s101200200037; Suarez A, 2003, TRANSPLANTATION, V75, P711, DOI 10.1097/01.TP.0000055216.19866.9A; Sugimoto M, 2007, J GASTROEN HEPATOL, V22, P1443, DOI 10.1111/j.1440-1746.2006.04613.x; Szkaradkiewicz A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/901564; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; Wu HY, 2009, CANCER EPIDEM BIOMAR, V18, P1945, DOI 10.1158/1055-9965.EPI-09-0250; Wu MS, 2003, INT J CANCER, V104, P617, DOI 10.1002/ijc.10987; Wu MS, 2005, CANCER EPIDEM BIOMAR, V14, P1878, DOI 10.1158/1055-9965.EPI-04-0792; Yamaoka Y, 1997, GUT, V41, P442, DOI 10.1136/gut.41.4.442; Yim JY, 2007, HELICOBACTER, V12, P333, DOI 10.1111/j.1523-5378.2007.00504.x; Zambon CF, 2005, CYTOKINE, V29, P141, DOI 10.1016/j.cyto.2004.10.013; Zhou Y, 2008, EUR J CANCER, V44, P2648, DOI 10.1016/j.ejca.2008.07.017; Zhuang W, 2010, DIGEST DIS SCI, V55, P1525, DOI 10.1007/s10620-009-0922-1	47	37	40	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29643	10.1371/journal.pone.0029643	http://dx.doi.org/10.1371/journal.pone.0029643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235320	gold, Green Published, Green Submitted			2022-12-27	WOS:000301123400082
J	Wang, YT; Huang, YL; Qiu, Q; Xin, GR; Yang, ZY; Shi, SH				Wang, Yutao; Huang, Yelin; Qiu, Qiu; Xin, Guorong; Yang, Zhongyi; Shi, Suhua			Flooding Greatly Affects the Diversity of Arbuscular Mycorrhizal Fungi Communities in the Roots of Wetland Plants	PLOS ONE			English	Article							MOLECULAR DIVERSITY; COLONIZATION; GLOMEROMYCOTA; BIODIVERSITY; SPECIFICITY; GRASSLAND; ECOSYSTEM; PATTERNS; SOILS; MODEL	The communities of arbuscular mycorrhizal fungi (AMF) colonizing the roots of three mangrove species were characterized along a tidal gradient in a mangrove swamp. A fragment, designated SSU-ITS-LSU, including part of the small subunit (SSU), the entire internal transcribed spacer (ITS) and part of the large subunit (LSU) of rDNA from samples of AMF-colonized roots was amplified, cloned and sequenced using AMF-specific primers. Similar levels of AMF diversity to those observed in terrestrial ecosystems were detected in the roots, indicating that the communities of AMF in wetland ecosystems are not necessarily low in diversity. In total, 761 Glomeromycota sequences were obtained, which grouped, according to phylogenetic analysis using the SSU-ITS-LSU fragment, into 23 phylotypes, 22 of which belonged to Glomeraceae and one to Acaulosporaceae. The results indicate that flooding plays an important role in AMF diversity, and its effects appear to depend on the degree (duration) of flooding. Both host species and tide level affected community structure of AMF, indicating the presence of habitat and host species preferences.	[Wang, Yutao; Huang, Yelin; Qiu, Qiu; Xin, Guorong; Yang, Zhongyi; Shi, Suhua] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Yutao] S China Normal Univ, Key Lab Ecol & Environm Sci Guangdong Higher Educ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; South China Normal University	Wang, YT (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	lssxgr@mail.sysu.edu.cn	jiang, anyi/GPT-0379-2022	Huang, Yelin/0000-0002-2514-0144	National Natural Science Foundation of China (NSFC) [U0633002, 30871475]; Sun Yat-sen University; Project of Science and Technology of Guangdong Province and Zhuhai City [2010B020311005, 200901022]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Sun Yat-sen University; Project of Science and Technology of Guangdong Province and Zhuhai City	This research was financially supported by the National Natural Science Foundation of China (NSFC, U0633002; 30871475), Zhang Hong-da Science Research Fund of Sun Yat-sen University, the Project of Science and Technology of Guangdong Province and Zhuhai City (2010B020311005; 200901022), and the Reserve Key Project of Sun Yat-sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Baar J, 2011, AQUAT BOT, V94, P53, DOI 10.1016/j.aquabot.2010.09.006; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Bidartondo MI, 2002, NATURE, V419, P389, DOI 10.1038/nature01054; Borowicz VA, 2001, ECOLOGY, V82, P3057; Colmer TD, 2003, PLANT CELL ENVIRON, V26, P17, DOI 10.1046/j.1365-3040.2003.00846.x; Daniell TJ, 2001, FEMS MICROBIOL ECOL, V36, P203, DOI 10.1111/j.1574-6941.2001.tb00841.x; de la Pena E, 2006, NEW PHYTOL, V169, P829, DOI 10.1111/j.1469-8137.2005.01602.x; Fitter AH, 2005, J ECOL, V93, P231, DOI 10.1111/j.0022-0477.2005.00990.x; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Helgason T, 2007, J ECOL, V95, P623, DOI 10.1111/j.1365-2745.2007.01239.x; Hijri I, 2006, MOL ECOL, V15, P2277, DOI 10.1111/j.1365-294X.2006.02921.x; Husband R, 2002, MOL ECOL, V11, P2669, DOI 10.1046/j.1365-294X.2002.01647.x; Ipsilantis I, 2007, APPL SOIL ECOL, V35, P261, DOI 10.1016/j.apsoil.2006.09.003; Juniper S, 2006, MYCORRHIZA, V16, P371, DOI 10.1007/s00572-006-0046-9; JUSTIN SHFW, 1987, NEW PHYTOL, V106, P465, DOI 10.1111/j.1469-8137.1987.tb00153.x; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Kozlowski T. T., 1984, Flooding and plant growth, P129; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Kuhn G, 2001, NATURE, V414, P745, DOI 10.1038/414745a; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Li LF, 2010, FEMS MICROBIOL ECOL, V71, P418, DOI 10.1111/j.1574-6941.2009.00815.x; Lugo A. E., 1974, Annual Review of Ecology and Systematics, V5, P39, DOI 10.1146/annurev.es.05.110174.000351; Martinez-Garcia LB, 2011, SOIL BIOL BIOCHEM, V43, P682, DOI 10.1016/j.soilbio.2010.12.006; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; McLean E., 1983, METHODS SOIL ANAL PA, V9, P199, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C12; Merryweather J, 1998, NEW PHYTOL, V138, P117, DOI 10.1046/j.1469-8137.1998.00888.x; Miller SP, 2000, NEW PHYTOL, V145, P145, DOI 10.1046/j.1469-8137.2000.00566.x; Nielsen KB, 2004, MYCOL RES, V108, P616, DOI 10.1017/S0953756204000073; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Opik M, 2003, NEW PHYTOL, V160, P581, DOI 10.1046/j.1469-8137.2003.00917.x; Opik M, 2008, NEW PHYTOL, V179, P867, DOI 10.1111/j.1469-8137.2008.02515.x; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Pi N, 2009, AQUAT BOT, V90, P222, DOI 10.1016/j.aquabot.2008.10.002; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; R Core Team, 2021, R LANGUAGE ENV STAT; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosendahl S, 2008, NEW PHYTOL, V179, P1154, DOI 10.1111/j.1469-8137.2008.02535.x; Sanders IR, 2003, TRENDS PLANT SCI, V8, P143, DOI 10.1016/S1360-1385(03)00012-8; Santos JC, 2006, NEW PHYTOL, V172, P159, DOI 10.1111/j.1469-8137.2006.01799.x; Schechter SP, 2008, MOL ECOL, V17, P3198, DOI 10.1111/j.1365-294X.2008.03828.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Sengupta A, 2002, MYCORRHIZA, V12, P169, DOI 10.1007/s00572-002-0164-y; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stockinger H, 2010, NEW PHYTOL, V187, P461, DOI 10.1111/j.1469-8137.2010.03262.x; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Sudova R, 2011, AQUAT BOT, V94, P183, DOI 10.1016/j.aquabot.2011.02.003; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vandenkoornhuyse P, 2002, MOL ECOL, V11, P1555, DOI 10.1046/j.1365-294X.2002.01538.x; Wang YT, 2010, PLANT SOIL, V331, P181, DOI 10.1007/s11104-009-0244-2; Wilde P, 2009, ENVIRON MICROBIOL, V11, P1548, DOI 10.1111/j.1462-2920.2009.01882.x; Wirsel SGR, 2004, FEMS MICROBIOL ECOL, V48, P129, DOI 10.1016/j.femsec.2004.01.006; Wubet T, 2004, NEW PHYTOL, V161, P517, DOI 10.1046/j.1469-8137.2003.00924.x	63	78	89	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24512	10.1371/journal.pone.0024512	http://dx.doi.org/10.1371/journal.pone.0024512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	22216215	Green Submitted, Green Published, gold			2022-12-27	WOS:000294803200023
J	Zhang, ZJ; Ng, R; Man, SC; Li, TYJ; Wong, W; Tan, QR; Wong, HK; Chung, KF; Wong, MT; Tsang, WKA; Yip, KC; Ziea, E; Wong, VT				Zhang, Zhang-Jin; Ng, Roger; Man, Sui Cheung; Li, Tsui Yin Jade; Wong, Wendy; Tan, Qing-Rong; Wong, Hei Kiu; Chung, Ka-Fai; Wong, Man-Tak; Tsang, Wai-Kiu Alfert; Yip, Ka-chee; Ziea, Eric; Wong, Vivian Taam			Dense Cranial Electroacupuncture Stimulation for Major Depressive Disorder-A Single-Blind, Randomized, Controlled Study	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; PLACEBO NEEDLE; ACUPUNCTURE; FLUOXETINE; MECHANISMS; BRAIN; TOLERABILITY; EXPRESSION; PROJECTION; EFFICACY	Background: Previous studies suggest that electroacupuncture possesses therapeutic benefits for depressive disorders. The purpose of this study was to determine whether dense cranial electroacupuncture stimulation (DCEAS) could enhance the antidepressant efficacy in the early phase of selective serotonin reuptake inhibitor (SSRI) treatment of major depressive disorder (MDD). Methods: In this single-blind, randomized, controlled study, patients with MDD were randomly assigned to 9-session DCEAS or noninvasive electroacupuncture (n-EA) control procedure in combination with fluoxetine (FLX) for 3 weeks. Clinical outcomes were measured using the 17-item Hamilton Depression Rating Scale (HAMD-17), Clinical Global Impression-severity (CGI-S), and Self-rating Depression Scale (SDS) as well as the response and remission rates. Results: Seventy-three patients were randomly assigned to n-EA (n = 35) and DCEAS (n = 38), of whom 34 in n-EA and 36 in DCEAS group were analyzed. DCEAS-treated patients displayed a significantly greater reduction from baseline in HAMD-17 scores at Day 3 through Day 21 and in SDS scores at Day 3 and Day 21 compared to patients receiving n-EA. DCEAS intervention also produced a higher rate of clinically significant response compared to n-EA procedure (19.4% (7/36) vs. 8.8% (3/34)). The incidence of adverse events was similar in the two groups. Conclusions: DCEAS is a safe and effective intervention that augments the antidepressant efficacy. It can be considered as an additional therapy in the early phase of SSRI treatment of depressed patients. Trail Registration:Controlled-Trials.com ISRCTN88008690	[Zhang, Zhang-Jin; Ng, Roger; Man, Sui Cheung; Li, Tsui Yin Jade; Wong, Wendy; Wong, Hei Kiu] Univ Hong Kong, LKS Fac Med, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Man-Tak; Tsang, Wai-Kiu Alfert; Yip, Ka-chee] Kowloon Hosp, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Tan, Qing-Rong] Fourth Mil Med Univ, Dept Psychiat, Xian 710032, Shaanxi, Peoples R China; [Chung, Ka-Fai] Univ Hong Kong, LKS Fac Med, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Ziea, Eric; Wong, Vivian Taam] Hosp Author, Chinese Med Sect, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Air Force Military Medical University; University of Hong Kong	Zhang, ZJ (corresponding author), Univ Hong Kong, LKS Fac Med, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China.	zhangzj@hku.hk	Wong, Wendy/H-3939-2016; zhang, zheng/HCH-9684-2022; zhang, zhang/GQZ-6804-2022	Wong, Wendy/0000-0001-8731-0498; wang, li/0000-0002-1459-3412	Food and Health Bureau of Hong Kong [06070831]	Food and Health Bureau of Hong Kong	This study was supported by Health and Health Services Research Fund (HHSRF) from Food and Health Bureau of Hong Kong (ref.No.: 06070831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell A, 2005, DRUG DISCOV TODAY, V10, P578, DOI 10.1016/S1359-6446(05)03398-2; Allen JJB, 2006, J CLIN PSYCHIAT, V67, P1665, DOI 10.4088/JCP.v67n1101; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andreescu C, 2011, J CLIN PSYCHIAT, V72, P1129, DOI 10.4088/JCP.10m06105; ARBAB MAR, 1988, J CEREBR BLOOD F MET, V8, P54, DOI 10.1038/jcbfm.1988.8; Arroll B, 2005, ANN FAM MED, V3, P449, DOI 10.1370/afm.349; Barnes Patricia M, 2004, Adv Data, P1; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Benham A, 2009, ACUPUNCT MED, V27, P65, DOI 10.1136/aim.2008.000174; Blier P, 2003, EUR NEUROPSYCHOPHARM, V13, P57, DOI 10.1016/S0924-977X(02)00173-6; BLIER P, 1994, TRENDS PHARMACOL SCI, V15, P220, DOI 10.1016/0165-6147(94)90315-8; Clark L, 2009, ANNU REV NEUROSCI, V32, P57, DOI 10.1146/annurev.neuro.31.060407.125618; Dhond RP, 2007, J ALTERN COMPLEM MED, V13, P603, DOI 10.1089/acm.2007.7040; Enck P, 2010, AUTON NEUROSCI-BASIC, V157, P68, DOI 10.1016/j.autneu.2010.03.005; Fink M, 2001, FORSCH KOMP KLAS NAT, V8, P368, DOI 10.1159/000057254; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Han JS, 2003, TRENDS NEUROSCI, V26, P17, DOI 10.1016/S0166-2236(02)00006-1; Hong CJ, 2003, J CLIN PSYCHIAT, V64, P921, DOI 10.4088/JCP.v64n0810; Huang Y, 2004, SHANGHAI ZHEN JIU ZA, V23, P5; Keller Martin B, 2002, Psychopharmacol Bull, V36 Suppl 2, P133; Kirkcaldie M, 1997, CONVULSIVE THER, V13, P83; KUBOTA K, 1988, ANAT ANZEIGER, V165, P229; Kwon YB, 2000, AM J CHINESE MED, V28, P435, DOI 10.1142/S0192415X00000519; La Marca R, 2010, CLIN SCI, V118, P537, DOI 10.1042/CS20090264; LEE HC, 1994, J GERIATR PSYCH NEUR, V7, P216, DOI 10.1177/089198879400700404; Lee HJ, 2004, AM J CHINESE MED, V32, P795, DOI 10.1142/S0192415X04002405; Li A, 2007, BRAIN RES, V1186, P171, DOI 10.1016/j.brainres.2007.10.022; Li Hong-Jie, 2011, Zhongguo Zhen Jiu, V31, P3; Simpson KL, 1997, J COMP NEUROL, V385, P135; Simpson KL, 1999, J COMP NEUROL, V411, P524, DOI 10.1002/(SICI)1096-9861(19990830)411:3<524::AID-CNE13>3.0.CO;2-X; Smith CA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004046.pub3; STARK P, 1985, J CLIN PSYCHIAT, V46, P53; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Takahashi T, 2010, NEUROSCI RES, V68, P103, DOI 10.1016/j.neures.2010.06.012; Takahashi T, 2006, J GASTROENTEROL, V41, P408, DOI 10.1007/s00535-006-1773-6; Ulett GA, 1998, BIOL PSYCHIAT, V44, P129, DOI 10.1016/S0006-3223(97)00394-6; van Dijk KRA, 2002, REV NEUROSCIENCE, V13, P257; Wang H, 2008, J AFFECT DISORDERS, V111, P125, DOI 10.1016/j.jad.2008.04.020; Yeung WF, 2011, SLEEP, V34, P807, DOI 10.5665/SLEEP.1056; Yu YWY, 2006, EUR NEUROPSYCHOPHARM, V16, P498, DOI 10.1016/j.euroneuro.2005.12.004; Zhang WJ, 2009, J ALTERN COMPLEM MED, V15, P837, DOI 10.1089/acm.2008.0607; Zhang ZJ, 2010, J AFFECT DISORDERS, V124, P9, DOI 10.1016/j.jad.2009.07.005; Zhang ZJ, 2009, J NERV MENT DIS, V197, P619, DOI 10.1097/NMD.0b013e3181b05fd1; Zhang ZJ, 2011, ECAM IN PRESS; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004; Zhou F, 2010, ACUPUNCTURE THERAPY FOR NEUROLOGICAL DISEASES: A NEUROBIOLOGICAL VIEW, P32, DOI 10.1007/978-3-642-10857-0_2	48	102	105	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29651	10.1371/journal.pone.0029651	http://dx.doi.org/10.1371/journal.pone.0029651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238631	gold, Green Submitted, Green Published			2022-12-27	WOS:000301188800023
J	Zhang, Z; Wang, WZ; Shi, ZB; Wang, L; Zhang, JX				Zhang, Zhen; Wang, Wenzhong; Shi, Zhanbiao; Wang, Li; Zhang, Jianxin			Mental Health Problems among the Survivors in the Hard-Hit Areas of the Yushu Earthquake	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HOPKINS SYMPTOM CHECKLIST-25; TRAUMATIC STRESS; ADULT SURVIVORS; PTSD CHECKLIST; GENDER; INSTRUMENTS; PREVALENCE; EXPOSURE; VICTIMS	Background: On April 14, 2010, an earthquake registering 7.1 on the Richter scale shook Qinghai Province in southwest China. The earthquake caused numerous casualties and much damage. The epicenter, Yushu County, suffered the most severe damage. As a part of the psychological relief work, the present study evaluated the mental health statuses of the people affected and identified the mental disorder risk factors related to earthquakes. Methods: Five hundred and five earthquake survivors living in Yushu County were investigated 3-4 months after the earthquake. Participant demographic data including gender, age, marital status, ethnicity, educational level, and religious beliefs were collected. The Earthquake-Specific Trauma Exposure Indicators assessed the intensity of exposure to trauma during the earthquake. The PTSD Checklist-Civilian version (PCL-C) and the Hopkins Symptoms Checklist-25 (HSCL-25) assessed the symptoms and prevalence rates of probable Posttraumatic Stress Disorder (PTSD) as well as anxiety and depression, respectively. The Perceived Social Support Scale (PSSS) evaluated subjective social support. Results: The prevalence rates of probable PTSD, anxiety, and depression were 33.7%, 43.8% and 38.6%, respectively. Approximately one fifth of participants suffered from all three conditions. Individuals who were female, felt initial fear during the earthquake, and had less social support were the most likely to have poor mental health. Conclusions: The present study revealed that there are serious mental problems among the hard-hit survivors of the Yushu earthquake. Survivors at high risk for mental disorders should be specifically considered. The present study provides useful information for rebuilding and relief work.	[Zhang, Zhen; Wang, Wenzhong; Shi, Zhanbiao; Wang, Li; Zhang, Jianxin] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS	Zhang, JX (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	zhangjx@psych.an.cn	Wong, Wendy/H-3939-2016; zhang, zheng/HCH-9684-2022; zhang, zhang/GQZ-6804-2022	Wong, Wendy/0000-0001-8731-0498; wang, li/0000-0002-1459-3412	Youth Foundation of the Institute of Psychology, CAS [Y0CX441S01]; Development Foundation of the Institute of Psychology, CAS [O9CX143014]	Youth Foundation of the Institute of Psychology, CAS; Development Foundation of the Institute of Psychology, CAS	The Youth Foundation of the Institute of Psychology, CAS (No. Y0CX441S01) and the Development Foundation of the Institute of Psychology, CAS (No. O9CX143014) supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acierno Ron, 2007, Am J Public Health, V97 Suppl 1, pS103, DOI 10.2105/AJPH.2006.087007; Altindag A, 2005, COMPR PSYCHIAT, V46, P328, DOI 10.1016/j.comppsych.2005.01.005; Armenian HK, 2000, ACTA PSYCHIAT SCAND, V102, P58, DOI 10.1034/j.1600-0447.2000.102001058.x; Basoglu M, 2004, J TRAUMA STRESS, V17, P133, DOI 10.1023/B:JOTS.0000022619.31615.e8; Bland SH, 1997, J NERV MENT DIS, V185, P188, DOI 10.1097/00005053-199703000-00008; BLUMENTHAL JA, 1987, PSYCHOSOM MED, V49, P331, DOI 10.1097/00006842-198707000-00002; Bramsen I, 2000, AM J PSYCHIAT, V157, P1115, DOI 10.1176/appi.ajp.157.7.1115; BROMET E, 1995, EPIDEMIOL REV, V17, P113, DOI 10.1093/oxfordjournals.epirev.a036166; Chen CH, 2007, COMPR PSYCHIAT, V48, P269, DOI 10.1016/j.comppsych.2006.12.003; Chen YY, 2006, J RELIG HEALTH, V45, P371, DOI 10.1007/s10943-006-9040-y; Cook J.D., 1990, J TRAUMA STRESS, V3, P541, DOI [10.1002/jts.2490030406, DOI 10.1002/JTS.2490030406, 10.1007/BF02039587]; Cox BJ, 2004, BEHAV RES THER, V42, P105, DOI 10.1016/S0005-7967(03)00105-0; David D, 1996, J TRAUMA STRESS, V9, P607, DOI 10.1002/jts.2490090316; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; DiGrande L, 2008, J TRAUMA STRESS, V21, P264, DOI 10.1002/jts.20345; Elhai JD, 2005, J TRAUMA STRESS, V18, P541, DOI 10.1002/jts.20062; Falsetti SA, 2003, J TRAUMA STRESS, V16, P391, DOI 10.1023/A:1024422220163; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Gavranidou M, 2003, DEPRESS ANXIETY, V17, P130, DOI 10.1002/da.10103; Grant DM, 2008, J ABNORM PSYCHOL, V117, P662, DOI 10.1037/a0012591; GREEN BL, 1992, J NERV MENT DIS, V180, P760, DOI 10.1097/00005053-199212000-00004; Huang L., 1996, CHIN MENT HLTH J, V10, P160; Kumar MS, 2007, AM J PUBLIC HEALTH, V97, P99, DOI 10.2105/AJPH.2005.071167; Kun P, 2009, PUBLIC HEALTH, V123, P703, DOI 10.1016/j.puhe.2009.09.017; Li HH, 2010, PSYCHOL REP, V107, P733, DOI 10.2466/03.15.20.PR0.107.6.733-739; Lilly MM, 2009, J ANXIETY DISORD, V23, P767, DOI 10.1016/j.janxdis.2009.02.015; Liu AZ, 2006, CAN J PSYCHIAT, V51, P350, DOI 10.1177/070674370605100603; Liu MX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014706; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Sharan P, 1996, AM J PSYCHIAT, V153, P556; Shi Qi-chang, 2005, Zhonghua Yufang Yixue Zazhi, V39, P229; Solomon Z, 2005, SOC PSYCH PSYCH EPID, V40, P947, DOI 10.1007/s00127-005-0973-3; Stratta P, 2012, J RELIG HLT IN PRESS; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Tsai KY, 2007, J PSYCHIATR RES, V41, P90, DOI 10.1016/j.jpsychires.2005.10.004; van Griensven F, 2006, JAMA-J AM MED ASSOC, V296, P537, DOI 10.1001/jama.296.5.537; Ventevogel P, 2007, SOC PSYCH PSYCH EPID, V42, P328, DOI 10.1007/s00127-007-0161-8; Wang L, 2009, J TRAUMA STRESS, V22, P444, DOI 10.1002/jts.20439; [王婷 WANG Ting], 2009, [中国老年学杂志, Chinese Journal of Gerontology], V29, P1272; Wang XD, 2000, AM J PSYCHIAT, V157, P1260, DOI 10.1176/appi.ajp.157.8.1260; [王相兰 WANG Xianglan], 2008, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V29, P367; Weathers F., 1993, P ANN C INT SOC TRAU; Wu KK., 2008, HONG KONG J PSYCHIAT, V18, P144; Xu JJ, 2011, INT J PSYCHIAT MED, V42, P167, DOI 10.2190/PM.42.2.e; Yu S., 2011, J SICHUAN NORMAL U S, V38, P45; Zhang YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022371; Zhang Z, 2011, PUBLIC HEALTH, V125, P293, DOI 10.1016/j.puhe.2010.12.008; Zhangs W., 1998, CHINESE J PSYCHIAT, V31, P69	50	102	105	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46449	10.1371/journal.pone.0046449	http://dx.doi.org/10.1371/journal.pone.0046449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	020RP	22238631	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500041
J	Li, Y; Farooq, M; Sheng, DL; Chandramouli, C; Lan, T; Mahajan, NK; Kini, RM; Hong, YH; Lisowsky, T; Ge, RW				Li, Yan; Farooq, Muhammad; Sheng, Donglai; Chandramouli, Chanchal; Lan, Tian; Mahajan, Nilesh K.; Kini, R. Manjunatha; Hong, Yunhan; Lisowsky, Thomas; Ge, Ruowen			Augmenter of Liver Regeneration (alr) Promotes Liver Outgrowth during Zebrafish Hepatogenesis	PLOS ONE			English	Article							HEPATIC STIMULATOR SUBSTANCE; DISULFIDE RELAY SYSTEM; MITOCHONDRIAL SULFHYDRYL OXIDASE; INTERMEMBRANE SPACE; RESPIRATORY-CHAIN; PROTEIN IMPORT; CYTOCHROME-C; GENE; HEPATOPOIETIN; YEAST	Augmenter of Liver Regeneration (ALR) is a sulfhydryl oxidase carrying out fundamental functions facilitating protein disulfide bond formation. In mammals, it also functions as a hepatotrophic growth factor that specifically stimulates hepatocyte proliferation and promotes liver regeneration after liver damage or partial hepatectomy. Whether ALR also plays a role during vertebrate hepatogenesis is unknown. In this work, we investigated the function of alr in liver organogenesis in zebrafish model. We showed that alr is expressed in liver throughout hepatogenesis. Knockdown of alr through morpholino antisense oligonucleotide (MO) leads to suppression of liver outgrowth while overexpression of alr promotes liver growth. The small-liver phenotype in alr morphants results from a reduction of hepatocyte proliferation without affecting apoptosis. When expressed in cultured cells, zebrafish Alr exists as dimer and is localized in mitochondria as well as cytosol but not in nucleus or secreted outside of the cell. Similar to mammalian ALR, zebrafish Alr is a flavin-linked sulfhydryl oxidase and mutation of the conserved cysteine in the CxxC motif abolishes its enzymatic activity. Interestingly, overexpression of either wild type Alr or enzyme-inactive Alr(C131S) mutant promoted liver growth and rescued the liver growth defect of alr morphants. Nevertheless, alr(C131S) is less efficacious in both functions. Meantime, high doses of alr MOs lead to widespread developmental defects and early embryonic death in an alr sequence-dependent manner. These results suggest that alr promotes zebrafish liver outgrowth using mechanisms that are dependent as well as independent of its sulfhydryl oxidase activity. This is the first demonstration of a developmental role of alr in vertebrate. It exemplifies that a low-level sulfhydryl oxidase activity of Alr is essential for embryonic development and cellular survival. The dose-dependent and partial suppression of alr expression through MO-mediated knockdown allows the identification of its late developmental role in vertebrate liver organogenesis.	[Li, Yan; Farooq, Muhammad; Sheng, Donglai; Chandramouli, Chanchal; Lan, Tian; Mahajan, Nilesh K.; Kini, R. Manjunatha; Hong, Yunhan; Ge, Ruowen] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Farooq, Muhammad] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Kini, R. Manjunatha] Virginia Commonwealth Univ, Med Coll Virginia, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Lisowsky, Thomas] MultiBIND Biotec GmbH, Cologne, Germany	National University of Singapore; King Saud University; Virginia Commonwealth University	Li, Y (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsgerw@nus.edu.sg	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	Singapore Biomedical Research Council [BMRC/01/1/21/18/068]; Ministry of Education [R-154-000-475-112]; NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Ministry of Education; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the Singapore Biomedical Research Council grant BMRC/01/1/21/18/068 and Ministry of Education grant R-154-000-475-112 to Dr. Ge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Cao Y, 2009, FREE RADICAL BIO MED, V47, P1057, DOI 10.1016/j.freeradbiomed.2009.07.017; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen XX, 2003, J BIOL CHEM, V278, P49022, DOI 10.1074/jbc.M304057200; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Daithankar VN, 2010, BIOCHEMISTRY-US, V49, P6737, DOI 10.1021/bi100912m; Daithankar VN, 2009, BIOCHEMISTRY-US, V48, P4828, DOI 10.1021/bi900347v; Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004; Farooq M, 2008, DEV BIOL, V317, P336, DOI 10.1016/j.ydbio.2008.02.034; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Gandhi CR, 1999, HEPATOLOGY, V29, P1435, DOI 10.1002/hep.510290522; Gandhi CR, 2009, J CELL PHYSL; Gatzidou E, 2006, WORLD J GASTROENTERO, V12, P4951, DOI 10.3748/wjg.v12.i31.4951; GHOSH C, 1994, CELL BIOL TOXICOL, V10, P167, DOI 10.1007/BF00757560; HAGIYA M, 1994, P NATL ACAD SCI USA, V91, P8142, DOI 10.1073/pnas.91.17.8142; HE FH, 1993, HEPATOLOGY, V17, P225, DOI 10.1016/0270-9139(93)90081-W; Hofhaus G, 1999, EUR J CELL BIOL, V78, P349, DOI 10.1016/S0171-9335(99)80069-7; Ilowski M, 2011, BIOCHEM BIOPH RES CO, V404, P148, DOI 10.1016/j.bbrc.2010.11.083; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kondili VG, 2005, DIGEST DIS SCI, V50, P297, DOI 10.1007/s10620-005-1598-9; Korzh S, 2001, MECH DEVELOP, V103, P137, DOI 10.1016/S0925-4773(01)00330-6; LABRECQUE DR, 1975, J PHYSIOL-LONDON, V248, P273, DOI 10.1113/jphysiol.1975.sp010973; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; Li Y, 2002, EUR J BIOCHEM, V269, P3888, DOI 10.1046/j.1432-1033.2002.03054.x; Li Y, 2000, J BIOL CHEM, V275, P37443, DOI 10.1074/jbc.M004373200; Liatsos GD, 2003, DIGEST DIS SCI, V48, P1929, DOI 10.1023/A:1026157901805; LISOWSKY T, 1995, GENOMICS, V29, P690, DOI 10.1006/geno.1995.9950; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Lisowsky T, 2001, DIGEST LIVER DIS, V33, P173, DOI 10.1016/S1590-8658(01)80074-8; Lu CR, 2002, FASEB J, V16, P90, DOI 10.1096/fj.01-0506fje; Lu J, 2002, WORLD J GASTROENTERO, V8, P353; McClure KD, 2008, DEV BIOL, V319, P68, DOI 10.1016/j.ydbio.2008.04.004; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Passeri MJ, 2009, HEPATOLOGY, V49, P443, DOI 10.1002/hep.22667; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Tanigawa K, 2000, J GASTROENTEROL, V35, P112, DOI 10.1007/s005350050023; Thasler WE, 2005, HISTOPATHOLOGY, V47, P57, DOI 10.1111/j.1365-2559.2005.02172.x; Thirunavukkarasu C, 2008, J HEPATOL, V48, P578, DOI 10.1016/j.jhep.2007.12.010; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; Wang CP, 2006, WORLD J GASTROENTERO, V12, P4859; Wang G, 1999, J BIOL CHEM, V274, P11469, DOI 10.1074/jbc.274.17.11469; Wang WZ, 2007, BIOCHEMISTRY-US, V46, P3246, DOI 10.1021/bi602499t; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wiedenmann J, 2009, IUBMB LIFE, V61, P1029, DOI 10.1002/iub.256; Yabu T, 2001, FISHERIES SCI, V67, P333, DOI 10.1046/j.1444-2906.2001.00233.x; Yang XM, 1997, SCI CHINA SER C, V40, P642, DOI 10.1007/BF02882695	52	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30835	10.1371/journal.pone.0030835	http://dx.doi.org/10.1371/journal.pone.0030835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22905149	gold, Green Published			2022-12-27	WOS:000301703800034
J	Li, YY; Zhu, RN; Qian, Y; Deng, J				Li, Yuyun; Zhu, Runan; Qian, Yuan; Deng, Jie			The Characteristics of Blood Glucose and WBC Counts in Peripheral Blood of Cases of Hand Foot and Mouth Disease in China: A Systematic Review	PLOS ONE			English	Review							ENTEROVIRUS 71; OUTBREAK; INFECTIONS; MALAYSIA; TAIWAN; MANIFESTATIONS	Background: Outbreaks of Hand Foot and Mouth Disease (HFMD) have occurred in many parts of the world especially in China. We aimed to summarize the characteristics of the levels of blood glucose and white blood cell (WBC) counts in cases of HFMD in Mainland China and Taiwan, using meta-analysis based on systematic review of published articles. Methods: We systematically reviewed published studies, from the MEDLINE and WANFANG Data, about the levels of blood glucose and WBC counts in cases of HFMD until 15(th) June 2011, and quantitatively summarized the characteristics of them using meta-analysis. Results: In total, 37 studies were included in this review. In Mainland China and Taiwan, generally, the average level of blood glucose, the prevalence of hyperglycemia, WBC counts and the prevalence of leukocytosis increased with the severity of the illness. There was no significant difference in the prevalence of leukocytosis between ANS (autonomic nervous system dysregulation)/PE (pulmonary edema) group and CNS (central nervous system) group, and in the average level of blood glucose between healthy controls and mild cases of HFMD. WBC counts in cases infected by EV71 were less than those in cases infected by CA16. Conclusions: our analyses indicated that blood glucose and WBC counts increased with the severity of HFMD disease, which would help doctors to manage patients efficiently.	[Li, Yuyun; Zhu, Runan; Qian, Yuan; Deng, Jie] Capital Inst Pediat, Virol Lab, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP)	Li, YY (corresponding author), Capital Inst Pediat, Virol Lab, Beijing, Peoples R China.	qybds1129@163.com	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abubakar S, 1999, SCAND J INFECT DIS, V31, P331, DOI 10.1080/00365549950163734; AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Ahmad K, 2000, LANCET, V356, P1338, DOI 10.1016/S0140-6736(05)74253-7; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chen JH, 2010, ACTA ACAD MEDICINAE, V32, P363; Chen WB, 2000, 5 DIAGNOSTICS; Chu PY, 2001, ARCH VIROL, V146, P589, DOI 10.1007/s007050170164; Cui LD, 2011, CHINA PRAC MED, V6, P50; Dai W, 2011, CHINESE COMMUNITY DO, V13, P88; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding NZ, 2009, VIRUS RES, V145, P157, DOI 10.1016/j.virusres.2009.06.006; Fan XC, 2009, ANHUI MED J, V30, P253; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsia SH, 2005, PEDIATR INFECT DIS J, V24, P331, DOI 10.1097/01.inf.0000157219.19674.98; Huang S, 2008, ANHUI MED J, V29, P361; Huang YF, 2003, J INFECTION, V46, P238, DOI 10.1053/jinf.2002.1117; Jiang J, 2010, J QILU NURSING, V16, P119; Kehle J, 2003, J NEUROVIROL, V9, P126, DOI 10.1080/13550280390173364; Li CC, 2002, SCAND J INFECT DIS, V34, P104, DOI 10.1080/00365540110077119; Li JM, 2009, CHIN PEDIAT EMERG ME, V16, P142; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li Q., 2010, ANHUI MED J, V31, P1410; Li SH, 2010, CHIN PECIATR EMERG M, V17, P49; Li SH, 2010, CHIN J CLIN INFECT D, V3, P337; [李玉芬 Li Yufen], 2010, [临床儿科杂志, Journal of Chinical Pediatrics], V28, P1011; Liao Y, 2010, JILIN MED J, P4075; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Liu J, 2009, ANHUI MED J, V30, P261; Liu X, 2010, CHIN J MED ULTRASOUN, V7, P1844; Liu Ying-xia, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P475; Lu CY, 2002, J MED VIROL, V67, P217, DOI 10.1002/jmv.2210; Luo LP, 2010, J N CHINA COAL MED U, V12, P356; Mai LL, 2011, CHINESE J NEW CLIN M, V4, P356; MANTEL N, 1959, J NATL CANCER I, V22, P719; [毛国顺 MAO Guoshun], 2008, [中华传染病杂志, Chinese Journal of Infections Diseases], V26, P387; [毛月燕 MAO Yue-yan], 2009, [中华传染病杂志, Chinese Journal of Infections Diseases], V27, P35; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Qian N, 2010, THESIS QINGDAO U, P17; Shen Q, 2011, J MED RES, V40, P93; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Tang LP, 2009, CHIN J M ISDIAGN, V9, P6840; Verbruggen SCAT, 2007, CLIN NUTR, V26, P677, DOI 10.1016/j.clnu.2007.08.012; Wang HC, 2010, CHINA CLIN PRAC MED, V4, P155; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wei XL, 2010, SHANDONG MED J, V50, P70; World Health Organization, 2017, GUID DRINK WAT QUAL, VFourth, DOI 10.1016/S1462-0758(00)00006-6; Yan ZW, 2011, CHIN J GEN PRACT, V10, P343; Yang T, 2010, ACTA MEDCINAE SINICA, V23, P68; Yu LX, 2011, CHIN PEDIAT EMERG ME, V18, P57; [岳保珠 Yue Baozhu], 2010, [中国全科医学, Chinese General Practice], V13, P2239; Zhang GH, 2010, CHINA CLIN PRAC MED, V4, P132; Zhang JH, 2010, CHINESE FOREIGN MED, V8, P12; Zhang Shou-Bin, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P38; Zhao H., 2008, J CLIN PEDIAT, V26, P467; Zheng NH, 2011, CHINA MODERN DOCTOR, V49, P126; Zhou AR, 2000, 5 BIOCH; [周大明 Zhou Daming], 2010, [重庆医科大学学报, Acta Universitatis Scientiae Medicinae Chongqing], V35, P1724	63	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29003	10.1371/journal.pone.0029003	http://dx.doi.org/10.1371/journal.pone.0029003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22905149	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400018
J	Li, YQ; He, ZG				Li, Yuqing; He, Zheng-Guo			The Mycobacterial LysR-Type Regulator OxyS Responds to Oxidative Stress and Negatively Regulates Expression of the Catalase-Peroxidase Gene	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATOR; PATHOGENIC MYCOBACTERIA; TUBERCULOSIS; KATG; FURA; SENSITIVITY; SMEGMATIS; MACROPHAGES; RESISTANCE; PROTEINS	Protection against oxidative stress is one of the primary defense mechanisms contributing to the survival of Mycobacterium tuberculosis in the host. In this study, we provide evidence that OxyS, a LysR-type transcriptional regulator functions as an oxidative stress response regulator in mycobacteria. Overexpression of OxyS lowers expression of the catalase-peroxidase (KatG) gene in M. smegmatis. OxyS binds directly with the katG promoter region and a conserved, GC-rich T-N-11-A motif for OxyS binding was successfully characterized in the core binding site. Interestingly, the DNA-binding activity of OxyS was inhibited by H2O2, but not by dithiothreitol. Cys25, which is situated at the DNA-binding domain of OxyS, was found to have a regulatory role for the DNA-binding ability of OxyS in response to oxidative stress. In contrast, the other three cysteine residues in OxyS do not appear to have this function. Furthermore, the mycobacterial strain over-expressing OxyS had a higher sensitivity to H2O2. Thus, OxyS responds to oxidative stress through a unique cysteine residue situated in its DNA-binding domain and negatively regulates expression of the katG gene. These findings uncover a specific regulatory mechanism for mycobacterial adaptation to oxidative stress.	[Li, Yuqing; He, Zheng-Guo] Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China.	hezhengguo@mail.hzau.edu.cn	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	National Natural Science Foundation of China [31025002, 30930003]; Fundamental Research Funds for the Central Universities [2011PY140]; Hubei Chutian Scholar Program; NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Chutian Scholar Program; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Natural Science Foundation of China (31025002, 30930003), the Fundamental Research Funds for the Central Universities (2011PY140) and Hubei Chutian Scholar Program (to Z-GH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Chen H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001602; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; DERETIC V, 1995, MOL MICROBIOL, V17, P889, DOI 10.1111/j.1365-2958.1995.mmi_17050889.x; Dhandayuthapani S, 1996, J BACTERIOL, V178, P3641, DOI 10.1128/jb.178.12.3641-3649.1996; Domenech P, 2001, MICROBES INFECT, V3, P713, DOI 10.1016/S1286-4579(01)01422-8; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Italiani VCS, 2011, J BACTERIOL, V193, P1734, DOI 10.1128/JB.01339-10; Jittawuttipoka T, 2009, J BACTERIOL, V191, P7372, DOI 10.1128/JB.00788-09; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Lee HI, 2010, J BIOCHEM, V147, P511, DOI 10.1093/jb/mvp197; Li YQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Master S, 2001, J BACTERIOL, V183, P4033, DOI 10.1128/JB.183.13.4033-4039.2001; Milano A, 2001, J BACTERIOL, V183, P6801, DOI 10.1128/JB.183.23.6801-6806.2001; Muraoka S, 2003, J MOL BIOL, V328, P555, DOI 10.1016/S0022-2836(03)00312-7; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Pagan-Ramos E, 1998, J BACTERIOL, V180, P4856; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; Sala C, 2003, J BACTERIOL, V185, P5357, DOI 10.1128/JB.185.18.5357-5362.2003; Sala C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-33; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Sreevatsan S, 1996, J CLIN MICROBIOL, V34, P2007, DOI 10.1128/JCM.34.8.2007-2010.1996; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Yu K., 1999, Tubercle and Lung Disease, V79, P191, DOI 10.1054/tuld.1998.0203; Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x; Zhang H, 2008, FEBS J, V275, P753, DOI 10.1111/j.1742-4658.2007.06241.x; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	36	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30186	10.1371/journal.pone.0030186	http://dx.doi.org/10.1371/journal.pone.0030186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22905149	Green Published, gold, Green Submitted			2022-12-27	WOS:000301454400077
